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Vascular endothelial growth factor production from epidermal keratinocytes is enhanced by
vasoactive intestinal peptide and cytokines
M Kakurai,1 N Umemoto,3 M Ohsawa,3 N Fujita,4 Y Furukawa,5 T Inoue,6 T Demitsu3 and
H Nakagawa1 1 Dermatology, Jichi Medical School, Minamikawachi-machi, Tochigi, Japan, 2
Dermatology, Jichi Medical School, Minamikawachi-machi, Tochigi, Japan, 3 Dermatology, Jichi
Medical Shool Omiya Medical Center, Saitama, Saitama, Japan, 4 Division of Endocrinology and
Metabolism, Department of Medicine, Jichi Medical School, Minamikawachi-machi, Tochigi,
Japan, 5 Division of Molecular Hematopoiesis, Center for Molecular Medicine, Jichi Medical
School, Minamikawachi-machi, Tochigi, Japan and 6 Dermatology, Akita University School of
Medicine, Akita, Akita, Japan
Vascular endothelial growth factor (VEGF) can induce angiogenesis. VEGF has been implicated in
the angiogenesis observed in psoriatic lesion. Recent evidences suggest an active role of vasoactive
intestinal peptide (VIP) in the pathogenesis of inflammatory skin disease such as psoriasis. The aim
of this study is to determine whether VIP and cytokines (IL-4/IFN-γ/TNF-α) can induce the pro-
duction of VEGF from keratinocytes. DJM-1 cells (human epidermal keratinocyte cell line) were
incubated for 6 h in the presence of VIP (10µM) and/or cytokines (1ng/ml). The concentrations of
VEGF in the supernatants were assessed by a specific enzyme-linked immunosorbent. VEGF from
VIP-and /or cytokines-treated DJM-1 cell were significantly increased compared to the control. The
combination of VIP and IFN-γ synergistically enhanced VEGF from DJM-1 cells.These results sug-
gest that several inflammatory cytokines and VIP from mast cells and nerve ending are capable of
inducing VEGF production from keratinocytes, resulting in the angiogenesis of inflammatory der-
matoses such as psoriasis. 
0003
The bicyclic monoterpene diol AGI-1140 induces angiogenic factors
MT Canning, HL Yarosh, JW Galvin, DA Brown and DB Yarosh AGI Dermatics, Freeport, NY
Angiogenesis is an important step in wound healing in skin. The bicyclic monoterpene diol AGI-
1140 (2,2-dimethyl-3-propanyldiol-norbornane) has been shown to induce nitric oxide (NO) pro-
duction in mouse melanoma cells and since NO production is an inducer of angiogenesis, we exam-
ined the ability of AGI-1140 to induce molecular markers of angiogenesis. AGI-1140 induced NO
production in both human umbilical vein and microvascular endothelial cells in a dose-dependent
manner. Treatment of endothelial cells with 500 µM AGI-1140 caused an increase in cellular inva-
sion through a reconstituted basement membrane similar to the increase produced by 100 ng/ml
vascular endothelial growth factor (VEGF), an angiogenic factor now in clinical testing. Zymographic
analysis revealed that both AGI-1140 and VEGF increases matrix metalloproteinase-2 (MMP-2;
Gelantinase A) secretion from endothelial cells. The addition of 1 ng/ml transforming growth fac-
tor β (TGF-β) to AGI-1140 further increases MMP-2 secretion, while it did not increase the secre-
tion induced by VEGF. ELISA analysis revealed that VEGF caused a substantial increase in the
expression of platelet derived growth factor (PDGF-BB), while AGI-1140 only slightly increased
PDGF-BB expression. However, AGI-1140 in combination with TGF-β increased the expression of
PDGF-BB synergistically, while the combination of VEGF and TGF-β did not further increase PDGF-
BB expression above that of VEGF alone. VEGF expression was not affected by AGI-1140 as meas-
ured by ELISA. Therefore, AGI-1140 alone stimulates some, but not all, molecular markers of angio-
genesis. 
0005
The characterization of pericytes with 3G5 antigen in angiogenesis of decubitus skin
A Gushi ,1,2 T Matsuyama2 and T Kanzaki1 1 Dermatology, Kagoshima Univercity Faculty of
Medicine, Kagoshima, Kagoshima, Japan and 2 Immunology and Medical Zoology, Kagoshima
University Faculty of Medicine, Kagoshima, Japan
It has been reported the pericyte population is heterogenous in the phenotypical markers and loca-
tions of normal and diseased tissues. Although it has been accepted that perycytes express α-SMA
or desmin, several reports showed the presence of α-SMA or desmin negative pericytes. 3G5 anti-
gen is expressed on α-SMA negative pericytes in normal skin. Additionally, HMW-MAA has been
shown as a activated pericyte marker in tumor stroma and angiogenesis. The purpose of this study
is to characterize pericyte in granulation tissues by these markers. Immunohistochemical staining
and double immunofluorescence staining were performed on sections from normal and decubitus
tissues. 3G5 positive cells, and α-SMA, desmin or HMW-MAA were exclusively present in normal
and decubitus tissues. Futhermore, the presence of interstitial 3G5 positive cells without the co-
existence of type4 collagen were found. And a part of these cells showed double positive with AS02,
which was used as a marker for fibroblast, in the papillary dermis. Our data suggest that the inter-
stitial 3G5 positive cells might be pericyte precursor cells in angiogenesis. 
0004
Vascular endothelial growth factor receptor 2 gene expression by endothelial cells is inhibited
by PPARα agonists but not by PPARγ agonists
M Meissner,1 M Stein,1 K Reisinger,1 R Kaufmann1 and J Gille2,1 1 Dept. of Dermatology, Goethe-
University, Frankfurt am Main, Germany and 2 Dept. of Molecular Biology, Max-Planck-Institute,
Bad Nauheim, Germany
Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors, mainly
implicated in the regulation of lipid and glucose homeostasis. In addition, natural and synthetic PPAR
agonists may control inflammatory processes by inhibition of distinct proinflammatory genes. As
signaling via the vascular endothelial growth factor receptor 2 (VEGFR2) pathway is critical for
angiogenic responses during chronic inflammation, we explored whether anti-inflammatory effects
of PPAR ligands could be mediated in part through diminished VEGFR2 expression. In this study,
PPARα agonists are found (WY-14643, fenofibrate) to potently inhibit endothelial VEGFR2 expres-
sion, whereas predominant PPARγ ligands (ciglitazone, 15d-PGJ2) remained without discernable
effects. Time- and concentration-dependent inhibition is demonstrated both at the level of protein
(FACS, Western blot analysis) and mRNA VEGFR2 expression (Northern blot analysis). Inhibitory
effects of PPARα agonists on transcriptional activity of the VEGFR2 promoter is conveyed by an
element located between bp −60 and −37 that contains two adjacent consensus Sp1 transcription fac-
tor binding sites. Constitutive Sp1-dependent DNA binding to this sequence is decreased by PPARα
treatment, indicating that PPARα activation may interfere with Sp1-dependent VEGFR2 transcrip-
tion. Since PPARα agonists greatly attenuate VEGF-driven capillary-like network formation as
VEGFR2-dependent endothelial cell function, anti-inflammatory effects of PPARα ligands may be
likely mediated in part via reduced VEGFR2 expression. 
0002
Normal epithelial cells modulate capillary size in a human in vitro angiogenesis model pro-
duced by the self-assembly method
M Rochon,1 CJ Roberge,1 L Germain1,2 and FA Auger1,2 1 Laboratoire des Grands Brules, Hopital
du Saint-Sacrement du CHA, Quebec, QC, Canada and 2 Departement de Chirurgie, faculte de
Medecine, Universite Laval, Quebec, QC, Canada
Epithelial cells can modulate the vascularization of their underlying stroma according to their meta-
bolic needs by secreting a multitude of soluble factors to modulate the properties of the nearby cap-
illaries. To determine the importance of epithelial cells on the organization of endothelial cells into
capillaries, a human self-assembled cutaneous angiogenesis model was used. This in vitro angio-
genesis model is devoid of exogenous or animal extracellular matrix components, and contains a
dynamic tridimensionnal capillary network responsible to external stimuli. When keratinocytes were
seeded on the surface of our in vitro model of angiogenesis, the capillaries were small (area covered
less than 50 µm2), ressembling those found in the human skin. On the other hand, when capillaries
were grown in the absence of epithelial cells, they then formed bigger capillaries (area covered
more than 50 µm2). The size of these giant capillaries can be reduced by the addition of epithelial
cells (skin, cornea, uterus) on our in vitro model of angiogenesis. The formation of the giant capil-
laries in our in vitro model devoid of keratinocytes can also be prevented by the addition of ker-
atinocyte’s conditionned media. These results demonstrate that keratinocytes do not have to be in
direct contact with the reconstructed stroma to modulate capillary size. Furthermore, such results
also emphasize the importance of soluble factors produced by keratinocytes in the homeostasis of
the microcirculation’s vessels. 
0006
Fibroblast growth factor-2 induces Lef/Tcf-dependent transcription in human endothelial cells
W Holnthoner,1 M Pillinger,1 M Groger,1 K Wolff,1 A Ashton,2 C Albanese,2 P Neumeister,2
R Pestell2 and P Petzelbauer1 1 Dermatology, Univ. of Vienna Med. School, Vienna, Austria and 2
The Albert Einstein Comprehensive Cancer Center, New York
Lef/Tcf proteins belong to a family of architectural transcription factors, which control develop-
mental processes and play an important role in oncogenesis. Classical activators of Lef/Tcf-depend-
ent transcription comprise the Wnt family of proteins, which translocate beta-catenin into the nucleus
and allow the formation of transactivation-competent Lef/Tcf/beta-catenin complexes. Here we show
that in human endothelial cells fibroblast growth factor-2 (FGF-2) reduces GSK-3 activity and aug-
ments nuclear levels of beta-catenin. FGF-2 induced Lef/Tcf-dependent transcription of a cyclin D1-
luciferase construct. Gel shift assays revealed binding of Tcf-4 as the only Lef/Tcf family member
and of beta-catenin to the Lef/Tcf site in the cyclin D1 promoter. Cotransfection with a dominant-
negative Tcf-4 construct inhibited the FGF-2-induced cyclin D1 promoter activity. Overexpression
of an uninhibitable GSK-3beta mutant resulted in partial inhibition of FGF-2-mediated cyclin D1
induction. The importance for cyclin D1 in FGF-2-induced angiogenesis in vivo is shown in cyclin
D1-/- mice, where FGF-2-induced new vessel formation was significantly reduced compared with
FGF-2-induced angiogenesis in cyclin D1+/+ mice. In conclusion, FGF-2 is a novel modulator of
Lef/Tcf/beta-catenin signaling in endothelial cells, suggesting that angiogenic properties of FGF-2
are at least in part mediated by Lef/Tcf/beta-catenin activation. 
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Vascular endothelial growth factor and psoriasis
HS Young,1,2 AM Summers,2 M Bhushan,1 PE Brenchley2 and CE Griffiths1 1 Hope Hospital,
Dermatology Centre, Salford, Manchester, United Kingdom and 2 The Manchester Institute of
Nephrology and Transplantation, Manchester Royal Infirmary, Manchester, United Kingdom
Psoriasis is associated with inappropriate vascular expansion in the upper dermis. Vascular endothe-
lial growth factor (VEGF) is a multifunctional cytokine that promotes both angiogenesis and vas-
cular permeability. VEGF is produced by epidermal keratinocytes and elevated levels are found in
plaques of psoriasis. The VEGF gene is polymorphic and located at chromosome 6p.21, close to a
known chromosomal locus for psoriasis susceptibility (PSORS1). The aim of this project was to
investigate the frequencies of two VEGF polymorphisms at −460 (in the promoter region) and at
+405 (in the 5’UTR), in patients with Type 1 (onset40 years) chronic plaque psoriasis compared
to healthy controls and to measure plasma levels of VEGF and the soluble VEGF receptor (flt1).
DNA was isolated from whole blood using Qiagen DNA kits (Qiagen Ltd UK) and VEGF geno-
typing performed by PCR–RFLP in 160 psoriatic patients and 102 healthy controls. Plasma VEGF
and flt1 levels were assayed using validated ELISA kits (R&D Systems). There were no significant
differences in genotype frequencies at the −460 or +405 sites comparing all psoriasis patients with
controls. However, patients with severe disease (defined as PASI12) showed significantly increased
frequency of the +405 CC genotype (p•0.05) and C allele (p=0.028) compared to healthy controls.
Patients with psoriasis onset between 20 and 40 years also showed significantly increased frequency
of the +405 CC genotype (p•0.015) and C allele (p=0.016) compared to healthy controls. Plasma
levels of VEGF and flt1 were significantly detectable in psoriatics compared with controls (p•0.001)
and mean plasma levels of VEGF and flt1 were markedly elevated compared with controls. In sum-
mary, we have demonstrated a significant association of the VEGF +405 CC genotype and C allele
with both severe psoriasis and age of disease onset. Plasma levels of VEGF and flt1 are increased in
patients with psoriasis. These results may imply a pathogenic role for VEGF in psoriasis. 
0008
UVB-induced skin angiogenesis is associated with a switch in the balance of vascular endothe-
lial growth factor and thrombospondin-1 expression
K Kajiya,1 K Yano,1 T Yokoyama,1 M Ishiwata1 and M Detmar2 1 Shiseido Life Science Research
Center, Yokohama, Japan and 2 Dermatology, Massachusetts General Hospital and Harvard
Medical School, Charletown, MA
We have previously shown that targeted over-expression of the endogeneous angiogenesis inhibitor
thrombospondin-1 (TSP-1) in the epidermis prevents chronic ultraviolet-B (UVB)-induced angio-
genesis and cutaneous photo-damage in mice, suggesting that angiogenesis plays a critical role in
the mediation of UVB effects on the skin. However, the molecular regulation of angiogenesis fac-
tors and inhibitors by acute UVB irradiation still remains to be elucidated. We performed quantita-
tive analyses of cutaneous vascularity and of VEGF and TSP-1 expression after acute UVB irradi-
ation of mouse skin. Skin vascularity in the upper dermis was greatly increased until day 8 after a
single dose of UVB irradiation (200 mJ/cm2), associated with up-regulation of VEGF mRNA expres-
sion and with down-regulation of TSP-1 mRNA expression in the hyperplastic epidermis. After 13
days, skin vascularity was normalized with down-regulation of VEGF mRNA expression and up-
regulation of TSP-1 mRNA expression to the levels in non-UVB irradiated skin. Double immuno-
fluorescence stains revealed pronounced induction of the TSP-1 receptor CD36 in CD31-positive
vessels at day 8 after UVB irradiation, associated with vascular endothelial cell apoptosis. These
results demonstrate that acute UVB irradiation reverses the expression balance between VEGF and
TSP-1, leading to shift towards a pro-angiogenic environment. They also suggest that both VEGF
and TSP-1 play critical roles in the control of angiogenesis induced by acute UVB irradiation. 
0009
Expression of the lymphatic-specific homeobox gene Prox1 in differentiated blood vascular
endothelium induces the lymphatic endothelial cell phenotype
Y Hong,1 N Harvey,2 Y Noh,1 V Schacht,1 S Hirakawa,1 G Oliver2 and M Detmar1 1 Cutaneous
Biology Research Center, Mass. General Hospital, Charlestown, MA and 2 Department of
Genetics, St. Jude Children, Memphis, TN
It has been previously shown that polarized expression of the homeobox gene Prox1 in a subpopu-
lation of venous endothelial cells of the embryonic cardinal vein promotes and maintains the bud-
ding of endothelial cells that will form the lymphatic vascular system. In Prox1 deficient mice,
endothelial cells fail to acquire the lymphatic phenotype; instead, they remain as blood vascular
endothelium. To investigate whether Prox1 is sufficient to induce a lymphatic fate in differentiated
blood vascular endothelium, Prox1 cDNA was ectopically expressed by adenoviral gene transfer in
primary human blood vascular endothelial cells and by transient plasmid cDNA transfection in immor-
talized microvascular endothelial cells. Transcriptional profiling combined with quantitative real-
time RT-PCR and Western blotting analyses revealed that Prox1 expression upregulated the lym-
phatic endothelial cell markers podoplanin and vascular endothelial growth factor receptor-3.
Conversely, genes such as laminin, VEGF-C, neuropilin-1 and intercellular adhesion molecule-1,
whose expression has been associated with the blood vascular endothelial cell phenotype, were down-
regulated. These results were confirmed by the use of specific antibodies against some of these mark-
ers in sections of embryonic and adult tissues. These findings validate our previous proposal that
Prox1 is a key player in the molecular pathway leading to the formation of lymphatic vasculature
and identify Prox1 as a master switch in the program specifying lymphatic endothelial cell fate. 
0010
TNFα induction of tissue factor in human dermal endothelial cells requires protein kinase CK2
activity
SA Sexton,1 KA Casper,1 FM O’Reilly,1,2 D Shugar3 and RA Swerlick1,2 1 Derm, Emory Univ
School of Med, Atlanta, GA, 2 Derm, Dept of Veterans Affairs Med Center, Decatur, GA and 3 Inst
Biochem Biophys, Polish Acad Sciences, Warsaw, Poland
Tissue factor (TF), or thromboplastin, is a cell surface receptor that serves as an initiator of blood
coagulation and has been implicated in angiogenesis and tumor growth. The regulation of TF expres-
sion in endothelial cells is not fully defined and involves multiple signaling pathways. Previous stud-
ies have suggested that NF-kB activation, a critical event in TNFα-mediated TF induction, requires
PI-3 kinase (P3K) activity. Other studies in large vessel endothelium have suggested that activation
of P3K actually inhibits TF expression. In order to address the role of P3K in TF induction in skin
microvascular endothelial cells, we examined the effect of LY294002 (LY) and wortmannin (WM),
inhibitors of the P3K pathway, on TNFα-mediated TF induction. LY pretreatment partially blocked
TNFα-mediated cell surface expression of TF in a concentration-dependent fashion. In contrast, WM
pretreatment superinduced TF expression at the protein, steady-state mRNA, and transcriptional lev-
els. Despite inhibiting TNFα-mediated increases in cell surface TF expression, LY had no effect on
TNFα-mediated increases in TF mRNA or total cell TF protein as assessed by western blot. These
data suggested that P3K activity was not essential for TNFα-mediated TF induction in HDMEC.
Previous studies have suggested that LY is also an inhibitor of protein kinase CK2 (CK2), an activ-
ity that we confirmed using in vitro kinase assays with CK2-specific peptides. Since any LY effects
on TF induction may be a consequence of inhibition of both P3K and CK2, we examined whether
a specific inhibitor of CK2 would block TNFα-mediated TF induction. TBB, a specific ATP site-
directed inhibitor of CK2, blocked TNFα-mediated induction of cell surface TF protein expression.
This blockade was associated with inhibition of both total cell TF and TF mRNA induction. These
data suggest that CK2 activity is critical for cytokine induction of TF and may provide a rationale
for novel anti-TF therapy. 
0011
Thrombospondin-2 deficiency accelerates UVB-induced angiogenesis and cutaneous
photo-damage
K Yano,1 Y Shirakata,1 LF Brown,2 P Bornstein3 and M Detmar1 1 Dermatology,
CBRC/MGH/Harvard Medical School, Charlestown, MA, 2 Biochemistry, University of
Washington, Seattle, WA and 3 Pathology, Beth Israel Deaconess Medical Center/Harvard Medical
School, Boston, MA
Chronic ultraviolet-B (UVB) irradiation of the skin results in epidermal hyperplasia, degradation of
extracellular matrix molecules, formation of wrinkles and pronounced angiogenesis. We have pre-
viously reported that the cutaneous vascular system plays a critical role in the mediation of UVB
induced skin damage, and that over-expression of thrombospondin-1 in the epidermis prevents chronic
skin damage and angiogenesis. Here, we studied the biological function of the related endogeneous
angiogenesis inhibitor thrombospondin-2 (TSP-2) in the pathology of UVB induced skin damage.
We subjected TSP-2 deficient mice and wild-type control mice to a twelve weeks UVB irradiation
regimen. After twelve weeks UVB irradiation (cumulative UVB dose: 7.23 J/cm2), TSP-2 deficient
mice showed pronounced wrinkle formation and increased angiogenesis with disorganized collagen
fibers and increased inflammatory cell infiltration in the dermis, as compared with wild-type con-
trols. Immunohistochemistry for CD31 and computer-assisted image analysis of CD31 stained sec-
tions revealed increased skin vascularization and proliferation of endothelial cells in TSP-2 defi-
cient mice after chronic UVB irradiation. Moreover, in situ hybridization revealed a strong
up-regulation of VEGF mRNA expression in the suprabasal keratinocytes of the epidermis of TSP-
2 deficient mice after chronic UVB irradiation as compared with wild-type mice. These results demon-
strate that lack of TSP-2 results in enhanced angiogenesis, leading to increased skin damage after
chronic UVB irradiation, They also suggest that TSP-2 plays a protective role in the control of cuta-
neous photo-damage. 
0012
P-selectin expression in human dermal microvascular endothelial cells
Y Miyazaki, M Wu, T Satoh, H Yokozeki and K Nishioka Department of Dermatology and
Immunodermatology, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan
P-selectin, a member of the selectin family of adhesion receptors, is a 140-kDa glycoprotein stored
in the Weibel-Palade bodies of endothelial cells and the α-granules of platelets. Upon cellular acti-
vation, P-selectin is rapidly redistributed from secretory membranes to the surface of endothelial
cells, where it mediates rolling of neutrophils, lymphocytes and eosinophils. Whereas the regulation
of P-selectin expression has been intensively studied on cultured human umbilical vein endothelial
cells (HUVEC), the kinetics and mechanism of P-selectin expression in human dermal microvas-
cular endothelial cells (HDMEC) are still unclear. In this study, we analyzed the regulatory mecha-
nisms of P-selectin expression on cultured HDMEC by flowcytometry and cell-based ELISA. His-
tamine stimulated HDMEC to express P-selectin within minutes. IL-4, IL-13 and substance P induced
a marked increase in P-selectin expression after 24 hr in culture. In contrast, neither TNFα, IL-1α
nor INF-γ exhibited any effect on P-selectin expression in HDMEC as assessed by cell-based ELISA.
Laser scanning microscopy examination revealed constitutive P-selectin expression on the luminal
surface of dermal endothelial cells in normal skin. The increased luminal exopression of P-selecitin
was observed in skin lesion of urticaria, atopic dermatitis and bullous pemphigoid but not psoriasis
vulgaris and P.P.P. These data indicate that constitutive luminal expression of P-selectin in dermal
endothelial cells may be involved in the leukocyte trafficking. IL-4, IL-13, substance P as well as
histamine could promote the interaction of leukocytes with dermal endothelial cells via enhancing
P-selectin expression. 
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Pharmacologic evidence of an autocrine angiopoietin2-tie-2 loop in the pathogenesis of heman-
gioma of infancy
B Govindarajan,1 JL Arbiser,1 X Bai1 and F Cerimele1 1 Dermatology, Emory University, Atlanta,
GA, 2 Surgery, Emory University, Atlanta, GA, 3 Department of Pathology, Beth Isreal Deaconness
Hospital, Boston, MA and 4 Department of Surgical Research, Childrens Hospital, Boston, MA
Hemangiomas of infancy represent the most common tumor of childhood. Treatment of large heman-
giomas remains unsatisfactory, and may lead to significant morbidity. We hypothesized that autocrine
loops may play a role in hemangioma formation. We found that the endothelial specific receptor,
tie-2, is constitutively activated in human hemangiomas. Using a murine model of hemangioma,
bend3 cells, we found that hemangiomas in mice express both tie-2, and its ligand, angiopoietin-2.
In order to determine whether tie-2/angiopoietin-2 interactions are functional in vivo, we infected
bend3 cells with a recombinant adenovirus expressing a soluble tie-2/Fc protein, or as a control,
adenovirus expressing Fc protein alone. Expression of soluble tie-2/Fc led to a significant inhibition
of hemangioma formation in mice, compared with Fc fragment alone. Our findings suggest that tie-
2/angiopoietin loops are functionally important in the development of human hemangiomas, and that
pharmacologic inhibition of these autocrine loops may lead to improved treatment for hemangiomas 
0015
Identification of vascular lineage-specific genes by transcriptional profiling of isolated cuta-
neous blood vascular and lymphatic endothelial cells
S Hirakawa,1 Y Hong,1 N Harvey,2 V Schacht,1 K Matsuda,1 T Libermann3 and M Detmar1 1
Dermatology, Massachusetts General Hospital, Charlestown, MA, 2 Genetics, St. Jude Children’s
Research Hospital, Memphis, TN and 3 BIDMC Genomics Center, Beth Israel Deaconess Medical
Center, Boston, MA
In mammals, the lymphatic vascular system develops by budding of lymphatic progenitor endothe-
lial cells from embryonic veins to form a distinct network of draining vessels with important func-
tions in the immune response and in cancer metastasis. However, the lineage-specific molecular char-
acteristics of blood vascular versus lymphatic endothelium have remained poorly defined. Comparative
gene array analyses of cultured BVEC and LEC revealed that only 1.6% of genes showed an at least
2-fold increased expression in LEC (1.2% in BVEC), including Prox1 and podoplanin as known
lymphatic markers, in agreement with the close lineage connection between both types of vascular
cells. Transcriptional profiling studies revealed increased expression of several extracellular matrix
and adhesion molecules in BVEC, including versican, collagens, laminin and N-cadherin, and of
the growth factor receptors endoglin and vascular endothelial growth factor receptor-1 (VEGFR-
1/Flt-1). Quantitative real-time RT-PCR and differential immunostains of human skin confirmed the
blood vessel-specific expression of these genes. During embryonic development, endoglin expres-
sion was gradually downregulated on lymphatic endothelium whereas VEGFR-1 was absent from
lymphatics. We also identified several genes with specific expression in LEC. These results demon-
strate that some lineage-specific genes are only expressed during distinct developmental stages and
they identify new molecular markers for blood vascular and lymphatic endothelium with important
implications for future studies of vascular development and function. 
0017
Treatment with the angiogenesis inhibitor vasostatin decreases vascularity and edema forma-
tion in an experimental delayed-type hypersensitivity reaction in the skin of mice
P Velasco,1 R Huegel,1 L Sierra,2 D Sicks,1 E Christophers,1 JM Schroder,1 G Tosato2 and B Lange-
Asschenfeldt1 1 Department of Dermatology, University of Kiel, Kiel, S-H, Germany and 2
National Cancer Institute, National Institutes of Health, Bethesda, MD
Angiogenesis, increased vascular hyperpermeability and upregulation of proangiogenic factors are
characteristic features of several inflammatory cutaneous diseases. Recently, mice that overexpress
the proangiogenic agent placental growth factor (PlGF) were reported to have increased cutaneous
inflammation. Conversely, PlGF knockout mice demonstrated a diminished inflammatory response
while mice that lack the endogenous angiogenesis inhibitor thrombospondin 2 exhibited a persist-
ent and prolonged inflammation.  Yet, little is known about the effect of antiangiogenic treatment on
the timecourse and extent of a cutaneous inflammation. Vasostatin is the 180 amino acid NH2 domain
of calreticulin known to inhibit angiogenesis in vitro and in vivo and has been shown to potently sup-
press tumor growth. We induced a delayed-type hypersensitivity (DTH) reaction in the ear skin of
wildtype FVB mice with and without vasostatin treatment in order to investigate any potential alle-
viative effect resulting from the suppression of angiogenesis.  We report that 24 and 48 hours after
the initial challenge, the vasostatin-treated mice exhibited 38% and 31% less edema respectively
when compared to the untreated mice. This trend was observed throughout the investigated recov-
ery period of 7 days where the treated mice demonstrated 50% less inflammation starting 72 hours
post challenge. Using computer-assisted morphometric image analysis of CD31(PECAM-1)-stained
frozen sections, we found decreased vascularity in the vasostatin-treated mice 24 and 48 hours after
challenge.  Our results reveal an important role for angiogenesis during an inflammatory response
and suggest that therapeutic approaches aimed at maintaining vascular quiescence could prove ben-
eficial in the treatment and prevention of cutaneous inflammations. 
0016
Constitutive transgenic expression of dominant negative tuberin leads to a skin and brain
phenotype in mice
B Govindarajan,1 JL Arbiser,1 D Brat,2 X Bai,1 C Cohen,2 E Murad1 and F Cerimele1 1
Dermatology, Emory University, Atlanta, GA, 2 Pathology, Emory University, Atlanta, GA and 3
Department of Genetics, Uppsala University, Upsala, Sweden
Tuberous sclerosis (TS) is a common autosomal disorder caused by loss or malfunction of tuberin
or hamartin. Many tumors in TS do not demonstrate loss of heterozygosity (LOH) for these genes,
implying that dominant negative forms of these genes may account for some neoplasms in TS. In
order to test this hypothesis, we expressed a dominant negative allele of tuberin (∆RG) behind a
CMV promoter in NIH3T3 cells and in transgenic mice. This allele binds hamartin, but has a dele-
tion in the C-terminal protein, leading to constitutive activation of rap1 and rab5/rabaptin. Expres-
sion of ∆RG in 3T3 cells led to a strong induction of reactive oxygen species (ROS), induction of
VEGF, and malignant transformation in vivo. Expression of ∆RG in transgenic mice led to high level
expression in all murine tissues examined, including skin, kidney, liver, and brain. Surprisingly, mice
developed a fibrovascular collagenoma, which closely resembles Shagreens patches observed in
human patients with TS. In addition, deficient migration of periventricular external granule cells in
the brain was observed, which may be precursors of the subependymal giant cell astrocytomas seen
in TS patients. Thus, expression of a dominant negative tuberin in all tissues can lead to a tissue-
specific phenotype resembling some of the findings in human TS. Our data is the first to suggest
that specific signaling abnormalities may underlie specific pathology (Shagreens patch subependy-
mal giant cell astrocytoma) in a human genetic disorder 
0014
The endogenous angiogenesis inhibitor thrombospondin 1 is up-regulated in acute allergic con-
tact dermatitis in human skin
R Huegel,1 P Velasco,1 K Jahnke,1 J Brasch,1 E Christophers,1 JM Schroder,1 M Detmar2 and
B Lange-Asschenfeldt1 1 Department of Dermatology, University of Kiel, Kiel, S-H, Germany and
2 Cutaneous Biology Research Center, Massachusetts General Hospital/Harvard Medical School,
Charlestown, MA
In cutaneous inflammatory diseases such as eczema and psoriasis, increased vascularity and vascu-
lar hyperpermeability are characteristic features. Vascular endothelial growth factor A (VEGF-A)
and other proangiogenic growth factors are potently upregulated in inflamed lesions, conversely, the
endogenous angiogenesis inhibitor thrombospondin 2 (TSP)-2 was recently found to play an impor-
tant role in the control of an experimental delayed-type hypersensitivity reaction in the skin of mice.
In order to investigate the biologic role of angiogenesis in human cutaneous inflammation, we
quantified the vascularity (number, size and density) in acute allergic contact dermatitis and normal
skin using computer-assisted morphometric image analysis of collagen-IV and CD31(PECAM-1)-
stained frozen sections. Furthermore, we compared the levels of TSP-1 expression in inflamed lesions
and healthy skin from the same donor. We report that vessel density in the inflamed skin was already
increased 72 hours after the onset of an inflammation (our earliest timepoint). In the inflamed lesions,
we found TSP-1 protein expression in the basement membrane, in some extravasated leukocytes but
mainly in blood vessels surrounded by perivascular infiltrate. TSP-1 mRNA at this timepoint was
confined to these blood vessels. In normal skin, TSP-1 expression was found in the basement mem-
brane and in some basal keratinocytes of the hair follicle. CD36, one of the receptors for TSP-1, was
also upregulated in the inflamed lesions and was expressed primarily by inflammatory cells. Our
data implicate TSP-1 as a modulator of endothelial cell function during an inflammation. Further
characterization of additional receptors, as well as investigating the time course of TSP-1 upregula-
tion in these lesions will elucidate the role of TSP-1 during an inflammatory response. 
0018
Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis
and survival
SS Dadras,1,2 T Paul,1 J Bertoncini,1 LF Brown,3 A Muzikansky,4 C Garbe,5 MC Mihm2 and
M Detmar1 1 Dermatology/Cutaneous Biology Research Center, Massachusetts General
Hospital/Harvard Medical School, Charlestown, MA, 2 Pathology, Massachusetts General
Hospital/Harvard Medical School, Boston, MA, 3 Pathology, BI Deaconess Medical
Center/Harvard Medical School, Boston, MA, 4 Biostatistics, Massachusetts General
Hospital/Harvard Medical School, Boston, MA and 5 Dermatology, University of Tubingen
Medical School, Tubingen, Germany
Malignant melanomas of the skin are distinguished by their propensity for early metastatic spread
via lymphatic vessels to regional lymph nodes, and lymph node metastasis is a major determinant
for the staging and clinical management of melanoma. However, the importance of tumor-induced
lymphangiogenesis for lymphatic melanoma spread has remained unclear. We investigated whether
tumor lymphangiogenesis occurs in human malignant melanomas of the skin and whether the extent
of tumor lymphangiogenesis may be related to the risk for lymph node metastasis and to patient sur-
vival, using double immunostains for the novel lymphatic endothelial marker LYVE-1 and for the
panvascular marker CD31. Tumor samples were obtained from clinically and histologically closely
matched cases of primary melanomas with early lymph node metastasis (n=18) and from non-metasta-
tic melanomas (n=19). Hot spots of proliferating intratumoral and peritumoral lymphatic vessels
were detected in a large number of melanomas. The incidence of intratumoral lymphatics was sig-
nificantly higher in metastatic melanomas and correlated with poor disease-free survival. Metasta-
tic melanomas had significantly more and larger tumor-associated lymphatic vessels, and a relative
lymphatic vessel area of greater than 1.5% was significantly associated with poor disease-free and
overall survival. In contrast, no differences in the density of tumor-associated blood vessels were
found. VEGF and VEGF-C expression was equally detected in a minority of cases in both groups.
Our results reveal tumor lymphangiogenesis as a novel prognostic indicator for the risk of lymph
node metastasis in cutaneous melanoma. 
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An extract of the root of Lithospermun erythrorhison accelerates wound healing in diabetic
mice
N Fujita,1,2 I Sakaguchi,1 H Kobayashi,2 N Ikeda,1 Y Kato,1 M Minamino3 and M Ishii2 1 Institute
of Cosmetic Sciences, Club Cosmetics Co., LTD., Ikoma, Nara, Japan, 2 Department of
Dermatology, Osaka City University Graduate School of Medicine, Osaka, Osaka, Japan and 3
Flouveil Co., LTD., Osaka, Osaka, Japan
Many people suffer from intractable bedsores, which sometimes develop because of chronic meta-
bolic failure in patients. An extract of the root of Lithospermun erythrorhison (SK) has been reported
to have an effect on wound healing. However, the effects of SK have not been studied in chronic
wounds, such as bedsores. The healing-impaired diabetic ( db/db ) mouse is a good model for the
investigation of clinical healing therapies. Therefore, we examined whether SK accelerates wound
healing in db/db mice. Full-thickness round wounds of 6-mm diameter were created on the backs of
mice. After applying SK, we covered the wound with a film dressing to keep it moist. At three weeks,
wound closure was complete in SK-treated mice but not in controls. Capillary vessel number and
collagen synthesis increased early in wound healing in SK-treated wounds. At this time, vascular
endothelial growth factor (VEGF)-positive neutrophils had infiltrated the wound and the appear-
ance of apoptotic fibroblasts and endothelial cells in the granulation tissue was more advanced than
in the controls. Where the wound was covered with epithelium, infiltration of VEGF-positive cells
and apoptotic cells tended to decrease. These results suggest that the inflammatory phase was short-
ened, and the proliferative and maturation phases were advanced by SK. It has been known that SK
also has anti-bacterial activity. Therefore, we conclude that SK is useful for wound healing in db/db
mice, and could potentially help patients with intractable bedsores. 
0020
Mice overexpressing placenta growth factor and lacking vascular endothelial growth factor in
the skin exhibit increased vascularization but normal vessel permeability
L Brogelli,1 L Zaccaria,1 H Rossiter,2 N De Luca,1 L Tatangelo,3 E Tschachler,2,4 G Zambruno1 and
T Odorisio1 1 IDI IRCCS, Rome, Italy, 2 University of Vienna Medical School, Vienna, Austria, 3
Istituto Regina Elena, Rome, Italy and 4 CE.R.I.E.S., Neuilly Seine, France
Among the members of the vascular endothelial growth factor family (VEGF), placental growth
factor (PlGF) has recently been demonstrated to have strong angiogenic and permeabilizing prop-
erties in animal models. However, it has not been clarified, yet, whether PlGF exerts these effects
only by enhancing VEGF-driven angiogenesis and permeability or also by activating its own recep-
tor. To addess this issue in an in vivo model, mice overexpressing PlGF and lacking VEGF in the
skin (PlGF+/VEGF-) were obtained by crossing mice overexpressing murine PlGF under the con-
trol of the keratin 14 promoter (PlGF+) and mice with keratin 5-Cre/LoxP-mediated deletion of
VEGF (VEGF-). Skin vascularization was investigated by analyzing whole mount ear preparations
after perfusion with Lycopersicon esculentum lectin and by immunohistochemical staining with
PECAM-1 and alpha-smooth muscle actin of skin sections from the back. PlGF+/VEGF- as well as
PlGF+ mice had an increased number of vessels (p<0.01), with augmented diameter (p<0.05) and
branching (p<0.01) in comparison with wild type littermates, and showed features of active angio-
genesis, such as glomeruloid bodies and spikes. In agreement with these data, the area of PECAM-
1 positive vessels in back skin sections was increased in PlGF /VEGF- and PlGF+ mice in compar-
ison with wild type mice (p<0.05). Vessel permeability was studied by evaluating leakage sites in
Ricinus communis perfused whole mount ear preparations, and by transmission electron microscopy
of back skin. In comparison with wild type mice, the number of permeability sites was not modified
in PlGF+/VEGF- animals, while it was markedly increased in PlGF+ mice (p<0.01). Our data indi-
cate that, in the absence of keratinocyte-derived VEGF, PlGF overexpression can promote skin angio-
genesis, while it is not able to increase vessel permeability. 
0021
Paclitaxel encapsulated in cationic liposomes diminishes tumor angiogenesis and melanoma
growth in a humanized SCID mouse model
R Kunstfeld,1 G Wickenhauser,1 M Teifel,2 W Umek,3 K Naujoks,2 K Wolff,1 U Michaelis2 and
P Petzelbauer1 1 Dermatology, Vienna General Hospital, Vienna, Austria, 2 mbt Munich
Biotechnology AG, Martinsried, Germany and 3 Gynecology, Vienna General Hospital, Vienna,
Austria
Paclitaxel is an alkaloid which inhibits endothelial cell proliferation, motility and tube formation at
nanomolar concentrations. Cationic liposome preparations have been shown to target blood vessels.
We wished to explore the possibility that paclitaxel encapsulated in cationic liposomes carries pacli-
taxel to blood vessels and thereby provides an anti-angiogenic effect. We used a humanized SCID
mouse melanoma model, which allows to analyze tumor growth and tumor angiogenesis in an
orthotopic tumor model. Here, human melanoma cells grow on human dermis and are in part nour-
ished by human vessels. We show that paclitaxel encapsulated in liposomes prevents melanoma
growth and invasiveness and improves survival of mice. Moreover, liposome-encapsulated paclitaxel
reduces vessel density at the interface between the tumor and the human dermis and reduces endothe-
lial cell mitosis to background levels. In contrast, equimolar concentrations of paclitaxel solubilized
in Cremophor EL had only insignificant effects on tumor growth and did not reduce the mitotic index
of endothelium in vivo, although the anti-proliferative effect of solubilized paclitaxel in Cremophor
EL in vitro was identical to that seen with liposome-coupled paclitaxel. In conclusion, we present a
model of how to exploit cytotoxic effects of compounds to prevent tumor growth by using cationic
liposomes for targeting an anti-proliferative drug to blood vessels. 
0022
Sodium lauryl sulfate induces VEGF expression in immortalized keratinocytes via an egr-1,
MEK1-dependent mechanism
FM O’Reilly,1,2 KA Casper,1 M Newton-West1 and RA Swerlick1,2 1 Derm, Emory Univ, Atlanta,
GA and 2 Derm, Dept of Veterans Affairs Medical Center, Decatur, GA
Irritant contact dermatitis (ICD) is characterized acutely by erythema and edema evolving with
chronic exposure to hyperkeratosis and lichenification. The cellular and molecular mechanisms
involved in ICD are poorly understood. Keratinocytes are a major target for irritants resulting in
activation and secretion of soluble mediators e.g vascular endothelial growth factor (VEGF), a pow-
erful pro-inflammatory and angiogenic agent. We determined whether sodium lauryl sulfate (SLS),
a model irritant, induces VEGF expression in HaCat cells at non-toxic concentrations. In order to
best define the appropriate dosing for maximum cell viability, testing with SLS was performed at
different concentrations (0.1-0.001%) and exposure times (5-60 minutes). Five minute exposure to
concentrations of SLS as high as 0.01% resulted in minimal effects on cell viability. Under these
conditions, VEGF mRNA expression was upregulated 5-30 fold after one hour, responses that were
comparable to TGFα treatment. Using oligonucleotide probes from the egr-1 responsive region of
the VEGF promoter in EMSA, we demonstrated that SLS treatment resulted in the appearance of
nuclear complexes that bound the VEGF promoter derived EMSA probe. Supershift analysis demon-
strated these complexes contained egr-1 protein. SLS treatment resulted in increased levels of steady
state egr-1 mRNA, suggesting that SLS may target egr-1 gene expression. As previous studies have
linked egr-1 induction to MEK1 activation, we examined whether PD98059, a specific inhibitor of
MEK1, blocked SLS-induced VEGF expression. Pretreatment of HaCat cells with PD98059 prior
to SLS treatment blocked VEGF induction as well as SLS mediated egr-1 expression, whereas the
proteasomal inhibitor MG-132 had no effect. These data suggest that irritants such as SLS may tar-
get MEK1 activation and egr-1 induction. These studies provide insight into novel approaches for
the development of relevant in vitro test systems to investigate the mechanisms and prevention of
ICD. 
0023
Transgenic VEGF overexpression induces enlargement of cutaneous lymphatic vessels that is
further enhanced by delayed-type hypersensitivity reactions
R Kunstfeld,1 S Hirakawa,1 C Lin,2 P Velasco,1 V Schacht,1 X Wei2 and M Detmar1 1
CBRC/Dermatology, Massachusetts General Hospital, Boston, MA and 2 Wellman Laboratories of
Photomedicine, Massachusetts General Hospital, Boston, MA
Lymphatic vessels (LV) are pivotal for the maintenance of fluid balance in the skin. Under physio-
logic conditions, most LV are collapsed, whereas in inflammation, LV are dilated in response to the
increased vascular leakage and edema formation. Vascular endothelial growth factor-A (VEGF-A)
has been shown to be upregulated in inflammatory skin diseases including psoriasis. Whereas the
importance of VEGF-A as an inducer of blood vessel permeability and angiogenesis is well estab-
lished, its influence on LV has remained unknown. We investigated delayed-type hypersensitivity
reactions (DTH) in the ear skin of transgenic mice with epidermis-specific overexpression of VEGF-
A and in wild-type littermates. Immunostains for the lymphatic-specific hyaluronan receptor LYVE-
1 revealed enlargement of dermal LV in VEGF-A transgenic mice already in non-inflamed skin.
These findings were confirmed by in vivo fluorescence confocal microscopy. Elicitation of DTH
reactions led to a significantly more pronounced edema formation and LV enlargement in VEGF-A
transgenic mice as compared with wild-type controls. Whereas tissue swelling and dilation of LV
disappeared within 7 days after elicitation in wild-type mice, they persisted for more than 2 weeks
in VEGF-A overexpressing mice. Double labeling for LYVE-1 and for the lymphatic-specific home-
obox gene Prox-1 confirmed the lymphatic identity of the dilated vessels. After challenge, VEGF-
A transgenic mice developed chronic inflammatory skin lesions resembling psoriasis. This effect
persisted even after vascular permeability had largely returned to baseline levels. Our findings
reveal that VEGF-A, in addition to its known effects on blood vessel angiogenesis, also exerts
potent effects on cutaneous lymphatic vessels. 
0024
Podoplanin/T1-alpha deficiency disrupts lymphatic patterning and causes lymphedema
V Schacht,1 MI Ramirez,2 S Hirakawa,1 Y Hong,1 D Feng,3 N Harvey,4 MC Williams,2
AM Dvorak,3 HF Dvorak,3 G Oliver4 and M Detmar1 1 CBRC/Dermatology, Massachusetts
General Hospital/Harvard Medical School, Charlestown, MA, 2 Pulmonary Center/Department of
Medicine, Boston University School of Medicine, Boston, MA, 3 Departments of Pathology, Beth
Israel Deaconess Medical Center/Harvard Medical School, Boston, MA and 4 Department of
Genetics, St. Jude Childrens Hospital, Memphis, TN
Within the vascular system, the mucin-type transmembrane glycoprotein podoplanin/T1alpha is pre-
dominantly expressed by lymphatic vascular endothelium, and recent studies have shown that it is
regulated by the lymphatic-specific homeobox gene Prox1. We examined the role of podoplanin in
vascular development by studying its expression pattern and the effects of gene disruption in mice.
Within the vascular system, podoplanin is first expressed around E11.0 and in a subset of budding
Prox1-positive lymphatic progenitor cells. Expression is predominantly restricted to the lymphatic
endothelium during later development, and ultrastructural analysis revealed its localization to the
luminal and abluminal plasma membrane of lymphatic vessels. Podoplanin-null mice have defects
in lymphatic, but not blood vessel pattern formation. These defects are associated with diminished
lymphatic transport, congenital lymphedema and dilation of cutaneous and intestinal lymphatic
vessels. Podoplanin was also weakly expressed in the basal epidermis of newborn wild-type mice,
but gene disruption did not alter epidermal differentiation. Studies in cultured endothelial cells
revealed that podoplanin promotes cell adhesion and migration. This glycoprotein therefore appears
to be important for endothelial cell migration and patterning of the lymphatic vascular system. 
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Identification of proteins expressed in oxidative stress-induced states in cultured human der-
mal microvascular endothelial cells
K Chung,1 M Ha,2,1 D Bang,1 Y Park1 and K Lee1,2 1 Department of Dermatology and Cutaneous
Biology Research Institute, Yonsei University College of Medicine, Seoul, South Korea and 2 BK21
Project for Medical Sciences, Yonsei University College of Medicine, Seoul, South Korea
Aerobic metabolism has been known to produce reactive oxygen species (ROS) that are regarded as
toxic byproducts. However, ROS can also act as intracellular signaling molecules in vascular cells
and they can mediate phenotype changes in vascular endothelial cells that may be considered both
physiological and pathological. To clarify the molecular mechanisms of ROS signaling, we exam-
ined the H2O2-responsive proteins using proteomics tools. Changes in the protein expression were
studied in cultured human dermal microvascular endothelial cells exposed to low- and high-level
hydrogen peroxide for various time intervals and intracellular ROS production was examined using
flow cytometry and spectrophotometer. Proteins were separated from dose dependent and time course
series experimental conditions by two-dimensional electrophoresis, and they were visualized by sil-
ver staining and quantified by image processing. The proteins of interest were subjected to in-gel
digestion with trypsin, and the masses of resulting peptides were determined by matrix-assisted laser
desorption/ionization time-of-flight mass spectrometry. This tryptic mass map was used to identify
the proteins through the search of a protein-sequence database. At least 117 proteins were stimu-
lated by H2O2, whereas 46 proteins were repressed by this treatment. The majority of changes
occurred within the first 15 min of cell stimulation. Oxidative stress challenge results in a dramatic
change of protein profile and their mapping may give a global view of the cellular changes elicited
by H2O2. The results could provide the framework for understanding the mechanisms of cellular
redox homeostasis and H2O2 metabolism. 
0027
Determination of the functional integrity of skin autonomous vascular regulation with laser
Doppler technique
G Szabad,1 D Paprika,2 L Kemeny,1 A Dobozy1 and L Rudas2 1 Department of Dermatology and
Allergology, Medical University of Szeged, Szeged, Csongrad, Hungary and 2 Department of
Medical Intensive Care Unit, Medical University of Szeged, Szeged, Csongrad, Hungary
Local and systemic regulatory mechanisms are responsible for maintaining proper skin blood sup-
ply. Failure of the skin autonomous vascular regulation poses severe problems in diseases like lym-
phoedema, diabetes mellitus, leg ulcers, Raynaud syndrome, etc. Determination of the integrity of
cutaneous autonomous regulation of blood supply could be an important prognostic factor in the
treatment of these diseases. We aimed to develop a non-invasive method for monitoring the integrity
of skin autonomous vascular regulation. First we used baroreflexes under physiological conditions
to initiate changes in skin blood flow. After this we used bretylium locally to neutralize sympathetic
activity by presynaptically blocking noradrenalin release. Servo-photopletysmography was used to
monitor haemodynamic changes, while laser Doppler technique was used for measurement of skin
blood flow. Without bretylium treatment cutaneous vascular resistance showed a significant, three-
fold increase in the hypotonic phase of the baroreflex maneuver. Bretylium treatment completely
inhibited this increase. Our data indicate that baroreflex stimulus results in vasoconstriction of skin
arterioles and this vasoconstriction is the result of sympathetic efferent activity. We propose that
monitoring of cutaneous vascular resistance over bretylium treated and non-treated skin areas is a
convenient and non-invasive method to determine the functional integrity of skin autonomous reg-
ulation of blood supply. 
0029
Enhanced expression of HIF1alpha in squamous cell carcinoma
CC Miller, RW Agnello, C Tanck, JB VanBuskirk and GA Scott Dermatology, University of
Rochester, Rochester, NY
The purpose of this study is to better define the role of hypoxia inducible factor 1-alpha (HIF1alpha)
in epidermal tumorigenesis. HIF1alpha is a transcription factor that regulates cellular adaptive
responses to hypoxia including the expression of angiogenic factors such as vascular endothelial
growth factor (VEGF). In the current study, we have investigated the regulation of HIF1alpha mRNA
expression in human keratinocytes by hypoxic conditions in vitro and we have evaluated the levels
of HIF1alpha and VEGF protein in squamous cell carcinomas in vivo. In the first set of experi-
ments, pre-confluent primary human keratinocyte cultures derived from adult surgical specimens
were exposed to hypoxia (<2% O2) or normoxia (21% O2) for 48 hours and then harvested for total
RNA. Northern analysis demonstrated a significant increase in the levels of HIF1alpha-specific
mRNA in the hypoxic cells; this was confirmed by quantitative RT-PCR to represent a 6.1±1.9-fold
increase over normoxic controls. In the subsequent set of experiments, histological sections obtained
from squamous cell carcinoma biopsy specimens underwent immunohistochemical analysis using
antibodies directed against HIF1alpha and VEGF. Immunostaining patterns demonstrated markedly
enhanced HIF1alpha protein levels in the acanthotic tumor epithelium when compared to adjacent
uninvolved epithelium. Staining was particularly enhanced in areas surrounding vascular channels
within the tumor mass and around areas of necrosis. Immunostaining for VEGF demonstrated an
identical pattern. Thus, it appears likely that hypoxia encountered in an expanding squamous cell
carcinoma results in enhanced HIF1alpha expression which drives VEGF expression stimulating
the angiogenic response necessary for sustaining tumor growth. 
0028
Keratin5-Cre/LoxP-mediated inactivation of vascular endothelial growth factor sensitizes
mouse skin to UVB-induced photodamage
C Barresi,1 H Rossiter,1 EF Wagner2 and E Tschachler1,3 1 Department of Dermatology, Vienna
University Medical School, Vienna, Austria, 2 I.M.P., Vienna, Austria and 3 CE.R.I.E.S., Neuilly,
France
Excessive exposure of skin to sunlight results in erythema, dilation of dermal blood vessels and vas-
cular hyperpermeability, suggesting that these changes in the dermal vasculature are necessary
components of the protective response to UV-induced photodamage. Vascular Endothelial Growth
Factor (VEGF) is one of several pro-angiogenic factors that are induced in skin after UVB irradia-
tion, and epidermal keratinocytes (KC) are the major source of VEGF in skin. Using the Cre/LoxP
system under the control of the keratin5 promoter, we have generated mice in which VEGF has been
inactivated in epidermal KC (VEGF-A∆k5-cre/∆k5-cre), and used these animals to study the con-
tribution of KC-derived VEGF to acute UVB-induced photodamage. We found that these mice devel-
oped burn-like lesions after a single UVB irradiation, at a dose at which the control mice were unaf-
fected. At higher doses, at which the control mice also showed acute photo-damage, the
VEGF-A∆k5-cre/∆k5-cre mice developed the lesions earlier and healed more slowly. Microscopic
examination of the irradiated skin revealed massive inflammation, with complete loss of the epi-
dermis in the mutant but not in the control mice, and CD31 stained blood vessels were missing in
the vicinity of the basal membrane of mutant mice. Active caspase 3 staining revealed more apop-
totic cells in the dermis, but lower numbers in the epidermis of mutant mice, suggesting that the lat-
ter may have died by necrosis. Proliferating cells were reduced in the epidermis of the mutant mice.
Short-term repeated irradiation with a lower dose of UVB did not induce open wounds in old mice,
but resulted in a scar-like lesion only in mutant mice. In addition they showed more pronounced
hyperplasia, lack of sub-epidermal blood vessels and increased number of apoptotic cells in the epi-
dermis. These results suggest that in the absence VEGF in epidermal KC, skin is sensitized to UVB-
induced photodamage. 
0026
Signaling events during induction of PAI-1 expression by SPC in cultured human dermal
fibroblasts
K Kye, E Chae, Y Piao, J Lee and K Suhr Dermatology, Chungnam Nat’ Univ. Hosp., Taejeon,
South Korea
Sphingosylphosphorylcholine (SPC) is a bioactive lipid stimulating wound healing. Although SPC
is known to act as a mitogen in wound healing, the exact mechanism how to accelerate wound heal-
ing is not fully elucidated. Plasminogen activator inhibiter-1 (PAI-1) is also well known to affect
wound healing by regulating the fibrinolytic environment of the wound area. Under the hypothesis
that SPC could affect wound healing through PAI-1, we tested PAI-1 expression by SPC and found
that SPC stimulated the expression of PAI-1 in human dermal fibroblasts at the protein and mRNA
levels. SPC induced an oscillatory increase in the intracellular calcium concentration ([Ca2+]) in
human dermal fibroblasts. Preincubation with thapsigargin, but not with EGTA ameliorated PAI-1
induction by SPC, suggesting that an increase of intracellular [Ca2+] from internal stores could medi-
ate PAI-1 induction by SPC. This effect of SPC on PAI-1 expression through increasing intracellu-
lar [Ca2+] could be inhibited by the blocking of Gi-coupled-protein receptor prior to treatment of
SPC, but not by blocking 00 the tyrosine kinase receptor. Although PKC activation by phorbol-12-
myristate-13-acetate alone could induce PAI-1 production, deactivation of PKC could not block
induction of PAI-1 production by SPC. SPC also induced MAPK phosphorylation of p42/44 ERK
in human dermal fibroblasts and pretreatment with PD98059 for blocking of the MEK pathway could
attenuate SPC-induced PAI-1 expression. Therefore, we could reach a conclusion that SPC could
affect the wound healing through PAI-1 induction mediated by a Gi-protein-coupled receptor and
ERK, with an increase in the intracellular Ca2+ level. 
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Treatment of facial angiofibromas with topical pimecrolimus and tazarotene gel
EA Connelly,2 E McLaughlin,1 MK Spraker1 and JL Arbiser1 1 Dermatology, Emory University,
Atlanta, GA and 2 Dermatology, University of Minnesota, Minneapolis, MN
New insights into the pathogenesis of tuberous sclerosis-associated skin lesions suggest that angiofi-
bromas are angiogenic neoplasms. Our purpose was to treat facial angiofibromas in patients with
tuberous sclerosis with topical agents known to have antiangiogenic activity. Three patients were
treated with a regimen of pimecrolimus every morning and tazarotene 0.1% gel every evening. At
two months, patients were evaluated clinically. To date, two patients have been evaluated after two
months of treatment and in both there has been a significant reduction in the size and color of the
angiofibromas. Historically, topical treatment of facial angiofibromas has been disappointing. Cur-
rent treatment of angiofibromas with ablative and vascular lasers, while effective at treating exist-
ing lesions, has not been shown to prevent the development of new lesions.  Ideal treatment of angiofi-
bromas would not only treat existing lesions but also prevent the development of new angiofibromas.
Recently, studies on a rat model with kidney tumors associated with tuberous sclerosis have shown
that rapamycin has an effect on the tumors with induction of apoptosis and a reduction in cell pro-
liferation. Rapamycin like pimecrolimus and tacrolimus are macrolide antibiotics which bind FKBP
(FK506 binding protein) and inhibit the calcineurin pathway. Pimecrolimus is a topical immunomod-
ulator approved for use in atopic dermatitis. Lastly, retinoids were chosen because they have been
shown to have antiangiogenic activity. We offer a new approach to the topical treatment of angiofi-
bromas with the combined use of pimecrolimus cream and tazarotene gel. We acknowledge the small
number of patients in our study, and will continue to expand on the series. 
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Formation of microvessels in tissue equivalents using blood-derived endothelial precursor cells
EF Kung,1 SK Crane,1 F Wang,1 JS Pober1,2 and JS Schechner1 1 Dermatology and
Interdepartmental Program in Vascular Biology and Transplantation, Yale University, New Haven,
CT and 2 Pathology, Yale University, New Haven, CT
We previously demonstrated that human skin equivalents can be vascularized and perfused through
microvessels lined by cultured human endothelial cells (EC). Such cultured EC are generally allo-
geneic (or xenogeneic) to the graft recipient and may induce a destructive immune response. We have
now identified conditions for forming perfused microvessels using EC derived from blood precur-
sor cells. Endothelial precursor cells (EPC) were propagated from human umbilical cord blood by
incubation in selective culture media. In the first 10-14 days, the cells elongated, but did not divide.
Thereafter, they developed a uniform spindle-shaped morphology and proliferated, displaying a
growth pattern typical of EC. After passage, 95% were confirmed to be EC by flow cytometric detec-
tion of CD31 and TNF induced E-selectin expression. These EC cultured from umbilical cord blood
formed capillary-like tubes when suspended in 3D culture in collagen/fibronectin gel and also migrated
into devitalized human dermis in vitro, displaying behavior equivalent to cultured EC isolated from
blood vessels. Differentiated EPC seeded in collagen/fibronectin gel or onto the underside of acel-
lular dermis were implanted subcutaneously into immunodeficient mice. One month after engraft-
ment, 3 of 6 gel and 3 of 3 dermal tissue-like implants were observed to contain multiple microves-
sels. These vessels were reactive with anti-human CD31 antibody and contained erythrocytes,
indicating that they were both lined by human EC and had inosculated with the mouse circulation.
Perfused microvessels were also successfully formed in vivo in 5 of 5 subcutaneously implanted col-
lagen/fibronectin gels seeded with EPC transduced with Bcl-2, an anti-apoptotic gene, which we
have shown to augment vascular maturation in tissue equivalents. Forming microvessels from blood
derived EPC in vivo offers an approach to vascularize synthetic tissue, such as skin equivalents,
with a source of EC autologous to the recipient. 
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UV down-regulates the angiogenesis inhibitor thrombospondin-1 in normal human keratinocytes
M Kosmadaki,1 Y Noh,2 M Yaar,1 M Detmar2 and BA Gilchrest1 1 Dermatology, Boston University
School of Medicine, Boston, MA and 2 Mass General Hospital, Charlestown, MA
Exposure of human skin to ultraviolet (UV) irradiation results in cutaneous angiogenesis. A balance
between positive and negative angiogenic factors maintains vascular homeostasis and when dis-
rupted, angiogenesis ensues. The proangiogenic factors vascular endothelial growth factor (VEGF),
basic fibroblast growth factor, and interleukin-8 are upregulated within hours of physiologic UVB
irradiation to skin. However, the effect of UVB on angiogenic inhibitors thrombospondin (TSP)-1
and -2 is not known. To determine UV irradiation effect on TSP-1 and 2, normal human keratinocytes
were exposed to increasing doses of solar simulated irradiation (5 -50mJ/cm2, metered at 285±5nm)
or were sham irradiated. Total cellular RNA, proteins and cellular supernatants were collected at
different intervals after irradiation and processed for northern and western blot analyses. There were
no consistent modulations of TSP-1 expression in sham irradtiated cells or in cells irradiated with 5
and 15mJ/cm2. However, within 1hr, TSP-1 mRNA was downregulated with 30 and 50mJ/cm2, respec-
tively. Maximal downregulation of 75 % was observed within 6 through 24 hrs with 50 mJ/cm2. TSP-
1 returned to baseline levels within 48 hrs after irradiation. However interestingly, within 72 and
through 96 hrs, TSP-1 expression was upregulated with 30 and 50 mJ/cm2. Western blot analysis of
cell lysates for TSP-2 did not show consistent modulations. However, because TSP-2 is primarily a
secreted protein, TSP-2 levels were determined in cell supernatants. Within 96 hrs there was a sub-
stantial decrease of TSP-2 levels in UV irradiated supernatants. Our findings confirm that both TSP-
1 and 2, the major angiogenic inhibitors in skin, are expressed and synthesized by normal human
keratinocytes. Furthermore, UV irradiation downregulates TSP-1 mRNA and decreases TSP-2 secre-
tion. In addition to angiogenic factors, TSP-1 and 2 may have an important role in the pathophysi-
ology of UV-induced angiogenesis in a variety of cutaneous disorders. 
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Lymphatic microvascular endothelial cells are specialized in scavenging and killing microbial
pathogens: a protective role for the lymph node environment?
E Kriehuber,1,2 S Amatschek,1,2 G Stingl2,1 and D Maurer1,2 1 DIAID, Vienna, Austria and 2 CEMM,
Vienna, Austria
Lymphatic microvascular endothelial cells (LECs) are interposed between cutaneous tissues and the
lymph node (LN) environment. A well-established mode of antigen transport from the skin to the
LN is the shuttling of dendritic cell (DC)-bound antigen via dermal lymphatic vessels. In this study,
we sought to investigate whether and how soluble, non DC-bound pathogens are handled by LECs.
Capitalizing on the recent advancement of culturing purified dermal LECs, gene chip based profil-
ing of podoplanin+/VE-cadherin+/CD31+/CD45- LECs revealed the expression of a large repertoire
of antigen uptake receptors, among them the macrophage mannose receptor, endosialin and the c-
type lectin P1. To investigate the functional capacity of LECs to bind, take up, and clear microbial
pathogens, LECs were exposed to FITC-labeled yeast, E. coli and S. aureus bioparticles. LECs effi-
ciently bound those microbes and internalized them with an average surface half-life of less than 60
min as demonstrated by trypan blue quenching of extracellular FITC moieties. Once internalized,
pathogens or their degradation products remained cell-associated since 90% of the ingested biopar-
ticle-bound I125 activity was retained in LECs for at least 48h. Importantly, we demonstrated in clas-
sical killing experiments that LECs are capable of eliminating E. coli. The killing efficacy is, how-
ever, less pronounced than that of macrophages or monocyte-derived DCs. Taken together, we
demonstrate that LECs express a plethora of antigen uptake receptors and in line with this finding,
are capable of binding, ingesting, and killing microbial pathogens. We speculate that LECs build up
a functional pattern recognition receptor decorated barrier specialized to shield lymph nodes from
damage through invading microorganisms. 
0034
Rapamycin inhibits growth of human malignant melanoma in an animal xenograft model
A Sekulic,1 MR Pittelkow1 and SN Markovic2 1 Dermatology, Mayo Clinic, Rochester, MN and 2
Oncology, Mayo Clinic, Rochester, MN
We examined effectiveness of rapamycin as an anti-melanoma agent in NOD scid mice bearing
human tumors. Rapamycin is a novel immunosuppressive agent that inhibits signaling through the
mammalian Target Of Rapamycin (mTOR). Recently, rapamycin has received renewed attention as
a potential anti-tumor agent following reports demonstrating a role for mTOR in regulating expres-
sion of Vascular Endothelial Growth Factor (VEGF), one of the most potent angiogenic factors. We
injected NOD scid mice subcutaneously with human A375 melanoma cell line. 100% of injected
mice developed tumors. As tumors approached measurable volume (2 mm diameter), mock treat-
ment or treatment with rapamycin by daily intraperitoneal injections (2 mg/kg/day) was initiated.
Whereas tumors in untreated mice displayed typical logarithmic growth, tumors in rapamycin treated
animals initially exhibited slow growth followed by growth arrest. At the time of sacrifice the aver-
age tumor volume in untreated animals was 4000 mm3, whereas in rapamycin treated animals tumor
volumes reached a plateau of 500 mm3. Interestingly, rapamycin discontinuation resulted in renewed
tumor growth. However, growth could again be arrested by rapamycin re-treatment. This response
strongly suggests an anti-angiogenic mechanism of action. Indeed, A375 cells in culture produced
significant levels of VEGF, which was strongly inhibited by rapamycin treatment. The effects of
tumor-produced VEGF are likely limited to the tumor microenvironment as no significant increase
in VEGF in the serum of tumor-bearing mice was observed. Immunohistochemical analysis of tumors
demonstrated significant decrease in the number and size of intratumoral blood vessels in response
to rapamycin, consistent with inhibition of tumor angiogenesis. These studies provide further evi-
dence for effectiveness of anti-angiogenic agents such as rapamycin for treatment of melanoma. 
0035
In vivo model of adhesion molecule regulation in synthetic human microvessels
DR Enis,1 AM Bothwell,2 JS Pober1,3 and JS Schechner3 1 Department of Pathology, Yale School
of Medicine, New Haven, CT, 2 Section of Immunobiology, Yale School of Medicine, New Haven,
CT and 3 Department of Dermatology, Yale School of Medicine, New Haven, CT
Human umbilical vein endothelial cells (HUVEC) that have been retrovirally transduced to overex-
press Bcl-2, suspended in collagen-fibronectin gels, and implanted into CB.17 SCID/beige mice
form mouse smooth muscle/pericyte-invested, human EC-lined microvessels containing elements
which morphologically resemble arterioles, capillaries, and venules. In normal human skin, TNF
induction of E-selectin and VCAM-1 is confined to venular EC, whereas ICAM-1 is induced on all
EC. Here, we compared the responses of Bcl-2-HUVEC to TNF before and after in vivo implanta-
tion. In newly formed gels (prior to implantation into mice), Bcl-2 HUVEC responded to TNF by
upregulating E-selectin, VCAM-1, and ICAM-1 on all cells. However, when gels were implanted
into SCID/beige mice for 30-60 days before s.c. injection of TNF (500ng), only a subset of Bcl-2-
HUVEC upregulated E-selectin and VCAM-1, whereas all EC showed ICAM-1 upregulation (indi-
cating all vessels were exposed to TNF). Subsequent anti-α-actin staining demonstrated that the sub-
set of Bcl-2-HUVEC which upregulated E-selectin had a pattern of smooth muscle/pericyte investment
consistent with venular differentiation. The correlation of morphologic features of vascular matura-
tion and patterns of E-selectin or VCAM-1 upregulation suggests this model may be useful in analy-
sis of microvascular differentiation and its relationship to adhesion molecule regulation. 
0036
Total IgE serum level, but not total IgE blister fluid level; intensity of IgG and IgG4 skin
deposits; and ECP serum and blister fluid levels, correlates with severity of active human bul-
lous pemphioid
M Dmochowski, M Bowszyc-Dmochowska and A Danczak-Pazdrowska Dermatology, University
School of Medicine, Poznan, Poland
It appears that human bullous pemphigoid (BP) at an initial stage is a substantially Th-2 mediated
disorder. Also, there are reports suggesting that total IgE serum level correlates with the disease activ-
ity in human BP. The purpose of this study was to examine, using proper methods of statistical analy-
sis, whether the action of IgE or IgG1 and IgG4 subclasses of IgG tissue-bound BP autoantibodies
or eosinophils parallels most closely the entire active disease process in human BP. Nineteen patients
with untreated confirmed BP at the blistering stage were enrolled in this study. A numerical grading
system of active BP lesions was developed which included assessment of blisters, wheal-like lesions,
pruritus/burning and area of skin involved. We evaluated total IgE and ECP serum and fresh (less
than 24 hours old) blister fluid levels with fluoroenzymeimmunoassays, and the intensity of IgG
and IgG4 dermal-epidermal junction (DEJ) deposits using direct immunofluorescence on saline-sep-
arated skin (SSDIF) with titration of FITC-conjugated anti-human IgG and IgG4 antibodies. Since
IgG1 DEJ deposits were infrequently detected and generally weak and IgE DEJ deposits were detected
in none of BP patients studied, despite using sensitive SSDIF, the analysis of their intensities could
not be performed and their correlation studies were not done as planned initially. The statistical analy-
sis using Spearman’s rank correlation test revealed that, among laboratory parameters evaluated, only
total IgE serum level correlated with the intensity of active lesions in human BP. Additionally, there
was no correlation between the intensity of IgG and IgG4 DEJ deposits. Thus, it seems that IgE-
mediated phenomena, albeit conceivably in a disease-nonspecific manner, might be more important
than both IgG1/IgG4-mediated and eosinophil-mediated processes in pathogenesis of human BP. 
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Inhibition of scratch behavior accompanied by reduced c-Fos expression in the spinal dorsal
horn of histidine-decarboxylase gene knockout mice on contact dermatitis
M Seike,1 R Hamada,1 M Ikeda,1 H Kodama,1 T Terui2 and H Ohtsu3 1 Dermatology, Kochi
Medical School, Nankoku, Kochi, Japan, 2 Dermatology, Tohoku University Graduate School of
Medicine, Sendai, Miyagi, Japan and 3 Cellular Pharmacology, Tohoku University Graduate
School of Medicine, Sendai, Miyagi, Japan
Patients with contact dermatitis suffer from strong itch sensation. In the present study, the role of
chronic eczema-induced histamine on scratch behavior and neural conduction of itch sensation
were investigated. Using L-histidine decarboxylase (HDC) gene knockout mice, which lack hista-
mine in the body, chronic contact dermatitis was induced by repeated application of diphenylcyclo-
propenone on a hind paw. Scratching behavior was exclusively induced in HDC (+/+), whereas it
was barely observed in HDC (-/-) mice. Expression of c-Fos was specifically up-regulated in HDC
(+/+) mice in lamina I of the spinal dorsal horn. These results demonstrate that the afferent pathway
of itch sensation, in a chronic contact dermatitis model, is transmitted by histamine below the lum-
ber level, and connects with the CNS through lamina I of the spinal dorsal horn. 
0039
Ultraviolet light exposure suppresses contact hypersensitivity by abrogating endothelial inter-
cellular adhesion molecule-1 up-regulation at the elicitation site
K Komura, S Sato, M Hasegawa, S Kawara and K Takehara Dermatology, Kanazawa University
Graduate School of Medical Science, Kanazawa, Ishikawa, Japan
Exposure to ultraviolet (UV) light-B radiation has the potential to affect humans. One of the most
significant effects of UV radiation is systemic immune suppression that exacerbates a number of
infectious diseases and permits the outgrowth of skin tumors.  Hapten sensitization through UV-
exposed skin induces systemic immune suppression, which has been experimentally demonstrated
by inhibition of contact hypersensitivity (CHS). Although this UV-induced effect has been shown
to be mediated by inhibition of the afferent phase of the CHS response, the UV effects on the effer-
ent (elicitation) phase remain unknown. Since the elicitation phase is in part regulated by expres-
sion of cell adhesion molecules, UV-induced suppression of CHS was investigated in mice lacking
either L-, P-, or E-selectin, or ICAM-1. Interestingly, UV exposure resulted in suppression of CHS
responses in each of the selectin-deficient mice but not in the ICAM-1-deficient (ICAM-1-/-) mice.
ICAM-1 deficiency did not affect the afferent limb since ICAM-1-/- mice were sensitized to hapten
and had normal generation of hapten-specific suppressor and effector T cells. This UV-induced
immunosuppression was associated with a lack of up-regulation of endothelial ICAM-1 expression
and TNF-a production after Ag challenge at elicitation sites. Local TNF-a injection immediately
before elicitation abrogated the UV-induced CHS inhibition, which was accompanied by increased
endothelial ICAM-1 expression. TNF-a production was down-regulated by IL-10, a possible medi-
ator produced by hapten-specific suppressor T cells that are generated by UV exposure. These results
indicate that UV exposure inhibits CHS by abrogating up-regulation of endothelial ICAM-1 expres-
sion after Ag challenge at sites of elicitation. 
0041
Severe recalcitrant and ulcerative mixed connective tissue disease responding to intravenous
immunoglobulin therapy
KL Hamacher, RA El-Azhary, MR Pittelkow and MD Davis Dermatology, Mayo Clinic, Rochester,
MN
High-dose IVIG has been used as a treatment modality in various diseases including dermatomyositis,
lupus erythematosus, scleroderma and pansclerotic morphea. The presentation will discuss IVIG
therapy for immune-mediated sclerosis syndromes and mechanisms of action. A 27-year old male
presented with a 3-month history of widespread painful skin ulcers and 40-pound weight loss asso-
ciated with prostration. Shortly after hospital admission, he developed acute Raynauds syndrome
with dry gangrene formation involving all digits. His course was complicated by widespread herpes
simplex infection, myositis, glomerulonephritis, interstitial lung disease and hemolytic anemia. Skin
biopsy showed morphea. Pertinent laboratory findings included pancytopenia, elevated antinuclear
and extractable nuclear antibodies and an elevated anti-U1 RNP. Initial treatment consisted of high-
dose Solumedrol, Mycophenolate Mofetil, Trental, Norvasc and Heparin. Despite intensive wound
care and aggressive immunosuppressive treatment for 3 months, he did not improve. High-dose IVIG
(0.5 mg/kg weekly) was initiated. Within 3 weeks, his ulcerations healed, his systemic manifesta-
tions and overall status significantly improved. His elevated autoantibodies are unchanged to date.
Mixed connective tissue disease is a rare disorder with overlapping features of scleroderma, systemic
lupus erythematosus and dermatomyositis. Extensive skin ulcers as seen in our patient have rarely
been described. The mechanism of action of IVIG is thought to be due to its ability to downregulate
an IgG transport receptor and therefore accelerate the rate of IgG catabolism. Pathogenic autoim-
mune antibodies are likely neutralized by this mechanism. In addition, it reduces fibrosis in tight
skin mice, probably by modulating TGF-beta and IL-4 expression. It inhibits T-cell proliferation,
modulates cytokine production and interferes with complement activation. IVIG also improves
opsonization and has antibacterial activity that may have contributed to the rapid healing of the
cutaneous ulcers. 
0040
Epitopes and pathogenic activity of anti-desmoglein-1 in a subset of pemphigus foliaceus patients
expressing only IgG1 autoantibodies
MK Hacker, M Janson, JA Fairley and M Lin Dermatology, Medical College of Wisconsin,
Milwaukee, WI
Pemphigus foliaceus (PF) is an immunobullous diseases characterized by superficial blisters and IgG
autoantibodies against the desmosomal antigen, desmoglein-1 (Dsg1). Previously, it was shown that
IgG1 and IgG4 are the predominant isotypes of autoantibodies in these patients and only the latter
isotype of anti-Dsg1 was capable of eliciting the experimental PF in neonatal mice. These results
suggest that these two subclasses of autoantibodies may recognize different epitopes or express dis-
tinct tissue specificity. Based on our recent study, it is clear that IgG1 anti-Dsg1 recognizes both lin-
ear and conformational epitopes but fails to bind mouse skin. Anti-Dsg1 of the IgG4 isotype, on the
other hand, only recognizes conformational epitopes, but is able to bind mouse skin. In this report,
we described a subset of PF patients (4 of 52) who only expressed IgG1 anti-Dsg1 throughout their
clinical courses. The sole IgG1 autoantibody profile in these patients was established by ELISA and
direct and indirect immunofluorescent studies. Furthermore, we found that the IgG1 anti-Dsg1
from this subset of PF patients was able to reproduce the clinical, histological, and immunological
features of the disease when injected into neonatal mice. Epitope analysis revealed that IgG1 anti-
Dsg1 from these patients recognized both linear and conformational epitopes. Furthermore, using
domain-swapped desmoglein proteins and recombinant Dsg1 fragments in ELISA and immunoblot-
ting experiments, respectively, we found that the conformational epitopes of anti-Dsg1 autoanti-
bodies are located at the N-terminus of Dsg1, whereas the linear epitopes are spread throughout the
ectodomain of Dsg1. Our results further illustrate the complexity of autoimmune responses in patients
with PF. 
0038
Construction of naive human antibody library and generation of anti-keratin antibodies
W Gang and L Yufeng Dermatology Center of Chinese PLA, Xijing Hospital, Xi, Shaanxi, China
Antikeratin(AK) autoantibodies is proved exist in human serum and is a very important element in
human immune system. For furthering the studies on AK autoantibodies, it is necessary to generate
antikeratin human monoclonal antibodies. The aim of our present study was to construct a large naive
human antibody library and then select anti-keratin antibodies from it. DNAs coding for κ chain and
Fd fragments of human IgG and IgM repertoires were amplified by PCR from the peripheral blood
mononuclear cells of non-immununized healthy donors and cloned into phagemid vector to construct
respectively light and heavy chain libraries. And then a Fab fragment phage library was generated
by combining the light chain and heavy chain genes. Human epidermal keratin was used as antigen
to select antibodies from the library. By combination of light chain and heavy chain genes, five indi-
vidual Fab fragment phage libraries each have approximately 0.5∼4∞108 independent clones were
generated and a total antibody library containing 1∞109 different clones was obtained. Three dif-
ferent specific phage antibodies against keratin were isolated by panning the library. One of them
could express soluble Fab fragments and recognize Mr 48 000 keratin specifically. DNA sequenc-
ing of the variable regions demonstrated that the VH and VL of the antibody come from the human
VH1 and Vκ2 families respectively. We conclude that the successful construction of the naive human
phage antibody library create favorable conditions for preparing human monoclonal antibodies by-
passing immunization. The produced anti-keratin antibody would be useful in the studies on keratin
and AK autoantibodies. 
0042
Cholinergic stimulation inhibits pemphigus IgG-induced acantholysis and ameliorates clini-
cal disease in a patient with pemphigus vulgaris
SA Grando,1 J Arredondo,1 A Chernyavsky,1 M Pittelkow,2 Y Kitajima3 and V Nguyen1 1
Dermatology, University of California Davis, Sacramento, CA, 2 Dermatology, Mayo Clinic,
Rochester, MN and 3 Dermatology, Gifu University, Gifu City, Japan
Pemphigus vulgaris (PV) is an autoimmune, IgG autoantibody-mediated disease of mucocutaneous
adhesion. Patients develop autoantibodies to adhesions molecules mediating intercellular cohesion
of keratinocytes and to keratinocyte cholinergic receptors regulating cell adhesion. To determine
whether a cholinergic agonist can abolish PV IgG-induced acantholysis, littermates of neonatal
athymic nude mice were injected with PV IgG simultaneously with 0.04 mg/g body weight of car-
bachol (CCh). None of mice injected with PV IgG simultaneously with CCh developed skin lesions.
To elucidate the mechanism of anti-acantholytic action of CCh, we measured the expression of adhe-
sion molecules in monolayers of normal human keratinocytes incubated overnight in the presence
of 0.25 mM of CCh, using semi-quantitative western blot and immunofluorescence. CCh caused ele-
vation of the relative amount E-cadherin in keratinocytes (P<0.05), without changing that of plako-
globin (P>0.05). Since phosphorylation plays an important role in determining function of adhesion
molecules, we also investigated the effects of CCh on pemphigus IgG-induced phosporylation of E-
cadherin and plakoglobin, using the DJM-1 cells. PV IgG increased the phosphorylation levels of
E-cadherin and plakoglobin, whereas in the presence of 0.5 mM of CCh this effect of PV IgG was
attenuated. Pyridostigmine bromide (PBr), an acetylcholinesterase inhibitor, produced effects sim-
ilar to those of CCh, which justified its administration to a patient with active PV that was resistant
to treatment with systemic glucocorticosteroids. The PV patient treated with PBr (Mestinon), 360
mg per day, demonstrated direct strong interrelationship between the use of the cholinomimetic and
the ability to maintain his pemphigus under control. Thus, novel anti-acantholytic therapies may be
developed using cholinergic drugs. 
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Elevation of IL-4 but not IFN-γ in the sera of patients with autoimmune chronic urticaria
W Sun,1 Z Bi1 and Y Wan2 1 Nanjing Medical University, Nanjing, China and 2 Providence
College, Providence, RI
Chronic urticaria has been long considered a disease of unknown origin. Recent investigation has
revealed that one third of patients with chronic idiopathic urticaria (CIU) have circulating func-
tional autoantibodies against the high affinity IgE receptor, Fc εR I or IgE, suggesting that this dis-
ease may be diagnosed by a positive intracutaneous autologous serum skin test. In this study, we
investigated whether the sera of patients with autoimmune chronic urticaria reflect predominance of
a Th1 or Th2 phenotype. Using the ELISA technique, we measured IL-4 and IFN-γlevel in the sera
of 40 chronic urticaria patients, including 15 patients with positive autologous serum skin test (ASST+)
and 25 patients with negative autologous serum skin test (ASST-), and 26 healthy control subjects.
We found that significant difference (p<0.005) existed of IL-4 levels in the sera of ASST+ chronic
urticaria patients (6.05±2.74 pg/ml) vs. healthy controls (3.74±1.25 pg/ml). IL-4 levels were also
elevated in ASST- chronic urticaria patients (5.46±3.02 pg/ml) compared to healthy controls (p<0.01).
No significant differences in IL-4 levels were observed between ASST+ and ASST- chronic urticaria
patients. No detectable levels of IFN-g were found in any sera of chronic urticaria patients and con-
trol subjects. We also observed a prevalent Th2 pattern in chronic urticaria patients. However, in
autoimmune chronic urticaria patients there is not a prevalence of Th1 or Th2 cytokine pattern com-
pared to ASST- chronic urticaria. 
0044
An animal model of atopic dermatitis: lesional skin immunophenotyping delineates a CD 4 +
T cell-predominated inflammatory infiltrate associated with up-regulation of adhesion mole-
cules
P Venkataramani,1 T Grzeszkiewicz,1 S Lin,1 B Prabhakar1 and LS Chan1,2 1 Dermatol &
Microbio/Immuno, Univ. of IL at Chicago COM, Chicago, IL and 2 VA Westside, Chicago, IL
An animal model of chronic, pruritic, inflammatory skin disease has been developed in an epider-
mally expressed IL-4 Transgenic (IL-4-Tg) mouse line closely resembling human atopic dermatitis
(AD) [J Invest Dermatol 2001; 117:977-83]. To define the in-situ inflammatory cell types and inflam-
matory mediators, immunofluorescence microscopy was performed on lesional and non-lesional
(NL) skin of 15 PCR-confirmed IL-4-Tg mice and on skin of 15 age-matched Non-Tg mice. Statis-
tical analyses performed, using a two-tailed Student t-Test at a 95% confidence level, showed a CD4+
T cells-predominated inflammatory infiltrate in lesional skin, a finding consistent with human AD.
Every one of the dermal inflammatory cell types examined were significantly increased in number
within lesional skin when compared with NL skin and Non-Tg mouse skin (all with a p value of
<0.0001): CD11a+ bone marrow-derived leukocytes, CD3+ T cells, CD4+ T cells, CD8+ T cells,
CD23+ macrophages, P-selectin glycoprotein ligand (CD162)+ leukocytes, L-selectin (CD62L)+
activated leukocytes. In the lesional dermis the CD3+ T cells composed nearly 30% of CD11a+
leukocytes while the CD4:CD8 T cell subsets ratio was 2.5:1. In the lesional epidermis, a few CD4+
T cells (0.27/high power field (HPF)) and CD8+ T cells (1.83/HPF) were detected, and IA/IE+ anti-
gen presenting cells were significantly increased when compared with NL skin (p<0.0001) and Non-
Tg mouse skin (p<0.0001). Whereas adhesion molecules were undetectable in NL and Non-Tg mouse
skin (except ICAM-1), they were highly expressed in lesional dermal blood vessels: ICAM-1 (5.47
vessels/HPF), VCAM-1 (1.96/HPF), E-selectin (4.41/HPF), P-selectin (7.91/HPF). Moreover, we
also detected prominent lesional keratinocyte expressions of VCAM-1 and ICAM-1, a reported find-
ing in human AD. Our data further support a close resemblance of our IL-4-Tg mouse disease
model with human AD. 
0045
Human beta-defensin expression in a new buccal epithelial tissue model
K Joseph,1 BA Dale,2 JR Kimball,2 B Breyfogle,1 PJ Hayden,1 JE Sheasgreen1 and M Klausner1 1
R & D, MatTek Corporation, Ashland, MA and 2 Oral Biology, University of Washington, Seattle,
WA
Oral epithelia function as microbial barriers against bacteria and yeast that are resident in the oral
cavity. These microbes can be categorized as non-pathogenic (commensal) and pathogenic (result-
ing in caries, gingivitis, and periodontal disease, etc.). The epithelium is actively involved in recog-
nition and response to bacteria, setting into motion the innate immune responses that are an impor-
tant part of periodontal health and disease. One epithelial response is the expression of antimicrobial
peptides of the human beta-defensin (hBD) family. A new, three-dimensional model of the human
buccal epithelium, based on normal human oral epithelial cells cultured in serum free medium, has
been developed. Histologically, the tissue is 20-30 cell layers thick with cells becoming increas-
ingly squamous toward the apical surface . No evidence of cornification is present and immuno-stain-
ing shows the expression of cytokeratin K13 in the suprabasal layers. Cytokeratin K4, the expres-
sion partner of K13, has also been detected by immuno-blotting.  These features are characteristic
of buccal epithelium. Additional immuno-staining revealed the presence of hBD-1 and the recently
discovered hBD-3 in the suprabasal layers; hBD2 was not expressed. The hBD-1 and hBD-2 results
parallel those of un-inflamed epithelia, however the hBD-3 result has not been previously reported.
Based on these initial results, further investigation of the tissue model’s hBD expression in unstim-
ulated and bacterially challenged tissue is warranted. 
0046
Avena Rhealba® inhibits arachidonic acid cascade, cPLA2 and COX2 expression in human
keratinocytes. Interest in cutaneous inflammatory disorders
M Aries,1 C Vaissiere,1 E Pinelli,2 B Pipy,3 M Charveron1 and Y Gall1 1 Cell Biology Research
Laboratory, Pierre Fabre Research Institute, Toulouse, Toulouse, France, 2 Ecole Nationale
Superieure d, Toulouse, Toulouse, France and 3 Institut National de la Sante et de la Recherche
Medicale, Toulouse, Toulouse, France
Prostaglandins and leukotrienes represent an heterogeneous family of lipid mediators involved in
inflammation and cell response regulation. During cutaneous inflammatory diseases, epidermal
eicosanoid biosynthesis is dysregulated. Soothing oatmeal preparations seem to achieve special ben-
efits on damaged skin and in patients suffering from eczema. Oatmeal extracts are present in cos-
metic formulations such as emollients, skin softeners, moisturizers and skin protectors. Avena
Rhealba®, a white oat species of Avena Sativa, is present in a variety of dermatological and anti-
irritant products, and has beneficial effects on skin inflammation. The aim of the present study was
to investigate the effects of Avena Rhealba® oatmeal extract on the cutaneous metabolism of arachi-
donic acid (AA) and eicosanoids, as well as on the expression of cPLA2 and COX2 in the human
keratinocyte cell line HaCaT. Avena Rhealba® was found to inhibit the A23187-triggered increases
in the levels of [3H]-arachidonic acid mobilization and of [3H]-labelled metabolites of the cyclooxy-
genase and 5-lipoxygenase pathways. A closer examination by enzymatic immunoassay EIA of the
effects of Avena Rhealba® on 6KPGF1α, the stable metabolite of PGI2 released in cell supernatants,
revealed the dose-dependent inhibition of this AA metabolite. Avena Rhealba® also decreased the
A23187-induced cPLA2 and COX2 expression, as shown by cPLA2 immunodetection, and as revealed
by RT-PCR analysis of cPLA2 and COX2 mRNA expression. Our results demonstrate the regulator
properties of Avena Rhealba® with respect to inflammatory response showing, therefore, a real inter-
est of Avena Rhealba® in cutaneous inflammatory disorders. 
0047
Efalizumab modulates an array of adhesion-related and activation-controlling surface pro-
teins on T lymphocytes and inhibits anti-CD3-induced T cell activation in adults with moder-
ate to severe psoriasis
Y Vugmeyster,1 K Howell,1 MF Chamian,2 MH Kagen,2 P Gilleaudeau,2 E Lee,2 W Dummer,1
S Pippig,1 B Hunte,1 S Bodary1 and JG Krueger2 1 Genentech, Inc., South San Francisco, CA and
2 Rockefeller U., New York, NY
The purpose of this study was to evaluate expression of adhesion molecules as well as numbers for
various T cell subsets in peripheral blood lymphocytes from 13 subjects with moderate to severe
plaque psoriasis treated with a humanized monocloncal antibody to CD11a (efalizumab). Flow cyto-
metric analyses of peripheral blood mononuclear cells were conducted on Days 0, 14, 28, and 56 of
treatment. Analysis of adhesion molecules revealed down-modulation of CD11a and CD18 on CD3+
lymphocytes persisting throughout the course of treatment. Similar to previously reported down-reg-
ulation of VLA-4, downmodulation was also observed for beta7 and, to some extent, for CD11b and
L-selectin markers. There were no significant changes in the levels of CD11c, CD44, and cutaneous
lymphocyte antigen. Down-modulation of the adhesion molecules is likely to contribute to the anti-
adhesive effects of efalizumab. T cell numbers in the peripheral blood were increased during treat-
ment. There was a marked increase in CD8+ memory cells, a T-cell population that is selectively
increased in psoriatic lesions. This suggests re-trafficking or blocked tissue entry of an important
disease-relevant cell population. Naive, but not effector CD8+ T-cell numbers were also increased,
consistent with reduced entry into lymph nodes. No clear treatment-related pattern in Type 1 to
Type 2 T cell ratio was noted. A decrease in the expression levels of CD4, CD8, CD2, and T-cell
receptor alpha- and beta-chains on T cells was also observed, whereas CD3 expression stayed rela-
tively constant. Using a T cell activation assay in which an antibody to CD3 induces increased expres-
sion of CD25 and CD69 activation markers, we observed that efalizumab treatment inhibits this
response. This is the first demonstration in humans that inhibition of activation is a mechanism of
action of efalizumab. 
0048
Macrophage migration inhibitory factor expression by human dermal microvascular
endothelial cells in response to thrombin and factor Xa
T Shimizu, J Nishihira, R Abe, H Watanabe, A Honda and H Shimizu Dermatology, Hokkaido
University Graduate School of Medicine, Sapporo, Hokkaido, Japan
Activated coagulation factors, aside from their critical role in thrombosis, also have inflammatory
properties and these may be important during wound healing. Thrombin and factor Xa (FXa) are
key proteases in the coagulation cascade and promote tissue repair responses. Both thrombin and
FXa evoke a proinflammatory response in endothelial cells. Macrophage migration inhibitory fac-
tor (MIF) is a proinflammatory cytokine, that has now been implicated in skin wound healing
processes. This study investigated whether thrombin and FXa can upregulate MIF expression in
human dermal microvascular endothelial cells (HDMEC). Thrombin increased MIF mRNA levels
and stimulated the release of MIF protein in a time- and concentration-dependent manner by HDMEC.
Thrombin-induced MIF mRNA expression was significantly reduced by thrombin-specific inhibitor
hirudin. A synthetic thrombin receptor agonist peptide (TRAP-6) induced MIF mRNA expression;
indicating that the protease-activated receptor (PAR)-1 may be important in mediating MIF expres-
sion. Exposure of cells to FXa also stimulated the production of MIF. The effects of FXa were blocked
by antithrombin III, but not by hirudin, suggesting that FXa elicits these responses directly and not
via thrombin. In this study, we have also demonstrated that PAR-1 and PAR-2 mRNA expression
was upregulated by MIF treatment in HDMEC. In conclusion, these findings suggest that HDMEC
may be a significant source of MIF in the inflammatory response to skin injury, and that MIF pro-
duction is an important biologic consequence of PAR-1 and PAR-2 induction. 
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Calcitonin gene-related peptide and adrenomedullin down-regulate cytokine-induced microvas-
cular endothelial cell adhesion molecule expression
TE Scholzen,1 M Fastrich,1 T Brzoska,1 S Grundmann,1 CA Armstrong,2 JC Ansel2 and TA Luger1
1 Dermatology & Ludwig-Boltzmann Inst., Univ. of Muenster, Muenster, Germany and 2
Dermatology, Northwestern Univ., Chicago, IL
Adrenomedullin (ADM) and the related neuropeptide calcitonin gene-related peptide (CGRP) are
potent vasodilators and potentially capable of modulating biologic functions of epidermal and der-
mal cells. CGRP and ADM activate high-affinity G-protein coupled receptors consisting of recep-
tor-activity modifying proteins (RAMPs) and a seven-transmembrane domain calcitonin receptor-
like receptor (CRLR) with RAMP-1/CRLR as CGRP and RAMP2/CRLR as presumed ADM
receptors. In this study we have tested the hypothesis that endothelial cell (EC) adhesion molecule
(ICAM-1, VCAM-1) expression in human dermal microvascular EC (HDMEC) transfected with
CGRP/ADM receptor components is modulated by CGRP or ADM, respectively. HDMEC isolated
from human foreskins or cells of the EC line HMEC-1 were transfected with cDNA expression vec-
tors for RAMP-1, RAMP-2 and CRLR with efficacies of 40 - 50%. Stimulation of EC overexpress-
ing R1/CRLR or R2/CRLR with CGRP or ADM (0.01-1000 nM), respectively, resulted in a dose-
dependent upregulation of intracellular cAMP indicating that the receptors are functional. Importantly,
stimulation of HDMEC cells transfected with R1/CRLR or R2/CRLR with TNFα in combination
with CGRP or ADM revealed a reduction of the TNF-induced expression of ICAM-1 and VCAM-
1. However, neither transfection of HDMEC with the orphan CRLR nor R1 and R2 alone was suf-
ficient to mediate full cAMP induction or reduction of TNFα-induced adhesion molecule expres-
sion, which confirms the notion that RAMP expression is essential for CGRP/ADM receptor function
and pharmacology. Thus, these novel data suggest that CGRP and even more pronounced ADM by
activating high-affinity CGRP and ADM receptors increase intracellular cAMP and are capable of
antagonizing TNFα-induced EC ICAM-1 or VCAM-1 expression, which may be of importance for
the regulation of leukocyte-endothelial cell interaction during cutaneous neurogenic inflammatory
responses. 
0051
Th1 predominance of fluorouracil-induced discoid lupus erythematosus in TCR α chain knock-
out mouse
T Yoshimasu,1 F Furukawa,1 T Ohtani,1 A Hiroi1 and N Seo2 1 Wakayama Medical University,
Wakayama, Japan and 2 Hamamatsu University School of Medicine, Hamamatsu, Japan
Fluorouracil (FU) is well known to induce discoid lupus-like eruption in Japan. It is still obscure
which cytokines are involved in the development of DLE. In this study, we established the murine
model of FU-induced discoid lupus and studied the immunological characteristics of models of
C57BL/6J (B6) mice, TCR α KO mice, and TCR δ KO mice treated with FU and UVB. FU was dis-
solved with PBS and intraperitoneal injection (0.2mg or 2mg) was performed every two day. UVB
(200mJ/cm2 ) was irradiated to relative mice 5 times a week. Experimental group were as follows;
PBS injection group, FU injection group, UVB irradiation group and the group of FU injection +
UVB irradiation. TCR α KO mice treated with 0.2mg FU + UVB showed rapidly and frequently
marked erythema at the neck and back with positive subepidermal IgG deposits. B6 mice treated
with 2mg FU and UVB developed a slight erythema around the neck. B6 mice treated with PBS or
FU alone had no changes. B6 mice treated with UVB and TCR α KO mice treated with FU showed
high frequency of hyperkeratosis and perivascular lymphoid cell infiltration. CD 4+ T cells were pre-
dominantly observed in dermis of skin lesions. CD 8+ T cells also appeared slightly in epidermis
and dermis in the skin lesions. In the skin lesions of TCR α KO mice treated with 0.2mg FU + UVB,
Th1 type cytokine production such as IFN-γ and TNF-α were predominant by RT-PCR methods.
However, anti-nuclear antibody of this group was low as well as other groups without eruption. We
established drug-induced DLE model with using FU and UVB irradiation. We proposed that the asso-
ciation of Th1 type cytokine and T cells was pathogenic in the mechanism of drug induced DLE as
well as idiopathic CCLE. 
0053
VEGFR-2 antibody accelerates disease activity in lupus-prone NZB/W F1 mice
H Watanabe,1 AJ Mamelak,1 AK Brice,2 E Weiss,1 L Wachtman,2 B Wang,1 I Freed,1
KL Gabrielson,2 N Yokota,3 DJ Hicklin,4 RS Kerbel5 and DN Sauder1 1 Dermatology, Johns
Hopkins University, Baltimore, MD, 2 Comparative Medicine, Johns Hopkins University,
Baltimore, MD, 3 Nephrology, Johns Hopkins University, Baltimore, MD, 4 Immunology Division,
ImClone Systems Inc., New York, NY and 5 Cancer Biology Research, Sunnybrook and Women,
Toronto, ON, Canada
Inhibition of angiogenesis has shown significant promise in the treatment of solid tumors. Angio-
genesis inhibitors have also demonstrated benefit in certain inflammatory and autoimmune dis-
eases, including psoriasis. Vascular endothelial growth factor (VEGF) is one of the main mediators
of angiogenesis. In Systemic Lupus Erythematosus (SLE), levels of VEGF have been correlated with
some clinical and laboratory parameters, as well as overall disease activity. To further examine the
role of VEGF in SLE we examined the effect of anti-VEGF receptor-2 (VEGFR2) antibody treat-
ment using the murine model for SLE (the NZB/W F1 mouse). We hypothesized that anti-VEGFR2
would delay the onset of clinical disease and reduce mortality. Anti-VEGFR2 antibody was admin-
istered IP to NZB/W F1 mice (beginning at 6-8 weeks of age) every three days. After 12 weeks of
treatment, the anti-VEGFR2 antibody-treated group displayed decreased renal function and moder-
ate (2+) proteinuria, with severe (3+) proteinuria by 18 weeks. In contrast, the control group demon-
strated trace proteinuria at 12 weeks, with 1+ - 2+ proteinuria by 18 weeks. Histopathologic exam-
ination of kidneys demonstrated advanced membranous glomerulonephritis at 12-14 weeks. These
changes, although present, were significantly less prominent in the PBS control group. Mortality at
18 weeks was 76%, compared to 21% in the control mice. Thus, anti-VEGFR2 antibody treatment
accelerated the severity of renal disease and mortality rate in this murine model of SLE. If these find-
ings can be extrapolated to human studies, our findings could have profound implications on anti-
angiogenesis therapies in patients with underlying autoimmune disorders. 
0052
The α-defensin HNP-1 inhibits superantigen-mediated T cell activation
WH Boehncke Dermatology, Johann Wolfgang Goethe-University, Frankfurt, Hessen, Germany
T-cells recognize antigen in the context of antigen-presenting HLA molecules. Antigens are typi-
cally up to 24 amino acids long and bind to the HLA binding groove in an extended conformation.
To identify potential autoantigens in psoriasis, lesional epidermis from patients was removed using
a dermatome. Subsequently, HLA class-II bound peptides were acid-eluted from keratinocytes.
Peptide fractions obtained by HPLC were submitted to microsequencing by Edman degradation.
Two dominant molecules were identified as α-defensins HNP-1 and -2. Their masses indicate unusual
lengths of 30 and 29 amino acids, respectively. Utilizing molecular modelling, an HLA binding super-
motif can indeed be identified. Bulky” peptides could prevent a bridging between HLA molecule
and T-cell receptor, which is a prerequisit for T-cell activation by bacterial superantigens. To test
this hypothesis, T-cells were incubated with staphylokokkal superantigens SEA and SEB in the pres-
ence of HNP-1. In agreement with the hypothesis, a dose-dependent inhibition of the expression of
activation markers as well as cytokine secretion was observed. To date, defensins have only been
isolated from HLA class-II molecules of cell types expressing them upon stimulation, e.g. in inflam-
mation. Defensins are capable of out-competing antigen (Blood 2000, 95: 2890) and of blocking
superantigen-mediated T-cell activation. Hence, they might play an important role during down-
regulation of inflammation. Given the function of superantigens as triggers for psoriasis, this mode
of action could also be explored therapeutically. 
0050
The localization of autoantigens in SPD-type and IEN-type of IgA pemphigus—post embed-
ding immunoelectron microscopic study
N Ishii,1 T Hashimoto1 and A Ishida-Yamamoto2 1 Department of Dermatology, Kurume Univercity
School of Medicine, Kurume, Fukuoka, Japan and 2 Department of Dermatology, Asahikawa
Medical College, Asahikawa, Hokkaido, Japan
IgA pemphigus is a rare autoimmune bullous disease characterized by IgA deposition at keratinocyte
cell surfaces. Clinically and histologically, IgA pemphigus is divided into two major subtypes; sub-
corneal pustular dermatosis (SPD) type and intraepidermal neutrophilic IgA dermatosis (IEN) type.
Using cDNA transfection and living cell immunofluorescence, we previously showed that, desmo-
collin 1, one of desmosomal cadherins, is the autoantigen in SPD-type of IgA pemphigus, but the
autoantigen in IEN-type is still unclear. In the present study, we investigated antigen localization by
using a post-embedding immunoelectron microscopy. We examined three sera each of SPD type
and IEN type of IgA pemphigus. In the SPD-type, the majority of gold particles were observed in
the intercellular spaces between keratinocytes at the desmosomal areas. No significant labeling was
observed elsewhere. In the IEN-type, the gold particles were mainly observed in the intercellular
spaces in the non-desmosomal areas. These results confirm that the IgA in the sera of SPD type IgA
pemphigus react with extracellular domain of desmocollins. In contrast, the autoantigen for IEN type
may not be desmosomal proteins. IEN type IgA pemphigus may be the first pemphigus group of
autoimmune bullous dermatosis which reacts with non-desmosomal transmembranous protein. 
0054
Anti-inflammatory effect of peroxisome proliferator-activated receptor agonists through the
suppression of nuclear factor κB in human epidermal keratinocytes
M Ikeda, Y Hirose, R Hamada, M Seike, M Matsumoto and H Kodama Dermatology, Kochi
Medical School, Nankoku, Kochi, Japan
Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors belong-
ing to the nuclear receptor family. We showed that the agonists to PPAR-α and -γ strongly inhibited
interleukin (IL)-1β-induced IL-8 synthesis by cultured normal human epidermal keratinocytes
(NHEKs) at mRNA and protein levels. To clarify the mechanisms involved in this anti-inflamma-
tory process, we examined the effect of PPAR-γ agonists on nuclear factor κB (NF-κB) and IκB, a
ubiquitous transcription factor and its inhibitory molecule, by immunohistochemical staining and
electrophoretic mobility shift assay. A PPAR-γ agonist, 15-deoxy-∆12, 14-prostaglandin J2 (PGJ2),
enhanced the expression of IκB in the cytoplasm. PGJ2 inhibited the nuclear translocation of NF-
κB in IL-1β-stimulated NHEKs. Troglitazone, another PPAR-γ agonist, did not show the inhibitory
effect on NF-κB activation. These findings indicate that the anti-inflammatory effect of PPAR-γ ago-
nists takes place through at least two pathways, namely NF-κB-dependent and NF-κB-independent
pathways. 
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CD4+ T cell-associated pathophysiology critically depends on CD18 gene dose effects in a murine
model of psoriasis
D Kess,1,2 T Peters,1,2 J Zamek,2 C Wickenhauser,3 S Tawadros,2 C Sunderkotter,4 W Muller,5
T Krieg2 and K Scharffetter-Kochanek1 1 Dermatology and Allergy, University, Ulm, Germany, 2
Dermatology, University, Cologne, Germany, 3 Pathology, University, Cologne, Germany, 4
Dermatology, University, Munster, Germany and 5 Experimental Immunology, GBF,
Braunschweig, Germany
Previously, a CD18 hypomorphic polygenic PL/J mouse model with severe reduction of CD18 (β2-
integrin) of 2-16% of the wild-type results in the development of a psoriasiform skin disease. To
investigate the interrelationship of reduced CD18 gene dose effects on T cells in the pathogenesis
of this dermatitis, immunostainings and in vivo depletion experiments were performed. CD4+ and
CD8+ T cells were significantly increased in the skin of affected CD18 hypomorphic compared to
wild-type mice. Depletion of CD4+ T cells, but not of CD8+ T cells, resulted in a complete resolu-
tion of the severe psoriasiform dermatitis, indicating a central, CD8+ T cell independent role of CD4+
T cells in the pathogenesis of the disease. In contrast to the CD18 hypomorphic PL/J mice, CD18
null mutants of the same strain did not develop the psoriasiform dermatitis. This is in part due to a
lack of T cell emigration from blood vessels of the skin, as after oxazalone challenge, allergic con-
tact dermatitis could be induced in CD18 hypomorphic and wild-type mice but not in CD18 null
mutants. Hence, 2-16% of CD18 gene expression is obviously sufficient for T cell emigration driv-
ing an inflammatory phenotype in CD18 hypomorphic PL/J mice. Our data suggest that the patho-
genic involvement of CD4+ T cells depends on a gene dose effect with reduced expression of the
CD18 protein in the underlying mouse model. This inflammatory skin model may have general rel-
evance to polygenic human inflammatory diseases. 
0056
Th1 and Th2 cytokine mRNA profiles in a murine scleroderma model
J Tao, Y Zhang and AC Gilliam Dermatology, Case Western Reserve University, Cleveland, OH
We have investigated T helper cell (Th1 and Th2) cytokine mRNA levels in skin from a murine model
for scleroderma, sclerodermatous graft versus host disease (mScl GVHD). Bone marrow and spleen
cells from B10.D2 (H-2d) mice were transplanted to lethally irradiated BALB/cJ (H-2d) mice. The
transplanted mice developed cutaneous monocyte/macrophage and T cell infiltrates, skin thicken-
ing, and lung fibrosis, while syngeneic transplanted mice showed no disease. We analyzed a panel
of Th1 (IFN-γ, IL-2) and Th2 (IL-5, IL-6, IL-10, IL-13) cytokines by assessing the levels of skin
total RNA with semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR). IFN-
γ, IL-2, and IL-10 mRNAs were up-regulated during development of skin fibrosis consistent with
both Th1 and Th2 profiles in this animal model for chronic scleroderma. This result is similar to the
mixed Th1/Th2 profile in human scleroderma, in which the cytokine profile may be a useful sero-
logic marker for severe disease. Of interest, cytokines (IFN-γ and IL-10) that inhibit collagen pro-
duction by fibroblasts in vitro were paradoxically elevated in vivo as fibrosis developed, suggesting
a complex immunomodulatory environment in early fibrosing disease. 
0057
Regulatory role for macrophage migration inhibitory factor in TNCB-induced allergic contact
dermatitis
I Takeuchi,1 Y Kusakari,1 J Matsunaga,1 T Terui,1 J Nishihira2 and H Tagami1 1 Department of
Dermatology, Tohoku University School of Medicine, Sendai, Miyagi, Japan and 2 Department of
Molecular Chemistry, Hokkaido University Graduate School of Medicine, Sapporo, Japan
The cytokine macrophage migration inhibitory factor (MIF) has emerged to be an important regu-
lator of the inflammatory response and is critically involved in the development of septic shock,
arthritis, hepatitis, and glomerulonephritis. Although MIF expression was limited to the basal layer
in normal human epidermis, it was reported that MIF expression was markedly up-regulated in var-
ious skin conditions such as atopic dermatitis, psoriasis, and UVB-induced dermatitis. In this study,
we sensitized 10-week old C3H female mouse by 2,4,6-trinitrochlorobenzene (TNCB). Western-blot
analysis showed that highest expression level of MIF in the ear skin was seen at 1 h after the elici-
tation and the up-regulation continued to 6 h in comparison with the basal level (0 h). We also meas-
ured dopachrome tautomerase activity of MIF using the same samples and observed that MIF enzyme
activity was elevated in the same time-course manner as shown in western-blotting.
0058
Saccharomycopsis ferment filtrate inhibit lipopolysaccharide-induced inflammatory effect
S Shen,2,1 W Lee,4,3 C Hu2,1 and T Yoshii5 1 Dermatology, Taipei Municipal Wan-Fang Hospital-
Affiliated to Taipei Medical University, Taipei, Taiwan, 2 Dermatology, Taipei Medical University,
Taipei, Taiwan, 3 Dermatology, Taipei medical university hospital, Taipei, Taiwan, 4 Institute of
Medical Science, Taipei Medical University, Taipei, Taiwan and 5 Tecnique center, Procter and
Gamble, Kobe, Japan
Yeast extracts have been used extensively to perform several beneficial biological activities; how-
ever, the mechanism is still undefined. In the present study, we provided evidences to demonstrate
that saccharomycopsis ferment filtrate (SFF) is able to inhibit lipopolysaccharide (LPS)-induced
nitric oxide (NO) production in a concentration-dependent manner without notable cytotoxic effects
on cells by MTT assay. A decrease in NO production by SFF was associated with an induction of
heme oxygenase-1 (HO-1) protein expression and an inhibition in iNOS protein by Western blot-
ting. Hemin, a HO-1 inducer, dose dependently induced HO-1 protein, was accompanied by a sup-
pression in iNOS protein expression. Furthermore, addition of hemin stimulated SFF-induced HO-
1 protein, at the same time, potentiated the inhibitory effects of SFF on LPS-induced NO production
and iNOS protein expression. These results provided an interesting correlation between HO-1 induc-
tion and NO inhibition, and predicted SFF inhibited LPS-induced NO production might be medi-
ated by HO-1 induction. 
0059
Involvement of apoptosis in bleomycin-induced scleroderma
T Yamamoto and K Nishioka Dept. of Dermatology, Tokyo Medical and Dental University, Tokyo,
Tokyo, Japan
We previously established a mouse model for scleroderma induced by repeated injections of bleomycin
(BLM). In this study, we examined the possible involvement of apoptosis in the development of der-
mal sclerosis induced by BLM. TUNEL analysis showed positive staining in keratinocytes and
infiltrating mononuclear cells following BLM treatment. TUNEL-positive fibroblasts were also scat-
tered, but not endothelial cells. DNA fragmentation was detected at 3 and 4 weeks after BLM expo-
sure. Fas and FasL expression was upregulated at protein and mRNA levels. Expression as well as
activity of caspase-1 and -3 was also increased following BLM exposure. These findings suggest an
important role of apoptosis in the pathogenesis of bleomycin-induced scleroderma. 
0060
Immunosuppression by induction of heme oxygenase 1: in vitro mechanism and effect in mod-
els of allergic contact dermatitis
J Listopad, C Schoenbein, R Sabat, K Asadullah and W Doecke Experimental Dermatology,
Schering AG, Berlin, Germany
The strong antiinflammatory and immunosuppressive potency of the stress protein heme oxygenase
1 (HO-1) has been proven in many models of inflammatory injury and autoimmunity. Hitherto, the
underlying immune mechanisms have been poorly understood, and no data are available about the
effect of HO-1 induction in models of inflammatory dermatoses. In our study, the potent HO-1 inducer
Cobalt-Protoporphyrin IX (Co-PP) strongly suppressed T-cell proliferation in mixed lymphocyte
reaction (MLR). This inhibition was due to a depression of antigen-presenting capacity, accessory
molecule expression, and stimulatory cytokine secretion of monocytes. In vivo, dendritic cells (DC)
represent the main antigen-presenting cells. Remarkably, the HO-1 inducer Co-PP led to an almost
complete inhibition of the differentiation, maturation, and function of monocyte-derived dendritic
cells. So, a strong decrease of the expression of DC markers (CD1a, CD83) and accessory mole-
cules (HLA-DR, CD86) was observed accompanied with an increase of the expression of phago-
cytic receptors (CD14, CD16). Together these changes indicated a switch of the DCs to an imma-
ture and macrophagic phenotype. In fact, the antigen-presenting capacity of Co-PP-treated
monocyte-derived DCs was strongly diminished in MLR with allogeneic CD4+ T-cells. The in vivo
immunosuppressive activity of HO-1 induction was tested in DNFB (Type 1) and TMA (Type 2)
models of ear inflammation in mice. Treatment with the HO-1 inducer Co-PP at 24h before chal-
lenge dose-dependently depressed ear edema, infiltration, and cytokine levels. Importantly, Co-PP
also strongly suppressed T-cell-dependent inflammation when applied around sensitisation to pre-
vent the initiation of the specific immune response. We hypothesise that the inhibition of DC matu-
ration and function is the crucial mechanism for this immunosuppressive activity of HO-1 induction
which may represent a novel approach for the treatment of T-cell mediated dermatoses like psoria-
sis, contact eczema, and atopic disease. 
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Human bullous pemphigoid antigen 2 (hBPAG2) in transgenic murine skin elicits immune
responses in wild type (wt) mice that show fidelity to those seen in patients with bullous pem-
phigoid
E Olasz,1 J Roh,2 C Yee,2 J Vogel,2 K Arita,3 M Akiyama,3 H Shimizu3 and KB Yancey1 1
Dermatology, Medical College of Wisconsin, Milwaukee, WI, 2 Dermatology Branch, NCI, NIH,
Bethesda, MD and 3 Dermatology, Hokkaido University Graduate School of Medicine, Sapporo,
Japan
BP is a subepidermal blistering disease characterized by IgG autoantibodies against BPAG2, a type
II transmembrane collagen that promotes adhesion of basal keratinocytes to epidermal basement
membrane (BM). To model experimental immune responses against this protein, we produced
C57BL/6 Tg mice expressing hBPAG2 in murine epidermis under the control of a human keratin 14
promoter. Monoclonal and polyclonal antibodies identified hBPAG2 in the epidermal BM of Tg
mice; post-embedding immunogold electron microscopy of cryofixed and cryosubstituted Tg skin
showed that the carboxyl terminus of hBPAG2 was appropriately localized beneath hemidesmo-
somes within the superior aspect of the lamina densa. Grafts of Tg skin placed on gender-matched,
syngeneic wt mice elicited IgG that bound: 1) human and Tg epidermal BM; 2) BPAG2 extracted
from human keratinocytes; and 3) the NC16A domain of hBPAG2. Production of such IgG in naive
mice was prompt (detectable within 17±3 days), robust (titer > 1280), and durable (present >270
days). Lymph nodes and splenocytes from wt mice grafted with Tg skin contained T cells that dis-
played antigen-specific proliferative responses to the NC16A domain of hBPAG2. Anti-hBPAG2
IgG did not develop in MHC class II -/- mice grafted with Tg skin, indicating that cognate interac-
tions between T cell receptor/peptide-class II MHC determinants were crucial for antigen-specific
IgG production in this model. Grafts of hBPAG2 Tg skin on syngeneic wt mice elicited B and T cell
responses against the same portion of hBPAG2 that is bound by autoantibodies and T cell lines from
patients with BP. This Tg approach has yielded an experimental model in which immune responses
to hBPAG2 can be elicited, characterized, and potentially modulated or blocked in vivo. 
0063
Level of vascular endothelial growth factor is elevated in atopic dermatitis
H Matsuo, Y Zhang, E Morita and S Dekio Dermatology, Shimane Medical University, Izumo,
Shimane, Japan
Atopic dermatitis (AD) is a chronic inflammatory dermatosis occurring mostly on the basis of atopic
diathesis. The characteristics of AD skin lesions are continuous erythema and recurrent exudative
change due to hyperpermeability. Vascular endothelial growth factor (VEGF), of which six distinct
splice variants (VEGF 121, 145, 165, 183, 169, 206) have been described, plays an important role
in the vascular permeability and angiogenesis associated with many malignant tumors. Recently, in
inflammatory dermatosis, such as psoriasis, expression of VEGF was found to be enhanced in the
epidermis of the lesions. In this study we investigated the level of VEGF in the lesional scales of
patients with AD to know an involvement of VEGF in the pathogenesis of AD. The contents of VEGF
were measured using an ELISA kit and the molecular mass of VEGF was determined by western
blot analysis of proteins immunoprecipitated with agarose conjugated anti-VEGF antibody. As a
result, the level of VEGF in the lesional scales was 202±120 pg/mg scale, n=23, and was signifi-
cantly high compared with that obtained from normal scales of the patients(10.3±5.6 pg/mg scales,
n=23). The result suggests that VEGF is involved in the inflammatory process of AD and blockade
of the action may be a new therapeutic strategy for AD. On immunoblotting, two bands, 20 and 15
kDa were detected possibly corresponding to VEGF165 and 121, but not in normal scales. 
0065
Differentiation of subepidermal autoimmune bullous diseases in laser scanning confocal
microscopy
K Wozniak and C Kowalewski Dermatology, University of Medicine in Warsaw, Warsaw, Poland
We studied 50 patients fulfilling clinical and immunelectron microscopic criteria for bullous pem-
phigoid-BP (38) cicatricial pemphigoid-CP (7) and epidermolysis bullosa acquisita (5). Laser scan-
ning confocal microscopy (LSCM) technique was used to perform three dimentional reconstruction
(3D) of basement membrane zone (BMZ) as well as to determine the localization of the in vivo bound
IgG at the BMZ in patients skin in compare to the localization of lamina lucida and lamina densa
markers. In vivo bound IgG were visualized by labeling with FITC-conjugated goat anti-human
IgG antibody, whereas BMZ markers were labeled with anti-mouse Cy5-conjugated antibodies. Exci-
tation of FITC and Cy5 was simultaneously performed with laser lines of 488 nm and 637 nm respec-
tively. In BP in vivo bound IgG was localized on the epidermal side of laminin-5 and co-localized
with beta4 -integrin. In CP cases IgG was in vivo bound at the dermal-epidermal junction between
localization of laminin-5 and collagen IV. In EBA in vivo bound IgG was found to be present on the
dermal side of collagen IV. 3D reconstruction of various regions of BMZ was performed in 20 microm-
eters thick perilesional patients skin with BP (3), CP (3) and EBA (3). A stack of 40 optical slides
was collected automatically every 0.5 micrometers step with the scan speed 166Hz by computer pro-
gram integrated with LSCM. Our studies revealed only numerous invaginations of BMZ on the
level of lamina lucida and lamina densa in BP and CP. In EBA we noticed discontinuous staining on
the level of sublamina densa region and large clumps of collagen VII vertically orientated to the BMZ
extending into the deep dermis. LSCM allows differentiation of autoimmune subepidermal bullous
diseases. These methods are of special value in those cases in which circulating autoantibodies are
not detectable. 
0064
The immunofluorescence pattern induced by sera from patients with palmoplantar pustulo-
sis
E Hagforsen and G Michaelsson Department of Medical Sciences, Dermatology, University of
Uppsala, Uppsala, Sweden
PPP patients have an increased prevalence of autoimmune diseases. We have recently reported that
47% of sera (n=45) from patients with PPP give an immunofluorescence (IF) of the papillary endothe-
lium in palmar skin from healthy subjects. The aims of this study was a) to screen a larger group of
PPP patients (n=89) with regard to IF in the palmar skin in order to confirm our first results; b) to
screen other skin areas (elbow, scalp, gluteal region) for IF and c) to screen non-dermal tissues (thy-
roid gland, parathyroid gland, pancreas, liver, kidney, intestine) for IF with indirect immunofluo-
rescence technique. All specimens were from healthy subjects and other normal tissue specimens
had been removed in conjunction with surgery. Furthermore, PPP sera were screened for the pres-
ence of bands specific for PPP with Western blot on homogenates from palmar skin from a healthy
smoker. Forty-seven percent of the 89 PPP sera gave an IF of palmar endothelium (from healthy
donors). IF was unchanged when sera were taken from the same patient at several occasions over a
period of up to 5 years (n=8). Sera which induced an IF in palmar skin also gave an IF in elbow and
gluteal skin but only of the inner surface of the vessel and there was no chain-like pattern as in the
palm. The endothelium in the scalp was, however, negative. IF positive sera also induced an IF of
endothelium in the parathyroid gland and also -but much less pronounced - in the thyroid gland,
pancreas, liver, kidney, intestine. For comparison sera from healthy subjects and from patients with
hand eczema were also screened and gave no IF. With Western blot PPP sera showed reactivity against
4 different (not identified) antigens from palmar skin with molecular weights from 33 to 43 kDa.
None of these bands were observed with control sera. The immunofluorescence results indicate that
PPP may be a systemic autoimmune disease involving the endothelium. 
0062
Cleavage of desmosomes occurs without keratin retraction in vivo in pemphigus vulgaris model
mice
A Shimizu, A Ishiko, K Tsunoda, T Ota, M Amagai and T Nishikawa Dermatology, Keio University
School of Medicine, Tokyo, Japan
Pemphigus vulgaris (PV) is an autoimmune blistering disease caused by IgG autoantibodies against
desmoglein3 (Dsg3). The exact mechanism of blister formation after IgG autoantibody binding is
still unknown and three mechanisms are proposed: 1) keratin retraction, 2) specific depletion of Dsg3
from desmosomes (DMs) and 3) direct inhibition of the adhesive function of Dsg3. Previously, we
have demonstrated that Dsg3 in DMs is fully accessible in vivo by IgG autoantibodies and that
Dsg3 is not apparently depleted from DMs in vivo by immunoelectron microscopic studies with PV
model mice. In this study we focused on acantholytic and non-acantholytic lesions of PV model mice
by immunoelectron microscopy to elucidate the molecular mechanism of blister formation. A lot of
half-split DMs were found at the blister roof (basilar surface of suprabasilar cells) as well as floor
(apical surface of basal cells) in acantholytic area of PV model mice, and the half-split DMs were
decorated with IgG and their plaques were accompanied with keratin filament insertion. Desmo-
plakin was detected between keratin filaments and attachment plaques of the half DMs as much as
observed in DMs in non-acantholytic areas. A few degrading DMs, which were decorated with IgG
and lacked connection of keratin filaments, were found at the lateral surface, but not at the apical
surface, of the basal keratinocyte in both acantholytic and non-acantholytic lesion. In those degrad-
ing DMs, desmoplakin was localized at the end of keratin filaments in the cytoplasm indicating ker-
atin filaments retract from DMs with desmoplakin attached. These results indicate that the cleavage
of DMs takes place without keratin filament retraction from the attachment plaques in vivo. Together
with our previous finding that Dsg3-/- mice form a lot of half-split DMs in the acantholytic area, our
current findings strongly suggest that blister formation in PV is mainly induced by loss of function
of the desmosomal Dsg3 in vivo but not by keratin retraction. 
0066
Successful treatment of autoimmune urticaria with a combination of plasmapheresis and intra-
venous corticosteroid
E Morita,1 S Honda,1 H Matsuo,1 T Tanaka,2 M Hide2 and S Dekio1 1 Dermatology, Shimane
Medical University, Izumo, Shimane, Japan and 2 Dermatology, Hiroshima University, Hiroshima,
Hiroshima, Japan
A 66-year-old woman presented with a 5-months history of urticaria unresponsive to H1-antago-
nists. Histological examination of the lesion revealed no sign of vasculitis. No significant abnor-
malities were found on physical examination, or laboratory examination including urinalysis, com-
plete blood cell count, serum electrolytes, liver function tests, creatinine, blood urea and nitrogen
and total serum IgE. Specific IgE antibodies in the serum were not detected. Intracutaneous testing
of autologous serum revealed a 12 x 10-mm wheal and flare reaction. Histamine-releasing test with
the serum showed 28% histamine release from basophils of a healthy donor, and this was signifi-
cantly enhanced (81%) when IgE on the cells were stripped by lactate-treatment, suggesting the anti-
FceRI-alpha antibodies (competitive type) in the serum. Theurticaria was partially reactive to the
intravenous corticosteroid but the wheal was refractory. Then the patient was treated with plasma-
pheresis (4 times) and intravenous immunoglobulin (0.4g/kg/day for 5 days) followed by intravenous
corticosteroid (500mg/day for 3 days). After the treatment there was a complete remission for more
than 3-months. Repeat intracutaneous testing and histamine-releasing test to autologous serum became
negative, indicating an abrogated autoantibody response. The result suggests an involvement of
autoantibodies in the urticaria and efficacy of a combination of plasmapheresis and intravenous cor-
ticosteroid in this case. 
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BDCA-2 and CD91 are co-expressed by plasmacytoid dendritic cells in skin lesions of subacute
cutaneous lupus erythematosus, discoid LE, and dermatomyositis
D Racila and RD Sontheimer Dermatology, Univ. of Iowa College of Medicine, Iowa City, IA
INF-α/Β-producing, CD11c(-), CD123[high] antigen-presenting PDC might play a role in the patho-
genesis of both the systemic and cutaneous features of LE. We have begun studies to further char-
acterize the phenotype of this cell and to determine its specificity for different clinical types of cuta-
neous LE as well as related autoimmune skin disorders. Lesional biopsies were collected from patients
with SCLE (n=6), DLE (n=1 ), and dermatomyositis (DM) (n=1). Using a frozen section immuno-
fluorescence (IF) microscopy, we confirmed that PDC are present in a patchy distribution within the
inflammatory infiltrate near the dermal-epidermal junction of SCLE, DLE, as well as DM skin lesions.
No such reactivity was observed in 6 biopsies from normal human newborn foreskin. Using a multi-
color IF technique, we have also demonstrated for the first time that PDC in cutaneous LE and DM
skin lesions also express BDCA-2, a novel PDC-specific type II C-type lectin that mediates antigen
capture and inhibition of INF-α/Β production. In 5/6 SCLE patients, CD91 (the α-2-macroglobulin
receptor) was found to be co-expressed with BDCA-2 on PDC. These preliminary results suggest
that BDCA-2(+), CD91(+) PDC are present in the inflammatory infiltrate of LE-specific skin lesions.
However, this cell type is not specific for cutaneous LE in that it is also present in other autoimmune
inflammatory dermatoses such as DM and psoriasis (personal communication, Brian Nickoloff, M.D,
Ph.D.). As excessive production of INF-α/Β is thought to play a central role in the immunoregula-
tory abnormalities of LE, modulation of the BDCA-2 signaling pathway in PDC might provide a
therapeutic strategy for cutaneous LE and perhaps other autoimmune skin diseases. In addition, the
co-expression of CD91 by PDC in cutaneous LE lesions makes this cell type a candidate for an
autoantigen presenting cell since CD91 is known to mediate the uptake of heat shock protein-anti-
genic peptide complexes and cross presentation of such peptide antigens. 
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IgG4 is the predominant IgG subclass in gestational pemphigoid
T Patton,1 RW Plunkett,2 EH Beutner2 and J Deng1 1 Dermatology, VAMC and Univ. of Pittsburgh,
Pittsburgh, PA, PA and 2 Microbiology, State University of New York, Buffalo, NY
Past evidence indicates the linear deposition of C3 along basement membrane zone of skin (BMZ)
and presence of circulating HG factor as the hallmarks for gestational pemphigoid. This study was
designed to evaluate the effect of IgG subclass distribution on the result of direct immunofluores-
cence (DIF) of specimens from patients with gestational pemphigoid. Ten available skin biopsy spec-
imens were obtained from our tissue banks, and subjected to indirect immunofluorescence (IIF) to
detect the presence of IgG as well as its subclasses along BMZ of skin. All 10 specimens had strong
C3 linear staining, but only 5 of them with trace amount of IgG staining along BMZ under DIF. All
10 specimens were positive for IgG deposition in IIF. On IIF for IgG subclasses, all 10 specimens
were positive for IgG4, while 7 for IgG2, 5 for IgG1 and 4 for IgG3. The results of this study indi-
cates that IgG can be detected on the skin specimens of patients with gestational pemphigoid, if IIF
is employed, and IgG4 is the predominant IgG subclass involved. 
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Role of Fc receptors in autoimmune bullous pemphigoid
ME Trimberger, LA Diaz and Z Liu Dermatology, University of North Carolina at Chapel Hill,
Chapel Hill, NC
Bullous pemphigoid (BP) is a subepidermal bullous dermatosis of the elderly. BP patients exhibit
circulating and tissue-bound autoantibodies directed against the hemidesmosomal antigens BP180
and BP230. Using an animal model of BP, which involves the injection of neonatal BALB/c mice
with rabbit anti-murine BP180 (mBP180) antibodies, we have shown that subepidermal blistering
triggered by anti-mBP180 IgG depends upon complement activation, mast cell degranulation, and
neutrophil infiltration. The molecular mechanism for neutrophil activation in experimental BP has
previously remained unknown. In this study, we tested the hypothesis that infiltrating neutrophils are
activated through the molecular interaction between Fc receptors (FcR) on neutrophils and the Fc
domain of pathogenic anti-BP180 IgG. We found that FcgRI and III double-gene knockout mice
and FcgRIII single-gene knock out mice are resistant to experimental BP. In vivo deposition of
pathogenic IgG and complement component C3 were detected in the skin of the FcgR-deficient mice,
but the mice showed no clinical or histological skin lesions. FcR blocker specific for FcgRII and III
abolished the BP phenotype in wild-type mice injected with pathogenic IgG in vivo and inhibited
activation of wild-type neutrophils stimulated by pathogenic IgG in vitro. Pathogenic IgG activated
wild-type neutrophils to secrete neutrophil elastase and gelatinase B, but failed to stimulate FcR-
deficient neutrophils to release these proteolytic enzymes. In addition, we found that the patholog-
ical function of anti-mBP180 IgG depends entirely on its Fc domain; F(ab’)2 fragments of IgG had
no pathogenic activities in vivo or in vitro. Results from this study establish that FcgRIII plays a
critical role in the activation of infiltrating neutrophils, which in turn release proteolytic enzymes
resulting in dermal-epidermal blister formation. These findings give us novel insights into the
immunopathology of BP and other IgG- and neutrophil-mediated autoimmune diseases and may
help us to develop new therapeutic strategies for these diseases. 
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Extracellular matrix protein 1 is a target autoantigen in lichen sclerosus
N Oyama,1 I Chan,2 SM Neill,1 AP South,2 T Hamada,2 V Wessagowit,2 MM Black,1
F Wojnarowska3 and JA McGrath2 1 Department of Immunofluorescence, St John’s Institute of
Dermatology, London, United Kingdom, 2 Department of Cell and Molecular Pathology, St John’s
Institute of Dermatology, London, United Kingdom and 3 Department of Dermatology, The
Churchill Hospital, Oxford, United Kingdom
Lichen sclerosus (LS) is a chronic mucocutaneous scarring disease of unknown etiology. However,
previous studies have found associations between LS and specific HLA subtypes as well as other
autoimmune disorders, raising the possibility that the pathogenesis of LS might be explained, in part,
by development of autoantibodies to an as yet unidentified target antigen in skin and mucous mem-
branes. One putative autoantigen is the glycoprotein extracellular matrix protein 1 (ECM1). The
rationale for this is based on histological similarities between LS and the genetic disorder lipoid
proteinosis that results from mutations in the ECM1 gene. In this study, we analyzed serum autoan-
tibody profiles in patients with ano- and extra-genital LS by immunoblotting (human epidermal and
dermal extracts) and detected circulating IgG autoantibodies in 57/78 samples (73.1%). Specific
immunoreactivity to ECM1 was confirmed in these cases by generating a full-length GST-fusion
protein. Positive reactivity to the recombinant protein was also detected in ano-genital lichen planus
(16/44, 36.4%), but to a lesser extent in systemic lupus erythematosus (3/45, 6.7%), systemic scle-
rosis (1/22, 4.5%), bullous pemphigoid (3/40, 7.5%) and normal control samples (1/35, 2.9%). Indi-
rect immunofluorescence using affinity purified IgG fractions from LS sera revealed intense cyto-
plasmic staining in the basal keratinocyte layer in a similar distribution to labeling with a polyclonal
anti-ECM1 antibody raised against a C-terminal oligopeptide. The positive staining was blocked by
pre-absorption of the affinity purified IgGs with excess recombinant ECM1 protein in a dose-depend-
ent manner, but not with GST alone or with recombinant BPAG2 NC16A protein. These data pro-
vide evidence for a specific humoral immune response to ECM1 in LS, as well as some cases of
lichen planus, and provide new clues to disease pathogenesis. 
0071
Objective in vivo quantification of edema
G Stamatas, M Southall, H Ouyang, F Liebel, C Saliou and N Kollias Johnson & Johnson
Consumer Products, Skillman, NJ
Edema is associated with the expression of skin inflammation. It is characterized by an increase in
extracellular water in the dermis leading to swelling. It frequently present together with vascular
reactions. Edema and erythema are typically graded visually. In this study we investigated the
objective assessment of histamine-induced edema in vivo with novel optical methods. Histamine
was delivered iontophoretically from aqueous solutions at concentrations of (0-0.1% w/v) to the volar
forearms of volunteers. The current delivery was 0.5 mA for 30 seconds. Measurements were acquired
at the maximum of the reactions (20-30 min after treatment). The erythema and edema became evi-
dent at 15 min and lasted for 1-2 hours. The erythema intensity and the area of involvement were
quantified by diffuse reflectance spectroscopy (DRS) and by hyperspectral imaging in the visible.
The change in volume, the total area of involvement and the maximum height of the edema response
were measured by 3D imaging. Extracellular water accumulation in the dermis at the edematous area
was quantified by hyperspectral imaging in the NIR range. All measured parameters (oxy-hemo-
globin concentration, extracellular water accumulation, swelling volume) demonstrated dose depend-
ence. The skin responses ranged from perifollicular erythema at low doses to intense erythema plus
edema extending beyond the treated site for high doses. The erythema intensity as measured by
DRS increased linearly up to 0.001% of histamine. The range of the measured edema height at max-
imum was 0.16-0.96 mm and the range of the measured edematous volume was 0.3-140 mm3. Extra-
cellular water accumulation was documented by spectral imaging of the treated site at 970 nm ref-
erenced to 900 nm. In summary, we have demonstrated that parameters that characterize cutaneous
edema, accumulation of extracellular water in the dermis, local increase in the volume of the tissue,
and erythema, can be quantified accurately in vivo non-invasively by optical methods. Such meth-
ods can be applied to effectively measure the extent of an edematous response as well as the effi-
cacy of treatments. 
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Tolerance escape of autoreactive B lymphocytes against desmoglein 3 in transgenic model mice
T Ota,1,4 M Aoki,1 K Tsunoda,1,2 K Shimoda,3 T Nishikawa,1 M Amagai1 and S Koyasu4 1
Dermatology, Keio Univ., TOKYO, Japan, 2 Dentistry and Oral Surgery, Keio Univ., TOKYO,
Japan, 3 Laboratory Animal Center, Keio Univ., TOKYO, Japan and 4 Microbiology and
Immunology, Keio Univ., TOKYO, Japan
Pemphigus vulgaris (PV) is an anti-desmoglein3 (Dsg3) IgG mediated autoimmune blistering dis-
ease. It remains unclear how self-tolerance against Dsg3, a peripheral antigen, is broken to trigger
the disease. The purpose of this study is to understand the mechanism of B cell tolerance against
Dsg3 using anti-Dsg3 autoantibody producing transgenic mouse model. We isolated a monoclonal
IgG antibody AK7 that recognizes native mouse Dsg3 in vivo from PV model mice produced by
adoptive transfer of Dsg3-/- splenocytes into Rag2-/- mice. cDNAs for heavy and light chain vari-
able regions were isolated from the AK7 hybridoma and introduced into transgenic constructs con-
taining IgM backbone. We then generated IgM transgenic mice (AK7-LH1) in C57BL/6 mice express-
ing endogenous Dsg3. Self tolerance are considered to be established by deletion or inactivation of
self-reacting lymphocytes. In AK7-LH1 mice, AK7-IgM expressing B cells were detected in the bone
marrow where most of self-reactive B cells against central antigens are eliminated. Surprisingly,
however, AK7-IgM expressing B cells were also observed in the peripheral lymphoid organs, includ-
ing spleen and lymph nodes. More than 90% of heavy-chain transgene positive B cells recognized
recombinant Dsg3. Dsg3 recognizing B cells were as much as 13.7±2.5% of total splenocytes (n=5).
Furthermore, AK7-IgM was readily detected in circulation and the titers of anti-Dsg3 IgM were
over 10 times higher than those of PV model mice. There was in vivo IgM deposition on keratinocyte
cell surfaces of mucosal epithelia where Dsg3 is expressed, although there was no apparent PV phe-
notype in these mice. Thus, Dsg3-reacting B cells were not deleted nor inactivated in our transgenic
mouse model. These findings indicate that Dsg3-reactive B cells, at least partially, escape from self-
tolerance, and shed light on a new aspect of mechanism for peripheral tolerance. 
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Identification of the hRDH-E2 gene, a novel member of the SDR family, and its increased
expression in psoriatic lesions
T Mabuchi,1 Y Matsuzaka,2 K Okamoto,2 G Tamiya,2 M Iizuka,1 Y Umezawa,1 T Matsuyama,1
H Inoko2 and A Ozawa1 1 Department of Dermatology, Tokai University School of Medicine,
Isehara, Kanagawa, Japan and 2 Department of Molecular Life Science, Tokai University School
of Medicine, Isehara, Japan
To identify novel psoriasis-associated genes, we focused on several ESTs (expressed sequence tags)
whose expression was predominantly increased in the affected skin in patients with psoriasis vul-
garis, as assessed by microarray assay. In the present study, a full-length cDNA corresponding to
one of those ESTs (AI440266) was isolated by screening of cultured human keratinocyte cDNA
libraries. This cDNA has an open reading frame of a 309-amino-acids protein, sharing significant
homology to one of the short-chain alcohol dehydrogenase/reductase (SDR) family that can catalyze
the first and rate-limiting step that generates retinaldehyde from retinol. So, this gene was designated
as hRDH-E2 (human epidermal retinal dehydrogenase 2). The hRDH-E2 gene has a single func-
tional copy on chromosome 8q12.1, spanning approximately 20 kb with seven exons. The deduced
amino acid sequence contains three motifs that are conserved in the SDR family. Qualitative RT-
PCR demonstrated that the mRNA levels of hRDH-E2 were significantly elevated in the affected
skin in psoriasis patients as compared to the unaffected skin in patients and the normal skin in healthy
individual. These results suggest that hRDH-E2 may be involved in the pathogenesis of psoriasis
through its critical role in retinol metabolism in keratinocyte proliferation. 
0075
Increased serum calcium and decreased parathyroid hormone levels in patients with palmo-
plantar pustulosis
G Michaelsson,1 E Hagforsen,1 E Lundgren2 and K Michaelsson2 1 Dep medical
Sciences/Dermatolgy and Venereology, Uppsala, Sweden and 2 Dep Surgery, University Hospital,
Uppsala, Sweden
Palmoplantar pustulosis (PPP) is a chronic disease considered to be a variant of psoriasis. Ninety
percent of the patients are women and 95% are smokers at the onset of the disease. We have reported
that sera from PPP patients give an immunofluorescence (IF) of the papillary endothelium in pal-
mar skin from healthy subjects. In addition, when sections from other organs than skin were screened
for IF with PPP sera there was a strong IF in the parathyroid endothelium. This finding raised the
question if there might be an abnormal function of the parathyroid gland in conjunction with PPP.
Sixty-one women with PPP were compared with regard to the levels of albumin modified serum cal-
cium and parathyroid hormone (PTH) with 155 randomly selected population-based female con-
trols. Age-adjusted mean calcium and PTH levels with 95% confidence intervals (95% CI) were esti-
mated by the GLM procedure of the SAS software. Age-adjusted serum calcium was found to be
significantly higher (p<0.0001) in patients (mean 2.48 mmol/l; 95% CI 2.46-2.51) compared to
controls (mean 2.37 mmol/l; 95% CI 2.35-2.38). Furthermore, we found suppressed PTH levels in
cases compared to controls (mean 24.0 nmol/l; 95% CI 20.7-27.3 versus 31.1 nmol/l; 95% CI 29.0-
33.2), p for difference 0.0005. In comparison with the control group PPP patients had an odds ratio
of 13.0 (95% confidenece interval 4.0-41.8) for diabetes type 2. The results indicate that there is an
abnormal calcium homeostasis and parathyroid function in PPP patients resulting in high serum cal-
cium and suppressed PTH levels. It may be speculated that the raised serum calcium is induced by
compensatory mechanisms, e g PTH related protein. As mildly elevated calcium levels have been
found to be associated with increased prevalence of diabetes the abnormal calcium homeostasis in
PPP might be associated with the highly increased risk for diabetes. 
0077
Mannose binding lectin in UV-irradiated skin
M Rosenbaum,1 W Zhang,1 M Bashir,1 GC Ang,1 E Kwon1 and VP Werth1,2 1 Department of
Dermatology, University of Pennsylvania, Philadelphia, PA and 2 Dermatology, Philadelphia VA
Hospital, Philadelphia, PA
Exposure of apoptotic keratinocytes to the immune system is a likely trigger of photosensitive cuta-
neous autoimmune diseases. We previously reported that dermatomyositis is associated with an
increased frequency of three mannose binding lectin (MBL) polymorphisms that have been linked
to decreased MBL protein production, MBL54A, MBL57A, and the MBL-LX promoter polymor-
phism (Werth VP et al. JID in press). We now report the distribution of MBL within normal and UV-
irradiated human skin. By immunohistochemistry using a monoclonal anti-MBL antibody (clone
1C10, IgG2b, generous gift of G. Stahl), we detected no MBL in normal skin. 24h after a dose of
30 mJ UVB/cm2 , MBL was detected on the surface of apoptotic TUNEL-positive keratinocytes in
the epidermis. To examine possible sources for this MBL, we irradiated human keratinocytes in vitro
then harvested them at 3, 6, and 24 h. Neither MBL mRNA (by RT-PCR) nor MBL protein (by
ELISA) were detected, indicating no endogenous MBL production by these cells, even under UVB
stimulation. As positive controls, RT-PCR easily detected MBL mRNA in human HuH7 hepatoma
cells and TNF mRNA in UV-irradiated keratinocytes. We conclude that non-keratinocyte derived
MBL binds to apoptotic keratinocytes after irradiation in vivo, consistent with a possible protective
role of MBL in removing apoptotic keratinocytes. 
0076
Mucous membrane pemphigoid: T- and B-cell reactivity to BP180 predominately targets the
C-terminal domain
A Powell, S Albert, MM Black, AC Hayday, P Shepherd, JE Setterfield, SJ Challacombe and
N Oyama Guy’s King’s and St. Thomas’ Medical School, London, United Kingdom
Mucous membrane pemphigoid (MMP) and bullous pemphigoid (BP) are distinct subepidermal
immunobullous diseases associated with autoantibodies against a common antigen, the transmem-
brane hemidesmosomal protein BP180. MMP is a heterogeneous disorder and can affect multiple
mucosal sites. HLA haplotype associations and activated T-cell infiltrates within lesional histology,
provide indirect evidence that cellular immunity has a role in MMP. Our aim was to study T- and B-
cell responses against BP180 in MMP relative to BP and normal controls (NC). Eighteen MMP (all
with oral involvement), 11 BP and 13 NC subjects were studied. The entire portion of the extracel-
lular domain (ECD) of BP180 was synthesized as three (GST-tagged) overlapping recombinant frag-
ments in E.coli and immunoblotted against the sera. T-cell reactivity to BP180-ECD fusion proteins
was assayed by H3-thymidine uptake stimulation studies. Immunoblotting revealed that 61% of MMP
(11/18), all BP (11/11), and none of the NC had autoantibodies reactive to BP180 fusion proteins.
Within most reactive sera were antibodies to more than 1 portion of the BP180-ECD. Autoantibod-
ies reacted to C-terminal predominantly in MMP (10/18) and to N-terminal in BP (10/11). A simi-
lar correlation was seen in T-cell responses, 55% (10/18) of MMP, 54% (6/11) of BP and 23%
(3/13) of NC showed T-cell reactivity to BP180. T-cell reactivity to multiple portions of BP180-ECD
was seen in both BP and MMP. The specificity of T-cell reactivity did not always predict autoanti-
body specificity. The incidence of HLA-DQB1*0301 in MMP (75%) was considerably higher than
in BP (40%) or NC (23%). Our data suggest that autoreactive T-cells may have a role in the
immunopathogenesis of MMP and that specificity of target epitope on BP180-ECD may influence
clinical disease phenotype within the pemphigoid group. 
0074
Fcα-dependent granulocyte activation is required for blister induction by IgA1 autoantibod-
ies to the cleaved ectodomain of BP180/Type XVII collagen
C Sitaru,1 A Kromminga,2 GJ Oostingh,1 E Brocker 1 and D Zillikens 1 1 Dept. of Dermatology,
Univ. of Wuerzburg, Wuerzburg, Germany and 2 IPM, Hamburg, Germany
IgA plays an important role in immune exclusion at mucosal surfaces and, by binding to its recep-
tor on myeloid cells, triggers a plethora of effector functions. While IgA is important for the immune
defence, IgA autoantibodies are associated with various autoimmune conditions. However, a direct
pathogenic role of IgA autoantibodies has not yet been demonstrated. Linear IgA disease (LAD), an
autoimmune subepidermal blistering disease, is associated with IgA autoantibodies to BP180/type
XVII collagen. These autoantibodies preferentially bind to the cleaved 120 kDa ectodomain of this
protein. The aim of the present study was to investigate the blister-inducing potential of IgA autoan-
tibodies in LAD. Interestingly, serum from patients with LAD (n=10), but not from normal controls,
induced subepidermal splits in cryosections of human skin when co-incubated with leukocytes from
healthy volunteers. IgA1 fractions of LAD patients’ sera, purified by Jacalin affinity chromatogra-
phy, retained the blister inducing capacity, while serum depleted of IgA1 was not pathogenic. Recruit-
ment of granulocytes at the dermal-epidermal junction, but not of peripheral blood mononuclear
cells, was a prerequisite for split induction. These granulocytes were activated as revealed by their
capacity to reduce nitro blue tetrazolium to formazan. F(ab’)2 fragments of patients’ IgA, lacking
the effector Fc portion, lost their split-inducing capacity. Importantly, preadsorption of IgA autoan-
tibodies against the shed ectodomain, but not against a recombinant form of full-length type XVII
collagen, abolished their blister-inducing potential. In summary, for the first time, we demonstrate
the pathogenicity of autoantibodies of the IgA isotype. In addition, our findings suggest that epi-
topes, generated by cleavage of the type XVII collagen ectodomain, are important for binding of
blister-inducing IgA autoantibodies to this target antigen. 
0078
E-cadherin loss by keratinocytes differentiates psoriasiform dermatitis from psoriasis, and
cutaneous T cell lymphoma
RS Kalish,1,2 Y Ullman,3 B Assy,3 Y Shefer,4 S Serafimovich3 and A Gilhar3 1 Dermatology, SUNY
@ Stony Brook, Stony Brook, NY, 2 Division of Dermatology, North Shore - Long Island Jewish
Health System, New Hyde Park, NY, 3 Skin Research Laboratory, B. Rappaport Faculty of
Medicine, Technion-Israel, Haifa, Israel and 4 Ha’emek Medical Center, Affula, Israel
Keratinocyte loss of E-cadherin is associated with spongiosis, and results from cleavage of E-cad-
herin during Fas mediated apoptosis (J Invest Dermatol 117:927-934, 2001). It was hypothesized
that loss of keratinocyte E-cadherin may differentiate eczematous psoriasiform dermatitis from pso-
riasis, and cutaneous T-cell lymphoma (CTCL) / mycosis fungoides, which to not exhibit spongio-
sis. Fixed, paraffin embedded tissue sections were stained for E-cadherin using monoclonal antibody
HECD-1, and immunoperoxidase. Focal loss of E-cadherin was observed in areas of spongiosis in
all (9) specimens of spongiotic psoriasiform dermatitis. In contrast, no loss of E-cadherin was observed
in the epidermis of (13) slides of psoriasis, or (9) slides of CTCL / mycosis fungoides. This further
supports the role of E-cadherin cleavage and Fas mediated apoptosis in spongiotic dermatitis. If
confirmed with larger series, E-cadherin may be a useful marker in the differential diagnosis of CTCL. 
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U-serrated immunodeposition pattern differentiates epidermolysis bullosa acquisita from other
subepidermal immunobullous diseases
RM Vodegel, MF Jonkman, HH Pas and MC De Jong Dermatology, Universital Hospital
Groningen, Groningen, Groningen, Netherlands
Epidermolysis bullosa acquisita can be differentiated from other subepidermal bullous diseases by
sophisticated techniques, such as immunoelectron microscopy, salt-split skin antigen mapping, flu-
orescence overlay antigen mapping, immunoblot and ELISA. We discovered that the diagnosis can
also be made by routine direct immunofluorescence microscopy. Studying 156 frozen skin biopsies
from patients with various subepidermal immunobullous diseases we found three distinct linear flu-
orescence patterns at the basement membrane zone: true linear, n-serrated, and u-serrated. The true
linear pattern, often seen in conjunction with either the n- or the u-serrated pattern, was found in any
subepidermal immunobullous disease with non-granular depositions. In bullous pemphigoid, mucous
membrane pemphigoid, anti-epiligrin cicatricial pemphigoid and linear IgA disease the n-serrated
pattern was found, corresponding with depositions located in hemidesmosomes, lamina lucida or
lamina densa. However, in epidermolysis bullosa acquisita and bullous SLE the u-serrated staining
pattern was seen, corresponding with the ultralocalization of type VII collagen in the sublamina densa
zone. The diagnosis of epidermolysis bullosa acquisita with IgG or IgA autoantibodies directed
against type VII collagen was confirmed by immunoelectron microscopy, salt-split skin antigen map-
ping, fluorescence overlay antigen mapping, or immunoblot. Using this pattern recognition by direct
immunofluorescence microscopy we discovered several cases of epidermolysis bullosa acquisita,
who otherwise would have been missed and erroneously diagnosed as a form of pemphigoid or lin-
ear IgA disease. 
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Anti-idiotypic IgG blocks the reactivity and pathogenicity of anti-desmoglein-3 autoantibod-
ies from patients with pemphigus vulgaris
MK Hacker, EB Olasz, JA Fairley, KB Yancey and M Lin Dermatology, Medical College of
Wisconsin, Milwaukee, WI
Idiotypic networks are thought to play an important role in the regulation of immune responses.
Applying this strategy, it has recently been demonstrated that specific anti-idiotypic IgG is able to
modulate the pathogenic effects induced by autoantibodies in several autoimmune diseases. Pem-
phigus vulgaris is an autoimmune blistering disease mediated by pathogenic autoantibodies against
the desmosomal cadherin, desmoglein-3. In this study, we generated anti-idiotypic IgG against affin-
ity purified Fab fragments of anti-desmoglein-3 autoantibodies isolated from a patient with muco-
cutaneous pemphigus vulgaris and used it as an interventional tool to counteract the reactivity and
pathogenic activity of autoantibodies from other patients with pemphigus. Using ELISAs employ-
ing baculovirus-encoded recombinant forms of desmoglein-3 and desmoglein-1, we found that anti-
idiotypic IgG was able to inhibit the reactivity of anti-desmoglein-3 autoantibodies from patients
with mucocutaneous pemphigus vulgaris in a specific and dose dependent manner. Interestingly,
anti-idiotypic IgG did not impair the ability of IgG from patients with pemphigus foliaceus to bind
desmoglein-1 in control ELISA experiments. Furthermore, anti-idiotypic IgG neutralized the path-
ogenic effect of IgG autoantibodies from patients with pemphigus vulgaris in a murine passive trans-
fer animal model. Such inhibition was specific in that anti-idiotypic IgG did not block the ability of
autoantibodies from patients with pemphigus foliaceus to elicit superficial, intraepidermal blisters
in neonatal mice. These data suggest that pathogenic anti-desmoglein-3 autoantibodies exhibit a com-
mon idiotype(s) and that the generation of anti-idiotypic IgG against such idiotype(s) represents a
rational approach for blocking the development of this life threatening immunobullous disease. 
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Endogenous overproduction of TNFα in photosensitive autoimmune diseases
VP Werth,1,2 E Kwon,1 M Bashir,1 KE Sullivan,3 P Patel1 and W Zhang1 1 Department of
Dermatology, University of Pennsylvania, Philadelphia, PA, 2 Dermatology, Philadelphia V.A.
Hospital, Philadelphia, PA and 3 Immunologic and Infectious Diseases, Childrens Hospital of
Philadelphia, Philadelphia, PA
Exposure of apoptotic keratinocytes to the immune system is a likely trigger of photosensitive cuta-
neous autoimmune diseases. TNFα, an important mediator of apoptosis, exhibits a promoter poly-
morphism (–308A) that is overrepresented in SCLE and adult DM and shows increased activity in
promoter-reporter constructs in vitro (Werth et al. JID 115:726,2000). In the current study, we sought
i) to directly document increased activity of the endogenous TNFα gene in cells derived from SCLE
patients with vs. without this genetic polymorphism; and ii) to compare TNFα gene activity in SCLE
vs. healthy control cells matched for TNF genotype. Primary skin fibroblasts were grown from SCLE
patients with each of the TNF promoter genotypes (AA, GA, and wild-type GG). After UVB irra-
diation (30 mJ/cm2), cells from the AA individual showed over 3-fold as much TNFα in culture
supernatant relative to the GA and GG cells (207.4 vs. 34.5 and 66.7 ng/ml per 106 cells). The SCLE
group as a whole produced more TNFα relative to genotype-matched controls (114.8±53.1 pg/ml
vs. 8.6±5.6 pg/ml, p<0.06, Mann-Whitney test). We next examined TNFα in vivo. In non-diseased
control subjects (5/group), basal TNFα staining in skin biopsies showed substantially higher levels
in GA (34.5±1.45 AU) than in GG (21.86±1.15 AU, quantitated using Metamorph image analysis,
p<0.001). We conclude that the –308A polymorphism is associated with increased TNFα accumu-
lation in culture medium and in skin. Importantly, even when matched for TNFα genotype, SCLE
cells secrete more TNFα than do cells from healthy controls, suggesting that additional factors may
also contribute to TNFα production. Overall, these results are consistent with the model in which
increased TNFα secretion accelerates apoptosis, thereby stimulating the immune system leading to
autoimmune diseases. 
0082
Expression of a dominant-negative AP-1 modulates PKCα and NFκB regulated genes and
rescues PKCα overexpressing mice from TPA-induced skin inflammation
C Cataisson,1 S Torgerson,1 A Pearson,1 M Gerdes,1 A Wang,1 J Subleski,2 C Vinson,1 R Wiltrout2
and SH Yuspa1 1 Laboratory of Cellular Carcinogenesis and Tumor Promotion, Nationnal Cancer
Institute, Bethesda, MD and 2 LE, NCI, Frederick, MD
Transgenic mice overexpressing PKCα in the basal layer of epidermis exhibit severe intraepidermal
neutrophilic inflammation when treated topically with 12-0-tetradecanoylphorbol-13-acetate (TPA).
Keratinocytes from PKCα / 2X TRE-luciferase bigenic mice experienced a sustained increase of
AP-1 reporter activity in response to TPA. Crossing PKCα transgenic mice with transgenic mice
expressing a dominant negative AP-1 (A-FOS) targeted to skin prevented the TPA-induced inflam-
matory infiltrate in vivo. As detected by confocal microscopy, nuclear factor kappa B (NFκB) translo-
cated to the nucleus of transgenic keratinocytes within 30 minutes of TPA treatment. Among tran-
scripts detected on cDNA microarrays of TPA treated PKCα keratinocytes were several chemokines.
As assessed by RT-PCR or RNAse protection assay, expression of transcripts for inflammatory
cytokines (TNFα, IL1α) and chemokines (MIP-2, MIP-1α, MIP-3 α) increases in TPA treated PKCα
keratinocytes. To elucidate the role of NFκB on TPA-induced gene expression, keratinocytes were
infected with the recombinant adenovirus encoding mutated IkappaB super repressor (IκBsr) that
locks NFκB in a cytosolic protein complex, preventing its nuclear action. To analyze the role of AP-
1, an adenovirus encoding the AP-1 dominant negative (A-FOS) was used similarly. Inhibiting NFκB
activation abolished MIP-2, MIP-3α and TNFα induction and decreased the expression of IL-1α
and Mip1α transcripts. In contrast, A-FOS further increased the expression of IL-1α and MIP-2
possibly by increasing NFκB binding activity. Together these results implicate PKCα as a regulator
of a subset of cutaneous cytokines and chemokines responsible for intraepidermal inflammation. Our
results point to a central role of AP-1 transcriptional activity and suggest that PKCα and AP-1 fac-
tors could provide novel targets to treat cutaneous inflammation. 
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Role for Langerhans cell depletion in pathogenesis of psoriasis
BJ Nickoloff,1 J Qin,1 O Boyman,2 TN Dam3 and FO Nestle2 1 Pathology, Loyola, Maywood, IL, 2
University of Zurich, Zurich, Switzerland and 3 University of Aarhus, Aarhus, Denmark
Despite previous reports noting reduced numbers of epidermal Langerhans cells (LCs) in psoriatic
plaques (PP skin), neither the mechanism nor the significance of LC depletion is well understood.
When superantigen (SA)-activated CD4+ (but not CD8+) T cells are injected into symptomless (PN)
skin engrafted onto SCID mice, PP skin is created. However, cellular targets mediating phenotype
conversion are unknown. Immunostaining engrafted normal (NN) skin and PN skin revealed pres-
ence of epidermal CD1a+/S100+ LCs (n=12). After injection of CD4+ (but not CD8+) T cells, PN
grafts converted to PP skin were depleted of epidermal LCs. Also, LCs remained present in NN skin
injected with either CD4+ or CD8+ T cells. To determine if SA activated T cells kill LCs, blood-
derived CD14+ cells were exposed to GM-CSF/IL-4/TGF-β to produce CD1a+ E-Cad+ LCs, and
labeled with 51Cr. Killing of LCs was measured by 51Cr release after 4 hr exposure to T cells at var-
ious target:effector ratios (1:5 to 1:40). Comparing mixtures of CD4 plus CD8+ T cells derived
from non-psoriatic subjects (at 1:20 ratio) revealed 18 +/-7% killing of LCs (n=9), whereas 48 +/-
19% LC killing was observed with psoriatics (n=3). Using negative selection, normal purified SA-
activated CD4+ T cells induced killing of LCs (14 +/-5%). When SA-activated mononuclear cells
were exposed to either 1,25-(OH)2 Vit D3 or cyclosporin A (n=2), injection into PN skin was accom-
panied by increased LCs, but no conversion to PP skin. Further evidence linking LC depletion to
psoriasis included loss of LCs in PP skin developing in a second animal model using immunodefi-
cient mouse strain-AGR engrafted with PN skin. On day 56, when PP skin spontaneously developed
in 5 of 7 grafts, no CD1a+ LCs were present in psoriatic epidermis. Taken together, these results
indicate SA-activated CD4+ T cells can kill LCs, and LC depletion may contribute to creation of PP
skin. Novel therapies designed to prevent LC depletion and/or replenish epidermal LCs are indicated
to restore immunohomeostasis in psoriasis. 
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Screening for novel targets in severe chronic plaque psoriasis
AR Goppelt,1 B Reitmaier,1 J Ruegemer,2 C Biederer,1 S Fritz,1 A Fuerst,1 S Mestermann,1 N Max,1
J Regenbogen,1 S Bluemel,1 B Bieger,1 M Otte1 and D Abeck2 1 SWITCH Biotech AG, Neuried,
Bavaria, Germany and 2 Klinik fuer Dermatologie und Allergologie der TU Muenchen am
Biederstein, Muenchen, Bavaria, Germany
The aim of this study was to identify novel target genes for the development of psoriasis treatments.
Gene expression was monitored in skin tissue derived from healthy individuals, and compared to
lesional and non-lesional skin from psoriasis patients with a PASI score of at least 12. cDNA array
based primary screens revealed more than 200 genes to be differentially expressed with a factor
greater than 2. Many genes encoded proteins that have been described to be involved in apoptosis
or proliferation and formation of the cornified envelope. The regulation of individual transcripts
was verified on a single patient level by means of Real time RT-PCR. The spatial expression of a
subset of candidate genes was further characterized by in situ hybridization and immunohisto-
chemistry. Selected targets were validated with respect to biological functions crucial in the patho-
physiology of the disease, e.g. their modulation affected the proliferation rate of skin cells in vitro.
These results demonstrate that our functional genomics approach has yielded valid targets that are
suitable for future development of therapeutics in psoriasis. 
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The clinical and immunological evaluation of pemphigus in the Cukurova region of Turkey
A Akman,1 S Uzun,2 C Uslular2 and M Durdu2 1 Dermatology, Nevsehir State Hospital, Nevsehir,
Turkey and 2 Dermatology, Cukurova University, Adana, Turkey
Pemphigus vulgaris is a potentially life-threatening disease which is more frequently seen in certain
ethnic groups and endemic regions. The aim of this study was to determine the clinical and immuno-
logical patterns of pemphigus in Cukurova region of Turkey. For this purpose, 50 cases who had
administrated to Cukurova University Medical Faculty Department of Dermatology, between Novem-
ber 1998 and April 2002, and diagnosis as pemphigus with clinically, histopathologically and with
immunopathologically. The diagnosis were pemphigus vulgaris were 39 patients, pemphigus foli-
aceus in 11. The age range were 13-85. The male to female ratio was 1:1.3. The mortality rate was
4% ( two in pemphigus vulgaris). The association between clinical activation with immunofloures-
cent and ELISA results were analyzed biostatistically with chi-square test. According to data, a sig-
nificant relationship betweenclinical activity of the disease and the epidermal and circulating anti-
body titers was found. However, in spite of this relationship, this assays were not found predictive
for relapses. Further studies are needed to determine the genetic and environmental risk factors. 
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Autocrine regulation of tumor necrosis factor-α in keratinocytes
S Lisby1 and C Hauser2 1 Bispebjerg Hospital, Copenhagen, Denmark and 2 Hopital Cantonal,
Universitaire, Geneva
TNFα is critically implicated in the regulation of many inflammatory diseases, including Psoriasis
and Contact Dermatitis. However, the induction and regulation of TNFα in skin not fully described.
In this study, we investigated whether autocrine regulation of TNFα is present in the skin. Using the
BALB/c-derived PAM212 and the C3H-derived HDII keratinocyte cell lines, we performed in vitro
stimulations using recombinant murine TNFα. We observed a dose-response of TNFα-mediated
induction of TNFα in keratinocytes using both cell lines. To study the intracellular signalling mech-
anisms involved in the observed increased expression of TNFα mRNA, we addressed the importance
of different protein kinases. Using selective inhibitors, we found that blocking PKC- but not PKA-
dependent signalling mechanisms, a dose-dependent inhibition of the autocrine regulation of TNFα
in keratinocytes was found. To determine whether the increase in TNFα mRNA observed upon
stimulation with rTNFα was due to an increase in promoter activity of the TNFα gene and thus rep-
resented an increase in transcription, HDII cells were transfected with a Chloramphenicol acethyl
transferase (CAT) construct containing the full length (minus 1059bp to +138bp) TNFα promoter
fragment, before stimulations. This resulted in an increase in transcription of the TNFα gene in the
keratinocytes. Furthermore, no change in stability of the TNFα mRNA was detectable thus exclud-
ing significant translational regulation. Thus, an autocrine regulation of TNFα in keratinocytes was
demonstrated. The induction was regulated at the transcriptional level and required PKC-dependant
signalling. These results indicate that even a minor induction of pro-inflammatory cytokines in skin
could have profound effects. Finally the observation of autocrine regulatory pathways in keratinocytes
implicates the keratinocyte as an amplifier with regard to pro-inflammatory cytokine secretion 
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Humoral and cellular immune responses against human papillomavirus type 5 proteins favor
its involvement in the immunopathogenesis of psoriasis
S Majewski,1 E Mahe,2 M Malejczyk,1 M Favre,2 G Orth2 and S Jablonska1 1 Department of
Dermatology and Venereology, Warsaw School of Medicine, Warsaw, Mazowieckie, Poland and 2
Unite des Papillomavirus, Pasteur Institut, Paris, France
In our previous studies we found in 90% of psoriatic plaques DNA of epidermodysplasia verruci-
formis (EV) HPVs, mainly oncogenic HPV5, as well as in over 25% of the patients presence of anti-
bodies against HPV5L1 capsid epitopes. To find out whether EV HPVs are involved in the
immunopathogenesis of psoriasis we studied prevalence of specific antibodies against HPV5 E6
and E7 oncoproteins by means of radio-immunoprecipitation assay with in vitro translated E6/E7
proteins. Cell-mediated immunity (CMI) was studied by the T cell proliferation assay with the use
of HPV5a VLPs (virus-like particles). Production of cytokines by VLP-stimulated PBMC was meas-
ured by specific ELISA. Antibodies against E6/E7 HPV5 proteins were found in a very high per-
centage (51.7%) of psoriatic patients (n=29), comparable to that (55.6%) in EV patients (n=9), and
were rarely (3.1%) detected in atopic dermatitis (n=32) and in healthy individuals (2.3%, n=42).
The presence of anti-E6/E7 antibodies provides strong evidence that in the psoriatic epidermis EV
HPV5 life cycle is activated and the viral oncoproteins known to stimulate keratinocyte prolifera-
tion are expressed. Studies on CMI showed that HPV5 VLPs stimulated T lymphocyte proliferation
in patients with psoriasis (n=7), and this was associated with an increased production of IFNg (p<0.05),
cytokine crucially involved in the pathogenesis of psoriasis. In contrast, T lymphocytes from EV
patients (n=4) did not respond to HPV5a VLPs, as measured by the proliferation assay and IFNg
production. Our data support the hypothesis that HPV5 and other EV-HPVs are involved in the patho-
genesis of psoriasis both by direct stimulation of keratinocyte proliferation (by E6/E7 oncoproteins)
and, indirectly, by serving as a target for humoral and cellular (auto)immune reactions. 
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An animal model of atopic dermatitis: cDNA microarray analyses of mRNA in chronic lesional
skin delineate a balanced Th1/Th2 inflammatory cytokine profile
L Chen1 and L Chan1,2 1 Dermatol & Micro/Immunol, UIC, Chicago, IL and 2 VA Westside,
Chicago, IL
An animal model of chronic inflammatory skin disease has been developed in an epidermally expressed
IL-4 Transgenic (IL-4-Tg) mouse line closely resembling human atopic dermatitis (AD) [J Invest
Dermatol 2001; 117:977-83]. To define the in-situ inflammatory cytokines and mediators, cDNA
microarray analyses on 96 gene-coded membranes were performed with reversely transcribed mRNA
extracted from chronic lesional (>30 disease days) and non-lesional (NL) skin of 7 PCR-confirmed
IL-4-Tg mice and skin of 2 age-matched Non-Tg mice. DNA hybridization followed by chemilu-
minescence autoradiography was used to determine the cytokine and mediator levels, normalized to
house-keeping gene GAPDH. Most of the cytokine mRNAs examined were highly increased in the
lesional skin when compared to the NL and non-Tg mouse skin respectively, with the average fold
increase depicted below: IL-4, 2.0, 6.8; IL-3, 7.6, 9.9; IL-5, 5.6, 9.7; IL-10, 4.5, 3.9; IL-13, 2.1, 4.1;
IL-2, 2.4, 3.2; IL-12p40, 7.4, 5.4; IFN-γ, 3.4, 8.8; IL-1β, 11.1, 23.1; IL-6, 4.9, 11.0; IL-17, 7.7, 13.4;
TNF-α, 1.5, 4.9; TNF-β, 4.5, 5.7; G-CSF, 4, 6.6; GM-CSF, 2.9, 4.8.  Co-stimulation molecules were
similarly increased in folds: CD40L, 2.5, 4.4; OX40L, 1.7, 4.7. In addition, these molecules were
also increased many folds in the NL skin when compared to non-Tg mouse skin: IL-4, 3.6; IL-3,
1.5; IL-5, 4.3; IL-10, 2.2; IL-13, 3.5; IL-2, 1.9; IL-12p40, 2.8; IFN-γ, 6.9; IL-1β, 2.6; IL-6, 4.3; IL-
17, 2.0; TNF-α, 4.4; TNF-β, 3.0; G-CSF, 5.6; GM-CSF, 3.8; CD40L, 2.4; OX40L, 2.9. The ratio of
fold-increase in lesional skin compared to non-Tg mice for the critical Th2:Th1 cytokines were close
to one: IL-4:IL-12p40, 1.3; IL-4:IFN-γ, 0.8. The highest fold of increase was in IL-1β, a non-Th-
specific inflammatory cytokine.  Together, our data delineate a balanced Th1/Th2 cytokine profile
in chronic lesional skin, thus further supports a close resemblance of our IL-4-Tg mouse disease
model with human AD. 
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Cutaneous endothelial cell activation in normal skin of patients with dermatitis herpetiformis
associated with increased serum levels of IL-8, sE-selectin and sL-selectin
RP Hall, F Takeuchi and RD Streilein Dermatology, Duke University Medical Center, Durham, NC
The mechanisms that lead to skin lesions in DH patients are not known. We have previously demon-
strated that circulating neutrophils in patients with DH have an increased expression of CD11b and
decreased surface L-sel. Development of an inflammatory response also requires that endothelial
cells at the site express adhesion proteins including E-sel, which are controlled by pro-inflamma-
tory cytokines and chemokines including IL-8. We hypothesized that an active immune response in
the gut of DH patients would result in elevated levels of IL-8 and be associated with an increased
expression of endothelial cell E-sel in the skin and in increased soluble E-sel. Skin biopsies were
obtained from the inner arm of 7 DH patients and 11 normal subjects, RNA isolated, and cDNA pre-
pared. Real-time PCR was performed to measure the expression of E-sel and ICAM-1. Sera from
51 patients with DH were analyzed for the presence of IL-8, sE-sel and sL-sel. DH patients’ skin
expressed markedly increased levels of E-sel mRNA. Mean E-sel mRNA expression in DH skin
was 26.8 (range 5.5 -54.4) times greater than that of a control, normal skin(p<0.001). No increased
expression of ICAM-1 was seen in DH skin. Increased serum IL-8 was seen in 41% of DH
patients(range 3.2 - 5,900 pg/ml; nl < 31.2 pg/ml).  Elevated levels of sE-sel (37%) and sL-
sel(35%)were seen in some DH patients. Serum IL-8 levels decreased in 2 of 2 patients after being
on a GFD and sE-sel and sL-sel decreased in 1 of 2 patients. These studies demonstrate that patients
with DH have elevated levels of serum IL-8, increased expression of E-sel in the skin and that this
may be a result of the gut inflammatory response to gluten. Endothelial cell activation along with
neutrophil priming may play a critical role in the development of skin lesions in patients with DH
and may represent a common mechanism for other cutaneous manifestations of inflammatory dis-
ease of the gut. 
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Transfer of alopecia areata in the human scalp graft/prkdcscid (SCID) mouse system is char-
acterized by a TH1 response
A Gilhar,1 M Landau,1 B Assy,1 N Karin,2 R Shalaginov,1 S Serafimovich1 and RS Kalish3,4 1 Skin
Research Laboratory, Flieman Medical Center and Rappaport Faculty of Medicine, Technion
Institute of Technology, Haifa, Israel, 2 Immunology, Faculty of Medicine, Technion Institute of
Technology, Haifa, Israel, 3 Dermatology, SUNY @ Stony Brook, Stony Brook, NY and 4 Division
Dermatology, North Shore - Long Island Jewish Health System, New Hyde Park, NY
Alopecia areata is an autoimmune condition directed at hair follicles, which results in loss of hair.
It is possible to transfer hair loss, along with the immunohistologic findings of alopecia areata, to
human scalp grafts on Prkdcscid (SCID), mice by injection of autologous activated lesional T-cells.
This study examines the cytokine profile of T-cells and follicular epithelium following transfer of
hair loss. Two consistent findings significantly associated (p<0.01) with hair loss were production
of interferon-gamma inducible protein-10kD (IP-10) by follicular epithelium (13/13), and produc-
tion of interferon-gamma (INF-gamma) by infiltrating T-cells (10/12). Non-injected control grafts
re-grew hair, and were generally negative for IP-10 (positive 2/9), and INF-gamma (positive 2/9),
but expressed of IL-10 on the follicular epithelium (7/9). IL-4 and TNF-alpha were each expressed
by infiltrating cells in only (1/12) grafts with hair loss, suggesting that TNF-alpha inhibitors may
not be clinically useful. This data supports an INF-gamma TH1 pathogenesis for hair loss in alope-
cia areata. Biological response modifiers directed at INF-gamma and TH1 T-cell responses may be
useful in the therapy of alopecia areata. 
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Exaggerated B cell signaling by disrupted CD22/SHP-1 inhibitory regulation in the tight-skin
mouse
M Fujimoto,1 N Asano,1 H Okochi,1 TF Tedder3 and S Sato2 1 Int. Med. Ctr. Jpn., Tokyo, Japan, 2
Kanazawa Univ., Ishikawa, Japan and 3 Duke Univ. Med. Ctr., Durham, NC
Positive and negative signals from extracellular stimuli control lymphocyte responses and maintain
self-tolerance, and altered balance of signal transduction in lymphocytes may result in development
of autoimmune diseases. The tight-skin (TSK) mouse, a genetic animal model for human systemic
sclerosis (SSc), develops cutaneous fibrosis resembling SSc. While the known TSK mutation is in
the gene encoding the extracellular matrix glycoprotein fibrillin 1, TSK mice exhibit a skewed humoral
response and produce autoantibodies specific and characteristic for human SSc. We assessed the
molecular mechanisms that established abnormal B cell signaling thresholds in TSK mice. Remark-
ably, circulating B cells from TSK mice exhibited characteristic phenotype of chronically activated
B cells with down-regulated surface IgM expression and up-regulated MHC class II expression, sug-
gesting that TSK B cells had intrinsic abnormalities in B cell antigen receptor (BCR) signal trans-
duction. Analyses of intracellular signaling events revealed that BCR cross-linking induced exag-
gerated calcium responses and augmented activation of ERK activation in TSK B cells. Furthermore,
functions of CD22, a B cell-specific siglec protein, was specifically impaired in TSK B cells since
BCR ligation induced significantly diminished CD22 phosphorylation as well as modest SHP-1 asso-
ciation with CD22 in TSK B cells. Consistently, CD19, a major target of CD22 negative regulation,
was hyperphosphorylated in TSK B cells after BCR ligation. Additionally, analyses of CD22-defi-
cient TSK B cells demonstrated that hyperactivation of TSK B cells was dependent on CD22 expres-
sion. As have been recently reported, signal termination provided by negative regulatory pathways
such as Lyn/CD22/SHP-1 complex play a key role in preventing autoimmune reactions. These find-
ings suggest that disrupted inhibitory signal provided by CD22 contributes to the characteristic fea-
tures of autoimmunity in TSK mice and provide a novel potential therapeutic target of SSc. 
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Disruption of tumor necrosis factor receptor p55 accelerates collagens deposition in an animal
model of scleroderma
H Murota,1,2 Y Hamasaki,1 T Matsuyama2 and I Katayama1 1 Dermatology, Nagasaki University
Graduate School, Nagasaki, Japan and 2 Molecular Microbiology and Immunology, Nagasaki
University Graduate School, Nagasaki, Japan
Increases in the serum concentration of the soluble tumor necrosis factor receptor p55 (TNFRp55)
correlate with scleroderma severity and inhibit TNF- mediated signaling. However, there is no
direct evidence for TNFRp55 mediating the specific functions of TNF in the disease. To determine
the role of TNFRp55-mediated signaling in the pathogenesis of scleroderma, wild-type and TNFRp55
deficient (TNFRp55-/-) mice received a subcutaneous injection of bleomycin (BLM) each day.
TNFRp55-/- mice began to develop severe sclerotic changes of the dermis on day 3 of the subcuta-
neous injections of BLM, and produced anti-nuclear antibodies, while wild-type mice did not. The
collagen content in the BLM-treated TNFRp55-/- skin after 5 days of injections was almost 3-fold
that in the skin of the untreated mice and the BLM-treated wild-type mice. The expression levels of
fibrogenic cytokines, procollagen alpha 1 and the matrixmetalloproteinase (MMP)-9 mRNAs were
unaffected in both wild-type and TNFRp55-/- skin, with or without BLM treatment. Induction of
MMP-1 protein expression was significantly inhibited, and induction of MMP-2 expression main-
tained longer in the BLM-treated TNFR p55-/- skin. These results raised the hypothesis that aber-
rant expression of MMP-1, and -2 expression in TNFRp55-/- mice might cause severe accumula-
tion of collagen in BLM-treated skin. On the one hand, BLM-treated wild-type mice exhibited
sclerosis of skin after about 3 weeks of BLM-injection, whereas saline-treated group did not. Inter-
estingly, significant elevation of sTNFRp55 in sera was observed in BLM-treated wild-type mice.
This reproducibility of this phenotype among these BLM-induced mice models demonstrated that
impaired TNFRp55-signaling might also occur in scleroderma patients. This report might provide a
basis for understanding the pathogenesis of scleroderma and formulating therapeutic intervention. 
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Protein expression profile of acute guttate psoriasis lesions
LM Carlen,1,2 AA Alaiya,2,1 A Bergman,3 J Coffey,4 S Becker,2 G Auer2 and M Stahle-Backdahl1 1
Department of Dermatology, Karolinska Hospital, Stockholm, Sweden, 2 Unit of Cancer
Proteomics, CCK, Stockholm, Sweden, 3 Department of Clinical Chemistry, Stockholm, Sweden
and 4 Micromass UK Ltd, Manchester, United Kingdom
Protein patterns in lesional and non-lesional skin of 11 patients with acute, untreated guttate psori-
asis triggered by streptococcal throat infection were analysed using two-dimensional polyacrylamide
gel electrophoresis (2-DE) and compared with normal healthy skin from controls and acute induced
contact eczema. The biopsies were taken from the same body location in all subjects. Protein expres-
sion pattern was highly reproducible between samples. The expression pattern was evaluated by com-
puter-assisted image analysis (PDQUEST). Forty-five proteins had a statistically significant differ-
ential expression between lesional and non-lesional psoriatic skin. These proteins were used in
hierarchal cluster analysis of control, non-lesional and lesional psoriasis skin. All psoriasis non-
lesional skin samples clustered with the control skin and all psoriasis lesions were distinctly clus-
tered. When the same analysis was done for control skin and psoriatic skin lesions, expression of 47
protein spots differed significantly. Examining the overlap between the two datasets revealed 13 spots
common to both sets. The 45 protein spot dataset was re-evaluated after adding data from eczema-
tous and healthy skin samples. The resulting dataset of 41 proteins that remained differentially
expressed could be used to classify the samples correctly into three groups with control skin and
non-lesional psoriatic skin in one group and lesional psoriatic and eczematous skin in the other two
groups. Protein expression data also revealed a distinct set of 13 proteins that showed at least twofold
up-or down regulation between psoriatic lesions and normal skin. These proteins were identified
using matrix assisted laser desorption/ionization mass spectrometry. This study demonstrates the
potential to discover psoriasis specific proteins using proteome analysis and the potential for objec-
tive classification of such lesions. 
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Bullous pemphigold IgE and IgG react with BP180 site outside the immunodominant NC16A
domain
C Fu,1 GJ Giudice1 and JA Fairley1,2 1 Dermatology, Medical College of Wisconsin, Milwaukee, WI
and 2 Zablocki VA Medical Center, Milwaukee, WI
Bullous pemphigoid (BP) is an autoimmune skin disease characterized by the development of autoan-
tibodies directed against the hemidesmosomal protein BP180 (BPAg2, type XVII collagen). IgG
from the majority of BP sera reacts within the 75 amino acid non-collagenous domain 16 of BP180,
termed NC16A. In addition to IgG antibodies, IgE class antibodies directed against BP180 are also
present in the sera of BP patients. We have recently shown that mast cells in the skin of BP patients
are coated with IgE and fragments of BP180, and the circulating basophils from these patients undergo
antigen-specific degranulation when exposed to recombinant BP180. The current studies were
designed to identify in more detail the regions of BP180 with which the BP180-specific IgE reacts.
30 BP patients were initially studied by ELISA and immunoblotting. Twenty-two (73%) had IgG
reactivity to NC16A by ELISA and 15 (50%) had IgE reactivity to NC16A. One patient was iden-
tified that had IgG and IgE reactivity to full-length BP180 extracted from keratinocytes but no reac-
tivity to NC16A, suggesting he had reactivity exclusively outside the NC16A domain. Seven patients
were studied in more detail. In order to facilitate these studies two constructs were used: one encom-
passing the entire extracellular domain of BP180 termed sec180 and sec180∆NC16A, the extracel-
lular domain from which the NC16A region had been deleted.  BP patients were tested for IgG and
IgE reactivity with these two recombinant proteins by immunoblotting. 4/7 were positive for IgG
reactive with sec180 and 2/7 reacted with sec180∆NC16A. IgE reactivity in these 7 patients paral-
leled IgG reactivity. One patient was identified with IgG and IgE reactivity exclusively outside the
NC16A domain. This suggests that in addition to NC16A, epitopes outside this region may be path-
ogenically relevant. 
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Normal wound healing in mice lacking the platelet-activating factor receptor
D Railan,1 KM Howard,2 MS Olson2 and JB Travers1 1 Dermatology, Indiana University,
Indianapolis, IN and 2 University of Texas Health Sciences Center, San Antonio, TX
Platelet-activating factor (1-alkyl-2-acetyl-glycerophosphocholine; PAF) is a glycerophosphocholine-
derived lipid mediator implicated in numerous inflammatory processes. PAF is synthesized by cells
in response to numerous stimuli, including cytokines, growth factors, and cellular injury. PAF acts
via a specific receptor (PAF-R), a G-protein coupled transmembrane protein. Many cells important
in wound healing including neutrophils, moncocyte/macrophages, endothelial cells and keratinocytes
all synthesize this mediator and express PAF-Rs. The objective of this study was to assess the role
of the PAF signaling system in a murine model of wound healing. Wild-type C57BL6 or mice defi-
cient in PAF-Rs (J. Exp. Med. 187:1779-1788, 1998) were subjected to a 5 mm punch biopsy on
back skin, and the rate of wound healing was monitored over time. The healing rate of PAF-R-neg-
ative and normal mice appeared equal, with all wounds completely healed by 14-18 days. These stud-
ies suggest that the PAF-R is not essential in this murine model of wound healing. 
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Systemic exposure to the inflammatory lipid mediator platelet-activating factor results in
immunosuppression in mice
KS Draft, MA Darst, MD Southall and JB Travers Dermatology, Indiana University, Indianapolis,
IN
Platelet-activating factor (1-alkyl-2-acetyl-glycerophosphocholine; PAF) is a glycerophosphocholine-
derived lipid mediator implicated in numerous inflammatory processes. Epithelial cells synthesize
PAF and related 1-acyl-PAF-like species in response to various stimuli including ultraviolet light
irradiation (UVB), ionophores, or cellular damage. In addition to producing PAF, cells ranging from
granulocytes to keratinocytes also express the PAF receptor (PAF-R). Activation of the epidermal
PAF-R leads to the production and release of PAF, IL-6, IL-8, IL-10, TNF, and eicosanoids. Given
that activation of the PAF system induces both pro- and anti-inflammatory cytokines, the objective
of these studies was to define the effects of a systemic PAF-R agonist on immune function in a
delayed-type-hypersensitivity model. C57BL6 Mice were sensitized with the topical antigen dini-
trofluorobenzene (DNFB) on shaved back skin. Seven days after sensitization, the ears of mice were
painted with either DNFB or vehicle control. Twenty-four hours after application of DNFB to ears,
5 mm punch biopsies were obtained and biopsy thickness and weight were assessed as measures of
the inflammatory response. To examine the role of PAF, mice were systemically pre-treated with var-
ious doses of the PAF-R agonist carbamoyl-PAF (CPAF) through intraperitoneal administration,
prior to sensitization with DNFB. In alternate experiments, mice were systemically exposed to the
known immunosuppressant UVB radiation prior to sensitization with DNFB. Intraperitoneal injec-
tion of CPAF resulted in a significant inhibition of allergic contact dermatitis in this model system.
Furthermore the inhibition of immune response induced by CPAF was comparable to the inhibition
observed following ultraviolet B radiation. These studies suggest that systemic exposure to a PAF
agonist results in an immunosuppressive response and could indicate a putative role of PAF in
UVB-induced immunosuppresion. 
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Augmentation of chemotherapeutic agent-induced cytokine production by expression of the
platelet-activating factor receptor in a human epithelial carcinoma cell line
MA Darst, M Al-Hassani, T Li, Q Yi, JM Travers and JB Travers Dermatology, Indiana University,
Indianapolis, IN
In addition to their known cytotoxic effects, chemotherapeutic agents can also trigger cytokine pro-
duction in tumor cells. Many chemotherapeutic agents are also potent pro-oxidative stressors. Although
the lipid mediator platelet-activating factor (1-alkyl-2-acetyl-glycerophosphocholine; PAF) is syn-
thesized in response to oxidative stress, and many epidermal carcinomas express PAF receptors (PAF-
R) linked to cytokine production, it is not known whether PAF is involved in chemotherapeutic agent-
induced cytokine production. These studies examined the role of the PAF system in
chemotherapy-mediated cytokine production using a model system created by retroviral-mediated
transduction of the PAF receptor-negative human epidermal carcinoma cell line KB with the human
PAF-R. The presence of the PAF-R in KB cells resulted in an augmentation of production of cytokines
interleukin-8 and tumor necrosis factor-alpha induced by chemotherapeutic agents etoposide and
mitomycin C. Oxidative stress was found to mediate chemotherapeutic agent-induced activation of
the epidermal PAF-R because it was mimicked by treatment with an organic hydroperoxide, and
inhibited by antioxidants. The transcription factor nuclear factor kappa (NFkappa)-B was also essen-
tial to this cytokine production augmentative effect, because it was blocked by inhibition of the
NFkappaB pathway using a super-repressor IkappaBM mutant. These studies provide evidence for
a novel pathway whereby the epidermal PAF-R can augment chemotherapy-induced cytokine pro-
duction through an NFkappaB-dependent process. 
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Regulatory T cells are induced by enhanced RANK-RANKL signaling in transgenic mice
K Loser, A Mehling and S Beissert Department of Dermatology, University of Munster, Munster,
Munster, Germany
RANK-RANKL interaction plays an important role in the regulation of T cell/DC communication,
DC survival as well as lymph node formation. RANK is expressed on DC, whereas RANKL is found
on activated T cells. Accordingly, epidermal Langerhans cells (LC) express RANK and RANKL
transcripts are detectable in skin upon inflammation. To investigate the role of RANK-RANKL sig-
naling in cutaneous immunity, transgenic (tg) mice were generated that overexpress RANKL under
control of the skin-specific Keratin-14 (K14) promoter. K14-RANKL-tg mice develop normally and
have a uniform expression of the transgene in basal keratinocytes yet RANKL is not detectable in the
serum. The number of epidermal LC is normal in tg mice. Blockade of RANK-RANKL interactions
has been described to inhibit the development of CD4+CD25+ regulatory T cells (Treg). Since in K14-
RANKL-tg mice increased signaling via this pathway is induced, we hypothesized that these tg mice
harbor enhanced numbers of Treg. Indeed, a 2-3-fold increase in numbers of CD4+CD25+ Treg cells
is found in K14-RANKL-tg mice. These Treg cells are characterized by expression of GITR, CTLA-
4, and CD45RBlow. In vitro, the Treg cells from tg mice were anergic, suppressive and produced IL-
10. The anergic state could be overcome by stimulation with CD3, CD28 and IL-2. To investigate if
these Treg cells from tg mice were functional in vivo contact hypersensitivity (CHS) was induced
using DNFB as a hapten. Tg mice show significantly reduced CHS responses. This suppression was
transferable since injection of isolated Treg cells from DNFB-sensitized K14-RANKL-tg mice into
littermates previously immunized with DNFB inhibited the elicitation of CHS. This suppression was
antigen-specific because transfer into oxazolone-immunized recipients failed to inhibit the elicitation
of CHS. Treg cells play an integral role in controlling autoimmunity. Therefore, we used K14-CD40L-
tg mice, which develop severe systemic autoimmune disease, including auto reactive T cells and
autoantibody, and crossed them to K14-RANKL-tg mice. The double transgenic did not develop
autoimmune disease implying that the RANK-RANKL induced Treg suppressed the K14-CD40L-
induced autoimmune phenotype. Together, these data provide first evidence that stimulation of RANK-
RANKL signaling by overexpression of RANKL induces Treg cells in vivo. 
0101
Differential sets of immunodominant T cell epitopes of desmoglein 3 are recognized by autore-
active T cells from pemphigus vulgaris patients and healthy individuals
CM Veldman, KL Gebhard and M Hertl Dermatology, Universityhospital of Erlangen, Erlangen,
Bavaria, Germany
Pemphigus vulgaris (PV) is an autoimmune mediated disease, associated with circulating auto-Ab
to the desmosomal glycoprotein desmoglein 3 (Dsg3). Previous studies from our lab and others iden-
tified autoreactive Th1 and Th2 cells against Dsg3 supporting the idea, that autoreactive T cells are
critical for the induction and regulation of Ab production in PV. Moreover, healthy carriers of the
PV-prevalent HLA class II alleles, HLA-DRB1*0402 and HLA-DQB1*0503, showed an exclusive
Th1 cell response against Dsg3 at frequencies similar to those in patients, indicating that distinct
HLA class II alleles seem to be important for T cell recognition of Dsg3 peptides. The aim of this
study was to characterize T cell recognition of Dsg3 in patients and Dsg3-responsive healthy indi-
viduals. Dsg3-reactive Th1 and Th2 clones (isolated by MACS secretion assay) from PV patients
(n=14) and healthy donors (n=13) were co-cultured with 17mer peptides of the extracellular domain
(ECD) 1-5 of Dsg3 and HLA class II matched APC. Proliferative response was determined by the
incorporation of 3H-thymidine. Both, Dsg3-autoreactive Th1 and Th2 cells from PV patients rec-
ognized a limited set of epitopes located in the ECD1 (DG2), ECD2 (DG3, DG4, DG5) and ECD3
(DG6, DG7). Dsg3-reactive T cells from healthy donors showed responsiveness to Dsg3-peptides
DG2, DG5 and DG8 located in the ECD1, ECD2 and ECD5, respectively. All the identified Dsg3
peptides exhibited similar or identical residues at positions 1 and 4 and some of them also at posi-
tion 6, representing most likely anchor motives with the restricting HLA class II alleles. Our find-
ings strongly suggest that T cell recognition of Dsg3 is restricted to limited epitopes of the ECD of
Dsg3 and thus differential epitope recognition of Dsg3 in patients and healthy donors may contribute
to the different clinical phenotypes. 
0100
Pemphigus vulgaris IgG-induced acantholysis in organ and cell culture—kinetics of appear-
ance of apoptotic effectors
M Frusic-Zlotkin,1 X Wang,4,1 F Bregegere,2,1 B Michel3 and Y Milner1 1 David and Inez Myers
Skin Biology and Biochemistry Laboratory, Hebrew University of Jerusalem, Jerusalem, Israel, 2
Laboratoire du Vieillissement, Universite Paris 7, 2 Place Jussieu, Paris Cedex 05, France, 3
Michel Skin Care Enterprises, Inc., Beachwood, OH and 4 Harvard Medical School, Boston, MA
We have shown before that acantholytic lesions in pemphigus vulgaris (PV) patients’skin show abun-
dance of apoptotic cells that are enriched with apoptotic proteins like P53, Bax etc. Furthermore we
have shown that PV-IgG in cell and organ culture (in the presence of interferon-γ) causes acantholytic
lesions. Lesional cells are enriched in apoptotic markers like FasR, FasL, caspases and reveal degraded
DNA, characteristic of apoptosis. In order to address the question if apoptosis induces acantholysis
or vice versa, we followed the appearance of apoptotic markers in cell and organ cultures treated by
PV-IgG in respect to acantholytic lesion formation. Our data show up-regulation of apoptotic effec-
tors at early time points (10-30 h), when no apparent change in cell-cell contacts was observed, while
acantholytic lesions appeared only after 2-3 days of incubation with PV-IgG. Normal human ker-
atinocytes treated with PV-IgG displayed time-dependent secretion of soluble (onset at 5 h incuba-
tion) and membranal FasL, FasR, enrichment in caspase 8 and activation of caspases 1 and 3. In
skin organ culture, immunohistochemistry revealed mobilization/membranal localization of DISC
members, FADD and caspase 8, preceding formation of the intraepidermal blister by ~ 24 h. The
typical suprabasilar split in organ culture appeared after prolonged incubation (52 h) and correlated
very well with the further elevation of caspase 3 activity. Our data provide the first insight into the
molecular mechanism of PV-IgG-induced acantholysis, and highlight a possibility of apoptosis induc-
tion as a plausible mechanism in induction of acantholysis by the pemphigus autoimmune antibod-
ies. 
0098
Evidence for a pro-inflammatory role of proteinase-activated receptor-2 during cutaneous
inflammation in vivo
M Steinhoff,1 S Seeliger,1 C Derian,3 J Buddenkotte,1 C Sunderkotter,1 R Nawroth,2 D Vestweber,2
P Andrade-Gordon3 and TA Luger1 1 Dermatology, Muenster, NRW, Germany, 2 ZMBE, Muenster,
Germany and 3 R.W. Johnson Pharmaceutical Res Institute, Spring House, PA
Contact dermatitis (CD) is a frequent dermatological disease characterized by acute to chronic inflam-
mation of the skin. Proteinase-activated receptor-2 (PAR2), a G protein-coupled receptor for certain
proteases, is localized on keratinocytes, endothelial cells and nerve fibers, and has been shown to
play a role during inflammation of several tissues. However, the underlying mechanism of PAR2-
induced regulation of inflammation is still fragmentary. Therefore, we were interested in whether or
not PAR2 is involved in cutaneous inflammation using a model of induceable allergic (ACD) and
irritant (ICD) contact dermatitis. In wild-type (PAR2+/+) mice, PAR2 agonists induced an increased
intradermal edema and enhanced plasma extravasation. These inflammatory responses were signif-
icantly diminished in PAR2-deficient (PAR2-/-) mice and controls. Morphological analysis revealed
a dramatic increase of spongiosis and intradermal edema along with enhanced infiltration of neu-
trophils and monocytes in PAR2+/+ mice as compared to PAR2-/- mice. Interestingly, nitric oxide
(NO) inhibitors significantly diminished these effects indicating a role of NO in PAR2-induced
inflammatory responses of the skin. Functional studies at the RNA- and protein level further revealed
PAR2-induced upregulation of the cell adhesion molecules ICAM-1 and E-selectin by HDMEC dur-
ing inflammation suggesting that PAR2 directly regulates CAM function during skin inflammation.
PAR2 agonists also stimulated upregulation of mediators involved in cutaneous inflammatory
responses such as IL-6 and NO in murine and human (dermal) endothelial cells. Together, these
results strongly suggest a proinflammatory role of PAR2 during CD and probably other inflamma-
tory dermatoses, characterized by edema, plasma extravasation and recruitment of inflammatory
cells. Thus, PAR2 antagonists may be therapeutic tools for the treatment of inflammatory skin dis-
orders such as CD and atopic eczema. 
0102
Psoriasin expression in normal and diseased skin
E Wandel,1 B Rosin,1 R Glaeser,2 J Schroeder 2 and M Sticherling 1 1 Department of Dermatology,
university of leipzig, Leipzig, Saxony, Germany and 2 Department of Dermatology, University of
Kiel, Kiel, Germany
Psoriasin is a member of the S100 gene family and was first detected in abnormally proliferating
keratinocytes in psoriatic epidermis. Subsequently, it was found to be up-regulated in abnormally
differentiating keratinocytes in addition to breast and bladder cancer. Psoriasin may exert an effect
as a chemotactic factor for inflammatory cells. Very recently psoriasin has been shown to display
antimicrobial activity against E. coli by depletion of zinc ions. The purpose of this study was to deter-
mine the patterns of psoriasin expression in infectious and noninfectious inflammatory skin disor-
ders. The expression of psoriasin mRNA and protein was determined by in situ hybridisation using
a specific probe generated in the lab and immunohistochemically using a commercially available
monoclonal antibody on paraffin sections of normal human skin of different localisations and in
several inflammatory skin disorders. Expression of psoriasin mRNA was constitutively high in epi-
dermis of normal skin whereas immunoreactivity was found predominantly in areas which are highly
exposed to both, microbial challenge and UV-radiation (e.g. nose, forehead). In inflammatory skin
diseases, the mRNA expression of psoriasin in the epidermis was generally high and increased
immunoreactivity was found in psoriasis, folliculitis and condyloma acuminata throughout the
spinous layer whereas patients with lichen ruber or eczema showed only little staining in upper
parts of the epidermis. This study demonstrates the modulation of psoriasin expression in both healthy
skin and infectious/ non-infectious skin diseases. The distinct expression in psoriatic skin explains
the clinical experience of a low incidence of bacterial infection as well as indicating biological
functions of the protein yet unknown, but beyond antibacterial activity. 
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CD44-Hyaluronan interactions mediate lymphocyte adherence to dermal endothelium under
shear stress in acute cutaneous graft-versus-host disease
M Milinkovic1,2 and R Sackstein1,2 1 Dermatology, Brigham and Women’s Hospital, Boston, MA
and 2 Harvard Skin Disease Research Center, Harvard Medical School, Boston, MA
Acute graft-versus-host disease (aGVHD) is a major complication of allogeneic hematopoietic
stem cell transplantation (HSCT), which is a treatment of choice for certain hematologic malignan-
cies and genetic disorders. Acute cutaneous GVHD (acGVHD) is the most frequent presentation of
this disease. Lymphocytic infiltrates of the papillary dermis are the earliest feature of acGVHD and
occur at times of profound lymphopenia, indicating that the migration of lymphocytes from vascu-
lar to dermal compartments is highly efficient. To examine the molecular basis of this lymphocy-
totropism, we performed adherence assays to analyze lymphocyte-dermal endothelial interactions
under shear stress conditions which mimic blood flow. We observed binding of lymphocytes to der-
mal endothelial cells in acGVHD reactions, but not in other post-HSCT skin eruptions. Pre-incuba-
tion of lymphocytes with functional blocking antibodies against LFA-1 and L-selectin, as well as
treatment of skin sections with blocking antibodies directed against the endothelial proteins E-selectin,
P-selectin, ICAM-1 and VCAM-1, had no effect on lymphocyte adherence to dermal endothelium.
Neuraminidase and keratanase digestions of skin sections had no effect on binding of lymphocytes
to endothelium, whereas heparitinase and chondroitinase ABC digestion partially blocked, and
hyaluronidase digestion completely blocked binding. Consistent with these findings, lymphocyte
adherence to dermal vessels under shear was abrogated by pre-incubation of lymphocytes with
function blocking anti-CD44 monoclonal antibody (Hermes 1) or by soluble hyaluronan (HA).
Immunohistochemical staining for HA showed discrete HA depositions at endothelium supporting
lymphocyte binding. Taken together, our data suggest that recruitment of lymphocytes to skin in
acGVHD depends in part on upregulated endothelial expression of HA and that analysis of HA
expression on dermal endothelium may aid in diagnosis and management of acGVHD. 
0104
Detection of RNase 7 immunoreactivity in inflammatory skin diseases
M sticherling ,1 F rastar,2 J harder,2 E Wandel1 and J Schroeder 2 1 Department of Dermatology,
University of Leipzig, Leipzig, Saxony, Germany and 2 Department of Dermatology, University of
Kiel, Kiel, Germany
The skin as the largest human organ is constantly exposed to various microbes. Surprisingly how-
ever the incidence of clinically manifest skin infections is rather low. Apparently, there are potent
protective mechanisms which counteract microbial attacks. A 14.5-kDa antimicrobial ribonuclease,
termed RNase 7, was isolated from skin-derived stratum corneum. RNase 7 exhibited potent ribonu-
clease activity and revealed broad spectrum antimicrobial activity against many pathogenic microor-
ganisms and remarkably potent activity (lethal dose of 90% < 30 nM) against a vancomycin-resist-
ant Enterococcus faecium.  To obtain antibodies against Rnase, 7 Balb/c mice were immunized with
natural protein purified from psoriatic scales. One out of several monoclonal antibodies raised showed
distinct epidermal immunoreactivity on both acetone fixed cryostat sections and formaldehyde fixed,
paraffin embedded sections of human skin. In normal human skin, RNase 7 immunoreactivity was
found in all epidermal layers and remarkably high in biopsies of the trunk. In chronic plaque type
psoriasis, signals were detected in upper layers below and within parakeratotic layers around microab-
scesses. Eczema showed a similar pattern whereas in folliculitis a diffuse epidermal staining was
found. Surprisingly, dermal vasculature is stained as well. These findings support the idea of an
important role of antimicrobial peptides in skin disorders beside protection from infections. 
0105
Critical role of galectin-3 in phagocytosis by macrophages
H Sano,1 D Hsu,1 JR Apgar,3 L Yu,1 S Izui2 and F Liu1 1 Department of Dermatology, University
of California, Davis, Sacramento, CA, 2 Department of Pathology, University of Geneva, Geneva,
Switzerland and 3 BD Pharmingen, La Jolla, CA
Macrophages are functionally important in the skin as scavengers of apoptotic cells and invading
pathogens through their phagocytic activity. However, signal transduction into macrophages fol-
lowing extracellular stimuli for phagocytosis is not fully understood. As a member of a large fam-
ily of animal lectins, galectin-3 is also expressed abundantly in macrophages, but its functions in
this cell type are not clearly defined. We have studied the effect of galectin-3 gene targeting on the
phagocytic function of macrophages. Compared to wild-type macrophages, galectin-3-deficient (gal3-
/-) cells exhibited reduced phagocytosis of IgG-opsonized erythrocytes and apoptotic thymocytes in
vitro. Gal3-/- mice showed attenuated phagocytic clearance of apoptotic thymocytes by peritoneal
macrophages in vivo, and reduced IgG-mediated phagocytosis of erythrocytes by Kupffer cells, in
a murine model of autoimmune hemolytic anemia. Gal3-/- macrophages exhibited a lower degree
of actin rearrangement upon FcR crosslinkage. Additional experiments indicate that extracellular
galectin-3 does not contribute appreciably to the phagocytosis-promoting function of this protein.
Moreover, confocal microscopic analysis of macrophages containing phagocytosed erythrocytes
revealed localization of galectin-3 in phagocytic cups and phagosomes. Finally, gal3-/- macrophages
showed significantly reduced activation of protein kinases Lyn and Syk upon FcR cross-linkage.
These results indicate that galectin-3 contributes to macrophage phagocytosis through an intracel-
lular mechanism by regulating critical signaling pathways. Thus, galectin-3 may play an important
role in both innate and adaptive immunity by contributing to phagocytic clearance of microorgan-
isms and apoptotic cells. 
0106
Cross-reactivity among candidate autoantigens in psoriasis
N Yawalkar, K Suh, S Sadat, TS Kupper and D Jones Dermatology, Brigham and Women, Boston,
MA
The etiology of psoriasis is unknown, but is thought to be the result of an autoimmune reaction against
a skin antigen or antigens. We have undertaken an expression cloning project to identify these autoanti-
gens, and have previously reported three candidate proteins. These are keratin 13, a mucocutaneous
keratin upregulated in wound healing; hnRNP-A1, a spliceosome component previously implicated
in rheumatoid arthritis; and a previously uncharacterized protein which we refer to as PAAg-1. We
now report results of detailed screening of serum samples to all three of these antigens. As is the
case with autoantigens in other autoimmune diseases, reactivity was found in subsets of both patients
and healthy controls. However, we also made the surprising observation that subjects which react to
one protein often react to two or all three proteins. Two potential explanations are that these subjects
have a higher degree of general autoreactivity, or that the antibodies cross-react. To test these expla-
nations, we immunoprecipitated serum antibodies to keratin 13, and found that these antibodies do
in fact cross-react with hnRNP-A1 and PAAg-1. We draw two conclusions from this: (1) the epitope
we have identified does appear to be immunodominant, strengthening the possibility that it is of sig-
nificance in psoriasis, and (2) the cross-reactivity between a skin keratin and an antigen previously
implicated in arthritis may be related to the association between skin psoriasis and psoriatic arthri-
tis. Finally, we present evidence that an additional cross-reactivity of these antibodies is to the tax
protein of HTLV-1. Although typical HTLV-1 infection is not seen in psoriasis patients, a relation-
ship between psoriasis and a “tax-only” carrier state or exposure to a related retrovirus are intrigu-
ing possibilities. 
0107
Non-invasive sampling and cytokine profiling for prediction of irritant skin reactions
NR Benson, R Wong and V Tran DermTech International, San Diego, CA
This study examined the ability of a non-invasive tape harvesting technique, coupled with cytokine
mRNA profiling to: 1] predict the ability of a dilute irritant (0.05% SLS) to cause irritation after
extended occlusive patching; and 2] predict the future severity of a skin reaction after 6 hours of
occlusive patching of an irritant (1.0% SLS). In two different trials, up to 10 subjects were patched
with SLS and water from 6 hours to 9 days with differing concentrations of SLS. The sites were
then shave biopsied or harvested using Epidermal Genetic Information Retrieval adhesive films
(EGIR films). The films are used to collects skin cells from the surface of the skin. With the EGIR
technique, 4 adhesive tapes are applied to a skin site and removed. The cells adherent to the films
are extracted for RNA which is quantitated by non-competitive, semi-quantitative RT-PCR and nor-
malized to b-actin. Shave biopsies were extracted for total RNA and similarly assayed. The follow-
ing cytokine mRNAs were assayed and normalized to b-actin: IL-1a, IL-1b, IL-8 and TNFa. In the
trial with dilute SLS (0.05%), 7 subjects displayed varying reactions to occlusive patching and on
average took up to 4 days to display any clinical reaction. 6 subjects showed increases of 4-to-200-
fold in one or more of IL-1a, IL-1b or IL-8 at the SLS site compared to the water site. These increases
were rarely sustained for more that 24 hours and were evident before clinical symptoms in at least
4 subjects. In a second trial with 1% SLS, 10 subjects were occlusively patched with SLS and water
at two replicate sites for 6 hours and 24 hours. One replicate site was harvested at 6 hours and the
cytokine profile compared to clinical symptoms at 24 hours. Results showed that subjects with the
most extreme clinical symptoms at 24 hours also had the largest increases in cytokine mRNAs at 6
hours, thus the 6-hour time point was predictive of the 24-hour clinical result. We believe that the
application of EGIR tapes and cytokine profiling may allow the prediction of irritant reactions in
less than 24 hours. 
0108
Immunomodulatory functions of substance P in autoimmune hair loss
F Siebenhaar,1,2 AA Sharov,2 TY Sharova,2 JP Sundberg,3 M Maurer1 and VA Botchkarev2 1
Dermatology, University Mainz, Mainz, Germany, 2 Dermatology, Boston University, Boston, MA
and 3 Jackson Laboratory, Bar Harbor, ME
Neuropeptides such as substance P (SP) play a critical role in the cross talk of the skin nervous and
immune system, and SP is known to control immune cell functions by acting through the NK-1 recep-
tor. Here, we have studied the role of SP in alopecia areata (AA) an autoimmune disease of the hair
follicle characterized by perifollicular inflammatory cell infiltrates. In C3H/HeJ mice induced to
develop AA, SP expression assessed by ELISA was markedly reduced in lesional skin as compared
to normal skin (p<0.01). In addition, RT-PCR analyses showed levels of neutral endopeptidase (NEP),
the most important SP-degrading enzyme, to be greatly upregulated in lesional skin, which may
explain the low levels of SP found in AA affected skin. Immunofluorescence (IF) staining for NEP
and NK-1 revealed pronounced NEP expression by follicular keratinocytes of the outer root sheath,
whereas NK-1 was found to be predominantly expressed by intra- and perifollicular T cells and
macrophages (MΦ). To test the functional relevance of our findings, we assessed T cell and MΦ
numbers in AA lesions of C3H/HeJ mice after treatment with SP or vehicle. Notably, SP signifi-
cantly reduced the numbers of perifollicular CD4+ and CD8+ T cells (p<0.05 and p<0.01, respec-
tively) as well as MΦ (p<0.01) indicating that SP can modulate the extent of inflammatory cell infil-
trates in AA. As we have recently shown that the neurotrophic factor BDNF can induce apoptosis in
T cells infiltrating AA lesions by acting via the p75NTR receptor, we assessed BDNF expression in
AA skin by IF staining. Interestingly, BDNF was most strongly expressed by NK-1 positive infil-
trating immune cells. Thus, SP may control inflammatory cell populations in AA lesions directly or
by inducing the release of pro-apoptotic BDNF. Our findings suggest that low levels of SP, possibly
due to increased degradation by NEP, contribute to the induction of AA lesions and that exogenous
SP can reduce hair follicle damaging cell populations in AA affected skin. 
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Application of microarray-based data for class prediction in psoriasis
M Mallavarapu,1 K Luettich,1 Z Hiang,2 H King1 and AA Sinha1 1 Dermatology, Weill Medical
College of Cornell University, New York, NY and 2 Microarray Core Facility, Weill Medical College
of Cornell University, New York, NY
Psoriasis is a chronic inflammatory skin disease affecting 2% of the population and is believed to
be multigenic in origin. There is strong evidence to support an autoimmune process, however, the
precise mechanisms of disease induction and progression are not fully understood. We used DNA
chips for the identification of significant alterations in gene expression profiles of nine psoriatic
patients. Image data was first obtained and analyzed using MAS v5.0, and metrics files were sub-
sequently exported and analyzed using GeneSpringTM v4.2.1 using a non-parametric test with a P-
value cut-off at 0.05. Three hundred genes were found to be differentially expressed in psoriatic
skin when compared to non-lesional skin. Of these, 202 genes were up-regulated and 98 were down-
regulated in psoriatic skin. Functional classification of the differentially expressed sequences reveals
that the majority encode structural proteins (KRT15, CDH19, IVL, TGM1), or are involved in cell
cycle regulation (RB1, CKS2, CDC37), signal transduction (LYN, SYK, ARGBP2, STAT1) and host
immune response (DEFB4, IL1RN, IL4R, SCYA22). Hierarchical clustering showed a distinct gene
expression pattern distinguishing lesional from non-lesional skin. Further, we identified a set of 10
genes that can accurately predict psoriasis using the K-nearest-neighbor prediction method. Gene
expression profiles of these 10 predictor genes were confirmed using real-time RT-PCR. Subse-
quent analysis of the predictor gene expression levels in histologically unclassified samples was then
used for class prediction of psoriatic vs non-psoriatic skin, and prediction was confirmed by histol-
ogy. We demonstrate here that predictor gene expression profiles can be employed as a supplemen-
tal diagnostic tool for the identification of psoriasis and distinction from other inflammatory skin
conditions. 
0111
Pathogenic antigen-specific immune responses to human bullous pemphigoid antigen 2
(hBPAG2) transgenic (Tg) skin in wild type (wt) mice are dependent on CD4+ T cells and are
mediated by hBPAG2-specific IgG
EB Olasz, M Lin, Z Lazarova and KB Yancey Dermatology, Medical College of Wisconsin,
Milwaukee, WI
It is hypothesized that IgG autoantibodies in patients with bullous pemphigoid (BP) are pathogenic
and that T cells provide crucial signals for their production. Recently, we produced phenotypically
normal, C57BL/6 Tg mice that stably express immunoreactive hBPAG2 in murine epidermal BM.
To develop and characterize experimental immune responses to hBPAG2, Tg skin was grafted onto
gender-matched, syngeneic wt, MHC I -/-, MHC II -/-, or CD4 -/- mice. Median graft survival time
(MST) was 28 and 30 days in wt and MHC I -/- mice, respectively; graft loss followed development
of antigen-specific IgG in both strains and thus was independent of CD8+ T cell activity. Tg skin
placed on previously grafted wt mice (i.e., mice with anti-hBPAG2 IgG) displayed a MST of only
12 days. Direct IF microscopy of Tg skin grafts placed on “immune” wt mice identified in situ deposits
of IgG, IgM, and C3 in epidermal BM. Light microscopy studies of such grafts identified vacuolar
alterations and granulocyte-rich infiltrates forming just beneath basal keratinocytes like those seen
in early lesional skin from patients with BP. Interestingly, Tg skin placed on MHC class II -/- mice
demonstrated ongoing survival (> 180 days); these mice consistently failed to develop hBPAG2-spe-
cific IgG. CD4 -/- mice had significantly delayed loss of Tg skin grafts (MST=60 days) that again
followed the development of hBPAG2-specific IgG. Adoptive transfer of hBPAG2-specific CD4+ T
cells to CD4 -/- mice bearing Tg skin prompted graft loss only subsequent to development of anti-
hBPAG2 IgG (rather than immediately following the administration of antigen-specific CD4+ T
cells). In sum, these findings indicate that loss of Tg skin in these grafting paradigms is mediated
by antigen-specific IgG. hBPAG2 in Tg skin elicits specific and pathogenic immune responses in
naive wt mice that mimic the consequences of immune responses to this protein in patients with BP. 
0113
Global gene expression analysis identifies a novel apoptotic pathway in cutaneous lupus
erythematosus
K Luettich,1 Z Xiang,2 AA Sinha1 1 Department of Dermatology, Weill Medical College of Cornell
University, NewYork, NY and 2 Microarray Core Facility, Weill Medical College of Cornell
University, New York, NY
The molecular basis for the initiation and mechanisms of progression in lupus are not well under-
stood. However, it is becoming increasingly clear that the pathogenesis of many human diseases is
associated with a dysregulation of apoptotic pathways. Apoptosis serves to remove superfluous, dam-
aged or harmful cells in a wide variety of physiological contexts and is crucial for tissue morpho-
genesis and for maintaining cellular homeostasis. Autoantibodies in sera from LE patients have
been shown to recognize antigens present within apoptotic blebs, suggesting that apoptotic cells serve
as a source of autoantigens and play a major role in the development of this disease. We used DNA
chips to search for significant alterations in the gene expression profiles of 6 LE patients. Ninety-
five genes were found to be differentially expressed in LE skin relative to non-lesional skin. Hier-
archical clustering analysis demonstrated a distinct gene expression pattern distinguishing affected
from non-affected skin. Of the 95 differentially expressed genes (DEGs), 84 genes were up-regu-
lated and 11 were down-regulated in LE skin. Classification of the 95 DEGs based on ontology
revealed that the majority are involved in apoptosis, host response mechanisms and signal trans-
duction. Interestingly, we found an up-regulation in expression of genes encoding both pro-apop-
totic mediators (FAS, CASP10 and GZMB) and anti-apoptotic mediators (TRAF1 and TNFAIP3)
in cutaneous LE lesions. Our preliminary data also suggests the execution of a novel apoptotic path-
way involving the expression of 2’-5’-oligoadenylate synthetase (OAS) genes and proteins in LE
skin lesions, which might contribute to the induction and/or maintenance of the autoimmune state. 
0112
Alopecia areata phylogenetic tissue arrays
S Whitehead,1 KA Silva,2 M Hogan,3 T Olivry,4 TL Gross,5 RW Dunstan,6 KJ McElwee,7
D Whiting,8 LE King1 and JP Sundberg1,2 1 Dermatology, Vanderbilt University, Nashville, TN, 2
Research, The Jackson Laboratory, Bar Harbor, ME, 3 BD Biosciences Pharmingen, San Diego,
CA, 4 North Carolina State University, Raleigh, NC, 5 Idexx Corporation, West Sacramento, CA,
6 Pfizer Global Research and Development, Ann Arbor, MI, 7 Dermatology, Philip University,
Marburg, Germany and 8 Baylor, Dallas, TX
Alopecia areata is a relatively common human autoimmune skin disease that targets anagen stage
hair follicles. Clinically and pathologically similar diseases occur in mice, rats, dogs, and other
species. Variability between individuals in outbred species suggests that either there are many fac-
tors involved in the disease or that several diseases with similar features are lumped together. Cre-
ation of tissue arrays consisting of 49 punch biopsies on a single microscope slide provides a tool
to directly compare the histologic features between cases. Parallel slides from cases in other species
permits phylogenetic comparisons. Immunohistochemical analyses of these tissues provides ways
to analyse immediately many samples tested with the same antibody at the same time. We found
that although patterns are similar between individuals as well as between species, there is more vari-
ability than generally reported. These tissue arrays will be available to investigators later this year
through the National Alopecia Areata Repository (hppt://www.AlopeciaAreataRegistry.org). 
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Phenolic-based compounds completely inhibit interleukin-1-induced prostaglandin E2 pro-
duction through a mechanism independent of COX-2 or phospholipase A2 in human fibrob-
lasts
DR Smith1 and BB Fuller1,2 1 Biochemistry and Molecular Biology, University of Oklahoma
Health Sciences Center, Oklahoma City, OK and 2 Cutanix Corporation, Los Altos, CA
Prostaglandin E2 (PGE2) is a potent vasodilator and is known to play a critical role in inflammatory
skin disorders. PGE2 production from the substrate arachidonic acid, which is released from mem-
brane glycerophospholipids by phospholipase A2, is controlled by two rate-limiting steps. The first
step is catalyzed by cyclooxygenase (COX), which converts arachidonic acid to the intermediate
prostanoid PGH2.  Two isoforms of the COX enzyme have been identified: cyclooxygenase 1 (COX-
1), which is a constitutive enzyme, and cyclooxygenase 2 (COX-2), which is induced by inflamma-
tory stimuli, such as lipopolysacharide (LPS) or the cytokine interleukin-1 (IL-1). The second step
of PGE2 synthesis is the terminal conversion of PGH2 to PGE2, which is catalyzed by PGE2 syn-
thase (PGES). PGES is also induced by the inflammatory stimuli LPS and IL-1.  Inhibition of enzymes
in the pathway of PGE2 production, such as phospholipase A2 and COX-2, have proven to be ben-
eficial in the reduction of inflammation. However, compounds able to inhibit PGES have yet to be
identified. Upon screening a library of phenolic-based compounds, CX-452 and CX-1090 were found
to completely inhibit IL-1 induced PGE2 production in human dermal fibroblasts. These effects were
not due to the direct inhibition of the phospholipase A2 or COX-2 enzymes. Further, CX-452 and
CX-1090 did not affect COX-2 mRNA or protein abundance. They also did not significantly inhibit
PGES protein abundance. The action of these compounds on the activity of the PGES enzyme sug-
gests a novel and potentially clinically useful mechanism for inhibiting PGE-2 production. 
0114
Staphylococcus aureus induces TNF-α expression in primary cultured human keratinocytes
M Guo, D Yao and GJ Murakawa Dermatology, Wayne State University, Detroit, MI
Bacterial infections of the skin are clinically recognized through inflammation, suggesting a pro-
inflammatory immune response. Yet little is known regarding the role of skin cells in the pro-inflam-
matory response to invading bacteria. Toward this regard, we studied the role of human keratinocytes
in the host immune response to infection with Staphylococcus aureus, the most common cause of
cutaneous bacterial infections. Particularly, we focused on investigating the involvement of pro-
inflammatory cytokines in S. aureus infection. Specifically, we have characterized the ability of S.
aureus to induce the cytokine TNF-α,an essential mediator of inflammatory and immunological reac-
tions during host defense, using human keratinocytes. TNF-α mRNA synthesis of infected ker-
atinocytes was examined using Reverse Transcriptase- Polymerase Chain Reaction (RT-PCR). Con-
currently, TNF-α protein expression was studied using Enzyme Linked-Immuno-Sorbent Assay
(ELISA). Previously we have shown that S. aureus adheres rapidly and efficiently to human ker-
atinocytes, followed by a slow but persistent invasion (~2-4% in 4 hr) and subsequent intracellular
replication. TNF-α mRNA expression was induced at 6 hr and 24 hr after S. aureus infection, and
decreased at 48 hr post infection. Similarly, TNF-α protein levels were increased 2-fold and 8-fold
at 6 hr and 24 hr after S. aureus infection, respectively. Infection of keratinocytes with several other
strains of S. aureus showed similar TNF-α induction. Entry by bacteria into human keratinocytes is
critical for increased TNF-α secretion. In conclusion, our study showed that human keratinocytes
secrete TNF-α in response to S. aureus invasion. Expression of TNF-α by keratinocytes in response
to S. aureus infection is recognized as one of the early events following the infection by variety of
human pathogens. TNF-α is an important pro-inflammatory cytokine not only because it plays a cru-
cial role in pathogenic events accompanying bacterial invasion, but it also can function in synergy
with other cytokines that are involved in inflammatory reactions. 
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Increased expression of CD132 and multiple IL-2 family receptors in psoriasis vulgaris
J Cohen, A Haider, I Cardinale, T Kikuchi and JG Krueger Laboratory for Investigative
Dermatology, Rockefeller University, New York, NY
The IL-2 family receptors (IL-2R, IL-4R, IL-7R, IL-9R, IL-15R and IL-21R) have not been well
characterized in psoriasis. This family is defined by its shared use of the common gamma chain
(CD132) for signal transduction. We used RT-PCR, FACS and immunohistochemistry (IHC) to exam-
ine expression of these receptors in skin biopsies. CD132 mRNA was upregulated in lesional ver-
sus nonlesional skin (p<0.02). IHC for CD132 showed expression confined to infiltrating leuko-
cytes with no detectable expression on keratinocytes. FACS identified CD132 on the surface of T
cells and dendritic cells in psoriatic skin with highest expression on activated dendritic cells. T cells
in lesions expressed higher levels of CD132 than those in peripheral blood. IL-2Rα, IL-4R, IL-7R
and IL-21R mRNA were also upregulated in psoriasis lesions (p values<0.02). IL-15R mRNA was
consistently detected in lesional and nonlesional skin. FACS demonstrated upregulation of IL-2Rα,
IL-7R and IL-15R on the surface of cutaneous T cells when compared to those in peripheral blood.
FACS also showed that dendritic cells expressed IL-15R, upregulated IL-2Rα and IL-7R in their
activated subpopulation and were the only cell type studied to express IL-4R. IHC suggested co-
expression of IL-2Rα and IL-7R with CD132. IHC for IL-15 stained keratinocytes as well as the
inflammatory infiltrate. Although IL-9R mRNA showed a downward trend in lesional skin, IHC indi-
cates possible expression on psoriatic blood vessels. IHC for IL-21R produced intense keratinocyte
staining but this is unlikely to represent a functional receptor in the absence of co-expression with
CD132. Interestingly, we were unable to detect IL-21 mRNA in lesional or nonlesional skin. These
data suggest a complex biology of the IL-2 family receptors in psoriasis and have important impli-
cations for receptor-directed therapies. 
0116
Corticosteroids block acantholyis by strengthing cell-cell adhesion
H Suzuki, MS Kolodney and S Yoo Division of Dermatology, UCLA, Los angeles, CA
Corticosteroid therapy transformed pemphigus vulgaris (PV) from a fatal disease to a highly treat-
able one. Although corticosteroids have well characterized immunosupressive properties, the pre-
cise mechanism of these agents in pemphigus has remained elusive. We used an in vitro model of
PV antibody mediated acantholysis to examine the mechanism through which corticosteroids inhibit
acantholysis. Pretreatment with methylprednisolone blocked PV antibody mediated acantholysis of
human epidermal keratinocytes. We measured the effect of corticosteroid treatment on the function,
levels, and localization of desmosomal components in keratinocytes. Using a mechanical cell dis-
persion assay, we found that corticosteroids caused a dramatic strengthening of keratinocyte cell-
cell adhesion. This change in adhesion was associated with increased levels of desmoglein 3 protein
and the assembly of desmoplakin containing foci at sites of cell-cell contact. These results suggest
that strengthening of keratinocyte adhesion may contribute to the therapeutic action of corticosteroids
in PV and other vesiculobullous diseases. 
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Mast cells induce aberrant angiogenesis in a model of rheumatoid arthritis
M Kneilling,1 L Hultner,3 B Pichler,2 R Mailhammer,3 L Morawietz,4 S Solomon,5 J Sabatino,2
W Weber,2 V Krenn,4 R Haubner,2 H Illges5 and M Rocken1 1 Dermatology, Eberhard Karls
University, Tuebingen, Baden Wuertemberg, Germany, 2 Nuclear Medicine, Technical University,
Munich, Germany, 3 GSF, Institute of Clinical Molecular Biology and Tumor Genetics, Munich,
Germany, 4 Pathology, Humboldt University, Charite, Berlin, Germany and 5
Immunology/Biology, University of Konstanz, Konstanz, Germany
Auto-antibodies against glucose-6-phosphate isomerase induce T cell-independent arthritis in mice.
As mast cells are important amplifiers of T cell-dependent and T cell-independent inflammation, and
can produce mediators involved in angiogenesis, we studied whether mast cells influence neoan-
giogenesis, a hallmark of psoriasis arthritis and other chronic inflammatory diseases. Comparing
wild type mice, mast cell-deficient kitW/W-v mice and mast cell-reconstituted kitW/W-v mice, we
found that mast cells were essential for pannus formation and integrin αvβ3-expression and neoan-
giogenesis during chronic inflammation. This was confirmed by in vivo-quantification of activated
αvβ3 integrin using radio-labeled RGD-peptide and positron emission tomography. In consequence,
therapeutic mast cell-degranulation inhibitors also prevented αvβ3-activation, angiogenesis and tis-
sue destruction. As these data unravel a critical role of mast cells and mast cell-derived mediators in
chronic inflammation, inhibition of mast cell-degranulation may not only attenuate acute arthritis
but also the late damages of psoriais arthritis resulting from neovasularization and scar formation. 
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Psoriasis-like inflammatory skin disease in mice with epidermis-specific-ablation of IκB kinase 2
I Haase1 and M Pasparakis2 1 Dermatology, University of Cologne, Cologne, NRW, Germany and
2 EMBL Mouse Biology Programme, Monterotondo, Italy
Cutaneous inflammation involves interactions between several cell types that populate different com-
partments of the skin. The role of epidermal keratinocytes in its pathogenesis is not well charac-
terised. Using conditional gene targeting we have ablated the gene for IκB kinase 2 (IKK2) specif-
ically from the epidermis of mice. Deletion of IKK2 attenuates cytokine stimulated NFκB activation
but does not stimulate proliferation or inhibit differentiation of keratinocytes. After exposure to the
extramaternal environment, newborn mutant mice develop a severe inflammatory skin disease that
closely resembles human psoriasis. We show that the pathogenesis of this disease does not require
alpha/beta T lymphocytes but depends on the presence of the type I receptor for tumour necrosis
factor (TNF). Our results suggest that epidermal keratinocytes can control skin inflammation and
are capable of initiating a psoriasis like skin disease in mice. The pathogenesis of this disease involves
interactions between epidermal keratinocytes and dermal cells and depends on TNF- mediated cell-
cell communication. 
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HLA pocket polymorphisms define functionally-active desmoglein 3 sequences in pemphigus
vulgaris
WR Miele,1 AK Moesta,1 J Rasmussen,2 J Zhang,2 S Stevanovic,3 HG Rammensee,3 L Steinman4
and AA Sinha1 1 Dermatology, Weill Medical College of Cornell University, New York, NY, 2
Peptimmune Corp, Cambridge, MA, 3 University of Tubingen, Tubingen and 4 Stanford University,
Stanford, CA
Susceptibility to pemphigus vulgaris (PV) is correlated with the HLA alleles DRB1*0402 and
DQB1*0503, but the mechanism of HLA mediated susceptibility is not understood. While disease
is ultimately mediated by anti-desmoglein 3 (Dsg3) antibodies, an initial T cell response restricted
to HLA DRB1*0402 or DQB1*0503 is presumably required to generate anti-Dsg3 autoantibodies.
There is no consensus regarding T cell epitopes relevant for disease induction and/or propagation.
We have defined a DRB1*0402 motif to deduce Dsg3 sequences able to form MHC II-peptide com-
plexes. Top scoring peptides were synthesized and screened for functional activity by proliferation
assays with patient PBMC. T cell reactivity to 4 peptides was observed. Response to at least one pep-
tide was detected in 5/9 patients that typed as DRB1*0402. Two epitopes, Dsg3 809-823 and 962-
973 are contained within the cytoplasmic region of Dsg3, while Dsg3 190-204 and 341-355 map to
the extracellular domains. All stimulatory sequences (Dsg3 190-204, 341-355, 809-823, and 962-
976) were shown to directly complex with purified DRB1*0402/DRA1*0101 molecules in a com-
petitive binding assay. Two peptides able to bind DRB1*0402 did not stimulate T cell response in
any patients (or HLA matched controls), suggesting T cell tolerance to at least some portions of the
Dsg3 self protein. We also show a response within one patient to two peptides (Dsg3 341-355 and
190-204) and another to three peptides (Dsg3 962-973, 190-204, and 809-823). Our data suggest
that the intracellular and extracellular portions of Dsg3 harbor disease relevant T cell epitopes and
that multiple epitopes may be operative in the autoimmune response in an individual patient. These
findings may be of clinical relevance regarding disease initiation and subsequent epitope spreading. 
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Construction of human TNF-α expression vectors under the control of TNF-α promoter poly-
morphisms
GJ Poggioli,1 D Marr,1 VP Werth,2 YG Shellman1 and DA Norris1 1 Dermatology, University of
Colorado Health Sciences Center, Denver, CO and 2 University of Pennsylvania, Philadelphia, PA
Tumor necrosis factor-α (hTNF-α) is involved in apoptosis and immunomodulation. Studies have
shown that the hTNF-α promoter polymorphism, -308A, results in increased transcription follow-
ing UVB irradiation in the presence of interleukin-1. This promoter polymorphism is prevalent in
subacute cutaneous lupus erythematosus (SCLE) and may represent a mechanism contributing to
photosensitive dermatitis and the development of autoimmunity. To investigate the role of hTNF-α
expression from the -308A TNF-α promoter polymorphism, we constructed vectors expressing hTNF-
α under the control of the wild type promoter (-308G) and -308A polymorphic promoter. A multi-
step cloning strategy was utilized to create these constructs, and the vector sequences were confirmed
by sequencing. We will use these constructs to investigate whether the -308A promoter polymor-
phism of human TNF-α affects apoptosis as well as translocation of intracellular antigens to the cell
surface. Furthermore, we plan to investigate whether TNF-α-induced apoptosis leading to the pres-
entation of intracellular antigens results in the development of autoimmunity seen in cutaneous LE.
These studies will contribute to our understanding of the pathogenesis of SCLE and may direct
research toward potential treatments for SCLE. 
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Gene expression profiling in vitiligo by cDNA microarray analysis provides support of immune-
mediated mechanisms of disease
M Mallavarapu,2 AA Sinha,2 Z Xiang1 and K Luettich2 1 Dermatology, Weill Medical College of
Cornell University, New York, NY and 2 Microarray Core Facility, Weil Medical College of Cornell
University, New York, NY
Vitiligo is a debilitating skin disease with areas of pigment loss, affecting one or two of every 100
people. The cellular and molecular mechanisms leading to the destruction of melanocytes in this
disorder have not yet been elucidated. The three prevailing theories of the pathogenesis of vitiligo
are the immune hypothesis, the neural hypothesis, and the self-destruct hypothesis. According to the
available data, it is likely that the loss of epidermal and follicular melanocytes in vitiligo may be the
result of several different pathogenetic mechanisms. Microarray technology allows for simultane-
ous screening of a wide range of genes that may be involved in the pathogenesis of multigenic dis-
eases such as vitiligo. In our studies, DNA chips were used for the identification of significant alter-
ations in the gene expression profiles of 7 vitiligo patients. Image data was first obtained and analyzed
using MAS v 5.0, and metrics files were subsequently exported and analyzed using GeneSpringTM
v4.2.1 using a parametric test with a P-value cut-off at 0.05. Hierarchical clustering showed a dis-
tinct gene expression pattern distinguishing affected from unaffected skin. We report 75 differen-
tially expressed genes (DEGs) when comparing affected with unaffected skin. Of these, more than
40 were up-regulated in lesional skin and more than 30 were down-regulated in lesional skin. Func-
tional classification of the DEGs show that the majority are involved in signal transduction (GLI,
PLCG2, CAMP-GEFII), immune response (CD86, INDO, LIFR, TNFAIP3), and DNA replication
and repair (RPA3, RECQL). In addition, a small set of DEGs encodes oncogenes. This microarray-
based expression data defining vitiligo was confirmed by real time RT-PCR and further functional
analysis with a larger data set of skin samples are currently undertaken. 
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Immunization with pemphigus anti-idiotype F(ab)’2 fragments elicit anti-epithelial antibodies
in adult Balb\c mice
E Avalos and R Herrera-Esparza Immunology, CBE, Universidad Autonoma de Zacatecas,
Guadalupe, Zacatecas, Mexico
The immunization with anti-idiotype antibodies would elicit antibodies capable to recognize certain
epitopes like the original antibody does, such recognition would be elicited by internal images. The
major goal of present study was elicit anti-epithelial antibodies in adult Balb\c mice by Cre anti-idio-
type antibody from pemphigus foliaceous previously described. For this purpose six adult Balb\c
mice were immunized weekly with Cre anti-idiotype F(ab)’2 fragments. IgG anti-idiotype was digested
by pepsin, and F(ab)’2 fragments were purified by gel filtration chromatography in Sephacryl S-
300. All immunized animals developed anti-epithelial antibodies, starting at the 4th week. Fine speci-
ficity by ELISA demonstrated anti-desmoglein 1 antibodies in three animals after two months, this
animals developed blisters, and their skin biopsies exhibited intraepidermal blisters and acantolysis.
Direct immunofluorescence showed IgG deposition along inter-cellular spaces of epidermal cells.
Controls were negative. In conclusion, anti-epithelial antibodies can be elicited by internal images
of pemphigus anti-idiotypes. 
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High frequency of BRAF mutations in melanocytic skin lesions of various dignity
AS Yazdi,1 G Palmedo,2 MJ Flaig,1 H Kutzner2 and CA Sander1 1 Dermatology, Ludwig-
Maximilians-University Munich, Munich, Germany and 2 Dermatology, Dermatopathologische
Gemeinschaftspraxis, Friedrichshafen, Germany
Genes of the RAF family are components of intracellular signal transduction pathways. BRAF encodes
a kinase that mediates cell growth and malignant kinase pathway activation, which can be target of
a specific therapy. A recent study reported about the T1796A point-mutation in exon 15 of the BRAF
gene in a high frequency in melanoma cell lines and in 6 of 9 primary malignant melanomas (MM).
In order to evaluate the role of the T1796A BRAF mutation in tumorigenesis of malignant melanomas
we screened 303 melanocytic skin lesions for the presence of the specific BRAF mutation includ-
ing malignant melanomas, malignant melanomas in situ, various types of melanocytic nevi, Spitz
nevi and malignant melanomas with an underlying nevus by single strand conformational polymor-
phism (SSCP)and direct DNA sequencing. The frequency of the mutation in malignant melanomas
was considerably low (28/97), but the specific nucleotide change could be detected in several non-
malignant melanocytic skin lesions (39/187). Papillomatous nevi showed the highest frequency of
the T1796 A mutation (20/27), whereas in Spitz nevi (0/63) and blue nevi (0/19) the mutation could
not be detected at all. Combined lesions of malignant melanomas and nevi showed the mutation both
in the microdissected nevus (3/14) and melanoma cells or both lesions had the wild-type (10/14)
allele, whereas in only one case the mutated nucleotide could be identified solely in the malignant
melanoma part. We screened 303 (including 94 laser-capture microdissected tissue samples) for the
presence of T1796A. As the specific mutation of BRAF was found in similar frequency in both malig-
nant and benign lesions, other factors are supposed to play a role in oncogenesis of malignant
melanomas. 
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Insulin-like growth factor-1 stimulates bcl-2-like gene expression and protects against
dexamethasone-induced apoptosis in neonatal mouse skin
H Su and C Lin Biotechnology, Pingtung University, Pingtung, Taiwan
Growth factors and hormones are believed to play important roles in skin growth, differentiation
and tumor formation. Insulin-like growth factor 1 (IGF-1) has been identified as a survival factor in
many tissues including the skin, but the molecular mechanism of IGF-1 in skin carcinogenesis is not
completely understood. Using RNA differential display, a 358-bp message has been identified in
the skin of IGF-1-injected mice but not in controls. Confirmation of expression of this gene in the
skin by ribonuclease protection assay showed that its expression is dependent on the treatment of
IGF-1. Using rapid amplification of 5’ cDNA ends, we have successfully cloned a 3473-bp full-
length gene (GenBank accession No. AY170344), which has 99% sequence homology to a bcl-2-
like gene. The latter has been identified as a proto-oncogene in several murine myeloid cell lines. In
addition, IGF-1 can prevent epidermal keratinocytes against dexamethasone- (DEX-) induced apop-
tosis, based on the findings that DNA laddering was present in the control mice but not in IGF-1-
and DEX-treated ones. Further, using a photometric enzyme-linked immunoassay to quantitate ker-
atinocyte death, we found that after addition of DEX, the amounts of cytoplasmic histone-associ-
ated DNA fragments were not significantly (p > 0.05) different in IGF-1-treated cells compared
with untreated cells but significantly (p < 0.001) higher amounts of DNA fragmentation were observed
in vehicle-treated compared with untreated cells. Our current data demonstrated that IGF-1 plays an
anti-apoptotic role in the proliferation of mouse skin and this, at least in part, may be mediated through
expression of bcl-2. 
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Differential regulation of inflammatory signaling pathways by retinoids and corticosteroids
in human sebocytes
MK Oeff,1 H Seltmann,1 SR Bornstein2 and CC Zouboulis1 1 Dept of Dermatology, UKBF, The
Free University of Berlin, Berlin, Germany and 2 Dept of Endocrinology, Heinrich Heine
University, Duesseldorf, Germany
The combination of 13-cis retinoic acid (13cRA) and corticosteroids has been shown to be markedly
effective in severe inflammatory acne, such as acne fulminans. On the other hand, we and others
have currently shown that human epithelial cells are likely to modulate inflammatory signals by
intrinsic mechanisms. The toll-like receptor (TLR) / CD14 pathway, which is involved in the innate
immunity by being able to recognize microbial components, and cytokine /chemokine synthesis has
been implicated as such mechanisms. We address here the influence of 13cRA, hydrocortisone and
the microbial components lipopolysaccharide (LPS), and lipoteichoic acid (LTA) on TLR2 and TLR4
mRNA and protein expression (TaqMan quantitative PCR and immunocytochemistry, respectively)
as well as interleukin-1α (IL1α), IL6, and IL8 mRNA expression and synthesis (TaqMan PCR and
ELISA). Phorbol 12-myristate 13-acetate (PMA) served as positive control. SZ95 sebocytes expressed
TLR2 and TLR4, IL1α, IL6, and IL8 on mRNA and protein levels. LPS enhanced TLR2 and cytokine
/ chemokine expression, but not TLR4 (n=7, p<0.05), while LTA barely exhibited any effect. 13cRA
suppressed IL1α and IL6 synthesis but has no effect on TLR or IL8 expression. Hydrocortisone
suppressed TLR4 and cytokine expression but did not affect TLR2 expression (n=7, p<0.05). PMA
increased TLR and cytokine / chemokine expression dramatically (n=7, p<0.001). The present work
provides first evidence that retinoids and corticosteroids exhibit distinct anti-inflammatory activi-
ties on epithelial skin cells and, therefore, the retinoid / corticosteroid combination may be mean-
ingful in severe inflammatory skin diseases. 
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Advances in phytotherapy of skin cancer
AP Singh and S Malhotra Natural Products, Ind Swift, Mohali, Punjab, India
Medicinal herbs are significant source of synthetic and herbal drugs. Before the availability of syn-
thetic drugs, man was completely dependent on herbs as healthcare system. Medicinal herbs have
been on the forefront whenever we talk about anticancer remedies. Vinblastine, Vincristine, Podophyl-
lotoxin and Taxol are reputed drugs in the field of chemotherapy. Psoralens in association with UV
light has been employed for the treatment of skin cancer. Medicinal plants have not been exploited
to their potential, as far as treatment of skin cancer is concerned. The paper reviews latest develop-
ments in phytotherapy of cancer. Silymarin (Silybum marianum) has shown protective effects against
photocarcinogensis in mouse skin model. The drug offered significant protection against UVB-
induced carcinogensis. Curcumin, the active constituents of Curcuma longa, effectively inhibited
metastasis of melanoma cells in animal studies. Laboratory and animal studies have shown that active
constituent of Rosmarinus officinalis, carnosolic acid and ursolic acid inhibited the skin tumori-
gensis. Pheophorbide-A inhibited skin tumor promotion in ICR mouse. Cassiamin isolated from Cas-
sia siames demonstrated chemoprotective effects against mouse skin carcinogensis. Salvia offici-
nalis and Withaferin-A obtained from Withania somnifera inhibited skin tumors in DBMA (dimethyl
benzanthracene) induced complete carcinogensis. We conclude that medicinal plants and natural
products have demonstrated significant results in animal models. The phytochemicals with poten-
tial anticancer activity should be screened for large-scale clinical trials. 
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Utility of a microarray scanner to enhance intra-operative margin control during Mohs micro-
graphic surgery
RC Burrows, JE Olerud and S Iwamoto Dermatology, University of Washington, Seattle, WA
Mohs micrographic surgery for the removal of squamous and basal cell carcinoma relies on the intra-
operative examination of hematoxylin and eosin (H&E)-stained frozen biopsy sections during the
surgical procedure to confirm clearance of the tumor margin. In certain cases, ambiguity can arise
in evaluating the H&E sections due to the presence of inflammatory infiltrate or ambiguity in judg-
ing the morphology of tiny nests of cells that may or may not be malignant. In this study we have
employed the use of a rapid immuno-labeling procedure in conjunction with a microarray scanner
as an adjunct to the H&E sections in evaluating the clearance of the tumor margin in ambiguous
cases. The scanning method provided a complete image of the entire Mohs surgery section, includ-
ing histological details. This eliminated the need to draw a freehand Mohs map. We were able to
generate scanned images of the entire Mohs section for viewing within 20 minutes of receiving the
frozen section. Our wide-spectrum keratin antibody clearly labeled the epidermis, sebaceous glands,
eccrine and apocrine glands, hair-follicles and the tumor. Double-labeling using a wide spectrum
keratin and keratin 19 allowed us to clearly distinguish small nests of tumor cells from non-malig-
nant cells that appeared ambiguous on the H&E slide. The rapid immuno-labeling and scanning
methodology can serve as valuable adjunct to the evaluation of the H&E sections currently used in
Mohs surgery. The scanning methodology is extremely helpful in cases of ambiguity, to identify
hidden tumor cells. Thus, this novel application of a microarray scanner has a significant and prac-
tical use in clinical settings such as that in Mohs micrographic surgery. 
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Inducible, haploinsufficiency of PTEN in transgenic mouse skin is a lesion-eliciting event dur-
ing activated Ha-ras-mediated papillomatogenesis
CL Alexander,1 JA Gold,1 H Wu2 and DA Greenhalgh1 1 Squamous Cell Biology and Dermatology,
Division of Cancer Sciences and Molecular Pathology, Glasgow University, Glasgow, G11 6NU,
United Kingdom and 2 HHMI & Department of Molecular and Medical Pharmacology, UCLA
School of Medicine, Los Angeles, CA
To investigate the role of PTEN tumour suppressor gene failure in Ha-ras-mediated transgenic mouse
skin carcinogenesis, mice containing a floxed PTEN allele were mated to HK1.ras mice carrying an
inducible cre recombinase expressed from the K14 keratin promoter [K14.CreP]. On topical appli-
cation of the progesterone agonist Ru486, cre recombinase acts to ablate exon 5 of the floxed PTEN
allele(s) and inactivate function exclusively in keratinocytes, including stem cells. HK1.ras line 1276
expresses v-Ha-ras in transit amplifying keratinocytes and suprabasal cells to elicit an initiated epi-
dermis, which does not exhibit spontaneous papillomas, despite an ear tag wound promotion stim-
ulus. On treatment with Ru486, HK1.ras 1276 mice heterozygous for the K14/PTEN floxed allele
developed novel benign tumours at wounded [ear tag] sites by 3-4 weeks, whilst 1276 siblings
homozygous for the K14/PTEN allele rapidly developed highly keratotic ear lesions, within 2-3
weeks of treatment, apparently independent of wound promotion, and displayed a dorsal skin hyper-
keratosis. These data demonstrate that inducible haploinsufficiency and reduction in the function(s)
of PTEN is sufficient to cooperate with wound associated Ha-ras-mediated papillomatogenesis, dis-
playing an apparent lesion-eliciting event. The highly keratotic nature to the lesions following com-
plete PTEN ablation highlights a disruption to the ordered differentiation kinetics of initiated/benign
lesion keratinocytes and suggests a response mediated by failures in cell-cell adhesion and/or adhe-
sion signalling. 
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A mitochondrial genome-wide screen for mutations in UV-induced tumors in mouse skin
A Eshaghian1 and JE Sligh1,2 1 Division of Dermatology, Vanderbilt University Medical Center,
Nashville, TN and 2 VA Tennessee Valley Healthcare System, Nashville, TN
The mitochondrial genome of most North American laboratory mouse strains is a 16,295 bp circu-
lar DNA molecule that encodes 13 polypeptides involved in oxidative phosphorylation and a com-
plete set of tRNAs and rRNAs required for their translation on mitochondrial ribosomes. The accu-
mulation of homoplasmic mitochondrial DNA (mtDNA) point mutations has been observed in various
human malignancies including our labs findings of these mutations in non-melanoma skin cancers.
We sought to identify the potential role of mtDNA point mutations in the pathogenesis of cutaneous
tumors in an animal model. We excised cutaneous tumors induced in the hairless mouse by repeti-
tive doses of UVA and UVB light delivered over ten weeks. We designed and optimized oligonu-
cleotide primer pairs that span the entire mouse mitochondrial genome to produce 51 amplicons with
a minimum of 15 percent overlap. The PCR products amplified from tumor DNA were mixed with
PCR products amplified from wild type mouse mtDNA.  Thermal denaturation of these mixed mtDNA
amplicons was followed by slow cooling, allowing for the formation of heteroduplexes if the ampli-
fied DNA fragments contain genetic variation. The WAVE system (Transgenomics) is a sensitive,
high throughput, column-based method used to detect DNA variation as small as a single base change
within the amplicon by denaturing high-pressure liquid chromatography (DHLPC). The mixed
PCR products were applied to the HPLC column at a temperature that partially denatures the strands
and the DNA was subsequently eluted using increasing concentrations of acetonitrile and measured
with UV light detection. Using this method, homoduplex DNA produced a single peak and was
resolved from heteroduplex DNA which produced multiple peaks. We are currently sequencing the
amplicons that produced heteroduplex peaks for identification of the specific nucleotide changes.
This method allows for convenient screening of the entire mitochondrial genome for mutations poten-




Tumor suppressor and motility functions of p16INK4A growth arrest in normal and prema-
lignant epidermis and oral epithelium
E Natarajan,1,5 M Saeb,2 JD Omobono,1 SB Woo,3,5 PH McKee2,4 and JG Rheinwald1,4 1
Dermatology, Brigham and Women’s Hospital, Boston, MA, 2 Pathology, Brigham and Women’s
Hospital, Boston, MA, 3 Oral Medicine and Diagnostic Sciences, Brigham and Women’s Hospital,
Boston, MA, 4 Harvard Medical School, Boston, MA and 5 Oral Medicine, Infection, and
Immunity, Harvard School of Dental Medicine, Boston, MA
A high frequency of mutation, deletion, and promoter silencing of the p16INK4A (p16) gene in pre-
malignant dysplasias and squamous cell carcinomas (SCC) of epidermis and oral epithelium has
identified p16 as a tumor suppressor. The point during neoplastic progression at which p16 is expressed
and impedes formation of an SCC has remained unknown. Upregulation of p16 expression has been
found to cause senescence arrest and to limit the lifespan of normal human keratinocytes in culture,
suggesting the possibility that excessive or spatially abnormal cell growth in vivo may trigger p16
expression. We examined 77 archival epidermal and oral mucosal biopsy specimens to test three
increasingly focused hypotheses about the setting in vivo in which p16 expression occurs. We found
that p16 expression does not result from chronic hyperproliferation but does occur heterogeneously
in cells of dysplastic and carcinoma in situ (CIS) lesions, most consistently by cells at the invasive
fronts of early SCCs. Such cells coexpressed p16 and laminin 5 gamma 2 (lam5g2), the latter iden-
tified previously by others as a marker of early invasion in carcinomas. Cells in normal keratinocyte
cultures also coordinately upregulated p16 and lam5g2, associated with increased motility. Ker-
atinocytes at the edges of experimental wounds made in confluent cultures also upregulated p16 and
lam5g2, accompanying migration to fill the wound. Some cell lines that were p16-deficient or engi-
neered to resist p16 arrest secreted lam5g2 and were motile. Thus, p16 expression does not cause
but, rather, is induced coordinately with lam5g2. These results identify the point at which p16 acts
as a tumor suppressor in vivo and suggest that normal keratinocytes may use the same mechanism
to generate non-proliferative, motile cells for wound repair. 
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Optimization of DNA microarray hybridization methods to detect cancer-related changes in
gene expression in cultured human keratinocytes
Z Guo,1 RV Jensen,3 SK Boches,5 SR Gullans2,4 and JG Rheinwald1,4 1 Dermatology, Brigham and
Women’s Hospital, Boston, MA, 2 Medicine, Brigham and Women’s Hospital, Boston, MA, 3
Neurology, Brigham and Women’s Hospital, Boston, MA, 4 Harvard Medical School, Boston, MA
and 5 Harvard School of Dental Medicine, Boston, MA
The validity and reliability of DNA microarray hybridization for characterizing gene expression has
remained uncertain. We have compared gene expression profiles of four normal primary keratinocyte
and five squamous cell carcinoma (SCC) cell lines of human oral epithelial and epidermal origin.
Fluorescent cRNA samples were prepared from RNA isolated from cells growing exponentially in
GIBCO ker-sfm medium and hybridized to Affymetrix U95Av2 arrays. Four cell lines were also ana-
lyzed on the Affymetrix U133 Set and on the Amersham/Motorola CodeLink Bioarray. Affymetrix
hybridization signals were normalized to a target intensity of 100 and analyzed using MASv5.0,
dChip and RMA programs. Duplicate samples and repeat scans of the same hybridization often var-
ied by 2-fold or more for signal calls less than 30, so genes for which no sample yielded a signal
higher than 30 were excluded from analysis. 58 genes were identified for which expression levels
of normal vs. SCC cells (U95Av2/MASv5.0) differed more than 3-fold with P values (t-test) of 0.015
or better. These 58 included genes encoding 10 transcription factors, 12 membrane receptor signal
pathway proteins, 7 adhesion proteins, and 5 RNA binding proteins. Real-time PCR confirmed the
results for 25 of 28 genes tested (89%). Results for the U133 Set and U95Av2 were similar and the
CodeLink chip confirmed 70% of PCR-verifiable genes identified by U95Av2. MASv5.0 was more
sensitive than dChip or RMA in detecting PCR- verifiable differences. Our study has determined
systematic methods for identifying verifiable differences in gene expression using multiple plat-
forms, thereby providing the basis to search for genes involved in keratinocyte aging, senescence,
immortalization, and malignant transformation. 
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Specificity of p16-enforced growth arrest and Id1 action in keratinocyte senescence
N Radoja,1 LB Gray,1 SC Browne1 and JG Rheinwald1,2 1 Dermatology, Brigham and Women’s
Hospital, Boston, MA and 2 Harvard Medical School, Boston, MA
The expansion potential in culture of keratinocytes and several other epithelial cell types is limited
by a mechanism that culminates in expression of the G1/S cdk inhibitor p16INK4A (p16). We have
sought to identify exogenous molecules that might arrest keratinocyte growth by activating the
same p16-dependent mechanism. We had reported recently that normal keratinocytes engineered to
evade p16- and p53-dependent growth arrest mechanisms, as well as a premalignant keratinocyte
line that had undergone deletion and mutational loss of the p16 and p53 loci, bypass the normal
replicative lifespan limit and continue to divide for a substantial extended lifespan until halted by a
short telomere crisis. P16- and p16-/p53-deficient keratinocyte lines and an Id1-overexpressing,
extended lifespan keratinocyte line were compared to normal keratinocytes for their sensitivity to a
variety of agents that inhibit keratinocyte growth in the GIBCO ker-sfm medium system. We tested
the potential involvement of p16 by immunocytology, flow cytometry, and p16 promoter-reporter
activity assays. TPA, TGF-beta, serum, IFNgamma, and TNFalpha proved equally inhibitory to nor-
mal, p16- and p16/p53-deficient, and Id1-overexpressing cells. P16 levels and promoter activities
were not altered significantly by treatment with any of these agents. Senescing normal keratinocytes
exhibited p16 expression and arrested in G1, whereas keratinocytes engineered to express a p16-
resistant cdk4 senesced with many cells in G2. The latter resembled the behavior of skin fibroblasts,
which arrest at senescence from a p53-dependent p21cip1 induction. These results demonstrate that
p16 induction in keratinocytes is not a generalized stress response to many types of growth inhibitory
signals. They suggest, instead, that p16 induction has a more specialized role as a senescence mech-
anism in culture and tumor suppressor mechanism in vivo. 
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Expression of chemokine receptor CXCR4 in basal cell carcinoma
M Wu and M Lu Department of Dermatolgy, China Medical College, Taichung, N/A, Taiwan
Beside the well-known role to regulate leukocyte trafficking, chemokines and their receptors also
play important roles in the regulation of mitosis, apoptosis, survival and angiogenesis, which may
enhance tumor growth or metastasis. Herein we investigated the possible involvements of chemokines
and chemokine receptors in the carcinogenesis of basal cell carcinoma (BCC), the most common
human cancer with unique clinical behaviors featuring local invasion and extremely rare metastasis.
Real-time quantitative RT-PCR was used to measure the expression levels of several chemokine
receptors (CXCR4, CCR7, CCR10) in various human skin cancer cell lines including BCC, squa-
mous cell carcinoma and melanomas. The expression level of CXCR4 in BCC cell line was ~64-
fold more than in other cancer cell lines and normal controls (cultured human keratinocytes and
fibroblasts). The expression of CXCR4 in BCC cell line was further confirmed using conventional
RT-PCR, immunofluorescent staining and western blotting. Immunohistochemistry studies using tis-
sue samples from BCC lesions showed heterogeneous CXCR4 expression in 18 out of 26 (~69%)
specimen. The up-regulation of CXCR4 in BCC suggests its possible role in tumor growth or inva-
sion. Transgenic and xenograft studies are currently under way to determine whether overexpresson
of CXCR4 in BCC may alter tumor behavior in nude mice. 
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Stat3 is required for survival of epidermal keratinocytes against apoptotic stimuli and for skin
cancer development despite its down-regulation by mutagens
S Sano,1 N Komazawa,2 M Kira,1 J Umeda,1 S Itami,1 M Tarutani,1 K Yoshikawa1 and J Takeda2 1
Dermatology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan and 2 Social
and Environmental Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan
A growing number of studies have demonstrated that Stat3 is involved in cancer development, although
the underlying mechanism is not completely understood. To investigate the role of Stat3 in skin car-
cinogenesis, we took advantage of keratinocyte-specific Stat3 deficient (K5.Stat3-/-) mice. The epi-
dermis of these mutant mice exhibited larger number of apoptotic keratinocytes upon UVB irradia-
tion or DMBA treatment than that of wild-type mice, and transfection of Stat3 gene normalized the
survival of their keratinocytes, indicating that Stat3 is required for protecting keratinocytes from
apoptosis. Interestingly, in wild-type keratinocytes, UVB irradiation resulted in down-regulation of
Stat3 and its downstream molecule, Bcl-xL. Stat3 overexpression via gene transfer further desensi-
tized wild-type epidermis to UVB-induced apoptosis. These results suggest that down-regulation of
Stat3 and Bcl-xL partly contributes to keratinocyte apoptosis of wild-type mice when treated with
UVB. Furthermore, requirement of Stat3 and Bcl-xL for skin tumor development was clearly shown
by the finding that no skin tumor arose in K5.Stat3-/- or K5.Bcl-xL-/- mice, respectively, through
the two-stage protocol of DMBA plus TPA. In sum, we conclude that Stat3 and its downstream Bcl-
xL not only function as anti-apoptotic molecules to give rise to skin tumor but also are down-regu-
lated by genotoxic stimuli, including UVB or chemical carcinogens, so that they reduce the future
risk of carcinogenesis. 
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Increased expression of p21 and p27 in spindle cell and epithelioid cell nevi (Spitz nevi) in the
absence without increased expression of oncoproteins distinquishes these nevi from malignant
melanoma
JK Smith,2 KJ Smith,1,3 S Hamza,3,1 D Sanders4 and H Skelton3,1 1 Dermatology, University of
Alabama, Birmingham, Birmingham, AL, 2 Vanderbilt Medical School, Nashville, AL, 3 Pathology,
University of Alabama, Birmingham, Birmingham, AL and 4 Dermatopathology Services PC,
Birmingham, Birmingham, AL
Spitz nevi usually occur in children and are biologically benign. However, because they may have
significant cytologic atypia in some cases the differentiation from malignant melanoma is difficult.
Although immunohistochemical markers have not been useful in differentiating these two entities,
we wanted to determine if a battery of markers for cyclin dependent kinase inhibitors (CDKI)s and
oncoproteins might help. We examined histologic sections from thirty primary malignant melanomas
(MM), twenty Spitz nevi using a battery of immunohistochemical stains including cyclin-D-1, c-
myc, H-ras, p16, p21, p27, and p53. All Spitz nevi showed +3 nuclear staining for p21, +1-3 nuclear
staining for p27, +1 nuclear staining for p16 in two lesions and +1 cytoplasmic staining for H-ras in
three lesions. Cyclin D1, c-myc, and p53 were all negative. Although some of the MMs showed a
similar pattern of staining for p21 and p27, the melanomas that did, all showed increased expression
of one or more the following; cyclin D1, c-myc, and p53 and in some cases also showed higher lev-
els of expression of H-ras and/or p16. A Spitz nevus would not be favored in the absence of signif-
icant expression of p21 and co-expression of p27. Although this pattern of expression of CDKIs
would not eliminate all cases of MM, addition immunohistochemical stains for cyclin D1 and/or c-
myc were positive in these MMs and not in any Spitz nevi. 
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p53 regulation is abnormal in xeroderma pigmentosum group E diploid human fibroblasts
T Itoh and S Linn Dept. of Molecular and Cell Biology, University of California, Berkeley, CA
The tumor suppressor p53 is crucial for maintaining cellular homeostasis and genome stability after
DNA damage. Mutations in the DDB2 gene give rise to the E subgroup of xeroderma pigmentosum.
Although p53 itself and its downstream-regulated genes have been extensively investigated, little is
known of an initial enhancement of the p53 protein level that leads to apoptosis and cell cycle arrest.
Moreover, the functions of the DDB2 gene product are still unclear. We report here that the DDB2
gene and its protein product regulate p53 protein levels and hence p53-mediated responses to DNA
damage.  
0138
Molecular mechanism of Sphingosine-1-phosphate receptor Edg isoform mediated bimodal
regulation of mouse malignant melanoma B16 cell migration and invasion
K Arikawa,1 N Takuwa,1 H Yamaguchi,2 K Takehara1 and Y Takuwa1 1 Physiology and
Dermatology, Kanazawa University Graduate School of Medicine, Kanazawa City, Ishikawa,
Japan and 2 Surgery, University of Tokyo, Tokyo, Japan
Sphingosine-1-phosphate (S1P) is a unique lysophospholipid mediator that potently inhibits migra-
tion and invasion of certain tumor cells. It has remained unknown whether the inhibitory effects of
S1P are mediated through either one of the Edg family G protein-coupled S1P receptors or by pro-
posed intracellular action of S1P. We investigated molecular mechanisms for S1P inhibition by using
Boyden chamber migration and invasion assay techniques and pull-down assays for quantification
of GTP-bound active forms of small GTPases in B16 mouse melanoma cells. B16 cell migration
across fibronectin-coated porous membrane and invasion through Matrigel layer were inhibited by
S1P and less potent Edg5/S1P2 receptor agonists, dihydro-S1P and sphingosylphosphorylcholine,
with expected relative potencies. The S1P-selective antagonist JTE013 completely abolished the
responses to these agonists, as well as the inhibition by the S1P precursor sphingosine, which is inac-
tive as an agonist for the S1P receptors, indicating that the sphingosine effects were mediated via
S1P2 stimulation, most likely by S1P that was converted from sphingosine. S1P induced inhibition
and activation, respectively, of small GTPases Rac and RhoA in B16 cells, which were abrogated
by JTE013. Adenovirus-mediated expression of a dominant negative Rac mutant, N17Rac, mim-
icked the inhibitory effects of S1P, whereas inactivation of RhoA by C3 toxin completely prevented
S1P inhibition of migration. These results indicate that endogenously expressed S1P2 negatively reg-
ulates cell motility and invasion through ligand-dependent reciprocal regulation of cellular Rac and
RhoA activities. We also found that in the presence of JTE013, S1P rather stimulated Rac and migra-
tion in B16 cells that overexpress either S1P1 or S1P3, unvailing counteractions between S1P2 and
S1P1 or S1P3 chemotactic receptor. 
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Epidemiologic and tumor characteristics of coexisting melanoma and nonmelanoma skin can-
cers
J Lowe, L Yin, C Hussussian, R Pierce, G Peterdy and LA Cornelius Washington University School
of Medicine, Saint Louis, MO
The purpose of this study was to determine whether patients diagnosed with both melanoma and
nonmelanoma skin cancers (study group) have specific demographic and clinical characteristics
that differentiate them from persons with solitary melanoma (control group). The p16, bcl-2 and
p53 tumor expression profiles of melanomas in each patient group were evaluated by immunohis-
tochemistry. Our study identified several significant differences in patients diagnosed with a single
melanoma in comparison to those with both melanoma and NMSCs. Patients with both tumors were
significantly older (60.7 yrs vs 50.2 yrs), their melanomas were less advanced at the time of diag-
nosis (Breslow’s depth 0.68 mm vs 1.21 mm; mean Clark’s level 2.2 vs 2.8), and they were less likely
to have a positive sentinel node biopsy (11% vs 29%) for lesions of similar Breslow’s depth (mean
depth of tumors examined 1.6 mm vs 1.8 mm). In addition, when melanomas of both groups, matched
for tumor characteristics, were studied histologically for expression of p53, bcl2 and p16 protein,
overexpression of p53 (indicative of p53 stabilization due to mutation) was demonstrated in a sig-
nificantly higher percentage of melanomas in patients with multiple tumors (65% vs 20%). We pro-
pose that, as in patients with LMM, patients with melanoma of any histologic subtype and a previ-
ous or subsequent NMSC, are more likely to demonstrate overexpression of p53 protein, and an
improved prognosis compared to their counterparts with solitary melanomas. 
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Novel agents and targets for skin cancer chemoprevention: studies with pomegranate fruit
extract
F Afaq, M Saleem, R Brans and H Mukhtar Dermatology, University of Wisconsin, Madison, WI
Because primary prevention has proven inadequate in reducing rising incidence of skin cancer,
there is a need to develop novel preventive approaches. Pomegranate fruit extract (PFE) derived from
the tree Punica granatum contains several polyphenols and anthocyanidins, and its antioxidant activ-
ity, though varies depending upon the variety, is higher than that of red wine and green tea. In the
present study, we evaluated whether PFE could possesses anti-tumor promoting effects. We deter-
mined the effect of topical application of PFE to CD-1 mice against 12-O-tetradecanoylphorbol-13-
acetate (TPA)-induced conventional markers, and other markers of skin tumor promotion. We found
that topical application of PFE (2 mg/mouse) 30 min prior to TPA (3.2 n mole/mouse) application
onto the skin of CD1 mice afforded significant inhibition, in a time-dependent manner, against
TPA-mediated increase in skin edema and hyperplasia. Topical application of PFE was also found
to result in substantial inhibition against TPA-induced epidermal ornithine decarboxylase (ODC)
activity and protein expressions of ODC and cyclooxygenase-2. Because of the role of mitogen acti-
vated protein kinases (MAPK) in inflammatory responses, proliferation, survival and apoptosis, we
next assessed the effect of PFE on TPA-mediated activation of MAPK pathway in mouse epidermis.
Employing Western blot analysis and immunohistochemistry, we found that topical application of
PFE resulted in inhibition of TPA-induced phosphorylation of extracellular-signal-regulated protein
kinases, p38 and c-Jun terminal kinases in the epidermis. Since the nuclear factor kappa B (NF-κB)
has been implicated in cellular proliferation and tumor promotion, we next determined the effect of
PFE on TPA-mediated activation of NF-κB pathway. Our data showed that pre-application of PFE
to mouse skin significantly inhibited TPA-induced activation of NF-κB, IKKα, and degradation of
IκBα. The results of our study, for the first time, provide suggestion that PFE could be a useful anti-
tumor promoting agent in mouse skin. 
0141
Genome-wide scanning for aberrant CpG methylations in human melanomas by methylation-
sensitive-representational difference analysis
J Furuta,1,2 S Yamashita,1 F Otsuka2 and T Ushijima1 1 Carcinogenesis Division, National Cancer
Center Research Institute, Chuo-ku, Tokyo, Japan and 2 Dermatology, University of Tsukuba,
Tsukuba, Ibaraki, Japan
Aberrant CpG methylations play important roles in the development and progression of a variety of
human cancers. However, little is known about aberrant CpG methylations in melanomas. Here,
genes that are inactivated by aberrant CpG methylations in human melanomas were searched for by
a genome-wide scanning technique for aberrant methylations, methylation-sensitive-representational
difference analysis (MS-RDA) [PNAS, 94:2284, 1997]. Eighty DNA fragments that were differen-
tially methylated between the primary human epidermal melanocyte, HEM, and a melanoma cell
line, MeWo, were isolated by MS-RDA using two methylation-sensitive restriction enzymes, HpaII
and SacII. Seventy-one DNA fragments differentially methylated between HEM and another
melanoma cell line, WM-266-4, were similarly isolated. A total of 144 DNA fragments were found
to be aberrantly methylated in MeWo and/or WM-266-4, but not in HEM. By analyzing their flank-
ing genomic structures using a human genome database, 107 of the 144 DNA fragments were found
to be derived from CpG islands (CGIs), and 16 of them were located in 5′ regions of genes. Methy-
lation statuses of these CGIs were analyzed by methylation-specific PCR using six melanoma cell
lines, including MeWo and WM-266-4, and HEM. Six of the 16 CGIs were shown to be aberrantly
methylated in some of the melanoma cell lines but not in HEM. The six genes downstream of these
aberrantly methylated CGIs are expected to be silenced, and are candidate tumor-suppressor genes
in melanomas. 
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Oleandrin: a novel agent for skin cancer chemoprevention
H Mukhtar, M Saleem, MH Aziz, R Brans and F Afaq Dermatology, University of Wisconsin,
Madison, WI
Primary prevention has proven inadequate in reducing rising incidence of skin cancer, emphasizing
the need to develop novel skin cancer chemopreventive strategies. Oleandrin, derived from the leaves
of Nerium oleander has been shown to possess anti-inflammatory and tumor cell growth-inhibitory
effects. Here, we provide evidence that oleandrin could possesses anti-tumor promoting effects. We
determined the effect of topical application of oleandrin to CD-1 mice against 12-O-tetrade-
canoylphorbol-13-acetate (TPA), a widely studied skin tumor promoter, -induced conventional and
novel markers of skin tumor promotion. Topical application of oleandrin (2 mg/mouse) 30 min prior
to TPA (3.2 n mole/mouse) application onto the skin afforded significant inhibition, in a time-depend-
ent manner, against TPA-mediated increase in cutaneous edema and hyperplasia, and epidermal
ornithine decarboxylase activity and protein expression. In search for novel markers of skin tumor
promotion, we found that TPA application to mouse skin resulted, as an early event, in an increased
expression of phosphatidyinositol 3-kinase (PI3K), phosphorylation of AKT at threonine308, and acti-
vation of nuclear factor kappa B (NF-κB). Topical application of oleandrin prior to TPA application
to mouse skin resulted in significant reduction in TPA-induced expression of PI3K and phosphory-
lation of AKT, and inhibition of NF-κB activation. NF-κB is a eukaryotic transcription factor that
is critically involved in regulating the expression of various genes that participates in inflammation,
apoptosis and cell proliferation. Employing Western blot analysis and immunohistochemistry, we
found that oleandrin application to mouse skin resulted in inhibition of TPA-induced activation of
NF-κB, IKKα, and degradation of IκBα in mouse epidermis. Our data suggest that oleandrin could
be a useful anti-tumor promoting agent because it inhibits several biomarkers of TPA-induced tumor
promotion in an in vivo animal model. One might envision the use of chemopreventive agents such
as oleandrin in an emollient or patch for chemoprevention or treatment of skin cancer. 
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Pigment epithelium-derived factor, an inhibitor of angiogenesis, suppresses melanoma growth
by inducing tumor cell apoptosis
R Abe,1 T Shimizu,1 S Yamagishi,2 H Watanabe,1 H Nakamura,1 M Takeuchi3 and H Shimizu1 1
Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan, 2 Medicine,
Kurume University School of Medicine, Kurume, Japan and 3 Biochemistry, Hokuriku University,
Kanazawa, Japan
Tumor angiogenesis is essential for the growth of primary and metastatic tumors. It is regulated by
proangiogenic factors and also anti-angiogenic factors secreted by tumor and host cells. Pigment
epithelium derived factor (PEDF), recently identified as one of the inhibitors of angiogenesis, is
known to induce endothelial cell apoptosis. Our aim was to elucidate the mechanism of melanoma
grow inhibition by PEDF. First, we determined the expression levels of PEDF in human malignant
melanoma cell. PEDF was shown to be constitutively produced by several melanoma cell lines. We
transfected the human PEDF gene into melanoma cell (G361). Stable PEDF transfectant cells (PEDF-
G361) secreted high level of PEDF compared with that of Mock-transfectant cells (Mock-G361).
The medium obtained from PEDF-G361 culture, induced higher levels of endothelial cell apopto-
sis compared with that of Mock-G361 culture medium. Interestingly, the PEDF-G361 proliferation
rate was significantly lower than Mock-G361. Blocking the Fas receptor using anti-Fas Ab increased
the proliferation rate, indicating PEDF mediated melanoma cell apoptosis was dependent on the Fas
pathway. Furthermore, the tumor growth rate of PEDF-G361 xenografts in athymic mice was reduced
compared to Mock-G361. In conclusion, PEDF mediates tumor inhibition not only by its anti-
angiogensis effect but also by direct induction of tumor apoptosis. 
0144
Down-regulation of µ opioid receptor in Fas/FasL knock out mice
M Bigliardi,1,2 S Buechner,1 T Rufli1 and P Biglairdi2 1 Dermatology, Univ Hospital Basel, Basel,
Switzerland and 2 Research, Univ Hospital Basel, Basel, Switzerland
Opioids such as morphine can promote programmed cell death by enhancing the expression of pro-
apoptotic Fas receptor protein; This effect goes through the sustained activation of opioid receptors.
In different tissues such as neural crest, endometrium and lymphocytes opioids control apoptosis.
Additionally opioid receptors induce apoptosis in lung cancer cells. We have published that func-
tional µ opiate receptor exist in human keratinocytes and β endorphin between 10-100 nM down reg-
ulate µ opiate receptor expression. In this work we show that β endorphin at 60 nM induces apop-
tosis in epidermis of cultured skin equivalent (appligraf) using tunnel reaction. In addition We also
observe the downregulation of µ opiate receptor in basal cell carcinoma cells in which the Fas
receptor system is downregulated. This points to the intercorrelation of Fas receptor with µ opiate
receptor. Therefore, we investigate the µ opiate receptor expression in epidermis of Fas receptor defi-
cient (lpr) mice and Fas ligand deficient (gld) mice. Indeed, our immunohistochemstry results indi-
cate that there is downregulation of µopiate receptor in both lpr and gld mice; The downregulation
of µ opiate receptor in lpr mice are more dramatic than in gld mice. These data show that opioid
receptor system is involved in apoptosis in epidermis and suggest a connection between opioid recep-
tors and Fas receptor system in epidermis. This could be important in control of UV induced skin
cancers, especially basal cell carcinoma because apoptosis plays an important role in the elimina-
tion of irreversibly UV damaged keratinocytes. 
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Tumor development and gene expression profiling following epidermal abrasion
CS Trempus,1 R Ali,1 RS Faircloth,1 S Wei,1 A Heinloth,1 E Lobenhofer,1 L Bennett,1 RJ Morris,2
JF Mahler,3 M Battalora4 and RW Tennant1 1 NCT, NIEHS, Research Triangle Park, NC, 2
Department of Dermatology, Columbia University, New York, NY, 3 Laboratory of Experimental
Pathology, NIEHS, Research Triangle Park, NC and 4 Department of Product Safety, BASF-
Aktiengesellschaft, Ludwigshafen, Germany
The v-Ha-ras transgenic mouse (Tg.AC) develops papillomas following several tumor promotion
regimens, including chemical treatment and UV radiation, and much of our evidence indicates a fol-
licular origin of tumors in these mice. To directly test this hypothesis, we subjected Tg.AC mice to
a single epidermal abrasion. 100% of the abraded mice developed papillomas by 5 weeks post-abra-
sion, compared to 0% in the non-abraded controls. Transgene expression was detected by 18 days
post-abrasion by RT-PCR and in situ hybridization, with expression localizing to the proliferative
(PCNA-positive) compartment of the lesions. High density microarray analysis was conducted on
RNA from singly abraded Tg.AC and FVB/N (background strain) mice at days 5, 9, and 18 post-
abrasion to: 1) generate an expression profile during epidermal remodeling, and 2) to elucidate genes
or gene pathways uniquely affected by ras transgene expression. The abraded skin of both strains of
mice highly expressed genes in the Epidermal Differentiation Complex (ECD) over all three-time
points, including S100A8 (calgranulin) and sprr2A. In addition, a serine protease inhibitor, Stefin
3, was highly overexpressed, highlighting along with the ECD genes the extensive terminal differ-
entiation and stratification processes occurring with remodeling. Genes discriminating Tg.AC from
FVB/N at the various time points fell into several categories, including extracellular matrix, DNA
excision repair, and inflammation. In summary, we have demonstrated that a single epidermal abra-
sion is sufficient to induce papillomas in the Tg.AC mouse, implicating hair follicle stem cells in
tumor formation. In addition, high density microarray analysis has provided insight into gene expres-
sion changes occurring over time during epidermal remodeling. 
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CXCR4 activates beta1 integrin-mediated binding of B16 murine melanoma cells to lung-
derived endothelial cells
AR Cardones, T Murakami and ST Hwang Dermatology Branch, NCI, NIH, Bethesda, MD
The chemokine receptor, CXCR4, is expressed by human melanomas and its ligand, CXCL12, is
frequently produced at sites of melanoma metastasis. We previously showed that CXCR4-transduced
B16 cells (CXCR4-B16) metastasized 6-10 fold better than control B16 cells to the lung after i.v.
inoculation and bound 3-fold better (vs. control cells) to pulmonary endothelial cells (EC). Herein,
we examine CXCR4-mediated binding of B16 to EC and recombinant adhesion molecules in vitro
in order to determine the role of tumor- and EC-derived adhesion molecules in tumor metastasis.
First, by flow cytometry, unstimulated primary lung EC showed constitutive expression of VCAM-
1 whereas skin-derived EC did not. All B16 cell lines tested showed constitutive expression of beta1
(CD29), but not beta2, integrins. Second, under physiologic shear stress conditions (1.5 dynes/cm2)
in a flow chamber, CXCR4-B16 cells bound to monolayers of lung EC at least two-fold more effi-
ciently than to skin-derived EC (p=0.002). As recorded by real-time video, CXCR4-B16 arrest on
EC was rapid, resistant to further shear, and showed no evidence of transient rolling. Interestingly,
CXCR4-B16 cell binding to EC was completely blocked by anti-CD29 mAb. Under similar flow
conditions, CXCR4-B16 cells arrested 40-fold better than mock-transduced-B16 cells on plastic
plates coated with recombinant VCAM-1-Ig and CXCL12 (p<0.0001). Third, CXCR4-B16 exposed
to CXCL12 rapidly increased binding affinity (within 30 sec) for soluble VCAM-1-Ig as detected
by a flow cytometric assay. Thus, using a novel method for observing tumor cell-EC interactions,
we show that beta1-integrin plays a critical role in CXCR4-mediated binding of B16 tumor cells to
both EC and recombinant VCAM-1. Consequently, the beta 1 integrin may be a potential target for
inhibition of tumor metastasis. Lastly, the differential expression of VCAM-1 by lung vs. skin-derived
EC may explain why the lung is a favored site of initial tumor localization following vascular dis-
semination. 
0149
Survivin targeting triggers rapid translocation of mitochondrial apoptosis-inducing factor in
melanoma cells
T Liu2 and D Grossman1,2 1 Departments of Dermatology and Oncological Sciences, University of
Utah, Salt Lake City, UT and 2 Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
Apoptosis, or programmed cell death, is commonly dysregulated in melanoma and resistance to
apoptosis likely accounts for treatment failure in patients with advanced disease. We have shown
previously that the Inhibitor of Apoptosis protein Survivin, a known caspase inhibitor, is highly
expressed in melanoma and that blocking Survivin causes melanoma cell apoptosis and prevents
tumor formation. To investigate how Survivin protects melanoma cells from apoptosis, we examined
the kinetics of apoptotic events using melanoma cells stably transfected with a tetracycline-regulated
Survivin dominant-negative mutant (Survivin-T34A). Late-stage apoptosis (DNA fragmentation)
occurred in these cells by 24-48 hrs, but not in control cells transfected with wild-type Survivin.
Apoptosis induced by Survivin targeting, but not UVB, was resistant to the pan-caspase inhibitor z-
VAD-fmk. Immediately following expression of Survivin-T34A (Western blot, 4 hrs), we detected
phosphatidylserine transposition (Annexin V binding, 4 hrs), mitochondrial depolarization (JC-1
shift, flow cytometry, 11 hrs), and mitochondrial release of cytochrome c and Smac/DIABLO (West-
ern blot, 8 hrs). These mitochondrial events were preceded by nuclear translocation of mitochondr-
ial apoptosis-inducing factor (AIF, Western blot and immunofluorescence, 4 hrs), known to cause
mitochondrial content release and mediate caspase-independent apoptosis. By contrast, activation
of terminal caspase-3 (48 hrs) and upstream caspase-8 (48 hrs) and caspase-9 (24-48 hrs), as assessed
by precursor loss and appearance of cleavage fragments on Western blots, was incomplete and rel-
atively delayed. Specific inhibitors of caspase-8 (z-IETD-fmk) and caspase-9 (z-LEHD-fmk) were
less protective than z-VAD-fmk in preventing apoptosis induced by Survivin targeting. Thus despite
its reported function as a caspase inhibitor, Survivin primarily acts to restrain AIF in mitochondria
and thereby protect melanoma cells from caspase-independent apoptosis. 
0148
Topical tacrolimus potentiates carcinogenesis in mouse skin and reduces the lymph node
CD4/CD8 ratio
Y Niwa,1 T Terashima2 and H Sumi3 1 Niwa Institute for Immunology, Tosashimizu, Kochi, Japan,
2 Dept. of Dermatology, Osaka City University Medical School, Osaka, Japan and 3 Dept. of
Internal Medicine, National Cancer Center Hospital East, Kashiwa, Japan
Tacrolimus (FK506) is a potent macrolide immunosuppressant, widely used for preventing graft
rejection in liver and kidney transplantation. Recently, topical FK506 has been used to treat atopic
dermatitis (AD) because of its T cell immunosuppressive effect. However, since 7% of patients under-
going systemic administration of FK506 for liver transplantation subsequently develop malignancy
(Transplantation, 66, 1193, 1998), we sought to investigate the carcinogenic effect of topical FK506.
We used a standard cutaneous tumor induction protocol in which the shaved dorsal skin of CD-1
mice was treated with the tumor initiator of DMBA, followed by promoting treatment with TPA,
with or without FK506 ointment. After 14 wk, there was marked synergy between FK506 and the
DMBA/TPA regimen (new tumors per mouse per week in the FK506/DMBA/TPA group vs.
DMBA/TPA group, p<0.01). The CD4/CD8 ratio in axillary and inguinal lymph nodes in FK506-
treated mice was significantly decreased. The CD4/CD8 ratio in blood was also reduced by 5 wk
after initiation, even though the serum FK506 concentration after topical application is 50 to 100
fold lower than when the drug is systemically administered. The concentration of FK506 in lymph
nodes after topical treatment was found not to differ significantly from that after systemic FK506
administration. These findings suggest that topical application produces high concentrations of FK506
in lymph, with subsequent depletion of CD4 T cells. Tumor formation was also accelerated in mice
treated with topical FK506 after UVL irradiation, compared with control mice irradiated with UVL
alone. Use of topical FK506 for the treatment of AD has become widespread, largely because of its
steroid-sparing effect. Our data suggest that restraint should be exercised in prescribing this regi-
men, especially for use on the face, and the safety of this drug should be re-examined. 
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DNA methylation profile of malignant melanoma, basal cell carcinoma, and squamous cell car-
cinoma of the skin
H Fujiwara and M Ito Dermatology, Niigata University, Niigata, Niigata, Japan
Epigenetic regulation of the expression of tumor suppressor genes plays important role in tumor
development. DNA methylation of gene promoter is a major pathway of the epigenetic regulation,
however, its detail has not well studied in skin neoplasms.  With the power of non-isotopic cytosine
extension assay and methylation specific PCR, we analyzed promoter methylation status of p16, p14,
p15, e-cadherin, and von Hippel-Lindau tumor suppressor genes in various skin cancers. In squa-
mous cell carcinoma gene promoter methylation of each gene was detected in 8/12, 2/12, 0/12, 12/12,
and 0/12 cases, respectively. In basal cell carcinoma and malignant melanoma p16 and e-cadherin
promoter were methylated in less than half the cases; p14, p15, or VHL genes were not methylated.
Promoter DNA methylation may play an important role in the development of skin neoplasms,
especially in squamous cell carcinoma. 
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Pericyte-like location of GFP melanoma cells: ex vivo and in vivo sudies of extravascular migra-
tory metastasis
C Lugassy,1 H Kleinman,2 J Engbring,2 D Welch,3 J Harms,4 R Rufner,1 P Fernandez,1 S Patierno1
and R Barnhill1 1 George Washington University, Washington, DC, 2 NIH, Bethesda, MD, 3
University of Alabama, Birmingham, AL and 4 Pennsylvania University, Hershey, PA
We have previously described in melanoma the angio-tumoral complex, in which tumor cells occupy
a pericyte-like location on the outside of the endothelium. The pericyte-like location of melanoma
cells raises the possibility that tumor cells are migrating along the abluminal surface of the endothe-
lium, a mechanism termed Extravascular Migratory Metastasis. In this study, we have used human
and murine melanoma cells that stably express Green Fluorescent Protein to follow the interaction
of tumor cells with vessels over time. We have developed ex vivo model systems to study melanoma
cell interactions with vessels that have sprouted from rat and chick aortic rings. We observed tro-
pism between tumor cells and endothelial cells, and a pericyte-like location of tumor cells spread-
ing along the vascular channels. We have also used the in vivo chick chorioallantoic membrane assay.
Using fluorescence microscopy, we have observed the dissemination pathway of melanoma cells
along vessels at the single cell level. Single tumor cells were regularly observed spreading along ves-
sels several centimeters from the tumor. Confocal laser scanning microscopy and histopathology
confirmed the pericyte-like location of tumor cells, without any observation of mosaic vessels or
intravasation of tumor cells. Despite the fact that C8161 cells growing alone in Matrigel were able
to form connected structures, we did not observe vascular mimicry in the ex vivo and in vivo assays. 
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Tazarotene-induced gene-3 is suppressed in basal cell carcinomas and up-regulated by tazarotene
in vivo
X Ni, R Talpur, K Herne, C Schulz, S Ward, B Jackson, P Hazarika, A Josephs and M Duvic Dept.
of Dermatology, University of Texas, MD Anderson Cancer Center, Houston, TX
Tazarotene, a synthetic RAR-β/γ selective retinoid, is approved for acne and psoriasis. Tazarotene-
induced genes identified by differntial display PCR from human keratinocytes include Tazarotene-
induced gene 3 (TIG-3), an RAR-β/γ selective retinoid-induced class II tumor suppressor that inhibits
cell growth [Disepio et al,PNAS,1998]. TIG-3 is downregulated in both psoriasis and squamous cell
carcinomas [Duvic et al,CCR,2000]. To study TIG-3 in basal cell carcinomas (BCC) and as chemo-
prevention, we enrolled 22 patients in a clinical trial to measure TIG-3 protein and mRNA in base-
line and treated BCC and paired normal skin. Immunohistochemistry with anti-rTIG-31-164 and in
situ hybridization with riboprobes were conducted in 19 pairs of BCCs from 14 patients before and
after 0.1% Tazarotene gel applied for 6-12 weeks before surgery. Loss of or decreased TIG-3 pro-
tein was detected in 14 of 19 BCC (74%) and mean level was 2.17 fold less in BCC than in overly-
ing normal epidermis (P=0.00002). Decreased TIG-3 mRNA was detected in 18 of 19 lesions (95%)
and mean level was 2.63 fold less than in overlying epidermis (P=0.00001). Eleven of 16 BCC(69%)
evaluated after therapy had increased TIG-3 protein expression of 1.96 fold compared to baseline
(P=0.0002). Similarly, ten of 16 tumors (63%) had increased TIG-3 mRNA, with 2.67 fold increase
after therapy (P=0.0276). Twelve of 16 (75%) BCC with decreased TIG-3 mRNA at baseline had
clinical responses and 9 of 12 showed upregulation of TIG-3 mRNA. Expression of TIG-3 protein
and mRNA is selectively decreased in BCCs and is restored by treatment with topical tazarotene in
patients. TIG-3, as a retinoid inducible tumor suppressor, may explain retinoid activity in skin can-
cer, and serve as an intermediate biomarker for chemoprevention trials. 
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Resistance of CD1-deficient mice to UV skin carcinogenesis is associated with increased ker-
atinocyte apoptosis
Y Matsumura, DX Nghiem, AM Moodycliffe, SE Ullrich and HN Ananthaswamy Dept. of
Immunology, Univ. of Texas, M.D. Anderson Cancer Center, Houston, TX
CD1 is a nonpolymorphic major histocompatibility complex I-like molecule. Murine CD1 has been
implicated in the development and function of Natural Killer T cells. Recent studies have demon-
strated that CD1-/- mice are resistant to UV-induced immune suppression and skin damage com-
pared to wild-type mice. Our recent studies have shown that CD1-/- mice are also more resistant to
skin cancer induced by solar-simulated UV radiation than wild-type mice. To determine the mech-
anisms involved in the resistance of CD1-/- mice to UV-induced skin damage and carcinogenesis,
we investigated the time course and kinetics of keratinocyte cell death after acute and chronic UV
irradiation with a solar simulator. After acute UV exposure (5 kJ/m2), the number of TUNEL-pos-
itive keratinocytes peaked at 24-48 hours after irradiation in both groups. However, the TUNEL-pos-
itive keratinocytes were eliminated from the skin at 72 hours post-UV in wild-type mice, but they
still persisted until 96 hours post-UV in CD1-/- mice. The kinetics of p53 protein expression closely
followed the kinetics of apoptotic cell death. The persistence of apoptotic keratinocytes in CD1-/-
mouse skin correlated with high levels of p53 expression at 96 hours post-UV. Chronic UV irradia-
tion (5 kJ/m2, 3x/wk) for 1-3 weeks resulted in induction of a significantly higher number of apop-
totic keratinocytes in CD1-/- mice than in wild-type mice. After 12 weeks of chronic UV, clusters
of p53-positive, abnormal keratinocytes were present in wild-type mouse skin, but not in CD1-/-
mouse skin. In addition, after 30 weeks of chronic UV, clusters of p53-positive, abnormal fibrob-
lasts were present in wild-type mouse skin, but not in CD1-/- mouse skin. These results indicate that
the resistance of CD1-/- mice to UV-induced skin damage and UV carcinogenesis may in part be
due to increased cell death and elimination of keratinocytes and fibroblasts containing DNA dam-
age and p53 mutations. 
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Apoptotic resistance by AAA-protein, SPAF in malignant melanoma
Y Liu, G Vanderbeek, S El-Hizawi  and M Kulesz-Martin Dermatology, Oregon Health & Science
University, Portland, OR
Malignant melanoma is one of the most formidable diseases arising from skin. This disease is resist-
ant to apoptosis and refractory to conventional therapeutic regimens. Apoptosis can be induced
through various pathways, implying a variety of mechanisms by which malignant melanoma cells
may develop apoptotic resistance. In search of altered gene expression in a cloned epidermal model
of carcinogenesis, we have identified a novel spermatogenesis associated factor (SPAF) that is altered
and overexpressed in an aggressive squamous cell carcinoma. SPAF protein contains two ATPase
modules which classify it as a novel member of AAA-protein family (ATPase associated with diverse
activities). Analysis of SPAF mRNA expression in various human cancers revealed that SPAF is
highly expressed in the majority of malignant melanoma samples tested. Furthermore, analysis of
the human SPAF gene unveiled a unique bi-directional genomic structure in connection with FGF-
2, a growth factor overexpressed in virtually all malignant melanoma. The prevalent expression of
SPAF and FGF-2 in malignant melanoma and their genomic connection suggest that SPAF expres-
sion is an oncogenic event that may synergize with FGF-2 in melanomagenesis. In normal testis,
SPAF expression is restricted to spermatogonia in the early stage of spermatogenesis. However SPAF
expression is exclusively absent in spermatogonia undergoing apoptosis. In view of its localization
to mitochondria and membership in a AAA subfamily involving membrane fusion, SPAF is postu-
lated to increase the apoptotic threshold by stablizing the mitochondrial membrane. Ongoing stud-
ies are, 1) to evaluate the effect of SPAF expression on apoptotic resistance in malignant melanoma
cells by means of RNA interference, and 2) to detect SPAF expression in radial growing versus ver-
tical growing malignant melanoma. These studies will not only shed light on SPAF activities as a
novel mechanism in apoptosis and melanomagenesis, but also may provide targets for molecular
prognosis and therapy for malignant melanoma. 
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Shift of gap junctional communication and cell adhesion during melanoma development
NK Haass,1,2 JM Brandner,1 E Wladykowski,1 G Li,2 M Herlyn2 and I Moll1 1 Dermatology and
Venerology, University Hospital Hamburg-Eppendorf, Hamburg, Hamburg, Germany and 2 The
Wistar Institute, Philadelphia, PA
There is a dynamic shift in cell adhesion molecule expression during melanoma development - namely
the down-regulation of E-cadherin and up-regulation of N-cadherin. The loss of E-cadherin in malig-
nant melanoma (MM) is associated with gap junction incompatibility with keratinocytes and the gain
of N-cadherin with development of gap junctions (GJ) with fibroblasts and endothelial cells. Cell
adhesion by cadherins might be required for the formation of GJ. GJ play a major role in cell-cell-
communication. They form channels between adjacent cells allowing the diffusion of small mole-
cules (e.g. second messengers). GJ consist of two hemichannels called connexons, each formed by
six transmembrane proteins called connexins (Cx). Ten of the known 21 connexins are expressed in
human skin. GJ formed by different connexins are selective for different molecules. Thereby they
control the specificity of cell-cell-communication. This work concerns the expression of Cx30 and
Cx26 in MM and melanocytic nevi and in epidermis adjacent to these lesions. Investigations were
performed by immunofluorescence microscopy using specific antibodies. Cx30 and Cx26 are only
weakly, if at all, expressed in normal interfollicular epidermis. Now we show that both proteins nei-
ther occur in MM nor in melanocytic nevi. In contrast both Cx30 and Cx26 are expressed in the epi-
dermis adjacent to MM but not to melanocytic nevi. These results clearly show an induction of
Cx30 and Cx26 in normal interfollicular epidermis adjacent to MM. There is no such induction in
benign melanocytic nevi. Previously we demonstrated similar results investigating GJ proteins in
malignant epithelial skin tumours and Merkel Cell carcinoma. There was no such induction in the
epidermis adjacent to semimalignant and benign lesions. So one might suggest that the change of
GJ composition in the epidermis adjacent to malignant skin tumours may play a role in the metas-
tasation of these tumours. 
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Characterisation of the cylindroma tumour suppressor gene
AD Regamey,1 D Hohl,1 A Unden,3 P Itin,2 J Liu,1 R Toftgard3 and M Huber1 1 Dermatology,
University Hospital CHUV, Lausanne, Switzerland, 2 Kantonsspital, Aarau, Switzerland and 3
Karolinska, Huddinge, Sweden
Familial and sporadic cylindromas, benign adnexal skin tumors, are caused by mutations in the cylin-
dromatosis (CYLD) gene located on chromosome 16q12. The ubiquitously expressed CYLD gene
encodes a putative tumor suppressor molecule. Protein motif analysis revealed a central domain con-
taining CAP-Gly sites found in microtubule-binding (MT) proteins, and a C-terminal region with
similarities to the active site of deubiquitinating enzymes and to Zn fingers.  Transfection of an expres-
sion vector with the FLAG-tagged full-length CYLD cDNA (pCYLD1) into 293T and cos7 cells
demonstrated that CYLD is localized to the perinuclear compartment. Confocal immunofluores-
cence microscopy and spin-down microtubule binding assays revealed no association between CYLD
protein and microtubules. To examine the biological role of CYLD, its effect on cell growth was
investigated by colony transformation assays in 293T cells using cotransfection with pCYLD1 and
pBabe-puro. After 2-week culture under puromycin selection the number of resistant colonies was
drastically reduced in CYLD transfected cells compared with pBabe-puro alone, arguing in favor of
a strong cell growth inhibitory effect of CYLD. Furthermore, colony transformation assays using
truncated forms of CYLD indicated that the N-terminal domain alone strongly suppresses cell growth.
A yeast two-hybrid screen using HaCaT cDNA library as prey and full-length CYLD as bait, and
coimmunoprecipitation in 293T cells, identified 2 novel proteins, p30 and p40, which physically
associate with CYLD. Furthermore, alpha-galactosidase assays in yeasts demonstrated that it is the
CAP-Gly domains of CYLD which specifically interact with p30. In situ hybridisation and immunos-
taining showed that patched1 and Gli2 are overexpressed in cylindroma. These data indicate that
full-length CYLD does not bind to microtubules, the N-terminal domain of CYLD has a strong sup-
pressive activity on cell proliferation and that the Shh signalling pathway is activated in cylindro-
mas. 
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Characterization of basal cell carcinoma by multifunctional optical coherence tomography
J Strasswimmer,1,2 MC Pierce,1 B Park1 and JF deBoer1 1 MGH Dermatology, Wellman Labs-
Harvard University, Boston, MA and 2 Dermatology, Yale University, New Haven, CT
The puropse of our study is to describe features of basal cell carcinoma (BCC) identified using mul-
tifunctional optical coherence tomography (OCT). Diagnosis of BCC by biopsy is invasive, painful,
and the information is available at only one time point. Moreover, it is subject to sampling error,
including misidentification of aggressive sub-types. As more BCCs are treated with non-surgical
intervention, there is a need to monitor these lesions for completeness of resolution and for early
detection of recurrence. OCT uses broad-band light to harmelssly generate non-invasive vertical
“optical biopsy” images of the skin. It has the potential to become a useful tool for BCC manage-
ment, but it has not yet been applied to the analysis of skin cacer. OCT has been available for sev-
eral years, but no suitable system has been developed for skin cancer imaging. We developed a device
with several enhancements, including improved image quality as well as simultaneous calculation
and display of Doppler analysis (for blood flow measurenents), polatization sensitivity (to detect
subtle changes in conneective tissue structure), and real-time imaging (to render the device practi-
cal for the clinician). Multifunctional OCT was used to identify features of BCC which are distin-
guishible from normal perilesional skin. Imaging of BCCs reveal several tumor characteristics iden-
tified by multifunctional OCT. Altered intensity signals of the tumor lobules, septae, and tumor stroma
are clearly visualized; Doppler information detects tumor-associated neovasculatization; the polar-
ization states of tumor components are altered when compaed with the pattern normally observed
in the papillary and reticular dermis; the device is practical for clinical use because it is fiber-optic
based and the information is presented in real-time. Multifunctional OCT has the potential to become
a useful and practical clinical aid for BCC diagnosis and monitoring of therapy. 
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Alpha-melanocyte stimulating hormone alters the apoptotic response to ultraviolet radiation
SV Dixon, SJ Robinson and E Healy Dermatopharmacology, University of Southampton,
Southampton, Hampshire, United Kingdom
Variants of the melanocortin 1 receptor (MC1R) gene are associated with red hair and fair skin type
in humans, and increase susceptibility to skin cancer. Alpha-melanocyte stimulating hormone (αMSH)
has potent biological activity in addition to its effects on pigmentation (e.g. anti-inflammatory and
immunomodulatory), and recent research by several groups suggests that MC1R variants may increase
the risk of developing skin cancer through their effects on non-pigmentary pathways. Exposure to
ultraviolet radiation (UVR) causes skin cancer, and therefore it is possible that αMSH / MC1R sig-
nalling may alter the non-pigmentary response of cells to UVR, for example through effects on cell
viability. In this study, we have examined the effects of αMSH on UV-induced apoptosis, independent
of the protection afforded by melanin pigmentation, in MC1R / Mc1r null amelanotic melanoma cells
stably transfected with wild type human MC1R. Transfected B16G4F murine and RPMI-7951 human
melanoma cells were cultured in the presence or absence of 10-6M αMSH prior to and following
UV irradiation with a TL12 lamp. Cells were analysed for apoptosis using flow cytometry for annexin
V cell surface binding at 24 hours following UV-exposure. All experiments were carried out in trip-
licate wells, and on three separate occasions. Sensitivity to UV-induced apoptosis varied between
the two MC1R transfected melanoma cell lines. However, αMSH significantly increased the per-
centage of cells binding annexin V; B16G4F mean 17.8 ± SEM 6.3, B16G4F+αMSH mean 22.7 ±
SEM 6.9 (p=0.020), and RPMI-7951 mean 29.9 ± SEM 7.2, RPMI-7951+αMSH mean 36.5 ± SEM
9.2 (p=0.028). The results suggest that signalling via the αMSH / MC1R pathway increases apop-
tosis following exposure to UV. As this may have implications for skin cancer susceptibility, further
work using variant MC1R stable transfectants is investigating the effects of MC1R variants on this
parameter. 
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Reactive oxygen is implicated in Epstein-Barr virus-induced neoplasia
F Cerimele,1 E Murad,1 J Sixbey,2 C Cohen,4 K Wilman3 and G Klein3 1 Dermatology, Emory
University, Atlanta, GA, 2 Dermatology, Louisiana State University, Baton Rouge, LA, 3 Tumor
Biology, Karolinska Institute, Stockholm, Sweden and 4 Pathology, Emory University, Atlanta, GA
Epstein-Barr Virus (EBV) is the virus implicated in the vast majority of virally-induced human can-
cers. Among the cancers implicated in EBV-induced neoplasia are cutaneous leiomyosarcoma, Burkitts
lymphoma, Hodgkins disease, nasopharyngeal carcinoma, and gastric carcinoma. The precise mech-
anisms of EBV-induced oncogenesis are not completely understood. We have previously demon-
strated that hypermethylation of tumor suppressor genes is a hallmark of reactive oxygen species
(ROS) induced carcinogenesis, and other laboratories have demonstrated that EBV-induced cancers
display hypermethylation of the p16ink4a tumor suppressor genes. We have also demonstrated that
reactive oxygen induces the angiogenic switch. We analyzed a series of EBV-induced and sporadic
(EBV-) Burkitts lymphoma cell lines for reactive oxygen. EBV-induced lymphomas demonstrated
high levels of ROS compared with EBV- Burkitts lymphoma cells. Infection of EBV negative cells
with EBV resulted in increased levels of ROS. In addition, EBV+ cells demonstrated activation of
MAP kinase, while EBV- cells did not show activation of MAP kinase. Treatment of EBV positive
cells with a potent antoxidant, ebselen, led to decreased growth and inhibition of NFkB signaling.
NFkB signaling in EBV negative cells is dependent upon PI3 kinase signaling, but not reactive oxy-
gen. Pharmacologic therapy with appropriate antioxidants may lead to prevention of EBV-induced
neoplasia in immunocompromised patients, and to enhanced therapies for patients with existing
tumors. 
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(-)-Epigallocatechin-3-gallate directly induces apoptosis and inhibits proliferation of human
melanoma cell lines
M Nihal, H Mukhtar and GS Wood Dept of Dermatology and VAMC, University of Wisconsin,
Madison, WI
Melanoma accounts for ~ 4% of all skin cancer cases and ~79% of skin cancer-related deaths in the
USA. Because of the growing incidence and high mortality of melanoma, novel approaches for its
management are warranted. Chemoprevention by naturally occurring agents present in the diet may
be a useful strategy. Green tea polyphenolic compounds have shown great promise as chemopre-
ventive agents in a variety of cell lines and animal tumor model systems. EGCG, the major polyphe-
nolic antioxidant present in green tea, is believed to be critical for its chemopreventive effects. Employ-
ing a series of human melanoma cell lines A-375 and G-361 (malignant melanoma) and Hs-294T
(metastatic melanoma), and normal human epidermal melanocytes (NHEM), we evaluated the chemo-
preventive effects of EGCG against cells of melanocytic lineage. EGCG treatment was found to result
in a dose-dependent decrease in cell viability by trypan blue exclusion. The MTT assay revealed
that EGCG (1, 2, 5, 10, 20, 40, 80 µg/ml) treatment of the cells resulted in significant dose-depend-
ent inhibition in the proliferation of all melanoma cell lines studied. This effect was significantly
greater than that in NHEM at similar EGCG dose. Western blot analysis revealed that EGCG- treated
melanoma cell lines showed significant evidence of apoptosis as evident from the cleavage of 115
kDa poly (ADP-ribose) polymerase protein (PARP) into ~89 kDa and ~27 kDa proteins. In addi-
tion, EGCG treatment of the melanoma cell lines resulted in a significant i) decrease in the expres-
sion of Ki-67 nuclear protein (by immunostaining of cytospin preparations) and the colony forma-
tion ability (by soft agar colony formation assay), and ii) increased binding to Annexin-V (by flow
cytometry). To our knowledge, this study is the first to demonstrate the direct, selective anti-prolif-
erative/pro-apoptotic effects of EGCG against melanoma cell lines. This raises the possibility that
EGCG, at physiologically attainable concentrations, may have chemopreventive and/or therapeutic
potential for human melanoma. 
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GLI2 is expressed in normal human epidermis and BCC and induces GLI1 expression by bind-
ing to its promoter
MS Ikram,1 G Regl,2 GW Neill,1 A Frischauf,2 F Aberger,2 A Quinn1 and M Philpott1 1 Centre for
Cutaneous Research, Barts and The London Queen Mary’s School of Medicine & Dentistry,
University of London, London, United Kingdom and 2 Institute of Genetics, University of Salzburg,
Salzburg, Austria
SHh binds to its receptor patched (Ptch), leading to the activation and repression of target genes via
zinc-finger Gli family transcription factors. These proteins act in a combinatorial fashion: GLI1 and
GLI2 have activating effects, whereas GLI3 (and at times GLI2) have repressor activities. Deregu-
lation of the SHh pathway leads to a number of human diseases, including birth defects and basal
cell carcinoma (BCC) of the skin. Hereditary as well as sporadic BCCs are associated with PATCHED
mutations. In transgenic mouse model systems targeted expression of GLI1 or GLI2 induces BCC
formation. However, our understanding of the molecular mechanisms of SHh signalling and GLI
activity in human keratinocytes and their role in tumourigenesis is still very limited. We have pre-
viously shown that GLI1 is expressed in the outer root sheath (ORS) of hair follicles and in BCC
but not in normal interfollicular epidermis, and that GLI2 is expressed at elevated levels in BCC com-
pared to normal skin. We also identified a positive feedback mechanism between GLI1 and GLI2 in
the HaCat cell line using time course gene expression analysis indicating that GLI1 is likely to be
directly regulated by GLI2. In this study we have shown with western blot and RT-PCR analysis that
retrovirally expressed GLI2 induces endogenous GLI1 expression in human primary keratinocytes.
In-addition, band shift assays show that GLI2 specifically binds the GLI binding consensus sequence
in the GLI1 promoter confirming that GLI2 directly activates GLI1. Finally, using in situ hybridis-
ation we have shown that GLI2 is expressed in interfollicular epidermis and ORS of hair follicles in
normal skin as well as in BCC tumour islands. These results suggest an important role for GLI2 in
regulating epidermal proliferation and skin tumorigenesis. 
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Gene expression profile in squamous cell carcinoma complicating recessive dystrophic epi-
dermolysis bullosa using cDNA microarray analysis
R Mallipeddi, V Wessagowit, A South, R Eady and J McGrath Cell and Molecular Pathology, St
John’s Institute of Dermatology, London, United Kingdom
Recessive dystrophic epidermolysis bullosa (RDEB) sufferers have an increased risk of developing
squamous cell carcinoma (SCC) with more than 75% developing SCC by the age of 60-years. It is
the major cause of premature death in this disorder. However, little is known about why these tumors
develop and why they behave so aggressively. To explore tumor biology further, we compared the
gene expression profiles in SCCs and uninvolved skin from RDEB patients (n=3) with SCCs and
normal skin from non-EB patients (n=3). Total RNA was extracted from 6mm punch biopsies. cDNA
was radiolabeled with 33P and hybridized to Dermarray™ nylon filters (Research Genetics Inc.) that
contain 4022 skin-expressed genes. Images were scanned using a Storm 840 PhosphorImager and
analysis was performed with Pathways™ 4 software. Overall, 58 genes in the RDEB group and 68
genes in the non-RDEB group showed differential gene expression, defined as at least a two-fold
difference between lesional and non-lesional tissue. Selected genes were confirmed by RT-PCR
and/or immunohistochemistry. Both groups showed down-regulation of epidermal differentiation
complex genes in SCC including profilaggrin, keratin 10 and keratin 1. Other down-regulated genes
in both groups included death-associated protein kinase 3 (ZIP kinase), lysyl oxidase and D-aspar-
tate. Matrix metalloproteinase 1 was up-regulated in SCC of all non-RDEB subjects and 2/3 SCC
of the RDEB group. Differences in gene expression between the two groups also included laminin
5, which was up-regulated in the non-EB group but not in the EB group. Tumour rejection antigen
gp96 (ZAP128) was down-regulated in all of the non-RDEB group but none of the RDEB group.
Insulin like growth factor binding protein 3 was more up-regulated in the non-EB SCCs than EB
SCCs This study highlights differences in the gene expression profile of SCC complicating RDEB
and provides new insight into tumor biology in this genodermatosis. 
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Enhanced nodal metastasis and protection from Fas-mediated apoptosis in B16 murine
melanoma transduced with CCR10
T Murakami,1 AR Cardones,1 FO Nestle2 and ST Hwang1 1 Dermatology Branch, National Cancer
Institute, Bethesda, MD and 2 Department of Dermatology, University of Zurich, Zurich,
Switzerland
CCR10 is a CC chemokine receptor that has been reported to be commonly expressed (at the mRNA
level) by human melanoma cells. One of its known ligands, CCL27, is constitutively expressed by
epidermal keratinocytes. Using specific anti-CCR10 antibodies, we have determined that CCR10 is
expressed by human melanoma. To evaluate the potential role of CCR10 in melanoma progression,
B16 murine melanoma cells were retrovirally transduced with cDNA for CCR10 (CCR10-B16) and
luciferase (for quantitative analysis). Following footpad inoculation (4x105 cells/footpad), CCR10-
B16 cells formed tumors that were 40% larger than those derived from vector-transduced-B16 cells
(p<0.005). Regional (popliteal) LN metastasis (>90%) was often observed with CCR10-B16-injected
mice while nodal metastasis was uncommon (<20%) in pLNCX2-B16-injected mice. After ear
inoculation (1x105 cells/ear), 13 of 15 mice injected with CCR10-B16 cells developed a solid tumor
with frank metastases to the cervical lymph node (LN) occurring in 14 of 15 mice. In contrast, mice
injected with vector (pLNCX2)-transduced B16 cells rarely formed tumors in the ear (2 of 15) or
showed metastasis to the draining LN (3 of 15). Histologically, a dense dermal inflammatory cell
infiltrate was observed in the ear skin of pLNCX2-B16-injected mice at the inoculation site, but not
CCR10-B16-injected mice. To address whether CCR10 ligation might protect tumor cells from Fas-
mediated apoptosis (a major mechanism of host tumor defense), CCR10-B16 cells were treated
with interferon-gamma to upregulate Fas expression, exposed to FasL (+/-CCL27) to induce apop-
tosis, and then stained with annexin V-FITC to quantify apoptosis. In the presence of CCL27, apop-
tosis was reduced from 52% to 22% in CCR10-B16 cells (p=0.009, baseline apoptosis=17%). Thus,
CCR10 plays a potentially critical role in the growth, survival, and metastasis of melanoma cells
and may provide a mechanism for tumor cells to evade host immune destruction. 
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Effective DEAE dextran-mediated transfection of primary blood lymphocytes, dendritic cells,
and immature hematopoietic cells for use in functional DNA repair assays
K Thoms,1 J Baesecke,2 C Neumann1 and S Emmert1 1 Dermatology, Goettingen University,
Goettingen, Lower Saxony, Germany and 2 Hematology and Oncology, Goettingen University,
Goettingen, Lower Saxony, Germany
The host cell reactivation (HCR) assay measures the ability of transfected cells to repair plasmid
DNA damage as reflected in the recovery of luciferase activity. We established the HCR assay to
measure DNA repair capacity of primary blood lymphocytes, dendritic cells, and CD34+ cells using
an optimized DEAE dextran transfection protocol. 2x105 cells were transfected with 250 ng plas-
mid DNA. Primary blood lymphocytes were isolated by Ficoll gradient and, after cryopreservation,
PHA stimulated for 3 days. Immature dendritic cells were derived from primary blood monocytes
(6 day cultures in the presence of IL-4 and GM-CSF). CD34+ cells were isolated from cord blood
by MACS and, after cryopreservation, cultured in stem cell medium. We obtained luciferase activ-
ities 1000-fold, 200-fold, and 350-fold above background activity with undamaged plasmids in the
different cell types, respectively. In addition, we established a plasmid shuttle vector mutagenesis
assay using primary blood lymphocytes. 2x106 PHA stimulated lymphocytes were transfected with
250 ng reporter plasmid using DEAE dextran. After 2 days the plasmids were harvested from the
cells and transformed into bacteria. Blue colonies indicate complete DNA damage repair whereas
white bacterial colonies indicate mutations resulting from unrepaired DNA damage. These two func-
tional DNA repair assays established with different primary cells will enable us to test individuals
for their capacity of different DNA repair pathways like nucleotideexcision, baseexcision, or dou-
ble strand break repair depending on the type of DNA damage induced in the plasmid. 
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Topical DNA oligonucleotide therapy reduces UV-induced mutations and prevents cancers in
hairless mice
D Goukassian,1 E Helms,1 H van Steeg,2 C Oostrom,2 J Bhawan,1 N Kobayashi,3 T Mori3 and
BA Gilchrest1 1 Dermatology, Boston University School of Medicine, Boston, MA, 2 Laboratory of
Health Effects Research, NIPHE, Eindhoven and 3 Dermatology, Nara University, Nara, Japan
UV irradiation causes DNA mutations in skin that may lead to skin cancer. We have shown that treat-
ment of cells or skin with DNA oligonucleotides increases DNA repair capacity (DRC) through up-
regulation of repair proteins. To investigate in vivo the effect of topical T-oligo treatment on DRC,
UV-induced mutation frequency (MF) and carcinogenesis, we used hairless mice transgenic for the
lacZ/pUR288 mutation-indicator gene. First, we evaluated the effect of thymidine dinucleotide, (pTT
100 µM) pretreatment (10 days) on the removal of cyclobutane pyrimidine dimers (CPDs) and MF
after a single dose of UVB (30 mJ/cm2). By 72 hours no CPDs remained in the skin of pTT-treated
mice, whereas in diluent-treated animals 15±4% of CPDs remained (p<0.05). Moreover, compared
to control, pTT treatment decreased the UV-induced MF by 31±5% (p<0.03). Mice then received 5
consecutive cycles (150 days) of one week of daily topical pTT (or vehicle alone) treatment followed
by 3 weeks of daily UVB; 160 days after the initial UV irradiation mice were evaluated for tumor
incidence, size and multiplicity, histology, as well as MF. pTT pretreatment significantly decreased
the prevalence of malignancies between weeks 6 and 24 after initial UVB exposure. By 160 days
100% of control mice had tumors vs 25% of pTT-treated mice (p<0.036). There was a 91% decrease
in the average number of tumors/mouse (3±1.3 vs. 0.25, p<0.05) in pTT vs diluent-treated mice. No
tumors developed in sham irradiated mice. Compared to diluent, pTT treatment decreased by 28%
MF (p<0.08) as assessed in irradiated non-tumor-bearing samples 160 days after initial UVB. We
conclude that topical pTT treatment of mouse skin enhances DRC, decreases mutation frequency
and carcinogenesis following UV irradiation. Our data suggest that topical DNA oligonucleotide
therapy may prevent malignancies due to UV and other environmental carcinogens. 
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Hyperphosphorylation of p70S6k and ribosomal protein S6 in tuberous sclerosis skin tumors
is inhibited by rapamycin
F Takeuchi,1 J Wang,1 J Moss2 and TN Darling1 1 Dermatology, Uniformed Services University,
Bethesda, MD and 2 P-CCMB, National Heart Lung and Blood Institute, National Institutes of
Health, Bethesda, MD
Patients with tuberous sclerosis complex (TSC) possess inactivating mutations in the TSC1 or TSC2
genes that predispose to developing tumors. Recently it was shown that these tumor suppressor genes
function to inhibit the mTOR signaling pathway, a mitogen-activated pathway that stimulates cell
growth through phosphorylation and activation of p70S6k and its substrate ribosomal protein S6.
The aims of this study were to determine whether the mTOR pathway is activated in TSC skin tumors,
and whether hyperactivity can be inhibited by rapamycin, an inhibitor of mTOR being tested for
treatment of TSC internal tumors. In immunohistochemistry studies, cells immunoreactive for phos-
pho-p70S6k and phospho-S6 were observed scattered in the dermis of 1 angiofibroma and 2 peri-
ungual fibromas, but not in the dermis of normal appearing skin. In Western blot studies, total and
phosphorylated p70S6k and S6 were measured in cells serum starved for 48 hours to remove serum
stimulation of the mTOR pathway. Phospho-p70S6k and phospho-S6 were faint or undetectable in
fibroblasts cultured from TSC normal appearing skin, and detectable as moderate to intense bands
in stromal cells from 3 angiofibromas, 1 periungual fibroma, and 1 shagreen patch. The addition of
rapamycin (200 nM) to TSC tumor stromal cells for 24 hours dramatically reduced or eliminated
phosphorylation of p70S6k and S6 in all three types of TSC skin tumors. Immunocytochemistry
showed that 20 nM rapamycin decreased or eliminated cytoplasmic staining for phospho-p70S6k or
phospho-S6 in cells cultured from 2 angiofibromas and 1 periungual fibroma. These data indicate
that TSC skin tumors show increased activation of the mTOR signaling pathway, and that rapamycin
inhibits this growth stimulatory pathway. TSC skin tumors may be useful as readily accessible sur-
rogates to demonstrate adequate drug levels in ongoing clinical trials of rapamycin for TSC internal
tumors. 
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BRAF exon 15 mutations in melanoma: presence in primary melanomas and evidence for
constitutive ERK activation in the absence of mutation
JT Elder,1,3 J Poynter,2 C Ge,1 J Johnson,1 R Nair,1 B Redman,2 M Soengas1 and S Gruber2 1
Dermatology, Univ of Michigan, Ann Arbor, MI, 2 Internal Medicine, Univ of Michigan, Ann Arbor,
MI and 3 VA Med Ctr, Ann Arbor, MI
Mutations in the BRAF gene (predominantly T1796A yielding V599E) were recently reported in a
high proportion of melanoma cell lines and metastases (Davies et al., Nature 417:949). However,
that study presented no data on primary melanomas. In preliminary experiments, we have detected
BRAF exon 15 mutations in 14 of 66 (21.2%) primary melanomas. We also found the BRAF T1796A
mutation in 11 of 21 (52.4%) metastatic melanomas and in 13 of 21 melanoma cell lines (61.9%).
Two of the 21 lines contained a GT1795-96AA (V599K) mutation. To ask whether BRAF muta-
tions act through the MEK-ERK pathway to stimulate growth, we treated normal human melanocytes
(NHM) and 12 melanoma lines with the MEK inhibitor U0126. Cells (5,000/cm2) were seeded in
96-well dishes and maintained for 4 d in 0 to 10 uM U0126. NHM displayed only limited growth
inhibition (97.7 of control (%C) at 3 uM and 72.1%C at 10 uM). Growth inhibition was also limited
in the 4 melanoma lines without exon 15 mutations (82.2+/-5.5%C at 3uM and 70.7+/-2.6%C at
10uM). BRAF mutant lines displayed marked variability in growth inhibition (15 to 119%C at 3 uM,
and 25-101%C at 10 uM). Only 3 of the 8 mutant lines tested were inhibited by >50%. By immunoblot-
ting, phospho-ERK remained elevated in all melanoma lines after prolonged (24-72 hr) elimination
of serum from DMEM, whereas it was markedly reduced (by 60-95%) in NHM after prolonged
removal of the growth factor supplement from M154. These results demonstrate the presence of
BRAF mutations in primary as well as metastatic melanomas. They also demonstrate that melanoma
cell lines, unlike normal melanocytes, maintain a high level of signaling through the ERK pathway
in the absence of growth factors, irrespective of BRAF exon 15 mutation status. However, the fact
only 3 of 8 lines carrying exon 15 mutations were growth-inhibited by U0126 indicates that inputs
independent of or distal to MEK are also involved in the proliferation and/or survival of melanoma
cells. 
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Immunophenotyping of cutaneous B cell lymphomas by flow cytometry
J Guitart,1 C Querfeld,1 D Variakojis,2 A Rosenberg,3 L Glass3 and C Golsby2 1 Dermatology,
Northwestern University, Feinberg School of Medicine, Chicago, IL, 2 Pathology, Northwestern
University, Feinberg School of Medicine, Chicago, IL and 3 Dermatology, University of South
Florida, Tampa, FL
Immunophenotyping of cutaneous B cell lymphomas (CBCL) by immuno- histochemistry has sig-
nificant shortcomings. The panel of antibodies available for paraffin embedded tissue is limited. Con-
versely, there is an extensive panel of markers for frozen tissue, but processing artifact frequently
hampers the interpretation. Our goal was to evaluate the feasibility of flow cytometric immunophe-
notyping of skin biopsies. We evaluated 37 skin biopsies from 36 patients with suspicious lesions
for CBCL. Clinicopathological correlation was available on all cases. The samples were evaluated
by 3-4 color cytometry techniques using variable panels depending on the number of cells extracted
from the biopsy. Adequate cell suspension samples were obtained in most cases with mechanical
pressure from a single 4mm punch biopsy. There were 6 cases of reactive lymphoid hyperplasia (B-
cell type), 24 primary CBCL, including 9 cases of follicular center cell, 5 marginal zone and 10
large B-cell lymphomas (LBCL). There were 7 secondary CBCL (3 small lymphocytic, 1 diffuse
small cleaved, 1 lymphoplasmacytic and 2 large cell lymphomas). Light chain restriction was detected
in 77.4% (24/31) of lymphomas. All 6 RLH cases were polyclonal. We were unable to detect clon-
ality on 7 lymphomas including 5 LBCL. Nevertheless,clonality was detected on 7/12 LBCL. Fur-
ther evaluation with additional markers (CD5, CD10, FMC7, CD23, bcl-2) was helpful in subtyp-
ing the lymphomas. With the exception of LBCL which can yield either negative surface immuno-
globulins or inadequate sampling due to cell fragility, flow cytometry is superior to immunohisto-
chemistry(formalin fixed or frozen tissue) for immunophenotyping primary and secondary CBCL. 
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Hemidesmosome integrity is required for invasive human epidermal neoplasia
S Ortiz-Urda, Q Lin, M Marinkovich, M Lazarov, M Dajee and P Khavari Dermatology, VA Palo
Alto and Stanford University, Stanford, CA
The recent generation of Ras-driven invasive human epidermal neoplasia resembling squamous cell
carcinoma (SCC) provides the opportunity to study the functional importance of proteins over-
expressed in SCC. These include the hemidesmosome components BP180, a6b4 integrin and laminin
5. These proteins promote cellular adhesion, growth and survival, however, their importance in car-
cinogenesis is unknown. To study this, we used cells from genetically characterized patients with
junctional epidermolysis bullosa (EB) due to mutations in the COL17A1, ITGb4 and LAMB3 genes.
Oncogenic Ras was co-expressed with IkBa in primary human keratinocytes deficient in these pro-
teins and injected subcutaneously into nude mice to assay tumor formation. While normal controls
produced rapidly growing tumors in 100% of animals within 2 weeks, Ras-IkBa expressing cells
lacking either BP180, laminin 5 or a6b4 integrin all failed to produce any tumors (n=5/group). In
each case, retroviral re-expression of the previously absent protein restored tumorigenicity, con-
firming that failure of tumor formation was due to its absence. In contrast, TGM1 mutant cells from
patients with lamellar ichthyosis formed tumors with the same kinetics as controls, indicating that
impaired tumor formation is not a non-specific feature of genodermatoses keratinocytes. Consistent
with these genetic studies, injection of blocking antibodies to laminin 5 and a6b4 integrin also
inhibited tumor formation while control IgG entirely failed to abolish tumorigenesis. Of interest, pri-
mary human keratinocytes from keratin 5 mutant EB simplex patients also failed to form Ras-driven
tumors, suggesting that normal cytoskeletal interactions with hemidesmosomes might also be required
for tumorigenesis. These data indicate that proteins necessary for hemidesmosome function are
required for Ras-driven human epidermal neoplasia and provide a new genetic approach to study
the role of individual proteins expressed in human cancer. 
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Printed small molecule arrays for discovery of small molecules that interact with a protein of
interest
P Nghiem,1,3 Y Kim,1 M Longo,1 J Bradner,3 A Koehler,2 X Li,2 D Barnes-Seeman,2 S Park2 and
S Schreiber2 1 Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown,
MA, 2 Chemistry, Harvard University, Cambridge, MA and 3 Dana-Farber Cancer Institute,
Boston, MA
Discovery of small molecules that inhibit specific target proteins is typically a costly process requir-
ing abundant purified protein and a robust bioassay. ATR is a protein kinase involved in the replica-
tion checkpoint for which a potent specific inhibitor would be of great interest. We have taken a novel
approach to discover inhibitors for ATR, a large (301 kDa) protein that is not readily purified and
for which no simple bioassay exists. Approximately 7,000 compounds from a diversity-oriented syn-
thetic chemical library were robotically arrayed onto activated glass microscope slides to form
covalently captured compounds. Cellular extracts were prepared from 293T cells that over-expressed
Flag (epitope)-tagged ATR and from mock transfected cells. After sequential incubation with a mouse
anti-Flag antibody and a fluorescently-labeled anti-mouse antibody, slides were read in a fluores-
cence scanner. Six small molecules reproducibly yielded a signal with lysates from Flag-ATR trans-
fected cells but never with mock-transfected lysates. The compounds were structurally very similar
to each other suggesting that they might recognize a common target (presumably ATR). The six com-
pounds were tested for functional activity in a cell-based premature chromatin condensation assay
and four of the six demonstrated inhibition of the ATR pathway. The most potent of these is being
studied with structure-function analysis and in vitro kinase assays. Printed small molecule arrays
have thus far been used successfully with purified proteins. This is the first application of this new
technology to a target protein in a cellular lysate. This efficient approach has the potential to allow
discovery of small molecules relevant to many biological systems. 
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Alternative splicing of 25-hydroxyvitamin D3-1α-hydroxylase (Cyp27B1) in malignant
melanoma
J Reichrath,1 B Diesel,2 M Rech,1 E Meese,2 W Tilgen1 and M Seifert1,2 1 Department of
Dermatology, Universitaetskliniken des Saarlandes, Homburg, Saarland, Germany and 2 Institute
of human genetics, Universitaetskliniken des Saarlandes, Homburg, Saarland, Germany
In vitro studies have demonstrated that the biologically active vitamin D metabolite 1,25-dihydrox-
yvitamin D3 (1,25(OH)2D3) suppresses proliferation and induces differentiation in various cell types,
including melanoma cells. There are two hydroxylases involved in the formation of circulating
1,25(OH)2D3 Theses hydroxylases belong to a class of proteins known as cytochrome p450 mixed
function monooxidases. 25-hydroxyvitamin D3-1α-hydroxylase catalyses the synthesis of
1,25(OH)2D3 from 25-hydroxyvitamin D3 in the kidneys. Previous reports have shown that
1,25(OH)2D3 is also synthesized in cells from various extra-renal tissues including keratinocytes
and activated macrophages. Increasing evidence indicates that extra-renal 25-hydroxyvitamin D3-
1α-hydroxylase may act in many tissues via the local production of 1,25(OH)2D3 as a major regu-
lator of cell growth in an autocrine or paracrine fashion. In this study we show the expression of 1α-
hydroxylase for 25-hydroxyvitamin D3 in primary cutaneous malignant melanoma and in various
melanoma cell lines and report the expression of several alternatively spliced 1α-hydroxylases mRNAs
including transcripts encoding truncated proteins. Additionally, the regulation of these newly detected
splicevariants by various vitamin D analogs was analyzed. Alternative splicing is a frequent feature
in the expression of many p450 genes and is considered as an important factor in regulating the
enzyme level. This is the first report of alternatively spliced mRNAs of the 1α-hydroxylase gene in
melanoma that influence the 1α-hydroxylase activity level and the local synthesis of vitamin D
metabolites in these cells. 
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Cutaneous T cell lymphoma: allelic loss at 10q23.33 and Fas gene mutations
EM Wain, TJ Mitchell, R Russell-Jones and SJ Whittaker Skin Tumour Unit, St Johns Institute of
Dermatology, London, United Kingdom
Chromosomal abnormalities at 10q have been identified in mycosis fungoides (MF) and Sezary Syn-
drome (SS) using cytogenetic techniques. Fas (CD95/Apo-1) gene mutations have been identified
in other lymphoproliferative disorders resulting in defective lymphocyte proliferation. This study
fine maps the area of deletion on chromosome 10q using loss of heterozygosity (LOH) and analy-
ses Fas, a candidate gene within the minimal region of deletion, using PCR/SSCP analysis. In patients
with MF (45) and SS (15), DNA extracted from either skin biopsies or peripheral blood and matched
unaffected tissues (controls) was analysed for LOH at each of 19 microsatellite markers in the region
10q22.3-10q26.13. Allelic loss was found in 26/60 samples (43%). 15/45 (33%) patients with MF
had LOH (1/3 - stage Ia disease, 1/8 - Ib, 12/29 - IIb and 1/3 - IVa). LOH was found in 11/15 (73%)
patients with SS. The pattern of allelic loss was similar in SS and MF. Two minimal regions of dele-
tion (MRD) were found: the first at 10q23.33 (between microsatellite markers D10S583 and D10S571)
and the second at 10q25.3-10q26.11 (between microsatellite markers D10S187 and D10S221).
PCR/SSCP using 13 primer pairs spanning the 9 exons of Fas was performed on 40 DNA samples
(20 MF and 20 SS). Band shifts were seen in 6/40 (15%) patients (2/20 MF, 4/20 SS). 4/6 band
shifts were in exon 1 and 2/6 in exon 3. 3/6 samples demonstrating band shifts in Fas also had LOH
at 10q23.3 suggesting biallelic inactivation of Fas. DNA sequence analysis is being performed to
determine if the observed band shifts represent novel Fas gene mutations. This extensive allelotyp-
ing data defines 2 MRDs on chromosome 10q in CTCL which provide the basis for targeting fur-
ther candidate gene analysis. Results suggest that the Fas gene is an important potential target on
10q for gene inactivation in CTCL. 
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The first detailed study of multiple forms of mtDNA damage in NMSC
A Harbottle, S Durham, K Krishnan, J Betts and MA Birch-Machin Dermatology, University of
Newcastle Upon Tyne, Newcastle Upon Tyne, Tyne and Wear, United Kingdom
Mitochondrial DNA (mtDNA) damage, predominantly encompassing point mutations, has been
reported in a variety of cancers. We present in human skin, the first detailed study of the distribu-
tion of multiple forms of mtDNA damage in non-melanoma skin cancer (NMSC) compared to his-
tologically normal perilesional dermis and epidermis. It includes the first entire spectrum of dele-
tions found between different types of skin tumours and perilesional skin (n=30). Using long extension
PCR to amplify the entire mt genome, 20 different deletion species were observed. Quantification
by real-time PCR assay showed more deletions occured in the BCC (mean %-deletions=25.1±13.2)
compared to SCC (mean %-deletions=12.3±18.0) (p=0.036, 2 sample t test) patients. We also per-
formed the first quantitative analysis of the common deletion as well as the first identification of spe-
cific tandem duplications in tumour and the normal perilesional skin. Furthermore, DNA sequenc-
ing of 4 mutation ‘hotspot’ regions of the mt genome in 30 samples identified several mutions, e.g.
there was an unreported somatic heteroplasmic C to T transition at np438 in a 77-year-old SCC
patient. Moreover, there were two heteroplasmic changes, a T to C transition at np16093 in the non-
coding D-loop and an A to G transition at np215 in the coding region, in the tumour of an 88-year-
old BCC patient which were absent in the perilesional dermis and barely detectable in the associ-
ated epidermis. 81 unreported and reported homoplasmic single base changes were also identified
in the other NMSC patients. However these mutations were present in both tumour and perilesional
skin, which suggests that the use of histologically normal perilesional skin from NMSC patients,
may be limited. In summary, it is unclear whether mtDNA damage has direct causal link to skin
cancer or it may reflect underlying nDNA instability. 
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ATR regulates chromosomal fragile sites by enforcing the replication checkpoint
P Nghiem,1,3 Y Kim,1,2 J Bradner,3,2 A Casper,5 M Longo,1,4 T Glover5 and S Schreiber2 1
Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown, MA, 2
Chemistry/HHMI, Harvard University, Cambridge, MA, 3 Dana-Farber Cancer Institute, Boston,
MA, 4 Dermatology, Harvard Medical School, Boston, MA and 5 Univ of Michigan, Ann Arbor, MI
The replication checkpoint is required for the response to UV and other forms of DNA damage by
ensuring that DNA replication is complete prior to mitosis. Here we describe studies that reveal
greater detail of the role of the protein kinase ATR (ataxia telangiectasia and Rad3-related) in the
replication checkpoint and genomic fidelity. We inhibited ATR function using small interfering RNA
(siRNA; duplexed 21-nucleotide RNA oligos of identical sequences to ATR). While control RNAs
had no effect, siRNA to ATR caused a several-fold inhibition of ATR protein expression and partial
functional inhibition of ATR. Specifically, siRNA increased sensitivity to caffeine (an inhibitor of
ATR), augmented premature chromatin condensation, and induced chromosomal gaps and breaks
at classically defined ‘fragile sites’ in cells treated with aphidicolin (slows DNA replication). Because
cancer cells often have insertions and translocations at these same fragile sites, this finding suggests
that ATR function may be limiting in malignant cells. To study ATR’s role in skin in vivo we gen-
erated transgenic mice using a keratin-14 promoter linked to dominant negative alleles of either
ATR or its downstream target Chk-1. Five independent founders carrying one of these transgenes (3
of ATR; 2 of Chk-1) are viable and without apparent defects in skin or hair at 4 months of age. This
suggests that partial inhibition of the replication checkpoint is well tolerated in the absence of DNA
damage. These findings suggest that ATR plays a key role in maintaining genomic fidelity by pre-
venting premature chromatin condensation, an event that occurs mostly at ‘fragile sites’ that repli-
cate late in S phase, and that partial inhibition of ATR function would be expected to be more detri-
mental to malignant than benign cells. 
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Description of a novel antigen expressed in activated dermal cells and at the tumor–stroma–bor-
der of dermal tumors in situ
U Anderegg,1,2 M Sticherling,2 U Haustein1 and A Saalbach2,1 1 Saxon Academy of Science,
Leipzig, Germany and 2 Dept. of Dermatology, University of Leipzig, Leipzig, Germany
In previous investigations we isolated a novel cDNA that is induced in fibroblasts by supernatants
from malignant melanoma cell lines in vitro. This cDNA, Mel4b3, is induced by TGFbβ and Inter-
leukin-1 in fibroblasts, keratinocytes and endothelial cells in vitro. The mRNA was detected in situ
in skin biopsies of malignant melanoma, sqamous cell carcinoma, but not in benign naevi or normal
skin. The tumor associated expression was mostly found at the tumor–stroma border. Interestingly,
often cells of the outer root sheath of the hair follicle expressed this mRNA also in healthy skin.
Sequence comparison revealed high homology to KIAA1866, a model reference sequence that was
predicted from NCBI contig NT-029991 by automated computational analysis. However, the pre-
dicted protein coding sequence of KIAA1866 was distal from the open reading frame found in our
sequencing work for Mel4b3. We developed polyclonal antibodies against peptide sequences of
Mel4b3 and screened the expression of the mRNA as well as of the detectable antigen in order to
test whether this peptide co–localizes with the mRNA message in probes from normal skin and skin
tumors, especially malignant melanoma. Using in situ hybridization and immunohistochemistry we
could show that the predicted peptide obviously exists and the immunohistochemical data clearly
co–localize with mRNA expression in the skin specimen investigated. From these studies we con-
clude that the corresponding antigen might be associated with cell activation found in tumor devel-
opment and hair growth. 
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Loss of PKC-alpha expression may enhance the tumourigenic potential of Gli1 in BCC
GW Neill, LR Ghali, JL Green, MS Ikram, AG Quinn and MP Philpott Dermatology, Barts and the
London, Queen Mary’s School of Medicine and Dentistry, London, United Kingdom
Aberrant signalling of the SHh pathway is associated with the formation of several neoplasms includ-
ing BCC; this is primarily due to mutation of the PTCH1 tumour suppressor gene. Although PTCH1
mutations have not been identified in all BCCs examined, Gli1 is consistently upregulated suggest-
ing that other factors may be relevant to tumour formation. Recent evidence has shown that Gli1
induces expression of Wnt isoforms and PDGFR alpha thus showing that SHh signalling is linked
to other major signalling pathways. However, apart from known components of the SHh pathway
that regulate Gli1 (such as PKA), little is known about other aspects of cell signalling which may
influence Gli1 activity. Therefore, we determined the expression profile of two PKC isoforms in
BCC sections and also their effect on Gli1 activity. We observed that neither PKC Alpha nor PKC
Delta are expressed in tumour islands. In BCC sections containing hair follicles PKC-A is strongly
expressed in the outer root sheath (ORS) whereas PKC-D is predominant in the inner root sheath.
As we have previously shown that Gli1 is expressed in the ORS, we employed a luciferase reporter
assay to determine if PKC-A regulates Gli1 activity; we also determined if PKC-D regulates Gli1
activity. In mammalian 293T cells, co-expression of constitutively active (ca) PKC-A reduced Gli1
activity by over 60% whereas ca-PKC-D increased activity over 2-fold. Western analysis demon-
strated that the increase in Gli1 activity induced by PKC-D was not due to an increase in Gli1 pro-
tein. Surprisingly, despite reducing Gli1 activity, PKC-A actually increased Gli1 protein indicating
that Gli1 activity would be further reduced if the values were also normalized to protein levels. The
origin of BCC is uncertain but immunostaining studies have implicated that it may arise from the
ORS of the hair follicle. We propose that loss of PKC-A expression may be important to BCC for-
mation; this may in part be due to the predicted increase in Gli1 activity. 
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The vitamin D system in malignant melanoma
M Rech,2 M Seifert,2 V Meineke,1 H Palm,2 W Tilgen2 and J Reichrath2 1 Department of
Dermatology, Universitaetskliniken des Saarlandes, Homburg, Saarland, Germany and 2 Institute
of Radiobiology, Federal Armed Forces Medical Academy, Munich, Bayern, Germany
We analyzed key components of the vitamin D system in malignant melanoma (MM) in situ using
immunhistochemistry and in melanoma cell lines (BuHom, MelJuso, MelJu, MeWo, A375) in vitro
using real-time PCR (LightCycler). Additionaly, effests of the vitamin D analogs on growth and on
expressioin of key components of the vitamin D system was analysed in melanoma cell lines. We
detected strong vitamin D receptor (VDR) immunoreactivity in MM. Comparing VDR staining
with staining for Ki-67, or apoptotic cells (terminal UTP nucleotide end labelling assay), no corre-
lation was found. In melanoma cell lines, the majority of tumor cells revealed VDR immunoreac-
tivity in vitro. Incubation of MelJuso cells with 1,25(OH)2D3 resulted in a reduction of the number
of Ki-67-positive tumor cells and a reduced incorporation of pyrimidine analogue BrdU into the
DNA of proliferating cells, indicating responsiveness of these cell lines to the antiproliferative effects
of 1,25(OH)2D3. Using real time PCR, we have quantified mRNA expression of vitamin D recep-
tor (VDR) and of vitamin D-25-hydroxylase, 25-hydroxyvitamin D-1α-hydroxylase, 25-hydrox-
yvitamin D-24-hydroxylase. Expression levels were determined as ratio between target genes and
the reference gene PBGD. Interestingly, all enzymes were deected in melanoma cell lines. Our find-
ings indicate that (i) VDR protein as well as mRNA for VDR, 25-OHase, 1α-OHase and 24-OHase
are strongly expressed in MM. (ii) VDR expression in MM is not exclusively regulated by the pro-
liferative activity of these tumor cells, but additional, unknown mechanisms (iii) alterations in VDR
expression and in the synthesis and metabolism of vitamin D metabolites may involved in the growth
regultion of MM (iv) MM may be considered as potential target for therapy with new vitamin D
analogs that exert little calcemic side effects or by pharmacological modulation of 1,25(OH)2D3
sythesis/metabolim in these tumor cells 
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Immunolocalization of low affinity PGE2 receptors, EP1 & EP2, in human epidermis and non-
melanoma skin cancer
RL Konger1 and AP Pentland2 1 Pathology & Laboratory Medicine & Dermatology, Indiana
University School of Medicine, Indianapolis, IN and 2 Dermatology, University of Rochester
School of Medicine, Rochester, NY
In this study, we examine the immunolocalization of the low-affinity PGE2 receptors, EP1 and EP2,
in normal human epidermis and human squamous cell carcinoma (SCC) and basal cell carcinoma
(BCC). Cyclooxygenase-2 (COX-2) expression is markedly elevated in non-melanoma skin cancers.
Overexpression of COX-2 as well as treatment with COX-inhibitors results in decreased invasive
behavior in a variety of tumor cell lines. We have previously reported that loss of the EP2 subtype
of PGE2 receptor results in increased invasiveness in spontaneously immortalized HaCaT cells
[Am. J. Pathol., 161:2079-2086, 2002]. We have therefore hypothesized that PGE2-mediated down-
regulation of low-affinity PGE2 receptors may be involved in acquisition of the invasive phenotype.
Using two monoclonal antibodies developed against the human EP1 and EP2 receptors, we performed
immunohistochemical staining of normal human epidermis and non-melanoma skin cancers. In
normal epidermis, EP1 and EP2 receptors both demonstrated perinuclear and cytoplasmic or cell
membrane localization. Both demonstrated increased staining in the stratum granularis, with scat-
tered sparing of the basal compartment. Eccrine glands, smooth muscle, hair follicles, and sebaceous
glands all stained positive for both EP1 and EP2 receptors. EP2 receptor staining was variably decreased
to absent in 4/5 SCC, increased in 1/5 SCC and absent in 3/3 BCC. EP1 immunostaining was decreased
to absent in 6/6 SCC and absent in 1/1 BCC. In general, areas of tumors which stained positive were
more superficially located or in more differentiated areas. Areas of deeper penentration and highly
cellular areas generally demonstrated decreased to absent immunostaining. These results examin-
ing a small series of non-melanoma skin cancer strongly support our hypothesis that loss of low-
affinity PGE2 receptor expression is associated with acquisition of the invasive phenotype. 
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Specific T helper cells selectively inhibit tumor angiogenesis through TNF-receptor1-depend-
ent signaling
H Braumueller,1 BJ Pichler,2 M Kneilling,1 C Weigert,1 K Ghoreschi1 and M Roecken1 1
Dermatology, Eberhard Karls University, Tuebingen, Baden-Wuerttemberg, Germany and 2
Nuclear Medicine, Technische University, Munich, Bavaria, Germany
RIP1-Tag2 transgenic mice are an established model for multistage tumorigenesis and angiogene-
sis. In these mice the large T antigen (Tag) of the Simian Virus 40 is only expressed in insulin-pro-
ducing β cells of the pancreas, leading to the successive development of islet cell hyperplasia, ade-
nomas, and finally invasive, highly vascularized carcinomas. As we recently found that adoptive
transfer of Tag-specific Th1 cells is highly efficient in inhibiting tumor growth, we investigated the
underlying mechanisms, including the role of Tumor necrosis factor (TNF) signalling. At 6 weeks,
RIP1-Tag2+TNF-receptor1 (TNFR1)-/- mice were treated with Tag specific Th1 cells weekly. Th1
cells were generated by stimulating Tag-specific, T cell receptor-transgenic CD4+ T cells from C3H
mice with Tag and antigen presenting cells in the presence of CpG 1668 oligonucleotide. We fol-
lowed blood glucose levels and performed histology. To evaluate, whether TNFR1 signaling inter-
feres with the anti-angiogenetic effect of Th1 cells, we used a glycosylated RGD-peptide with
selective binding to integrin αvβ3, a marker for endothelial cell activation and angiogenesis. Adop-
tive transfer of Th1 cells doubled life span of RIP1-Tag2 positive TNFR1+/+ mice. In sharp con-
trast, Tag-specific Th1-cells did not prolong life of RIP1-Tag2+TNFR1-/- mice. Importantly, at 12
weeks TNFR1-/- mice had large, vascularized islet carcinomas, whether they were treated with
Th1-cells or not. Quantifying angiogenesis in vivo with radio-labeled integrin αvβ3 proved that Tag-
specific Th1 cells prevented activation of integrin αvβ3 in tumors of normal RIP1-Tag2+ mice, while
it failed to inhibit αvβ3 in RIP1-Tag2+TNFR1-/- mice. As we recently found that tumor-specific
Th1 cells efficiently prevent tumor growth through mechanisms independent of tumor cell killing,
the data provided here show that Th1 cells control tumor growth and angiogenesis through TNFR1-
mediated signaling. 
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Regulated expression of a dominant/negative AP-1 (A-FOS) targeted with the Keratin 5 pro-
moter alters epidermal inflammation, tumorigenesis, and causes blindness
M Gerdes, M Levy, A Woods, A Glick, J Moitra, C Vinson and SH Yuspa National Cancer Institute,
Center for Cancer Research, Bethesda, MD
To address the specific role of the AP-1 family in stages of skin tumorigenesis, transgenic mice were
generated with a dominant negative Fos protein (A-FOS) under the control of the tetracycline oper-
ator region (tet-O-A-FOS). These mice were crossed with Keratin 5-Tet-transactivator mice, such
that A-FOS is targeted to basal skin keratinocytes and hair follicle outer root sheath in the absence
of doxycycline (Dox) in bi-genic mice. Tumors were induced in bi-genic and control ( single trans-
genic and bi-genic on Dox) mice by a single application of DMBA followed by repeated applica-
tion of PMA. Unexpectedly, bi-genic mice without Dox developed twice as many benign lesions as
bi-genic mice on Dox or single transgenic mice. However, tumors on bi-genic mice off of Dox were
small sebaceous adenomas, whereas tumors in all control groups were squamous papillomas or car-
cinomas. When papilloma bearing A-FOS mice on dox were placed on normal feed, the rate of malig-
nant conversion was reduced and tumors had mixed sebaceous and squamous components.  PMA
treatment alone resulted in an inflammatory infiltrate, basal cell apoptosis and altered gene expres-
sion profiles on chip based microarrays in bi-genic mice off dox compared to controls. Aged bi-genic
mice off Dox develop eye reddening and alopecia, a syndrome compatible with vitamin A deficiency
that improved by implantation of time-release retinoic acid pellets, though was not completely
reversible. Aged bi-genic mice also were blind and lacked rods and cones, possibly secondary to
K5-A-FOS expression in the retinal pigment epithelium. Consistent with an impact on retinoid
pathways, changes in the expression of retinoid metabolizing enzymes and binding proteins were
detected on cDNA microarrays of bi-genic skin. Together, these studies provide insight into the role
of AP-1 in skin tumorigenesis and the interplay between retinoid and AP-1 pathways. 
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A model system for studying p16INK4a expression
G Li, MS Eller and BA Gilchrest Dermatology, Boston University School of Medicine, Boston, MA
The p16INK4a gene product is a major mediator of replicative senescence and functions as a tumor
suppressor. p16INK4a expression is often lost in melanoma through deletion, mutation or hyperme-
thylation of its promoter. Furthermore, methylation of the p16INK4a promoter is known to decrease
as cells age. We have shown that oligonucleotides homologous to the telomere 3’ overhang (T-
oligo) activate multiple, anti-proliferative and cancer-prevention cellular response and that a one
week exposure of human fibroblasts (fb) to T-oligo induces a senescent phenotype, mimicking replica-
tive senescence induced by serial passage in vitro. In order to develop a model to study p16INK4a
gene regulation during senescence and carcinogenesis, normal human fb were treated with the T-
oligo pGTTAGGGTTAG, complementary control oligo or diluent alone for up to seven days and
then collected for analysis. Western blot showed that p16INK4a protein was selectively first induced
5 days after T-oligo treatment and remained elevated through 7 days. p16INK4a was also induced 5
days after transfection of fb with a dominant-negative telomere repeat binding factor, TRF2DN, known
to cause telomere disruption. Western analysis further showed that T-oligo induces the Ets-1 tran-
scription factor, a known regulator of the p16INK4a promoter, but interestingly within 24 hours, much
earlier than the observed p16INK4a protein induction at day 5. Furthermore, a transfection of fb with
a p16INK4a promoter luciferase construct revealed a 4 to 5 fold increase in promoter activity within
48 hours of T-oligo treatment. These data suggest that exposure of the telomere 3’ overhang induces
transcription of p16INK4a protein expression via Ets-1, but that p16INK4a induction lags behind pro-
moter activation by 48-72 hours, consistent with a requirement for promoter demethylation. T-oli-
gos appear to mimic a physiologic signal for p16INK4a induction and may provide a valuable model
for exploring its altered regulation in melanoma. 
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A novel approach to melanoma therapy using telomere overhang-induced DNA damage sig-
nals
N Puri, MS Eller, H Byers, J Kubera, S Dykstra and BA Gilchrest Dermatology, Boston University
School of Medicine, Boston, MA
Melanoma, the most fatal form of skin cancer, is highly resistant to chemotherapy. We have shown
that treatment of the aggressive MM-AN human melanoma cell line with an 11-base oligonucleotide
homologous to the telomere 3’ overhang sequence (T-oligo) induces cell cycle arrest, apoptosis, and
differentiation of these cells. This apoptotic response is mediated at least in part by the p73 tumor
suppressor. To further elucidate the mechanism of T-oligo effects, we examined expression of livin/ML-
IAP an anti-apoptotic protein over-expressed in melanoma. By western blot, T-oligo but not a con-
trol complementary oligo or diluent alone, dramatically down-regulated livin. Furthermore, T-oligo
enhanced the apoptotic response of MM-AN cells to cisplatin. To determine the effect of T-oligo on
MM-AN tumorigenicity and metastasis in SCID mice, 3 groups of 5 mice each were injected with
cells pretreated for 48 hrs with T-oligo, complementary or diluent. After 40 days, the average num-
ber of metastatic tumors in the control groups were 15.8 and 9.6, compared to 0.8 in the T-oligo pre-
treated group (p<0.05). Tumor volume was reduced 85-95% and 4 of the 5 mice receiving the T-
oligo treated cells were free of detectable metastases. In order to determine whether T-oligo can affect
the growth of pre-existing tumors, MM-AN cells were injected subcutaneously into the flank of SCID
mice. Sites were injected twice daily with 60 nmoles of T-oligo or controls. At autopsy (day 22),
there was no significant difference in tumor size between diluent and control oligo-treated mice, but
T-oligo treatment reduced tumor volume by 84-88% (p<0.05), to clinically undetectable size in 3 of
6 mice. In tissue sections T-oligo treated tumors showed apoptosis (TUNEL staining) and greatly
enhanced expression of the differentiation associated proteins gp100 and TRP-1. We propose that
T-oligos mimic a physiologic DNA damage signal that is frequently masked in malignant cells and
induces innate anti-cancer responses. 
0183
Smad3 knockout mice exhibited resistance to chemically-induced skin carcinogenesis which
correlated with the lack of TPA-mediated AP-1 activation
X Wang,1 AG Li,1 M Zhang,2 W He2 and C Deng3 1 Otolaryngology, Dermatology, Cell &
Developmental Biology, Oregon Health & Science University, Portland, OR, 2 Dermatology,
Baylor College of Medicine, Houston, TX and 3 Genetics of Development & Disease, NIDDK, NIH,
Bethesda, MD
Smad3, a signaling mediator of transforming growth factor β, has been suggested to be a tumor sup-
pressor. To evaluate the role of Smad3 in skin carcinogenesis, we applied a skin chemical carcino-
genesis protocol to Smad3 knockout mice (Smad3-/- and Smad3+/-) and their wildtype littermates
(Smad3+/+, wt). Dimethylbenz[a]anthracene (DMBA) was applied to 3-day-old mouse skin, fol-
lowed by applications of 12-O-tetradecanoylphorbol-13-acetate (TPA) twice a week for 30 weeks.
Thirty weeks after DMBA initiation, 87% wt mice developed skin tumors, most of which were papil-
lomas with a few squamous cell carcinomas (SCCs). Surprisingly, only 6.7% Smad3-/- mice devel-
oped tumors which were all papillomas. Smad3+/- mice also exhibited reduced tumorigenesis (47%)
and fewer SCCs in comparison with wt mice. Further analysis revealed that Smad3 knockout mice
were resistant to TPA-induced epidermal hyperproliferation and tumor promotion. To further ana-
lyze the molecular mechanisms of the TPA resistance in Smad3 knockout skin, we examined the
major AP-1 family members. TPA application significantly induced levels of c-Jun, JunD and c-Fos
in wt skin. In contrast, these proteins were not elevated in Smad3-/- skin, and the levels of AP-1 pro-
teins in Smad3+/- skin were only elevated up to 50% of those in wildtype skin. TPA application also
induced phosphorylation and nuclear translocation of AP-1 family members in wt skin. However,
both phosphorylation and nuclear translocation of AP-1 proteins were not detectable in TPA-treated
Smad3-/- and Smad3+/- skin. Taken together, our study suggests that Smad3 may be required for
TPA-mediated AP-1 activation. Thus, the lack of AP-1 activation in the epidermis may partially
confer a resistance to chemically induced skin carcinogenesis to Smad3 knockout mice. 
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Interrupting activated Notch signaling triggers apoptosis in melanoma cells
J Qin,1 V Chaturvedi,1 M Hendrix,2 L Seftor,2 MF Denning,1 A Weeratana,3 M Bittner,3 J Trent,3
P Rizzo,4 L Miele4 and BJ Nickoloff1 1 Pathology, Loyola, Maywood, IL, 2 U of Iowa, Iowa City,
MD, 3 NIH, Bethesda, MD and 4 U of Illinois, Chicago, IL
Malignant melanoma (MM) cells are difficult to kill. This study explored Notch signaling in MM.
Immunostaining melanocytes (MC) in normal skin (n=10) revealed no Notch receptor expression.
Notch-2 immunostaining revealed strong expression in 7/22 (32%) benign nevi, 10/19 (52%) cuta-
neous MM, 56/76 (74%) cases of metastases. Notch-4 staining was strong in 14% of nevi, 95% of
cutaneous MM, and 70% of metastases. Staining to detect Notch-1 or Notch-3 was not consistently
positive in benign or MM lesions. Western blotting of MM lesions (n=4) confirmed overexpression
of the activated (75 kd) and precursor (125 kd) forms of Notch-4 in all cases; whereas only precur-
sor forms (110 kd) of Notch-2 were detectable. Compared to MCs, activated Notch-4 was overex-
pressed in MM lines. Interrupting Notch activation was accomplished using a gamma secretase
inhibitor (GSI). Exposure to GSI of early passage MM lines (n=5), and established MM lines (n=5);
produced concentration and time dependent induction of apoptosis amongst MM cells with 2 lines
relatively resistant (< 5% apoptosis, 18 hrs; 10 µM), but all other lines were sensitive (20-40%
apoptosis). GSI reduced activated Notch-4 levels within 2-4 hrs; accompanied by accumulation of
transmembrane form. Serial biochemical analysis before, and beginning 6 hr after GSI exposure,
revealed apoptotic machinery included activation of caspases 3,7,8,9, BID with release of SMAC
and cytochrome C from mitochondria. Caspase inhibitors blocked apoptosis. GSI triggered apopto-
sis was characterized by initial increase (1 hr) of phosphorylated p38 MAPK, followed 2 hr later by
accumulation of p53 containing key phosphorylated residues. These results demonstrate Notch-4 as
the predominately active receptor in MM. Interruption of Notch signaling using GSI triggers apop-
tosis in MM. We conclude that Notch signaling plays an important survival role in MM, and repre-
sents an attractive novel therapeutic target. 
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Clusterin inhibits keratinocyte growth in vitro and reduces skin tumorigenesis in vivo
I Viard-Leveugle,1 A Thomas-Tikhonenko,2 P Wehrli,1 B Aronow3 and LE French1 1 Dermatology,
Geneva University Hospital, Geneva, Switzerland, 2 Pathobiology, University of Pennsylvania,
Philadelphia, PA and 3 Molecular Developmental Biology, Childrens Hospital Research
Foundation, Cincinnati, OH
Clusterin (ApoJ, SP-40,40) is a ubiquitous secretory glycoprotein that is known to suppress certain
forms of apoptosis. It is produced by keratinocytes in vitro and expressed by suprabasal differenti-
ating keratinocytes in vivo, and can be induced by TPA. Here we show that recombinant clusterin
inhibits the growth of primary human keratinocytes in a dose dependent manner. The growth inhibitory
effect of clusterin is also observed in other primary epithelial and endothelial cells but not fibrob-
lasts. In accordance with this, anti-sense transfected clusterin A431 cells, that lack endogenous
clusterin, show a significant growth advantage over mock-transfected and wild-type A431 cells in
vitro. Microarray analysis of keratinocyte gene expression following clusterin exposure suggests that
clusterin modulates the expression of several key genes implicated in the control of keratinocyte
growth and differentiation. The in vivo role of clusterin was investigated in a chemical (DMBA/TPA)
skin tumorigenesis model using wild type (WT) and clusterin-knock out (KO) mice. In this model,
the mean number of papillomas per mouse was significantly increased in KO compared to WT
mice. In conclusion, our results show that clusterin inhibits keratinocyte proliferation in vitro and
early stages of skin tumorigenesis in vivo. 
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DNA damage and senescence responses are induced by degradation of telomere-specific DNA
MS Eller and BA Gilchrest Dermatology, Boston University School of Medicine, Boston, MA
During aging, telomeres gradually shorten and when critically short, cells die by apoptosis or enter
a state of growth arrest known as senescence. Conversely, malignant conversion of cells occurs only
when this safeguard is bypassed, usually through expression of telomerase. Senescence is associ-
ated with short telomeres, but the mechanism by which telomere shortening renders cells nonpro-
liferative is unclear. Normally, telomeres form a loop structure with the 3’ single-stranded overhang
(tandem repeats of TTAGGG) protected within the duplex DNA. Upon experimental telomere loop
disruption, this overhang is exposed, removed and the cells undergo DNA damage responses such
as p53 induction, apoptosis or development of a senescent phenotype. We and others have shown
that mammalian cells respond to DNA oligonucleotides homologous to the overhang (T-oligos) by
induction of DNA damage responses, apoptosis or senescence, suggesting that exposure of the
TTAGGG sequence is the salient event in loop disruption. We now report that T-oligos containing
nuclease-resistant phosphorothioate (ps) backbone linkages are inactive and do not induce a cell
cycle arrest or apoptosis in Jurkat cells as do physiologic nuclease-sensitive phosphodiester (pde)-
linked T-oligos. Confocal microscopy revealed identical cellular uptake and nuclear localization of
fluorescently-labeled ps- and pde-T-oligos, but ps-T-oligos did not induce phosphorylation of p53-
serine 15 or the S-phase checkpoint protein p95/Nbs1, as do pde-T-oligos. In order to further study
the basis of activity, we constructed 11-base T-oligos with ps linkages between the first 3 bases (2
linkages) either only on the 3’ terminus, the 5’ terminus, or both termini. T-oligos blocked at both
termini were inactive but opening one terminus to nuclease digestion restored their activity with a
preference for an open 3’ end, as would be the case after overhang exposure in vivo. These data pro-
vide the first experimental evidence that the telomere-mediated DNA damage and senescence
responses require digestion of the exposed 3' overhang.
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Gene expression patterns for diagnostics, prognostics and biology of CTCL
LC Showe,1 AH Rook,2 EC Vonderheid,3 M Wysocka,2 L Kari,1 A Loboda,1 M Nebozhyn1 and
MK Showe1 1 The Wistar Institute, Phila., PA, 2 UPMS, Phila., PA and 3 JHU, Baltimore, MD
We have used cDNA arrays of peripheral blood mononuclear cells to identify gene expression pat-
terns that are characteristic of patients with leukemic forms of cutaneous T-cell lymphoma, prima-
rily Sezary syndrome. Highly overexpressed genes include Th2 specific transcription factors Gata-
3 and Jun B both required for Th2 differentiation and IL-4 expression. Other highly overexpressed
genes include integrin 1, expressed on skin homing T-cells, proteoglycan 2, a cell surface protein
that binds L-Selectin and regulates chemokine function, the RhoB oncogene, the apoptosis induc-
ing cytokine TRAIL and the Map Kinase inhibitor Dual-specificity Phosphatase 1. Highly down reg-
ulated genes include CD26 and Stat-4 as well as the Interleukin 1 receptors. Message for the actin-
bundling protein plastin-T, a gene that is not normally expressed in lymphoid tissue, was detected
in 35 of the 45 patients examined. Aberrant expression of the gene in CTCL T-cells may provide a
unique new marker for diagnosis for a high percentage of patients. Expression of a panel of 4 of the
significant genes, monitored by quantitative Real-time PCR identifies 100% of patients regardless
of tumor burden suggesting a simple diagnostic test that monitors the expression levels of a small
number of genes may be developed.  Our analyses suggest that many similar panels may allow diag-
nosis with other sets of genes. We have extended these studies to the identification of genes whose
patterns of expression were able to identify patients with poor prognosis. Although these patients
are more difficult to recognize, we have identified 40 genes whose patterns of expression detect a
class of patients within the 45 whom we analyzed, who will succumb within six months of sam-
pling, regardless of their tumor burden. Since the number of genes queried in pilot studies was
small, more informative genes for prognosis and responsiveness to therapy will be identified in
studies with 15,000 genes in a larger number of patients. 
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NRAS and BRAF mutations in primary human melanomas
NE Thomas,1,6 S Edmiston,2,6 A Alexander,2,6 RC Millikan,2,6 P Groben,3 D Ollila,4 T Hensing5 and
K Conway2,6 1 Dermatology, University of North Carolina, Chapel Hill, NC, 2 Epidemiology,
University of North Carolina, Chapel Hill, NC, 3 Pathology, University of North Carolina, Chapel
Hill, NC, 4 Surgery, University of North Carolina, Chapel Hill, NC, 5 Medicine: Oncology,
University of North Carolina, Chapel Hill, NC and 6 Lineberger Comprehensive Cancer Center,
University of North Carolina, Chapel Hill, NC
NRAS genes encoding activating mutations have been found in 4 to 40% of primary melanomas, and acti-
vating mutations encoded in the BRAF gene, downstream of RAS in the RAS-RAF-MEK-ERK-MAP
pathway, were found in 59% of melanoma cell lines and 6 of 9 primary melanomas. We plan to extend
this information by carrying out a population-based study of NRAS and BRAF mutations including pos-
sible etiologies and have analyzed a pilot series of 18 archived primary human cutaneous melanomas from
the UNC Hospitals Pathology Laboratories. Mutational status of tumor cells from paraffin-embedded tis-
sue sections was determined using SSCP (single strand conformational polymorphism) analysis, con-
ducted at two different temperatures, followed by sequencing of samples showing band shifts on SSCP
to identify affected codons and exact base changes. These melanomas, with Breslow depths ranging from
0.73 to 10.5 mm, were screened for mutations in and around NRAS codons 12,13,18 and 61 and within
BRAF exon 15. BRAF exon 15, which encodes a kinase activation segment, was selected for this initial
study because 4 of 5 BRAF mutations previously reported in primary melanoma were found in this exon.
Of the 18 melanomas analyzed in this study, 6 were positive for NRAS and 4 were positive for exon 15
BRAF mutations. The NRAS and exon 15 BRAF mutations were found to be exclusive of each other in
these melanomas, consistent with the possibility that exon 15 BRAF mutation may abrogate the need for
NRAS activation in melanoma. All 6 NRAS mutations were at sites of putative pyrimidine dimers,
implying a possible link between NRAS activation and ultraviolet exposure in melanoma. For all 4 BRAF
positive tumors, surrounding areas of normal skin were negative for the BRAF mutation. Because the
BRAF alterations are specific for the tumor, these findings are consistent with BRAF exon 15 mutations
being somatically acquired mutations rather than germline polymorphisms. 
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Detection of mitochondrial DNA mutations in non-melanoma skin cancer: possible genetic
selection in tumorigenesis
W Girald-Rosa,1 AC Musiek,1 R Vleugels1 and JE Sligh1,2 1 Division of Dermatology, Vanderbilt
University Medical Center, Nashville, TN and 2 VA Tennessee Valley Healthcare System, Nashville,
TN
Mitochondrial DNA (mtDNA) mutations have been found in colon carcinoma and a variety of other
human malignancies. Surprisingly, these mutations were often present in all of the mtDNA copies
(homoplasmic) within the tumor cells. Proposed theories to explain the role of these mtDNA changes
in tumorigenesis have included that they impart a possible selective growth advantage or that they
arise by random stochastic segregation. We explored the role of mtDNA changes in non-melanoma
skin cancer (NMSC). Paired tissue specimens of NMSC tumors and adjacent tumor-free margin skin
were obtained from excisions in our clinic. DNA was isolated from the specimens for screening of
the entire mitochondrial genome by multiplexed denaturing high-performance liquid chromatogra-
phy (DHPLC,) a column-based method for detection of DNA sequence variation. PCR-amplified
segments of the mtDNA from the tumors were annealed with the PCR products amplified from the
margin skin, allowing for the formation of heteroduplexes in regions of DNA mismatch. Regions of
the mtDNA that formed heteroduplexes were detected by DHPLC and sequenced to determine the
specific nature of the mtDNA base changes.  A variety of polymorphisms as well as homoplasmic
point mutations in the mtDNA have been identified including protein synthesis mutations affecting
the mtDNA-encoded rRNA subunits and mutations affecting specific subunits of NADH-ubiquinone
oxidoreductase (complex I) and cytochrome c oxidase (complex IV).  Additionally, long extension
PCR detected an abundance of mtDNA deletions from the margin skin that were generally absent
from the tumor specimens. We propose that the relative lack of mtDNA deletions within NMSC
tumor specimens and the finding of a variety of mtDNA point mutation in NMSC tumors argues
against the random segregation theory of mtDNA mutation homplasmy and suggests a role for genetic
selection of specific mtDNA haplotypes in NMSC development. 
0189
Immunization with the tumor antigen hedgehog-interacting-protein reduces and anti-rejec-
tion drug administration increases BCC formation in ptc1 +/- mice treated with ionizing radi-
ation
A Vogt,1 JL Hebert,1 L Kopelovich,3 DR Bickers2 and EH Epstein1 1 Dermatology, University of
California San Francisco, San Francisco, CA, 2 Dermatology, Columbia University, New York, NY
and 3 National Cancer Institute, Bethesda, MD
Basal Cell Carcinomas (BCCs) in humans or in ptc1 +/- mice all overexpress hedgehog target genes
such as Gli1, Hedgehog interacting protein (Hip), platelet-derived growth factor alpha, and Ptc1
itself. Our survey of normal adult mouse tissues indicates that their level of Hip mRNA expression
is much lower than is that in BCCs.  Accordingly we have selected this protein for immunization to
try to prevent the development of BCCs in ptc1 +/- mice treated with ionizing radiation. Recombi-
nant Hip protein fragments were injected subcutaneously in combination with CpG adjuvant every
two weeks for 5 months. Immunization in ptc1+/- mice was well tolerated and induced peptide-spe-
cific B and T-cell responses detectable by ELISA, Western Blot, delayed type hypersensitivity, and
ELISPOT assays. The number of BCCs in mice immunized over the course of 5 months with 2 dif-
ferent HIP-derived peptides, PT27 and PT209, was reduced by 45% (p<0.001) and 36% (p<0.01),
respectively. In contrast, the number of tumors was increased 2.1 fold (p<0.0001) in ptc1 +/- mice
treated for 4 months with a combination of the anti-rejection drugs Cyclosporin A and Prednisolone
at doses sufficient to cause immunosuppression. We conclude that immunization with proteins specif-
ically upregulated by hedgehog signalling may be a novel preventive option for patients such as those
with the basal cell nevus syndrome who have a high likelihood of developing large numbers of BCCs.
In addition, these mice seem to provide a good model for anti-rejection drug enhancement of non-
melanoma skin cancers in humans who have received organ transplants. More generally, these data
suggest that the host s immune system may help control the development of BCCs and that this pro-
tective activity may be enhanced by immunization with tumor antigens. 
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PLZF regulates and suppresses melanoma proliferation and tumor growth
K Yamasaki,1 X Dai,1 D Nanba,2 K Shiraishi,1,2 Y Yahata,1 S Tokumaru,1 M Tohyama,1
Y Shirakata,1 K Sayama,1 S Higashiyama2 and K Hashimoto1 1 Dermatology, Ehime University
School of Medicine, Onsen-gun, Ehime, Japan and 2 Medical Biochemistry, Ehime University
School of Medicine, Onsen-gun, Ehime, Japan
Melanoma is a malignant skin tumor with a poor prognosis. In melanoma cells, mutations and the
abnormal expression of genes related to the cell cycle regulating pathway, such as
p16INK4A/p15INK4, CDK4/6, and cyclinD, have been reported. These abnormal genes are thought
to be involved in the pathogenesis of melanoma. We hypothesized that other cell cycle regulatory
genes are also involved in melanoma. Therefore, we examined 13 human melanoma cell lines and
found that PLZF (promyelocytic leukemia zinc finger) was absent in all 13 cell lines, whereas it was
expressed in normal human melanocytes. PLZF was first reported in 1995 as an abnormal fusion
gene in acute premyeloid leukemia, in which cyclinA transcription was accelerated (Chen et al.,
1995). Although the function of PLZF fusion proteins has been well studied, the function of normal
PLZF is not clear. Recently it has been suggested that PLZF works as a transcriptional repressor. To
elucidate the biological meaning of the absence of PLZF in human melanoma, we generated four
PLZF-transduced melanoma cells (375p, 397p, 526p, and 624p). Surprisingly, PLZF-transduction
suppressed the proliferation of 375p, 397p, 526p, and 624p to 52, 45, 79, and 48% compared to vec-
tor-transduced melanoma cells, respectively. In PLZF-transduced melanoma cells, cyclinA and
cyclinD mRNA expression was suppressed. Transplantation of both PLZF- and vector-transduced
melanoma cell lines to SCID mice revealed that PLZF-transduced melanoma cells reduced tumor
volume compared to vector-transduced melanoma cells (375p, 397p, and 526p to 8, 11, and 39% on
day 30, and 17, 46, and 44% on day 60, respectively). Combined, PLZF regulates melanoma growth
in vitro and in vivo. These data suggest that the absence of PLZF expression is related to unregu-
lated melanoma growth, and that PLZF will be a target of gene therapy in melanoma. 
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The N-terminal domain of IL-1a associates with chromatin and enhances tumor conversion in
two-stage carcinogenesis
J Murphy, BE Rich and TS Kupper Dermatology, Brigham & Women, Boston, MA
IL-1a is stored in abundance in keratinocytes as an active 31 kDa precursor. Cleavage produces the
proinflammatory 17 kDa C-terminal domain and a 16 kDa N-terminal pro-domain of unknown func-
tion. The pro-domain contains a nuclear localization signal and transforms fibroblastic cells in vitro.
To examine its function in cutaneous epithelial cells, we expressed a proIL-1a-gfp fusion protein in
cultured mouse and human keratinocytes and observed nuclear localization and association with
chromatin. To test pro-domain function in vivo, transgenic mice were created that constitutively
express the pro-domain in skin using the K14 promoter. In two K14/pro founder lines (ProA and
ProB), skin was histologically similar to control littermates suggesting that transgene expression
did not disrupt normal skin development or induce inflammation. Following application of the two-
stage carcinogenesis protocol, the early kinetics of papilloma formation and tumor incidence for both
Pro lines were similar to their littermate controls. However, the peak papilloma burden for the ProA
mice preceded that of their FVB littermates by 9 weeks. A subsequent precipitous decline in benign
tumor burden of the ProA mice was accompanied by a decrease in average carcinoma latency (6
weeks; p=0.02), a 2.5 fold higher conversion frequency at 30 weeks post-initiation, and an increase
in tumor size (p=0.03), suggesting that pro-IL-1a acted to enhance malignant tumor formation. For
the lower-expressing ProB line, a significantly higher average papilloma burden occurred early in
promotion (week 16; p<0.05) but the time of the peak papilloma burden, maximum number of
papillomas, and carcinoma formation were not significantly different from controls. These results
suggest that pro-IL-1a plays a role in the conversion of benign to malignant lesions, potentially coop-
erating with mutated H-ras to promote the outgrowth of initiated cells. A thorough understanding of
the determining factors and pathways regulating the contribution of pro-IL-1a to tumor conversion
may provide a target for cutaneous tumor intervention. 
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Polyphenols extracted from green tea reduce UV-induced apoptosis of keratinocytes
MS Matsui,1 A Schwarz,2 D Gan,1 T Mammone,1 N Gross,2 S Staender2 and T Schwarz2 1 BRD,
The Estee Lauder Companies, Inc., Melville, NY and 2 Dermatology, University Muenster,
Muenster, Germany
Green tea chemoprevention has been a focus of research for several years, as a polyphenolic frac-
tion isolated from green tea (EGCG) has been shown to inhibit the development of ultraviolet radi-
ation (UV)-induced skin cancers and to mitigate UV-induced erythema, thymine dimers, Langer-
hans cell depletion and immune suppression. Because the mechanism for these protective effects
may include modulation of UV-induced apoptosis, experiments were designed to investigate this
possibility. The human epidermoid carcinoma cell line KB and normal human keratinocytes were
exposed to EGCG (0.05-0.5%) either 5 hours before and immediately after, or only immediately
after UVB irradiation (250 J/m2). UVB-induced apoptosis was reduced in UVB-exposed cells treated
with EGCG under both conditions as determined by a DNA fragmentation ELISA. These data were
supported by increased caspase-3 activation, a protease involved in UVB-induced apoptosis. These
observations would exclude the possibility that the protective effect of EGCG is due to absorbance
of UVB wavelengths. It has also been observed that the immunostimulatory cytokine interleukin-
12 (IL-12) reduces UVB-mediated apoptosis and sunburn cell formation. This effect appears to be
due to a reduction of UVB-induced DNA damage, which is mediated via induction of DNA repair
by IL-12. We therefore examined the ability of EGCG to induce IL-12. For that purpose, blood mono-
cytes were obtained from human volunteers, exposed to EGCG and 24 hours later the amount of IL-
12 released was measured by using an ultrasensitive IL-12 ELISA. EGCG significantly induced the
secretion of IL-12 by monocytes. Based on these findings we speculate that EGCG might reduce
UVB-induced apoptosis via induction of IL-12 and subsequent upregulation of DNA repair. It remains
to be determined whether these effects are related to green tea inhibition of UV-induced skin cancer. 
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DNA mismatch repair enzyme hMSH2 in malignant melanoma
M Seifert,1 W Tilgen,1 G Wuest,1 S Scherer,2 C Welter1 and J Reichrath1 1 Department of
Dermatology, Universitaetskliniken des Saarlandes, Homburg, Saarland, Germany and 2
Department of Cell Biology, Albert-Einstein-College of Medicine, New York, NY
Human hMSH2 is a well characterized component of the DNA mismatch repair system that has been
implicated in cellular mutagenesis, tumorigenesis and chemotherapeutic resistance of malignant
melanoma. hMSH2 is directly involved in microsatellite instability in hereditary nonpolyposis col-
orectal cancer (HNPCC). Microsatellite instability has also been shown in malignant human skin
tumors of epithelial and melanocytic origin. Like hMSH2, the p53 tumor suppressor protein plays
an important role in maintaining the fidelity of the cellular genome. P53 mutations are frequent in
a variety of cancers. We have investigated hMSH2 and p53 expression in melanocytic tumors. We
found strong nuclear immunoreactivity for hMSH2 and p53 that was elevated in malignant melanoma
and melanoma metastases as compared to acquired nevi. Using the reverse transcription-polymerase
chain reaction, we detected strong hMSH2 mRNA expression in each of 8 melanoma cell lines
analysed (highest amounts in SK-MEL-25 cells, lowest amounts in MML-I cells).  A relevant stress
that activates p53 function is UV-light. We showed that upon UV-irradiation p53 activates tran-
scription of the human mismatch repair gene hMSH2. Additionally, we identified a response ele-
ment for p53 in the hMSH2 promoter and could show that hMSH2 up-regulation critically depends
on functional interaction with c-Jun. In conclusion, our findings indicate that hMSH2 is involved in
p53 mediated pathways in response to stress, including UV-radiation in malignant melanoma. These
mechanisms may be of importance for tumorigenesis and chemotherapeutic resistance of malignant
melanoma. 
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Opposite roles of protein kinase C isoforms in regulating human HaCaT keratinocyte prolif-
eration, differentiation, and tumor genesis
T Biro,1 H Papp,1 E Bodo,1 J Lazar,1 G Czifra,1 I Kovacs,2 K Gaspar,3 I Juhasz3 and L Kovacs1 1
Department of Physiology, University of Debrecen, MHSC, Debrecen, Hungary, 2 Department of
Pathology, Kenezy Hospital, Debrecen, Hungary and 3 Department of Dermatology, University of
Debrecen, MHSC, Debrecen, Hungary
The protein kinase C (PKC) system plays crucial roles in the regulation of proliferation, differenti-
ation, and tumor formation of several cell types. In this study we examined the specific roles of PKC
isoforms in the human keratinocyte cell line HaCaT, which possess several PKC isozymes (the con-
ventional cPKCα, β; the novel nPKCδ, ε, θ, η; and the atypical aPKCζ). Expressions of differenti-
ation markers were investigated by Western blotting, whereas the proliferation of the cells was assessed
by a bromo-deoxy-uridine cell proliferation ELISA kit. Tumor genesis was assessed by intrader-
mally injecting HaCaT cells overexpressing certain PKC isozymes to immunodeficient mice. Inhi-
bition of cPKC and nPKC isoforms by GF109203X resulted in suppression of late-terminal differ-
entiation but had no effect on proliferation. However, Go6976 (inhibitor of the cPKC isoforms) and
Rottlerin (the inhibitor of nPKCδ), besides both inhibiting differentiation similarly to the effect of
GF109203X, respectively suppressed or stimulated cell growth. Consistent with these findings
(suggesting opposite roles of some PKC isoforms), recombinant stable overexpression of PKCα or
PKCδ decreased proliferation capacity and increased the expression levels of differentiation mark-
ers; in addition, the overexpressing cells formed smaller and more differentiated tumors. In contrast,
the overexpression of cPKCβ or nPKCε had opposite effects: stimulated proliferation and (more
aggressive) tumor growth, and inhibited differentiation. Our findings, therefore, strongly argue for
pivotal yet antagonistic roles of certain PKC isozymes in the regulation of cellular proliferation and
differentiation in human HaCaT keratinocytes. 
0197
The involvement in keratinocyte differentiation of the mitogen-activated protein kinase path-
way terminating in extracellular signal-regulated kinase-1/2
WB Bollag,1,2 X Zhong,2 X Zheng2 and DM Hardy2 1 Medicine (Dermatology), Medical College
of Georgia, Augusta, GA and 2 Institute of Molecular Medicine & Genetics, Medical College of
Georgia, Augusta, GA
We have previously demonstrated that the protein kinase C (PKC)-activating phorbol ester, 12-O-
tetradecanoylphorbol 13-acetate (TPA) activates phospholipase D (PLD) in primary mouse epider-
mal keratinocytes. Furthermore, we showed that inhibiting PLD-mediated lipid signal production
inhibited TPA-induced transglutaminase activity. This result suggested a role for PLD in keratinocyte
differentiation independent of the activation of classical or novel protein kinase C isoforms by PLD-
generated lipid second messengers. Data in the literature suggest that one product of PLD activity,
phosphatidic acid, can serve to recruit Raf-1 to the membrane, where it can be activated and initiate
the mitogen-activated protein kinase cascade that culminates in activation of extracellular signal-
regulated kinase-1/2 (ERK-1/2). This pathway has been implicated in the proliferative response of
keratinocytes to ligation of integrins. However, we found that inhibition of ERK-1/2 activation inhib-
ited TPA-induced transglutaminase activity, a marker of keratinocyte differentiation. Nevertheless,
inhibition of PLD-mediated signal generation had no effect on TPA-elicited ERK-1/2 activity nor
did inhibition of ERK-1/2 affect PLD activation, suggesting that these two pathways operate in par-
allel. Indeed, inhibition of the two pathways produced additive effects. Finally, inhibition of ERK-
1/2 activation also inhibited transglutaminase activity stimulated by elevated extracellular calcium
levels or 1,25-dihydroxyvitamin D. Thus, these results suggest an involvement of both the PLD and
ERK-1/2 signaling pathways in mediating keratinocyte differentiation independent of one another. 
0196
Invasive phenotype of tumorigenic keratinocytes (SKv) correlates with their constitutional
expression of MMP-9 and -2
D Nowicka,2,1 W Mevizou,1 S Duhieu,1 C Kowalewski,2,1 S Majewski2,1 and M Haftek1,2 1 Unit
346, INSERM/CNRS, E. Herriot Hospital, Lyon, France and 2 Dept. of Dermatology, Warsaw
Medical University, Warsaw, Poland
Four SKv lines, harbouring integrated copies of the HPV16 genome are derived from the same tumoral
lesion of bowenoid papulosis and show either an invasive phenotype (SKv e1, l1) or follow a localised,
growth (SKv e2, l2) when inoculated in mice. As organotypic cultures represent an interesting model
for studies on skin cancers, we have used SKv lines to reproduce in vitro intradermal invasion of
carcinomas in the absence of influences from supplementary cellular elements, e.g.: fibroblasts.
The cells were seeded on de-epidermised and devitalised human dermis (DED) and cultured for 1
to 4 weeks at the air/medium interface. Every week, the cultures were examined histologically and
immunohistochemically. The culture supernatants were harvested for zymographic, ELISA and West-
ern blot analysis of matrix metalloproteinases (MMP) 2 & 9. In four series of experiments performed
on DED from different donors, we have obtained an active penetration through the basement mem-
branes of SKv e1, but not of the other SKv lines, in the presence of 1% of foetal calf serum in the
medium. The invasion of the dermis and in vitro vertical migration through porous membranes were
absent when the serum was totally substituted by Prolifix of vegetal origin. MMP-9 and MMP-2
were overexpressed by the invasive SKv type, both on DED and in immersed cultures without serum.
Active forms of the enzymes were observed with zymography but were not measurable with ELISA.
Our study indicates that SKv e1 can actively degrade basement membranes in the absence of other
cell types. This rare phenomenon may be exploited for comparative studies of cancers reconstructed
with human tumoral keratinocytes originating from the same biopsy but behaving differently, in a
model comprising only one type of cells. 
0194
BRAF mutations in primary melanoma vary with site and age, and are not associated with out-
come
JL Maldonado,2 J Fridyland,1 H Patel,1 AN Jain,1 DG Albertson,1 D Pinkel1 and BC Bastian2,1 1
Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA and 2
Dermatology, University of California, San Francisco, CA
The serine/threonine kinase BRAF has been reported to be frequently activated by somatic muta-
tion in melanoma. To date no information is available on the distribution of BRAF mutations among
different types of melanoma and their association with outcome. We sequenced the kinase domain
in exon 15 of BRAF in DNA extracted from paraffin blocks of 116 invasive primary melanomas of
four categories: 44 from skin without evidence of severe solar elastosis as an indication of chronic
sun damage (CSD), 10 from skin with CSD, 41 from glabrous (non hair-bearing acral) skin, and 21
from mucosa. Clinical follow-up information was available from 89 patients with an average fol-
low-up time of 37 months. The proportion of tumors with mutations varied significantly (p<0.01)
between groups: 52% (23/44) on sun-exposed skin without CSD, 17% (7/41) on glabrous skin, 10%
(1/10) on skin with CSD, and 9.5% (2/21) on mucosal sites. Independent of tumor class we found
that patients with BRAF mutations were significantly younger (p<0.026). The age dependence was
striking and indicated that the increased incidence of melanoma with age was due primarily to the
increase of tumors without BRAF mutations. There was no association between mutation status and
tumor thickness, metastasis, or death from disease. Array-CGH of 68 of the cases found that all cases
with a mutation that had increased copy number of the BRAF region had selectively increased the
mutated allele. This indicates that BRAF mutations precede the copy number increase of chromo-
some 7 and are one of potentially several genes driving this frequent aberration. This observation
together with the lack of association with tumor thickness and outcome suggests that BRAF muta-
tions occur relatively early in melanoma. In summary, our data indicate different genetic routes to
melanoma that depend on anatomic site and sun-exposure patterns and suggest that melanomas with-
out BRAF mutations may take longer to develop. 
0198
Over-expression of RhoC GTPase significantly increases Akt phosphorylation in a human
melanoma cell line WM1617
Y xu, YG Shellman, D Marr and D Norris Dermatology, B153, University of Colorado Health
Science Center, Denver, CO
RhoC GTPase is a transforming oncogene for human mammary epithelial cells and can lead to highly
invasive phenotype, akin to that seen in inflammatory breast cancer. The gene profiling approach
identified RhoC as one of the genes that enhance metastasis in human melanoma cell line A375, and
mouse B16 melanoma cell line. Over-expression of RhoC correlates with progression of ductal ade-
nocarcinoma of the pancreas and has been shown to modulate the induction of vascular endothelial
growth factor (VEGF), basic fibroblast growth factor (bFGF), interleukin-6 (IL-6), and interleukin-
8 (IL-8) in breast cells. To clarify the contribution of RhoC in human melanoma progression, we
have established stable transfectants over-expressing RhoC, using human melanoma cell lines rep-
resenting distinct stages in melanoma progression. We investigated whether over-expression of RhoC
affects PI3K and NF-kappaB activity in these cells, since these two signaling pathways are impor-
tant to cell survival, and might be associated with melanoma progression. Western blot showed that
over-expressing of RhoC in a human metastatic cell line, WM1617, up-regulated phosphorylated
Akt (pAkt) compared with the control. However, expression of Bcl-2 and PCNA was not signifi-
cantly changed. We also used a dual luciferase reporter assay to assess NF-kappaB activity in these
cells and found that RhoC does not enhance NF-kappaB activity in these cells. We are investigating
whether this up-regulation of pAkt affects cell proliferation, apoptosis and other characteristics related
to melanoma progression in these and other melanoma cells. In summary, over-expression of RhoC
activated Akt, but not NF-kappaB in these cells. 
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Induction of cutaneous melanoma in human skin by growth factors and UVB is dependent on
age
C Berking,1,2 R Takemoto,2 K Satyamoorthy,2 D Elder3 and M Herlyn2 1 Department of
Dermatology, Ludwig-Maximilians-University of Munich, Munich, Germany, 2 The Wistar
Institute, Philadelphia, PA and 3 Department of Pathology, University of Pennsylvania School of
Medicine, Philadelphia, PA
We have shown recently that a combination of three growth factors - basic fibroblast growth factor
(bFGF), stem cell factor (SCF) and endothelin-3 (ET-3) - together with exposure to UVB can induce
invasive melanoma in neonatal human skin within four weeks. We now investigated if melanocytes
can also be transformed in skin from adults. Thirty-eight human skin samples from the abdomen,
breast or face from 11 different adult donors were grafted to severe combined immunodeficiency
disease (SCID) mice. Increased cutaneous expression of bFGF, SCF and ET-3 in the skin grafts was
induced by intradermal injections of adenoviral vectors (Ad5) containing the respective growth fac-
tor genes. Additionally, half of the grafts received 50 mJ/cm2 UVB radiation three times weekly.
The combined expression of bFGF, SCF and ET-3 led to the formation of nevi and in situ melanomas
within 4 weeks of treatment. Interestingly, this seemed to be independent from the exposure to UVB.
However, in contrast to our experience with neonatal skins, the lesions in adult skins were less severe
and non-invasive. Our data suggest that melanocytes in young people are more prone to malignant
transformation by UVB than in adults. This is in accordance with the recently published transgenic
hepatocyte growth factor (HGF) mouse model in which UVB exposure of transgenic neonates led
to melanoma development, while irradiation of transgenic mice at older age had no such effect. In
summary, these data provide experimental support for the epidemiological observations that sunburn
particularly in childhood is associated with an increased risk of melanoma development. 
0200
Alpha-difluoromethylornithine (DFMO), a Suicidal Inhibitor of Ornithine Decarboxylase
(ODC) Prevents Basal Cell Carcinomas (BCCs) in Ptc+/- Heterozygous Knockout Mice
X Tang,1 J Russo,1 EH Epstein,2 L Kopelovich,3 DR Bickers1 and M Athar1 1 Dermatology,
Columbia University, New York, NY, 2 UCSF, San Francisco, CA and 3 Chemoprevention, NIH,
Bsthesda, MD
UVB is a known risk factor for human nonmelanoma skin cancer including BCCs. Skin exposure
to UVB induces ODC, which drives continued proliferation and clonal expansion of initiated cells
leading to tumor development. DFMO is an ornithine analog that irreversibly inhibits ODC activity
and inhibits tumorigenesis in various organs in murine models. ODC is over-expressed in human
and murine BCCs. In this study we assessed the effects of oral administration of DFMO on UVB-
induced BCCs in ptc+/- mice. Sixty ptc+/- mice were irradiated with UVB (240 mJ/cm2 3 times/week)
for 32 weeks. Thereafter, UVB was discontinued and mice were divided into two groups of 30 ani-
mals each whereby approximately the same number of tumors were present in each group. Group-
1 animals then received water for the next twenty weeks and Group-2 mice received 1% DFMO in
drinking water. Five mice from each group were randomly selected and killed at week 37 and their
dorsal skin removed for biochemical, histochemical and immuno-histochemcal assays. The remain-
ing animals were continued on the same protocol and all tumors were recorded weekly. After 52
weeks the experiment was terminated, mice were killed and tissues harvested. Twenty weeks after
cessation of UVB irradiation, tumor numbers in Group-1 mice receiving water were increased to
300% above baseline whereas in Group-2 mice, tumor number was reduced by ~35% as compared
to controls. The number of BCCs and SCCs in DFMO-treated animals was reduced to ~60% of base-
line whereas fibrosarcomas were unaffected. DFMO also reduced UVB-induced overexpression of
cell cycle proteins such as cyclins A2, B1 and D1 that drive proliferation and also inhibited the expres-
sion of COX-2, a marker of tumor promotion. Our data indicate that DFMO is a potent inhibitor of
UVB-induced BCCs and SCCs in ptc+/- mice and that strategies directed at inhibiting ODC could
be useful for cancer chemoprevention in human populations. 
0201
Comparative microarray analysis of the patch and plaque stages of Mycosis Fungoides: impli-
cating a role for oxidative stress?
AJ Mamelak,1 J Alder,3 J Kowalski,2 D Bilu,1 H Watanabe,1 I Freed,1 B Wang,1 E Vonderheid1 and
DN Sauder1 1 Dermatology, Johns Hopkins University, Baltimore, MD, 2 Cellular and Molecular
Medicine, Johns Hopkins University, Baltimore, MD and 3 Oncology Biostatistics, Johns Hopkins
University, Baltimore, MD
Mycosis Fungoides (MF) is the most common of a heterogeneous group of malignant T-cell lym-
phomas, formally known as Cutaneous T Cell Lymphoma. MF is traditionally thought of as a clonal
CD4+ memory T cell disorder primarily manifesting in the skin. MF has a variable presentation
with overlap between clinical stages and in its initial stages, is difficult to distinguish from other
inflammatory diseases. In the present study, we sought to delineate genomic differences between ini-
tial presentation and later disease. We hypothesized that developing unique gene expression profiles
for each clinical stage of this malignancy could directly aid in diagnostics, while providing insight
into overall disease classification, prognosis and pathogenic mechanisms underlying this disorder.
We utilized cDNA microarray technology to construct gene expression profiles from skin biopsies
taken from patch and plaque stage MF patients. A 1717 cDNA microarray containing characterized
human genes relevant to immunity and cancer was used for differential gene expression analysis of
patch versus plaque MF lesions. The data obtained was subjected a non-parametric, nested analy-
sis, which selected 20 genes as potentially differentially expressed. Among the candidate genes iden-
tified was an anti-oxidant protein, a member of the RAS oncogene family, and a xenobiotic-metab-
olizing gene involved in the metabolism of carcinogens. Susceptibility to cancer is frequently a
pathological consequence of extensive oxyradical damage that leads to a cycle of cell death and
regeneration and causes mutations in cancer-related genes. This data could suggest a role for oxida-
tive stress and oxyradical overload in the development and pathogenesis of MF, as observed in other
types of tumors. 
0202
Evidence that the induction of growth arrest in malignant melanoma by peroxisome prolifer-
ator-activated receptor (PPAR) γ agonists is partly independent of activation of PPARγ
R Moessner,1 U Schulz,1 U Krueger,1 P Middel,2 L Fuezesi,2 C Neumann1 and K Reich1 1 Dpt. of
Dermatology, Georg-August-University, Goettingen, Germany and 2 Dpt. of Pathology, Georg-
August-University, Goettingen, Germany
Peroxisome proliferator-activated receptor (PPAR) γ is a member of the nuclear receptor superfam-
ily and believed to act as a heterodimer with retinoid X receptor (RXR). Recently, we demonstrated
expression of PPARγ in benign melanocytic naevi, primary cutaneous melanomas, melanoma metas-
tases as well as in melanoma cell lines. We also showed that different PPARγ-specific agonists includ-
ing the thiazolidindione derivates troglitazone and rosiglitazone dose-dependently inhibited cell pro-
liferation in melanoma cell lines. The induction of growth arrest appeared to be through withdrawal
from the cell cycle, but was independent from apoptosis. In support of this finding, troglitazone was
found to downregulate the expression of cyclin D1 associated with a reduction of detectable hyper-
phosphorylated retinoblastoma (Rb) gene product. Several experiments were performed with the aim
to further dissect the mechanisms involved in the growth inhibition induced by of PPARγ agonists.
First, we found that the sensitivity of melanoma cell lines towards the anti-proliferative effects of
troglitazone correlated with the protein expression levels of PPARγ. Upon stimulation of cell lines
with PPARγ agonists, PPARγ translocated from the cytoplasm to the nucleus as monitored by elec-
tron microscopy and immunogold labeling. However, pre-incubation of cell lines with the PPARγ-
specific antagonist GW9662 did only reverse growth inhibition by approximately 50%. In addition,
co-stimulation of melanoma cell lines with PPARg and RXR agonists did not further enhance the
effects of PPARg agonists. We conclude that PPARγ agonists may inhibit cell growth in malignant
melanoma at least partly independent of the activation of PPARγ. 
0203
Expression of proliferating cell nuclear antigen in mouse skin at different time points follow-
ing ultraviolet B exposure
SR Palep, RN Saladi, J Moore, M Lebwohl and H Wei Dermatology, Mount Sinai School of
Medicine, New York, NY
Proliferating cell nuclear antigen (PCNA) is involved in DNA replication, recombination, and repair.
PCNA is found throughout the basal layer in normal skin, however in malignant skin lesions PCNA
has been seen in all layers of the epidermis and dermis. We previously reported that PUVA and
UVB exposure diminished the expression of PCNA in mouse skin. The aim of this study is to eval-
uate PCNA expression at different time points following exposure to both acute and chronic levels
of UVB. In part I of this study SKH-1 mice (3/group) were sacrificed at the following time points:
6, 12, 24, 48, 72 hrs, and 7 days after exposure to UVB 1.5kj/m2. In Part II of this study mice were
sacrificed at the time points: 6, 12, and 24 hrs after chronic UVB exposure of 3kj/m2. Immunohis-
tochemistry was performed on paraffin skin sections with anti-PCNA antibody. PCNA expression
was quantitated by measuring the number of positively stained cells per 100 keratinocytes. In Part I
(1.5kJ/m2 UVB), the results showed the usual pattern of PCNA throughout the basal layer of nor-
mal skin. Significantly diminished expression was seen in 6hrs, subsequent time points, 12 hrs to 7
days, PCNA positive cells were progressively increased with pagetoid distribution in all layers of
the epidermis. The diminished PCNA expression at the 6 hrs time point is possibly due to the skin
undergoing immediate damage in response to UVB. Progressive reactivation of PCNA expression
is a result of repair mechanisms initiated by the immune system. In Part II (3kJ/m2 UVB), at 6, 12,
and 24 hrs, although there was a progressive increase of PCNA positive cells, the relative number
of positive cells were decreased in comparison to Part I. The decrease in the number of PCNA pos-
itive stained cells is in response to the chronic levels of UVB. The progressive pagetoid extension
of the PCNA cells may indicate a malignant transformation. In conclusion, PCNA can serve as a
marker associated with DNA damage and repair, the expression being dose dependent and time
related. 
0204
Constitutive activation of the ERK1/2 pathway in human melanoma cells, M21 and M24, con-
tributes to their enhanced motility and invasiveness in vitro
M Fedesco, J Fan, M Chen, DT Woodley and W Li Dermatology and The Norris Cancer Center,
University of Southern California, Los Angeles, CA
Enhanced migration by melanoma cells is thought to play a critical role in the pathological devel-
opment of the cancer. The mechanisms, however, remain unclear. We investigated the signal trans-
duction in human melanocyte and melanoma migration and invasion. Using a colloidal gold migra-
tion assay with a quantitative computer-assisted analysis (defined as Migration Index or MI), we
show here that human melanoma cell lines M21 (primary and invasive) and M24 (primary and metasta-
tic) migrate three to ten times better than parental melanocytes on all major extracellular matrices
(ECMs) used. We found that, among the three major MAPK cascades (ERK1/2, p38 and JNK), the
ERK1/2 pathway was constitutively activated in both M21 and M24 cells, but not in melanocytes.
Further, constitutive activation of ras and Mek1 was also detected in M21 and M24, suggesting that
the activating signal initiates from an upstream activator in the plasma membrane. To study the role
of constitutive activation of the ERK1/2 pathway in M21 and M24 migration and invasion, we blocked
Mek1 signaling by infecting the cells with a lentiviral vector carrying a dominant negative Mek1
gene and by using Mek1-specific inhibitors U0126 and PD98059. These cells were then subjected
to a colloidal gold migration assay and an invasion assay in Matrigel-coated Boyden chambers. The
results showed that blockade of ERK1/2 signaling reduced the melanoma cell migration and inva-
sion by 60-80%. We also found that the Erk1/2 pathway is necessary, but not sufficient for fully medi-
ating the elevated migratory signals in melanomas. Overexpression of a constitutively active Mek1
(Mek-EE) in melanocytes did not confer a similar enhanced motility phenotype upon normal
melanocytes. In conclusion, identification of the Ras-Mek1-ERK1/2 pathway as a key control mech-
anism for melanoma migration and invasion suggests potential targets for drug design and therapy
of this cancer. 
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Protein kinase C epsilon transgenic mice and the development of metastatic squamous cell car-
cinoma: the role of inflammation
Y Li, D Wheeler, L Chaiswing, A Verma and T Oberley Molecular and Environmental Toxicology
Center, University of Wisconsin, Madison, WI
Protein kinase C (PKC) is a family of phospholipid-dependent serine/threonine kinases. In mouse
epidermis, PKCε is one of the skin tumor promoter agent 12-O-tetradecanoylphorbol-13-acetate
(TPA) receptors. We have previously reported that FVB/N transgenic mice which overexpress PKCε
in basal epidermal cells develop papilloma-independent metastatic squamous cell carcinoma (mSCC)
elicited by an initiation (7,12-dimethylbenz[a]anthracene)-promotion (TPA) protocol (Cancer Res.,
93: 635-643, 2001). The present histological studies were performed to define the role of cell death
and proliferation in the mechanisms associated with development of mSCC in PKCε transgenic mice.
Dorsal skin samples were fixed for histological examination at 0, 12, 24, 48, 72, and 96 hrs after a
single topical application of 5nmol TPA to FVB/N wild type and PKCε transgenic mice. Recruit-
ment of neutrophils into the skin was observed as early as 12 hrs while skin necrosis was observed
at 12, 24, and 48hrs after TPA treatment in PKCε transgenic mice. Increase in skin necrosis corre-
lated with increased numbers and size of neutrophil foci found in skin. The epidermis was completely
damaged at 48 hr, but epidermal cell regeneration occurred at 72 hrs post TPA treatment in PKC
transgenic mice. The regenerated skin was disordered and showed extensive hyperplasia with evi-
dence of hyperkeratosis. However, these histological changes were observed neither in PKCδ over-
expressing transgenic nor in wild type mice. Evidence indicates that precursor cells for papillomas
reside in the interfollicular epidermis while carcinoma precursor cells reside in the follicular epi-
dermis (Cancer Res., 60:226-229, 2000). The results presented indicate that PKCε overexpression
leads to neutrophil-mediated destruction of epidermis followed by epidermal regeneration from fol-
licular epidermal cells. Taken together these results may explain the mechanism of the development
of papilloma- independent mSCC in PKCε transgenic mice. 
0207
Immunohistochemical evaluation of lycopene’s protective effect against ultraviolet B (UVB)-
induced photodamage in vivo
Z Fazekas,1 RN Saladi,1,2 D Gao,1 Y Lu,1 M Lebwohl1 and H Wei1 1 Dermatology, Mount Sinai
School of Medicine, New York, NY and 2 Dermatopathology, Mount Sinai Medical Center, New
York, NY
Lycopene is a known potent antioxidant found in tomatoes, and its anticancer properties against cer-
tain types of cancers have been well documented in the scientific literature. However, only few inves-
tigations explore lycopene’s potential role against UVB-induced skin damage in vivo. During the
process of photocarcinogenesis, UVB radiation is capable of inducing oxidative DNA damage, induc-
ing DNA photoproducts, and promoting the expression of early response genes. The goal of our study
was to examine if topical lycopene has a potential protective effect against UVB-induced carcino-
genesis in vivo, at the level of initiation and promotion. One hour prior to UVB (3 kJ/m2 at two min-
imal erythema dose) exposure, female SKH-1 mice were topically treated with two different doses
of lycopene (0.05 and 0.1 µmol). Mice were sacrificed 24 hours post UVB irradiation, and immuno-
histochemical staining was performed for the detection of 8-hydroxy-2’-deoxyguanosine (8-OHdG),
<6-4> dipyrimidine photoproducts (<6-4> DPs), c-fos, and c-jun. The changes caused by the UVB
exposure was expressed by the significantly increased number of positively stained cells for 8-OHdG,
<6-4> DPs, c-fos, and c-jun in the positive control, and there were no stained cells for these mark-
ers in unexposed skin. Topical application of lycopene reversed and inhibited the damaging effects
of UVB radiation, and immunostaining revealed marked reduction in the number of positively stained
cells for the aforementioned markers in the lycopene plus UVB treated group. These results sug-
gest, that the naturally occurring carotenoid lycopene may have a protective effect against photo-
carcinogenesis in vivo, by interfering at the level of initiation and promotion. 
0209
Role of prostaglandin E2 receptors in the pathogenesis of ultraviolet B (UVB)-induced non-
melanoma skin cancers
JL Lee, DR Bickers and M Athar Department of Dermatology, Columbia University, New York, NY
Enhanced prostaglandin production via cyclooxygenase-2 (COX-2) upregulation is a likely con-
tributing factor in UV-induced non-melanoma skin cancer (NMSC). Prostaglandin E2 (PGE2) is the
major prostaglandin present in the skin and is increased following exposure to UVB. PGE2 has four
cellular receptors, designated EP1, EP2, EP3, and EP4. This study investigated the expression of
PGE2 receptors in the murine SKH-1 model of SCC and ptc+/- model of basal cell carcinoma (BCC).
All mice were subjected to a standard complete UVB carcinogenesis protocol and EP expression
monitored throughout. The EP1 prostaglandin receptor was expressed at low levels in normal SKH-
1 epidermis, but upregulated in UVB-induced hyperplastic skin, benign papillomas, and SCCs. EP1
receptor expression increased as early as 8 hours after a single UVB exposure and persisted for at
least 72 hours. EP2 receptor expression was patchy in normal and UVB-irradiated SKH-1 epider-
mis, with variable expression in UVB-induced SCCs. Patchy suprabasal EP3 receptor expression
was present in SKH-1 normal and chronic UVB-exposed epidermis, with moderate expression in
some UVB-induced papillomas and SCCs. The EP4 receptor was expressed at low levels in normal
and chronic UVB-exposed SKH-1 epidermis but at high levels in sebaceous glands, with variable
expression in UVB-induced papillomas and SCCs. In ptc+/- mice, all four EP receptors were detected
in normal and chronic UVB-exposed epidermis, but no EP receptor expression was detected in UVB-
induced BCCs. These findings demonstrate that the EP1 receptor, in contrast to the other EP recep-
tors, is induced by chronic UVB exposure in SKH-1 skin and is upregulated in UVB-induced hyper-
plastic skin, papillomas, and SCCs, but not in ptc+/- murine UVB-induced BCCs. Our data suggest
that the increased susceptibility to UVB-induced SCCs associated with overexpression of COX-2
may act through augmented PGE2 signaling via enhanced EP1 receptor expression. This pathway
does not appear to be involved in the pathogenesis of BCCs. 
0208
p53 stabilization by CP-31398 restores wild type p53-dependent function in ultraviolet B (UVB)-
irradiated murine skin and in A431 cells
M Athar,1 X Tang,1 L Kopelovich2 and DR Bickers1 1 Dermotology, Columbia University, New
York, NY and 2 Div.Chemoprevention, NIH, Bethesda, MD
Mutations in the tumor suppressor gene p53 are detectable in more than 50% of all human malig-
nancies including those affecting skin. p53 is essental for maintaining genetic stability following
genotoxic stresses induced by DNA damaging agents such as UVB. Mutant p53 protein is incapable
of transactivating its downstream target genes required for DNA repair or apoptosis. CP-31398 is a
small molecular weight styrylquinazoline that restores wild-type DNA-binding conformation to
mutant p53 protein and re-establishes tumor suppressor functions in vivo. In this study we assessed
the effects of parenteral administration of CP-31398 on p53 and p53-dependent downstream target
proteins in UVB-irradiated skin of ptc+/- and SKH-1 hairless mice, well-defined models for BCCs
and SCCs, respectively. Chronic exposure of ptc+/- and SKH-1 mice to UVB was carcinogenic and
led to p53 mutations in tumors and in skin adjacent to tumors. CP-31398 (50 mg/kg/12hr, i.p.) restored
the wild-type p53 in skin of UVB-irradiated (240mJ/cm2, single exposure) ptc+/- mice. In addition,
there was augmented expression of p53-responsive genes such as p21 and mdm2. Furthermore, CP-
31398 reduced UVB-induced overexpression of Bcl-2, PCNA and cyclin D1 but augmented pro-
apoptotic Bcl-XS expression. To further validate the effects of this agent on mutant p53, SKH-1 mice
that were chronically irradiated with UVB were treated with CP-31398. This resulted in a marked
increase in wild-type p53 as well as up-regulation of p21 and Bcl-XS, and a significant down-regu-
lation of Bcl-2. Furthermore, treatment of A431 cells carrying mutant p53 with CP-31398 resulted
in a dose-dependent induction of p21 and Bax and diminution of cyclin D1 overexpression. We also
observed an increase in Cytochrome C release followed by activation of caspase 3, associated with
G1 arrest and accumulation of cells in sub-G1. These results indicate that CP-31398 restores p53-
dependent cell-cycle arrest and apoptosis in skin by stabilizing mutant p53 protein. 
0206
Human melanoma cells exhibit enhanced matrix attachment and cellular motility compared
with melanocytes
W Li, G Henry, M Fedesco, YD Clerck and DT Woodley Dermatology and The Norris Cancer
Center, University of Southern California, Los Angeles, CA
The migration of cells on extracellular matrix (ECM) components is a critical process for cancer
cell invasion and metastasis into tissues. Human melanoma cells are highly metastatic. The purpose
of this study was to compare the ability of human melanoma cells and human melanocytes to attach
and migrate on relevant ECM components. We used a well-characterized computer-assisted cell
migration assay in which cells are plated on ECMs and allowed to migrate for 14 hours (before the
cell doubling time). After migration, the computer sums the migration tracks in each field and cal-
culates the area that the motility tracks consume in each field, a so-called Migration Index (MI). We
found that, in the absence of growth factors, melanocytes did not attach or migrate on any of the
matrices tested. Under the same conditions, two human melanoma cell lines (M21 and M24) migrated
on all the matrices with MIs of 3-6. In the presence of growth factors, melanocytes migrated mini-
mally on the matrices tested. The MIs were: Laminin = 1, Collagen = 3.5, Vitronectin = 7, Fibronectin
= 10. In contrast, M21 and M24 exhibited much greater cellular motility on laminin, collagen and
fibronectin. The MIs were: Laminin = 10 (for M24), Fibronectin = 18, and Collagen = 25. Interest-
ingly, however, compared with melanocytes, melanoma cells exhibited decreased migration on vit-
ronectin: MI = 4 (compared with 7 for melanocytes). In a standard cell-matrix attachment assay, the
human melanoma cells attached to all of the matrices 5 to 10 fold greater than human melanocytes.
FACS analysis of integrin receptors showed that melanoma cells had five-fold the number of α3β1
integrin receptors compared with melanocytes. This may explain why melanoma cells are capable
of attaching to and migrating on laminin, while melanocytes cannot. In conclusion, melanoma cells
exhibit attachment and migratory properties on ECMs that are distinct from melanocytes. These
properties may relate to their metastatic and invasive phenotype. 
0210
The effects of 12-O-tetradecanoylphorbol-13-acetate, a tumor-promoting agent, and calcium
on protein kinase D in primary keratinocytes
E Dodd, S Ray and WB Bollag Institute of Molecular Medicine and Genetics, Medical College of
Georgia, Augusta, GA
In order to investigate the role of protein kinase D (PKD) in keratinocyte proliferation and differ-
entitation, we studied the effects of 12-O-tetradecanoylphorbol-13-acetate (TPA), a tumor-promot-
ing agent, and calcium, a differentiating agent, on PKD message levels, protein levels, and activity.
We performed a time-point analysis by treating primary keratinocytes for 1, 8, 16, 24 and 48 hours
with 100 nM TPA and for 8, 16 and 24 hours with 1 mM calcium. We isolated total protein and per-
formed western analysis using two primary antibodies: one to detect total PKD levels, regardless of
phosphorylation status, and one to detect PKD phosphorylated at the serine 916 residue, an indirect
measure of kinase activation. We quantified protein levels using enhanced chemiflourescence analy-
sis. We discovered that PKD activity and protein levels, to a lesser degree, were affected in a bipha-
sic manner in response to TPA with an initial increase followed by a decrease and finally a recov-
ery to control levels. This effect on PKD mirrors the acute biphasic response of TPA in keratinocytes
in vitro and in epidermis in vivo, where there is an initial stimulation of differentiation followed by
proliferation and/or tumor formation. Conversely, the differentiating agent, calcium, caused a decrease
in PKD activity and protein levels when compared to control. We are currently isolating total RNA
with Trizol at different time points for northern blot analysis. Together, these results suggest that
PKD activity corresponds with proliferation and that PKD levels and activity are downregulated dur-
ing differentiation. Thus, PKD may be an important molecule in terms of possible targets of TPA
tumor-promoting activity. 
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DNA damage and cell cycle alterations in ultraviolet B-induced murine and human basal cell
carcinomas
AL Kim,1 Y Zhu,1 L Kopelovich,2 DR Bickers1 and M Athar1 1 Department of Dermatology,
Columbia University, New York, NY and 2 Division of Chemoprevention, National Cancer Institute,
Bethesda, MD
Aberrant activation of sonic hedgehog characterizes BCCs and mutations in p53 and patched (PTCH)
are a feature of UVB-induced murine BCCs and sporadic human BCCs. p53 and ptch are both
tumor suppressor genes and are crucial regulators of cell cycle responses to mutagenic agents such
as UVB that could explain its carcinogenicity. In this study we tested the hypothesis that UVB-
induced BCCs develop because of cell cycle alterations in epidermal keratinocytes carrying mutant
ptch. DNA damage checkpoint responses involved in its repair were assessed. Phosphorylation-
dependent activation of cell cycle checkpoint kinases Chk1 and Chk2 was detected in both murine
and human BCCs, which correlated with enhancement of Chk1- and Chk2-associated kinase activ-
ities. Chk1 and Chk2 phosphorylate p53 in vitro at serine 20, a site important for p53 stabilization.
Phosphorylation of serine 15 also occurs in response to DNA damage. p53 phosphorylation was con-
firmed at serines 15 and 20 suggesting that DNA-damage checkpoint responses are active in both
UVB-induced murine and sporadic human BCCs. Cdc25C phosphatase which is regulated by Chk1
and Chk2 was overexpressed in BCCs and showed both cytoplasmic and nuclear localization by
immunohistochemical staining.We also analyzed the expression of cyclins and their partner kinases
related to G1 and S cell cycle transitions and observed up-regulation of cyclins D1 and E as well as
cdk4 and cdk6 in both human and murine BCCs. Furthermore the kinase activity of the cyclinB1-
cdc2 complex which is crucial for regulation of the G2/M transition was increased in murine and
human BCCs. These results indicate that UVB produces cell cycle alterations important for the patho-
genesis of human and murine BCCs and reiterate the relevance of the ptc+/- mouse model for human
BCCs. 
0212
Characterization of porokeratosis by microarray analysis demonstrates similarities with pso-
riasis not with squamous cell carcinoma
C Hivnor, F Singh, A VanVoorhees, L Dzubow and J Seykora Department of Dermatology,
University of Pennsylvania, Philadelphia, PA
Porokeratosis is a disorder of keratinization characterized clinically by annular plaques demonstrating
a well-demarcated, raised hyperkeratotic border. At the cellular level, porokeratosis demonstrates a
clonal proliferation of keratinocytes exhibiting abnormal differentiation; the abnormal clone forms
the cornoid lamella, a stack of parakeratin, which is a histologic hallmark of the disease. Although
porokeratotic lesions can progress to squamous cell carcinoma (SCC), many do not. In addition, if
progression to SCC occurs, the transformation may take years. Therefore, lesions of porokeratosis
contain clonally altered cells with an increased propsensity for neoplastic transformation relative to
unremarkable skin. To better understand the pathophysiology of porokeratosis, we dissected the
cornoid lamella from a porokeratotic lesion, isolated the total RNA, and performed microarray analy-
sis. Surrounding unremarkable epidermis from the same lesion served as a control. We conducted
parallel studies on psoriatic lesions and SCC. Our results demonstrate much greater similarity between
genes expressed in porokeratosis and psoriasis than between porokeratosis and SCC. Relative to
unremarkable skin, genes including calgranulin A and B, psoriasin 1, keratin 6, and keratin 16 were
upregulated in porokeratosis and psoriasis but not in SCC. To confirm the validity of our microar-
ray analysis, immunohistochemistry for keratin 16 was performed. In porokeratotic lesions, keratin
16 is highly expressed in keratinocytes forming the cornoid lamella but not in the adjacent ker-
atinocytes. The results of our study demonstrate that there is significant similarity in the gene expres-
sion patterns of porokeratosis and psoriasis. 
0213
Biochemical activity of Trim32, a cell survival gene associated with carcinogenesis
A Albor, EJ Horn, S El-Hizawi and K Molly Dermatology, Oregon Health and Science University,
Portland, OR
We have used a multistage chemical keratinocyte carcinogenesis model to analyze the genetic events
leading to initiation and progression of skin carcinogenesis. Elevated expression of Trim32, a mem-
ber of the tripartite motif family was detected in several, independently derived initiated and tumori-
genic cell lines. Elevated Trim32 expression also occurred in all UVB-induced mouse skin tumors
tested, but in less than 25% of chemically induced tumors. Furthermore, forced expression of Trim32
in a non-transformed mouse keratinocyte cell strain increased in vitro carcinogenic initiation. Trim32
contains an amino terminal RING zinc finger domain, characteristic of proteins with E3-ubiquitin
ligase activity, and a carboxy terminal NHL domain, which mediates protein-protein interactions.
Using GFP-Trim32 fusion proteins, Trim32 localized to the cytoplasm, forming a uniform punctu-
ate pattern dependent on the RING domain. This is consistent with the reported function of the RING
domain in the formation of supramolecular structures. To understand the biochemical functions of
Trim32, a yeast two-hybrid approach was used to identify Trim32 interacting partners. Piasg, the
mouse homologue of human PIASy, interacted with Trim32 both in yeast and in mammalian. PIASy
is an E3-sumo conjugating enzyme, which inhibits the activity of several transcription factors (includ-
ing Lef1, Stat1 and p53) through sumoylation. GFP-Piasg protein showed an intense nuclear fluo-
rescence and weak diffuse cytoplasmic fluorescence, consistent with the presence of both nuclear
import and export signals in the Piasg protein. We have analyzed the possible ubiquitylation activ-
ity of Trim32, and its effects on Piasg stability. We hypothesize that Trim32 may reduce the stabil-
ity of Piasg protein as it shuttles into the cytoplasm, thus antagonizing Piasg modulation of tran-
scription factors and cell growth and survival. 
0214
Inducible activation of a p53 R172H allele accelerates mouse skin carcinogenesis
C Caulin,1 G Lang,2 G Lozano2 and DR Roop1 1 Departments of Molecular and Cellular Biology
and Dermatology, Baylor College of Medicine, Houston, TX and 2 Department of Molecular
Genetics, University of Texas M.D. Anderson Cancer Center, Houston, TX
Most of the p53 mutations found in human tumors are missense mutations that result in the expres-
sion of altered forms of p53. Previous mouse models overexpressing the mutant, p53 R172H, in the
epidermis suggested that this mutant p53 promotes carcinogenesis through gain-of-function activi-
ties. Since the p53 R172H transgene was expressed at levels 4-8 fold higher than wild type p53, it
was unclear whether p53 R172H functions as a true gain-of-function mutation in the genetic sense.
To ultimately address this question we have generated transgenic mice expressing one p53 R172H
allele in the presence of a wild type allele exclusively in the epidermis. The p53 R172H allele remains
silent until activation by an inducible Cre recombinase placed under the control of the keratin 5 pro-
moter. After topical application of an inducer (RU486) Cre is activated, which results in focal acti-
vation (removal of a floxed stop cassette) of the p53 R172H allele in epidermal stem cells. Mice
expressing the p53 R172H allele were subjected to a skin carcinogenesis protocol. These mice develop
tumors faster than control wild type littermates. In addition, the rate of progression to malignant
carcinoma was also dramatically accelerated in mice expressing the p53 R172H allele (70% con-
version of p53 R172H allele tumors vs. 0% of wild type control tumors; 32 wk. after initiating pro-
motion). Furthermore, carcinomas arising in mice that express the mutant p53 R172H allele were
shown to metastasize to lymph nodes and lungs. Immunological staining confirmed that mutant p53
was expressed in the epithelial component of tumors at all stages of tumor development and pro-
gression. This model provides the strongest in vivo data to date that the p53 R172H allele exhibits
a true gain-of-function at the genetic level. 
0215
Benzo[a]pyrene metabolites enhance the formation of reactive oxygen species and DNA oxidative
damage in UVA-irradiated calf-thymus DNA
Y Luo, D Guevara, RN Saladi, M Rui, B Goldwyn, M Lebwohl, D Gao and H Wei Dermatology,
Mount Sinai School of Medicine, New York, NY
Benzo[a]pyrene (BaP) metabolites are capable of inducing reactive oxygen species (ROS) and BPDE-
DNA adducts, an initial event in the process of carcinogenesis. UV light activates ROS that con-
tribute significantly to carcinogenesis by inducing oxidative DNA damage primarily represented in
these studies as elevated 8-hydroxy-2’-deoxyguanosine (8-OHdG). We reported previously,
benzo[a]pyrene and UVA synergistically induce oxidative DNA damage based on considerably
increased levels of 8-OHdG. The levels of 8-OHdG in human epidermoid carcinoma cells are much
higher than in calf thymus DNA, suggests the metabolized benzo[a]pyrene (in vivo) activates more
effectively with UVA. In this study, BaP and BaP-formed metabolites are studied by using UV spec-
troscopy and HPLC quantitation of 8-OHdG. To determine the specific ROS that participate in the
UVA-induced oxidative DNA damage, various ROS quenchers including sodium azide (NaN3), cata-
lase, mannitol and superoxide dismutase (SOD), were studied. Among selected quenchers, NaN3
and SOD were found to inhibit 8-OHdG formation. However, NaN3 inhibited 8-OHdG to a much
greater extent than SOD. In addition, NaN3 was found to be the most effective ROS quencher which
dose-dependently inhibited 8-OHdG formation by suppressing singlet oxygen generation. We also
found BaP metabolites induced 3-folds the levels of 8-OHdG when compared with BaP alone. There-
fore, BaP metabolites induce singlet oxygen by contributing substantially to DNA oxidative dam-
age, which differ from superoxide anion, the most contributing agent in parent BaP. Among ben-
zopyrene metabolites, BPDE and BaP-7,8-dione were studied. The data showed that BPDE when
irradiated by UVA at small concentrations can induced approximately 10 folds of 8-OHdG than the
parent benzopyrene. BaP-7,8-dione did not induce significant oxidative DNA damage when com-
pared to parent BaP. In conclusion, BaP metabolites are more potent in generating ROS and 8-OHdG
than parent BaP alone, indicating more potential role in carcinogenesis. 
0216
The synergistic carcinogenic effects of benzo(a)pyrene with ultraviolet radiation: models &
mechanisms
RN Saladi,1,2 E Perez,1 D Gao,1 S Palep,1 Y Luo,1 Y Lu,1 RG Phelps,1,2 M Lebwohl1 and H Wei1 1
Dermatology, Mount Sinai School of Medicine, New York, NY and 2 Dermatopathology, Mount
Sinai Medical Center, New York, NY
Human skin cancer incidence has alarmingly increased over the past twenty years. It has been estab-
lished that ultraviolet (UV) light is a major cause for skin cancers. Although there has been increased
awareness and use of sunscreens, skin cancer incidence is still inclining. Hence, further investiga-
tion is necessary to better understand the causes of skin cancer. Humans, apart being exposed to UV
rays, and are constantly exposed to environmental pollutants. It has been reported that UVA in com-
bination with certain chemicals in the atmosphere can produce toxic substances that affect human
health. We previously reported that oxidative DNA damage was significantly increased by BaP
combination with UVA, than UVB. Further we have also reported that the combination of exposures
to benzo(a)pyrene and UVA synergistically increased the risk of DNA damage in vivo. BPDE adducts,
p53 and 8-OHdG levels were increased over time, in the mice exposed to BaP plus UVA. In the cur-
rent study we further more investigated the carcinogenic effects of synergistic BaP and UVA expo-
sure in SKH-1 hairless mice. Mice were divided into 4 groups of 20 following, Untreated, BaP alone,
UVA alone and BaP plus UVA. Mice were treated for 3 times a week/ 25 weeks with the average
doses of 2 µg BaP, followed 2 hours later by 40 kJ/m2 UVA irradiation. From weeks 25-30 mice were
only observed while noting the multiplicity of tumors. The results showed that BaP alone or UVA
alone did not induce tumors. However, by the end of the 30 weeks, in the group exposed to BaP plus
UVA, approximately 70 % of the mice had developed skin tumors with an average multiplicity of
2.2/ mouse. In addition, this group of mice had developed more skin wrinkles and shown significant
morphological and histological skin changes. Our results seem to show that atmospheric pollution
in combination with UVA light causes a time dependent accumulation of DNA damage and further
can induce the multiplicity and incidence of skin tumors. 
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Identification of differentially-expressed genes in human basal cell carcinomas by DNA microar-
rays
LK Chipps,1 S Wang,2 JE McInturff,3 K Uyemura4,3 and J Kim2 1 Keck School of Medicine at
University of Southern California, Los Angeles, CA, 2 Department of Medicine, Division of
Dermatology, David Geffen School of Medicine at UCLA, Los Angeles, CA, 3 David Geffen School
of Medicine at UCLA, Los Angeles, CA and 4 Geriatrics Research Education and Clinical Center
(GRECC), West Los Angeles VA Medical Center, Los Angeles, CA
The molecular mechanism of basal cell carcinoma (BCC) development from normal keratinocytes
is poorly understood. We have used DNA microarray technology to analyze differential gene expres-
sion in cultured BCC versus normal keratinocytes in order to detect genes that may be important in
the development of BCC. In addition, we employed microarrays to compare differential gene expres-
sion in BCC tissues and normal tissues from the same patients. We found that over 3,000 genes are
upregulated in BCC and over 800 genes are downregulated in BCC when compared to same-donor
normal skin. BCC demonstrates unique expression patterns of keratins, collagens, matrix metallo-
proteinases, growth factors, and cytokines. Elucidation of the distinctive BCC gene expression pat-
terns may be valuable to our understanding of BCC development and progression, and these pat-
terns may provide targets for new diagnostic and therapeutic options for patients with this common
skin cancer. 
0219
Model system to examine the role of the IGF-1R during the UVB response in human ker-
atinocytes
DF Spandau2,1 and DA Lewis2 1 Dermatology, Indiana University School of Medicine,
Indianapolis, IN and 2 Biochemistry & Molecular Biology, Indiana University School of Medicine,
Indianapolis, IN
The major risk factor associated with the occurrence of non-melanoma skin cancer is exposure to
the UVB component of sunlight. Exposure of keratinocytes to UVB directly damages cellular DNA.
Dependent on the dose, keratinocytes respond to UVB irradiation by repairing the damaged DNA
or undergoing apoptosis. An alternative response to UVB irradiation is stress-induced senescence.
Previously, we have shown that stress-induced senescence following UVB irradiation is dependent
on the activation of the insulin-like growth factor-1 receptor (IGF-1R). This presents an interesting
dichotomy of functions, which depends on the specific cell type and a specific cellular environment,
since the IGF-1R serves as a conduit for mitogenic keratinocytes growth prior to UVB exposure.
However, following UVB irradiation, the IGF-1R enhances cell survival while inhibiting further cel-
lular proliferation. In order to study the role the IGF-1R plays in the response of keratinocytes to
UVB irradiation, we have developed a model system which we can selectively inactivate the func-
tion of the IGF-1R. HaCaT cells were transduced with the reverse tet repressor and a cDNA of the
IGF-1R which contains an inactivating mutation in the ATP-binding domain of the tyrosine kinase.
Expression of this mutant cDNA will dominantly repress the activity of wild-type IGF-1R. Since
the function of the IGF-1R is required for normal growth of HaCaT cells, the expression of the dom-
inant-negative IGF-1R mutant can be induced by the addition of doxycyline to the cells. The effect
of UVB irradiation can then be determined both in the presence and absence of functional IGF-1R
depending on the presence of doxycycline in the culture medium. This model system will be used
to dissect the biochemical pathways involved in the response of keratinocytes to UVB irradiation
both with active and inactive IGF-1Rs. 
0221
Odontogenic keratocysts in transgenic mice overexpressing the hedgehog signaling effector
Gli2
M Grachtchouk, L Wei, J Liu, A Wang and A Dlugosz Dermatology, University of Michigan, Ann
Arbor, MI
Odontogenic keratocysts are found in up to 80% of individuals with Nevoid Basal Cell Carcinoma
Syndrome (NBCCS), and like BCCs, they are believed to arise due to deregulated activation of the
hedgehog signaling pathway. We previously demonstrated that K5 promoter-driven expression of
the hedgehog signaling effector Gli2 is sufficient for formation of BCCs. We now report that K5-
Gli2 mice frequently develop odontogenic keratocysts. As they aged, some K5-Gli2 transgenic
founders exhibited misaligned incisors while others developed obvious mandibular or maxillary
masses. Examination of H&E-stained coronal sections from these mice revealed keratinizing jaw
cysts and extensive bone remodeling that were strikingly similar to findings in humans with odon-
togenic keratocysts. Two mouse lines selected for further study revealed the keratocyst phenotype
to be highly-penetrant. In the K5-Gli2#27 line, 100% of mice over 6 months of age (N=18) had ker-
atocysts; in K5-Gli2#995 mice, 91% of mice sacrificed after 7 months of age (N=11) had kerato-
cysts. Progeny from multiple generations, currently up to F5, continued to produce keratocysts.
Immunostaining of mouse keratocysts revealed the presence of keratins K5, K10, and K17, a ker-
atin expression profile reported in human odontogenic keratocysts. In younger animals, relatively
small cysts were found just lateral to molar roots. This localization is consistent with the proposed
origin of keratocysts from the epithelial rests of Malassez, cell clusters that are left behind as much
of the epithelial root sheath regresses during late stages of tooth formation. Taken together, our find-
ings reveal a remarkable degree of phenotypic similarity between K5-Gli2 mice and NBCCS patients
in terms of defects arising in epithelial cells, strongly supporting the concept that endogenous GLI2
mediates responses to deregulated hedgehog signaling in humans. 
0220
Peripheral nerves, vascularization, and tumorigenesis in DsRed2-transfected tumors in a mouse
model of cancer pain
P Wacnik,1 B Christine,2 H Mike,3 B Blazar,3 B Alvin,4,5 B Kren,6 G Wilcox,1 M Hordinsky2 and
ME Ericson2 1 Pharm, U of MN, MPLS, MN, 2 Derm, U of MN, MPLS, MN, 3 Peds, U of MN,
MPLS, MN, 4 Vet Pathbio, U of MN, MPLS, MN, 5 Neurosci, U of MN, MPLS, MN and 6 Med, U
of MN, MPLS, MN
Anatomical and functional relationships between the peripheral nervous system and cancers are
poorly understood though recent evidence suggests that physical and biochemical interactions between
peripheral nerves and tumor cells may be important to both tumor biology and cancer-associated
pain. Introduction of coral-derived red fluorescent protein, DsRed2, into a NCTC-2472 fibrosarcoma
line has made it possible to accurately distinguish the tumor from surrounding tissue both in vivo
and in immunostained sections of the hindlimb in our mouse model of primary tumor-induced mechan-
ical hyperalgesia (2001, J Neurosci. 21:9355). Like the parental line, implantation of DsRed2-2472
cells into and around the calcaneus bone of the C3H/He mouse produces equivalent tumor growth
rate, bone remodeling, and robust mechanical hyperalgesia. 2472-DsRed2 cells were implanted into
eighty mice and mechanical hyperalgesia testing (wherein a normally non-noxious von Frey monofil-
ament is applied repeatedly to the plantar surface of each hind paw) was conducted at days 5 and 12
post implantation. We used stereological analysis from confocal data sets of immunostained sections
to quantify PGP9.5+ and CGRP+ nerves, and blood vessels (CD31+) in DsRed2-2472 fibrosarco-
mas near the skin at the site of hyperalgesia testing. Results: 1) over time, tumors in hyperalgesic
mice have fewer PGP9.5+ nerves and blood vessels; 2) tumors in hyperalgesic mice are more densely
innervated by CGRP+ nerves than non-hyperalgesic mice; and 3) tumors from hyperalgesic mice
are less densely vascularized than non-hyperalgesic mice. Given the unique vascularity and inner-
vation of solid tumors we hypothesize that changes in sensory innervation and vascularity of the
growing tumor contribute to the progressive tumor-induced hyperalgesia observed in our mouse
model of tumor pain. 
0218
Shikonin inhibits proliferation of human melanoma cell lines
JO Moore, D Gao, RN Saladi, S Maryles, S Palep, M Lebwohl and H Wei Dermatology, Mount
Sinai School of Medicine, New York, NY
The incidence of human skin cancer in the United States is increasing at an alarming rate. Half of
all new malignancies are skin cancers and it is estimated that 20% of Americans will suffer from
some form of skin cancer in their lifetime. Melanoma is a potentially lethal skin cancer, with a higher
incidence of mortality than basal and squamous cell carcinomas. More than 80% of skin cancer deaths
are from melanoma. Due to the lethal nature of melanoma skin cancer, and lack of curative therapy,
it is of the utmost importance to investigate new preventative agents targeted against this disease.
Shikonin, a derivative of the plant Erythrohizon Lithospermum, is a commonly used herbal medi-
cine in China. Pharmacological investigation of Shikonin supports this compound’s therapeutic effi-
cacy as a potent anti inflammatory with anti tumor and wound healing properties. The present study
investigates the effect of Shikonin on human melanoma cell lines. The melanoma cells were trans-
ferred to a 96 well micro plate culture system. After incubation the cells were treated with 9 differ-
ent concentrations of Shikonin. Cellular viability was quantified by utilizing neutral red assay uptake,
and measurment of absorbance with spectrophotometry. Shikonin dose dependently inhibited the
proliferation of melanoma cell lines when tested against A101D, A875 and OM431. Furthermore,
other melanoma cell lines showed similar inhibitory effects when treated with Shikonin. The mech-
anism by which Shikonin inhibited the growth and proliferation of malignant melanoma cells is
thought to be through induction of apoptosis. In conclusion, Shikonin demonstrates a promising
capacity to reduce human melanoma cell line proliferation in vitro. With subsequent investigations,
Shikonin may serve as a novel chemo preventive agent against human melanoma cancers. 
0222
Contribution of selectin ligands to eosinophil recruitment into the skin: do eosinophils have a
skin homing receptor?
T Satoh, M Kaneko, M Wu, H Yokozeki and K Nishioka Dermatology and Immunodermatology,
Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan
Selectins mediate the initial adhesion of leukocytes to endothelial cells. Mouse T cells migrate into
inflamed skin only when they express ligands for both E- and P-selectin. To understand relative
roles of selectins in eosinophil recruitment in inflamed skin, we examined the expression of sialyl-
Lewis x (sLex) structures and selectin ligands on eosinophils from patients with atopic dermatitis
using whole blood flow cytometry. None of the eosinophils from the blood of patients exreppsed
HECA-452 (a lymphocyte receptor for skin homing), 2H5 or CSLEX1 epitopes, and they had little
avidity for soluble E-selectin. Moreover, none of the infiltrative eosinophils in the skin lesions of
patients expressed any type of sLex structures on the surface. In contrast, blood eosinophils bound
to soluble P-selectin. The amount of P-selectin that bound to eosinophils was significantly grater in
patients with atopic dermatitis than in healthy donors. PSGL-1 expression between these two groups
did not differ. The α(1, 3) fucosyltransferases (FucT) are important in the construction of sLex
structures and functional selectin ligands. Eosinophils, unlike neutrophils, expressed a large amount
of FucT-IV mRNA, but remarkably less or no FucT-VII mRNA. These data indicate that eosinophil
interaction with endothelial P-selectin is far more important than interaction with E-selectin for
recruitment into the inflamed skin. None of HECA-452, 2H5, CSLEX1 or FH6 antigens functioned
as a specific receptor to promote preferential skin infiltration via adhesion to endothelial E-selectin.
FucT-IV in eosinophils may be more relevant to the generation of functional P-selectin ligand than
FucT-VII. 
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Fibroblast α3 nicotinic receptor mediates cutaneous effects of tobacco smoke
J Arredondo,1 LL Hall,1 V Nguyen,1 A Chernyavsky,1 KE Pinkerton2 and SA Grando1 1
Dermatology, University of California, Davis, CA and 2 Institute of Toxicology and Environmental
Health, University of California, Davis, CA
To establish molecular mechanisms of effects of tobacco products on precocious skin aging and
impaired wound healing, we studied the cell cycle progression and tissue remodeling function of
dermal fibroblasts (DF) in the skin of rats and mice after their exposures for 3 weeks to environ-
mental cigarette smoke or drinking water containing equivalent concentrations of nicotine (Nic),
using RT-PCR and immunoblotting. We also exposed human DF to 10 mM Nic for 24 h in the pres-
ence or absence of mecamylamine, an antagonist of nicotinic acetylcholine receptors (nAChRs). Nic
caused 1.9- to 28-fold increase of mRNA and protein levels of p21, cyclin D1, Ki-67, and PCNA,
and 1.7- to 2-fold increase of the apoptosis regulators Bcl-2 and caspase 3. Nic also upregulated
expression of collagen type Iα1 and elastin, as well as matrix metalloproteinase-1. Mecamylamine
abolished Nic-induced alterations, indicating that they resulted from pharmacologic stimulation of
nAChRs. To establish relevance of these findings to a specific nicotinergic pathway, we studied human
DF transfected with anti-α3 nAChR antisense oligonucleotides and murine DF from α3 nAChR
knockout mice. In both cases, lack of α3 was associated with the alterations in the fibroblast growth
and function that were just as opposite to those observed in DF treated with Nic, suggesting that the
nicotinic effects on DF were in the most part mediated by α3 nAChR. In addition to α3, the nAChR
subunits detected in human DF were α5, α7, β2, and β4. The exposures of DF to Nic altered the rel-
ative amounts of each of these subunits, leading to reciprocal changes in ligand-binding kinetics.
Thus, some of deleterious effects of tobacco on cutaneous extracellular matrix turnover stem from
Nic-induced alterations in the unfolding of the genetically-determined program of growth and tis-
sue remodeling function of DF, as well as alterations in the structure and function of fibroblast
nAChRs. 
0224
Organizing a laminin-5 matrix: the role of the cytoskeleton
G deHart and J Jones Cell and Molecular Biology, Northwestern University, Chicago, IL
Laminin-5 is a major structural component of the basement membrane in skin. We have developed
a model system to analyze how laminin-5 is organized into the matrix of keratinocytes. In the model,
keratinocytes are plated onto surfaces coated with rat laminin-5. Normal keratinocytes rapidly remodel
rat laminin-5 into higher order assemblies including rings and arcs as they spread over the coated
substrate. These arrays of laminin-5 are assembled in an α3β1 integrin-dependent manner, as indi-
cated in studies using function-perturbing integrin antibodies and keratinocytes derived from α3 inte-
grin-null mice. Moreover, keratinocytes extend filopodia and lamellipodia over the substrate as they
remodel the surface-bound laminin-5 suggesting that that these cytoskeletal-rich protrusions are
involved in assembling matrix polymer into the ring-like patterns under the cells. To test this we
treated keratinocytes with various cytoskeleton-disrupting drugs. Agents that induce microtubule
depolymerization have no impact on the ability of cells to organize arrays of laminin-5. However,
drugs that disrupt the actin cytoskeleton inhibit laminin-5 matrix assembly in our model. Further-
more, keratinocytes that have been treated with a Rho Kinase inhibitor are incapable of organizing
laminin-5 into ring-like arrays, revealing that actomyosin contractility and the formation of stress
fibers are necessary for this process. Together, our data indicate that functional cooperativity of inte-
grins, the actin cytoskeleton and small GTPases determines the precise supramolecular assembly of
laminin-5 in the matrix of keratinocytes. 
0225
Impaired epithelization by keratinocytes on glycated collagen I--possible mechanism for dete-
riorated wound healing in diabetes mellitus?
K Morita,1 R Nagai,2 T Koga,1 Y Moroi,1 K Urabe,1 S Horiuchi2 and M Furue1 1 Dermatology,
Kyushu University, Fukuoka, Fukuoka, Japan and 2 Biochemistry, Kumamoto University,
Kumamoto, Japan
Advanced glycation end products (AGEs), that is, products resulting from accelerated chemical mod-
ification of proteins by sugars during hyperglycemia, contribute to the pathogenesis of diabetic
complications. Extracellular matrix proteins are prominent targets for nonenzymatic glycation because
of their slow turnover rates. The aim of this study was to investigate the influence of nonenzymatic
glycation of collagen I on wound epithelization. Experimental wound closure by keratinocytes was
dramatically promoted on a native collagen I-coated dish compared to an uncoated dish in vitro.
When collagen I was glycated with 33 mM glycolaldehyde for up to 144hs, large amounts of AGEs
were detected in glycated collagen I. Glycated-collagen I failed to promote epithelization by ker-
atinocytes. The proliferative capacity of keratinocytes did not differ between native collagen I- and
glycated-collagen I-coated dishes. In contrast, the adhesion assay revealed that the ability of ker-
atinocyte-collagen I adhesion profoundly deteriorated in a glycation intensity-dependent manner
when collagen I was glycated by glycolaldehyde. Adhesion was mediated by the binding of a2b1
integrin on keratinocytes to its ligand GFOGER peptides on native collagen I. However, the GFOGER
peptides, per se, could not be directly glycated by glycolaldehyde treatment. These findings suggest
1) that glycation produced substantial amounts of AGEs in collagen I, 2) that the keratinocytes lost
their adhesive, but not proliferative, capacity on glycated-collagen I, and that epithelization was
indeed inhibited on glycated-collagen I, and 3) that the GFOGER sequence (a2b1 integrin binding
site) of collagen I may be masked by a conformational change in glycated-collagen I without direct
glycation of GFOGER motif. 
0226
Size control of decorin dermatan sulfate during remodeling of collagen fibrils in healing skin
K Kuwaba,1 M Kobyashi,2 Y Nomura,3 S Irie1 and Y Koyama1 1 Nippi Research Institute of
Biomatrix, Nippi Inc., Adachi-ku, Tokyo, Japan, 2 Department of Food and Nutritional
Environment, College of Human Life and Environment, Kinjo Gakuin University, Nagoya, Japan
and 3 Applied Protein Chemistry, Faculty of Agriculture, Tokyo University of Agriculture and
Technology, Tokyo, Japan
Decorin is the dominant dermatan sulfate (DS) proteoglycan distributed on the surface of collagen
fibrils in the skin. Non-covalent binding of decorin core protein to type I collagen regulates the rate
of fibrillogenesis. However a role of its DS chain in organization of collagen fibrils in the skin remains
unclear. In order to investigate temporal changes in decorin DS during inflammation and subse-
quent healing of the skin, 2,4-dinitrofluorobenzene (DNFB) was applied once to the dorsal skin of
a mouse and subsequent changes of decorin DS were investigated. Electron microscopic observa-
tion revealed that elongated decorin DS was localized among thin collagen fibrils packed loosely in
DNFB-treated skin on day 15. In contrast, decorin DS of normal size was distributed among thick
collagen fibrils packed tightly in vehicle-treated skin or DNFB-treated skin on day 35. Molecular
size of decorin DS increased on day 15 after DNFB application, but decreased to almost normal size
on day 35. Disaccharide composition of DS changed most conspicuous on day 15 and content of
IdoA2S-GalNAc4S disaccharide unit was in inverse proportion to weight-average molecular weight
of decorin DS (Y=-0.6X+21.7, r2=0.99). These results suggest that size and disaccharide composi-
tion of decorin DS is modulated coordinately in post-inflammatory healing processes, and that con-
trol of the size and composition of decorin DS plays important roles in remodeling of collagen fib-
rils by regulating interfibrillar space in healing skin. 
0227
P-selectin-dependent lung colonization of melanoma cells is targeted by heparin treatment
RJ Ludwig,1 JE Schultz,1 M Podda,1 TM Zollner,1,3 C Tandi,1 WH Boehncke,1 R Kaufmann1 and
J Gille2,1 1 Dept of Dermatology, J.W. Goethe-University, Frankfurt a.M., Germany, 2 Dept. of
Molecular Biology, Max-Planck-Institute, Bad Nauheim, Germany and 3 Schering AG, Berlin,
Germany
Interactions between cancer cells and vascular endothelium profoundly affect the spread of circu-
lating tumor cells. Increasing evidence suggests that heparin may exert therapeutic effects in metasta-
tic disease. Our studies employing the B16 melanoma lung metastasis model revealed that heparin
inhibited lung colonization only prior to melanoma cell inoculation, whereas heparin treatment ini-
tiated after injection failed to suppress lung metastases. These data indicate that heparin interfered
with extravasation and initial cell survival. P-selectin-dependent interactions represent a critical
step in cell extravasation from the circulation. We thus hypothesized that heparin may reduce melanoma
metastases by inhibition of P-selectin binding to its ligands. Since lung colonization is almost com-
pletely prevented in P-selectin-/- (P-/-) mice, we next determined whether P-selectin expression by
platelets may affect melanoma metastases. In comparison to wild-type (P+/+) controls, lung metas-
tases formation was markedly suppressed by P-/- bone marrow transplantation into P+/+ mice (by
> 65%), suggesting that platelet P-selectin expression contributes to experimental lung coloniza-
tion. The potential impact of endothelial P-selectin in melanoma rolling was evaluated by intravital
microscopy of the murine ear, studying interactions of melanoma cells with vascular endothelium.
Compared to P+/+ mice, melanoma rolling was reduced by 80% in P-/- mice. To analyze whether
heparin inhibits melanoma rolling in a P-selectin-dependent fashion, we investigated the effect of
heparin on melanoma rolling in both P+/+ and P-/- mice. Whereas in P-/- mice rolling remained unaf-
fected by heparin, in P+/+ mice heparin treatment reduced rolling of three different melanoma cell
lines in a dose-dependent manner. These data support the assumption that both platelet and endothe-
lial P-selectin are potential targets of heparin action in melanoma metastasis formation. 
0228
In vitro keratinocyte dissociation assay to evaluate blister-inducing activity of pemphigus IgG
autoantibodies
K Ishii,1,2 R Harada,2 I Matsuo,3 Y Shirakata,4 K Hashimoto4 and M Amagai1 1 Dermatology, Keio
University School of Medicine, Tokyo, 2 Dermatology, Tokyo Electric Power Company Hospital,
Tokyo, Japan, 3 Dermatology, Teikyo University Ichihara Hospital, Ichihara, Japan and 4
Dermatology, Ehime University School of Medicine, Matsuyama, Japan
Patients with pemphigus vulgaris (PV) have circulating anti-desmoglein3 (Dsg3) IgG autoantibod-
ies which induce blister formation. Indirect immunofluorescence or ELISA, which are currently used
to measure titers of circulating IgG autoantibodies, do not necessarily provide scores reflecting the
strength of blister-inducing activity. The purpose of this study is to develop an in vitro assay to eval-
uate pathogenic strength of anti-Dsg3 IgG antibodies in disruption of cell adhesion. As isoforms of
Dsg compensate each other in their adhesive function, we used primary cultured normal human ker-
atinocytes (NHK) that have low Dsg2 expression while most of keratinocyte cell lines express high
level of Dsg2. We also added exfoliative toxin A which specifically cleaves Dsg1 to the assay. We
incubated NHK with various antibodies and obtained a dissociation index by comparing numbers
of cell particles after mechanical stress by pipetting. When AK23 mAb, which induced PV pheno-
type in mice when its hybridoma cells were inoculated, and AK7 mAb, which failed to induce the
phenotype, were compared, the dissociation index of AK23 mAb was 47.1 times higher than AK7
mAb. When human sera obtained from patients with PV (n=3) in an active stage and in remission
were compared, the dissociation indexes of sera from the active stage were 2.1 to 18.5 times higher
than those of sera in remission. This dissociation assay will provide a simple and objective method
to measure the disruption of cell adhesion associated with blister-inducing activity of pemphigus
autoantibodies and a valuable tool to elucidate the molecular mechanism of blister formation and
Dsg-mediated cell-cell adhesion. 
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Impaired Langerhans cell migration in the hyaluronan synthases-1 and -3 double knockout
mice
ME Mummert,1 TD Camenisch,2 DI Mummert,1 L Ellinger,1 JA McDonald3 and A Takashima1 1
UT Southwestern, Dallas, TX, 2 Univ Arizona, Tucson, AZ and 3 Univ Utah, Salt Lake City, UT
Hyaluronan (HA), a large glycosaminoglycan consisting of disaccharide units of D-glucuronic acid
and N-acetyl-D-glucosamine, serves as a structural component of both epidermis and dermis. HA
synthesis is catalyzed by HA synthases (HAS)-1, 2, and 3, which differ from each other in catalytic
activities and molecular sizes of the final products. We observed recently that: 1) dendritic cells (DC)
express HAS1, 2, and 3 mRNA, whereas keratinocytes predominantly express HAS2 and 3 mRNA,
2) DC display newly synthesized HA on the surfaces, 3) DNFB-triggered Langerhans cell (LC)
migration can be blocked by a HA inhibitor, Pep-1, and 4) Pep-1 also inhibits DC-dependent T cell
activation (J Exp Med 192:769; J Immunol 169:4322). To study physiological functions of HA more
directly, we have created HAS1/3 double knockout (DKO) mice. Unlike the HAS2 KO mice, show-
ing embryonic lethality due to developmental defects in cardiac and vascular systems, HAS1/3 DKO
mice were born in a Mendelian fashion and exhibited no apparent abnormality. HAS1/3 DKO mice
were comparable to the wild-type (WT) controls in the number or morphology of LC in normal
skin. Unlike the WT counterparts showing significantly (P<0.001) reduced surface densities of epi-
dermal LC after DNFB application, LC numbers remained unchanged in HAS1/3 DKO mice before
(667 ± 73 cells/mm2) and 24 hr after DNFB treatment (696 ± 84 cells/mm2). DNFB-induced matu-
rational changes (e.g., elevated IA expression and prolonged dendrites), however, were observed in
epidermal LC even in HAS1/3 DKO mice. Bone marrow DC cultures generated from HAS1/3 DKO
mice were indistinguishable from WT counterparts in the surface HA expression or the ability to
activate allogeneic T cells. Likewise, T cells isolated from HAS1/3 DKO mice showed normal pro-
liferative responsiveness to mitogens. We propose that HAS1 and HAS3 deficiency primarily affects
HA synthesis and expression in keratinocytes, thereby inhibiting LC migration from epidermis, but
not other LC functions. 
0231
Up-regulation of MMP-2 Activation and melanoma cells invasiveness by elastin derived pep-
tides through the 67 kDa elastin binding protein
C Ntayi,1 W Hornebeck2 and P Bernard1 1 Dermatology, Faculty of Medicine, Reims, France and
2 Biochemistry, Faculty of Medicine, Reims, France
The interactions between elastin-derived peptides and the 67 kDa elastin binding protein (EBP),
was shown to trigger matrix metalloproteinases (MMPs) expression. Here, we examined whether
soluble κ-elastin, obtained from alkaline hydrolysis of insoluble elastin, could influence the expres-
sion of MMP-1 and MMP-2, and invasiveness of human melanoma cell lines. Our results showed
that plating melanoma cells on a κ-elastin substrate resulted in an increase of MMP-2 and TIMP-2
levels, an overprocessing of MT1-MMP, whereas the expression of MMP-1 and integrin αvβ3 were
not altered. As melanoma cells showed a positive immunostaining for EBP, the increase of MMP-2
secretion was reproduced by VGVAPG, a ligand of EBP, and was inhibited by lactose which can
dissociate EBP from the cell surface. Including κ-elastin within the collagen gels up-regulated MMP-
2 but not MMP-1 activation, associated to a decrease of TIMP-2 levels. As a consequence, melanoma
cells invasiveness was enhanced by κ-elastin, and the implication of MMP-2 in this process was con-
firmed since exogenous supply either of rec. TIMP-2, or BB-94, a broad-spectrum MMP inhibitor,
reduced this process. Furthermore, the κ-elastin-enhanced melanoma cells invasiveness was signif-
icantly prevented after treatment with a S-Gal antibody which can recognize EBP at the cell surface.
Altogether, these data suggest that elastin and/or elastin-derived peptides, could up-regulate MMP-
2 activation through interactions with EBP, thus facilitating melanoma cells invasion into the dermis. 
0233
Laminin 10 colocalizes with laminin 5 in the epidermal basement membrane zone beneath
hemidesmosomes
JR McMillan, M Akiyama, H Nakamura and H Shimizu Department of Dermatology, Hokkaido
University Graduate School of Medicine, Sapporo, Hokkaido, Japan
Laminins comprise a family of over 20 extracellular glycoproteins that are involved in cell-basement
membrane zone (BMZ) adhesion. In skin, laminin isoforms are present in the epidermal BMZ, around
blood vessels (BVs), nerves and adnexal structures. Recently, specific antibodies have become avail-
able that recognize laminin chains. The antibody 4C7 recognizes the terminal globular domain of
the laminin α5 chain in laminins 10 (α5, β1, γ1) and 11 (α5, β2, γ1). Laminin 5 (α3, β3, γ2) is a
well-studied hemidesmosome (HD)-associated laminin. We therefore compared the α5 chain expres-
sion with laminin 5 in normal and diseased skin. Laminin α3 and α5 chains were linearly expressed
in the epidermal BMZ, except beneath melanocytes. The α5 chain but not the α3 chain was expressed
around BVs in adult skin. Late anagen hair follicles stained with anti-α3 and α5 chain antibodies
showed typical expression patterns described for HD antigens. In cultured RAC-11P bladder cells,
that assemble HD-like structures in vitro, both α3 and α5 chains colocalized to discrete focal areas
beneath sub-confluent cells presumed to be HDs. Finally, immunogold electron microscopy local-
ized the α5 terminal globular domain to the lower lamina lucida (n=200 gold particles). The major-
ity (75%) of α5 chain labeling was restricted to beneath HDs, similar to laminin 5 (77% labeling
restricted to HDs). Laminin α3 and α5 chain expression was assessed in control (n=4) and patients
skin suffering from epidermolysis bullosa (EB, n=11). Laminin α5 chain expression was normal in
control and all EB subtypes. This was in contrast to the α3 chain that was reduced or absent in JEB
subtypes. These data suggest that the α5 chain exhibits an expression pattern restricted to beneath
HDs, similar to the α3 chain of laminin 5, however the stable expression of α5 chains is independ-
ent of laminin 5. This further supports the hypothesis that several laminin variants may covalently
assemble as a multi-molecular complex that together promotes stable epithelial-BMZ attachment. 
0232
The specificity-determining loop of the β4 integrin I/A-like domain regulates laminin-5 bind-
ing
D Tsuruta, S Hopkinson, K French and J Jones Cell and Molecular Biology, Northwestern
University, Chicago, IL
α6β4 integrin nucleates hemidesmosome assembly and stabilizes binding of epidermal cells to
laminin-5. Analyses of the crystal structure of β3 integrin suggest that its I/A-like domain plays a
role in ligand binding. Moreover, a “specificity-determining loop” (SDL) in the I/A-like domain of
β1 integrin has been proposed to regulate ligand binding and connects directly to α subunits. Here
we investigated whether an SDL-like motif within the I/A domain of β4 integrin regulates binding
to laminin-5 and/or to α6 integrin. We generated point mutations within the SDL region of β4 inte-
grin subunit tagged with green fluorescent protein (GFP-β4SDLmut). We also generated a mutation
within the I/A-like domain of the β4 integrin, lying outside the SDL region (GFP-β4I/Amut). We
transfected constructs encoding the mutated β4 integrin and GFP-conjugated wild type β4 integrin
(GFP-β4wt) into 804G cells, which assemble hemidesmosomes, and human endothelial cells, which
lack β4 integrin. In transfected 804G cells, GFP-β4wt and GFP-β4I/Amut protein colocalize with
hemidesmosome proteins BP180, BP230 and laminin-5. However, in at least 50% of 804G cells
expressing GFP-β4SDLmut, hemidesmosome protein localization is disrupted. In endothelial cells
expressing these same transgenes, GFP-β4wt protein and the mutant proteins are expressed at the
cell membrane and associate with α6 integrin as indicated by precipitation studies of surface-labeled
cells. When transfected endothelial cells are plated onto laminin-5 matrix arrays, GFP-β4wt and
GFP-β4I/Amut proteins localize precisely with laminin-5 molecules in the extracellular matrix. In
sharp contrast, in endothelial cells expressing GFP-β4SDLmut, mutant protein fails to co-distribute
along cell-matrix adhesion sites with laminin-5. These results suggest that the SDL segment of the
β4 integrin subunit is not required for the formation of α6β4 integrin heterodimers, but is required
for ligand binding and certain signaling from matrix to cells that regulates hemidesmosome assembly. 
0230
There is disassembly of adherens junction with increase in cytosolic β-catenin in psoriatic epi-
dermis
R Hazan,3 K Kuroda,1 RE Gordon,2 AN Sapadin,1 A Triana3 and R Fleischmajer1 1 Dermatology,
Mount Sinai Medical Center, New York, NY, 2 Pathology, Mount Sinai Medical Center, New York,
NY and 3 Ruttenberg Cancer Center, Mount Sinai Medical Center, New York, NY
β-catenin, a component of adherens junction (A-J), regulates cell-cell adhesion and cell prolifera-
tion, and is increased in various neoplasias. Psoriatic epidermis shows an increase in proliferation
and transepidermal migration of keratinocytes. We asked the question as to whether alterations in
A-J may play a role in psoriasis. Skin biopsies from involved and uninvolved areas (5 patients) and
normal skin controls were studied by electron microscopy (EM), immunocytochemistry (ICC) and
by Western blots. EM revealed an increase in intercellular spaces and a reduction in interdigitated
extensions, where A-J are frequently located. There was a reduction in cell membrane β-catenin and
an absence of the cortical F-actin cytoskeleton in the mid and lower epidermis. These findings are
compatible with disassembly of A-J. Western blots of Triton-100 extracts showed a marked increase
in cytosolic β - catenin in involved skin, while E-cadherin was not solubilized. c-Src, a kinase local-
ized in A-J, which is known to phosphorylate β-catenin, was increased in involved skin as shown by
ICC and by Western blot. Fyn and EGF-R were not increased. The above findings suggest that dis-
assembly of A-J may play a role in regulating keratinocyte proliferation and migration in psoriatic
skin. 
0234
Suppression of serine proteinases and matrix metalloproteinases facilitates basement mem-
brane assembly in skin-equivalents and improves grafting efficiency
Y Ogura, Y Matsunaga, K Kadoya, T Nishiyama and S Amano Skin Biology Research Labs.,
Shiseido Life Science Research Center, Yokohama-Shi, Kanagawa-Ken, Japan
The basement membrane (BM), located at the dermal-epidermal junction (DEJ), plays important
roles not only in adhesion between epidermis and dermis, but also in controlling skin functions. BM
structures such as hemidesmosomes, lamina densa, and anchoring fibrils, are rarely observed at the
DEJ of skin-equivalents (SE) prepared by culturing human keratinocytes on contracted type I col-
lagen gel containing human fibroblasts. We have recently demonstrated that a matrix metallopro-
teinase (MMP) inhibitor, CGS23027A (CGS), enhances BM formation in SE by increasing deposi-
tion of BM components, especially type VII collagen, and improving the continuity of laminae densae
(Exp. Cell Res., 271, 249-262, 2001). In the present study, we searched for factors other than MMPs
that impair basement membrane assembly in SE. We found that urokinase-type plasminogen acti-
vators were present in culture medium of SE and that aprotinin, a serine-proteinase inhibitor, or
tranexamic acid, a plasmin controller, facilitated deposition of laminin 5 and type IV collagen at the
DEJ. The deposition of type VII collagen at the DEJ was much further enhanced by the combina-
tion of these agents with CGS. Aprotinin plus CGS increased hemidesmosome numbers, and the
density and continuity of laminae densae. The effect of the BM quality of SE on grafting of SE to
nude mice was examined. Grafted SEs prepared in the presence of aprotinin plus CGS showed bet-
ter structure of the DEJ and epidermis than control SE cultured without these inhibitors. These results
suggest that plasmin-like serine proteinases other than MMPs may impair the assembly of BM in
SE by degrading non-collagenous domains of BM components, and that suppression of MMPs and
plasmin-like enzymes would be effective to improve the quality of SEs for grafting and in vitro
studies. 
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Lock and key: calcium-stabilized conformation of desmoglein 1 is necessary for hydrolysis by
staphylococcal exfoliative toxin
Y Hanakawa,1 T Selwood,1 D Woo,1 C Lin,1 K Nishifuji,2 M Amagai,2 NM Schechter1 and
JR Stanley1 1 Univ. of PA, Philadelphia, PA and 2 Keio Univ, Tokyo, Japan
The blisters in bullous impetigo are caused by ET, a serine protease that shows exquisite specificity
in its cleavage of one peptide bond, at a calcium (Ca) binding site in the loop connecting extracel-
lular domains (EC) 3 and 4, in human and mouse Dsg1, but does not cleave other even closely related
molecules. To demonstrate that the site-specificity of ET, compared to the sequence-specificity of
related serine proteases, such as trypsin, is dependent on the conformation of Dsg1, we showed that
Dsg1 preincubated at 56o or higher was not cleaved by ET, but was cleaved by trypsin. Similarly,
Dsg1 pretreated at pH 4.5 was not cleaved. Furthermore, pretreatment of Dsg1 with EDTA or dial-
ysis against buffer without Ca prevented cleavage by ET, but not trypsin, even after Ca repletion.
Tryptophan fluorescence and circular dichroism demonstrated an irreversible change in conforma-
tion of Dsg1 after Ca depletion. This change in conformation was confirmed by loss of epitopes iden-
tified by pemphigus foliaceus sera as shown by ELISA and immunofluorescence adsorption stud-
ies. Further analysis revealed that only EC1-3 with 4 amino acids after the cleavage site at the end
of EC3, but not EC4-5, were necessary for proteolysis. Dog Dsg1, although highly homologous to
human Dsg 1, is not cleaved by ET, but substitution of 121 amino acids around the EC2-3 junction
from human Dsg1 allows cleavage, showing that this area, 47 amino acids away from the cleavage
site, is critical to maintain the correct conformation for hydrolysis. These data suggest that ET fits
onto native Dsg1 amino-terminal to the cleavage site, like a key in a lock, to align with the cleavage
site, allowing proteolysis. The crystal structure of ET and inferred crystal structure of Dsg1, from
comparison with C-cadherin, shows such a fit is possible. This strict dependence on conformation,
rather than amino acid sequence flanking the scissile bond, explains the exquisite hydrolytic speci-
ficity of ET for one site in Dsg1. 
0236
Fibroblast invasion of a fibrin clot requires syndecan 4
RA Clark and F Lin Dermatology, SUNY Stony Brook, Stony Brook, NY
After tissue injury, fibroblast migration from the peri-wound collagenous stroma into the fibrin-laden
wound is critical for granulation tissue formation and subsequent healing. Previously we found that
fibroblast transmigration from a collagen matrix into a fibrin matrix required the presence of fibronectin
(FN). The integrins, alpha4beta1, alpha5beta1 and alphavbeta3, which are known to ligate FN, were
found necessary for clot invasion. Now we have examined another family of cell surface receptors:
the proteoglycans (PG). From these studies we found that syndecan 4, a heparin sulfate PG, was
required for fibroblast migration into the clot. This conclusion was based on beta-xyloside inhibi-
tion of glycanation and specific glycosaminoglycan (GAG) degradation. Syndecan 4, a cell surface
receptor, known to bind many cationic growth factors, binds FN at the highly cationic Hep II domain
as judged by affinity binding with recombinant Hep II. We also found that platelet-derived growth
factor (PDGF), which is required to stimulate fibroblast migration, markedly increased cell levels
of Syndecan 4-core protein in a time and dose dependent fashion. Increase gene expression was
demonstrated by transcriptional studies. These results demonstrate that Syndecan 4 is essential for
fibroblast migration into fibrin clots and that PDGF, the stimulus for migration, induces the pro-
duction of syndecan 4. 
0237
Fibroblast invasion of a fibrin clot requires a novel dermatan sulfate-CD44
RA Clark,1 F Lin,1 D Greiling2 and JR Couchman2 1 Dermatology, SUNY Stony Brook, Stony
Brook, NY and 2 Cell Biology, University of Alabama, Birmingham, AL
After tissue injury, fibroblast migration from the peri-wound collagenous stroma into the fibrin-laden
wound is critical for granulation tissue formation and subsequent healing. Previously we found that
fibroblast transmigration from a collagen matrix into a fibrin matrix required the presence of fibronectin
(FN). The integrins, alpha4beta1, alpha5beta1 and alphavbeta3, which are known to ligate FN, were
found necessary for clot invasion. Now we have examined another family of cell surface receptors:
the proteoglycans (PG). From these studies we found that dermatan sulfate (DS) was required for
fibroblast migration into the clot. This conclusion was based on beta-xyloside inhibition of glyca-
nation and specific glycosaminoglycan (GAG) degradation. CD44, a cell surface receptor known to
bind hyaluronan (HA), not infrequently exists as a PG, decorated with various GAG chains includ-
ing HS and chondroitin (CS), and as such can bind FN. From neutralizing antibody experiments we
found that the CD44 core protein was required for fibroblast invasion of the clot. While resting fibrob-
lasts expressed mostly non-glycanated CD44H core protein, platelet-derived growth factor (PDGF),
the stimulus for cell migration, induced glycanation of CD44 with CS and DS, but not HS. Thus,
DS-CD44H proteoglycan is essential for fibroblast migration into fibrin clots and PDGF induces
the production of CS- and DS-glycanated CD44H. 
0238
Engineered “Smart” matrix to replace the corrupt provisional matrix in chronic wounds and
wounds of the elderly
RA Clark,1 J An,1 D Greiling,1 AJ Khan,1 J Schwarzbauer,2 X Ren1 and G Prestwich3 1
Dermatology, SUNY Stony Brook, Stony Brook, NY, 2 Dept of Molecular Biology, Princeton
University, Princeton and 3 Dept of Medicinal Chemistry, University of Utah, Salt Lake City, UT
Many alterations occur in soft tissue healing of the elderly. One set of alterations, that includes pro-
liferative senescence, low growth factor generation and meager cell response to growth factors, results
in suboptimal cell migration and proliferation. Another set of alterations, that includes robust neu-
trophil infiltration, increase levels of matrix metalloproteinases (MMPs) and decrease levels of enzyme
inhibitors, results in deficient fibronectin (FN) matrix in the wound bed. Since human dermal fibrob-
lasts require FN for migration through a fibrin clot, a deficient FN matrix in wounds of the elderly
may greatly compound the intrinsic problems of an aging fibroblast population. Chronic wounds
also contain high levels of MMPs and an inadequate FN matrix. To address these problems we
designed a “Smart” matrix for wound repair that is composed of the FN molecular domains required
for fibroblast migration linked to a backbone matrix in such a way to retard proteolysis. Synthetic
peptides and recombinant proteins were used to delineate the molecular domains needed for human
fibroblast migration over fibronectin. The 9th and 10th fibronectin type III repeats, which contain
RGD and PHSRN synergy cell adhesion sequences, support almost maximal fibroblast adhesion,
but not migration of primary dermal fibroblasts. Specific sequences within the heparin domain and
the IIICS region are also required for migration. These findings predict and additional data confirm
the necessity for the cooperation of multiple integrin and non-integrin receptors for fibroblast migra-
tion on fibronectin. The 3 FN domains found necessary and sufficient for optimal human dermal
fibroblast migration have been linked to a backbone of intermolecularly cross-linked hyaluronan as
a first generation of “Smart” matrix for wounds. 
0239
Differential effects of laminin-5 and laminin-10 on human keratinocytes
J Gao,1 N Nguyen,1 A Minnick,1 J Li2 and MP Marinkovich1 1 Dermatology and Program in
Epithelial Biology, Stanford University, Stanford, CA and 2 Dermatology, University of Miami,
Miami, FL
Laminins 5 and 10 appear to play different roles in the skin. For example, we recently demonstrated
that laminin-10 null mouse skin shows defective morphogenesis but normal dermal-epidermal cohe-
sion, whereas laminin-5 deficient skin shows dysadhesion and normal morphogenesis. To deter-
mine the mechanisms responsible for differences of laminin function in the skin, we studied the
effects of laminins 5 and 10 in cultured human keratinocytes. We performed attachment studies of
laminin-5 null (JEBK) keratinocytes to dishes coated with purified laminins 5 and 10. JEBK showed
similar levels of attachment to laminin-5 or laminin-10 under normal conditions, however, after
growth factor depletion, JEBK showed significant impairment of short term and long term adhesion
to laminin-10 compared to laminin-5. After attachment, JEBK showed increased spreading and flat-
tening when plated on laminin-5 compared to laminin-10. JEBK showed impairment of hemidesmo-
some formation on laminin-10 compared to laminin-5. JEBK showed inhibition of focal adhesion
formation on laminin-10 compared to laminin-5, especially under growth factor starving condi-
tions. Consistent with these results, normal keratinocytes (NK) incubated with laminin-5 inhibitory
antibodies showed decreased FAK phosphorylation compared to NK incubated with laminin-10
inhibitory antibodies. Both laminins 5 and 10 appeared to play roles in cell migration. In scratch
assays, NK cells showed impairment of migration either in the presence of laminin-5 or laminin-10
inhibitory antibodies. Interestingly, JEBK showed significantly increased migration in scratch assays
on laminin-10 compared to laminin-5. Under growth factor depleting conditions, JEBK plated on
laminin-10 showed reduced proliferation compared to JEBK plated on laminin-5. In summary, we
have shown a number of differences in the effects of laminin-5 and laminin-10 on keratinocytes,
which could account for the different roles that these molecules play in the development and func-
tion of the skin. 
0240
Characterization of the interaction of the bullous pemphigoid antigen 1 (BP230) and desmo-
plakin with distinct intermediate filament proteins
L Fontao,1 B Favre,1 S Riou,1 D Geerts,3 F Jaunin,1 J Saurat,1 KJ Green,2 A Sonnenberg3 and
L Borradori1 1 Dermatology, University Hospital of Geneva, Geneva, Switzerland, 2 Pathology and
Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL and 3 Cell
Biology, The Netherlands Cancer Institute, Amsterdam, Netherlands
BP230 and DP are members of the plakin family of cytolinkers. Despite their high homology, their
COOH termini associate with distinct intermediate filaments (IF). We studied sequences within their
COOH termini necessary for their interaction with keratins K5/K14, keratins K8/K18, and type III
IF vimentin by yeast three-hybrid, cell transfection and overlay assays. We found that BP230 inter-
acts with K5/K14, but not with K8/K18 or vimentin, via a region encompassing both the B and C
subdomains and the COOH extremity, including a COOH-terminal 8-amino acid stretch. The C
subdomain with the COOH-terminal extremity of DP bind to K5/K14 and K8/K18, while its linker
region is able to associate with K8/K18 and vimentin. Results obtained with chimeric constructs in
which distinct regions of BP230 were swapped with the equivalent sequences in DP confirmed the
importance of the linker and/or the COOH extremity of DP for IF binding. Furthermore, the poten-
tial of DP to interact with IF proteins in yeast seems to be regulated by phosphorylation of Ser 2849
within its COOH terminus. Strikingly, BP230 and DP only interacted with cytokeratins when both
type I and type II keratins were present, suggesting that the tertiary structure induced by their het-
erodimerization is critical for their association with plakins. Removal of the head and tail domain
from K5 and K14 did not abrogate their binding to DP and BP230. Our findings indicate that 1)
sequences within the linker and the COOH extremity of plakins have a critical impact on their bind-
ing activity by conferring specificity for various IF proteins ; 2) the association of DP and BP230
with epidermal and simple keratins requires heterodimerization of these IF proteins; and 3) the rod
domain of K5/K14 harbors important recognition sites for plakins. 
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Laminin 10 expression and correlation with squamous cell carcinoma invasiveness
R Romagosa,1 K Nouri,1 Y Zhang,1 S Saghari,1 C Ricotti,1 G Elgart,1 MP Marinkovich2 and J Li1
1 Dermatology and Cutaneous Surgery, University of Miami, Miami, FL and 2 Department of
Dermatology, Stanford University, Stanford, CA
As it has recently been appreciated that the aggressive behavior of malignant tumors is related to
their extracellular environment, the goal of this study was to examine the expression of laminin 10,
a newly identified major extracellular matrix component of skin basement membranes, in human
squamous cell carcinomas (SCC). Skin samples were collected from 50 patients, including 10 actinic
keratosis (AK), 13 SCC in-situ or Bowen’s Disease (BD), 19 invasive SCC and 8 normal controls.
Frozen sections were examined by immunofluorescent staining with monoclonal antibody 4C7,
which is specific for the alpha 5 chain of human laminin 10. A Zeiss Axiovert 200 microscope with
a digital camera and image analysis system was used to capture the images. The intensity of stain-
ing was quantified and expressed as mean gray value per pixel (square picture element). Statistical
differences between groups were determined by one-way analysis of variance. Significant higher
expression of laminin 10 was detected in the basement membranes of invasive SCC tumor masses
and newly formed tumor blood vessels compared with normal skins. Strikingly, the studies demon-
strated incremental expression pattern as tumors progress from pre-malignant lesions of AK to malig-
nant SCC. The mean gray values were 4.11 for normal skin, 8.66 for AK, 9.21 for BD and 14.29 for
SCC. P< 0.001 when comparing AK, BD, SCC to normal skin and when comparing SCC to AK and
BD respectively. In addition, by Western blot and immunofluorescent staining, high expression of
laminin 10 was found in cultured SCC cells compared with normal human epidermal keratinocytes.
The studies revealed a clear correlation between the expression level of laminin 10 and SCC tumor
stage of invasiveness and indicate that laminin 10 play important roles in SCC angiogenesis and inva-
sion. Investigations of animal model and mechanisms involved are underway. 
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The effects of keratinocytes and fibroblasts on the formation of basement membrane in skin
equivalent models
D Lee,1 E Lee,1 K Cho2 and J Yang1 1 Dermatology, Sungkyunkwan University School of Medicine
Samsung Medical Center, Seoul, South Korea and 2 Dermatology, Seoul National University,
Seoul, South Korea
The cutaneous basement membrane (BM) plays important functions in normal and pathologic con-
ditions. To investigate the effects of keratinocytes and fibroblasts on the formation of cutaneous
BM, 1. human skin keratinocytes were cultured on dead de-epidermized dermis (KC-DED) 2. ker-
atinocytes and fibroblasts on DED (KC+FB-DED) 3. keratinocytes on reticular dermis (KC-dermis)
4. keratinocytes and fibroblasts on reticular dermis (KC+FB-dermis) 5. keratinocytes on collagen
gel without fibroblasts (KC-CG) 6. keratinocytes on fibroblast-populated collagen matrix (KC-FBCG)
7. keratinocytes on DED combined with fibroblast-populated collagen matrix (KC-DED+FBCG) in
air-liquid interface for 10 days and immunohistochemical and electron microscopic studies were
done. In KC-dermis, KC-CG and KC-DED, β 4 integrin, laminin, type 4 and 7 collagen were all
expressed at the dermo-epidermal junction. In KC+FB-dermis or KC-FBCG, laminin, type 4 and 7
collagen were expressed more strongly than KC-dermis or KC-CG. In KC+FB-DED and KC-
DED+FBCG, type 4 collagen was expressed more strongly than KC-DED. Electron microscopic
studies showed that in KC-dermis and KC-CG, formation of BM was rarely seen. In KC-FBCG,
BM zone such as hemidesmosomes, lamina lucida, lamina densa and anchoring fibril were formed,
although BM was not still continuous. In KC-DED, KC+FB-DED and KC-DED+FBCG, BM zone
was found similarly to that in normal skin. Interestingly, in KC+FB-DED some fibroblasts in upper
dermis and partial loss of basal lamina around the fibroblasts were seen. These results show that
keratinocytes produce β 4 integrin, laminin, type 4 and 7 collagen. Also, fibroblasts stimulate expres-
sion of components of BM and formation of BM zone, suggesting that fibroblasts may produce
laminin, type 4 and 7 collagen or influence the effects of keratinocytes on the formation of BM. 
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Detail of N-linked oligosaccharides from dermis
R Uematsu,1,2 H Nakagawa1 and S Nishimura3 1 Sapporo Laboratory for Glycocluster Project,
Japan Bioindustry Association, Sapporo, Hokkaido, Japan, 2 Basic Research Laboratory, Kanebo
Ltd, Odawara, Kanagawa, Japan and 3 Graduated School of Science, Hokkaido University,
Sapporo, Hokkaido, Japan
Oligosaccharides of lipids and proteins control cell developments and function as ligands for inter-
cellular adhesion receptors, cell matrix proteins, growth factors, toxin and microbes. Many histo-
chemical studies using lectin and antibodies recognizing saccharide moieties have shown the pres-
ence of different cell surface glycoconjugates in skin. However, it has not been clear detail structures
of whole oligosaccharides and where the saccharide component binds lipid or protein. In this study,
we analyzed detail structures and ratios of N-linked oligosaccharides from murine dermis. Dermis
was diegested using trypsin and chymotrypsin. N-linked oligosaccharides were released from gly-
copeptidase by digestion with N-glycosidase F. The reducing ends of the oligosaccharides were
derivertived with 2-aminopyridine. The pyridylamino oligosaccharides were identified by two-dimen-
sional HPLC mapping technique. As a result, we determined 14 kinds of oligosaccharide of dermis.
Complex type oligosaccharide was 87.74% of total and high mannose type was 12.26%. And, we
makes clear that the most predominant structure is Galβ1-4GlcNAcβ1-2Manα1-3(Galβ1-4Glc-
NAcβ1-2Manα1-6)Manβ1-4GlcNAcβ1-4(Fucα1-6)GlcNAc. 
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Aging alternations of N-linked oligosaccharides from dermis
H Nakagawa,1 R Uematsu1,2 and S Nishimura3 1 Japan Bioindustry Association, Sapporo,
Hokkaido, Japan, 2 Basic Research Laboratory, Kanebo Ltd, Odawara, Kanagawa, Japan and 3
Graduate School of Sciences, Hokkaido University, Sapporo, Hokkaido, Japan
Oligosaccharides moieties of glycoproteins play important roles for modulation of protein proper-
ties as stability and biological activities, and various molecular recognition processes by their struc-
tural diversity. There are many evidences that structures and ratios of oligosaccharides are altered in
various physiological and pathological events, such as tissue differentiation, cancer, immune response,
development, fertilization and aging. However, it has not been understood alternations of skin oligosac-
charides. In this study, we obtained dermis from young and aged mice, and compared structures and
ratios of N-linked oligosaccharides with two-dimensional sugar mapping technique using pyridy-
lamino labeling. As a result, the ratio of, galactose residues on, biantennary complex type oligosac-
charide was decreased in aged dermis. Furthermore the ratio of bisecting N-acetylglucosamine and
α1-6fucose residue was increased. 
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Cellular phosphorylation initiated by pemphigus vulgaris IgG binding to the demosomal cad-
herin desmoglein 3
DS Rubenstein, P Berkowitz, P Hu, Z Liu and LA Diaz Dermatology, University of North
Carolina-Chapel Hill School of Medicine, Chapel Hill, NC
In the human autoimmune blistering disease pemphigus vulgaris (PV), pathogenic antibodies bind
to the desmosomal cadherin desmoglein 3 causing suprabasilar epidermal cell-cell detachment (acan-
tholysis). The mechanism by which PV antibodies trigger acantholysis remains unknown; however,
proposed mechanisms include (1) proteinase activation, (2) steric hindrance, and (3) activation of
transmembrane signaling that down regulates cell-cell adhesion. We sought to investigate the poten-
tial of PV IgG to initiate signaling events by disruption of desmosome mediated cell-cell adhesion.
Normal human keratinocytes, cultured in the presence of [32P]-H3PO4, were exposed to PV IgG, con-
trol IgG or buffer. Two dimensional gel electrophoresis of 32P-labeled keratinocyte extracts was
used to identify changes in protein phosphorylation. Dose and time dependent changes in protein
phosphorylation were observed in cells treated with PV IgG. These observations suggest that PV
IgG induced changes in desmosomal adhesion likely activate cellular signal transduction cascades
and provide support for the hypothesis that transmembrane signaling may have a pathogenic role in
PV IgG induced acantholysis. 
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Detection of alternative splicing in COL7A1 : inserting 9 amino acid residues into the fibronectin
type III linker domain
D Sawamura,1 M Goto,1 K Yasukawa,1 A Kon,2 M Akiyama1 and H Shimizu1 1 Dermatology,
Hokkaido University, Sapporo, Japan and 2 Dermatology, Hirosaki University, Hirosaki, Japan
Type VII collagen is the major component of anchoring fibrils within the cutaneous basement mem-
brane zone. The large amino-terminal noncollagenous domain (NC1) interacts with various extra-
cellular matrix (ECM) proteins and contributes to the dermal-epidermal attachment. The purpose of
this study was to detect alternative splicing of COL7A1transcript encoding the NC1 domain. We
also examined expression of the alternative splicing in situations relating wond healing and skin
remodeling. Amplification of overlapping cDNAs from keratinocytes using RT-PCR identified alter-
native splicing, which was generated by a different exon 18 acceptor site 27 bp upstream from the
common acceptor site. Expression of this alternatively spliced transcript differed among several cell
types. An exon-trapping experiment using a related genomic DNA fragment comfirmed existence
of this alternative splicing. The 9 amino acid residues GPLTLPLSP from the 27 bp nucleotides were
inserted into the linker of fibronectin type III (FN3) domains. This insertion was suggested to con-
tribute to flexibility of the linker of FN3 domains and may affect the interactions between the NC1
domain and ECM proteins. Treatment with transforming growth factor TGF-β1, which promotes
wound healing and skin remodeling, enhanced the expression of this 27bp transcript. Furthermore,
keratinocyte biopsies from the wound edge of patients with epithelizing skin ulcers showed a sig-
nificant increase in the 27bp-transcript expression compared with normal keratinocytes from steady-
state body sites. These results suggest that amino acid variation of this alternative splicing may have
some role in dermal-epidermal adhesion, wound healing and skin remodeling. To our knowledge,
this is the first evidence of alternative splice insertion of a small peptide into the linker region of the
FN3 domains, a common motif within modular proteins. 
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Assessment of splice variant-specific functions of desmocollin 1 in the skin
X Cheng, K Mihindukulasuriya and P Koch Molecular & Cellular Biology and Dermatology,
Baylor College of Medicine, Houston, TX
Desmocollins (dsc) are thought to be essential for the assembly and function of desmosomes. Each
of the three known dsc genes encodes two proteins (a and b-form), the corresponding mRNAs are
generated by differential splicing. The a-forms bind several desmosomal plaque-proteins and are
thought to be necessary to assemble the plaque and to connect the desmosome to intermediate fila-
ments. No specific function has been associated with the b-forms. To investigate the function of an
dsc a-form in-vivo, we have generated mice that are deficient for desmocollin 1a. Surprisingly,
homozygous mutant mice showed no abnormal phenotype in terms of birth weight, growth rate,
coat development and skin development. Immunofluorescence microscopy of newborn skin with
various antibodies against desmosomal proteins and other cytoskeleton markers revealed no obvi-
ous abnormalities in epidermal differentiation. Furthermore, the remaining dsc1 isoform was expressed
in mutant skin and incorporated into desmosomes, suggesting that dsc1a is not required for the incor-
poration of dsc1b into desmosomes. However, gene expression profiling indicated several interest-
ing biochemical abnormalities in mutant mice. For example, dsc2 expression was dramatically up-
regulated, and several hair keratins as well as keratin-associated proteins were down-regulated in
these mice. Further studies will have to determine whether subtle ultra-structural abnormalities occur
due to these biochemical changes. Finally, dsc1a-/- mice do not show any of the phenotypes that
occur in dsc knockout mice, i.e. mice that are deficient for both dsc1 splice variants. Our interpre-
tation of these results is that dsc1a is not required to establish and maintain desmosomal adhesion.
However, a minimal amount of dsc1 transmembrane receptors, provided by dsc1b, is necessary to
maintain structural integrity of the skin. 
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The novel MMP-21 is expressed during skin carcinogenesis and induced by TGF-beta1
UK Saarialho-Kere,1 K Ahokas,1 J Lohi,3 M Karjalainen-Lindsberg,3 O Elomaa,2 H Lohi2 and
J Kere4,2 1 Department of Dermatology, University of Helsinki, Helsinki, Finland, 2 Department of
Medical Genetics, University of Helsinki, Helsinki, Finland, 3 Department of Pathology, University
of Helsinki, Helsinki, Finland and 4 Department of Biosciences at Novum, Karolinska Institute,
Stockholm, Sweden
We have recently cloned a novel metalloproteinase, MMP-21, from placenta cDNA (Ahokas et al.
Gene 2002:301:31). This 57 kDa protein contains a signal sequence, a prodomain, a zinc-binding
catalytic domain, and a hemopexin-like domain flanked by two Cys residues, a furin activation
sequence but no transmembrane sequence. It is an orthologue for the Xenopus MMP and most closely
related to MMP-17, -23 and -25. By Northern analysis, MMP-21 is expressed at low levels during
fetal development. By RT-PCR it has been detected in many adult tissues and epithelial cancer cell
lines. By immunohistochemistry MMP-21 was found in the epithelium of colon and ovarian can-
cers. The aim of this study was to investigate the role and regulation of MMP-21 in epithelial cell
lines and skin cancer. To study the expression and cellular localization of MMP-21, we used ker-
atinocyte and HaCaT cell cultures, quantitative TaqMan RT-PCR, transfections to 293A cells, and
immunohistochemistry on human tissues with our polyclonal antibodies. MMP-21 transfected into
293A cells resulted in cytoplasmic staining. MMP-21 is not expressed by unstimulated primary ker-
atinocytes, but is present in HaCat cells. Of several cytokines relevant in development and skin can-
cer tested, TGF-beta1 induced MMP-21 in HaCat cells. Analogously, MMP-21 protein was unde-
tectable in normal skin or premalignant conditions such as Bowen’s disease. It is not induced by
benign keratinocyte hyperproliferation as seen in chronic ulcers or psoriasis nor by migrating phe-
notype as evident in normally healing wounds. MMP-21 is not detected in basal cell cancer but a
subset of squamous cell cancers (Grade III tumors) express MMP-21 in cancer cells at the invading
front, suggesting that this metalloproteinase is an important contributor to the invasion of cutaneous
squamous cell cancer. 
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Analysis of Jararhagin, a collagen mimetic substrate, on MMP expression: characterization
of functional domains for integrin receptor activation
K Grimm,1 JW Fox,2 P Zigrino,1 AS Kamiguti3 and C Mauch1 1 Department of Dermatology,
University of Cologne, Cologne, Germany, 2 Health Science Center, University of Virginia,
Charlottesville, VA and 3 Department of Haematology, Royal Liverpool University Hospital,
Liverpool, United Kingdom
Cell matrix interactions play an important role in wound healing, tumor invasion and metastasis. We
have shown, that binding of the adhesion molecule integrin α2β1 to type I collagen initiates several
signalling events including the regulation of matrix metalloprotease (MMP) synthesis and activa-
tion, in particular of MMP-1 and MMP-14. Due to the function to degrade matrix components these
enzymes are crucial for tissue remodeling. Synthesis of MMP-1 and MMP-14 was found to be induced
upon treatment of fibroblasts in monolayer culture with Jararhagin, as seen in western and northern
blots, which was comparable to that obtained in fibrillar collagen lattices. This snake venom metal-
loprotease containing a disintegrinlike (Dis) and a metalloprotease (MP) domain binds α2β1 inte-
grin and induces intracellular signalling events similar to collagen. In addition treatment with Jararha-
gin leads to a change of cell morphology to a spindle-like phenotype and an inhibition of
collagen/integrin interaction. To get more insights in the mechanisms underlying the Jararhagin/inte-
grin interaction we further chararcterized signalling by other SVMPs. We tested recombinant Dis
and MP domains with high homology to Jararhagins domains. Adhesion assays have shown that the
Dis but not the MP domain are bound by fibroblasts. Alterations of cell morphology as observed by
Jararhagin were only induced by the MP domain but only in its active state while the Dis domain
did not affect the cell shape. Interestingly, both domains were able to independently induce MMP-
1 synthesis and MMP-14-mediated pro MMP-2 activation and to interfere with collagen interactions.
These data show that both domains are responsible for the inducing effect on MMP synthesis. More-
over, as the Dis but not the MP domain binds to fibroblasts these two domains use different path-
ways to affect MMP synthesis. 
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Modulation of skin collagen metabolism by dehydroepiandrosterone in human skin in vivo
M Shin, G Rhie, K Cho, K Kim, H Eun and J Chung Seoul National University College of
Medicine, Seoul, South Korea
Dehydroepiandrosterone (DHEA) and its sulfate conjugate (DHEA-S) are the most abundantly pro-
duced adrenal steroids whose levels in human are decreased according to aging. DHEA showed
beneficial effects on delaying the onset of diabetes, immune decline, obesity, and tumor. DHEA
may be related to the process of skin aging through the regulation of production and degradation of
extracelluar matrix. In this study, to investigate the effect of DHEA as an anti-skin aging agent, we
have examined whether DHEA can modulate type I procollagen, MMP-1 and TIMP-1 expressions
in human skin in vivo. 5% DHEA in ethanol:olive oil (1:2) was topically applied to buttock skin of
old volunteers (n=6, average 80yrs) 12 times for 4 weeks. Topically applied DHEA significantly
increased the expression procollagen mRNA and protein by 117 % (p<0.05) and 122% (p<0.05)
compared with vehicle treated skin, respectively, as determined by RT-PCR and western blot. The
expression of TIMP-1 mRNA and protein was increased by 106 % and by 120 % (p<0.05), respec-
tively. MMP-1 mRNA expression was decreased by 48%(p<0.01), and MMP-1 protein tended to
decrease. We also studied the time-and dose-dependent effects of DHEA on the expression of type
I procollagen, MMP-1 and TIMP-1 mRNA and protein in human dermal fibroblasts. In cultured
dermal fibroblast, DHEA(10µM-50µM) increased production of procollagen α1 (I) mRNA and
protein, compared with control cells. In contrast, the expression of MMP-1 mRNA and protein was
decreased at 10µM for 72hr. The expression of TIMP-1 mRNA and protein showed a dose-depend-
ent increase compared with control cells. Treatment of DHEA in the cultured fibroblast suppressed
the UV-induced AP-1 binding activity and MMP-1 protein expression. These results strongly sug-
gest the possibility of using DHEA as an anti-skin aging agent of human skin. 
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Role of novel desmosomal cadherin, desmoglein 1-β, in cell-cell adhesion and blistering dis-
eases
D Brennan,1 Y Hu,1 D Corealle,1 Y Choi,1 S Joubeh,1 A Kljuic,2 J Wahl,3 A Zlotogorski,4
A Christiano,2 J Uitto,1 L Pulkkinen1 and M Mahoney1 1 Dermatology and Cutaneous Biology,
Thomas Jefferson University, Philadelphia, PA, 2 Dermatology, Columbia University, New York,
NY, 3 Oral Biology, University of Nebraska Medical Center, Omaha, NE and 4 Dermatology,
Hadassah University Medical Center, Jerusalem, Israel
Desmogleins (Dsg) are transmembrane core components of the cell-cell adhesion structure, the
desmosomes, and belong to the cadherin supergene family of calcium-dependent adhesion mole-
cules. In addition to the three known isoforms of Dsgs (Dsg1, Dsg2, and Dsg3), we recently cloned
a novel mouse desmoglein gene (Dsg1-β) sharing high homology to both mouse Dsg1 (Dsg1-α)
and human DSG1. The Dsg1-β gene is 32 kb downstream of the Dsg1-α gene and is encoded by 15
exons spanning 45 kb on mouse chromosome 18. Sequence conservation between Dsg1-α and Dsg1-
β (96% identity) diverges significantly at exon 11 (79%) particular in the region that encodes the
extracellular anchoring domain. Dsg1-β protein shares 94% and 76% identity with mouse Dsg1-α
and human DSG1, respectively. To examine the expression pattern of Dsg1-β, we raised antibodies
against Dsg1-β, which did not recognize Dsg1-α. We showed that Dsg1-β was co-expressed with
Dsg1-α in the differentiating cell layers of the epidermis. The most striking difference was observed
in the eye where Dsg1-α was completely absent while Dsg1-β was highly expressed in the limbal
epithelial cells. Although an orthologous DSG1-β gene was not found in the human genome, we
detected Dsg1-β expression in the highly differentiated cell layers of the human epidermis of skin.
Interestingly, while staining for Dsg1-β was normal in non-striate palmoplantar keratoderma tissue,
Dsg1-β expression was disrupted in epidermis of striate palmoplantar keratoderma (S132X) patient
with a nonsense mutation in the DSG1 gene. These results suggest that in human, Dsg1-β maybe an
alternatively spliced product of the DSG1 gene. 
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New collagen-peptide improves skin structure and promotes cell adhesion, differentiation and
extra cellular matrix synthesis
E Bauza,1 E Roux,1 A Perrin,1 C Dal Farra,1 J Sabatier2 and N Domloge1 1 Research Center,
Vincience, Sophia Antipolis, Sophia Antipolis, France and 2 CNRS UMR 6560, faculte de
Medecine, Marseille, Marseille, France
In the skin, collagen plays a crucial role in maintaining structural integrity, tissue remodeling, and
wound healing, and is also very important for cell adhesion and migration. We have developed a syn-
thetic oligo collagen-like peptide and studied its effect on human cultured skin cells and ex vivo mod-
els. Cell adhesion assay using HaCaT cells showed that when the cells were seeded in the presence
of 0.001 mM of peptide, their adhesion to the microplates was clearly enhanced. Cell migration assay
showed no evidence of increased cell migration caused by the peptide. Time course studies and H&E
staining of cultured fibroblasts confirmed the role of the peptide in enhancing cell adhesion that led
to a nice uniform cell sheet in treated wells. Immunofluorescence studies on subconfluent fibrob-
lasts revealed that treatment of the cells with 0.001 mM of the peptide increased the expression of
ECM molecules (such as fibronectin, collagen I and III). Treatment of A431 cells with the peptide
enhanced their synthesis of keratin and adhesion molecules such as integrins (alpha 6, beta 1) and
laminin 5. Moreover, human skin ex vivo studies showed that skin samples treated with the peptide
and cultured for 72 hours, exhibited a remarkably better epidermal and dermal structure than con-
trol samples. The epidermis showed no signs of stress, and the dermis had a superior fibrillar struc-
ture in the peptide-treated samples. Interestingly, immunofluorscence studies of differentiation mark-
ers expression in skin samples, such as filaggrin, showed an increased expression of filaggrin in
peptide-treated samples and confirmed that the peptide enhanced epidermal differentiation. These
results show that this new collagen-like peptide stimulates ECM biosynthesis and exhibits a great
number of collagen-like effects on skin cells. This peptide is therefore of great interest in tissue regen-
eration and in topical skin care products.
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A secretion from Cryptomphalus aspersa increases human fibronectin matrix assembly capac-
ity by CHO cells
C Dominguez-Jimenez,2 R Tejedor,1 J Alonso-Lebrero1 and J Pivel1 1 Research and Development,
Industrial Farmaceutica Cantabria, Madrid, Madrid, Spain and 2 Immunology Department,
Hospital Universitario de la Princesa, Madrid, Madrid, Spain
SCA is a secretion obtained from the molluscus Criptomphalus aspersa when submitted to controlled
stress challenge. Its main components are a non-copper hemocyanin, a fibroblast growth factor “like”
protein, antioxidants enzymes (SOD) and hyaluronic acid. A preparation containing SCA has been
successfully used in wound repair in radiodermitis showing beneficial skin repair properties. The
aim of this study is to evaluate if repairing activity of SCA is related to matrix reorganization capac-
ity. Extracellular matrix play and important role in cellular metabolism and functions, as cells receive
information from the exterior through the adhesion receptors present on the cellular membrane.
Matrix assembly assay is a new model used to study the effect of active ingredients on matrix organ-
ization by studying their effect on the assembly of human fibronectin. We used CHO cells that assem-
ble human fibronectin when an optimal concentration is used. In our study, we determined the pro-
assembly activity of SCA in presence of CHO cells when suboptimal concentration of human
fibronectin ared used. SCA is negative for fibronectin content as determined by ELISA and West-
ern-blot techniques. CHO cells are incubated overnight in the presence of different concentrations
of human fibronectin and different concentrations of SCA. Then, cell were fixed and analyzed by
indirect immunofluorescence with antibodies anti-human fibronectin. SCA is able to induce fibronectin
assembly by CHO cells in presence of suboptimal concentration of human fibronectin. No assem-
bly is observed in absence of SCA in those experimental conditions. As fibronectin is not present in
SCA, this pro-assembly capacity could be due either to integrin activation on CHO cells or by a direct
interaction of fibronectin with a cell-interacting SCA component. In conclusion, this proassembly
activity may be related to the wound repair effects, which was found in radiodermitis patients. 
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Dystroglycan in skin and cutaneous cells: beta-subunit is shed from the cell surface
C Herzog,1 C Has,1 C Franzke,1 F Echtermeyer,2 S Kroeger,5 R Faessler,4 E Gustafsson3 and
L Bruckner-Tuderman1 1 Dermatology, Univ. of Muenster, Muenster, Germany, 2 Physiological
Chemistry, Univ. of Muenster, Muenster, Germany, 3 Experimental Pathology, Univ. of Lund, Lund,
Sweden, 4 Biochemistry, Max Plank Institute, Martinsried, Germany and 5 Physiological
Chemistry, Univ. of Mainz, Mainz, Germany
The hemidesmosome attaches the epidermis to the dermis and is critical for stable connection of the
basal epithelial cell cytoskeleton with the basement membrane. Post-translational processing of
several molecular components of the adhesion complex, such as collagen XVII, laminin 5 or colla-
gen VII, regulates its functions in keratinocyte adhesion and motility. In muscle, a similar supramol-
ecular aggregate, the dystrophin glycoprotein complex links the inside of muscle cells with the
basement membrane. A component of the muscle complex, dystroglycan, a type I transmembrane
protein, also occurs in epithelia. Here we characterized the expression and biochemical properties
of authentic and recombinant dystroglycan in human skin and cutaneous cells in vitro. In skin, dys-
troglycan is present at the epidermal basement membrane, and it is produced by both keratinocytes
and fibroblasts in vitro. The biosynthetic dystroglycan precursor was efficiently processed to the
alpha- and beta-subunits. A special feature of the cutaneous cells was that the extracellular part of
the transmembranous beta-subunit was proteolytically shed from the cell surface thus releasing the
alpha-subunit into the culture medium. Shedding of the beta-subunit was enhanced by EGF, IL-1
beta and phorbol esters, and inhibited by inhibitors of furin, serine proteinases and metalloproteinases,
suggesting that an enzyme cascade is involved in this process. Deficiency of perlecan, a major base-
ment membrane proteoglycan and ligand of alpha-dystroglycan, enhanced shedding, suggesting that
lack of a binding partner destabilizes the epithelial dystroglycan complex and renders it prone to
cleavage. Taken together, we identified dystroglycan as a novel component of the epidermal base-
ment membrane and extended the spectrum of proteins in this zone that are regulated by post-trans-
lational proteolytic processing. 
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New progress in fermentation technology: development of an elastin-stimulating yeast lysate
JV Gruber, L Lods, S Jindal and C Johnson Arch Personal Care, South Plainfield, NJ
It is well known that extracts for Saccharomyces cerevisiae (Baker’s Yeast) that have been grown
under conditions of cellular stress such as energy sources like heat or UV light, or application of
toxic materials such as hydrogen peroxide causes the yeast to respond and produce defensive cellu-
lar components. These defensive components, called stress response elements, are typical of most
eukaryotic cells and human skins cells are no exception. Because the stress response of yeast and
human skin cells are so similar, stress elements isolated from yeast have found applications in skin
care formulations. The characteristics of the yeast stress response can be influenced by the growth
peptone that the yeast is grown in. This offers an opportunity to further influence the stress response
through manipulation of the yesat growth media to stimulate the yeast to produce various cytokines
and growth factors similar to human-based growth factors. We have begun to explore colorimetric
methods for measuring key extracellular matrix proteins in skin cells and have developed an in vitro
assay for measuring soluble elastin production in confluent human fibroblast cultures and in full
thickness human tissue models. The method relies on a combination of technologies involving cul-
turing of human testing substrate (cells or tissue), treatment of these substrates with the test materi-
als and examination of soluble elastin production through a colorimetric assay that specifically iso-
lates soluble elastin precursors. Using this testing methodology we have found that a new yeast lysate
being developed in our laboratories appears to have a statistically significant positive influence on
soluble elastin production in vitro. 
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Dermatan sulfate synthesis is stimulated by three-dimensional culture
PA Lee, KR Taylor, RL Chen, VB Morhenn and RL Gallo (SID) Dermatology, University of
California, San Diego and VA Medical Center, San Diego, CA
Dermatan sulfate (DS) is the predominant glycosaminoglycan (GAG) in the extracellular matrix of
skin. It plays key roles in biological processes including development, growth and wound healing
by binding and activating growth factors and enzymes such as FGFs and heparin cofactor II. While
monolayer or two dimensional (2D) cell culture is a common in vitro model for studying these
processes, three dimensional (3D) culture is required for recapitulation of many events observed in
vivo. The factors responsible for this phenotypic shift in 3D versus 2D are not known. The purpose
of this study was to determine if a change in quantity and composition of GAGs or proteoglycans
(PGs) produced by fibroblasts grown in 3D collagen gel culture compared to 2D monolayer on col-
lagen could explain functional differences. Disaccharide analysis was performed using reverse phase
HPLC with post-column derivatization and fluorescence detection. Expression of DSPG was ana-
lyzed by immunoblot and Western blot. Abundance of DS-specific 4 and 2 sulfotransferases was
evaluated by real time PCR. Disaccharide analysis showed fibroblasts in 3D culture produced 11
fold more DS and chondroitin sulfate (CS) than fibroblasts in 2D culture. This analysis also revealed
that all DS from 2D fibroblasts was unsulfated, while 89% of 3D fibroblast DS was 4-O sulfated.
The DSPG decorin was abundant in extracts from 3D culture but absent in 2D fibroblasts while syn-
decans 1 and 4 remained unchanged. The abundance of DS-specific 4-O sulfotransferase transcript
decreased by 85% in 3D culture, suggesting feedback inhibition. These data demonstrate that the
change from 2D to 3D stimulates the synthesis of dermatan sulfate by fibroblasts. Given that the
level of DS in 3D culture resembles the in vivo situation, and that 4-O sulfation of DS is required
for activation of several growth factors, cytokines, and enzymes, this characteristic of the extracel-
lular matrix of 3D fibroblast cultures may be essential to the function of such tissue constructs. 
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Shedding of collagen XVII/BP 180: specific structural motifs influence cleavage from cell sur-
face
C Franzke,1 K Tasanen,3 L Borradori2 and L Bruckner-Tuderman1 1 Dermatology, Univ. of
Muenster, Muenster, NRW, Germany, 2 Dermatology, CMU-DHURDV, Geneva, Switzerland and 3
Dermatology, Univ. of Oulu, Oulu, Finland
Collagen XVII, an epithelial adhesion molecule, belongs to the family of transmembrane collagens.
This novel family currently includes seven members with extracellular collagenous C-termini which
can be shed from cell surfaces. Shedding of collagen XVII is mediated by membrane-bound ADAMs,
which cleave their substrates close to the cell surface. They do not require strict sequence speci-
ficity, implicating a structural motif for substrate recognition. Here we analyzed the shedding of
collagen XVII, which is cleaved within the juxtamembranous non-collagenous NC16A domain. To
localize the sequences required for shedding, COS cells were transfected with cDNA for full-length
collagen XVII and different recombinant deletion mutants. The full-length form was expressed and
shed efficiently, but mutants with large deletions within the NC16A domain were not. In contrast,
deletion of the 18 most N-terminal amino acids within the NC16A domain, enclosing a furin cleav-
age site, did not prevent shedding, excluding a role for furin as a genuine convertase. Analysis of
defined small deletions pointed to amino acids residues 528-547 of collagen XVII as the recogni-
tion site for ADAMs. This region spans the putative N-terminus of the 97 kD LABD antigen, a frag-
ment of collagen XVII ectodomain, which is recognized by autoantibodies in linear IgA disease.
Secondary protein structure predictions of the deletion mutants revealed that all non-shed mutants
shared an NC16A domain with a positive net charge and included one α-helix with a putative
amphiphatic element, which can cause conformational changes in the collagen XVII homotrimer.
The data indicate that the conformation of the NC16A domain and steric availability of the cleav-
age site to ADAMs influence the shedding and thereby regulate cell adhesion and motility. Further,
mutations in the NC16A domain are likely to change the conformation of the ADAMs recognition
site and thus contribute to abnormal shedding of collagen XVII in junctional epidermolysis bullosa. 
0258
The integrin-matrix metalloproteinase-9 association and epidermal growth factor recep-
tor/matrix metalloproteinase-9 signaling are regulated by gangliosides
X Wang, P Sun and AS Paller Dermatology, Northwestern University, Chicago, IL
Gangliosides regulate cell migration on fibronectin(FN) by binding with the integrin α5 and inhibit-
ing signaling through focal adhesion kinase(FAK). Although the predominant ganglioside of ker-
atinocytes, GM3, affects cell migration, it does not bind α5 integrin to influence FAK signaling.
Given the inhibition by GM3 of EGF receptor(EGFR) signaling and the regulatory role of EGF on
expression of matrix metalloproteinase-9(MMP-9), a critical factor in cell locomotion, we hypoth-
esized that gangliosides are able to modulate MMP-9 activity. Using antisense oligomers(to accu-
mulate GM3), gene transfection of GD3 synthase(to deplete GM3), and gene transfection of gan-
glioside-specific sialidase and biochemical inhibition of ganglioside synthesis(to deplete gangliosides),
we developed in vitro and mouse models of endogenous alterations of gangliosides. GM3 accumu-
lation inhibited the migration on FN of the keratinocyte-derived SCC12 cell and dramatically decreased
expression and activity of MMP-9. GM3 depletion facilitated both SCC12 cell migration on FN and
cell invasive capacity. Mouse tumors with GM3 depletion grew 10-fold larger than controls. Both
in vitro and in the mouse, GM3 depletion led to increased expression and activity of MMP-9, acti-
vation of both EGFR and MAP kinase, and increased AP-1 expression. Inhibitors of EGFR and
MAPK phosphorylation blocked the expression and activity of MMP-9; these inhibitors of EGFR
and MAPK, MMP-9 blocking antibody, and recombinant tissue inhibitor of metalloproteinase-
1(TIMP-1) suppressed the increased migration induced by ganglioside depletion. Interestingly,
endogenous accumulation of GM3 totally prevented the co-immunoprecipitation of MMP-9 and inte-
grin α5β1, whereas ganglioside depletion facilitated their co-immunoprecipitation.In conclusion,
gangliosides regulate keratinocyte migration via both FAK and EGFR/MMP-9 signaling pathways,at
least in part by modulating the ability of α5β1 and MMP-9 to associate in the cell membrane. 
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Production of anti-desmoglein3 monoclonal antibodies from pemphigus vulgaris mouse model
produced by naive splenocytes adoptive transfer
K Tsunoda,1,2 H Kawasaki,1 M Aoki,1 T Nagai,2 T Nakagawa,2 T Nishikawa1 and M Amagai1 1
Dermatology, Keio University School of Medicine, Tokyo, Japan and 2 Dentistry and Oral Surgery,
Keio University School of Medicine, Tokyo, Japan
Pemphigus vulgaris (PV) is an autoimmune blistering disease caused by anti-desmoglein3 (Dsg3)
IgG autoantibodies. Previously we have produced PV mouse model by adoptive transfer of spleno-
cytes from Dsg3-/- mice immunized with recombinant Dsg3. Subsequently we isolated from the PV
model mice several anti-Dsg3 monoclonal antibodies (AK mAbs), one of which was proved to be
pathogenic. In this study, we attempted to produce PV model mice without active immunization and
isolate monoclonal antibodies (NAK mAbs) from those mice. When 5x107 splenocytes isolated from
naive Dsg3-/- mice were transferred about 80% of recipient mice developed the PV phenotype includ-
ing oral erosions with suprabasilar acantholysis in histology. There were no apparent differences in
the phenotype between the recipient mice with naive splenocytes and those with immunized spleno-
cytes. The frequency of the phenotype appearance was dependent on the number of splenocytes trans-
ferred. We then isolated 8 NAK mAbs from the PV model mice produced by naive splenocytes. All
of these clones reacted with mouse Dsg3 but not with mouse Dsg1 by ELISA and stained cell sur-
faces of cultured keratinocytes. When their hybridoma cells were inoculated in recipient mice, all
of them showed in vivo IgG deposition in hard palates, but without apparent induction of the PV
phenotype. The precise comparison of AK and NAK mAbs will provide valuable information to clar-
ify the immunological mechanism of pathogenic antibody production against Dsg3 in PV model
mice. 
0260
Keratinocyte biointegration to poly (2 hydroxyethyl methacrylate) (pHEMA) implants
Y Miyashita,1 NG Knowles,1 ML Usui,1 RA Underwood,1 AJ Marshall,2 KD Hauch,2
CM Giachelli,2 BD Ratner,2 WG Carter3,4 and JE Olerud1 1 Medicine (Dermatology), University of
Washington, Seattle, WA, 2 Bioengineering, University of Washington, Seattle, WA, 3 Pathobiology,
University of Washington, Seattle, WA and 4 Fred Hutchinson Cancer Research Center, Seattle, WA
Adverse complications from cutaneous insertion of medical devices such as catheters or glucose sen-
sors, result in significant morbidity and mortality. Keratinocytes (KCs), stimulated to migrate, typ-
ically marsupialize along the sides of the implant, creating a space in which bacteria can invade and
form biofilms. In order to preclude bacterial colonization or biofilm formation at this biomaterial/skin
interface, the basal KC must attach or biointegrate with the device. To systematically study the bio-
material/skin interface, we developed a rafted organ culture (ROC) model using newborn foreskin
implanted with porous poly (2-hydroxyethyl methacrylate) (pHEMA) rods. Since pHEMA, used
for contact lenses, precludes protein adhesion, we chemically modified pHEMA with carbonyldi-
imidazole (CDI) and immobilized KC adhesion promoting proteins such as fibronectin (FN) and
laminin 5 (Lam 5) to the surface of pHEMA. ROCs were grown for six days, fixed in 10% neutral
buffered formalin (NBF) for paraffin embedding, fixed in 1/2 strength Karnovsky’s for Epon embed-
ding or frozen for embedding in O.C.T. then sectioned for morphology and immunohistochemistry.
Our results show successful integration of migrating KCs into the pHEMA pores. The integrated
KCs were characterized for general morphology, as well as for differentiation and proliferation mark-
ers by immunohistochemistry. 
0261
Quantitative evaluation of molecules secreted by senescent human dermal fibroblasts cul-
tured in monolayer versus collagen gel: description of an iterative treatment model
C Gondran and J Franchi LVMH Branche Parfums et Cosmetiques, Saint Jean de Braye, France
At the moment, one of the main challenges in the field of dermatology is the understanding of cuta-
neous alterations which occur during the menopause. These changes are supplementary to other
intrinsic (physiological) or extrinsic (photoaging) modifications. The hormonal deprivation of steroids
and especially estrogens, accentuates some parameters of physiological ageing. The main signs of
cutaneous ageing linked to the menopause are observed at the dermal level, as the reduction of
water and collagen content results in a slimmer dermis. The acknowledged phenomenon of a decrease
in the proliferative capacity of fibroblasts with ageing, may lead to a quantitative and qualitative
reduction of the dermal macromolecules. Our objective was make the fibroblasts grow older through
successive subcultures using in vitro methods and as time went on, we observed the changes in param-
eters implied in the ageing process : type I and III collagen, elastin, matrix metalloproteinase-1 and
-2 (MMP), and interleukine 8. The behaviour of these in vitro aged fibroblasts was traced both in
monolayer cultures and in three-dimensional cultures after inserting the cells into a collagen gel in
order to mimic the cutaneous environment. In senescent fibroblasts, we observed a quantitative
decrease in extracellular matrix protein synthesis associated with a quantitative increase in mole-
cules implied in degradation : MMP-1 and IL-8. These phenomena were particularly noticeable in
three-dimensional cultures. As our studies were orientated towards selecting ingredients able to mod-
ulate the parameters modified with ageing, we adapted our model to an iterative application over a
period of 5 months. Our work was carried out using the soja plant as it has a high content of phy-
toestrogens, which are notorious for the treatment of mature skin. 
0262
Novel role of angiotensin II in fibroblasts: induction of fibroblast migration by angiotensin II
via HB-EGF-mediated EGF receptor transactivation
Y Yahata, Y Shirakata, S Tokumaru, K Yamasaki and K Hashimoto Dermatology, Ehime University
School of Medicine, Ehime, Japan
Angiotensin II (AngII) has a well-defined role in controlling systemic blood pressure and volume
homeostasis. Recently, AngII has been reported to accelerate wound healing in animal models. There-
fore, we compared the wound-healing rate in AngII type 1a receptor (AT1aR)-deficient and wild-
type mice. A cutaneous wound was made with an 8-mm punch biopsy and the wound area was meas-
ured on day 8. The wound area was 28.6 and 14.1 mm2 in AT1aR-deficient and wild-type mice,
respectively. The AT1aR-deficient mice showed significant retardation of wound healing. This led
us to examine the effect of AngII on fibroblast growth and migration using human fibroblasts. The
presence of AT1R in human fibroblasts was confirmed by RT-PCR and a binding assay. AngII induced
fibroblast migration in a dose-dependent manner, with a 1.9-fold optimum at 10-7 M, while AngII
had no effect on fibroblast growth. Several groups have reported that ligand binding to the G-pro-
tein-coupled receptor (GPCR) induced EGF receptor (EGFR) transactivation via HB-EGF shedding
(the proteolytic conversion of membrane-anchored HB-EGF to the soluble form). Since AT1R is a
GPCR, we hypothesized that AngII-induced fibroblast migration is mediated by an EGFR transac-
tivation mechanism. AngII induced the phosphorylation of EGFR, with a maximum at 30 min, and
this was prevented by the presence of valsartant, an AT1R antagonist. Furthermore, valsartant also
inhibited AngII-induced fibroblast migration by 90%. Anti-HB-EGF neutralizing antibody (3 mg/ml)
inhibited AngII-induced fibroblast migration completely. CRM197, a non-toxic mutant of diphthe-
ria toxin, specifically inhibits HB-EGF by binding to its EGF-like domain. CRM197 inhibited AngII-
induced fibroblast migration almost completely at 1 mg/ml. In conclusion, we showed a new bio-
logical function of AngII in skin wound healing via enhanced fibroblast migration. Furthermore, this
was mediated by EGFR transactivation via HB-EGF shedding through the AngII/AT1R signaling
pathway. 
0263
PUVA induces both cytoplasmic and nuclear changes that are responsible for a long-term
growth arrest of human dermal fibroblasts
W Ma, M Wlaschek, LA Schneider, C Hommel and K Scharffetter-Kochanek Dermatology, Univ.
of Ulm, Ulm, Germany
We have shown previously that following single PUVA treatment human dermal fibroblasts undergo
a long-term senescence-like growth arrest. However, the molecular mechanisms underlying this
growth arrest are not known in detail. Nuclear effects as well as membrane damages have been attrib-
uted to be responsible. To address the question whether nuclear or membrane related damage seem
responsible for the long-term growth arrest, we performed cell fusion experiments using kary-
oplasts of PUVA-treated fibroblasts and enucleated cytoplasts of normal fibroblasts as well as vice
versa. Fibroblasts were stably transfected with GFP and neomycin as marker genes and treated with
PUVA. At different time points post PUVA karyoplasts expressing GFP and neo(r) were fused with
cytoplasts of parental fibroblasts labeled with latex beads. Hybrids were selected in G418 contain-
ing medium and the successfully fused cells showed GFP expression and included latex beads. Sim-
ilarly, cytoplasts of PUVA-treated cells were stained with Hoechst-33342 before fusion to label
contaminating nuclei after fusion and fused with karyoplasts of normal fibroblasts. Hybrids with
cytoplasts or karyoplasts isolated from PUVA-treated fibroblasts up to one week post treatment died
within 5 days. Hybrids with PUVA-treated cytoplasts and karyoplasts selected from time points at
two to four weeks post treatment were viable and behaved in different way. Hybrids with PUVA
karyoplasts from cells at 4 weeks after treatment proliferated for up to 17 days after fusion. In con-
trast, hybrids with cytoplasts from PUVA treated cells did not die but were temporarily growth arrested
for up to 12 days after fusion. From these experiments we conclude that PUVA treatment induces
damages in both the nuclear (DNA) and the cytoplasmic compartments. We hypothesize that cyto-
plast effects are less damaging compared to nuclear effects by PUVA. In addition, PUVA-induced
factors in the cytoplast seem to have an ability to redirect the cells to a proliferating or growth arrest
state. 
0264
The Thy-1 molecule on activated human dermal microvascular endothelial cells specifically
interacts with CD11b (αM-integrin) on leukocytes—impacts on inflammatory processes
A Wetzel,1 U Anderegg,2,1 U Haustein,2 M Sticherling1 and A Saalbach2,1 1 Dept. of Dermatology,
University of Leipzig, Leipzig, Saxony, Germany and 2 Saxon Academy of Science, Leipzig, Saxony,
Germany
Previous work demonstrated that human Thy-1 is a newly identified activation associated cell adhe-
sion molecule on human dermal microvascular endothelial cells (HDMEC). Thy-1 is involved in the
adhesion of monocytes and polymorphnuclear cells (PNC) to activated HDMEC. In this study we
identified the corresponding ligand of the Thy-1 molecule on these cells. First, we generated a mon-
oclonal antibody (mAbAW2) against PNC and monocytes that blocks the binding of Thy-1 protein
to its ligand. This antibody as well as the purified Thy-1 show identical binding patterns compared
to an anti-CD11b antibody. Blocking experiments revealed that both, the mAb AW2 as well as the
purified Thy-1 inhibit the binding of an anti-CD11b antibody to monocytes and PNC. These data
suggest that Thy-1 binds to CD11b (αm-chain of integrins) on PNC and monocytes. Cell adhesion
studies showed that mAbAW2 as well as anti-CD11b-antibodies were able to block the adhesion of
PNC and monocytes to Thy-1 transfected CHO-cells as well as to Thy-1-expressing activated HDMEC
emphasizing an essential role of Thy-1 / CD11b interaction for cell adhesion. The CD11b is a well
characterized cell adhesion molecule on monocytes and PNC. Until now it has been thought that
ICAM-1 is the main cellular ligand of CD11b. Our data first time provide evidence that human Thy-
1 on activated HDMEC is a second cellular ligand of CD11b mediating the binding of monocytes
and PNC to activated endothelium, possibly regulating invasion of leukocytes into inflamed tissues. 
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Cutaneous microfibrils control transforming growth factor-β (TGF-β) activity through latent
TGF-β binding protein-1
K Yamamoto,1 Z Isogai,1 RN Ono,2 NL Charbonneau,2 M Yoneda3 and LY Sakai2 1 Dermatology,
Nagoya City University Medical School, Nagoya, Aichi, Japan, 2 Biochemistry and Molecular
Biology, Oregon Health and Science University and Shriners Hospital for Children, Portland, OR
and 3 Aichi Prefectural College of Nursing and Health, Nagoya, Japan
TGF-β is a potent growth factor that enhances production of extracelluar matrix. TGF-β is involved
in wound healing and fibrosis. Cutaneous microfibrils are mainly composed of fibrillin and an
extracellular element with elasticity. Recently, latent transforming growth factor-β binding protein-
1 (LTBP-1) has been found to interact with fibrillin and localize to microfibrils. Therefore, cutaneous
microfibrils target TGF-β within dermal connective tissues via LTBP-1. However, mechanism how
TGF-β is released from cutaneous microfibrils is unknown. Expression of both spliced and non-
spliced forms of LTBP-1 by dermal fibroblasts was shown. Extraction studies using guanidine
hydrochloride suggested non-covalent interaction between microfibrils and LTBP-1. Other extrac-
tion studies utilizing plasmin treatment revealed the presence of cross-linked LTBP-1 in aged skin.
Immunohistochemical analysis after plasmin treatment also showed decreased staining of LTBP-1
in a concentration of plasmin dependent manner, suggesting that plasmin released LTBP-1 from cuta-
neous microfibrils. Western blot analysis of the treated solution showed consistent amount of release
of LTBP-1 from dermal matrix. These results indicate that cutaneous microfibrils regulate TGF-β
activity through proteolytic release of LTBP-1. 
0267
Tetraspanins CD9, CD151, and CD81 are implied in the adhesion of normal human melanocytes
M Garcia Lopez, A Garcia Diez and PF Penas Dermatology, Hospital de la Princesa, Madrid,
Madrid, Spain
Tetraspanins are a family of transmembrane proteins (25-50 kD) with at least 28 distinct members
in mammals, that are abundantly expressed in different type of cells (endothelial cells, T and B lym-
phocytes, keratinocytes...). This family has been implicated in cell motility, adhesion, metastasis,
cell proliferation, differentiation and intracellular signaling. Integrins are a large group of cell-sur-
face ab heterodimers that function as key adhesion receptors for the extracellular matrix. Tetraspanins
have been found to modulate signaling, compartmentalization, intracellular trafficking and recycling
of integrins. Although some tetraspanins have been described in melanoma cells, their function
have not been explored in normal human melanocytes. We found that normal human melanocytes
express CD9, CD63, CD151, and CD81 by flow cytometry analysis. Fluorescence microscopy stud-
ies showed localization of CD9, CD151 and CD81 mainly at the cell membrane and in the intercel-
lular junctions, with predominant intracellular expression of CD63. We studied their influence in
the melanocyte adhesion and found that monoclonal antibodies against these molecules inhibit the
adhesion to collagen matrix. 
0269
Over-expression of retinoic acid receptorα in the cell-line COS-1 results in increased matrix
metalloproteinase-1 production
Ratnayaka, CE Griffiths and RE Watson Dermatology Centre, University of Manchester, Manchester,
United Kingdom
Retinoic acid receptor α (RARα) is increased in aged, photoprotected epidermis. In order to inves-
tigate the role of RARα in intrinsic aging, transient over-expression of this gene was performed in
an in vitro model system, which was then examined for biomarkers of an aged phenotype.  The gene
encoding RARα was cloned into the plasmid pSG5 and transiently transfected into COS-1 cells.
Whole cell lysates and media were harvested at 24 and 48 hrs post transfection and assayed for RARα
and a panel of senescence-associated biomarkers: matrix metalloproteinase-1 (MMP-1), heat shock
protein 70 (Hsp70) and p16 (n = 4). In additional experiments (n = 3), transfected cells were sup-
plemented with 100nM all-trans retinoic acid (tRA; in dimethylsulfoxide) for 24 hours prior to
sample preparation. Following transfection with 5mg of construct, consistent over-expression of the
receptor was observed at both 24 and 48 hrs. Treatment of the cells with t-RA resulted in clearance
of the receptor. MMP-1 was increased in the presence of over-expressed RARα at 48 hrs post trans-
fection; the level returned to baseline following the addition of tRA. Constitutive levels of Hsp70
remained unaffected at both time points, and subsequent treatment with tRA had no effect. Likewise,
p16 expression remained unaltered.  This study identifies that over-expression of RARα results in
increased production of MMP-1 and confirms that addition of tRA reduces these levels; this is in
agreement with in vivo observations in aged skin following topical tRA treatment. Additionally, treat-
ment with tRA directly reduces the artificially high receptor load in transfected COS-1 cells. It appears
that RARα may play an important role in the mechanisms of intrinsic aging. 
0268
Pemphigus vulgaris provides novel insights into keratinocyte differentiation
L Williamson, D Baumann, H Posthaus, A Zakher, M Wyder, M Suter and E Muller Animal
Pathology, University of Bern, Bern, Switzerland
We recently demonstrated that plakoglobin plays a central role in pemphigus vulgaris (PV). Here
we further corroborate the involvement of this protein in the disease process. While keratinocytes
from β-catenin knock-out mice responded to antibody binding with keratin retraction and loss of
desmosome-mediated adhesion like wild type cells, plakoglobin knock-out cells did not. Moreover,
mouse epidermal keratinocytes differentiated normally in the absence of β-catenin while plakoglo-
bin knock-out cells formed a hyperproliferative epidermal sheet when grown at the air-liquid inter-
face. Concomitantly, plakoglobin knock-out cells showed impaired upregulation of proteins such as
desmoglein1 and loricrin which are characteristic for terminal differentiation. Collectively our results
indicate that plakoglobin but not β-catenin is essential for differentiation of interfollicular epider-
mal keratinocytes. The fact that PV antibodies interfered with the localization of plakoglobin at the
plasma membrane and in the nucleus therefore strongly suggests that the function plakoglobin exerts
during normal keratinocyte differentiation is hampered in PV. 
0266
The body-site specific expressions of the extra cellular matrix and integrin families explain
the distinct features of the trunk, palm-sole and oral mucosa
M Yasuda,2,1 K Takahashi,1 Y Miyachi1 and O Ishikawa2 1 Dermatology, Kyoto University, Kyoto,
Kyoto, Japan and 2 dermatology, Gunma University, Maebashi, Gunma, Japan
Epidermal keratinocytes are well known to change their biochemical and morphological character-
istics depending on their body. For example, suprabasal keratin K1/K9 or K4/K13 are dominant in
the palmo-plantar skin or oral mucosa, respectively, instead of the ubiquitous K1/K10 expressed in
the trunk type epidermis. However, dermal components are not yet known for their distinct features
among each body site. We thus used a combination of the subtractive mRNA screening and cDNA
array to identify human cDNAs, which specifically and selectively expressed in the dermal fibrob-
lasts established from each body site. In this process, two cDNA clones encoding a fibronectin and
a pregnancy specific beta 1 glycoprotein are frequently identified in the fibroblasts derived from
trunk skin, compared with the fibroblasts derived from other body sites. mRNA for fibronectin is
highly abundant in the fibroblasts derived from trunk skins, compared with those of sole skins and
oral mucosa. Whole skin extracts containing both epidermal and dermal components also revealed
that sole skin and oral mucosa are apparently scarce for fibronectin whereas more abundant for vit-
ronectin compared with trunk skin in the Western blot analysis. Meanwhile, various integrins were
also distributed in the distinct spatially differentiation pattern. Trunk fibroblasts had more abundant
integrins alpha 5 and alpha V than sole or oral mucous fibroblasts. Integrins alpha 4 and beta 1 showed
no obvious difference among these fibroblasts. These tendencies of distinct expression are also con-
firmed in the immuno-histochemistry of various skin sites. Fibronectin is recently recognized to act
as the migration guidance and the survival factors of neural crest cell, especially melanocytes. Our
observations concerning about the paucity of fibronectin at palmo-planter skin and oral mucosa might
well explain the reason why these body regions are less melanogenic regardless of the race and skin
color types. 
0270
Inhibition of matrix metalloproteinase activities by green tea polyphenols
H Yang, P Gambino, B Costello, C Oresajo and JA Hayward The Collaborative Group, Ltd., Stony
Brook, NY
Green Tea Polyphenols (GTP) and its major component (-)-epigallocatechin gallate (EGCG) pos-
sess strong anti-oxidant, anti-inflammatory, and anti-carcinogenic properties. To substantiate the
benefit of GTP and EGCG to matrix integrity, we have investigated their effects on several matrix
metalloproteinase activities. Our target enzymes were MMP-1 (interstitial collagenase), MMP-2
(72 kDa gelatinase-A), MMP-3 (stromelysin-1), MMP-8 (neutrophil collagenase), and MMP-9 (92
kDa gelatinase-B). Activities were measured via digestion of fluorogenic peptide substrates, zymog-
raphy using gelatin or casein substrates, and digestion of native substrate detected with SDS-PAGE.
Flurogenic peptides were Dnp-Pro-Cha-Gly-Cys(Me)-His-Ala-Lys(Nma)-NH2 for collagenase and
gelatinase detection, and NBD-Arg-Pro-Lys-Pro-Leu-Ala-Nva-Trp-Lys(DMC)NH2 for stromelysin
detection. Using these substrates, 0.01% GTP and EGCG inhibited all of the targeted MMP activi-
ties by more than 90%. This efficacy was confirmed by gelatin zymography (MMP-2 and MMP-9),
casein zymography (MMP-1 and MMP-3), and by digestion of purified human collagen type I with
SDS-PAGE detection (MMP-8). The reversibility of inhibition was revealed by incubating MMP-2
with GTP and EGCG followed by gelatin zymography analysis. Our results suggested GTP and
EGCG are capable of reversibly inhibiting the MMPs believed to be responsible for the major struc-
tural alterations of dermal matrix that are related to an aged appearance of the skin. 
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Cysteine proteases initiate matrix degradation in early stages of melanoma invasion
A Klose,1 R Dennhoefer,1 G van Muijen,2 T Krieg,1 C Mauch1 and N Hunzelmann1 1 Dermatology
and Center for Molecular Medicine, University of Cologne, Cologne, Germany and 2 Pathology,
UMC St. Radbound, Nijmegen, Netherlands
Assessment of the interactive mechanisms of matrix degradation during tumor invasion requires an
in vitro model system closely reflecting the complexity of the in vivo situation. We established an
optimized in vitro invasion system for melanoma cell lines using dead deepidermized dermis (DDD)
as an appropriate model to analyze tumor cell migration, stroma degradation and changes in expres-
sion levels of matrix degrading proteases. Four melanoma cell lines (MV3, SkMel28, SkMel23,
WM164) differing in their invasiveness were seeded either on the dermal side or on the basement
membrane (BM) of the DDD. After two weeks of incubation all melanoma cells invaded the dermis,
however, only MV3 and SkMel28 cells were also able to degrade the BM. To analyze the responsi-
ble protease activities, we performed in situ gelatin zymography of cryosections under two differ-
ent conditions that employed neutral or acidic pH values to favor matrix metalloproteinases or cys-
teine proteinases (CPs), respectively. Gelatinolysis in this system generally correlated with the
invasiveness of the cells. Under neutral conditions, gelatinolysis was detected in melanoma cells
seeded on the dermal side but not when cultured on the BM. In contrast, at acidic pH, where CPs
are preferentially active, proteolytic activity was detected in melanoma cells seeded on the dermis
as well as in those seeded on the BM, suggesting that the activity of CPs is important for the early
invasion process. Additionally, a modified method of gelatin zymography under special buffer con-
ditions favoring the CPs revealed strong proteolytic activities in the supernatants of these cells, indi-
cating the involvement of several CPs. The herein described tumor invasion system, combined with
the new technique of acidic gelatin zymography, helps to improve our understanding of the complex
mechanisms of matrix degradation and metastasis and revealed that CPs may crucially contribute to
the invasion process. 
0272
Disruption of β1 integrin induces keratinocyte stem cell anoikis through the extrinsic apop-
totic pathway
A Marconi, C Fila, R Tiberio, A Giannetti and C Pincelli Dermatology, University of Modena and
Reggio Emilia, Modena, Emilia-Romagna, Italy
Cell survival requires interaction with the extracellular matrix and integrins control cell death in
many cell settings. We have shown recently that keratinocyte stem cell (KSC) expressing highest
levels of β1 integrin, are protected from apoptosis (anoikis). In this study, we analyze the molecu-
lar mechanisms underlyng anoikis of KSC caused by disruption of integrin signaling. KSC were
isolated according to their adhesive capacity to type IV collagen and characterized by their expres-
sion of β1, α6β4 integrin, ∆N p63 as well as by the colony forming efficiency. TUNEL staining,
PARP cleavage and flow cytometry analysis revealed that % apoptotic cells was significantly lower
in KSC than in the more differentiated keratinocyte subpopulations (TUNEL, p<0.05; FACS, p<0.01).
Anti-β1 integrin caused apoptosis in both KSC and more differentiated cells, while it decreased
Bcl-2 and survivin protein levels in KSC. We next analyzed the caspase pathway during anoikis.
Upon treatment with anti-β1 integrin, both initiator and effector caspases were activated earlier in
more differentiated cells than in KSC. In particular, caspase-8 was activated at 3 hrs, bid at 3-6 hrs,
caspase-3 at 3-6 hrs, while caspase-9 at 6-9 hrs. Inhibition of caspase-8 delayed the activation of
caspase-9, caspase-3 and bid; moreover, inhibition of caspase-8 partially prevented KSC anoikis. On
the contrary, inhibition of caspase-9 did not exert any effect on caspase-10, caspase-8 caspase-3 and
bid, while it failed to protect KSC from anoikis. This study indicates that disruption of β1 integrin
signal induces anoikis in KSC. The extrinsic apoptotic pathway seems to play a major role in this
process. 
0273
Keratinocyte stratification following ectopic desmoglein 1 expression in vitro; a possible mech-
anism for rising above the rest
S Getsios,1 RL Dusek,1 AC Huen,1 F Fehrmann2 and KJ Green1 1 Pathology & Dermatology,
Northwestern University Feinberg School of Medicine, Chicago, IL and 2 Microbiology &
Immunology, Northwestern University Feinberg School of Medicine, Chicago, IL
Desmoglein (Dsg) 1 is a member of the cadherin family of calcium-dependent cell adhesion mole-
cules that is present in the desmosomes of the upper epidermis and is a molecular target in several
human skin diseases. Previous studies have shown that normal human epidermal keratinocytes
(NHEKs) fail to express Dsg1 but the expression of this desmosomal cadherin is markedly up-reg-
ulated in cells undergoing terminal differentiation. Using an organotypic model for epidermal dif-
ferentiation, we confirmed that Dsg1 is restricted to the upper layers of differentiated cells that formed
over time in these cultures. To define the role(s) of Dsg1 in keratinocyte differentiation, a retroviral
gene delivery system was employed to force the expression of this cell adhesion molecule in undif-
ferentiated NHEKs. The ability of ectopic Dsg1 to localize to cell borders and increase cell adhe-
sion in infected NHEKs was directly related to the levels of extracellular calcium present in the cul-
ture medium. In spite of the largely cytoplasmic distribution of ectopic Dsg1 in NHEKs cultured at
low calcium, the expression of this desmosomal cadherin was associated with keratinocyte stratifi-
cation. Desmocollin 1, a desmosomal molecule expressed only at later stages of keratinocyte dif-
ferentiation, was also up-regulated in these stratified cells. By incubating keratinocytes in a hang-
ing drop of culture medium, we also observed the reorganization of NHEKs into multilayered cellular
aggregates following Dsg1 expression in low calcium. In contrast, the ability of keratinocytes to strat-
ify in culture was not altered by the overexpression of the related desmosomal cadherin subtype,
Dsg3. Collectively, these studies suggest that Dsg1 expression is involved in promoting keratinocyte
differentiation in a manner that is not directly related to its adhesive functions. 
0274
Dermatan sulfate supports KGF-dependent keratinocyte proliferation and migration
J Trowbridge, K Taylor, J Rudisill and RL Gallo (SID) Dermatology, University of California, San
Diego and VA Medical Center, San Diego, CA
Glycosaminoglycans (GAGs) such as Dermatan Sulfate (DS) Heparan Sulfate (HS) and Hyaluronic
acid (HA) are key regulatory molecules in development, maintenance and repair of the skin. DS is
the predominant sulfated GAG in the dermis and is released in wound fluid after injury. Recently,
we have shown DS is more potent than HS or other GAGs in its ability to act in vitro as a cofactor
for FGF-7 (KGF). Unlike other members of the FGF family, KGF is a potent mitogen whose activ-
ity is a specific paracrine factor for cells of epithelial origin. To test the relevance of the activity
observed for DS in the KGF model system, we investigated the ability of DS to promote cellular
proliferation and migration of primary human keratinocytes. Cells in complete growth medium treated
with exogenous DS repaired defects in their monolayer 2-3 days faster than untreated cells or cells
treated with other GAGs. Keratinocytes in minimal medium showed increased proliferation in the
presence of DS when they were treated with KGF. This effect was dose dependent and reversed at
high DS concentrations (>50ug/ml) where DS inhibited growth. Evaluation of p44/p42 phosphory-
lation using KGFR-expressing cells deficient in endogenous GAG demonstrated that stimulation by
DS was mediated through the rapid activation of MAPK by the KGF-DS-KGF-receptor complex.
Finally, the ability and potency of DS to act as a cofactor for KGF was shown to be strictly depend-
ent upon GAG structure. Minimal length and sulfation structure of DS required for KGF dependent
signaling was defined as an iduronate-rich octasaccharaide containing extensive 4-O sulfation. These
data demonstrate that DS released from the extracellular matrix acts as a cofactor for KGF-depend-
ent signaling, and that release of this GAG is dose and sequence-specific. Interaction of carbohy-
drate sequence encoded in GAGs with amino acid sequence encoded proteins is an essential ele-
ment of cutaneous biology. 
0275
Role of zyxin, a focal adhesion phosphoprotein, in melanocyte migration and differentiation
HR Byers and SG Dykstra Dermatology, Boston Univ Sch Medicine, Boston, MA
Focal adhesions link extracellular matrix proteins, integrins and the cytoskeleton as well as gener-
ate signals for cell spreading, proliferation and survival. We have shown that the expression of
zyxin, a focal adhesion phosphoprotein involved in spatial control of actin assembly, is directly related
to cell spreading and proliferation and inversely related to differentiation in melanoma cells and
melanocytes. Here we investigate the relationship of melanocyte differentiation to cell migration and
zyxin expression using isolated human neonatal melanocytes in serial passages, Western immunoblots
and digital time-lapse and confocal microscopy. Early passage non- or hypo-pigmented diaphanous
melanocytes exhibit high mean migration rates and numerous large zyxin-labeled focal adhesions
whereas late passage stellate or dendritic pigmented melanocytes exhibit low mean migration rates
and relatively few small zyxin-labeled focal adhesions. Actin bundle organization and complexity
reflect zyxin localization and Western immunoblots confirm a decrease in zyxin expression as dif-
ferentiation increases and migration rates fall. These findings support a role of zyxin in melanocyte
migration and differentiation. 
0276
The mouse desmosomal cadherin gene cluster contains a novel family member, desmoglein 4
RC Bauer,1 H Bazzi,2 H Lam,1 A Martinez-Mir1 and AM Christiano1,2 1 Dermatology, Columbia
University, New York, NY and 2 Genetics & Development, Columbia University, New York, NY
Desmogleins are members of the cadherin superfamily, and as such represent critical structural
components of the desmosomal cell-cell junctions in keratinocytes and other epithelia. The genes
encoding mouse desmogleins are localized within 350 kb of chromosome 18, within a desmosomal
cadherin gene cluster also containing the three mouse desmocollin genes. Here, we describe a novel
mouse desmoglein gene, designated desmoglein 4 (Dsg 4), which is localized within the desmoso-
mal gene cluster, between Dsg1 and Dsg3. The gene arrangement of the desmosomal cadherin clus-
ter in mouse is: Cen-Dsc3-Dsc2-Dsc1-Dsg1γ,Dsg1α,Dsg1β-Dsg4-Dsg3-Dsg2-Tel. Dsg4 has 40%,
40%, 40%, 34% and 43% amino acid identity to Dsg1α,β, γ, 2 and 3, respectively. Comparison of
its exon-intron structure reveals a high level of evolutionary conservation expected from these related
family members.  In contrast to Dsg1α, Dsg1β and 3, whose expression is largely restricted to the
skin, Dsg4 is also expressed in the brain, skeletal muscle, heart, kidney, among other tissues, sug-
gesting a more widespread role in cell adhesion, in parallel with Dsg2 and Dsg1.  Dsg4 is present
in the human and rat genomes in the identical location, and a high degree of amino acid homology
suggests functional importance of the gene and corresponding protein in mammalian skin. The
identification of this novel desmosomal cadherin gene will facilitate mutation detection in mice
with phenotypes manifesting in the skin and other tissues. 
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A novel pemphigus vulgaris antigen, desmoglein 3-like molecule, is disrupted in desmoglein
3-/- mice that have pemphigus-like lesions
VT Nguyen Dermatology, University of California, Davis, CA
Pemphigus vulgaris (PV) autoantibodies (Ab) to keratinocyte (KC) antigens (Ag) other than
desmoglein (Dsg) 1 and 3 have been shown to induce PV-like lesions in Dsg3-/- mice (129xBL/6
Dsg3null strain). While PVAb absorbed by recombinant protein of extracellular (EC) domain of Dsg3
can induce PV-like lesion in neonatal mice, the Ab also strongly recognize other epidermal Ag of
Dsg3-/- mice including a 130 kDa protein. I have hypothesized that the pathogenic Ab may target
KC Ag with similar peptide sequence to Dsg3EC. Blast searching of the Genebank database for mol-
ecules with homology to Dsg3EC revealed a computational predicted novel Dsg3-like molecule.
3217bp reading frame of the molecule were amplified from human epidermal cDNA by overlap-
ping RT-PCR. The cDNA encodes for a polypeptide of 117kDa that is 55% similar to Dsg3 and con-
tains all 4 conserved regions of a cadherin. Since the EC of Dsg3-like molecule is more than 90%
similar to Dsg3EC, I asked if Dsg3 PVAb could recognize the novel molecule. Recombinant pro-
tein of Dsg3-like EC was generated by pQE30 expression vector transformed into E. coli and used
for Western blot. The protein appeared to be strongly recognized by affinity purified PVIgG to
Dsg3EC. Unlike Dsg3-/- ancestors (B6; 129X1-Dsg3tm1Stan strain), only few rare older Dsg3-/-
mice of 129xBL/6 Dsg3null strain were found to have lesions. Since Dsg3-like molecule contains
an identical stretch of contiguous antigenic peptide contained in the immunogen previously used to
generate antibody for testing the absence of Dsg3 in B6; 129X1-Dsg3tm1Stan mice, I suspected
that these exceptional mice might inherit from their ancestors to be homozygous for disrupted
Dsg3-like gene. 1278 bp cDNA coding for partial Dsg3-like homolog was amplified from mouse
epidermal cDNA by RT-PCR. PCR genotyping showed 4 out of 5 exceptional mice to be homozy-
gous for disrupted Dsg3-like gene in addition to disrupted Dsg3 gene. Thus the data suggest that
novel Dsg3-like molecule may have an important role in mediating KC adhesion and it is one of the
KCAg targeted by pathogenic PVAb. 
0279
Role of connective tissue growth factor in the pathogenesis of scarring in Steven Johnson Syn-
drome
MS Razzaque,1 T Khan,1 CS Foster2 and AR Ahmed1 1 Department of Oral Medicine and
Diagnostic Sciences, Harvard School of Dental Medicine, Boston, MA and 2 Immunology and
Uveitis Service, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA
Stevens Johnson Syndrome (SJS) is a rare vesiculobullous disease characterized by an acute cuta-
neous eruption that involves the skin and mucosal membranes. Conjunctiva is one of the commonly
affected mucosal surface in patients with SJS. In the advance stages, development of conjunctival
fibrosis is associated with blindness in a significant number of patients with SJS. In the present study,
we examined the role of transforming growth factor beta 1 (TGF-b1) and connective tissue growth
factor (CTGF) in conjunctival scarring in patients with SJS. Biopsies from conjunctiva of 7 patients
with SJS, and 5 control subjects, were studied for the expression of type I and type III collagens,
TGF-b1, and CTGF, by using immunohistochemistry and quantitative real-time PCR. The role of
TGF-b1 on the induction of collagen, and CTGF was also studied using fibroblasts isolated from
conjunctival tissues. Compared to controls, an increased expression of interstitial collagens (type I
and III) was detected in conjunctival biopsy sections of SJS patients, as detected by immunohisto-
chemistry. Similarly, in contrast to the weak and sparse expression of TGF-b1 and CTGF in control
conjunctiva, elevated expression of these fibrogenic molecules was observed in conjunctiva of patients
with SJS. By quantitative real-time PCR, an increase in the expression of type I collagen (3.3 fold),
TGF-b1 (1.7 fold) and CTGF (3.4 fold) was detected in the conjunctival tissues obtained from patients
with SJS, compared to controls. When conjunctival fibroblasts were treated with TGFb1, upregula-
tion in the expression of type I collagen, and CTGF was detected. Increased levels of TGF-b1 and
CTGF might regulate increase synthesis and production of interstitial collagens, and thereby could
contribute significantly to the development of conjunctival scarring in patients with SJS. 
0281
Increased expression of integrin-linked kinase correlates with melanoma invasion
D Dai,1 N Makretsov,2 EI Campos,1 M Martinka,2 C Huang,1 Y Zhou,1 D Huntsman2 and G Li1 1
Medicine, University of British Columbia, Vancouver, BC, Canada and 2 Pathology, University of
British Columbia, Vancouver, BC, Canada
Cell adhesion to extracellular matrix (ECM) is an important process that controls cell survival, shape,
migration, proliferation, and differentiation. Integrin-linked kinase (ILK), a key component of the
cellular ECM adhesion, has been studied extensively in recent years. Overexpression of ILK in epithe-
lial cells results in anchorage-independent cell growth with increased cell cycle progression. Fur-
thermore, increased ILK expression is correlated with progression of several human tumor types,
including breast, prostate, brain, and colon carcinomas. To investigate the role of ILK expression in
melanoma progression, we employed the tissue microarray technique and examined the ILK expres-
sion in 67 human primary malignant melanoma biopsies by immunohistochemistry. Our data showed
that ILK was highly overexpressed in 16 of 67 cases (24%). We found that overexpression of ILK
was significantly correlated with the thickness of the tumors (P<0.05). Of the six cases which have
lymph node metastases, five showed overexpression of ILK in primary tumors. Furthermore, our
analysis also indicated that melanoma patients older than 60 years of age had more ILK overex-
pression than those younger than 60 years (P<0.01). Overexpression of ILK was not associated with
the histological types or the location of the tumors. Taken together, our data suggest that ILK over-
expression may play an important role in melanoma progression. 
0280
Measurement of the mechanical properties of actin filament and keratin intermediate filament
networks in a monolayer of cultured human epidermal keratinocytes
JC Selby, SA Boppart and MA Shannon Beckman Institute for Advanced Science and Technology,
University of Illinois at Urbana-Champaign, Urbana, IL
Arguably, the biological basis of the robust mechanical properties of the epidermis can be contributed
to (i) highly organized actin and keratin intermediate filament networks within individual keratinocytes,
and (ii) the cell-cell junctions, namely desmosomes and adherens junctions, that anchor the cytoskele-
tal networks between adjacent keratinocytes into a functional tissue. Although many rheological
studies have investigated the viscoelastic properties of isolated actin and keratin intermediate fila-
ments, few researchers have attempted experiments geared towards quantifying the mechanical prop-
erties of organized and anchored cytoskeletal networks as they exist in a confluent monolayer of
human keratinocytes cultured in vitro. Towards this end, an experimental blister-type, load-dis-
placement apparatus has been designed and constructed to measure the dynamic differential pres-
sures and deflections of a microfabricated, clamped, circular, elastic polydimethylsiloxane (PDMS)
membrane upon which normal human keratinocytes have been plated and cultured into a confluent
monolayer. Simple mechanical models of isotropic, bi-layered, linear elastic, incompressible mem-
branes convert measured pressure-induced deflections of a composite substrate (PDMS + keratinocyte
monolayer) into cellular stresses and strains. Therefore, pressure-deflection data collected from a
composite substrate during a temporal study of adherens junction and desmosome assembly (induced
by the well-known calcium switch) can be used to characterize the formation of organized and
anchored cytoskeletal filament networks within the keratinocyte sheet. It is hoped that an advanced
understanding of the constitutive mechanical behaviors of organized and anchored actin and inter-
mediate filament networks may provide valuable insight into their respective biological functions
within the epidermis in states of both health and disease. 
0278
The triple-helical domain of type VII (anchoring fibril) collagen promotes human epidermal
keratinocyte migration via α2β1 and α3β1 integrins
M Chen, K Lipman, T Atha, S Oshtory and DT Woodley Dermatology, University of Southern
California, Los Angeles, CA
Recent studies suggest that anchoring fibrils and anchoring filaments are collapsed and in contact
with the basal keratinocytes. Type VII collagen (COL VII), the major component of anchoring fib-
rils, consists of a central collagenous triple helical domain (TH) flanked by a 145 kDa N-terminal
noncollagenous (NC1) globular domain and a small 34 kDa C-terminal noncollagenous (NC2) domain.
In this study, we determined whether recombinant COL VII promoted the migration of human epi-
dermal keratinocytes and dermal fibroblasts and identified the cell surface receptor involved. Recom-
binant COL VII vigorously promoted human fibroblast and keratinocyte migration. Cell migration
on COL VII was divalent cation dependent and was inhibited by EDTA. Although COL VII contains
four RGD sequences, the migration of keratinocytes and fibroblasts on COL VII was not inhibited
by the presence of RGD peptides. By using function-blocking monoclonal antibodies, COL VII medi-
ated cell migration was completely inhibited by monoclonal antibodies directed against the integrin
subunits α2, α3 and β1, but not by antibodies to α5, α6, and β4. To further localize the domain within
COL VII that promotes cell migration, we subjected a series of COL VII domain constructs, includ-
ing the pure NC1 and NC2 domains and a truncated minicollagen that lacked 684-amino acids of
central triple helical domain, to the migration assays. Using these purified mutant proteins, the migra-
tion promoting activity of COL VII was mapped to 684 amino acids (residues 1920-2603) within
the triple helical domain. Further, two generated G2049E and R2063W mutations, next to the 39
amino acid helical interruption hinge region, that are associated with recessive dystrophic epider-
molysis bullosa, showed significantly reduced ability to promote keratinocyte migration. We con-
clude that cell motility induced by COL VII is mediated by a 684 amino acid segment within the TH
and by the α2β1 and α3β1 integrin receptors on the cell surface. 
0282
Characterization of molecular mechanisms underlying mutations in dystrophic epidermoly-
sis bullosa using site-directed mutagenesis
M Chen, T Atha, K Lipman, Y Huang, I Bykhovskaya and DT Woodley Dermatology, University
of Southern California, Los Angeles, CA
Type VII collagen (COL VII) is the major component of anchoring fibrils, structures which medi-
ate epidermal-dermal adherence. COL VII gene (COL7A1) mutations cause dystrophic epidermol-
ysis bullosa (DEB), a genetic mechano-bullous disease, but the underlying molecular mechanisms
leading to DEB clinical phenotypes are unknown. In this study, we introduced 4 individual substi-
tution mutations, G2049E, R2063W, G2569R and G2575R, into the COL VII expression vector using
site-directed mutagenesis. All four mutations result in a total absence of anchoring fibrils in reces-
sive DEB patients. The mutant constructs were transfected into human 293 cells and stably trans-
fected cell clones isolated. All but R2063W synthesized and secreted a 290 kDa mutant COL VII
alpha chain at levels similar to the wild type COL7A1. Biochemical characterization of the purified
mutant COL VII proteins and structural and functional comparisons with wild type COL VII demon-
strated: (1) The G2569R and G2575R mutations near the end of the triple helical domain adjacent
to noncollagenous NC2 resulted in mutant COL VII with an increased sensitivity to protease and a
decreased ability to form trimers. (2) The G2049E and R2063W mutations next to the 39 amino
acid helical interruption hinge region produced mutant COL VII with reduced ability to support ker-
atinocyte and fibroblast migration. (3) Limited proteolytic digestion of mutant G2049E and R2063W
proteins yielded aberrant fragments and revealed reduced stability of the triple helix. These muta-
tions cause a local destabilization of the triple-helix that exposes an additional highly sensitive pro-
teolytic site that maps within the region of the mutation. The R2063W mutation also resulted in the
secretion of an unstable degraded 200 kDa COL VII mutant protein. We conclude that these COL7A1
mutations are located within motifs of different importance for the function of COL VII. Protein pro-
cessing, folding, stability, and cell-matrix binding may be altered by specific mutations in the COL7A1
gene. 
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Essential oil of neroli is a potent inhibitor of MMPs activities
C Lasserre1 and E Tschachler1,2 1 Biology Unit, CERIES, Neuilly sur Seine, Hauts de seine, France
and 2 Dermatology, University of Vienna, Vienna, Austria
Induction and activation of matrix metalloproteinases (MMPs) including MMP1, MMP2, MMP3
and MMP9 has been demonstrated to play a crucial role in skin photoaging. The aim of this study
was to identify inhibitors of MMP1, MMP2, MMP3, MMP9 activities and synthesis in order to coun-
teract the degradation of the extracellular matrix components. To this purpose, several plant extracts
were evaluated for their inhibitory potential. Extracts were incubated with MMP activated with p-
aminophenyl mercuric acetate. The enzymatic activity was monitored by the addition of a fluores-
cent substrate specific for the respective MMP. We observed an inhibition of the activities of the 4
aforementioned MMPs with the essential oil of Neroli (EON) (Bigaradier,Citrus aurantium, extract)
and an extract of dried Green Tea leaves (GTL) (Camellia Sinaesis) rich in flavanols which was
used as a positive control. Inhibition of MMPs activity, up to 100%, was dose dependent and the
MMP2 inhibition was confirmed by gelatin zymography. No regulation of MMP1, pro-MMP2, pro-
MMP9 expression by keratinocytes was detected at the concentrations used. Our data demonstrate
the essential oils may contain potent inhibitors of MMPs and therefore represent interesting candi-
dates for the treatment of skin disorders due to MMP activation. 
0284
Targeted inhibition of human collagenase-3 (MMP-13) expression by antisense ribozyme inhibits
squamous cell carcinoma growth in vivo
R Ala-aho,1 M Ahonen,1 SJ George,2 J Heikkila,3 R Grenman,4 M Kallajoki5 and V Kahari1 1
Centre for Biotechnology, University of Turku, Turku, Finland, 2 Bristol Heart Institute, University
of Bristol, Bristol, United Kingdom, 3 Department of Biochemistry, Abo Akademi University,
Turku, Finland, 4 Department of Otorhinolaryngology, University of Turku, Turku, Finland and 5
Department of Pathology, University of Turku, Turku, Finland
Squamous cell carcinomas (SCCs) of the head and neck are characterized by high tendency to invade
locally and metastasize to lymph nodes. Collagenase-3 (MMP-13) is specifically expressed by tumor
cells of SCCs. To specifically examine the role of MMP-13 in the growth and invasion of SCC, we
constructed a hammerhead ribozyme targeted against human MMP-13 mRNA. The anti-MMP-13
ribozyme effectively cleaved MMP-13 transcripts in vitro. Delivery of MMP-13 antisense ribozyme
into metastatic cutaneous SCC cells with a recombinant adenovirus, RAdMMP-13ASRz, resulted
in potent and specific inhibition in production of proMMP-13 and suppressed invasion of SCC cells
through Matrigel by 80%. In vivo injection of RAdMMP-13ASRz into human SCC xenografts estab-
lished in SCID mice inhibited tumor growth by 50-75%, inhibited MMP-13 expression and gelati-
nolytic activity, and reduced number of proliferating cells by 30%. The MMP-13 antisense ribozyme
delivery also resulted in apoptosis in SCC cells within 72 hours. These results show, that MMP-13
plays an important role in SCC tumor growth in vivo identifying MMP-13 as a potential therapeu-
tic target in SCCs of the head and neck. 
0285
Keratinocytes grow at the medium/air interface on a basement membrane-like sheet formed
by cell-released proteins
L Eckhart,1 C Reinisch,1 S Inoue,2 P Messner,3 M Dockal,1 C Mayer1 and E Tschachler1,4 1
Department of Dermatology, University of Vienna Medical School, Vienna, Vienna, Austria, 2
Department of Anatomy and Cell Biology, McGill University, Montreal, QC, Canada, 3 Centre for
Ultrastructure Research, University of Agricultural Sciences, Vienna, Austria and 4 Centre de
Recherches et d’Investigations Epidermiques et Sensorielles (CE.R.I.E.S.), Neuilly, 92521, France
Epithelial cells require adherence to a matrix for regular growth. During standard keratinocyte cell
culture in serum-free medium, we observed that cell colonies formed not only on the bottom of the
culture vessels but also at the medium/air interface. Coomassie blue staining detected a protein mem-
brane that extended up to several centimeters between the colonies of floating cells. Ultrastructural
investigation of this membrane revealed structures that closely resembled those of basement mem-
branes and immunochemical staining confirmed the presence of laminins-1 and -5, representative
components of basement membranes. Cells attached to the floating sheet were proliferating and could
be cultivated for up to six months. Our finding that matrix proteins released by keratinocytes are
able to self-assemble into basement membrane-like sheets gives new insight into the formation of
the epithelial/mesenchymal interface. The fact that these membranes can sustain continued cell growth
opens new ways for cultivation of epithelial cells. 
0286
Regulation of ADAM9 expression in human skin tumors
P Zigrino, C Mauch and R Nischt Dermatology, University of Cologne, Cologne, Germany
ADAM9 belongs to a family of metalloprotease disintegrins (ADAMs) which are membrane-anchored
glycoproteins thought to be involved in protein ectodomain shedding and cell-cell or cell-matrix
interactions. However, the precise biological functions of ADAM9 are still unclear. The aim of this
study was to analyze the regulation of ADAM9 expression in tumor cells in vitro and in vivo in human
skin tumors. RNA analyss of melanoma cell lines with different invasive abilities showed ADAM9
expression in all cell lines independent of their invasive capacities. ADAM9 expression did not depend
on cell density, was not altered by growth factors and cytokines, and by culture on different extra-
cellular matrix proteins (i.e. fibronectin, type IV collagen, monomeric collagen type I) used as pla-
nar substrates. However, we observed down-regulation of ADAM9 expression upon culture of
melanoma cells within three-dimensional lattices of fibrillar type I collagen, whereas, culture within
three-dimensional gels consisting of alginate, a polysaccharide, did not alter transcript levels. These
results indicate a specific regulatory effect of fibrillar collagen on ADAM9 expression. In various
skin tumors, by immunohistochemical stainings, we found an intense staining of ADAM9 primarily
in basal keratinocytes and in some suprabasal cells. In contrast, basal cell carcinoma cells displayed
in most cases no or a faint staining. In malignant melanoma, ADAM9 appeared to be more diffusely
distributed and the staining restricted to the melanoma cells within the invading part. Surprisingly,
ADAM9 protein was not only detected in the melanoma cells but also in peritumoral stromal fibrob-
lasts while it lacked in fibroblasts distant of the tumor site. These findings suggest that in vitro ADAM9
expression is poorly regulated by cell proliferation and soluble factors while fibrillar collagen has a
putative novel regulatory role on ADAM`s expression. In addition, the distinct distribution pattern
of ADAM9 in human skin tumors implicates a potential role of this protease in the aberrant pheno-
type displayed in neoplasia. 
0287
Human melanoma cells induce synthesis of proMMP1 in co-cultured dermal fibroblasts by
secreting bFGF and IL-1α
S Loeffek,1 P Zigrino,1 G von Muijen2 and C Mauch1 1 Dermatology, University of Cologne,
Cologne, Germany and 2 Pathology, University Hospital, Nijmegen, Netherlands
Proteolytic degradation of the extracellular matrix is one major event in invasion and metastasis of
malignant melanoma. This process is achieved by the concerted action of different proteolytic enzymes
including the matrix metalloproteinases (MMPs). Using in situ zymography we have shown that in
human melanoma increased MMP activity is localized at the border of tumor cells and the peritu-
moral connective tissue emphasizing the role of tumor-stroma interactions in the modulation of the
enzyme activity. To study the mechanisms of tumor-stroma interactions we have co-cultured BLM
melanoma cells and human dermal fibroblasts (dFb) either in direct cell-cell contact or in transwell
chambers, in which the cells, separated, can communicate by soluble factors. In both systems syn-
thesis of proMMP1 was increased. Culturing dFb in the presence of media from BLM cells resulted
in a strong induction of proMMP1 synthesis suggesting that soluble factors are responsible for this
induction e.g. IL-1αand bFGF that are known to be potent inducers of proMMP1 synthesis and are
produced by the BLM cells. Culture of dFb with IL-1αand bFGF were indeed effective in inducing
MMP1 synthesis. Competition of IL-1αwith recombinant IL-1RA and neutralizing antibodies, dose-
dependently decreased but failed to completely abolish synthesis of proMMP1. Similarily, bFGF
antibodies dose-dependently inhibited proMMP1 synthesis suggesting that this induction is caused
by multiple soluble factors. In human melanoma tissue we observed increased IL-1αand bFGF pro-
tein in the melanoma cells corroborating the role of these factors in vivo. We also showed that in
vitro melanoma cells produce increased amounts of IL-1αupon contact with connective tissue pro-
teins e.g. type I collagen. In conclusion, these results suggest that the contact of melanoma cells
with dermal matrices might induce synthesis and secretion of soluble factors, eg. IL-1αthat in turn
can activate dermal Fb to produce proteases. 
0288
Dsg1δ is a novel member of the mouse desmosomal cadherin cluster
H Bazzi,2 A Kljuic,2 H Kim,2 A Martinez-Mir1 and AM Christiano1,2 1 Dermatology, Columbia
University, New York, NY and 2 Genetics & Development, Columbia University, New York, NY
The mouse desmogleins are members of the desmosomal cadherin superfamily, and are key struc-
tural components of the desmosome. Like in the human genome, the genes encoding mouse
desmogleins are tightly clustered within 350 kb of chromosome 18, within a desmosomal cadherin
gene family also containing the three desmocollin genes. We have characterized a novel mouse
desmoglein gene, which is highly homologous to both mouse and human Dsg1, and have desig-
nated it desmoglein 1γ (Dsg1c). Dsg1γ shares 83% amino acid identity to the previously described
mouse Dsg1, now designated as Dsg1α, and 32% and 40% identity to mouse Dsg2 and 3 respec-
tively. The Dsg1γ gene maps within the desmosomal gene cluster, between Dsc1 and Dsg1α. Com-
parison of its exon-intron structure reveals a high level of evolutionary conservation with related
family members. In contrast to Dsg1α and Dsg3 whose expression is largely restricted to the skin,
Dsg1γ is also expressed in the brain, skeletal muscle, and liver, among other tissues, and is thus
more similar to Dsg2 in its tissue distribution. Thus, the gene arrangement of the desmosomal cad-
herin cluster in mouse is: Cen-Dsc3-Dsc2-Dsc1-Dsg1γ,Dsg1α,Dsg1β-Dsg4-Dsg3-Dsg2-Tel. Inter-
estingly, an orthologous Dsg1δ gene was not found in the current version of the human or rat genomes,
suggesting that the desmosomal cadherin gene cluster contracted during mammalian evolution. 
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Venous leg ulcers and apoptosis: a TIMP-3 mediated pathway ?
Y Herouy,1 M Idzko,2 T Hildenbrand,1 MJ Ali,4 J Clement,1 D Ferrari,3 F Di Virgilio3 and
J Norgauer1 1 Department of Dermatology, University Hospital, Freiburg, Germany, 2 Department
of Pneumology, University Hospital, Freiburg, Germany, 3 Department of Experimental Medicine,
University Hospital, Ferrara, Italy and 4 Department of Gastroenterology, University Hospital,
Freiburg, Germany
Tissue inhibitor of metalloproteinase-3 (TIMP-3) belongs to a family of secreted proteins that reg-
ulate the activity of several metalloproteinases and is an inducer of apoptotic cell death. The prodeath
domain of TIMP-3 resides in its N-terminal region and apoptosis is induced by the activation of a
signaling cascade involving caspase-8 and -9. Venous leg ulcers account for the majority of chronic
wounds and lack clinical signs of necrotic events. Here we determined the protein expression of
TIMP-3, FAS/CD95 by immunohistochemistry, the caspase-8 and caspase-9 protein expression and
activity by caspase activity assays as well as the DNA-fragmentation by positive DNA in situ nick
end-labeling (TUNEL) in tissue specimens of venous leg ulcers or healthy skin controls. Staining
with anti-TIMP-3 displayed an intense signal around collagen bundles in the reticular dermis of
venous leg ulcers. Staining with Fas/CD95 showed an intense cellular immunoreactivity in lesions
in comparison with healthy controls. Immunoblotting with caspase-8 and -9 antibodies revealed
prominent bands for the processed forms as well as the active subunits of these apoptosis regulators.
Lesional skin displayed strongly increased activity for caspase-8 and caspase-9 in comparison with
healthy controls measured by caspase activity assays. Moreover, quantification of apoptotic cells by
TUNEL revealed significantly elevated apoptotic cell death in venous leg ulcers in comparison with
healthy controls. In summary our data for the first time provide evidence that venous leg ulcers could
be the result of an apoptotic signaling pathway, which might be induced through a TIMP-3-medi-
ated inhibition of proteinase-dependent ECM-degradation. These results suggest that controlling pro-
grammed cell death may have therapeutic potential in preventing venous leg ulceration. 
0291
The 97 kDa and 120 kDa fragments of type XVII collagen have different N-termini
Y Hirako,1 Y Nishizawa,2 C Sitaru,1 A Opitz,1 K Marcus,3 E Butt-Dorje,4 K Owaribe5 and
D Zillikens1 1 Dept. of Dermatology, Univ. of Wuerzburg, Wuerzburg, Germany, 2 Dept. of
Anatomy, Nagoya University, Nagoya, Japan, 3 Ruhr University, Bochum, Germany, 4 Institute of
Clinical Biochemistry, Univ. of Wuerzburg, Wuerzburg, Germany and 5 Graduate School of Human
Informatics, Nagoya University, Nagoya, Japan
Type XVII collagen is a hemidesmosomal transmembrane glycoprotein. Several subepidermal blis-
tering diseases are associated with an autoimmune response to this molecule, including linear IgA
disease (LAD). Two proteolytic fragments of type XVII collagen are the major antigenic targets in
LAD, including epidermis-derived 97 kDa (LABD97) and keratinocyte-derived 120 kDa (LAD-1)
polypeptides. Both fragments were assumed to have the same N-terminus within the membrane-
proximal 16th non-collagenous A (NC16A) domain of type XVII collagen. However, in contrast to
LABD97, the N-terminus of LAD-1 has not yet been identified. To address this issue, in a first set
of experiments, we immunoadsorbed serum from a rabbit, immunized against the recombinant NC16A
domain, using 9 overlapping fragments covering this entire domain [amino acid (aa) 490 to 565].
Antibodies purified against a peptide covering aa 521-532 still labeled LAD-1 indicating that its N-
terminus is different from that of LABD97 (aa 531, alanine). To determine the exact cleavage site
of LAD-1, we performed N-terminal sequencing of the protein affinity-purified from concentrated
medium of cultured keratinocytes (DJM-1 cells). This revealed leucine at aa position 524 as the N-
terminus of the polypeptide. Interestingly, this position was 7 aa upstream of the N-terminus of
LABD97. Mass spectrometry of protease-digested fragments of LAD-1 demonstrated the presence
of fragments containing aa 528, confirming that the N-terminus of LAD-1 is different from that of
LABD97. These data suggest that the 120 kDa and 97 kDa fragments are generated through differ-
ent proteolytic processes from type XVII collagen. 
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Cloning and characterization of kindlin, a novel actin cytoskeleton and focal adhesion-associ-
ated protein expressed in keratinocytes
G Ashton,1 F Smith,2 D Siegel,3 A South,1 V Wessagowit,1 N Oyama,1 E Epstein,3 R Eady,1
I McLean2 and J McGrath1 1 Cell and Molecular Pathology, St John’s Institute of Dermatology,
London, London, United Kingdom, 2 Human Genetics Unit, Ninewells Hospital and Medical
School, Dundee, Scotland, United Kingdom and 3 Department of Dermatology, University of
California San Francisco, San Francisco, CA
Numerous cytoskeletal and cell junction proteins are known to have critical roles in keratinocyte
migration and adhesion, although it is likely that further, as yet unidentified proteins might also con-
tribute. We report a new structural protein, kindlin, that we recently identified as being abnormally
expressed in the autosomal recessive skin fragility-poikioloderma disorder, Kindler syndrome (OMIM
173650). The gene for this protein, designated KIND1, is located on 20p12 and encodes a 677
amino acid peptide with homology to the focal adhesion protein, talin. Like talin, kindlin has a FERM
(band4.1/ezrin/radixin/moesin) domain suggesting a role in linking the actin cytoskeleton to the
plasma membrane. This novel protein also has a pleckstrin homology domain and may therefore
function in signal transduction. Multiple tissue northen blotting of keratinocyte cDNA revealed strong
expression of a 4.9kb transcript in colon, kidney and placenta and lower expression levels in heart,
skeletal muscle, liver and small intestine. An additional 5.8kb transcript was also present in colon.
There was an absence of expression in spleen, lung and peripheral blood leukocytes. Further north-
ern blotting and RT-PCR showed the transcript was expressed in cultured keratinocytes but not in
cultured fibroblasts. A kindlin-GFP fusion protein was shown to co-localize with the actin cytoskele-
ton and also with vinculin, a component of focal contacts, in both keratinocytes and PtK2 cells. In
summary, we have identified a new keratinocyte structural/signaling protein that is associated with
the actin cytoskeleton and focal contacts and which is abnormally expressed in Kindler syndrome. 
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Mice deficient in neonatal Fc receptor (FcRn) are resistant to pemphigus foliaceus
N Li,1 LA Diaz,1 DC Roopenian2 and Z Liu1 1 Department of Dermatology, University of North
Carolina at Chapel Hill, Chapel Hill, NC and 2 The Jackson Laboratory, Bar Harbor, ME
Pemphigus foliaceus (PF) is an IgG autoantibody-mediated cutaneous blistering disease. PF autoan-
tibodies bind to the extracellular domain of desmoglein-1 (Dsg1), an epidermal cell adhesion mol-
ecule, and lead to a progressive epidermal cell-cell detachment known as acantholysis. PF autoan-
tibodies are pathogenic as demonstrated by passive transfer into neonatal mice. The serum titers of
PF autoantibodies correlate with disease activity and extent of the skin involvement. The FcRn medi-
ates the intestinal absorption of maternal IgG in neonatal rodents and the transplacental transport of
maternal IgG in humans. Recent studies have suggested that FcRn also plays a role in protecting cir-
culating IgG from catabolism. The aim of this study was to test a hypothesis that mice deficient in
FcRn are protected from PF because lack of the FcRn, an IgG protective receptor, results in accel-
erated degradation of pathogenic autoantibodies. To test this hypothesis, wild-type and FcRn-defi-
cient mice were injected intraperitoneally with Dsg1-affinity purified pathogenic autoantibodies from
PF patients and examined clinically, histologically, and immunologically for PF disease pheno-
types. We found that FcRn-deficient mice were resistant to experimental PF. Circulating levels of
PF autoantibodies in FcRn-deficient mice were significantly reduced compared to normal mice.
These results indicate that FcRn regulates the serum IgG levels by protecting circulating IgG from
degradation and blocking FcRn function could control antibody-mediated autoimmune diseases such
as PF. 
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A novel human desmosomal cadherin gene family member, desmoglein 4
A Kljuic,2 H Bazzi,2 A Martinez-Mir1 and AM Christiano1,2 1 Dermatology, Columbia University,
New York, NY and 2 Genetics & Development, Columbia University, New York, NY
The human desmogleins are members of the desmosomal cadherin superfamily of proteins, and are
critical structural components of the desmosome. Desmogleins serve as autoantibodies in acquired
bullous dermatoses such as pemphigus vulgaris and pemphigus foliaceous. In addition, inherited
mutations in desmoglein 3 result in the bal/bal phenotype in mice, and human desmoglein 1 muta-
tions result in a form of striated keratoderma. Clearly, desmogleins are important determinants of
cell-cell adhesion between keratinocytes of the skin and hair follicle. The genes encoding human
desmogleins are localized within 350 kb of chromosome 18q12, within a desmosomal cadherin gene
cluster also containing the three desmocollin genes. In this study, we characterized a novel human
desmoglein gene, designated desmoglein 4 (DSG4), and mapped it within the desmosomal gene clus-
ter, between DSG1 and DSG3. DSG4 has 38%, 36% and 46% amino acid identity to DSG1, 2 and
3, respectively. Comparison of its exon-intron structure reveals a high level of evolutionary conser-
vation expected from these related family members.  In contrast to DSG1 and 3, whose expression
is largely restricted to the skin, DSG4 is also expressed in the brain, skeletal muscle, heart, kidney,
pancreas and thymus, among other tissues.  DSG4 orthologs with high homology are also present
in the mouse and rat genomes in the identical location between Dsg1 and Dsg3, suggesting func-
tional importance of the gene and corresponding protein. Interestingly, the newly identified Dsg1
isoforms in the mouse genome, Dsg1α and Dsg1β, are not represented in the human genome. Cur-
rently, the gene arrangement of the desmosomal cadherin cluster in the human genome is: Cen-Dsc3-
Dsc2-Dsc1-Dsg1-Dsg4-Dsg3-Dsg2-Tel. The identification of this novel desmosomal cadherin gene
will facilitate mutation detection in human disorders with cell adhesion defects in the skin and other
tissues. 
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Analysis of the dermo-epidermal junction in mice lacking the basement membrane proteins
nidogen-1 and nidogen-2
M Korthals,1 C Schmidt,2 D Breitkreutz,2 N Miosge,3 N Smyth,4 T Krieg1 and R Nischt1 1
Dermatology, University of Cologne, Cologne, Germany, 2 German Cancer Research Center,
Heidelberg, Germany, 3 Histology, University of Goettingen, Goettingen, Germany and 4
Biochemistry II, Med. Faculty, University of Cologne, Cologne, Germany
Nidogens are a small family of related proteins which includes the two mammalian species, nido-
gen-1 and nidogen-2. Based on biochemical and structural studies it has been proposed that nido-
gens act as connecting elements for basement membrane (BM) assembly. To elucidate this role fur-
ther, mice deficient in either nidogen-1 or both isoforms were generated. Nidogen-2 deficient mice
for cross-breeding had been kindly provided by B. Skarnes (University of California, Berkely,
USA) and characterized by B. Bader (Max-Plank-Institute for Biochemistry, Martinsried, Germany).
The absence of either nidogen-1 or nidogen-2 did not affect BM formation in general. By contrast,
mice lacking both nidogen isoforms die shortly after birth showing a wide range of developmental
defects. Surprisingly, the gross morphology of skin appeared normal with no signs of blister for-
mation. In addition, no differences in epidermal keratinization between mutant and wild-type skin
were observed. So far immunostaining with other BM components did not reveal major differences
at the dermo-epidermal junction in mutant skin when compared to wild-type controls. However, at
the ultrastructural level disruption and thinning of basement membranes as well as aberration in
hemidesmosomes were detected, being currently analyzed in greater detail. Furthermore, we inves-
tigated BM synthesis and assembly in three-dimensional cocultures using human epidermal ker-
atinocytes or HaCaT cells and skin fibroblasts from newborn nidogen-deficient mice. With NID1 -
/-//NID2 +/- fibroblasts neither a distinct deposition of nidogen-1 or nidogen-2 was detectable in
contrast to control cultures with wild-type fibroblasts. Surprisingly, there was also no deposition of
laminin-10, but of some collagen IV, while laminin-5 was only slightly affected. Integrin alpha6beta4
appeared largely normal. 
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Interaction of Bia-1 with integrin α1 tail regulates collagen expression
A Horstmeyer,1 D Kessler-Becker,1 M Plomann,2 D Piecha,1 D Petersohn,1 T Krieg1 and B Eckes1
1 Dermatology, University of Cologne, Cologne, Germany and 2 Institute for Biochemistry II,
University of Cologne, Cologne, Germany
Interaction of fibroblasts with extracellular matrix proteins influences a large number of cellular
functions. The contact with most ECM proteins is mediated by integrin receptors of the β1 family,
and binding of the integrin cytoplasmic domains to intracellular proteins is thought to initiate sig-
nal transduction. A yeast-two hybrid screen was performed, resulting in identification of proteins
which bind to the conserved membrane-proximal region and others which bind either to several or
exclusively to individual integrin cytodomains. Of the specific binding partners for α1 integrin, one
was further analyzed. Termed Bia-1, it represents an as yet unknown protein which displays the struc-
tural organization characteristic of the TRIM protein family: RING finger, zinc-binding and coiled-
coil domains and a B30.2 box, which is indicative of protein interactions and potential dimerization.
To study the biological function of Bia-1 and its possible role in modulating collagen synthesis, spe-
cific antibodies were produced for immunostaining and immunoprecipitation. Further, fibroblasts
were engineered to either overexpress Bia-1 or expression was reduced by transfecting antisense
oligodeoxynucleotides. In both approaches, Bia-1 and collagen (α1 or α2 (I)) mRNA levels were
regulated in opposite directions, i.e. low Bia-1 levels correlated with high collagen synthesis. These
results were confirmed by culturing untransfected primary skin fibroblasts under conditions of
well-characterized modulation of collagen synthesis. These results strongly support a role for the
cytoplasmic protein Bia-1 in initiating the signaling cascade elicited by activation of α1β1 integrin
and regulating collagen synthesis. 
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Emerging phenotypes of mice lacking integrin α2β1
K Strick,1 K Elias,1 M Aumailley,2 C Mauch,1 B Nieswandt,3 T Krieg1 and B Eckes1 1
Dermatology, University of Cologne, Cologne, Germany, 2 Biochemistry II, University of Cologne,
Cologne, Germany and 3 Rudolf Virchow Center, Wuerzburg, Germany
Cell - collagen interactions play vital roles in development and tissue homeostasis. Integrin α2β1 is
one of the most important and abundantly expressed receptors which mediates these interactions. To
study α2β1 functions in vivo, we generated mice lacking the α2 subunit. Surprisingly, mice defi-
cient in α2β1 develop apparently normally and reproduce, indicating that no major developmental
defects arise from α2-deficiency. The skin of these animals is normal at gross morphological inspec-
tion. However, functional analysis of fibroblasts and keratinocytes cultured from the skin of α2-/-
animals revealed impairment in attachment, migration, contractile capacity, protease secretion as
well as cytoskeletal abnormalities, all required for normal wound healing. Further, α2β1 was pos-
tulated as the major collagen receptor on platelets, mediating platelet adhesion to collagen and required
for the formation of a hemostatic plug following injury. Indeed, differences in adhesion and colla-
gen-induced aggregation by α2-deficient platelets were observed. However, bleeding times and
platelet counts were normal in α2-/- mice. We then applied antibodies to block another collagen
receptor, GPVI, which completely abrogated adhesion to collagen fibrils. Furthermore, intravital
microscopy following endothelial injury demonstrated normal thrombus formation in vivo in α2-
deficient mice. These results confirm that integrin α2β1 plays a supportive rather than essential role
in hemostasis. 
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Unidirectional organization of alpha-smooth muscle actin microfilament network is lost in aged
human dermal myofibroblasts
T Zuliani, C Gondran, S Talbourdet, F Bonte and M Dumas Laboratoires R et D, L.V.M.H. Branche
Parfums et Cosmetiques, Saint Jean de Braye, France
Skin myofibroblasts (MF) participate in wound healing contraction and dermal neoformation. Their
contractile activity is attributed to a well-developed cytoplasmic microfilament network composed
of myosin and actin, particularly alpha-smooth muscle actin (alpha-SMA), expressed throughout the
philogenetic tree in cells whose main function is contraction. MF are connected to the extracellular
matrix by specialized structures called fibronexi, where actin microfilaments and extracellular fib-
rils are organized into a close association, mediated by the integrin family of adhesion receptors.
alpha-SMA expression was investigated by direct immunostaining on 8 normal dermal fibroblast
(DF) strains from abdominal skin of healthy females (24 to 60 year old) after 10 days treatment with
1 ng/ml TGF-beta1, a potent inducer of the MF phenotype. Indirect immunostaining of integrin-
beta1 and cell adhesion measurement on coated type I collagen were also performed. Alpha-SMA
expression was stimulated by TGF-beta1 in all strains (by a factor 2 to 20) but no significant differ-
ences were observed between young and old strains the latter exhibiting the largest heterogeneity.
Interestingly, confocal microscopy showed a multidirectional alpha-SMA microfilament network in
older cells, the younger ones showing an unidirectional feature. Adhesion was greater for MF than
for DF according to the higher integrin-beta1 expression measured on these cells but no statistical
differences were observed between the two age groups. We hypothesize that the impairment of wound
strength as a function of age may be due to a dispersion of the contractile forces throughout the mul-
tidirectional actin microfilament network of MF, more than a reduced ability of aged cells to express
alpha-SMA in response to cytokines or a defect in their adhesion properties. 
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Cystein-rich protein (CYR61), a mediator of collagen homeostasis, is elevated in chronologi-
cally aged, photoaged, and UV-irradiated human skin in vivo
T He, T Quan,Y Shao, JJ Voorhees and GJ Fisher Dermatology, University of Michigan, Ann Arbor,
MI
Chronologically aged, photoaged, and UV irradiated human skin have in common reduced synthe-
sis of procollagen and elevated expression of matrix-degrading metalloproteinases (MMPs). Mole-
cular mechanisms responsible for these abnormalities in chronologically aged, photoaged, and UV
irradiated human skin remain largely unknown. Cystein-rich protein (CYR61) is an extracellular
matrix-associated protein, which has been implicated in regulation of collagen and MMP expres-
sion. We have investigated expression of CYR61 in chronologically aged, photoaged, and UV irra-
diated human skin in vivo, and its functions in human skin fibroblasts. Laser capture microdissec-
tion coupled real-time RT-PCR and immunohistology revealed that CYR61 mRNA and protein were
predominantly (80%) expressed in dermal cells in human skin. Over-expression of CYR61 in human
skin fibroblasts, by adenoviral vectors, reduced type I procollagen mRNA expression (60%, n=3)
and increased MMP-1 (2-fold, n=3), MMP-3 (2-fold), and MMP-9 (3-fold) mRNA expression.
CYR61 mRNA levels (measured by quantitative real-time RT-PCR) were increased 3.9 fold in sun-
protected aged (80+years) human skin, compared to young human skin (20-30 years, n=6, p<0.05).
CYR61 mRNA levels were increased 2.9 fold in photoaged forearm skin, compared to subject-
matched sun-protected hip skin (n=4, p<0.05). UV-irradiation (2MED solar-simulated UV) of human
skin in vivo transiently induced CYR61 mRNA with maximum induction of 6.6-fold at 8 hours post
UV (n=5, p<0.05). CYR61 gene expression returned to its initial basal level 24 hours post UV.
These data demonstrate the ability of CYR61 to regulate MMP and collagen expression in human
skin fibroblasts. Elevated expression of CYR61 may be a key mediator of aberrant collagen home-
ostasis observed in aged and photoaged human skin. Suppression of CYR61 expression represents
a novel therapeutic target to improve the health of aged and photoaged human skin. 
0299
Molecular mechanisms of connective tissue remodeling induced by CO2 laser resurfacing of
human skin in vivo
J Orringer, GJ Fisher, S Kang, C Hammerberg, T Johnson and JJ Voorhees Dermatology, University
of Michigan, Ann Arbor, MI
Relatively little is known regarding molecular mechanisms of dermal extracellular matrix remodel-
ing following CO2 laser resurfacing for photodamaged skin. We have investigated expression pat-
terns of key genes involved in dermal matrix remodeling following CO2 laser treatment. Focal areas
of photodamaged forearms were treated with two passes using the Coherent Ultrapulse laser (300mJ,
60W). Treatment resulted in complete removal of interfollicular epidermis. Total RNA was extracted
from full thickness skin samples, and mRNA levels of specific genes were quantified by real-time
reverse transcriptase PCR. Specific proteins were localized by immunohistochemistry, using frozen
sections. CO2 laser resurfacing resulted in rapid and marked induction of primary cytokines IL-1β
and TNF-α (maximal induction of 14-fold and 11-fold, respectively within 3 days). IL-1β and TNF-
α are known to induce matrix-degrading metalloproteinases (MMP) and repress type I and type III
procollagen (COL) expression. Maximal induction of MMP-1 (collagenase, 39,130-fold); MMP-3
(stromelysin, 1,040-fold), and MMP-9 (gelatinase B, 61-fold, n=10) was observed within 6 days post
treatment. MMP-1 and MMP-3 mRNA levels returned to near baseline by 28 days post treatment,
whereas MMP-9 remained elevated. TGF-β is the major regulator of procollagen production. TGF-
β1 and TGF-β3, but not TGF-β2, were induced within seven days, following the peak of MMP expres-
sion, and remained elevated for 28 days. Increased expression of type I and type III COL coincided
with increased TGF-β expression. COL I and III mRNA levels continued to rise for at least 28 days
(maximally increased 6-fold and 5-fold, respectively). Increased expression of tropoelastin, fibrillin-
1 and fibrillin-2 mRNA was observed at 28 days post treatment. CO2 laser resurfacing biochemi-
cally affects repair of photodamaged skin by initially inducing MMP-mediated removal of actini-
cally damaged collagen, and subsequently stimulating deposition of newly synthesized collagen. 
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The armadillo family protein p120 modulates cadherin expression by regulating cadherin inter-
nalization and degradation
AP Kowalczyk,1,2 K Xiao,1 DF Allison,1 MD Kottke,1 S Summers,1 PA Vincent3 and V Faundez2 1
Dermatology, Emory University, Atlanta, GA, 2 Cell Biology, Emory University, Atlanta, GA and
3 Center for Cardiovascular Sciences, Albany Medical College, Albany, NY
The cellular mechanisms that regulate cadherin levels are poorly understood. Cadherins are coupled
to the actin cytoskeleton by the armadillo family protein β-catenin, which binds to the c-terminal
domain of classical cadherins. p120 is also an armadillo protein, but p120 binds to the cadherin juxta-
membrane domain. In the present study, we sought to determine the mechanisms by which armadillo
family proteins regulate cadherin expression in microvascular endothelial cells (MEC). To address
this question, a mutant cadherin comprising the extracellular domain of the IL-2 receptor and the
VE-cadherin (VE-cad) cytoplasmic tail was expressed in MEC. The mutant cadherin caused the rapid
internalization and degradation of endogenous VE-cad, an effect that was mediated by the endoso-
mal-lysosomal pathway. Interestingly, removal of the β-catenin binding domain from the mutant cad-
herin tail had no effect, but mutation of the p120 binding domain ablated the ability of the mutant
to trigger endocytosis of endogenous VE-cad. Over-expression of p120 but not beta-catenin increased
endogenous VE-cad levels and rescued the down-regulation of VE-cad caused by the mutant cad-
herins. Furthermore, VE-cad levels were dramatically reduced in MEC in which p120 levels were
knocked down using siRNA. To determine the mechanisms by which p120 regulates cadherin expres-
sion, MEC were treated with chloroquine to inhibit lysosomal degradation and thereby trap intra-
cellular pools of VE-cad that entered the endocytic pathway. Over-expression of p120 inhibited the
accumulation of intracellular VE-cad in chloroquine treated cells, whereas β-catenin had no effect.
These data indicate that p120 modulates cadherin expression in MEC by regulating cadherin inter-
nalization and lysosomal degradation. These findings suggest a new paradigm in which the cellular
levels of p120 function as a set point mechanism that controls cellular levels of cadherins. 
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Putative role for protein kinase D in adherens junction formation
BA Shapiro, DM Hardy and WB Bollag Program in Cell Signaling, Institute for Molecular
Medicine and Genetics, Augusta, GA
In order to elucidate the role of the anti-differentiative protein kinase D (PKD) in keratinocyte mat-
uration, we studied PKD’s effect on adherens junction (AJ) formation in cultured mouse keratinocytes
(KCs). Using the calcium switch to promote AJ formation, we treated KCs with various PKD/pro-
tein kinase C (PKC) inhibitors to determine their effect on AJ formation. We monitored AJ forma-
tion by isolating the TritonX-100 insoluble fraction from KCs, and then western blotted this frac-
tion for E-cadherin, an AJ protein. We observed that compounds that potently inhibited PKD and
PKC induced AJ formation, while compounds that inhibited PKC, but did not inhibit PKD effec-
tively, had little effect. Thus we hypothesize that PKD’s anti-differentiative role in keratinocyte
biology is through, at least in part, inhibition of AJ formation. 
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Human intracisternal A-type particle retrovirus proteins in systemic sclerosis patients
M La Placa,1 T Bianchi,1 F Vitone,2 D Gibellini,2 L Muratori,3 C Varotti1 and M Re2 1 Department
of Clinical and Experimental Medicine, University of Bologna, Dermatology Section, Bologna, 2
Microbiology Section, Bologna, Italy and 3 Department of Internal Medicine, Cardioangiology
and Hepatology, Bologna, Italy
Systemic sclerosis (SSc) is a connective tissue disease considered to be an autoimmune disorder.
Although both cellular microchimerism and molecular mimicry of some common infectious agents,
such as cytomegalovirus and parvovirus B19, have been implicated in its pathogenesis, the aetiol-
ogy of SSc remain unknown. Human endogenous retroviruses (HERVs) have been identified in Sjoö-
gren sindrome, insulin-dependent diabetes mellitus, multiple sclerosis, rheumatoid arthritis, systemic
lupus erythematosus (SLE) and congenital heart block. Serum antibodies specific for human intracis-
ternal A-type particles (HIAP), a human endogenous retrovirus recognized by monoclonal antibody
against HIV-1 p24 capsid protein, have been associated to primary biliary cirrhosis, SLE, familial
erosive arthritis and some patient with SSc. In this study, we performed western blot studies on 42
SSc patient sera, in comparison with 18 sera from primary biliary cirrhosis (PBC) patients and 52
healthy subjects (blood donors) to investigate a possible reactivity to HIAP retroviral proteins.
Western blot reactivity to two or more HIAP proteins was detected in 10 (55.5%) serum samples
from PBC patients and in 28 (66%) SSc patients. Only one healthy subject (1.9%) showed positive
results to HIAP proteins. Our results showed a strong association between HIAP seroreactivity and
the detection of autoantibodies to ds-DNA and antimitochondrial, anticentromere and anti-Scl70
antibodies. HIAP reactivity may be attributable either to an autoimmune response to antigenically
related cellular proteins or to a specific antibody process, as consequence of a pathological process.
Although the direct involvement of an A-type endogenous retrovirus in the aetiology of autoimmu-
nity is still an open question, we can consider that endogenous retrovirus, HIAP proteins in partic-
ular, are an hallmark of autoimmune disease. 
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Characterization of ST2L expression in circulating lymphocytes from patients with atopic
dermatitis: up-regulation of ST2L in atopic dermatitis
N Umemoto,1 H Okazaki,2 T Demitsu,1 M Kakurai,3 H Sato,2 D Hirata,2 H Nakagawa,3
S Tominaga,4 S Kano2 and S Minota2 1 Department of Dermatology, Jichi Medical School Omiya
Medical Center, Saitama, Saitama, Japan, 2 Division of Rheumatology and Clinical Immunology,
Department of Medicine, Jichi Medical School, Minamikawachi-machi, Tochigi, Japan, 3
Department of Dermatology, Jichi Medical School, Minamikawachi-machi, Tochigi, Japan and 4
Department of Biochemistry, Jichi Medical School, Minamikawachi-machi, Tochigi, Japan
Th2/Tc2/NK2 cells have been suggested to express ST2L in vivo. We examined ST2L expression
in peripheral blood lymphocytes from patients with atopic dermatitis (AD), which has been postu-
lated to be a Th2-mediated disease, and then analyzed the possible correlation between these values
and the levels of several clinical parameters. ST2L expression in peripheral blood CD4+, CD8+ T
cells and CD56+ NK cells from 23 AD patients and 11 sex- and age-matched healthy control sub-
jects were studied by flow cytometry. The percentages of ST2L+ cells in CD4+, CD8+, CD56+; cells
were significantly higher than those in healthy controls subjects (ST2L+ in CD4+: 13.5±6.2% vs
4.7±2.7%, p<0.0001, ST2L+ in CD8+: 9.6±5.4% vs 3.1±1.1%, p=0.0140, ST2L+ in CD56+:
10.8±5.7% vs 2.2±0.7%, p=0.0001). The percentage of ST2L+ cells in CD4+CD45RO+ T cells cor-
related positively with the total serum IgE, LDH, eosinophil counts and skin scores in AD patients.
The frequency of ST2L+ cells in peripheral blood lymphocytes might be a useful maker of disease
activity in AD. 
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Three-dimensional structures of cutaneous-free nerve endings during epidermal regeneration
M Ishihara, M Mihara, N Yamada, MP Rivera and A Yamamoto Dermatology, Tottori University,
Faculty of Medicine, Yonago, Tottori-Ken, Japan
The aim of the study was to investigate re-innervation of cutaneous nerves in granulation tissue of
burn wounds. Newly epithelialized skin tisuues just attached to the granular tissues of burned ulcer
were obtained during debridement procedure. Obtained skin specimen were fixed with 0.01% glu-
taraldehyde and 0.1% paraformaldehyde in 0.1M phosphate buffer solution and they were immersed
in 0.2% EDTA-2Na/ 125 Unit/mL dispase to facilitate separation of the epidermis from the dermis.
The epidermal components were carefully removed using microforceps under the stereoscopic micro-
scope. The separated dermal surface was observed three-dimensionally by the scanning electron
microscope (SEM) and subepidermal nerve network was studied by the immunofluorescence anti-
body method (IF) with protein gene product 9.5. Distribution of substance P (SP) and calcitonin
gene-related peptide (CGRP) and expression of the nerve growth factor receptor(NGFR) were also
examined by the double-labeled IF of PGP 9.5 and SP, CGRP or NGFR and were viewed under the
confocal laser scanning microscope. Results: SEM showed that numerous short length axon-like
structures with a diameter and length of about 1 and 10 micrometer respectively, were seen pene-
trating through the basal lamina and one of these structures ended as a terminal expansion. Cell
body of a terminal Schwann cell appeared on the basal lamina and possessed long slender dendrites.
It was observed that there was an increase of PGP 9.5-positive fiber networks, arranged parallel and
vertical against the granular tissues. The CGRP-positive substances appeared as granules on the PGP
9.5-positive fibers, but the SP-positive substances were seldom seen. Expression of the NGFR were
also seen prominent on the elongated PGP 9.5-positive fibers. These results confirm that dermal re-
innervation has a strong relationship with epidermal regeneration. 
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Human papillomavirus can be present in malignant melanoma but does not worsen the prog-
nosis
M La Placa,1 S Venturoli,2 S Ambretti,2 F Bonvicini,2 M Cricca,2 T Bianchi1 and C Varotti1 1
Department of Clinical and Experimental Medicine, University of Bologna, Dermatology Section,
Bologna, Italy and 2 Microbiology Section, Bologna, Italy
Although the aetiology of malignant melanoma is still unknown, environmental, hormonal and genetic
factors have been implicated in its pathogenesis. These include lower skin phototypes, with fair or
red hair and blue eyes, the amount of sun exposure and previous sunburns, a familial predisposition
and increased number of dysplastic nevi. The role of human papillomavirus (HPV) in many neo-
plastic diseases, including cervical cancer and non-melanoma skin tumors, has been widely studied.
Occasionally, HPV has been detected in some biopsy specimens from malignant melanoma, sug-
gesting that HPV can be correlated with a more rapid melanoma progression and a poorer clinical
outcome. In this study, to further investigate the presence of HPV DNA, we performed two differ-
ent PCR-ELISA methods on 51 malignant melanoma, in comparison with 33 dysplastic nevome-
lanocytic nevi (Clark’s nevi) and 15 healthy skin. We utilized two different consensus primer sets to
optimize the detection of HPV DNA and, in particular, the consensus primer pair MY09 and MY11
to amplify a 450 bp segment of the L1 gene of 30 HPV genotypes and the consensus primer pair
GP5+ and GP6+ to amplify a 150 bp segment of the L1 gene of 24 HPV genotypes. In both exper-
iments, amplified products were separately hybridized with type specific biotynilated probes for
high-risk HPV genotypes (HPV-16, 18, 31, 33, 35, 39, 45 and 52). HPV DNA was detected in 7
(14%) melanoma and 5 (15%) dysplastic nevi with MY PCR-ELISA, while with GP PCR-ELISA,
HPV was identyfied in 11 (21%) melanoma and 8 (24%) dysplastic nevi. All HPV positive samples
in MY PCR were positive also in GP PCR. The presence of HPV in malignant melanoma was not
correlated to Breslow thickness microstage or other severity parameters. Our results suggest that
HPV can be present in melanoma and in other melanocytic conditions, however we did not find a
direct association between the virus and the melanoma progression. 
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CD56: a useful marker for diagnosing Merkel cell carcinoma
M Kurokawa, S Maeda, T Nishida, F Nakayama, M Amano, K Ogata and M Setoyama
Dermatology, Miyazaki Medical College, Kiyotake, Miyazaki, Japan
Merkel cell carcinoma (MCC) of the skin is an aggressive but rare malignant neuroendocrine tumor.
For its pathological diagnosis, we use a panel of immunohistochemical markers, such as cytokeratin
20 (CK 20), epithelial membrane antigen (EMA), chromogranin A, neuron specific enolase (NSE),
synaptophysin, and Leu7 (CD57) to demonstrate its epithelial and neuroendocrine features. CD56,
or neural cell adhesion molecule (NCAM), has been demonstrated recently as the tumor marker of
the pulmonary neuroendocrine cell system. Its expression in MCC, however, has still rarely been
investigated. Furtheremore, in such very few previous studies on NCAM expression in MCC, all the
tumor cells were not necessarily demonstrated to express NCAM. Therefore, to study the immunore-
activity of CD56 in MCC, especially using a monoclonal antibody of a clone 1B6, different from
those adopted in the previous reports, we reexamined CD56 expression immunohistochemically in
5 MCC cases, along with the conventional panel of markers described above, using paraffin-embed-
ded tissue sections. CD56 revealed the most diffuse and intense positive staining, which was noted
along the cell borders, in all specimens compared with other neuroendocrine tumor markers. The
results of our study indicate that CD56, especially a new monoclonal antibody (clone 1B6), is a use-
ful immunohistochemical marker for MCC. 
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Stereological analysis of substance P expression in patients with delusions of parasitosis
S Prawer,1 M Ericson,1 C Baker,1 R Hille,2 G Bart,3 J Sedgewick4 and M Hordinsky1 1
Dermatology, University of Minnesota Medical School, Minneapolis, MN, 2 University of North
Dakota School of Medicine, Grand Forks, ND, 3 Laboratory of the Biology of Addictive Diseases,
Rockefeller University, New York, NY and 4 Neuroscience, University of Minnesota Medical
School, Minneapolis, MN
Delusions of parasitosis (DOP) is the unshakable conviction that one is infested by parasites, despite
contradictory findings from an appropriate clinical evaluation. Our objective was to investigate the
possibility of a neurogenic component being responsible for the abnormal sensations that these
individuals experience. We hypothesized that the expression of the neuropeptide substance P (SP)
and/or calcitonin gene-related peptide (CGRP) is altered in individuals with DOP. Four-mm punch
biopsy specimens were taken from affected and non-affected skin of two patients diagnosed with
DOP. Control skin biopsy specimens were site, age, and sex matched. Biopsy sections were triple
labeled with primary antibodies to protein gene related peptide (PGP 9.5), SP, and CGRP, and then
secondary antibodies conjugated to either Cyanine-3.18 or -5.18. All sections were subsequently
labeled with Ulex europaeus agglutinin (UEA I) conjugated to fluorescein. Image data sets were col-
lected with a BioRad MRC1024 confocal imaging system. Nerve and blood vessel densities were
quantified using stereology with a special emphasis on epidermal sensory fibers. Neuronal SP expres-
sion was increased in affected and non-affected skin of individuals with DOP compared to controls.
The density of SP-positive sensory fibers was 2-3 fold greater in affected vs. non-affected skin.
PGP, CGRP, and UEA 1 expression were variable. Increased SP expression in affected skin of indi-
viduals with DOP suggests that this neuropeptide may play an important role in the altered sensory
perception these patients experience. 
0308
Methods for the evaluation of health economic studies in dermatology
C Rogalski,1 U Paasch,2 O Brosteanu1 and M Loeffler1 1 University of Leipzig, Coordination for
Clinical Trials, Leipzig, Saxony, Germany and 2 Department of Dermatology, University of
Leipzig, Leipzig, Saxony, Germany
The warranty of adequate dermatological treatment provided by public health insurances is restricted
by low budgets. Economic studies should analyse the utilisation of available resources. Four main
categories, all dealing with incidental expenses, basically differ between their method of evaluation.
The techniques calculate on anticipated costs and consequences. Scientific assessment mainly results
from cost-minimisation (CMA), cost effectiveness (CEA), cost utility (CUA) or cost-benefit analy-
sis (CBA). CEA is an adequate technique for expected varying results of comparable treatments
measured in natural units (i.e. life-years gained, years of healed leg-ulcers) and not appropriate for
the comparison of different medical sectors and to decide about allocation resources. CMA is a spe-
cial form of CEA used in cases of alternative medications or treatments turn out to have the same
result to identify the one with the lowest cost. The proof of effectiveness is a pre-requisite. Similar
to CEA is CUA. There is a defined outcome (changes in the patients well-being) which is measured
in QALYs (Quality adjusted life-year). If the consequences of an intervention are not identical,
CBA is used and the benefit measured in monetary units. The assessment of the performed economic
evaluations is aggravated by the usually low economical knowledge of physicians. A check-list of
30 criteria was created including six crucial points to differentiate the significance of health eco-
nomic studies. The main concern concentrates on the justification for interventions/alternatives, the
choice and naming of the kind of economic evaluation, sources of estimation for efficiency/(primary)
outcome and separately listed prices and currencies. Discounting was performed, sensitivity and
incremental analysis were undertaken. Fulfilled crucial criteria were rated with three points, the other
criteria got one point. Good clinical studies achieved 40-48 points. This checklist is a good tool for




Psoriasis vulgaris and Malassezia yeasts: an immunological study
A Prohic Department of Dermatovenerology, University Clinical Center, Sarajevo, Bosnia, Bosnia
and Herzegovina
The role of Malassezia (M) species in psoriasis is, as yet undetermined, but there are several reports
indicating that these yeasts have been implicated as a trigger for the initiation of scalp lesions. The
purpose of our study was to evaluate the relationship between different Malassezia species isolated
from scalp and cellular immune-status of forty psoriatic patients. Samples were obtained by scrap-
ing the skin surface on the scalp lesions and inoculated on modified Dixon agar plates. The yeasts
were identified following the scheme established by Guillot et all. Additionally, we performed two-
color flow cytometry analyses to investigate the lympohocyte subpopulations. The most common
isolated species was M.globosa, found in more than a half of all isolates, followed by M.slooffiae,
M.restricta, M.furfur and M.sympodialis. We demonstrated a significant increase in the percentage
of suppressor T cells and a significant decrease in the percentage of helper/suppressor T cell ratio
as well as NK cells. However, we find no correlation between isolated species and the changes in
the peripheral blood lymphocyte subpopulations. 
0311
The kinetic changes of confocal histopathology of allergic and irritant contact dermatitis in
vivo
S Astner,1 E Gonzalez,2 F Rius-Diaz,1 A Doukas,1 M Tsingos1 and S Gonzalez1 1 Wellman
Laboratories of Photomedicine, Boston, MA and 2 Contact Dermatitis Unit, Department of
Dermatology, Mass General Hospital, Boston, MA
Reflectance-mode confocal microscopy (RCM) is a novel technique that enables non-invasive imag-
ing in vivo. It has previously been used to describe the histopathological features of contact der-
matitis. This work was designed to investigate the kinetic changes of both allergic and irritant con-
tact dermatitis (ACD and ICD) using this non-invasive technique to better understand their
pathogenesis. Subject volunteers with a diagnosis of ACD were patch tested with the allergen and
sodium lauryl sufate (SLS) and the results were compared against appropriate controls. RCM and
other non-invasive methods including transepidermal water loss (TEWL) and fluorescence excita-
tion spectroscopy (FES) were performed at 3 or more time points within up to three weeks after patch
removal. Statistical analysis of RCM results and FES was performed by MANOVA and 2D-ANOVA
respectively. Wilcoxon test for paired data was used to analyse TEWL results. Whereas parakerato-
sis, stratum corneum disruption and the presence of individual corneocytes are early events in ICD,
similar changes can occur later in ACD. Cutaneous disruption induced by irritants rapidly returns to
normal whereas the changes in ACD can last up to four weeks. RCM demonstrates significant dif-
ferences in the increase of epidermal thickness between ACD and ICD (p < 0.01, days 2 and 3) and
between ICD and control (p< 0.05 for all timepoints). Similarly, the difference in TEWL between
ACD and ICD, as well as between ICD and control was significant at all time points (p < 0.020).
FES on the other hand, while it showed significant differences between ACD and ICD (p< 0.02) did
not show significant differences between ACD and controls. We conclude that non invasive optical
methods such as RCM, TEWL and FES offer significant advantages to study the quantitative param-
eters of kinetic changes in acute contact dermatitis reactions. 
0312
Morphologic spectrum of halo nevi including dysplastic changes: a study of 103 cases
TW Mully, S Tam and H Kamino Dermatopathology Section, New York University School of
Medicine, New York, NY
Halo nevi are benign proliferations of melanocytes with a characteristic clinical appearance. The
histopathologic features include a dense lymphocytic infiltrate admixed with benign appearing
melanocytes that contain varying amounts of melanin. Although halo changes have been described
in commmon and Spitz’s nevi, there is little information in the literature regarding the morphologic
spectrum of the melanocytic component. We reviewed a large series of halo nevi paying attention to
the presence of dysplastic changes. We studied 103 cases diagnosed as halo nevus between 1994-
2000 for dysplastic changes by light microscopic examination of architectural pattern, degree of
cytologic atypia, inflammation, and stromal changes. We assessed the degree of peripheral depig-
mentation in all cases by Fontana-Masson stain. In 12 cases with very dense lymphocytic infiltrates,
we evaluated the expression of melanocyte-associated antigens: S-100 protein, Melan-A, bcl-2 pro-
tein, HMB-45, and c-kit. Sixty-three out of 103 halo nevi had features of dysplastic nevi. In 8/103
cases, we identified evidence of regressed dysplastic nevi such as lamellar fibroplasia and bridging
of rete ridges. Thirty-six out of 103 were common nevi: 15 of these showed melanocytic enlarge-
ment and crowding of nests of melanocytes within the dermis and four showed complete regression
of melanocytes. Four out of 103 were Spitz’s nevi. In 12/12 densely inflamed halo nevi, melanocytes
expressed S-100 protein, Melan-A, bcl-2 protein, and HMB-45, but in 11/12 cases c-kit staining
was weak to absent. In contrast, the only densely inflamed halo nevus which we stained that strongly
expressed c-kit in junctional and dermal melanocytic nests showed dysplastic features. These data
expand the morphologic spectrum that can be seen in the melanocytic component of halo nevi. In
our series of 103 halo nevi, we identified features of dysplastic nevi in 61%. We also report that 11/12
densely inflamed halo nevi had decreased melanocytic expression of c-kit; however one case with
dysplastic features strongly expressed c-kit. 
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The involvement of apoptosis-related proteins in primary and metastatic lesions of human
malignant melanomas
T Shukuwa,1,3 I Katayama2 and T Koji3 1 Dermatology, Sasebo City General Hosp., Nagasaki,
Japan, 2 Dermatology, Nagasaki University School of Medicine, Nagasaki, Japan and 3 Histology
and Cell Biol., Nagasaki University School of Medicine, Nagasaki, Japan
In the previous study, we have found that the decreased rate of TUNEL positive melanoma cells was
significantly correlated with the poor prognosis of melanoma patients, where the rates of Fas and
FasL positive cells were also lowered. For a further understanding of the regulation of melanoma
cell apoptosis and its relationship to prognosis, we investigated the specimens from primary and
metastatic lesions of the melanoma patients, which were divided into stage 3 (n=7) and 4 (n=7)
(AJCC staging system for cutaneous melanoma, 2002), by TUNEL staining and immunohisto-
chemistry for Fas, FasL, Bcl-2 and Bax. As a result, there was no significant difference in TUNEL
positive rates between primary and metastatic lesions. The correlation between TUNEL- and Fas-,
or FasL-positive rates in melanomas was significant in primary lesions and metastatic lymph nodes.
Also, there were significant correlations in primary lesions between the positive rates of TUNEL and
Bcl-2, or Bax in melanoma cells. Moreover, in the lymph nodes, the rate of TUNEL-, Fas- and
FasL-positive melanoma cells, as well as the ratio of Bax positive rate to Bcl-2 positive rate (B/B
ratio) of melanoma cells in stage 4 melanomas was less than that of stage 3 melanomas. Among these
positive rates of melanoma cells in primary lesions and lymphocytes in both primary lesions and
lymph nodes, there was no difference between stage 3 and 4. Therefore, it is possible that the apop-
tosis of melanoma cells and infiltrating lymphocytes in primary and metastatic lesions may be reg-
ulated by the Fas/FasL and the Bcl-2/Bax systems, and that the expression of the Fas system and the
B/B ratio of melanoma cells in metastatic lymph nodes may affect the prognosis of the patients
through the regulation of apoptosis induction, while the apoptosis of infiltrating lymphocytes may
not influence the prognosis of the patients. 
0315
CD30/CD7 ratio in lymphomatoid papulosis
DP Fivenson,1 R Gustin,1 A Ormsby2,1 and HW Lim1 1 Dermatology, Henry Ford Health System,
Detroit, MI and 2 Pathology, Henry Ford Health System, Detroit, MI
The diagnosis of many cutaneous malignancies can be problematic, and usually requires the use of
immunohistochemical studies. CD7 is often used when diagnosing mycosis fungoides (MF), as dele-
tion of this marker has been shown to be both sensitive and specific for diagnosis of mycosis fun-
goides. Lymphomatoid papulosis (LyP) is a CD30+ lymphoproliferative disorder that has long been
associated with hematologic malignancies, especially mycosis fungoides (MF), but the degree to
which CD7 is expressed in LyP has not been studied. This study was designed to: 1) determine the
relationship between CD30 and CD7 expression in LyP as compared to MF; 2) evaluate the CD30/CD7
relationship in specimens read as “dermatitis” from the same group of patients; and 3) compare
CD7 deletion between patients with isolated LyP and patients with both LyP and MF. All available
tissue blocks from patients (N=19) with LyP were stained both CD30 and CD7 and assessed using
a semiquantitative 0-4 scale. Concurrent diagnoses from these patients included MF (n=6) and der-
matitis (n=13); these specimens were also studied. A total of 58 tissue samples were evaluated from
19 patients. This included 32 LyP, 6 MF and 21 dermatitis specimens. The mean+/-SD CD30 expres-
sion was 2.39+/-2.04, 0.67+/-1.03 and 1.00+/-0.95 for LyP, MF and dermatitis respectively (p=0.026).
The mean+/-SD CD7 expression was 3.10 +/-1.22, 0.83+/-0.98 and 2.33+/-1.68 for LyP, MF and
dermatitis respectively (p=0.010). The results showed that there was a statistically significant decrease
in CD7 expression, without CD30 upregulation, in both MF and dermatitis lesions from patients with
the diagnosis of LyP. They also confirm the increase of CD30 expression in LyP and the loss of CD7
expression in MF reported previously. Our results suggest that the CD30/CD7 ratio may be a useful
tool in evaluating suspicious eruptions presenting in the context of LyP. 
0317
Clinical evaluation of topical sodium L-ascorbyl-2-phosphate lotion (10%W/V) in patients with
acne
T Nishikawa,1,6 H Ikeno,2 T Ohba,3 T Tsuzuki,4 E Isogai,5 H Isogai,6 T Yamashita,6 K Kimura,6
H Asanuma,7 T Okayasu1 and S Arashima1 1 Sapporo Campus, Hokkaido University of Education,
Sapporo, Japan, 2 Ikeno Clinic of Dermatology, Tokyo, Japan, 3 NorthBio, Sapporo, Japan, 4
Showa Denko, Tokyo, Japan, 5 Health Sciences University of Hokkaido, Sapporo, Japan, 6 Sapporo
Medical University, Sapporo, Japan and 7 Kojinkai, Chitose, Japan
The etiology of acne vulgaris involves a complex relation among several causes or factors in the
pathogenesis of the disease. Ascorbic acid (vitamin C) is contained in many kinds of cosmetics and
there are many reports on its physiological effects, such as the inhibition of melanogenesis and pre-
vention of lipid peroxidation. Moreover its strong anti-oxidization effects and inhibitory effects of
sebaceous secretion have been reported. L-ascorbyl-2-phosphate (abbreviated as APS) (which is pro-
duced by SHOWA DENKO K.K.) is dissolved in water, so we expect that the solution containing
APS may be effective for acne vulgaris. Here for the first time, we report on the clinical evaluation
of 10% APS lotion used by patients with acne vulgaris. Eighteen subjects with acne (18 women),
18 to 22 years of age were enrolled in this study. This was an open comparison study. These patients
were instructed to apply the 10%(W/V) APSL topically to the acne lesions on one side of the face
only, twice a day, after washing the face in the morning and the evening. Treatment was continued
for 8 weeks. At the beginning and at 4 weeks and 8 weeks of treatment, patients were observed for
clinical response. The clinical response of each patient was evaluated by an observation of both sides
of the face and rated on a 5-point scale. Clinical improvements of inflammation, and papules-pus-
tules were obtained in 83.3% and 94.4% of the APSL treated side, but only 5.6% and 16.7% in the
untreated side of the faces respectively. This is the first time the evaluation of topical 10%APSL in
patients with acne has been reported. 
0316
Oral dexamethasone tablets for pulse therapy in pemphigus
M Jonkman,1 G Toth,1 M Eilders,2 M Laseur2 and D Uges2 1 Dermatology, Groningen University
Hospital, Groningen, Netherlands and 2 Pharmacy, Groningen University Hospital, Groningen,
Netherlands
High-dose glucocorticoid pulse therapy aims at periodically strong immunosuppression and may
reduce the daily maintenance dose of glucocorticoids, thus limiting the hazards of continuous long-
term steroid intake. Pulse therapy is usually given intravenously rather than orally, without evidence
to support the necessity of the intravenous route. Oral therapy is preferable because it avoids venipunc-
tures, decreases costs, and improves patient convenience. In this study we investigated the bioavaili-
bity and tolerability of 300 mg oral dexamethasone in pemphigus patients. Four patients with pem-
phigus vulgaris were enrolled in this study. Tablets containing dexamethasone 50 mg were produced
in our hospital pharmacy. The dexamethasone European Pharmacopoeia (Eur Pharm) was hydrophyl-
ized with methylcellulose 15 MPA-s (Eur Pharm). The tablets were prepared by direct compression
using cellulose mycrocrystalline (Eur Pharm, Avicel pH 101) and magnesium stearate (Eur Pharm).
Serum samples were drawn after intravenous and oral pulse administration and analyzed by a vali-
dated, suitable, selective HPLC procedure. The area-under-the curve (AUC) of oral dexamethasone
was 55.8% (range 43-65%) of that of intravenous dexamethasone. Mean peak concentration (Cmax)
after intravenous administration of dexamethasone 200 was 5040 µg/L; the mean Cmax after an
oral dose was 2580 µg/L, with mean time to Cmax of 2.25 hours. Oral high dose dexamethasone
was well tolerated. With a bioavailibity of 55,8% oral administration of dexamethasone 358 mg is
equivalent to an intravenous dose of dexamethasone 200 mg. Since it is unknown whether the effects
of pulse therapy are due to AUC or Cmax, we concluded that oral dexamethasone 300 mg in 50-mg
tablets can be used as oral pulse therapy. The new dexamethasone tablets have reliable pharmaco-
logic and technical characteristics and appear to be safe. They are suitable for use in clinical trials
such as PEMPULS (www.pempuls.nl), in which the therapeutic effect of oral high-dose dexam-
ethasone pulse therapy is evaluated. 
0314
Immunomodulator effect on erythema of rosacea
JT Bamford,1,2 IV Haller3 and BA Elliott2 1 Dermatology, SMDC ST. Mary, Duluth, MN, 2 Family
Practice, School of Medicine Duluth, University of Minnesota, Duluth, MN  and 3 Education and
Research, SMDC, Duluth
This study was a 12-week open label clinical trial in which patients were treated with 0.1% Tacrolimus
Topical Ointment (TTO)for an off lable indication, rosacea. Twenty-four patients with rosacea iden-
tified as having predominantly either erythrotelangiectatic (ET) or papulopustular (PP) subtypes were
enrolled (13 ET and 11 PP). Erythema was statistically improved in both groups. Most subjects dis-
liked the consistency of the ointment base used in TTO. Five patients withdrew from the study; most
of these reported an increase of papulopustular lesions. We hypothesize that the observed benefit is
due to down regulation of local immune and inflammatory processes. These findings suggest that
the role tacrolimus on the vascular system in subjects with rosacea. 
0318
Hormonal effects on psoriasis in pregnancy
JE Murase,2 GD Weinstein,2 D Cooper,4 TJ Garite1 and KK Chan3 1 Dermatology, UC Irvine,
Irvine, CA, 2 Ob-gyn, UC Irvine, Orange, CA, 3 Ob-gyn, Long Beach Memorial, Long Beach, CA
and 4 General Clinical Research Center, UC Irvine, Orange, CA
Hormonal changes in estrogen and progesterone are believed to result in altered immune surveil-
lance of autoimmune diseases such as psoriasis. Psoriasis tends to improve during pregnancy, pos-
sibly due to a hormone-induced down-regulation of the immune system. All prior research on pso-
riasis during pregnancy has been retrospective, often with the patient completing the survey several
years after pregnancy. This is the first study which quantifies how psoriasis fluctuates in pregnancy
and postpartum and measures women’s hormone levels (estradiol, estrone, estriol, progesterone) in
pregnancy to determine which, if any, correlate with psoriatic change 1200 patients were screened
at UCI and Long Beach Memorial prenatal offices. 85 patients were enrolled (55 study group, 30
control). Data collection July 2000 - April 2003. Severity of psoriasis assessed and blood drawn at
10, 20, 30 wks of pregnancy and 6 & 24 wks postpartum. * Improved in pregnancy 52% (no change
24%, worsened 24%) * Worsened postpartum 62% (no change 31%, improved 7%) * Out of women
with >15% body coverage who improved, the psoriatic plaques present 1st trimester cleared 85%
by 3rd trimester * Progesterone did not correlate with psoriatic change; estrogen did correlate with
psoriatic improvement * Ratio of estrogen-progesterone had the most significant correlation with
improvement (r-squared of 0.62) Estrogen, and not progesterone, correlated with psoriatic improve-
ment. Estrogen is a member of the nuclear receptor family, which includes retinoids, vitamin D, and
thyroid derivatives that are currently used to treat psoriasis. We believe that this research has the
potential to be useful in developing new clinical approaches to the management of psoriasis as well
other autoimmune diseases, such as rheumatoid arthritis, multiple sclerosis, and linear IgA disease,
which have fluctuation patterns similar to psoriasis in pregnancy. 
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Phenotype does not affect anthralin-induced inflammation
L Naysmith, K Waterston, T Ha and JL Rees Systems Group, Dermatology, University of
Edinburgh, Edinburgh, United Kingdom
There is considerable inter-individual variation in response to cutaneous stimuli, but what factors
underpin this variability and what proportion can be explained by genetics? We wished to determine
what role hair and skin pigmentation plays in the inflammatory response induced by anthralin, includ-
ing effects of covariables on anthralin-mediated tolerance. 83 volunteers of whom 26 were red heads,
range 16-72 yrs (median 38yrs) and skin types I-VI, had doubling doses of anthralin in Lassars
paste (LP) from 0.005-0.08% applied in duplicate to the back for 24 hours using 8mm Finn cham-
bers (Epitest). In addition 30 volunteers -12 red heads- had a 4cm x 4cm patch of mid back skin pre-
treated with 0.005% and 0.01% anthralin in LP, under occlusion, for 24 hours on successive days.
A similar size patch of LP was applied to the opposite side of the back as a control. On Day 3 each
site was challenged for 24 hours with LP, 0.02, 0.04 and 0.08% of anthralin in LP using 8mm Finn
chambers. The inflammatory response was quantitatively assessed on Day 5 using the Moor laser
Doppler. This was validated for skin pigmentation by measuring temperature dependant change in
flux in 10 individuals of skin types I-VI. Hair samples were assayed for melanin content using HPLC.
Hair colour was classified using the L’Oreal hair colour standards chart in addition to Tristimulus
colourimetery (Minolta Chroma Meter) to objectively measure hair colour and skin colour from
photo exposed and photo protected sites. As expected there was significant inter-individual varia-
tion in anthralin dose response curves (P<0.01) and more than a 60% reduction in erythema at the
induced dithranol sites (P<0.01). When comparing skin types I-III and IV-VI there was a significant
% difference in flux between the control and induced site at 0.04% anthralin (P<0.01), but other-
wise neither hair colour, skin colour nor skin type had any effect on anthralin induced inflammation
or tolerance (P>0.1). Thus in contrast to UV radiation, pigmentary phenotype cannot be used to pre-
dict anthralin mediated inflammation or tolerance. 
0320
Kinetics of response to therapy in pemphigus vulgaris
A Mizrachi and J Bystryn Dermatology, NYU School of Medicine, New York, NY
The response of PV to therapy is usually expressed in terms of partial or complete remissions, end-
points that may take several years to reach. To develop earlier end-points that would permit more
rapid evaluation of treatment, we examined the time usually required to complete 3 major phases in
the treatment of PV, i.e. control of disease activity, consolidation of treatment, and reaching the
mid-point of the maintenance phase.  The study was conducted in 37 consecutive patients with PV
treated conventionally with prednisone in doses that were rapidly escalated in increments of 50%
until disease activity was controlled (no new lesions and beginning healing of established lesions).
That level was maintained until lesions were approximately 80% healed (end of consolidation phase).
Steroid doses were then decreased by approximately 50% every two weeks. Adjuvants were used if
there was a relative contraindication to steroids or if the disease flared when steroids were tapered.
The end-points of the study were the time to control disease activity, to complete the consolidation
phase, and to reduce peak doses of steroids by 50%; all measured from initiation of therapy at NYU.
The median time to control disease activity was 14 (range 6-210) days, to the end of consolidation
was 32 (range 12-245) days, and to reach the mid-point of maintenance was 53 (range 26-259) days.
These end-points were reached more quickly in patients treated with higher (>90 mg/day) doses of
steroids, but were unrelated to initial disease severity.  These results provide previously unavailable
data on the kinetics of the response of PV to treatment. They also provide several early end-points
of response to therapy that can be used to compare more rapidly the effectiveness of new therapeu-
tic modalities for PV. 
0321
Non-invasive diagnosis of pigmented lesions
B Rao, M Kolipakam, B Katz and I Rahman Dermatology, UMDNJ-Robert Wood Johnson Medical
School, New Brunswick, NJ
This paper examines the different instruments used to aid dermatologists in establishing a diagno-
sis, how these benefit the patient, and improve follow-up care. The instruments range from simple
loups and the variety of dermatoscopes (oil vs. non-oil based), to computer-assisted diagnostics and
in-vivo microscopic imaging. Dermoscopy is a tool that most benefits those well-versed in its use.
It can be used as a handheld alone, or with attachments such as photodermoscopes or videoscopes.
Dermlite® has put out a new, non-oil dermatoscope, which is held above the skin, and may enhance
visualization of vascular patterns. Newer computer-assisted instruments have been developed based
upon various algorithms that may not necessarily use dermoscopy. Dermogenius® utilizes algo-
rithms adopted from space technology, and supplements the ABCD rule by extra visualized dermo-
scopic features. Melafind® 100 employs multispectral imaging in order to examine different pene-
trations of the skin. MicroDERM® is a trained worldwide databank that operates through its archive
of images. Vivascope 1000® is a non-invasive, in-vivo microscopic imaging technique that uses the
naturally occurring refractive index variations in tissue without the use of stains. Some of these instru-
ments may be costlier than others, but may require less formal training for the physician. Various
instruments exist that aid the physician in non-invasive diagnosis of pigmented lesions. Their unique
technologies allow for greater applications of the traditional methods of analysis. The new mor-
phologic dimensions revealed, and the data they generate, are increasingly the subject of research
to find more criteria for objective diagnosis. 
0322
The difference in number and size of senile angiomas on skin subjected to irradiation for breast
cancer compared to skin on the opposite non-irradiated breast
M Deutsch and J Flickinger Radiation Oncology, University of Pittsburgh Medical Center,
Pittsburgh, PA
Senile or cherry angiomas are part of the aging process and although sometimes they may be visu-
ally unsightly by their number and size, are not associated with any physiological or clinical impair-
ments. To determine the effect of high dose x-irradiation on these lesions, the authors did a careful
analysis of the number and largest size of cherry angiomas on the breasts of 207 women presenting
for followup after previous high dose breast irradiation for unilateral breast cancer. One observer
(MD) counted and measured the angiomas on the irradiated and opposite “control” breast of every
patient. The 207 women ranged in age from 27-85 years (median 60 years) at the time of treatment.
All irradiated breasts received a minimum of 5000 cGy in daily fractions of 180-200 cGy, five days
per week, over 5-6 weeks. About 2/3 received adjuvant hormonal therapy and/or chemotherapy. The
interval from radiotherapy to followup examination for angiomas ranged from 4-283 months (median
85). Twenty-six women (12.6%) had more angiomas on the irradiated breast skin and 48 women
(23.2%) had an equal number on both breasts. One hundred thirty-three (64.3%) had fewer angiomas
on the irradiated breast skin (P<0.0005 by the two tailed paired t-test). Angiomas on the irradiated
breast skin were smaller (P<0.0005). Increasing age at treatment was the only factor predicting for
a significant decrease in the number and size of ipsilateral versus contralateral angiomas. Thus, high
doses to the skin received during irradiation of underlying malignancies can be associated with a
decrease in the number and size of senile angiomas. Since these angiomas have no clinical signifi-
cance, they do not require treatment. 
0323
Selective and sustained impairment of γδ T cells and NK cells in patients with atopic dermati-
tis is driven by monocytes
M Katsuta, M Inaoka, Y Takigawa and T Shiohara Kyorin, Mitakashi, Tokyo, Japan
Although impaired type 1 responses have been demonstrated in patients with atopic dermatitis(AD),
it remains undetermined whether innate immune cells capable of producing type 1 cytokines are also
impaired and if so, whether their functions are intrinsically altered. We first compared the number
of γδ+T cells and NK cells as well as adaptive immune cells such as αβ+T cells in the whole blood
of AD patients and healthy controls. We found that whereas the numbers of αβ+T cells did not dif-
fer in these groups, those of γδ+T cells and NK cells were profoundly decreased in patients with
AD. We next analyzed intracellular cytokine expression of proinflammatory (TNF-α), type-1 (IFN-
γ) and type-2(IL-4) cytokines in these subsets after stimulation with PMA and ionomycin for vari-
ous time intervals(0-2h, 2-4h and 4-6h) in these groups. Upon >2h stimulation, expression of TNF-
α and IFN-γ, but not IL-4, in NK cells was significantly decreased in patients with AD as compared
with controls (5.6% vs 9.6% in TNF-α; 19.2% vs 36.5% in IFN-γ, respectively). Furthermore, analy-
sis of IFN-γexpression in γδ+T cells also showed a dramatic decrease in AD patients (35.0% vs
47.0%). In contrast, no significant differences were noted in between AD and controls in cytokine
expression of adaptive immune cells. Surprisingly, removal of CD14+ monocytes from PBMC did
lead to a dramatic recovery of the ability to produce IFN-γ and TNF-α of NK cells and γδ+T cells,
but not αβ+T cells, to the levels more than that observed in controls. By contrast, these cytokine
production in controls were not enhanced on the depletion of CD14+ monocytes. These observations
indicate that a pronounced defect in the ability to produce TNF-α and IFN-γ of NK cells and γδ+T
cells in AD patients is driven by monocytes. 
0324
An open study comparing efficacy of 5% sodium L-ascorbyl-2-phosphate lotion versus 1%
clindamycin phosphate lotion and vehicle lotion in the treatment of acne vulgaris
H Ikeno,1 T Nishikawa2 and K Ohmori3 1 Ikeno Clinic of Dermatology and Plastic Surgery, Tokyo,
Japan, 2 Medicine and nursing, Hokkaido University of Education, Sapporo, Japan and 3 Plastic
Surgery, Tokyo Metropolitan Police Hospital, Tokyo, Japan
We reported the efficacy of 5% sodium L-ascorbyl-2-phosphate lotion (5% APL) in the treatment
of acne achieved by an open comparative study at the SID meeting in 2002. This time, we studied
the clinical efficacy of 5% APL, 1% clindamycin phosphate lotion (1% CL) and vehicle (VE) for
the treatment of acne vulgaris. One hundred patients were assigned to receive 5% APL (n=40), 1%
CL (n=40) and vehicle (n=20) topically. Efficacy was assessed in 5 grades at the beginning and at
4, 8, and 12 weeks of treatment based on clinical photographs and the reduction rate of lesion counts.
Patients were instructed to refrain from receiving treatment which has some possibility to have effects
on acne lesions, such as administration of antibiotics, pill and sex hormone, metronidazole, retinoid
and so on for 4 weeks prior to enrollment in the study. The number of patients who complied with
the treatment protocol was 37 on 5% APL, 35 on 1% CL, 17 on VE. Efficacy rate for APL was 75.7%,
Cl 62.9% and VE 17.6%. The efficacy of 5% APL was superior to that of 1% CL, which is widely
prescribed in the treatment of acne vulgaris in the western countrieas. This data supports the hypoth-
esis that 5% APL showed the excellent efficacy in the treatment of acne vulgaris, and therefore is
better than 1% CL. This is the first demonstration of comparing efficacies between 5% APL, 1% CL
and VE. 
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Effect of narrowband UVB maintenance therapy on the duration of remission for psoriasis: a
prospective randomized clinical trial
G Boztepe Senturk,1 A Karaduman,1 S Sahin,1 M Hayran2 and F Kolemen1 1 Department of
Dermatology, Hacettepe University, Faculty of Medicine, Ankara, Sihhiye, Turkey and 2 Omega
Contract Research Organization, Ankara, Kavaklidere, Turkey
Narrowband uvb phototherapy (nbuvb) is an effective treatment for psoriasis.Little is known about
the duration of remission after nbuvb for psoriasis and the effect of maintenance therapy on the
duration of remission.The aim of this study was to determine whether a two-month maintenance
nbuvb effect the duration of remission.Patients were exposed to nbuvb three times weekly until ini-
tial clearing (defined by a 75% decrease of the PASI score).After initial clearing patients were ran-
domly assigned to one of the 2 groups;namely maintenance group and no maintenance group.Patients
designated to receive maintenance were treated further twice weekly for the first and once weekly
for the next month.Patients in the no maintenance group received no further therapies.Both groups
were followed for a minimum of 6 months.Of 50 patients enrolled, 46 (92%) cleared.Numbers of
patients randomized to maintenance and no maintenance were 22 and 24, respectively.Six months
after initial clearing 12 patients (55%) who received maintenance and 12 patients (50%) who did
not receive maintenance were still clear.Life table analysis indicated that there was no statistically
significant difference between maintenance and no maintenance groups for the probability of remain-
ing in remission 6 months after initial clearing (p=0.76).During the first 2 months after initial clear-
ing 2 patients in the maintenance group but non in the no maintenance group flared.The results of
our study suggest that a two-month maintenance nbuvb fails to effect the duration of remission for
psoriasis.However the observation that during the first 2 months after initial clearing 2 patients in
the no maintenance group but no patients in the maintenance group flared encourage us to increase
the number of patients in both groups for further investigation of the effect of maintenance nbuvb
on the duration of remission. 
0327
Erythromelalgia: vasculopathy or neuropathy, or both? A prospective study of vascular and
neurophysiologic studies in erythromelalgia
M Davis, P Sandroni, T Rooke and P Low Dermatology, Neurology and Vascular Medicine, Mayo
Clinic, Mayo Foundation, Rochester, MN
To assess the frequency and type of vascular changes and neurologic abnormalities in patients with
erythromelalgia. Prospective study of patients during periods without symptoms and with provoked
symptoms. Setting: Tertiary referral center. Sixty-seven patients presenting with erythromelalgia
from 1999 through 2001. Test nerve function and vascular function in patients without symptoms;
test vascular function after provoking symptoms. In those patients in whom symptoms could be
elicited, vascular function with and without symptoms was assessed by measurement of local skin
temperature, laser Doppler flow, and transcutaneous oximetry. Neurologic assessment included elec-
tromyography, nerve conduction studies, and autonomic reflex screening (quantitative sudomotor
axon reflex test, adrenergic function testing, heart rate response to deep breathing, and Valsalva ratio).
Autonomic reflex screening was performed on 57 of the 67 patients (85.1%). Results were abnor-
mal for 49 of the 57 (86.0%) patients who had autonomic reflex screening. Of these 57, 46 (80.7%)
had abnormal quantitative sudomotor axon reflex test results, 14 (24.6%) had abnormal adrenergic
function, and 15 (26.3%) had abnormal cardiovagal function. Electromyography and nerve con-
duction studies were performed in 24 of the 67 patients (35.8%). Of these 24, 14 (58.3%) had abnor-
mal electromyographic results and 10 (41.7%) had abnormal nerve conduction study results. Vas-
cular function studies, with and without symptoms, were performed in 13 of the 67 patients. During
symptoms, the mean temperature of the toe skin increased by 7.8 C, and blood flow increased by
10.2-fold. Paradoxically, mean transcutaneous oximetry measurements did not change. This prospec-
tive study extends and confirms our previous observation that most patients with erythromelalgia
have small fiber neuropathy, in addition to other forms of neuropathy. 
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Review of malignant melanoma in West China during 20 years
G Tianwen,1 S Dongjie,1 L Chunying,1 L Rongqing,4 L Qing,2 L Ruosheng,3 D Qingchun,4
H Hong,1 H Gaosheng,2 H Fei,4 M Fucheng,2 L Fengxuan,3 Z Baiyu,4 Y Xiaochu3 and L dongmei3
1 Dermatology Center of Chinese PLA, Xijing Hospital, Xi, Shaanxi, China, 2 Department of
Pathology, Xijing Hospital, Xi, Shaanxi, China, 3 Department of Dermatology, Xinan Hospital,
Chongqing, China and 4 Department of Pathology, Xinan Hospital, Chongqing, China
Xijing Hospital and Xinan Hospital are the biggest hospitals in the North-West China and South-
west China respectively. We collected and analyzed the data of malignant melanoma (MM) in the
two hospitals from 1981 to 2000. There were 353 cases of MM  confirmed by pathological exami-
nation. Two hundred and fifty one cases were cutaneous malignant melanoma (CMM), and it was
0.063% of the total number biopsies, 0.578% of total number malignant tumor of the corresponding
period. It was 0.044% and 0.073% of the total number biopsies in 1980s and 1990s respectively.
The average growth rate was 3.4%. There were 231 cases that the lesion site could be learned from
the available data. Among them, 47.0% were in the feet, 16.3% in the hands, 13.5% in the head and
neck, 11.2% in the trunk. There were 202 cases that the causes have been mentioned in the avail-
able data. 25.7% were with the history of trauma in the primary site of MM, 19.3% originated from
congenital small nevi. Among the 185 cases that with clinical and pathological data, 23.2% were in
clinical stage1,21.1% in clinical stage2,32.4% in clinical stage 3, 17.8% in clinical stage 4,7.0% in
Clark level 1,8.1% in Clark level 2, 15.1% in Clark level 3, 23.8% in Clark level 4, 19.5% in Clark
level 5, 26.5% of them that the level of tumor infiltration was difficult to judge. Compared with the
data of Europe and American, there are some characteristics of the CMM of West China: the inci-
dence rate of CMM increases slowly; acral site is the predominant location of CMM; trauma is an
important inducement of MM in acral site; congenital small nevi play an important role in the onset
of MM. 
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Analysis of predominant risk factors for developing melanoma among a cohort of patients at
high-risk for developing melanoma
SQ Wang,1 AW Kopf,2 D Polsky2 and D Lazovich1 1 Dermatology, University of Minnesota,
Minneapolis, MN and 2 Dermatology, New York University School of Medicine, New York, NY
The objective of our work was to analyze the predominant risk factors for developing melanoma
(MM) in a cohort of high-risk patients and to evaluate the probability of developing MM in this
cohort. Consecutive medical records from a dermatology office were reviewed. A total of 398 patients
were selected who met the criteria of having (1) total cutaneous photograph as an aid for follow-up,
(2) annual total cutaneous exam, and (3) at least six months of clinical follow-up. Risk factors, includ-
ing age, sex, prior personal history of MM, family history of MM, personal history of non-melanoma
skin cancer (NMSC), presence of classic atypical moles syndrome (CAMS, a triad of more than 100
moles, having atypical moles, and having one mole greater than 8mm in diameter), and presence of
one or two of the CAMS triad, were estimated with univariate and multivariate analyses. Using the
Kaplan-Meier method, the ten-year probability for developing MM was computed separately for
patients who met the CAMS criteria (i.e., CAMS) and for those who did not meet the CAMS crite-
ria (i.e., non-CAMS). Results: The cohort contained 237 CAMS and 161 non-CAMS patients. The
mean follow-up period was 96.4 months. Univariate analysis identified age, prior personal histories
of MM and history of NMSC as statistically significant risk factors. Multivariate analysis showed
that only prior personal history of MM remained significant with a hazard ratio (H.R.) of 2.0 (adjusted
95% C.I 1.2-3.3). Hazard ratios for age and history of NMSC were no longer significant [adj. H.R.
for age was 1.03 (95% C.I. 1.0-1.1); adj. H.R. for history of NMSC was 1.7 (95% C.I. 0.98-3.0)].
The cumulative 10-year risk for MM was 20% for the CAMS patients and 16% for the non-CAMS
patients. The difference between the risks was not statistically significant. Conclusion: In this cohort
of patients at high-risk for MM, a previous history of personal MM is the most significant risk fac-
tor for developing MM. 
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CD158k is a marker of the circulating tumor T cell clone in the blood of patients with Sezary
syndrome
M Bagot,1 E Guigne,1 V Schiavon,1 H Echchakir,1 M D’Incan,3 P Musette,2 L Boumsell,1
A Moretta4 and A Bensussan1 1 Inserm U448, Creteil, Paris, France, 2 Hop C Nicolle, Rouen,
France, 3 H Dieu, Clermont Ferrand, France and 4 Ist Naz per la Ricerca sul Cancro, Genova,
Italy
CD158k belongs to the family of immunoglobulin-like inhibitory receptors. It is normally expressed
on a minority of NK and CD3+CD8+ T lymphocytes. We have shown that CD158k is expressed by
a major subset of CD4+ lymphocytes in patients with Sezary Syndrome. The aim of the present work
was to study the correlation between the percentages of Sezary cells determined by cytomorphol-
ogy, and of circulating CD158k+ lymphocytes in a larger group of patients, and to assess whether
the CD158k+ phenotype was restricted to the malignant clonal population. We studied by flow cytom-
etry the expression of CD4 and CD158k on lymphocytes of 35 patients with Sezary Syndrome and
6 erythrodermic controls. 12 Sezary patients had additional analyses during follow-up. We found a
positive correlation between the percentages of CD158k+ lymphocytes and Sezary cells (r:0.58,
p=0.0002), and between the percentages of CD4+CD158k+ lymphocytes and Sezary cells (r:0.61,
p=0.0004). We also found a parallel decrease of the percentages of CD158k+ cells and Sezary cells
in 6 patients who evolved into a complete or partial remission, and parallel increasing numbers of
the percentages of CD158k+ cells and Sezary cells in 6 patients with a progressive disease. In a
patient with more than 85% of Sezary cells and of circulating TCRVb2+ lymphocytes, we found
that more than 85% of circulating lymphocytes were reactive with both anti-TCRVb2 and anti-
CD158k mAbs. All CD158k+ lymphocytes were included in the TCRVb2+ cell population. Further,
we isolated with a flow cytometer cell sorter the TCRVb2+CD158k+ cell population and showed
that the sorted TCRVb2+ lymphocytes exhibit a unique TCRVb2 junctional region, indicating that
CD158k receptor expression was restricted to the malignant clonal population. Therefore, CD158k
expression could be a useful tool to identify the circulating tumor T-cell clone, for the staging and
the follow-up of patients with a Sezary syndrome. 
0330
Adhesion molecule expression in vascular endothelial cells and cytokine production by
macrophages in xanthoma
M Matsumoto, S Kunimitsu, M Ikeda, M Yokogawa and H Kodama Dermatology, Kochi Medical
School, Nankoku, Kochi, Japan
To investigate the process of foam cell recruitment in xanthelasma palpebrarum, we examined endothe-
lial adhesion molecule expression and cytokine production by macrophages using immunohisto-
chemistry and in situ hybridization. ICAM-1 was constitutively expressed, but E-selectin and VCAM-
1 were not expressed in endothelial cells of the vessels without cell infiltration. These endothelial
cells did not produce MCP-1, IL-1β, TNF-α and TGF-β. At the sites of infiltration with macrophages,
immature foam cells and lymphocytes, endothelial cells significantly expressed E-selectin and VCAM-
1, but ICAM-1 was not expressed. Macrophages produced much more MCP-1 and IL-1β than endothe-
lial cells. TNF-α production was extensive, but TGF-β production was small both in macrophages
and endothelial cells. Within the foam cell nests, neither ICAM-1 nor E-selectin and VCAM-1 were
expressed in endothelial cells. Foam cells and endothelial cells did not produce MCP-1, TNF-α, IL-
1β and TGF-β. These findings suggest that E-selectin and VCAM-1 contribute to the adhesion of
monocytes to endothelial cells, and MCP-1 of macrophage origin plays an important role as chemoat-
tractant for monocyte/macrophages in xanthoma. In addition, IL-1β and TNF-α produced by
macrophages should be potent cytokines in the foam cell infiltration. Mature foam cells, however,
have lost such activities. TNF-α produced by endothelial cells might induce the adhesion molecule
expression in an autocrine manner. 
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Peroxiredoxin I is expressed in normal melanocytes and malignant melanoma in human
S Lee, Y Nah and J Choi Dermatology, Chonnam National University Medical School, Gwangju,
South Korea
Peroxiredoxin (Prx) is a kind of peroxidase to remove hydrogen peroxide, and has been identifed as
at least 6 isotypes in mammalian tissue. In our previus study, Prx I, II, and III are revealed to be
expressed in the skin. This study was aimed to evaluate the expression of Prx I in normal melanocytes
and malignant melanomas in human. For immunohisotchemical study in melanomas, Prx I immunos-
taining was evaluated in paraffin-embedded samples from 17 Korean acral lentiginous melanomas
(ALM) using an ABC technique. In relation to Prx I expression and the histologic levels of ALM,
the superficial ALM was arbitrarily defined that tumor cells were invasive to the papillary dermis,
and the deep ALM was defined that tumor cells reached to the reticular dermis. The intensity of Prx
I staining was graded as +3 (stronger than epidermal staining), +2 (similar to epidermal staining),
+1 (weaker than epidermal staining), and 0 (negative staining). In normal melanocytes, the ubiqui-
tous expression of Prx I was identified by Western blot analysis, and the Prx I expression was local-
ized to the cytoplasm by a confocal microscopy. The same pattern of Prx I expression was identi-
fied in several cell lines of malignant melanoma, such as G361, TMX13, A375SM, and A375P. In
normal melanocytes and the melanoma cell lines, Prx I protein expression was induced from 24-48
hrs after hydrogen peroxide treatment at 5-10 micromolar concentration. Among 10 of the superfi-
cial ALM, 4 of (+1), 4 of (+2), and 2 of (+3) were graded, respectively. Among 7 of the deep ALM,
3 of (+1), 3 of (+2), and 2 of (+3) were graded, respectively. This study showed that Prx I is identi-
fied as a novel peroxidase in melanocytes and malignant melanoma in human. Further studies are
warranted for the relation between the Prx I expression level and the tumor invasiveness or metas-
tasis in malignant melanomas. 
0332
Correlation of clinical severity and ELISA scores for NC16a domain of BP180 in bullous pem-
phigoid
Y Tsuji, M Akiyama, Y Yamanaka, T Kikuchi, KC Sato-Matsumura and H Shimizu Dermatology,
Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan
Titers of circulating autoantibodies detected by indirect immunofluorescence (IIF) have been used
for the diagnosis and evaluation of disease activity in bullous pemphigoid (BP). In BP, the major
pathogenic epitope is known to be the non-collagenous extracellular domain (NC16a) of the 180-
kD transmembrane hemidesmosomal protein (BPAG2). Recently, an ELISA kit using the NC16a
domain recombinant protein (BP180 ELISA kit) has become commercially available to measure the
quantities of pathogenic autoantibodies circulating in BP patients. In the present study, we investi-
gated the correlation of clinical severity and ELISA scores in clinically, histopathologically and
immunohistopathologically typical BP patients. Ten patients with a typical form of BP and one refrac-
tory BP patient who died despite extensive treatment were included in this study. Antibody titers in
sera from these patients were measured using BP180 ELISA kit and an analysis of ELISA scores
and its correlaton with disease activity was performed. ELISA scores were significantly reduced after
successful therapy with systemic corticosteroid, although IIF titers did not show apparent correla-
tions in all the cases. In three patients, ELISA scores were under the cutoff value even from the
onset of the disease and remained unchanged after successful treatment. In the patient with reflac-
tory BP, ELISA scores also showed a fair correlation with disease course, although IIF titers did not
clearly reflect disease activities. In conclusion, this commercially available kit more closely and
correctly followed disease activities than the IIF titers. This BP ELISA system may be a useful tool
to evaluate the disease activity and to assess the effectiveness of the treatment of BP patients in major-
ity of BP patients whose pathogenic epitope exists in the NC16a domain. 
0333
Pruritogenic mediators in psoriasis vulgaris
M Nakamura, M Toyoda and M Morohashi Department of Dermatology, Toyama Medical and
Pharmaceutical University, Toyama, Toyama, Japan
To clarify the mechanism and mediators involved in the pruritus of psoriasis vulgaris, we quantita-
tively compared itch-associated factors in lesional skin from psoriatic patients versus skin without
pruritus using a panel of histologic and immunohistologic parameters. When compared to psoriatic
patients devoid of pruritus, lesionalskin from patients with pruritus showed the following charac-
teristic features; a rich innervation both in the epidermis and in the papillary dermis, an increase in
neuropeptide substance P-containing nerve fibers in perivascular areas, decreased expression of neu-
tralendopeptidase in the epidermal basal layer as well as in the endothelia of blood vessels, many
mast cell showing degranulating processes in the papillary dermis, a strong immunoreactivity for
nerve growth factor throughout the entire epidermis and an increased nerve growth factor content in
lesional skin homogenates, an increase in the expression of high-affinity receptors for nerve growth
factor(Trk-A) in basal keratinocytes and in dermal nerves, an increased population of IL-2-immunore-
active lymphocytes, and a strong expression of E-selectin on vascular endothelial cells. A signifi-
cant correlation was observed between the severity of pruritus and PGP9.5-immunoreactive intraepi-
dermal nerve fibers, NGF-immunoreactive keratinocytes, expression of Trk-A in the epidermis and
the density of immunoreactive vessels for E-selectin. These findings indicate that possible prurito-
genic mediators in psoriatic lesional skin are neurogenic factors including innervation, neuropep-
tide substance P, neuropeptide-degrading enzymes and nerve growth factor, activated mast cells,
one or more cytokines and endothelial-leukocyte adhesion molecules. These data document for the
first time itch-related local markers in psoriasis, and suggest complex and multifactorial mechanisms
of pruritus in the disease. These results provide the groundwork for further studies to evaluate the
efficacy of anti-pruritic treatment for psoriatic patients. 
0334
Three separate studies support the systemic safety of fluticasone propionate cream, ointment
and lotion in the treatment of severe and extensive eczema in children as young as 3 months
SF Friedlander,1 J Hanifin2 and EJ Glazenburg3 1 University of California, San Diego, CA, 2 Oregon
Health Sciences University, Portland, OR and 3 GlaxoSmithKline BV, Zeist, The Netherlands
Three open, multicenter studies in paediatrics with extensive moderate to severe eczema evaluate the
safety of FP 0.05% cream, FP 0.005% ointment and FP 0.05% lotion and investigated effects on
hypothalamic pituitary adrenal (HPA)-axis function using the cosyntropin stimulation test (CST).
In total, 135 children (82 were 3months - 3yr, 53 were >3-5yr) with extensive moderate to severe
eczema (mean BSA involvement = 60-68%) applied FP twice daily for 3-4 weeks. There were no
clinically significant differences in mean cortisol levels pre-and post-CST before or at end of, reg-
ular FP treatment. Pre-CST cortisols for all 3 FP formulations were similar before and after treat-
ment. Before FP, the cortisols pre-CST for cream, ointment and lotion were (mean±sd) 14±7, 12±5,
13±6µg/dL, and post-CST were 31±7, 27±4, 35±6µg/dL, respectively. After FP, the cortisols pre-
CST for cream, ointment and lotion were 12±7, 11±5, 12 ±6µg/dL and post-CST were 29±7, 25±4,
33±8µg/dL, respectively. Of the 120 children with end-treatment post-CST cortisols, 117 had nor-
mal responses (defined as 18µg/dL), only 3 had low values. One patient had samples taken at an
inappropriate time of day and 2 had normal cortisols 7-12 days after cessation of therapy. No cor-
relation was apparent between cortisols and available FP levels. Data from the 3 studies indicated
that even extensive application of FP cream has minimal potential to cause atrophogenic effects.
There were no withdrawals due to adverse events or clinically significant shifts in laboratory values.
In paediatric patients, some as young as 3 months, FP in cream, ointment or lotion formulation,
applied daily for up to 4 weeks, is safe for the treatment of severe and extensive eczema. 
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Acute generalized exanthematous pustulosis: does it exist?
B Sassolas,1 S Halevy,2 F Bazin,3 L Naldi,4 A Dunant 5 and A Sidoroff 6 1 Dermatology, Chu Brest,
Brest, France, 2 Soroka University Medical Center, Beer-Sheva, Israel, 3 Inserm U 444, Paris,
France, 4 University of Bergamo, Bergamo, France, 5 Institut Gustave-Roussy, Villejuif, France
and 6 University of Innsbruck, Innsbruck, France
Among pustular eruptions was defined in the early 80’s, the Acute Generalized Exanthematous Pus-
tulosis (AGEP). This reaction, mainly drug induced, is characterised by the acute onset of dozens to
hundred of small, pinhead-sized non-follicular sterile pustules. They often arise on an edematous
erythema, with accentuation of lesions in big folds. Recognition of this disease and its separation
from acute pustular psoriasis is not worldwide admitted. During a 5 year-period, in a multinational
case control study (EuroSCAR) based on an European detection network devoted to study severe
cutaneous adverse reaction, we actively detected cases of acute pustular eruption. We recorded demo-
graphic data, previous medical history, clinical and histopathological description of the eruption, and
recent drug intake. Cases were ascertained as definite or possible AGEP by an international expert
committee, based on a scoring system taking into account morphology of the eruption, course of the
disease and histopathology. We evaluated 150 potential community cases of acute exanthematous
pustular eruption. Among those, 96 cases fulfilled criteria for AGEP. Mean age of patients was 55,5,
(4-91) with a male/female sex-ratio of 0,8. Age repartition differs from that of Stevens Johnson syn-
drome and toxic epidermal necrolysis. The death rate was 4%. Erythema and pustules were wide-
spread in 89% and 73% of patients with folds accentuation in 46% and 50% respectively. Recent
herpes infection, HIV and other infections, autoimmune diseases, atopy, cancer and psoriasis were
not associated or risk factors. Based on these prospectively collected data, we confirm the reality of
this disease, with specific clinical pattern and evolution and no association to psoriasis. 
0336
Pear-seed extract--a remarkable anti-aging active ingredient that significantly diminishes
skin wrinkles and roughness: an in vivo study
G Oberto, A Berghi, E Bauza, D Peyronel, C Dal Farra  and N Domloge Research Center,
Vincience, Sophia Antipolis, France
Compensating for age-related hormonal decline has recently become an essential approach to skin
aging. Phytohormones are natural plant compounds with body-hormone-like activity. Consequently,
enthusiasts have promoted phytohormones as the natural alternative to age-related hormonal decline.
In this area, we developed a pear-seed extract rich in phytohormones, and we investigated its anti-
aging properties in this double blind in vivo study. The study was conducted on twenty healthy
women, age 40 to 62. The volunteers applied the cream formula with 2.5% of the extract, or placebo,
on the eye zone area twice a day for 8 weeks. Skin wrinkles and surface roughness were evaluated
clinically, using pictures, and through silicon replicas followed by statistical treatment using the
matched paired student test. Silicon replica results showed that pear-seed extract application on the
skin significantly reduced the number of skin wrinkles (-15.5%) and average wrinkle depth (-5.5%).
Interestingly, highly significant results were found concerning the effect of the extract on reducing
the total surface of wrinkles (-37,9%), total wrinkle length (-24.4%), and average wrinkle length (-
13.6%). Moreover, analysis of skin roughness showed that application of the extract to the skin
improved its texture and significantly reduced average roughness (Ra, - 5.7%). Furthermore, clini-
cal examination of the volunteers skin following scoring method revealed a net visible improvement
of skin surface and reduction of wrinkles by 18% in the extract-treated sides. These results demon-
strate a remarkable and very significant effect of pear-seed extract on reducing skin wrinkles and
decreasing skin roughness, which is of great interest in anti-aging skin care products. 
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Reductions in circulating memory T cells correlate with clinical improvement and prolonged
responses to alefacept in psoriasis
KB Gordon Northwestern University, Chicago, IL
Scientific and clinical evidence supports a critical role for memory T cells in the pathogenesis of
psoriasis. This randomized, double-blind, placebo-controlled, parallel-group study examined the
relationship between the pharmacodynamic and antipsoriatic effects of alefacept, a biologic agent
that targets CD4+ and CD8+ memory T cells involved in psoriasis pathogenesis. Patients with chronic
plaque psoriasis (n=553) were randomized to 1 of 3 cohorts: alefacept for 2 courses; alefacept in
course 1, placebo in course 2; or placebo in course 1, alefacept in course 2. In each course, alefacept
7.5 mg or placebo was administered by IV bolus once weekly for 12 weeks followed by 12 weeks
of observation. One or 2 courses of alefacept reduced CD4+ and CD8+ memory T cells, with neg-
ligible effects on the naive population. There was no evidence of a cumulative effect of alefacept on
total lymphocyte or lymphocyte subset counts. Most patients had CD4+ counts above the lower limit
of normal at 12 weeks after the last dose in the first course (88%) and second course (83%) of ale-
facept. In course 1, alefacept-treated patients with the largest decreases in memory T cells experi-
enced the greatest reductions in disease activity (P<.001). The majority of the alefacept-induced
reductions in the memory T-cell population preceded the peak improvement in Psoriasis Area Sever-
ity Index. Lasting remissions were evident in patients who responded to alefacept. The duration of
clinical benefit was significantly longer among patients who had the greatest reduction in memory
T cells relative to patients who experienced less of a reduction in memory T cells. In conclusion, 1
or 2 courses of IV alefacept selectively reduced circulating memory T cells and spared the naive T-
cell population. The reductions in memory T cells were related to all measures of disease activity
evaluated and the duration of response to therapy, suggesting that the memory T cell plays a key role
in psoriasis. Results suggest that reduction of the pathogenic T-cell population can lead to pro-
longed remissions of psoriasis. 
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Repeated courses of IM alefacept in psoriasis: rationale and design of an international study
that mimics the clinical practice setting
GG Krueger,1 KB Gordon,2 P van de Kerkhof3 and W Sterry4 1 University of Utah Health Sciences
Center, Salt Lake City, UT, 2 Northwestern University, Chicago, IL, 3 University Hospital
Nijmegen, Nijmegen, The Netherlands and 4 University Hospital Charite, Berlin, Germany
Psoriasis is a chronic, relapsing skin disease that typically requires life-long treatment. Alefacept is
a novel biologic agent that improves psoriasis by selectively targeting the T cells involved in the dis-
ease pathogenesis. It has been shown to have an encouraging clinical profile in multiple random-
ized, placebo-controlled studies and retreatment trials. To understand the best way to manage exist-
ing therapies during a course of alefacept, an international study is being conducted to mimic the
clinical practice setting. Approximately 400 patients with chronic plaque psoriasis will be enrolled
in this open-label study in which topical treatments, narrowband or broadband ultraviolet B light,
systemic retinoids, and prednisone will be permitted as concomitant therapies. Cyclosporine and
methotrexate will be tapered over the first 6 weeks of alefacept therapy. Patients must be at least 16
years of age, require systemic therapy, have normal CD4+ lymphocyte counts (at least 300 cells/mm3
if on stable dose of prednisone), and be naive to alefacept therapy. In each course, alefacept 15 mg
will be administered once weekly by IM injection for 12 weeks followed by 12 weeks of observa-
tion. Patients may receive up to 3 treatment courses. The primary objective is to evaluate the safety
of repeat courses of alefacept, as assessed by adverse events, selected blood chemistries, vital signs,
and physical examinations. Other prespecified objectives are to determine the efficacy of initial and
repeat courses of alefacept and the duration of response after the first 2 courses. Circulating total
and CD4+ and CD8+ lymphocyte counts will be determined. Physician Global Assessment will be
performed at baseline and at multiple times during the observation period. 
0341
Use of topical tacrolimus in combination with 6% salicylic acid for treatment of psoriasis:
results of a double blind right to left trial
CL Carroll, SR Feldman and R Balkrishnan Dermatology, Wake Forest University Health Sciences,
Winston-Salem, NC
Topical tacrolimus is an effective anti-inflammatory agent in atopic dermatitis but appears less effec-
tive on thick, scaly psoriasis lesions. The purpose of this study is to assess whether combined use
with a penetration enhancer is effective. Twenty-three subjects with generally symmetric psoriasis
were randomized to salicylic acid/placebo vs. salicylic acid/topical tacrolimus in this left-right com-
parison study. Treatment was given for eight weeks. The primary outcome was the change in the sum
of erythema, scale and thickness scores from baseline to end of treatment. The medications were
well tolerated. Significant improvement was found in subjects with moderate to good adherence.
Fifty percent of the subjects completing the study requested a prescription for tacrolimus. The pre-
liminary data suggest that combination therapy using salicylic acid with topical tacrolimus may
increase the effectiveness of the topical tacrolimus in the treatment of psoriasis. 
0340
Electronic monitoring of medication adherence in skin disease clinical studies: results of a pilot
study
R Balkrishnan, CL Carroll, VC Khanna, FT Camacho and SR Feldman Wake Forest University
Health Sciences, Winston-Salem, NC
Medication non-adherence is a financial burden to the medical system and is understudied in der-
matology. Currently all studies involve self-report, pill counts or medication tube weights which have
been shown to be inaccurate. The purpose of this study was to examine medication adherence to
topical therapy using electronic monitors. Topical salicylic acid was administered in a jar with an
electronic cap (MEMS cap) that monitors of usage of medication to ten subjects participating a clin-
ical study for localized psoriasis. The MEMS cap data were compared to data recorded by patients
on dosing calendars. Eight out of 10 subjects reported more medication use on their logs than was
actually recorded by the MEMS caps. Self reported use of topical medications is inaccurate and much
of the failure of topical medications is likely due to medication non-adherence. Electronic medica-
tion monitors, like the MEMS cap, may be integrated into future clinical trials to accurately show
response vs. non-response vs. non-adherence to investigational therapies. 
0338
Alefacept plus ultraviolet B light as combination therapy for psoriasis
J Ortonne,1 A Khemis1 and J Koo2 1 Hopital L Archet II, Nice, Cedex, France and 2 University of
California-San Francisco Medical Center, San Francisco, CA
T cells play a critical role in the pathogenesis of psoriasis. Alefacept is a novel and selective bio-
logic agent that blocks the natural interaction between LFA-3 on antigen-presenting cells and CD2
on T cells to inhibit T-cell activation and proliferation. In addition, alefacept engages FcγRIII recep-
tors on accessory cells to reduce pathogenic memory T cells. Monotherapy with alefacept is well
tolerated; remissions lasting 7-8 months have been demonstrated after 12 weeks of once-weekly dos-
ing. Ultraviolet B (UVB) light is frequently used for the treatment of psoriasis. It directly targets rap-
idly proliferating keratinocytes and T cells in the skin and has a relatively rapid onset of action. The
combination of alefacept and UVB light has the potential to provide synergistic efficacy and lower
the cumulative dose of UVB light, thereby resulting in less photodamage and increased convenience.
The combination of alefacept and either narrowband (NB) or broadband (BB) UVB light was eval-
uated in an open-label study of patients with chronic plaque psoriasis. Patients (approximately 60)
were enrolled at 2 sites: 1 in France (NB UVB) and 1 in the US (BB UVB). All patients received
alefacept 15 mg IM once weekly for 12 weeks. Patients were randomized (1:1:1) to receive either
no UVB light, UVB light 3 times/week until clear or for up to 6 weeks, or UVB light 3 times/week
until clear or for up to 12 weeks. An observation period of 12 weeks followed the treatment period.
The primary objective was to determine the safety and tolerability of combination therapy, prima-
rily via assessments of adverse events, including infections, changes in minimum erythematous dose,
and skin irritation. The efficacy of combination therapy was determined by assessments of Psoria-
sis Area Severity Index and physician and patient global evaluations. Results will be presented. 
0342
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Alefacept is efficacious for treatment of psoriasis regardless of response to prior therapy or
disease severity: pooled analyses of phase 3 trials
E Rizova1 and J O’Gorman2 1 Biogen, Inc., Nanterre, Cedex, France and 2 Biogen, Inc.,
Cambridge, MA
The efficacy and safety of alefacept have been evaluated in 2 randomized, double-blind, placebo-
controlled phase 3 trials including >1000 patients with chronic plaque psoriasis. Alefacept 7.5 mg
IV, alefacept 10 mg IM, alefacept 15 mg IM, or placebo were administered oce weekly for 12 weeks
followed by 12 weeks of observation. In both studies, almost 80% of patients had received prior sys-
temic or phototherapy. Baseline disease severity was similar for the 2 trials. Across all treatment
groups, median body surface area (BSA) involvement ranged from 20-24% and median Psoriasis
Area Severity Index (PASI) from 13.2-15.9. In the pooled alefacept group (n=706), a 75% or greater
reduction in PASI was achieved at any time during treatment or follow-up by 34% of patients who
reported no change or worsening of disease during prior therapy, 26% of patients who reported
improvement on prior therapy, and 34% of patients who had not received prior systemic or pho-
totherapy. Corresponding percentages in the placebo group (n=354) were 12%, 9%, and 12% (all
P<=0.002 vs alefacept). A 50% or greater reduction in PASI at any time during treatment or follow-
up was achieved by 60% of alefacept patients who reported no change/worsening with prior sys-
temic or phototherapy, 52% of those who had had improvement, and 60% of those with no previous
exposure to systemic or phototherapy. In the placebo group, 23%, 29%, and 36% of patients, respec-
tively, met this criterion (all P<=.001 vs alefacept). For patients with BSA >30%, a 75% or greater
reduction in PASI was achieved by 25% of alefacept-treated patients (n=225) compared with 10%
of placebo-treated patients (n=108). The corresponding response rates for those with BSA of 30%
or lower were 31% for alefacept (n=481) and 10% for placebo (n=245). In conclusion, alefacept
was efficacious irrespective of response to prior systemic or phototherapy and regardless of disease
severity. 
0344
The usefulness of a BP180 NC16A-domain ELISA in the serodiagnosis of pemphigoid gesta-
tionis and in differentiating between pemphigoid gestationis and pruritic urticarial papules
and plaques of pregnancy
Y Sakuma-Oyama,1 A Powell,1 N Oyama,1 S Albert,1 BS Bhogal,1 MM Black1 and T Nishikawa2
1 Department of Immunofluorescence, St John’s Institute of Dermatology, London, England,
United Kingdom and 2 Department of Dermatology, Keio University School of Medicine, Tokyo,
Japan
Pemphigoid gestationis (PG) is a rare pregnancy associated subepidermal immunobullous disease,
targeting hemidesmosomal proteins. Clinically, PG can resemble PUPPP and accurate differentia-
tion between these two pruritic pregnancy related dermatoses has important implications for foetal
and maternal prognosis. Epitope mapping studies show that autoantibodies in 90% of PG sera tar-
get a well-defined membrane proximal NC16a domain of BP180 (Morrison et al. J Clin Invest
1988;81:2023-26). The purpose of this study was to examine the usefulness of a commercially
available NC16a-domain ELISA in the serodiagnosis of PG, and its diagnostic value in differenti-
ating PG from PUPPP. Sera from 410 female subjects, consisting of PUPPP (n=164), normal female
healthy volunteers (NHV), 18-50 years old (n=164) and pre-treatment PG patients (n=82) were
assayed in duplicate according to the manufactures instructions. Receiver-operating-characteristic
(ROC) analyses were performed to determine a cut-off value for the diagnosis of PG and differen-
tiation from PUPPP. The average ages of PG, PUPP, and NHV were 32, 31 and 33, respectively. A
cut-off value of 18 units is associated with a specificity and sensitivity of 99% (326/328) and 88%
(72/82), respectively. The average coefficient of variation was 4.3%. None of the NHV and two of
the PUPPP sera results were greater than 18. False positive and false negative results were further
investigated by western immunoblotting studies using human epidermal extract and recombinant
polypeptides encompassing the entire BP180 extracellular domain. The NC16a ELISA has a sensi-
tivity consistent with the finding that 10% of PG sera react with BMZ epitopes outside the NC16a
domain and is highly specific in differentiating PG from PUPPP. 
0345
Prognostic factor analysis for plaque psoriasis
R Sakai,1,3 S Matsui,1 M Fukushima,1 H Yasuda,2 H Miyauchi2 and Y Miyachi3 1
Pharmacoepidemiology, Kyoto University, School of Medicine & Public Health, Kyoto, Japan, 2
Dermatology, Kurashiki Central Hospital, Kurashiki, Japan and 3 Dermatology, Kyoto University,
Graduate School of Medicine, Kyoto, Japan
Many patients with plaque psoriasis have good prognosis. However, some patients have refractory
disease with poor response to drug therapy. Little attention has been given to the prognostic factors
which determine the progression of psoriasis. The purpose of this study was to explore the prog-
nostic factors and develop an index to assess the risk for progression of the disease. In March 2001,
data including patients’ clinical characteristics and disease condition at the time of diagnosis as well
as the current disease condition was collected for 169 psoriasis patients who visited Kurashiki Cen-
tral Hospital from March 1991 to March 1996 (median follow-up time 11.6 years). Ten factors of
patients’ clinical characteristics at diagnosis (age, sex, body mass index, the state of alcohol drink-
ing and smoking, and the presence of concomitant diseases including joint pain, hypertension, hyper-
lipemia, diabetes, and the others; all were binary) were analyzed using logistic regression to asso-
ciate the factors with the probability of progression or no change of the disease following diagnosis.
Age (Odds ratio (OR) 0.271; 95% confidence interval (CI) 0.102-0.723; p=.0091), sex (OR 2.670;
95%CI 1.018-7.001; p=.0459) and body mass index (OR 2.735; 95%CI 1.009-7.415; p=.0480) had
significant effects. Based on the result, an index was developed by using these three factors as fol-
lows; age < 40 years (1 point), male (1 point), and body mass index  25 (1 point). The sum of these
three binary factors formed four subgroups (0-3 points). The rate of progression or no change of the
disease for each subgroup (0, 1, 2 and 3) was 5%, 28%, 42% and 100% respectively. This prognos-
tic index should be validated in future studies. The developed index may be useful in the design of
future clinical trials for psoriasis and in the selection of appropriate therapeutic approaches for indi-
vidual patients. 
0346
Cutaneous squamous cell carcinoma incidence is not increased in rheumatoid arthritis patients
receiving etanercept
M Lebwohl,2 R Blum,2 D Kim,1 T Do,1 W Wallis,1 A Rubin,1 D Burge1 and R Zitnik1 1 Amgen, Inc,
Thousand Oaks, CA and 2 Dermatology, Mount Sinai Hospital, New York, NY
A recent report described 7 cases of cutaneous squamous cell carcinoma (SCC) in patients treated
for rheumatoid arthritis (RA) with etanercept (ENBREL®) (J Am Acad Dermatol 2001, 45:953-6).
Treatment with immunosuppressive agents such as cyclosporine has been associated with increased
incidence of SCC, however data from animal models and clinical trials suggest that TNF inhibition
does not increase malignancy rates. Because cancer surveillance is a central element in the etaner-
cept pharmacovigilance program, we explored the potential association between etanercept therapy
and SCC in RA patients, calculating observed and expected incidences of SCC from pooled etaner-
cept clinical trials and long-term extension studies. Through 04/02, 1442 RA study patients received
etanercept therapy with 4044 patient-years of cumulative exposure. Median and maximal durations
of exposure were 3.7 and 5.7 years, respectively. The NCI Surveillance, Epidemiology, and End
Results database (SEER) was used to determine expected number of all malignancy types for the
general population. SEER does not provide incidence figures for non-melanoma skin cancers, so we
used two published reports (from northern and southern US latitudes) to calculate incidence of SCC
in an age- and sex-matched cohort from the general US population. The incidence of all cancers in
etanercept-treated patients was less than expected. An age- and sex-matched population would be
expected to have 6 to 13 cases of SCC in the interval of observation. However, only 4 cases were
observed. Epidemiologic analysis of clinical trials provides additional perspective on the cancer
risk associated with etanercept therapy. In long-term clinical studies with over 4000 patient-years of
exposure, RA patients on etanercept therapy did not have an increased rate of malignancies. Impor-
tantly, the rate of SCC was well below the expected rate. 
0347
Effect of short-contact topical tretinoin therapy on lower extremity ulcers in diabetic patients
W Tom, DH Peng and T Hata Dermatology, University of California, San Diego, San Diego, CA
Topical tretinoin is a potential therapy to enhance the healing of wounds, given its properties of
increasing granulation tissue, collagen synthesis, angiogenesis, and fibroplasia. The purpose of the
current study was to test the hypothesis that topical tretinoin can improve healing of lower extrem-
ity ulcers in diabetic patients. This was a prospective, randomized, double-blind, placebo-controlled
study involving 24 patient volunteers from the Diabetic Foot Clinic. Patients were divided into two
treatment groups- treatment with topical tretinoin 0.05% solution and treatment with control normal
saline solution. Exclusion criteria were: unable to give informed consent, having a known bleeding
disorder, pregnancy at time of enrollment, patients with infected ulcers, and patients with lower
extremity ulcers due to large arterial disease. At the initial visit, photographs were taken for meas-
urements of the initial size of all lower extremity ulcers. Patients were then randomly assigned to
one of the two treatment groups. Solution was applied direct to the wound bed and left in contact
for a maximum of 10 minutes daily, then rinsed off with normal saline. This was done once daily
for 4 weeks. Photographs and measurements of ulcer size were taken every 2 weeks after starting
the assigned treatment, for a maximum of 16 weeks or until complete healing of the ulcer occurred,
whichever came first. Tretinoin 0.05% solution reduced the mean time to ulcer healing relative to
control normal saline solution (p< 0.05). For superficial ulcers (<1mm depth), subjects in both groups
achieved complete healing by the end of the study. For deeper ulcers, 6/7 patients in the tretinoin
treatment group achieved complete healing at 16 weeks as compared to1/4 patients in the control
group. Patients continued to receive standard care for their ulcer. Topical tretinoin can improve the
process of wound healing for diabetic ulcers. It decreases time to healing, without significant irrita-
tion. It has potential utility as an adjuvant therapy to current methods of treating diabetic foot ulcers. 
0348
Interleukin-18 in atopic dermatitis and psoriasis
S Yasumoto,1 M Higuchi,1 M Okamoto,2 T Hoshino2 and T Hashimoto1 1 Dermatology, Kurume
University School of Medicine, Kurume, Japan and 2 Internal Medicine, Kurume University School
of Medicine, Kurume, Japan
Interleukin (IL)-18 is a proinflammatory cytokine known to be produced by keratinocytes and to
have a broad role in inflammatory responses. Since IL-18 may contribute to both Th1 type responses
and Th2 type responses depending on the circumstances they involved, enhanced expression of IL-
18 had been reported both in atopic dermatitis and psoriasis. To elucidate the possible role played
by IL-18 in atopic dermatitis and/or psoriasis, IL-18 and IL-18 receptor (R) were stained by a stan-
dard immunohistochemical technique using anti-IL-18 and anti-IL-18R arpha chain monoclonal anti-
bodies in parafin-embeded tissue samples. In the lesional skin of atopic dermatitis and also in pso-
riasis, the staining of IL-18 was significantly enhanced in all the layers of epidermis compaired to
normal control, while IL-18 R was also enhanced but localized in keratinocytes in subcorneal layer.
Serum IL-18 levels were measured by ELISA. In comparison to normal control group, both patients
with atopic dermatitis and psoriasis were found to exbit increased IL-18 levels, which appeared to
be correlated with disease severity. These results may suggest that IL-18 is not the primary patho-
genic cytokine either in atopic dermatitis or in psoriasis. However, IL-18 may be involeved in the
cutaneous inflammatory process and/or keratinocyte changes, such as acanthotic epidermis seen both
in atopic dermatitis and psoriasis. 
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Fiberoptic confocal imaging of tbe skin
JJ Miller,1 MG Fleming,1,2 MM Janson1 and JA Fairley1,2 1 Dermatology, Medical College of
Wisconsin, Milwaukee, WI and 2 Zablocki VA Medical Center, Milwaukee, WI
Fiber optic confocal imaging (FOCI) is a new technology for imaging the skin. FOCI uses visible
light (488 nM) to non-invasively produce high magnification (1000x) fluorescent images in-vivo. In
contrast, most previous work with in-vivo confocal microscopy has used reflectance mode. A fiber
optic laser scanning instrument, the Stratum (Optiscan, Melbourne Australia), was used to image a
number of skin disorders as well as normal skin. Patients who were scheduled to have a skin biopsy
were asked to participate in the study (FMLH IRB#02-111, MCW HHRC #187-02). Fluorescein,
0.2% was used as a fluorophore and 0.2 cc was injected in the high dermis at the site to be imaged.
The site was then three dimensionally imaged to a depth of 200 micrometers. Controls included
imaging adjacent, non-diseased tissue from the same patient and imaging the diseased area without
the addition of dye. Following FOCI, the patient proceeded with a biopsy and FOCI images were
compared to standard histologic images. No autofluorescence of the skin was found with the Stra-
tum. FOCI provided clear images of the epidermis and the papillary dermis.  The stratum corneum,
stratum granulosum, stratum spinosum, stratum basale and papillary dermis could be identified by
their specific morphologic features.  The clarity of FOCI images also revealed micro-anatomical
structures, such as eccrine ostia and the capillary plexus of the papillary dermis. Imaging of the
autoimmune sub-epidermal blistering disease, bullous pemphigoid, allowed identification and local-
ization of the blister cavity at the basement membrane zone. In contrast, pemphigus foliaceus, char-
acterized by autoantibody binding to desmoglein 1 on the epidermal keratinocyte surface and sub-
corneal blisters, demonstrated widening of the intercellular spaces and a superficial blister cavity on
FOCI. These studies indicate that FOCI can be used to identify specific morphologic features of
normal and diseased skin. 
0351
UV-free phototherapy: development and first clinical results
J Krutmann,1,2 K Medve-Koenigs,1,2 N Mahnke,2 T Ruzicka,2 U Ranft1 and JH Wilkens3 1 Institut
fuer umweltmedizinische Forschung (IUF) at the Heinrich-Heine-University, Duesseldorf,
Germany, 2 Department of Dermatology, Heinrich-Heine-University, Duesseldorf and 3 OptoMed
Group, Berlin/Wildau, Germany
Phototherapy with ultraviolet (UV) radiation is of benefit for patients with atopic dermatitis (AD).
Since UV radiation is a complete carcinogen, UV therapy is usually not used for the longterm treat-
ment of children and young adults and in combination with immunosuppressants. Phototherapy with
UVA-1 (340-400 nm) radiation induces apoptosis in skin infiltrating T-cells via the generation of
singlet oxygen. In the present study we have asked whether phototherapy with visible light, which
according to current knowledge does not cause skin cancer but can generate singlet oxygen, can be
used for the treatment of AD. For this purpose a novel large-area, laser-like photonic partial body
irradiation device (DermoDyne) has been developed. Over 40% of the radiation is being emitted
between 400-500 nm, with 26% of the spectral energy between 400-450 nm. Emission in the UV
range is 1.5% between 380-400 nm, 0.1% between 360-380 nm, 0.01% between 340-360 nm and
no emission below 340 nm. The residual UVA-1 emission was less than 1 J/cm2 per treatment, and
thus, by definition (ICNIRP/IRPA), DermoDyne therapy is UV-free. Patients with atopic hand and
feet eczema (n=10) were first treated for 2 weeks (3x/week) with a sham irradiation device emitting
the identical spectrum but at a significantly reduced fluence (factor 105 less), after which they were
subjected to DermoDyne treatment (3x/week) for another 4 weeks. Sham irradiation did not cause
any improvement, as assessed by means of the DASI score, and in fact, one patient dropped out
because of worsening of eczema. In contrast, the 9 remaining patients showed a significant improve-
ment after 4 DermoDyne treatments (DASI, before 34.8; after 4 irradiations: 23.33; p<0.0002), with
further significant improvement after another 8 irradiations (DASI, after 12 irradiations: 7.44; p<
0.0001). This study demonstrates the first successful use of UV-free phototherapy. 
0353
Treatment of moderate-to-severe psoriasis with human monoclonal antibody to human IL-12
CL Kauffman,1 N Aria,1 E Toichi,2,3 T McCormick,2 KD Cooper,2 AB Gottlieb,4 DE Everitt,5
B Frederick5 and MA Mascelli5 1 Division of Dermatology, Department of Medicine, Department
of Pathology, Georgetown University Medical Center, Washington, DC, 2 Department of
Dermatology, Case Western Reserve University, Cleveland, OH, 3 Kyoto Univ. Graduate School of
Medicine, Kyoto, Japan, 4 UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ and
5 Centocor Inc., Malvern, PA
The safety and efficacy of single, ascending, intravenous doses of a human monoclonal antibody to
human IL-12 was assessed in patients with moderate-to-severe psoriasis. In this phase I, nonran-
domized, open-label, multicenter study patients received a single intravenous infusion of a human
monoclonal antibody to human IL-12. Eighteen patients with at least 3% body surface area involve-
ment were sequentially enrolled into ascending groups (0.1 mg/kg, 0.3 mg/kg, 1 mg/kg, and 5 mg/kg).
Six millimeter punch biopsies were performed the day prior to infusion, at 48 hours and 2 weeks
post-infusion and analyzed using quantitative Taqman PCR to compare levels of cutaneous cytokine
mRNA. Average Psoriasis Area and Severity Index (PASI), Physician’s Global Assessment (PGA)
and blood work were obtained during a 16 week period. PASI scores were reduced 56% by week 8
and 50% at week 16 among patients in the lower dose groups (0.1 mg/kg and 0.3 mg/kg, n = 8). In
the higher dose groups (1.0 mg/kg, 5 mg/kg, n = 10), PASI scores were reduced by 75% by week 8
and 87% at week 16. Treatment was well tolerated with no drug related serious adverse effects.
Absolute total CD4 counts fell to below 400 in 2 patients for less than 5 days. At 72 hours follow-
ing study drug administration, CD16+56 counts decreased by >20% from baseline in 8 of 17 patients
evaluated. Quantitative assessment of cutaneous cytokine mRNA showed IFNγlevels were signifi-
cantly reduced at 2 weeks post infusion. In summary, a single intravenous infusion of a human mon-
oclonal antibody to human IL-12 was well tolerated and induced significant clinical improvement
in this open-label, phase I study. 
0352
Celecoxib prevention of BCCs in basal cell nevus syndrome patients
J Yu,1 M Aszterbaum,1 M Stiller,2 L Kopelovich,3 DR Bickers2 and EH Epstein1 1 Dermatology,
UCSF, San Francisco, CA, 2 Dermatology, Columbia University, New York, NY and 3 National
Cancer Institute, Bethesda, MD
Cancer chemoprevention studies in humans are difficult to conduct even in genetically-susceptible
populations because the tumor incidence generally is so low that either large numbers of subjects
must be studied or surrogate end points must be substituted for the actual cancer of interest. Patients
with the basal cell nevus syndrome (BCNS) represent a uniquely attractive population for chemo-
prevention studies because they develop multiple tumors annually, thus permitting the rapid accu-
mulation of statistically significant data in a small cohort. We have initiated a clinical trial to assess
the efficacy of an oral cyclooxygenase-2 inhibitor in preventing BCCs in this population. The study
design is a randomized double-blind trial of subjects receiving placebo or celecoxib, 200 mg bid,
for two years. Patients are seen at sites in New York, Cleveland, San Francisco, or Los Angeles
every three months, and their tumors are treated by their local primary skin care physician (PSCP)
by whatever technique seems best suited to that tumor. The primary end point of the study is the
number of BCCs of  3 mm diameter developing during the two years of therapy, and the enumer-
ation is based on the records of the PSCPs, visits to the sites, and patient histories. We now have
enrolled 40 of the projected 60 subjects, and they have been in the study for up to 18 months. No
study-related adverse events have been detected, and only one subject has had to be eliminated for
non-compliance. Among the obstacles to full enrollment are the rarity of BCNS, and the reluctance
of patients to participate in a trial in which they may receive only placebo, to discontinue previously
prescribed NSAIDs, and to come for visits every three months despite travel reimbursement. Nonethe-
less this population is very important for chemoprevention studies, and our involvement with BCNS
patients has shown how committed they are to finding preventive approaches to their multiple health
problems. 
0350
Age-related changes of skin microtopography in Caucasian and Japanese women
SI Guehenneux,1 I Le Fur,1 A Laurence,1 R Vargiolu,2 H Zahouani,2 C Guinot1 and E Tschachler1,3
1 CE.R.I.E.S., Neuilly Sur Seine, France, 2 Ecole Centrale De Lyon, Lyon, France and 3
Dermatology, University of Vienna, Vienna, Austria
The skin surface is characterized by a special relief which reflects the three-dimensional organiza-
tion of the deeper layers and the functional status of the skin. The aim of this study was to compare
changes of skin microtopography with age in Caucasian and Japanese women. Two studies were per-
formed simultaneously during winter time in Paris and Sendai on 356 Caucasian and 120 Japanese
healthy women respectively, aged from 20 to 80 years. Skin replicas were obtained from the volar
forearm and analysed by interferometry. This analysis yielded to 12 standard “global parameters”
generally used to describe surface topography and 13 “local parameters” including distribution of
the lines according to their orientation, depth of lines and an anisotropy index. Statistical analyses
included principal component analysis in order to visualize the links between the 25 parameters,
and Pearson correlation coefficient to study the link with age for each parameter in both popula-
tions. All but one of the “global parameters” were found to be positively correlated with age. More-
over, Caucasian and Japanese women showed an increase in the “density of lines” >60µm of depth
and a decrease of the “density of lines” <60µm with age. This phenomenon was found to be more
pronounced and to appear at a younger age in Caucasians. Concerning the age-related changes in
the “density of lines” according to their orientation, no significant change was found in the Japan-
ese, whereas important changes were found in Caucasians, resulting to an important increase in skin
anisotropy with age. Our results demonstrate that in both Caucasian and Japanese women important
changes of the skin microtopography occur with age and that these changes were found to be more
pronounced and to appear at a younger age in Caucasians. 
0354
Correlation between the presence of C5-9 and immunoglobulins in skin and their clinical rel-
evance
PM Lamb, E Abell and J Deng Dermatology, VAMC and Univ. of Pittsburgh, Pittsburgh, PA
Past evidence suggests direct immunofluorescence (DIF) could be a very useful tool in clinical
medicine. In the past two decades, presence of C5-9 in dermoepidermal junction (DEJ) has been
suggested to be unique for dermatomyositis. This study was designed to search for the correlation
between C5-9 deposition and immunoglobulins in skin, and its relevance in clinical medicine. Skin
biopsy specimens were transported to laboratory in Michel’s solution, and processed for DIF and
indirect IF (IIF) for C5-9 deposition. A total of 996 samples from patients was included. Among
them, 129 were positive for IgG, while 47 for IgM, 49 for IgA, 156 for C3, and 183 for C5-9. 61
were lupus band test positive, and 58 of them had LE. 3 others had granuloma faciale and actinic
keratosis. All those 61 cases were also positive for C5-9 in granular staining pattern along DEJ. There
were 51 bullous pemphigoid (BP) cases with IgG and C3 staining. 4 of them also had IgM and/or
IgA along BMZ. 50 of those 51 BP cases were positive for C5-9 along BMZ. 7 pemphigus patients
were included, and all of them had igG, C3 and C5-9 staining along IC space of skin. 12 cases of
dermatitis herpetiformis were included, and 4 of them also had IgG, IgM, C3 as well as C5-9 stain-
ing along DEJ. There were 16 patients with prodromal BP. 5 of them had IgG, C3 and C5-9 linear
staining along BMZ. 9 other patients had C3 and C5-9 only. While the remaing 2 patients with pro-
dromal BP had granular C5-9 staining along BMZ. Out of 996 specimens, 21 had granular C5-9
staining along DEJ only. The diagnosis of those 21 cases included 2 for prodromal BP, 10 for early
LE, 4 for lichenoid vacuolar interface dermatitis and others such as drug reaction, allergic dermal
reaction or urticarial vasculitis. In conclusion, there is strong correlation between the presence of
C3 and C5-9 staining among those patients with definite diagnosis. Presence of only C5-9 staining
along DEJ might suggest the early stage of BP or LE, if there is appropriate clinical setting. 
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A randomized comparative study of Psoriasis Area and Severity Index, Psoriasis Global Assess-
ment, and Lattice System-Global Psoriasis Score in rating psoriasis
CN Ellis1 and RG Langley2 1 Dermatology, University of Michigan, Ann Arbor, MI and 2
Dermatology, Dalhousie University, Halifax, NS, Canada
Accurate and reliable assessment of disease severity in psoriasis is essential in clinical research to
document response to treatment. The reliability of current clinical outcome measures is uncertain.
Therefore, we examined the relative variation in two commonly used outcome measures (Psoriasis
Area and Severity Index [PASI], and Psoriasis Global Assessment [PGA]), and in a newer measure,
Lattice System Global Psoriasis Score (LS-GPS), when used for rating psoriasis severity. This was
a single center, randomized evaluation of 35 patients with psoriasis involving 17 investigators who
were either experienced (53%; 9/17) or inexperienced (47%; 8/17) in using PASI and PGA. Each
investigator evaluated each patient with each rating system in the morning and again in the after-
noon. Using an analysis of variance model, we assessed the variation in the results of scoring pso-
riasis between (inter-rater) and within (intra-rater) investigators. The PASI, PGA, and LS-GPS were
highly correlated (r>0.8 for all comparisons). PGA had the lowest intra-rater variation (sigma=0.2),
followed by LS-GPS (sigma=0.5) and PASI (sigma=2.5). LS-GPS provided the most scores that were
exactly the same at the two evaluations (reliability coefficients were 36% and 49% lower for PGA
and PASI, respectively). As expected, there was higher inter-rater variability in assessing the same
patient than that of the same rater over time. Inter-rater variation was low for PGA (sigma=1.2) and
LS-GPS (sigma=1.7), and highest for PASI (sigma=8.8). Experience was beneficial in reducing vari-
ation in PASI scores but was not required with PGA or LS-GPS. PASI, PGA, and LS-GPS are reli-
able measures for assessing psoriasis. Because the numerical PASI may not be used by the US FDA,
systems like the PGA and LS-GPS that provide word-based, intuitive ratings of psoriasis, and do
not require experience, are useful. 
0356
Severe hand dermatitis is responsive to topical bexarotene 1% gel
P Sheth,1 D Breneman,1 V Stevens2 and J Hanifin3 1 U. Cincinnati, Cincinnati, OH, 2 Ligand
Pharmaceuticals Inc, San Diego, CA and 3 Oregon Health Sciences U., Portland, OR
Hand dermatitis is a common and therapeutically challenging clinical problem. Topical bexarotene
gel 1%, an RXR selective retinoid in an alcohol gel, was tested in 55 patients with chronic severe
hand dermatitis. Patients were randomly assigned to one of three treatment groups: bexarotene gel
monotherapy or bexarotene gel in combination with either mometasone or with hydrocortisone
ointment. Bexarotene gel applications were escalated every two weeks from QOD to TID; steroids
were applied BID. Overall results (completed in 51 of 55 patients) showed 50% improvement in
67% of patients and 90% improvement in 35% of patients by physician assessments. Patients treated
with bexarotene gel monotherapy had higher response rates of 79% at 50% improvement and 39%
at 90% improvement, similar to results with the combination of mometasone and bexarotene gel.
The combination with hydrocortisone ointment had a lower response rate than bexarotene gel alone,
perhaps due to formulation interactions. Responses were confirmed at multiple evaluations. Both
dorsal and palmar surfaces responded to treatment. Responses were confirmed by an independent
computer-generated hand eczema area severity index. The median time for response was 5 weeks at
50% improvement and 10 weeks at 90% improvement. Responses were durable through the four-
week follow-up. Bexarotene gel treatment reached BID in 87% and TID in 73% of patients. Adverse
events included occasional mild/moderate pain/burning in 11%, and local irritation in 30% of patients.
Bexarotene gel monotherapy had the lowest incidence of pain and fewer adverse events. Three patient
withdrawals were related to adverse events, one of which was related to bexarotene. Local adverse
events were minimized by confining bexarotene gel only to dermatitis lesions. The promising response
rate with limited side effects suggests bexarotene gel may have therapeutic potential for hand der-
matitis. 
0357
Correlation of National Psoriasis Foundation score components with quality of life measures
in psoriasis
KP Callis, CS Carlin and GG Krueger University of Utah Health Sciences Center, Salt Lake City,
UT
Psoriasis has a profoundly negative impact on an individuals? Quality of Life (QoL). Despite this,
the Psoriasis Area and Severity Index (PASI) score, which has been shown to have a poor correla-
tion to quality of life measures, remains the most commonly used measurement tool in clinical tri-
als. While the PASI score is purely an objective measurement of the character and amount of psori-
asis, an alternative assessment tool, the National Psoriasis Foundation (NPF) score, includes two
aspects of subjective patient input (the patient-reported itch and the patient-reported global assess-
ment) in addition to three other objective measures (physician global assessment, change in body
surface area of psoriasis, and target plaque induration). The intent of this study is to: 1) measure cor-
relation between the patient-reported parts of the NPF score and validated QoL measures and 2)
introduce and run correlations on two newly designed measures, a five point desired improvement
tool and a 100 point life quality assessment (LQA) scale. To perform this analysis, we designed a
questionnaire to be given at baseline and follow-up visits to all adult psoriasis patients presenting to
the University of Utah Dermatology clinics that is composed of: 1) the Dermatology Life Quality
Index (DLQI), 2) Psoriasis Quality of Life Index (PQLI), 3) patient reported itch, 4) patient global
assessment, 5) the desired improvement tool, and 6) the LQA scale. Study design includes correla-
tion of the above components at baseline and correlation of their change over time on approximately
200 patients. Correlation coefficients on the first 50 patients follow: DLQI and PQLI (r=0.99), DLQI,
DLQI and LQA scale (r=0.58), DLQI and the desired improvement tool (r=0.29), and DLQI and
patient itch + global + LQA (r=0.57). The correlation between the QoL measures and the patient
reported portions of the NPF, will likely increase when analyzed as change over time and indicates
that the NPF score may be an easy and consistent assessment of the impact of psoriasis on a patients?
life. 
0358
Primary cutaneous peripheral T cell lymphoma, unspecified: favorable outcome for patients
with localized disease regardless of cell morphology
S Dick,1 K Kim,1 J Harvell,2 S Kohler,2 R Hoppe3 and Y Kim1 1 Dermatology, Stanford Univ,
Stanford, CA, 2 Path, Stanford Univ, Stanford, CA and 3 Rad Onc, Stanford Univ, Stanford, CA
Peripheral T-cell lymphoma, unspecified (PTCL, NOS) is a WHO classification for a heterogeneous
group of T-cell lymphomas that are not identified as recognizable subtypes. To study the clinico-
pathologic features and outcome, we present a retrospective analysis of 12 pts evaluated at Stanford
w/primary cutaneous PTCL, NOS (nonepidermotropic, CD3+, CD20-, CD30-, CD56-). The M:F
was 5:1. IPIs ≤ 1. Age range was 24-87, w/median of 53. Nine pts (75%) had localized dz (8 soli-
tary). Three pts (25%) had generalized dz. Of 9 pts w/localized dz, 5 received local XRT, 2 systemic
chemo+(EXC or XRT), 2 observed w/o tx. Two pts w/generalized dz received multiple systemic tx,
1 observed w/o tx. Four-year overall survival for localized vs generalized dz was 88% vs 50%.
Four-year event-free-survival for localized vs generalized dz was 88% vs 0. Eighty-nine percent of
pts w/localized dz had no evidence of dz at last f/u. Follow-up ranged from 5-114 mos, w/median
f/u of 39 mos. Three pts died (25%); 2 had generalized dz, 1 had localized dz w/locally invasive
bone involvement at presentation. Two dermatopathologists independently reviewed and confirmed
the pathology for all 12 pts. Using EORTC histologic criteria, 4 patients presented w/large T-cell
morphology, all w/localized dz, only 1 progressed/died. Two of 8 pts w/small/medium cell mor-
phology (generalized dz) progressed/died. The initial interobserver agreement for histologic subtype
was only 75%. Lack of agreement was due to difficulties in determining the proportions of neoplastic
vs reactive T-cells and the accurate percentage of large neoplastic T-cells. These difficulties call into
question the utility of EORTC histologic subtyping for prognostic and therapeutic purposes. In con-
clusion, PTCL, NOS, localized, appears to have a favorable outcome and localized treatments are
appropriate. PTCL, NOS, generalized, may warrant more aggressive tx w/systemic therapies. 
0359
Kappa opioid system is itch suppressive: a new approach for itch treatment
K Takamori,1 S Maruyama,2 F Gejyo,3 T Ebata4 and H Kumagai5 1 Dept of Dermatology, Juntendo
University Urayasu Hospital, Urayasu, Chiba, Japan, 2 Dept of Medicine, Jyouetsu General
Hospital, Jyouetsu, Niigata, Japan, 3 Dept of Medicine, Niigata University School of Medicine,
Niigata, Japan, 4 Dept of Dermatology, Jikei University School of Medicine, Komae, Tokyo, Japan
and 5 Dept of Medicine, Keio University School of Medicine, Shinjuku, Tokyo, Japan
Although itch is common symptom, severe itch is difficult to manage and its mechanism is not yet
to be fully elucidated. Recently, the mu opioid system has been suggested as being one of the major
pathways for itch sensation. We examined endogenous opioid systems in hemodialysis patients who
suffer from uremic pruritus and found that kappa opioid system contributes itch control as well as
mu opioid system. In itchy patients, serum mu opioid peptide (beta-endorphin) and its receptor on
peripheral lymphocyte were relatively expressed more than kappa opioid peptide (dynorphin A) and
its receptor, respectively. This observation may consist with the pruritogenic action of mu opioid
agonist and suggests the importance of the balance of mu and kappa opioid systems. A novel kappa
opioid agonist TRK-820 expressed remarkable antipruritic action against mouse scratching induced
by substance P or morphine. The drug also exerted antipruritic action in antihistamine-resistance
uremic pruritus patients. These results propose a new hypothesis that mu opioid system is itch-
inducible and kappa opioid system is itch-suppressive. These results also show that kappa opioid
agonist is potential antipruritic drug to treat various pruritic diseases. 
0360
Preventive effects of cystine derivatives on glycolic acid-induced cutaneous irritation
J Mizushima,1 Y Takino,2 I Sonoda,3 I Yoshimura,3 K Sakamoto2 and M Kawashima1 1 Department
of Dermatology, Tokyo Women’s Medical University, Tokyo, Japan, 2 AminoScience Laboratories,
Ajinomoto Co., Inc., Kanagawa, Japan and 3 Faculty of Engineering, Tokyo University of Science,
Tokyo, Japan
Recently, glycolic acid has proved to be a versatile peeling agent and now widely used to treat acne,
although it may induce skin irritation, characterized by stinging, burning and itching. Therefore
substances capable of counteracting sensory irritation are of great practical interest. In an attempt to
discover new anti-irritant compounds and the methodology of evaluating the skin irritation, we
evaluated the efficacy of cystine derivative (N, N’- Diacetyl-L-cystine dimethyl ester; DACDM) in
reducing chemically-induced skin irritation on the basis of own previous study. We examined as fol-
lows on the basis of double blind test utilized glycerin solution as control ; 1: Sample was applied
to the cheek on the half face. 2: After 4 minutes, 20% glycolic acid was applied to the same spot. 3:
The magnitude of the irritative sensation was evaluated each minute for the first 10 minutes after
topical application using a visual analogue scale. We analyzed the experiment data by a type III analy-
sis of variance assuming the test substance, the order of application and the individuality of subjects
as the factors to influence the irritancy. The analysis revealed that DACDM reduced the irritative
sensation by 12 percent. The response in the first application of glycolic acid on the cheek produced
a response 10% greater than the one in the second. This study demonstrated that DACDM applica-
tion as a pretreatment may act as a topical anti-irritant agent, especially, in reducing chemically-
induced skin irritation and that the adopted methodology is effective for evaluating the efficacy of
chemicals on the skin irritation. We propose that it is useful for the analysis of preventive effects of
cutaneous irritation to utilize both of a visual analogue scale and analysis of variance. 
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Topical mycophenolate mofetil 2% ointment therapy for psoriasis
C Huang, SY Fong and Y Zhou Division of Dermatology, Vancouver Hospital & Health Sciences
Centre, Vancouver, BC, Canada
Mycophenolate mofetil (MMF) is a selective inhibitor of activated lymphocytes. It has been shown
to have anti-psoriatic activities in previous non-controlled studies. However, its topical usefulness
in treating psoriasis has not been systemically investigated. The purpose of this clinical trial is to
evaluate the efficacy and side effects of topical MMF 2% ointment for stable plaque-type psoriasis.
This is a randomized double blind placebo controlled pilot study. Five patients with stable plaque-
type psoriasis were recruited with informed consent. Two comparable targeted lesions covering 0.5%
to 2% body surface area from each patient were selected. One target lesion was randomly assigned
to receive a 2% MMF hydrophilic ointment twice daily for 4 weeks followed by an optional 4 addi-
tional weeks. The other received the vehicle ointment. A pharmacist coded the MMF and the placebo
ointments so that both the patients and the study physicians were blinded of the contents. Modified
psoriasis area and severity index (PASI) was assessed for each lesion at week 0, 1, 2, 4 weeks (and
optionally at week 8). One patient withdrew because of pruritus that developed on both lesions after
two days into the trial. The remaining four patients finished the study. At week 4, the modified PASI
of MMF-treated lesion decreased by 28% whereas the vehicle-treated lesion decreased by 15%
(p>0.05). No significant side effects were observed. Contrary to previous non-controlled reports,
topical MMF 2% ointment showed no significant efficacy for plaque-type psoriasis in this controlled
trial. 
0363
Unusual CD4- CD8- malignant T cells expressing CCR4 Th2 chemokine receptor but bearing
cytotoxic molecules in an adult T cell leukemia patient presenting with a purupuric eruption
S Takatoshi, H Yoko, T Miho, Y Osamu, H Ryosuke and T Yoshiki Department of Dermatology,
University of Occupational and Environmental Health, Kitakyushu, Fukuoka, Japan
A high incidence of occurrence of skin eruptions is well known in adult T cell leukemia (ATL) and
they include papules, plaques, nodules/tumors, and erythroderma. Tumor cells of ATL are CD4+
CD25+ T cells in most cases and have various cytokine expression/production patterns. We found
that unusual double-negative malignant T cells were present in an ATL patient with a purpuric erup-
tion. A 78-year-old Japanese woman had purpuric and erythematous lesions on the face and trunk.
Approximately 60% of peripheral blood lymphocytes were positive for CD2, CD3, CD25, CD45RO,
HLA-DR and TCR-alpha/beta, but negative for CD4, CD7, CD8, CD30, CD45RA, CD56 and TCR-
gamma/delta. Lymphocytes with the same phenotype infiltrated in the skin lesions with lympho-
cytic vasculitis and resultant extravasation of erythrocytes. Southern blot analyses exhibited mono-
clonal rearrangement of TCR-c-beta-1 and biclonal integration of HTLV-1 proviral DNA in a skin
biopsy specimen as well as circulating lymphocytes. The circulating tumor cells expressed Th2
chemokine CCR4 but not Th1 receptor CXCR3. An intracytoplasmic cytokine staining study revealed
that the tumor cell did not produce either IFN-gamma or IL-4 upon stimulation with Ca ionophore
and phorbol myristate acetate. Despite their Th2 chemokine receptor expression, the malignant T
cells bore granzyme B as assessed by both intracytoplasmic flow cytometry and immunohisto-
chemistry of biopsied lesional skin. These findings demonstrated that there exist ATL malignant T
cells expressing Th2 type chemokine receptor but bearing cytotoxic molecules, which may lead to
the purpuric erution in our case. 
0365
Clinical evaluation of a cream containing MMP and PKC inhibitors on sensitive and irritated
skin
C Bernard,1 C Jean Christophe,2 P Nathalie2 and M Philippe2 1 Clinical Research Consultant,
Toulouse, France and 2 R&D, Laboratoires Expanscience, Epernon, France
Matrix metalloproteases (MMPs) and PKC are implicated in several skin pathologies, especially
inflammatory cutaneous disorders. More over, several molecules regulate the migration of skin den-
dritic cells, which are potent antigen presenting cells implicated in the primary T-cell-mediated
immune response of the skin, among which MMPs and PKC. The aim of this study was to evaluate
the clinical efficiency of an innovative topical product containing both MMPs and PKC inhibitors
on sensitive and irritated skin predispose to allergy. 103 volunteers (mean age 39.7 years) were
enrolled by 20 dermatologists. Among the panellists, 50 had a sensitive skin and 53 an irritated skin.
The panellists have applied the product twice a day during 1 month. Subjective and objective crite-
ria were evaluated by the dermatologist at T0 and T30. An auto-evaluation was performed by the
volunteers. Its tolerance was also evaluated. The results showed a clear improvement of the objec-
tive and subjective clinical features, respectively -69 and -82%, of sensitive and irritated skin (ery-
thema, dryness, desquamation, pruritus, stinging, burning). The auto-evaluation by the panellists
showed that the cream has an immediate and long lasting effect (protective and apaising), and that
it was able to improve the skin tolerance (66%). Moreover, the product was well tolerated and the
cosmetic qualities were also delinated. In conclusion, this innovative cream containing an MMPs
and a PKC inhibitor has proven its efficiency in the management of sensitive and irritated skin. 
0364
Involvement of the endoplasmic reticulum stress in pathogenesis of Darier’s disease
T Onozuka,1 D Sawamura,1 K Yokota,1 H Shimizu,1 S Oyadomari2,3 and M Mori2 1 Dermatology,
Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan, 2 Molecular
Genetics, Kumamoto University School of Medicine, Kumamoto, Kumamoto, Japan and 3
Metabolic Medicine, Kumamoto University School of Medicine, Kumamoto, Kumamoto, Japan
The endoplasmic reticulum (ER) provides the site for folding and processing newly synthesized
secretor and membrane proteins, and contributes to cellular Ca2+ signaling and storage. Various
adverse conditions, collectively called ER stress, including a decrease of Ca 2+ concentration in ER
can interfere with ER function resulted in inducing accumulation of unfolded or misfolded proteins
in ER. And these are collectively called ER stress. ER stress was known to upregulate expression of
ER chaperones, inhibition of genetic translation, and inducing transcription factor C/EBP homol-
ogy protein (CHOP) that leads to cell apoptosis. The cause of Darier’s disease (DD) was identified
to be the result of mutations in the ATP2A2 gene encoding sarco/endoplasmic reticulum Ca 2+
pomp (SERCA2) that actively transported Ca 2+ from the cytosol into the ER lumen. In this study,
we exposed DD culture keratinocytes to the conditions eliciting ER stress, and examined expression
of the several ER chaperones which controlled the maintenance of protein tertiary structure and
diminishing the load of detrimental ER misfolded protein. The results showed that the chaperones
expression was increased in DD keratinocytes compared with normal. ER stress also induces
CHOP/GADD153, a C/EBP family transcription factor, which is involved in ER stress-induced cell
apoptosis. CHOP expression and cell death ratio by ER stree was more prominent in DD keratinocytes
compared with normal keratinocytes.  Our results indicate that DD keratinocytes are more prone to
induce ER stress and suggested that ER stress may be involved in the pathogenesis of DD. 
0362
Use of bone marrow-derived cells for the treatment of recalcitrant chronic wounds
EV Badiavas1,2 and V Falanga1,3 1 Dermatology and Skin Surgery, Roger Williams Medical Center,
Boston University School of Medicine, Providence, RI, 2 Pathology, Brown University School of
Medicine, Providence, RI and 3 Biochemistry, Boston University School of Medicine, Boston, MA
Chronic wounds show a number of phenotypic changes that are believed to be responsible for the
inability of these wounds to heal. Among the changes reported is evidence of senescence in cells
derived from chronic wounds. These findings indicate that chronic wounds may be deficient in res-
ident stem cells. Replacement of stem or progenitor cells might then correct some of these abnor-
malities. Recent evidence suggests that bone marrow can provide stem cells to non-hematopoietic
tissues including the liver, heart and skin. With this interest, we examined the use of autologous
bone marrow cells in the treatment of four patients with chronic wounds of greater than one year
duration who had not responded previously to standard and advanced modalities of treatment includ-
ing application of bioengineered skin and autologous skin grafting. All patients showed complete
and sustained wound closure following treatment with autologous bone marrow derived cells. His-
tological analysis of the treated wounds strongly suggested engraftment of bone marrow cells into
the wound bed. There was clinical and histological evidence of reduced scarring, dermal rebuilding
and increased vascularity in the treated wounds. These findings provide initial proof of principle for
the feasibility of using autologous bone marrow cells in diseased human skin, and suggest a prom-
ising approach to non-healing chronic wounds. 
0366
Melanoma or not? Cancer testis antigens (CTAs) may help!
M Lueftl,1 G Schuler1 and A Jungbluth2 1 Dermatology, University of Erlangen, Erlangen,
Germany and 2 Ludwig Institute for Cancer Research, New York, NY
CTAs are expressed in a variety of malignant tumors. No CTA expression was found in normal adult
tissues, except male germ cells and placenta. To date, more than 20 CTAs or antigen families have
been identified. Due to their tumor-associated expression, CTA expression may be useful for the
distinction between benign and malignant neoplasms. However, the incidence of CTA expression in
malignant tumors varies greatly and is often low. The present study was done to analyze the value
of CTAs for the discrimination of cutaneous melanoma and nevus. Materials and Methods: 38 pri-
mary melanomas and 19 nevi (including 3 Spitz and 10 dysplastic nevi) were analyzed for their
expression of CTAs by immunohistochemistry (IHC) using the following monoclonal antibodies
(mAb)/to the following antigens: mAb MA454/MageA1; mAb 57B/Mage-A4, mAb ES121/NY-
ESO-1. In a subset (n=5) of high risk melanomas, the CTA panel was extended to 3 additional
CTAs: mAb CT7-33/Mage-C1, mAb M3H67/Mage-A3, mAbGage/Gage. Results: All 19 nevi were
negative for MA454, 57B and ES-121. In melanoma, the immunoreactivity was as follows: MA454:
8/38 (21%), 57B 11/38 (29%), ES121 9/38 (24%). The expression pattern varied from focal to homo-
geneous. These data are lower than the results of a previous study, but are most probably due to the
high number of low risk melanomas (<1mm tumor thickness, n=21) tested in our series. However,
19/38 (50%) were positive for at least one CTA and all 5 high risk melanomas (with 6 CTAs being
tested) were positive for at least one CTA. Conclusion: Our analysis confirms previous studies, that
CTA expression is present in cutaneous melanoma but not in nevi. Since the histopathological diag-
nosis of melanoma can be difficult in cases without clear-cut morphological signs of malignancy,
CTAs may be useful in the determination of suspected malignancy in melanomas. The low inci-
dence of paticular CTAs can be overcome by increasing the number of CTAs analyzed. Further
studies are required to establish the optimal combination of CTAs for analysis of malignancy-sus-
pect melanocytic neoplasms. 
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Bimosiamose, a pan-selectin antagonist improves disease manifestation both in human psori-
atic skin SCID mice and psoriatic patients--selectin antagonists as a new treatment strategy
for inflammatory diseases
M Friedrich,1 G Wolff,2 S Philipp,1 N Schoetzau,1 K Berens,3 S Kang,4 T Dam,4 R Zahlten2
and W Sterry1 1 Dermatology, University Hospital Charite, Berlin, Germany, 2 Revotar
Biopharmaceuticals AG, Hennigsdorf, Berlin, Germany, 3 Texas Biotechnology Corporation,
Houston, TX and 4 Dermatology, University of Michigan, Michigan, MI
The selectin family of vascular cell adhesion molecules is comprised of structurally related carbo-
hydrate binding proteins, which mediate the initial rolling or “tethering” of leukocytes on the vas-
cular endothelium following inflammation or injury. In T-cell-mediated diseases this process is one
of the crucial events in initiating and maintaining inflammation. Therefore selectins are an attrac-
tive target for the development of new anti-inflammatory therapeutics. We investigated bimosiamose,
a synthetic pan-selectin antagonist in psoriasis. Using the human psoriatic skin-SCID mouse trans-
plant model, bimosiamose caused a decrease of disease severity as well as prevention of psoriasis
in symptomless psoriatic skin. Therefore in a phase-II open clinical trial, we administered bimosi-
amose (600mg/day) over 14 days in five psoriatic patients. As demonstrated by assessment of pso-
riasis area and severity index (PASI), patients demonstrated significant improvement at the end of
the study (p=0.02) which was paralleled by a reduction of epidermal thickness, a decrease of CD3+
and CD4+ cells and a reduction of P-selectin expression in immunohisto-chemical analysis. Flow
cytometric analyses showed a reduction of peripheral CD45RO+ T-cells. Assessment of safety param-
eters showed no abnormal findings during the time of therapy. These data suggest that selectin antag-
onists may be a promising strategy for the treatment of inflammatory diseases. 
0368
Topical application of 17β-estradiol modulate extracellular matrix proteins in aged human
skin in vivo
E Son,1 J Lee,1 B Lee,1 I Chang1 and J Chung2 1 Skin Research Institute, Amore-Pacific
Corporation R&D Center, Yongin, South Korea and 2 Dermatology, Seoul National University
College of Medicine, Seoul, South Korea
It has been known that decreased level of estrogen in postmenopausal women is associated with
skin wrinkling and loss of elasticity. However, the changes of major components of extracellular
matrix protein (ECM), such as procollagen, tropoelastin and fibrillin, after topical 17β-estradiol
application to aged human skin are unknown. The purpose of this study was to determine the effects
of topically applied 17β-estradiol on the expression of type I procollagen, tropoelastin and fibrillin
in human aged skin. 17β-estradiol (0.01%) and its vehicle (70% propylene glycol, 30% ethanol) were
applied topically to the aged (70~80y, 4 females and 4 males) human buttock skin under occlusion
for 2 weeks (3 times/week). The skin samples were obtained by punch biopsy. We demonstrated
that epidermal thickness in aged human skin was significantly increased after topical 17β-estradiol
application. The immunohistochemical stain of type I procollagen protein demonstrated increased
expression of procollagen in the dermal fibroblasts and extracellularly along the dermoepidermal
junction. By western blot analysis, we also demonstrated that 17 β-estradiol increased the expres-
sion of type 1 procollagen protein significantly in human skin in vivo and decreased MMP-1 pro-
tein expression significantly in four out of 8 volunteers. Using immunohistochemical staining, we
demonstrated that tropoelastin and fibrillin protein were stained in association with elastic fibers,
and topical application of 17 β-estradiol in aged skin increased the tropoelastin and fibrillin expres-
sion significantly. These data suggest that topical application of 17β-estradiol may improve cuta-
neous ECM alternations in aged human skin. 
0369
Bullous pemphigoid antigen 1 and a 190kD protein in addition to desmoglein 1 as immuno-
logical targets in superficial pemphigus with a combined cell surface and basement mem-
brane immune staining pattern
F Karlhofer,1 T Hashimoto,2 K Slupetzky,1 M Kiss,3 Y Liu,2 M Amagai,4 F Pieczkowski,1
D Foedinger,1 R Kirnbauer1 and G Stingl1 1 Dermatology, University of Vienna, Vienna, Austria, 2
Dermatology, Kurume University, Fukuoka, Japan, 3 Dermatology, University of Szeged, Szeged,
Hungary and 4 Dermatology, Keio University, Tokyo, Japan
Pemphigus foliaceus and pemphigus erythematosus (PE) are frequently considered generalized and
localized variants of the same disease process (i.e. superficial pemphigus). Distinct from pemphi-
gus foliaceus, PE displays immune depositions at the dermal-epidermal junction, which suggests
additional immunopathological mechanisms. We present three patients with clinical and histopatho-
logic signs of superficial pemphigus, who all exhibit an immunomorphology characteristic of PE.
Complement depositions in a granular-linear fashion were consistently found at the dermal-epider-
mal junction besides in vivo bound and circulating anti-keratinocyte cell surface antibodies.
Histopathology showed subcorneal acantholysis, and all sera contained anti-desmoglein 1 but not
anti-desmoglein 3 antibodies detected by enzyme-linked immunosorbent assays (ELISA). Additional
antibodies against a 230kD protein and against a 190kD protein co-migrating with bullous pem-
phigoid antigen 1 (BP230) and with periplakin, respectively were present in all patients’ sera. Since
two sera specifically reacted with BP230 by ELISA, the presence of BP230-specific antibodies could
be associated with dermal-epidermal immune staining in these patients. In PE dermal-epidermal
immune staining is generally attributed to the deposition of immune complexes, while the presence
of BP230-specific antibodies has not been reported in this disease previously. Perhaps, these patients’
unique antibody profile permits to discriminate between patients with superficial pemphigus that
display additional dermal-epidermal immune staining from those with conventional pemphigus
foliaceus on a molecular basis. Further studies will be required to substantiate the frequency of this
occurrence and to unravel its pathogenic significance. 
0370
Ethnic variability in the skin response induced by Ivory Soap: a non-invasive, high-resolution
evaluation
N Burnett,1 E Gonzalez,2 S Astner,1 F Rius-Diaz,1 A Doukas3 and S Gonzalez1 1 Dermatology,
Mass General Hospital, Boston, MA, 2 Contact Dermatitis Unit, Dermatology, Mass General
Hospital, Boston, MA and 3 Wellman Labs., Mass General Hospital, Boston, MA
Data regarding the susceptibility of irritant contact dermatitis (ICD) as a function of race has been
contradictory. This study was designed to non-invasively evaluate and characterize ethnical differ-
ences in acute ICD reactions induced by diluted Ivory dish-soap. In the first experiment, 10 subject
volunteers (5 Caucasians, 5 African-Americans) were recruited and patch tested to different con-
centrations of Ivory soap solutions. Each site was exposed for 24 hours and clinical scoring was per-
formed at 4, 24, and 48 hours to determine the clinical threshold. In the second experiment, 20 sub-
ject volunteers (10 Caucasian, 10 African American) were patch tested and evaluated 24 hours after
patch removal by reflectance-mode confocal microscopy (RCM), Fluorescence Excitation Spec-
troscopy (FES) and TEWL. At 24 and 48 hours, the clinical thresholds for irritancy in the black group
were significantly higher (p<0.032, p<0.016), with a mean clinical threshold of 10% Ivory soap solu-
tion in the white and 20% in the black group. The second experiment demonstrated significantly
higher clinical thresholds for ICD in the black compared to the white group (p< 0.0001). RCM fea-
tures of ICD including stratum corneum disruption, parakeratosis and spongiosis were more severe
in white than black skin at the 10% and 20% sites but differences were not significant at the sub-
threshold site. The FES spectrum for both groups showed a broad band at 300 nm (emission at 340
nm). The band increased in intensity in the first day after the application of the irritant (p<0.04) and
in all cases returned to baseline by day 7. The mean TEWL at the 10% and 20% sites was signifi-
cantly higher in the white group. The results of our non-invasive evaluation indicates ethnic vari-
ability and suggests that black skin may indeed be more resistant to contact irritants than it has pre-
viously been reported. 
0371
Determination of effect of sun care skin nutrients on sun sensitivity in healthy women: a placebo-
controlled, double-blind study
KM Truelsen1 and B Hughes-Formella2 1 Cosmeceuticals, Ferrosan A/S, Soeborg, Copenhagen,
Denmark and 2 Bioskin GmbH, Hamburg, Germany
The effect of dietary supplementation with a new preparation containing carotenoids derived from
natural tomato and palm fruit extracts on skin color and melanization levels was investigated in this
double-blind, placebo-controlled study. Forty healthy women, aged 18-50 years with s kin type II,
were randomly assigned to two treatment groups. One capsule Imedeen Tan Optimizer™ providing
19.5 mg palm fruit extract, 3.8 mg lycopene, 10 mg Vitamin E and 60 mg Vitamin C or a placebo
capsule was taken daily over a 12 week period. The first four weeks of the study simulated a prepa-
ration phase. During the remainder of the study, skin color on un-irradiated buttock skin was meas-
ured with a Chromameter with subsequent calculation of the Individual Typological Angle (ITA ).
The ITA provides an assessment of the skins melanization level and color tone, and thereby an indi-
rect assessment of the sensitivity to sunlight . Lower ITA values reflect increased melanization
level and a darker skin tone. The ITA was lower in the group supplemented with Imedeen Tan Opti-
mizer™ (active group) after 33 days of supplementation, suggesting that the preparation phase before
sun exposure should be at least 4 weeks. The ITA decreased further in the active group over the fol-
lowing weeks, resulting in statistically lower ITA values in the active group compared to the placebo
by day 46 (Mann-Whitney U test p=0.0326). In conclusion, supplementation with Imedeen Tan Opti-
mizer™ leads to decreased sun sensitivity as evidenced by a decrease in ITA in normal, un-irradi-
ated skin. This supports an increasing protection of the skin against erythema beginning after approx-
imately 4 weeks of supplementation. 
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Quantitative topographical characterisation of psoriasis
DA McKay, K Waterston, A Patterson, R Weller and J Rees Dermatology, University of Edinburgh,
Edinburgh, Scotland, United Kingdom
Psoriasis varies in clinical presentation, disease severity, treatment response and relapse. This makes
for an indistinct and heterogeneous population. The classification of psoriasis allows for stratifica-
tion of patients, but little is known about the frequency of patterns observed, whether age and sex
affect distribution, and what predictors there are for therapeutic response. We undertook digital pho-
tography of patients with psoriasis and mapped the number and size of plaques together with the
presence of scale and inflammation at six body sites. Surface area involvement was estimated at each
site. 152 patients (83 m, 69 f) referred for phototherapy were studied, median age of 40 years. Median
total plaque count was 180 plaques per patient, with no significant difference between males and
females, but was lower in patients over 40 years. Small (<1cm) plaques were the most common size
of plaques, comprising 77% of all plaques assessed. Medium (1-5 cm) and large (>5cm) plaques
were less common, at 19% and 4% of the total plaque count respectively. The frequency of plaque
size did not vary at different body sites. Most patients had a mixed pattern of presentation with small,
medium and large plaques. Isolated small plaque (guttate) psoriasis was most common on the trunk,
comprising 33% of the total patient group. The legs were the most common site for psoriatic plaques
in terms of absolute numbers of plaques and the estimated %area of involvement. This predilection
for the legs was negated when normalised for body surface area. Scale was present in 77% of patients
with large plaques, but only 27% of patients with small plaques, suggesting scale is not an inde-
pendent marker of disease severity, as currently used in PASI scores. The presence of inflammatory
change was not affected by plaque size, but was more common on the trunk. Psoriasis is regarded
as a having a symmetrical distribution:left-right comparison confirms no significant differences
between each side in terms of plaque size and number. We plan to look at topographical character-
istics as a predictor of therapeutic outcome. 
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Reduction of postherpetic neuralgia with the use of valacyclovir-gabapentin combination ther-
apy for acute herpes zoster
G Torres,1 MH Brentjens,2 K Sra,1 E Yu1 and SK Tyring1,2 1 Center for Clinical Studies, University
of Texas Medical Branch, Houston, TX and 2 Department of Dermatology, UTMB, Galveston, TX
Recurrence of the varicella zoster virus, known as herpes zoster(HZ), occurs in approximately 20%
of the population and is most common after the fifth decade of life. Pain from postherpetic neural-
gia (PHN) is one of the most debilitating sequelae of HZ.  It has been shown that after conventional
antiviral treatment of acute HZ, 40% of patients with severe pain at onset and 30% of those with
moderate pain at onset continued to have pain at six months. In this study we analyzed the impact
of gabapentin as an additive to valacyclovir therapy on the reduction of incidence of PHN. Herpes
zoster patients age 50 and older, within 72 hours of rash onset and experiencing moderate to severe
pain were enrolled. Patients were treated with valacyclovir one gram three times daily for seven
days as well as analgesic medications as needed. Concomitant therapy with open label gabapentin
300 mg daily was started on the initial visit and the dose was escalated weekly as tolerated by the
patients. Treatment with gabapentin was continued for either a four or eight week period depending
on the patients’ pain level. Preliminary data analysis reveals that, after the combination therapy,
only 10% of patients have pain at the six month follow-up visit. This represents a 70% reduction
when compared to conventionally treated patients with moderate to severe pain at presentation,
approximately 35 % of whom would be expected to still have pain at month six. For those patients
who still had pain at month six in our study, the average pain was only 1.8 on a 0 to 10 pain scale.
These results show promise for the prevention and/or reduction of the pain of PHN by using gabapentin
along with antiviral medications in the treatment of acute herpes zoster. 
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Estimation of the minimal tumor load detected by the serological melanoma markers S100B
and MIA
A Schneeberger,1 T Jandl,1 F Koszik,1 H Korschan,1 H Kittler,2 R Kutil,1 B Thomas,5 S Robert,4
B Volc-Platzer,3 SN Wagner1 and G Stingl1 1 DIAID, Dpt of Dermatol, Univ Vienna Medical
School, Vienna, Austria, 2 DGD, Dpt of Dermatol, Univ Vienna Medical School, Vienna, Austria,
3 Dpt of Dermatol, Gen Hosp, Linz, Austria, 4 Dpt of Dermatol, Fed Acad Hosp, Feldkirch,
Austria and 5 Dpt of Dermatol, Donauspital, Vienna, Austria
Melanoma cells express S100B and Melanoma inhibitory activity (MIA). Both of them can be detected
in sera of melanoma patients and have been proposed as melanoma markers. In the present study,
we made an effort to estimate the minimal tumor load detectable by the use of either marker. To this
end, serum samples of 334 melanoma and 224 control patients were tested for their S100B and MIA
concentrations. Results obtained were compared to the S100B- and MIA production rates of 15 early
passage human melanoma lines. We found that the mean S100B/MIA concentrations and the preva-
lence of elevated S100B/MIA levels correlate with the stage of the disease. In the group of patients
with stage IV disease, 84% were found to test positive for S100B and 76% for MIA. Evaluation of
the melanoma lines’ S100B- and MIA production rates revealed that 12 (80%) produced S100B
which ranged from 282 to 16,680 µg/10e6 cells /72h. Eleven (73%) were shown to secrete signifi-
cant amounts of MIA ranging from 12.9 to 2311.4 ng/10e6 cells /72 h. S100B was primarily released
from dying cells while MIA was found to be secreted actively. Provided that the S100B- and MIA
expression of the melanoma lines is representative of the patient’s melanoma cells both in terms of
expression level and pattern, the minimal tumor load detectable by S100B and MIA was estimated
to range from 1.01x10e7 to 2.5x10e10 and from 6.7x10e8 to 2.5x10e10 cells, respectively. We con-
clude that melanoma cells of various patients differ with regard to their S100B and MIA production
rates and propose that the latter represent one factor determining a given patient’s serum S100B and
MIA level. 
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CTLA-4 expression in peripheral monocytes from patients with cutaneous T cell lymphoma
HK Wong,1 C Hedgcock,1 M Hafner,1 C Berger,2 R Edelson2 and H Lim1 1 Dermatology, Henry
Ford Health System, Detroit, MI and 2 Dermatology, Yale University, New Haven, CT
Cutaneous T cell lymphoma (CTCL) is a malignancy of memory, effector, CD4 T cells that prefer-
entially home to the skin. The pathogenesis of this chronic cutaneous malignancy however remains
an enigma and no genetic aberration has been identified consistently that is diagnostic. To study
whether potential abnormalities exist in peripheral blood monocytes (PBMC) from patients with
CTCL, we have focused on the regulation of CTLA-4 expression, a gene that we have identified to
be increased in CD45RO, CD4 T cells. This is a gene whose function at the biochemical level down
regulates T cell activation. This product has previously been identified to be expressed on CD8 T
cells and regulatory T cells. We hypothesized that this gene may be expressed at increased levels in
peripheral blood cells in patients with CTCL since the malignant cell is a memory CD4 T cell. In
analysis of resting peripheral T cells from normal volunteers, CTLA-4 is minimally expressed, less
than 3% of cells as measured by flow cytometry. Upon induction by PMA, low level CTLA-4 can
be rapidly induced in the peripheral T cells from normals, between 5-29%. In unstimulated PBMC
from patients with CTCL, there was minimal expression of CTLA-4. However when CTCL cells
were stimulated, we observed an increased ability to express CTLA-4 that correlated with more
severe disease. Patients with stage 1 or II (n=10) expressed CTLA-4 in a pattern not statitically dif-
ferent from normals. However, patients with erythrodermic MF and those with high Sezary cells
had 50-70% of their T cells positive for CTLA-4 staining when stimulated with phorbol esters. The
molecular basis for this finding may reflect underlying biochemical abnrmalities in CTCL. These
findings indicate that better characterization of CTLA-4 regulation may lead to further understand-
ing of the pathogenesis of CTCL. 
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Wrinkles effacement by topical tretinoin is associated with an increase in the thickness of pap-
illary dermal repair zone in human skin in vivo
S Cho, S Kang, G Fisher and J Voorhees Dermatology, University of Michigan, Ann Arbor, MI
Topical tretinoin (RA) is an effective therapy of photodaged skin. Wrinkle effacement by RA is asso-
ciated with an induction of procollagen I. Since procollagen requires further processing, its expres-
sion levels do not necessarily correlate with formation of mature collagen. In a mouse model of
photoaging, topical RA increases the thickness of the dermal repair zone (DRZ), which represents
formation of new collagen matrix. In human studies, however, such data are not available, perhaps
due to longer treatment period required for its detection. Thus, we investigated the DRZ thickness
following a long-term (>6 mths) use of RA in photoaging. Twenty-eight Caucasian females with
moderate to severe photoaging were treated daily with 0.05% RA (Renova). Their mean age was 62
and mean therapy duration was 2.3 years (0.5-4.3). Fine wrinkles, coarse wrinkles and overall sever-
ity of photodamage were clinically assessed using a semi-quantitative grading scale [0 (none) to 9
(most severe)]. Crow’s feet area was biopsied at baseline and end of treatment. The specimens were
processed for Verhoeff-van Gieson elastic tissue stain and the DRZ thickness above solar elastosis
but below the basal lamina was measured using image analysis software. Following RA therapy,
fine wrinkles decreased from a mean of 7.1 to 5.0 (p<0.0001), coarse wrinkles from 7.1 to 6.1
(p<0.0004), and overall severity from 7.2 to 6.0 (p<0.0001). Histologically, papillary dermal thick-
ness increased significantly from a mean of 17.5 µm at baseline to 40.3 µm (p<0.00004) after treat-
ment. Correlation between clinical improvement and dermal thickening however, was not statisti-
cally significant. The thickened DRZ was identified to be collagen with Masson-trichrome stain. In
conclusion, topical RA effectively treats photoaged skin. With its long-term use, there is a signifi-
cant increase in collagen matrix deposition in the DRZ. This increased collagen matrix most likely
is one cause of wrinkle effacement by RA. 
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Graft-versus-host disease, as seen by reflectance confocal microscopy and correlation with the
corresponding histology
M Huzaira and S Gonzalez Dermatology, Harvard Medical School, Boston, MA
Acute graft-versus-host disease (GvHD) is a major cause of morbidity and mortality after allogeinc
bone marrow transplantation. Of all organ dysfunction associated with GvHD, the skin serves as the
earliest and most frequent target. The current gold standard, skin biopsies, has major limitations.
Reflectance confocal microscopy (RCM) is a novel technique that can visualize skin non-invasively
and in vivo with high resolution and depth and offers significant advantages over routine biopsies.
The objective of this study was to detect early signs of cutaneous GvHD before clinically apparent
using RCM. RCM was performed in a well-established swine model of mixed chimerism at various
time points after the allogenic bone marrow transplant. The imaged areas were subsequently biop-
sied for histologic correlation. Morphologic features as seen by RCM correlated well with the his-
tology. Characteristics of (i)normal skin, (ii)early phase of dermal and epidermal inflammation with-
out clinical evidence of skin rash, and (iii)skin necrosis followed by (iv)complete re-epithelialization
and development of chronic GvHD were clearly demonstrated by RCM. Non-invasive in vivo RCM
maybe the ideal tool for monitoring the early signs of cutaneous GvHD. It may allow the early detec-
tion of skin inflammation before it is clinically apparent. Prompter treatment may thus improve the
outcomes of acute cutaneous GvHD. 
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CTCL patients have decreased T cell receptor rearrangement excision circles 
K Yamanaka, N Yawalkar, DA Jones, K Ferenczi, S Sadat and TS Kupper Dermatology, Brigham
and Women’s Hospital, Harvard Skin Disease Research Center, Brookline, MA
For many years, it has been appreciated that advanced stage CTCL patients are severely immuno-
suppressed. We previously reported that the T cell repertoire in these patients is dramatically con-
tracted, despite the presence of often relatively normal absolute numbers of T cells. In this report,
we investigate the hypothesis that the remaining T cells have expanded abnormally to fill this empty
T cell “space”. T-cell receptor rearrangement excision circles (TRECs) in CD3+ T cells are formed
during gene rearrangement in the thymus and diluted by subsequent cell division. Their concentra-
tion is therefore a measure of unexpanded naive T cells relative to T cells which have undergone
expansion. 25 patients with CTCL and 3 normal controls were recruited, and TREC concentration
was determined using real-time quantitative PCR. Our results demonstrate decreased TRECs in many
stage III/ IV patients and some stage I/ II patients, compared with both normal controls and previ-
ously published normal values. Subgroup analysis did not demonstrate a statistically significant
correlation between TRECs and age, stage, or number of contracted profiles on spectratype analy-
sis. However, among CTCL patients with a dominant peripheral blood T cell clone as determined
by FACS analysis, there was a significant decrease in TRECs. Since a malignant CTCL clone is
TRECs negative, the decrease in TRECs we observed suggests antigen independent expansion in
the remaining pool of nonmalignant T cells. This decrease was not simply a dilutional artifact as
demonstrated by experiments using Jurkat T cell clones mixed with normal T cells. We conclude that
these data are consistent with antigen independent proliferation of T cells to compensate for loss of
T cell diversity in CTCL. 
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The pharmacokinetics and pharmacodynamics of efalizumab following 12 weeks of subcuta-
neous treatment in subjects with moderate to severe plaque psoriasis in a phase I, open-label,
multi-center study
D Mortensen,1 P Walicke,1 P Kuebler,1 A Gottlieb,2 J Krueger,3 C Leonardi,4 B Miller5 and A Joshi1
1 Clinical and Experimental Pharmacology, Genentech, Inc., South San Francisco, CA, 2 Robert
Wood Johnson Medical School, New Brunswick, NJ, 3 The Rockefeller University, New York, NY, 4
Central Dermatology, St. Louis, MO and 5 Oregon Medical Research Center, Portland, OR
Efalizumab is a recombinant humanized monoclonal antibody against CD11a, the alpha sub-unit of
LFA-1, which is expressed on the surface of leucocytes. Binding of CD11a by efalizumab results in
saturation of available CD11a binding sites (ABS) and down-modulation of cell surface CD11a
expression (CSE). This event is believed to inhibit the activation of lymphocytes, therefore decreas-
ing T-cell migration to the dermis and epidermis. The pharmacokinetics (PK) and pharmacodynamics
(PD) of efalizumab were assessed for a total of 24 wks, including 12 wks of SC treatment with 1.0
or 2.0 mg/kg/wk.  Steady-state serum efalizumab levels were achieved by 4 and 8 wks following
administration of 1.0 and 2.0 mg/kg/wk efalizumab, respectively. At steady-state, peak serum con-
centration (Cmax) was 12 and 31 mg/mL, occurring ~2 days after a SC dose. Serum trough levels
of efalizumab were 9 and 24 mg/mL and SC clearance (CL/Fss) was 24 and 16 mL/kg/day for the
1.0 and 2.0 mg/kg/wk doses, respectively. Following the last dose, serum efalizumab fell below the
limit of quantification by 25 (1.0 mg/kg/wk) and 44 days (2.0 mg/kg/wk). During treatment, maxi-
mal saturation of ABS (>95% of baseline) and down-modulation of CSE (15-30% of baseline) on T
lymphocytes was observed for both dose groups. Similar changes were also observed on B cells,
NK cells, monocytes and neutrophils, but to a lesser extent. Absolute counts of circulating lympho-
cytes more than doubled compared to baseline while levels of monocytes and neutrophils remained
stable. PD effects were reversible for both dose groups and by 5-8 weeks after the last dose, ABS
and CSE returned to or exceeded baseline and lymphocyte counts were within normal range. 
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Fibroblasts cultured from chronic wounds show decreased expression of TGF-beta type II
receptor and altered Smad3 and p42/44 MAPK signaling
V Falanga,1,2 B Kim,3 H Kim,3 S Park,3 J Cha,3 T Yufit1 and S Kim3 1 Dermatology, Roger Williams
Medical Center, Providence, RI, 2 Dermatology and Biochemistry, Boston University, Boston, MA
and 3 Laboratory of Cell Regulation and Carcinogenesis, NCI/NIH, Bethesda, MD
The pathogenic mechanims underlying impaired healing in chronic wounds are largely unknown
but, recently, increasing evidence points to phenotypic alterations in the resident wound cells. Cel-
lular senescence and decreased responsiveness to growth factors, such as TGF-beta 1, are some of
the reported abnormalities. Here we determined some of the possible mechanisms underlying these
phenotypic changes in fibroblasts from chronic venous ulcers. We cultured fibroblasts from the
edge of venous ulcers of nine patients and, in each case, compared the findings to fibroblasts cul-
tured from acute wounds created simultaneously in the same patients. Using Northern analysis and
affinity labeling, we show that venous ulcer fibroblasts have markedly (more than four-fold) decreased
expression of the Type II receptor. This finding is not the result of genetic mutation, as shown by
experiments with receptor satellite instability. The downregulation of Type II receptor expression
seems to affect downstream signaling pathways. Thus, we found that venous ulcer fibroblasts have
more than a 3-fold decrease in the phoshorylation of Smad3 and p42/44 MAPK in response to TGF-
beta 1. Transduction of the venous ulcer fibroblasts with a constitutively phosphorylated form of the
receptor abrogated these abnormalities. The proliferative and synthetic response of ulcer fibroblasts
to TGF-beta 1 was markedly decreased. We conclude that venous ulcer fibroblasts have diminished
expression of TGF-beta Type II receptor and that this, in turn, may lead to altered signal transduc-
tion abnormalities. Moreover, these findings suggest possible ways to address and treat the abnor-
mal cellular phenotype in chronic wounds. 
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An animal model for adult cutaneous mastocytosis
M Tharp and I Chan Department of Dermatology, Rush Presbyterian-St. Luke’s Medical Center,
Chicago, IL
The adult form of mastocytosis represents an abnormal growth and accumulation of mast cells in
the skin and other organs. While at least two adult-onset mastocytosis mast cell lines exist (HMC-1
and RMT), at present there is no vivo model for the investigation of human cutaneous mastocyto-
sis. Such a model might be particularly advantageous for the investigation of new treatments for this
disease. Thus, the purpose of this study was to establish a murine model, so that the growth of human
mastocytosis mast cells could be studied and the effect of therapeutic agents on these cells could be
examined. Two established mastocytosis mast cell lines, HMC-1 and RMT which express autoacti-
vated KIT, were used in this study. SCID Beige nude mice were injected intradermally on the flanks
with different numbers (1, 5, 10, 50, 100 and 300 x103 cells in PBS) per site of HMC-1 and RMT
cells. Human mast cell growth was detected in both cell lines within one week and by two weeks,
mast cell tumors, ranging in size from 1x1 to 8x12 mm, were noted for both HMC-1 and RMT. Biop-
sies were obtained from the injection sites. For HMC-1, mast cell infiltration in the dermis was evi-
dent, but epidermotropism was not detected. The atypical morphology of these cells noted in cul-
ture did not change after being injected in the skin. New blood vessel formation, similar to
telangiectasias seen in adult mastocytosis skin lesions, was noted in each injection site but was more
prominent in the 300 and 100 X 103 sites. RMT cells also formed dermal and subcutaneous infil-
trates. No epidermal involvement was seen, and in contrast to HMC-1, no neovascualrization was
noted. We conclude from this study that HMC-1 and RMT mastocytosis cell lines can survive and
grow in the skin of SCID animals. HMC-1 cells, but not RMT cells, appear to promote new blood
vessel formation similar to changes seen in adult cutaneous mastocytosis suggesting the elaboration
of endothelial growth factors. This animal model should prove useful for the investigation of human
cutaneous mastocytosis and new therapies for this disorder. 
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Hereditary hemochromatosis gene mutations associated with porphyria cutanea tarda
MR Pittelkow, K Mehrany and LA Drage Dermatology, Mayo Clinic, Rochester, MN
Hereditary hemochromatosis represents the most common single gene mutation inherited in whites.
An increased frequency of hereditary hemochromatosis gene mutations occurs in patients with por-
phyria cutanea tarda. Polymerase chain reaction analysis of peripheral blood for hemochromatosis
gene (HFE) mutations is available for clinical use.  We present 8 patients with porphyria cutanea
tarda subsequently found to have hereditary hemochromatosis by hepatic pathology or harboring
mutations in the HFE gene.  Retrospective review of patients diagnosed with both porphyria cutanea
tarda and hereditary hemochromatosis or HFE gene mutations between 1976 and 2000. Eight patients
with porphyria cutanea tarda (6 male, 2 female; age range, 4-60 years; mean age at diagnosis of por-
phyria cutanea tarda, 42 years) were subsequently found to have hepatic iron overload or HFE gene
mutations. Two patients had liver biopsy findings compatible with homozygous hereditary hemochro-
matosis. In the other 6 patients, HFE gene analysis revealed 3 homozygous C282Y, 1 compound
heterozygous C282Y/H63D, and 2 heterozygous C282Y mutations. Seven patients (88%) had no
specific signs or symptoms of hereditary hemochromatosis at diagnosis.  Porphyria cutanea tarda
can be an important cutaneous marker for patients with mutations of the HFE gene. HFE gene analy-
sis should be performed in patients who present with porphyria cutanea tarda. The functional sig-
nificance of C282Y and H63D HFE gene mutations, their frequency and association with porphyria
cutanea tarda are reviewed. 
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Clinical efficacy of a novel non-steroidal anti-inflammatory molecule in treating symptoms of
rosacea: identification of inflammatory mediators inhibited by CX-452
ZD Draelos,2 BK Pilcher,1 DR Smith3 and BB Fuller3 1 Research & Development, Cutanix
Corporation, Oklahoma City, OK, 2 Biochemistry and Molecular Biology, OU Helath Sciences
Center, Oklahoma City, OK and 3 Dermatology Consulting Services, High Point, NC
Chronic inflammatory skin conditions, including rosacea and eczema, are characterized by a release
of pro-inflammatory mediators from multiple skin cell types leading to increased vascular perme-
ability, release of proteases, and the emigration of immune cells into the tissue. Current treatments
are dominated by corticosteroids that are only intermittently used because of associated side-effects.
Development of novel topical non-steroidal anti-inflammatory molecules would provide relief with-
out concomitant side effects. Screening of a phenolic chemical library identified CX-452, a natu-
rally occurring compound that displays in vitro anti-inflammatory activity. To determine in vivo effi-
cacy, topical formulations containing 1% CX-452 were tested by Franz cell analysis to optimize skin
delivery. A formulation providing optimum flux of CX-452 into the skin was evaluated for efficacy
in reducing the symptoms of rosacea. 30 patients with moderate rosacea were enrolled in a blinded,
placebo-controlled clinical study. 20 patients were treated with 1% CX-452 lotion and 10 were treated
with an identical lotion without CX-452. Patients were evaluated at 2 and 4 weeks using 4 indices:
erythema, desquamation, uneven skin tone, and dermatitis, and an overall severity score recorded.
Results showed that rosacea severity decreased significantly from baseline (p<0.01) in 13/18 sub-
jects (72%) with an average improvement of 68%. In contrast, placebo-treated patients had no sig-
nificant improvement. An additional clinical study for eczema found that 88% of patients (15/17)
using CX-452 showed an average of 67% improvement in symptoms. Given the proven in vivo effi-
cacy, topical products containing CX-452 may provide effective non-steroidal relief for a wide vari-
ety of inflammatory skin disorders. 
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Advanced techniques to measure DMSO response of human skin
I Sadiq, T Stoudemayer and AM Kligman S.K.I.N., Incorporatred, Conshohocken, PA
Dimethyl Sulfoxide (DMSO) when applied to human skin results in a wheal and flare reaction. This
has been used in the past to assess the barrier function of skin. The quantification of wheal and ery-
themal flare has traditionally been done clinically and by measuring hydration, transepidermal water
loss, blood flow and ultrasonic imaging. The advancements in bioengineering technology have led
us to study this phenomenon more thoroughly. We have observed the time-course of wheal evolu-
tion using a spectrophotometric technique. The start, maxima and the resolution of wheal were fol-
lowed for 60 minutes. The surface structure and shape of the wheal were imaged using a fringe pro-
jection device. The optical coherence tomography showed cross-sectional pictures of the wheal
including the swelling of the stratum corneum. Laser-Doppler blood flow imager documented the
flare reaction. Changes in visco-elastic properties were observed using a ballistometer. 
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A clinical model to evaluate pressure ulcer therapy
R Maas-Irslinger,1 OH Mills2 and ML Sigler3 1 R&D, Healthpoint, Ltd., San Antonio, TX, 2 Robert
Wood Johnson Medical School, New Brunswick, NJ and 3 Stephens & Associates, Carrollton, TX
Finding new safe and effective treatment modalities for the treatment of pressure ulcers represent a
significant and complex problem for those working in the wound care area. Classical management
calls for reduction of pressure and improved patient care. At present this arena is populated by numer-
ous modalities. We present here the use of three models in which six safety and efficacy parameters
can be globally assessed, for the selection of new modalities. These models provide useful prelim-
inary evidence pertaining to the safety, efficacy and potential modes of action for this product and
for others in development. Given the complex etiology of a pressure ulcer our system has to reflect
both acute and chronic disruption of physiological processes. This research details studies address-
ing: peripheral blood flow; transepidermal water loss; reepithelialization, erythema and scabbing of
laser created wounds; and the repeated insult patch test. The studies involved the use of an ointment
whose active ingredients are Trypsin, Balsam of Peru and Castor Oil in a non-petrolatum formula-
tion (Xenaderm®) which was compared to saline or untreated skin. In wounds created using an
Erbium:YAG Laser (n=20), the ointment showed significant improvements in reepithelialization,
erythema and scabbing compared to the control over the 10-day study. Laser Doppler evaluation
(n=10) indicated that the ointment increased blood flow significantly compared to an untreated area
at 1 and 3 hour post-treatment. A human repeated insult patch test (n=200) was conducted for 6 weeks
(induction and challenge phases). No potential for contact irritation or allergy was seen with the oint-
ment. The relevance of this methodology will be discussed and related to a basis for further studies
to better evaluate therapies for complex wounds. 
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5% imiquimod cream for treatment of intraepithelial squamous cell carcinoma
GK Patel,1 R Goodwin,1 M Chawla,1 P Laidler,2 P Price,3 A Finlay1 and R Motley1 1 Department
of Dermatology, University of Wales College of Medicine, Cardiff, United Kingdom, 2 Pathology,
University of Wales College of Medicine, Cardiff, United Kingdom and 3 Wound Healing Research
Unit, University of Wales College of Medicine, Cardiff, United Kingdom
Cutaneous intraepithelial squamous cell carcinoma (Bowen’s disease) is a common pre-malig-
nancy, in which up to 5% of patients develop invasive squamous cell carcinoma. We present an 18-
month prospective randomised placebo controlled trial of 5% imiquimod cream in the treatment of
biopsy proven intraepithelial squamous cell carcinoma. 31 patients with a target lesion between 1-
20sq.cm were recruited. Patients were excluded if they had psoriasis or were immunosuppressed. A
random number generator was used to blind treatment allocation to either 5% imiquimod or matched
placebo. Treatment was applied daily to the lesion, at night, for 16 weeks. Efficacy was assessed by
biopsy, planimetry and photography at week 28, as well as by clinical assessment at week 52. Sta-
tistical analysis was undertaken with Chi square and Phi tests. The median age was 76 years (range
54 to 86). Lesions were on the lower limb (21), upper limb (8) and face (2). The median duration of
lesions was 36 months and 11 had failed to respond to other treatments. The median surface area
was 213 sq.mm and 2 lesions were ulcerated. 12 of the 15 cases receiving imiquimod and 14 of the
16 cases that recieved placebo completed the study. 7 cases treated with imiquimod and none of the
placebo group had complete clinical and histological resolution, with no signs of recurrence at week
52. The response to imiquimod based on histology at week 28 was statistically significant, p<0.01
and Phi<0.01. Intention to treat analysis after the treatment period further validated these findings,
the 2 placebo treated cases that withdrew had no clinical improvement, whilst the 2 cases on imiquimod
that were withdrawn had clinical resolution. One case was lost to follow-up. 5% imiquimod cream
appears to be an effective treatment for intraepithelial squamous cell carcinoma. 
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Proliferation and apoptosis during wound repair
J Butmarc,1 T Yufit,1 P Carson1 and V Falanga1,2 1 Dermatology, Roger Williams Medical Center,
Providence, RI and 2 Dermatology and Biochemistry, Boston University School of Medicine,
Boston, MA
The edges of chronic wounds typically show acanthosis with the absence of epidermal migration,
and there are questions about the migratory and proliferative activity of keratinocytes in chronic
wounds. In order to determine the status and contribution of keratinocyte proliferation and apopto-
sis to the wound healing process, we performed immunohistochemistry for a proliferation marker
(Ki-67) and apoptosis (TUNEL staining) on specimens obtained from the edges of acute wounds
and chronic ulcers. Twelve patients with chronic venous leg ulcers underwent biopsies of normal
thigh skin and chronic ulcers, and the initial thigh biopsy sites were re-biopsied after 48 hours to
create an acute wound. The specimens were routinely processed for histology and immunohisto-
chemistry. Immunostaining for Ki-67 was uniformly increased after wounding, with marked spar-
ing of the advancing epidermal edge of acute wounds. However, Ki67 immunostaining was dra-
matically increased in ulcers. Apoptosis staining was very high at baseline in normal skin, and slightly
increased after wounding. It was lower at baseline in chronic ulcers but increased at the advancing
epidermal edge. With wounding, there was increased keratinocyte migration. The migrating ker-
atinocytes closest to the edge of the wound, however, showed decreased proliferation as demon-
strated by Ki-67 immunostaining. Contrary to what is commonly thought, chronic wound keratinocytes
are actively proliferating. Keratinocyte apoptosis continues and in fact increases during healing, sug-
gesting that it is part of the normal mechanism for wound repair. 
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Azelaic acid 15% gel versus metronidazole 0.75% gel as topical therapy for papulopustular
facial rosacea: results of a 15-week randomized trial
BE Elewski Dermatology, University of Alabama, Birmingham, AL
Given the chronic nature of facial rosacea, safe and cosmetically acceptable topical therapies that
alleviate papules, pustules, and persistent erythema are needed. The efficacy, tolerability and safety
of a new formulation of azelaic acid 15% gel (AzA gel) was compared with metronidazole 0.75%
gel as treatment for moderate, papulopustular (stage 2) facial rosacea. In a 15-week, multicenter,
double-blind study, 251 patients were randomized to twice-daily AzA gel or metronidazole gel.
Efficacy variables included reduction in inflammatory lesions, erythema and telangiectasia ratings,
investigator’s global assessment (IGA) (static score), and investigator and patient overall improve-
ment ratings. Efficacy analyses were carried out on the intent-to-treat (ITT) population using the
last observation carried forward (LOCF) method. AzA gel demonstrated continuous improvement
in inflammatory lesions and erythema through week 15, while the efficacy of metronidazole gel
plateaued after week 8. At the end of study medication, AzA gel showed significantly greater reduc-
tions in nominal lesion count (-12.9) vs metronidazole (-10.7) (P=.0033) and a greater percent decrease
in lesions (-72.7% vs -55.8%, respectively) (P=.0002). With AzA gel, erythema severity was
“improved” in 56% of patients vs 42% with metronidazole gel (P=.017). No clinically relevant effect
on telangiectasia was noted. AzA gel had a higher success rate based on the IGA (P=.0157), a
higher overall improvement rating (P=.0049), and scored higher on the patient’s overall assessment.
Both treatments were cosmetically acceptability. No serious or systemic treatment-related adverse
events were reported in either group. The most frequently reported AEs were mild to moderate
facial signs and symptoms, with a higher incidence in the AzA gel group. Azelaic acid 15%, twice
daily for 15 weeks, significantly and continuously improved two principal rosacea symptoms (inflam-
matory lesions and erythema) compared with metronidazole 0.75% gel. 
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The effect of bioengineered skin on cell proliferation
T Yufit,1 J Butmarc,1 P Carson1 and V Falanga1,2 1 Dermatology, Roger Williams Medical Center,
Providence, RI and 2 Dermatology and Biochemistry, Boston University School of Medicine,
Boston, MA
Skin substitutes are increasingly being used in the treatment of difficult to heal wounds but their
mechanisms of action remain uncertain. These constructs are able to synthesize and release growth
factors and cytokines, and it is widely believed that this property is responsible for their stimulation
of wound repair. In this in vitro study, we used a Boyden chamber co-culture system consisting of
a neonatal fibroblast monolayer in the bottom well and various types of skin substitutes in the upper
chamber. A filter with a pore size of 3 um separated the two chambers. Using histology, immunos-
taining, RT-PCR, and measurements of DNA synthesis in the fibroblast monolayer, we determined
the proliferative response of the fibroblast monolayer when exposed to different types of skin sub-
stitutes: 1) a non-living construct (NLC) from pig intestinal mucosa; 2) a dermal living construct
(DLC) consisting of neonatal fibroblasts in an absorbable matrix material; and 3) a living epidermal
dermal construct (LEDC) consisting of living keratinocytes and fibroblasts in a collagen matrix. We
found a 3-fold increase in DNA synthesis in the fibroblast monolayer incubated with NCL for 24 h
but not with the other two constructs. Various sizes and amounts of the living constructs showed no
difference in cell proliferation. Incubating the skin substitutes in DMEM prior to use in the co-cul-
ture system decreased the stimulatory effect of NLC on the fibroblast monolayer, but continued to
have no effect with the living constructs. We conclude that the general assumption that living skin
substitutes work primarily by the release of cytokines and growth factors needs to be re-visited. Other,
more complex mechanisms may be at work. 
0390
dHPLC based mutation detection for dystrophic epidermolysis bullosa
E Pfendner, S Fratta, S Sadowski and J Uitto Dermatology and Cutaneous Biology, Thomas
Jefferson University, Philadelphia, PA
Epidermolysis bullosa (EB) is a group of inherited skin disorders characterized by skin fragility after
minor trauma. In its severest forms, EB may be lethal in the neonatal period, or severely debilitat-
ing, and therefore prenatal diagnosis is often requested by EB families, especially for the dystrophic
(DEB) and junctional forms. To facilitate prenatal diagnosis, screening of the candidate genes spe-
cific to each of the major EB types has been undertaken in over 700 EB families by the DebRA Mol-
ecular Diagnostics Laboratory at Thomas Jefferson University in Philadelphia, PA. Among these
families, 347 were DEB and 183 were junctional. Because of the relatively large size (32 kb) of the
COL7A1 gene, the candidate gene for DEB, and the large number of exons (118) in it, direct sequenc-
ing is both labor intensive and costly. The method used for mutation screening until recently utilized
heteroduplex scanning by conformation sensitive gel electrophoresis (CSGE), which resulted in the
detection of 68% of all putative mutations in the COL7A1 gene in DEB patients and over 90% in
JEB patients. Because of this low detection rate in DEB, a new mutation detection strategy was
adopted utilizing denaturing high performance liquid chromatography (dHPLC, WAVE® Transge-
nomics). The mutation detection rate in the COL7A1 gene in DEB families using the dHPLC method
approaches now 95%. The dHPLC method is less labor intensive than CSGE, is cheaper than sequenc-
ing the entire COL7A1 gene, can be automated for 96-well plate platform, and is more sensitive. The
dHPLC method enhances the identification of COL7A1 mutations in DEB and results in more accu-
rate prenatal diagnosis in families at risk for recurrence. 
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Treatment with oral pimecrolimus significantly improves psoriasis with a clear dose-response
effect
C Griffiths,1 L Dubertret2 and A Gottlieb3 1 University of Manchester, Manchester, United
Kingdom, 2 Hopital Saint Louis, Paris, France and 3 UMDNJ, New Brunswick, NJ
There is a need for systemic therapies that are both effective and safe for treatment of moderate to
severe psoriasis. Pimecrolimus is a non-steroid, selective inflammatory-cytokine inhibitor. It has
been shown to display high cutaneous anti-inflammatory activity with low potential for affecting
the systemic immune response. We performed a double blind, placebo controlled study to evaluate
the efficacy and safety of oral pimecrolimus for the treatment of moderate to severe psoriasis. In a
double-blind, placebo-controlled, parallel-group, dose-finding study, 143 adult patients with mod-
erate to severe chronic plaque psoriasis were randomized to receive either placebo or oral pime-
crolimus 10, 20 or 30 mg bid (1:1:1:1 assignment ratio). The study consisted of 12 weeks of dou-
ble-blind treatment and a 12-week post-treatment follow up phase. Efficacy was assessed by: (i)
Psoriasis Area Severity Index (PASI) and; (ii) the percentage of patients who were clear or almost
clear of psoriasis as defined by the investigator’s global assessment. The median change of PASI
from baseline showed a dose-dependent effect and was greatest for the 30mg bid group. At 12 weeks,
the median percentage reduction in PASI was 80%, 58%, 17% and 10% in the 30 mg-bid, 20 mg-
bid, 10 mg-bid and placebo groups respectively. Following treatment with the highest dose of pime-
crolimus, 43% of patients were clear or almost clear of disease following 12 weeks of treatment. In
the two highest dose cohorts of pimecrolimus, more than half of the patients had not experienced
disease relapse 10 weeks after stopping treatment. Oral pimecrolimus was well tolerated and no clin-
ically significant changes were observed in physical or laboratory measurements. Oral pimecrolimus
appears to be highly effective in the treatment of psoriasis and provides rapid and dose-dependent
disease control. Based on its high level of efficacy and convenience, pimecrolimus has the potential
to become a systemic treatment of choice for the management of moderate to severe psoriasis. 
0392
Prolonged contact of bioengineered skin with the wound bed leads to increased closure rates
of diabetic foot ulcers
LJ Saap1 and V Falanga1,2 1 Dermatology, Roger Williams Medical Center, Providence, RI and 2
Dermatology and Biochemistry, Boston University School of Medicine, Boston, MA
A bioengineered skin construct (BSC; Apligraf), consisting of human foreskin keratinocytes and
fibroblasts in a collagen matrix, has been shown to accelerate the healing of diabetic neuropathic
foot ulcers. In these and in other types of chronic wounds, the altered appearance of the construct
after a few days in the wound bed can be confusing, and may erroneously lead to the suspicion of
infection and be removed prematurely. There have been no studies to address the question of how
long a bioengineered skin construct needs to remain in the wound for optimal results. To obtain infor-
mation on this important question, we evaluated serial photographs of 74 diabetic foot ulcer patients
who were treated with BSC. We examined the photographs at days 7 and 14, and assessed whether
remnants of the bioengineered skin were debrided completely at these visits. We then determined
whether the percentages of patients with healed ulcers by week 12 was affected by the removal of
the construct. We found the following rates of complete wound closure: 46% for patients with BSC
removed only at day 7; 47% for patients with BSC removed at both day 7 and day 14; 56% for patients
with BSC removed only at day 14; and 72% for patients with BSC not removed at day 7 nor day 14.
Together, the rate of complete wound closure for patients with BSC removed either by day 7 or 14
or both was 49% versus 71% for patients with BSC not removed by day 14 (p=0.047, two-sided chi-
square test). In conclusion, maintaining BSC in the wound bed for at least 14 days leads to improved
rates of wound closure. 
0393
A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant
endpoint
CS Carlin,1 SR Feldman,2 JG Krueger,3 A Menter4 and GG Krueger1 1 University of Utah Health
Sciences Center, Salt Lake City, UT, 2 Wake Forest University, Winston-Salem, NC, 3 Rockefeller
University, New York City, NY and 4 Baylor Medical Center, Dallas, TX
A 75% reduction in the PASI score (PASI 75) is the current benchmark of primary endpoints for
most clinical trials of psoriasis. Many consider this endpoint too stringent as it places effective ther-
apies at risk of failing to demonstrate efficacy. We hypothesized that a 50% reduction in the PASI
score (PASI 50) represents a meaningful change in a persons? life and thus is a better primary end-
point. To test this, we an analyzed PASI scores, quality of life (QoL) data, and desired re-treatment
scores from a number of clinical trials in addition to the elements of PASI. This analysis shows: 1)
The PASI score is not linearly reflective of psoriasis severity, eg a reduction in area of 95% without
a change in redness, scaliness, and induration (ESI) can be only a 66% reduction in PASI; likewise
a drop in ESI from an average of 3 to 1 (a very meaningful reduction) is not a 75% reduction. 2)
Treatment with methotrexate, an effective psoriasis therapy, more frequently reaches PASI 50 than
PASI 75 as evidenced by a recent open trial in which 63% of patients achieved PASI 50 vs. 26%
achieving PASI 75. 3) Improvement in QoL exists at PASI 50, using the Dermatology Quality of Life
Index a very significant improvement, (61% active vs. placebo) was found in several recent large
clinical trials. 4) Patients achieving PASI 75 frequently defer therapy until they are well below PASI
50; a clinical trial where retreatment was patient initiated showed patients did not re-treat until their
PASI dropped to an average of 20% improvement from baseline. 5) Effective, meaningful therapies
are consistently differentiated from placebo at PASI 50 as evidenced by histologic and photographic
parameters of clinical trials of alefacept, efalizumab, and etanercept. We conclude that PASI 50
equates to a clinically meaningful improvement in psoriasis and represents a discerning primary end-
point. 
0394
Efficacy and tolerability of azelaic acid 15% gel as topical therapy for moderate, papulopus-
tular rosacea established in two phase 3 randomized trials
AA Hebert Dermatology, University of Texas-Houston Medical School, Houston, TX
Rosacea is a common inflammatory facial dermatosis. The efficacy, safety, and tolerability of a novel
aqueous gel formulation of azelaic acid 15% (AzA gel) as a topical therapy for moderate, papulo-
pustular rosacea was evaluated. In two identically designed Phase 3, multicenter, double-blind stud-
ies, 664 patients were randomized to AzA gel or vehicle twice daily for 12 weeks. Efficacy variables
included nominal and percent reduction in inflammatory lesions, erythema and telangiectasia rat-
ings, investigator’s global assessment (IGA) (static score), and investigator and patient overall improve-
ment ratings. Efficacy analyses were carried out on data from the intent-to-treat (ITT population)
using the last observation carried forward (LOCF) method. Pooled results of both studies are pre-
sented. With AzA gel, continuous reductions in inflammatory lesions and erythema were seen. At
the end of study medication, AzA gel was superior to vehicle in mean reduction in lesion count (-
9.9 vs -6.7, respectively) (P<.0001) and percent decrease in lesion count (-54.1 vs -39.1) (P<.0001).
Significantly more AzA gel patients showed improvement of erythema than vehicle patients: 45%
vs 28% (P<.0001). Therapeutic success on the IGA was achieved in significantly more AzA-gel
patients vs vehicle: 61% vs 45% (P<.0001). AzA gel was rated superior on both physician and patient
ratings of overall improvement. No notable improvement in telangiectasia was observed. No seri-
ous adverse events (AEs) were reported. Most treatment-related AEs were mild or moderate sen-
sory cutaneous symptoms (eg, burning, stinging). Approximately 90% of patients rated both treat-
ments cosmetically acceptable and local tolerability “good” or “acceptable despite minor irritation”.
These studies establish that azelaic acid 15% gel is a safe and tolerable topical therapy that provides
continuous improvement of two principal symptoms of moderate, papulopustular rosacea (inflam-
matory lesions and erythema). 
0395
Autoallergy—a novel pathomechanism in chronic urticaria
A Hanau, H Peter, M Metz, M Magerl, J Knop, P Staubach and M Maurer Department of
Dermatology, University Hospital Mainz, Mainz, Rheinland-Pfalz, Germany
Patients with chronic urticaria (CU) are reported to frequently exhibit IgG autoantibodies against
thyroid antigens such as thyroid peroxidase (TPO) or thyroglobulin (TG). We, therefore, speculated
that some CU patients also express IgE autoantibodies against TPO and/or TG and that CU in these
patients may be autoallergic, i.e. due to skin mast cell activation by IgE-anti-TPO/TG and thyroid
antigens. To test this hypothesis we have developed an ELISA assay, which allows for the quantifi-
cation of IgE-anti-TPO serum levels. We found that 18% of 305 CU patients screened (but none of
34 healthy controls) exhibit IgE-anti-TPO of more than 7.5 IU/ml. One third of these CU patients
showed IgE-anti-TPO levels of >20 IU/ml, i.e. >2-fold more than the highest level found in healthy
controls. Interestingly, thyroidectomy in two IgE-anti-TPO+ CU patients resulted in a continuous
drop of IgE-anti-TPO levels and complete remission of CU within 8 weeks after surgery, indicating
that IgE-anti-TPO may be relevant for the induction of skin mast cell degranulation in CU. Fur-
thermore, we found that preincubation of mast cells with IgE-anti-TPO and challenge with TPO
results in strong mast cell degranulation and release of preformed mediators, supporting the view
that IgE-anti-TPO-mediated mast cell activation may be a functionally relevant pathomechanism in
CU. In summary, our findings encourage further investigations of autoallergic mechanisms in patients
with urticaria diseases. 
0396
Resistance towards arsenic trioxide involves constitutive activation of nuclear factor-kappa B
in human cutaneous T cell lymphoma
A Sors, F Jean-Louis, S Boland, F Verrechia, L Dubertret, A Mauviel, H Bachelez and L Michel
Dermatology, INSERM U532, IRP, Paris, France
Resistance to apoptosis induction by chemotherapeutic agents is a major problem in cancer therapy.
We recently showed that only high concentrations (about 5 micromolar) of arsenic trioxide (As2O3)
induce apoptosis of human cutaneous T cell lymphoma (CTCL) cells in vitro. Since the Nuclear Fac-
tor-kappaB (NF-kB) family of transcription factors has been implicated in promoting survival of var-
ious hematopoietic neoplams, including mycosis fongoides, we investigated the status of NF-kB
pathway in CTCL and its putative role in resistance to As2O3-induced apoptosis. Nuclear extracts
from CTCL cell lines (HuT78, Seax, Myla) and tumoral cells from 8 patients with Sezary Syn-
drome (SS) were studied for NF-kB nuclear DNA-binding activity by electrophoretic mobility shift
assay (EMSA). The localization of NF-kB proteins was analysed by immunocytochemistry and con-
focal microscopy with antibodies directed against the proteins p50, p52, p65, RelB and c-Rel. The
expression of cytoplasmic NF-kB inhibitors (I-kB) and contra-apoptotic molecules of the Bcl-2 fam-
ily was investigated by immunoblotting. Results demonstrate the presence of active NF-kB com-
plexes (p50/p65) in the nucleus by confocal microscopy and ligation with kB elements by EMSA.
Overexpression of Bcl-2 and BCl-Xl was detected in CTCL cell-lines and tumoral cells from SS
patients, as compared to normal PBMC, whereas I-kB protein levels were not reduced. Constitutive
nuclear translocation of NF-kB was almost totally reversed by cell treatment with the NF-kB inhibitors
(i.e. SN50, ALLN, MG132), as shown by EMSA and cytochemistry. As2O3-induced apoptosis was
potentiated by these inhibitors, as assessed by flow cytometric determination (annexin V / propid-
ium iodide staining, mitochondrial transmembrane potential alterations) and immnoblot analysis of
increased poly(ADP-ribose)polymerase cleavage. Our results demonstrate that constitutive activa-
tion of NF-kB contributes to the CTCL resistance to As2O3-induced apoptosis. 
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Development of a new aqueous gel formulation of azelaic acid 15% as topical therapy for
moderate, papulopustular rosacea
ZD Draelos Dermatology, Wake Forest University School of Medicine, High Point, NC
Azelaic acid has recently been reformulated as a 15% gel (AzA gel) to maximize drug release, sta-
bility and cosmetic acceptability for improved patient satisfaction in the treatment of papulopustu-
lar rosacea. AzA gel is an opaque polyacrylic-acid-based hydrogel that is free of fragrances or alco-
hol. The high amount of wetting agent and low lipid content provide a cooling effect, ensure good
skin humidification, and allow easy spreading. AzA gel has an adjusted pH of ~4.8 (close to the phys-
iological pH of skin). AzA gel is nonsticky and has no whitening effect. The gel contains a higher
amount of dissolved azelaic acid than the cream (25% vs 3%) as well as suspended microparticles
(~1-10 µM). This probably contributes to a higher skin permeation and improved bioavailability. In
a study with modified FRANZ cells and full-thickness skin of hairless mice, higher azelaic acid
dose fraction (29%) was measured in the stratum corneum and viable skin with AzA gel compared
with cream (4.2%) after a 24-hour dermal application of 14C-radiolabeled AzA 15% gel or 20%
cream (dose: 8-16 mg/2 cm2). With regard to percutaneous absorption, after 8 weeks of AzA gel
therapy, AzA plasma levels in 27 rosacea patients were well within the range associated with nutri-
tion and endogenous metabolism. Azelaic acid has a very low toxicity, is nonteratogenic (Pregnancy
Category B) and has been confirmed safe in worldwide clinical use. All AzA gel ingredients are Gen-
erally Recognized As Safe. In clinical studies in 457 patients treated with AzA gel, no serious treat-
ment-related adverse events (AEs) and no incidence of phototoxicity, sensitization, or photosensiti-
zation were reported. The most frequently observed AEs were primarily mild to moderate and transient
sensory symptoms (eg, burning, stinging, itching). The majority of patients rated local tolerability
and cosmetic acceptability satisfactory or better. Thus, azelaic acid 15% gel combines improved
stability and drug release, favorable cosmetic properties, and safety, making it a promising new top-
ical therapy for facial rosacea. 
0399
The relationship of atopy, autoimmunity and age at onset in alopecia areata
AJ McDonagh,1 AG Messenger,1 MJ Cork,1,2 P Birch2 and R Tazi-Ahnini2 1 Dermatology, Royal
Hallamshire Hospital, Sheffield, S Yorkshire, United Kingdom and 2 Genomic Medicine, University
of Sheffield, Sheffield, S Yorkshire, United Kingdom
The lifetime risk of alopecia areata (AA) is approximately 1.4% and a positive family history is
reported in 10-40% of cases. Several studies have now revealed association with genes of the MHC
or chromosome 21 with possible immunological importance in the pathogenesis. Information con-
cerning the distribution of age at onset of disease and the significance of atopy, autoimmunity and
nail involvement is limited and we have examined these factors in a series of 450 cases of AA. The
median age at onset in mild (patchy) AA was significantly later than in other clinical subtypes (29
vs 22 yr, p<0.004). Nail involvement was strongly associated with disease severity (p<0.00001).
Associated autoimmune disease including thyroid disease, pernicious anaemia and vitiligo was much
commoner in women with AA (p<0.001) but showed no clear association with disease severity. Atopy
was commonest in patients with alopecia universalis (35%) and ophiasiform alopecia (50%) rather
than in mild patchy disease (25%). The distribution of age at onset of AA in atopic individuals showed
a unimodal pattern with peak incidence at 10-13 years of age in striking contrast to the non-atopic
group that showed an additional peak at age 30-35. There was a trend towards a higher frequency of
familial cases among female patients with AA, in keeping with some earlier series and a positive
family history was less common in patients with AA of late onset. The observed patterns of heri-
tability for alopecia areata are in keeping with a polygenic inheritance model and in future genetic
studies, careful correlation of the clinical and genetic findings will be needed to understand the dis-
ease phenotpyes and guide the approach to developing new therapies. 
0401
Poor prognosis of arthritis-associated pyoderma gangrenosum
CA Charles,2 TL Bialy,1 AF Falabella,2 WH Eaglstein,2 FA Kerdel2 and RS Kirsner2 1 Department
of Dermatology and Cutaneous Surgery, University of Miami School of Medicine, Miami, FL and
2 Department of Dermatology, Emory University School of Medicine, Atlanta, GA
We have observed a refractory population of patients with pyoderma gangrenosum (PG) and tested
the hypothesis that differences exist in healing in patients with arthritis associated PG (APG) com-
pared to other groups of patients with PG. A retrospective chart review was performed of patients
treated during a two-year period. The patients had noninfectious chronic ulcerations typical for PG,
exclusion of relevant differential diagnoses and had consistent histopathology. Patients were treated
with systemic anti-inflammatory and immunosuppressive therapy including prednisone, methotrex-
ate, azathioprine, cyclophosphamide, or cyclosporine. Outcomes were compared between patients
with PG and APG, including complete healing, percent change in wound size and duration of ther-
apy. Percent decrease in wound size was defined as the change in wound size between the initial and
final visit divided by size at initial visit x 100. The target ulcer was defined as the largest ulcer in
patients with multiple ulcers. Paired t-tests and the sign rank test were performed. Eighteen patients,
10 patients with PG and 8 patients with APG, were studied. There were no significant differences
between the two groups in terms of age, race, gender, comorbidity, treatments, and size of ulcer pre-
treatment. Seven of 10 PG ulcers healed vs. 2 of 8 APG ulcers. There was a greater percentage
decrease in wound size in the PG vs. APG ulcers (mean decrease 78.9% vs. 23.4%; p= 0.099) and
a shorter mean duration of treatment (8.7 months compared to 14.8 months). Ulcers of APG appear
to be more refractory to treatment than ulcers of PG without arthritis, suggesting that APG ulcers
represent a unique subset. It is possible that APG may be characterized by unique pathophysiologic
mechanisms, or it may be that concomitant arthritis compromising venous return accounts for its
refractory nature. 
0400
Results of two phase II multiple-dose trials of an anti-CD80 monoclonal antibody (IDEC-114)
in patients with psoriasis
M Heffernan,1 R Matheson,2 A Gottlieb,3 N Chieffo,4 M Spellman4 and M Totoritis4 1 Washington
University School of Medicine, St. Louis, MO, 2 Oregon Medical Research Center, Portland, OR,
3 Robert Wood Johnson Medical School, New Brunswick, NJ and 4 IDEC Pharmaceuticals, San
Diego, CA
IDEC-114 is an anti-CD80 (B7.1) monoclonal antibody developed using PRIMATIZED® antibody
technology to minimize immunogenicity. In vitro and in vivo data demonstrated that IDEC-114 can
effectively block antigen-specific immune responses and IgG production, and interfere with the
progression of autoimmune diseases. Two Phase II, randomized, double-blind, placebo-controlled
studies of IDEC-114 have recently been completed in patients with moderate to severe plaque pso-
riasis. Therapy consisted of IV infusions of IDEC-114 (1, 2.5, or 5 mg/kg weekly x 8; 10 mg/kg
every other week x 8; 15 mg/kg monthly x 4) or placebo. A total of 228 patients were treated. A
favorable safety profile was observed. The majority of adverse events (AEs) were Grade 1 or 2 and
included headache, rigors, nausea, and upper respiratory tract infection. Two Grade 3 related AEs
were documented: limb abscess (possibly related) and syncope (of unknown relationship). Both
resolved. No anti-IDEC-114 antibody formation or T-cell depletion was detected. The mean Cmax
and AUC were dose-proportional, with a median serum T1/2 of approx. 15 days. The primary effi-
cacy endpoint was a 50% reduction from baseline in PASI score 2 weeks after completing treat-
ment. Although clinical activity was reported in patients receiving IDEC-114, with greater responses
in higher dose groups, no statistically significant difference between IDEC-114 and placebo was
seen. In summary, multiple infusions with IDEC-114 were safe and well tolerated in patients with
moderate to severe plaque psoriasis; however, the degree of clinical efficacy at these doses was lim-
ited. A Phase I/II study of IDEC-114 in relapsed or refractory, follicular NHL is ongoing. IDEC-114
is also being considered for other immunologic disorders. 
0398
Srcasm in cutaneous disease
M Pulitzer, M Hanson, W Li, L Mei and J Seykora Department of Dermatology, University of
Pennsylvania, Philadelphia, PA
Abnormal keratinocyte differentiation is associated with many cutaneous disorders, and can be iden-
tified histologically as an alteration in the ratio of compartments comprising the epidermis. Since it
is known that Src-family tyrosine kinases (SFKs) play an important role in keratinocyte differenti-
ation, it would be of interest to examine the levels of Srcasm: Src activating and signaling molecule,
in cutaneous diseases. As Srcasm is a molecule that activates SFKs and links these kinases to sig-
naling pathways regulating proliferation, differentiation, and apoptosis, cutaneous disorders in which
these processes are abberrant may show altered Srcasm expression . In order to correlate Srcasm
expression with cutaneous disease, mRNA in situ hybridization and immunohistochemistry for Srcasm
were performed. Biopsies of common lesions with aberrant keratinocyte differentiation were exam-
ined including psoriasis, seborrheic keratoses, and squamous cell carcinoma. All psoriatic biopsies
(n=9) demonstrated markedly increased levels of Srcasm mRNA throughout the lower epidermis rel-
ative to unremarkable skin and controls. Similarly, Srcasm mRNA was significantly increased within
SCIS and basaloid cells of seborrheic keratoses. Interestingly, well-differentiated squamous cell car-
cinoma does not appear to contain significantly increased levels of Srcasm mRNA. Immunohisto-
chemistry for Srcasm molecule in these lesions correlated with the levels of increased mRNA. There-
fore, altered levels of Srcasm appeared associated with some cutaneous diseases, notably psoriasis 
0402
Etanercept (ENBREL®) inhibits radiographic progression in patients with psoriatic arthritis
A Gottlieb,2 B Goffe,3 W Tsuji,1 R Zitnik1 and D Burge1 1 Amgen, Inc, Thousand Oaks, CA, 2
Robert Wood Johnson Medical Center, New Brunswick, NJ and 3 Minor and James Medical Center,
Seattle, WA
Results from a 24-week study of etanercept in 205 patients with psoriatic arthritis (PsA) were pre-
viously presented (Meese, Arthritis Rheum 2001; 44:S90). Etanercept provided significant clinical
benefit for both arthritis and psoriasis and was well tolerated. After all patients completed 24 weeks
of blinded study drug and the database was locked, they could enroll into a 1-year open-label exten-
sion. A primary endpoint of the study was comparison of radiographic progression in patients treated
with etanercept versus placebo. Radiographs of hands and wrists were taken at baseline and 24 weeks
in the blinded study, at initiation of open-label treatment, at 1 year from original baseline, and at
early termination during either part of the study. Pairs of independent readers, blinded to study treat-
ment and chronological order of images, read digitized x-rays of hands and wrists and scored for
erosions and joint space narrowing using a modified Sharp method (Sharp, Arthritis Rheum 1985;
28:1326-35). Additionally, other radiographic features of PsA were evaluated. X-rays were read and
scored from all 205 patients in the study. There was significantly less radiographic progression in
the etanercept group compared with the placebo group. The median rate of change from baseline to
1 year in total Sharp score was -0.03 units in the etanercept group versus +1.00 units in the placebo
group (p = 0.0001). Median rates of change in erosion scores were -0.09 units/year in etanercept
patients versus +0.66 units/year in placebo patients (p < 0.0001), and in joint space narrowing were
+0.05 units per year in etanercept patients versus +0.34 units/year in placebo patients (p = 0.0438).
Radiographic progression was measurable in this controlled study of patients with PsA. Patients
receiving placebo had progressive joint destruction as shown by increases in erosions, joint space
narrowing, and total Sharp scores. Structural damage was significantly inhibited in patients treated
with etanercept. 
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Cytokine response of atopic dermatitis patients to patch testing with dust mite and yeasts
H Ramirez,1,2 TS McCormick,1,2 M Ghannoum,1,2 KD Cooper1,3 and ST Nedorost2,1 1
Dermatology, Case Western Reserve Univ., Cleveland, OH, 2 University Hospitals of Cleveland,
Cleveland, OH and 3 VA Medical Center, Cleveland, OH
We determined mRNA cytokine expression on 8/14 atopic dermatitis (AD) patients (pts) following
postive atopy patch tests (APT) to dust mite or yeast. Patch tests were applied to intact or scarified
skin of the upper back with serial concentrations of Malassezia sympodialis (ms), Candida albicans
(ca) and Dermatophagoides pteronyssinus/farinae (df). Application sites were examined at 1, 6, and
48-72 hours after patch application. Punch biopsies were obtained from positive APT, total RNA was
extracted and RT-PCR was performed. 1/14 pts was APT positive to 1%, 10%, and 20% df at 1 hr.
Biopsy from the 20% df site was positive for IL-12p40. At 6hr, an additional pt responded to df and
was positive by PCR for IL-12p35 and IL-12 p40. Additionally, this pt was also APT positive to
80% ms on scarified skin, and IL-12p40 positive but IL-12p35 negative. Between 48-72hr, an addi-
tional 8 pts responded to either ca, ms or df; these responders tended to be those pts with a history
of severe AD. Two pts declined biopsy and were not included in this analysis. Of the remaining 6,
all were APT positive to df and one pt was also positive to ms. Three pts out of these 6 were posi-
tive for IL-12p40 only, two were positive for both IL-12p40 and IL-12p35, while one patient was
negative for both. 1/8 of the pts who was APT positive to 20% df and 80% ms at 6hr was also pos-
itive for IL-8. All 8 pts were negative for IL-6 expression from APT positive biopsy sites. IFNγ was
detected in biopsies taken at 48-72 hours in 4/8 pts. Cytokine analysis of biopsy sites from APT pos-
itive to df, ms and ca suggest that type I cytokines occurred within hrs of application of protein extract
from commensal yeasts. Patients with AD may develop protein contact dermatitis to proteins such
as those derived from commensal yeasts on the skin due to abnormal barrier function. Interestingly,
approximately half the pts demonstrate a type I cytokine response (IL-12p40, IFNγ) early in evolu-
tion of their APT reaction. 
0404
Topical delivery of vitamin C and magnesium ascorbyl phosphate enhanced by lasers and
microdermabrasion
T Tsai,5 W Lee,3,2 S Shen,1,5 C Hu,1,5 Y Huang1,2 and J Fang4 1 Dermatology, Taipei Medical
University, Taipei, Taiwan, 2 Dermatology, Taipei Medical University Hospital, Taipei, Taiwan, 3
Dermatology, Taipei Municipal Wan-Fang Hospital-Affiliated to Taipei Medical University, Taipei,
Taiwan, 4 Institute of Medical Sciences, Taipei Medical University, Taipei, Taiwan and 5
Pharmaceutics Laboratory, Graduate Institute of Natural Product, Chang Gung University, Tao-
Yuan, Taiwan
The objective of this study was to evaluate the ability of lasers and microdermabrasion, the skin resur-
facing techniques, to enhance and control the in vitro skin permeation and deposition of vitamin C.
The topical delivery of magnesium ascorbyl phosphate (MAP), The prodrug of vitamin C, was also
examined in this study. All the resurfacing techniques tested showed significant increase on the top-
ical delivery of vitamin C across and/or into the skin. The Er:YAG laser showed the greatest enhance-
ment on skin permeation of vitamin C among the techniques tested. The laser fluence and its spot
size were found to play an important role in controlling the drug absorption. An excellent correla-
tion was observed in the Er:YAG laser fluence and transepidermal water loss (TEWL), which is an
estimation of skin disruption. The permeation of MAP could not be enhanced by the Er:YAG laser.
The CO2 laser at the lower fluence could promote vitamin C permeation without any ablation of
stratum corneum (SC) and epidermal layers. On the other hand, the CO2 laser at the higher fluences
further enhanced drug permeation by the ablation effect. The microdermabrasion ablated the SC lay-
ers with the minimal disruption of skin according to TEWL levels. The flux and skin deposition of
vitamin C across microderabrasion-treated skin was approximately 20-fold higher than that across
intact skin. The techniques used in this study may be useful for basic and clinical investigation of
enhancement of topical vitamin C delivery. 
0405
Global safety and efficacy of more than 5 years of etanercept (ENBREL®) therapy in rheuma-
toid arthritis
M Lebwohl,3 M Sanda,2 J Wajdula,2 R Zitnik,1 D Burge1 and WJ Wallis1 1 Amgen, Inc, Thousand
Oaks, CA, 2 Wyeth, Collegeville, PA and 3 Dermatology, Mount Sinai Hospital, New York, NY
The safety and efficacy of etanercept in rheumatoid arthritis (RA) patients has been demonstrated
in multiple clinical trials and from over 4 years of post-marketing experience. Observations from
RA trials reflect experience with 2054 patients, some of whom have been receiving treatment for
more than 5 years (5549 patient-years). All patients participating in RA trials of etanercept were eli-
gible to enroll in open-label extension studies. Results from patients in all RA trials and open label
extension studies both in North America and Europe are presented here. The safety and clinical effi-
cacy of etanercept was evaluated in these patients at routine intervals. Results from 1442 patients
(4044 patient-years) in North America and 612 patients (1505 patient-years) in Europe demonstrate
continued safety of etanercept for more than 5 years of therapy. Overall, the rate of adverse events
remains low. The frequency of infections requiring hospitalization or intravenous antibiotics was
0.04 per patient-year in the total population (5549 patient-years), which is comparable to the rate in
control groups (0.04 per patient-year) in controlled trials. The incidence of malignancies was simi-
lar to the expected incidence calculated from the Surveillance, Epidemiology and End Results (SEER)
database (49 observed vs. 48 predicted). Long-term efficacy has also been sustained and substan-
tial. After 5 years of etanercept therapy (n = 119 in North America), 24% of patients had no tender
joints, 24% had no swollen joints, and 16% had disability scores of zero (per Health Assessment
Questionnaire). Patients treated with etanercept have been able to reduce or discontinue their corti-
costeroids while maintaining a clinical benefit. Etanercept continues to have an excellent safety pro-
file for the treatment of rheumatoid arthritis for more than 5 years. Clinical efficacy is sustained for
the duration of treatment. 
0406
Prolonged response durability following ENBREL®(etanercept) monotherapy
AB Gottlieb,2 A Feng1 and R Zitnik1 1 Amgen, Inc, Thousand Oaks, CA and 2 Robert Wood
Johnson Medical Center, New Brunswick, NJ
Etanercept was evaluated in a phase II multicenter, double blind randomized 24-week study, in which
56% of etanercept patients achieved 75% improvement in PASI (Gottlieb, et al., J Invest Dermatol
2002;119:234). In order to evaluate the durability of response to etanercept and safety following
withdrawal, patients were studied further during an extended follow-up period. 112 psoriasis patients
received etanercept 25 mg (n = 57) or placebo (n = 55) subcutaneously twice weekly in the 24-week
portion of the study. 17 patients in the etanercept group that completed the 24-week study entered
an extended study period and had follow-up evaluations of their psoriasis through week 52. Twelve
of these 17 had achieved PASI 75 during the blinded study. The time to disease relapse was calcu-
lated from last dose of etanercept to date of return to 75% and to 50% of the baseline PASI. The start
date of systemic therapy was used if that occurred prior to reaching the threshold PASI. The 17
patients in the etanercept group who entered the extended follow-up observation period had a median
of 24.3 weeks before they reached at least 75% of their baseline PASI. The 12 patients who had
achieved a PASI 75 at Week 24 had a median of 26.4 and 21.3 weeks following their last dose of
study drug before they reached at least 75% or 50% of their baseline PASI, respectively. In all patients
who were followed after etanercept discontinuation the disease relapse was gradual, and in no case
did a patient’s follow-up PASI score exceed the baseline value for that patient. No rebound flare,
conversion to pustular psoriasis, or appearance of new skin manifestations was observed after dis-
continuation of etanercept. Etanercept monotherapy is efficacious and well tolerated in the treatment
of psoriasis, with a response durability of over 5 months. Discontinuation of etanercept was not asso-
ciated with rebound flare or other untoward events. 
0407
A case of Netherton syndrome
N Sato, Y Simomura, F Sakamoto and M Ito Division of Dermatology, Niigata University,
Graduate School of Medical and Dental Sciences, Niigata, Niigata, Japan
A 2-year-old male presented erythematous macules, bow-shaped scaly lesion and partly ichthyosi-
form skin on his trunk and extreemities a few months after birth. At delivery, no abnormality was
found in his vital and appearance. His hair of scalp was found to be trichorrhexis invaginata, so called
bamboo hair. Skin biopsy was performed and achantosis of epidermis and slight inflamation of der-
mis was found. Clinicaly and pathologicaly, Netherton syndrome was suspected. The patient’s familly
were researched and his cousin was found to have bamboo hair. 
0408
In situ elastolytic activity in cutaneous melanoma
A Labrousse, P Birembaut, M Polette, A Durlach, W Hornebeck and P Bernard Dermatology,
University of Reims, Reims, France
Cancer invasion is accompanied by a tissue remodeling process that involves a proteolysis of extra-
cellular matrix, including elastin with further elastin-derived peptides (EDPs). In a series of biopsy
specimens from 22 melanomas (including 6 cutaneous and 7 pulmonary metastases) and 5 nevi, elas-
tic fibers were stained with orcein on histologic sections and morphologically and quantitatively
analysed. Sections were studied by immunohistochemistry for the expression of the following matrix
metalloproteases (MMP): MMP-2, MT1-MMP, MMP-1 and TIMP-2, by tumoral and stromal cells.
Whatever Breslow index, analysis of orcein stained sections revealed that elastic fibers have almost
disappeared, within tumor and peri-tumoral lymphocytic infiltrates, while they were more pre-
served within nevi. In primary melanomas, a degraded, thin appearance of elastic fibers (until total
absence) was observed at the immediate vicinity of the tumour, but never in nevi. A preserved or
“pushing” appearance, was less frequently observed in primary melanomas, but was common in nevi.
None tumour-induced elastosis was observed. MMP-2, MT1-MMP and MMP-1 were strongly and
similarly coexpressed by skin and pulmonary melanoma cells. A relationship with malignant phe-
notype was not evidenced, since their expression was also noted in the 5 nevi. These 3 proteases were
significantly more expressed in melanomas with Breslow >0.45 mm. A weak expression of TIMP-
2, in melanoma cells, was observed in only 2 cases. Overexpression of MMPs was not observed in
peri-tumoral stromal cells compared to healthy skin. In conclusion, elastolytic activity appears to be
greater in melanomas than in nevi, with particular presence of EDPs, suggesting acquired invasive
capacity by tumoral cells. Since these peptides are able to stimulate MMP-2 production and activa-
tion, they likely represent, a way for overexpression and activation for elastases, with possibility to
amplify tumoral response in melanomas. 
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Efficacy and safety of ENBREL® (etanercept) in patients with psoriasis: results of a phase III
study
C Leonardi,2 A Gottlieb3 and R Zitnik1 1 Amgen, Inc, Thousand Oaks, CA, 2 Probity Research
Group, St. Louis, MO and 3 Clinical Research Center, UMDNJ, New Brunswick, NJ
In previous psoriasis and psoriatic arthritis studies, etanercept produced significant improvement in
psoriatic skin disease. This phase III study was performed to confirm the efficacy and safety of etan-
ercept monotherapy in patients with psoriasis. In this multicenter, blinded, randomized study, patients
received either etanercept at one of 3 doses (25 mg once weekly [25QWk], 25 mg twice weekly
[25BWk] and 50 mg twice weekly [50BWk]), or placebo, by SC injection for 12 weeks. After 12
weeks, in a double blinded manner, all placebo patients began etanercept at 25 mg SC twice weekly,
and all patients in the three active groups continued on their initial dose, through 24 weeks. The pri-
mary endpoint was the proportion of patients achieving at least a 75% improvement in Psoriasis Area
and Severity Index (PASI) at 12 weeks. 652 patients enrolled and were dosed in the study. Groups
(n = 160, 162, 164 for etanercept 25QWk, 25BWk, and 50BWk, respectively; n = 166 for placebo)
were well matched for patient age, psoriasis duration, and disease severity. The percent of patients
achieving PASI 75 at the 12 week primary endpoint was significantly higher in the etanercept groups
(25QWk, 25BWk, 50BWk) vs. the placebo group (14%, 34%, and 49% vs. 4%, respectively; p
value =0.0006, <0.0001, and <0.0001, vs. placebo, respectively). In the three groups treated initially
with etanercept, efficacy continued to improve, with 25%, 44%, and 59% of patients, respectively,
achieving PASI 75 at 24 weeks. Statistically significant improvements in patient and physician global
assessments and DLQI confirmed efficacy of etanercept therapy. Etanercept was well tolerated. Num-
bers of patients reporting adverse events were similar between etanercept and placebo groups at 12
weeks. Conclusion: Etanercept monotherapy was efficacious and well tolerated in the treatment of
psoriasis. 
0411
The increased risk of skin cancer is persistent after discontinuation of PUVA: a cohort study
TE Nijsten and RS Stern Dermatology, Beth Israel Deaconess Medical Center, Boston, MA
Psoralen + ultraviolet A (PUVA)-treated psoriasis patients are at increased risk for squamous cell
carcinoma (SCC) and basal cell carcinoma (BCC). To assess the persistence of cancer risk among
patients who have discontinued PUVA and the risk of a first tumor with the passage of time, we
prospectively studied incidence and risk factors in a cohort of 1380 psoriasis patients treated with
PUVA between 1975 and 2001. We observed a total of 27,840 person-years of which 16,537 (59.4%)
person-years were considered years without PUVA exposure and documented 2,147 SCCs and 1,363
BCCs. In a multivariate analysis, which adjusted each risk estimate for all significant predictors of
tumor risk, level of PUVA exposure was the single most strongly factor associated with SCC and
BCC risk. Stopping PUVA for less than 15 years not significantly associated with a reduction of SCC
risk. Fifteen years or more after discontinuation of PUVA the risk reduction was close to significant
(IRR=0.79; 95%CI=0.62, 1.01). The risk of a first tumor is associated with level of PUVA exposure.
After 25 years, about 7% of patients with &#8804; 200 PUVA treatments and more than half of the
patients with &#8805; 400 treatments develop at least one SCC. Patients exposed to &#8805;200
treatments had a significant higher risk of a first BCC and after 25 years, almost one third of these
patients developed at least one BCC. In conclusion, substantial exposure to PUVA dramatically
increases the risk of non-melanoma skin cancer and prior exposure to PUVA remains an important
issue in the management of patients because the cancer risk associated with PUVA is persistent. 
0413
The impact of atopic dermatitis on young American children and their families: a qualitative
analysis
SL Chamlin,1 IJ Frieden,2,3 ML Williams2,3 and M Chren2,4 1 Division of Dermatology, Children’s
Memorial Hospital, Chicago, IL, 2 Department of Dermatology, University of California, San
Francisco, CA, 3 Department of Pediatrics, University of California, San Francisco, CA and 4
Dermatology, Veterans Affairs Medical Center, San Francisco, CA
Atopic dermatitis greatly affects the quality of life of afflicted children and their families. The impact
on psychological, social, and physical functioning is complex, and likely varies among children of
different ages. The effects of atopic dermatitis on the quality of life of very young American chil-
dren and their families are not well understood. To develop a conceptual model for understanding
and improving the quality of life of these patients, in-depth, structured interviews were conducted
with 26 parents of children with atopic dermatitis, ages 3-69 months, and 6 expert clinicians. Inter-
views were tape-recorded and transcribed. The specific ways in which atopic dermatitis affects the
lives of children and their families were rank ordered and categorized into domains according to sim-
ilarity in content; these domains were used to compose a conceptual framework. The respondents
reported 181 different and specific quality-of-life effects, which were categorized into 8 domains:
physical health, emotional health, physical functioning, and social functioning, for both the child
and the family. The most common reported effects on children were sleep disruption, itch, increased
crying, diet restriction, pain, and decreased social contact; the most common reported effects on the
family were co-sleeping and sleep deprivation, unsolicited advice from relatives and friends, worry,
staying home more, guilt, and sadness. These empirically-derived domains form the basis for a
comprehensive conceptual framework for the ways in which atopic dermatitis affects the quality of
life in young American children. Moreover, the framework can be used to develop a quantitative
measure of this important health outcome for atopic dermatitis. 
0412
Is there a relationship between atopic dermatitis and non-melanoma skin cancer?
DJ Margolis, ME Ming, R Levy, O Hoffstat and J Filip Dermatology, Epidemiology & Biostatistics,
University of Pennsylvania, Philadelphia, PA
Currently, we do not know if there is an association between atopic dermatitis (AD) and/or its ther-
apies and non melanoma skin cancer(NMSC). Isolated reports have appeared in the past describing
individuals with AD who have developed NMSC. While it is tempting to attribute these reports of
NMSC to AD and prior therapies, there is limited information that associates those with AD to an
increased occurrence of NMSC. The goal of this case-control study was to investigate whether indi-
viduals with a history of AD are more likely than other dermatologic patients to develop NMSC.
Cases (patients with NMSC) and controls (patients with warts, seborrheic keratosis, acne rosacea,
or dermatophyte infection and no history of NMSC) were randomly selected from an administrative
record database of all outpatients seen in the Department of Dermatology of the University of Penn-
sylvania. Patients were contacted by mailed survey to determine the odds of an association between
a history of AD, defined by the UK Working Party Diagnosis Criteria, and NMSC. 69.8% (N=3,207
out of 4,591) of those contacted completed the survey. 18.4% (254) of the controls had a history of
AD and 13.7% (210) of the cases. Using logistic regression, the unadjusted odds ratio of having AD
for those with a NMSC as compared to those with out a NMSC was 0.70(95% confidence interval
0.57-0.85). The fully adjusted odds ratio (confounders: age, gender, ethnicity, and topical steroid
use) was 0.78(0.61, 0.98). Varying the definition of AD had little effect on our result. Therefore, it
does not appear that patients with a history of AD are more prone to develop NMSC than other der-
matology patients. As a result, future long-term studies of any new therapy must focus on the inci-
dence of NMSC in AD patients and not assume that patients with AD have an increased risk of NMSC
due to their disease or previous therapies. 
0410
Neonatal head circumference, neonatal weight, and risk of eczema, hay fever, and asthma in
a large cohort of adolescents from Sheffield, England
KA Katz,1,3 DP Strachan2 and SJ Pocock3 1 Dermatology, University of Pennsylvania,
Philadelphia, PA, 2 Public Health Scienes, St. George’s Hospital Medical School, London,
England, United Kingdom and 3 Medical Statistics, London School of Hygiene and Tropical
Medicine, London, England, United Kingdom
Neonatal physical characteristics have been hypothesized to be markers of in utero thymic devel-
opment. Previous studies have linked greater birth weight to subsequent development of eczema,
and larger head circumference and lower birth weight to asthma. To investigate potential associa-
tions between neonatal head circumference and weight and atopic diseases in adolescents from
Sheffield, England, we linked responses to a questionnaire inquiring about physician-diagnosed
atopic disease to previously recorded neonatal measurements. Logistic regression methods were used
to relate diagnoses to neonatal measurements and potential confounders. Of 10,809 subjects, 16.2%
reported eczema, 16.5% hay fever, and 18.0% asthma. After adjusting for sex, age at time of the
questionnaire, maternal age and gestational age at birth, number of older and younger siblings, time
since birth of next older sibling, neonatal sickness, neonatal feeding type, and parental educational
backgrounds, hay fever was the only disease associated with neonatal measurements. Comparing the
highest to the lowest fifths of distributions, lifetime prevalence of hay fever was positively associ-
ated with neonatal head circumference (adjusted odds ratio 1.23, 95% CI 1.03-1.47) and with birth
weight (1.17, 0.99-1.39). Hay fever was inversely related to the ratio of head circumference to birth
weight (0.89, 0.75-1.05) and to gestational age. These associations were not substantially altered by
further adjustment for gestational age. Greater neonatal head circumference may be associated with
an increased risk of hay fever, but the inverse relationship between hay fever prevalence and the
ratio of head circumference to birth weight challenges the prior hypothesis that greater head cir-
cumference relative to body mass reflects abnormal thymic development in utero, increasing the like-
lihood of allergic sensitization. 
0414
The assessment of Fitzpatrick skin type using digital images
A Ehrlich,1 A Ostchega,2 AB Kimball3 and MC Turner4 1 Dept. of Dermatology, George
Washington University, Washington, DC, 2 NCHS, Hyattsville, MD, 3 Dept. of Dermatology,
Stanford University, Palo Alto, CA and 4 Dermatology Branch, NCI/NIH, Bethesda, MD
The use of digital imaging for the determination of skin pigmentation has potential utility in large
data collection studies such as the National Health and Nutrition Examination Survey (NHANES).
As part of the effort to include skin pigmentation data collection in the future of NHANES, a study
was undertaken to assess the validity of including a number of dermatological diagnoses, among
them Fitzpatrick skin type using digitalized images. The primary objective of this portion of the study
was to determine whether dermatologists could reliably determine skin type from digital images as
compared to an in-person assessment. Secondary objectives included agreement between: 1) self-
report of skin type and in-person exam, and 2) measurement of skin pigmentation using a Derma
Spectrometer (Cortex Technology, Hadsung, Denmark) versus the in-person exam. 498 of 558 sub-
jects who participated in a free skin cancer screening had photographs taken. The study included 151
men and 347 women, who classified themselves as follows: 418-white, 29-black, 12-Hispanic, and
35-other. Ten months after the screening, 2 dermatologists (D1&D2) read the images and recorded
the skin type. Percent agreement and simple Kappa statistics (κ) were used for analyzing the
dichotomized nominal categorical data, “burn” (types I&II) or “tan” (types III-VI). Agreement
between self reported skin type and in-person exam was poor (κ=.301)and fair (κ.4) for in-person
examiner and D1&D2. The concordance for “burn” (types I&II) was 50% for all but self reported
compared with in-person reading. Using the in-person dichotomized skin type classification as cri-
teria, the melanin index (dermatoscope reading) was statistically higher (p•.0001)for “tan” (index=35)
than for “burn” (index=31.53). Thus, digital images can be used for determining skin type with
acceptable reliability when dichotomized to groups that have a high risk of burning and those that
have a lower risk of burning. 
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The separation of year of birth from other factors determining the incidence and stage of dis-
ease at diagnosis of melanoma
JA Lee and LM Newcomer Public Health Sciences, Fred Hutchinson Cancer Research Center,
Seattle, WA
Birth cohort effects show that sun exposure in childhood and adolescence plays a major, but unquan-
tified, role in the causation of malignant melanoma. To explore these cohort effects we have extended
the poisson model traditionally used in the analysis of data from cancer registries. Birth cohort effects
represent responses to risk factors within the patient - early damage, bad habits acquired early etc.
- and not societial changes, such as more available or better care. The melanomas were registered
with the population based SEER program in 1975-99. The two factor poisson model generates a con-
stant for the whole model and factors for year of birth and year of age. Using these estimates and
the population at risk, we predicted the expected numbers of cases in each cell for each stage of the
disease. Then we removed the year of birth term from the prediction model and, with the other param-
eters unchanged, predicted new expected numbers of cases for each cell. The difference between the
two sets of expected numbers represents the birth cohort effect. Cohort effects for cases diagnosed
when metastatic are smaller than for locally invasive melanomas. In turn, cohort effects for locally
invasive cases are smaller than for those cases diagnosed in situ. For cases diagnosed 1995-99, for
males year of birth accounted for 98% of the in situ, 86% of the locally invasive, 73% of the regional
and 57% of the cases with distant spread. For females the proportions were 97% in situ, 81% locally
invasive, 63% regional and only 49% of the cases with distant spread at diagnosis. Melanomas asso-
ciated with year of birth are different from other melanomas. 
0416
Surveillance for colonization with methicillin-resistant Staphylococcus aureus in a dermatol-
ogy outpatient clinic
U Jappe, D Petzoldt and C Wendt Dermatology, University of Heidelberg, Heidelberg, Baden-
Wuerttemberg, Germany
During the past twelve years there was an increase of prevalence for methicillin-resistant Staphylo-
coccus aureus (MRSA) in German hospitals. There are only few reports discussing MRSA-infec-
tion in dermatology, and most of them focus on hospitalised patients and on MRSA spread, respec-
tively. Only two reports exist on MRSA investigations in dermatology outpatient clinics. Therefore,
a prospective study was performed on 231 dermatological outpatients, suffering from inflammatory
skin diseases (n=90), from venous leg ulcers (n=58), and from basal cell carcinoma (BCC)(n=83).
The following data were abstracted from the medical history: decubital ulcers, former antibiotic con-
sumption, number of attendences to hospitals, surgery with general anaesthetic, diabetes, hemodial-
ysis, infusion via catheter, physiotherapy. Anterior nares, perineal region and lesional skin was sam-
pled in each patient. All swabs were collected using commercially available transportation media.
Swabs were cultured on Columbia agar and mannitol salt agar using microbiology standard proce-
dures. The available MRSA strains were further characterised by pulsed-field gel electrophoresis
after digestion with the restriction enzyme SMaI. MRSA-positivity was detected in 1/32 patient with
atopic eczema, 2/3 with gram-negative foot infection, 2/2 with vasculitis, 1/1 with myiasis, 1/1 with
cheiropompholyx, 1/1 with a clavus, 1/1 with perianal eczema, 1/1 with vulvar eczema, 6/58 with
venous leg ulcers, 0/83 with BCC. Statistical analysis revealed that the presence of decubital ulcers
as well as the type of skin disease was significantly associated with MRSA-positivity. No mupirocin
resistance could be detected. According to our results particularly patients with decubital ulcers and
venous leg ulcers bear the risk of being colonised with MRSA and, therefore, should be screened. 
0417
Allopurinol is the medication most frequently associated with Stevens-Johnson syndrome or
toxic epidermal necrolysis in Europe
S Halevy,1 P Ghislain,2 M Mockenhaupt,3 J Fagot,4 J Schlingmann3 and J Roujeau2 1 Dermatology,
Soroka University Medical Center, Ben-Gurion University of the Negev, Beer-Sheva, Israel, 2
Service de Dermatologie, Hopital Henri Mondor, Creteil, France, 3 Dokumentationszentrum
Schwerer Hautreaktionen (dZh), Universitats-Hautklinik, University of Freiburg, Freiburg,
Germany and 4 INSERM U 444, Faculte de Medicine Saint-Antoine, Paris, France
The risk of allopurinol-induced SJS or TEN was investigated based on a European case control study
(EuroSCAR study). 379 validated cases with SJS or TEN and 1505 controls were enrolled from April
1997 to December 2001. Standard case-control methods were used for the estimation of crude rel-
ative risks (RR) with 95% confidence interval. Multivariate unconditional logistic regression was
used to adjust for potential confounding factors. With 66 exposed cases (17.4%) and 28 exposed con-
trols (1.9%), allopurinol was the drug most frequently associated with SJS and TEN, multivariate
RR=16 (9.1-28). Allopurinol exposure had increased since a prior study (1989-1993) for both cases
and controls (5.3% and 1.0%, respectively). The mean daily doses of allopurinol were higher in cases
as compared to controls (258±66 mg/day vs. 189±95 mg/day; p=0.001). The use of 200 mg or more
of allopurinol daily was associated with an increased risk for SJS or TEN: 36 (17-76) as compared
to lower daily doses: 3.0 (1.1-8.4). The risk period was restricted to short-term use of allopurinol
(<8 weeks): RR=264 (36- ) while no significant risk was found for long-term use (8 weeks): 1.5
(0.6-3.9). Indeed long-term users of allopurinol were more often exposed to other high-risk drugs
for SJS/ TEN than short-term users (p=0.0006). Exposure to diuretics was not associated with an
increased risk for SJS/TEN. Recent increase of allopurinol exposure rate in SJS/TEN cases and
controls probably implies overuse and inappropriate indication. 
0418
Psoriasis patients have an increased risk of lymphoma—results from a population based cohort
study in the United Kingdom
JM Gelfand, J Berlin, J Knauss, A VanVoorhees and DJ Margolis Dermatology, University of
Pennsylvania, Philadelphia, PA
Psoriasis affects about 1-2% of the population. Psoriasis is likely a disease of antigen presentation
and lymphocytes raising the possibility that its pathogenesis may also be associated with lympho-
proliferative malignancies. Furthermore, therapies for psoriasis target the immune system and may
have a theoretical risk of inducing lymphomas. We performed a cohort study to assess the risk of
lymphoma in psoriasis patients using the General Practice Research Database (GPRD). GPRD is a
medical records database and contains more than 35 million person years of follow-up. The GPRD
has been shown to validly capture data on a variety of medical conditions including lymphoma. The
population studied was a 10% sample of patients 65 or older examined between 1988-1996. First,
we validated our ability to ascertain psoriatics by showing that 95% of GPRD patients with psoria-
sis receive treatments consistent with this diagnosis and that the frequency of psoriasis in the GPRD
population is consistent with other population based studies. Subsequently we developed cohorts of
2,718 patients with psoriasis and 105,203 patients without psoriasis (reference population). Median
follow up time was 46 months. We observed 276 lymphomas. Psoriasis patients had a 2.95 relative
rate of developing lymphoma (95% CI 1.82, 4.76) as compared to those without psoriasis. This esti-
mate did not change if we controlled for age and sex using Cox multivariable proportional hazards
modeling. The rate of lymphoma changed little if we excluded mycosis fungoides (N=30) from our
lymphoma diagnosis. This study suggests that the GPRD can be an important population based
database to study psoriasis patients. Our results add to the growing literature demonstrating an asso-
ciation between psoriasis and lymphoma. Additional studies are necessary to determine if the increased
rate of lymphoma is related to psoriasis severity, psoriasis treatment, or an interaction between these
risk factors. 
0419
A sun awareness pilot project
G Franklin,2,1 C Coggin,1 D Mains1 and K Lykens1 1 School of Public Health, University of North
Texas Health Science Center at Fort Worth, Fort Worth, TX and 2 Dermatology, Columbia
University, New York, NY
Skin cancer is the most common cancer in the United States today, it is also the most preventable.
Sun overexposure results in approximately 90% of all skin cancers. Americans have a one in six
lifetime risk of developing skin cancer. The purpose of this pilot project was to increase the level of
sun protection knowledge and awareness in parents of six-month old infants. This pretest/posttest
study was modeled after the Australian Cancer Council’s “Slip! Slop! Slap!” campaign. Self-reported
baseline data about sun protective measures used by parents for themselves and their children was
obtained from five pediatric clinics. In addition, knowledge, attitudes, and beliefs about sun and sun
protection were investigated. The results showed an overall increase in parental sun protective knowl-
edge and awareness. Most of the respondents were female, married, age 31 to 40, college educated,
had one child, and had annual household incomes of $21,000. The ethnic distribution included 86%
Whites, 9% Hispanics, and 5% Blacks. Skin prototype used to estimate skin cancer risk, placed 9%
of the participants in the high risk group. Parents protected themselves more on average, than they
did their children. Pre-intervention 81.8% of parents used sunglasses, but they did not practice or
encourage this behavior to the same degree in their children. The most frequently used sun protec-
tive meaures for both parents and their children were sunscreen, sunblock, avoidance of the midday
sun, and seeking shade. In conclusion, post-intervention a significant number of participants made
behaviroal changes and were more aware of the risks of UV damage to the skin. Demographic char-
acteristics cannot be generalized to the population at large because they were skewed to highly edu-
cated Caucasians with high incomes. Although parents still generally inadequately protected their
children form sun overexposure, protection of children is an important responsibility for parents,
guardians, and physicians and should ideally become an everyday habit for everyone. 
0420
The National Registry for Ichthyosis and Related Disorders—health related quality of life and
patient reported outcomes
P Fleckman,1 G Hamill1 and MA Weinstock2,3 1 Medicine/ Dermatology, Univ of WA, Seattle, WA,
2 Dermatoepidemiology Unit, VA Medical Center, Providence, RI and 3 Dermatology, Brown
University, Providence, RI
Health related quality of life and patient reported outcomes were analyzed from questions (modi-
fied by permission from two published, validated instruments and additional, non-validated ques-
tions) embedded in the National Registry for Ichthyosis and Related Disorders. Indices provide scores
from 0 to 30, 30 being the most severe. Previous studies of adult dermatology outpatients in the UK
have determined an overall score of 7.3±6.3 (mean±SD) (unaffected, 0.5±1.1). Children registered
an overall score of 5.1±4.9 (normal children, 0.4±0.7; children with other chronic diseases, 0.7±2.5).
Information is available from 489 Registry enrollees. Data can be viewed for all individuals, or in
terms of disease diagnosis or severity of disease. The overall scores suggest Registry patients were
affected to a similar degree as the UK reference populations. Subjects 14 years old scored 7.6±6.2;
subjects •14 years old, 5.0±3.8. Scores were highest for those with the diagnosis of BCIE/EKH,
CIE/LI, Darier Disease, ichthyoses with systemic findings, and Netherton Syndrome. The score for
adults treated with systemic retinoids (used as a surrogate measure of disease severity) was 9.0±6.3,
while those not treated with systemic retinoids scored 6.5±5.9; children treated with systemic retinoids
scored 7.6±4.7, while those not treated with systemic retinoids scored 4.8±3.7. Little effect (scale
0-3) was seen on choice of career (0.9±1.1) or the ability to find childcare for affected children
(0.3±0.7). Many were dissatisfied with their initial diagnosis and treatment plan (1.6±0.9), but sat-
isfaction improved with subsequent consultations (1.1±0.6). Most subjects considered themselves
in excellent, very good, or good general health. The similarity in score between UK dermatology
outpatients and this population was unexpected and may reflect the more acute nature of the UK
population. These data illustrate the value and complexities of patient reported information. 
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Decreased incidence of malignant melanoma in Hungary between 1997-2001
J Szabo Non-ionizing Radiation, Natl. Inst. Radiobiol. Radiohygiene, Budapest, Hungary
In order to assess the possible impact of ozone depletion on detection rates for melanoma inncidence,
a frame of reference for the epidemiology of melanoma was established. Incidence rates were defined
as the number of newly diagnosed primary cutaneous melanoma per 100.000 inhabitants, adjusted
to the European population (European Standard Rate, ESR). Retrospective investigation of all his-
tologically verified melanomas diagnosed in Hungary in the period 1997-2001 was performed. A
total of 2332 cases were analysed. The age-adjusted incidence decreased in the period from 4,7 in
100.000 to 3,3 in 100.000 (from 4,3 in 100.000 to 3,3 in 100.000 for men and from 5,1 in 100.000
to 3,5 in 100.000 for women). Mortality rates remained largely unchanged, around 2 in 100.000.
These data, together with our previously presented regional melanoma data (1989-1998) suggest that
the short term trend for melanoma incidence in Hungary in the observed period is probably influ-
enced by the 8-11 years cyclical activity of the Sun. These findings also mean, that the variability
of UVB radiation within a cycle overcomes the possible UVB increase due to ozone depletion.
Long term analysis of baseline incidence is not possible, because it needs retrospective melanoma
data of at least three Sun cycles. 
0423
Validity of patient self-reported history of skin cancer
ME Ming,1 RM Levy,1 OJ Hoffstad,2 J Filip2 and DJ Margolis1,2 1 Dermatology, University of
Pennsylvania, Philadelphia, PA and 2 Biostatistics and Epidemiology, University of Pennsylvania,
Philadelphia, PA
Information regarding a patient’s past medical history is typically obtained through patient self-
report. However, to the best of our knowledge, no study to date has investigated the validity of using
this method for obtaining a medical history of skin cancer. We compared the responses to a mailed
survey asking about skin cancer history with the results of chart review for 300 patients seen in the
Department of Dermatology at the University of Pennsylvania between January 1998 and June 2001.
Two hundred of the 300 patients were randomly selected from those with ICD-9 documentation of
non-melanoma skin cancer, while the other 100 were randomly selected from those with ICD-9
documentation of warts, rosacea, dermatophytosis, or seborrheic keratosis. Patients were consid-
ered to have chart documentation of skin cancer if the medical record contained either a confirma-
tory pathology report or a report from Mohs micrographic surgery documenting a malignancy within
the Mohs specimen. After an exhaustive search, charts were located for 258 (86%) of the 300 eligi-
ble subjects. 188 (72.9%) of the 258 subjects with locatable charts had chart documentation of skin
cancer. Using chart documentation as the gold standard, patients correctly identified their basal cell
carcinoma status in 84.3% of cases; their squamous cell carcinoma status in 81.5% of cases; their
overall non-melanoma skin cancer status in 91.8% of cases; their melanoma status in 94.8% of cases;
and their overall skin cancer status in 92.6% of cases. Men were more likely than women to give
their correct overall skin cancer status (OR=3.60; 95% CI=1.32, 9.77). Those younger than 65 years
of age were more likely to give their correct squamous cell carcinoma status (OR=2.45; 95% CI=1.25,
4.79) or melanoma status (OR=3.61; 95% CI=1.04, 12.41), although there was no significant dif-
ference in the likelihood of their giving the correct overall skin cancer status. Patient self-report
appears to be a valid method for obtaining skin cancer history information. 
0425
Dysplastic nevi in persons with malignant melanoma: a matched case-control study
AR Shors,1 S Kim,1 E White2 and M Piepkorn1 1 Dermatology, University of Washington, Seattle,
WA and 2 Fred Hutchinson Cancer Research Center, Seattle, WA
The relationship between dysplastic nevi and malignant melanoma is debated. We sought to learn if
atypical nevi in persons with a new diagnosis of malignant melanoma demonstrated histologic dys-
plasia to a greater extent than atypical nevi in spousal controls. Patients were accrued into the study
following a new diagnosis of malignant melanoma. Full cutaneous examinations were performed,
and the single most clinically atypical macular nevus biopsied in both cases (n=81) and controls
(n=81). In addition, demographic and sun-related behavior data were obtained. The biopsies were
evaluated by a single dermatopathologist and graded on histologic dysplasia (0=no dysplastic fea-
tures, 1=mild dysplasia, 2=moderate dysplasia, 3=severe dysplasia). Odds ratios were calculated by
conditional logistic regression after adjustment for age, Fitzpatrick skin type, and number of blis-
tering sun burns. Dysplasia was a relatively common histologic finding, occurring in 119 (70%) of
study persons. All dysplastic nevi were graded as either mild (n=113) or moderate dysplasia (n=6).
Mild dysplasia was not associated with melanoma (adjusted OR 1.01, 95% CI 0.48-2.14) when com-
pared to nevi with no dysplastic features. Moderate dysplasia did appear to be related to melanoma,
although this was not a statistically significant association (adjusted OR 2.29, 95% CI 0.39-13.59).
Our findings suggest that mild dysplasia is a common histologic finding and does not occur more
commonly in nevi of persons with malignant melanoma. 
0424
Comparisons of efficacy and cost-effectiveness of topical immunomodulators in the manage-
ment of atopic dermatitis
W Abramovits,1 MM Prendergast,2 M Tokar2 and KB Tong3 1 Department of Dermatology,
University of Texas Southwestern School of Medicine, Baylor University, Dallas, TX, 2 Fujisawa
Healthcare, Inc., Deerfield, IL and 3 Quorum Consulting, Inc., San Francisco, CA
Background: The availability of new topical immunomodulators greatly improves treatment options
for patients with atopic dermatitis (AD). Objective: To propose ways to compare the efficacy and
cost-effectiveness of tacrolimus ointment and pimecrolimus cream as monotherapy for the treatment
of AD patients with moderate disease who are not responsive to or not well-controlled with topical
corticosteroids. Methods: Comparisons were made between Eczema Area and Severity Index (EASI)
scores, and converted to disease controlled days (DCDs) on treatment. Results: A comparison of
EASI scores for tacrolimus and pimecrolimus found that pimecrolimus was approximately 60 % as
efficacious as tacrolimus after two to four weeks of treatment. Based on these efficacy rates, aver-
age cost-effectiveness ratios were estimated at $7.34 per DCD for tacrolimus and $11.34 per DCD
for pimecrolimus. Sensitivity analyses found that pimecrolimus would be cost-effective only if its
efficacy approached 90 % of tacrolimus efficacy, or if the costs of the products were significantly
different than current AWPs. Conclusion: We estimate that the efficacy of pimecrolimus to be 60 %
of the efficacy of tacrolimus and therefore, tacrolimus to be more cost-effective for the treatment of
moderate AD. Sensitivity analyses revealed that pimecrolimus cream would need to be 90 % as effi-
cacious as tacrolimus ointment in order to be cost-effective in this patient population. 
0422
Tanning device usage: what are parents thinking?
KH Magee,1 S Poorsattar,2 K Seidel,2 W Lee3 and RL Hornung1,2 1 Pediatrics, University of
Washington School of Medicine, Seattle, WA, 2 Children’s Hospital and Regional Medical Center,
Seattle, WA and 3 Radiation Protection, Inc., Raleigh, NC
Given the increasing prevalence of tanning device usage among adolescents, our aim was to deter-
mine parental knowledge about indoor tanning and whether this affects their practices regarding
tanning device usage by their children. A survey was administered to 283 consecutive parents of
516 children attending an outpatient clinic. The survey consisted of three sections: family demo-
graphics; parental knowledge of the risks, regulations, and prevalence of tanning device usage by
minors; and past and current tanning device usage by the parent and their children. Parents were
also asked at what age they would allow their children to use tanning devices in the future.  Results
were summarized with descriptive statistics and Fisher’s exact tests using STATA. Of the 255 par-
ents who completed the majority of the quiz, 162 parents scored ≤70%. Only 16.7% of parents were
aware of the limited amount of sunburn protection provided by tanning devices, and 38.3% did not
know that tanning device exposure can be more harmful to adolescents than adults. Other frequent
misconceptions were that federal and state regulations limit tanning device exposure by minors
(37.9% and 31.8%, respectively). Lower scores on the knowledge quiz did not predict current or
past tanning device use by their children since tanning device usage incidence was 2.8% for chil-
dren of parents scoring <70% and 6.3% for parents scoring 70% (p=.172), though the predictive
power of the knowledge quiz was limited by the small number of children (25/516) reported to have
ever used tanning devices. Most parents (71%) never wanted their child to use tanning devices, regard-
less of age, but only 13.4% of parents had ever talked to their child about tanning devices. These
results suggest the need for more education to increase parental knowledge and awareness of the
indoor tanning trend among adolescents, which may ultimately help them to initiate discussion with
their children. 
0426
Effect of personalization and candy incentive on response rate for a mailed survey of derma-
tologists
RM Levy, M Shapiro and ME Ming Department of Dermatology, University of Pennsylvania,
Philadelphia, PA
Many techniques have been proposed to increase the response rate of a survey study. We investigated
the effect of incentives and personalization on the response rate to a mailed survey on issues sur-
rounding melanocytic lesions that was sent to 800 members of the American Academy of Derma-
tology. A modified version of the Dillman Total Design Method was used as the protocol for mail-
ing. Potential subjects were randomly assigned to one of four types of initial mailings: one with a
“personalized” hand-written note on the cover letter and a hard-candy incentive; one with a “per-
sonalized” note only; one with a candy incentive only; and one with no additional materials. Addi-
tionally, half of the individuals in each group were randomly chosen to receive a follow-up reminder
postcard with a hand-written signature, while the other half received a reminder postcard contain-
ing a pre-printed signature. Eighteen (2.25%) of the potential 800 subjects did not receive the sur-
vey because they had died or had been assigned an incorrect address, and those individuals were
excluded from analysis. Responders were defined as those who either completed the survey or
informed us that they would not be participating. 61.3% (241/393) of those receiving a “personal-
ized” note responded compared to 51.6% (201/389) of those not receiving notes (p=.006). 57.4%
(224/390) of those receiving candy responded compared to 55.6% (218/392) of those not receiving
candy (p=.607). 60.0% (234/390) of those who received a reminder postcard containing a hand-writ-
ten signature responded compared with 53.1% (208/392) of those receiving a postcard with a pre-
printed signature (p=.050). Our results suggest that including a “personalized” note in the initial
mailing and using hand-written signatures on the reminder postcard may be effective methods for
increasing the response rate to a mailed survey, but that candy incentive is not effective. 
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Surveillance variation in Medicare beneficiaries after excision of nonmetastatic melanoma
D Barzilai,1,2 S Koroukian,1 G Cooper,1 D Neuhauser,1 A Rimm1 and K Cooper2 1 Epidemiology
and Biostatistics, Case Western Reserve University, Cleveland, OH and 2 Department of
Dermatology, Case Western Reserve University, Cleveland, OH
We evaluated national surveillance variation after local excision of melanoma. Using Surveillance,
Epidemiology, and End Result (SEER)-Medicare linked data, we identified white Medicare eligible
patients >65 years diagnosed with local or regional stage incident invasive melanomas during 1992-
1996 and no previous cancer. The 3,317 patients had a median follow-up of 3.5 years. Surveillance
data were obtained from Medicare claims from 6 months following diagnosis through 1998 or cen-
sorship at subsequent cancer diagnosis or death. The percent of patients receiving at least one sur-
veillance test was: 94% for skin examination, 92% for chest x-ray, 24% for Chest CT, 33% for abdom-
inal/pelvic CT, 32% for abdominal ultrasound, 33% for head CT, 92% for liver enzyme, and 94%
for CBC. Of the tested patients, the median number of tests performed was: 8 for skin examination,
8 for chest x-ray, 3 for chest CT, 4 for abdominal/pelvic CT, 2 for abdominal ultrasound, 3 for chest
CT, 7 for liver enzymes, and 8 for CBC. Chi square analysis revealed significant (p<.05) variation
by SEER region for all tests except for chest CT.  Men were more likely to receive at least one chest
CT, abdominal/pelvic CT, and abdominal ultrasound, while women were more likely to receive skin
examinations. Older patients were more likely to receive surveillance testing. These figures corre-
spond to up to 2-fold or 25% absolute differences in the percent of patients receiving surveillance.
As expected, the proportion of patients tested increased with increasing tumor Breslow depth. Analy-
sis of Variance revealed that patients receiving at least one surveillance test generally did not vary
as significantly by SEER region, gender, or age in the mean number of tests received. We conclude
that there is substantial national variation in the presence of melanoma surveillance by geographic
area and patient characteristics, and that patients who do receive surveillance testing undergo mod-
erately large differences in follow-up testing regimens. 
0428
Risk of infections in relation to drugs intake for the induction of toxic epidermal necrolysis and
Stevens Johnson syndrome
J Bouwes Bavinck,1,2 C Viboud,2 M Mockenhaupt,2 L Naldi,2 A Sidoroff,2 S Halevy2 and
J Roujeau2 1 LUMC, Leiden, ZH, Netherlands and 2 EUROSCAR, FR, GE, IT, AU, Israel
Anti-infective drugs have a high suspicion to induce TEN and SJS. HIV-infected individuals also
have an increased risk. The question is whether other infections than HIV are associated with an
increased risk of TEN and SJS or that the antibiotics given for these infections are the causative
agents. Alternatively, infections could influence the risk of TEN and SJS by modulating antigenic-
ity of anti-infective or other suspected drugs. The EUROSCAR group (European group to study
Severe Cutaneous Adverse Reactions) used 379 validated cases of TEN or SJS and 1505 controls to
address this question. Drugs and infection history were collected. Relative risks were estimated and
multivariate logistic regression was used to adjust for potential confounders. Stratified analyses
among different drug groups were performed to calculate the impact of infections on the risk of
TEN and SJS. Although infections were associated with an increased risk of TEN and SJS with a
multivariate relative risk of 2.0 (1.5;2.8), this risk was low compared to the risks caused by HIV
infection: 10 (2.3;43) or by antibiotics: 8.0 (2.1;20). Stratified analyses showed no increased risk for
infection: 0.8 (0.3;2.2) in the individuals who were using anti-infective drugs. Infections were asso-
ciated with a slightly but not significantly increased risk in individuals who were using highly sus-
pected drugs (other than anti-infectives) with a relative risk of 2.1 (0.8;5.3) or drugs with a low or
moderate risk: 1.7 (1.0;2.8). Infections other than HIV do not appear to impose a significant risk for
TEN and SJS in contrast to e.g. erythema multiforme with or without mucosal involvement. The
anti-infective drugs given for these infections appear to be the causative agents. It cannot be excluded,
however, that infections could influence to a moderate extent the risk of induction of TEN and SJS
imposed by other drugs than anti-infectives. 
0429
Stevens-Johnson syndrome and toxic epidermal necrolysis: the risk of antiepileptic drugs
M- Mockenhaupt,1 A Dunant,2 A Sidoroff,3 S Halevy,4 L Naldi5 and J Schlingmann1 1 Dept. of
Dermatology, University of Freiburg, Freiburg, Germany, 2 Institut Gustave-Roussey, Villejuif,
France, 3 University Innsbruck, Innsbruck, Austria, 4 Dept. of Dermatology, Soroka University,
Beer-Sheva, Israel and 5 Dept. of Dermatology, Ospedali Riuniti, Bergamo, Italy
SJS and TEN are rare but life-threatening severe cutaneous adverse reactions (SCAR) to various
medications, among them antiepileptic drugs (AED). The following analysis is based on data ascer-
tained in the Euro-SCAR-study (case control surveillance of SCAR in Europe) comprising infor-
mation on 379 cases and 1505 controls between April 1997 and Dec. 2001. Compared to the results
of the former SCAR-study (1989 - 1993) an increased multivariate relative risk (RR) of 61 (CI 10-
190) was found for carbamazepine, a risk of 14 (3.3-56) for phenytoin and a risk of 18 (5.9-57) for
phenobarbital. In contrast, the multivariate RR for valproic acid was 2 (0.6-7.4) in the EuroSCAR-
study compared to 8.3 (1.8-40) in the SCAR-study. The univariate RR for lamotrigine was infinite
(14-inf.), as 14 cases but no controls were exposed. Comparing the exposure of certain AED in dif-
ferent countries, the RR for carbamazepine was substantially higher in France and Germany com-
pared to Austria, Israel, Italy, and The Netherlands. Lamotrigine showed a lower rate of exposure
among cases, valproic acid among cases and controls in Germany compared to other countries. The
time-latency between beginning of AED-use and onset of SCAR revealed a median of 15 days for
carbamazepine, 19.5 days for lamotrigine, but more than 365 days for valproic acid. The comed-
ication with highly suspected drugs was 75% for valproic acid but about 15% for other AED. In addi-
tion, the amount of comedication with another AED was esp. high for lamotrigine and valproic acid
(9/14, and 9/16 resp.). These 9 patients did not differ in terms of severity and time-latency, whether
they followed a lead-in period for lamotrigine or not. The risk profile of lamotrigine seems to be
comparable to that of carbamazepine and there is no increased risk for valproic acid to induce SCAR. 
0430
Development and validation of a health-related quality of life instrument for women with
melasma
R Balkrishnan,1 AJ McMichael,1 FT Camacho,1 FB Saltzberg,1 TS Housman,1 SR Feldman1 and
MM Chren2 1 Wake Forest University Health Sciences, Winston-Salem, NC and 2 University of
California at San Francisco, San Francisco, CA
Melasma can have significant emotional and psychological effects on those affected with the con-
dition. Our purpose was to develop and validate a disease-specific HRQoL instrument to identify
the areas of the patient’s life most impaired by melasma as well as the effects of the condition on
their level of functioning in correlation with disease severity, the Melasma Quality of Life scale
(MELASQOL). A random sample of 102 women with clinically diagnosed melasma were evalu-
ated by the investigator using the Melasma Area and Severity Index (MASI). These patients were
then anonymously surveyed using standard skin-disease HRQoL measures and a specially devel-
oped skin discoloration evaluation questionnaire. The 10-item MELASQOL scale was devised
from these components. The psychometric properties of the MELASQOL were comparable with
the properties of the DLQI and the SKINDEX-16. The discriminatory ability of the MELASQOL
is superior to the SKINDEX-16 and the DLQI for melasma. The three life domains most adversely
affected by melasma (social life, recreation/leisure, and emotional wellbeing) were highlighted by
this instrument. The high correlation with the DLQI, the SKINDEX-16, and the skin discoloration
questionnaire suggests that the new scale is a valid instrument, which can be used to monitor the
level of impairment individuals suffer due to their melasma. 
0431
Correlation of Breslow depth of melanoma and extent of tanning bed exposure as a measure
of dose-response relationship?
WW Ting, K Schultz, M Peterson, C Vest and RD Sontheimer Department of Dermatology,
University of Iowa College of Medicine, Iowa City, IA
Recent epidemiologic studies have suggested a potential association between tanning bed (TB) expo-
sure and cutaneous melanoma. Because most studies have focused on ever-use of TB, a possible rela-
tionship between the extent of TB exposure and risk of melanoma has yet to be elucidated. To fur-
ther examine the relationship between extent of TB use and melanoma, surveys assessing extent of
TB exposure were collected from academic dermatology clinic patients (n=1518). Medical records
were reviewed, and the Breslow depth obtained if applicable. A Pearson correlation coefficient was
computed to assess possible linear association between the extent of TB exposure (calculated as the
product of self-reported number of TB exposures and the average time spent per TB session) and
the Breslow depth of melanoma. Among patients surveyed, 32.1% reported a history of TB expo-
sure. Admitted TB users with melanoma reported greater average time spent per TB sessions, with
47.8% reporting sessions greater than 20 minutes compared to 22.0% among TB users with no his-
tory of melanoma (p<0.01). Similarly, admitted TB users with a history of melanoma were more
likely to report greater than 20 TB exposures compared to TB users without melanoma, though not
significantly so (62.1% vs. 47.3%, p=0.12). Furthermore, there is a positive though statistically
insignificant correlation between Breslow depth and overall TB exposure in minutes (n=23; Pear-
son r=+0.18, p=0.48). This study offers the first published attempt to examine a possible linear
dose-response relationship between the extent of TB exposure and risk of the development of cuta-
neous melanoma. Although the positive correlation between the depth of cutaneous melanoma inva-
sion and the estimated lifetime TB exposure is not statistically significant, a larger epidemiologic
study is needed to clarify this relationship given the solemn public health implications of this pop-
ular activity. 
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Diagnosis, treatment, and management of melanoma in situ by US dermatologists
CA Charles,1 SW Dusza,1 AA Marghoob,1 SA Oliveria,1 A Kopf,2 D Rigel2 and AC Halpern1 1
Medicine/Dermatology, Memorial Sloan-Kettering Cancer Center, New York, NY and 2 Ronald O.
Perlman Department of Dermatology, New York University School of Medicine, New York, NY
To assess current beliefs and practices of US dermatologists regarding the diagnosis, treatment, and
management of melanoma in situ (MIS). Methods: A survey was mailed to a random sample of
1200 practicing US dermatologists. Results: Response rate was 54%. 88% of responders believe
that MIS is a malignancy and 11% believe it is a premalignant condition. 30-48% stated that they
did not know whether untreated MIS would progress to invasive metastatic melanoma and 23-36%
stated that all MIS would progress. In the clinical evaluation of suspect lesions, 31% used no diag-
nostic tools, 59% used magnifying lens, and 18% used dermatoscope. 55% of dermatologists diag-
nose <10 MIS cases/yr while 8% diagnose >30 cases/yr. The preferred biopsy method was excisional
(39%), saucerization (34%), and incisional (punch/shave) 27%. 57% of responders sent all pigmented
lesions directly to a dermatopathologist. Responders estimated that approximately 60% of cases clin-
ically suspect for MIS were confirmed to be MIS on pathology. For clinically suspect lesions diag-
nosed on pathology as “benign”, 30% of dermatologists accepted the diagnosis and 70% pursued
additional pathology review. Regarding therapy, approximately 50% performed definitive excision
in >75% of cases in their office. 18% of dermatologists referred all cases to other physicians for
definitive excision. Regarding laboratory evaluation and follow-up, 77% of dermatologists do not
order lab tests/X-rays. After the first year of MIS diagnosis, 92% of dermatologists recommend skin
screening and follow-up exams every 3-6 months. Conclusion: Most respondents identified MIS as
a malignancy, however, apparently much confusion still surrounds the diagnosis and management
of MIS. In addition, most MIS cases are excised in dermatologists’ offices and this may have impli-
cations in accurately calculating MIS incidence rates. 
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Risk of melanoma is associated with tanning bed exposure, particularly among young females
K Schultz, W Ting, M Peterson, C Vest and RD Sontheimer Dermatology, University of Iowa Dept
of Dermatology, Iowa City, IA
Although deleterious effects of tanning bed (TB) exposures have been demonstrated at the molecu-
lar level, the epidemiologic association between the development of melanoma and TB exposure is
less than absolutely definitive. Previous literature has sporadically considered only a few possible
confounding factors, including sun sensitivity, sun exposure, and socioeconomic status. To further
explore the relationship between melanoma and TB use, surveys assessing TB exposure and sun pro-
tection practices were collected from academic dermatology clinic patients (n=1518), and review of
medical records was performed. Nearly one-third of patients had visited a TB (n=487). Women 45
years of age and younger accounted for about 60% of all TB users, with 59.4% of these women
reporting a history of TB use compared to 24.5% of women over the age of 45. After controlling for
confounding factors, including indoor vs. outdoor occupation and leisure activities, Fitzpatrick skin
type, history of blistering sunburn, use of sunscreen and sun protective clothing, history of pho-
totherapy, and level of education, ever-use of TB became a significant risk factor for the develop-
ment of melanoma (p<0.05;OR=1.83;95% CI=1.07-3.14). Among women 45 years of age and
younger, ever-use of TB was an even greater risk factor for the development of melanoma after con-
trolling for the same confounding factors (p<0.05;OR=3.25;95% CI=1.03-10.28). Furthermore,
female tanning bed users 45 and younger with melanoma tended to report more TB sessions (p<0.01)
and more time per session (p<0.01) than those with no history of melanoma. These results suggest
that a history of TB exposure is a significant risk factor for melanoma, especially among women 45
and younger, even after controlling for confounding factors. These findings reinforce the public health
urgency to increase awareness of the potential health hazard of TB exposure, particularly among
young females. Further studies are needed to clarify whether a dose-response relationship exists
between the extent of TB use and the risk of melanoma. 
0435
Evidence for a founder mutation in the fumarate hydratase gene in patients with multiple cuta-
neous and uterine leiomyomata from Iran
A Zlotogorski,1 GS Chuang,5 L Horev,1 S Brenner,2 M Landau,3 E Sprecher,4 A Martinez-Mir5 and
AM Christiano5,6 1 Dermatology, Hadassah Medical Center, Jerusalem, Israel, 2 Dermatology,
Sourasky Medical Center, Tel-Aviv, Israel, 3 Dermatology, Wolfson Medical Center, Holon, Israel,
4 Dermatology, Rambam Medical Center, Haifa, Israel, 5 Dermatology, Columbia University, New
York, NY and 6 Genetics & Development, Columbia University, New York, NY
Multiple cutaneous and uterine leiomyomata (MCL) syndrome is an autosomal dominant disease
characterized by the presence of concurrent benign tumors of smooth muscle origin (leiomyoma) in
skin and uterus. MCL can also be associated with renal cell cancer (HLRCC). The genetic locus for
MCL and HLRCC was recently mapped to chromosome 1q42.3-43 and subsequently, dominantly
inherited mutations in the fumarate hydratase gene (FH) were identified. Importantly, the analysis
of the FH gene in tumors of MCL patients revealed a second mutation inactivating the wild-type
allele in some of the tumors. Based on these findings, it has been suggested that FH may function
as a tumor suppressor gene in MCL. Previously, we reported different types of mutations in MCL
patients including missense, nonsense and frameshift mutations. Here, we report the identification
of the splicing mutation 905-1G>A in four families of Iranian origin. The mutation occurs at the
invariant G of the 3’ acceptor splice site (AG) of intron 6. The analysis of highly polymorphic mark-
ers in the vicinity of the FH gene showed a shared haplotype in these four families, suggesting that
905-1G>A represents a founder mutation. These results will allow for direct screening of the 905-
1G>A mutation in affected MCL families and sporadic patients of Iranian descent. 
0437
Atrichia with papular lesions in a series of non-consanguineous families defined by mutations
in the hairless gene
H Kim,1 A Zlotogorski,3 G Varigos,5 A Metzker,4 J Opie,5 A Martinez-Mir,2 AS Paller6 and
AM Christiano1,2 1 Genetics & Development, Columbia University, New York, NY, 2 Dermatology,
Columbia University, New York, NY, 3 Dermatology, Hadassah Medical Center, Jerusalem, Israel,
4 Dermatology, Sourasky Medical Center, Tel-Aviv, Israel, 5 Dermatology, Royal Children,
Parkville, VIC, Australia and 6 Dermatology and Pediatrics, Northwestern University Medical
School, Chicago, IL
Atrichia with papular lesions (APL) is a rare, recessively inherited disorder that results in complete
loss of scalp and body hair due to underlying mutations in the hairless gene. APL is easily confused
with the much more common complex genetic trait alopecia universalis, which has an unknown
genetic basis. Despite this clear demarcation at the molecular level, the two conditions can be indis-
tinguishable clinically. However, diagnostic criteria for APL have recently been delineated that allow
easy clinical distinction from alopecia universalis. These cardinal features of APL include: hair that
was shed early and never regrew, associated papular eruptions and complete lack of response to all
attempted treatments for alopecia universalis. Three families of Iraqi-Moroccan, Australian (of
English descent) and Russian descent with complete alopecia were recently ascertained, all of whom
had a single affected proband within a small nuclear family that denied any history of consanguin-
ity. In each of the probands, we identified compound heterozygous mutations on distinct alleles of
the hairless gene, thereby confirming the diagnosis of APL by molecular analysis. These findings
stress the importance of inclusion of APL in the differential diagnosis of alopecia universalis, par-
ticularly in families considered to be of low risk due to the lack of parental consanguinity. Accurate
diagnosis of APL is easily established by application of the diagnostic criteria and by mutation analy-
sis in the hairless gene. Moreover, discrimination between the two conditions allows for the sparing
of an aggressive and unnecessary alopecia universalis treatment regimen for APL patients. 
0436
Patients with palmoplantar psoriasis have more physical disability and discomfort than patients
with other forms of psoriasis: implications for clinical practice
AA Pettey, SR Rapp, R Balkrishnan, AB Fleischer and SR Feldman Wake Forest University Health
Sciences, Winston-Salem, NC
Psoriasis is a chronic, unpredictable and incurable disease that has a negative impact on patients’
quality of life. Palm and sole psoriasis can add to this negative impact as it directly affects activities
of daily living. This study estimated the prevalence of palmoplantar psoriasis in a patient population
and to describe the added impact on patient outcomes. 317 individuals with psoriasis completed a
comprehensive assessment battery. Patients with palmoplantar psoriasis (n=124, 39%) were com-
pared to patients without palmoplantar involvement with respect to functional disability, psychiatric
symptoms, physical and social discomfort, self-reported psoriasis severity and HRQL. The study
found that patients with palmoplantar involvement reported significantly greater physical disability
and physical discomfort than patients without palmoplantar involvement (both p<0.01). There were
no differences between the two groups with respect to psychosocial outcomes. Patients with pal-
moplantar psoriasis are affected to a greater degree by the physical aspects of the disease than patients
without palmoplantar involvement. 
0434
Is a high potency corticosteroid needed with the antifungal agent? An analysis of factors influ-
encing clotrimazole/betamethasone diproprionate prescriptions among US outpatient physi-
cians
JM Cook, R Balkrishnan, MP Shaffer, FB Saltzberg, SR Feldman and AB Fleischer Wake Forest
University Health Sciences, Winston-Salem, NC
Despite concern associated with the necessity of an additional fluorinated, high potency topical cor-
ticosteroid, the clotrimazole/betamethasone diproprionate combination remains a frequently pre-
scribed topical agent in the U.S. This research was performed to better understand the physician and
patient characteristics associated with the prescription of this combination medication in outpatient
settings. Data from the National Ambulatory Medical Care Survey (1990-2000) were used to deter-
mine the patient and physician factors associated with a prescription for clotrimazole/betamethasone
diproprionate. The most common diagnoses of patients treated with the drug were also determined.
Family medicine physicians were more than twice as likely (OR: 2.61, 95% CI: 1.59, 4.30) and
internists were more than 3 times as likely (OR: 3.52, 95% CI: 2.07, 5.97) to prescribe clotrimazole/
betamethasone diproprionate compared to all other physicians when faced with a dermatologic diag-
nosis. Prescription rates of the combination medication were higher among patients of non-white
race (OR: 1.55, CI: 1.07, 2.25). The increased risk of potentially inappropriate prescription of clotri-
mazole/ betamethasone diproprionate by primary care physicians and increased probability of med-
ication receipt in racial minorities is of concern, when safer alternatives such as antifungals or anti-
inflammatory medications without the side effects of the combination medication are easily available. 
0438
The effect of gender on workforce patterns of recent dermatology program graduates
A Chiu, C Jacobson and AB Kimball Dermatology, Stanford University, Stanford, CA
There currently appears to be a shortage of dermatologic services in the U.S., especially in medical
dermatology. Some have questioned whether the number of recent trainees practicing part-time is
contributing to this worsening shortage, and whether gender affects this choice. To address this ques-
tion, an anonymous survey was distributed to recent dermatology program graduates taking a board
exam review course in 2000. Women reported seeing patients an average of 25 hours per week (hrs/wk)
compared to 31 hrs/wk reported by men (p= 0.003). 43% of men had children compared to 34% of
women. The differences between genders was also affected by having children (p=.005). Women
who had children tended to see patients less often than women without children (23 hrs vs. 27 hrs),
but men with children saw patients about the same as men without children (31 hours vs. 30 hours).
The breakdown of hours spent in differing areas of dermatology practice showed men spent an aver-
age of 14 hrs/wk doing Mohs procedures while women only spent 2 hrs/wk (p< 0.001). Men spent
two hours more per week doing non-Mohs dermatologic surgery compared to women (7 hours vs.
5 hours, p= 0.003). Finally, men also spent more time performing cosmetics procedures than women
(4 hrs vs. 2 hrs, p= 0.020). Survey results suggest that women newly entering the workforce are work-
ing fewer hours then men. However, the actual hours spent practicing medical dermatology, where
the shortage of services is most acute, is roughly equal between genders because men spend more
hours practicing surgery and cosmetic procedures. According to this survey, both men and women
ranked location as the most important consideration when selecting a job. Questions that still need
to be addressed include how many actual patients per hour are seen, and whether these work pat-
terns seen early in a dermatologist’s career is representative of trends in the general workforce. 
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The role of fellowships in workforce patterns of recent dermatology graduates
C Jacobson, A Chiu and AB Kimball Dermatology, Stanford University, Stanford, CA
In light of the current shortage of medical dermatologic services in the U.S., concern has developed
about the number of trainees choosing surgical fellowships and other non-medically oriented-prac-
tices. To explore the choices of dermatologists entering the workforce, an anonymous survey was
distributed to dermatology training program graduates taking a board exam review course in 2000.
204 people responded to the survey, capturing 53% of the 2000 residency graduates (157) and a sub-
stantial number of fellows (42). At the time of the survey, 33 respondents (18%) were in a fellow-
ship program while 9 respondents (5%) had just completed one. 18 fellows (42%) participated in a
Mohs fellowship, the most popular. Bench research fellowships attracted 7 fellows (16%) and were
second in popularity. 4 (9%) respondents each were in cosmetic, pediatric dermatology, or der-
matopathology fellowships. While women comprised the majority of respondents (55.7%), male
respondents were more likely to have either completed or be currently employed in a fellowship
(32%) than women (17%, p=0.06). 45% of those completing or starting fellowships had student
loan debt while 60% of those not involved in fellowships had student loan debt. The average debt
for those completing fellowships, starting fellowships or not involved in fellowships was $57,000;
$79,000; and $77,000 respectively. Half of those finishing a fellowship went into an academic prac-
tice. Differentiating factors between graduates who chose to work in an academic practice (27) and
those who did not (136) included their increased emphasis on the importance of research (p<0.001)
and teaching (p<0.001) opportunities. Interestingly, debt level did not differ between those going
into academic practice and those who did not. In conclusion, a substantial number of trainees choose
to pursue fellowships, prolonging a significant debt burden and delaying entry into the workforce.
Second, the large number of people training in Mohs makes it unlikely that they will be able to prac-
tice Mohs full-time. Lastly, bench research is still attracting a significant number of fellows. 
0440
The accuracy of computer-assisted digital epiluminescent microscopy versus dermatologists
in the evaluation of pigmented lesions
S Kafaja,1 J Agard,1 H Jennifer,1 R Schpall,3 L Westerling2 and FC Beddingfield1 1
Medicine/Dermatology, UCLA, Los Angeles, CA, 2 School of Medicine, University of Southern
California, Los Angeles, CA and 3 School of Medicine, University of California, Irvine, CA
We evaluated the accuracy of recently developed computer-assisted digital epiluminescent microscopy
(CADEM) in evaluating pigmented lesions and assessing the need for a biopsy. At a university der-
matology clinic, pigmented lesions were scanned by CADEM and evaluated by a dermatology attend-
ing, then biopsied. Using the histopathologist’s evaluation as the gold standard, the accuracy of the
CADEM was compared to that of the dermatologist. We evaluated 127 lesions in 77 patients, of
which 107 lesions were included in the study. We excluded non-nevomelanocytic lesions. Lesions
were evaluated by both CADEM and dermatologists blinded to CADEM results, using a color-coded
evaluation scheme. Green indicated a biopsy was not necessary (e.g. normal nevus), yellow indi-
cated that a biopsy should be considered (e.g. nevus with architectural disorder and/or atypia), and
red that a biopsy was definitely indicated (e.g. melanoma). All evaluations rated as yellow or red by
the histopathologists were considered positive and all evaluations rated as green were considered
negative. Dermatologists had a sensitivity (SEN) of 81%, specificity (SPE) of 35%, positive pre-
dictive value (PPV) of 46%, and negative predictive value (NPV) of 74%. CADEM had a SEN of
65%, SPE of 54%, PPV of 49%, and NPV of 74%. Using any positive evaluation by either CADEM
or dermatologists but ignoring negative CADEM evaluations resulted in increased SEN (88%),
decreased SPE (28%), and a similar PPV (46%), and NPV (78%). Dermatologists had a higher sen-
sitivity, lower specificity, and similar predictive powers compared to CADEM. Using a positive
CADEM result to convince one to perform a biopsy, but not allowing a negative CADEM to dis-
suade one from doing a biopsy could enhance dermatologists’ sensitivity. Such technology, espe-
cially if better accuracy were achieved, could have significant implications for melanoma screening. 
0441
Comparison of skin biopsy triage decisions by store-and-forward teledermatology and face-
to-face dermatology in 49 patients with pigmented lesions and neoplasms
M Shapiro,1 WD James,1 R Kessler,1 FC Lazorik,1 J Tam,2 DS Nieves,3 K Katz1 and JJ Miller4 1
Dermatology, University of Pennsylvania, Philadelphia, PA, 2 Advisory Board Company,
Washington, DC, 3 Dermatology, University of Rochester, Rochester, NY and 4 Dermatology, Penn
State College of Medicine, Hershey, PA
The present study aimed to determine the relative efficacy of store-and-forward teledermatology ver-
sus face-to-face dermatology in triaging whether growths that a primary care physician finds con-
cerning for neoplasia warrant a biopsy. A primary care physician prospectively enrolled patients
between July 10, 1998 and August 4, 2000. This physician acquired images with an Olympus D-
600L digital camera. These 1.4 mega pixel images were stored in a compressed (4:1) Joint Photo-
graphic Experts Group format, downloaded to a personal computer, and transmitted to a telederma-
tologist by electronic mail through a private encrypted network. Clinical history and reason for
consultation accompanied the images. The patients were simultaneously scheduled to see a face-to-
face dermatologist. After assessing the case, the teledermatologist notified the primary care physi-
cian of whether a biopsy was indicated. The face-to-face dermatologist would open an envelope con-
taining the teledermatologist’s biopsy decision after he had made his own, in this way ensuring that
he was blinded to the teledermatologist’s biopsy vote. A biopsy was performed at that visit by the
face-to-face dermatologist if either he or the teledermatologist voted for biopsy. Sixty-one subjects
(33 male) were enrolled. Of the 49 evaluable patients, the face-to-face dermatologist and teleder-
matologist recommended a biopsy for the same 26 patients, yielding a sensitivity of the telederma-
tologist of 1.00 (95% confidence interval: 0.87, 1.00) and a specificity of 1.00 (95% CI: 0.85, 1.00).
The agreement between the two dermatologists (kappa) was 1.00 (95% CI: 0.72, 1.00). Store-and-
forward teledermatology may provide an accurate and cost-effective method of determining whether
to biopsy skin growths in patients seen by primary care physicians. 
0442
Differences in the perceptive importance and personal practice of sun protection among pri-
mary care physicians are reflected in their clinical practice
WW Ting, C Vest and RD Sontheimer Department of Dermatology, University of Iowa College of
Medicine, Iowa City, IA
There is inadequate data regarding sun protection awareness, personal practice, and patient educa-
tion among primary care clinicians. Anonymous surveys were mailed to staff and housestaff physi-
cians in the departments of medicine, family practice, and pediatrics. Among 170 primary care physi-
cians (29% response rate), 68% reported wearing sunscreen whenever they are outside, 8% did so
daily, and 7% never wore sunscreen. Additionally, 32% reported wearing protective clothing con-
sistently and 59% did so occasionally. Overall, when given a list of preventive medicine issues to
rank according to importance (1=least important, 10=most important), sun protection was given the
lowest relative ranking. Overall, the most important preventive medicine issue ranked by these cli-
nicians was smoking (9.0), followed by active lifestyle (8.2), then cholesterol (7.4), and lastly sun
protection (6.7). Pediatricians placed highest relative ranking of 7.7 for sun protection. Further-
more, pediatricians were the most consistent in providing sun protection education as 60% reported
this practice during greater than half of the visits followed by 32% of family physicians and 17% of
internists surveyed. Among staff physicians, 70% reported wearing sunscreen whenever they are out-
side, compared to 58% of housestaff physicians. Staff physicians reported providing sun protection
counseling more frequently than housestaff physicians, 32.8% vs. 8.3% respectively. Overall, the
greatest impediments in providing sun protection counseling reported by this cohort of clinicians
included inadequate time during office visits, not thinking about sun protection during office visits,
and lack of proper training. In short, differences in the perceptive importance and personal practice
of sun protection may be reflected in the self-reported clinical practice of these primary care physi-
cians. This reinforces the urgency and the opportunity to educate primary care clinicians to join the
public health effort to increase sun protection awareness. 
0443
Atrichia with papular lesions resulting from a novel homozygous missense mutation in the
hairless gene
M Paradisi,1 GS Chuang,2 C Angelo,1 C Pedicelli,1 A Martinez-Mir2 and AM Christiano2,3 1 Istituto
Dermopatico Dell’Immacolata, Rome, Italy, 2 Dermatology, Columbia University, New York, NY
and 3 Genetics & Development, Columbia University, New York, NY
Atrichia with papular lesions (APL, OMIM 209500) is a rare autosomal recessive disorder charac-
terized by complete and irreversible hair loss shortly after birth. Affected individuals also develop
papular lesions of keratin-filled follicular cysts over extensive areas of the body. Mutations in the
hairless gene, a putative single zinc-finger transcription factor protein, have been implicated in the
pathogenesis of this disorder. Here, we describe a small Italian family with two of four offspring
affected with APL. The proband is a 10-year-old girl with generalized body alopecia and absent
eyebrows and eyelashes at birth. In the first four years of life, she gradually lost all scalp hair and
developed diffuse skin-colored papular lesions on her limbs and face. A 4-year-old sister of the
proband presented with similar symptoms. In the past years, the younger sister has been shedding
the remaining scalp hair, sparing centroparietal and occipital areas of the scalp. Along with alope-
cia, the younger sister has recently begun to develop few papular lesions on the back. Both parents
and two other siblings of the proband are unaffected, and the parents denied any history of consan-
guinity. Sequence analysis of the hairless gene revealed a novel homozygous missense mutation in
exon 5. The mutation, designated E583V, resides in between LXXLL motif of TRIPS (thyroid hor-
mone receptor interacting proteins) in exon 5 and the six-cysteine zinc-finger motif in exon 6. Amino
acid sequence neighboring the LXXLL motif and zinc-finger domain encompassing the E583 is
highly conserved in human, monkey, rat and mouse hairless proteins. Further, this mutation was not
identified in a large number of unaffected, unrelated control individuals, arguing against it being a
polymorphism. Our findings extend the body of evidence implicating hairless gene mutations in the
pathogenesis of APL, and highlights the presence of the disease in small nuclear families. 
0444
The spectrum of drugs that may cause acute generalized exanthematous pustulosis is differ-
ent from the one for Stevens-Johnson syndrome or toxic epidermal necrolysis
A Sidoroff,1,2 A Flahault,2 J Bouwes Bavinck,2 S Halevy,2 B Sassolas2 and J Roujeau2 1 Department
of Dermatology and Venereology, University of Innsbruck, Innsbruck, Tirol, Austria and 2
EuroSCAR Study Group, Creteil, France
Acute generalized exanthematous pustulosis (AGEP) is a reaction mostly caused by drugs, charac-
terized by the acute occurrence of dozens to hundreds of small, pinhead-sized non-follicular sterile
pustules. In a multinational case contol study (EuroSCAR) we could detect 96 patients that fit the
criteria of this disease and could be classified as definite or probable cases according to a specially
developed scoring system. A thorough history of drug intake and previous diseases was used to deter-
mine the risk for different drugs for causing AGEP by comparing them with a group of 1009 hospi-
tal controls. Multivariate relative risks (RR) for drug coalitions and single drugs were calculated
adjusting for age, gender, country and the intake of other drugs with an elevated risk. For the fol-
lowing drugs an elevated RR for AGEP is probable (95% confidence intervals (CI) given in brack-
ets): ampicillins RR 23 (10-53.4); quinolones RR 19.88 (4.3-91); macrolide antibacterial agents RR
29 (9.6-87.7) - 10 cases attributed to pristinamycin; diltiazem RR 15.9 (4.5-55.3); antimalarial
drugs RR 12 (3.2-45.1). For sulfonamide antibacterials and terbinafine (4 cases vs. 0 controls) the
lack of exposed controls does not allow to calculate relative risks but the lower bound of the 95%
CI of 7.1 together with the absence of suspect comedication strongly suggests an elevated risk for
these drugs. Drugs with a known elevated risk for causing SJS/TEN like allopurinol or oxicam
NSAIDs were not risk factors for AGEP. The spectrum of causative drugs for AGEP thus differs from
that for SJS/TEN. High risk drugs for AGEP seem to be: pristinamycin, sulfonamide antibacterials,
ampicillins, quinolones, terbinafine, diltiazem, and (hydroxy)chloroquine. 
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Is there a marked rural/urban gradient for children with atopic dermatitis in South Africa?
H Williams,1 G Todd,2 S Tolosana2 and N Saxe2 1 Centre of Evidence-Based Dermatology,
University of Nottingham, Nottingham, Notts, United Kingdom and 2 Department of Dermatology,
University of Capetown, Capetown, South Africa
It is still unclear if a true urban/rural gradient exists for the occurrence of atopic dermatitis (AD)1.
The objective of this study was to determine the prevalence of AD in Xhosa children living in the
Eastern Cape (rural), informal settlements around Capetown (periurban) and in urban Capetown
itself. This was done by conducting three cross-sectional surveys of at least 1,000 children aged 3-
11 years in each of the settings using sampling frames based on local maps. Because of difficulties
in translating some commonly used questions about AD into the Xhosa language, AD prevalence
was determined by the presence or absence of typical signs based on the direct examination of the
skin by a trained dermatologist. In all, 3,058 children participated in the study, representing an over-
all response rate of 99.9%. All of the children were Black African, and most were from socio-eco-
nomically less advantaged communities. The point prevalence of AD according to a dermatologist
was 0.7%, 1.1% and 3.7% in rural, periurban and urban settings respectively, representing an increased
risk of AD if living in urban Capetown of 3.95 (95% confidence intervals 2.28 to 6.83, P<0.0001)
when compared with the other locations. The risk difference could not be explained by differences
in social class, age structure and age of migration between the study populations. This study pro-
vides some evidence to suggest that moving from a rural area characterised by open housing and
subsistence farming to an urban location is associated with a modest increased risk of AD. Another
striking finding of the study is that AD is very rare indeed in Xhosa children living in rural settle-
ments. Further study of these communities may identify important protective factors in the envi-
ronment that could lead to disease prevention. 
0447
Evaluation of a fast-track mole-check clinic at an academic dermatology office
NL Restauri, P Parham-Vetter and D Kress Dermatology, University of Pittsburgh, Pittsburgh, PA
This study evaluated the feasibility and effectiveness of a fast-track mole-check (FTMC) clinic in
an academic dermatology office. This retrospective chart review evaluated the following: length of
time to appointment, type of issues addressed, and diagnsoses for patients seen during the first six
months of a FTMC clinic. This new clinic was designed to provide rapid assessment of potential skin
cancers. For the 172 charts reviewed from the FTMC clinic, the average length between the appoint-
ment scheduling and office visit was two weeks, compared to an 8-12 week wait in the regular der-
matology clinic. Eighty-three percent of patients did not seek evaluation of secondary dermatologic
issues during their clinic visit, and the most common chief complaints were changing lesions (38%)
and new lesions (18%). Clincal assessment indicated 27% of patients had atypical or potentially
malignant lesions, including 28 atypical nevi, 9 possible melanomas, 8 possible basal cell carcino-
mas and 1 possible squamous cell carcinoma. Biopsies were performed on 28% of lesions and his-
tological findings included: 9 atypical nevi, 3 melanomas, 3 basal cell and 2 squamous cell carci-
nomas. Hence, 33% of biopsied lesions and 9% of all lesions evaluated were found to be skin cancer
or atypical. The FTMC clinic was designed to provide patients with potential skin cancers a much
faster evaluation than is available through the normal dermatology scheduling templates. Not only
was this clinic able to provide a rapid evaluation of the lesions, it was successful in diagnosing and
treating a significant number of skin malignancies and atypical lesions. Based upon these findings,
we conclude that this FTMC clinic is both feasible and effective. Dermatology offices where patients
must wait many weeks or months before getting an appointment to have a suspicious lesion evalu-
ated should consider similar programs to increase the early detection and treatment of potentially
deadly skin cancers. 
0449
Six-month evaluation of effect of thorough skin self-examination (TSSE) intervention on TSSE
practice and invasive procedures on the skin
MA Weinstock,1,2 PM Risica,3,4 RA Martin,4 W Rakowski,4 KJ Smith,3,4 M Berwick,3
MG Goldstein,3 T Lasater3 and G Burkholder3,4 1 Dermatoepidemiology Unit, V A Medical Center
- 111D, Providence, RI, 2 Dermatology, Brown University, Providence, RI, 3 Institute for
Community Health Promotion, Brown University, Providence, RI and 4 Community Health, Brown
University, Providence, RI
Monthly thorough skin self-examination has great potential for reducing melanoma mortality. The
Check It Out project is a randomized trial of a multicomponent intervention designed to encourage
TSSE, compared to a control dietary intervention. Participants were recruited in the practices of pri-
mary care physician volunteers. The intervention involved materials (including a videotape designed
for the project), brief one-on-one counseling by a health educator at the time of the office visit, a
follow-up phone call and later tailored written feedback. Assessments of outcome were by tele-
phone interview at 0, 2, 6, and 12 months. These results are from the baseline and 6 month inter-
views. Of the 1359 participants randomized, 1019 (75%) completed interviews at 6 months. For this
follow-up group there were slight differences (intervention vs. control) at baseline in gender (56%
vs. 62% women) and mean age (53 vs. 54 years) (p=.052 and .050), but not in performance of TSSE
(16% vs. 17%) or procedures performed on the skin in the prior 6 months (10.6% vs. 10.2%). How-
ever, at 6 months after intervention, 55% of the intervention group (as opposed to 35% of the con-
trol group) reported performing TSSE at least once in the prior 2 months (p<.0001). Also, a higher
proportion of the intervention group reported having a surgical procedure performed on their skin
after the intervention, although this was not statistically significant (8.9% vs. 6.9%, p=.2). The 6
month analyses suggest that the Check It Out intervention package is effective in increasing self-
reported TSSE practice and may result in more surgery being performed on the skin. We are evalu-
ating 12 month results and a possible modified intervention that may increase TSSE without unnec-
essarily increasing surgical procedures. 
0448
Impact of sulfonamide drug eruptions on 5-years survival rate of AIDS patients
PD Ghislain,1 JC Roujeau,1 M Eliaszewicz,2 A Flahault3 and E Caumes4 1 Service de
Dermatologie, Hopital Henri Mondor, Creteil, France, 2 Service des Maladies Infectieuses,
Hopital de l’Institut Pasteur, Paris, France, 3 Service de Biostatistiques, Hopital Tenon, Paris,
France and 4 Service des Maladies Infectieuses et Tropicales, Hopital de la Pitie-Salpetriere,
Paris, France
Cutaneous adverse drug reactions are frequent in AIDS patients. A 2001 publication reported a sig-
nificantly shorter survival rate among patients who stopped taking cotrimoxazole for adverse events.
Our aim was to determine whether sulfonamide induced eruptions had an effect on survival rate.
EPITOX was a multicenter prospective study originally designed to evaluate risk factors of drug
eruptions to sulfonamides in patients with AIDS. One hundred thirty-six patients hospitalized for
pneumocystis carinii pneumonia or cerebral toxoplasmosis had been included from June 1995 to
October 1997; 48 (36%) had experienced a drug eruption. The results of the initial study have been
published : both groups were comparable for HIV viral load, prior opportunistic infections and dif-
fered only in multivariate analysis by a higher CD8 T-cells count in patients with a drug eruption. A
follow-up evaluation was performed in 2002. No difference in follow-up duration was observed
between the groups with and without a drug eruption (19% and 16% lost to follow-up respectively).
Kaplan-Meyer overall survival rates showed only moderate differences between both groups. Actu-
arial two-years survival rate was 0.80 for patients with drug reaction (95% CI: 0.66-0.90) and 0.68
for patients without reaction (0.57-0.77). Five-years survival were respectively 0.72 and 0.61. By
logrank test the differences were not statistically significant (chi2 = 1.32, p= 0.25). Our work is the
first long-time prospective cohort study specially devoted to the evaluation of sulfonamide erup-
tions in AIDS patients. Even if it had not a very high statistical power, we observed no trend sug-
gesting a deleterious effect of drug reactions in long term survival of AIDS patients. 
0446
A survey of latex allergy work-place practices in US academic medical centers
P Parham-Vetter Dermatology, University of Pittsburgh, Pittsburgh, PA
This study assesses whether U.S. academic medical centers have complied with the 1997 recom-
mendations by the National Institute for Occupational Safety and Health (NIOSH) on latex allergy
in the workplace. This is a prospective survey of all U.S. academic medical centers, containing six
questions regarding latex allergy practices in these facilities. A response rate of 75% was received
from the 122 academic medical centers. The results of the surveys showed the following compli-
ance rates with NIOSH recommendations: 82% screen new employees for latex allergy; 37% screen
existing employees for latex allergy; 100% have non-latex gloves available for employees; 78% have
latex-allergy educational programs for employees; 62% have eliminated non-sterile powdered latex
gloves from the work-place; and 25% have eliminated sterile powdered latex gloves from the work-
place. This study shows that four years after the NIOSH recommendations were issued many aca-
demic centers have not complied. This is a significant issue since as many as 21% of all health care
workers have developed a type I hypersensitivity to latex. Dermatologists often encounter this allergy
manifesting as hand dermatitis in health care workers who wear latex gloves. However, this allergy
is not limited to merely a dermatitis; those with a type I allergy are at risk for developing symptoms
such as asthma, angioedema, anaphylaxis and even death from exposure to this allergen. Based
upon our results, academic medical centers should be encouraged to administer screening ques-
tionnaires for employees to identify those with or at high risk for latex allergy. Additionally, further
studies must be done to identify and help eliminate barriers to removing powered latex gloves from
academic medical centers since the aeroallergens from these gloves are the largest source of sensi-
tization for latex allergy in the workplace. 
0450
The Minnesota Massachusetts Indoor Tanning Study: patterns of indoor tanning use among
adolescents and teen access
M Demierre,1 J Forster,3 G Sorensen,2 D Lazovich,3 A Hickle,3 N Remba2 and E Hansen2 1
Dermatology, Boston University School of Medicine, Boston, MA, 2 Minnesota Sch. of Public
Health, Minneapolis, MN and 3 Harvard Sch. of Public Health, Boston, MA
Indoor tanning increases skin cancer risk. In the US, there are 2-3 million teenagers customers. Deter-
minants of use among adolescents are not known. In Minnesota (MN) and Massachusetts (MA), state
regulations require parental consent for teens to tan indoors. We investigated the proportion of teens
and their mothers who tan indoor and surveyed them on indoor tanning habits. We also evaluate
indoor tanning business compliance with state laws on teen access. We surveyed 1298 teens, 1313
parents (90% and 75% response in each area, respectively). Ever use of indoor tanning among teens
was higher in MN than MA (40.9% vs 22.1%, p < 0.0001). Among teens who tanned, 70% had started
before age 16, and only half of them had asked a parent to provide written consent. Indoor tanning
was significantly higher among girls, smokers, and teens who never used any sun protection. Posi-
tive attitudes toward or social aspects related to tanning were strongly associated with use. Among
mothers, use of indoor tanning was highly correlated with teen use. While mothers were in agree-
ment with their teen’s report of indoor tanning use, most were not aware of laws requiring their writ-
ten permission and only about half reported being very concerned if their teen tanned occasionally.
In each state, a random sample of 100 tanning businesses was visited twice by 15 y.o. girls attempt-
ing to purchase a tanning session. Only 38% of Boston businesses and 55% of Minnesota busi-
nesses consistently assessed age eligibility of the teens either by asking for age or birthdate. Despite
knowledge that teens were required to have parental consent, teens were able to purchase a tanning
session at least once in 81% of businesses. Our data highlight the need for interventions reinforcing
parents’ role in limiting teen access as well as the need for strict regulations, as the majority of tan-
ning businesses in both locations did not comply with state statutes. 
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Differences in age, sex, and body site location of different subtypes of basal cell carcinoma: do
they suggest different pathogenetic mechanisms?
R Corona, S Mastroeni, F Sera and G Annessi Clinical Epidemiology, Istituto Dermopatico dell’
Immacolata, Rome, Rome, Italy
Ultraviolet radiation has been recognized as the main etiologic factor for basal cell carcinoma(BCC),
whereas other exposures, such as ionizing radiation, and checmical carcinogens explain a small
proportion of these cancers. Because of clinical and histological differences, different pathogenetic
mechanisms have been hypothesized for subgroups of BCC. The aim ofthis study was to examine
patient and tumor characteristics of 15,702 BCCs observed in 12,151 patients at the Istituto Der-
mopatico dell’Immacolata, Rome, Italy, between October 1991 and January 2001, by reviewing all
the pathology reports. Fifty eight percent of BCCs occured in men, and 9% in patients aged 44 or
younger. Interestingly, the proportion of women in the 16-44 age group were significantly higher
than in the other age groups (56% vs. 40%, p=0.00). The prevailing histological type was nodular
(77%), whereas 10% were superficial and 6% morpheiform. The proportion of superficial BCCs
decreased with age, accounting for 19% of the tumors observed in the 0-44 age group and only for
5% of those observed among patients 75+ (p for trend = 0.00). Moreover, superficial BCC’s were
more common among women, and 67% of them occured on the trunk. An opposite trend was observed
for nodular BCCs. The proportion of BCCs located on the head/neck region increased with age, from
56% in the younger age group to 78% in the older one (p for trend = 0.00). A reverse tendency was
observed for tumors located on the trunk, which accounted for 40% of BCCs observed in patients
<44 years. The findings of this study suggest that superficial BCCs represent a well defined sub-
group within the clinical and histologic spectrum of basal cell carcinoma, and are likely accounted
for by a different pathogenetic model, based on a different pattern of sun exposure. According to the
other sources of evidences, chronic sun exposure seems to be associated to the development of nodu-
lar BCC, located in the head and neck region among older patients, whereas intermittent sun expo-
sure, along with genetic susceptibility factors, could play a role in the occurrence of superficial BCC. 
0452
Actinic keratoses: reliable assessment methods and a comparative trial between liquid nitro-
gen and topical 5-flurouracil
D Atkins,2,3 A Moore,1 C Vanexel,1 M Sternberg,5 RH Bang2,3 and SC Chen1,5 1 Dept of
Dermatology, Emory University, Atlanta, GA, 2 Dermatology, University of New Mexico,
Albuquerque, NM, 3 Dermatology, Albuquerque VAMC, Albuquerque, NM, 4 Dermatology, Atlanta
VAMC, Atlanta, GA and 5 HSR&D, Atlanta VAMC, Atlanta, GA
Although liquid nitrogen (LN2) and topical 5-flurouracil (5FU) are popular therapies for actinic
keratoses (AKs), no direct efficacy comparisons have been reported. Previous studies have also
reported poor reliability in counting AKs. We thus conducted a prospective, quasi-randomized sin-
gle-blinded trial to establish reliable methods to assess AK burden and to compare LN2 to 5FU. We
recruited subjects with 2% AKs involvement of their arms from the Albuquerque, NM VA derma-
tology clinic. In our reliability phase, we evaluated body surface area (BSA) and direct counting
(CT) of lesions > 5mm using correlations and paired mean differences between the initial and base-
line (2 weeks later) visit. We analyzed data where the blinded investigators were the same (intra-
rater) and different (inter-rater) at the two time points. In the efficacy phase, each subject received
LN2 on one arm and 5FU on the other arm. Blinded investigators evaluated subjects at baseline and
post therapy (4 months). We used an intention-to-treat analysis. 37 subjects enrolled; 2 did not fin-
ish the trial. Both BSA and CT correlated highly (p<0.05) and had similar mean differences between
the initial and baseline visits using intra- and inter-rater data. Using intra-rater data, LN2 and 5FU
demonstrated comparable efficacy in reducing AKs when measured by both assessment methods
(p<0.05). Using inter-rater data, neither therapy effectively reduced AKs by the CT method. The
BSA and CT methods have significant intra-rater reliability. BSA, more so than CT, also has sig-
nificant inter-rater reliability. LN2 and 5FU are each effective in decreasing AKs; they are similar
in efficacy when compared to each other. 
0453
The impact of managed care on dermatology outcomes: a critical review of the literature
EJ Hester,1 LM Schilling,3 SR Feldman2 and RP Dellavalle1 1 Dermatology, University of
Colorado Health Sciences Center, Denver, CO, 2 Dermatology, Wake Forest University, Winston-
Salem, NC and 3 Internal Medicine, University of Colorado Health Sciences Center, Denver, CO
Managed care, a health care delivery system utilizing a broad spectrum of cost-containing measures
including limited direct access to specialists, has significantly altered health care delivery in the US
over the last two decades. To assess the impact of managed care on dermatologic care, we per-
formed a MEDLINE search and critical analysis of peer-reviewed quantitative literature published
from 1980-2002. Qualifying articles mentioned ‘dermatology’and ‘managed care’ in the title, abstract
or MeSH terms, and addressed either dermatology 1) diagnostic precision and management, 2) health
care utilization, or 3) outcomes analysis. Forty-three articles were identified. Eleven articles exam-
ining diagnostic precision uniformly showed significantly higher performance by dermatologists
than non-dermatologists. Seven articles analyzed dermatology utilization using National Ambula-
tory Medical Care Survey data and reported numerous fluctuations in utilization from 1974 to 1994.
Overall, patients with managed care coverage received less care from dermatologists for dermatol-
ogy-related diagnoses than patients with fee-for-service payment. National Ambulatory Medical Care
Survey data also showed that 39% of patients with a single dermatological diagnosis are referred to
a dermatologist. Only one article (from 1983) examined the cost of care and showed similar man-
agement costs by dermatologists and non-dermatologists for dermatological disease. The results of
this literature review demonstrate a paucity of quantitative peer-reviewed literature on dermatology
health care delivery outcomes. National Ambulatory Medical Care Survey provides the best avail-
able data on dermatology practice, however this data has not been formally validated and appears
flawed in health maintenance organization measures. Lastly, the published literature fails to address
the ‘backlash’ against managed care currently affecting health care markets. 
0454
Gender and sentinel node status affect the decision of melanoma patients to undergo adjuvant
interferon Alfa-2b treatment
TL Bialy,1 BR Johns,1 DH Lawson,2 E Veledar,1 CV Washington1 and SC Chen1 1 Dermatology,
Emory University, Atlanta, GA and 2 Hematology/Oncology, Emory University, Atlanta, GA
Patients with thick (Breslow 4mm) primary melanomas (MM) and/or pathologic or clinical evidence
of regional nodal metastasis have a high risk of tumor recurrence after surgical treatment. High-
dose adjuvant interferon alpha 2b (IFNa2b) is a 1-year regimen that improves relapse-free and over-
all survival by approximately 10%, but has significant toxicity: 78% of patients experience severe
toxic symptoms, 50% of patients require dose reduction and 23% of patients discontinue treatment
before completion. The purpose of this study is to determine what patient characteristics and/or prog-
nostic factors (Breslow level, ulceration, and sentinel lymph node (SLN) status) contribute to MM
patients’decision to accept adjuvant IFNa2b. A concurrent retrospective chart and Emory Melanoma
Database review identified 781 patients who underwent SLN biopsy from 1994-2001. During the
study period, 135 of 781 (17.3%) patients had positive SLN or thick MM. These patients were
informed of a 50% risk of recurrence and disease-related mortality, and were offered adjuvant
IFNa2b. Odds ratios (OR) were estimated using multivariate logistic regression. We found that 60/135
(44%) decided to take IFNa2b while 75/135 (55%) declined. The IFNa2b group (mean age 48.8
years, 52% male, 48% female) had a mean Breslow level (mm +/-SD) 3.85 +/-2.79 with 30% ulcer-
ation and 78% positive SLN, while the non-IFNa2b group (mean age 51.9 years, 71% male, 29%
female) had a mean Breslow level 4.74 +/-3.26 with 35% ulceration and 64% positive SLN. Being
female and SLN positive status were strongly associated with patients who chose to take adjuvant
IFNa2b (OR=2.4; 95% CI: 1.17, 5.03 p=0.017) and (OR=2.2; 95% CI: 1.01,4.97 p=0.048), respec-
tively. Although all patients were informed that Breslow level 4mm and/or positive SLN status were
associated with 50% recurrence risk, only female gender and positive SLN status were significantly
associated with high-risk MM patients’ decision to undergo IFNa2b adjuvant treatment. 
0455
Prevalence and age-course of pigmented lesions and skin changes due to chronic UV exposure
in adults
T Schaefer,1 J Merkl,2 E Klemm,2 HE Wichmann3 and J Ring2 1 Social Medicine, Medical
University Luebeck, Luebeck, Germany, 2 Dermatology, Technical University, Munich, Germany
and 3 GSF Institute of Epidemiology, Neuherberg, Germany
Demographic changes and the rapid increase of skin tumor incidence indicate a need for a popula-
tion-based estimate of corresponding marker lesions. Little is known, however, on the prevalence
and age-course of such lesions from population-based studies. The KORA (COoperative health
Research in the Augsburg region) Survey 2000 comprised a random sample stratified for age and
sex of the adult population (25-74 years) of the City of Augsburg / Germany and two adjunct coun-
ties. At the study center 2323 subjects received a standardised dermatological examination (overall
response 67%). We assessed the frequency (0-10, 11-50, 51-100, >100) or severity (not present, mild,
moderate, severe) of the following skin signs: Common nevi (CN), Lentigines (solaris, seniles), Elas-
tosis, actinic keratosis, dysplastic nevus. The prevalence of CN according to the categories was 31.6%,
60.3%, 6.6% and 1.5% respectively. The number of CN decreased after the 3rd decade. The pro-
portion on subjects in the lowest category (0-10 nevi) increased correspondingly over age (25-34:
16.8%, 35-44:21.4%, 45-54:29.2%, 55-64:39.1%, 65-74:56.0%; pTrend<0.001). Lentigines solaris
(36.1%, 55.4%, 67.7%, 76.4%, 80.0%), Lentigines seniles (0.2%, 3.1%, 26.5%, 63.3%, 82.5%) and
elastosis (3.2%, 20.7%, 62.7%, 87.6%, 93.8%) were all significantly associated with age
(pTrend<0.001). In 2.8% of the subjects an actinic keratosis was diagnosed. Similarly, a significant
age-course was observed (0%, 0.2%, 0.5%, 4.3%,10.4%; pTrend<0.001). A dysplastic nevus was
recorded in 5,2% of the examined persons. As for CN the number is decreasing after the 3rd decade
(9.1%, 5.7%, 5.7%, 3.1%, 2.1%; pTrend<0.001). Skin signs of ageing and precursors of tumors are
frequent in the adult population and follow clear age courses. 
0456
Population-based assessment of cancer risk in relatives of melanoma probands
A Alexander,1 SA Leachman1 and LA Cannon-Albright2,1 1 Dermatology, University of Utah, Salt
Lake City, UT and 2 Genetic Epidemiology, University of Utah, Salt Lake City, UT
PURPOSE: We performed a relative risk assessment for all cancers of other sites in the first-degree
relatives of melanoma probands. We used the unique Utah Population Database (UPDB), which con-
tains the genealogy of the Utah pioneers and their descendents, record-linked to the statewide Utah
Cancer Registry (1966-2002). We present detailed estimates of relative risks for 30 major cancer
groups in relatives of melanoma probands. METHODS: The observed cancers occurring in the 23,419
first-degree relatives of 2,901 melanoma probands were compared to expected site-specific rates of
cancer using cohort-specific rates internal to the UPDB. RESULTS: 2075 total cases of all cancers
were observed in the 23,419 first-degree relatives. Relative risk of all cancers in this cohort was
1.3956 (p = 0.0000, 95% confidence interval [95% CI], 1.31-1.48). A nearly 3-fold risk of melanoma
was seen in first-degree relatives (p = 0.0000, 95% CI, 2.50-3.49). Cancers of the eye and pancreas,
notably associated with CDKN2A mutations, were also significantly increased in this cohort. Sev-
eral other cancer types with significant increases in relative risk were identified, including multiple
myeloma, non-Hodgkin’s lymphoma, and cancers of the kidney, stomach, colon, breast, and prostate.
Similar increased risks to relatives were seen when subpopulations of high-risk melanoma probands
were examined, such as age of onset before 50 years (n = 1418) and multiple primary melanoma (n
= 65). CONCLUSIONS:A survey of the Utah population suggests that relatives of melanoma probands
are at an increased risk of developing cancer of several other sites in addition to melanoma. Associ-
ations with pancreatic and eye cancers may be explained by the role of CDKN2A in these tumors.
It is likely that other cancer predisposition genes exist to explain 60-80% of familial melanoma
lacking a CDKN2A mutation. This data suggests that testing of other cancer predisposition genes
may be warranted, especially in familial melanoma. 
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Evaluation of baseline attitudes toward thorough skin self-examination (TSSE)
KJ Smith,1 MA Weinstock,4,3 PM Risica,1 RA Matrin,2 W Rakowski,2 MA Berwick,5
MG Goldstein,6 T Lasater,1 G Burkholder1 and B Richard1 1 Institute for Community Health
Promotion, Brown University, Providence, RI, 2 Community Health, Brown University, Providence,
RI, 3 Dermatology, Brown University, Providence, RI, 4 DermatoEpidemiology Unit, VA Medical
Center, Providence, RI, 5 Epidemiology, Sloan Kettering Cancer Center, New York, NY and 6
Health Communications, Bayer Institute, West Haven, CT
Regular self-examination of the skin provides opportunities to detect melanoma at earlier stages and
thus reduce skin cancer mortality. Current behavior change models suggest that attitudes are an impor-
tant component of motivation and behavior. Attitudes toward skin thorough skin self-examination
(TSSE) could influence motivation for or performance of TSSE tasks. The Check It Out project is
a randomized trial of a multi-component intervention designed to encourage TSSE. Participants were
recruited at the practices of primary care physicians. This analysis includes all participants who were
subsequently randomized into the clinical trial (N=1356). All recruited participants completed a base-
line survey, which included questions concerning attitudes about skin self-examination. This pres-
entation examines the factor structure of participant responses to 25 attitude domain questions.
Principal component analysis (with promax rotation) of attitude items revealed a 2 factor solution:
positive domain attitudes toward TSSE (α=.82, factor loadings ranged 0.44-0.81) and negative domain
attitudes toward TSSE (α=.77, factor loadings ranged 0.42-0.67). The factors accounted for 36% of
the total item variance. The correlation between factors was not significant (r=-0.13). A measure of
TSSE task performance was correlated with positive attitudes (r=+0.22, p<.0001) and with negative
attitudes (r=-0.20, p<.0001). The attitude scales explained 7% of the variance in the TSSE measure.
These results suggest that the attitude scales may be useful for predicting TSSE behavior. 
0459
Association between a promoter polymorphism in the IL16 gene and contact allergy
K Reich,1 G Westphal,2 A Schnuch,3 R Moessner,1 IR Koenig,4 A Ziegler4 and C Neumann1 1 Dept.
of Dermatology, Georg-August-University, Goettingen, Germany, 2 Dept. of Occupational
Medicine, Georg-August-University, Goettingen, Germany, 3 IVDK, Georg-August-University,
Goettingen, Germany and 4 Inst. of Medical Biometry and Statistics, University Luebeck, Luebeck,
Germany
IL-16 is a natural ligand to the CD4 molecule that induces chemotactic responses in CD4+ T cells,
eosinophils and monocytes. More recently, IL-16 has been implicated in the regulation of Langer-
hans cell migration, and data from animal models suggest that IL-16 could play an important role
during contact hypersensitivity reactions. Here, we investigated whether a promoter polymorphism
in the IL16 gene affects cytokine production and may influence susceptibility to contact allergy.
PBMC were isolated from healthy donors (n = 36) and stimulated with LPS or LPS together with
IL-10. Secreted levels of IL-16 were determined by ELISA. PBMC of carriers of at least one IL16-
295*C allele (C at position -295) produced significantly more IL-16 in response to LPS/IL-10 than
carriers of two wild-type alleles (T at position -295) (p = 0.0013). In a case-control study including
healthy individuals (n = 310) and polysensitized individuals with eczema (confirmed contact sensi-
tization to para-compounds and at least one other, structurally not related hapten; n = 86), the dis-
tribution of IL16-295 genotypes was significantly different in cases and controls (χ2 = 12.79, p =
0.0021). In particular, individuals with an IL16-295*C/C homozygous genotype were significantly
overrepresented among polysensitized compared with control subjects (7% vs. 1%; OR [95% CI] =
7.68 [1.88-31.37], p = 0.0043). We conclude that the IL16-295 promoter polymorphism may influ-
ence the production of IL-16 in response to IL-10, an anti-inflammatory cytokine released during
contact allergic reactions, and may contribute to a genetic basis of contact allergy. 
0461
Decision analysis as a tool to evaluate the utility of skin biopsy in acute graft-versus-host dis-
ease after allogeneic bone marrow transplant
B Firoz,2 S Lee,1 J Kvedar3 and A Qureshi3 1 Dana Farber Cancer Institute, Boston, MA, 2
Harvard School of Public Health, Boston, MA and 3 Massachusetts General Hospital, Boston, MA
Controversy has surrounded the utility of skin biopsy in the diagnosis of acute graft-versus-host dis-
ease (GVHD) in allogeneic bone-marrow transplant (a-BMT) patients. Acute cutaneous GVHD man-
ifests as a skin eruption seven to ten days post-transplant. A skin biopsy is frequently used as a screen-
ing tool to make the diagnosis. Often, skin biopsy findings cannot differentiate early acute GVHD
from other causes of a skin eruption. Nonetheless, skin biopsies are being performed as confirma-
tory tests increasing the potential for morbidity and cost of care. This study employs decision analy-
sis to address whether to perform a skin biopsy or not in a-BMT patients with a skin eruption up to
100 days post-BMT. First, a formal decision analysis has been performed, using the prior probabil-
ities of disease (GVHD in a-BMT) and sensitivity and specificity of skin biopsy from data published.
Pre-test probability of GVHD is 35-50% in post-BMT recipients, as obtained from numerous stud-
ies in the literature. A sensitivity analysis of prior prevalence of GVHD and test characteristics of
skin biopsy has been performed. This will help inform physicians how decision-making changes
based on differing opinions of prior-prevalence of disease, differing test characteristics and ways in
which this model can be used at various institutions. Second, a survey of dermatologists and oncol-
ogists who frequently treat GVHD patients has been performed nationally. Individual physician esti-
mates for prior probability of GVHD and sensitivity and specificity of skin biopsy will be used to
analyze their own decision making based on clinical scenarios presented in the survey.  Overall, this
is a novel approach to study decision making in dermatology. Specifically, this preliminary work
will form the basis for further investigation to delineate where improvements can be made in our
approach to the diagnosis and management of acute GVHD. 
0460
Identification of mutations in the ARS gene encoding SLURP-1 in six Turkish families with
mal de Meleda
G Hu,1 M Yildirim,2 O Yerebakan,3 V Baysal,2 E Yilmaz,3 H Inaloz4 and JT Celebi1 1 Dermatology,
Columbia University, New York, NY, 2 Dermatology, Suleyman Demirel University, Isparta, Turkey,
3 Dermatology, Akdeniz University, Antalya, Turkey and 4 Dermatology, Gaziantep University,
Gaziantep, Turkey
Mal de Meleda (MdM) is a rare form of palmoplantar keratoderma inherited in an autosomal reces-
sive manner. It is characterized by erythema and hyperkeratosis of the palms and soles, extending
to the dorsal aspects of the hands and feet (known as transgrediens keratoderma). Some of the com-
monly associated findings include nail abnormalities, keratotic plaques over the joints, perioral ery-
thema, brachydactyly, and pseudoainhum. In 1998 the MdM gene was mapped to chromosome 8qter
by linkage analysis. In a recent study, homozygous mutations in the ARS gene were identified in
families with MdM, implicating ARS as the causative gene for this disease. Subsequently, a patient
with MdM lacking mutations in ARS was reported, suggesting genetic heterogeneity. We describe
six Turkish families with MdM in which three different homozygous mutations in the ARS gene
were identified. While the R96X and 82delT are recurrent mutations, L98P is novel. Of interest, we
identified the R96X mutation in four unrelated families we studied. The identification of recurrent
mutations suggests that these may be hot spot mutations within the ARS gene, or alternatively a com-
mon ancestral allele. To determine whether the mutation in the Turkish population originated from
a common ancestor, we analyzed the R96X allele signatures in these families. Our results showed
that all four families shared a common haplotype at the MdM locus, suggesting a founder effect. 
0458
Integration of clinical and histological data by means of wireless PDA communication
E Roh, D Jukic and J Davie Dermatology, University of Pittsburgh School of Medicine, Pittsburgh,
PA
The purpose of this study was to develop a wireless database system that facilitates case-based entry
of clinical and pathological data and promotes information/reporting accuracy. We designed data-
base forms for Palm Pilot PDAs (personal digital assistants) for collection of pertinent clinical
information relevant to dermatopathologic diagnosis.  For the study, two dermatology residents and
a dermatopathology attending physician were trained to use Palm Pilot PDAs with this database soft-
ware. The clinical data generated from 45 randomly selected patients were wirelessly e-mailed to
the dermatopathologist to aid histologic diagnosis. Following dermatopathology signout, the resi-
dents were sent both (1) digital reports and (2) conventional faxed paper reports. Diagnostic accu-
racy, reliability, and turnaround times of these two reporting methods were recorded and compared.
In 39 of 45 cases, digital reports had better turnaround time than faxed paper reports; the other six
cases coincided with periods during which the clinicians were absent and could not access digital
reports. (In these instances, faxed paper reports were reviewed by a covering dermatologist). The
average turnaround time improvement for digital reports was +51.2 hours (range -230.7 to +232.7
hours). Digital reports were also more reliable: in one case, a faxed paper report was physically lost,
and never reviewed by the clinician. There were no electronic reports lost, because the clinician was
alerted and sent another digital report if original report review was not acknowledged within a
week. There was a 100% concordance rate between the data contained within the digital and faxed
paper reports. In conclusion, our wireless database system design greatly improves turnaround time
and delivery reliability over the conventional (faxed report) method. Our software is also easy to use
(mean training time under 45 minutes). Our research, therefore, suggests that there is much poten-
tial for wireless communication in dermatology and pathology, specifically via PDAs and other wire-
less devices. 
0462
Providing dermatological care to the indigent population
GJ Murakawa, R Abdul-Khalek and J Trepte Dermatology, Wayne State University, Detroit, MI
Medicaid is the government-subsidized program for the indigent and disabled population in the
United States, and funds 11.6% of the population. Moreover, an additional 14.6% of the population
in the U.S. is uninsured. Medicaid and indigent care patients pose difficult challenges in dermatol-
ogy clinics, including poor reimbursement, restricted formularies, and the complexity of medical
care. To date, there have been no published manuscripts discussing indigent care and dermatology
in the U.S. We have determined indigent care providers of dermatological services in Detroit, Michi-
gan, and the United States. We surveyed all Michigan dermatologists to determine who provides care
for Medicaid and indigent care services, and received responses from 145 of 249 dermatologists
(58%). Currently, 25.5% of dermatologists see no Medicaid patients and an additional 44.1% see
<1%; fewer dermatologists see these patients now compared to 5 years ago. University Dermatol-
ogy, the faculty practice of Wayne State University, treats the vast majority of this patient cohort,
with Medicaid patients accounting for 40% of the clientele. To determine indigent caregivers nation-
ally, a similar survey was sent to all members of the Association of Professors of Dermatology, and
52/100 responses were received. 78% of programs have state, city, or county hospital-based pro-
grams to absorb the costs of patient care and 42% of programs receive funding to cover faculty
salaries. Of the 10 largest metropolitans, 3 do not have a state, city, or county-based indigent care
program (Detroit, Washington, D.C., and Philadelphia). Indigent care is dispersed among several
programs in Washington, D.C., and Philadelphia, but University Dermatology is the principle care-
giver in metropolitan Detroit. Of the faculty practices, over 27% see <1% indigent patients and 69%
see <5%. In sum, few dermatologists provide substantial indigent care, both in private practice set-
tings and in academic medicine. Many challenges lie ahead in order to properly care for this patient
cohort. 
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Utilization of resources in a practice that provide care to private pay and indigent patients
R Abdul-Khalek, J Trepte and GJ Murakawa Dermatology, Wayne State University, Detroit, MI
Medicaid and indigent care patients pose difficult challenges in dermatology clinics, including poor
reimbursement, restricted formularies, and the complexity of medical care. To date, there has been
a paucity of investigations regarding the care of these patients. We have examined the utilization of
resources by Medicaid and indigent care patients in an office-based dermatology practice that cares
for private pay and indigent patients. Specifically, we have determined no-show rates, incoming calls,
outgoing calls, and physician calls at our practice site, in which state-funded programs cover 40%
of patient visits. During a five-month period, 6594 appointments were analyzed, and the average no-
show rate was 52.4% for all patients. Medicaid patients had a 57% overall no-show rate, in contrast
to non-Medicaid patients who had a 48% no-show rate. A total of 537 incoming calls were sur-
veyed, with 55% from Medicaid patients. The majority of incoming calls were for appointments,
with a disproportionate number of new appointments for Medicaid patients. A total of 397 outgoing
calls were surveyed, with Medicaid patients accounting for 55% of all calls. Most calls, 68%, were
made to confirm appointments. A total of 42 physician calls were surveyed, and 79% of these calls
were made to Medicaid patients. For incoming, outgoing, and physician calls, those to and from
Medicaid patients were longer, and accounted for the majority of calls regarding medication issues
and referrals. Medicaid patients utilize the majority of personnel resources, thereby increasing over-
head costs. Therefore, office-based practices that see a large proportion of Medicaid patients are at
a distinct disadvantage. 
0464
Quality of life and psychological distress in older patients with psoriasis
F Sampogna, C Melchi, P Pasquini, D Abeni and S Improve Epidemiology, IDI-IRCCS, Rome,
Italy
The ageing population is a growing public health concern. Our aim was to describe patterns and lev-
els of quality of life (QoL) and psychological distress in patients with psoriasis aged 60 years or
more. All adults hospitalised at IDI-IRCCS from Feb. 2000 to Feb. 2002 with psoriasis who gave
their informed consent were given the Skindex-29 QoL questionnaire and the 12-item General Health
Questionnaire (GHQ-12). Skindex-29 consists of three scales assessing social functioning, emotional
state, and symptoms. The GHQ-12 measures psychological distress. In both questionnaires higher
scores indicate a worst condition. Clinical severity was measured using PASI and SAPASI. Com-
parisons between groups were made using the Mann-Whitney U test. We studied 936 patients. Of
these, 223 were 60y old. PASI and SAPASI were similar in older and younger (age <60y) patients,
but QoL was significantly more impaired in the older group for all Skindex-29 scales (all p-val-
ues<0.01). Also GHQ-12 scores were significantly higher (p=0.013). Among the older patients,
women had much higher Skindex-29 and GHQ-12 scores, with increases ranging from 28% for the
emotions to 47% for the social functioning scales, all p-values<0.001, while clinical severity did not
differ in the two genders. Duration of disease (cutoff 5 years) did not change scores significantly,
although patients with longer experience of disease had higher scores on the emotions and social
functioning scales. In conclusion, we observed a strong association between older age and poor
QoL and increased psychological distress. Women seemed to suffer a heavier burden of disease.
These observations should alert dermatologists that similar levels of “objective” measures of clini-
cal severity may be associated with significantly different levels of QoL and psychological distress
in patients with psoriasis. Particular attention should be devoted to older patients, and among these,
to women. 
0465
Dermatological care in Chile
PR Figueroa Dermatology, World Dermatology Institute, Santiago, RM, Chile
The aim of the study is to assess the quality of dermatological care in Chile. A Chilean Database of
all dermatologists in the country was consulted, and a rate was calculated using the Chilean Census
data. There are 300 dermatologists in Chile for a population of 15 million people, that is a rate of 1
dermatologist per 50,000 people. Two thirds of the dermatologists are based in Santiago (Metro-
politan area) in which there is a third of the population, with a rate of 1 dermatologist per 25,000
people. In some regions in Chile there is an enormous shortage of specialists. The rate of dermatol-
ogists per population is less than the rate in the US and more than the rate in the UK. An increase in
specialists is required in Chile particularly in rural areas and in some extreme regions in the coun-
try. 
0466
Differences in quality of life of patients with nonmelanoma skin cancer at private and Veter-
ans Affairs clinics
M Chren,1,2 A Sahay,2 L Maddock1 and K Lindquist2 1 San Francisco VAMC, San Francisco, CA
and 2 University of California at San Francisco, San Francisco, CA
We have previously reported that patients with nonmelanoma skin cancer treated in a private setting
were more likely than those treated at a VA clinic to be treated with Mohs surgery, even after con-
trolling for demographic and clinical features that might have affected treatment choice. The goal
of this study is to learn how patients at the VA and private sites differed in the effects of their tumors
on their quality of life before therapy. We performed a prospective cohort study of consecutive patients
with non-recurrent nonmelanoma skin cancer diagnosed over 2 years at two sites, a private faculty
practice (PRIVATE, 837 patients) and the dermatology clinic at the affiliated VA hospital (VA, 540
patients). Data were collected from medical records and patient reports using standardized dataforms.
Skin-related quality of life was measured with Skindex-16; results are reported as 3 subscales: Symp-
toms, and the effects of skin disease on Emotions, and social and physical Functioning. Scores are
reported as values between 0 and 100; higher scores indicate worse quality of life. The response rate
was 60%. Compared with patients at the PRIVATE site, the VA patients reported worse symptoms
from the skin cancer (25 vs 18, p<0.01), and more effect of the skin cancer on their functioning (16
vs. 12, p=0.04), but not on their emotions (40 vs 41, p=0.64). VA patients were less likely than PRI-
VATE patients, however, to be worried about treatment (36 vs 42, p=0.01) or to be concerned about
scarring (24 vs. 32, p<0.01). Finally, compared to PRIVATE patients, VA patients reported that the
condition of their skin was less important to their overall quality of life (36% very or extremely
important, compared to 48%, p<0.01). We conclude that although nonmelanoma skin cancers affected
the quality of life of patients at the VA more than at the PRIVATE site, patients at the PRIVATE site
were more worried about treatments and scarring. This difference may have affected the choice of
treatments by clinicians at the two sites. 
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Transcription analysis of human peptidylarginine deiminase type I and type III genes
S Dong,1 T Kanno,1 A Kawada,2 T Tezuka2 and H Takahara1 1 Applied Biological Resource
Science, School of Agriculture, Ibaraki University, Inashiki-gun, Ibaraki, Japan and 2
Dermatology, Kinki University School of Medicine, Osaka-Sayama City, Osaka, Japan
Peptidylarginine deiminase (PAD) catalyzes the conversion of arginine residues to citrulline residues
in the presence of calcium ion. At least four isoforms types have been identified. The type II and IV
are widely expressed in various tissues. The type I is detected only in the epidermis and uterus. The
type III is present only in the hair follicle and epidermis. The gene of type III closely links to the
type I on human chromosome 1. In order to further define PAD regulation and function, we have
isolated and characterized the promoter of the structural genes of type I and III. Screening of human
genomic libraries and combining to PCR with human genomic DNA resulted in the isolation of 2.8
kb type I and 2.4 kb type III sequence upstream the translation start site. Deletion analysis in nor-
mal human epidermal keratinocytes (NHEKs), HaCat, COS-7 and HeLa cells identified a critical
region for type I promoter activity between -106 and -156. -94/-276 region was required for normal
activity for type III. Analysis of binding sites deletion imply that myeloid zinc finger 1 (MZF1) and
stress-response element (STRE) are critical cis-element for type I promoter activity, but CCAAT-
box and SP1 cis-element are required for type III. The time-course with transfer promoter-luciferase
vector of type I and III to different subculture cells of NHEK also revealed that regulation patterns
were different between type I and III. Our results indicate that the transcription of PAD type I and
III are regulated by different factors, although both of them are expressed in the skin. 
0468
Cystatin M/E deficiency in mice causes faulty cornification and impaired barrier function
P Zeeuwen,1 I van Vlijmen-Willems,1 W Hendriks,2 G Merkx3 and J Schalkwijk1 1 Dermatology,
University Medical Center, Nijmegen, Gelderland, The Netherlands, 2 Cell Biology, University
Medical Center, Nijmegen, Gelderland, The Netherlands and 3 Human Genetics, University
Medical Center, Nijmegen, Gelderland, The Netherlands
Cystatin M/E (CST6), a new member of the cystatin gene family, has a restricted expression pattern
in humans, which is largely limited to cutaneous epithelia. Although cystatin M/E possesses two
distinct biochemical properties, being a cysteine proteinase inhibitor and a substrate for transgluta-
minase, its physiological function is unknown. We isolated and characterised the mouse Cst6 ortho-
logue and mapped the gene to the proximal end of mouse chromosome 19. This region corresponds
to the locus of the spontaneous harlequin ichthyosis (ichq) mouse mutation, for which no causative
gene has been identified sofar. We found a nonsense mutation in the Cst6 gene of BALB/cJ-ichq/+
mice, which precludes the synthesis of functional protein. Immunohistochemistry confirmed the
absence of cystatin M/E at the protein level in phenotypically mutant mice. Mice that are homozy-
gous for two null alleles display a hyperplastic, hyperkeratotic epidermis and abnormal hair folli-
cles, and die between 5 and 12 days of age. As skin is the main site of cystatin M/E expression we
surmise that disturbed epidermal homeostasis is a probable cause of death in these mutant mice.
From day 5 onwards, homozygous mutant mice have decreased body weights compared to controls.
In addition, we demonstrated highly increased levels of transepidermal water loss in phenotypically
mutant mice, which make it very likely that these mice die of dehydration. In wild-type mice, cys-
tatin M/E was found in the stratum granulosum and in the infundibulum of the hair follicle indicat-
ing that the anatomical site in the skin where cystatin M/E is normally expressed correlates with the
abnormalities at the tissue level in mutant mice. Our data provide evidence that cystatin M/E is essen-
tial for correct formation of cornified layers, intact barrier function, and viability. 
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In vivo fluorescence confocal microscopy of skin in the transgenic green fluorescent protein
mouse
L Swindle, C Moricz, J Wolchok, K Busam and A Halpern Memorial Sloan Kettering Cancer
Center, New York, NY
In this study we describe the microscopic architecture of transgenic green fluorescent protein (GFP)
mouse skin, as viewed in vivo using a hand held fluorescence confocal microscope. Additionally,
the in vivo morphology of an induced inflammatory response imaged with the same system is pre-
sented. Transgenic GFP mouse (C57BL/6-TgN (ACTbEGFP)10sb) skin (ear and abdomen) was
imaged in vivo with a miniaturized fluorescence confocal microscope system (Stratum, Optiscan Pty
Ltd). GFP was excited with 488nm light and fluorescent emission was detected at >505nm. The
imaged sites were biopsied and cryosectioned. The in vivo images were correlated with ex vivo flu-
orescence microscopy and conventional histology. An immune modulator (imiquimod 5%), was top-
ically applied to the ear and abdomen for 24 hours with occlusion to induce an inflammatory response.
After treatment, the skin sites were imaged with the in vivo confocal system and again biopsied for
cryosectioning. The in vivo images were correlated with ex vivo fluorescence microscopy, conven-
tional histology, and immunohistochemistry utilizing CD11c antibody to identify dendritic cells.
On in vivo confocal imaging, keratinocytes, hair follicles, sebaceous glands and blood vessels dis-
played bright fluorescent emission, allowing them to be clearly viewed. In addition, fat and chon-
drocytes in the subcutaneous layer of the ear were observed to display a strong fluorescent signal.
In vivo confocal imaging of imiquimod treated skin showed a new population of cells, some with
dendritic morphology, in the deep epidermis and dermis. Conventional histology confirmed a pop-
ulation of inflammatory cells in the dermis, and CD11c antibody immunostain confirmed the pres-
ence of mouse dendritic cells. Real-time imaging of transgenic GFP mouse skin with a handheld
fluorescence confocal microscope provides a unique model for the study of mouse skin in vivo. Fur-
thermore, the ability to monitor a dynamic process in vivo has been demonstrated. 
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Hoxb13 knockout adult skin displays fetal-like characteristics and enhanced wound healing
JA Mack,1,4 SR Abramson,1,2 Y Ben,1 JC Coffin,1 JK Rothrock,1 EV Maytin,3,4 VC Hascall,3
C Largman5 and EJ Stelnicki2 1 Research, Cleveland Clinic Florida, Fort Lauderdale, FL, 2 Dental
Medicine, Nova Southeastern University, Ft. Lauderdale, FL, 3 Biomedical Engineering,
Cleveland Clinic Foundation, Cleveland, OH, 4 Dermatology, Cleveland Clinic Foundation,
Cleveland, OH and 5 Dermatology and Medicine, VA Medical Center and University of California,
San Francisco, San Francisco, CA
The purpose of this study was to determine if eliminating Hoxb13 function in adult skin would
enhance wound healing. Compared to adult skin wounds, fetal skin wounds made early in gestation
heal faster and with no scar. Two important factors implicated in fetal scarless wound healing are
the degree of differentiation and the higher levels of hyaluronan (HA) present in fetal skin and wounds.
HA is thought to inhibit differentiation. Hoxb13, a member of the highly conserved family of Hox
transcription factors, is expressed in fetal and adult skin. Its expression is significantly downregu-
lated in fetal wounds that heal without a scar compared to adult wounds. We postulated that elimi-
nating Hoxb13 from adult skin could improve wound repair. To test this, we evaluated adult skin
wounds in a Hoxb13 knockout (KO) mouse line. Tensiometry was used to measure the breaking
strength of incisional wounds. Overall, Hoxb13 KO wounds were stronger than wild-type (WT).
Histological evaluation indicated that Hoxb13 KO incisional wounds healed faster and with less
scar. Hoxb13 KO excisional wounds closed at a faster rate compared to WT. We determined that
Hoxb13 KO adult skin has higher levels of HA and reduced expression of several differentiation
markers as shown by biochemical and microarray analyses, respectively. We conclude that one
function of Hoxb13 in adult skin is to promote differentiation. We further propose that loss of Hoxb13
function in skin results in a more fetal-like state, and one consequence of this is improved wound
healing. 
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Role of AHNAK/desmoyokin in skin development and function
M Kouno,1,2 Y Takahashi,1 N Ishii,1 J Takeda2 and T Hashimoto1 1 Dermatology, Kurume University
School of Medicine, Kurume, Fukuoka, Japan and 2 Environmental Medicine, Osaka University
Medical School, Suita, Osaka, Japan
Desmoyokin was first isolated from bovine muzzle epidermis and thought to be an epidermal desmo-
some related protein. We previously demonstrated that desmoyokin gene is identical to AHNAK
gene which is expressed ubiquitously and down-regulated in neuroblastomas. According to various
in vitro experimental studies, AHNAK/desmoyokin was expected to be associated in epidermal cell
adhesion, signal transduction pathway of cell proliferation and differentiation, tumorigenesis, and
embryonic development, but no evidence have been revealed by means of in vivo experiments. In
order to investigate the functional roles of AHNAK/desmoyokin in vivo, we generated a null muta-
tion in mice. Southern analysis and immunoprecipitation analysis indicated that AHNAK/desmoyokin
was successfully disrupted. Mutant mice were viable and fertile and showed no gross developmen-
tal abnormalities. Integrity of the skin appeared normal in mutant mice. Electron micrographs of skin
sections revealed that the ultrastructure of cell-cell junction including epidermal desmosomes in
mutant mice were indistinguishable from that of wild-type animals. No tumorigenesis has been
observed in mutant mice up to 12 months of age. Therefore, we concluded that AHNAK/desmoyokin
is not essential for epidermal cell adhesion, and that AHNAK/desmoyokin deficiency has minimal
effect against cellular proliferation and differentiation process, tumorigenesis, and developemental
process in vivo. Recently, AHNAK/desmoyokin was shown to be immunoprecipitated with mono-
clonal antibody specific to a 3.7 million huge protein named of titin which shares structural simi-
larities with AHNAK/desmoyokin. That report and our results supposed that titin might largely com-
pensate for the lack of AHNAK/desmoyokin. 
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Phenotypical characterization of transit amplifying cells in normal human epidermis
M Franssen, P van de Kerkhof and P van Erp Dermatology, University Medical Center, Nijmegen,
Gelderland, The Netherlands
The epidermis contains two types of proliferative keratinocytes: stem cells with unlimited self-renewal
capacity and their daughters, transit amplifying cells, which have a more restricted proliferative
potential and high probability of undergoing terminal differentiation. The identification and isola-
tion of stem cells and their progeny is critical to our understanding of their growth regulation dur-
ing homeostasis, wound healing and disease. Using fluorescence-activated cell sorting (FACS),
immunohistochemistry and in vitro studies, we aspired a more precise isolation and characterisation
of transit amplifying cells, which could clarify their role in hyperproliferative skin disorders. Com-
paring stem cell and transit amplifying cell-enriched fractions derived from normal skin biopsies,
we addressed the question whether differences in growth behaviour and expression patterns could
be demonstrated. Keratinocyte fractions were FACS enriched for stem or transit amplifying cells on
the basis of β1- integrin expression and cultured on cover slips to allow characterisation of individ-
ual colonies. Subsequently, immunohistochemistry was used to examine the expression pattern of
cell surface markers (β1-, α6- integrin, transferrin receptor), keratinocyte differentiation (cytoker-
atin 10 and 6) and proliferation markers (Ki-67 antigen). Culturing keratinocytes on cover slips
proved beneficial with respect to morphological characterisation of individual colonies, and sug-
gested differential growth behaviour of colonies from β1-integrin bright and dim keratinocytes derived
from normal skin. Furthermore, remarkable differences were found with respect to expression pat-
terns of cytokeratin 10 and 6 in stem cell or transit amplifying cell enriched fractions. We propose
that these findings can be of relevance for further studies on transit amplifying cells and their role
in hyperproliferative skin disorders. 
0470
Phospholipase B expression in human epidermis
E Maury,1,2 MC Prevost,2 D Redoules,1 M Charveron1 and A Gassama-Diagne2 1 CERPER, Institut
de Recherche Pierre Fabre, Toulouse, France and 2 LML, Centre de Physiopathologie de Toulouse
Purpan, Toulouse, France
Phospholipase B (PLB) is an enzyme that can remove both sn-1 and sn-2 fatty acids of glyc-
erophospholipids and thus displays phospholipase and lysophospholipase activities. Analysis of
human epidermis homogenates indicated the presence of a 97 kDa PLB protein, being enriched in
the soluble fraction. Immunolabelling and in situ hybridization experiments showed that this enzyme
is expressed in the different layers of epidermis with an accumulation at the dermo-epidermis junc-
tion. RT-PCR data indicated that PLB is specifically expressed in natural and reconstructed epider-
mis and not in keratinocytes in culture suggesting a role in differentiation process. Using 3-RACE-
PCR and screening of human genome databases, we obtained a 3600 bp cDNA coding for human
PLB that share 74% identity with guinea pig PLB. Altogether, our results provide the first charac-
terization of human homologue of PLB. This enzyme should play an important role in the genera-
tion of free fatty acids involved in the epidermal barrier function. 
0474
Adipogenic hormones differentially regulate lipogenesis in human sebocytes and keratinocytes
D Thiboutot, K Gilliland and Z Cong Dermatology, Penn State University, Hershey, PA
An understanding of the factors that regulate sebaceous gland lipogenesis is key to the discovery of
drugs designed to reduce sebum production and improve acne. The adipogenic hormones
methylisobutylxanthine, dexamethasone and insulin (MDI) are known to promote the differentiation
of preadipocytes into adipocytes, a process that is accompanied by an increase in cell volume and
lipid synthesis. Adipocyte differentiation in turn is accompanied by an increase in the expression of
the peroxisome proliferator-activated receptor gamma (PPARg). The PPARs are expressed in human
skin and sebaceous glands. The goal of this study is to test the hypothesis that adipogenic hormones
induce lipogenesis in human sebocytes and that this process is accompanied by changes in the expres-
sion of PPARs. SV40-transfected human sebocytes (SEB-1 cells) were treated with MDI medium
or basal medium for 3 days, followed by analysis of 14C-acetate incorporation into neutral lipids
and uptake of 14C-oleic acid from the medium. Parallel experiments were performed in a sponta-
neously immortalized human keratinocyte line (HaCaT). Treatment of cells with MDI resulted in a
significant increase in the incorporation of acetate into neutral lipids in SEB-1 sebocytes compared
to HaCaT keratinocytes. When compared to basal medium, MDI significantly increased the incor-
poration of acetate into cholesterol, triglycerides, and cholesterol esters in both SEB-1 cells and
HaCaT cells. In SEB-1 cells, but not HaCaT keratinocytes, MDI treatment significantly increased
the incorporation of acetate into wax esters, a lipid class characteristic of sebocytes. MDI treatment
significantly increased the uptake of fatty acids by SEB-1 cells compared to basal medium. These
data further substantiate the hypothesis that sebocytes and adipocytes share common regulatory influ-
ences whereas sebocytes and keratinocytes respond differently to adipogenic stimuli. Further eluci-
dation of the mechanisms regulating sebaceous gland differentiation may provide a rationale for the
role of PPAR ligands in this process. 
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pH directly regulates epidermal permeability barrier homeostasis and stratum corneum
integrity/cohesion
JP Hachem,2,1 D Crumrine,2 JW Fluhr,2 BE Brown ,2 KR Feingold 2 and PM Elias2 1 Dermatology
Research, University of California, San Francisco and 2 Dermatology, AZ-VUB, Brussels, Belgium
Both exposure of stratum corneum (SC) to neutral pH buffers and blockade of acidification mech-
anisms, disturb cutaneous permeability barrier homeostasis and SC integrity/cohesion, but these
approaches all introduce potentially confounding variables. To study the consequences of SC neu-
tralization, independent of hydration, we applied two chemically-unrelated superbases, 1,1,3,3-
tetramethylguanidine (TMG) or 1,8-diazabicyclo [5,4,0] undec-7-ene (DBU), and assessed whether
discrete pH changes alone regulate cutaneous permeability barrier function and SC integrity/cohe-
sion, as well as the responsible mechanisms. Both TMG and DBU applications increased skin sur-
face pH in parallel with abnormalities in both barrier homeostasis and SC integrity/cohesion. The
latter was attributable to rapid activation (< 20 min) of serine proteases (SP), assessed by in situ
zymography, followed by SP-mediated degradation of corneodesmosomes (CD). Western blotting
revealed degradation of desmoglein 1, a key CD structural protein, in parallel with loss of CD. Co-
application of SP inhibitors with the superbase prevented the abnormality in SC integrity /cohesion.
The superbases also delayed permeability barrier recovery, attributable to decreased &#61538;-glu-
cocerebrosidase activity, assessed zymographically, resulting in a lipid processing defect on electron
microscopy. These studies demonstrate unequivocally that SC neutralization alone provokes SC func-
tional abnormalities, including aberrant permeability barrier homeostasis and decreased SC
integrity/cohesion, as well as the mechanisms responsible for these abnormalities. 
0476
A sustained increase in stratum corneum pH alone alters SC function
JP Hachem,2,1 M Man,1 D Crumrine,1 Y Ushida,1 BE Brown,1 KR Feingold 1 and PM Elias1 1
Dermatology Research, University of California, San Francisco, CA and 2 Dermatology, AZ-VUB,
Brussels, Belgium
The acidic nature of mammalian stratum corneum (SC) has been appreciated for more than a cen-
tury. Recent data, based on mouse models of SC alkalization (exposure to alkaline buffers and acid-
ification pathways inhibitors), suggest that an acute increase in SC pH provokes alteration in skin
barrier homeostasis and SC integrity/cohesion. To assess the functional outcomes of prolonged SC
neutralization on epidermal barrier homeostasis we applied a superbase, 1,1,3,3-tetramethylguani-
dine (TMG) twice daily for 5 consecutive days. Using this approach, we assessed whether pH changes
alone alter cutaneous permeability barrier function and SC integrity/cohesion, as well as the meta-
bolic basis for such alterations. A sustained neutralization of SC pH was paralleled by abnormali-
ties in both barrier homeostasis and SC integrity/cohesion attributable to an increase in serine pro-
tease (SP) activation visualized by in situ zymography. Quantitative electron microscopy and western
blot analysis demonstrate a decrease in CD density and degradation of desmoglein 1 (DSG1), a key
constituent of CDs, respectively. Also, superbase daily application induced alterations in perme-
ability barrier homeostasis paralleled by a decrease in beta-glucocerebrosidase (beta-GlcCerase)
activity due to a decrease in enzyme mass. Co-application of STI prevented the decrease in beta-Glc-
Cerase mass and the abnormality in barrier function. Finally, the activation/release of primary
cytokines, TNF-alpha, IL-1alpha and beta and IL-1ra, observed following SC sustainable neutral-
ization was successfully overridden by STI treatment. In conclusion, sustained SC neutralization
alone can provoke functional abnormalities mediated by the activation of SP, including decreased
SC integrity/cohesion, impaired permeability barrier homeostasis, and the activation/release of
cytokines. 
0477
Unsaturated fatty acids cause parakeratosis by inducing cornification in the middle layer of
epidermis
Y Katsuta and S Inomata Life Science Research Center, Shiseido Research Center, Yokohama,
Kanagawa, Japan
Unsaturated fatty acids, such as oleic acid, in sebum are known to be irritative and are considered
to be one of the causes of comedo. Our observations suggested that unsaturated fatty acids might
also be a cause of noticeable facial pores. Many parakeratotic corneocytes were detected around
facial pores, and topical application of unsaturated fatty acids to human or mouse skin induced parak-
eratosis. In order to clarify the mechanism of induction of parakeratosis by unsaturated fatty acids,
we applied oleic acid to hairless mouse back skin, and differentiation markers were analyzed histo-
logically. Cornified envelope formation was examined using an in situ transglutaminase (TGase)
activity assay. The activity was detected in the middle layer of epidermis of oleic acid-treated skin,
whereas it was restricted to the granular layer in normal skin. Localization of the enzyme in the
middle layer of the epidermis was also confirmed immunohistologically. On the other hand, TUNEL-
positive cells were observed only in the granular layer in both oleic acid-treated skin and normal
skin. This indicated that loss of nuclei in terminal differentiation of keratinocytes was restricted to
the granular layer even in thickened epidermis treated with oleic acid. These results suggest that
topical application of oleic acid induced formation of cornified envelope in the middle layer of the
epidermis without loss of nuclei, and this led to parakeratosis. 
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The metabolism of phytosphingosine in human keratinocytes
Y Takagi, T Yaginuma, T Kitahara and Y Takema Biological Science Laboratories, Kao
Corporation, Haga-Gun, Tochigi, Japan
Natural ceramides have various sphingoid bases. Mammals take in these ceramides, not only those
with a sphingosine base but also those with a phytosphingosine base, in their diet. However, most
mammalian organs have ceramides only with a sphingosine base but not with a phytosphingosine
base. As an exception, ceramides in the epidermis have three types of sphingoid base, sphingosine,
phytosphingosine, and dihydrosphingosine. Although all these types of ceramides can be converted
to sphingoid by epidermal ceramidase, the sphingoid in the stratum corneum is mainly composed
of sphingosine and contains very little phytosphingosine. Although much is known about sphin-
golipid metabolism, little is known about the metabolism of phytosphingosine in mammals. In this
study, we have examined the metabolism of sphingolipids to clarify whether human keratinocytes
can metabolize phytosphingosine. Cultured human keratinocytes take up most of the applied phy-
tosphingosine within 1 hour as well as they do sphingosine. Within 24 hours, most of that phy-
tosphingosine disappears, and less than half of the sphingosine remains in the cells as the free form.
Surprisingly, an increase in free sphingosine or sphinganin in keratinocytes was observed following
the uptake of phytosphingosine. From these results, human keratinocytes appear to take up phy-
tosphingosine actively and convert at least part of that into sphingosine. Analysis of sphingolipids
in the keratinocytes revealed an increase in ceramide and glucoslyceramide with the sphingosine
base following incubation with sphingosine. In contrast, incubation with phytosphingosine increases
the ceramides and glucosylceramides with the phytosphingosine base more than with the sphingo-
sine base. These conversions were observed with a peak around 1 hour after application. These data
suggest that keratinocytes take up phytosphingosine actively and metabolize that to other sphin-
golipids relatively quickly. 
0479
C1orf10, a novel marker of late terminal keratinocyte differentiation
R Contzler, M Uhlmann, R Panizzon, M Huber and D Hohl dermatology, CHUV, Lausanne, Vaud,
Switzerland
The epidermal differentiation complex (EDC) on human chromosome region 1q21 contains three
clustered families of genes encoding: (a) precursor proteins of the cornified cell envelope (involu-
crin, loricrin, SPRRs, xp5/LEP proteins) characterized by short tandem peptide repeats, (b) S100
proteins containing Ca2+-binding EF-hands and (c) the fused gene family (profilaggrin, trichohyalin,
repetin, hornerin) combining both characteristics. Recently, a novel gene C1orf10 with esophageal
expression has been reported but its genomic and structural characteristics as a fused gene of the
EDC were not recognized. The C1orf10 gene has 3 exons, the first untranslated, and a protein prod-
uct of 495 aa with a N-terminal Ca2+-binding motif of 90 aa and two consecutive repeats sequences
of 60 aa. Here we identified expression of C1orf10 transcripts in fetal bladder, scalp, foreskin and
in cultured keratinocytes by RT-PCR analysis. C1orf10 specific antibodies were raised against syn-
thetic peptides in rabbits and affinity purified. SDS-PAGE and Western blot analysis revealed a pro-
tein of 57 kDa in the cytoskeletal fraction of sequentially extracted foreskin. Immunofluorescence
microscopy revealed a punctate staining in the granular layer of the epidermis and in mucosal epithe-
lia. To investigate the subcellular localization and to understand the function of the C1orf10 protein
and its domains, different GFP fusion constructs were generated in the mammalian expression vec-
tor pEGFP. HeLa cells transfected with these constructs showed a diffuse cytoplasmic distribution
of the protein except for C1orf10 ∆EF which exhibited a granular pattern while EF-hand alone
localised similarly to that of GFP control. This suggests that N-terminus of C1orf10 differs from the
function of the profilaggrin B domain which localises primarily to the nuclear compartment. This is
consistent with the absence of a known nuclear localisation signal in C1orf10. In conclusion, C1orf10
is a novel marker of late epidermal differentiation and mainly located in the cytoplasm of granular
cells in the epidermis and mucosal epithelia. 
0480
Lamellar granule proteins are sequentially synthesized and transported through the trans-Golgi
network in keratinocytes
A Ishida-Yamamoto,1 S Yoshida,2 TJ O’Brien,3 G Serre,4 M Simon4 and H Iizuka1 1 Dermatology,
Asahikawa Medical College, Asahikawa, Japan, 2 Anatomy, Asahikawa Medical College,
Asahikawa, Japan, 3 Obstetrics and Gynecology, University of Arkansas for Medical Science,
Little Rock, AR and 4 Epidermis Differentiation and Rheumatoid Autoimmunity, U563INSERM-
University of Toulouse III, Toulouse, France
Lamellar granules (LGs) are small, membrane-bound organelles of the epidermis. Several reports
have suggested that LGs originate from Golgi apparatus. LGs contain lipids and several proteins
including corneodesmosin (Cdsn), kallikrein (KLK) 7, KLK8 and elafin. Differences in the timing
and position of LG protein synthesis, and whether these are sorted into different granules or are trans-
ported into a single type of granule remain unknown. To address these questions, we studied LG
protein localization in human epidermis using specific antibodies. Confocal laser scanning microscopy
revealed that these proteins were co-localized with TGN46, a glycoprotein found primarily in the
trans-Golgi network (TGN). Cdsn, KLK7 and KLK8 were all expressed in the superficial epidermis
of normal and psoriatic skin. Elafin was not expressed in normal epidermis, but was expressed in
psoriatic epidermis. In normal skin, Cdsn was the first to be expressed, before KLK7 and KLK8,
whereas in psoriatic skin elafin was the first one. Immunoelectron microscopy revealed that LGs
were part of the TGN. There was a definite but incomplete compartmentalization of each protein in
the TGN; fusion of some compartments and even close association of different molecules were
observed, indicating that different LG proteins share a trafficking system. The present study pro-
vided strong evidence for the sequential synthesis and trafficking of various LG proteins through
TGN and heterogeneity in LG contents. 
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Three-dimensional analysis of human epidermal structure from in vivo confocal microscopic
images
T Kuwahara,1 T Yamashita,1 Y Masuda,1 M Takahashi,1 J Wang,2 H Saito2 and S Ozawa2 1 Shiseido
Research Center (Shin-Yokohama), Yokohama, Japan and 2 Science and Technology, Keio
University, Yokohama, Japan
In vivo confocal laser scanning microscopy (CLSM) has made it possible to observe non-invasively
the inside of living human skin, mainly epidermal layers. We have developed a method to reconstruct
the three-dimensional (3D) structure of the epidermis from a sequence of automatically obtained
confocal images. A new image analysis method of 3D edge detection and 3D reconstruction based
on the Snakes method was used. The Snakes method1) is to evolve a curve, which consists of initial
broadly positioned control points on the image, through an image-derived energy-minimization
process so that it ultimately conforms to the feature of interest, such as the dermo-epidermal junc-
tion. To analyze the volumetric confocal images, we have developed the 3D Snakes method, which
uses the same image-derived energy functions as the Snakes model, but deforms them into 3D
space. This new method makes it possible to detect the area of epidermis automatically and to visu-
alize the precise structure of the epidermis, which consists of the surface of the stratum corneum
and the dermo-epidermal junction. This 3D reconstruction of the epidermal structure allows us to
analyze the thickness of the epidermis and the undulation of the dermo-epidermal junction in detail.
Our study of the structural variations of the epidermis in normal skin with this method revealed sub-
stantial differences between subjects of different ages, and between males and females, not only visu-
ally, but also quantitatively. Furthermore, detection of melanins, which appear as characteristically
bright reflective clusters in the confocal images, was investigated to elucidate the 3D distribution of
melanins within the epidermis. We conclude that in vivo CLSM will be a very useful tool for the
precise 3D analysis of epidermal structure. 
0483
Melanocortin 5-receptor: a marker of human sebocyte differentiation in vitro
W Li, L Zhang, M Anthonavage and M Eisinger Skin Reserch Center, Johnson & Johnson CPWW,
Skillman, NJ
Evidence for Melanocortin 5-Receptor (MC5-R) expression in human sebaceous glands and cultures
has been reported by Thiboutot et al., (2000), while studies by Bohm et al., (2002) failed to show
MC5-R expression in immortalized SZ 95 sebocytes. Since MC5-R has been shown to play a role
in sebum regulation in mice (Chen et al, 1997) we examined human sebocytes in primary cultures
and analyzed the correlation between sebaceous cell maturation, resulting lipid granule formation,
and MC5-R expression. Sebocytes derived from human facial skin were induced to differentiation
by melanocyte stimulating hormone (MSH) or cholera toxin. Melanocortin 5-R expression was
detected by immunostaining in cells 24-48 hours prior to the appearance of lipid droplets in their
cytoplasm and remained expressed in differentiated sebocytes, fully lipid laden. The immunoreac-
tivity was completely removed by absorption with the immunizing peptide. In addition, using RT-
PCR, presence of MC5-R was documented in differentiating sebocytes, but not in non-induced cul-
tures. To establish whether a correlation between visual observation of lipid granules and sebaceous
lipid production exists, a comparative examination of neutral lipids in cultured cells was performed.
Analysis of 14C labeled lipids by high performance thin layer chromatography showed: 1) squalene
and wax esters to be detectable only in differentiated cultures; 2) an increase in sebaceous neutral
lipids (cholesteryl esters, and triglycerides) in differentiated versus undifferentiated cells. Our stud-
ies show that sebocytes in culture can be induced to differentiate into sebaceous lipid producing cells,
displaying prominent lipid granules in their cytoplasm. The data also suggest that MC5-R can be
detected both in early and late stages of sebocyte differentiation. Since MSH, the agonist for MC5-
R can induce sebocyte differentiation, our results suggest involvement of MC5-R in human sebo-
genesis. 
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Flotillas of lipid rafts in transit amplifying cell-like keratinocytes
R Gniadecki and B Bang Department of Dermatology, Bispebjerg Hospital, Copenhagen, Denmark
Lipid rafts are dynamic membrane microdomains enriched in cholesterol and sphingolipid. Since
many membrane proteins (e.g. growth factor receptors) partition into rafts, these structures play a
crucial role in the regulation of a variety of cellular processes, such as proliferation, apoptosis and
cell motility. We have previously described that large lipid raft aggregates are readily detectable on
cultured keratinocyte cell line HaCaT by staining with the fluorescein-tagged cholera toxin (CTx-
FITC). In this paper we adopted this method for the detection of lipid rafts in human epidermis and
keratinocytes in culture. The double labelling with CTx-FITC and CD29 (β1 integrin) antibody
showed the non-overlapping clusters of basal cells: CD29dimCTx-FITCbright cells in the deep rete
ridges and CD29brightCTx-FITCdim cells at the tips of dermal papillae. A similar patchy, non-over-
lapping staining pattern was observed in vitro in confluent cultures of normal human keratinocytes
and HaCaT cells, further confirming the inverse relationship between the expression of β1 integrin
and the presence of lipid raft aggregates in the membranes. Studies on keratinocyte proliferation in
vitro by means of labelling with bromodeoxyuridine and antibodies against cyclin E and Ki67 revealed
that the CTx-FITCbright cells are mitotically active whereas a large proportion of CTx-FITCdim cells
are quiescent. We conclude that the epidermal stem-like cells, previously shown to occupy the tips
of dermal papillae and to exhibit high density of membrane β1 integrin have a low content of lipid
rafts. In contrast, the putative transit amplifying cells in deep rete ridges show an enrichment in lipid
rafts. Thus, lipid rafts may be a factor controlling the mitotic activity of epidermal keratinocytes and
possibly the differentiation of stem cells into the transit amplifying cells. 
0484
Epidermal dopamine receptors contribute to skin barrier homeostasis
S Fuziwara, K Inoue and M Denda Skin Biology Research Labs., Shiseido Research Center,
Yokohama-shi, Kanagawa-ken, Japan
Dopamine is a neurotransmitter and five subtypes of G protein-coupled receptors execute dopamin-
ergical action in nerve cells. Especially, the dopamine receptors D2 (DRD2), D3 (DRD3) and D4
(DRD4) play important roles in neuronal activity by down-regulating the intracellular cAMP sig-
naling pathway. In the present study, we demonstrated the expression of dopamine receptors in the
epidermis and their functional contribution for epidermal barrier homeostasis. The immunohisto-
chemical study showed the localization of DRD2 in the basal layer and that of DRD4 in stratum
granulosum of epidermis of both human and hairless mouse. RT-PCR also revealed the transcrip-
tion of DRD2 and DRD4 genes in cultured human keratinocytes and hairless mouse epidermis. In
hairless mice, topical application of Bromocriptine, known as a common agonist for both DRD2
and DRD4, accelerated the epidermal barrier recovery after barrier disruption by tape stripping and
it also reduced epidermal hyperplasia induced by acetone treatment under a low environmental humid-
ity. On the other hand, topical application of the DRD2-specific antagonist L-741,626, delayed bar-
rier recovery and enhanced epidermal hyperplasia. These results suggest that epidermal DRD2 and/or
DRD4 is associated with epidermal barrier homeostasis. 
0482
Unsaturated fatty acids in sebum cause parakeratosis around facial pores
Y Katsuta, T Iida, S Yoshida and S Inomata Life Science Research Center, Shiseido, Yokohama,
Kanagawa, Japan
Noticeable pores are one of the facial characteristics that concern women of various ages. Because
little is known about such facial pores, the physiological characteristics of the cheek skin of healthy
women volunteers were investigated. The volunteers were classified into three groups according to
apparent facial pore size. The group with larger pores was found to have more parakeratotic cor-
neocytes and higher transepidermal water loss (TEWL) values. This suggests that women with large
facial pores may have immature corneocytes. The group with larger pores was also found to have
larger amount of sebum, especially unsaturated free fatty acids such as palmitoleic acid (16:1) and
oleic acid (18:1). Corneocytes were obtained from human facial skin by a tape-stripping method
and nucleosomes were stained with Hoechst 33342. Parakeratotic corneocytes were mostly found
around sebaceous ducts which had the appearance of cone-shaped hollows containing sebum. We
applied sebum components to mouse skin, and found that unsaturated fatty acids induced signifi-
cant parakeratosis, whereas other components, such as saturated fatty acids, triolein and squalene,
had little effects. These results suggested that unsaturated fatty acids in sebum cause parakeratosis
around sebaceous ducts, and this might lead to noticeable facial pores. 
0486
Influx of calcium and chloride ions into epidermal keratinocytes regulates skin water imper-
meable barrier homeostasis
M Denda, K Inoue and S Fuziwara Shiseido Research Center, Yokohama, Japan
In the nervous system, influx of calcium and chloride ions into neurons regulates the signaling sys-
tem by exitation and inhibition, respectively. In the present study, we demonstrated the effects of the
ion influx into epidermal keratinocytes in the water impermeable barrier repair process of the skin
after its damage. Topical application of the excitatory neurotransmitters, glutamate and nicotine,
which activate the calcium channel, delayed the barrier repair after tape stripping. On the other
hand, the inhibitory neurotransmitter, GABA and glycine, which activate the chloride channel, accel-
erated the barrier repair. Topical application of the calcium ionophore, ionomycine, delayed the bar-
rier recovery and chloride ionophore 1 accelerated the barrier repair after the barrier disruption by
tape stripping and acetone treatment. Ionomycine increased the intracellular calcium ion concen-
tration in the cultuted keratinocyte while the chloride ionophore 1 increased the intracellular chlo-
ride ion concentration. Light microscopic and electro-microscopic observation showed the acceler-
ation of the exocytosis of the lipid-containing lamellar body by the chloride ionophore 1 and the
delay of the exocytosis by ionomycine. These results suggest that like the nervous system, influx of
calcium and chloride ions into the epidermal keratinocytes plays a crucial role in cutaneous barrier
homeostasis. 
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The effect of increased gravitational forces on human keratinocytes
K Yokota, M Ota, H Nakamura, T Onozuka, K Matsumura, D Sawamura and H Shimizu
Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan
Keratinocytes constitute the outermost layer of human skin. Many kinds of stresses including tem-
perature, mechanical force, gravity, and osmotic pressure from the surroundings may affect ker-
atinocyte growth and differentiation in vivo. Among those stresses, the effect of gravitational forces
on keratinocytes has yet to be fully elucidated. The aim of this study is to examine the effects of grav-
itational force on human keratinocytes. A human keratinocyte cell line, HaCaT cells were cultured
under standard conditions with or without pulsed application of centrifugal force. We used a simple
tabletop centrifuge to apply a centrifugal force to HaCaT cells, and applied approximately 40G for
30 minutes every 24 hours. After 4 days, the pulsed centrifugal force induced a maximum 20%
increase in proliferation as determined by the CellTiter 96(Promega, Madison, WI) assay. To deter-
mine the mechanism of this centrifugal force-induced keratinocyte proliferation, we conducted PCR-
based, cDNA subtraction analysis. Total RNA was prepared from HaCaT cells after 4 days’ culture
with or without centrifugal force treatment. Full-length cDNAs were amplified using a PCR-based
SMART&#65533;system (Clontech, Palo Alto, CA). Using these full-length cDNAs, subtractive
hybridization was performed to determine the genes which were induced by centrifugal force using
PCR-Select&#65533;cDNA subtraction kit (Clontech, Palo Alto, CA). A total of 300 subtracted
cDNA clones were analyzed by differential hybridization, and several candidate genes with up reg-
ulated expression were identified. 
0488
The cathelicidin antimicrobial peptide LL-37 induces proliferation of epithelial cells
M Stahle-Backdahl,1 JD Heilborn1 and G Weber2 1 Dermatology, Medicine, Stockholm, Sweden
and 2 Clinical Genetics, Karolinska, Stockholm, Sweden
The antimicrobial peptide LL-37 is the C-terminal active fragment of the hCAP18, the single cathe-
licidin protein in human. We have recently shown that LL-37 is induced in association with wound
healing and that it is lacking in chronic wound epithelium. The aim of the present study was to exam-
ine the potential role of LL-37 in the re-epithelialization process. We have used an ex-vivo wound
healing model composed of organ cultured human skin in which re-epithelialization reproducibly
occurs at 4-7 days. In this model LL-37 is strongly expressed in the epithelial cells migrating to cover
the wound surface. Treating such wounds with LL-37 specific antiserum dose-dependently inhib-
ited re-epithelialization and severely impaired the appearance of the individual keratinocytes. Evi-
dence of cell proliferation assessed as immunoreactivity for Ki67 was lacking in the epithelium of
the treated non-healing wounds suggesting that LL-37 may be involved in cell proliferation. Treat-
ing cultured HaCat cells and primary human keratinocytes with synthetic biologically active LL-37
peptide at 25, 50 and 100 µg/ml, dose-dependently increased proliferation rate of these cells. Cells
were cultured at 2 and 10% fetal calf serum respectively. 100 µg/ml of LL-37 at 2% serum concen-
tration severely affected the majority of cells indicating a cytotoxic effect. However, at 10% serum
concentration no sign of cytotoxicity was detected, which confirms the observation that the cyto-
toxic activity of cathelicidin α-helical peptides, such as LL-37, is inhibited by the presence of serum.
Proliferation was measured by flow cytometry and by assessing mitochondrial activity (WST-1). The
increase in proliferation was 30-40 % higher than that of non-treated cells and equal or higher than
that induced by epidermal growth factor. In summary, our data indicate a novel function for this
peptide which in addition to being antimicrobial may have a growth-factor effect in epithelial cells. 
0489
The characterization of epiplakin in NHEK cells
S Jang, H Zhao, O Kalinin, K Takahashi and PM Steinert NIAMS, NIH, Bethesda, MD
Epiplakin, a member of plakin family, is a 450 kDa protein consisting of 13 repeats homologous to
the B domain of desmoplakin. It lacks a rod domain and an amino-terminal domain characteristic
of all other plakins. Epiplakin is expressed in various tissues such as liver, digestive tract, salivary
gland, as well as skin. Here, we have characterized its distribution and the function in human pri-
mary epidermal keratinocytes (NHEK). A polyclonal antibody against the unique peptide sequences
of the linker regions between the last 5 repeated domains was used as an epitope. The results from
immnuofluorescence staining reveal that epiplakin is distributed in a filamenteus pattern in the cyto-
plasm with K5/K14 when cells are grown in low calcium medium (0.5 mM). Similar results were
observed in HaCaT, A431 epidermal cell lines, but no staining was found in primary human fibrob-
lasts. Interestingly, not all NHEK cells grown in low calcium medium showed positive epiplakin
staining: those of a large, flat morphology showed the strongest staining. Also, the percentage of
positive staining cells did not increase with cell density. However, the number of positive staining
cells increased with time that NHEK cells were maintained in high calcium medium (1.2 mM). This
was confirmed by western blots. In addition, western blots showed a very high molecular weight
protein complex recognized by epiplakin antibody, suggesting epiplakin might become cross-linked
with other epidermal proteins. In apparent support of a role in cell envelope barrier function, epi-
plakin co-localizes with K1/K10 filaments in 1-7 day high calcium cultures. Some epiplakin co-
localizes with involucrin and transglutaminase 1 at the cell peripheral. It does not co-localize with
profilaggrin granules. Taken together, these results suggest that (1) epiplakin is an important keratin
filament-associated protein; (2) it might be an early differentiation marker; (3) its expression is cal-
cium-dependent; (4) it interacts with different epidermal proteins during terminal differentiation;
and (5) it is a potential precursor for the cell envelope. 
0490
Beta-2-adrenergic receptor antagonist accelerates skin barrier recovery and reduces epider-
mal hyperplasia induced by barrier disruption
M Denda, K Inoue and S Fujiwara Shiseido Research Center, Yokohama, Japan
Effects of topical application of adrenergic receptor agonists and antagonists on epidermal barrier
repair rate after barrier disruption were studied. Agonists and antagonists of adrenergic beta 1 recep-
tor did not affect the barrier repair rate. On the other hand, the adrenergic beta 2 receptor agonist,
procaterol hydrochloride, delayed the barrier recovery and beta 2 receptor antagonist, ICI-118551,
blocked the delay. Moreover, topical application of ICI-118551 alone accelerated the barrier recov-
ery. Antagonists of alpha 1 and alpha 2 receptors did not affect the barrier recovery. The delay of
barrier repair induced by prodaterol hydrochloride was blocked by a voltage-gated calcium channel
blocker, verapamil. In cultured human keratinocytes, procaterol hydrochloride increased the intra-
cellular calcium concentration and the increase was blocked by ICI-118551 and also by verapamil.
Topical application of ICI-118551 partially blocked the epidermal hyperplasia induced by acetone
treatment under low environmental humidity. These results suggest that the adrenergic beta 2 recep-
tor is specifically associated with skin barrier homeostasis. 
0491
Desmoglein 3: a novel negative marker for epidermal stem cells
H Wan,1 MG Stone,2 C Simpson,3 LE Reynolds,2 JF Marshall,2 KM Hodivala-Dilke2 and RA Eady1
1 Cell and Molecular Pathology, St John’s Institute of Dermatology, London, United Kingdom, 2
Richard Dimbleby Department of Cancer Research, Cancer Research UK, London, United
Kingdom and 3 FACS Laboratory, Cancer Research UK, London, United Kingdom
No single method has been universally adopted for identifying and isolating epidermal stem/ pro-
genitor cells, and the emergence of new markers of stem cell populations is worth exploring. We
recently showed that clusters of basal keratinocytes at the bottom of the rete ridges in human palm,
previously recognized as a major repository of stem cells, had very low levels of desmoplakin pro-
tein and mRNA expression, compared with cells at the sides of the ridges or above the dermal papil-
lae. Furthermore, in populations of palm keratinocytes, selected by rapid adhesion to type IV colla-
gen, immunoblotting showed significantly reduced levels of desmoplakin and other major desmosome
proteins. Here we report for the first time the use of desmoglein 3 (Dsg3), a major desmosomal cad-
herin, as a negative cell surface marker to select for epidermal stem/progenitor cells from adult human
palm skin. Using FACS analysis we have been able to identify a cell population with a low Dsg3
expression which is also characterized by a high clonogenecity, colony forming efficiency and pro-
liferative potential but with a low ability to form paraclones, compared with populations with a higher
Dsg3 expression. Moreover, stringent sorting of populations showing both integrin b1-bright and
Dsg3-dull expression enables even further enrichment of epidermal stem cells. These findings pro-
vide the basis for a new strategy for epidermal stem/progenitor cell enrichment, and encourage fur-
ther study of the role of desmosomes in stem cell biology. 
0492
Trichohyalin functions in specialized epithelial tissues as a keratin intermediate filament matrix
protein and as a cell envelope barrier reinforcement protein
PM Steinert and LN Marekov Laboratory of Skin Biology, NIH /NIAMS, Bethesda, MD
Trichohyalin is expressed in specialized epithelia that are unusually mechanically strong, such as the
inner root sheath cells of the hair follicle. We have previously shown that trichohyalin is sequen-
tially subjected to post-synthetic modifications by peptidylarginine deaminases which covert many
of its arginines to citrullines, and by transglutaminases which introduce intra- and inter-protein chain
cross-links. Here we have characterized in detail the proteins to which it becomes cross-linked in
vivo in the inner root sheath of the mouse hair follicle. We show that it serves two principal roles.
First, it serves as an interfilamentous matrix protein by becoming cross-linked both to itself and to
the head and tail end domains of the unique inner root sheath keratin intermediate filament chains.
A new antibody reveals that arginines of the tail domains are modified to citrullines before cross-
linking which clarifies previous studies concerning the filament chain composition. Second, tri-
chohyalin serves as a reinforcement protein of the cornified cell envelope of the inner root sheath
cells by becoming cross-linked to several known barrier function structural proteins, and in turn is
cross-linked to the keratin filaments.  Together, our new data document that trichohyalin is a multi-
functional cross-bridging protein that functions in the inner root sheath and perhaps in other spe-
cialized epithelial tissues by conferring to and coordinating mechanical strength between their periph-
eral cell envelope barrier structures and their cytoplasmic keratin filament networks. 
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Notch-1 mediated signaling increases IKKα levels--a critical determinant controlling ker-
atinocyte terminal differentiation and cell survival
V Chaturvedi, J Qin, MF Denning, L Miele and BJ Nickoloff Pathology, Loyola University
Chicago, Maywood, IL
Epidermal formation depends on a balance between cell proliferation, differentiation, and death.
While deletion of IKKα gene blocks terminal differentiation in mice, biochemical pathways regu-
lating IKKα in epidermis are unknown. Notch receptors regulate cell fate in response to ligands such
as Jagged-1. In normal skin, Jagged-1 is expressed by keratinocytes (KCs) in basal cells and stra-
tum spinosum, but not in granular cell layer or by corneocytes. To explore a role for Notch signal-
ing in epidermopoiesis, human KCs were infected with retroviral constructs containing truncated
(constitutively activated) forms of Notch-1 receptor (NIC-1) and Notch-4 receptor (NIC-4). Compared
to empty linker control infection, which had no effect on KCs, infection with either NIC-1 or NIC-4,
triggered growth arrest accompanied by stratification. Biochemical analysis confirmed induction of
Notch-target genes such as Hes-1, and cell cycle regulator p21, as well as early/late differentiation
markers (involucrin-loricrin). Importantly, only NIC-1 triggered accumulation of IKKα accompanied
by decrease in pro-apoptotic PKCδ, whereas neither NIC-1 nor NIC-4 induced IKKβ levels. By con-
trast, cytokines such as IFN-γ plus TNF-α induced IKKβ but not IKKα. When Notch signaling was
interrupted by addition of a γ-secretase inhibitor (GSI), activated Notch receptor levels were reduced,
and KCs underwent apoptosis in a concentration and time dependent fashion blocked by addition of
caspase inhibitors. Apoptotic machinery involved in GSI-induced cell death included activation of
caspase 3 and release of cytochrome C from mitochondria. Given the critical role for IKKα in ter-
minal differentiation, we suggest that Notch-1 mediated signaling is responsible for endogenous
IKKα accumulation. Furthermore, abrupt loss of Jagged-1 in upper epidermal layers may trigger
cell death necessary for cornification following terminal differentiation. Thus, we propose Notch
signaling regulates KC proliferation, differentiation, and cell death. 
0495
Pentagonal symmetry in proliferating epidermal keratinocyte colonies: a topological model for
growth control
J Wille R&D, Bioderm Technologies, Inc., Trenton, NJ
Phase contrast microscope observations of serum-free cultures of normal human keratinocytes reveal
a high frequency (>90%) of pentagonally-shaped colonies over a wide range of colony sizes that per-
sist over many sequential cell generations. Macroscopic colonies derived from single cell isolates
also display pentagonal colony morphology. Pentagonal symmetry in two-dimensions (2-D) was
confirmed by a photographic technique known as “Markham rotation” where the order of reflective
symmetry of an object is enhanced by super-imposition of additional images of the object by sequen-
tial rotation of the image around its center of gravity at a constant angular displacement. Best-fit for
5-fold symmetry was confirmed for colonies ranging from 4 to 59 cells. Strict adherence to pentag-
onal symmetry is lost upon coalescence of individual colonies in confluent monolayer cultures and
instead, a “Chinese mosaic” of fours-fives-and sixs appears. Proliferating HaCat keratinocytes grow-
ing in serum medium also display a high frequency of 5-sided colonies. Finally, a review of pub-
lished photographs of other epithelial cell type indicates the presence of pentagonal shaped colonies.
The significance of these observations is not yet apparent, but one might speculate that proliferat-
ing cells possesses bilateral symmetry rotated around a perpendicular axis, dividing left and right
sides, that runs from one vertex (head-end) and bisect the opposite base side (tail-end), thus, creat-
ing a five-sided figure. Evidence for this postulate comes from observations of retracting cell-cell
contacts. Close packing of cells normally distributed in size according to their cell cycle proportions
during rapid (GT=24hrs) asynchronous exponential growth is compatible with the construction of
five-sided colonies. Finally, it is predicted that switching from growth to differentiation may involve
a change from five-sided open path networks to 3-, 4-, and 6-sided closed path networks. 
0497
S100 genes: identification of a novel one and their expression in keratinocytes
K Morita,1 FM Watt2 and Y Miyachi1 1 Department of Dermatology, Graduate School of Medicine,
Kyoto University, Kyoto, Japan and 2 Keratinocyte Laboratory, Cancerresearch UK, London,
United Kingdom
“Fused gene” subgroup of S100 family such as trichohyalin, repetin or fillagrin having S100 domain
at the N-termini is expressed with differentiation in keratinocytes. However, expression of S100
proteins themselves have not been fully investigated in keratinocytes. So far, seventeen S100 genes
have been identified in human. The fact that many human S100 genes are clustered at chromosome
1q21 (epidermal differentiation complex) implicates that they are involved in differentiation of ker-
atinocytes. Thus, we investigated mRNA expression of seventeen human S100 genes (S100A1 to
A14, S100B, S100P and S100Z) by means of RT-PCR in normal human keratinocyte cultured at
various extracellular Ca++ concentrations. At extracellular Ca++ concentration of 0.05mM(basal
condition), transcripts of S100A2, A4, A6, A8, A9, A10, A11 and A14 were detected. By elevation
of extracellular Ca++ concentration to 2.00mM(72 hours:calcium induced stratification), expression
of S100A13 and S100P mRNA was induced. Moreover, we found ESTs coding a novel S100 gene
(mouse and human) in Unigene database (NCBI, U.S.A) as frequently expressed ones in libraries of
skin. By RT-PCR, its transcript in normal human keratinocytes was equally and strongly detected at
the extracellular Ca++ concentration of 0.05mM, 0.15mM and 2.00mM. Northern blot analyasis in
tissues showed that the transcript was expressed in various tissues but most abundantly in the skin.
These results suggested that some S100 proteins are involved in differentiation or stratification of
keratinocytes. 
0496
The immunohistochemical analysis of the Myc/Mad1 expression in psoriasis
Y Ohta,1,2 N Saitoh,1,2 Y Hamada2 and K Katsuoka2 1 Faculty of Division of Dermatology,
Yokohama National Hospital, Yokohama, Japan and 2 Dermatology, Kitasato University School of
Medicine, Sagamihara, Japan
Mad1 is a Myc antagonist that heterodimerizes with Max and functions as a transcriptional repres-
sor. Recent observations indicated inhibition of proliferative activity subsequent to Mad1 overex-
pression has been demonstrated in a variety of cell types, including fibroblasts, keratinocytes, neu-
ral cells, haematopoietic cells. To elucidate whether c-Myc/Mad1 proto-oncogenes could be involved
in the dysregulation of psoriatic keratinocyte, in situ expression of Myc/Mad1 protein was investi-
gated immunohistochemically. Biopsy specimens were obtained from 12 patients with psoriasis vul-
garis and from 7 healthy volunteers. Clinically stable psoriatic plaques of diameter 2-4 cm were biop-
sied from centre to the perilesional uninvolved skin. Specific anti-human c-Myc mouse monoclonal
antibody (9E10) and rabbit polyclonal antibody against Mad1 (C-19) were used. Positive fluores-
cence signals were analysed using a confocal laser scanning microscope. In normal healthy skin, c-
Myc was weakly positive in the nuclei of basal keratinocyte, whereas Mad1 was expressed in the
cytoplasm of suprabasal layers. In fully-developed psoriatic epidermis, c-Myc expression was detected,
but similar staining intensity to that of normal skin. In contrast to the normal and fully-developed
psoriatic epidermis, c-Myc positive cells were increased in perilesional psoriatic epidermis. Mad1
expression was dramatically reduced in the fully-developed psoriatic lesions compared to perile-
sional uninvolved lesion. These findings suggested that Myc/Mad1 expression could be closely linked
with the proliferation/differentiation disorder of psoriatic lesional keratinocytes. Although the role
of c-Myc have not been completely elucidated in human epidermal cells, regulatory mechanisms of
c-Myc/Mad1 could provide a clue for both pathological and therapeutic approaches of psoriasis. 
0494
Human epidermal glucosylceramides as major precursors of stratum corneum ceramides
S Hamanaka,1 M Hara,1 H Nishio,1 F Otsuka2 and Y Uchida3 1 Dermatology, Hamanaka Hifu-ka
Clinic, Asaka, Saitama, Japan, 2 Dept. of Dermatology, RIKEN Frontier, Wako; Kanebo Ltd,
Tsukuba University, Odawara, Kanagawa, Japan and 3 Department of Dermatology, University of
California, San Francisco, CA
Not only as bulk constituents of ceramides (Cers) but also for their molecular heterogeneity which
comprises of eight species is important for epidermal permeability barrier function in the stratum
corneum (SC), we previously reported the structures of acylGlcCer and SM in epidermis. To further
delineate the role of glucosylCer (GlcCer) as potential precursors for SC Cer, we here demonstrated
the structures of human epidermal GlcCer species by gas chromatography-mass spectrometry, fast
atom bombardment-mass spectrometry and nuclear magnetic resonance. Epidermal GlcCers com-
prise six distinct molecular groups, GlcCers 1-6. GlcCer 1 contains sphingenine and non-hydroxy
(OH) fatty acids (FA), GlcCer 2, phytosphingosine and non-OH FAs, GlcCer 3, phytosphingosine
with one double bond and non-OH FA, GlcCer 4, sphingenine and α-OH FA, GlcCer 5, phytosph-
ingosine and α-OH FAs, GlcCer 6, phytosphingosine with one double bond and α-OH FA. Next,
acylGlcCers and GlcCers were treated with β-glucocerebrosidase and the Cers released were com-
pared with SC Cers. Taken together with our prior studies on epidermal SMs, all Cer species are
derived from GlcCers and fractions of Cers 2 and 5 are from SMs. 
0498
The head domain of keratin 5 binds to a dynein light chain, the cytoplasmic motor cargo com-
plex, and might be involved in the distribution of keratin filaments and melanosomes
S Nobuhara, T Idea, Y Miyachi and K Takahashi Dermatology, Kyoto University, Kyoto, Japan
Epidermolysis bullosa simplex with mottled pigmentation (EBS-MP), a rare variant of EBS, is dis-
tinctive with its hyper- and hypo-pigmented macules besides mild blister formation. All EBS-MP
cases are caused by the missense mutation occurred at the 25th proline residue in the early head
domain of keratin 5 (K5) so far. However, the etiological mechanisms, how this mutation located
outside the rod domain should lead to the blisters and pigment anomaly in EBS-MP, are not yet under-
stood. In this study, we tried to identify a protein, which binds to the head domain of K5 using yeast
two-hybrid system. Fifty amino acids stretch of the critical K5 head region was used as bait to
screen a human skin cDNA library. A tctex-1, a component of the cytoplasmic dynein light chains
(DLC) was isolated. Dynein is a microtubule-based molecular cargo complex, and works for the
directional transport of cytoplasmic proteins or organelles. DLC as well as dynein intermediate chain
(DIC) were also co-immuno-precipitated with the antibody against K5 from cultured keratinocytes
in vitro. We then prepared several truncated or modified bait constructs based on K5 head sequences,
and found that the 25th proline was essential for the binding with DLC at least in the yeast system.
In the cultured human keratinocytes, DLC and DIC were observed to spread granularly in the entire
cytoplasm and partly aligned with keratin filaments especially in the recovering process from the re-
plating. After co-cultivation of melanocytes and keratinocytes, melanosomes transferred in the ker-
atinocytes were occasionally observed to co-localize with dynein complex along the keratin fila-
ments. Our observation suggests that dynein could work for the distribution of K5 as well as
melanosomes along microfilaments under particular condition. The disturbance of the binding of
dynein and keratin filaments might cause the pigment anomaly and blisters noticed in EBS-MP. 
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A reconstructed innervated skin-equivalent : a new tool for investigating the dermo-cosmetic
product properties
J Franchi,1 R Steinschneider,2 C Colomban,2 C Marteau,1 E Quelven,2 Y Neveux,1 P Andre1 and
J Laurent2 1 Laboratoire Sciences du Vivant, LVMH Branche Parfums et Cosmetiques, Saint Jean
de Braye, France and 2 Bio Expertise Technologies, Marseille, France
Somatic neurons transfer sensitive information from the skin to the central nervous system. In response,
neuropeptides are delivered to epidermal cells. The release of neuropeptides such as CGRP from
sensory neurons to skin cells leads to either cell proliferation and cell differentiation or an inflam-
matory response via the secretion of cytokines and growth factors. In order to reproduce this phe-
nomenon, Bio Expertise technologies has developed an in vitro innervated skin model into a three
compartmented culture chamber. A first compartment contains a reconstructed epidermis from human
keratinocytes. A second compartment contains a culture of sensory neurons from rat dorsal root
ganglio. Epidermis and sensory neurons are separated by a third compartment constitued of a col-
lagen matrix retracted by human fibroblasts as a dermal structure equivalent. Histological analyses
have shown a reconstructed epidermis with 8-9 layers of keratinocytes including a basal layer, a
stratum spinosum and a stratum corneum. Laminin, transglutaminase, filaggrin, and cytokeratins are
visualized by immuno-staining. Sensory neuron cell bodies are identified using an anti b tubulin anti-
body. Neuritic fibers which cross the biological dermal matrix and which establish a network among
differentiated keratinocytes are stained with a neurofiber antibody. The neurons were mature and
functional, as demonstrated by the spontaneous release of the CGRP neuropeptide. This new model
offers an alternative method for testing the nerve-repairing capacity of molecules and the soothing
or anti-inflammatory properties of products that are applied either locally or systemically. 
0500
Skin interposition-grafting onto the chorioallantoic membrane of chick embryo as a model
for wound healing studies
E Roux, E Bauza, Z Djabari, C Dal Farra and N Domloge Research Center, Vincience, Sophia
Antipolis, France
There has been a struggle in recent years to develop a model that is closer to in vivo models, in order
to replace the animal testing needed for studying the different mechanisms of the skin and the effi-
cacy of ingredients. In this area, skin wound healing and repair studies are mainly performed on ani-
mals, due to poor in vitro substitutes to the complete structure of the skin and its interactions. More-
over, as our studies have shown that the use of an interposition technique to graft human skin onto
the chorioallantoic membrane (CAM) of chick embryo is a reliable model for human skin studies,
here we applied this technique for studies on human skin wound repair, and compared this method
to an ex vivo model. Three human skin biopsies were grafted by interposing them between the shell
and CAM membranes of 7-day old chick embryos. Parallel studies were performed using an ex vivo
method. All samples were kept in the incubator for 3 or 6 days, and then removed and paraffin embed-
ded for histological studies. Our results show that within 3 days, grafted skin samples showed greater
repair activity than ex vivo samples, and that after 6 days, the repair was more complete and remark-
ably better in the grafted skin. Good dermal repair and scar formation was consistently found in
grafted skin samples, with clear penetration of the dermal side by chick blood network that clearly
improved the quality and preservation of the skin. In contrast, in ex vivo samples dermal scarring
was partial, poor and only found in less than 40% of the samples. Epidermal cicatrisation was less
obvious, but was found higher in grafted skin than in ex vivo samples. These results suggest that this
method of interposition-grafting of multiple human skin biopsies onto the chick embryo, presents
an interesting model for studying wounded skin repair, and pushes us a step further toward alterna-
tive methods to animal testing 
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Recombinant type VII collagen sustains proliferation of the cultured keratinocytes
KC Sato-Matsumura, D Sawamura, M Goto, K Yokota and H Shimizu Dermatology, Hokkaido
University Graduate School of Medicine, Sapporo, Japan
Background: There is little information what happens on keratinocytes when they are exposed an
excess amount of the recombinant Type VII collagen (rCOLVII). To compare the proliferation rate
of normal human keratinocytes (NHK) and normal human fibroblast (NHF) after the addition of
rCOLVII. The rCOLVII was produced in the COL7A1 cDNA transfected with HaCaT and evalu-
ated for its ability to modulate the cultured cell proliferation. The rCOLVII expressing HaCaT cell
line was generated by FLP/FRT system (The Flp-In system, Invitrogen Corp., Carlsbad, CA). The
secreted rCOLVII into cultured medium was confirmed by western blot and was concentrated by
microconcentrater at the rate of 1:30. The cultured medium of HaCaT transfected with control plas-
mid was similarly concentrated and regarded as a control additive. The NHK or NHF were seeded
in 96 well ELISA plate and cultured for 24 hours in DMEM with 10% FCS supplemented with
rCOLVII or control additive. The cell proliferation rate was non-radioactively assayed using Cell
Titer 96 (Promega, Madison, WI). The absorbance at 570nm was recorded by 96 well plate reader
(Model 450 Microplate Reader; Biorad, Hercules, CA), one hour after the addition of the assay
reagent. The NHK supplemented with rCOLVII sustains proliferation comparing to the control. On
the other hand, the NHF supplemented with rCOLVII did not show great differences in its prolifer-
ation. Addition of rCOLVII may have a positive influence on the proliferation of cultured keratinocyte.
The proliferation of NHF was not much influenced by supplemented rCOLVII. 
0502
Antisense oligonucleotides inhibit androgen receptor expression and biological activity in epithe-
lial skin cells
S Fimmel,1 A Saborowski,1 B Terouanne,2 C Sultan2 and CC Zouboulis1 1 Dept of Dermatology,
UKBF, The Free University of Berlin, Berlin, Germany and 2 Pediatric Endocrine Unit, Hospital
A. de Villeneuve, University of Montpellier, Montpellier, France
Androgen effects are mediated by their binding to nuclear androgen receptor (AR) molecules avail-
able in skin cells. The latter are able to synthesize steroid hormones de novo which are mostly acti-
vated in sebocytes and degraded in keratinocytes. Androgen activity in vivo can be inhibited by sys-
temic administration of AR antagonists or inhibitors of androgen-metabolizing enzymes. In this study
we describe a novel strategy, namely the inactivation of AR mRNA by antisense oligonucleotides.
The human facial sebaceous gland cell line SZ95, which exhibits similar binding constants for AR
with primary genital fibroblasts, and human preputial keratinocytes were used as substrates. Several
antisense oligonucleotides were constructed and tested by applying various cell transfection systems
in vitro, whereas AR protein expression was sufficiently inhibited by thioat oligonucleotides and 2’-
O-methyl-RNA-antisense molecules using a cationic lipid-mediated transient transfection system.
Effective transfection was visualized by intracellular detection of fluorescein-labeled antisense
oligonucleotides. A concentration-dependent AR inhibition of up to 89% in SZ95 sebocytes and 25%
in keratinocytes could be detected 17 hrs after 4h-transfection by western blot analysis. The effect
was not due to inhibition of the motility of the AR-ligand complex, since translocation of AR from
cytoplasm into the nucleus could be detected. The transient effect was confirmed by annulation of
the inhibitory effect after 24 hr recovery time. Transfection had to be repeated to reestablish the effect.
Biological androgen activity, namely an increase of epithelial cell proliferation and differentiation,
was inhibited significantly after transfection with the antisense oligonucleotides against the AR. 
0503
Many faces of periplakin: specific antibodies recognize periplakin in basal cell layer of epi-
dermis
S Aho and S Kazerounian Dermatology and Cutaneous Biology, Thomas Jefferson University,
Philadelphia, PA
Periplakin was first identified as a precursor of the epidermal cornified cell envelope, mainly resid-
ing in desmosomes and in interdesmosomal plasma membrane of differentiated keratinocytes, espe-
cially within the outer layers of epidermis. We originally isolated periplakin cDNA through yeast
two-hybrid screening, using BPAG2/BP180/type XVII collagen intracellular domain as a bait. The
physiological importance of this interaction has remained unclear, especially when related to the
known expression pattern of periplakin in epidermis. However, the antibodies used so far have been
raised against the C-terminal peptide of periplakin, the region, which is heavily involved in protein-
protein interactions. Recently, the interaction of periplakin C-terminus with keratins, vimentin,
periphilin, protein kinase B, and mannose-6-phospate receptor 300, has been reported. In order to
avoid the false negative results in periplakin localization due to the epitope masking, different regions
of periplakin were selected as antigens. Polyclonal rabbit antiserum against periplakin head domain
(1), a mouse monoclonal antibody, recognizing the rod domain (2), and mouse polyclonal antiserum
against the tail domain (3), each revealed a unique staining pattern in human epidermis. We conclude
that periplakin head domain is accessible throughout the epidermis for the antibody recognition,
while the rod domain is readily accessible only in the basal cell layer. The tail domain is masked in
the basal cell layer by the protein-protein interactions, but is readily accessible in the outer layers of
epidermis, where the rod domain is cross-linked to ceramides and is responsible for assembly of
periplakin to the cornified cell envelope. We observed that while the soluble periplakin becomes
lost after the detergent extraction, the rod domain becomes unmasked. Multiple localizations and
protein-protein interactions indicate a role for periplakin as multifunctional cytolinker, similar to that
established for plectin. 
0504
Novel epidermal protein, periphilin
S Kazerounian and S Aho Dermatology and Cutaneous Biology, Thomas Jefferson University,
Philadelphia, PA
While keratinocytes go through the terminal differentiation in stratified squamous epithelia, multi-
ple proteins become cross-linked to form an insoluble layer of proteins, called the cornified cell enve-
lope. To initiate formation of this envelope, periplakin and envoplakin, members of plakin family of
proteins, bind to involucrin to form the scaffold on which several other proteins are assembled.
Recently, we identified a novel epidermal protein, when the periplakin carboxyl-terminus (a.a 1548-
1756) was used as a bait in a yeast two-hybrid screening. The protein was designated periphilin1.
Periphilin locus in human chromosome 12q12 (PPHLN1) is composed of at least 11 exons which
span about 110 kb. The open reading frame of 1122 base pairs encodes a polypeptide of 374 amino
acids. The EST-database search demonstrated the possibility of alternative splicing at the 5′-end
exons 2, 4, and 7, that can give rise to multiple protein isoforms. The PCR analysis of MTC-panels
revealed the transcript of this novel protein, in addition of keratinocytes, in skeletal muscle, placenta,
and heart. The carboxyl-terminus contains two helical regions resembling H2A and H2B regions in
keratin proteins and shows homology to vitellogenins, a family of lipid binding proteins. Monoclonal
antibody against the carboxy-terminal domain of periphilin stains the cell surface of keratinocytes
in the outer layers of epidermis, showing co-localization with periplakin. Periphilin is also detected
in nuclei throughout the epidermis. Various extraction procedures demonstrated the high insolubil-
ity of this protein, indicating possible cross-linking to a series of other proteins. Also, the sensitiv-
ity of periphilin to trypsin in keratinocyte cultures, together with the diffuse immunofluorescence
staining at the surface of differentiated keratinocyte layers, suggest that periphilin may be secreted
from the differentiated keratinocytes. In conclusion, the localization pattern and insolubility of this
protein indicates that we have characterized a novel component of the epidermis. 
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Human skin grafting onto chorioallantoic membrane of chick embryo, using the interposition
technique: histological studies and comparison to an ex vivo model
Z Djabari, E Bauza, E Roux, C Dal Farra and N Domloge Research Center, Vincience, Sophia
Antipolis, Sophia Antipolis, France
Different in vitro skin substitutes have been developed in recent years for the purpose of decreasing
animal testing and moving closer toward in vivo evaluation of the toxicity of products and efficacy
on the skin. Nevertheless, these methods are expensive and often incomplete. Moreover, ex vivo
method is limited to short-term studies . A few recent studies have shown that skin samples, or can-
cer xenografts survived grafting onto the chorioallantoic membrane (CAM) of chicken embryo.
Therefore, we were interested in developing this technique further in order to enable longer and bet-
ter survival of skin biopsies. In order to do this, we used an interposition technique where 3 mm
punch biopsies of human skin were interposed gently in between the shell and CAM membranes of
7-day old embryos. The eggs were kept in an incubator for 6 days, after which the membranes with
the grafted skin samples were incised and submitted to histological studies. For comparison and con-
trols, parallel studies included placing skin biopsies on the CAM after removal of the shell mem-
brane, as well as the culture of skin samples following ex vivo method. These studies showed that
skin grafted using the technique of interposition is markedly better than skin grafted by placement
on the CAM, especially concerning the epidermis and keratin layer. The grafted skin developed a
nice interaction with the CAM, which provided new evidence of aided skin nourishment. The grafted
skin showed a remarkable improvement and preservation over the ex vivo skin, with great structural
preservation even after 6 days. Our results confirm that skin grafting onto chick embryo is a very
interesting method, and the results show that the new interposition technique clearly improves grafted
skin quality. This technique offers an interesting test method for skin investigations in the field of
advanced in vitro methods and alternative methods to animal testing. 
0507
Differentiation-dependent localization of exocytosis machinery in epidermis suggests a role in
lamellar granule trafficking
GN Sando, H Zhu and KC Madison Marshall Dermatology Research Labs, University of Iowa,
Iowa City, IA
Mechanisms for transport of lamellar granule (LG) lipids to the site of barrier formation at the junc-
tion of the uppermost layer of the viable epidermis and stratum corneum are not understood. Elec-
tron microscopic evidence suggests that LGs originating from Golgi membranes fuse with granular
cell plasma membranes and extrude their contents into the extracellular compartment by exocyto-
sis. This scheme has recently been challenged by the cubic model of lipid trafficking in which the
machinery and energy to drive membrane fusion and exocytosis are not invoked. To elucidate molec-
ular processes involved in LG trafficking we examined human epidermis by confocal immunofluo-
rescence microscopy for the presence and location of proteins believed to mediate exocytosis in
neuronal and other specialized secretory cells. Antigens expressed in epidermis include: several
annexins (calcium and phospholipid binding proteins that promote membrane fusion); synaptotag-
min (involved in calcium-dependent exocytosis); NSF, VAMP-1/2, Vtip1, SNAPs, and several syn-
taxins (components of the SNARE complex); SCAMP-1 (mediates vesicle/plasma membrane fusion
in association with SNAREs); synapsin I (pre-fusion vesicle tethering protein); and Sec 3, 6, 8, and
the guanine nucleotide binding protein Ral A (components of the exocyst complex, required for polar-
ized exocytosis). Annexins 2 and 7, syntaxin 3, SCAMP 1, synapsin 1, and Ral A are preferentially
distributed at the junction of the stratum granulosum and stratum corneum and are partially colo-
calized with the LG markers AE17 antigen and glucosylceramides. These results show that proteins
important in vesicle/plasma membrane targeting and exocytosis are expressed in epidermis. The
differentiation-dependent distribution of several of these antigens and partial colocalization with
known LG components suggests their participation in a major secretory pathway of terminally dif-
ferentiated keratinocytes, the delivery of LG cargo for epidermal barrier assembly. 
0509
Effects of a moisturizer containing dimethicone and high levels of glycerin on keratinocyte pro-
liferation and epidermal architecture
R Wambaugh, M Choi, J Nguyen, SC Weiss and AB Kimball Dermatology, Stanford University,
Stanford, CA
Improved barrier function and skin appearance are well described effects of skin moisturizers. Dime-
thicone, an ingredient now found in many skin care products, has been shown to protect against irri-
tant injury and improve hand dermatitis. The purpose of this study was to assess the effects of twice
daily application of a moisturizer containing dimethicone and high levels of glycerin on keratin
expression, epidermal architecture, and barrier function in normal-appearing skin. A 4mm punch
biopsy was taken at baseline and after 28 days of bid application of a moisturizer containing dime-
thicone and high levels of glycerin from photodamaged forearms of 25 women. Post-treatment
biopsies were randomly assigned to be taken from the same arm or the opposite arm. Twenty-four
subjects completed the study. At baseline, keratins 10 and 14 were expressed in all specimens, and
k6 and k16 were not expressed in any specimen. At day 28, k10 and k14 were again expressed in all
specimens. Keratin 6 was expressed in 14 (58%) specimens and k16 in 19 (79%) specimens. No dif-
ference between the pairs where the biopsies were taken from the same or from the opposite arm
was evident. Maximal epidermal thickness, adjusted for baseline value and side, increased 0.017mm
(28%) from baseline (P<.001). There was no change in the appearance of the stratum corneum or
granular layer. Trans epidermal water loss decreased 0.55 (13%) from baseline, (p=0.03). Induction
of keratins 6 and 16, commonly associated with keratinocyte proliferation and wound healing, was
associated with increased epidermal thickness and improved barrier function in skin after 28 days
of treatment. This finding suggests that even clinically normal appearing skin may benefit struc-
turally from routine use of moisturizers containing dimethicone and high glycerin levels. 
0508
Carnitine is synthesized in the epidermis
O Tanno,1 N Hashimoto2 and S Inoue1 1 Basic Research Laboratory, Kanebo LTD., Odawara,
Japan and 2 Institute for Experimental Animals, School of Medicine, Kanazawa University,
Kanazawa, Japan
Carnitine is an essential cofactor in the transport of long-chain fatty acids across the inner membrane
of mitochondria, and thus plays an important role in energy metabolism via β-oxidation. In mam-
mals, carnitine homeostasis is maintained by endogenous synthesis and exogenous intake from dietary
sources. Carnitine synthesis has been thought to take place exclusively in the liver, kidney and
brain. Other tissues depend on active uptake via carnitine transporter. The aim of this study was to
clarify the homeostasis of carnitine in the epidermis, a tissue wherein the transport and biosynthe-
sis of carnitine remain obscure. Our findings as follows suggested that carnitine also synthesized in
the epidermis. Carnitine transport was defective in mice with juvenile visceral steatosis (JVS), though
the actual levels of carnitine and epidermal function in the JVS mice were not different from those
wild-type littermates. In cultured normal human keratinocytes, reverse transcription polymerase chain
reaction (RT-PCR) confirmed the gene expression of enzymes for carnitine biosynthesis; three enzymes
for carnitine biosynthesis were expressed (trimethyllysine hydroxylase, trimethylaminobutyralde-
hyde dehydrogenase, butyrobetaine dioxygenase). These observations confirmed that carnitine is
synthesized in the epidermis. 
0506
Fourier transform infrared microspectroscopy imaging of endogenous and exogenous mole-
cules in skin sections
DJ Moore R&D, Unilever Reseach US, Edgewater, NJ
Fourier transform infrared (FTIR) imaging microspectroscopy is a relatively new technology that
provides the opportunity to directly map the distribution of molecular components within a biolog-
ical sample, while maintaining sample architecture. In this approach the full information content
inherent in an infrared spectrum of a biological sample (such as a skin section) is directly coupled
with spatial information. In the currect experimental design a 400 x 400 micron sample area is directly
mapped to an array detector such that 4096 IR spectra are simultaneously generated with each spec-
trum corresponding directly to a specific 7 x 7 micron sample section. In recent studies this tech-
nology has demonstrated great promise for mapping molecular architecture and chemical composi-
tion in pathological and normal bone sections. This presentation will briefly describe FTIR
spectroscopic imaging technology and present recent data from our experiments with various skin
sections, including studies of transdermal delivery. In the transdermal delivery experiments we have
imaged the distribution of penetrants in skin and compared these with images of endogenous mol-
ecules, thereby providing direct spectroscopic images of penetrant location within skin. The current
experimental approach permits data to be acquired in a matter of minutes and without the use labelled
molecular probes (such as fluorophores). This presentation will highlight our initial studies, which
clearly demonstrate the potential of imaging FTIR microspectroscopy to directly map the distribu-
tion of exogeneous molecules in skin sections, as well as providing chemical composition images
of endogeneous molecules across a skin section. 
0510
Permeablity of sodium ascorbic acid-2-O-phosphate into the human skin and its scavenging
of intradermal free radicals
K Akagi,1 H Ikeno,2 E Masatuji-Kato3 and N Miwa4 1 Ikeno Clinic of Dermatology and Plastic
Surgery, Tokyo, Japan, 2 Ikeno Clinic of Dermatology and Plastic Surgery, Tokyo, Japan, 3
Research and Development Center, Showa Denko K.K., Chiba, Japan and 4 Laboratory of Gene
Control Technology, Hiroshima Prefectural University, School of Bioscience, Hiroshima, Japan
Sodium ascorbic acid-2-O-phosphate (APS) has been widely utilized as a skin brightening agent in
cosmetics. Recently, we reported APS exerted a remarkable efficacy for acne. In this study we
investigated its skin-permeability and scavenging of free radicals to reveal the mechanism underly-
ing this efficacy. When applied onto the skin, APS permeated into the epidermis and was quickly
converted to ascorbic acid (AsA). Each tiny human skin piece devided out of one biopsy from a vol-
unteer was placed in a modified Bronaugh’s diffusion chamber, with 2.0% APS, AsA, or ascorbic
acid-2-O-glucoside (AG) applied on it, and incubated for six hours. Then the isolated epidermis was
homogenized and the contents of AsA, APS, and AG were determined by HPLC. The epidermal AsA
content was the highest (2.8 nmol/mg protein) in APS treated skin, while it remained 0.4 and 0.6
nmol/mg protein in AsA- and AG-treated skin, respectively. The unconverted derivative contents
were similar (1.0 to 1.2 nmol/mg protein) in AG and APS treated skin, which indicated that the hydrol-
ysis rate of APS was much higher than that of AG. APS showed an excellent capability of quench-
ing free hydroxyl radicals in the skin. A human skin cell culture model (TESTSKIN) was pretreated
with 200 mM AsA, APS or AG for two hours, and the intradermal ESR spectrum was measured by
DMPO spin-trapping method under UVB irradiation. The amount of generated hydroxyl radicals
was significantly reduced in APS-treated culture, to 25 percent of non-treated control. AG showed
almost no scavenging due to its slower permeation and conversion to AsA. We believe those obser-
vations well explain the improving effects of APS on acne in clinical studies, in consideration along
with other biochemical activities of APS including enhancement of collagen synthesis and depig-
mentation. 
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A novel type I keratin-binding protein, okuribin, acts as a linker between keratin filaments
and the nuclear envelope
T Idei, S Nobuhara, M Yasuda, Y Miyachi and K Takahashi Kyoto University, Kyoto city, Kyoto
Prefecture, Japan
Keratin intermediate filaments are the major cytoskeletal proteins in the epithelial tissues, which are
widely distributed all through the cytoplasm. At the cell periphery keratins are bound to the desmo-
somal components such as desmoplakin, however, proteins, which would link the keratin filaments
to the cytoplasmic organelles, are not yet identified.  We thus tried to characterize proteins that
interact with keratins by yeast two-hybrid system. Employing the head and tail domains of epider-
mal type I and type II keratins as baits, we made several rounds of screening of the human skin cDNA.
A novel protein termed okuribin was cloned as a type I keratin binding protein. Okuribin directly
binds with the head domain of type I keratins K14, K16 and K18 but not with type II keratins. The
okuribin mRNA in size of 4.1 kilo-nucleotides was expressed in the various epithelial tissues includ-
ing skin as well as non-epithelial tissues like muscles. The okuribin protein predicted as a105 kDa
protein encoded by 950 amino acids possessing eight nuclear localization signals as well as a sig-
nal peptides and one putative transmembrane segment. When the okuribin cDNA was fused with
green fluorescence protein (GFP) or flag tag at its carboxyl terminus, and used for the forced expres-
sion into cultured keratinocytes, GFP and flag signals were observed predominantly along with the
nuclear membrane. We then prepared an antiserum against the synthetic 20 peptides corresponding
to the central region of okuribin. The endogenous okuribin in keratinocytes was observed mainly at
the outer nuclear envelope, and occasionally in the nuclei depending on the maturation of the nuclear
envelope verified by the staining intensity of lamin. The matured nuclei, where lamin and okuribin
were observed strongly at the inner and outer envelop, tend to be tightly surrounded or enclosed by
the keratin network in the immune-electron microscopy. From these data, okuribin is considered to
act as a missing link connecting the keratin filaments and juxta-nuclear space. 
0512
Suppression of hyaluronan synthesis by 4-methylumbelliferone retards keratinocyte migra-
tion and proliferation
K Rilla,1 J Hyttinen,1 K Torronen,1 J Rieppo,1 M Matto,2 M Tammi1 and R Tammi1 1 Anatomy,
University of Kuopio, Kuopio, Finland and 2 Department of Microbiology, University of Kuopio,
Kuopio, Finland
Hyaluronan is a glycosaminoglycan abundant in the extracellular matrix of basal and spinous lay-
ers of the epidermis, participating in normal keratinocyte proliferation and differentiation. In gen-
eral, high levels of tissue hyaluronan are associated with enhanced migration of cells, for example
in healing wounds, but also in aggressively growing tumours. Recent studies have used 4-methy-
lumbelliferone (MU) as a hyaluronan synthesis inhibiting agent in fibroblasts, but little information
about the mechanism of this inhibitory effect is available. We used a newborn rat epidermal ker-
atinocyte cell line (REK) to investigate the effect of MU on the hyaluronan metabolism and its bio-
logical consequencies. We found that MU (0.2-1 mM) has a dose dependent inhibitory effect on
hyaluronan secretion of these cells. At the same time the REK cells lost their typical polarized mor-
phology, their proliferation and migration was slowered and adhesion to substratum increased. The
RT-PCR showed that the diminished HA secretion level was related to reduced hyaluronan synthase
(Has2 and Has3) mRNA expression levels. This reduction was observed after 1 hour treatment,
excluding the possibility of a secondary effect. MU had no effect on the mRNA expression of the
hyaluronan receptor CD44. The results of this study support the idea of MU as a useful agent for
relatively specific inhibition of hyaluronan synthesis and establish the role of Has2 and Has3 in this
inhibition. MU has potential for clinical conditions that would profit from inhibition of excessive
hyaluronan production. 
0513
Induction of apoptosis in keratinocytes by mutant transglutaminase 1 lacking a Cys-cluster
for membrane anchoring
K Yamanishi, C Shen, M Matsuki, T Tsuda and H Mizutani Department of Dermatology, Mie
University Faculty of Medicine, Tsu, Mie, Japan
Transglultaminase 1 (TGase 1) is essential to formation of cornified envelope and development of
skin barrier. The function of TGase 1 is possibly achieved by membrane-anchoring of the enzyme
via fatty acid thioesterification of a Cys-cluster near the N-terminus. Indeed, a mutation in the Cys-
cluster has been reported in a case of autosomal recessive congenital ichthyosis, although the effect
of the mutation has not been delineated. In this study, to elucidate the biological role of the Cys-
cluster in keratinocytes, we visualized the intracellular location of TGase 1 by adenovirus-mediated
expression of a TGase 1-GFP fusion protein. When cultured human keratinocytes were infected with
recombinant adenovirus, a wild-type TGase 1-GFP was initially located around the nucleus and
then distributed over the cytoplasm as granules and on the cell periphery. In contrast, a mutant TGase
1-GFP, the Cys-cluster of which is replaced with Ala, was distributed diffusely in the cytoplasm as
well as around the nucleus and induced apoptosis of keratinocytes. Adenovirus-mediated expres-
sion of only GFP did not cause such apoptotic changes. These results suggest that the Cys-cluster
of TGase 1 is involved not only in membrane anchoring, but also in sequestration of the enzyme.
The restricted intracellular localization of TGase 1 may prevent keatinocytes from premature apop-
tosis due to unusual dislocation and activation of the enzyme during terminal differentiation. 
0514
A keratinocyte outgrowth system useful as a new tool for analyzing proliferation, migration,
and differentiation
H Ura, S Yano, M Fujimoto and H Okochi Regenerative Medicine, Research Institute IMCJ,
Shinjuku-ku, Tokyo, Japan
Normal human epidermal keratinocytes (KC) stop proliferation and differentiate at confluency.
This contact inhibition is thought to be mediated in part by mechanical tension. To prove this, we
created a new assay system. First, a 10mm diameter cloning ring was put on the center of the 60mm
dish coated with type I collagen. Then KC were plated in the ring and incubated 4-16h. The cloning
ring was removed, and the floating cells were washed away. Thus, we had a circular epidermal mono-
layer sheet only in the center of the dish. If we used SFM, whose Ca concentration is below 0.1mM,
as a medium, the KC in the perimeter migrated individually, and the KC in the center portion started
keratinizing. However, when we added calcium chloride to the SFM (final concentration more than
0.5mM), KC at the periphery showed marked lamellipodia without losing contact with the sur-
rounding cells. These KC showed coordinate sheet-like outgrowth as a whole. After a few days, the
diameter of the sheet increased 4mm/day constantly for several days without notable keratinization
in the center. BrdU labeling experiments revealed that the distribution of BrdU positive cells grad-
ually shifted from the center to the peripheral area. To maintain the expanding sheet structure, KC
have to migrate and proliferate as if they are under precise control. Otherwise, there should be some
free spaces or holes inside the sheet. The addition of cytocharasin D, an actin polymerizing inhibitor,
abolished complete KC outgrowth, and, after washing out the inhibitor, the KC resumed outgrowth.
These results suggest that actin polymerization is a driving force of this outgrowth. Addition of
AG1478, a tyrosine kinase inhibitor, partially inhibited outgrowth, indicating that growth factor medi-
ated signaling is also important for this outgrowth. Our culture system will help in understanding
the mechanisms of cell migration, proliferation and differentiation. Using this assay system, we can
learn more about wound healing, because this in vitro sheet-like outgrowth simulates an in vivo
injured site. 
0515
Calcium entry into keratinocytes induces cell surface expression of lysosomal membrane pro-
teins
R Jans,1 M Jadot2 and Y Poumay1 1 Histology-Embryology, University of Namur, Namur, Belgium
and 2 Physiological Chemistry, University of Namur, Namur, Belgium
During the final steps of epidermal differentiation, just before keratinocytes gain the stratum corneum
as keratinized dead cells, extracellular calcium ions enter into these epidermal cells and induce trans-
glutaminase activity and cornified envelope formation. An entry of calcium mediated by ionophores
has been reported to induce exocytosis of lysosomes in other cell types. In this study, we investigated
whether a similar phenomenon might occur during the final steps of keratinocyte differentiation.
Using autocrine culture conditions, ionomycin treatment induces cornified envelope formation in
keratinocytes, but also morphological changes including plasma membrane blebbing. No immedi-
ate alteration in cell viability can be detected using the ethidium bromide/acridine orange staining
assay, however the measurements of cytosolic enzyme activities (dipeptidylpeptidase III and lactate
deshydrogenase) in the culture medium suggest some membrane leakage, possibly associated with
cell blebbing. Simultaneously, the activity of a lysosomal enzyme (cathepsin C) in the culture medium
was increased upon ionomycin treatment. Using metabolic labeling followed by immunoprecipita-
tion, we found that ionomycin induces release of processed as well as unprocessed forms of cathep-
sin D in the culture medium. These results suggest that lysosomal and prelysosomal components are
also released upon ionomycin treatment. In order to assess whether this presence of lysosomal com-
ponents in culture medium might result from organelle exocytosis instead of membrane leakage only,
the cell surface expression of lysosome-associated membrane proteins (Lamps) 1 and 2 was com-
pared between untreated and ionomycin-treated keratinocytes, using biochemical and morphologi-
cal approaches. The appearance of both Lamps at the surface of ionomycin-treated keratinocytes
suggests that calcium entry could stimulate significant exocytosis of lysosomes, simultaneously to
terminal differentiation and possibly cell death. 
0516
Regulatory mechanisms of eosinophil chemoattractant production by normal human ker-
atinocytes
K Igawa,1 T Satoh,1 H Yokozeki,1 K Nishioka1 and M Hirashima2 1 Department of Environmental
Immunodermatology, Tokyo Medical and Dental University, Tokyo, Japan and 2 Department of
Immunology and Immunopathology, Kagawa Medical School, Kagawa, Japan
Eosinophils play a crucial role in the inflammatory process in allergic diseases. Selective eosinophil
chemoattractants (ECAs), such as eotaxins, are believed to be the key molecules produced at the
inflamed sites that induce eosinophil accumulation. In addition, ecalectin (galectin-9) isolated from
a human T-cell-derived expression library is a novel and eosinophil specific chemoattractant pro-
duced by several cell types, and could be also involved in this process. Keratinocytes are one of the
major regulators of the skin immune system and represent targets of eosinophil attacks in allergic
skin diseases. Keratinocytes may regulate eosinophil accumulation via the production of ECAs. To
understand regulatory mechanisms of eosinophil infiltration into the epidermis, we investigated the
expression of eotaxins (eotaxin-1, eotaxin-2 and eotaxin-3) and ecalectin in normal human ker-
atinocytes. Normal human keratinocytes were cultured in serum-free medium with several cytokines,
including 10ng/ml hrTNF-alpha, 10ng/ml hrIL-4, 10U/ml hrINF-gamma for 24hrs. RT-PCR analy-
sis revealed that eotaxin-1 mRNA expression was up-regulated by the combination of TNF-alpha
and IL-4 or IFN-gamma. Eotaxin-2 mRNA was constitutively expressed in these cells and no regu-
latory effect was seen with any types of cytokines tested. The expression of eotaxin-3 mRNA was
induced by IL-4, but not enhanced by the combination of TNF-alpha or IFN-gamma. Finally, ecalectin
mRNA expression was clearly increased when stimulated with INF-gamma. These results lead us
to conclude that selective eosinophil accumulation in the epidermis can be induced by not only Th2-
type cytokine stimulation through the production of eotaxin-1 or -3, but also Th1-type cytokine stim-
ulation through eotaxin-1 or ecalectin. Moreover, eotaxin-2 may in part contribute to the eosinophil
infiltration from the dermis to epidermis, as the production of eotaxin-2 by dermal fibroblast was
below the detectable level. 
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Inhibition of p53-activity in the skin is associated with an impaired terminal differentiation of
keratinocytes and down-regulates Caspase-14 expression
M Mildner,1 C Ballaun,1 N Romani,2 P Mrass,1 S Karner1 and E Tschachler1,3 1 Department of
Dermatology, Institute of Immunology, Allergy and Infectiouse Diseases, Vienna, Austria, 2
Department of Dermatology, Innsbruck, Austria and 3 CE.R.I.E.S., Neuilly, France
The tumor suppressor gene p53 plays a key role in the regulation of cellular responses to DNA dam-
age. However, the involvement of p53 in the differentiation of the skin is still poorly understood. In
this study we have investigated the effect of a chemical inhibitor of p53, α-Pifithrin (α-Pif), on ker-
atinocyte differentiation and Caspase-14 expression in skin-equivalents (SE). After incubation of
SE with α-Pif for 7 days we found a strong downregulation of p53 mRNA and protein, as well as
the p53 downstream element, p21WAF1/Cip1. H&E staining of these SE revealed a parakeratotic
phenotype. In addition electron microscopical analysis showed only few and small keratohyalin gran-
ules and few and underdeveloped odland bodies in α-Pif treated SE. Furthermore the basement mem-
brane was virtually not present and the hemi-desmosomes are only partially present and the inter-
cellular plaques are absent.  When analyzing expression of Caspase-14 in SE, we found a strong
reduction of Caspase-14 protein and mRNA by α-Pif. To study the effect of p53 inactivation on
Caspase-14 expression in vivo, we studied skin biopsies of Bowens disease, actinic keratosis and
condyloma accuminata, in which p53 is inactivated by mutations and HPV respectively, for Cas-
pase-14 expression. In lesional skin of all three diseases Caspase-14 expression was strongly reduced,
whereas it was not affected in adjacent skin. In conclusion, our results suggest that p53 plays an
important role in the terminal differentiation of epidermal keratinocytes, and that it is directly involved
in the regulation of Caspase-14 during this process. 
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Sphinganine N-acyltransferase (SNAT) activity in the de novo pathway during proliferation
and differentiation of human keratinocytes
H Sumida,1,3 M Yamane2 and R Tsuboi3 1 Dermatology, Tokyo Medical University Kasumigaura
Hospital, Amicho Inasiki-gun Ibaraki, Ibaraki, Japan, 2 Biochemistry, Tokyo Medical University,
Shinjuku-ku, Tokyo, Japan and 3 Dermatology, Tokyo Medical University, Shinjuku-ku, Tokyo,
Japan
Ceramides (CERs) are a major component of the stratum corneum, accounting for 30-40% of stra-
tum couneum lipids by weight. CER generation occurs either via reverse ceramidase or via sphin-
gomyelinase (SMase), the de novo pathway of sphingolipid biosynthesis. The present study exam-
ines the level of sphinganine N-acyltransferase (SNAT) activity in the de novo pathway during the
proliferation and differentiation of human keratinocytes. The materials used included biologically
negligible amounts of N-heptadecanoyl CoA, to serve as the substrate, and a high concentration of
defatted bovine albumin sphingosine complexes for use in the Vmax and HPLC thermospray-MS
assays. SNAT activity (pmol/min/mg protein or µg DNA) was highest 24 hours after subculture.
SNAT activity 48,72 and 96 hours after subculture tapered off gradually, compared with the drastic
decreases 24 hours post subculture. Reverse ceramidase activity was very low compared with SNAT
activity. A different time frame was required for the generation of each type of CERs. These results
suggest that SNAT, like serine-palmitoyl transferase, plays an important role in generating CERs
during keratinocyte differentiation. 
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Epidermal hyaluronan metabolism in CD44-negative mice
R Tammi,1 S Pasonen-Seppanen,1 J Rieppo,1 P Noble2 and MI Tammi1 1 Department of Anatomy,
University of Kuopio, Kuopio, Finland and 2 Department of Medicine, Yale University, New Haven,
CT
Hyaluronan is a major matrix constituent between the proliferating basal cells and the differentiat-
ing spinous cells of human skin, and CD44 has been suggested to be its major cell surface receptor.
We therefore studied the expression of hyaluronan in the epidermis of CD44 knockout mouse. In
the mouse, epidermal hyaluronan concentration was developmentally regulated, being high during
the fetal period and shortly after birth, but low in adult skin. This was in contrast to humans, where
high epidermal hyaluronan expression remains throughout the life. The amount and localization of
epidermal hyaluronan in the CD44 negative mice corresponded that of the wild type in embryonic
and adult mice under normal conditions. In the wild type mouse, a mild trauma caused by tape strip-
ping triggered a strong increase in the content of epidermal hyaluronan, concomitantly with epider-
mal hyperplasia and induction of CD44 expression. In the epidermis of CD44 -/- mice, the hyaluro-
nan response to tape stripping was weaker than in the wild type mice. Despite the lower total
hyaluronan content in CD44 negative epidermis hyaluronan was found in the upper spinous and gran-
ular cell layers which were hyaluronan negative in the wild type mice. Keratinocytes isolated from
wild type and CD44 negative mice synthesized hyaluronan at about the same rate. However, the
wild type cells retained more hyaluronen in the cell layer than the CD44 -/- cells. Histochemical
staining confirmed this finding and showed that hyaluronan in the wild type cells was localized on
the dorsal cell surfaces, while in CD44 negative keratinocytes hyaluronan was mainly located between
the cells and the substratum. Our data show that adult mouse epidermis is characterized by a low but
inducible hyaluronan expression. The expression of CD44 is induced concomitantly with hyaluro-
nan upon wounding, and is necessary the proper organization of hyaluronan in the keratinocyte
pericellular matrix. 
0520
The dialog between keratinocytes and sensory neurons in the skin : approach using a simpli-
fied in vitro model
R Steinschneider,1 C Colomban,1 C Marteau,2 E Quelven-Rocher,1 J Franchi,2 P Andre2 and
J Laurent1 1 Bio Expertise Technologies, Marseille, France and 2 LVMH Branche Parfums et
Cosmetiques, Saint Jean de Braye, France
There are numerous cell contacts between neuritic fibers and cutaneous cells, which has led to the
concept of a neuro-cutaneous system. The cell bodies of sensory neurons are localised in the dorsal
root ganglia on each side of the spinal chord. Somatic sensory neurons transfer sensitive informa-
tion from the skin to the central nervous system. In response to inflammatory injury, there is an
anterograde release of neuropeptides through nerve fibers toward the cell layers of the epidermis. In
vivo, local release of neuromediators such as Calcitonin Gene-Related Peptide (CGRP) and sub-
stance P lead to modulate inflammatory reactions by keratinocytes. Neuropeptides specifically mod-
ulate the proliferation of inflammatory cells and the production of cytokines. In vitro, sensory neu-
rons are mature after 9 days and release CGRP and substance P. Cultured with neuropeptides, human
keratinocytes are stimulated and release inflammatory cytokines such as IL-8 and TNF-a. When neu-
rons are cocultured with keratinocytes in 96 or 24 well-culture microplates it has been shown, using
an enzyme immunoassay, that, the release of neuropeptides into the culture supernatant increases.
In addition, the release of CGRP can be down- or up-regulated by incubating these cultures with spe-
cific compounds. Immunofluorescence staining performed directly in the wells with either anti-
neurofilament (PGP 9.5) or anti-neuropeptide (CGRP) antibodies permit both to control the integrity
of the neurons before dosages and to quantify staining modulation by image analysis. From the results
obtained with several products, the use of this model within its limitations is proposed for the screen-
ing of molecules with either anti-inflammatory or soothing properties . 
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Retinoic acid up-regulates hyaluronan production but retards keratinocyte differentiation
S Pasonen-Seppanen,1 M Tammi,1 D MacCallum,2 E Maytin,3 V Hascall3 and R Tammi1 1
Department of Anatomy, University of Kuopio, Kuopio, Finland, 2 Department of Anatomy and
Cell Biology, University of Michigan, Ann Arbor, MI and 3 Department of Biomedical Engineering,
Cleveland Clinic Foundation, Cleveland, OH
Vitamin A is known to influence epidermal differentiation and cause hyperproliferation. Our previ-
ous work has shown that growth factors stimulating keratinocyte proliferation and impairing differ-
entiation induce epidermal hyaluronan production. Hyaluronan is the main extracellular matrix mol-
ecule in the vital cell layers of epidermis but it is virtually absent in the terminally differentiated cell
layers. In the present work we studied the influences of vitamin A on epidermal morphology and
hyaluronan content in organotypic keratinocyte cultures and mouse skin in vivo. We found that top-
ical treatment of mouse epidermis with retinoic acid lead to a rapid increase in the epidermal hyaluro-
nan content, concomitantly with increased expression of the hyaluronan receptor CD44, and hyper-
trophy of the epidermis. After 4 days treatment the ear epidermis was ~1.5 times thicker than the
control epidermis, with hyaluronan and CD44 localizing in the basal and spinous cell layers. Organ-
otypic keratinocyte cultures treated with retinoic acid became thicker than control cultures, and
showed accumulation of hyaluronan in the basal and spinous layers, as well as increased CD44
expression. Differentiation was deficient in retinoic acid treated cultures, stratum corneum was
thinner and the expression of K10 was diminished compared to control cultures. The data show that
retinoic acid regulates hyaluronan metabolism in epidermis, and that the effect is targeted directly
to keratinocytes since it can be reproduced in a culture model lacking other cell types. The data also
confirm the previous findings that increased hyaluronan content correlates with delayed differenti-
ation in epidermis. 
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Delineating the role of PKCδ in skin proliferation, differentiation and wound healing utilizing
PKCδ null mice
E Yousufov,1 R Spiro,1 M Gartsbein,1 M Leitges2 and T Tennenbaum1 1 Faculty of Life Sciences,
Bar Ilan University, Ramat Gan, Israel and 2 Max Planck Institute, Hanover, Germany
PKCδ, a novel PKC isoform, is implicated in migration, proliferation and differentiation of ker-
atinocytes. We have further delineated the role of PKCδ isoform in skin, by studying the character-
istics of skin in vivo and in vitro utilizing PKCδ knockout (KOδ) mice. The KOδ mice are born viable
and upon adulthood, males are infertile. However, skin gross appearance and morphology is nor-
mal. Mouse keratinocytes isolated from wild type (WT) and KOδ mice were characterized in vitro.
In comparison to WT keratinocytes, KOδ cells attached poorly to the culture dish with plating effi-
ciency reduced by 75%. WT keratinocytes fully spread 2-4 hours following attachment. In contrast,
KOδ keratinocytes maintained a rounded morphology up to 24 hours following plating and cell migra-
tion was radically reduced. In addition, proliferation of KOδ keratinocytes as measured by thymi-
dine incorporation was reduced by 70%, as compared to WT cells. This was associated with an
increased differentiation potential of KOδ keratinocytes. Prior to Ca+2 elevation, KOδ keratinocytes
but not WT cells expressed high levels of spinous markers keratin 1 and 10 with no change observed
in expression pattern of Filaggrin, a granular differentiation marker. Expression of these markers was
further increased following Ca+2 elevation. We have next subjected KOδ mice to wound healing stud-
ies. Full skin incisions were made on the back of mice and wounds were followed for 7 days. Impaired
wound healing was observed only in KOδ mice but not in KOα or KOζ mice as analyzed by wound
strength and histology of wound closure. Interestingly, KOδ skin expressed higher levels of spinous
(K1) and granular (Loricrin) differentiation markers. Altogether, these results suggest PKCδ as a
crucial mediator of keratinocytes attachment, spreading, proliferation and differentiation processes
in skin in vivo and in vitro. 
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Characterization of newly-exposed human wound keratinocytes
ML Usui,1 RA Underwood,1 LA Muffley,1 WG Carter2,3 and JE Olerud1 1 Medicine/Dermatology,
University of Washington, Seattle, WA, 2 Pathobiology, University of Washington, Seattle, WA and
3 Fred Hutchinson Cancer Research Center, Seattle, WA
Upon injury to the skin, keratinocytes exposed to various components from blood, cell products and
extracellular matrix undergo dramatic changes in order to migrate across the wound bed and even-
tually close the wound. Historically, there have been two models proposed to explain epidermal
wound closure: 1) the “sliding model” in which the basal keratinocytes actively migrate across the
wound matrix and 2) the “rolling model” in which suprabasal keratinocytes actively roll over basal
keratinocytes and tumble onto the wound matrix. We used immunohistochemical methods to label
incisional human wounds of 6 hour, 1 day and 3 day duration to evaluate the keratinocytes along the
wound margin that are in direct contact with the wound matrix. Antibodies included keratin mark-
ers K10, K14, K15, K16, cell surface integrin receptors alpha 2, alpha 3, alpha 5, beta 4, the uncleaved
(precursor) form and the cleaved form of laminin 5. At the wound edge, a sub-population of suprabasal
keratinocytes, defined by anatomical location, show differential expression of keratins K14, K15,
K16, the cell surface integrin receptors alpha 2, alpha 3, alpha 5, beta 4, as well as the uncleaved
and cleaved forms of laminin 5. With the exceptions of K10 and K16, all of these proteins are typ-
ically associated with basal keratinocytes. Our results suggest that these migratory suprabasal ker-
atinoctyes at the wound margin are capable of rapid adaptation to the wound environment. We con-
clude that both suprabasal and basal keratinocytes are actively involved in epidermal wound closure
allowing the largest possible pool of epithelial cells to participate in this process. 
0524
Uptake and elimination of drugs and endogenous substances in cells of the human skin is an
active process
JM Baron,1 R Heise,1 M Neis,1 F Rodrigues,1 D Hoeller,1 S Joussen,1 C Sturm,1 A Dreuw,2
HF Merk1 and FK Jugert1 1 Dept. of Dermatology, RWTH, Aachen, NRW, Germany and 2 Dept. of
Biochemistry, RWTH, Aachen, Germany
Normal human epidermal keratinocytes (NHEK) have been shown to express a cell type specific pat-
tern of cytochrome P450 enzymes and efflux transport proteins showing that these cells metabolize
and excrete a variety of xenobiotics. Recently transport proteins (organic anion transporting polypep-
tides, OATPs) involved in the uptake of xenobiotics have been detected and here we analysed the
mRNA- and protein-expression profiles and functional activities of these proteins in NHEKs in com-
parison to primary liver cells. Constitutive expression of OATP -B, -D and -E was shown for the first
time in NHEKs on a molecular level using RT-PCR and northern blot analysis, as well as in human
skin tissue shown by tissue blot hybridization and immunohistochemistry. Expression of OATP-A
and -C was not detected in any of the keratinocyte samples. In contrast, liver tissue showed a sig-
nificant expression of OATP-A and -B as well as OATP-C, a weak expression of OATP-D and no
expression of OATP-E. These data revealed that NHEK express a specific profile of transporters
involved in drug influx. Using a newly developed uptake-transport assay, uptake and efflux of endoge-
nous substances and xenobiotics like estradiol-17b-glucuronide and estrone sulfate was inhibited in
NHEKs by specific inhibitors such as taurocholate or indomethacin, verifying the functional capac-
ity of the expressed OATPs and MRPs. Human dermal fibroblasts seem to have a lower influx trans-
port activity for estradiol-17b-glucuronide which correlates with the immunohistological data. Even
though the substrate specificity of the OATP isoforms and MRPs is only partially known till now,
our findings support the concept that uptake and elimination of large organic cations like drugs in
keratinocytes is an active and cell type specific transport process. 
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Function of the N-terminal calcium-binding domain in human profilaggrin
RB Presland and L Barnes  Dept. of Oral Biology, University of Washington, Seattle, WA
Profilaggrin, a protein expressed in epidermal granular cells, consists of multiple filaggrin units and
N- and C-terminal domains that differ from filaggrin. Profilaggrin is initially stored in keratohyalin
granules and, as cornification proceeds, it is proteolytically processed by calcium-regulated proteases
to generate the keratin-binding peptide filaggrin and a N-terminal peptide that contains a S100 cal-
cium-binding domain. The N-terminal peptide (AB domain), once cleaved from profilaggrin, local-
izes to nuclei in epidermal granular and transition cells and shows a similar nuclear distribution when
expressed in vitro (JID 119:661-69, 2002). To further understand the function of the N-terminal cal-
cium-binding domain in regulating profilaggrin expression or processing, we mutated the key acidic
residues in each S100 EF-hand and examined expression and processing of a profilaggrin minigene
in vitro. Both control and mutant profilaggrin minigene constructs (consisting of FLAG-AB-5 filag-
grin units) were expressed in COS-7 cells and rat keratinocytes. Expression was examined by both
indirect IF and Western blotting. Abrogation of calcium binding did not affect either expression of
the profilaggrin miniprotein, or formation of the keratohyalin-like granules observed in transfected
cells in vitro. Studies are in progress to determine if calcium binding affects profilaggrin processing
in cultured keratinocytes or in transgenic mice expressing this transgene. 
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Comparative proteomic profiling of murine skin
C Huang, K Foster, T DeSilva, J Zhang, Z Shi, K Van Kampen, C Elmets and D Tang Dermatology,
UAB, Birmingham, AL
Mammalian skin is regularly exposed to different environmental stresses, each of which results in
specific compensatory changes in protein expression that can be assessed by proteomic analysis.
We have established a reference proteome map of murine skin allowing the resolution of greater than
five hundred protein spots in a single two-dimensional polyacrylamide gel. Forty-four protein spots,
corresponding to 28 different cutaneous proteins, were identified using MALDI-TOF MS and the
Mascot online database searching algorithm. Twenty-five proteins were expressed at higher levels
in the epidermis, whereas only 9 were found predominantly in the sub-epidermal tissues. Proteins
of diverse function were identified, including those involved in apoptosis, growth inhibition, the
maintenance of structural integrity, translational control, energy metabolism, calcium binding, cho-
lesterol transport, and the scavenging of free-radicals. Five molecular chaperones including ER60,
GRP78, HSP60, HSP70, and HSP27 were also identified. Of these, HSP27 expression was confined
mainly to the epidermis, and expression of ER60 was found primarily in the sub-epidermal tissues.
Proteomic analysis of skin following heat or cold shock resulted in increased levels of HSP27, HSP60,
and HSP70 suggesting involvement of these chaperones in the cutaneous response mechanism to
temperature stress. These data establish numerous reference markers within the proteome map of
murine skin and provide an important framework for future efforts aimed at characterizing the epi-
dermal and sub-epidermal responses to environmental changes. 
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Epidermal stem cell frequency: a novel in vivo functional assay
TE Schneider,1 C Barland,1 AM Alex,1 ML Mancianti,2 Y Lu,3 JH Lawrence4 and R Ghadially1 1
Dermatology, University of California, San Francisco, CA, 2 Pathology, Alta Bates Medical Center,
Berkeley, CA, 3 Biostatistics Core, UCSF Cancer Center and Dept of Radiology, San Francisco,
CA and 4 Hematology/Oncology, VA Medical Center, San Francisco, CA
The field of hematopoietic stem cells has been greatly advanced by a quantitative, in vivo assay that
relies on the long-term repopulating ability of stem cells to define them. Using the same concepts
but different experimental parameters we developed an analagous repopulating assay to study stem
cell function in the epiderms. Our assay utilizes green fluorescent protein (GFP)+ keratinocytes and
GFP- keratinocytes from the interfollicular epidermis of neonatal GFP transgenic mice.  One mil-
lion GFP- keratinocytes are seeded with variable numbers of GFP+ keratinocytes in a silicone
chamber on the fascia of a severe combined immunodeficient mouse(SCID), and produce an epi-
dermis in two weeks.  Epidermis is harvested at 5-6 weeks, ensuring that all transit-amplifying and
differentiated cells have been lost. Chamber epidermis thus consists of stem cells initially added,
along with their subsequent progeny. Such long-term competitive assays ensure the detection of only
the most primitive stem cells. A limiting dilution design allows stem cell quantification. To deter-
mine stem cell frequency in neonatal murine epidermis limiting dilutions of GFP+ keratinocytes
were implanted, ranging from 50,000 to 3,250 GFP+ keratinocytes.  At 5-6 weeks presence or absence
of a GFP+ epidermal proliferation unit was determined by fluorescent microscopy of epidermal
whole mounts. Two different statistical methods for limiting dilution analysis, L-Calc and GEN-
MOD, were used. Stem cell frequency of neonatal murine epidermis was 1 in 26,500 (95% confi-
dence limits (1 in 14,000 to 1 in 51,000). The p-value of χ2 was not statistically significant, demon-
strating the validity and lack of inconsistency in our assay.  This assay will also allow us to study
changes in stem cell frequency with age and disease and to determine the efficacy of various puta-
tive stem cell isolation procedures. 
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Consequences of dominant-negative mutations in serine palmitoyltransferase: hereditary
sensory neuropathy and reduced epidermal barrier integrity
K Bejaoui,2 Y Uchida,1 J Fluhr,4 S Yasuda,3 M Nishijima,3 K Hanada3 and WM Holleran1 1
Dermatology (190), UCSF & VA Med Center, San Francisco, CA, 2 Day Neuromuscular Lab,
Charlestown, MA, 3 Biochemistry & Cell Bio, NIID, Tokyo, Japan and 4 Dermatology, Friedrich
Schiller Univ, Jena, Germany
Ceramides (Cer) are critical lipid components of the epidermal permeability barrier. Serine palmi-
toyltransferase (SPT), the enzyme that catalyzes the first committed step in Cer synthesis, com-
prises a heterodimer of two subunits derived from separate genes, SPTLC1 & SPTLC2. Mutations
in SPTLC1 are associated with hereditary sensory neuropathy type 1 (HSN1), a dominantly-inher-
ited degenerative disorder of peripheral nerves (Bejaoui, Nat Genetics 27:261, 2001 & JCI 110:1301,
2002). We investigated effects of SPTLC1 mutations (C133Y & C133W) identified in two HSN1
families, on extracutaneous SPT activity and sphingolipid synthesis, stratum corneum Cer distribu-
tion, ultrastructure, and epidermal barrier integrity. Although neither C133Y & C133W mutations
altered steady-state protein levels for SPT1 (or SPT2), each reduced SPT activity and Cer synthesis
(approx 50%) in HSN1 lymphoblasts. Consistent with a dominant-negative mechanism, mutated
SPT1 impaired the ability of normal SPT1 subunit to complement the SPT deficiency in Chinese
hamster ovary (CHO) cells lacking normal SPT1, and inhibited SPT activity in normal CHO cells.
Baseline transepidermal water loss (TEWL) was elevated (1.5- to 2.0-fold), and barrier integrity
was compromised (TEWL >2.5-fold elevated after 10 consecutive D-Squame strips) in an HSN1
patient with advanced peripheral neuropathy compared with healthy control values. Despite dimin-
ished barrier function, ultrastructure revealed areas with normal-appearing stratum corneum lamel-
lar membrane structures, and epidermis displayed a typical distribution of Cer species. These stud-
ies reveal a dominant-negative mechanism for SPT mutations associated with HSN1, and suggest,
despite altered SPT1 function, near-normal baseline epidermal de novo Cer generation, possibly
reflecting extra-cutaneous and/or dietary compensation. 
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Calcium-fluorescence lifetime imaging in ex vivo skin
MJ Behne,1 NP Barry,2 E Gratton2 and TM Mauro1 1 Dermatology, UCSF, San Francisco, CA and
2 LFD, UIUC, Urbana-Champaign, IL
Calcium controls essential processes of epidermis and keratinocytes, such as differentiation, sig-
naling, and cell adhesion, and is important in a number of pathogenetic processes, e.g., Darier Dis-
ease, Hailey-Hailey Disease, and Psoriasis. Previous studies of Ca2+ signaling in epidermis using
electron microscopy with Ca2+-precipitation methods, by proton-induced X-ray emission (PIXE),
or by applying Ca2+-sensitive dyes to tissue sections were limited, in that these technologies can
determine Ca2+ in only very small sample volumes, require frozen or fixed tissue, or determine total
Ca2+ only, irrespective of ionization- or binding-state. Only in cultured cells have fluorescent dyes
and transfected constructs been used to assess cellular or subcellular Ca2+ concentrations. Thus, extra-
cellular and intracellular absolute Ca2+ concentrations are unknown. In our recent publications, we
described Fluorescence Lifetime Imaging Microscopy (FLIM) to assess pH in intact epidermis. Here
we report another application of FLIM, to measure and visualize Ca2+ in ex-vivo biopsies of unfixed
epidermis. We show overall increasing Ca2+ concentrations from basal (SB) to granular (SG) layers,
confirming our prior PIXE and Ca2+-precipitation results. In addition, FLIM demonstrates a shift in
the cellular Ca2+ distribution pattern: while in the SC highest concentrations seem to be limited to
the cellular domain, i.e. the corneocytes, within the SG highest Ca2+ concentrations are found in the
extracellular compartment and in an ER-like distribution intracellularly, while the cytosol itself dis-
plays very low Ca2+ concentrations. Currently, we are expanding the dynamic range of the FLIM
methodology, so that both intracellular changes in the nanomolar range and extracellular changes in
the micromolar range of Ca2+ concentrations can be assessed. Comparison of changes in these two
compartments and their regulation are especially important to assess functional consequences in bar-
rier homeostasis and repair, as well as various pathologic states. 
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Linoleate is required for normal omega-esterification of ceramide & corneocyte lipid envelope
formation: insights from murine essential fatty acid-deficient epidermis
Y Uchida,1 M Hara,2 M Behne,1 P Elias1 and WM Holleran1 1 Dermatology (190), UCSF & VA
Med Center, San Francisco, CA and 2 Basic Research Lab, Kanebo Ltd., Odawara, Japan
Omega-hydroxy (OH) ceramides (Cer) are unique to the stratum corneum and essential for epider-
mal permeability barrier homeostasis. Whereas acylated-omega-OH-Cer (acylCer), esterified pre-
dominantly with linoleic acid, serve as constituents of extracellular lamellar bilayers in the SC, non-
esterified omega-OH Cer are covalently bound to cornified envelope proteins to form the
cornified-bound lipid envelope (CLE). Our prior studies reveal the following sequence for the for-
mation of omega-OH Cer & the CLE: 1) very long chain fatty acid synthesis precedes omega-hydrox-
ylation and subsequent Cer formation; 2) acylCer formation precedes acylGlcCer generation; 3) glu-
cosylation of omega-OH Cer and/or acylCer precedes covalent attachment to the CE; and finally, 4)
deglucosylation of acylGlcCer & covalently-bound omega-OH GlcCer is the final step that gener-
ates acylCer of the extracellular lamellar bilayers and omega-OH Cer of the mature CLE. Here, we
used the essential fatty acid-deficient (EFAD) murine model to investigate a key intermediate step;
i.e., whether omega-esterification, specifically with the essential fatty acid, linoleate, is required for
normal acylCer and/or acylGlcCer formation. A significant decrease in the levels of both (unbound)
acylGlcCer (0.84 vs. 2.1 ug/mg dry epidermis; p <0.01) and covalently-bound omega-OH Cer (0.82
vs. 1.9 ug/mg dry epidermis; p<0.001) was evident in EFAD vs. normal epidermis, respectively.
Although the content of both non-linoleate-containing acylCer and other unbound Cer species were
largely unchanged, the levels of GlcCer were significantly increased (>25%; p<0.01) in EFAD vs.
normal epidermis, confirming that glucosylation of normal acylCer precedes, and may be required
for, normal CLE formation. The diminished acylGlcCer and CLE despite near-normal acylCer lev-
els indicate that non-linoleic-containing acylCer are inefficient substrates not only for glucosylation,
but also for CLE formation. 
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Effects of multi-lamellar emulsion (MLE) on glucocorticoid induced barrier impairment
Y Kim,1 J Youm,1 B Park,1 S Lee2 and S Ahn3 1 Research Center, NeoPharm Co. Ltd., Daejeon,
South Korea, 2 Dermatology, Yonsei Univ. College of Medicine, Seoul, South Korea and 3
Dermatology, Yonsei Univ. Wonju College of Medicine, Wonju, South Korea
Repeated treatment with topical glucocorticoids can result in cutaneous abnormalities. The abnor-
mality in barrier homeostasis is corrected by ceramides, cholesterol and free fatty acids, which sug-
gests that the glucocorticoid induced inhibition of epidermal lipid synthesis is a major factor account-
ing for the derangement in cutaneous function. In a previous study, the combination of MLE and
steroids was shown to have a preventive effect on glucocorticoid-induced skin atrophy. In this study,
the levels of the mRNA for HMG-CoA reductase, fatty acid synthase (FAS), serine palmitoyltrans-
ferase (SPT) following 3, 6 days of topical 0.05% clobetasol-17-propionate (CP) and 0.05% CP in
MLE (MLE/CP) treatment were measured using a quantitative real-time PCR system. In addition,
this study examined whether providing MLE, as a lipid mixture twice daily for a week, immediately
after CP treatment would further normalize the glucocorticoid-induced barrier impairment. The
results of the first study showed that the MLE/CP treated skin had a slightly smaller reduction in the
HMG-CoA reductase, FAS and SPT mRNA levels compared to the CP treated skin. The results of
the second study showed that the topical application of CP to intact skin resulted in a significant
increase in the TEWL values compared to those from the vehicle treated group after a week (p<0.05),
whereas the topical application of MLE immediately after CP treatment prevented the glucocorti-
coid-induced TEWL increase. As for the epidermal thickness measurements using light microscopy,
the MLE treated skin immediately after CP treatment for a week showed a slightly lower decline
than the CP treated skin. In addition, the EM findings showed relatively well-conserved lamellar
bilayers in the MLE treated skin compared to the CP treated skin. These results suggest that the appli-
cation of MLE after a CP treatment should be effective in restoring the barrier impairment induced
by glucocorticoids. 
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Is the filaggrin-histidine-urocanic acid pathway required for stratum corneum acidification?
PM Elias,2 M Man,2 JW Fluhr,1,2 C Selden,5 RB Presland,3 P Fleckman,3 JP Sundberg4 and
KR Feingold 2 1 Dermatology, Friedrich-Schiller-University Jena, Jena, Thueringen, Germany, 2
Dermatology and Medicine, UCSF, San Francisco, CA, 3 Dermatology and Medicine, Univ. of
Washington, Seattle, WA, 4 The Jackson Laboratories, Bar Harbor, ME and 5 Division of Medicine,
Imperial College School of Medicine, Hammersmith Hospital, London, United Kingdom
Until recently, little was known about the origin or function of the stratum corneum (SC) acid man-
tle, beyond its putative link to colonization by normal and pathogenic microbial flora. Recent stud-
ies point to additional key SC functions that are regulated by pH: barrier function, SC integrity/cohe-
sion, and cytokine activation/release. Although exogenous processes, such as microbial metabolites,
sebaceous lipids, and/or eccrine gland products have been proposed to account for SC acidification,
2 endogenous processes recently were shown to mediate SC acidification: the sodium-protein (NHE1)
antiporter and phospholipid-derived free fatty acids. In this study, we examined the importance of
urocanic acid (UCA) generation by histidase-catalyzed deamination of histidine for SC acidifica-
tion. To assess the role of this pathway, we measured SC pH, hydration, and permeability barrier
homeostasis in 2 murine models, Peruvian (his/his mutant) mice, which display <10% normal his-
tidase activity, and in spontaneous mutant ‘flaky tail’ mice that reduced filaggrin, the precursor of
most, if not all of the histidine in the SC. Homozygous animals from both models displayed a nor-
mal SC pH, normal SC hydration, and normal barrier function (both basal & recovery kinetics).
Further, normal neonatal animals showed no increase in SC histidase activity during post-natal
acidification of the SC, suggesting that this pathway does not contribute to development of the SC
acid mantle. Together, these results suggest that the histidase pathway is not required for normal SC
acidification. 
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Differentiation-dependent transcriptional regulation of serine palmitoyltransferase in human
keratinocytes
Y Uchida,1 S Murata,2 S Linn,3 J Allegood,3 P Elias,1 A Merrill3 and WM Holleran1 1 Dermatology
(190), UCSF & VA Med Center, San Francisco, CA, 2 Dermatology, Jichi Medical Sch, Tochigi,
Japan and 3 Molec Cell Biol, Georgia Tech, Atlanta, GA
Serine palmitoyltransferase (SPT), the rate limiting enzyme for sphingolipid synthesis, is a het-
erodimer of two distinct gene products, SPT1 and SPT2. Given the importance of epidermal sphin-
golipids, including ceramide (Cer), glucosylceramide (GlcCer) & sphingomyelin as barrier lipid
components, we are studying the mechanisms by which SPT activity is regulated during epidermal
differentiation. We previously demonstrated that both SPT and GlcCer synthase expression are
increased through a PKC-dependent mechanism in cultured human keratinocytes (CHK) during
tetradecanoyl phorbol 13-myristate (TPA)-induced differentiation. Consistent with SPT activation,
Western blot analyses now reveal increases in both SPT1 & SPT2 subunits following TPA (10 nM)
treatment. Although quantitative real-time PCR analyses demonstrate a significant increase in SPT2
(2.3kbp) mRNA with time (1.6-, 3.0- & 1.8-fold at 8, 16 & 24h, respectively) following TPA, SPT1
mRNA was not significantly altered at any time point. Parallel Northern blot analyses confirmed the
increase in SPT2 mRNA, with no alteration in SPT1 mRNA levels. The pan-PKC inhibitor (Bis-
IM) abolished the increases in both enzyme activity and SPT2 mRNA levels, confirming the PKC-
dependence of this response. Finally, TPA significantly increased SPT2 promoter activity (4-fold;
p<0.01) in CHK transfected with a luciferase construct containing 1.8kb of the human SPT2 upstream
promoter. Given that SPT1 heterodimerizes with SPT2 to form active holoenzyme, these results: 1)
demonstrate that transcriptional upregulation of SPT2 is responsible at least in part for PKC-depend-
ent upregulation of SPT activity; 2) reveal that post-transcriptional regulation of SPT1 protein lev-
els also contribute to differentiation-dependent increases in SPT activity; and 3) suggest that con-
stitutive SPT1 mRNA levels are sufficient to accommodate differentiation-dependent increases in
SPT activity and subsequent sphingolipid synthesis. 
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Up-regulation of Tight Junction proteins in skin with altered barrier function
I Moll,1 E Proksch,2 S Kief,1 E Wladykowski,1 S Loges,3 J Jensen,2 NK Haass1 and JM Brandner1
1 Department of Dermatology and Venerology, University Hospital Hamburg-Eppendorf,
Hamburg, Germany, 2 Department of Dermatology, University of Kiel, Kiel, Germany and 3
Department of Hematology, University Hospital Hamburg-Eppendorf, Hamburg, Germany
Tight Junctions (TJ) are cell-cell junctions which are long known to play an important role in the
barrier function of simple epithelia and endothelia. Recently we and others have shown the existence
of TJ in stratified epithelia e.g. the epidermis. Knock-out mice deficient in claudin-1, which is an
important TJ-transmembrane protein, die at the first day after birth due to a tremendous transepi-
dermal water loss, hinting for the importance of TJ also for the barrier function of the skin. We were
interested in the expression and synthesis of TJ proteins in human and mouse skin with altered bar-
rier function, e.g. due to diseases, tape-stripping or culture conditions. By using RT-PCR-techniques,
immunolocalization and cell culture techniques we can show the time-dependent upregulation of
various TJ proteins, e.g. occludin and claudin 4, after impairment of the barrier function of the skin.
Moreover we show a down-regultation of TJ proteins in areas of diseased skin with acute inflam-
mation. The putative role of the various TJ proteins in the barrier function of the epidermis is dis-
cussed. 
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Expression of neutrophil gelatinase-associated lipocalin gene in human keratinocytes
J Lee, E Seo, K Kye and Y Piao Dermatology, School of Medicine, Chungnam National University,
Daejon, South Korea
Neutrophil gelatinase-associated lipocalin (NGAL) was originally identified as a 25-KDa protein
covalently associated with 92-KDa gelatinase from human neutrophils. Besides neutrophils, it is now
known to be expressed in most tissues normally exposed to microorganisms and its synthesis to be
induced in epithelial cells during inflammation. However, there have been no studies about its expres-
sion in the epidermis. We isolated NGAL gene using suppression subtractive hybridization to iden-
tify differentially expressed genes during keratinocyte differentiation. Northern analysis found that
its mRNA expression was increased in response to high concentrations of calcium in cultured human
keratinocytes. In situ hybridization and immunohistochemistry in normal human skin also confirmed
its expression in human epidermis. Westhern blot analysis showed abundant NGAL protein during
calcium-induced differentiation of human keratinocytes. Because NGAL protein is a secretary pro-
tein, a specific enzyme-linked immunosorbent assay was also used for the determination of NGAL
in cultured human keratinocytes medium, showing that the secretion of NGAL was increased hun-
dreds times in a time-dependent fashion following the addition of calcium in the medium. Based on
the these observations, there may be suggested that NGAL was expressed in human epidermis and
its synthesis was induced during keratinocyte differentiation, but further studies are necessary in
order to determine the functional roles of NGAL in human skin biology 
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A novel approach for the analysis of the nerve end organ in human skin
CM Reinisch,1 W Weninger,1,5 C Mayer,1 K Paiha,3 H Lassmann2 and E Tschachler1,4 1 Department
of Dermatology, University of Vienna Medical School, Vienna, Austria, 2 Division of
Neuroimmunology, Brain Research Institute, University of Vienna Medical School, Vienna, Austria,
3 Institute of Molecular Pathology, Vienna, Austria, 4 CE.R.I.E.S., Neuilly, France and 5 The
Center for Blood Research, Department of Pathology, Harvard Medical School, Boston, MA
Bearing the sensory nerve end organ, the skin is establishing contact to the environment and is as
such a very important part of our nervous system. Nevertheless, most of our knowledge about the
architecture of the skins nervous system is originating from the middle of the 20th century and still
surprisingly little is known about its three-dimensional topography. We used dermal sheet prepara-
tions, immunohistochemical staining thereof with antibodies to PgP9.5 and NCAM/CD56 and sub-
sequent confocal laser scanning microscopy in order to analyse the intact nerve end organ in situ in
three dimensions. Both antibodies showed a regular network of fibers throughout the entire super-
ficial dermis. Staining for PgP9.5 was weaker and nerve fibers were not decorated continuously, but
in a bead like fashion. NCAM/CD56 staining additionally presented protrusions with diameters rang-
ing from 5 to 15µm. In further immuno-electron microscopic analysis, we detected evidence for
ultrastructural features of Schwann cells ensheating terminal nerve endings. These endings appeared
to end freely and spread out within 25µm below the dermo-epidermal junction. To visualize the topo-
graphic relationship of the nerve end organ with other skin components, double staining with
NCAM/CD56 and anti-vWF was done. Larger trunks of the nerve end organ were found to inter-
twine with the superficial capillary plexus but no obvious relation of terminal nerve endings and
blood vessels could be found. Our novel approach will help to further characterize the nerve end
organ under physiologic conditions as well as during diseases of the skin. The fact, that nearly all
penicillate nerve endings spread out below the dermo-epidermal junction should make us think again
about the presence of nerve fibers in the epidermis. 
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In vitro assessment of cytoskeletal instability in patients with various keratin mutations
E Pavez Lorie, M Virtanen, H Torma and A Vahlquist Dept. of Medical Science/Dermatology,
Uppsala University, Uppsala, Sweden
The cytoskeleton of keratinocytes is composed of keratins, which constitute the intermediate fila-
ments (IF). Mutations in different keratin genes cause weakening of the IF network leading to var-
ious skin fragility syndromes (Epidermolysis bullosa simplex, due to K5/14 mutations and Epider-
molytic hyperkeratosis, due to K1/10 mutations). Such patients constitutively express an increased
level of heat-shock proteins (Hsp:s) in the epidermis, probably because the cells are continuously
repaired. To further characterize this stress-induced response in various keratin disorders, keratinocytes
were exposed to mild heat treatment (42 C for 30 min.) and harvested after 0-24h of post-incuba-
tion at 37 C. The mRNA and protein levels of Hsp 27 and 72 were examined by RT-PCR and West-
ern blot and the structure of IF by immunofluorescence, using a keratin antibody. In the heat-exposed
cells the IF network collapsed and the Hsp expression was subsequently elevated in a time-depend-
ent manner. These results support the idea of a correlation between alterations in the IF network and
the stress response of keratinocytes. Combining the analysis of the IF network and expression of
stress proteins after mild heat-treatment in vitro, might be a useful tool to study various methods to
improve the stability of keratinocytes with mutations in keratin genes. 
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Oleanolic acid stimulates differentiation of epidermal keratinocytes via PPAR-alpha pathway
G Nam, S Kim, W Park, K Kim, J Lee, C Lee, B Lee and I Chang Skin Research Team, Amore-
Pacific R&D Center, Yongin-si, Gyeonggi-do, South Korea
Naturally occurring triterpenoids like oleanolic acid and ursolic acid are known to have anti-inflam-
matory and anticarcinogenic activities in some cells. However, the effect of triterpenoid on epider-
mal keratinocytes is not fully understood. In this study we observed that oleanolic acid stimulates
differentiation of epidermal keratinocytes. The rate of formation of cornified envelope, a marker of
keratinocytes terminal differentiation, and the protein required in the process, transglutaminase were
found increased in human keratinocytes treated with oleanolic acid. This is a sharp contrast with
ursolic acid, which does not give effect on the differentiation of keratinocytes. In addition, we found
that differentiation induced by oleanolic acid is mediated by PPAR-alpha pathway. Increase in
PPRE(PPAR response element) activity due to oleanolic acid was observed to be related to PPAR-
alpha activity in CV-1 cells by reporter gene assay. These results suggest that oleanolic acid stimu-
late differentiation in epidermal keratinocytes presumably by activating PPAR-alpha. 
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Small changes in either or both Ca2+ affinity and Ca2+ transport rate in sarco(endo)plasmic
reticulum Ca2+-ATPase 2b will result in Darier’s disease
K Sato,1 Y Miyauchi,1 K Yamasaki,2 T Daiho,2 S Nakamura,1 A Ishida-Yamamoto,1 H Takahashi,1
H Suzuki2 and H Iizuka1 1 Dermatology, Asahikawa Medical College, Asahikawa, Hokkaido,
Japan and 2 Biochemistry, Asahikawa Medical College, Asahikawa, Hokkaido, Japan
Sarco(endo)plasmic reticulum Ca2+-ATPase 2b (SERCA2b) catalyzes ATP-dependent Ca2+ transport
from cytoplasm into ER lumen. Darier’s disease (DD) is caused by mutations in the gene encoding
this protein1) and thus believed to be the consequence of disturbance in the Ca2+ homeostasis in skin
cells. In the Ca2+ transport cycle, the enzyme is activated by binding of two cytoplasmic Ca2+ ions
to the high affinity transport sites, and then autophosphorylated by ATP to form obligatory phos-
phoenzyme intermediate (EP). During the subsequent hydrolysis of EP, the bound Ca2+ ions are
released into lumen. To understand what kind of and how much of changes in the properties of
SERCA2b are actually causing DD, we performed detailed kinetic analysis on the missense mutants
of which Ca2+ transport activity was found seemingly to be nearly normal or only moderately reduced
as compared with that of the wild type. These mutants were highly expressed in COS-1 cells as the
wild type, and thus recovered in microsomal fraction for the functional analysis. We found that
these mutants are categorized into three groups having; 1st, reduced Ca2+ affinity at the Ca2+ trans-
port sites (by only ~3 fold or more) but nearly normal transport activity; 2nd, normal Ca2+ affinity
but reduced rate of EP hydrolysis and thus of Ca2+ release into lumen (50-80% of that of the wild
type); 3rd, both the reduced Ca2+ affinity and reduced Ca2+ release rate. It would be expected that in
the 1st group, the cytoplasmic Ca2+ level in the skin cells is shifted to the level higher than the nor-
mal, while in the 2nd group, the rate of Ca2+ transport from cytoplasm into ER lumen is slowed.
Results indicate that either or both reduction (even only slight or moderate reduction) in the Ca2+
affinity and that in the Ca2+ transport rate in SERCA2b will result in DD. 
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Effects of ursolic acid and oleanolic acid on the skin barrier function
S Lim,1,2 S Jung,1 B Kim,1 H Ryoo,1 S Lee2 and S Ahn3 1 R&D center of Skinscience and
Cosmetics, ENRPANI Co., Inchon, South Korea, 2 Dermatology, Yonsei Univ. College of Medicine,
Seoul, South Korea and 3 Dermatology, Yonsei Univ. College of Medicine, Wonju, South Korea
Ursolic acid (UA) and Oleanolic acid (ONA), known as urson, prunol, and malol, are pentacyclic
triterpenoids which naturally occur in a large number of medicinal herbs and plants. They may
occur in their free acid form or as aglycones for triterpenoid saponins, which are comprised of a
triterpenoid aglycone, linked to one or more sugar moieties. Recently research, which led to the iden-
tification of UA and ONA, revealed several pharmacological effects, such as antitumor, anti-inflam-
matory, antimicrobial and anti-hyperlipidemic could be attributed to UA and ONA. Here, we intro-
duced the effect of UA and ONA on acute barrier disruption and normal epidermal barrier. To clarify
the effects of UA and ONA on skin permeability, both flank skin of 8-12 weeks hairless mice were
topically treated with samples (2mg/ml), then measured recovery rate using TEWL. The recovery
rate increased in these groups at 6h more than 20% compared to vehicle (Veh) group (p<0.05). For
verifying the effects of UA and ONA on normal epidermal barrier, hydration and TEWL were meas-
ured for 1 and 3 weeks after UA and ONA application (2mg/ml per day). We also investigated the
features of epidermis and dermis using electron microscopic (EM) and light microscopic (LM) exam.
Both samples increased hydration compared to Veh group from 1 week without TEWL alteration
(p<0.005). EM finding revealed that secretion and numbers of lamellar bodies and complete for-
mation of lipid bilayers were most prominent (ONA >UA>Veh). LM finding showed stratum corneum
was slightly increased and especially epidermal thickening and flattening was observed
(UA>ONA>Veh). Using Masson-trichrome and elastic fiber staining, we observed collagen thick-
ening and elastic fiber increasing by UA and ONA treatments. This result suggested that the effects
of UA and ONA related to not only skin barrier but collagen and elastic fibers. Taken together, UA
and ONA can be pertinent candidates to improve barrier function and for skin therapeutic agent. 
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Investigation of effective materials to increase sphingolipids in the skin
H kim,1 S Nam,2 W Choi,2 J Kim,2 C Park,2 S Ahn3 and S Lee1 1 Department of Dermatology,
Yonsei University College of Medicine, Seoul, South Korea, 2 Cosmeceuticals Team, DOOSAN
Biotech BU, Yongin, South Korea and 3 Department of Dermatology, Yonsei University Wonju
College of Medicine, Wonju, South Korea
Sphingolipids play an important role in the homeostasis and barrier function of human stratum
corneum (SC). Three major lipids in mammalian SC are ceramides, cholesterol, and free fatty acids
(FFA), which are organized into extracellular bilayers that serve the epidermal permeability barrier
function. Prior studies have provided indirect and direct evidence for the importance of epidermal
ceramides for the barrier. Ceramides are the major component of the stratum corneum, accounting
for 30%-40% of stratum corneum lipids by weight, and are composed of at least seven molecular
groups. In this study, we investigated the effective materials to increase sphinolipids of hairless
mice skin after barrier disruption. Serine (S), phosphatidylserine (PS), vitamin C (V), S/V mixture,
PS /V mixture were topically applied on the flank of mice after tape stripping. TEWL was measured
before, 0, 3, 6, 12 and 24h after barrier disruption. Topical application of S, PS, V, S/V and PS/V to
hairless mice improved the permeability barrier compared with vehicle application. And also S/V
significantly ameliorated on epidermal permeability barrier recovery. The major epidermal and SC
lipid species were separated by high performance thin-layer chromatography (HPTLC). Analysis of
lipid composition by HPTLC after S/V and PS/V application showed an obvious increase in all the
main components of SC lipids, which are known to constitute the permeability barrier of the skin.
We measured the gene expression of Serine palmitoyltransferase(SPT) following S, PS, V, S/V and
PS/V supplementation in human keratinocyte using RT-PCR. The expression level of SPT increased
significantly in serine vs vehicle-treated cells. Thus, S, PS, V, S/V and PS/V induce both increased
sphingolipid production and ehhancement of epidermal permeability barrier recovery. 
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EpiDerm™ Full Thickness, a dermal/epidermal skin equivalent with a fully developed base-
ment membrane
PJ Hayden, M Klausner, J Kubilus, S Ayehunie, B Burnham, GR Jackson and JE Sheasgreen
MatTek Corp., Ashland, MA
Paracrine signaling between dermal fibroblasts (FB) and epidermal keratinocytes (KC) is believed
to modulate skin responses during contact irritant or allergic reactions. Dermal FB also play an impor-
tant role in photo-aging and photo-damage, wound healing and cancer progression. To enable in vitro
study of these and other dermal phenomena in which FB-KC interactions are important, a full thick-
ness skin model composed of a FB-containing dermis/KC-containing epidermis was developed. Nor-
mal human epidermal KC and dermal FB were cultured to produce highly differentiated full-thick-
ness tissues extending wall-to-wall in cell culture inserts. Histologic examination of the tissue
shows a collagen dermis populated by numerous viable FB and an epidermis consisting of stratified
KC including basal, spinous, granular and stratum corneum components. Examination of tissue ultra-
structure at the dermal/epidermal junction by transmission electron microscopy revealed a well-
developed basement membrane. Hemidesmosomes were observed at the basal membranes of KC,
with associated tonofilaments extending into the cytoplasm. Well-defined, continuous lamina densa,
lamina lucida and fine anchoring filaments were present beneath the basal KC. Anchoring fibrils
with characteristic striated structure connected the lamina densa to the underlying collagen matrix.
Immunohistochemical analysis of basement membrane proteins was also performed on frozen tis-
sue sections. Protein markers of hemidesmosomes (alpha6 integrin), lamina lucida (laminin 5),
lamina densa (collagen IV) and anchoring fibrils (collagen VII) were specifically localized to the
dermal/epidermal junction. EpiDerm-FT overcomes shortcomings of previous skin equivalent mod-
els in terms of providing a wall to wall tissue as well as appropriate in vivo-like basement mem-
brane development. These attributes will enable more realistic in vitro studies of dermal/epidermal
phenomena. 
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Ceramide metabolism in the aged epidermis
J Jensen,1 S Winoto-Morbach,2 M Schunck,1 C Neumann,1 M Foerl,1 S Schuetze2 and E Proksch1
1 Dermatology, University of Kiel, Kiel, Germany and 2 Immunology, University of Kiel, Kiel,
Germany
Ceramides, are a major component of stratum corneum lipids and most important for skin barrier
function. The aging process reduces skin function, although basal skin barrier function remains nor-
mal, barrier repair is delayed after injuries to the skin. The present study examines the activities of
ceramide providing enzymes including ceramide synthase and sphingomyelinase in the epidermis
of young hairless mice (< 3 months) and aged hairless mice (>18 months). In addition, we also exam-
ined the activity of catabolic acid ceramidase in the metabolic breakdown of ceramide. The ceramide
synthase activity assay was performed using 14C-labeled palmitoyl-CoA as described in J Biol Chem
275: 30344-54, 2000. Acid sphingomyelinase activity, using 14C-sphingomyelin, was determined
as shown in J Clin Invest 104: 1761-70, 1999. For assaying katabolic acid ceramidase, 14C-palmi-
toyl-sphingosine was used as substrate according Adv Exp Med Biol 477: 305-15, 2000. Our results
showed a 40% reduction in ceramide synthase activity in the epidermis of senescent mice, in con-
trast to young mice. A 39% acid sphingomyelinase activity reduction was shown in the inner epi-
demis of aged controls in contrast to young controls. Acid sphingomyelinase activity was unchanged
in the uppermost epidermal layers. Ceramide catabolizing acid ceramidase activity also remained
unchanged. Based on this results, we correlate reduced permeability barrier repair in senescent skin
with both reduced ceramide synthase activity and lower sphingomyelinase activity in the inner lay-
ers of epidermis. Acid sphingomyelinase in the outer epidermis and acid ceramidase are essential in
maintaining basal skin barrier homeostasis and remain unchanged despite the aging process. 
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In situ characterization of proteasome in human keratinocytes—protein substrate overload
with cellular age
F Bregegere,2,1 Y Soroka,1 Y Eibi1 and Y Milner1 1 Myers Skin Laboratory, Hebrew University of
Jerusalem, Jerusalem, Israel and 2 Laboratoire de Biologie du Vieillissement, Universite Paris7,
Paris, France
Because modified proteins are accumulating in aging cells, proteasome, the main structure respon-
sible for protein turnover, is alleged to be controlling the aging process. We have investigated the
role of proteasome in keratinocyte aging. We showed [Petropoulos et al., J. Gerontol. 2000, 55A,
B220-B227] that accumulation of modified proteins occurs in aging keratinocytes, together with
decrease of proteasome specific activity in cell extracts. In order to determine true proteasome
activity within cells, we developed conditions for in situ measurement of proteasome activities in
permeabilized keratinocytes. Proteasome, as well as β-galactosidase as an aging marker, were assayed
in situ by using fluorogenic peptides or β-galactoside, respectively, in attached or suspended cells
obtained from cultures or from skin epidermis. The assay was performed either in microtiter plates
or in a flow cytometer. Amounts of cellular proteins were determined by protein staining in microplates,
and by FITC binding in flow-cytometric experiments. We observed a drastic increase in cell size
and protein content in aging keratinocytes, while proteasome activity per cell remained grossly con-
stant. Hence proteasome specific activity (per milligram of cellular protein) is significantly decreas-
ing with age, and the load of protein substrate might be too large. This may result in a reduction of
the relative proteolytic rate, and contribute to the accumulation of oxidated and modified proteins
in senescent cells. We directly investigated this point by inducing proteasome “shortage” in cell cul-
tures, due to the constant presence of the proteasome inhibitor MG132. Preliminary results showed
that cell size, protein content, and β-galactosidase activity, tend to increase in these conditions, as
well as other age-related markers. Further studies are under way in our laboratory, to verify the
involvement of proteasome in the aging processes via protein overload and protein modification. 
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Lympho-epithelial Kazal-type related inhibitor is expressed in stratified epithelia, undergoes
rapid proteolytic processing and shows specific defective expression in Netherton syndrome
E Bitoun,1 A Micheloni,2 L Lamant,3 A Tartaglia-Polcini,2 C Bodemer,4 J Mazereeuw-Hautier,5
F Boralevi,6 D Hohl,7 J Harper,8 G Delsol,3 M D’Alessio2 and A Hovnanian9 1 WTCHG, Oxford,
United Kingdom, 2 IDI-IRCCS, Rome, Italy, 3 INSERM U563, Toulouse, France, 4 Necker, Paris,
France, 5 Rangueil, Toulouse, France, 6 St Andre, Bordeaux, France, 7 Beaumont, Lausanne,
Switzerland, 8 GOSH, Londres, United Kingdom and 9 INSERM U563, Toulouse, Midi-Pyrénées,
France
We recently identified SPINK5, encoding LEKTI, a multidomain predicted Kazal-type serine pro-
tease inhibitor, as the defective gene in Netherton syndrome (NS). To study the yet unknown tissue
and cellular expression of LEKTI, we generated polyclonal antibodies raised against recombinant
N- and C-terminal parts of the protein. Immunofluorescence confocal microscopy showed that LEKTI
is strongly expressed in differentiated cultured human primary keratinocytes (HPK). Western blot
analysis on HPK extracts detected at least two glycosylated precursor isoforms of approximately
125 and 145 kDa. These are rapidly processed into C-terminal proteolytic fragments of approxi-
mately 42, 65 and 68 kDa in both cell extracts and conditioned media. Immunohistochemistry stud-
ies of normal human tissues revealed strong expression of LEKTI in the epidermal granular layer,
in the innermost layers of the hair follicle and in the duct of sebaceous glands. LEKTI expression
was also detectable in Hassal corpuscles of the thymus and in suprabasal layers of all stratified epithe-
lia tested. Immunohistochemistry of skin sections from 20 NS patients showed complete absence
(17 patients) or very weak and discontinuous LEKTI expression (3 patients). In contrast, strong
expression of LEKTI with redistribution in the upper spinous layers of the epidermis was observed
in all other congenital erythrodermas and keratinising disorders examined. These results demonstrate
that loss of LEKTI expression in the epidermis is a diagnostic feature for NS. They further support
a role of this protein in epithelial barrier formation, and set the stage for future investigation of the
specific activity of the proteolytic fragments identified. 
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MMP-9 expression from human keratinocytes in culture is induced by the ultraviolet-B irra-
diation
S Onoue,1 T Kobayashi,2 I Sasaki1 and H Shinkai2 1 Product Research Laboratories, KOSE
Corporation, Tokyo, Tokyo, Japan and 2 Clinical Biology of Extracellular Matrix
(F7)/Dermatology, Chiba University School of Medicine, Chiba, Chiba, Japan
Matrix metalloproteinase-9 (MMP-9), a kind of gelatinase, is known to be secreted from keratinocyte.
And MMP-9 expression in the epidermis has been reportedly induced in the case of apoptosis includ-
ing ultraviolet-B (UVB) irradiation. In the previous study, we showed MMP-9 induction from human
keratinocyte in culture by high calcium, which induces differentiation, a kind of programmed cell
death. In addition, we also showed that concomitant up regulation of MMP-9 and involucrin tran-
scripts are probably caused by the very similar gene regulatory elements, KRE-M9 and KRE-4, in
their respective promoters. In this study, we confirmed the induction of MMP-9 expression by UVB
irrradiation using primary human keratinocyte in culture. The secretion of MMP-9 was increased by
30 mJ/cm2 or more dose of UVB irradiation. More than 30 mJ/cm2 of UVB irradiation also decreased
the viability of keratinocytes. Furthermore, involucrin was also induced by UVB irradiation. We are
now further examining the responsible gene regulatory element in the MMP-9 promoter in the case
of up-regulation of MMP-9 expression after UVB irradiation. 
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Identification of normal human Merkel cells in cultures derived from human glabrous and
hairy skin sites
D Larouche, J Fradette, C Fugere, V Couture, I Martel, R Guignard and L Germain LOEX, Saint-
Sacrement Hospital, Laval University, Quebec, QC, Canada
Merkel cells represent a minor population of the epidermis. These cells are associated with nerves
and may function as slowly adapting mechanoreceptors. Merkel cells can be identified by the expres-
sion of distinct keratins (K), and K20 is considered the marker of choice for Merkel cells detection.
We took advantage of the human keratinocyte extraction technique with thermolysin and trypsin, to
harvest epithelial cells including Merkel cells from both hairy and glabrous skin biopsies. With appro-
priate culture conditions, immunolabeling for K20 revealed the presence of normal human Merkel
cells in primary and first subcultures (P1 and P2) of epidermal cells indicating their capacity to remain
viable in culture. Furthermore, when these K20-labelled cells were observed by electron microscopy,
the presence of dense-cored neurosecretory granules could be seen confirming Merkel cells identi-
fication. Occasionally, K20-expressing cell doublets were observed in primary cultures, suggesting
that proliferation could occur. In conclusion, we have been able to identify normal human Merkel
cells within epithelial cell cultures, and optimization of culture conditions will provide an in vitro
model to further study the biology of this peculiar population of cells. 
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Matrix metalloproteinase-9 expression from keratinocyte is down-regulated through KRE-M9
element by leptomycin B
T Kobayashi,1 H Wachi2 and H Shinkai1 1 Clinical Biology of Extracellular Matrix (F7)/
Dermatology, Chiba University School of Medicine, Chiba, Chiba, Japan and 2 Clinical Chemistry,
Hoshi Pharmaceutical College, Tokyo, Tokyo, Japan
Matrix metalloproteinase (MMP)-9 (also known as gelatinase B) has been suggested to play many
roles in tissue metabolism of pathophysiological conditions including tumor invasion and metasta-
sis, wound healing, and apoptosis including ultraviolet B irradiation, lichen planus, and keratosis.
In the previous study, we showed that concomitant upregulation of MMP-9 and involucrin transcripts
is probably caused by the very similar gene regulatory elements, KRE-M9 and KRE-4, in their respec-
tive promoters. Recently, much attention has been paid to leptomycin B (LMB), which is a modu-
lator for trafficking a variety of transcription factor-related proteins from nucleus to cytoplasm. In
this study, we examined the effect of LMB on the MMP-9 expression from human primary ker-
atinocytes in culture. We observed the selectively reduced secretion of MMP-9 in compariosn with
MMP-2 by gelatin-zymography and the reduced MMP-9 mRNA in comparison with GAPDH by
RT-PCR after the addition of LMB. These effects of LMB were observed even in the inductions of
MMP-9 expression by high calcium concentration or by the addition of TGF-β, TNF-α or IL-1 α.
We confirmed that KRE-M9 element in the MMP-9 promoter is responsible for this regulation
using luciferase assay. In conclusion, the application of LMB and its derivatives could be a useful
remedy for many pathological conditions in which MMP-9 are involved. 
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CYP2B19 immunoreactivity is expressed in human epidermal keratinocytes and induced dur-
ing differentiation in vitro
MM Neis,1,3 PA Ladd1,2 and DS Keeney1,2 1 Medicine & Biochemistry, Vanderbilt University,
Nashville, TN, 2 Research Service, Department of Veterans Affairs, Nashville, TN and 3
Dermatology, RWTH Aachen, Aachen, NW, Germany
The cytochrome P450 CYP2B19 is a keratinocyte-specific epoxygenase in mouse skin. CYP2B19
generates mainly epoxyeicosatrienoic (EET) acids from arachidonic acid. It is a specific, biochem-
ical marker for differentiated keratinocytes. P450-derived EETs are generally known to mediate
signals regulating cell growth and differentiation. The CYP2B19 product 14,15-EET activates trans-
glutaminases in situ, in differentiating mouse and human epidermal keratinocytes, and promotes
cornified cell envelope formation. We propose that a major function of CYP2B19-derived EETs is
to regulate epidermal cornification and that a functional CYP2B19 homologue is present in human
skin. Using Western immunoblotting and anti-CYP2B19 antibodies, we demonstrated that human
skin contains proteins immunologically related to CYP2B19. CYP2B19 immunoreactivity was up-
regulated in human epidermal keratinocytes during terminal differentiation in submerged cell cul-
ture. These results were corroborated by co-culturing human epidermal keratinocytes with colla-
gen-embedded, dermal fibroblasts. This three-dimensional skin model provides physiological
conditions mimicking in vivo gene expression patterns. After lifting the skin models to the air-liq-
uid interface, the expression of CYP2B19 immunoreactive proteins increased continuously over 14
days. We also demonstrated relatively low levels of CYP2B19 immunoreactivity in oral keratinocytes,
which naturally show parakeratotic or no keratinization. CYP2B19 immunoreactivity was propor-
tional to the extent of keratinization. In conclusion, we show evidence for a functional homologue
of CYP2B19 in human skin, which may regulate epidermal cornification. The 3D skin model will
be a useful tool to elucidate functions for human P450 epoxygenases during epidermal differentia-
tion. 
0550
Age-related expression of the mu-opiate receptor in normal human keratinocytes
E Noblesse, C Gondran, F Bonte and M Dumas Laboratoires R et D, L.V.M.H. Branche Parfums
et Cosmetiques, Saint Jean de Braye, France
There is increasing evidence that neurotransmitters play a crucial role in skin physiology. Human
epidermal keratinocytes mediate signals between the skin and the nervous system through regula-
tory neuropeptides. This include production of POMC derivatives such as beta-endorphin, a mole-
cule which binds with high affinity to mu-opiate receptors in epidermis. This receptor was recently
shown to be expressed by human epidermal keratinocytes both at the mRNA and protein levels and
that its expression was observed in the entire epidermis. Until now, no published data focus on the
possible modification of the mu-opiate receptor system as a function of age in human skin cells. In
this study we investigated the mu-opiate receptor expression by normal human keratinocyte strains
from various healthy females (20 to 70 year old) by semi-quantitative indirect immunofluorescence
analysis and confocal microscopy visualization. We observed a marked decrease of mu-opiate recep-
tors expressed by cells from older donors compared to young ones. In addition, preliminary results
on beta-endorphin secretion by keratinocytes from the same individuals suggest an increasing abil-
ity of old donors to produce this molecule even if a large heterogeneity was observed between the
strains. These results point out that modification of the mu-opiate receptor system could be an impor-
tant parameter in epidermal skin ageing and offer a new insight in the skin neuro-regulatory processes
of the elderly . 
0551
Study of tight junction components in monolayer and in fully-differentiated stratified cultures
of epidermal keratinocytes treated with a skin irritant
F Dupont, D Francois, F Herphelin, M Herin and Y Poumay FUNDP, Namur, Namur, Belgium
In the epidermis, both stratum corneum and tight junctions seem to be strongly involved in the in
vivo barrier function. Occludin and claudins are transmembrane proteins of the tight junction asso-
ciated with plaque proteins including ZO-1. While claudin-1 is expressed in all living layers of the
normal epidermis, occludin and ZO-1 are restricted to the granular layer. In monolayer autocrine
cultures of keratinocytes, the expression of claudin-1 and occludin is regulated by the confluence
state of the keratinocytes. Indeed, subconfluent keratinocytes express low mRNA levels for claudin-
1 and occludin. Confluence induces an important increase in both expressions. For claudin-1 and
occludin, mRNA expression becomes maximal at post-confluence of the culture, suggesting that
the expression of tight junction components is linked to epidermal differentiation. In parallel, study
of tight junction components has been also performed in vitro on fully differentiated stratified ker-
atinocytes cultured on inert polycarbonate filter. Tight junction components are expressed in the
reconstructed tissue exhibiting localization similar to the localization reported in vivo in the epi-
dermis. Such a reconstructed epidermis has been tested previously for its barrier function regarding
a known skin irritant (benzalkonium chloride) and its cell viability has been reported as decreased
in a dose-dependent manner. Benzalkonium chloride is thought to alter the barrier established at the
cornified layer of the tissue. In order to analyze whether the irritant also alters tight junctions in this
kind of tissue, the localization of claudin-1, occludin and ZO-1 was analyzed by immunostaining
after treatment with this compound. Benzalkonium chloride induces modifications on the localiza-
tion of tight junction components as showed by their diffuse staining and/or relocalization. These
results suggest that junctional barrier may be affected by chemicals exhibiting a strong irritant poten-
tial. 
0552
Autocrine albumin synthesis in the human epidermis
S Hasse,1 N Schuerer,2 NJ Gibbons,1 S Kothari,1 JM Wood1 and KU Schallreuter1,3 1 Biomedical
Sciences, University of Bradford, Bradford, West Yorkshire, United Kingdom, 2 University of
Osnabrueck, Osnabrueck, Germany and 3 Institute for Pigmentary Disorders, Greifswald,
Germany
The human epidermis forms the outer most layer of the human body and is therefore responsible to
form an adequate barrier to prevent water loss. The stratum corneum contains a large amount of lipids
such as fatty acids, cholesterol and ceramides. Since free fatty acids have to be bound to albumin,
we asked whether this protein is expressed in the human epidermis, because Rabilloud (1989) showed
the presence of serum albumin in the epidermis and suggested albumin uptake from the plasma into
the epidermis. Here we present for the first time DCoH/HNF-1α (dimerisation cofactor for HNF-1,
hepatocyte nuclear factor-1α) transcription of a splice variant of albumin in vitro in epidermal cells
and in situ in full thickness human skin, using immunofluorescence staining for albumin, DCoH
and HNF-1α. In order to demonstrate co-localisation of DCoH/HNF-1α and albumin double immuno-
fluorescence was utilised, yielding cytosolic and nuclear localisation. The data demonstrate the major
localisation of the DCoH/HNF-1α and albumin expression in the suprabasal cells, whereas the tran-
scription and protein expression is almost absent in the basal layer. The presence of both, albumin
and HNF-1α was supported by western blotting in cultured human epithelial cells. The results showed
that differentiated and undifferentiated keratinocytes as well as melanocytes can transcribe and syn-
thesise albumin and HNF-1α and that the earlier documented presence of albumin in the epidermis
is independent of uptake from the blood stream. Hence the human epidermis holds the capacity for
autocrine albumin synthesis. Since albumin binds calcium besides fatty acids we used computer mod-
elling for an additional investigation of a possible calcium-binding site. Here we provide evidence
for the first time for a specific EF-hands binding site for calcium. 
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Structural basis for the epidermal functional abnormalities in Vohwinkel disease
M Schmuth,1 J Fluhr,1 D Crumrine,2 Y Uchida,2 J Hachem,2 MJ Behne,2 D Moskowitz,2
K Feingold1 and PM Elias1 1 Dermatology, UCSF, San Francisco, CA and 2 Medicine, UCSF, San
Francisco, CA
Although loricrin is the predominant protein of the cornified envelope (CE), both k.o. and overex-
pression mutations produce minimal phenotypic alterations. In contrast, dominant-negative muta-
tions in the C-terminal domain of loricrin produce the characteristic phenotype of Vohwinkel dis-
ease (VD). Despite the recent production of transgenic mice with a comparable phenotype, the
pathogenesis of VD remains unknown. To ascertain the basis for the VD phenotype, we assessed epi-
dermal structure and/or stratum corneum (SC) function in 13 affected members of a previously-geno-
typed kindred of VD (Maestrini et. al., 1996), as well as in 5 unaffected family members and 6 nor-
mals. In addition to palmoplantar (honeycomb) keratoderma with pseudoainhum and mild-moderate
ichthyosis, affected patients often displayed sub-clinical skin fragility (+Nikolsky), with a cleavage
plane at or just above the outer granular layer. SC functional studies revealed abnormal basal per-
meability barrier function, but accelerated repair kinetics over both acral and proximal skin sites.
Despite evidence of keratinocyte fragility, increased water loss occurred predominantly via extra-
cellular domains, and the extracellular defect was linked to discontinuities in lamellar bilayers, fur-
ther attributable to an abnormal CE scaffold (in contrast, the corneocyte lipid envelope (CLE) and
its constituent ceramides were normal). The primary pathogenic role of the defective CE scaffold
was further underscored by the presence of a normal lamellar body (LB) secretory system, with
largely unimpeded secretion of LB contents. Accelerated barrier recovery in VD was explicable by
amplified LB production and secretion. These results show that the barrier abnormality in VD is due
to a defective CE scaffold, resulting in increased extracellular permeability, as shown previously for
another ‘scaffold disorder’, lamellar ichthyosis. 
0555
Protective effect of tocopherol gentisate on hydrogen peroxide-induced apoptosis, necrosis and
intracellular oxidation of normal human keratinocytes
T Zuliani,1 S Talbourdet,1 M Ratinaud,2 F Bonte1 and M Dumas1 1 Laboratoires R et D, L.V.M.H.
Branche Parfums et Cosmetiques, Saint Jean de Braye, France and 2 UMR CNRS 6101, Faculte de
Medecine, Limoges, France
Because of their external position in skin, epidermal cells are exposed to a variety of oxidative stress
among which tobacco smoke, pollutants, ozone and solar radiations are the major contributors lead-
ing to skin inflammation and premature ageing. One of the most powerful natural antioxidant is
alpha-tocopherol, a lipophilic cellular free radiacal scavenger. The present study investigate the pro-
tective effect of a new tocopherol derivative, tocopherol gentisate (TG), in which vitamin E is ester-
ified in ortho and para positions by gentisic acid (2, 5 dihydroxybenzoic acid), a natural metabolite
of salicilic acid. Apoptosis and necrosis were investigated by cytometry using a new double stain-
ing with the fluorescent probes JC-1 and TOTO-3, measuring respectively the mitochondrial trans-
membrane potential (collapsed in apototic and necrotic cells), and the plasmic membrane perme-
ability (maintained in apoptotic and unaltered cells). For intracellular oxidation cells were loaded
with the sensitive and permeant probe dichlorodihydrofluorescein diacetate, emitting a specific 529
nm-fluorescence when oxidized. Compared to non-treated control cells, populations treated for 24
h with 35 microM TG exhibited a marked reduction of apoptotic and necrotic status in favour of an
unaltered one (high mitochondrial potential and preserved plasmic membrane integrity) when exposed
to 800 microM H2O2. In addition, keratinocytes treated for 24 h with 3.5 to 35 microM GT harbor
a decrease of intracellular oxidation when exposed to a moderate stress (200 microM H2O2). We
conclude that GT protective effect on epidermal cells may take place through a reduction of reac-
tive oxygen species generated during acute oxidative stress, thus preventing damages of cellular com-
partments and organites and leading to a reduction of apoptosis and necrosis. 
0557
The armadillo protein p0071/PKP-4 differentially regulates adherens junction and desmosome
assembly
SV Setzer,1 C Calkins1 and AP Kowalczyk1,2 1 Dermatology, Emory University, Atlanta, GA and 2
Cell Biology, Emory University, Atlanta, GA
Adherens junctions and desmosomes are the major adhesive intercellular junctions in the epidermis.
These distinct adhesive structures contribute to epidermal organization and function by anchoring
actin and intermediate filament networks to sites of cell-cell contact. p0071/plakophilin-4 (PKP-4),
a member of the armadillo protein family, is related to both the adherens junction protein p120 and
to the desmosomal proteins, the plakophilins. In A431 epithelial cells, PKP-4 localized to both
adherens junctions and desmosomes, suggesting that PKP-4 might function in the coordinated assem-
bly of these intercellular junctions. In A431D cells, a subclone of A431 that lacks classical cadherins,
PKP-4 localized to the cytoplasm. Significantly, upon expression of classical cadherins in A431D
cells, PKP-4 was recruited to intercellular junctions. Site directed mutagenesis and yeast two hybrid
experiments revealed that PKP-4 bound directly to the highly conserved juxtamembrane domain of
classical cadherins, demostrating that cadherins bind and recruit PKP-4 to intercellular contacts. In
addition, PKP-4 interacted with the amino-terminal region of desmoplakin. Moreover, deletion muta-
genesis experiments indicated that PKP-4 interacted with the amino-terminal 164 amino acids of
desmoplakin. To examine the function of PKP-4 in the assembly of intercellular contacts, an aden-
oviral delivery system was used to express PKP-4 in A431 cells. Exogenously expressed PKP-4
enhanced the recruitment of E-cadherin and beta-catenin to adherens junctions. However, in strik-
ing contrast to plakophilin-1, which enhances desmoplakin incorporation into desmosomes, PKP-4
caused a dramatic loss of desmoplakin from cell-cell contacts. These data suggest that PKP-4 may
negatively regulate desmosome assembly, and furthermore, that PKP-4 may coordinate the molec-
ular cross talk that is thought to occur during desmosome and adherens junction assembly. 
0556
The use of an integrated multi-photon and optical coherence tomography microscope for three-
dimensional imaging of engineered skin
LJ Fahrner,1 A Zysk,1 W Luo,1 TE Eurell2 and SA Boppart1 1 Department of Electrical and
Computer Engineering, University of Illinois at Urbana-Champaign, Urbana, IL and 2
Department of Veterinary Biosciences, University of Illinois at Urbana-Champaign, Urbana, IL
Three-dimensional tissue constructs are a current focus in the field of tissue engineering. As engi-
neered tissues become increasingly complex, visualization of cell dynamics and tissue growth in
these three-dimensional constructs becomes increasingly difficult due to the thickness of highly-
scattering tissue samples. An integrated multi-photon microscope (MPM) and optical coherence
tomography (OCT) microscope has been constructed for visualizing three-dimensional engineered
tissue scaffolds and tracking the growth of engineered tissues on a micron scale. Imaging with OCT
is well-suited for this purpose because of the inherent capability of the technique to image deeper
into highly-scattering tissues than is possible with confocal or multi-photon microscopy. We have
constructed this integrated microscope to allow simultaneous imaging of tissue structure with OCT
and of tissue functionality with MPM. Human skin epithelial cells (keratinocytes) were grown over
a cultured layer of human dermal fibroblasts (Cascade Biologics Inc., Portland, OR) for a total growth
period of 8-12 days. OCT and MPM images of engineered skin have been captured and compared
to corresponding histology, demonstrating the use of this non-invasive, high-resolution imaging
instrument. This instrument has the potential to be an enabling diagnostic tool for future studies in
cell-cell interactions, cell-matrix adhesions, and the effect of mechanical and pharmacological stim-




Development of the stratum corneum pH gradient: localization and mechanisms leading to
emergence of optimal barrier function
MJ Behne,1,2 NP Barry,3 KM Hanson,3 I Aronchik,2 RW Clegg,3 E Gratton,3 K Feingold,1
PM Elias1,2 and TM Mauro1,2 1 Dermatology, UCSF, San Francisco, CA, 2 Dermatology Service,
VA Med. Center, San Francisco, CA and 3 LFD, UIUC, Urbana, IL
The surface pH of mammalian infants skin decreases rapidly towards adult levels in the first post-
natal week. Since basal barrier function is normal at birth, the basis for the higher risk for infections,
dermatitis, and percutaneous absorption of toxic agents in infants is unknown. We hypothesized that
delayed acidification of the stratum corneum (SC), which would further enhance barrier competence,
accounts for the functional deficits of neonates. In this report, we measured and visualized the tim-
ing and localization of the emerging acid mantle in neonatal rat SC by two photon Fluorescence Life-
time Imaging (FLIM). After retraction/involution of the periderm, emergence of an acidic pH cor-
related with development of the extracellular lamellar bilayer system by day 3. Although an initial
wave of acidity originates within the periderm, its activity does not influence pH-dependent lipid
processing; hence, barrier homeostasis remains defective. In contrast, the progressive, post-natal
development of acidic microdomains in the lower SC leads to an adult pattern of pH distribution,
with acidic microdomains also in the upper SC after the second post-natal day. This second wave of
acidity leads to efficient processing of lipids to form the mature extracellular lamellar bilayer sys-
tem. We assessed NHE1 expression as the predominant mechanism that acidifies SC, beginning in
microdomains at the SG/SC interface. Maximum protein levels of NHE1 occur just prior to birth,
followed by a gradual decline in expression over the first postnatal week. Thus, neonatal skin is
fully equipped to generate the acid mantle at birth, but full barrier competence requires the outward
spread of acidification from the SG/SC interface. Although these results define a developmental
sequence that leads first to acidification and then to barrier competence, the nature of the perinatal
trigger that initiates acidification remains unknown. 
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Identification of genes encoding novel mouse calmodulin-like skin proteins
SA Ray,1 Z Zhou,2 D Bernard,3 B Mehul,3 R Schmidt3 and DR Roop2,1 1 Interdepartmental
Program in Cell and Molecular Biology, Baylor College of Medicine, Houston, TX, 2 Molecular
and Cellular Biology and Dermatology, Baylor College of Medicine, Houston, TX and 3 Life
Sciences Research, LOreal, Centre Charles Zviak, Clichy, France
Epidermal differentiation is tightly controlled by a calcium gradient, which increases towards the
surface of the skin. During differentiation, keratinocytes express specific proteins including calcium-
binding proteins, such as the calmodulin-like skin protein (CLSP). Human CLSP was recently cloned
and shown to share 52% homology with the ubiquitously expressed calmodulin. Unlike calmodulin,
human CLSP appears to be expressed specifically in the skin in the stratum granulosum. Human
CLSP has also been shown to bind transglutaminase 3, a key calcium-dependent enzyme involved
in formation of cornified cell envelopes. These studies suggest that CLSP may be involved in regu-
lating keratinocyte differentiation. To further explore the role of CLSP in mediating calcium sig-
naling in the skin, we have cloned the mouse homologue of human CLSP. Mouse CLSP shares 50%
homology with human CLSP. RNase Protection Assays (RPA) confirmed that expression of mouse
CLSP was confined to the epidermis and other stratified epithelia, e.g. tongue, esophagus and
forestomach. Consistent with observations that human CLSP was only expressed in differentiated
keratinocytes, mouse CLSP was expressed at a late stage of skin development. Interestingly, analy-
sis of the mouse genomic sequence revealed the existence of another calmodulin-like gene adjacent
to mouse CLSP on chromosome 13. Subsequently, we cloned this gene and discovered that it was
also specifically expressed in the epidermis and other stratified epithelia. A comparison of mouse
and human genomic sequences confirmed that the region on human chromosome 10, which is syn-
tenic with mouse chromosome 13, encodes human CLSP, as well as the calmodulin-like protein
(CLP/CALML3). Future studies, including conditional knockout mouse models, will further eluci-
date the function of these calmodulin-like proteins in skin development and differentiation. 
0560
Correlation in AQP3, CD44 and claudin-1 expression in human skin epidermis
R Sougrat,1 J Verbavatz,1 C Heusele,2 C Gondran,2 S Schnebert2 and M Dumas2 1 Laboratoires R
et D, L.V.M.H. Branche Parfums et Cosmetiques, Saint Jean de Braye cedex, France and 2 Service
de Biologie Cellulaire, DBJC Bat 532, CEA/Saclay, Gif-sur-Yvette Cedex, France
AQP3, CD44 and claudin-1 are three keratinocyte plasma membrane proteins. CD44 is a receptor
for hyaluronate, the major component of the extracellular matrix, AQP3 is a water channel and glyc-
erol transporter and claudin-1 is a tight junction protein. In the present study, AQP3, CD44 and
claudin-1 expression were studied by semi-quantitative indirect immunofluorescence analysis in skin
biospsies from 30 healthy females donors. All exhibited normal skin epidermis structure, low TEWL
values (2-10 g/h/m2) and relatively high levels of all three markers. Nevertheless, results show sig-
nificant differences (2 to 3 fold) in the expression of AQP3, CD44 and claudin-1 between donors.
Interestingly, the expression of these markers was strongly correlated, with AQP3 and claudin-1
expression being positively correlated, while AQP3 and claudin-1 expression were negatively cor-
related with CD44 expression. CD44 is often found at open intercellular surfaces, thus suggesting
that CD44 is associated with intercellular fluid maintenance related to hyaluronate homeostasis.
The correlation between AQP3 and claudin-1 expression is consistent with a role for AQP3 in epi-
dermis water homeostasis: the more impermeable junctions are, the more AQP3 facilitates transcel-
lular water transport. These results suggest that regulations of these protein expressions may occur
in a coordinate manner in skin epidermis without affecting epidermis structure or barrier function. 
0561
Epithelial reprogramming of adult mouse central cornea to hair follicle and sebaceous glands
under inductive dermal influences: a novel approach to cellular therapy
K Sun,1 C Jahoda2 and AM Christiano1 1 Derm and Genet & Dev, Columbia U, NY, NY and 2 Biol
Sci, U Durham, Durham, United Kingdom
Gene therapy in the skin has been hampered by the inability to target/identify a stem cell, and the
lack of sustained gene expression. Several lines of evidence about the plasticity of stem cells in gen-
eral have prompted us to consider a novel approach to the treatment of inherited skin disorders. Rather
than searching for markers of the epidermal stem cell itself, we aimed at reprogramming other epithe-
lia into skin under the appropriate inductive (dermal) influences in vivo. If the donor cells, such as
cornea, were taken from an immunologically-compatible individual or did not elicit an immune
response, such cells could overcome the two major obstacles in gene therapy approaches: gene intro-
duction and targeting the stem cell. Building on the previous work of Ferarris et al, we performed
tissue recombination experiments using embryonic mouse dermis from day 14.5 embryos com-
bined with adult mouse central cornea cells. Recombinant grafts were implanted beneath the kidney
capsule of normal mice and retrieved after two weeks. Fully formed pilosebaceous units with mature
hair shafts and sebaceous glands had been induced, containing reprogrammed central cornea cells
as their epithelial component. Thus, we have demonstrated that differentiated adult cells can regen-
erate epidermis under the appropriate dermal influences. In this approach to cellular therapy, ectopic
donor epithelial cells, by definition, would contain an intact gene-of-interest, and importantly, it is
predicted that epidermal stem cells would be sequestered during the induction of the new skin and
hair follicle, thus providing a lifelong supply of genetically corrected cells. We are currently expand-
ing this technology to include other sources of donor epithelium, as well as developing methodol-
ogy to recapitulate the molecular events of epithelial reprogramming in vitro. 
0562
Two mouse models for defects in epidermal barrier function reveal the existence of multiple
compensatory pathways
Z Zhou,1 P Koch1,2 and DR Roop1,2 1 Molecular & Cellular Biology, Baylor College of Medicine,
Houston, TX and 2 Dermatology, Baylor College of Medicine, Houston, TX
We have recently demonstrated that a defect in barrier function resulting from the loss of loricrin, a
major cornified envelope (CE) protein, induces a compensatory response that activates the expres-
sion of known and novel CE components. Surprisingly, this occurs already in utero. In an attempt
to better understand the molecular mechanisms that re-establish skin barrier function, we have com-
pared two mouse models with different defects in the epidermal water bar” or “mortar” components
of the stratum corneum. The loricrin knockout mouse represents a defect in the “bricks” component,
i.e. cornified cell envelopes. The mouse model with a defect in the “mortar” component (lipids) was
unexpectedly generated when we inhibited retinoid signaling by over-expressing a dominant-nega-
tive retinoic acid receptor mutant (RARα403 in the epidermis of transgenic mice (Imakado et al.,
1995, Genes and Development 9:317-329). These mice exhibited altered lipid processing and failed
to form lipid multilamellar structures in the stratum corneum (Attar et al., 1997, Mol. Endocrinol-
ogy 11:792-800). To determine if a similar compensatory response was activated in both the loricrin
knockout and RARa403 mouse, we isolated RNA from phenotypic neonates and examined the expres-
sion of several novel genes recently identified within the epidermal differentiation complex (EDC)
located on mouse chromosome 3. Distinct induction patterns were observed for these genes as part
of the compensatory response to repair the barrier defect in each model. These results suggest that
different signaling pathways are activated depending on whether the barrier defect is in the “bricks”
or the “mortar”. 
0563
Manipulation of retinoid metabolism
ST Iobst,1 C Feinberg,1 M Matzke,1 C Arce,1 R Carson,1 M Barratt,1 A Cardenas,1 U Santhanam,1
S Granger,2 AV Rawlings,3 RL Weinkauf1 and IR Scott1 1 Skin Bioscience, Unilever Research and
Development-Edgewater, Edgewater, NJ, 2 Unilever Research and Development-Colworh,
Bedford, United Kingdom and 3 Unilever Research and Development-Port Sunlight, Chester,
United Kingdom
Vitamin A and its derivatives have been shown to provide a variety of skin benefits. Prescription
retinoic acid in particular has been shown to repair photodamaged skin and provide improvements
to lines/wrinkles and hyperpigmented skin. Cosmetic vitamin A derivatives, such as retinol and retinyl
esters, have been reported to provide modest improvement in the appearance of photoaged skin con-
ditions, however, are less efficacious than retinoic acid. There are several routes toward achieving
increased skin benefits from cosmetically acceptable forms of Vitamin A, which include enhancing
the stability and/or delivery profile of Vitamin A from a cosmetic formulation. An alternative route
is to increase the efficacy via modulation of retinoid metabolism. We have identified a series of mol-
ecules that modulate retinoid metabolism and have demonstrated their effects in vitro on transglut-
aminase, a marker of cellular differentiation. 
0564
S100A11 in human keratinocytes--evidence for multiple forms
A Broome1,2 and RL Eckert1,3 1 Physiology & Biophysics, CWRU School of Medicine, Cleveland,
OH, 2 Dermatology, CWRU School of Medicine, Cleveland, OH and 3 Oncology, CWRU School of
Medicine, Cleveland, OH
S100 proteins are important calcium-responsive signal transduction proteins that act by binding to
target proteins to alter target protein function. Although S100 proteins are thought to be important
calcium signal sensors in keratinocytes, limited information is available regarding their distribution
and function. In the present report, we show that soluble S100A11 protein is present in the cyto-
plasm, co-localized with the S100A11 target protein, annexin I, while non-dissociable high molec-
ular weight S100A11-containing complexes are present with the cytoskeleton. Treatment with cal-
cium causes S100A11 and annexin I to shift to the cell periphery via a mechanism that requires intact
microtubules. In contrast, S100A11 is not detected in the Golgi or endoplasmic reticulum, and cal-
cium-dependent movement is not inhibited by Golgi or endoplasmic reticulum disrupters. Immunos-
taining of uninvolved and involved psoriatic epidermal tissue reveals strong cytoplasmic S100A11
staining in basal cells, and peripheral staining in suprabasal cells, but the level of staining is not
increased in psoriasis. These results suggest that S100A11 exists in at least two pools, as soluble
cytoplasmic protein and as part of a covalent, cytoskeleton-associated complex. As S100A11 is a
known transglutaminase substrate, it is likely that the cytoskeleton-associated S100A11-containing
complex is formed via the action of membrane-associated type I transglutaminase. 
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Characterization of the novel epidermal differentiation marker suprabasin
G Park, S Lim and M Morasso (SID) Developmental Skin Biology Unit, NIH/NIAMS, Bethesda,
MD
Suprabasin is a recently reported novel gene expressed in mouse and human differentiating ker-
atinocytes. We identified Suprabasin using a SSH (Subtractive Suppressive Hybridization) method
between the proliferative basal and differentiating suprabasal populations of the mouse epidermis.
Transcripts of 0.7 and 2.2 Kb pairs were detected on Northern blots of mouse differentiated ker-
atinocytes. During embryonic development, suprabasin mRNA was detected at day 15.5, coincid-
ing with epidermal stratification. Suprabasin expression was also detected in the tongue, stomach,
uterus and thymus. Differentiation of cultured primary epidermal keratinocytes with 0.12 mM Ca++
resulted in the induction of suprabasin. The putative translated sequence has an amino terminal
domain, a central domain composed of repeats rich in glycine and alanine, and a carboxy terminal
domain. Cross-linking experiments with recombinant Suprabasin indicate that it is a substrate for
TGase2 and TGase3 activity. We have generated antibodies against suprabasin in hens that specifi-
cally detect the recombinant protein by western blot analysis. Immunohistochemical staining of
neonatal mouse skin showed that the suprabasin protein localizes to the most differentiated epider-
mal layers. Biochemical properties of suprabasin will be reported. Altogether, these results indicate
that suprabasin potentially plays a role in the process of epidermal differentiation. 
0567
Induction of aquaporin-3 (AQP3) at wound edge of mouse skin epidermis
K Yamada, P Agre and M Yasui Biological Chemistry, Johns Hopkins Univ. School of Medicine,
Baltimore, MD
The aquaporin family of water channel proteins includes at least eleven mammalian homologs. In
the skin, aquaporin-3 (AQP3) has been detected in the epidermis. AQP3-null mice exhibit relatively
dry skin and delayed recovery after injury, suggesting the relevance of AQP3 in skin biology. The
aim of the present study is to examine stress induced AQP3 protein expression. Injury was induced
by incision in dorsal skin of C57BL/6J female mice. Skin tissue sections including the wound edge
were isolated 6, 12, 24, 48, and 72 hrs after injury, then analyzed by immunofluorescence using an
affinity-purified polyclonal anti-AQP3. AQP3 immuno-staining was detected in basal and interme-
diate cell layers of epidermis as well as along the external root sheath of the hair follicle and in the
sebaceous gland in healthy mouse skin. AQP3 labeling was enhanced in the external root sheath of
the hair follicle in the vicinity of the wound edge after 12 hrs after injury, and in the basal and inter-
mediate cell layer of epidermis at the wound edge 48 hrs after injury, which continued through 72
hrs after the injury. The induction pattern of AQP3 after the skin injury was consistent with that of
inducible keratin 17. Our studies demonstrated that AQP3 may play a role in skin recovery after
injury. 
0569
Formation of omega-hydroxy ceramides and corneocyte lipid envelope during fetal barrier
ontogenesis
Y Uchida, M Schmuth, P Elias and WM Holleran Dermatology (190), UCSF & VA Med Center,
San Francisco, CA
Although the stratum corneum (SC) forms between day 17 and day 18 of gestation in the fetal rat,
permeability barrier function does not become competent until day 20-to-21 (term =22 days). Since
omega-OH ceramide (omega-OH Cer), are essential for epidermal barrier function, we investigated
the emergence of both unbound and covalently-bound (i.e., corneocyte lipid envelope or CLE) omega-
OH Cer and their respective precursor, acyl-glucosylCer (acylGlcCer), in relation to barrier onto-
genesis in the fetal rat model. Both acylGlcCer and other unbound GlcCer species were present in
epidermis from gestational age 17 days, as well as in newborn epidermis. Since the levels (per mg
of dry epidermis) of all glucosylated Cer species were higher in fetal than in neonatal epidermis,
conversion (deglucosylation) to corresponding non-glucosylated Cer occurs at-or-near term. Like-
wise, the content of unbound Cer species, including acylCer, increased progressively from day 17
to day 19, and all these Cer were lower in neonatal than in day 19 fetal epidermis. In contrast to
unbound GlcCer and Cer species, covalently-bound omega-OH Cer (CLE), known to be required
for normal barrier function, were not detectable in day 17 fetal epidermis, with only minimal CLE
evident at day 19. In contrast, the CLE-omega-OH Cer levels were markedly elevated in newborn
over fetal rat epidermis (i.e., approximately 20-fold vs. day 19, p<0.01). Finally, covalently-bound,
glucosylated omega-OH Cer were not detected at any fetal or neonatal stage. In summary, the sig-
nificant postnatal increase in CLE with concurrent decreases in both acylCer and acylGlcCer sug-
gest that the latter represent precursor lipids required for CLE formation. In addition, the lag time
between the initial generation of acylGlcCer/acylCer, and the subsequent formation of the CLE sug-
gests not only that this latter event occurs efficiently during the final stages of epidermal barrier onto-
genesis, but also that deglucosylation of glucosylated Cer occurs quickly following their covalent
attachment to the cornified envelope. 
0568
Ectopic expression of Klf4 accelerates formation of the epidermal permeability barrier
J Segre, J Jaubert and J Cheng GMBBB, NHGRI/NIH, Bethesda, MD
Dysfunction of the epidermal permeability barrier can result in dehydration, electrolyte imbalance,
and poor thermoregulation.  Immature skin is a portal of entry for infectious agents and potential
toxins in topically applied substances. As the skin is one of the last organs to mature in utero, pre-
mature infants born before 34 weeks gestation, are at great risk for complications.  The transcrip-
tion factor kruppel-like factor 4 (Klf4), as demonstrated by a targeted ablation, has a necessary and
selective function in barrier acquisition. We investigated whether Klf4 is a master regulator of this
process; i.e. whether Klf4 expression in utero is sufficient to establish the epidermal barrier.  Specif-
ically, we generated lines of mice that express Klf4 from a tetracycline inducible promoter when
crossed with transgenic mice expressing the tetracycline transactivator tTA from the epidermal ker-
atin 5 promoter. These mice exhibit acceleration in barrier acquisition as manifest by the exclusion
of a dye solution one day earlier in development than controls. Underlying this dye impermeability
are morphological changes, including an increased number of stratified layers, expression of termi-
nal differentiation markers, and assembly of cornified envelopes. By all criteria, Klf4 ectopic expres-
sion accelerates the normal process of terminal differentiation.  Although other transgenic mice
have perturbed barrier acquisition, these mice are the first to selectively accelerate the process of
barrier establishment. These studies show that Klf4 is a master regulator of barrier acquisition and
provide an animal model for studying how to accelerate the process of barrier acquisition for the pre-
mature infant. 
0566
Regulation of human involucrin gene expression requires interaction of multilpe transcrip-
tional regulatory elements and multiprotein complex formation
JF Crish,1 G Ramamurthy,1 F Bone1 and RL Eckert1,3 1 Physiology/Biophysics, Case Western
Reserve School of Medicine, Cleveland, OH, 2 Oncology, Case Western Reserve University School
of Medicine, Cleveland, OH and 3 Dermatology, Case Western Reserve University School of
Medicine, Cleveland, OH
Understanding the mechanisms that regulate differentiation-dependent epidermal gene expression
is of the utmost importance for understanding epidermal disease. Many studies have used cell cul-
ture models, but few laboratories have studied gene regulation under in vivo conditions that permit
rigorous assignment of physiological function. In the present report we describe in vivo studies that
identify the DNA elements responsible suprabasal-selective involucrin gene expression. Our stud-
ies reveal that a small region within the involucrin gene promoter, the distal regulatory region, is nec-
essary and sufficient for normal differentiation-appropriate involucrin expression. We show that this
region encodes multiple, distinct DNA regulatory elements that act in a combinatorial manner to pro-
duce the complete program of differentiation-dependent expression. A first element contains juxta-
posed AP1 and Sp1 sites. This element is sufficient for expression in the high granular layer, but,
remarkably, lower granular layer and spinous layer expression is absent. Moreover, inactivation of
the AP1 site within this element completely eliminates expression indicating that this site has a dual
function - serving as an on/off switch and also directing high granular layer expression. A spatially
distinct second element is required for expression in the low granular and spinous layers. This ele-
ment is not able to drive transcription alone - it drives expression in the low granular and spinous
layers only when linked to the first element. These results provide a concrete in vivo example of
spatially distinct DNA elements cooperating to recapitulate normal differentiation-dependent gene
expression. We describe a model in which proteins, anchored at DNA binding sites within elements
one and two, participate in formation of a large multiprotein regulatory complex that then contacts
the basal transcription machinery. 
0570
In vivo evidence for H2O2 - oxidation of epidermal albumin in vitiligo
H Rokos,1,2 KU Schallreuter,1,2 J Moore,1 S Hasse1 and JM Wood1 1 Clinical and Experimental
Dermatology, University of Bradford, Bradford, West Yorkshire, United Kingdom and 2 Institute for
Pigmentary Disorders in Association with the Ernst-Moritz-Arndt University, Greifswald,
Germany
Nowadays there is convincing in vivo and in vitro evidence for mM concentrations of epidermal
hydrogen peroxide (H2O2) accumulation in untreated patients with vitiligo. Earlier the fluorescence
excitation spectrum of epidermal tryptophan has been documented in human skin at 295nm. How-
ever, the origin of this tryptophan has escaped definition so far. Therefore the aims of this study
were to identify the source for epidermal tryptophan and to follow in vivo and in vitro the effect of
mM H2O2 on the characteristic fluorescence spectrum in normal healthy controls (n=12) and in
patients with vitiligo untreated (photo-skin type III, Fitzpatrick classification) (n=8) and treated (n=8).
Our in vivo results identified for the first time the single tryptophan of human albumin as one source
for tryptophan fluorescence and confirmed the excitation peak at 295nm. However, in untreated
patients lesional skin (n=8) we found 3 different groups based on the excitation spectra a) in the
region of 280nm (n=8) b) in the region of 290nm (n=5) c) in the region of 300nm (n=6). After con-
sequent removal of epidermal H2O2 with pseudocatalase (PC-KUS) the excitation spectra shifted in
all 8 patients to 280nm. These results suggested oxidation of epidermal albumin. Since albumin has
17 disulfide bridges it was subjected to performic acid oxidation. The cysteic acid residues product
was confirmed by Fourier-Transform Raman Spectroscopy yielding a major peak for the S=O stretch
at 1033cm-1. This peak was also detected in the lesional skin of patients with untreated vitiligo using
in vivo FT-Raman spectroscopy. Based on these results we propose that high concentrations of epi-
dermal H2O2 affect albumin homeostasis in the human skin. Since this protein is vital in the bind-
ing of unsaturated fatty acids, this discovery unmasked an important new pathomechanism, which
needs further investigation. 
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The lanceolate rat phenotype is characterized by a defect in hair follicle keratinization and
results from a mutation in the desmoglein 4 gene
C Jahoda,4 N Crossley,1 M Robinson,4 A Reynolds,4 R Porter,4 R Suresh,2 A Kljuic2 and
A Christiano3 1 School of Biomedical and Biological Sciences, University of Durham, Durham,
United Kingdom, 2 Clinical Sciences, University of Leeds, Leeds, United Kingdom, 3 Anatomy and
Physiology, University of Dundee, Dundee, United Kingdom, 4 Dermatology, Columbia University,
New York, NY and 5 Genetics & Development, Columbia University, New York, NY
Desmoglein 4 is a newly identified member of the desmosomal cadherin gene family in mammals.
The gene was recently cloned in the mouse, rat and human genomes, and was shown to underlie
both the lanceolate mouse phenotype (lah/lah), as well as the corresponding human disorder, local-
ized autosomal recessive hypotrichosis (LAH). LAH is characterized by a localized scalp-restricted
hypotrichosis with sparse and fragile hair shafts. In mouse, the lah/lah phenotype was named due to
the appearance of a lance head shaped defect in the keratinization of the hair shaft, and a profound
defect in the precortical hair matrix cells was described. Here, we report identification of the rat coun-
terpart of the lanceolate phenotype, designated lah/lah. Affected animals display hypotrichosis with
fragile and broken hair shafts. Histological analysis revealed the presence of lance-head abnormal-
ities on anagen hair shafts, as well as the presence of lance-tipped hairs emerging from the skin sur-
face. Based on the genetic and phenotypic analysis of the lah rat, we cloned and sequenced the rat
ortholog of the Dsg4 gene on rat chromosome 18, and identified a missense mutation in exon 6 of
the gene that was not present in a group of unrelated, unaffected animals. This residue is highly con-
served in the mouse and human genomes, suggesting that it is a functional mutation. Further, this
mutation occurs in the second extracellular repeat region, immediately downstream of the missense
mutation identified in the lah/lah mouse allele. Comparative histological analysis of the rat and mouse
phenotypes support an integral role for dsg4 in the differentiation of hair follicle keratinocytes. 
0572
Multiple keratinocyte sub-populations are involved in acute and chronic wound re-epithelial-
isation
GK Patel,1,2 C Wilson,2 PE Price,2 AY Finlay,1 KG Harding2 and PE Bowden1 1 Department of
Dermatology, University of Wales College of Medicine, Cardiff, United Kingdom and 2 Wound
Healing Research Unit, University of Wales College of Medicine, Cardiff, United Kingdom
The skin is a complex multifunctional organ that provides an effective environmental barrier and the
objective of cutaneous wound healing is restoration of epidermal integrity. Keratin intermediate fil-
aments are essential elements of the epithelial cell cytoskeleton and can be used to define keratinocyte
sub-populations. We have demonstrated that at least 7 different keratinocyte populations are involved
in wound re-epithelialisation (K5+K14+, K1+K10+, K1+K10+K6+K16+, K6+K16+, K6+K16+K17+,
K6+K17+, K5+K14+K6+K17+). However, it remains unclear if the different keratinocyte sub-popu-
lations are altered during impaired re-epithelialisation. Thus, we investigated moist versus dry acute
wounds, acute versus chronic wounds and healing versus non-healing chronic wounds. 21 subjects
with punch biopsy wounds treated with dry or moisture retentive dressing had post-wounding biop-
sies, using a “polo” biopsy technique. A further 20 subjects with chronic venous leg ulceration (VLU)
had ulcer edge biopsies. The VLU were classed as “healers”, if there was greater than 40% reduc-
tion in wound surface area within 4 weeks. Single- and double- immunofluorescence and immuno-
histochemistry studies were undertaken with specific antibodies against keratins (K5, K6, K10, K14,
K16 and K17), Ki67 and integrins (α3 and α5). The data was analysed using Chi square test. In all
wound types, all keratinocyte sub-populations were present. In acute wounds treated with dry dress-
ing, the overlying scab persisted, and re-epithelialisation was slower compared to those with mois-
ture retentive dressing. In non-healing VLU, K10 positive keratinocytes were more evident at the
VLU edge (χ2 = 6.13 and p = 0.05). Thus we conclude that wound re-epithelialisation is more com-
plex than previously thought and altered rates of healing do not automatically infer changes in ker-
atinocyte phenotype. 
0573
PCD/DCoH/HNF-1α protein expression as a useful marker for differential diagnosis of leu-
coderma
S Kothari1 and KU Schallreuter1,2 1 Clinical and Experimental Dermatology, University of
Bradford, Bradford, West Yorkshire, United Kingdom and 2 Institute for Pigmentary Disorders in
Association with the Ernst-Moritz-Arndt University, Greifswald, Germany
Previously it was shown that both mRNA and enzyme activities of 4a-pterin carbinolamine dehy-
dratase (PCD) are present in human epidermis. It was also recognised that PCD is down regu-
lated/deactivated by mM H2O2 in vitiligo. The aims of this study were to examine clinical similar
leucodermas (halo-nevus, regression area in melanoma and dysplastic nevus) to explore whether
these leucodermas are also initiated by H2O2 accumulation. Furthermore, we wanted to know whether
PCD exercises its function as dimersation cofactor for the transcription factor hepatocyte nuclear
factor-1 (DCoH/HNF-1) in this compartment. Therefore we utilised immunohistochemistry and
immunofluorescence to follow the expression of epidermal PCD/DCoH/HNF-1α and its transcrip-
tional target albumin in the different leucodermas compared to healthy controls. The results of this
study identified for the first time the presence of HNF-1α isoform and DCoH activity in human ker-
atinocytes and melanocytes in vitro and in situ. While PCD/DCoH/HNF-1α is almost absent in
lesional vitiligo, due to mM H2O2 levels, it is upregulated in the halo of Sutton’s disease, as well as
in the regression zones of melanoma and dysplastic nevus. These results have unmasked a distinct
difference in the pathogenesis of these leucodermas compared to vitiligo because the involvement
of H2O2 in the depigmentation process can be ruled out in halo nevus and the regression area of dys-
plastic nevus and melanoma. 
0574
In vitro percutaneous absorption in the MatTek EPI-606X skin construct and human skin
HA Raabe,1 M Klausner,2 G Pugh,3 J Kubilus,2 G Moyer,1 D Bagley3 and J Harbell1 1 Institute for
In Vitro Sciences, Gaithersburg, MD, 2 MatTek Corp., Ashland, MA and 3 Colgate-Palmolive Co.,
Piscataway, NJ
The rates of absorption of chemicals in human skin can be modeled in the in vitro percutaneous
absorption assay. Moreover, the impact of various vehicles on the permeation rates of chemicals can
also be evaluated. Benzoic acid (BA), was prepared in two vehicles (acetone and petrolatum) and
was tested in duplicate trials in an engineered human skin construct (EPI-606X, MatTek Corp.) and
in ex vivo human skin. The methods used are based upon guidance by the US Food and Drug Admin-
istration, with the exception that absorption was evaluated at 3 hours after test material application.
Tissues were mounted in flow-through diffusion cells (0.64 cm2 area) and tested for barrier function
by 3H2O passage, followed by a finite dose (9 µL) of 14C-labeled BA applied at 4 µg/cm2. Barrier
function was tested by applying 200 µL of 3H2O onto each tissue for 20 minutes. Non-absorbed 
3H2O
was removed after 20 minutes, and the tissues were maintained in the diffusion cells for an addi-
tional 60 minutes. The amount of 3H2O absorbed into the receptor fluid was measured during the
80-minute test. Results of the barrier tests showed that 1.71±0.33% (n=16) and 0.36±0.13% (n=6)
of the applied 3H2O dose permeated through the engineered and human donor skin, respectively.
Results of the percutaneous absorption of BA showed that in both skin models, the permeation rates
for BA prepared in petrolatum were significantly higher than for BA prepared in acetone. At 3
hours, permeation rates for BA prepared in petrolatum were 80.9% and 51.9% of applied dose, for
engineered skin and human skin, respectively (1.6 fold higher in engineered skin vs. human skin).
Permeation rates for BA prepared in acetone were 38.1% and 12.5% of applied dose, for engineered
skin and human skin, respectively (3.0 fold higher in engineered skin vs. human skin). These results
show that both the engineered and human skin can be used to evaluate the impact of vehicles on the
permeation rates of test chemicals. 
0575
Evidence for caspase activity during normal epidermal differentiation and in UV irradiatad
skin
R Underwood and MK Kuechle Medicine/Dermatology, University of Washington, Seattle, WA
Caspases are conserved cysteinyl aspartate specific proteases that, when activated, cleave substrates
that result in the apoptotic phenotype. 14 caspase family members have been described, although
not all tissues express the full suite of caspases. The epidermis expresses caspase -2, -3, -6, -8, -9,
and -14. Caspase-14 is unique among caspases in that its expression is limited to stratifying, corni-
fying epithelium, while caspases-2, -3, -6, -8, and -9 are expressed in multiple tissues. The mecha-
nism(s) of caspase interaction and activation during normal epidermal differentiation are not yet
known. To investigate this question, we incubated human skin biopsies with fluorescently labeled
caspase peptide substrates to localize caspase activity. A pan-caspase substrate, a caspase-3 selec-
tive substrate and a caspase-9 selective substrate were utilized. Normal skin biopsies and a biopsy
from UVB irradiated skin that demonstrated erythema were examined. In normal skin, we detected
caspase activity in the cells of the superficial granular layer and in a few scattered cells in the spin-
ous and basal layers. In skin exposed to 125mj UVB, the granular layer cell caspase activity was
increased in intensity, and there were increased numbers of cells in the spinous and basal layers that
recognized the caspase-3 and caspase-9 substrates. We postulate that normal epidermal differentia-
tion involves caspase activity at the superficial granular layer, while epidermal injury, as seen with
UV irradiation, results in increased caspase activity in the spinous layer not seen in normal epider-
mis. In vivo assays using specific labeled caspase substrates will help us determine the pathways of
caspase activation during normal epidermal differentiation, in diseased skin, and during the wound
healing process. 
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Caspase-14 processing is inhibited by calpain, but not caspase, inhibitors in vivo
AJ Chien,1 RB Presland1,2 and MK Kuechle1 1 Medicine/Dermatology, University of Washington,
Seattle, WA and 2 Oral Biology, University of Washington, Seattle, WA
Caspase-14 is the newest member identified in the caspase family of cysteinyl aspartate-specific pro-
teases, and contains all the structural features found in caspase family members. Caspase-14 is
expressed in stratified, cornified epithelium, and is processed to its large and small subunits only in
conditions that simulate normal epidermal terminal differentiation. Another feature unique to cas-
pase-14 is that it is processed to its large and small subunits at an isoleucine/lysine site, whereas other
caspase are processed at an aspartate residue (Chien et al; Biochem Biophys Res Comm 296: 911,
2002). The unique processing site of caspase-14 combined with the PEST sequences (proline, glu-
tamate, serine, and threonine enriched regions) at the site suggests calpain may be a candidate enzyme
responsible for caspase-14 cleavage. Calpain is expressed in the granular layers of the epidermis
and may be activated with the increasing intracellular calcium concentrations found during epider-
mal differentiation. To address this question, we subjected normal foreskin organ cultures to vary-
ing amounts of the calpain inhibitor, Z-LLY-FMK, as well as to varying amounts of the pancaspase
inhibitor Z-VAD-FMK. Processing of caspase-14 to its large and small subunits was inhibited in the
presence of the calpain inhibitor, but was unaffected in the presence of the pan-caspase inhibitor. The
novel processing site of caspase-14 and the inhibition of processing by a calpain inhibitor suggest
that this enzyme has unique mechanisms of regulation during epidermal terminal differentiation. 
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Bone marrow stem cell plasticity: assessing the ability of bone marrow stem cells to differen-
tiate into keratinocytes
Q Fan, CL Yee and JC Vogel Dermatology, NCI/NIH, Bethesda, MD
Adult stem cell plasticity raises the possibility that bone marrow-derived stem cells may be a source
for keratinocyte progenitors and be manipulated for gene therapy purposes. Previous reports describe
how bone marrow-derived stem cells may differentiate into neuronal, cardiac, muscle, and liver
cells in vivo, although the extent of this plasticity or transdifferentiation remains controversial. We
have previously investigated the degree of bone marrow derived keratinocytes in female patients
receiving bone marrow transplants from male donors. In order to further investigate differentiation
of bone marrow stem cells to keratinocytes in a murine model, bone marrow from B6,129S Rosa26
mice, that constituitively express beta-galactosidase in all cells, was transplanted via tail vein injec-
tion into lethally irradiated (9.5 Gy) congenic mice (B6,129S F2/J). In tissues of transplanted mice,
cells derived from donor Rosa26 bone marrow can be detected by beta-galactosidase expression
using double immunofluorescence (anti-beta-Gal and anti-CD45), X-Gal staining, or C12 fluores-
cein di-beta-D-galactopyronoside (C12FDG) imaging, along with confocal microscopy and FACS
analysis. Analysis of thymus, spleen, and lymph nodes confirmed complete engraftment of Rosa26
donor bone marrow cells. Preliminary analysis of epidermal sheets from mice after bone marrow
transplant (BMT) did not demonstrate any significant detection of Rosa26 donor derived keratinocytes.
Since evidence suggests that stem cell plasticity is enhanced by tissue injury, at 6 months post trans-
plant, mice underwent localized wounding by tape stripping (n=6). Epidermal sheets assessed at
different time points after wounding did not demonstrate significant numbers of Rosa26-derived ker-
atinocytes in either wounded or non-wounded skin. These data suggest that transdifferentiation of
bone marrow-derived stem cells into keratinocytes is a rare event and is not enhanced by injury. 
0579
Estrogen activity on human skin involves interaction with the insulin-like growth factor-I sig-
naling pathway
E Makrantonaki, MK Oeff, S Fimmel and CC Zouboulis Dept of Dermatology, UKBF, The Free
University of Berlin, Berlin, Germany
Estrogens have been suggested to exhibit a profound influence on skin aging. We have previously
shown that SZ95 sebocytes incubated with several hormones at levels similar to those found in post-
menopausal women showed significantly lower content of neutral lipids and increased c-myc mRNA
levels compared to those detected in sebocytes incubated with hormones at levels representing 20-
year-old women. In a new experimental series which tested the effects of hormones as single agents,
IGF-I, but not 17β-estradiol, amplified neutral and polar lipid production in SZ95 sebocytes (p<0.001)
and proliferation of breast area skin fibroblasts from a 60-year-old female (p<0.01). To investigate
the hypothesis of IGF-I signaling pathway involvement in estrogen effects on human skin, human
skin cells maintained in steroid-free medium were first tested and found to express IGF-I receptor
(IGF-IR) and estrogen receptor-α (ERα) using RT-PCR and Western blotting. 24-72 h treatment of
SZ95 sebocytes and fibroblasts with 17β-estradiol enhanced IGF-I synthesis (+28% and +41%,
respectively). On the other hand, cell treatment with IGF-I also enhanced synthesis of 17β-estradiol
(+37% in SZ95 sebocytes and +19% in fibroblasts). IGF-IR expression was significantly reduced
under IGF-I (-41 to -48%) and 17β-estradiol treatment (-37 to -48%) of SZ95 sebocytes for 48-72
h, while fibroblasts exhibited reduction of IGF-IR expression under IGF-I treatment (-47%, 48-72
h) but an initial increase under treatment with 17β-estradiol (+32% at 48 h, -15% at 72 h). ERα
expression did not change under any regimen tested. In conclusion, although skin cells express ERα
making them directly susceptible to estrogens, there is obviously a cross-talk between estrogen and
IGF-I signaling pathways. IGF-I is playing a major role in regulating lipid synthesis in sebocytes
and proliferation in fibroblasts and may, therefore, mediate the estrogen activity on normal and aged
skin cells. 
0581
Phenotypic diversity and mutation spectrum in hypotrichosis with juvenile macular dystro-
phy
E Sprecher,1 M Indelman,1 CP Hamel,2 M Surget,2 M Ramon,1 H Ganthos,3 B Miller,3 G Richard,4
R Lurie,5 R Leibu3 and R Bergman1 1 Department of Dermatology and Laboratory of Molecular
Dermatology, Rambam Medical Center, Haifa, Israel, 2 INSERM U.254, Montpellier, France, 3
Department of Ophthalmology, Rambam Medical Center, Haifa, Israel, 4 Department of
Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA and 5
Pediatric Dermatology Unit, Rabin Medical Center, Petach-Tikva, Israel
Hypotrichosis with Juvenile Macular Dystrophy (HJMD) is an autosomal recessive disorder char-
acterized by abnormal growth of scalp hair during infancy, and by the later occurrence of macular
degeneration leading to blindness during the first to third decade of life. We recently demonstrated
that HJMD results from mutations in CDH3. CDH3 encodes P-cadherin, which is expressed in the
hair follicle and in the retinal pigment epithelium. We assessed 4 additional familes affected with
HJMD for mutations in CDH3. Compound heterozygosity for a deletion (2112delG) and a non-
sense mutation (L168X) in CDH3 were found to underlie HJMD in a patient of French extraction.
Both mutations are predicted to result in the absence of functional P-cadherin. Affected individuals
of three apparently unrelated families of Arab Israeli origin were found to carry the same homozy-
gous missense mutation (R503H). This mutation alters a highly conserved Ca+2-binding site in the
fourth extracellular domain of P-cadherin, which affects the protein conformation. Using haplotype
analysis for a series of polymorphic markers encompassing the CDH3 gene, we obtained evidence
suggesting a founder effect for R503H in the Arab Israeli population. We compared the clinical fea-
tures of all HJMD families identified to date as carrying deleterious mutations in CDH3 and noticed
significant differences in hair morphology, associated skin findings and degree of visual disability.
Thus, our results firmly establish mutations in CDH3 as the cause of HJMD and demonstrate phe-
notypic heterogeneity in this disorder. 
0580
Initial step of hapten sensitization by nickel in an in vitro skin assay: suppression of allergic
cellular responses after application of emollient preparation
Z Tao, C Isabelle and C Marie Cell Biology Research Laboratory, Pierre Fabre Research Institute,
Toulouse, France
The aim of this study was to explore the barrier function and the usefulness of an emollient prepa-
ration Ictyane for the prevention of the induction of contact allergy by the sensitizer NiSO(4) in an
in vitro skin model. Langerhans cells (LCs) are the most potent antigen presenting cells in the skin
and play a critical role in the induction of contact allergy. Research on the phenotypical and func-
tional changes of keratinocytes and LCs were performed on skin explants undergoing chemical bar-
rier destruction, sodium dodecyl sulfate (SDS) irritation and NiSO(4) sensitization. Immunohisto-
chemical analysis showed that NiSO(4) applied on the skin induced the migration of LCs from the
epidermis to the dermis, upregulated the expression of intercellular adhesion molecule CD54, HLA-
DR antigen molecules on keratinocytes and dendritic cells, and upregulated co-stimulatory mole-
cules CD86 on LCs in damaged skin tissue. A synergistic effect was observed when SDS and NiSO(4)
were added simultaneously. However, none of these NiSO(4)-induced responses could be found in
undamaged skin sample under the same experimental conditions. To evaluate the effect of the emol-
lient preparation Ictyane, damaged skin explants were stimulated with the sensitizer NiSO(4) dur-
ing 4 hours. The emollient preparation prevented the upexpression of CD54 and the migration of
LCs from the epidermis to the dermis. These results suggest that this test system can be used to pre-
dict contact sensitizing ability of chemicals in an in vitro sensitization assay and indicate the impor-
tance of skin barrier in the inflammatory step of NiSO(4) contact sensitization. Restoring the bar-
rier function, Ictyane has a protective effect against stimulation with a contact sensitizer. 
0578
AccuskinTM, the Cell Sorted Skin Equivalent, as a model for active ingredient screening
W Hoeffler, J Lievers, K Kudrycki, B Mathy and D Finlay Xgene Corporation, San Carlos, CA
Xgene Corporation has pioneered the development of an entirely in vitro method for the growing of
full thickness human skin based upon a self-assembly method, where skin cells are induced to migrate
to correct positions in the reformation of tissue layers. Previously, it was widely believed that cor-
rect migration of cells to reform the tissue layers that make up more complex organs was only pos-
sible during embryonic development, but our Cell Sorted Skin Equivalent (CeSSE) method shows
that tissue cultured cells can retain the ability to migrate to reform skin under the appropriate con-
ditions. The Xgene Accuskin is an ideal testing platform for many applications. We find that chang-
ing the procedures used in production of the product can alter key characteristics of our model. Expo-
sure of the epidermal surface to air resulted in increased epidermal thickness and development of a
stratum corneum. Oil red staining showed lipid deposition correctly localized between the layers of
squames. To characterize the barrier formulations of Accuskin were exposed to 1% SDS and via-
bility was assessed by MTT assays. Exposure to air, and subsequent increased differentiation of the
epidermis, resulted in increased Effective Time-50 (ET50) values. We demonstrate a prototypical
active ingredient screen with retinoic acid on Accuskin. Single applications of microgram quanti-
ties of all-trans-retinoic acid were applied to the epidermal side of the 96 well format of Accuskin.
These wells were harvested 120 hours post application and examined by immunohistochemistry
and western blots. Our results indicate a decrease in elastin production in the dermis of the treated
Accuskin wells. Accuskin should be viewed as a platform technology that can be optimized to eval-
uate a variety of aspects of skin morphology and biological response to test compounds and active
ingredients. 
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Genome-wide view of fibroblast and endothelial differentiation
HY Chang,1,2 J Chi,2 D Botstein3 and PO Brown2,4 1 Dermatology, Stanford University, Stanford,
CA, 2 Biochemistry, Stanford University, Stanford, CA, 3 Genetics, Stanford University, Stanford,
CA and 4 HHMI, Stanford, CA
Although reciprocal epithelial-mesenchymal interactions are essential for skin development, the
diversity and functions of stromal cells in adult tissues remain incompletely understood. We have
characterized genome-wide patterns of gene expression in cultured human fibroblasts and endothe-
lial cells derived from organs and skin at different anatomical sites. Fibroblasts from each site dis-
played distinct and characteristic transcriptional patterns, suggesting that fibroblasts at different loca-
tions in the body should be considered distinct differentiated cell types. Groups of differentially
expressed genes include those involved in extracellular matrix synthesis, cell fate determination, and
cell migration. Several genes implicated in genetic diseases were expressed in fibroblasts in an
anatomic pattern that paralleled the phenotypic defects. Adult fibroblasts maintained key features of
Hox gene expression patterns established during embryogenesis, suggesting that Hox genes may
direct topographic differentiation and underlie the detailed positional memory in fibroblasts. In con-
trast, the prevailing order of endothelial differentiation is dictated by the vessel size from which
endothelial cells were derived. The gene expression programs characteristic of large vessel vs.
microvascular endothelial cells demonstrate systematic differences in cytoskeletal mechanics, matrix
interaction, and angiogenesis. The gene expression programs which specify arterial vs. venous
endothelium were identified. The arterial fate could be conferred in part by the expression of Hey2,
an artery-specific transcription factor; the venous fate appears to be coordinately regulated with devel-
opment of left-right asymmetry during embryogenesis. 
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Immune-mediated loss of transgene expression in skin: implications for cutaneous gene ther-
apy
S Ghazizadeh,1 RS Kalish2 and LB Taichman1 1 Deptartment of Oral biology and Pathology, SUNY
at Stony Brook, Stony Brook, NY and 2 Deptartment of Dermatology, SUNY at Stony Brook, Stony
Brook, NY
A clearer understanding of the immune-mediated loss of transgene from cutaneous epithelium is
necessary for development of effective clinical gene therapy protocols for patients who carry null
mutations in the target gene. we have used retrovirus-mediated transfer of lacZ to mouse skin as a
model to investigate the mechanism of immune- mediated transgene loss in skin. Transduction of
C57Bl/6 mouse skin resulted in elicitation of both humoral and cellular immune responses. Anti-
body responses did not play a major role in the loss of transgene, however the prevalance of trans-
gene-specific IgG2a and IgG2b subtypes suggested a Th-1 polarized response. Infiltration of the
transduced skin with CD4+ and CD8+ cells and induction of transgene-specific cytotoxic T lym-
phocytes implied a role for T-cell mediated responses. Transduction of mice deficient in either
major histocompatibility complex (MHC)-class I or -class II molecules resulted in transient trans-
gene expression. Only in mice lacking expression of both class I and class II MHC molecules, the
skin-directed transduction resulted in the persistent transgene expression. These data indicated a
primary role for T cell-mediated responses in the immune-mediated loss of transgene expression.
Furthermore, CD4 and CD8 T cells have overlapping roles and either population can effectively elim-
inate transduced cells. Therefore, long-term cutaneous gene therapy may require development of
strategies to interfere with activation or function of both T cell populations. 
0584
Extracellular matrix protein 1 gene mutations and protein expression in lipoid proteinosis
T Hamada,1,2 AP South,1 N Oyama,3 V Wessagowit,1 I Chan,1 T Hashimoto2 and JA McGrath1 1
Department of Cell and Molecular Pathology, GKT Medical School, London, United Kingdom, 2
Department of Dermatology, Kurume University School of Medicine, Kurume, Japan and 3
Department of Immunofluorescence, GKT Medical School, London, United Kingdom
The autosomal recessive disorder lipoid proteinosis (LP) results from mutations in extracellular
matrix protein 1 (ECM1), a glycoprotein expressed in several tissues (including skin) and com-
posed of two alternatively spliced isoforms, ECM1a and ECM1b, the latter lacking exon 7 of this
10-exon gene (ECM1). In this study, we sequenced ECM1 and identified pathogenic mutations in
13 unrelated patients with LP. We also generated a new rabbit polyclonal antibody to the c-terminal
15 amino acids of ECM1 and correlated skin immunostaining with genotype and phenotype. We
identified nine homozygous nonsense or frameshift mutations: R53X (exon3); 243delG (exon 4);
501ins C (exon6); 507delT (exon 6); R243X (exon 7); 735delTG (exon 7); 785delA (exon 7); 892delC
(exon 7) and 1190insC (exon 8), as well as two new compound heterozygous mutations: W160X/F167I
(exon 6) and 542insAA/R243X (exon 6/7), none of which were found in controls. Three mutations
(501insC, 507delT and R243X) each occurred in two subjects. Considerable clinical differences in
disease severity were seen in patients with homozygous nonsense or frameshift mutations but there
was better correlation between antibody staining and LP phenotype. Specifically, in normal skin the
antibody mainly labeled the basal keratinocyte layer. Labeling was slightly attenuated in relatively
milder cases (including those with exon 7 mutations) whereas it was markedly reduced in the most
clinically severe cases of LP. Taken with the previously documented mutations in ECM1, this study
demonstrates that exon 6 and 7 are the most common sites for ECM1 mutations in LP. Clinically, it
appears that mutations outside exon 7 are usually associated with a slightly more severe mucocuta-
neous LP phenotype, but skin immunostaining with the new anti-ECM1 antibody may provide a
more accurate reflection of clinical disease severity in this genodermatosis. 
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Representational difference analysis on Sezary cells
M Su, I Dorocicz and Y Zhou University of British Columbia, Vancouver, BC, Canada
The molecular nature of the abnormal cells in cutaneous T cell lymphoma (CTCL) is not clearly
understood. In order to isolate specific gene markers for CTCL lymphoma cells, we have studied
the cancer cells of Sezary syndrome, a leukemic form of CTCL. We used representational differ-
ence analysis to compare Sezary cells’ transcribed genes with that of normal T helper cells. We have
identified several candidate genes during initial screening. Confirmation with reverse transcription
coupled polymerase chain reaction (RT-PCR) verified that one gene, T-plastin, was present in Sezary
cells but not in normal T helper cells. Rabbit polyclonal anti-T-plastin antibody detected T-plastin
protein in Sezary cell but not in normal T cells by Western blot analysis. A cytoplasmic actin-bundling
protein, T-plastin has been known to be absent from the hematopoietic cells and hematological malig-
nancies previously. This raised the possibility that T-plastin can serve as a specific marker for Sezary
cells. In cultured fibroblast, T-plastin has been shown to change cellular structure and increase cell
motility. Previous reports indicated that Sezary cells are more mobile than the normal T helper cells
from the peripheral blood. It is possible that that T-plastin aberrant expression may be contributing
to the Sezary cell motility. Future experiments are in progress to define the precise role T-plastin
plays in the pathogenesis of CTCL, and to use it as a diagnostic aid. 
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Proliferating keratinocytes are putative sources of the psoriasis susceptibility related EDA+
oncofoetal fibronectin
M Szell,1,2 Z Bata,1,2 A Pivarcsi,1,2 A Koreck,2 L Kemeny1,2 and A Dobozy1,2 1 Dermatological
Research Group of the Hungarian Academy of Sciences, University of Szeged, Szeged, Hungary
and 2 Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary
The EDA+ oncofoetal isoform of fibronectin was recently reported to be overexpressed in psoriatic
uninvolved epidermis (Ting et al, 2000). It has been proposed that the abnormal presence of EDA+
oncofoetal protein at the dermal-epidermal junction in the uninvolved skin may provide the psori-
atic environment in which keratinocytes are in a preactivated state with regard to mitogenic signals
(e.g. T cell lymphokines). To determine the possible sources of cellular fibronectin in the non-lesional
psoriatic skin we aimed to investigate whether keratinocytes could produce the EDA+ oncofoetal
form of fibronectin. RT-PCR studies revealed that both cultured normal keratinocytes and HaCaT
cells express the EDA+ splice variant of fibronectin mRNA, and in HaCaT cells the EDA+/EDA- tran-
script ratio was elevated compared to normal keratinocytes. Keratinocytes and HaCaT cells showed
intracytoplasmic staining with an EDA+ fibronectin-specific antibody and among the positively
stained cells many showed mitosis. Using RT-PCR and Western blot analysis we showed that in
synchronized HaCaT cells the amount of both total fibronectin and the EDA+ isoform change with
the proliferation/differentiation stage of HaCaT cells and peaks in highly proliferating cells. Observed
differences in the pattern of mRNA and protein level changes suggest that not only transcriptional
but also post-transcriptional mechanisms play a role in the regulation of fibronectin expression in
HaCaT cells. Taken together, our results suggest that proliferating keratinocytes could be the sources
of the psoriasis susceptibility related EDA+ oncofoetal fibronectin. 
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A novel 15 basepair deletion mutation in keratin 5 causes the removal of 5 amino acids from
the highly conserved 2B rod domain in Weber-Cockayne epidermolysis bullosa simplex
MW Kemp,2 S Klingberg,1 L Lloyd,1 Y Wang,2 G Murrell,2 P Marr,2 L Vonthethoff2 and
DF Murrell2 1 Royal Brisbane Hospital, Brisbane, QLD, Australia and 2 St George Hospital,
Sydney, NSW, Australia
Epidermolysis Bullosa Simplex (EBS) is a blistering disease usually caused by missense mutations
in the keratin 5 and 14 genes. Here we report a strikingly mild form of EBS (Weber–Cockayne sub-
type) caused by a 15 bp deletion in exon 5 of keratin 5. The proband was the only member of a 3
generation non–consanguineous family to have EBS. Genomic DNA was isolated from whole blood
and PCR of all exons of K5 and K14 performed using specific primers and amplification for 35 cycles
at 94oC for 1 min, 55oC for 1min, and 72oC for 1 min. Analysis of the K5 and K14 genes from the
proband identified a 15bp deletion mutation in the 2B helical region of keratin 5, resulting in the
deletion of 5 amino acid residues; arginine, asparagine, lysine, leucine, alanine in positions 429 –
433. The normal reading frame of the amino acid sequence was maintained, and no other mutations
were detected in K5 exons 1–4 and 6–9. The screening of 50 normal controls, and remaining fam-
ily members failed to result in the finding of an identical mutation. This is the first report of a non-
missense mutation in the gene encoding keratin 5, which leads to the development of EBS–WC. As
the amino acid reading frame is maintained, the overall disruption to the secondary structure of the
final protein product is likely to be minimised. The alpha helical conformation favored by this
region already accommodates an inherent 3 residue deletion present in all keratins. Hence, a 5 residue
deletion may be accommodated to a certain extent within the alpha helical structure of the protein
such that the disease expression is relatively mild. In conclusion, this report gives further insight
into the complicated disease mechanisms that relate genotype to phenotype in EBS. 
0588
A novel compound heterozygous mutation in Werner syndrome results in WRN transcript
decay
FB Muller,1 A Tsianakas,2 C Kuwert,2 BP Korge1 and N Hunzelmann1 1 Dermatology, University
of Cologne, Cologne, Germany and 2 Dermatology, University of Hamburg, Hamburg, Germany
Werner syndrome (progeria adultorum, WS) is a rare autosomal-recessive progeroid disorder. The
clinical phenotype mimics accelerated aging including symptoms like premature graying, alopecia
and skin atrophy. Here we report a German WS patient carrying a previously reported as well as a
novel nonsense mutation of the WRN gene (1396delA and 2334delAC). By quantitative rT-PCR
analysis we demonstrate, that this compound heterozygous genotype leads to almost complete WRN
transcript decay. This is in contrast to previously reported mutations where a loss-of-function of sta-
ble truncated WRN gene products was considered to be the primary cause of the disease. 
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Novel and recurrent mutations in keratin K5 and K14 genes in epidermolysis bullosa simplex
Dowling-Meara: implications for disease phenotype and keratin filament assembly
FB Muller,1 H de Almeida Jr.,3 H Schumann,2 C Schmitt,4 L Bruckner-Tudermann,2 W Kuster5 and
BP Korge1 1 Dermatology, University of Cologne, Cologne, Germany, 2 Dermatology, University
of Muenster, Muenster, Germany, 3 Dermatology, Federal University of Pelotas, Pelotas, 4 Institute
of Forensic Medicine, University of Cologne, Cologne and 5 TOMESA-Clinic for Allergy, Skin and
Joint Diseases, and Rheumatism, Bad Salzschlirf, Germany
Epidermolysis bullosa simplex (EBS) is a group of autosomal-dominant genetic skin disorders with
an overall incidence of approximately 1:50.000. The EBS group is characterised by basal keratinocyte
lysis leading to the development of intraepidermal blisters on minor mechanical trauma. According
to the severity of symptoms, EBS is subdivided into three major subtypes. The most severe form is
the Dowling-Meara type (EBS-DM) showing a sudden and often life-threatening onset at birth. In
this study we investigate 5 familiar and 8 sporadic EBS cases of mainly German origin. We identi-
fied six new (K5:Glu168Lys, K5:Arg169Pro, K5:Glu170Lys, K14:Asn123Lys, K14:1218delG and
K14:Arg417Pro) and three previously reported (K5:Glu477Lys, K14:Leu122Phe and
K14:Arg125Cys) pathogenic mutations within the K5 and K14 genes. The single base pair deletion
in position K14:1218G (amino acid position 406) results in frame-shift and generation of a prema-
ture termination codon 35 codons downstream of the mutation. This mutation lead to an unexpect-
edly mild disease phenotype despite of a predicted severely altered protein sequence in the c-termi-
nal 2B domain of keratin 14 including the crucial RLLEGEE motif. The study discusses possible
implications of the novel mutations on protein structure, keratin intermediate filament (KIF) for-
mation and the corresponding phenotype and summarises the spectrum of mutations reported so far
in EBS-DM. 
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Cell death and defective protein trafficking are characteristic of skin disease-associated con-
nexin mutations
DP Kelsell,1 W Di,1 J Common,1 J Monypenny,2 D Davies,2 D Zicha2 and I Leigh1 1 Centre for
Cutaneous Research, University of London, London, United Kingdom and 2 Cancer Research UK,
London, United Kingdom
Distinct germline mutations within three connexin genes: Cx31, Cx30 and Cx26 underlie syn-
dromic and non-syndromic disease hearing loss and an array of epidermal phenotypes including ecto-
dermal dysplasia and Erythrokeratoderma variabilis (EKV). Recently, we have described a number
of functional analyses investigating the cellular effects of disease-associated connexin mutants. Here,
we have performed a detailed study of the functional effects on keratinocytes of a large panel of dis-
ease-associated mutant connexin proteins. After transfection of GFP-tagged connexin fusion pro-
teins, all epidermal disease-associated proteins were primarily cytoplasmic with limited trafficking
ability. In contrast, hearing loss associated mutant proteins could traffick to the plasma membrane
but dye transfer studies demonstrate defective intercellular channel activity. Further studies of the
skin disease-associated Cx31 mutations demonstrated a high incidence of cell death. This was not
observed with wildtype or deafness/neuropathy associated mutant Cx31 proteins. By time-lapse-
imaging of microinjected mutant Cx31/EGFP protein in keratinocytes, we reveal that all published
EKV mutations displayed a high rate of cell death compared to cells transfected with wildtype
Cx31/EGFP protein. Cell death was clearly indicated by cell blebbing, diffusion of microinjected
dye into the extracellular space and nuclear uptake of propidium iodide from the media. Fluores-
cence Activated Cell Sorting of WT- and mutant Cx31/EGFP transfected keratinocytes confirmed a
high percentage of cell death associated with only the EKV-associated mutant Cx31 proteins. Sim-
ilar to these findings, Cx26- and Cx30-skin disease associated mutations also show a reduced trans-
fection efficiency compared to WT or hearing loss only mutant protein suggestive of increased cell
death. Further experimental studies will be described towards elucidating the mechanism of mutant
connexin-mediated cell death in keratinocyte biology. 
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Effective suppression of proliferation of human melanoma cells by combinatorial siRNA mol-
ecules
J Yin,1 J Gao,2 Y Wan,3 R Shao,4 W Tian1 and J Wang2 1 AltCures Pharmaceutical, Inc.,
Cambridge, MA, 2 Sun Yat-Sen University, Guangzhou, China, 3 Providence College, Providence,
RI and 4 Institute of Medical Biotechnology, Beijing, China
Various cancers have been considered genomic diseases with the features of oncogene activation and
tumor suppressor inactivation. The genomic dysfunctionalities limit the effectiveness of conventional
therapy strategies and have thus forced considerable efforts for the past decade to explore alterna-
tive types of anticancer agents. Accumulating evidence indicates that chemically synthesized or in
vivo expressed short interfering RNA (siRNA) specifically and effectively direct homology-depend-
ent post-transcriptional gene silencing. In the present study, we investigated whether siRNA could
suppress the proliferation of human melanoma cells through interfering oncogene activities and
recovering the functions of tumor-suppressor gene. The results showed that single siRNA or com-
binatorial siRNAs were successfully transfected into melanoma cells with cationic lipid complexes.
These siRNA molecules not only specifically knocked down their cognate targets such as bcl-2,
cdk-2, mdm-2, pkc-alpha, tgf-beta1, N-ras, vegf and gfp mRNAs, but also effectively suppressed
the proliferation of melanoma cells to various extents. Our results indicated that human melanoma
cells preserve RNAi machinery and chemically synthesized and vector-driven siRNAs can be incor-
porated into intrinsic RNAi system for silencing target mRNA molecules. Our study also showed
that a combination of five different siRNAs displayed additive effects in inhibiting the growth and
differentiation of melanoma cells. Taken together, our intriguing findings provide important princi-
ples for predicting and selecting efficacious siRNAs as active agents for gene silencing, and suggest
that silencing of tumor-causing mRNAs by siRNA may provide the foundation for developing new
powerful gene drugs for the prevention and treatment of different human cancers including human
melanoma. 
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Interferon regulatory factor 2 is associated with type 1 psoriasis
JP Foerster,1 I Nolte,2 C Ehlert,1 M Bruinenberg,3 K Spaar,1 G van der Steege,3 V Kalscheuer,4
S Schweiger,4 P Seeman,5 M Staender,6 W Sterry1 and G te Meerman2 1 Dermatology, Charite
Hospital, Berlin, Berlin, Germany, 2 Medical Genetics, Academic Hospital, Groningen,
Groningen, Netherlands, 3 Genotyping facility, Academic Hospital, Groningen, Groningen,
Netherlands, 4 Human Genetics, Max Planck Institute for Molecular Genetics, Berlin, Germany, 5
Barmer Ostseeklinik, Seebad Prerow, Germany and 6 Fachklinik Bad Bentheim, Bad Bentheim,
Germany
Type 1 interferon is known to trigger flares of psoriasis. Recently, hypersensitivity to type 1 inter-
feron signaling was found to cause a skin disease, similar to human psoriasis, in mice deficient for
the transcription factor interferon regulatory factor 2 (IRF2). The human IRF2 gene is located 50 kb
from a previously identified candidate psoriasis susceptibility locus on chromosome 4q (PSORS3
at D4S1535). Therefore, we tested association of psoriasis with IRF2. We generated a sample con-
sisting of 157 families with a total of 521 individuals. Phase could be determined in 424 patient and
220 control haplotypes. Five novel microsatellite markers were developed and typed, and comple-
mented with three known markers to yield a set of eight markers spaced within 600 kb around the
IRF2 gene, three of which being located in the gene. While no statistically significant association
was detected between psoriasis and the unstratified patient population, association was detected
between type 1 psoriasis at two marker loci in the IRF2 gene with p-values of 0.005 and 0.009 (alle-
les), 0.0077 (genotypes), and 0.049 (two-locus haplotypes). Data analysis using a statistic measur-
ing excess haplotype sharing among patients (HSS statistic) confirmed association of IRF2 with type
1 psoriasis (p-value = 0.006). We found significant evidence for a potential protective allele (p =
0.026 after Bonferroni correction for multiple testing), as well as suggestive evidence for a poten-
tial risk allele (p = 0.082 after Bonferroni correction). These data identify IRF2 as a potential sus-
ceptibility gene for psoriasis. 
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The mechanism of action of a dominant connexin 26 mutation on epidermal differentiation
G Bakirtzis,1 S Jamieson,1 T Aasen,1 S Bryson,3 S Forrow,3 L Tetley,2 M Finbow,4 D Greenhalgh1
and MB Hodgins1 1 Dermatology, University of Glasgow, Glasgow, Scotland, United Kingdom, 2
Electron MIcroscopy Unit, IBLS, University of Glasgow, Glasgow, Scotland, United Kingdom, 3
Beatson Institute for Cancer Research, Glasgow, Scotland, United Kingdom and 4 Biological
Sciences, Glasgow Caledonian University, Glasgow, Scotland, United Kingdom
The connexins, gap-junction proteins, exhibit tissue-specific and overlapping expression patterns.
Mutations in connexin genes cause a range of diseases, but the roles of particular connexins in the
epidermal gap junction network remain unclear. As certain mutations of connexin 26 (Cx26) cause
dominantly-inherited keratodermas, we attempted to disrupt the epidermal gap junction network by
expressing a dominant Cx26 mutant (D66H: Vohwinkel Syndrome) under control of a K10 promoter
in suprabasal epidermal keratinocytes of transgenic mice. From 4 days after birth, transgenic mice
exhibited a transient, generalised epidermal scaling, with persistent zonal hyperkeratosis of the tail,
ears and digits, leading to constriction bands. Evidence for genetic modifiers of the phenotype was
obtained by comparing levels of transgene expression in epidermis. The thickened stratum corneum
was found to overlie areas of keratinocytes with nuclear TUNEL stain, consistent with apoptosis or
premature terminal differentiation. Cx26 and the related Cx30 accumulated in keratinocyte cyto-
plasm instead of at intercellular junctions. However, initial data have shown that transgenic epider-
mal keratinocytes expressing Cx26(D66H) in culture transferred Lucifer Yellow CH, indicating that
they remained well-coupled by gap junctions. It is possible that the mutant protein might act by mech-
anisms other than disruption of the epidermal gap junction network. This has implications for the
mechanism of action of mutant connexins in several human diseases. 
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Novel SLC39A4 mutations in Japanese acrodermatitis enteropathica patients
A Nakano,1 H Nakano,1 K Nomura,2 Y Toyomaki1 and K Hanada1 1 Dermatology, Hirosaki
University School of Medicine, Hirosaki, Aomori, Japan and 2 Dermatology, Aomori Prefectural
Central Hospital, Aomori, Aomori, Japan
Acrodermatitis enteropathica (AE) is a rare autosomal recessive disease characterized by skin involve-
ment due to defective intestinal zinc absorption. Usually the skin lesions include erythema, erosions
and small blisters in perioral, perianal regions and hands and feet, which develop at the term of ablac-
tation. The AE gene has been localized to chromosomal region 8q24.3 and subsequently the solute
carrier family 39, member 4 (SLC39A4) gene has been disclosed as the AE gene. SLC39A4 muta-
tions have been demonstrated in several AE families, and in this study we have examined two Japan-
ese AE families for SLC39A4 mutations. The mutation detection strategy consisted of polymerase
chain reaction amplification of all 12 exons and flanking intronic sequences, followed by direct
nucleotide sequencing. It revealed three novel mutations, 1017ins53, which creates a premature ter-
mination codon, and two missense mutations, R95C and Q303H. 
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Morphological and biochemical studies of human beta-mannosidosis—identification of a novel
beta-mannosidase gene mutation
Y Uchino,1 T Fukushige,1 S Yotsumoto,1 T Hashiguchi,1 H Taguchi,2 N Suzuki,2 I Konohana2 and
T Kanzaki1 1 Dermatology, Kagoshima University Faculty of Medicine, Kagoshima, Kagoshima,
Japan and 2 Dermatology, Hiratsuka City Hospital, Hiratsuka, Kanagawa, Japan
Beta-mannosidosis is a rare hereditary lysosomal storage disease cased by a deficiency of the enzyme
beta-mannosidase. To clarify its pathogenesis we did electron microscopic, biochemical and molec-
ular biological investigations of a Japanease patient with beta-mannosidosis. This is the first case of
beta-mannosidosis reported in Japan and the second report in which a gene mutation is identified.
The biological importance of beta-mannose moieties in glycoproteins in basal keratinocytes is sug-
gested. 
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Regulation of cell cycle re-enter after DNA damage imposed arrest in human keratinocytes
A Costanzo,1,3 S Nistico’,1 M Papoutsaki,1 E Palescandolo,3 S Vossio,3 N Pediconi,3 G di Bari,2
D Barila’,2 M Levrero3 and S Chimenti1 1 Dermatology, University of Rome “Tor Vergata”, Rome,
IT, Italy, 2 General Pathology, University of Rome “Tor Vergata”, Rome, Italy and 3 Andrea
Cesalpino Foundation, Gene Expression Lab, University of Rome “La Sapienza”, Rome, Italy
Damage to chromosomal DNA induces a complex cellular response designed to delay cell cycle pro-
gression until the DNA is repaired. In the event of irreparable damage the cell undergoes apoptotic
cell death in order to preserve genome integrity. The product of the proto-oncogene c-Jun and the
tumor suppressor protein p53 act in concert to regulate the cell fate after UV irradiation. This func-
tion of c-Jun is exerted through negative regulation of p53 association with the p21 promoter. As a
result, cells lacking c-Jun exhibit prolonged p21 induction, whereas constitutive c-Jun inhibits UV-
mediated p21 induction. We have found that the dominant negative isoform of the p73 gene (DNp73),
is a target of c-Jun and p53 during UV response of keratinocytes. Both c-Jun and p53 are recruited
in vivo on the DNp73 promoter to induce its transcription after UV stimulation of human keratinocytes.
The DNp73 protein acts to downregulate p53 response by displacing it from the p21 promoter thus
allowing the termination of UV imposed arrest. Cells lacking the p73 gene display a higher amount
of p53 on the p21 promoter, and are less able to re-enter the cell cycle after UV. Consistently, UV
treated cells in which the DNp73 transcript has been selectively knocked-out by RNA interference
display a prolonged cell cycle arrest. Our results unveil a novel regulatory loop that governs the
ability of the cell to make the decision between cell cycle arrest and proliferation after UV.Impor-
tantly this regulatory loop is activated only under conditions of repairable DNA damage and cells
are allowed to re-enter the cell cycle and it is already put into motion when the p53 stabilization has
not yet been counteracted by either the increase of MDM2 or other mechanisms. Thus, our results
identify a new paradigm in the regulation of the p53/p73 cellular response to DNA damage in ker-
atinocytes. 
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A novel type of epidermolysis bullosa simplex with migratory circinate erythema is due to elon-
gated tail domain of keratin 5
H Tosaki,1 S Kim,2 L Gu,1 Y Ichiki,1 J Park,2 M Nagai1 and Y Kitajima1 1 Dermatology, Gifu
University, Gifu, Japan and 2 Cutaneous Biology Research Institute,Brain Korea 21 Project for
Medical Science, Yonsei University College of Medicine, Seoul, South Korea
Epidermolysis bullosa simplex (EBS) is an autosomal-dominant inherited blistering skin disease
characterized by intraepidermal blister formation due to cytolysis of epidermal keratinocytes after
minor trauma, and categorized into three main subtypes, i.e. EBS-Dowling-Meara (OMIM 131760),
EBS-Ksbner (OMIM 131900), EBS-Weber-Cockayne (OMIM 131800). We report here two unre-
lated families in Japan (two cases) and Korea (5 cases) having patients with an unique type of EBS
and a novel mutation in the keratin gene, KRT5; i.e., frameshift and delayed stop codon inconsis-
tent with any subtype described above. The patients showed migratory circinate erythema and mul-
tiple vesicles on the circular belt-like areas affected by erythema. Electron microscopy of skin biop-
sies showed a reduction in the number of keratin intermediate filaments in the basal cells without
tonofilament clumping. Immunohistochemical analysis showed no staining of Keratin 5 (K5) in basal
cells by using monoclonal antibody C-50 against K5/8, whereas western blot analysis showed K5
peptide. We identified a novel heterozygous deletion mutation (1649delG of KRT5) in cases of both
families. This deletion was predicted to produce a mutant K5 protein with a frameshift of its termi-
nal 41 amino acids, and 35 amino acids longer than the wild type K5 protein due to a delayed ter-
mination codon. The mutant K5 protein in the lesional skin was detected by the western blotting with
affinity purified polyclonal antibody against C terminal 11 peptides of elongated K5. Since the
same abnormal elongated mutant K5 gene and protein were found in the independent families, the
abnormal elongated keratin protein is likely to lead to an atypical clinical phenotype that has never
been reported, possibly by interfering with the functional interaction between keratin and its asso-
ciated protein. 
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Ultraviolet B-induced repression of class II nuclear hormone receptors in keratinocytes
M Schmuth,1,2 P Lau,3 Z Xie,2 Y Oda,2 DD Bikle,2,3 PM Elias3 and KR Feingold2,3 1 Dermatology,
University of Innsbruck, Innsbruck, Tyrol, Austria, 2 Medicine, UCSF, San Francisco, CA and 3
Dermatology, UCSF, San Francisco, CA
Class II nuclear hormone receptors heterodimerize with retinoid X receptor (RXR) and bind to
response elements in target genes, which regulate differentiation and lipid metabolism in keratinocytes.
In the present study we evaluated whether UV irradiation alters the expression of class II nuclear
hormone receptors; peroxisome proliferator activated receptors (PPAR), liver X receptors (LXR),
constitutive androstane receptor (CAR) and thyroid receptors (TR). mRNA levels of PPAR-alpha
and LXR-alpha were decreased by 50% 24 hours after UVB treatment of primary cultured ker-
atinocytes. As previously reported retinoid X receptor (RXR)-alpha and vitamin D receptor (VDR)
were also decreased 24 hours after UVB exposure. In contrast PPAR-delta was increased, and LXR-
beta, CAR, and TRs were unchanged. PPAR-gamma was not detectable on Northern blots. Time
course studies revealed that these decreases occurred as early as 6 hours after UVB exposure. In
addition, mRNA levels of acetyl-CoA-oxydase, a target gene for PPAR-alpha, and ATP-binding
cassette transporter (ABC)-1, a target gene for LXR-alpha, were similarly decreased after UVB expo-
sure. In cultured keratinocytes transfected with a response element for either PPAR or LXR, we
observed a marked decrease in promoter transactivation that was not rescued by ligand treatment,
over-expression of the receptor, or the combination of the two. Finally, we also observed down reg-
ulation of DRIP, a transcriptional co-activator of these nuclear hormone receptors suggesting that
the inhibition of gene expression by UV light is secondary to not only decreases in PPAR and LXR
alpha but also to post receptor mechanisms that link the binding of transcription factors to DNA
with increased transcription. The UV-induced down regulation of DRIP, PPAR-alpha, LXR-alpha
results in the decreased expression of downstream target genes that could be a protective mecha-
nism to prevent the accumulation of inflammatory lipid metabolites. 
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Germline fumarate hydratase mutations in families with multiple cutaneous and uterine leiomy-
omata
GS Chuang,1 A Zlotogorski,4 B Glaser,5 L Horev,4 A Waldman,6 DE Engler,1 D Gordon,3
LJ Spelman,7 I Hatzibougias,9 J Green,8 A Martinez-Mir1 and AM Christiano1,2 1 Dermatology,
Columbia University, New York, NY, 2 Genetics & Development, Columbia University, New York,
NY, 3 Laboratory of Statistical Genetics, Rockefeller University, New York, NY, 4 Dermatology,
Hadassah Medical Center, Jerusalem, Israel, 5 Endocrine & Metabolism Service, Hadassah
Medical Center, Jerusalem, Israel, 6 Dermatology, Haemek Medical Center, Afula, Israel, 7 South
East Dermatology, Brisbane, QLD, Australia, 8 Dermatology, St. Vincent, Melbourne, VIC,
Australia and 9 Institute of Pathology, Thessaloniki, Greece
Cutaneous leiomyomata are rare benign tumors originating from the arrector pili muscle of the hair
follicle. They can be associated with uterine fibroids in a syndrome called multiple cutaneous and
uterine leiomyomata (MCL) and with uterine leiomyomata and renal cell cancer (HLRCC). MCL
is inherited as an autosomal dominant trait, providing an excellent opportunity for the study of the
common non-Mendelian manifestation of isolated uterine fibroids. Previously, linkage analysis iden-
tified the genetic locus for MCL and HRLCC on chromosome 1, and mutations were identified in
the fumarate hydratase gene (FH). Fumarate hydratase, a component of the tricarboxylic acid cycle,
has been hypothesized to act as a tumor suppressor gene in the development of cutaneous and uter-
ine leiomyoma and renal cell cancer in this syndrome. Here, we report the clinical and mutational
analysis of five families with MCL, with the identification of five new mutations affecting highly
conserved residues of the FH protein. The identification of a particular FH mutation in each MCL
family will allow for close follow-up of those individuals at risk for the development of aggressive
papillary renal cell cancer. These results provide further evidence for the role of the FH gene in the
pathogenesis of MCL and may eventually facilitate the development of new therapeutic options for
affected individuals. 
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The involvement of immunoglobulin E class switch in scleroderma skin tissue
T Ohtsuka and Y Soji Department of Dermatology, Dokkyo University School of Medicine, Tochigi,
Japan
It has been suggested that of mast cells are involved in the formation of Systemic sclerosis (SSc)
abnormalities. The mechanism of mast cell activation in SSc, however, remains unknown.
Immunoglobulin isotype switching is an important process whereby B cells generate different types
of effect on antibody molecules. We sought to determine whether switch circular DNAs are excised
via looping out and deletional recombination in undergoing isotype switching in SSc. Isotype switch
to the e locus can be achieved by direct switch from m to e, sequential switching from m to e via g,
and triple step sequential switching from m to e via an a and g gene. We used nested PCR to amplify
and analyze the S fragments from switch circles for direct and sequential switch for all the samples.
We confirmed the results by sequencing the PCR products after TA cloning. Twenty-eight of 52 SSc
skin tissues showed the presence of IgE class switch. This occurrence rate was significantly higher
than those of normal skin tissue (4 of 62, P<0.01) and that of SSc blood cells (3 of 27, P<0.01). No
significant difference was found for direct switch among SSc tissue (5), SSc blood cells (1) and nor-
mal tissue (4). The occurrence rate of sequential switch in SSc tissue (23) was significantly higher
than that of 2 SSc blood cells (P<0.01). These results showed that IgE class switch is specifically
involved in the formation of SSc skin tissue abnormality. 
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Mild recessive epidermolytic hyperkeratosis associated with a keratin 10 donor splice site muta-
tion in a family of Norfolk Terrier dogs
KM Credille,1 KF Barnhart,1 JS Minor1 and RW Dunstan2 1 Comparative Dermatology
Laboratory, Texas A&M University, College Station, TX and 2 Pfizer Global Research and
Development, Ann Arbor, MI
Although the genetic basis for a large number of heritable epidermolytic diseases has been recog-
nized in humans, a spontaneous keratin mutation in a non-human species has not been confirmed.
In this report, we describe the phenotype and genotype of a mild form of epidermolytic hyperker-
atosis in an inbred family of Norfolk Terriers. Seven affected dogs were identified in a family pedi-
gree extending through 5 generations consistent with an autosomal recessive mode of inheritance.
In all dogs, the disease manifested shortly after birth when drying with a towel resulted in blister
formation. As animals aged, the skin became hyperpigmented and mild trauma continued to result
in loss of the upper epidermis. Histologic features included mild epidermal hyperplasia, epidermol-
ysis with separation at the granular cell layer, abundant large keratohyaline granules and a hyperk-
eratotic stratum corneum composed of thin corneocytes. Electron microscopy confirmed cytolysis
and decreased tonofilaments. Clinical and morphologic features suggested a mutation in one of the
superficial keratin genes. Immunohistochemical staining of formalin-fixed sections for keratin 10
(K10) and keratin 1 (K1) demonstrated no K10 staining in affected dogs but normal K1 staining
when compared to controls. Based on these results, the genomic DNA sequence for canine K10 was
generated in unaffected and affected dogs by PCR. Sequence analyses revealed affected dogs were
homozygous for a G- to- T mutation at +1 position of the consensus GT donor splice site in intron
5 of K10. This mutation activates alternative exonic and intronic donor splice sites in intron 4, exon
5 and intron 5 resulting in premature termination codons in most transcripts that occur in sites cor-
responding to a region at the end of the 2B rod domain. The outcome of this mutation appears to be
a marked decrease in K10 mRNA levels and an absence of normal protein as demonstrated by real-
time PCR and Western blotting. 
0603
Pathogenic mutations affecting Cx31 and Cx30.3 impair gap junction function and induce cell
death
F Rouan, L Yi, J Uitto and G Richard Dermatology and Cutaneous Biology, Thomas Jefferson
University, Philadelphia, PA
Erythrokeratodermia variabilis (EKV), an autosomal dominant skin disorder with transient erythe-
matous patches and hyperkeratosis, is genetically heterogeneous and may be caused by dominant
mutations in the connexin genes GJB3 and GJB4, encoding connexin 31 (Cx31) and connexin 30.3
(Cx30.3), respectively. Mutations in both genes affect either the glycine 12 residue in the amino-ter-
minus or the transmembrane domains of these closely related proteins. We investigated a series of
similar or distinct mutations involving orthologous residues in both genes to directly correlate their
functional consequences. The wildtype (wt) proteins and 4 different Cx31 or Cx30.3 mutants were
fused at the 3′end with autofluorescent YFP or CFP and expressed in HaCat cells in comparison to
mock vector controls. Fluorescence microscopy confirmed proper protein expression and revealed
formation of large gap junction plaques with wtCx31 and wt Cx30.3. The mutants F137L-Cx31 and
F137L-Cx30.3 both accumulated in the cytoplasms of cells and did not form visible gap junctions.
Cell-cell communication between expressing cells did not exceed background levels as shown by
dye coupling. In addition, the expression of F137L-Cx31 was associated with a high incidence of
cell death, while this characteristic was much less pronounced for F137L-Cx30.3. Co-expression of
F137L-Cx31 with wtCx31 did not rescue the phenotype or prevent cell death, illustrating the dom-
inant effect of this mutation. Formation of gap junction plaques was variable for other Cx31 and
Cx30.3 mutants but all showed reduced to absent dye coupling. Our results demonstrate that differ-
ent connexin mutations, depending on their nature and location, lead to distinct pathomechanisms
yet any disturbance of the normal function of Cx31 or Cx30.3 results in disease.  
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Unique human keratinocyte cell surface gene products identified by serial analysis of gene
expression (SAGE)
CL Yee, CL Tock and JC Vogel Dermatology Branch-NCI, National Institutes of Health, Bethesda,
MD
Better characterization of global expression of keratinocyte (KC) membrane proteins will enable
identification of novel KC specific markers. Traditional proteomic approaches such as 2D gel elec-
trophoresis have not elucidated a complete representation of the KC membrane. In this investiga-
tion, the membrane fraction of human neonatal foreskin (n=15) KC mRNA, isolated by equilibrium
density centrifugation, was used to create a SAGE library. This fraction of total mRNA ideally rep-
resents secreted and membrane associated KC proteins. The resulting library contained 2233 genes
represented by 25,822 sequence tags. Each gene in the library is identified by a unique sequence
tag, and the relative abundance of each gene is related to the frequency of occurrence of that tag. Of
the 231 abundantly expressed genes (tag count >0.05% of total tags), 32% (n=73) encoded riboso-
mal proteins, 41% (n=95) were previously identified genes, and 27% (n=63) were unknown gene
products. Previously identified genes included KC specific genes such as K1, K10, K5, K14, and
membrane associated proteins such as desmoplakin, beta-4 integrin, and connexin 43. Importantly,
this library was enriched for both known membrane associated proteins and unknown novel gene
products when compared to published human epidermal SAGE libraries of total cellular proteins and
a universal (multi-tissue) SAGE library. Furthermore, 9 of the unknown gene products were not pres-
ent in the other epidermal libraries, and were limited to expression in <2% of over 3000 SAGE
libraries, indicating these gene products were unique and specific to this KC library. In conclusion,
the SAGE library derived from the membrane fraction of human epidermis enhances the retrieval of
expressed membrane associated genes that are unique to human neonatal foreskin KC. Further char-
acterization of the 9 tissue restricted unknown genes may identify human KC cell membrane mark-
ers useful for studying the biological function of different KC subpopulations. 
0604
Detection of retroviral-mediated expression of latency-associated peptide delivered by trans-
duced macrophages to murine skin
Y Zhang, J Tao, C Wu, SA Ismail and AC Gilliam Dermatology, Case Western Reserve University,
Cleveland, OH
We have developed a new method to deliver an immunomodulatory molecule, latency associated
peptide (LAP), a naturally occurring antagonist for TGF-β to murine skin by gene transfer utilizing
UV light to produce a cutaneous influx of monocyte/ macrophages. Bone marrow (BM) cells from
BALB/cJ mice are transduced in vitro with a retroviral construct (MSCV) containing green fluo-
rescent protein (GFP) for detection, human LAP (hLAP) and an internal ribosome entry site (IRES).
The transduced BM cells are then driven in vitro to monocyte/ macrophages with GM-CSF. A con-
struct containing only GFP serves as control. Four million transduced monocyte/ macrophages con-
taining either GFP or GFP-hLAP are injected intravenously into BALB/cJ mice and then one group
is exposed to UVB (72MJ) to induce monocyte/ macrophage infiltration into skin. Recipients are
sacrificed 60 hours after UV irradiation. Western blot and immunostaining are used to document the
synthesis of hLAP. PCR is used to detect GFP and hLAP sequences in recipient skin. By flow cyto-
metric analysis more than 80% of transduced BM cells are driven to CD11b+ and MOMA+ mono-
cyte/ macrophages by 10 days of culture in GM-CSF. When stained with anti-hLAP Ab, BM cells
transduced with construct containing GFP-hLAP are both GFP and LAP positive. In recipient skin,
we found transduced macrophages expressing GFP by examining the fresh frozen skin sections by
fluorescence microscopy. We also detected GFP and hLAP sequences by PCR analysis in recipient
skin in which GFP and LAP are stronger in UV irradiated skin compared with non-UV skin. GFP
and LAP sequences are also detected in other organs (lung, blood, spleen) by PCR analysis. Our
data suggest that human LAP gene product can be delivered to skin with overexpressing transduced
cells. This macrophage-based gene transfer method may be a potentially useful immunotherapy for
monocyte/ macrophage and TGF-β-driven fibrosing diseases such as scleroderma. 
0602
Severely reduced levels of the mRNAs for lysyl hydroxylase 2 in skin fibroblasts from three
patients with Ehlers-Danlos-like symptoms do not result from mutations in the coding region
for LH2
HN Yeowell,1 LC Walker1 and AS Teebi2 1 Dermatology, Duke University Medical Center,
Durham, NC and 2 Clinical Genetics, University of Toronto, Toronto, ON, Canada
The Ehlers-Danlos syndrome encompasses a heterogeneous group of connective tissue disorders
characterized by tissue fragility, hyperelasticity of the skin and hypermobility of the joints. Patients
with the autosomal recessive type VI form of EDS (EDS VI: kyphoscoliosis type) have a similar clin-
ical phenotype accompanied by significant kyphoscoliosis. At the biochemical level, skin fibroblasts
from EDS VIA patients (the originally-described form of EDS VI), have significantly decreased
levels of lysyl hydroxylase (LH) activity (<25% of control), as a result of mutations in the LH1
gene. LH hydroxylates specific lysine residues in the collagen molecule that are precursors for the
formation of crosslinks which provide collagen with its tensile strength. In addition to LH1, two
other isoforms of LH, LH2 and LH3, have been characterized, but no disorder has been linked to
mutations in the genes for LH2 and LH3. We have measured LH activity, levels of mRNAs for the
isoforms LH1, LH2, and LH3, and collagen crosslinking patterns in skin fibroblasts from 3 patients
who have a mixed phenotype of EDS. Although their levels of LH activity (70-96% of control), pat-
tern of collagen crosslinking in long term fibroblast cultures, and mRNAs for LH1 (69-111% of
control) and LH3 (87-129% of control) were in the normal range, the mRNAs for LH2 were decreased
to barely detectable levels (<5% of control). To determine whether this was due to mutations in the
LH2 gene, the full length cDNA for LH2 was amplified by RT-PCR from the 3 cell lines, cloned and
sequenced. No mutations could be detected in the LH2 coding sequences that could account for the
severely decreased mRNAs for LH2. This suggests that the decreased expression of LH2 may be
caused either by abnormalities in the regulatory region of the LH2 gene or by changes in other fac-
tors that may be required for the expression of LH2. 
0606
A very mild form of non-Herlitz junctional epidermolysis bullosa: type XVII collagen rescue
by outsplicing of mutated exon 30
S van Zalen, M Pasmooij, M Nijenhuis, GJ Kloosterhuis, G Meijer, MF Jonkman and HH Pas
Center for Blistering Diseases, Department of Dermatology, Universtity Hospital Groningen,
Groningen, Groningen, Netherlands
Non-Herlitz junctional epidermolysis bullosa (JEB-nH) is a nonlethal variant of junctional epider-
molysis bullosa with an autosomal recessive inheritance pattern. Pathogenic mutations have been
found in the COL17A1 gene encoding type XVII collagen, a homotrimeric, hemidesmosomal trans-
membrane protein. Absence of type XVII collagen protein results in a clinical phenotype with gen-
eralized blistering, mild mucosal involvement, incomplete universal atrophic alopecia, pigment
changes, rudimentary nails and dental abnormalities. Milder forms however do exist with limited
blistering and preservation of scalp hair. In this study we investigated an adult patient with an extremely
mild form of JEB-nH. Immunofluorescence microscopy of non-lesional skin showed reduced pres-
ence of the type XVII collagen endodomain and almost normal presence of the ectodomain. Sequence
analysis of genomic DNA and cDNA identified two novel heterozygous mutations in COL17A1: a
point mutation, 2356C->T, and a single base pair deletion, 3432delT. This latter 3432delT exon 48
mutation results in out-of-frame reading, thereby generating a premature termination codon. The
2356C->T point mutation in exon 30 also results in a premature termination codon, but here the read-
ing frame is restored by skipping the 36 nucleotides long exon 30. This skipping of exon 30 is not
found in normal keratinocyte mRNA. In cultured cells type XVII collagen was present at 15% of
the normal level. Immunoblotting confirmed the 12 amino acid deletion by showing a type XVII col-
lagen molecule running in SDS-PAGE at an approximately 1 kDa lower position. We conclude that
this unusual mild form of JEB-nH is therefore the result of the in-frame deletion of exon 30, lead-
ing to 12 amino acid deletion in the COL15 domain and an at least partly functional type XVII col-
lagen molecule. This particular type of rescue mechanism has not been observed before for type
XVII collagen. 
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Development of autologous, cell-based gene therapy using primary dermal fibroblasts
KM Matsuda,1 J Bertoncini,1 JP Vacanti2 and M Detmar1 1 Dermatology, CBRC/Massachusetts
General Hospital, Charlestown, MA and 2 Tissue Engineering and Microfabrication Laboratory,
Massachusetts General Hospital, Boston, MA
We have previously demonstrated the feasibility of systemic, cell-based anti-angiogenic gene ther-
apy for cancer treatment, using bio-engineered implants of immortalized mouse 3T3 fibroblasts that
were retrovirally transduced to express the angiogenesis inhibitor thrombospondin-2. In this study,
we investigated the feasibility of autologous cell-based gene therapy using primary dermal fibrob-
lasts that were isolated from adult mouse skin. Primary fibroblasts were transduced with a retro-
virus carrying a GFP reporter gene. The transduced fibroblasts were purified by cell sorting and were
seeded onto 3-dimensional meshes consisting of a dense network of biodegradable polymer fibers.
These cell-populated meshes were then implanted subcutaneously into the identical mice from which
the primary fibroblasts had been previously isolated. Thirty days after autologous implantation, the
histological detection of GFP-expressing fibroblasts by fluorescence microscopy confirmed the sur-
vival and the maintenance of gene expression of a number of the genetically engineered fibroblasts.
These results indicate that autologous transplantation of retrovirally transduced primary dermal
fibroblasts on biodegradable matrices might serve as novel strategy for cell-based gene therapy. 
0608
The regulation of glucocorticoid receptor alpha and beta in cultured human keratinocytes by
long-term, high concentrations of glucocorticoids
K Shimizu, S Bae, H Murota and I Katayama Dermatology, University, Nagasaki, Nagasaki, Japan
The actions of glucocorticoid (GC) are mediated by the GC receptors (GR), which are divided into
two isoforms, namely GR alpha and GR beta, by the alternative splicing. GR beta acts as an endoge-
nous inhibitor against the native receptor GR alpha. The suppression of GR alpha, the up-regulation
of GR beta and the decrease of GR alpha/ GR beta ratio have been reported in the human GC insen-
sitive asthma and leukemia cases. GR alpha and GR beta were usually expressed in normal skin and
we confirmed that the expression of GR alpha mRNA decreased in the steroid insensitive lesional
skins as compared to sensitive lesional skins in cases of psoriasis vulgaris. The administration of
steroids is usually performed daily for a long time in many clinical cases. That is why the long-term
administration of steroids is thought to be involved in the acquisition mechanism of steroid insensi-
tivity. In order to clarify the acquisition mechanism, we conducted the long-term culture of human
keratinocyte under the high concentration of GC. We cultured human neonatal epidermal keratinocytes
under the high and low concentrations of GC for 3 passages. We examined the expressions of GR
alpha and GR beta mRNA at the end of each passage. The down-regulations of GR alpha and GR
beta were confirmed in cultured human keratinocytes at mRNA level under the condition of high
concentrations of GC. We are now investigating the expression of GR alpha and GR beta in cultured
human keratinocytes at the protein level under the conditions of high and low concentrations of GC. 
0609
De novo mutatations in monilethrix
L Horev,1 K Djabali,2 J Green,4 R Sinclair,4 A Martinez-Mir,2 A Ingber,1 AM Christiano2,3 and
A Zlotogorski1 1 Dermatology, Hadassah University Medical Center, Jerusalem, Israel, 2 Genetics
& Development, Columbia University, New York, 3 Dermatology, Columbia University, New York
and 4 Dermatology, St. Vincent, Melbourne
Mutations in the hair keratins hHb1 and hHb6 have been recently reported to cause monilethrix, an
autosomal dominant hair shaft disorder, characterized by variable degrees of hair fragility and fol-
licular hyperkeratosis. We found 10 families with monilethrix in which the parents were not clini-
cally affected, and sequenced the hair keratin hHb1, hHb3 and hHb6 genes in 7 patients. In 5 patients
no mutations were found, while in 2 patients, we identified de novo germ line missense mutations,
at the helix termination motif, E402K (hHb6) and E413K (hHb1). This study emphasizes the key
role of hair keratins hHb1 and hHb6 in the pathogenesis of monilethrix, while also demonstrating
the heterogeneity of this disease, and its high tendency for new mutations. 
0610
Myelodysplastic syndrome in mice lacking IkappaB-alpha
RA Rupec,1 B Rebholz,1 B Eckelt,1 S Moosmann,2 I Foerster,3 K Pfeffer3 and R Huss2 1
Department of Dermatology, University of Munich, Munich, Germany, 2 Department of Pathology,
University of Munich, Munich, Germany and 3 Department of Medical Microbiology, Immunology
and Hygiene, Technical University of Munich, Munich, Germany
Newborn mice deficient for the gene coding for IkappaB-alpha, ikba, develop an increase in num-
bers of neutrophils in liver, spleen and bone marrow resulting in a myeloproliferative disease. Accord-
ing to the WHO category this hematological disorder would be best classified best as a chronic
myelomonocytic leukemia (CMML) in the group of Myelodysplastic / Myeloproliferative diseases
(MDS/MPD) or with an excess of blasts with more than 20 % blasts in the blood and / or bone mar-
row as a secondary acute myeloid leukemia. In order to analyse the mechanism responsible for the
myeloproliferative disorder, we generated mice allowing complete or tissue-specific deletion of ikba,
utilizing the Cre-loxP recombination system. An increase in granulocyte progenitors and changes in
the expression level of Notch1 and its target gene Hes-1 are found in granulocytes isolated from these
mice. The Notch ligand Jagged1, transiently expressed in fetal liver of wildtype mice at E12, remains
upregulated in the liver of IkappaB-alpha-deficient mice. Importantly, mice with a specific deletion
of IkappaB-aalpha in granulocytes show normal myelopoiesis, despite constitutive NF-kappaB acti-
vation. No Notch1 expression is found in granulocytes and no prolonged Jagged1 expression can be
found in these mice. These results identify IkappaB-alpha as a key regulator in perinatal myelopoiesis
via Jagged1 and Notch1. Moreover, this model demonstrates how a loss of control leadsto the devel-
opment of myelodysplastic syndrome / myeloproliferative resulting in secondary acute myeloid
leukemia. 
0611
Genomic sequence analysis of PSORS1
RP Nair,1 P Stuart,1 J Epperson,1 I Nistor,1 N Dubal,1 M Weichenthal,2 S Jenisch,2 E Christophers,2
JJ Voorhees 1 and JT Elder1 1 Dermatology, University of Michigan, Ann Arbor, MI and 2
Dermatology, University of Kiel, Kiel, Germany
The most consistently replicated psoriasis susceptibility locus, PSORS1, maps to the MHC Class I
region. We fine-mapped PSORS1 to the vicinity of HLA-C and CDSN by recombinant ancestral
haplotype analysis (AJHG 66:1833, 2000). This region contains seven genes other than HLA-C,
and several of these display highly significant allelic associations with psoriasis in multiple studies.
However, the observed associations could generally be explained equally well or better by the pres-
ence of HLA-Cw6, an allele long known to be associated with psoriasis. In an effort to identify the
PSORS1 gene, we have sequenced a 200 kb region spanning HLA-C and CDSN in 4 risk and 6 non-
risk haplotypes. Sequence analysis identified over 2200 polymorphisms including over 230 inser-
tion/deletions (indels), the remainder being SNPs. Cluster 26 (Cw7, B8, non-risk, T:NT = 53:64,
TDT p = NS) displayed remarkable similarity to all Cw6-positive risk chromosomes from 0.5 to
128.5 kb telomeric to HLA-C, a region which includes the OTF3, TCF19, and HCR genes. Cluster
17 was previously found to confer marginal risk (Cw8, B65, T:NT = 21:10, TDT p = 0.048). If Clus-
ter 17 is risk, there are no coding variations in HLA-C or any of the other 7 genes that are unique to
risk. If Cluster 17 is non-risk, the only candidates for risk in the 200 kb region are HLA-Cw6 and a
combination of 3 coding SNPs in the CDSN gene. However, this CDSN allele has been ruled out in
Oriental populations (Tissue Antigens 60:77). Cluster 17 demonstrates substantial centromeric diver-
gence from all Cw6-bearing chromosomes beginning 15.3 kb telomeric to HLA-C.  The most promi-
nent feature of this divergence was a 9.7 kb indel located centromeric to HLA-C. While our final
conclusions will depend upon a better assessment of the risk associated with Cluster 17, the avail-
able sequence data favor HLA-Cw6 itself as the best candidate for PSORS1. This would be in keep-
ing with the presence of CD8-positive T cells in the epidermis of psoriatic lesions. 
0612
Type I collagen regulation of gene expression in collagen-related diseases
ME Lacouture,1,2 B Chaletzky2 and LB Klickstein2 1 Section of Dermatology, University of
Chicago, Chicago, IL and 2 Division of Rheumatology, Immunology & Allergy, Brigham &
Women’s Hospital, Boston, MA
Decreased or structurally abnormal type I collagen (COL1) leading to a reduction in cell prolifera-
tion, differentiation and extracellular matrix (ECM) protein synthesis results in conditions charac-
terized by reduced mechanical strength of connective tissues, such as Ehlers-Danlos Syndrome types
VIIA and VIIB, and Osteogenesis Imperfecta. Here we used an in vitro method to select cells with
high survival and proliferative indices when cultured on limiting amounts of COL1. Through DNA
array analysis, we defined a pattern of cytokine and cytokine receptor gene expression that corre-
lated with the increased survival and proliferation. A mesenchymal cell line (HOS) was cultured on
plastic substrates coated with either low or high levels of COL1. Collagen was labeled with 125I to
accurately measure site densities. mRNA transcripts encoding 700 cytokine-related genes were
assessed by DNA array analysis. Immunofluorescence microscopy was used to visualize corre-
sponding alterations in the cytoskeleton and β1 integrin distribution. We found enhanced expression
of several genes involved in cell growth and ECM synthesis: transforming growth factor β-receptor
II (TGFβRII), proliferation inducing ligand (APRIL), human homologue of a canine orphan recep-
tor and tissue inhibitors of metalloproteinases 1 and 4. One of these, TGFβRII, mediated enhanced
cell growth and attachment to COL1 when stimulated by soluble TGF-β, a TGFβRII agonist. In addi-
tion, stimulation of TGFβRII increased cell spreading and integrin clustering (per immunofluores-
cence), that correlated with increased cell survival. Subsequent, broader Affymetrix array analysis
of HOS cells confirmed that the TGFβ-TGFβR-SMAD pathway is important when cells are adher-
ent and growing on limiting amounts of collagen. This genomics approach permitted us to identify
candidate cytokine gene families that may be involved in the pathophysiology of CRD, a first step
in the development of new therapies for these debilitating conditions. 
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Transgenic mouse models support HCR as an effector gene in the PSORS1 locus
J Kere,1,2 O Elomaa,2 S Suomela,3 K Asumalahti,2 I Majuri,2 Z Mirzaei,1 K Dahlman-Wright,1
I Thesleff,4 M Mikkola4 and U Saarialho-Kere3 1 Department of Biosciences at Novum, Karolinska
Institute, Huddinge, Sweden, 2 Department of Medical Genetics, University of Helsinki, Helsinki,
Finland, 3 Department of Dermatology, University of Helsinki, Helsinki, Finland and 4 Institute of
Biotechnology, University of Helsinki, Helsinki, Finland
Genetic susceptibility for psoriasis is regulated to the greatest extent by the PSORS1 locus. Three
strongly psoriasis-associated susceptibility alleles have been identified within it, namely HLA-
Cw6, HCR*WWCC and CDSN*5, but strong linkage disequilibrium between them has made it dif-
ficult to distinguish their individual genetic effects (Asumalahti K et al., HMG 2002:11:589). With
the aim of understanding the functional role of HCR, we have engineered transgenic mice with either
a nonrisk allele of HCR or the HCR*WWCC risk allele under the control of the K14 promoter. These
choices were motivated by the apparently dominant effect of PSORS1 on psoriasis susceptibility and
the physiological expression of HCR in basal keratinocytes. The HCR*WWCC protein has been pre-
dicted to differ from the nonrisk alleles by having a shorter first alpha-helical domain. Mice that
express either of the transgene mRNAs and proteins develop and grow normally. Without environ-
mental challenge, the skin appears grossly normal for both the nonrisk and risk transgene models.
Global expression studies using the Affymetrix platform revealed that five out of 12,000 genes assayed
are specifically and consistently upregulated in the HCR*WWCC risk allele mice as compared to
the nonrisk allele mice. These include type II epidermal keratin and two genes of the small proline-
rich protein family cluster. The small proline-rich protein cluster that in human maps to the chro-
mosome 1q21 psoriasis susceptibility locus PSORS4 is known to be among the most strongly upreg-
ulated in psoriatic as compared to normal skin (Bowcock A et al., HMG 2001:10:1793). Our results
suggest that the HCR risk allele has specific functional consequences relevant to the pathogenesis
of psoriasis and that HCR constitutes an essential gene in the PSORS1 locus. 
0615
Molecular and cellular analysis of a Japanese patient with xeroderma pigmentosum comple-
mentation group D who has the clinical features of Cockayne syndrome
M Fujimoto,1 S Moriwaki,2 T Tsuru,1 M Mori,1 T Yamagata,1 A Satoh,1 T Murakami,1 S Murata,1
M Ohtsuki,1 M Momoi,1 T Therina,3 AR Lehmann3 and H Nakagawa1 1 Jichi Medical School,
Tochigi, Japan, 2 Hamamatsu University School of Medicine, Hamamatsu, Japan and 3 University
of Sussex, Brighton, United Kingdom
Xeroderma pigmentosum (XP) and Cockayne syndrome (CS) are distinct disorders associated with
defects in excision repair of UV-induced DNA damage. In addition to the classical forms, some
patients show characteristics of both diseases (XP/CS complex). Complementation studies have
revealed that these patients belong to XP groups B, D and G, and only two XPD/CS patients have
been reported. Here we report a new individual with the XPD/CS complex, who expired at the age
of 2 with squamous cell carcinoma and liver failure. The level of NER measured as UDS was 33 %
that of normal cells. As with the two previously described XPD/CS patients, the new patient’s cells
introduce uncontrolled breaks into their genomic DNA following UV-Irradiation. The mutations pre-
viously identified in two XPD/CS patients locate in the C-terminal third of XPD protein, which is
involved in interactions with another subunit of the TFIIH complex, designated p44. This interac-
tion stimulates the helicase activity of the XPD within the TFIIH complex. In contrast, we have iden-
tified one causative mutation in the XPD gene as a G to A transversion at base 217 in the allele
inherited from patient’s mother, which was confirmed by the PCR-RFLP method. This results in a
gly47 to arg change in the 1st DNA helicase domain of the XPD protein. This mutation was detected
previously in the heterozygous state in a XPD patient with severe symptoms (XP1NE). In our case,
there is no parental consanguinity and the alleles are heterozygous. Standard bidirectional sequenc-
ing of cDNA did not reveal the mutation in the second allele. Using PCR on genomic DNA from the
proband and his father, we were unable to detect any mutations in the 5’-UTR including the GC,
CAAT and TATA boxes. Further study on this strain will give us important clues to unveil the mech-
anisms of DNA-repair abnormalities. 
0617
Cooperation of connexin 30.3 and 31 is essential for assembly and stability of connexons
L Plantard,1 M Huber,1 R Panizzon,1 P Meda2 and D Hohl1 1 Dermatology, CHUV, Lausanne, VD,
Switzerland and 2 Morphology, CMU, Geneve, GE, Switzerland
Connexins are homologous proteins with 4 transmembrane domains, major components of gap junc-
tions. We have recently identified mutations in either connexin 31 (Cx31) or 30.3 (Cx30.3) to be
causally involved in erythrokeratodermia variabilis (EKV), an autosomal dominant disorder of ker-
atinization. The F137L mutation in either Cx31 or Cx30.3 leads to EKV. This amino acid is highly
conservated in connexin family and is oriented towards the channel pore. However the mechanism
by which the Cx30.3 F137L mutation leads to the disease is unclear and may occur either by a dom-
inant negative effect or by haploinsufficiency. Here we studied the effect of this mutation on expres-
sion, trafficking and localization of cotransfected Cx31 and Cx30.3 in connexin-deficient HeLa cells.
Cx31 and Cx30.3 cDNAs were cloned into a selectable mammalian expression plasmid allowing
the coexpression of both inserts with fused tags. Different plasmids with various combination of
inserts (WT Cx31, WT Cx30.3 or M Cx30.3) have been constructed. HeLa cells transfected by
these plasmids expressed high levels of RNA and proteins. Coexpressed WT Cx31 and WT Cx30.3
colocalized and appeared as large plaques at the plasma membrane as revealed by an anti N-Cad-
herin antibody indicating that Cx are addressed to the cell membrane. Moreover we were able to
coprecipitate Cx30.3 and Cx31 under these conditions indicating that both connexins interact phys-
ically. WT Cx31 and Cx30.3 alone are located at plasma membrane, at cell-cell contacts but as
small plaques or dots. Contrary, when mutant Cx30.3 is coexpressed with WT Cx31, the staining
remains diffuse and mainly in the perinuclear space. In conclusion, our results indicate the impor-
tance of quality control mechanism in the assembly of Cx30.3-31 connexons before they reach the
plasma membrane. 
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Alterations of calcium homeostasis in Mal de Meleda
F Chimienti,1 R Hogg,2 L Plantard,1 M Huber,1 D Bertrand2 and D Hohl1 1 Dept of Dermatology,
CHUV, Lausanne, VD, Switzerland and 2 Department of Physiology, CMU, Geneva, GE,
Switzerland
Calcium has an established role in the homeostasis of mammalian skin, and a gradient of calcium
concentration increasing from the basal layer to the stratum granulosum modulates keratinocyte pro-
liferation and differentiation. Recent evidence revealed the importance of calcium pumps and nico-
tinic receptors in squamous differentiation. Mal de Meleda (MdM) is an autosomal recessive inflam-
matory palmoplantar keratoderma in which we have identified mutations in the gene encoding for
SLURP-1 (Secreted Ly-6/uPAR-related protein 1). Analysis of SLURP-1 transcripts by Northern
blot and RT-PCR revealed that SLURP-1 is expressed in palmoplantar skin and in foreskin. SLURP-
1 has homologies with the Ly-6/uPAR/neurotoxin protein superfamily characterized by conserved
disulfide bridges and a C-terminal consensus sequence CCXXXXCN. This family includes CD59
(protectin), E48 antigen and lynx1 which modulates nAChRs in the CNS. Contrary to other family
members, SLURP-1 lacks a GPI anchor and contains a predicted signal peptide sequence, suggest-
ing that it is a secreted protein. Indeed, 293T cells transfected with a mammalian SLURP-1 expres-
sion vector secrete the protein into the culture medium. Moreover, tagging at both N- and C-termini,
allowed to demonstrate that the signal peptide of SLURP-1 is proteolytically processed during secre-
tion. N-Glycosidase assays of transfected mammalian and insect cells, indicate that SLURP-1 is not
glycosylated even tough this is predicted on N64 in silico. Finally, we tested whether SLURP-1 could
directly modulate nicotinic receptors, similarly to lynx1. Recombinant 6XHis-tagged SLURP-1
was produced in mammalian 293T cells, purified with Ni-NTA resin, and used to assess the effect
of SLURP-1 on human α7 nAChRs expressed in Xenopus oocytes. Indeed, it appears that SLURP-
1 interacts with α7 nAChRs and is able to modulate the amplitude of the ACh-evoked currents. We
hypothesize that SLURP1 modulates intracellular calcium content in keratinocytes, thus acting as a
signal in normal growth and development of palmoplantar keratinocytes. 
0614
Hepatocyte growth factor prevents and ameliorates dermal sclerosis in a mouse model of scle-
roderma
M Wu,1 H Yokozeki,1 S Takagawa,1 T Yamamoto,1 T Satoh,1 Y Kaneda2 and K Nishioka1 1
Environmental Immunodermatology, Tokyo Medical and Dental University, Graduate School of
Medicine, Tokyo, Japan and 2 Division of Gene Therapy Science, Osaka University, Graduate
School of Medicine, Osaka, Japan
Systemic sclerosis (ssc) is a connective tissue disorder with an unknown etiology. There are currently
no effective therapies for ssc. hepatocyte growth factor (HGF), originally identified and cloned as a
potent mitogen for hepatocytes, induces the mitogenic and antiapoptotic activity in various epithe-
rial cells and prevents the organ fibrosis by inhibiting the induction of TGF-beta1. HGF may be a
potent candidate to prevention of dermal sclerosis. working with a bleomycin (BLM) -induced scle-
roderma model mice, we performed two transfections of human HGF cDNA into the skeletal mus-
cle and showed that this treatment not only prevented the dermal sclerosis simultaneously injected
BLM but also improved dermal sclerosis induced by BLM 4 weeks before. RT-PCR, ELISA and an
immunohistochemical analysis revealed that both mRNA and protein of HGF were detected inthe
skin, lung and muscle and the serum after two transfections of human HGF cDNA. And these analy-
sis also revealed that this treatment significantly reduced both the expression of the TGF-beta1 mRNA
and the production of TGF-beta1 on macrophage-like cells which infiltrated in the dermis and the
fibroblastic cells in BLM-induced scleroderma. Furthermore, HGF gene transfection prevented and
ameliarated not only dermal sclerosis but also lung fibrosis induced by subcutaneous BLM injec-
tion. These results indicated that gene therapy by the transfection of the human HGF cDNA may
thus be a useful therapy for ssc and lung fibrosis involved in ssc. 
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Gene expression profile in keratinocytes from patients with recessive dystrophic epidermoly-
sis bullosa following scratch wounding
V Wessagowit, R Mallipeddi, J McGrath and A South Dept of Cell and Molecular Pathology, St
John’s Institute of Dermatology, London, United Kingdom
Generalized recessive dystrophic epidermolysis bullosa (RDEB) results from loss-of-function muta-
tions in the anchoring fibril protein, type VII collagen. Clinically, there is trauma-induced blister-
ing, chronic erosions and poor wound healing. The aim of this study was to examine gene expres-
sion profiles to assess the early molecular events in RDEB keratinocytes in response to injury. Primary
confluent keratinocyte cultures were established from 3 RDEB subjects and 3 controls. RNA was
harvested at baseline, at 6 hours and at 12 hours after scratch wounding. cDNA was hybridized to
DermArray Human GeneFilters and the results were quantified using Pathways™ software. Only
changes above two-fold were considered significant and the results were confirmed by semi-quan-
titative reverse transcription PCR. In RDEB wounded cells, three genes were downregulated at 6
hours compared with controls. These were psoriasin 1, stromelysin 2 and ubiquitin-conjugating
enzyme E2G2 (UBE2G2). There were no significant changes at any other time-points. Psoriasin 1
is an S100 EF-hand calcium-binding protein with putative roles in calcium signal transduction, cell
differentiation and cell cycle progression, although its precise function in keratinocyte cell biology
is unknown. Stromelysin 2 is a metalloproteinase family member and is highly expressed in chron-
ically inflamed diabetic and venous ulcers, but no previous data exists on its expression in either in
vivo or in vitro RDEB wounds. UBE2G2 is an enzyme in the ubiquitin pathway that is relevant to
cell homeostasis in several biological contexts. In summary, our study suggests that there are sig-
nificant differences in the gene expression profile of RDEB keratinocytes compared to controls dur-
ing the early phase of wound healing. These differences may have relevance to cell migration and
keratinocyte proliferation and provide insight into the pathological mechanisms that contribute to
delayed and poor wound healing in RDEB. 
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Wound healing’s transcriptional signature in epidermis of normal human skin
M Tomic, B Lee, C Vouthounis and O Stojadinovic Dermatology, NYU School of Medicine, New
York, NY
As a complex process involving highly coordinated, interacting regulatory pathways in different
cell types, wound healing is a prototype biological process to be studied by gene array technology.
Using this technology we have the ability to advance beyond the analysis of individual genes, and
analyze globally functional pathways and interactions of cellular components that regulate and
carry out cellular processes. To determine the transcriptional patterns of the normal wound healing
process in epidermis we performed gene array analysis of the wounded normal human skin at 4, 48
and 96 hours post-wounding using Affymetrix HU95 chips. We found 930 genes to be significantly
regulated (14.7% of all genes found expressed). Overall, we found that the 4 and 48 hours tran-
scriptional patterns are more similar to each other than to those at the 96 hours time point. As expected,
we found that the adhesion molecules (such as desmosomal components) are initially suppressed (4
and 48 hours) whereas they start to increase at the 96 hours time point. Tight junction genes were
strongly suppressed 4 and 48 hours post-wounding thus indicating junctional rearrangements that
are expected from the cellular preparation for movement. At the 96 hours these genes became de-
repressed - their levels were restored to the levels prior to the wounding. In addition, MMP1, 2 and
10 were induced at 4 and 48 hours time points. Cell cycle and DNA synthesis genes, although
expressed in early time points, are strongly induced at the 96 hours point. This is rather unexpected,
because it was assumed that migration and proliferation overlap in time, and in combination is one
of the initial keratinocyte’s responses to wounding. Our results indicate that in response to wound-
ing, keratinocytes first migrate and subsequently divide. This kinetics also correlates with the induc-
tion of steroidogenic enzymes. Taken together, our results show very specific regulatory pattern lead-
ing to particular keratinocyte phenotype during wound healing. 
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Large-scale genomic approach to identify diagnostic/ prognostic marker and drug target can-
didate genes linked to skin diseases
B Peters,1 D Freihoff,1 J Baron,2 C Mauch,3 J Wenzel,4 H Merk,2 T Krieg,3 T Bieber4 and A Bosio1
1 Drug Target Discovery, memorec Stoffel GmbH, Cologne, Germany, 2 Department of
Dermatology, University of Aachen, Aachen, Germany, 3 Department of Dermatology, University
of Cologne, Cologne, Germany and 4 Department of Dermatology, University of Bonn, Bonn,
Germany
The aim of our studies is to identify drug target candidate genes and diagnostic/ prognostic marker
genes linked to inflammatory skin diseases and skin cancers. In a pilot project, we constructed two
SAGE libraries (30000 tags) using RNA of 21 psoriasis biopsies and of 22 healthy individuals respec-
tively. Comparison of the two SAGE libraries revealed about 70 differentially (>2-fold, p<0.01)
expressed genes, some of them already known to be associated with psoriasis, like protease inhibitor
3, keratin 6A or the S100 calcium binding proteins, e.g. psoriasin 1. Confirmation of our results was
achieved using the PIQOR array technology. Each of the psoriasis biopsies and the healthy controls
were hybridized versus a common reference on PIQOR Skin1.0 arrays. The PIQOR Skin1.0 array
comprises about 1300 genes expressed in human skin diseases or normal skin. The expression pro-
files of individual patients allowed us to distinguish between genes differentially expressed in indi-
viduals or subgroups, and putative universal marker genes for psoriasis. Our results clearly demon-
strate that SAGE data from pooled samples should always be confirmed by analysis of individual
biopsies. Otherwise the identification of putative marker genes allowing a new pathological classi-
fication of the disease might be missed or individual differences in gene expression might be mis-
interpreted as universal. 
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Mutations in a novel actin-extracellular matrix linkage gene cause Kindler syndrome
DH Siegel,1 GS Ashton,2 WI McLean,3 RJ Eady,2 JA McGrath,2 EH Epstein1 and the K S
Consortium1 1 Dermatology, UCSF, San Francisco, CA, 2 Cell and Molecular Pathology, St. John’s
Institute of Dermatology, GKT Medical School, St. Thomas’ Hospital, London, United Kingdom
and 3 Human Genetics Unit, Ninewells Hospital and Medical School, Dundee, United Kingdom
Kindler syndrome (OMIM 173650) is a very rare, autosomal recessive genodermatosis with skin
fragility and diffuse poikiloderma. A genome-wide scan on 26 patients from a genetically isolated
Amerindian tribe in Panama mapped the disorder to 20p12.3. Haplotype analysis reduced the region
to 0.6 cM between D20S905 and D20S194 containing 15 genes. This was confirmed in patients from
the United States, Britain, Italy, Oman, Jordan, Turkey, Saudi Arabia, Afghanistan, Pakistan, and
Japan by linkage and/or homozygosity mapping. Loss-of-function mutations were identified in the
FLJ20116 gene (KIND1 encoding the protein kindlin) by direct sequencing of genomic DNA. The
patients from Panama, the United States and Oman had nonsense mutation R271X. Nonsense muta-
tion R288X was detected in both a British and a Turkish patient and Q65X was detected in a Jor-
danian patient. A splice site mutation in was found in Saudi Arabian patients. In all cases, the affected
were homozygous for the null-allele. Kindlin is the human homologue of the C. elegans protein
UNC112, a membrane-associated structural/signaling protein that has been implicated in linking
the actin cytoskeleton to the extracellular matrix. Immunofluorescence labeling with polyclonal
rabbit anti-kindlin antibody showed markedly reduced staining in KS patient epidermis, particu-
larly in keratinocytes, compared with controls. Prominent reduplication of the lamina densa was seen
on electron microscopy, consistent with the proposed function of kindlin by analogy to UNC112.
This is the first demonstration of a defect in actin-extracellular matrix linkage, rather than keratin-
extracellular matrix linkage, causing an inherited skin fragility syndrome. 
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Genetics of proliferative activity of keratinocyte stem cells in vitro
NV Popova, KA Teti, KQ Wu and RJ Morris Dermatology Department, Columbia University, New
York, NY
Several converting lines of evidence suggest that the cellular targets for carcinogenesis and tumor
promotions in the cutaneous epithelium are keratinocyte stem cells, including in vitro clonogenic
cells with high proliferative potential. These observations indicate that understanding the regulation
of keratinocyte stem cell number and proliferative potential is critical for understanding the devel-
opment of skin cancer. To address this problem and to look toword the identification of stem cell
regulatory genes, we have tested two inbred mouse strains, C57BL/6 and BALB/c and their hybrid
(BALB/cxC57BL/6)F1 in a sensitive and quantitative in vitro assay for clonogenic keratinocytes
(KCs). Following examination of 4000 KCs, we found that the average size, the area of all
colonies/dish, and the area of the largest colony/dish were always higher in the C57BL/6 then in the
BALB/c mice. Their (BALB/cxC57BL/6)F1 hybrid had a KC size intermediate between the parental
strains. Hence, the average KC size in C57BL/6 mice was 2.3 mm2, in BALB/c - 1 mm2, while
(BALB/cxC57BL/6)F1 was 1.6 mm2. The average area of colonies/dish in C57BL/6 mice was 191.9
mm2, in BALB/c - 52.8 mm2, while (BALB/cxC57BL/6)F1 was 102.3 mm2. The maximal area of
an individual colony was 12.6 mm2 C57BL/6, 4.9 mm2 in BALB/c, while 9.9 mm2 in
(BALB/cxC57BL/6)F1 mice. We conclude that KC size is probably genetically regulated. This
finding sets the stage for the mapping and identification of genes involved in the proliferative activ-
ity of keratinocyte stem cells. This research was supported in part by NIH grants CA45293, CA87780,
and CA97957 and by grants from the Lankenau Foundation (RJM). 
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Retroviral-mediated gene transfer of latency associated peptide into murine bone marrow cells
and generation of LAP-producing macrophages
C Wu, Y Zhang, J Tao and AC Gilliam Dermatology, Case Western Reserve University, Cleveland,
OH
Monocyte/macrophage cells play a critical role in fibrosis via TGFβ1. Latency associated peptide
(LAP) is a natural antagonist to TGFβ1 that binds to and inactivates mature TGFβ1. We have shown
that recombinant human LAP (hLAP), when administered intravenously, can inhibit fibrosis in
mice with sclerodermatous graft versus host disease (Scl GVHD), a model for human scleroderma.
To establish a gene therapy for scleroderma and Scl GVHD through expression of hLAP in mono-
cyte/macrophages, a bicistronic murine stem cell virus (MSCV) retroviral vector encoding hLAP,
an internal ribosome entry site (IRES), and the green fluorescent protein (GFP) for detection was
used to overexpress the hLAP protein. Stable retroviral producer cell lines were established by trans-
fecting packaging cell line GP+E86 with the hLAP MSCV retroviral vector. B10.D2 mouse bone
marrow (BM) cells were then successfully transduced by the stable retroviral producer cells, and
driven in vitro into monocyte/macrophages using GM-CSF. We characterized the transduced BM
cells by flow cytometry for stem cells, macrophages and dendritic cells (CD34, CD11b, CD11c and
DEC205). We also showed expression of hLAP by ELISA and western blot analysis of super-
natants. Our data demonstrate that most of the transduced cells after 10 days in culture are CD11b+,
and the overexpressed hLAP does not affect their differentiation into macrophages. 
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Identification of a locus for type I punctate palmoplantar keratoderma on chromosome 15q22-
23
A Martinez-Mir,1 D Londono,4 D Gordon,4 A Grunn,3 E Uribe,5 L Horev,6 IM Ruiz,5 NO Davalos,5
O Alayan,6 J Liu,3 T Gilliam,3 JC Alanis,7 A Zlotogorski6 and AM Christiano1,2 1 Dermatology,
Columbia University, New York, NY, 2 Genetics & Development, Columbia University, New York,
NY, 3 Columbia Genome Center, Columbia University, New York, NY, 4 Laboratory of Statistical
Genetics, Rockefeller University, New York, NY, 5 Hospital General Occidente Zapopan, Jalisco,
Mexico, 6 Dermatology, Hadassah Medical Center, Jerusalem, Israel and 7 Dermatologia,
Servicio Medico Universidad Autonoma Nuevo Leon, Monterrey, Mexico
The identification of the molecular basis of disorders of keratinization has significantly advanced
our understanding of skin biology, revealing new information on key structures in the skin such as
the intermediate filaments, desmosomes and gap junctions. Among these disorders, there is an extraor-
dinarily heterogeneous group known as palmoplantar keratodermas, for which only a few molecu-
lar defects have been described. Here, we report the identification of the first locus for type I punc-
tate palmoplantar keratoderma (MIM# 148600). A genomewide scan was performed on an extended
autosomal dominant pedigree from Israel and linkage to chromosome 15q22-23 was identified. With
the addition of two new families with the same phenotype, from Mexico and Israel, we confirmed
the mapping of the locus for punctate PPK to a 9.98-cM interval, flanked by markers D15S534 and
D15S818 (maximum two-point LOD score of 4.23 at q=0.01 for marker D15S988). No obvious can-
didate genes were found in the critical linkage interval. These findings will facilitate the identifica-
tion of a new gene involved in skin integrity that could also contribute to the understanding of the
multiple organ involvement in the syndromic forms of PPK, associated with different types of malig-
nancies, hearing loss and cardiomyopathy, among others. 
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Expression of DDR2 and metalloproteinases in human melanocytes and melanoma cell lines
J Siddiqui,1 LF Meisner,2 JA Johnson3 and GS Wood1 1 Dept. of Dermatology, University of
Wisconsin and VAMC, Madison, WI, 2 Dept. of Population Health Sciences, UW Madison,
Madison, WI and 3 Dept. of Molecular Cytogenetics, Wisconsin State Laboratory of Hygiene,
Madison, WI
Matrix metallopoteinases (MMPs) degrade the extracellular matrix and facilitate tumor invasion and
metastasis. There is strong evidence that DDR2 (a tyrosine kinase localized to chromosome lq21-
23) is capable of up-regulating certain MMPs. If the expression of DDR2 correlates with the expres-
sion or activation of MMPs in melanoma, this could identify DDR2 as a novel target for MMP reg-
ulation. Therefore, we used microarrays, differential tyrosine kinase display, real-time PCR, fluorescent
in-situ hybridization (FISH) and Northern blot analysis to study the expression of DDR2, MMP1
and MMP2 in normal human epidermal melanocytes and three human melanoma cell lines:Hs-294T,
G-361 and A-375. Evaluation of gene expression indicated that DDR2, MMP1 and MMP2 are over-
expressed in melanoma cell lines relative to normal melanocytes. To determine if DDR2 overex-
pression was due to gene amplification,we used FISH to determine DDR2 copy number and corre-
lated it with DDR2 expression. Expression of DDR2 did not parallel the DDR2 gene copy number.
The highest DDR2 expression was observed in the Hs-294T line with only 3 copies of the DDR2
gene. The second highest expression was observed in the G-361 line, which had up to 6 copies of
DDR2 due to the presence of chromosomal rearrangements containing the DDR2 gene,although
instability of this line led to most cells losing one or another of the chromosomes containing DDR2.
The A-375 cell line had the lowest gene expression, despite having three or more copies of the chro-
mosome 1 segment containing DDR2. Therefore, the level of DDR2 gene expression does not appear
to be directly related to its gene copy number, but rather may be controlled by genes at other loci
that promote or are required for DDR2 expression.This may prove relevant to understanding the
role of DDR2 in regulating the expression of MMPs in human melanomas. 
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Injection of genetically-engineered fibroblasts corrects regenerated human epidermolysis
bullosa skin tissue
S Ortiz-Urda, Q Lin, M Marinkovich and P Khavari Dermatology, VA Palo Alto and Stanford
University, Stanford, CA
Current therapeutic strategies for genodermatoses rely on grafting genetically engineered epidermal
tissue. Drawbacks limit applying this approach to humans, including the fragility of engineered epi-
dermal tissue and the need to remove existing tissue prior to grafting. Because fibroblasts are robust
cells that synthesize and secrete extracellular matrix, we explored their utility in recessive dystrophic
epidermolysis bullosa (RDEB), a disorder due to defective extracellular type VII collagen. Primary
fibroblasts from 4 previously characterized RDEB patients with COL7A1 mutations were engineered
for >4-fold human type VII collagen overexpression. Intradermal injection of these cells into intact
RDEB skin regenerated on scid mice stably restored correctly localized type VII collagen expres-
sion in vivo and normalized hallmark RDEB disease features, including sub-epidermal blistering
and anchoring fibril defects. Expression was stable for the 16-week duration of the experiment. BMZ-
localized collagen VII was detected up to 75um away from the nearest collagen VII[+] cells in the
dermis, as verified by serial 5um cryosections, indicating that the fibroblast-produced protein can
be delivered from sites many cell diameters away in the tissue. Of interest, regions more distant
from the intradermal injection site displayed blistering in areas transitioning to absent collagen VII
protein, demonstrating the corrective impact of restoring this protein on tissue cohesion. Collagen
VII overexpression at higher levels than normal is required in this approach because normal fibrob-
lasts failed to deliver detectable protein to the overlying epidermal basement membrane zone. Injec-
tion of genetically engineered fibroblasts thus provides a simplified approach to correcting human
disorders of secreted matrix proteins. 
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A novel clinical subtype of epidermolysis bullosa simplex associated with pyloric atresia is
caused by plectin gene (PLEC1) mutations
H Nakamura,1 D Sawamura,1 JR McMillan,1 S Park,2 T Nakamura,3 Y Ogiso3 and H Shimizu1 1
Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan, 2
Shizuoka Children’s Hospital, Shizuoka, Shizuoka, Japan and 3 Nagano Children’s Hospital,
Nagano, Nagano, Japan
Epidermolysis bullosa (EB) can be divided into three major subtypes, EB simplex (EBS), junctional
EB (JEB), and dystrophic EB, according to the level of basement membrane zone (BMZ) tissue
separation within the basal keratinocyte, lamina lucida, sub-lamina densa, respectively. While PLEC1
mutations cause EBS associated with muscular dystrophy (EBS-MD), JEB associated with pyloric
atresia (JEB-PA) results from mutations in the genes (ITGA6 and ITGB4) encoding the hemidesmo-
some integrin α6β4. In this study, we identified three individuals from two families with EBS asso-
ciated with pyloric atresia (EBS-PA) caused by PLEC1 mutations. Electron microscopy of the patient’s
skin revealed an intraepidermal plane of cleavage, hypoplastic hemidesmosomes (inner plaques) and
a reduced keratin filament association. While immunofluorescence showed normal expression of
α6β4 integrin, monoclonal antibodies against plectin, a large multifunctional plakin protein, were
completely absent or markedly attenuated in the BMZ of the two patients. Sequence analysis of
genomic DNA demonstrated that both probands harbored novel mutations in PLEC1. One patient
was compound heterozygous for a premature termination codon (PTC) and a splice-site mutation
(Q305X/1395G->A). The other patient harbored homozygous PTCs (R1189X) as well as a het-
erozygous PTC (Q2538X); the former was of paternal origin and the latter was of maternal origin.
Intragenic polymorphism analysis suggested that the occurrence of the homozygous PTC (R1189X)
was due to segmental uniparental disomy. It is well known that PLEC1 mutations can lead to EBS-
MD, but there have been no reports in which PLEC1 mutations lead to EBS-PA. These results con-
firm the existence of a novel subtype of EBS-PA resulting from PLEC1 mutations, and provide fur-
ther information about the roles of plectin/α6β4 integrin in intestinal development and in the
classification of EB. 
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Does the position of premature termination codon in COL7A1 correlate to the severity of the
clinical phenotype in recessive dystrophic epidermolysis bullosa?
A Ishiko, T Masunaga, T Ota and T Nishikawa Dermatology, Keio University School of Medicine,
Tokyo, Japan
Recessive dystrophic epidermolysis bullosa (RDEB) is an inherited skin disease in which type VII
collagen is a responsible protein. It has been reported that the position of premature termination
codon (PTC) in the type VII collagen gene (COL7A1) correlates with the clinical severity in RDEB
by presenting three cases possessing different combination of recurrent mutations, 5818delC (exon
70), 6573+1GtoC (intron 81) and E2857X (exon 116). However, we have experienced a notable
exceptional case of mitis RDEB that possessed upstream PTC combination but showed very mild
phenotype. The patient was a 9-month-old Japanese male with no family history of blistering skin
disorder. Erosions and blisters had been present on acral skin at birth, but generalized blistering or
fusion of digits has not been observed until the age of two. The patient and the father had a single
nucleotide deletion within exon 64 (5504delA), which has not been previously reported, and causes
a frame shift and exchange of five amino acids before creating a PTC. The adenine deletion also cre-
ates GT sequence and is supposed to have potential to be recognized as splicing donor site that splices
out 30 bps including the PTC. However, reverse transcriptase (RT)-PCR showed the single base dele-
tion causing the frame shift and PTC, and alternative products were not detected. The patient and
the mother were shown to have a recurrent donor splice site mutation at intron 81 (6573+1GtoC),
and confirmed by RT-PCR to cause activation of cryptic donor splicing site resulted in downstream
PTC as reported previously. Although the PTCs in our case located more upstream, clinical pheno-
type was apparently milder than three reported cases. There is still a possibility that a small amount
of mRNA undetectable by RT-PCR produces truncate protein. Otherwise the additional factor that
affects ability to form anchoring fibrils should be considered for the elucidation of the genotype-
phenotype relationship in RDEB. 
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Clinical and pathological correlations in genetically-distinct forms of atrichia
H Lam,1 A Zlotogorski,4 Z Hochberg,7 P Mirmirani,3 A Metzker,5 D Ben-Amitai,6 A Martinez-Mir,1
AA Panteleyev1 and AM Christiano1,2 1 Dermatology, Columbia University, New York, NY, 2
Genetics & Development, Columbia University, New York, NY, 3 Dermatology, University Hospital
of Cleveland and Case Western Reserve University, Cleveland, OH, 4 Dermatology, Hadassah
Medical Center, Jerusalem, Israel, 5 Dermatology, Sourasky Medical Center, Tel-Aviv, Israel, 6
Dermatology, Rabin Medical Center, Petah-Tikva, Israel and 7 Division of Endocrinology, Meyer
Children’s Hospital, Haifa, Israel
The genetic basis of two distinct forms of atrichia with papules has recently been defined at the
molecular level. In atrichia with papular lesions (APL, OMIM 209500), a rare autosomal recessive
disease characterized by early-onset of atrichia, followed by a papular eruption, mutations in the
hairless gene (HR) on chromosome 8p21 have recently been identified. Atrichia with papules also
occurs in the clinical setting of vitamin D-dependent rickets type IIA, also known as Rickets-Alope-
cia syndrome, (VDRRIIA, OMIM 277440), resulting from mutations in the vitamin D receptor
gene (VDR) on chromosome 12q12-q14. Despite the distinct genetic basis for both forms of atrichia,
the clinical findings are strikingly similar and exhibit classical pathognomonic features unique to
this phenotype. In this study, we sought to document the clinical and molecular features of APL and
VDRRIIA in three families with APL and two families with VDRRIIA. Histological analysis and
detailed clinical histories were taken from affected individuals, and molecular analysis of the HR
and VDR genes was performed on genomic DNA from probands and family members. We under-
score the genetically heterogeneous basis of atrichia by identification of several novel pathogenetic
mutations in the HR and VDR genes in all families studied. Increased awareness of these two dis-
eases will allow early diagnosis and potential therapeutic intervention for the rickets in VDRRIIA,
and avoidance of treatment of the atrichia in both APL and VDRRIIA. 
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Identification of factors which interact with the calcium response element of human keratin 1
and analysis of its functional role
Y Kawachi,1 F Otsuka1 and DR Roop2 1 Dermatology, University of Tsukuba, Tsukuba, Ibaraki,
Japan and 2 Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX
We have previously identified a functional calcium responsive element (CaRE), 3’ of the human K1
gene that consists of a composite AP-1/steroid hormone element. In the present study we demon-
strate that in a low calcium environment, when the CaRE is unable to activate a target promoter, the
AP-1 site is occupied by either c-Jun or JunB and the hormone response element is bound by COUP.
Overexpression of c-Jun, or COUP in primary keratinocyte cultures cotransfected with a CaRE
reporter construct specifically suppressed calcium activation of the promoter by the CaRE. In con-
trast, we found that overexpression of c-Fos in primary keratinocytes activated the CaRE reporter
construct in the absence of calcium while c-Jun, JunB or JunD did not. These results suggest that
Jun and COUP bind to the CaRE in undifferentiated keratinocytes to suppress transcription of HK1.
Upon initiation of differentiation, c-Fos displaces Jun from the CaRE to activate expression of K1
in post-mitotic keratinocytes. Glutathione S-transferase pull down assay demonstrated the direct
binding of COUP to c-Jun and c-Fos in vitro. The binding affinity of COUP to c-Jun seemed to be
higher than that to c-Fos, suggesting that COUP and c-Jun can cooperatively suppress the expres-
sion of HK1 in undifferentiated keratinocytes via their direct interaction. Taken together, these data
provide evidence for both physical and functional interactions among COUP and AP-1 factors dur-
ing differentiation of keratinocytes. 
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A novel member of the S100 family is alternatively spliced and overexpressed in psoriatic skin
R Wolf,1 A Mirmohammadsadegh,1 B Lysa,2 U Tartler,1 G Michel,1 M Walz1 and T Ruzicka1 1
Dermatology, Heinrich-Heine University, Duesseldorf, NRW, Germany and 2 Clinic of
Dermatovenerology, Charles University, Prague, Czech Republic
By gene expression profiling of psoriatic skin, we have identified a new member of the human S100
family. Differential display screening of normal and psoriatic skin revealed a cDNA (clone 110) that
is highly upregulated in lesional skin. Initial sequence analysis showed high homology to a non-
coding cDNA. By subsequent cDNA cloning of psoriatic skin, a corresponding coding region which
is present in two alternatively spliced mRNA-isoforms was identified. The splice variants detected
are about 0.5 kb and 4.4 kb in length and differ in their untranslated regions. Both isoforms share a
coding region predicting a protein of 101 amino acids that shares high homology to the S100A7
protein. Analysis of the deduced amino acid sequence revealed two potential EF-hand motifs as Ca2+-
binding domains. By sequence comparison, we have localized this gene on human chromosome
1q21, within the region of the epidermal differentiation complex where other members of the S100
family are clustered. Analysis of genomic DNA revealed that the gene is split into three exons and
two introns spanning a total of about 7 kb. Increased expression of the mRNA-splice variants in pso-
riatic skin was confirmed by RT-PCR and Northern blot analysis. In-situ hybridization revealed a
markedly increased number of mRNA molecules in the basal and suprabasal epidermal layers of
psoriatic skin when compared to healthy skin tissue. Our data on expression and distribution of this
gene suggest that it may be involved in processes of epidermal proliferation and differentiation and
might be of pathophysiological importance in psoriasis. 
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Photoprotective gene transfer in keratinocytes
M Cario-Andre, V Casoli, C Pain, C Ged, H de Verneuil and A Taieb INSERM E 217, Bordeaux,
France
We have previously demonstrated that UV irradiation induces direct and oxidative DNA damage,
protein and lipid oxidation and subsequently sunburn cell formation in epidermal reconstructs. The
UV-induced generation of free radicals is associated with a decrease in the activity of the two major
antioxidant enzymes, catalase and superoxide dismutase (SOD). Catalase and SOD activities are
down-regulated respectively by superoxide anion and hydrogen peroxide and their oxidation at the
protein level diminish their activities. Since SOD induces the formation of hydrogen peroxide, the
substrate of catalase, a change in the SOD/catalase ratio may be more deleterious than an equal
decrease of the two activities. We have previously shown that the SOD/catalase ratio is higher in
low phototype skin and increases with the content in linoleic acid, the most UV-oxidation prone
polyunsaturated fatty acid. We have demonstrated further that sunscreens and antioxidant mole-
cules protect efficiently against sunburn cell formation without protecting completely DNA, lead-
ing to mutations, which might cause skin cancer in fair skinned individuals. Thus, we have hypoth-
esized that a “reinforcement” of enzymatic antioxidant defences may help protecting against skin
cancer in high risk individuals. To evaluate this strategy, we have constructed bicistronic lentiviral
vectors with catalase (and EGFP as marker) or SOD and (DsRed2 as marker). Our preliminary
research shows that 293Tcells transfected by catalase/EGFP or SOD/ DsRed2 have increased enzy-
matic activity in correlation with an increased protein expression and an increased number of fluo-
rescent cells. The UV-induced decrease in catalase activity was less important in keratinocytes
transduced by catalase/EGFP than in non-transduced keratinocytes. The transgene was correctly
expressed and stable in epidermal reconstructs. The long term effect of the transgene will be stud-
ied using xenografted reconstructs in immunodeficient mice. 
0633
Transduction of monocyte-derived dendritic cells with lentiviral vectors for melanoma
immunotherapy
J Arrighi,1 S Abraham,1 F Leuba,1 A Steinkasserer,2 L Jenne2 and V Piguet1 1 Dermatology and
Venerology, University Hospital of Geneva, Geneva, Switzerland and 2 Dermatology, University of
Erlangen, Erlangen, Germany
Genetically engineered dendritic cells (DCs) presenting specific antigens (Ags) to T cells may be of
great interest for cancer immunotherapy. The expression of GFP under the control of different pro-
moters (EF-1alpha, CMV or PGK promoters) was measured by transducing either human mono-
cytes or immature/mature DCs with lentivectors (LVs). Up to 70% of human mature DCs expressed
GFP. Human immature DCs could be further differentiated with LPS into mature DCs expressing
high levels of costimulatory molecules, showing that LV transduction did not affect the normal mat-
uration process. In addition, transduction efficiency was evaluated in human Good Manufacturing
Practice (GMP) mature DCs with serum-free conditions. Over 90% GFP expression was obtained
with no significant apoptotic effect. Furthermore, we developed novel tools to target transgene expres-
sion using LVs containing a CD83 DC specific promoter. The specificity of these vectors targeting
DCs is demonstrated on cell lineages generated from transduced CD34+ hematopoietic stem cells
as well as on monocyte-derived DCs. Comparison with LVs bearing HLA-DRalpha or MHC class
II transactivator promoters will be shown. In addition, results showing transduction of human DCs
with LVs encoding for siRNA specific for surface receptors important for DC function will be pre-
sented. We are currently investigating in vitro specific immune responses elicited by human DCs
transduced with lentivectors encoding for melanoma-associated Ags. Altogether these results point
to lentivectors as promising candidates for DC-based immunotherapy purposes due to high trans-
duction ability, targeting properties and capacity of inducing Ag-specific immune responses. 
0634
Refinement of PSORS1 by haplotype sharing analysis: non-conserved mutations in an intact
retroviral dUTPase open reading frame
JP Foerster,1 I Nolte,2 J Junge,1 M Bruinenberg,3 C Ehlert,1 G van der Steege,3 K Spaar,1
V Kalscheuer,4 S Schweiger,4 P Seeman,5 M Staender,6 W Sterry1 and G te Meerman2 1
Dermatology, Charite Hospital, Berlin, Berlin, Germany, 2 Department of Medical Genetics,
Academic Hospital, Groningen, Netherlands, 3 Genotyping Facility, Academic Hospital,
Groningen, Netherlands, 4 Max Planck Institute for Molecular Genetics, Groningen, Germany, 5
BARMER Ostseeklinik, Seebad Prerow, Germany and 6 Fachklinik Bad Bentheim, Bad Bentheim,
Germany
The nature of the PSORS1 mutation is still enigmatic. We previously developed a haplotype shar-
ing test as a tool to refine association mapping. Using this method we narrowed the target region to
a 7 kb interval around marker M6S168 by re - analyzing published data (Nair et al, Am J Hum Gen,
2000). This result was highly significant (increase of - log p value from 4,5 at nearby markers to
11,9 at M6S168). This finding was confirmed in an independent patient sample containing 423 patient
and 226 control haplotypes. To identify mutations distinguishing the disease - associated haplotype,
we pooled DNA from patients homozygous for a high risk haplotype (n = 10) and DNA from con-
trol probands homozygous for a non-disease associated haplotype (n = 4) differing from the high-
risk haplotype only at marker M6S168. Both DNA pools were sequenced over a length of 4.2 kb
telomeric of M6S168, focussing on a region containing endogenous retroviral sequences. A total of
17 base pair variations between both pools were identified, yielding an average of one bp exchange
per 250 base pairs. Four of the identified base pair exchanges were clustered in an open reading frame
encoding an HERV-K derived dUTPase containing all five conserved protein motifs. Two of these
mutations encode predicted amino acid exchanges (R119 ->G; K122 ->R) between the fourth and
the fifth conserved enzyme motif. Our data confirm and refine the PSORS1 locus previously mapped
by Nair et al. to a 10 kb interval and suggest that PSORS1 may not reside in a classical gene but
rather exerts its effect through modification of endogenous retroviral sequence activity. 
0635
Haplotype analysis of distantly-related populations implicates corneodesmosin in psoriasis sus-
ceptibility
F Capon,2,3 IK Toal,2 JC Evans,2 MH Allen,1 S Patel,2 D Tillman,4 D Burden,4 JN Barker1 and
RC Trembath2 1 Institute of Dermatology, Kings College London, London, United Kingdom, 2
Division of Medical Genetics, University of Leicester, Leicester, United Kingdom, 3 Division of
Human Genetics, “Tor Vergata” University of Rome, Rome, Italy and 4 Department of
Dermatology, Western Infirmary, Glasgow, United Kingdom
Psoriasis is a common skin disorder, inherited as a multifactorial trait. A major locus underlying dis-
ease susceptibility has been mapped to chromosome 6p21, within a 150 kb segment of the Major
Histocompatibility Complex class I region. This interval contains 3 genes carrying psoriasis asso-
ciated alleles: HLA-C, alpha-Helix Coiled coil Rod homologue (HCR) and Corneodesmosin (CDSN).
We have recently derived ancestral haplotypes spanning these genes and identified a rare chromo-
some (cluster D), originating from a double recombination event that had replaced the region con-
taining HCR risk alleles, while preserving the genomic segments that encompass the HLA-C and
CDSN disease-associated SNPs. This observation suggested that CDSN SNPs might be required to
confer psoriasis susceptibility, together with HLA-C risk alleles. In the present study we have analysed
6 coding and 10 non-coding CDSN SNPs in 171 UK and 30 Indian parent-offspring trios. We have
identified a 16 SNP chromosome showing significant disease association in both datasets (p < 10-10
and p = 3.9 x10-3, respectively) and occurring on both sets of haplotypes (clusters D and E) known
to confer psoriasis susceptibility. Altogether, our results support a disease model requiring the pres-
ence of CDSN susceptibility alleles on haplotypes bearing HLA-C related risk SNPs, as the data pro-
vide evidence that these risk alleles have not been maintained together solely by linkage disequilib-
rium. 
0636
Topically-regulated control of hematopoiesis via direct cutaneous gene transfer
P Khavari and Z Siprashvili VA Palo Alto and Stanford University, Stanford, CA
The capacity for direct and topically controllable gene delivery to intact human skin tissue repre-
sents a major goal in cutaneous gene transfer. Among gene transfer vectors, lentiviruses are attrac-
tive for this purpose because they infect both dividing and non-dividing cells within skin after direct
administration. HIV-1-based lentiviral vectors were generated in which gene expression is driven by
5 high-affinity glucocorticoid responsive elements placed upstream of the adenovirus 2 major late
promoter core TATA sequence. As a product for regulated gene delivery, we used erythropoietin
(EPO) because of the need to control the stimulation of hematopoiesis. Furthermore, we had previ-
ously demonstrated that a single intradermal injection of an unregulated CMV-driven EPO lentivec-
tor to human skin grafted on scid mice effectively delivers EPO protein to the bloodstream and boosts
hematocrit dramatically. 5ug of p24 equivalent of the regulated EPO lentivectors were injected into
full thickness human skin grafts on scid mice (n=5/group). 7 days later, glucocorticoid was admin-
istered, as either three consecutive administrations of 60ug intraperitoneal dexamethasone or as top-
ical clobetasol propionate. Serum levels of human EPO rose from undetectable to a peak of 23mIU/ml
in 3 days. 2 cycles of glucocorticoid stimulation led to corresponding rises and falls in hematocrit
from an average of 42% at baseline to a peak of 67.5% 10 days after stimulation. Topical stimula-
tion with clobetasol was as effective as systemically administered dexamethasone. Regulated lentivec-
tors thus provide a platform for regulated and reversible direct cutaneous gene delivery of therapeutic
polypeptides to the systemic circulation. 
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Gene transfer to cells and skin tissue via reversible plasmid condensation with protein trans-
duction domains
P Khavari, Z Siprashvili, P Wender, S Oliver and F Scholl Dermatology, VA Palo Alto and Stanford
University, Stanford, CA
Nonviral gene transfer offers biosafety, stability and expense advantages over viruses, however, it
has suffered from poor efficiency. Recently, new molecular transporters in the form of protein trans-
duction sequences (PTS) derived from proteins such as HIV1 TAT and Drosophila antennapedia have
been found to rapidly traverse cell and visceral tissue barriers, including the blood-brain barrier. Car-
rying cargo up to 40nm in size, these transporters appear to rely on arginine residues that are also
present in evolutionarily conserved sperm protamines that facilitate delivery of macromolecules such
as the male haploid genome. Since arginine-rich peptides facilitate uptake of macromolecules such
as proteins, liposomes and iron nanoparticles, we explored their potential in enhancing plasmid DNA
delivery. In their unmodified form, known protein transduction sequences, including hepta-arginine
and Tat47-57, failed to support effective gene delivery. However, by flanking a core of consecutive
arginines with amino-, and carboxy-terminal cysteines in vitro gene transfer was observed. Fur-
thermore, interspersing arginines with glycine and histidine residues achieved reversible plasmid
condensation and dramatically increased transfection levels in a variety of cell types, including pri-
mary human fibroblasts. Gene transfer efficiency was superior in most settings to benchmark com-
mercially available approaches. Unlike most available cationic homopolymers that function only in
vitro, these new peptides also increased gene expression in both murine and human tissue in vivo,
leading to >4.5 fold increased levels over naked DNA as measured quantitatively by in vivo biolu-
minescence. Thus, cysteine-flanked, internally spaced arginine-rich (CFIS-R) peptides represent a
new approach to efficient nonviral plasmid delivery using rationally designed protein transduction
domains. 
0639
Processing and staining of mouse skin for laser capture microdissection and nucleic acid retrieval
MJ Arin,2 M Longley,3 X Wang 3,1 and DR Roop3,1 1 Dermatology, University of Cologne, Koeln,
Germany, 2 Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX and 3
Dermatology, Baylor College of Medicine, Houston, TX
In the study of disease, tissue heterogeneity limits the information available from the analysis of
biological samples. To study genetic changes that occur in a particular cell type, tiny subpopulations
of cells need to be isolated to reduce the risk of contamination. Laser capture microdissection (LCM)
has been emerging as one of the methods of choice. The skin is an attractive organ for the applica-
tion of LCM since it is composed of a complex mixture of different cell types. Here we describe the
use of LCM in the analysis of an animal model of a hereditary blistering disorder, epidermolytic
hyperkeratosis (EHK). We demonstrate that tiny subpopulations of keratinocytes can be readily iso-
lated by LCM. Since our mouse model allows the induction of the phenotype in a circumscribed
area of the skin, two genetically different populations of keratinocytes could be isolated from the
same mouse. Microdissected keratinocytes from persisting hyperkeratotic lesions were a source of
genomic DNA and were further subjected to PCR analysis. Cells from phenotypically normal skin
served as a control. We demonstrate that LCM has proven a valuable and reliable tool in the isola-
tion of pure samples of keratinocytes from different areas of mouse skin. The information obtained
by LCM provided new insight into the molecular and cellular basis of mosaic skin disorders. 
0641
Transcriptional control of the Ese-2 gene by a novel keratinocyte-specific factor
S Sinha and R Tummala Biochemistry, SUNY at Buffalo, Buffalo, NY
The epidermal differentiation process is controlled in part by transcription factors that regulate the
expression of a myriad of genes that are unique to each stage of differentiation. We are studying
Ese-2, an Epithelium-specific Ets domain transcription factor that is expressed only during the late
stages of epidermal differentiation. Our goal is to identify and characterize the upstream signals and
transcription factors that control the differentiation-specific expression of Ese-2. We have shown that
the minimal promoter region of Ese-2 is in an open chromatin configuration as judged by the pres-
ence of a keratinocyte-specific DNAse I hypersensitive site. Serial deletion analysis has revealed that
a 125 bp fragment of the Ese-2 promoter harbors most of the transcriptional activity as measured by
reporter assays in transient transfection of keratinocytes. Interestingly, the Ese-2 promoter segment
shows remarkable up regulation of transcriptional activity when the transfected keratinocytes are
induced to differentiate by increasing the Ca++ concentration in the culture medium. We have per-
formed a detailed study of this promoter segment by mutational analysis as well as by gel shift assays.
Our studies have revealed a novel Keratinocyte-Specific Factor (KSF) that binds to the promoter of
Ese-2 and confers most of the activity of the promoter. We are currently performing additional stud-
ies to determine the precise cis-elements that confer the differentiation-specific expression of Ese-
2 promoter. Collectively these studies should provide new insights into the molecular mechanisms
of epidermal differentiation. 
0640
A novel nonsense mutation of transglutaminase 1 gene in a pedigree with lamellar ichthyosis
Y Yang, H Yang, T Ma, D Bu, P Tu and X Zhu Dermatology, Peking University First Hospital,
Beijing, China
Autosomal recessive lamellar ichthyosis is a severe skin disorder characterized by generalized hyper-
keratosis. Gene mutations of transglutaminase 1 (TGM1), which mediates cross-links in the forma-
tion of the cell envelop during epidermal terminal differentiation, have been identified as causes of
lamellar ichthyosis. Previous genetic analysis has also demonstrated genetic heterogeneity in lamel-
lar ichthyosis. Here we report that a novel homozygous nonsense gene mutation of TGM1, Q202X,
in a Chinese patient with lamellar ichthyosis. Accordingly, his parents and one brother carry a het-
erozygous mutation. In addition, TGM1 transcript was undetectable in patient,s skin by using RT-
PCR and in situ hybridization. Further immunohistochemical study revealed the absence of transg-
lutaminase 1 enzyme activity in patient,s skin. Our findings suggest that this nonsense TGM1 mutation,
Q202X, is responsible for the lack of mRNA transcripts and protein expression in the skin. As a
consequence, this causes defective cell envelops in cornified layers, which in turn perturbs barrier
function of the epidermis and leads to lamellar ichthyosis clinically. 
0638
Phenotype-genotype corelation of a xeroderma pigmentosum variant patient
S Emmert,1 H Inui,2 CS Seitz,3 A Gratchev,4 K Zachmann,1 S Goerdt,4 C Neumann1 and
KH Kraemer2 1 Dermatology, Goettingen University, Goettingen, Lower Saxony, Germany, 2 Basic
Research Laboratory, National Cancer Institute, Bethesda, MD, 3 Dermatology, Wuerzburg
University, Wuerzburg, Bavaria, Germany and 4 Dermatology, Heidelberg University, Mannheim,
Baden-Wuerttemberg, Germany
We examined the clinical, molecular, and genetic features of a newly diagnosed xeroderma pig-
mentosum variant (XPV) patient. XP3GO is a 33 y old Caucasian male who is not sun sensitive.
Around puberty he noticed freckling in the UV-exposed areas of his skin. At age 22 he started to
develop skin cancers including multiple primary melanomas, but also basal cell and squamous cell
carcinomas. There is no known consanguinity of his parents. We established a XP3GO fibroblast
strain and found normal DNA repair levels as reflected by normal host cell reactivation of a UV-
treated luciferase gene-containing reporter plasmid. Post-UVC cell survival of XP3GO fibroblasts
was normal, but was reduced in the presence of 2 mM caffeine, a hallmark of XPV cells. XPV cells
are defective in polymerase eta. Western blot analysis revealed undetectable levels of polymerase
eta protein. Mutational analysis of the polymerase eta gene showed a deletion of exon 6 in cDNA
due to a homozygous deletion of an about 1.3 kb region in the genomic DNA that includes exon 6.
This deletion leads to a severely truncated and potentially non-functional polymerase eta protein.
The ensuing loss of effective translesional synthesis past UV photoproducts produces an increased
tendency of XP3GO cells to incorporate incorrect bases in DNA that results in a skin cancer-prone
phenotype. 
0642
Cardiovascular disease in pseudoxanthoma elasticum is not linked to mutations in ABCC6
H Kozic,1 B Oldemeyer,2 E Kusseluk,1 A Saxena,1 J Uitto1 and F Ringpfeil1 1 Dermatology,
Jefferson Medical College, Philadelphia, PA and 2 Cardiology, Creighton University, Omaha, NE
Pseudoxanthoma elasticum (PXE) is a heritable multi-system disorder that affects the skin, eyes
and cardiovascular system with vast intra and interfamilial variability. While clinical manifestations
of the latter do not differ from those encountered in the aging population, in PXE they tend to occur
at a much younger age and are associated with significant morbidity. We investigated the prevalence
of cardiovascular disease among 60 families with PXE and attempted correlation to specific muta-
tions in the ABCC6 gene, shown to underlie PXE. The most frequently encountered manifestations
include claudication (19%) and coronary artery disease (12%), followed by GI bleeding and hyper-
tension. These symptoms were not linked to one specific mutation or a particular protein domain.
In addition, two large families with at least 3 siblings affected with PXE had prominent cardiovas-
cular disease in affected and unaffected individuals. These individuals did not show segregation of
a specific cardiovascular phenotype with their genotype. In fact, several siblings with PXE had no
evidence of cardiovascular disease despite cardiological examination at an advanced age. Further-
more, we examined the prevalence of the common polymorphism R1268Q, which had previously
been reported to be associated with hyperlipidemia. The frequency was equal in individuals with
PXE and the general population and we could not confirm an association with this polymorphism
and an altered lipid profile. These data suggest that there is no direct association between mutations
in ABCC6 and cardiovascular disease, but it seems that early onset cardiovascular disease might be
facilitated by an alternative pathomechanism in PXE. 
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Sustained in vivo expression of human type VII collagen in mice by gene-corrected dystrophic
epidermolysis bullosa fibroblast-mediated gene transfer
R Ram, Y Huang, T Atha, MJ Abrishami, EA Williams, DT Woodley and M Chen Dermatology,
University of Southern California, Los Angeles, CA
Dystrophic epidermolysis bullosa (DEB) is a family of inherited mechano-bullous disorders caused
by mutations in the type VII collagen (COL VII) gene and subsequent perturbations in anchoring
fibrils. We previously used a lentiviral vector to express full-length COL VII in RDEB keratinocytes
(KCs) and fibroblasts (FBs) and demonstrated the correction of the RDEB cellular phenotype in
vitro. In this study, we evaluated the feasibility of using gene corrected RDEB FBs for gene therapy
in an animal model. To accomplish this, 10 million gene corrected or uncorrected RDEB FBs or
normal human FBs were injected intradermally into the skin of athymic hairless mice. Skin biop-
sies were obtained every week after injection and subjected to immunostaining using antibody spe-
cific for human COL VII . Gene-corrected RDEB FBs or normal human FBs were able to synthe-
size and deposit human COL VII within the mouse basement membrane zone (BMZ). The expression
of human COL VII was sustained for at least 3 months (the last time point examined at this time),
as were anchoring fibrils. Further, injected gene-corrected human RDEB FBs or normal human FBs
were stably maintained in the mouse dermis. In contrast, mouse skin injected with parental RDEB
FBs entirely lacked human COL VII staining at the BMZ. Interestingly, skin injected with gene-cor-
rected RDEB KCs or normal human KCs intradermally failed to synthesize and deposit human
COL VII within the mouse BMZ, and injected human keratinocytes were lost two weeks after injec-
tion. These results indicate that in vivo long-term, stable production of human COL VII can be
achieved by direct application of fibroblast-mediated gene transfer. Since skin FBs can be passaged
30-60 times in vitro and are easy to grow in large numbers, it is likely that RDEB patients could be
helped by gene correcting only their FBs ex vivo, culturing them in quantity and then injecting them
back into the skin high in the dermis like injecting Zyderm for wrinkles. 
0644
Rapid RFLP detection of mutations and functional alterations in the human XPD DNA repair
gene
T Ueda,1 SG Khan,1 T Shahlavi,1 K Oh,1 H Inui,1 DB Busch,2 JJ DiGiovanna1,3 and KH Kraemer1
1 Basic Research Laboratory, National Cancer Institute, Bethesda, MD, 2 AFIP, Washington, DC
and 3 Dermatology, Brown Medical School, Providence, RI
Xeroderma pigmentosum (XP) is an autosomal recessive disease that is characterized by hypersen-
sitivity to sunlight and markedly increased susceptibility to skin cancer in association with defec-
tive DNA repair. The XP gene, XPD, is a helicase that plays an important role not only in nucleotide
excision repair but also in transcription as a member of the basal transcription factor complex, TFIIH.
Defects in the XPD gene result in several different clinical phenotypes including XP with skin dis-
ease, XP with skin and neurological disease, the XP/Cockayne syndrome complex, or trichoth-
iodystrophy (TTD), a disorder with brittle hair without increased cancer susceptibility. We analyzed
cells from patients that have reduced post-UV cell survival and used a plasmid host cell reactivation
(HCR) assay to assign 18 cell lines to XP complementation group D. We developed RFLP assays to
detect 24 XPD missense mutations that have been reported. Eleven of the XP-D cell lines we tested
had a common base substitution mutation, C2125T, which resulted in a missense alteration (R683W)
in helicase domain VI. One of these patients was homozygous for this mutation. Five of these patients
had XP with neurological disease, 2 had XP with only skin disease and 4 have unknown symptoms.
We created an expression vector containing XPD cDNA with the C2125T mutation and found com-
plete absence of function in the HCR assay.  Three other patients had different mutations that were
detectible by the RFLP assays. XPD mutations were not detected in 4 XP-D cell lines by these
RFLP assays. RFLP assays may be used to rapidly identify mutations in XP cells in complementa-
tion group D. 
0645
Topically regulated transgene expression in epidermal keratinocytes
T Cao,1 C Ding,1 W He,2 SY Tsai,3 BW O’Malley,3 K Csiszar,1 X Wang2,3 and DR Roop3,2 1 Pacific
Biomedical Research Center, University of Hawaii at Manoa, Honolulu, HI, 2 Department of
Dermatology, Baylor College of Medicine, Houston, TX and 3 Department of Molecular and
Cellular Biology, Baylor College of Medicine, Houston, TX
A major challenge for current gene therapy is controlling the expression level of therapeutic genes.
An inducible gene-switch system was recently developed that allowed regulated expression of
transgenes. The purpose of this study is to explore the possibility of using the epidermis as a secre-
tory machinery to produce therapeutic proteins with the gene-switch system to treat systemic defi-
ciencies. Epidermal keratinocytes have been shown to secrete proteins into the circulation via the
vascular system within the dermis. We established a transgenic mouse model in which expression
of a human growth hormone (hGH) reporter gene could be activated by topical application of an
inducer. In the absence of an inducer, the Gene-switch activator protein was inactive, and hGH was
not transcribed. In the presence of an inducer, the activator protein up-regulates hGH transcription
in basal keratinocytes. High levels of hGH were detected in the circulation within hours after a sin-
gle induction, with the maximum levels about 200-fold higher than controls. The serum levels of
hGH were dependent on the amount of inducer applied, and repeated induction resulted in increased
weight gain in transgenic versus control mice. Furthermore, physiological levels of hGH were detected
in the serum of nude mice after topical induction of small transgenic skin grafts. These results clearly
demonstrate the feasibility of using the gene-switch system to regulate the delivery of therapeutic
proteins into the circulation via genetically modified keratinocytes. We are currently testing whether
a similar transgenic system could be used for the treatment of hemophilia B in a mouse model. 
0646
Development of in vivo gene therapy for dystrophic epidermolysis bullosa using newly engi-
neered minimal lentiviral vectors
T Atha, Y Huang, C Chang, DT Woodley and M Chen Dermatology, University of Southern
California, Los Angeles, CA
Dystrophic epidermolysis bullosa (DEB) is a family of inherited mechano-bullous disorders caused
by mutations in the type VII collagen (COL VII) gene and subsequent perturbations in anchoring
fibrils. The lack of therapy for DEB provides an impetus to develop gene therapy strategies. An ex
vivo approach for cutaneous gene transfer requires surgical transplantation of genetically modified
cells with potential pain and scarring at graft sites. As an alternative, direct vector administration to
skin would permit corrective gene transfer and long-term transgene expression without the compli-
cations associated with ex vivo therapy. We previously developed a minimal lentiviral vector to express
full-length COL VII in RDEB keratinocytes and fibroblasts. In this study, we assessed the ability of
lentiviral vectors to achieve COL VII gene transfer in vivo using an animal model. We generated and
intradermally injected vesicular stomatitis virus envelop G pseudotyped lentiviral vectors encoding
COL VII transgene into the skin of athymic hairless mice. Skin biopsies were obtained every week
after injection and subjected to immunostaining using an antibody specific for human COL VII and
the antibodies specific for cell-surface proteins to mark cell types. Immunostaining demonstrated
that recombinant lentiviral vectors transduced mouse dermal fibroblasts with high efficiency. The
cellular expression of COL VII remained stable in vivo. In contrast, very limited transduction of basal
or suprabasal mouse epidermal keratinocytes was detected. Interestingly, one week after a single
injection, mouse cells transduced by lentiviral vectors synthesized and deposited human COL VII
within the mouse basement membrane zone. The delivered COL VII expression was confined locally
at the injection sites since there was no BMZ immunostaining for human COL VII in uninjected
skin sites. These data indicate that efficient and long-term in vivo COL VII gene transfer into skin
via direct lentiviral vector injection may offer a valuable approach to the treatment of DEB. 
0647
Identification of XP-C heterozygotes using real-time quantitative reverse transcriptase-PCR:
a novel approach to study cancer susceptibility in XP-C gene carriers
SG Khan,1 T Shahlavi,1 DB Busch,2 T Ueda,1 H Inui,1 S Emmert,1 V Muniz-Medina,1 CC Baker,1
JJ DiGiovanna,1,3 A Khadavi1 and KH Kraemer1 1 Basic Research Laboratory, National Institutes
of Health, Bethesda, MD, 2 AFIP, Washington, DC and 3 Dermatology, Brown Medical School,
Providence, RI
XP-C is an autosomal recessive disorder that requires two mutant copies of the gene to express the
clinical phenotype including skin neoplasms. One study, performed before XP genes were cloned,
suggested that carriers of an XP gene (estimated from pedigrees) are predisposed to skin cancer
(JNCI, 62: 1415, 1979). Now that XP genes have been cloned, it should be possible to study cancer
risk in known XP heterozygotes. Here we describe a test to detect XP-C heterozygotes. First, we
characterized the causative mutations in the XPC gene in cell cultures from 8 patients assigned to
XP-C by host cell reactivation. All mutations resulted in premature termination codons (PTC). We
then confirmed that the cell lines from the parents were heterozygous for the same mutation by
DNA sequencing.  We developed real-time quantitative reverse transcriptase-PCR (QRT-PCR) assays
to measure XPC mRNA levels (amounts of exons 4 or 12) in the cell lines. Relative to 10 normal
controls the mean XPC mRNA levels were 31% (exon 4) and 23% (exon 12) in 8 XP-C cell lines.
This reduced XPC mRNA from XP-C patients was anticipated from the presence of PTC that induce
nonsense-mediated mRNA decay. The mean XPC mRNA levels in cell lines from 13 XP-C het-
erozygotes was intermediate (69% and 66% of normal). This novel approach allows the testing of
individuals at risk for being XPC heterozygotes and should permit the study of a genetic predispo-
sition to sun-induced skin cancers in XPC heterozygotes. 
0648
Regulation of alternative splicing of GL11 in normal skin and in basal cell carcinoma
JA Rothnagel,1,2 J Beesley,1 I Ross1 and X Wang1 1 Biochemistry and Molecular Biology, The
University of Queensland, Brisbane, QLD, Australia and 2 Institute for Molecular Bioscience,
Brisbane, QLD, Australia
The oncogene GLI1, encodes a zinc-finger transcription factor that is regulated by the Sonic hedge-
hog-Patched signaling pathway. Aberrant signaling of this pathway results in over-expression of
GLI1, which is associated with carcinogenesis and has been found to occur in liposarcomas, astro-
cytomas, medulloblastomas, rhabdomyosarcomas and basal cell carcinomas (BCCs). We have pre-
viously identified two alternative GLI1 transcripts in human tissues that differ in their 5’-untrans-
lated regions (5’-UTRs). The longer 5’-UTR variant is formed by the splicing of exons 1 and 1A
and contains multiple uATGs and uORFs, which directly result in translation repression of the main
ORF. The shorter 5’-UTR, which is generated by skipping of exon 1A, lacks these features and is
associated with high levels of expression of the main ORF. Notably, the longer form is the predom-
inant transcript in adult and neonatal tissues, while the shorter form is the only variant detected in
BCCs. In order to identify functional RNA cis-elements we generated both wild type and mutant
GLI1 pre-mRNA minigene constructs and analysed their spliced products in transfected cells. These
studies identified potential splicing enhancer and silencer sequences in intron 1 and exon 1A. In
parallel, we tested the ability of several splicing modulators to influence splicing decisions in co-
transfection experiments. Of these only Tra2beta1, Tra2beta3 and ASF produced a significant change
in the ratio of spliced products. Interestingly, Tra2beta1, which is itself an alternatively spliced
product of the Tra2beta gene, antagonized the action of Tra2beta3 and ASF. Although, the relative
activity of these splicing modulators in BCCs is not yet known, our results are consistent with other
studies showing that expression of splicing factors is altered in tumour cells. These results also sup-
port our hypothesis that the large increase in GLI1 levels observed in BCCs is not only due to increased
gene transcription but also to the skipping of exon 1A. 
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Intracellular calcium regulation in SERCA2 heterozygous cells
I Aronchik,2 MJ Behne,1,2 GE Shull3 and TM Mauro1,2 1 Dermatology, UCSF, San Francisco, CA,
2 Dermatology Service, VA Med. Center, San Francisco, CA and 3 Dep Mol Gen, Biochem,
Microbiol, UC, Cincinnati, OH
Darier’s disease (DD) is a rare autosomal dominant disease caused by a mutation of the ATP2A2
gene, encoding the SERCA2 Ca2+ ATPase. The ATP2A2 is localized to the endoplasmic reticulum
of cells and is important in Ca2+ -induced Ca2+ signaling, which controls essential keratinocyte
functions such as differentiation, motility and cell-to-cell adhesion. Previously, we have shown that
Golgi Ca2+ stores, controlled by a similar Ca2+ ATP’ase ATP2C1, are essential for normal Ca2+ sig-
naling, and that mutations in the ATP2C1 cause the similar acantholytic disorder Hailey Hailey dis-
ease. To test how the ER-localized ATP2A2 mediates Ca2+ signaling, we used a mouse model of
DD, the SERCA2+/- mouse, where one copy of the SERCA2 gene was deleted. Keratinocytes derived
from SERCA2+/- mice showed distinct abnormalities in Ca2+ signaling, including altered baseline
Ca2+ concentrations and impaired responses to raised extracellular Ca2+. In addition, recovery rates
from Ca2+ loads induced both by raised extracellular Ca2+ and release of intracellular Ca2+ using thap-
sigargin were altered, suggesting upregulation of other Ca2+ transport mechanisms such as intracel-
lular ATP2C1 or plasma membrane Ca2+ transporters such as the plasma membrane Ca2+ ATPase or
Na+/Ca2+ antiporter. Capacitive Ca2+ influx was blunted in keratinocytes from SERCA2+/- mice,
suggesting that the ATP2A2 mediates Ca2+ influx stimulated by intracellular Ca2+ store release.
Finally, total cell store Ca2+ was decreased in SERCA2+/- cells, demonstrating that ER Ca2+ con-
trolled by the ATP2A2 constitutes a major intracellular Ca2+ store in the keratinocyte. These exper-
iments suggest that the Golgi and ER Ca2+ ATPases serve different, but coordinated functions, in
controlling Ca2+ -induced signaling in keratinocytes. Further experiments will allow us to determine
how these different Ca2+ signals control keratinocyte differentiation, cell-to-cell adhesion, and
apoptosis. 
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Genetic polymorphism of IL-12 p40 gene in the Japanese population with Behcet’s disease
H Yanagihori, M Tojo, K Nakamura and F Kaneko Dermatology, Fukushima Medical University
School of Medicine, Fukushima, Fukushima, Japan
Behcet’s disease (BD) is a chronic inflammatory disorder characterized by oral and genital ulcera-
tions and various cutaneous, ocular, manifestations. It has been reported that immunological abnor-
malities and genetic factor play a great role in its pathogenesis. However, the mechanism of them is
imperfectly understood. Th1 type proinflammatory cytokines such as IL-12 and interferon-gamma
are detected predominantly in the lesional skin of patients during active phase of the disease. The
purpose of the study is to examine the polymorphism of IL-12 p40 gene in BD. Previous reports of
single nucleotide polymorphism (SNP) in the IL-12 p40 gene revealed that the most common SNP
was position 1188 in the 3’ untranslated region (UTR) in several autoimmune diseases. We studied
IL-12 p40 gene polymorphism of 17 Japanese with BD and 63 Japanese healthy volunteers. Genomic
DNA was obtained and was amplified by polymerase chain reaction (RCR). PCR products were
digested with TaqI and restriction fragment length polymorphism (RFLP) method was performed.
We revealed that allele A frequency of BD patients and healthy controls were 0.559 and 0.492, respec-
tively, and that C frequency of BD and healthy was 0.441 and 0.508, respectively. These were no
differences of IL-12 p40 gene in 1188 genotype between BD and healthy controls. However, AA
genotype tended to be decreased in BD, compared to healthy controls. These date suggest that IL-
12 p40 gene is susceptible in BD in terms of SNP analysis, although further analysis should be nec-
essary to conclude this. 
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Genetic correction of DNA repair deficient/cancer prone xeroderma pigmentosum group C
keratinocytes
M Thierry, O Chevallier-Lagente, C Arnaudeau, F Brellier, F Bernerd, A Sarasin and T Magnaldo
Life Sciences, Centre National de la Recherche Scientifique, Villejuif, France
Xeroderma pigmentosum (XP) is a rare photosensitive and cancer prone syndrome transmitted as
an autosomal recessive trait. Most of the cancers developed by XP patients are basal- and squamous
cell- carcinomas strikingly restricted to sun-exposed parts of the skin. Cells from most classical XP
patients are deficient in nucleotide excision repair, a versatile biochemical mechanism for removal
of ultraviolet-induced DNA lesions. Among the seven classical XP complementation groups known
to date (XP-A to XP-G), XP-C is the most common one in Europe and North Africa. We have under-
taken genetic correction of XP-C fibroblasts and particularly keratinocytes, which are most relevant
cells in relation to skin cancer and, have proven recently to be capable of reconstructing XP-C skin
in vitro. Primary keratinocytes from XP-C patients were transduced with a retroviral vector stably
driving the expression of the wild-type XPC protein. These genetically corrected XP-C keratinocytes
recover normal levels of DNA repair capacity, cell survival and clonal transition toward UVB irra-
diation. We also show that, in the absence of UV, XP-C keratinocytes exhibit intrinsic cell cycles
abnormalities, and b-1 integrin overexpression, defects that are also both fully reversed after genetic
correction. Finally, in vitro reconstruction of skin from genetically corrected XP-C keratinocytes
opens the first rational perspective to XP tissue therapy. 
0652
Alteration of the epidermis of patients homozygous and heterozygous for a mutation in con-
nexin 26
JM Brandner,1 CG Meyer,2 B Huesing,1 GK Amadofu,3 RD Horstmann2 and I Moll1 1 Department
of Dermatology and Venerology, University Hospital Hamburg-Eppendorf, Hamburg, Hamburg,
Germany, 2 Bernhard-Nocht-Institut fuer Tropenmedizin, Hamburg, Germany and 3 Kwame
Nkrumah University of Science and Technology, Kumasi, Ghana
Gap-junctions (GJ) are cell-cell junctions important for direct communication and coordination of
adjacent cells by forming selective channels for small molecules, e.g. second messengers. They
play important roles in proliferation, migration, and differentiation of many cell types. GJ consist of
connexins (Cx), a growing family of membrane-spanning proteins. Mutations in Cx 26 have been
shown to result in deafness. Recently we demonstrated an increased thickness of the epidermis of
Ghanaian patients homozygous and heterozygous for the mutation R143W in Cx 26 and discussed
an evolutionary advantage of carriers of this mutation. Here we show the molecular details of the
epidermis of these patients by using immunohistochemistry and demonstrate alterations of the syn-
thesis and distribution of barrier-forming and differentiation specific proteins, i.e. cornified enve-
lope proteins, tight junction proteins and cytokeratins, in the skin of heterozygous and homozygous
carriers of the mutation. The possible roles of these alterations for a heterozygous advantage are dis-
cussed. 
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A case of malignant peripheral nerve sheath tumor with sporadic neurofibromatosis type 1
resembling a malignant fibrous histiocytoma
K Tanito,1,2 M Liew,2 M Hang,2 M Niimura1 and D Viskochil2 1 Dermatology, Jikei University
School of Medicine, Tokyo, Japan and 2 Pediatrics, University of Utah, Salt Lake City, UT
A case of malignant peripheral nerve sheath tumor (MPNST) in a 46-year old female with sporadic
Neurofibromatosis type 1 is reported. She had been our patient for 13 years. Physical examination
showed cafe-au-lait spots, severe scoliosis and hundreds of cutaneous neurofibromas, mostly on her
trunk. Fluorescence in situ hybridization using a P1-bacteriophage probe spanning exons 2-11 demon-
strated a deletion of the NF1 gene. Her constitutional DNA was examined at 8 intragenic polymor-
phic sites and only 1 allele at each site was identified, which supports the likelihood this is a whole
gene deletion. We used 30 polymorphic markers distributed across all chromosome arms to evalu-
ate genome stability in 5 separate neurofibromas from this patient. Two neurofibromas showed allelic
imbalance at 9q, whereas all other markers demonstrated bi-allelic balance. This indicates normal
genomic stability in dermal neurofibromas in a deletion patient. She was admitted to our hospital
with a painful mass on her right shoulder that had grown rapidly for 7 months. MRI demonstrated
a large tumor in the right shoulder, and she underwent a total tumor resection. Histological exami-
nation of the tumor revealed nuclei that were variable in size and showed remarkable atypia and
proliferation of spindle-shaped cells and pleomorphic areas. The tumor demonstrated a mixed pat-
tern of typical MPNST and malignant fibrous histiocytoma. Immunohistochemically, the tumor cells
were negative for S-100 protein, NSE, CD34, HMB-45 and positive for CAM5.2. After surgery, the
patient presented with local recurrence and multiple pulmonary and brain metastasis. She died 26
months after diagnosis. This case supports the hypothesis that increased tumor burden predicts the
possibility of a whole-gene deletion, and may increase the chance of a MPNST arising. Combining
surveillance of signs and symptoms with whole-gene deletion detection screening could help in the
early detection of MPNST. 
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Genetic analysis of PSORS1 single nucleotide polymorphisms (SNPs) in late onset, guttate
and palmoplantar pustular psoriasis
MH Allen,1 K Asumalahti,5 M Ameen,1 J Evans,2 C Veal,2 J Leman,3 AD Burden,3 CE Griffiths,4
RC Trembath,2 J Kere5 and JN Barker1 1 Institute of Dermatology, Kings College London, London,
United Kingdom, 2 Division of Medical Genetics, Univ of Leicester, Leicester, United Kingdom, 3
Dermatology, Western Infirmary, Glasgow, United Kingdom, 4 Dermatology Centre, University of
Manchester, Manchester, United Kingdom and 5 Medical Genetics, University of Helsinki,
Helsinki, Finland
The major susceptibility locus for psoriasis vulgaris (PV) is a 200kb region (PSORS1) within the
MHC on chromosome 6p21.3. Candidate genes in this region including HLA-C, HCR and CDSN
show association with familial (early onset) PV. Late onset psoriasis (LOP) is defined by disease
onset post 40 years of age and is sporadic. Guttate psoriasis (GP) and palmoplantar pustulosis (PPP)
are distinct clinical subtypes of psoriasis and may occur concurrently with PV. Our aim was to
assess the role the PSORS1 locus in LOP, GP and PPP. Genotyping for HLA-C alleles and a total of
19 SNPS located within PSORS1 was performed on LOP (n = 150), GP (n=137), PPP (n=106) and
controls (n = 309). Statistical analysis was by the Chi-squared test. LOP demonstrated limited asso-
ciation to PSORS1 genes ie HLA-Cw6 (p = 0.001), CDSN*5 (p = 0.013) and HCR 325 (p = 0.023).
In contrast, GP showed very strong association with HLA-Cw6 (p = 4 x 10 -40), CDSN 1243 (p = 4
x 10 -7) and HCR SNPs (eg HCR 325 p = 2 x 10 -21). Predicted haplotypes from population data
(PHASE 1.0) showed that these GP alleles exist on a similar risk haplotype to that recently reported
for PV. PPP showed no association with these genes and no correlation with age of onset for disease
was observed. Thus GP is almost exclusively associated with the PSORS1 risk haplotype, indicat-
ing a common genetic basis for susceptibility to GP and PV. Molecular studies of GP are therefore
likely to be highly informative. The LOP group may contain a minority of individuals with early
onset-type disease hence the limited association with PSORS1 SNPs. For future LOP studies PSORS1
association may be helpful as an exclusion criterion. PPP appears to have a different genetic aetiol-
ogy. 
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Comprehensive and systematic analysis of function and expression of all the 51 missense mutants
of sarco(endo)plasmic reticulum Ca2+-ATPase 2b found in Darier’s disease patients
Y Miyauchi,1 K Yamasaki,2 K Sato,1 T Daiho,2 H Takahashi,1 A Ishida-Yamamoto,1 S Nakamura,1
H Suzuki2 and H Iizuka1 1 Dermatology, Asahikawa Medical College, Asahikawa, Hokkaido,
Japan and 2 Biochemistry, Asahikawa Medical College, Asahikawa, Hokkaido, Japan
Darier’s disease (DD) is caused by mutations in endoplasmic reticulum Ca2+-ATPase 2b protein
(SERCA2b)1) responsible for Ca2+ uptake coupled with ATP hydrolysis and hence Ca2+ homeosta-
sis in skin cells. To reveal consequences of the mutations and thus to understand the mechanism for
DD, we introduced all of each 51 missense mutations so far reported with DD pedigrees into SERCA2b
cDNA and expressed the protein in COS-1 cells. The expression level and function (the specific
ATPase and Ca2+ uptake activities) of the expressed mutants were determined with microsomes pre-
pared from the cells, and compared with those of the wild type. The expression level and specific
ATPase activity varied dramatically depending on the mutations introduced. In 33 mutants among
51, the activity was almost completely lost regardless of their expression level. In contrast, the other
18 mutants showed fairly high activity (80-40% of that of wild type) and also high (only moderately
reduced) expression level. Some of these mutants possessed no Ca2+ uptake activity in spite of high
ATPase activity, thus being non-functional (the “uncoupled” mutants), but others possessed the “cou-
pled” Ca2+ uptake activity. Results indicated that not only complete loss of function and expression
but also slight or moderate reduction in the function and expression of SERCA2b will likely result
in severe changes in Ca2+ homeostasis and thus cause DD. Importantly, results further suggested
that possible improvement in protein stability and processing during expression in some mutants
may increase both their expression level and the active fraction of the expressed mutants, thus pos-
sibly lead to normal Ca2+ homeostasis. Kinetic and physical properties of all the mutants and their
processing in the cells are now being further explored. 
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Identification of DLx3 interacting factors using a retroviral system and mass spectrometry
analysis
N Rodriguez,1 S Lim,1 L Pannell2 and M Morasso (SID)1 1 Developmental Skin Biology Unit,
NIH/NIAMS, Bethesda, MD and 2 University of South Alabama, Mobile, AL
Dlx3 is a homeodomain protein that is essential in murine skin differentiation and early develop-
ment. Mutations in the human DLX3 gene result in a truncated protein that is associated with the
autosomal inherited human Tricho-Dento-Osseous (TDO) syndrome. In order to identify Dlx3 cofac-
tors or binding proteins, a retrovirus expression system was used to generate a stable Dlx3 trans-
duced HeLa cell line. Cells were transduced with a recombinant retrovirus expressing a bicistronic
mRNA encoding FLAG-Dlx3 linked to an IL2R subunit surface marker. The Dlx3 and Dlx3TDO
coding sequences were subcloned to generate FLAG-HA-Dlx3 or FLAG-HA-Dlx3TDO as N-ter-
minal tagged proteins. The detection of the IL2R on the surface of the transduced cells was used to
sort out expressing cells using magnets and Dynalbead-anti IL2R magnetic beads. The sorted cells
were expanded and nuclear extracts were prepared from recombinant HeLa and control HeLa cells,
and protein complexes were purified using consecutive anti-Flag and anti-HA affinity columns. The
affinity purified protein complexes were separated on SDS-PAGE gel electrophoresis. Coomassie
blue-stained protein bands on SDS-PAGE gels that are specifically observed only in the Dlx3 trans-
duced and Dlx3TDO samples will be excised, destained, digested with trypsin. Direct identification
of the specific interacting proteins will be performed by mass spectrometry. MS peptide mapping
and MS/MS sequence will be used to search the protein and EST databases for protein identifica-
tion. The results of potential interacting proteins that associate with Dlx3 or Dlx3TDO, and their
roles in transcriptional activation will be reported. 
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PSORS1C3, a new gene in the PSORS1 region on chromosome 6p21.3
SJ Holm, LM Carlen, T Rosenmuller, L Mallbris, F Sanchez, KP O’Brien and M Stahle-Backdahl
Dermatology, Karolinska Institutet, Stockholm, Sweden
The psoriasis susceptibility locus PSORS1 on chromosome 6p21.3 has under the last few years
been under thorough examination in the search for a major genetic factor underlying the cause of
psoriasis. Several putative candidate genes have been investigated but the strongest association in
this region shown to date is still that of the HLA-C allele Cw*0602. However, controversy sur-
rounds whether this is a true psoriasis gene or a marker in linkage disequilibrium with the PSORS1
gene. Therefore the search continues. Although the MHC region is one of the most gene dense regions
in our genome the area surrounding HLA-C is bereft of genes. We therefore concentrated our efforts
in searching for new possible candidates at this locus. Here we present PSORS1C3 (Psoriasis Sus-
ceptibility 1 Candidate 3), a newly cloned gene located telomeric to HLA-C in the minimum risk
region. We have characterized this gene with regard to psoriasis involvement in the Swedish popu-
lation. PSORS1C3 is composed of three exons and stretches a 4.4 kb region in a centromeric to telom-
eric direction. From Northern blot analysis we have found PSORS1C3 to be expressed in various
tissues including normal and psoriatic skin, and 3’ and 5’RACE have been used in order to confirm
the size. We amplified all exons in 3 PCR fragments and sequenced from both ends in a series of
Swedish psoriasis individuals, while comparing them to healthy population matched controls. Assem-
bly of resulting sequences was performed in the Staden sequence assembly package and polymor-
phisms were identified using the Trace-Diff function. Using this association analysis we have found
significant association to psoriasis by single nucleotide polymorphisms in two of the exons. This
association could be explained by linkage disequilibrium with Cw*0602 however, the biological
function of this gene is still unknown and hence variations within it may have a biological signifi-
cance. 
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Induced apoptosis, and altered adhesion, proliferation and gene expression of keratinocytes
in the epidermis of mice deficient in the laminin γ2 chain
L Pulkkinen,1 X Meng,1 J Klement,1 D Leperi,1 D Birk,1 T Sasaki,2 R Timpl2 and J Uitto1 1
Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA and 2
Biochemistry, Max-Planck Institute for Biochemistry, Munchen, Germany
Junctional epidermolysis bullosa (JEB) is associated with mutations in six distinct genes expressed
in the cutaneous BMZ; these include LAMA3, LAMB3 and LAMC2 which encode laminin 5 sub-
unit polypeptides. Here we generated a mouse model for JEB by inactivating the laminin γ2-chain
gene by targeted frameshift deletion of exon 8 in Lamc2. Heterozygous mice were phenotypically
normal, while Lamc2-/- mice showed blistering phenotype on day 1-2 of neonatal period, and died
within 5 days of birth. The Lamc2-/- mice demonstrated absent expression of laminin γ2-chain on
the BMZ and attenuated expression of α3 and β3-chains of laminin. Transmission electronmicroscopy
revealed rudimentary, poorly developed hemidesmosomes. Epidermis of the Lamc2-/- mice revealed
induced apoptosis in the basal cells of the blistered skin, suggesting that cell-matrix adhesion pro-
vided by laminin 5 plays a role in cell survival in vivo. The targeted mutation was shown by RT-PCR
to result in two transcripts in vivo, harboring the deletion of either exon 8 or exons 8 and 9 com-
bined, and resulting in premature termination codons in exon 9 or 10, respectively. Thus, the targeted
mutation resulted uniformly in null-allele in vivo. The cultured Lamc2-/- keratinocytes demonstrated
slightly positive staining with γ2-chain specific antibodies, which could be explained by the pres-
ence of a transcript with partial restoration of the reading frame due to alternative splicing in vitro.
Nevertheless, primary keratinocytes cultured from Lamc2-/- mice proliferated in different matrices,
including plastic, type IV collagen, laminin and Matrigel, and attached to type IV collagen and
Matrigel as efficiently as the wild type keratinocytes, while their attachment on plastic and laminin
was significantly weaker. In summary, Lamc2-/- mouse recapitulates human JEB and provides novel
insight into the role of laminin 5 in keratinocyte biology. 
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Identification of a receptor-selective, ligand-dependent nuclear receptor coregulator from
epidermal keratinocytes
AM Flores, L Li and BJ Aneskievich Pharmaceutical Sciences, University of Connecticut, Storrs,
CT
Keratinocyte (KC) response to peroxisome proliferators (PPs) is complex with ultimate effects on
differentiation-associated gene expression and in some cases cell replication. Part of this multi-faceted
response to PPs may have to do with the availability of different PP activated receptor (PPAR) pro-
tein coregulators at different stages of KC maturation. We have recently extended our investigation
of KC response to PPs to include analysis of coregulator expression as well as isolation and char-
acterization of potentially epidermal-specific PPAR coactivators/corepressors. Using the carboxyl
terminal portion of PPARalpha in a yeast-two-hybrid screening of a human KC cDNA library, a
new coregulator was isolated. This clone has partial homology to a previously identified PPAR coreg-
ulator and appears to be an isoform derived from alternative splicing suggesting yet another means
of controlling coregulator function. Relative amounts of the isoform transcripts vary in different
epithelial and non-epithelial tissues. Functionally, in activating gene expression the variants differ
in their ability to cooperate with PPAR and other nuclear receptors relevant to KCs. These activities
are however dependent on the reciprocal interaction of hydrophobic amino acid motifs in the coreg-
ulator and nuclear receptor. Notably, while relatively small (predicted mass of 26.9 and 32.5kD) com-
pared to other nuclear receptor coregulators, these proteins possess intrinsic activating functions
that contribute to their regulation on nuclear receptor-mediated transcription. Additionally there is
coregulator interaction domain beyond the hydrophobic motif allowing for further protein-protein
interactions in the transcription complex. We expect defining the repertoire of coregulators present
in keratinocytes will improve our understanding PPAR function in general and the mechanism of
the epidermal response to PPs in particular. 
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The clinical spectrum of Keratitis-Ichthyosis-Deafness syndrome
S Sundaram,1 C Willoughby,2 P Itin,3 A Jan,4 P Hyde,1 R Ryynaenen,5 A Lewanda,6 V Sybert4 and
G Richard1 1 Thomas Jefferson University, Philadelphia, PA, 2 Univ. of Liverpool, Liverpool, 3
Kantons Hosp., Aarau, Switzerland, 4 Univ. of Washington, Seattle, WA, 5 University Hospital,
Oulu, Finland and 6 Inova Hospital for Children, Falls Church, VA
Keratitis-Ichthyosis-Deafness syndrome (KID) is an ectodermal dysplasia due to dominant muta-
tions in GJB2 encoding the gap junction protein Cx26. To delineate the clinical spectrum of this dis-
order, we evaluated 7 patients with sporadic KID between 3 to 56 years of age. The most consistent
features observed were sensorineural hearing loss (SNHL), palmoplantar keratoderma, cheilitis/per-
leche, skin infections, and follicular hyperkeratoses. SNHL was bilateral in 6 of the 7 patients and
ranged in severity from moderate (2), to severe (2), to profound (4). All but the youngest patient had
corneal neovascularization and in 5 patients it was accompanied by keratitis and/or photophobia.
We noted a marked variability of the cutaneous phenotype. A subset of 3 patients had sharply demar-
cated, figurate outlined, erythematous and hyperkeratotic plaques on the face and limbs. Four patients
demonstrated no erythema and presented with spiculate follicular hyperkeratoses, diffuse, acanthotic
thickening of the skin, or both. The features of one child were distinctive and overlapped with Clous-
ton syndrome, including atrichia, nail dystrophy, and facial dysmorphism. During puberty, 2 males
of this group and 1 female progressively developed a follicular occlusion syndrome. They had pus-
tules, large inflammatory cysts, multiple nodules and draining sinuses of the scalp leading to scar-
ring alopecia. This clinical presentation is suggestive of an underlying defect in keratinization of the
hair follicle. The 3 oldest patients of our cohort had a history of mucocutaneous squamous cell car-
cinoma developing between the ages of 38 to 53. This high incidence illustrates the need for care-
ful cancer screening in these patients and underscores the specific role of Cx26 in carcinogenesis
that is not yet fully understood. 
VOL. 121. NO. 1 JULY 2003 ABSTRACTS
0661
Genetics of alopecia areata using a mouse model
JP Sundberg,1,2 KA Silva,1 D Boggess,1 KJ McElwee,1,3 LE King,2 R Li,1 G Churchill1 and
GA Cox1 1 Research, The Jackson Laboratory, Bar Harbor, ME, 2 Dermatology, Vanderbilt
University, Nashville, TN and 3 Dermatology, Philip University, Marburg, Germany
Alopecia areata (AA) is an autoimmune disease that targets actively growing (anagen) hair follicles
in humans, mice, rats, dogs, horses, and cattle. C3H/HeJ mice spontaneously develop AA from 5
months of age and older in females and later in males. Frequency of AA approached 20% in a
colony by 18 months of age. C57BL/6J mice do not develop AA. A segregating F2 population of
female mice (n=1096) was generated from crossing these two strains. AA (n=138) and clinically nor-
mal (n=214) mice were genotyped at 12 months of age using 211 microsatellite probes. The peak
LOD score on mouse Chromosome 17 (10.9) was around marker D17Mit134 at 16.9 cM from the
centromere. The mouse histocompatibility locus, H2, the mouse equivalent of HLA in humans, was
a likely candidate. Twelve month old C3H.SW-H2b/SnJ mice (C3H/HeJ congenic mice in which
the H2k purported susceptibility locus was replaced with the H2b purported resistance locus) did
not develop AA supporting this locus as being important in AA. A suggestive linkage was also
found on mouse Chromosome 9 (LOD score 2.0) around D9Mit206, 20 cM from the centromere.
The interval on mouse Chromosome 17 contains several orthologous genes potentially associated
with human AA. 
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CCL18 identified in CD1a+ cells of Langerhans cell histiocytosis by suppression subtractive
hybridisation
P Seldon, S Alam and A Chu Dermatology, Imperial College, London, United Kingdom
The purpose of this study was to identify differentially expressed genes in purified CD1a+ cells iso-
lated from Langerhans Cell Histiocytosis (LCH) lesions. Suppression subtractive hybridisation allows
for the generation of a disease specific cDNA library from as little as 0.05 µg of total RNA and nor-
malizes the relative abundance of cDNA species during hybridisation, increasing the sensitivity of
this methodology and allowing identification of rare mRNA transcripts not identifiable by other
methods. Dermal nodule and donor skin were decontaminated in RPMI 1640 medium containing
penicillin, streptomycin and amphotericin B for 30 minutes and the epidermis and dermis separated
after dispase digestion. Epidermal and dermal cell suspensions were formed by syringe disruption
of trypsin digested epidermis and sieve disruption of collagenase digested dermis. Cell suspensions
were washed and the Langerhans cells (LC) or LCH cells were purified using mouse anti-human
CD1a (NA1/34) antibody and anti-mouse immunoglobuln coatd Dynal beads. Cytoplasmic RNA
was purified by cell lysis and guanidine isothiocyanate/phenol/chloroform extraction. Pooled RNA
from seven donors was used as driver to reduce major histiocompatibility differences. The Smart
PCR cDNA synthesis kit (BD Clontech) was used to selectively reverse transcribe poly (A)+ RNA
and the resulting cDNA used to generate a suppression subtractive library using the PCR-select cDNA
subtraction and TOPO TA cloning Kits (BD Clontech and Invitrogen; respectively). Colonies con-
taining differentially expressed gene products were identified by cDNA array, sequenced and
sequences identified using the Blast program. Colony 50585 failed to hybridise to reverse sub-
tracted or LC probes, but showed strong hybridisation to LCH probes and increased hybridisation
to forward subtracted probes. Sequencing of this plasmid identified an insert 168 bases in length
which was matched by Blast analysis to the chemokine CCL18. We have demonstrated the expres-
sion of CCL18 in LCH CD1a+ cells and the lack of expression in normal LC. 
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N-terminal deletion of laminin A3A isoform causes the chronic granulation tissue disorder
LOC syndrome
I McLean,1 KJ Hamill,1 FJ Smith,1 NV Whittock,1 CM Coleman,1 JA McGrath,3 RA Eady,3
CS Munro,4 AD Irvine,2 T Jamil5 and L Consortium5 1 Human Genetics Unit, University of
Dundee, Dundee, Scotland, United Kingdom, 2 Cell and Molecular Pathology, St John’s Institute
of Dermatology, London, United Kingdom, 3 Department of Dermatology, Southern General
Hospital, Glasgow, United Kingdom, 4 Department of Dermatology, Our Lady’s Hospital for Sick
Children, Dublin, Ireland and 5 Hasham M Jamil Trust, London, United Kingdom
Laryngo-onycho-cutaneous (LOC or Shabbir) syndrome (OMIM 245660) is an autosomal recessive
disorder characterised by cutaneous erosions, nail dystrophy and excessive vascular granulation tis-
sue, particularly in the conjunctiva and larynx. Although this syndrome has some features in com-
mon with epidermolysis bullosa (EB), skin blistering is not a clinical feature and LOC only occurs
in the Punjabi Muslim population. Ultrastructural and immunohistochemical assessment of skin
showed no consistent abnormalities. Genomewide homozygosity mapping using consanguineous
families localised the gene to a 500 kb region on chromosome 18q11.2 with a LOD score of 19.8.
This region contained the laminin alpha-3 gene (LAMA3) in which homozygous null-alleles cause
the lethal Herlitz form of junctional EB. Detailed investigation of the locus revealed 2 novel tran-
scripts (LAMA3B2 and LAMA3C) in addition to the known LAMA3A and LAMA3B isoforms.
The complete LAMA3 gene was shown to consist of 77 exons spanning more than 320 kb of genomic
DNA. The mutation in all LOC families was found to be a frameshift in exon A1 (118insG), spe-
cific to the LAMA3A isoform. Interestingly, the mutant transcript is rescued from nonsense-medi-
ated decay by use of an alternative translation start site, therefore leading to an unusual N-terminal
deletion of LAMA3A. This data points to a hitherto unknown role for the LAMA3A N-terminus in
control of granulation tissue formation in LOC patients and perhaps in other disorders associated
with abnormal wound healing. 
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Interleukin-20 is up-regulated in psoriasis and responds to conventional and novel biologic
therapy
E Lee,1 I Cardinale,1 F Wang,1,2 MF Chamian1 and JG Krueger1 1 Investigative Dermatology,
Rockefeller University, New York, NY and 2 Weill Medical College-Cornell University, New York,
NY
IL-20, a new member of the IL-10 family of cytokines, has been implicated in psoriasis on the basis
of observed increases in IL-20R mRNA in lesional skin and the presence of epidermal hyperplasia
in transgenic mice overexpressing IL-20. To further investigate the role of IL-20, we used real-time
PCR to quantify mRNA levels for IL-20 cytokine, IL-20Rα, and IL-20Rβ in skin extracts. In 19/19
psoriatic patients, IL-20 mRNA levels were elevated when we compared matched pairs of non-
lesional (NL) and lesional (PS) skin. Mean expression (normalized to the housekeeping gene hARP)
was 36.2 for NL and 948.9 for PS skin (expression was 26-fold higher on average in PS skin,
p<0.0001). Furthermore, when epidermis was split from dermis in PS biopsies, most of the IL-20
mRNA (>90%) was found by RT-PCR to be localized to the epidermis. We also found IL-20Rα and
IL-20Rβ mRNA decreased in PS compared to NL skin. Mean expression of IL-20Ra was 39.7 in
PS skin compared to 57.4 in NL skin (p=0.047), while mean expression of IL-20Rβ was 3.42 in PS
skin compared to 4.98 in NL skin (p=0.015). Expression of IL-20Rα and IL-20Rβ in skin of unaf-
fected controls was greater than that in psoriatic lesions (in contrast to results in published reports)
and overall similar to levels in NL skin. Following various forms of therapy, IL-20 mRNA levels
were found to return to those seen in NL skin. In lesional skin, IL-20 mRNA levels normalized after
therapy with NB-UVB light (80% decrease, p=0.035), as well as alefacept (82% decrease, p=0.004).
Considering that alefacept specifically targets T-cells, these data argue that T-cells are proximate reg-
ulators of increased IL-20 expression in psoriasis. 
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Novel mechanism of revertant mosaicism in Dowling-Meara epidermolysis bullosa simplex
FJ Smith,1 SM Morley2 and I McLean1 1 Human Genetics Unit, University of Dundee, Dundee,
United Kingdom and 2 Department of Dermatology, Ninewells Hospital, Dundee, United Kingdom
The severe Dowling-Meara form of epidermolysis bullosa simplex (EBS-DM) is caused by domi-
nant-negative mutations in keratins K5 and K14, which are specifically expressed in the basal ker-
atinocytes of the epidermis. The most common mutation in EBS-DM patients is the missense muta-
tion R125C in exon 1 of the K14 gene. Here, as part of an on-going gene therapy initiative, we made
keratinocyte cell line from a sporadic case known to carry the R125C mutation. This female patient
was in her early 20s and had suffered from widespread herpetiform blistering since birth, typical of
EBS-DM. A skin biopsy was taken from a blister-free site on the lower back, from which primary
keratinocytes were cultured. As a routine check, the full-length K14 cDNA was sequenced using ker-
atinocyte mRNA. Surprisingly, the R125C mutation was barely detectable in keratinocyte cDNA
whereas it was present in a 1:1 ratio with the normal allele in lymphocyte DNA. Also, in the cDNA
sequence, very low levels of overlapping sequence traces could be seen upstream of the R125C muta-
tion. These overlapping traces were clearly visible when genomic DNA derived from the keratinocyte
cultures was sequenced. This was found to be a heterozygous 1 bp insertion mutation, designated
242insG, which creates a premature termination codon immediately downstream. The insertion was
completely absent in lymphocyte DNA. Cloning of the keratinocyte genomic PCR products revealed
that the R125C allele also carried the 242insG frameshift. Thus, in this non-lesional area of the
patient’s epidermis, the allele carrying the dominant-negative mutation has been silenced by the
occurrence of a second, nullifying, mutation. Immunofluorescence staining of the primary cultures
with a K14 antibody showed that only a small percentage of cells had filament aggregates, presum-
ably cells lacking the revertant mutation. This case represents a novel mechanism of revertant
mosaicism with implications for gene therapy. 
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Genotype-phenotype correlations in KID syndrome: novel GJB2 mutations and association
with squamous cell carcinoma
G Richard,1 D Wasserman,1 S Sundaram,1 H Kozic,1 P Itin,2 A Lewanda,3 R Antaya,4
C Willoughby5 and J Uitto1 1 Dermatology and Cutaneous Biology, Thomas Jefferson University,
Philadelphia, PA, 2 Kantons Hospital, Aarau, Switzerland, 3 Inova Hospital for Children, Falls
Church, VA, 4 Yale Medical School, New Haven, CT and 5 Un. of Liverpool, Liverpool, United
Kingdom
Keratitis-Ichthyosis-Deafness syndrome (KID) is a rare ectodermal dysplasia affecting multiple strat-
ifying epithelia resulting from dominant mutations in GJB2, encoding the gap junction protein Cx26.
To explore the spectrum of mutations and extend genotype-phenotype correlations of this clinically
heterogeneous disorder, we screened GJB2 in 5 unrelated patients with sporadic KID syndrome. All
had hyperkeratosis of the skin, sensorineural hearing loss, and with one exception, corneal vascu-
larization and palmoplantar keratoderma. Sequence analysis revealed in each patient a missense
mutation of GJB2. We identified 2 novel mutations in the amino-terminus (NT) of Cx26 as well as
the common D50N mutation. One patient was found to be homozygous for a G to A transition not
present in the mother’s DNA. Haplotype analysis excluded paternal isodisomy of ch. 13, suggest-
ing the presence of a GJB2 deletion on one allele. Two patients of our cohort developed squamous
cell carcinoma at sites of hyperkeratotic, and chronically infected plaques on the legs. Nevertheless,
other cutaneous features differed, including symmetrical plaques of erythrokeratoderma on face
and extremities, or pustules, cysts, draining sinuses and deep scars consistent with follicular occlu-
sion syndrome. Both individuals carried different GJB2 mutations, including D50N and a novel mis-
sense mutation changing the charge of the NT domain. Taken with the previously documented
mutations, our results indicate that codon 50 in the first extracellular domain of Cx26 is a muta-
tional hot spot, while other mutations cluster in the cytoplasmic NT. Patients carrying D50N and
other KID mutations are at high risk for squamous cell carcinoma, yet the specific mechanisms by
which faulty Cx26 leads to tumorigenesis remain to be elucidated. 
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Epidermal compartments display different patterns of expression of a secreted gene product
in an in vivo gene delivery model
G Militello, H Lu, A Goldbeck, Y Lee, J Gelfand and S Fakharzadeh Dermatology, University of
Pennsylvania, Philadelphia, PA
The epidermis is an attractive target tissue for expressing genes that give rise to a secreted product.
In vivo delivery of naked plasmid DNA represents one approach for given applications of cutaneous
gene therapy. We speculated that different epidermal compartments may show varied patterns of
transgene expression using this approach. To test this hypothesis, we delivered a secreted alkaline
phosphatase (SEAP) marker gene under control of either the CMV, involucrin (inv), or keratin 14
(k14) promoters to mouse skin using gene gun-mediated DNA transfer. Five adult CD-1 mice were
included in each group. Each construct was delivered to 8 sites (1 µg/site) of depilated back skin
under 400 psi of pressure. Blood samples were obtained from each mouse prior to gene delivery and
at days 1, 2, 4, and 7 after treatment. SEAP levels were measured using a chemilumenesence assay.
Mice receiving a SEAP transgene under control of either the CMV or inv promoters typically showed
peak SEAP levels at day 1, although peak levels were about 2.5 fold greater for CMV mice (27.3
ng/ml) compared to inv mice (11.1 ng/ml). By day 7, SEAP levels declined to near background for
inv mice (0.36 ng/ml), although higher SEAP levels were observed for CMV mice (1.66 ng/ml). In
contrast, k14 mice showed substantially lower peak SEAP levels (3.0 ng/ml), and these were observed
at day 4. Day 7 levels (1.6 ng/ml) were comparable to day 1 levels (1.8 ng/ml). Increasing number
of sites and amount of DNA per site yielded higher blood levels of SEAP. X-gal staining of skin
receiving a lacZ gene confirmed expression was limited to epidermis and hair follicles for all pro-
moters. Although factors such as promoter strength and efficiency of gene delivery to different com-
partments may influence overall expression levels, these results suggest transient expression directed
to basal keratinocytes may be more sustained and consistent compared to suprabasal keratinocytes.
Studies with alternative compartment-specific promoters may help further substantiate these results. 
0668
Sustainable corrective TGM1 gene delivery in human lamellar ichthyosis patient skin in vivo
using integrating non-viral plasmid gene transfer
F Scholl, Q Lin, B Thyagarajan, M Calos and P Khavari Dermatology, VA Palo Alto and Stanford
University, Stanford, CA
Genetic correction of genodermatoses represents a potentially effective molecular therapy, how-
ever, the viral vectors comprising the mainstay of such efforts suffer from major biosafety and cost
concerns. Recent development of nonviral approaches to integrate plasmid DNA, such as via the
phiC31 integrase which has been recently studied in epidermolysis bullosa, offer an attractive alter-
native to viral vectors. Integrating plasmids overcome the prior difficulties with transience of gene
delivery seen with episomal plasmids, which are rapidly lost in self-renewing tissues such as epi-
dermis. To test the ability of this strategy to stably correct the human genetic skin disease, lamellar
ichthyosis (LI), we generated an attB sequence-containing phiC31 integrase transfer vector encod-
ing transglutaminase 1 (TGase1). After gene transfer in vitro, primary LI keratinocytes were used
to regenerate skin tissue on immune deficient mice [n=5 mice per vector group]. TGase1 expression
was sustained in vivo by this approach out to 5 months post-grafting, the duration of the experiment.
In addition, corrected tissue demonstrated smooth surface texture and normalization of barrier func-
tion, as measured by transepidermal water loss (TEWL). In contrast, mock-transfected LI controls
failed to demonstrate any detectable TGase1 expression as expected and grafts failed after 1 month.
Further, uncorrected skin tissue was hyperkeratotic and displayed markedly increased TEWL. These
data confirm that durable gene delivery spanning multiple epidermal turnover cycles can be achieved
in multiple human genetic skin disorders using non-viral gene transfer, suggesting that integrating
plasmids may provide a useful broad plaform for future cutaneous gene therapy efforts. 
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A scoring system for predicting CDKN2A status in a population-based melanoma clinic
H Tsao,1,2 G Yang,1 K Niendorf,2 A Sober,1 D Bell2 and J Fullerton1 1 Dermatology, Massachusetts
General Hospital, Boston, MA and 2 Center for Cancer Risk Analysis, Massachusetts General
Hospital, Boston, MA
With the availability of commercial CDKN2A testing, a simple and reproducible method of identi-
fying potential carriers in clinical practice is essential. To this end, we devised a simple scoring sys-
tem to evaluate CDKN2A carrier risk. We have prospectively enrolled 88 probands (from 88 inde-
pendent families) who had a personal history of melanoma and (i) one other 1st-degree relative with
melanoma (ii) two or more relatives with melanoma or (iii) three or more multiple primary melanomas.
The extant literature suggests that multiple primary melanomas, number of affected relatives in a
kindred and age of onset prior to 35 are all factors related to CDKN2A mutation carrier status. In
order to accommodate these variables into a single instrument, we assigned 1 point for each primary
melanoma diagnosed in the proband, 1 point for each additional family member with melanoma and
1 point for a diagnosis prior to age 35. A cumulative score was then assigned to each of the probands.
We then analyzed CDKN2A exons 1α and 2 by direct sequencing and exon 1β by PCR-SSCP. Twelve
sequence variants (12/88 or 14%) were detected including 2 novel germline mutations (Ala60Thr;
Met53Val). There were 36 probands with a score of 2, 26 probands with a score of 3, 16 probands
with a score of 4 and 10 probands with a score of >5. The rates of germline CDKN2A variants were
8%, 7.7%, 12.5% and 50% for individuals with scores of 2, 3, 4 and >5, respectively. Known dele-
terious mutations occurred only in probands with a score of >4. The recurrent 24-bp duplication was
seen in 3 low-score probands suggesting that it is a lower-risk allele; this finding is compatible with
data that have failed to prove a functional consequence for the 24-bp duplication. In summary, we
devised the first iteration of a simple instrument to predict who is at risk for harboring CDKN2A
mutations and who may be appropriate for genetic testing. Furthermore, our scoring scheme may
also predict the potential likelihood that a sequence variant actually represents a deleterious muta-
tion. 
0670
VDR coactivator complexes involved in 1,25(OH)2D3 regulation in normal and transformed
keratinocytes
Y Oda,1 RJ Chalkley,2 S Chang,1 L Huang,2 AL Burlingame2 and DD Bikle1 1 Endocrinology,
University of California San Francisco/VAMC, San Francisco, CA and 2 Pharmaceutical
Chemistry, UCSF, San Francisco, CA
Cell programs such as proliferation and differentiation involve the sequential activation and repres-
sion of gene expression. Vitamin D, via its active metabolite 1,25(OH)2D3, controls the prolifera-
tion and differentiation of keratinocytes by directly regulating gene transcription. We have shown
that two classes of coactivator complexes, DRIP (the vitamin D receptor interacting proteins)/Medi-
ator and the p160 steroid receptor coactivator family (SRC), are sequentially utilized during normal
differentiation. Using GST-VDR affinity beads, VDR binding complexes were purified from ker-
atinocytes and identified by mass spectrometry (MS). The multi-protein DRIP complex was identi-
fied from normal proliferating keratinocytes. Following differentiation, SRC family members replaced
major DRIP proteins. Nuclear extracts from squamous cell carcinoma (SCC) showed a similar DRIP
complex as proliferating keratinocytes. Detailed analysis using tandem MS peptide sequencing of
the complex from normal keratinocytes revealed the presence of heat shock protein (hsp) in addi-
tion to the DRIP complex. The hsp have been implicated in active dis-assembly of steroid hormone
receptor-coactivator complexes. Differential expression of DRIP205, SRC-2 and 3 was also observed.
Western analysis using cultured normal keratinocytes showed that DRIP205 decreases, whereas SRC-
3 increases during differentiation. In contrast, both DRIP205 and SRC-3 were over-expressed in
SCC. These results were consistent with immuno-staining of DRIP205 and SRC in sections of nor-
mal skin and SCC tumors. These results suggest that VDR coactivators of DRIP and SRC are sequen-
tially involved in VDR transactivation during normal differentiation, but this transition fails in
transformed cells probably because of lack of critical factors involved in the disassembly of such
complexes. 
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Cell cycle regulation of the CYLD tumor suppressor
JT Celebi Dermatology, Columbia University, New York, NY
CYLD is a novel tumor suppressor gene that was discovered by positional cloning of the linkage
interval for familial cylindromatosis (FC), also known as Brooke-Spiegler syndrome or turban tumor
syndrome. FC is an autosomal dominantly inherited disease characterized by a variety of skin
appendage tumors. Germline mutations in CYLD have been demonstrated in families with FC, and
loss of heterozygosity at the CYLD locus has been found in these neoplasms, suggesting that CYLD
functions as a tumor suppressor. However, at the molecular and cellular level, the mechanism (s) of
CYLD tumor suppression remains largely unknown. We expressed two distinct segments of CYLD
in E.coli as fusion proteins with GST. Each fusion protein was purified and used as an immunogen
to generate polyclonal antibodies. The antibodies were then purified using affinity chromatography
and used for immunoblotting and immunofluorescence studies. We first demonstrated that the CYLD
protein is expressed in the nuclear and cytoplasmic compartments in cells. Immunofluorescence stud-
ies showed punctate nuclear staining pattern in some, but not all, interphase cells. Therefore, we syn-
chronized T24 bladder carcinoma cells at G0 by contact inhibition and HeLa cells during the M phase
with nocodazole. These studies showed that CYLD resides within the cell nuclei and its expression
remains low or undetectable just prior to the G1/S transition. As S phase begins, the CYLD expres-
sion increases dramatically and the protein aggregates into nuclear speckles as observed by immuno-
fluorescence microscopy, suggesting that CYLD may be cell cycle regulated, possibly during the S-
phase progression. Thus, our findings provide the first evidence that CYLD is regulated in a cell
cycle specific manner, and suggest that cell cycle regulation of CYLD may be important in CYLD-
mediated tumorigenesis. 
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Pseudoxanthoma elasticum--development of a mouse model by targeted ablation of ABCC6
Y Matsuzaki, J Terlizzi, K Li, D Leperi, J Klement, L Pulkkinen and J Uitto Dermatology and
Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA
Pseudoxanthoma elasticum (PXE) is characterized by calcification of pleiotropic elastic structures
in the skin, eyes, and the cardiovascular system. The mutated gene was recently shown to be ABCC6
encoding MRP6, a transmembrane protein of unknown function, expressed primarily in the liver. We
have embarked on development of a mouse model for PXE using targeted ablation of the ABCC6
gene. The targeting construct replaced 6.9 kb of genomic sequence resulting in elimination of exons
15-18 from the corresponding mRNA (545 bp), which is out-of-frame predicting a null allele. South-
ern analysis and genomic PCR showed the final products to be homozygous for the deletion in the
ABCC6 gene. Northern analysis of polyA+-RNA from the liver revealed that the mutant ABCC6
mRNA was not expressed, suggesting that it is unstable. Staining of liver from wild-type mice with
antibody anti-MRP6 antibody revealed membrane-associated staining, while the staining was entirely
negative in the ABCC6-/- mice. These findings confirm that the mice are truly null with regard to
MRP6 expression. Examination of elastic structures by histochemical stain (Verhoeff-van Gieson)
and by immunohistochemistry with anti-elastin antibody revealed that the elastic structures in the
eye (Bruch’s membrane), in the skin, and in the aorta were apparently normal in ABCC6-/- mice at
eight weeks of age, and von Kossa staining for calcium was negative. These findings suggest that
the development of the elastic fiber network in tissues affected in PXE is normal in these mice, at
least during the early stages of development. Thus, the findings in the ABCC6 knock-out mice are
consistent with late-onset of human PXE. 
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Splicing in humans: exceptions from the rules
B Buchroithner,1 A Klausegger,1 U Ebschner,2 I Anton-Lamprecht,2 C Lanschuetzer,1 H Hintner1
and J Bauer1 1 Dermatology, General Hospital, Salzburg, Austria and 2 Inst. for Ultrastruct. Res.
of Skin, University, Heidelberg, Germany
Alternative splicing is an important yet little understood mechanism, which enables protein diver-
sity by providing multiple transcripts and therefore several proteins encoded by a single gene.
Bioinformatics assume that 33-59% of human genes have at least two splice variants. This explains
the large number of estimated 150,000 proteins in contrast to only approximately 30,000 genes in
the human genome. The highly conserved consensus sequence (AGgt) at the EXON/intron border
is essential for correct splicing as it is targeted and cleaved by the spliceosome. We report a patient
suffering from junctional epidermolysis bullosa, an inherited skin blistering disease, which in this
case is caused by aberrant splicing in combination with a nonsense mutation (R635X) in the gene
coding for the β-chain of the laminin-5 protein. Reduced protein expression was shown by almost
complete lack of immuno reaction with the anti-kalinin antibody pAK4101 unsing immunoelectron
microscopy. A single basepair substitution (3009C∅T) in exon 20 changes the sequence AGGC to
AGGT, which serves as a new splice site. Analysis of patient′s RNA revealed that the spliceosome
recognizes the newly introduced exonic splice site preferentially over the original one farther down-
stream. This splice variant is not predicted by the common splice site scoring system of Shapiro and
Senapy, which deduces the splicing probability from given RNA sequences. Although the newly
introduced consensus sequence shows a score of only 68.6 in contrast to 92.2 of the original one,
the mutated sequence is easily recognized by the spliceosome. These results represent an exception
from the well-known provisions of splicing. 
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Increased expression of IL-23p19 and p40 subunit mRNA in psoriasis vulgaris
E Lee,1 I Cardinale,1 MF Chamian,1 WL Trepicchio,2 JL Oestreicher,2 D Pittman2 and JG Krueger1
1 Investigative Dermatology, Rockefeller University, New York, NY and 2 Molecular Genetics,
Genetics Institute, Cambridge, MA
E Lee, I Cardinale, MF Chamian, WL Trepicchio, JL Oestreicher, D Pittman and JG Krueger. Lab-
oratory for Investig. Dermatology, The Rockefeller University, New York, NY; Dept of Molecular
Medicine, Genetics Institute, Cambridge, MA Psoriasis, the most prevalent T-cell mediated disor-
der affecting the general US population, is best characterized as a Type I immune deviation with
increased expression of cytokines induced by interferon-γ (IFN-γ). Interleukin-23 (IL-23), a recently
described hetreodimeric cytokine, has activity and structural similarity to IL-12, which is a pro-
inflammatory cytokine. It shares the p40 subunit with IL-12 but the other subunit, named p19, is
distinct from p35 of IL-12. We have examined the gene expression patterns of the IL-23 p19 sub-
unit by quantitative RT-PCR and report an increase in relative gene expression in lesional skin com-
pared to non-lesional skin (22.3-fold; p=0.001). The p40 subunit, shared by IL-12 and IL-23, also
increases compared to non-lesional skin (11.6-fold; p=0.003), while the p35 subunit does not demon-
strate any significant change. Knowing that the p40 subunit is shared between IL-12 and -23 creates
a more complicated signaling pathway. While the function of IL-23 in psoriatic skin as an inflam-
matory mediator is unknown, this data supports a role for this new cytokine in the inflammatory envi-
ronment. 
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Genetic heterogeneity of cutis laxa: a heterozygous tandem duplication within the fibulin-5
gene
D Markova,1 Y Zou,1 F Ringpfeil,1 T Sasaki,2 G Kostka,2 R Timpl,2 J Uitto1 and M Chu1 1
Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA and 2 Max-
Planck-Institut for Biochemie, Martinsried, Germany
Inherited cutis laxa is a connective tissue disorder characterized by loose skin with variable internal
organ involvement, resulting from paucity of elastic fibers. Frameshift mutations in the elastin gene
have previously been reported in three families with autosomal dominant inheritance, and a family
with autosomal recessive cutis laxa was recently reported to have a homozygous missense mutation
in the fibulin-5 gene. In this study, we analyzed the gene expression of elastin and fibulins -1 through
-5 in fibroblasts from five cutis laxa patients. One patient was found to express both normal (2.2 kb)
and mutant (2.7 kb) fibulin-5 mRNA transcripts. The larger transcript contains an internal duplica-
tion of 483 nucleotides, resulting in the synthesis and secretion of a mutant fibulin-5 protein with
four additional tandem calcium-binding epidermal growth factor-like motifs. The mutation arose
from a 22 kb tandem gene duplication, encompassing the sequence from intron 4 to exon 9. No fibu-
lin-5 or elastin mutations were detected in the other patients. The results demonstrate that a het-
erozygous mutation in fibulin-5 can cause cutis laxa, and also suggest that fibulin-5 and elastin gene
mutations are not the exclusive cause of the disease. 
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MMLV vectors efficiently transduce collagen VII cDNA and allow preclinical gene therapy
trials in dystrophic EB
Y Gache,1 C Baldeschi,1 M Del Rio,2 F Larcher,2 L Bruckner-Tuderman,3 J Ortonne1 and
G Meneguzzi1 1 INSERM U385, UFR Medecine, Nice, France, 2 Project on Cell and Molecular
Biology and Gene Therapy, CIEMAT, Madrid, Spain and 3 Dermatology, University Hospital
Muenster, Muenster, Germany
Gene therapy of genodermatoses is limited by the availability of vectors able to accommodate and
transfer large cDNAs. Since MoMLV retroviruses are the most used vectors for gene therapy, we
assessed their suitability to correct the genetic defect of keratinocytes of patients with recessive dys-
trophic epidermolysis bullosa (RDEB). RDEB is an inherited skin blistering disorder due to muta-
tions in collagen VII which assembles into the anchoring fibrils of the papillary dermis. The colla-
gen VII cDNA (9 kb) cloned into a pLZRS retrovirus was transduced into primary collagen VII-null
RDEB keratinocytes and fibroblasts. The highly efficient gene transfer resulted in secretion of the
recombinant polypeptide that displayed the structural properties of the wild-type collagen VII. The
transduced keratinocytes lost the hypermotility characteristic of the RDEB cells, and efficiently
deposited immunoreactive collagen VII at the dermal-epidermal junction of transplantable ex-vivo
reconstructed skin. The artificial skin grafted onto SCID mice generated a basement membrane
with mature hemidesmosomes and anchoring fibrils. This approach of genetic therapy was vali-
dated in a spontaneous animal model of RDEB dog in which mutated collagen VII molecules are
expresssed and assembled in abnormal anchoring fibrils. Ex vivo transduction of the dog RDEB
keratinocytes with MoMLV retroviruses expressing the dog wild-type collagen VII cDNA and con-
struction of artificial skin using the infected cells demonstrated the stable reversion of the RDEB
phenotype. Our results demonstrate that the currently utilized retroviral vectors efficiently transfer
the large collagen VII cDNA into primary RDEB keratinocytes and produce transplantable epithe-
lia permanently expressing the curative transgene. They also open new perspectives for the use of
retroviral vectors in the transfer of genes encoding large polypeptides. 
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The molecular role of cyclin-dependent kinase inhibitor 2A in the familial melanoma syndrome
S Leachman,1,2 PA Porter-Gill,2,1 HM Erickson,2,1 S Soo,2,1 J Judd,2,1 R Harris,1 L Meyer1 and
SR Florell1 1 Dermatology, University of Utah, Salt Lake City, UT and 2 Huntsman Cancer
Institute, University of Utah, Salt Lake City
Germline mutations in cyclin-dependent kinase inhibitor 2A (CDKN2A, p16, INK4a) are found in
20-40% of melanoma kindreds, making it the major melanoma predisposition gene. It is well-estab-
lished that CDKN2A negatively regulates entry into the cell cycle through inhibition of the cyclin
D1-cyclin-dependent kinase 4/6 complex. However, despite these scientific insights, the molecular
mechanisms by which a CDKN2A mutation preferentially induces melanocytic tumors of the skin
is poorly understood. A large Utah melanoma kindred carrying a temperature-sensitive germline
CDKN2A mutation was utilized to test the hypothesis that primary cultures of nevus-derived cells,
fibroblasts, and lymphoblasts derived from carriers and non-carriers of this mutation would demon-
strate temperature- and tissue-dependent CDKN2A expression changes. Primary cultures of nevus-
derived cells were grown at 34*C, 37*C, and 40*C and analyzed by Western blot, fluorescence-
activated cell sorting, and cDNA microarray. Carrier-derived cells demonstrated a baseline and
temperature-dependent elevation of total and phosphorylated Rb (S780) relative to non-carrier-derived
cells. Cell-cycle analysis also demonstrated a shift into G2/M phases of the cell cycle in carrier-
derived cells relative to non-carrier-derived cells. Expression analysis identified 30 genes that showed
a significant difference in expression (ANOVA p< 0.001) when compared at 34*C and 40*C in car-
rier and non-carrier samples. Several of these genes are not known to be downstream targets in the
CDKN2A pathway. A structural and functional comparison of the differentially-regulated genes will
be presented. 
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Differential regulation of the human hairless promoter
A Engelhard1 and AM Christiano1,2 1 Dermatology, Columbia University, New York, NY and 2
Genetics and Development, Columbia University, New York, NY
Mutations in the human hairless gene (hr), which is expressed predominantly in the skin and brain,
are responsible for atrichia with papular lesions. Expression of hr in the skin is regulated in a hair
cycle-dependent manner. During catagen, hr expression is differentially regulated among the dif-
ferent cellular compartments of the hair follicle (HF) itself, and abrogation of hr leads to the loss of
structural integrity of the HF in humans and mice. Although the tightly regulated control of hr expres-
sion is essential for HF cycling, the elements which regulate expression remain unknown. In order
to further understand the control of hr expression, we previously cloned the human hr promoter and
identified a thyroid hormone response element (TRE) at 2.7 kb upstream of the CAP site. hr has been
identified as an early response gene to thyroid hormone (T3) stimulation in the developing rat brain,
however, whether the same regulation occured in skin remained undetermined.  We previously demon-
strated T3 transcriptional upregulation through the hr TRE in neuroblastoma cells but not in ker-
atinocyte cell lines, suggesting that the regulation of hr in skin is TR-independent. Through tran-
sient transfection of additional luciferase gene reporter constructs linked to a series of further delimited
promoter deletions, the signal sequences responsible for the high basal level of expression in ker-
atinocytes has been narrowed, and a unique sequence responsible for the differential activity of the
promoter identified. Furthermore, the activity of the sequences in contexts other than the hr promoter
was examined by the addition of regulatory sequences to a minimal promoter in reporter gene assays.
Further dissection of cis-acting regulatory regions of the human hr promoter will provide new insight
into the mechanisms of HF cycling and the highly controlled expression of hair cycle genes. 
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Different banal nevi have different gene expression patterns
LJ Meyer2,1 and LA Schmidt1,2 1 Dermatology, Univ of Utah, Salt Lake City, UT and 2 GRECC,
SLC VAMC, Salt Lake City, UT
Gene expression patterns in common nevi may reflect the earliest genetic changes leading to
melanoma. We have cultured common compound nevi from adults as well as a giant congenital nevus
from a child, and normal skin melanocytes, and compared their gene expression profiles. Our hypoth-
esis was that we would see a single major pattern of gene regulatory differences between all banal
nevi and normal melanocytes from the same person cultured under the same conditions. Melanocytes
and nevomelanocytes were grown in specialized media supplemented with specific growth factors.
All were harvested at the 3rd or 4th passage. RNA was extracted using a Qiagen kit, and Poly-A +
RNA was amplified using the Arcturus system. cDNA was reverse transcribed incorporating the Cy3
fluor and this sample cDNA was applied in to a 6912 spot DNA-microarray simultaneously with
similarly amplified Cy5 labeled reference cDNA (Stratagene). Pattern detection was sought using
K-means clustering and principal component analysis with Spotfire. Comparisons were made between
all normal skin melanocytes, between each patient’s melanocytes and their nevi, as well as across
all samples. Curiously, one large group of genes had a decrease in expression in normal melanocytes
correlating with the age of the patient from which the melanocyte cultures were started. Multiple
cultures from one patient showed only slight differences between each other and that same patient’s
normal skin. In other cases, nevus cultures from the same patient demonstrated different patterns of
gene expression, in one case having a similarity to the congenital melanocytic nevus culture. We con-
clude that different nevi even from the same person can express remarkably different patterns of gene
expression, even though all nevi samples in these experiments were banal compound nevi derived
from persons thought to be at a normal melanoma risk. In no case was a known growth regulatory
pathway clearly evident. We feel this technique will be useful, as much larger numbers of nevi of
different histological subtypes and from patients at risk for melanoma are sampled. 
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Interaction of hairless and TR is dispensable for hair cycling
K Djabali,1 A Zlotogorski,3 A Metzker4 and AM Christiano1,2 1 Dermatology, Columbia University,
New York, NY, 2 Genetics & Development, Columbia University, New York, NY, 3 Dermatology,
Hadassah Medical Center, Jerusalem, Israel and 4 Dermatology, Sourasky Medical Center, Tel-
Aviv, Israel
Atrichia with papular lesions (APL, MIM 209500), is a rare autosomal recessive disease character-
ized by early-onset of atrichia, followed by a papular eruption within the first years of life. Recent
studies demonstrating linkage to chromosome 8p21 and further mutation detection in the hairless
gene (HR) have established the molecular cause of APL. In this study, we describe a 16 year old
female with APL, and identified a homozygous missense mutation in hr, designated D1012N in the
hr-thyroid receptor interacting domain 2 (TRID2). Recently, in vitro interaction assays identified
two clusters of hydrophobic residues within hr, at positions 790 to 804 and 1001 to 1015, named
TRID1 and TRID2 respectively. Interestingly, these TRID motifs are similar to the ones reported in
the nuclear receptor corepressors N-CoR and SMRT which form multiprotein complexes that often
include histone deacetylase.  To determine whether this mutation abolishes the hr-TR interaction
mediated by TRID2, we performed transient transfection with plasmids encoding the mutant D1012N
hr and TR, followed by co-immunoprecipitation. We found no disturbance in the interaction or local-
ization, and have therefore determined that this mutation does not dramatically affect the integrity
of the hr-TR interaction, nor does it alter the nuclear distribution of the two proteins. This result sug-
gests that the TRID2 domain is dispensable for the hr-TR interaction in the skin. The mutation
D1012N must therefore be involved in disruption of hr protein folding and protein-protein interac-
tion, or with other component(s) of the hairless regulatory complex that remain to be identified. 
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Genetic heterogeneity in the multiple lentigines/LEOPARD/Noonan syndromes
T Pacheco,1 N Oreskovich1 and P Fain2 1 Dermatology, University of Colorado Health Sciences
Center, Denver, CO and 2 Medicine and Human Medical Genetics, University of Colorado Health
Sciences Center, Denver, CO
Multiple Lentigines syndrome (MLS) is a rare autosomal dominant disorder, characterized by dif-
fuse cutaneous lentigines that may occur with non-cutaneous manifestations. Recent reports char-
acterize the Multiple lentigines (MLS)/LEOPARD syndrome (MIM 151100) and the Noonan syn-
drome (MIM 163950) as allelic disorders, based on the finding that both syndromes may be caused
by mutations in the PTPN11 gene (MIM 176876). We previously excluded PTPN11 as the cause of
MLS based on genetic linkage studies in a large family with autosomal dominant inheritance of the
disorder suggesting that the MLS is a distinct entity and is not a subtype of the Noonan Syndrome.
As part of that study, we also excluded the genes responsible for other clinically overlapping disor-
ders, including von Recklinghausen neurofibromatosis (NF1), Carney syndrome types I and II (CNC1
and CNC2), Peutz-Jeghers syndrome (PJS), and Cowden disease (CD). We show that MLS in this
family is due to a mutation in a novel gene that maps to the long arm of chromosome 6(q24-25). The
highest LOD seen in the initial genome screen was 2.29 for marker D6S1581, which maps to the
long arm of chromosome 6. Linkage informativeness for this region was increased by genotyping
markers from a higher density (5 cM) mapping set. The results are definitive in positioning the MLS
locus in the 10-cM region between markers D6S308 and D6S411 based on a maximum LOD of 4.129
at marker D6S1654, (odds favoring linkage > 10,000:1) and a 1-lod confidence interval. The segre-
gation of chromosome 6q haplotypes supports the statistical evidence for linkage with 3 recombi-
nants confirming a position for the MLS locus proximal to marker D6S441 and one recombinant
confirming a position distal to marker D6S308. The 12-13 Mb region between D6S308 and D6S411
contains nearly 100 known or predicted genes. Candidate genes are being studied to identify the
responsible gene. 
0682
Mutations in fumarate hydratase cause hereditary leiomyomatosis and renal cell carcinoma
in North American families
J Toro,1 ML Nickerson,2 MB Warren,2 M Wei,1,3 GM Glenn,1 ML Turner,4 L Stewart,1 P Duray,4
P Choyke,4 M Merino,4 W Linehan,4 LS Schmidt3 and B Zbar2 1 Division of Cancer Epidemiology
and Genetics, NCI, Rockville, MD, 2 Laboratory of Immunology, NCI, Frederick, MD, 3 Intramural
Research Support Program, SAIC, NCI, Frederick, MD and 4 Center for Cancer Research, NIH,
Bethesda, MD
Hereditary leiomyomatosis and renal cell cancer (HLRCC) is a genodermatosis characterized by
smooth muscle tumors of the skin and uterus and/or renal neoplasms. Although the identification of
germline mutations in fumarate hydratase(FH) supports FH as the susceptibility gene for HLRCC,
its role in North American families is unknown. Using DNA sequence analysis we screened for germline
mutations in FH in 35 North American families with cutaneous leiomyomas. We also investigated the
health problems associated with HLRCC particularly uterine leiomyomas (fibroids) and renal tumors.
Sequence analysis revealed germline mutations in FH in 31/35 families. We found 20 different muta-
tions in FH, of which 18 were novel. Of these 20 mutations, 2 were insertions and 5 were deletions
that caused frameshifts leading to premature truncation of the protein, and 13 were missense muta-
tions. Eleven unrelated families shared the R190H mutation and 2 unrelated families had the Y422C
mutation. Eighty-one individuals (47 women and 34 men) had cutaneous leiomyomas. Ninety-eight
percent (46/47) of women with cutaneous leiomyomas had uterine fibroids. Eighty-nine percent (41/46)
of women with leiomyomas and uterine fibroids had a total hysterectomy, 44% of whom had a hys-
terectomy by the age of 30. We identified 14 individuals from 5 families with unilateral and solitary
renal tumors. Six individuals from 4 families had papillary type II renal cell carcinoma and one indi-
vidual from one family had collecting duct renal cell carcinoma. Renal cell carcinoma was associ-
ated with an aggressive clinical behavior. with 9/14 dead of metastatic disease within 5 years of diag-
nosis. Mutations in FH are associated with HLRCC in North American families. HLRCC is associated
with clinically significant uterine fibroids and aggressive renal tumors. Our study expands the histo-
logic spectrum of renal tumors and mutations in FH associated with HLRCC. 
0683
Birt-Hogg-Dubé syndrome: identification of a novel gene and its clinical manifestations
J Toro,1 ML Nickerson,2 MB Warren,2 G Glenn,1 ML Turner,4 P Duray,4 N Sharma,2 M Merino,4
W Linehan,4 B Zbar2 and LS Schmidt3 1 Genetic Epidemiology Branch, DCEG, Rockville, MD, 2
Immunology, LIB, NCI, Frederick, MD, 3 SAIC-Frederick, Inc., Frederick, MD and 4 Center for
Cancer Research, NCI, NIH, Bethesda, MD
The Birt-Hogg-Dubé syndrome (BHD), a genodermatosis characterized by benign tumors fibrofol-
liculomas, renal tumors and spontaneous pneumothorax. Previously we localized the BHD gene to
chromosome 17p11.2 by linkage analysis. Recombination mapping in BHD families delineated the
susceptibility locus to 700 kb on chromosome 17p11.2. Sequence analysis of the 14 coding exons
revealed frameshift or termination mutations in a panel of BHD families. Mutations were located
along the entire length of the coding region excluding the 5’UTR. The majority of BHD mutations
were predicted to truncate the BHD protein, folliculin, with a 44% frequency of insertion/deletion
mutations within a hypermutable C8 tract in exon 11. Tissue expression of the 3.8 kb transcript was
widespread including kidney, lung, and skin. Folliculin, is a novel protein that was highly conserved
across species. Genotype and phenotype features will be discussed in detail. BHD is the first gene
associated with renal oncocytoma, chromophobe renal cancer, spontaneous pneumothorax and fibro-
folliculomas. 
0684
Study of the neuroprotective and anti-apoptotic properties of ETRY50, a new neurotrophic
agent
I Imbert, P Lafitte and J Nicolay Biologie, Exsymol, Monaco, Monaco
In vitro experiments carried out on the rat pheochromocytoma (PC12) cell line, considered as a model
of peripheral neurons, show the properties of a new neurotrophic agent, capable to oppose to neu-
ronal degeneration and death induced by oxidative stress and aging. In a first body of experiments
NGF-differentiated PC12 cells were stressed by UVB-radiations or growth factor deprivation, and
the protective effect of ETRY50 was assessed both qualitatively (microscopical monitoring of cell
morphology) and quantitatively (dosage of LDH activity in the culture medium). The antioxidant
properties of ETRY50 were determined with chemical tests, and its ability to induce neuronal dif-
ferentiation as a NGF-like factor, was determined on undifferentiated PC12 cultivated in absence or
with sub-optimal amounts of NGF. Finally, interleukines (Il-6, Il-10) and neuropeptides (NPY, VIP)
production, and the expression of early (bax/Bcl2) and late markers (caspase 3) of the apoptotic
process were measured by ELISA or RT- PCR. Sub-millimolar concentrations of ETRY50 provide
effective protection against UVB irradiation and growth factor deprivation. Experimental data sup-
port the idea that the neuroprotective and anti-apoptotic properties of ETRY50 result from its strong
free radical scavenging effect, together with its neurotrophic effect, promoting neuronal differenti-
ation and life span prolongation. Prevention of apoptosis correlated well with retained neuron-like
morphology (improved neurite outgrowth), and the neurochemical study provides some insights into
ETRY50’s mechanism of action (IL-6 overexpresion). This low molecular weight lipophilic com-
pound appears as a promising agent capable to preserve the neurocutaneous network, bringing ben-
efits in many physiopathological mechanisms involving cutaneous innervation, including age-related
sensitivity loss and impaired immune function, pigmentation disorders or dry skin. 
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Rapid measurement of serum cytokines in psoriasis patients and correlation with disease sever-
ity
SE Jacob,2 M Nassiri,1 V Vincek1 and FA Kerdel2 1 Dermatology, University of Miami, Miami, FL
and 2 Pathology, University of Miami, Miami, FL
Psoriatic plaques have been shown to contain increased levels proinflammatory cytokines. In addi-
tion, serum levels of IL-6, IL-7, IL-8, and INF-γ have been reported to be significantly elevated in
psoriatic patients with active disease. The objectives of this study were to evaluate serum cytokine
profiles in psoriasis patients by a rapid new technique and to correlate these levels with disease sever-
ity. We analyzed single serum samples from 10 patients with active untreated psoriasis and 3 healthy
volunteers for all the major type 1 and type 2 cytokines using the LINCOplex ELISA multi-analyte
detection system. Disease severity, including erythema, induration, scale, and surface area, was
assessed by the PASI. The Spearman rank order test was used to determine correlations between
cytokine levels and disease severity indices. When compared to normal sera, IFN-γ was markedly
elevated in all sera from psoriasis patients (mean ± Standard Error of Mean (SEM)=33.8 ± 1.3 for
psoriatics versus mean ± SEM = 7.6 ± 2.2 for normals, P = 0.001) and positively correlated with all
indices of disease severity (Spearman r = >0.6). IL-8 was moderately increased (mean ± SEM =
24.4 ± 1.8 for psoriatics versus mean ± SEM = 6 ± 2.4 for normals, P = 0.02) and positively corre-
lated with the degree of erythema (Spearman r = >0.6). Mean IL-2 and IL-12 levels were not sig-
nificantly elevated in sera from psoriasis patients. Interestingly, serum IL-10 levels were below detec-
tion levels in psoriatics compared to normals (mean ± SEM = 8.6 ± 2.7). In summary, a new ELISA
system allowed rapid and reliable detection of numerous cytokines in single serum samples from
patients with psoriasis; type 1 and pro-inflammatory cytokines were elevated in psoriatics and cor-
related with parameters of disease severity. We suggest this new tool will be useful in further under-
standing psoriasis pathogenesis and may allow for improved prognosis of individual patients. 
0687
MAPK pathway inhibition is correlated with the down-regulation of MMP-9 secretion induced
by TNF-alpha in human keratinocytes
M Serres, S Holvoet, C Barthollet, C Vincent and D Schmitt Dermatology, Inserm U346, Lyon,
France
MMP-9 is the major gelatinase able to degrade collagen IV secreted by keratinocytes actively involved
in tissue regeneration, wound-healing or tumorigenesis. MMP-9 being the predominant protease
secreted in vivo by activated human keratinocytes, the regulation of its secretion was investigated.
Our previous studies had demonstrated a high migration and secretion of MMP-2 and -9 by ras-trans-
fected HaCaT cells. Presently, our studies using zymography, ELISA and RT-PCR demonstrated that
pro-MMP-9 (92 kDa) expression and secretion is up-regulated by TNF-alpha, a major pro-inflam-
matory cytokines involved in several pathologies. Under our experimental conditions, MMP-9 was
essentially up-regulated via MAPK activation from Ras, Raf, MEK, Erk and AP-1 cascade, and NF-
kappaB to a lesser extent whereas stress kinases, p38 MAPK and JNK were not implicated. The pre-
treatment of cells with specific inhibitors of MAPK pathway downregulated MMP-9 mRNA and
protein expression. As from in vitro studies MMP-9 is only present on its inactive form, the regula-
tion of its active form (86 kDa) induced by plasminogen is under investigation. MMP-9 activity being
controlled by TIMP-1, collagenases as MMP-1 and -13, and stromelysin-1 (MMP-3), the activation
of these enzymes by TNF-alpha was also verified. These data suggest that the control of MAPK
transduction signal pathways may offer a novel therapeutic approach for specifically inhibiting MMP
activities up-regulated in inflammatory disorders and cancerogenesis processes. 
0689
Quantitative analyses of mRNA expression for every member of the fibroblast growth factor
family in skin at various stages of hair cycle
M Kawano,1,2 S Suzuki3 and T Imamura1,2 1 Age Dimension Research Center, National Institute of
Advanced Industrial Science and Technology (AIST), Tsukuba, Ibaraki, Japan, 2 University of
Tsukuba, Tsukuba, Ibaraki, Japan and 3 Advangen, Inc., Tsukuba, Ibaraki, Japan
The results of previous gene knockout experiments demonstrated the important role of fibroblast
growth factor-5 (fgf-5) gene products in mouse hair cycle regulation. Our studies showed that the
gene translates into two proteins (FGF-5 and FGF-5S) through generation of alternatively spliced
mRNAs, and suggest that they have opposite effects on hair growth. FGF-5S expressed in hair fol-
licles antagonized FGF-5’s ability to suppress/shorten the anagen phase of the hair cycle. In addi-
tion, in vitro experiments suggested that the activities of FGF-5 and FGF-5S were exerted via spe-
cific receptor(s) on dermal papilla cells through inhibition of the release of an uncharacterized,
growth-stimulating factor(s) from outer root sheath cells. Against that background, we have com-
prehensively profiled the dynamic expression of FGF in skin and hair follicles. This entailed quan-
tifying the absolute copy numbers of the expressed mRNAs for virtually the entire FGF family (cur-
rently 22 members) in mouse skin at various stages of the hair cycle. We found that some of the
members were highly expressed in the skin and/or hair follicles, and that the expression levels cor-
relating uniquely with the hair growth cycle. 
0688
Apoptosis and mitotic catastrophe in human keratinocytes expressing the protein kinase C
delta catalytic domain
LA Sitailo, SS Tibudan and MF Denning Pathology, Loyola University Medical Center, Maywood,
IL
Cell death by apoptosis is a general response of tumor cells to radiation or genotoxic drugs, how-
ever alternative cellular mechanisms, such as mitotic catastrophe, can also limit the lifespan of genet-
ically damaged cells. In a wide variety of cells undergoing apoptosis, protein kinase C delta (PKCδ)
becomes cleaved by caspase-3 in its hinge domain to generate a constitutively active catalytic domain
fragment. PKCδ is the only PKC isoform proteolytically activated in human keratinocytes under-
going UV-induced apoptosis, and PKC activation is a required component of the UV apoptotic pro-
gram. To elucidate the cellular effects of PKCδ cleavage in apoptosis, we generated a retrovirus
encoding the catalytic domain of PKCδ (PKCδ-cat) corresponding to the fragment generated by cas-
pase-3 cleavage. HaCaT keratinocytes infected with the PKCδ-cat virus were TUNEL positive and
showed morphological and ultrastructural features of apoptosis. Analysis of DNA content by pro-
pidium iodide staining however identified a substantial cell cycle arrest in the G2/M phase and
polyploidy, but not sub-G1 DNA content. The polyploidy was confirmed by morphological identi-
fication of interphase cells with multiple nuclei, a hallmark of mitotic catastrophe. Rhodamine 123
staining of PKCδ-cat-infected HaCaT cells also showed significant depolarization of mitochondrial
membrane potential, which could be blocked by over-expression of Bcl-2 or Bcl-xL. The inhibition
of apoptotic cell death by Bcl-2 and Bcl-xL further increased the accumulation of polyploid cells,
indicating that apoptosis is an alternative fate or subsequent event to mitotic catastrophe. Expres-
sion of a PKCδ-cat ATP binding mutant (K378A) was not able to induce any of the observed changes,
demonstrating that kinase activity of PKCδ-cat is required. These results indicate that the common
apoptotic effector PKCδ-cat is also able to restrict cell growth by inducing mitotic catastrophe, and
thus is an important target for killing tumor cells that are resistant to apoptosis. 
0686
Epidermal growth factor activates calpain in keratinocytes via the MAP kinase signaling path-
way and induces apoptosis
A Inoue, M Yamazaki and H Ogawa Dermatology, Juntendo University School of Medicine, Tokyo,
Japan
Calpain, a calcium-activated cysteine protease in cytoplasm, plays a role in keratinocyte differenti-
ation by contributing to profilaggrin processing. Calpain has two ubiquitously expressed isozymes,
mu-and m-calpain. The signal transduction of epidermal growth factor (EGF) to Ras is involved in
cell proliferation, differentiation, apoptosis and cell survival, depending on its signal strength and
duration via Raf, PI3K and RalGDS. The Raf-MEK-ERK pathway is well characterized and induces
several transcription factors. In this study, HaCaT keratinocytes were cultured with EGF with/with-
out MEK inhibitor (PD98059), ERK2 inhibitor (5-iodotubercidin), PI3 kinase inhibitor (LY294002)
and calpain inhibitor I. Subsequently, the processing of alpha-spectrin, one of the major calpain
substrates, was observed using immunoblots. As a result, EGF alone induced the processing of alpha-
spectrin, which was inhibited by PD98059 and calpain inhibitor I. However 5-iodotubercidin and
LY294002 failed to inhibit this process. Furthermore, degradation of Bcl-2 was observed when HaCaT
keratinocytes were cultured with EGF. This degradation was inhibited by calpain inhibitor I.
Immunoblots revealed the early degradation of m-calpain molecule. These findings suggest that MEK
induces m-calpain activation in HaCaT keratinocytes, which in turn triggers apoptosis via degrada-
tion of Bcl-2 molecules. 
0690
Cyclic adenosine 3′,5′-monophosphate-elevating agents inhibit transforming growth factor-β-
induced SMAD3/4-dependent transcription via a protein kinase A-dependent mechanism
M Schiller, F Verrecchia and A Mauviel INSERM U532, Institut de Recherche sur la Peau, Hopital
St. Louis, Paris, France
SMAD proteins transduce signals from the TGF-β receptors to regulate the transcription of specific
target genes. In this report, we have investigated the effects of cyclic adenosine 3′,5′-monophosphate
(cAMP), a key second messenger in the cellular response to various hormones, on SMAD-depend-
ent signaling in human HaCaT keratinocytes. Using either an artificial SMAD3/4-dependent reporter
construct or the natural TGF-β target, plasminogen activator inhibitor 1 (PAI-1), we show that
membrane-permeable dibutyryl cAMP, and other intracellular cAMP-elevating agents such as the
phosphodiesterase inhibitor isobutyl-methylxanthine, the adenylate cyclase activator forskolin, or
exogenous prostaglandin E2 (PGE2), interfere with TGF-β-induced SMAD-specific gene transac-
tivation. Inhibition of protein kinase A (PKA), the main downstream effector of cAMP, with H-89,
suppressed cAMP-dependent repression of SMAD-driven gene expression. Inversely, co-expression
of either an active PKA catalytic subunit or that of the CRE-binding protein (CREB) blocked SMAD-
driven gene transactivation. cAMP-elevating agents failed to inhibit nuclear translocation and DNA
binding of SMAD3/4 complexes but abolished the interactions of SMAD3 with the transcription
co-activators CBP and p300 in a PKA-dependent manner. These results suggest that suppression of
TGF-β/SMAD signaling and resulting PAI-1 gene transactivation by cAMP-inducing agents occurs
via PKA-dependent, CREB-mediated, disruption of SMAD-CBP/p300 complexes. 
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Comparison of site-matched papillary and reticular dermal fibroblasts
M Sorrell,1 M Baber,1 D Asselineau2 and AI Caplan1 1 Biology, Case Western Reserve University,
Cleveland, OH, 2 Case Western Reserve University, Cleveland, OH, 3 L’Oreal Life Sciences
Research, Clichy, France and 4 Case Western Reserve University, Cleveland, OH
Interfollicular skin contains two subpopulations of fibroblasts, papillary cells that reside in the super-
ficial dermis adjacent to the epidermis and reticular cells that reside in the deep dermis. This study
compares interactions between these two site-matched populations of fibroblasts with adult ker-
atinocytes. Site-matched papillary and reticular cells produced significantly different amounts of sig-
naling molecules that potentially affect keratinocyte proliferation and/or differentiation: keratinocyte
growth factor (KGF), granulocyte-macrophage growth factor (GM-CSF), and interleukin-6 (IL-6).
Papillary cells produced proportionally less KGF and more GM-CSF than did their reticular coun-
terparts. Unstimulated papillary cells also produced less IL-6. Interactions between these two pop-
ulations of fibroblasts and adult keratinocytes were also compared in an in vitro model where ker-
atinocytes and fibroblasts were randomly mixed in a type I collagen matrix. Fibroblasts and
keratinocytes spontaneously sorted with keratinocytes forming solid, but highly organized cellular
masses that contained epidermal cells with varying degrees of differentiation. The appearance of the
terminal differentiation marker filaggrin was more prominent when papillary cells were present. Fur-
thermore, basement membrane formation was enhanced when papillary cells were present. These
studies indicate that site-matched papillary and reticular dermal fibroblasts interacted differently
with adult keratinoctyes. These results suggest that papillary fibroblasts are programmed to more
effectively support the epidermis than are corresponding reticular cells. These results have signifi-
cant implications for the production of skin equivalents and for enhancing our understanding of der-
mal fibroblast physiology. 
0692
Evaluation of the effects of a zinc/iron solution on the migration of fibroblasts in an in vitro
incisional wound healing model
A Feiner, A Cazzaniga, SC Davis, D Berman and PM Mertz Dermatology and Cutaneous Surgery,
University of Miami, Miami, FL
We have previously reported that in-vivo application of a new zinc/iron solution enhanced healing
in acute partial thickness and second-degree burn wounds. There is evidence that zinc can enhance
collagen synthesis but less is known about the role of iron. The purpose of this study was to deter-
mine which component(s) of the zinc/iron solution may be responsible for the enhancement of heal-
ing. Fibroblast cells in an in-vitro incisional healing model were grown to confluency on the bot-
toms of polystyrene well clusters. Digital photographs were taken with an inverted microscope at
time zero after wounding. Subsequently, the wells were divided into eight treatment groups with
two wells per solution. The treatment groups were as follows: growth media alone, distilled water,
zinc, iron and zinc/iron solution. Growth media was added to all treatments except distilled water.
After 24 hours of incubation, digital photographs were taken of the wound area with an inverted
microscope. The percent migration of fibroblasts from baseline to 24 hours was measured using pho-
tographic digital planimetry. Results suggested that the combination of both zinc/iron solution was
the most effective treatment when compared to zinc or iron alone. These results suggest a synergis-
tic mechanism of action for the zinc/iron solution. 
0693
Alteration of TGF-β/Smad pathway in aged and photoaged human skin
K Kim, K Han, J Seo, K Cho, H Eun and J Chung Dermatology, Seoul National University
Hospital, Seoul, South Korea
In an effort to characterize TGF-β signaling and to determine its association with the aging and pho-
toaging processes, we directly compared the expressions of TGF-β/Smad in intrinsically aged and
photoaged human skin in vivo. This study examined expressions of TGF-β1, TGF-β2, TGF-β3, Smad
2, Smad 3, Smad 4, Smad 7, phosphated Smad 2 (pSmad 2), together with TβRI and TβRII, in tis-
sue pairs of sun-exposed and sun-protected skin of both young (20~25y) and old (>75y) subjects by
RNase protection assay and immunohistochemistry. The expression levels of TβRII mRNA and
protein in the epidermis of forearm skin of old person were significantly lower than those of buttock
and upper-inner arm skin of the same individuals. Immunohistology of TGF-β1 revealed prominent
staining in the epidermis in buttock skin of young volunteers. This staining was substantially reduced
in sun-exposed and sun-protected skin of old volunteers. In the epidermis, the expressions of Smad
7 mRNA in both the intrinsically aged and photoaged skin of old subjects were significantly higher
than in the sun-protected skin of young subjects, and increased more in photoaged epidermis. The
level of Smad 3 among Smads was expressed at greater level in the dermis of photoaged skin when
compared with sun-protected skin of young and old persons. A decreased immunoreactivity for
pSmad 2 in the epidermis of forearm skin was seen versus intrinsically aged buttock skin. This
decrease was also found in the epidermis of upper-inner arm skin from old individuals compared
with young individuals. These results suggest that UV-induced down-regulation of TβRII and con-
certed over-expression of Smad 7 may trigger an inhibition of TGF-β-induced phosphorylation of
Smad 2. This impaired TGF-β/Smad signaling could lead to decreased collagen synthesis and wrin-
kles observed especially in photoaged skin. 
0694
Smads regulate collagen gel contraction by human dermal fibroblasts
K Sumiyoshi,1,2 A Nakao,2 Y Setoguchi,3 R Tsuboi1 and H Ogawa1,2 1 Department of Dermatology,
Juntendo University School of Medicine, Tokyo, Tokyo, Japan, 2 Atopy Research Center, Juntendo
University School of Medicine, Tokyo, Tokyo, Japan and 3 Department of Respiratory Medicine,
Juntendo University School of Medicine, Tokyo, Tokyo, Japan
Transforming growth factor-beta(TGF-beta) is a cytokine that enhances wound healing, a complex
process encompassing a number of overlapping phases including wound contraction. The Smad fam-
ily of signaling proteins functions as a principal transduction expressway from the TGF-beta recep-
tors. However, their roles in wound contraction remain unclear. Here we examined the effect of Smad
proteins on wound contraction using an in vitro type I collagen gel contraction assay with human
dermal fibroblasts infected with adenoviruses carrying Smads. Addition of TGF-beta1 to dermal
fibroblasts embedded in collagen gel significantly enhanced their contraction. TGF-beta1-mediated
collagen gel contraction was further enhanced by Smad3, a major signal transducer in the Smad fam-
ily, in fibroblasts. Interestingly, overexpression of Smad3 alone significantly enhanced collagen gel
contraction by fibroblasts when compared with fibroblasts overexpressing a control lacZ. In this con-
dition, even a very low concentration of TGF-beta1 that did not affect the collagen gel contraction
by itself enhanced the contraction by fibroblasts overexpressing Smad3, suggesting synergistic effect
of TGF-beta1 and Smad3. In contrast, TGF-beta1-mediated collagen gel contraction was suppressed
by overexpression of Smad7, a major inhibitory regulator in the Smad family, in fibroblasts. In addi-
tion, RT-PCR analysis showed that the differential effects of Smad3 and Smad7 appeared to be
associated with TGF-beta1 mRNA levels induced in fibroblasts. Thus, modulation of Smad3 or
Smad7 expression in dermal fibroblasts affected their contraction of collagen gels possibly by reg-
ulating both TGF-beta signaling and TGF-beta expression in fibroblasts. 
0695
Expression and function of neurotrophins and neurotrophin receptors in human keratinocytes
C Fila,1 A Marconi,1 M Dumas,2 D Baracchi,1 J Franchi,2 F Bonte’2 and C Pincelli1 1 Dermatology,
University of Modena and Reggio Emilia, Modena, Emilia-Romagna, Italy and 2 LVMH Branche
Parfums et Cosmetiques, Saint Jean de Braye, France
The family of human neurotrophins (NTs) includes nerve growth factor (NGF), brain-derived neu-
rotrophic factor (BDNF), neurotrophin-3 (NT-3) and NT-4/5. The aim of the present study was to
evaluate the expression and function of NTs in human keratinocytes. RT-PCR and ELISA, respec-
tively, revealed that human keratinocytes synthesize and release BDNF, NT-3 and NT-4/5. In par-
ticular, keratinocyte stem cells express and secrete higher levels of NGF as compared to “young”
transit amplifying (TA) cells (pg/ml 851±40 vs. 618±70, p<0.05), while NGF levels are almost unde-
tectable in TA cells. Keratinocytes express the low-affinity p75 receptor which binds all NTs, the
high-affinity NGF receptor trkA and the NT-3 receptor trkC. By contrast, keratinocytes express
only a truncated form of trkB, the BDNF high-affinity receptor, with an altered cytoplasmic domain.
Furthermore, NT-3 significantly stimulates keratinocyte proliferation in a dose dependent manner,
as shown by 3H thymidine incorporation (100 ng/ml, p<0.01). Moreover, addition of an anti-NT-3
neutralizing antibody blocks keratinocyte proliferation (1:5, p<0.05). On the contrary, no effect of
NT-4/5 or BDNF on keratinocyte growth is observed. NTs other than NGF fail to protect keratinocytes
from UVB-induced apoptosis (TUNEL). Interestingly, while NGF decreases upon UVB irradiation,
NT-3 and NT-4 are up-regulated. UVA dose-dependently increases NT-3 levels, as compared to sham
(pg 585±100 vs. 178±21, p<0,05), whereas it does not affect the other NTs. NT-3 and NGF stimu-
late each other release, while they fail to affect either BDNF or NT-4/5, as shown by ELISA. These
results strongly suggest that a complex neurotrophin network exists in human keratinocytes. In this
context, NGF and NT-3 seem to play an important role. 
0696
High-density oligonucleotide array analysis of interleukin-6 sensitive and resistant human
melanoma cells
Z Li, TA Luger and M Boehm Ludwig Boltzmann Institute for Cell Biology and Immunobiology of
the Skin, Muenster, Germany
Cytokine resistance is a well described phenomenon of advanced melanoma and has been estab-
lished for interferons and interleukin-6 (IL-6). The molecular base for IL-6 resistance in melanoma
still remains elusive. We performed high-density oligonucleotide array analysis of two representa-
tive human melanoma cell lines, WM35 (derived from an early primary tumor; IL-6 sensitive) and
WM9 (derived from a metastasis; IL-6 resistant) stimulated with IL-6 for various time points (1, 3,
6 and 12 h). Hybridization of biotinylated cRNA samples was performed on HuGeneFL Affymetrix
gene chips. Data evaluation, cleansing, extraction and analysis of the approximately 5600 genes
was performed by the Gene Data Analyst vs.1 Expressionist software. The filter criteria included a
minimum threshold of 100, normalization by the logarithmic mean and a quality setting of p<0,04.
Only robust changes with a change factor of >3 were regarded as significant. IL-6 treatment of WM35
cells resulted in a time-dependent induction of several known IL-6 responsive genes such as the tran-
scription factors NF-IL6beta, junB and c-fos, none of which being regulated in WM9 cells. In con-
trast, IL-6 treatment of WM9 cells led to an upregulation of proleukin-1beta and the chemokine IL-
8, the latter a known growth factor for melanoma. By applying the above criteria, several novel
IL-6-regulated functional gene clusters were identified in WM35 cells which included transcription
factors (e. g. transducin-like enhancer protein, hypoxia-inducible factor 1alpha), cell cycle players
(e. g. cdc2-related kinase), signal transduction components (e. g. dual-specificity phosphatase-
5/hVH3/B23) and enzymes crucially involved in DNA synthesis (e. g. deoxyguanosine kinase). None
of these genes was significantly altered by IL-6 in WM9 cells. Further studies are required to con-
firm these data at the protein level and to assess the relevance of the identified gene products with
regard to IL-6-induced growth arrest and IL-6 resistance. 
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Dual mechanisms of (-)-epigallocatechin-3-gallate-induced cell survival in human epidermal
keratinocytes
JH Han, KH Cho, KH Kim, HC Eun and JH Chung Dermatology, Seoul National University
College of Medicine, Seoul, Korea, Seoul, South Korea
Green tea is widely consumed as a beverage. Its potential beneficial effects such as anti-cancer and
antioxidant properties may be mediated by (-)-epigallocatechin-3-gallate (EGCG), a major con-
stituent polyphenol in brewed green tea. Recently, EGCG was found to have a pronounced growth
inhibitory effect on cancer cells, but not on normal cells. In this study, the effects of EGCG on cell
proliferation and UV-induced apoptosis was investigated in normal epidermal keratinocytes, and
the molecular mechanisms through which EGCG may act in vivo and in vitro were determined. The
topical treatment of EGCG to aged human skin stimulated the proliferation of epidermal keratinocytes,
and resulted in an increase in the epidermal thickness. In addition, the topical application of EGCG
to human skin was also observed to inhibit the UV-induced apoptosis of the epidermal keratinocytes.
EGCG increased the phosphorylation at the 112th and 136th serines of the Bad protein in epidermal
keratinocytes. EGCG-induced Erk phosphorylation was found to be critical for the phosphorylation
of the 112th serine, and EGCG-induced activation of the Akt pathway is involved in the phospho-
rylation of the 136th serine, respectively. Furthermore, EGCG increased the Bcl-2 expression level,
but decreased the Bax expression level in epidermal keratinocytes, leading to an increase in the Bcl-
2 to Bax ratio. In conclusion, EGCG promotes keratinocyte survival, and inhibits the UV-induced
apoptosis by dual mechanisms; by phosphorylating the 112th and 136th serines of the Bad protein
through the Erk and Akt pathways, respectively, and by increasing the Bcl-2 to Bax ratio. The two
proposed molecular mechanisms associated with the EGCG-induced cell proliferation may act under
different kinetics to promote the survival of keratinocytes. 
0699
Keratinocyte-specific HB-EGF-deficient mice show marked retardation of skin wound heal-
ing
Y Shirakata,1 S Tokumaru,1 K Yamasaki,1 Y Yahata,1 M Tohyama,1 K Sayama,1 S Higashiyama2
and K Hashimoto1 1 Dermatology, Ehime University School of Medicine, Ehime, Japan and 2 2nd
Medical Biochemistry, Ehime University School of Medicine, Ehime, Japan
Cutaneous wound healing requires precise coordination of epithelization, dermal repair, and angio-
genesis. For epithelization, the most important growth factor is the EGF family. Heparin-binding
EGF-like growth factor (HB-EGF), a member of the EGF family, stimulates the growth of normal
human keratinocytes in an autocrine manner. HB-EGF is thought to play an important role in skin
wound healing, although there have been no studies of the involvement of HB-EGF in skin wound
healing in vivo using a mouse model. Since germline targeting of the HB-EGF gene resulted in
embryonic lethality or severe growth retardation, we generated keratinocyte-specific HB-EGF-defi-
cient mice (KS-HB-EGF-/-mice) using Cre/loxP technology in combination with the keratin 5 pro-
moter. A cutaneous wound was made on the backs of mice using a 6-mm punch biopsy and wound
closure was measured by migration of the epidermal edge stained with anti-keratin antibody. There
was no difference in wound closure between KS-HB-EGF-/- and wild-type mice on day 3. How-
ever, wound closure was markedly retarded in KS-HB-EGF-/- mice compared to wild-type mice
(30.7 and 44.5% on day 5, 78.3 and 96.7% on day 9 in KS-HB-EGF-/- and wild-type mice, respec-
tively). To further clarify the role of HB-EGF in cutaneous wound healing, we performed a scrap-
ing wound assay using normal human keratinocytes. HB-EGF mRNA was rapidly induced, opti-
mally 2.8 fold 2 h after scraping, although slight increases in TGF-alpha, amphiregulin, and epiregulin
mRNA were observed. Furthermore, the addition of recombinant HB-EGF accelerated wound clo-
sure in the scraping wound assay, whereas anti-HB-EGF blocking antibody inhibited wound closure.
Combined, HB-EGF plays an important role in skin wound healing by accelerating keratinocyte
migration. In conclusion, we clearly demonstrated for the first time that HB-EGF is the most impor-
tant growth factor in the epithelization of skin wound healing in vivo using keratinocyte-specific HB-
EGF-/- mice. 
0701
Deficient pro-IL 16 expression in stage III CTCL
C Curiel-Lewandrowski,1 N Horst,2 MF Demierre2 and W Cruikshank2 1 Dermatology, Beth Israel
Deaconess Medical Center, Boston, MA and 2 Pulmonary and Dermatology, Boston University,
Boston, MA
Pro-interleukin-16 has been identified as a novel 80 kDa regulatory protein of T cell growth. The
presence of pro-IL-16 in the nucleus results in cell cycle arrest while the loss of nuclear pro-IL-16
following T cell activation facilitates cell cycle progression. In previous experiments we have observed
that T cell lines derived from Sezary Syndrome (SS) patients, HUT78 and H9, either completely lack
pro-IL-16 protein, or express a mutated form of pro-IL-16 that does not translocate into the nucleus,
leading us to investigate the ability of primary CTCL T cells to generate pro-IL-16 protein. Lym-
phocytes were isolated from 5 patients diagnosed with stage III CTCL. Cell lysates were assessed
by western blot analysis using a monoclonal anti-IL-16 antibody. We determined that two patients
lacked complete IL-16 protein, confirmed by northern blots and southern blots; and 2 patients
expressed a truncated form of IL-16 (68kDa) not found in normal T cells. Only one patient expressed
pro-IL-16 at the appropriate weight, however at greatly reduced levels. Using flow cytometric
analysis for intracellular pro-IL-16, 80% of normal T cells contained high levels of pro-IL-16. In
contrast, cells from SS patients, where pro-IL-16 could be detected, had significantly lower expres-
sion, ranging from 1.5% to 31% by FACS analysis. We next correlated expression of pro-IL-16 with
CD25 and found that there was a negative correlation, consistent with the concept that pro-IL-16
functions to limit cell cycle progression. Interestingly, all SS T cells appeared to express lower lev-
els of pro-IL-16 as compared with T cells from normal individuals, suggesting that all T cells are
altered in association with SS. These preliminary data indicate that T cells from SS patients either
lack IL-16 protein completely or express significantly reduced pro-IL-16 levels. The overall reduced
level of pro-IL-16 protein in SS cells likely represents a contributing factor to the dysregulated growth
associated with CTCL. 
0700
Distribution of HB-EGF and TGF-α in normal and psoriatic skin
M Yoshida,1 H Uchiwa1 and S Watanabe2 1 Basic Research Laboratory, Kanebo LTD., Odawara,
Kanagawa-ken, Japan and 2 Department of Dermatology, Teikyo University School of Medicine,
Itabashi-ku, Tokyo, Japan
TGF-α and HB-EGF are members of the EGF family that regulate keratinocyte proliferation. Sev-
eral reports have suggested differences in the regulatory system for their expression in the epider-
mis. We examined the distribution and dynamics of TGF-α and HB-EGF in normal and psoriatic
epidermis, using immunohistochemical and in situ hybridization procedures. Immunohistochemi-
cal analyses showed that HB-EGF and TGF-α were distributed in the divided area of normal epi-
dermis, with the former found in the basal layer and the latter in the suprabasal layers. With the
increase of epidermal thickness from the peripheral area to the center of psoriatic plaque, a gradual
increase of HB-EGF-expressing layers was observed from the near side of the basal layer. TGF-α
expressing cells gradually decreased, accompanied by an increase of HB-EGF-expressing cells, and
finally disappeared from the epidermis, whereas HB-EGF was produced throughout the whole area.
In the center of psoriatic plaque areas that accompanied more seriously developed epidermal hyper-
plasia along with invagination of the epidermis, TGF-α expression was observed in the core part of
the stratum papillare, whereas HB-EGF was expressed throughout the whole area of the epidermis.
The results of in situ hybridization completely agreed with those of immunohistochemical studies
for TGF-α. Furthermore, the expression pattern of K10 keratin, which is a differentiation marker for
epidermal keratinocytes, resembled that of TGF-α, and in vitro analyses using cultured keratinocyte
showed that keratinocytes differentiated by calcium treatment or stratification began to express TGF-
α. We concluded that TGF-α expression is triggered in a differentiation-associated manner in ker-
atinocytes and the number of HB-EGF expressing cells is closely correlated to keratinocyte prolif-
eration in the epidermis. 
0698
Keloid-derived fibroblasts show “myofibroblast” phenotype associated with IFN-gamma resist-
ance
T Hasegawa,1 A Nakao,2 K Sumiyoshi1 and H Ogawa1,2 1 Department of Dermatology, Juntendo
University School of Medicine, Tokyo, Tokyo, Japan and 2 Department of Atopy Research Center,
Juntendo University, Tokyo, Japan
Interferon-gamma (IFN-gamma) has been noted as a potential therapeutic agent for various fibrotic
disorders, in part, through its antagonistic effect on transforming growth factor-beta (TGF-beta).
Keloid is a fibrotic skin disorder that results in an excessive deposition of extracellular matrix,
which is associated with altered-expression of or -responses to TGF-beta in dermal fibroblasts. We
sought to determine whether IFN-gamma antagonized TGF-beta-mediated responses observed in
keloid-derived dermal fibroblasts. Type 1 collagen production, fibroblast contractile activity, and
alpha-smooth muscle actin (alpha-SMA) expression were assessed by using Western blotting, an in
vitro type 1 collagen gel contraction assay, and immunofluorescence study in normal and keloid-
derived human dermal fibroblasts in the presence or absence of IFN-gamma and/or TGF-beta. In
contrast to normal dermal fibroblasts, IFN-gamma did not inhibit TGF-beta-induced type 1 colla-
gen production, contractile activity, and alpha-SMA expression in keloid-derived dermal fibroblasts.
Interestingly, keloid-derived dermal fibroblasts constitutively expressed type 1 collagen and alpha-
SMA with increased capacity to contract a collagen matrix. In contrast to normal dermal fibroblasts,
keloid-derived dermal fibroblasts showed “myofibroblast” characteristics that were associated with
unresponsiveness to IFN-gamma. Thus, IFN-gamma may not be therapeutically useful for keloid
and clarification of the mechanisms underlying the IFN-gamma resistance would be important for
better understanding of the pathophysiology. 
0702
Lack of macrophage migration inhibitory factor significantly delays cutaneous wound
healing
Y Zhao,1 T Shimizu,1 R Abe,1 A Honda,1 J Nishihira2 and H Shimizu1 1 Dermatology, Hokkaido
University Graduate School of Medicine, Sapporo, Hokkaido, Japan and 2 Molecular
Biochemistry, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan
Macrophage migration inhibitory factor (MIF) has emerged as a potent pro-inflammatory factor.
MIF is induced by various stimuli such as wounding and infection and regulates inflammatory and
immunological responses. We have previously demonstrated that increased MIF expression in the
wound healing process in rats and MIF production by wounded fibroblasts was increased by the
endotoxin (lipopolysaccharide, LPS). In order to evaluate the function of MIF, we studied the cuta-
neous wound healing process using an MIF knockout (KO) mice that we recently produced. We
examined fifteen MIF KO and wild type (WT) mice in each group. Following the excision of a 4X4
mm biopsy wound from dosal skin of MIF KO mice and WT mice, healing was significantly delayed
in MIF KO mice compared to WT mice (p<0.001). LPS treatment at concentrations of 1-2 ug/ml in
the culture medium significantly stimulated cultured fibroblast proliferation in WT mice, compared
to MIF KO mice fibroblasts after incubation for more than 5 days. Additionally, a significant increase
in fibroblast migration was observed from WT mice compared to MIF KO mice. Therefore, exces-
sive expression of MIF may directly or indirectly stimulate cell proliferation and migration, which
profoundly modulates the wound healing process. These data clearly indicated that MIF may be
crucial for cutaneous wound healing. 
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Differential expression of angiogenic cytokines in atypical scleroderma induced by malignan-
cies
K Kikuchi, T Hoashi, N Yazawa and K Tamaki Department of Dermatology, University of Tokyo,
Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan
Pseudoscleroderma or atypical scleroderma as a paraneoplastic syndrome is a rare condition. We
treated 5 patients considered as atypical scleroderma induced by malignancies, i.e. paraneoplastic
syndrome from 1995 to 2001 in our department. This is a 7 % out of all referred patients of systemic
sclerosis during the period. In all five cases, lung fibrosis or esophageal dysfunction was not detected.
Antinuclear antibody was negative in 4 out of 5 cases. Raynaud’s phenomenon was not observed.
We detected malignancy (3 lung and 1 nasopharyngeal) during the intensive investigations. One
patient revealed extensive skin sclerosis on hands and forearms after she developed metastatic beast
cancer. Three cases which lung cancers were successfully removed. As angiogenic factors, basic
fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) and their receptors
expression were investigated both in tumor and in the sclerodermatous skin lesion of each case by
immunohistochemical method. We already reported serum bFGF or VEGF level was elevated in
patients of systemic sclerosis (SSc). Serum bFGF level in 5 atypical cases was elevated in coma-
parison with normal controls or systemic SSc patients. Serum VEGF level in 5 atypical cases was
elevated compaired with normal controls. However there was no significant difference between atyp-
ical cases and usual SSc patients. Histopathologically more prominent lymphocytic infiltration was
observed in the sclerodermatous dermis of atypical cases. Strong expression of bFGF was observed
not only in endothelial cells and keratinocytes but also in fibroblasts. The expression of flag and bek
was also elevated in fibroblasts of atypical cases. There was no significant difference of VEGF between
in atypical cases and SSc specimen. The expression of cytokines of 4 biopsied or resected tumors
were also investigated. Strong expression of bFGF and VEGF was observed in each cases. It was
suggested bFGF, angiogenic and fibrogenic cytokine, is involved in the fibrogenesis of such cases. 
0704
Novel small molecule antagonists of interleukin 7 signal transduction
L Gu and BE Rich Dermatology, Brigham and Women’s Hospital, Boston, MA
Interleukin 7 (IL-7) is a growth factor for early B and T cells that protects cutaneous T-cell lym-
phoma (CTCL) cells from apoptotic cell death. IL-7 transgenic mice develop a cutaneous lympho-
proliferative disorder and lymphomas. JAK3 tyrosine kinase is essential for signal transduction in
response to IL-7. Therefore, inhibitors of JAK3 kinase block the biological effects of IL-7 and may
have therapeutic value. A cell-based proliferation assay has been developed for high-throughput
screening. By differential screening with IL-7 dependent (JAK3) and IL-3 dependent (JAK2) cell
lines, we found two compounds with significantly increased potency and another compound that
appears specific for JAK3. Lymph nodes of IL-7 transgenic mice are 5-10 times larger than those of
normal mice and are readily visualized by MRI imaging. The efficacy of one compound, 5H4, was
evaluated by treating 4 IL-7 transgenic mice with 5H4 by intraperitoneal injection for 16 days. Lymph
nodes of individually tracked 5H4-treated mice reduced in size by 30% while those of vehicle-treated
mice were unaffected. At necropsy the lymph nodes of the 5H4-treated mice appeared flaccid while
the lymph nodes of the vehicle-treated mice were turgid. Histology of the 5H4-treated lymph nodes
revealed loose porous tissue in contrast to the lymph nodes of vehicle treated mice, which were tightly
packed. Small molecule kinase inhibitors block IL-7 signaling in vitro and in vivo and may have
therapeutic value as pharmacological agents for the treatment of lymphomas and inflammatory dis-
orders. 
0705
Differential regulation of importin alpha 2 expression by TGFβ and IFN-γ in normal human
epidermal keratinocytes
N Umegaki, K Tamai, H Nakano, R Moritsugu, T Yamazaki and K Hanada Dermatoligy, Hirosaki
University, Hirosaki, Aomori, Japan
One of the most important issues in the dermatological research is to clarify molecular mechanisms
of signal transduction on the epidermal differentiation. Despite accumulation of numerous infor-
mations on this topics, almost no report on nuclear transportation regulation in the epidermal dif-
ferentiation can be found. Here, we studied expression pattern of importin alpha (IMPA) 1, 2, 3, 4
and 5 subtypes, all of which are known to bind nuclear localizing signal (NLS) of various proteins,
such as transcriptional factors, to regulate active nuclear transportation, in cultured normal human
keratinocytes (NHK) and cultured normal human skin fibroblasts (NHF). Northern analysis exhib-
ited that both NHK and NHF expressed all subtypes of IMPA. In the both cell types, IMPA2, 3 and
4 seemed to be major subtypes, while IMPA1 and 5 were minor in terms of relative mRNA expres-
sion. Next, we investigated modulation of IMPAs expression by TGF-β and IFN-γ, which are known
to inhibit and induce epidermal differentiation, respectively. TGF-β stimulation of 5 ng/ml in NHK
culture medium resulted in selective down-regulation of IMPA2 mRNA expression, and about 70%
inhibition was observed after 24 hours. On the other hand, 100U/ml of IFN-γ in NHK culture specif-
ically up-regulated IMPA2 expression. Maximal induction, which was about 2 times higher as com-
pare to initial expression level, was observed after 6 hours incubation, and the expression level was
gradually reduced to reach about 20% of initial expression level, suggesting dual regulation of IMPA2
by IFN-γ. Addition of cycloheximide, a protein synthesis inhibitor, antagonized the effect of both
TGF-β and IFN-γ on IMPA2 expression, indicating requirement of on-going protein synthesis for
IMPA2 regulation by TGF-β and IFN-γ. No other IMPAs were modulated by these cytokines. These
data suggest that nuclear translocation mechanisms regulated by IMPA2 might be specifically involved
in signal transduction pathway for the epidermal differentiation, at least induced by TGF-β and
IFN-γ. 
0706
Identifying a new role for the eicosanoid 12-HETE: modulator of keratinocyte migration
R Isseroff,1 JW Newman,2 VA Ziboh,1 JC Ojingwa,1 BD Hammock,2 CE Pullar1 and B Shi1 1
Dermatology, University of California,Davis, Davis, CA and 2 Entomology, University of
California, Davis, Davis, CA
Eicosanoids are widely recognized mediators of the inflammatory and immunologic responses, and
their role as messengers in other cellular processes is rapidly expanding. We report here on the role
of the eicosanoid, 12-hydroxyeicosatetraenoic acid (12-HETE), a product of arachidonic acid metab-
olism by the enzyme 12 lipoxygenase (LOX) in modulating keratinocyte migration. When conflu-
ent cultures of human neonatal keratinocytes are wounded, they generate 12-HETE, while unwounded
cultures do not. Levels of 12-HETE vary over the course of wound healing, increasing about 30 fold
over the 48 hours post-wounding. Inhibiting 12- HETE production in the wounded cultures by pre-
treating them with the LOX inhibitor nordihydroguaiaretic acid completely prevents cell migration
and healing of the wound, which can be totally reversed by adding exogenous 12-HETE to the cul-
ture. Using LC/MS we identify 12-HETE in vivo, in the wound medium of suction induced blisters
of human skin, further supporting the hypothesis that it modulates keratinocyte migration. Finally,
its role in mediating migration can be derived by the ability of exogenously added 12-HETE to acti-
vate and phosphorylate the EGF receptor, and the downstream ERK1/2 MAP kinase, two required
components of the pro-migratory signaling cascade in keratinocytes. Thus, we demonstrate that 12-
HETE is generated during the course of wound healing and activates the EGF/ERK kinase pathway,
culminating in keratinocyte migration. Exploiting this HETE-mediated signaling pathway may result
in novel pharmacological approaches to enhance wound healing. 
0707
Transcriptional profiling and dissection of signaling pathways responsive to proinflammatory
cytokine TNFα
M Blumenberg,1 T Banno1,2 and M Adachi1,3 1 Dermatology, NYU School of Medicine, New York,
NY, 2 Dermatology, Institute of Clinical Medicine, Tsukuba University, Tsukuba, Ibaraki, Japan
and 3 Dermatology, Faculty of Medicine, University of Tokyo, Tokyo, Japan
The effects of TNFa are mediated by two well-characterized signaling pathways, NFkB and MAPK,
which regulate expression of proinflammatory, immune response, proliferative and apoptotic genes.
Using microarrays, we profiled the TNFa-mediated transcriptional changes in human epidermal ker-
atinocytes during 48-hours post-treatment. TNFa induces proinflammatory and immunomodulatory
genes, prominently chemokines, membrane receptors, MMPs and other proteases. Surprisingly,
epidermal differentiation markers, basement membrane and antiapoptotic proteins are induced as
well. Using parthenolide to block specifically the NFkB pathway, we found that this pathway pro-
vides the antiapoptotic stimulus. Microarrays of TNFa+Parthenolide-treated cells identify chemokines,
epidermal differentiation markers and proteases among the NFkB-dependent genes. Microarrays
predicted an important antiapoptotic role for CFLAR/FLIP in TNFa responses. Using RNA-inter-
ference to target CFLAR/FLIP or NFkB as control, and TUNEL microscopy, we confirmed the anti-
apoptotic functions of both CFLAR/FLIP and NFkB. Our data provide a global description of tran-
scriptional effects of TNFa in keratinocytes, define the specific roles of the NFkB pathway and
identify CFLAR/FLIP as an essential antiapoptotic protein. 
0708
Basic fibroblast growth factor adminstration reduces scar formation in acute incisional wounds
I Ono,1 Y Akasaka,2 T Hida,1 T Yamashita,1 H Jin1 and K Jimbow1 1 Dept of Dermatology, Sapporo
Medical University, Sapporo, Hokkaido, Japan and 2 Department of Pathology, Toho University,
Tokyo, Tokyo, Japan
This study examines the relationship between the level of apoptosis and the degree of wound heal-
ing after the treatment of bFGF. Full-thickness incisional wounds were created on the backs of rats,
and their healing processes were examined with respect to the level of apoptosis and the width of
the granulation tissue or scar with/without the direct intradermal injection of recombinant bFGF in
addition to suturing. The histology of the bFGF group on day 4 showed strong inflammatory reac-
tion at the injured site when compared with the control. At the higher magnification of the bFGF-
treated wound, infiltrated inflammatory cells, fibroblasts, and capillaries were evident. On day 7,
there were increased accumulations in fibrotic tissue, cellular infiltration, and capillaries in the bFGF-
treated wound when compared with the control. Morphometry of the wound tissue revealed that all
parameters of the width in the group treated with 1 mcg of bFGF exceeded those in the control
group on day 7. However, all parameters of the width on days 14 and 28 were significantly lower in
thebFGF-treated group than in the control non-bFGF-treated group. The results of examinations of
apoptosis by TUNEL metod and caspase-3 indicate that the exogenous administration of bFGF wound
to acute incisional wounds accelerates apoptosis in the dermal healing tissue at the early phase, and
that this apoptotic cell death contributes to the total reduction of cellularity at the late phase of wound
healing and leads the scar less visible. Clinical significance of bFGF administration to reduce scar
formastion was also evaluated and the results will be discussed. 
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Flotillin-2 transformation of a non-metastatic melanoma line is associated with differential
expression of PAR-1 and other important signal transduction genes
P Hazarika, S George, S Patel and M Duvic Dermatology, MD Anderson Cancer Center, Houston,
TX
Flotillin-2 (flot-2) is a 41.7 kDa, highly conserved caveolae/lipid raft associated protein. Metastatic
melanoma cell lines and lesions have increased Flot-2 expression. When flot-2 was transfected into
the non metastatic melanoma line (SB2), two separate transformed SB2 clones were highly tumori-
genic and metastatic in nude mouse xenograft model. To determine how over-expression of flotillin-
2 participates in progression of MM, we compared differential gene expression of transfected SB2
cells on two distinct oligonucleotide microarrays. When 100 ug of mRNA was hybridized to a can-
cer related DNA pathway array (CG-8) of 1100 unique sequenced 75-oligomers, only one gene, the
thrombin receptor, PAR-1 was upregulated and was confirmed by Western blotting. Further experi-
ments used either 5 ug of amplified mRNA or 120 ug of unamplified RNA with the standard microar-
ray (CG4_1) of 2304 genes in duplicate. mRNAs from SB2-flot-2 transfected stable clones were
compared to mRNAs from GFP-vector transfected lines. In the standard microarrays, unamplified
samples revealed 34 upregulated and 12 down-regulated genes and amplified experiment showed
94 upregulated and 105 down-regulated genes (p= 0.05). Genes upregulated in flot-2 transfected
lines include PAR-1 and uPA (urokinase type plasminogen activator), focal adhesion kinase (FAK)
and PDZ-RhoGEF while RhoE, Stat-1, NFkBIA, Thrombospondin-1 and TIMP-2 were down- reg-
ulated. PAR-1 protein is known to transform melanoma and other candidate genes identified in this
manner are also implicated in melanoma. This suggests that transformation of non-metastatic SB2
cells to metastatic melanoma cells may be mediated by genes controlling invasion, cell-cycle, angio-
genesis, actin cytoskeleton organization, and apoptosis. Validation of differential gene expression
identified by microarray analysis may increase our understanding of melanoma progression. 
0711
Cyclosporin A induces secretion of cyclophilin B in keratinocytes by a calcineurin-independ-
ent pathway
P Fearon and NJ Reynolds Dermatological Sciences, University of Newcastle, Newcastle upon
Tyne, Tyne and Wear, United Kingdom
Phorbol-ester induced cutaneous inflammation can be inhibited in SCID mice by cyclosporin A (CsA)
indicating that CsA exerts pharmacological effects in skin, independent of T-cells. We have previ-
ously shown that in keratinocytes, CsA induces secretion of cyclophilin B (CypB), a CsA binding
protein, via the constitutive secretory pathway. The aim of this study was to investigate the mecha-
nism by which CsA induces CypB secretion. Firstly, the effects of calcineurin inhibition on CypB
secretion were investigated. Keratinocytes were treated with the calcineurin inhibitors CsA, tacrolimus
and cypermethrin; also CsH and rapamycin, an immunosuppressive drug that binds to FKBP12, but
does not inhibit calcineurin. Secondly, as CsA inhibits keratinocyte growth, the effects of growth
inhibition on CypB secretion were investigated. Keratinocytes were treated with TGF-β, retinoic
acid and vitamin D3. Following incubation with the indicated agonists for 24h, 48h and 96h, con-
ditioned keratinocyte culture medium was collected and analysed using Western blotting with a poly-
clonal antibody to CypB. As previously reported, CsA induced secretion of CypB. Neither the cal-
cineurin inhibitors tacrolimus and cypermethrin, nor rapamycin or CsH induced secretion of CypB
when compared with vehicle control at all timepoints. In addition, pre-treating keratinocytes with
cypermethrin prior to adding CsA failed to inhibit secretion of CypB, indicating that inhibition of
calcineurin is neither sufficient nor necessary for induction of CypB secretion. Secondly, TGF-β,
retinoic acid and vitamin D3 failed to induce CypB secretion suggesting that the growth inhibitory
effects of CsA are either completely distinct from other growth inhibitory pathways, or unrelated to
CypB secretion. These findings provide evidence for the presence of a calcineurin-independent sig-
nalling pathway for CsA in keratinocytes and could account, at least in part, for the non-immune
effects of CsA that are observed in skin. 
0713
New synthetic tripeptide with pleiotropic effects on epidermal cells
K Cucumel, J Botto, C Dal Farra and N Domloge Research Center, Vincience, Sophia Antipolis,
Sophia Antipolis, France
One of the essential mechanisms of cell activation and signal transduction is the activation of cell
membrane-related receptors, such as G-protein-coupled receptors. Being interested in the funda-
mental mechanisms of cell activation as an approach to cell aging, we developed a synthetic tripep-
tide, and tested its effects on cell activation. Cellular ATP assessment in human fibroblasts treated
with 1% of the peptide, revealed an increase in cellular level of ATP. This increase started within 5
minutes, and reached its maximum after 15 minutes of administration of the peptide. Together with
the peptide structure, this activation suggests that the peptide probably stimulates APnA (ATP reser-
voir molecules) receptors in the cells directly. As Ca2+ is important for cell signalling, and in order
to investigate the effect of this peptide on cellular Ca2+ level, we monitored Ca2+ expression in
selected single HaCaT cells in response to peptide administration, using a fluorescent probe and con-
focal microscopy. The selected cells elicited maximum fluorescence intensity after 90 s of peptide-
treatment, and dropped down to basal level thereafter. Moreover, Erg expression, a very early marker
of differentiation, was found to have increased in cultured epidermal HaCaT cells. This expression
was studied, and it showed that the addition of the peptide into cultured cells stimulated cell differ-
entiation. These results were confirmed by further studies on keratin synthesis. Additional tests on
in vitro wound repair and protein synthesis confirmed general cell activation by this new peptide.
These results strongly suggest that the structure of this new peptide, in addition to its great similar-
ity to the described APnA receptor, is probably responsible for ATP induction. This peptide also
shows evidence of cell activation via other G-protein-coupled receptors in epidermal cells. Taken
together, these results demonstrate an interesting effect of the new tri-peptide on cell activation that
is of great interest for topical skin regenerating and energizing products 
0712
Activation of corticosteroid regulatory pathway during wound healing
O Stojadinovic, B Lee, C Vouthounis and M Tomic Dermatology, NYU School of Medicine, New
York, NY
Corticosteroids are known as inhibitors of wound healing but the exact mechanism of this inhibition
is largely unknown. Therefore, we used two different approaches, immunocytochemistry and global
transcriptional analysis to identify the mechanism through which corticosteroids inhibit wound heal-
ing. Using immunocytochemistry, we discovered nuclear translocation of the glucocorticoid recep-
tor (GR) at the wound edge that is completely absent from unwounded skin. This suggests that GR
is released from its cytoplasmic inhibitor and translocated to the nucleus, directly indicating recep-
tor activation during the process of wound healing. Using Affymetrix HU95A gene chips we com-
pared the expression profiles of human skin 4, 48 and 96 hours upon wounding with human skin
unwounded, but treated topically with corticosteroids. These analyses revealed that the expression
pattern of corticosteroid treated skin does not have a significant overlap with the pattern of the 4 and
48 hours post-wounded skin. Importantly, we found a strikingly significant overlap with the 96 hours
post-wounded skin: 33.2% genes identified as significantly regulated in corticosteroid-treated skin
were also significantly regulated in skin 96 hours post wounding. Furthermore, we found 54% of
those to be identically regulated, which means that 166 genes were identically regulated in both cor-
ticosteroid-treated skin and the skin 96 hours post-wounding. Specifically, we found a similar tran-
scriptional pattern of genes that participate in adhesion, proliferation, migration, Wnt pathway and
steroidogenic enzymes, to mention a few. Overall, we found that wound healing activates corticos-
teroid pathway whereas it dominantly inhibits EGF/TNFalpha pathway, resulting in inhibition of
migration, increase of proliferation and change of adhesion of keratinocytes. We conclude that cor-
ticosteroid serve as natural inhibitors of normal wound healing, i.e. a switch that ”resets“ keratinocytes
from their activated phenotype back to deifferentiating phenotype. 
0710
Epidermal cell signalling and activation by a new diacylglycerol-rich extract
E Bauza, C Coquet, K Cucumel, C Dal Farra and N Domloge Research Center, Vincience, Sophia
Antipolis, Sophia Antipolis, France
Cell signalling and activation have been at the center of research for a long time. Among important
cellular signalling paths is tyrosine kinase receptor activation that results in PKC phosphorylation
and activation by diacylglycerol (DAG), which induces different important cellular responses. In
order to induce direct and rapid cell activation, we developed a new DAG-rich extract and tested its
effect and mechanisms of action on cultured human epidermal cells and fibroblasts, in dose course
studies. PKC activation by the extract was investigated by immunoblotting studies that showed MAR-
CKS substrate phosphorylation in cultured human cells through activated PKC. Moreover, the new
extract increased basal cellular levels of the MAPK family (MAPK/ERK, p38MAPK and SAPK/JNK)
and, interestingly, increased phosphorylated MAPK/ERK, which confirms MAPK/ERK activation
after administration of the extract. This activation was dose-dependent. Since MAPK/ERK is impli-
cated in different cell functions such as cell growth regulation and differentiation, additional stud-
ies on differentiation and proliferation markers were performed. These studies showed that PKC acti-
vation by the DAG-rich extract results in the activation of differentiation response more than
proliferation. Interestingly, ATP evaluation studies revealed an increase in cellular level of ATP after
administration of the extract. This increase started within 5 minutes, and reached its maximum after
15 minutes of administration. Furthermore, we monitored Ca2+ expression in selected single cells
in response to administration of the extract, using a fluorescent probe and confocal microscopy. The
selected cells elicited maximum fluorescence intensity within 60 s and dropped down to basal level
thereafter. These ATP and Ca2+ results strongly suggest that DAG-rich extract activates cell targets
other than PKC as well. These studies demonstrate that this new DAG-rich extract exhibits very inter-
esting properties by combining different essential mechanisms of cell activation that are of interest
for energizing and regenerating skin care products 
0714
RelA-/- epidermis displays hyperproliferation with normal differentiation
JY Zhang, S Tao and P Khavari Dermatology, VA Palo Alto and Stanford University, Stanford, CA
Overexpression studies that alter NF-kB function lead to dramatic changes in epidermal growth. It
is therefore unexpected that no epidermis-intrinsic growth abnormalities are apparent in mice lack-
ing the 4 of 5 NF-kB subunits examined to date. NF-kB subunits, however, display genetic redun-
dancy and RelA/p65-deficient adult epidermis has not been studied due to embryonic lethality, leav-
ing open a potential role for RelA in this setting. To address this, we generated developmentally
mature RelA-/- skin. RelA-/- skin lacked RelA protein expression and was notable for marked hyper-
plasia, which remained stable over 8 weeks in vivo. RelA+/- control tissue was similar to wild-type
RelA+/+ skin in every respect assessed. Hyperplasia in RelA-/- epidermis was due to increased cell
division, as confirmed by >4-fold elevation in epidermal mitotic index. Unlike epidermis of Ikk1-/-
mice or mice with epidermal IkBa overexpression, RelA-/- epidermis lacked alterations in cell death.
These findings indicate that epidermal RelA deficiency leads to increased proliferation without alter-
ing apoptosis. RelA-/- epidermis also expresses correctly localized differentiation markers, indicat-
ing that RelA is dispensable for normal differentiation. Unlike Ikk2-/- tissue, RelA-/- skin lacked
inflammatory cell infiltrate and induction of MCP-1, IL-b and TNFa. Moreover, keratinocytes were
hyperproliferative in culture, indicating that increased cell division due to RelA loss is epidermal
cell-autonomous rather than a reactive response to inflammation. Hyperproliferation is TNFR1-
dependent because deletion of Tnfr1 normalized RelA-/- skin cell division and blocking antibodies
to TNFR1 but not TNFR2 inhibited keratinocyte proliferation induced by NF-kB blockade. Fur-
thermore, TNFR1-dependent JNK activation occurred in RelA-/- epidermis and JNK inhibition abol-
ished IkBa mediated hyperproliferation. These findings suggest that NF-kB RelA antagonizes TNFR1-
JNK epidermal proliferative signals and identify a non-redundant role for RelA in restraining epidermal
growth. 
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Antigen-specific regulatory function of anergic CD4+ T cells is controlled by CTLA-4 and MAP
kinase p38 signaling
S Kubsch,1 S Ludwig,2 E Graulich,1 H Adler,1 J Knop1 and K Steinbrink1 1 Department of
Dermatology, University of Mainz, Mainz, Germany and 2 Institut fuer Medizinische
Strahlenkunde und Zellforschung, University of Wuerzburg, Wuerzburg, Germany
Previous results demonstrated that human IL-10-treated dendritic cells (DC) induce anergic CD4+
T cells with antigen-specific regulatory function. This study analyzed altered cell cycle and signal
transduction pathways in these anergic T cells compared to optimally stimulated T cells (cocultured
with mature DC). Accumulation of the G1-specific cyclin D3/D2-cdk4 complexes and high levels of
the cdk inhibitor p27Kip1 were observed in anergic T cells resulting in an inhibited activation of Rb
and an arrest of cell cycle progression in the G1 phase as compared to stimulated control T cells.
Addition of IL-2 and functional blocking of the highly expressed CTLA-4 molecule on the anergic
T cells induced a downregulation of p27Kip1 and a complete inhibition of the antigen-specific regu-
latory function as demonstrated by high proliferation and enhanced IFN-γ production of cocultured
T cells. Notably, analysis of signal transduction pathways demonstrated a markedly enhanced and
sustained activity of the MAP kinase p38 during primary culture and after restimulation. Additional
analysis of the kinase MAPKAP2/3, the downstream substrate of p38, revealed a significantly
increased activity, suggesting an altered critical pathway of signal transduction in anergic T cells.
Inhibition of the MAP kinase p38 using the specific inhibitor SD203580 completely impaired the
induction of anergic CD4+ T cells as demonstrated by restimulation experiments and IL-2 produc-
tion. Importantly, compared to control T cells these T cells also lost their antigen-specific suppres-
sor function. Our data show an important role of CTLA-4 and MAP kinase p38 signaling for the
induction of antigen-specific anergy and regulatory function in CD4+ T cells induced by IL-10-treated
DC. 
0716
Psoriasis-like phenotype induced by constitutively active Rac1 overexpression in the basal
epidermis
CN Dey, EA Waterman, J Chu, M Bradley, N Nguyen, C Davis, AJ Russell and MP Marinkovich
Dermatology/Comparative Medicine, Stanford Univ., Stanford, CA
Rac1 GTPase promotes cell proliferation; however, its role in proliferative skin disorders remains
unclear. To study the role of Rac1 in the skin, we cloned myc-tagged V12Rac1 cDNA into vectors
with K14 or K1 promoters and produced transgenic mice overexpressing constitutively active Rac1
in the basal or suprabasal epidermis, respectively. Multiple transgene copies were detected in V12Rac1
+/- mice by Southern blot and Rac1 transgene expression was verified by Western blot. Between 1-
3 weeks, K14V12Rac+/- mice showed generalized, indurated, erythematous, hyperkeratotic skin
eruptions. Stratified squamous mucosal tissues were largely unaffected. Histology showed greatly
thickened epidermis, parakeratosis, focal hypogranulosis, elongated rete ridges and dilated blood
vessels in dermal papillae. There was an associated mixed inflammatory infiltrate with neutrophils,
and immune cells were also occasionally noted in the epidermis, including stratum corneum. Microar-
ray analysis of K14V12Rac1+/- skin showed overexpression of many genes that were also found to
be overexpressed in psoriatic skin. After 3 weeks, the skin changes in K14V12Rac1+/- mice sub-
sided, however pruritic, persistant, indurated, erythematous plaques of epidermal hyperplasia could
be readily induced by minor trauma. Treatment with topical corticosteroids and occlusion improved
the skin lesions. Interestingly K1V12Rac1+/- mice showed no skin changes, suggesting that over-
expression of active Rac1 in basal epidermis was causative in producing skin lesions. Overexpres-
sion of Rac1 in human keratinocytes grafted as skin equivalents to SCID mice produced mild epi-
dermal hyperplasia without inflammation, raising the possibility that the immune system could
contribute to the phenotype. In summary, these studies suggest that V12Rac1 overexpression in basal
epidermis of immune competent mice may be a useful model for studying hyperproliferative skin
disorders such as psoriasis. 
0717
Global comparison of genes expressed in skin, cultured keratinocytes and artificial skin equiv-
alents, using large DNA microarrays
M Blumenberg,1 A Gazel,1,2 P Ramphal,1 M Rosdy,2 B De Wever,2 N Hosein,1 B Lee1 and
M Tomic-Canic1 1 Dermatology, NYU School of Medicine, New York, NY and 2 SkinEthic
Laboratories, Nice, France
Cultured keratinocyte monolayers and skin equivalents are widely used as surrogates for skin in basic
and applied research, but a systematic comparison of physiological processes and genes expressed
in the three systems has not been done. To identify the similarities and differences between expressed
genes in skin, skin equivalents and cultured keratinocytes, we used large oligonucleotide microar-
rays to derive comprehensive transcriptional profiles. Five independent replicates of each system,
15 microarrays total, yielded extensive, statistically consistent data. We used self organizing maps,
correlation clustering algorithms and simple 2-fold difference in expression to identify the differ-
entially expressed genes. The three methods identify largely overlapping lists of differentially
expressed genes. As expected, skin and skin equivalents were similar to each other, while keratinocyte
cultures differed. Cultured cells do not express epidermal differentiation markers, while expressing
a much higher number of cell cycle and DNA replication genes. Skin, in comparison with cultured
cells and skin equivalents, expressed a higher number of receptors, secreted proteins and transcrip-
tion factors, perhaps reflecting the presence of cell types absent from monocultures. Unexpectedly,
mitochondrial proteins were severely suppressed in skin. Interestingly, Bcl2 interacting apoptotic
proteins are suppressed in keratinocyte cultures, leading to the hypothesis that these proteins effect
the biochemical processes that epidermal differentiation and apoptosis have in common. 
0718
Estrogens modulate epidermal keratinocyte cell function
M Yaar,1 S Sevrain,1 J Cantatore,1 A Traish2 and BA Gilchrest1 1 Dermatology, Boston University
School of Medicine, Boston, MA and 2 Biochemistry, Boston University School of Medicine,
Boston, MA
Decreased serum estrogen levels in postmenopausal women is associated with dermal thinning and
slower wound healing, however, the exact role of estrogens in the function of keratinocytes remains
unclear. The objective of this study is to investigate the mechanism by which estrogens modulate
keratinocyte cellular function. Normal human keratinocytes (Kc) express the ERα and ERΒ and their
levels are modulated by physiologic concentrations of estradiol (E2) (10-8-10-11M). Studies on 3H-
thymidine incorporation showed that that E2 (10-10M) stimulates Kc proliferation. This estrogen-
mediated effect was abrogated by treatment with pure anti-estrogen (ICI 182780, 10-7M). To inves-
tigate estrogen modulation of skin keratinocytes, cells were maintained in growth factor free medium
and stimulated with E2 (10-10M). Cells were harvested and expression of c-fos and c-jun mRNA were
determined by northern blotting. c-fos and c-jun mRNAs were maximally induced above diluent con-
trol 250% and 200% respectively, within 1 hour. Western blotting displayed maximal 150% induc-
tion of cyclin D1 protein within 4 hours. Further, within 30 min of E2 administration tyrosine phos-
phorylation of the cytoplasmic extracellular signal-regulated kinases 1 and 2 (ERK) were observed
with maximal phosphorylation 1 hr after stimulation. Epidermal growth factor receptor mRNA was
also induced the by 160% and 300%, respectively after addition of E2 (10-10, 10-11M). This induc-
tion, however, was observed only after 48 hrs, consistent with an indirect effect of estrogen. Our
results suggest that in Kc, E2/ER complex transactivates genes via the classic pathway and stimu-
lates cytoplasmic signal transduction pathways. Thus, modulating estrogen signaling in skin may
improve cutaneous function in post-menopausal women. 
0719
Reactive oxygen generation is required for actin rearrangements and EGF receptor signaling
in migrating keratinocytes
AL Sillman and R Isseroff Dermatology, University of California,Davis, Davis, CA
Reactive oxygen species (ROS) are now recognized as second messengers participating in normal
cellular signaling pathways. We asked whether ROS are important in the signaling pathways that
control human epidermal keratinocyte migration. Keratinocytes were plated on a collagen I substrate
and incubated with N-acetyl cysteine (NAC) to decrease intracellular ROS levels. Cells were imaged
using time-lapse photomicroscopy, and the migratory speeds of the cells analyzed. NAC-incubated
keratinocytes showed a 25% reduction in migrational velocity compared to keratinocytes maintained
in control medium. Effects of NAC treatment were also examined in a wounded monolayer assay,
wherein a scratch is made in a confluent monolayer of keratinocytes, and migration of cells from
the wound edge to “heal” the wound is monitored by time-lapse photomicroscopy. NAC-treated
wounded keratinocyte monolayers showed over a 3.6-fold reduction in the rate of healing 17 h post-
wounding compared to a control wounded monolayer. NAC-induced impairment of healing was
reversible, and NAC-treated cultures healed within 60 h of NAC removal. Cytoskeletal morphology
was also affected by the NAC treatment. NAC-treated cells demonstrated an absence of lamellipo-
dia, as well as increased cortical actin, stress fibers, and large, vinculin-positive focal adhesions.
Immunoblot analysis revealed that NAC treatment of keratinocyte monolayers decreased EGF recep-
tor (EGFr) tyrosine phosphorylation 4-fold. Since phosphorylation of the extracellular signal-regu-
lated kinase (ERK) 1/2 occurs as a downstream event in the EGFr pro-migratory signaling cascade,
we evaluated ERK1/2 phosphorylation in NAC-treated wounded cultures. NAC treatment of ker-
atinocyte monolayers reduced the activation of ERK1/2 by 2- to 3-fold at 5 and 10 min post-wound-
ing. We conclude that ROS are important second messengers in the EGFr signaling pathway lead-
ing to keratinocyte migration. Depletion of ROS results in a blunted EGFr signaling response, leading
to altered cytoskeletal morphology and reduced migrational speed. 
0720
Novel regulatory mechanism of keratinocyte migration: PP2A activation by β2-adrenergic
receptor agonists
CE Pullar and R Isseroff Dermatology, University of California,Davis, Davis, CA
Activation of the β2-adrenergic receptor (β2AR) in keratinocytes inhibits their cell migration by
decreasing the phosphorylation of the pro-migratory signaling component, the extracellular-signal-
related kinase ERK. Here we demonstrate that these effects are mediated by theβ2AR-induced acti-
vation of the serine/threonine phosphatase PP2A. Pre-treating cultured human neonatal keratinocytes
with the PP2A inhibitor, okadaic acid (OA, 10nM), completely reverses β2AR agonist-induced retar-
dation of keratinocyte migratory speed as well as β2AR agonist-induced inhibition of wound heal-
ing of a confluent sheet of keratinocytes. OA pre-treatment also prevents the β2AR-induced reduc-
tion in ERK phosphorylation, implicating PP2A in these processes. Since signaling components are
often assembled into intracellular complexes, we explored whetherβ2AR activation could induce the
intracellular association of β2AR with other signaling components. Stimulation of keratinocytes with
the β2AR agonist isoproterenol results in a rapid association of β2AR with PP2A, as well as a 43%
increase in association of PP2A with ERK. This suggests that macromolecular complex formation
induced by β2AR activation facilitates PP2A activation and regulates downstream ERK activity.
Finally, we find that β2AR activation results in a rapid (30 second) and transient (returning to base-
line by 10 min) 2-fold increase in PP2A activity in keratinocytes. Since PP2A is inactivated by
phosphorylation of its catalytic subunit, we reasoned that β2AR activation may modulate the phos-
phorylation state of PP2A. Indeed, we found that β2AR activation reduces by 93% the phosphory-
lation of the pool of PP2A that is specifically associated with, and co-precipitates with ERK. Thus,
this study provides the first evidence that β2AR activation in keratinocytes modulates migration via
a novel pathway utilizing PP2A to mediate ERK phosphorylation and alter the pro-migratory sig-
naling pathway. Exploiting this signaling pathway may result in novel therapeutic approaches for
control of cell migration. 
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Activation of phospholipase C-γ1 by c-Src-phosphorylated phosphatidylinositol 3-kinase is
required for calcium-induced keratinocyte differentiation
Z Xie, PA Singleton, J Cao and DD Bikle Endocrine Unit, VA Medical Center, University of
California, San Francisco, CA
In normal human keratinocytes, calcium induces the protein synthesis of phospholipase C-γ1 (PLC-
γ1) which hydrolyzes phosphatidylinositol-4,5-bisphosphate (PIP2) to the second messengers inos-
itol-1,4,5-triphosphate (IP3) and 1,2-diacylglycerol (DAG). These messengers then promote the
release of calcium from intracellular stores and the activation of protein kinase C, respectively, which
trigger keratinocyte differentiation. To determine whether the activation of PLC-γ1 plays a role in
mediating keratinocyte differentiation, we first examined the effect of Src family kinase inhibitor
PP2 on these events. We found that the treatment of cells with PP2 prevented calcium-stimulated
PLC-γ1 activity and induction of the keratinocyte differentiation markers involucrin and transglut-
aminase. The increase in PLC-γ1 activity was seen as early as 5 minutes after calcium administra-
tion. The increase in PLC-γ1 activity was accompanied by an increase in the protein level and the
enzyme activity of c-Src with minimal changes in Fyn. However, unlike the activation of PLC-γ1 by
EGF, calcium activation of PLC-γ1 was not a result of tyrosine phosphorylation, suggesting that
PLC-γ1 is activated by c-Src indirectly and through a non-phosphorylation mechanism such as phos-
phatidylinositol-3,4,5-trisphosphate (PIP3). PIP3 is generated by phosphatidylinositol 3-kinase (PI3K).
To investigate this mechanism, we examined the effect of PI3K inhibitors on PLC-γ1 activity and
keratinocyte differentiation. Our results showed that the PI3K inhibitors LY294002 and wortman-
nin blocked the induction of keratinocyte differentiation markers as well as PLC-γ1 activity by cal-
cium. Calcium induced the phosphorylation of p85α subunit of PI3K and the activities of p110 sub-
units of PI3K, mainly γ and δ subtypes. These data provide support that the activation of PLC-γ1 by
PI3K, which is phosphorylated by c-Src, is required for calcium-induced keratinocyte differentia-
tion presumably by increasing the level of PIP3. 
0723
9-O-acetylation of ganglioside GD3 may promote the hyperproliferative phenotype of ker-
atinocytes in psoriasis and cutaneous carcinoma
AS Paller, P Sun and X Wang Dermatology, Northwestern Univ., Chicago, IL
Ganglioside 9-O-acetylGD3, an acetylated derivative of GD3, is significantly expressed in psoriatic
epidermis and in cutaneous carcinomas, but is undetectable in normal epidermis. The role of 9-O-
acetylGD3 expression in these skin disorders is unknown, although a T-cell costimulatory role has
been suggested. We hypothesized that 9-O-acetylation of GD3 promotes epithelial cell hyperprolif-
eration and cell survival, and investigated the mechanisms of these putative effects. We stably trans-
fected a ganglioside-specific 9-O-acetyltransferase into the keratinocyte-derived SCC12 cells, and
have evaluated resultant transfectants both in culture and in a mouse tumor model. 9-O-acetyltrans-
ferase transfection led to a marked reduction of GD3 expression and increased 9-O-acetylGD3
without significantly depleting GM3. Overexpression of 9-O-acetylGD3 led to significant increases
in proliferation of transfected cells in culture, regardless of incubation with serum or in serum-free
medium on a fibronectin or vitronectin matrix. Consistently, subcutaneous inoculation of 9-O-acetyl-
transferase-transfected cells resulted in tumors that were 8-fold larger than control SCC12 cell tumors
after 40 days. This increase in proliferation correlated with increased EGFR and MAPK phospho-
rylation in 9-O-acetyl transferase overexpressors. 9-O-acetylGD3 expression also led to increased
cell survival, consistent with the previous demonstration that GD3 triggers apoptosis, regardless of
matrix. 9-O-acetyltransferase overexpression activated PKCα without affecting its expression, whereas
functional blockade of 9-O-acetylGD3 prevented PKCα activation. These data suggest that shifts in
ganglioside expression contribute to the phenotype of hyperproliferation and increased cell survival
of psoriatic keratinocytes and cutaneous carcinoma cells. 
0725
Calcium sensing receptor forms a signaling complex with IP3R, PLCγ1 and golgi Ca-ATPase
in keratinocytes
C Tu1,2 and DD Bikle1,2 1 Endocrine Unit, VA Medical Center-San Francisco, San Francisco, CA
and 2 Department of Medicine, University of California, San Francisco, CA
Calcium is critical for regulating keratinocyte differentiation. Raising extracellular calcium con-
centration above 0.07 mM induces a rapid rise in intracellular free calcium and enhances expression
of differentiation marker genes in keratinocytes. We previously reported that the calcium sensing
receptor (CaR) is required for mediating these calcium-induced cellular responses. CaR knockdown
results in a reduction of calcium release from internal stores. This result implies an interaction between
CaR and other calcium regulating molecules, through which CaR regulates internal calcium stores.
Double fluorescence immunostaining examined by confocal microscopy showed that CaR colocal-
izes with IP3R and PLCγ1 in intracellular compartments. To further investigate the possibility of
complex formation between CaR and other calcium signaling molecules we performed subcellular
fractionation and determined whether these proteins were found in the same fractions. Keratinocyte
membranes were subjected to a 15-50% discontinuous sucrose gradient. After high-speed centrifu-
gation, each fraction was collected and analyzed by immunoblotting. Whereas the non-glycosylated
CaR was found in the ER/cis-golgi fractions, the mature glycosylated forms of the CaR were found
in the trans-golgi fractions. Whereas the ER calcium pump, SERCA2, was found in the ER fraction,
ATP2C1, the human homologue of a yeast golgi Ca-ATPase PMR1, as well as other calcium regu-
lating proteins including IP3R and PLCγ1 were found in the trans-golgi fractions. Co-immunopre-
cipitation studies using antibodies against CaR, IP3R, PLCγ1 and ATP2C1 demonstrated that these
antibodies not only precipitated their target proteins but also reciprocally brought down the other
three molecules from the trans-golgi fractions. These results indicate that in keratinocytes CaR, IP3R,
PLCγ1 and ATP2C1 form an intracellular complex in trans-golgi. Our data suggest that the interac-
tions among these molecules regulate calcium release from intracellular stores. 
0724
Induction of apoptosis by p33ING1 via Bcl-2 and caspase-3
M Chin, K Cheung, V Ho and G Li Medicine, University of British Columbia, Vancouver, BC,
Canada
The biological functions of the tumor suppressor ING1 have been studied extensively in the last five
years. Four alternatively spliced forms of ING1, p47ING1, p33ING1, p27ING1, and p24ING1 have
recently been identified. ING1 has been shown to mediate growth arrest, senescence, apoptosis,
anchorage-dependent growth, chemosensitivity, and DNA repair. In addition, it has been shown that
ING1 requires the presence of p53 to exert its biological functions. Induction of apoptosis has been
demonstrated by adenovirus-mediated transfer of both p33ING1 and p53 in glioma and esophageal
carcinoma cells. Apoptosis can also be facilitated by UV irradiation in human fibroblast and melanoma
cells expressing p33ING1. To further investigate the molecular pathway by which p33ING1 induces
apoptosis, we overexpressed p33ING1 by adenoviral infection in HEK293 cells, and subsequently
assayed for the frequency of cell death. Our results, supported by two independent assays, indicated
that overexpression of p33ING1 enhanced apoptosis by as much as 70% in HEK293 cells compared
to vector controls. We also showed that the expression of p53 decreases with increasing levels of
p33ING1. The biological significance of this relationship between p53 and p33ING1 is yet to be
determined. Furthermore, other proteins that were reduced in expression were Bcl-2 and procaspase-
3, suggesting that the apoptotic pathway regulated by p33ING1 depends on the inhibition of the anti-
apoptotic protein Bcl-2 and the activation of caspase-3. Taken together, these results strongly indi-
cate that p33ING1 participates in apoptosis via the Bcl-2/caspase-3 pathway. 
0722
EGFR-integrin crosstalk is regulated by endogenous changes in ganglioside expression
P Sun, X Wang and AS Paller Dermatology, Northwestern Univ., Chicago, IL
Endogenous modulation of ganglioside GM3 expression affects EGFR signaling through a direct
interaction of GM3 with the EGFR; however, GM3 is not able to interact with and regulate α5β1
signaling directly. We hypothesized that ganglioside modulates ligand-independent inhibition of the
EGFR signaling by suppressing the complexing and resultant crosstalk between integrin α5β1 and
the EGFR. Endogenous levels of ganglioside GM3 were modulated in keratinocyte-derived SCC12
cells by antisense treatment (increased GM3) or by treatment with PPPP or transfection with gan-
glioside-specific sialidase cDNA (ganglioside depletion). Cells were then starved of EGF and serum,
and plated on fibronectin (FN) or plastic. Endogenous accumulation of GM3 inhibited proliferation,
whereas ganglioside-depletion stimulated cell proliferation, regardless of growth in the presence of
EGF ligand or starved of EGF but in the presence of FN. Similarly, GM3 overexpression inhibited
integrin-dependent EGFR activation, while ganglioside depletion enhanced integrin-dependent EGFR
activation in the presence of FN. Inhibition of EGFR or MAPK activation and treatment with FAK
antisense oligonucleotides further suppressed the phosphorylation of EGFR, FAK, and MAPK. Incu-
bation with cytochalasin D also further suppressed the phosphorylation of FAK and MAPK. These
studies of signaling pathway inhibition provide evidence that the effect of ganglioside occurs upstream,
probably at the membrane level. EGFR and α5β1 are both found in membrane immunoprecipitated
with either anti-EGFR or anti-α5β1 antibody; endogenous overexpression of GM3 eliminated the
co-immunoprecipitation, while depletion of ganglioside augmented it, suggesting that the mecha-
nism of the ganglioside-induced inhibition of crosstalk involves blockade of complexing of the EGFR
with integrin. These studies show that endogenous modulation of ganglioside expression affects
EGFR-integrin crosstalk, at least in part by preventing association of EGFR and integrin α5β1, and
may be a powerful tool for regulating epithelial cell proliferation and cell motility. 
0726
Visualisation in real time of NFAT2 nuclear translocation induced by differentiation signals in
human keratinocytes
S Sikkink, WI Al-Daraji and NJ Reynolds Dermatological Sciences, University of Newcastle-
Upon-Tyne, Newcastle-Upon-Tyne, England, United Kingdom
The transcription factor nuclear factor of activated T cells (NFAT) has recently been implicated in
both mice and humans and we have previously reported expression of calcineurin and NFAT1 in
human keratinocytes. In this study we investigated the subcellular localisation and translocation of
NFAT2 using a fusion protein comprising full-length human NFAT2 and green fluorescent protein
(GFP) and real time confocal imaging. Reverse transcription/PCR and western analysis demonstrated
the presence of NFAT2 in cultured normal human keratinocytes. Following transfection with GFP-
NFAT2, keratinocytes were treated with agents that induced a rise in intracellular calcium and visu-
alised by confocal microscopy. The proportion of GFP-NFAT2 within the nucleus was quantified as
a function of time. GFP-NFAT2 appeared predominantly cytoplasmic in un-treated keratinocytes
although cells with clear nuclear GFP-NFAT2 localisation were also observed. Ionomycin (1 µM)
induced nuclear translocation by 3-6 mins that was maximal at 10-20 mins (n=3). TPA (50 nM) and
increased extracellular calcium (1.5 mM [Ca2+]o) induced nuclear translocation of GFP-NFAT2
with slower kinetics compared to ionomycin. Pre-treatment of keratinocytes with the phosphatase
calcineurin inhibitor cyclosporin A (1 µM) inhibited nuclear translocation of GFP-NFAT2. Inter-
estingly, GFP-NFAT2 was observed to translocate to discrete regions within the keratinocyte nuclei.
The nature of these intranuclear bodies remains to be determined but it is intriguing that the size of
these bodies increased over time as GFP-NFAT2 accumulated. In summary, these data indicate that
NFAT2 subcellular localisation is tightly regulated by calcium and differentiation signals through
calcineurin activation and suggests that NFAT2 may play a role in regulating keratinocyte differen-
tiation. 
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Blockade of the epidermal growth factor receptor induces a deranged chemokine expression
in keratinocytes leading to enhanced skin inflammation
S Pastore, F Mascia, V Mariani and G Girolomoni Lab. of Immunology, Istituto Dermopatico dell,
Roma, Italy
In chronic inflammatory skin disorders such as psoriasis, atopic dermatitis and allergic contact der-
matitis, keratinocytes produce inflammatory mediators and undergo increased proliferation leading
to epidermal hyperplasia. Leukocyte-derived TNF-α and IFN-γ are mostly responsible for induc-
tion of inflammatory mediators and increased expression of growth factors. Here we investigated the
impact of the EGF receptor (EGFR) and the EGF family growth factor TGF-α on TNF-α- and IFN-
γ-induced chemokine expression by keratinocytes. Extended epidermal EGFR and TGF-α expres-
sion was detected not only in psoriasis but also in chronic atopic dermatitis and chronic allergic con-
tact dermatitis. In cultured human keratinocytes, metalloproteinase-dependent shedding of the mature
form of TGF-α was rapidly induced by both TNF-α and IFN-γ, and directly contributed to early
EGFR transactivation. When added exogenously, TGF-α dose-dependently down-regulated TNF-α-
and IFN-γ-induced expression of CCL2, CCL5 and CXCL10. In contrast, TGF-α synergized with
TNF-alphaα for CXCL8 induction. Conversely, impairment of autocrine EGFR-ligand system by
the selective EGFR tyrosine kinase blocker PD168393 prior to stimulation with cytokines led to
increased CCL2, CCL5 and CXCL10, but reduced CXCL8. In mouse contact hypersensitivity, impair-
ment of EGFR tyrosine kinase activity by a single topical administration of PD168393 prior to hap-
ten challenge induced an exacerbated inflammatory response, which was associated to increased epi-
dermal levels of CCL2, CCL5 and CXCL10, and higher numbers of CD4+ and CD11b+ leukocytes
infiltrating the skin. Similar perturbations were obtained with local painting of the MEK1/2 inhibitor
PD98059. In conclusion, EGFR signaling may serve as a mechanism to dampen skin inflammation
and protect epithelial cells from injury. On the other hand, the blockade of EGFR signaling on epithe-
lial cells may be exploited to enhance inflammatory responses. 
0728
Nerve growth factor affects anagen-catagen transformation of cultured human anagen hair
follicles
MG Hansen,1,2 R Overall,2,1 P Pertile,1 PC Arck,2 R Paus1 and EM Peters2,1 1 Dermatology,
University Hospital Eppendorf, Hamburg, Hamburg, Germany and 2 Psychoneuroimmunology,
Charite Campus Virchow Clinics, Humboldt-University of Berlin, Berlin, Germany
Our understanding of neurotrophin signaling in many non-neuronal tissues is increasing daily since
the discovery of the prototypic nerve growth factor (NGF). Recently, we could show, that brain
derived nerve growth factor (BDNF) is playing a crucial role in murine and human hair follicle regres-
sion (catagen). We here investigate, presence and function of NGF and its high affinity receptor
tyrosinekinase A (TrkA) in human anagen hair follicles by rtPCR, in situ, immunofluorescense and
organ culture. NGF and TrkA are expressed in the anagen hair follicle with distinct distribution pat-
terns: NGF is dominant in more differentiated keratinocytes such as the inner root sheath. It is also
expressed by the hair matrix, dermal papilla cells, the arrector pili muscle and the sebaceous glands.
Outside the follicular compartment NGF can be detected in Langerhans cells, mast cells and nerve
fiber bundles. Complementary, TrkA expression is dominant in the more undifferentiated keratinocytes
of the outer root sheath with little expression outside the follicular compartment. These observa-
tions suggest NGF/TrkA signaling in epithelial growth control in the anagen hair follicle. In fact,
NGF did decrease hair shaft elongation in high concentrations. Also, hair follicles cultured with
50ng/ml NGF displayed a progressed catagen-like hair cycle stage. Interestingly, apoptosis of hair
follicle keratinocytes did not increase (TUNEL-assay) under NGF treatment, while the number of
proliferating (Ki-67-immunoreactivity) keratinocytes did, indicating a higher turn-over rate in the
regressing hair bulb. NGF-neutralizing antibodies had no significant effect in this culture model. This
suggests, that NGF is playing part in epithelial tissue remodeling during anagen-catagen transfor-
mation in the human hair follicle. 
0729
Regulation of parathyroid hormone-related protein gene expression by EGF family ligands in
primary human keratinocytes
Y Cho,1 DF Spandau,2 DA Lewis2 and JG Foley1,2 1 Medical Sciences, Indiana University School
of Medicine, Bloomington, IN and 2 Dermatology, IUSM, Indianapolis, IN
Cultured primary human keratinocytes were the first non-cancer derived cell type reported to pro-
duce the humoral hypercalcemia factor, PTHrP. Normal keratinocytes produce more PTHrP than
some squamous cell carcinoma cell lines. Emerging evidence suggests that only a subset of ker-
atinocytes produce high levels of PTHrP in vivo. It is likely that conditions associated with growth
in culture activate PTHrP gene expression in primary keratinocytes. In culture, keratinocytes pro-
duce a number of EGF-like ligands, as well as express the receptors for these ligands, the erbB fam-
ily receptors. To investigate the impact of erbB receptor signaling on PTHrP gene expression, pri-
mary human foreskin keratinocytes were treated with inhibitors of erbB1 (PD 153035) or erbB2 (AG
825) and subsequently stimulated with EGF. PTHrP gene expression was then assessed by quanti-
tative RT-PCR, RNase protection, and reporter gene assays. Stimulation of erbB1 by exogenous EGF
or endogenously produced EGF-like ligands accounts for more than 90% of PTHrP mRNA produced
by rapidly growing primary keratinocytes. In differentiated keratinocytes, both erbB1 and erbB2 sig-
naling stimulates PTHrP gene expression. ErbB-family dependant activation of PTHrP expression
was due to increased transcription of the PTHrP gene. This induced transcriptional activity was due
to the activation of the PTHrP P3 promoter and required the Ets transcription factor-binding site.
Future experiments will identify the specific ErbB1 ligand, second messenger pathway and Ets fac-
tor responsible for stimulation of PTHrP gene expression in human keratinocytes. These findings
suggest EGF-like ligand expression, overexpression of erbB receptors and the acquisition of specific
Ets factors may stimulate PTHrP production in hyperproliferative epidermal conditions as well as
epidermal tumors. 
0730
Interleukin-1 augments UV-induced apoptosis by different mechanisms
D Kulms, B Poeppelmann and T Schwarz Department of Dermatology, University Muenster,
Muenster, Germany
Treatment of KB cells with the death ligands FasL or TRAIL and irradiation with UVB, respectively,
induces apoptotic cell death. Prestimulation of KB cells with interleukin-1 (IL-1) which activates
the transcription factor nuclear factor kB (NFkB) was shown to protect cells from FasL- and TRAIL-
induced apoptosis via upregulation of the inhibitor of apoptosis proteins (IAP) c-IAP and x-IAP. In
contrast, UVB- induced apoptosis was significantly enhanced upon prestimulation with IL-1 and
coincided with a strong NFkB-mediated release of the proapoptotic cytokine tumor necrosis factor
a (TNFa) in the range of 100 pg/ml. No TNFa release occurred upon treatment of KB cells with IL-
1 plus either one of the death ligands. Surprisingly, costimulation of cells with 100 pg/ml TNFa and
UV resulted only in a rather weak enhancement of UV-induced apoptosis, indicating that other mech-
anisms besides TNFa release have to be involved in the apoptosis enhancing effect of IL-1. Semi-
quantitative PCR analysis revealed that NFkB-dependent transcription of c-IAP and x-IAP as well
as of FLIP (FLICE inhibitory protein), another anti-apoptotic protein, was significantly downregu-
lated by UV. This downregulation seemed to be critically dependent on UV-induced DNA-damage,
since it could be reversed by addition of liposomes containing the DNA repair enzyme photolyase.
Addition of IL-1 to UV-exposed cells caused a further downregulation of the antiapoptotic proteins,
thus explaining the enhanced death rate of UV-exposed cells in the presence of IL-1. Together, these
data demonstrate that IL-1 enhances UV-induced apoptosis in several ways, first by inducing the
secretion of TNFa and second by supporting the downregulation of antiapoptotic proteins. This fur-
ther indicates that the combination of IL-1 and UV can cause transcriptional up- (TNFa) and down-
regulation (antiapoptotic proteins) of different genes in parallel and thereby contribute to the same
biological effect, i.e. enhancement of apoptosis. 
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IL-6-type cytokines up-regulate expression of multi-drug resistance associated proteins in
NHEKs and dermal fibroblasts
A Dreuw,1,2 R Heise,2 S Joussen,2 D Hoeller,2 HF Merk,2 FK Jugert,2 HM Hermanns1 and
JM Baron2 1 Department of Biochemistry, RWTH Aachen, Aachen, NRW, Germany and 2
Department of Dermatology, RWTH Aachen, Aachen, Germany
Normal human epidermal keratinocytes (NHEK) and dermal fibroblasts have been shown to express
a cell-type specific pattern of influx and efflux transport proteins as well as extrahepatic cytochrome
P450 enzymes showing that these cells metabolize and excrete a variety of xenobiotics like drugs.
In this project we analysed the influence of IL-6-type cytokines on the expression of multidrug resist-
ance associated proteins (MRP1-5). Using RT-PCR, real-time PCR, cDNA microarrays and calcein
acetoxymethyl ester transportassays we were able to show that stimulation of NHEKs, HaCat ker-
atinocytes or human dermal fibroblasts with IL-6 in combination with its soluble IL-6 receptor (sIL-
6R) or Oncostatin M for 48 hours resulted in an upregulation of MRP-expression and activity. Incu-
bation of NHEKs with 20ng/ml IL-6 and 1 µg/ml sIL-6R for 48h revealed the upregulation of MRP1,
MRP3, MRP4 and MRP5 expression on the mRNA-level. Efflux activity of these cells was increased
by 70%. Expression of these genes was stronger upregulated in HaCat keratinocytes. Incubation of
dermal fibroblasts with IL-6/sIL-6R resulted in a 40% upregulation of MRP3 expression, efflux activ-
ity was upregulated by 60%. Incubation with Oncostatin M even resulted in a nearly 100% upregu-
lation of MRP3 expression in these cells. It is well known that several inflammatory skin diseases
like psoriasis show an enhanced expression of IL-6-type cytokines. Therefore the upregulation of
efflux drug transporters by these cytokines may have an important influence on pathogenesis and
treatment of these diseases. 
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The p75 neurotrophin receptor modulates apoptosis and differentiation in a subpopulation of
human keratinocytes
D Baracchi, A Marconi, M Pignatti, C Fila and C Pincelli Dermatology, University of Modena and
Reggio Emilia, Modena, Emilia-Romagna, Italy
The p75 neurotrophin receptor (p75NTR) belongs to the TNF-receptor superfamily and signals apop-
tosis in many cell settings. We have shown previously that human keratinocytes express p75NTR,
although its role has never been investigated. The aim of the present study was to analyze the pat-
tern of expression and the function of p75NTR in human keratinocytes. First, p75NTR is localized
in a minor subpopulation of basal keratinocytes as well as in suprabasal cells, with an irregular and
patchy pattern. Second, p75NTR mRNA is more expressed in keratinocytes slowly adhering (tran-
sit amplifying cells, TA) than in keratinocytes rapidly adhering (stem cells, KSC) to type IV colla-
gen. % p75NTR positive cells was higher in TA than in KSC, as evaluated by immunohistochem-
istry in situ. Moreover, p75 protein was more expressed in confluent than in subconfluent keratinocytes,
as shown by western blot. BDNF, which signals through p75NTR in keratinocytes, induces cell cycle
arrest in G2M. Moreover, BDNF (50-75-100 ng/ml) reduces keratinocyte growth in a dose- and time-
dependent (24-48-72 hrs) manner, as shown by the MTT assay (50 ng/ml, p< 0.05). BDNF also
induces keratinocyte apoptosis in a dose-dependent fashion (100 ng/ml, p<0.05 at 48 hrs), as shown
by TUNEL. Anti-p75 neutralizing antibody partially inhibits the BDNF-induced keratinocyte cell
death. Finally, p75NTR expression completely disappears in sections from psoriatic lesions. We spec-
ulate that p75NTR modulates apoptosis and possibly differentiation in a subpopulation of keratinocytes 
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Inhibition of the IFNγ-mediated Jak-STAT signaling pathway by iron chelators occurs via
down-regulation of the IFNγ receptor-1
AK Gira,1 KA Casper,1 SM Naik,1 SW Caughman1,2 and RA Swerlick1,2 1 Dermatology, Emory
University, Atlanta, GA and 2 Dermatology, Dept of Veterans Affairs Medical Center, Atlanta, GA
Interferon-gamma (IFNγ), a cytokine important in inflammation and cell cycling, mediates its effects
by binding to IFNγ receptor complex and activation of the Jak-STAT signaling pathway. Activation
of this cascade results in nuclear translocation of phosphorylated STAT1 homodimers that bind to
GAS motifs in the promoters of target genes, such as interferon regulatory factor 1 (IRF-1). Prior
studies by our laboratory have identified that IFNγ dependent transcription of IRF-1 in dermal endothe-
lial cells (HDMEC) requires iron. In this study, we investigated whether activation of the Jak-STAT
signaling pathway, an essential step in IFNγ mediated IRF-1 gene transcription, requires iron. IFNγ
treatment of HDMEC resulted in STAT1 activation and nuclear translocation as assessed by elec-
trophoretic mobility shift assay and supershift studies using IRF-1 promoter based oligonucleotides.
Pretreatment of HDMEC with the iron chelator dipyridyl (DP) inhibited IFNγ mediated complex
formation in a concentration- and time-dependent fashion. In contrast, DP pretreatment had no effect
on TNFα mediated activation and translocation of NF-kB. To assess if DP-mediated inhibition of
STAT1 DNA binding was due to decreased STAT1 activation, we measured levels of total and phos-
phorylated STAT1 protein by western analysis. IFNγ induced STAT1 phosphorylation was almost
completely inhibited by DP pretreatment, while not affecting total cellular STAT1 protein levels.
Removal of iron did not affect the expression of Jak1, Jak2, or IFNγ receptor 2, which are all nec-
essary for IFNγ mediated STAT1 activation. However, DP pretreatment downregulated the expres-
sion of IFNγ receptor-1 (IFNGR1) protein, the critical receptor chain mediating IFNγ ligand bind-
ing and Jak activation. These data provide evidence that iron is essential for IFNγ mediated cell
signaling via iron dependent expression of IFNGR1 and define a novel link between iron and immune
function. 
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Overexpression of wildtype transforming growth factor β1 (TGFβ1) in the epidermis of trans-
genic mice results in phenotypes that mimic psoriasis
AG Li,1 D Wang,1 X Feng2 and X Wang1 1 Otolaryngology, Dermatology, Cell & Dev. Biology,
Oregon Health & Science University, Portland, OR and 2 Surgery, Mol. Cell. Biology, Baylor
College of Medicine, Houston, TX
Psoriasis is an inflammatory skin disorder. Overexpression of TGFβ1, a growth inhibitor for ker-
atinocytes, has been found in psoriatic epidermis. This has been assumed to be a negative feedback
that counteracts with increased growth factors in psoriasis. We have developed transgenic mice over-
expressing wildtype TGFβ1 driven by a keratin 5 promoter (K5.TGFβ1wt). Surprisingly, these mice
displayed phenotypes that resembled psoriasis at macroscopic and pathological levels. Besides exhibit-
ing major characteristics of psoriasis, i.e., epidermal hyperplasia, inflammation and angiogenesis,
K5.TGFβ1wt skin showed additional psoriatic phenotypes that have not been found in other mouse
models for psoriasis. These include Koebner’s sign, basement membrane degradation and
microabcesses. Among these phenotypes, matrix metalloproteinases-mediated basement degrada-
tion appeared to be a key step towards a psoriasis-like inflammation in transgenic skin. Further-
more, K5.TGFβ1wt skin exhibited molecular changes that usually occur in psoriasis. IL-1, the pri-
mary pro-inflammatory cytokine, IL-8 (MIP-2 in murine), a hallmark chemokine in psoriasis, and
several other chemokines were upregulated in K5.TGFβ1wt skin. Increased angiogenesis accompa-
nied by the elevated expression of vascular endothelial growth factor and its receptor were found in
transgenic skin. Moreover, multiple kerationcyte growth factors were elevated in the dermis of trans-
genic skin. These include keratinocyte growth factor and insulin-like growth factor-1. Elevation of
these growth factors by the paracrine effect of TGFβ1wt apparently overcame the growth inhibitory
effect of the TGFβ1 transgene on keratinocytes and led to epidermal hyperplasia and hyperprolifer-
ation in K5.TGFβ1wt skin. Taken together, we provide evidence that TGFβ1 overexpression func-
tions as an initiator and coordinator in the development of a psoriasis-like skin disorder. 
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Effects of spingosine-1-phosphate on apoptosis of B16 melanoma cells
J Shin, W Kang and K Yoon Dermatology, Ajou University School of Medicine, Suwon, Kyungki-
do, South Korea
The bioactive sphingolipid metabolite sphingosine-1-phosphate (S1P) is the ligand for a family of
five G protein-coupled receptors, the Edg (endothelial differentiation gene) receptors, which includes
Edg -1, 3, 5, 6, and 8. Activation of these receptors by S1P regulates diverse processes, including
cell migration, angiogenesis, vascular maturation, heart development, and neurite retraction. A few
studies of the relationship between S1P and melanoma cells have been reported. They reported that
S1P inhibited motility of cultured melanoma cells. Melanocytes and melanoma cells are known to
be of neural origins. The effects of S1P on apoptosis of neural cells are diverse depending on the
cell line. There has been no report on the effect of S1P on melanoma cell growth. In present study,
we investigated in vitro the effects of S1P on B16 melanoma cell proliferation. For the first time, we
confirmed the expression of Edg-1, 3, and 5 on cytoplasm of B16 melanoma cells by Western blot
and immunocytochemistry methods. We observed the inhibitory effect of S1P on proliferation of
B16 melanoma cells by in vitro culture in a dose-dependent pattern. We also observed that S1P at a
dose of 10 µmol induced apoptosis of B16 melanoma cells by TUNEL assay. Currently we are
researching whether S1P induces the activation of caspases and JNK in order to confirm the signal-
ing pathway of apoptosis induced by S1P in B16 melanoma cell line. 
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Significance of immunohistochemical determination of HER-2/neu, CD117 (c-Kit) and vas-
cular endothelial growth factor expression in malignant melanoma
A Potti,1,2 K Sholes,1 N Moazzam,1 E Langness1 and SA Mehdi2,1 1 Division of Oncology, Veterans
Affairs Medical Center, Fargo, ND and 2 Department of Medicine and Division of Oncology, UND
School of Medicine and Health Sciences, Fargo, ND
HER-2/neu, a 185kd oncoprotein, is a recently identified therapeutic target in several solid tumors.
Similarly, currently, there exist target-directed therapies against CD117 (c-Kit) and vascular endothe-
lial growth factor (VEGF), both of which likely play a role in melanogenesis. To evaluate the role
of HER-2/neu, c-Kit and VEGF in malignant melanoma, we studied individual oncoprotein over-
expression in 202 subjects. An extensive chart review was performed to obtain demographic and
clinical data. In addition, overexpression of HER-2/neu (using the DAKO Hercep test), c-Kit (using
the rabbit polyclonal antibody A4502) and VEGF (utilizing the avidin-biotin-complex method) was
evaluated on paraffin-embedded tissue samples. 109 males (54%) and 93 females (46.0%) with a
mean age of 57 years (range: 15-101 years) were included in the study. Of the 202 specimens, only
2 (0.9%) revealed HER-2/neu overexpression, whereas 46 (22.8%) overexpressed c-Kit, and 42
(20.8%) specimens showed VEGF overexpression. Multivariate analysis (after adjusting for age, sex,
EC0G score, Breslow thickness, stage and therapy) did not show a survival difference between the
c-Kit positive and negative groups (p=0.36), and likewise between the VEGF positive and negative
patients (p=0.25). Interestingly however, c-Kit was more likely to be overexpressed in the superfi-
cial spreading type (63.0% of c-Kit positive samples). In contrast, VEGF was overexpressed pref-
erentially in amelanotic melanoma (33.3% of VEGF positive specimens). From our large study, it is
evident that HER-2/neu has no role in melanogenesis or melanoma therapy, and, despite the lack of
prognostic value, since 43.6% of melanoma specimens revealed either c-Kit or VEGF expression,
the therapeutic role of anti-VEGF monoclonal antibody therapy and/or signal transduction inhibi-
tion using tyrosine kinase inhibitors warrants further evaluation. 
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Global transcriptional responses of human keratinocytes to heat shock
M Blumenberg and P Gunjal Dermatology, NYU School of Medicine, New York, NY
While most cell types react in vitro to heat stress at the molecular level by activating a “heat-shock
response”, only the epidermal keratinocytes are the commonly a target of burns in humans in vivo.
To define the responses of human keratinocytes to heat-shock, we used large oligonucleotide microar-
rays that can measure transcription of 12,000 genes at once, and probed them with mRNAs from
heat-treated and control keratinocytes. We tested four time points, 1, 4, 24 and 48 hrs post-treat-
ment; each with a corresponding, untreated control. As expected, the heat-shock proteins are induced,
but we also observed in human keratinocytes a significant induction of genes involved in DNA repair,
cell cycle, the inositol phosphate pathway and coding for cytochromes. In contrast, the cornified
envelope components, translation factors and many cytoskeletal and nucleoskeletal proteins were
suppressed, as were the Ras and Rho pathway components. Interestingly, a large number of cell sur-
face receptors, as well as secreted protein factors are regulated by heat-shock, suggesting that ker-
atinocytes alert the surrounding tissue to the occurrence of heat damage. From these results, we
conclude that keratinocytes, when damaged by heat, elaborate an extensive program of self-protec-
tion and repair, but also alert the underlying tissue that a burn has occurred. 
0738
Involvement of extracellular regulated protein kinase in fibroblast by interleukin 6
S Shen,1,5 Y Chen,3 W Lee2,4 and C Hu1,5 1 Dermatology, Taipei Municipal Wan-Fang Hospital-
Affiliated to Taipei Medical University, Taipei, Taiwan, 2 Graduate Institute of Medical Sciences,
Taipei Medical University, Taipei, Taiwan, 3 Graduate Institute of Pharmacognosy Science, Taipei
Medical University, Taipei, Taiwan, 4 Dermatology, Taipei Medical University Hospital, Taipei,
Taiwan and 5 Dermatology, Taipei Medical University, Taipei, Taiwan
Keloids are characterized by the proliferation of fibroblasts and an increased accumulation of extrace-
cellular matrix, but no specific etiology has been identified for the pathogenesis of this disorder.
Interleukin-6 (IL-6) is an important immunoregulatory cytokine that has been implicated in a num-
ber of fibrotic autoimmune diseases such as scleroderma, interstitial nephritis, and pulmonary inter-
stitial fibrosis. However, the role of IL-6 in the development of keloids is still unclear. In this study,
keloid fibroblasts and NIH3T3 fibroblasts were stimulated by IL-6 in the presence or absence of
PD98059, a specific MAPK/ERK kinase-1 inhibitor, and proliferation rate was examined. The results
showed that IL-6, at dose of 60 ng/mL and 10 ng/mL, stimulated proliferation in keloid and NIH3T3
fibroblasts, associated with induction of ERK1/2 phosphorylation. Pretreatment of fibroblasts with
PD98059 showed dose-dependent inhibition on IL-6-induced proliferation and MAPK phosphory-
lation. However, p38 and JNK proteins were remained unchanged in IL-6 treated cells. These results
demonstrated that phosphorylation of ERK proteins were involved in IL-6-induced proliferation, and
suppression of MAPK phosphorylation might be beneficial in treatment of keloid. 
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Protein kinase C alpha associates with phospholipase D1 and enhances both basal phospholi-
pase D activity and invasive potential in a protein phospholylation-independent manner in
human melanoma cells
M Oka,1 T Kageshita,2 T Ono,2 T Kuroki3 and M Ichihashi1 1 Department of Dermatology, Kobe
University Graduate School of Medicine, Kobe, Hyogo, Japan, 2 Department of Dermatology,
Kumamoto University School of Medicine, Kumamoto, Kumamoto, Japan and 3 Gifu University,
Gifu, Gifu, Japan
It is well known that phospholipase D (PLD) plays a crucial role in the signal transduction of many
types of cells, and is activated by protein kinase C alfa (PKC alfa) when cells are stimulated. To elu-
cidate the role of PLD in melanoma,the mechanism of regulation of basal PLD1 activity by PKC
alfa was examined in a human melanoma cell line HM3KO using an adenovirus-mediated gene trans-
fer technique. Immunoprecipitation study showed that PLD1 and PKC alfa are associated physio-
logically in resting melanoma cells. Further immunoprecipitation study after adenovirus-mediated
simultaneous overexpression of PLD1 and PKC alfa, or PLD1 and the kinase-negative mutant of
PKC alfa revealed that both PKC alfa and the kinase-negative mutant of PKC alfa are associated with
PLD1 in melanoma cells in the absence of an external signal. Overexpression of PKC alfa or the
kinase-negative mutant of PKC alfa in melanoma cells by the adenovirus vectors resulted in the
enhancement of basal PLD activity in a viral dose-dependent manner. Furthermore, enhanced basal
PLD activity increased the in vitro invasive potential of HM3KO cells. These results suggest that
PKC alfa associates with PLD1 and enhances basal PLD activity in a protein phosphorylation-inde-
pendent manner via direct protein-protein interaction in melanoma cells, which contributes to high
invasive potential of cells. 
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Keratinocyte growth factor receptor is expressed in proliferating HaCaT cells and is down-
regulated by dithranol
S Csilla,1 M Szell,2,1 N Kopasz,3 A Pivarcsi,2,1 ZC Bata,1,2 L Kemeny1,2 and A Dobozy1,2 1
Department of Dermatology and Allergology, University of Szeged, Szeged, Csongrád, Hungary, 2
Dermatological Research Group of the Hungarian Academy of Sciences, University of Szeged,
Szeged, Hungary and 3 Department of Orthopedy, University of Szeged, Szeged, Hungary
Keratinocyte growth factor (KGF) is a paracrine modulator of keratinocyte growth. Both KGF and
its receptor, KGFR shows elevated levels of mRNA and protein expression in the hyperproliferative
skin disease, psoriasis. We studied the expression of KGFR in relation with keratinocyte prolifera-
tion and differentiation using synchronized HaCaT cell model system. The effect of dithranol on
KGFR expression was also investigated. HaCaT cells were synchronized by contact inhibition and
serum starvation then released from cell quiscence by passage and addition of serum. Using reverse
transcription PCR and Western blot techniques KGFR mRNA as well as protein levels were deter-
mined in the cultured cells after moved from cell quiscence in the cell cycle and started to differen-
tiate. Reverse transcription PCR reactions showed that KGFR mRNA expression considerably
increased in the proliferating cells. At the same time KGFR protein was not detectable in differen-
tiated only in proliferating HaCaT cells. These results suggest that KGFR expression is regulated
both at the transcriptional and post-transcriptional levels in HaCaT cells. Treatment with the differ-
ent concentrations of dithranol resulted in a dose-dependent decrease of KGFR both at the mRNA
and protein levels, suggesting that down-regulation of KGFR may be part of the effect of this antip-
soriatic agent. 
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IGF-II-mediated expression of angiogenetic factors VEGF and IL-8, and COX-2 in human ker-
atinocytes
T Kim and H Kim Dermatology-Immunology, Kangnam St. Mary, Seoul, South Korea
Cytokines upregulated in psoriasis include IGF-II, IL-6, IL-8, TGF-a and VEGF, which are pre-
sumably associated in the pathogenesis of psoriasis. To examine the relationship between the cytokines
involved in the angiogenesis, we monitored the expression of VEGF and IL-8 as well as an inflam-
matory factor COX-2 in the IGF-II treated human keratinocytes and explored the IGF-II signaling
pathways with respect to the expression of VEGF, IL-8 and Cox-2. IGF-II induced VEGF and Cox-
2 at the levels of mRNA and protein not only in the primary keratinocytes but also in HaCaT cells.
The elevated expression of VEGF, however, was abrogated when pretreated with inhibitors of tyro-
sine kinase, src and ERK, respectively, while inhibitors of PI3 kinase and PKC blocked to a less
degree the IGF-II mediated VEGF expression and the p38 inhibitor did not. Up-regulation of COX-
2 by IGF-II also disappeared in the cells pretreated with inhibitors of tyrosine kinase, src, PI3 kinase
and PKC, respectively. Electrophoretic mobility shift assay demonstrated that the nuclear extracts
from the IGF-II treated cells contained enhanced DNA binding activities for the NF-kB and the AP-
1 probes. Blocking the DNA binding activities of NF-kB and AP-1 diminished the levels of the IGF-
II stimulated induction of VEGF and COX-2. Moreover, the IL-8 induction by IGF-II was abolished
by inhibitors of tyrosine kinase, src, ERK and PI-3 kinase, respectively. These results suggest that
the induction of VEGF, IL-8 and COX-2 by IGF-II in the human keratinocytes may involve two sig-
naling pathways: the tyrosine kinase-src-ERK-AP-1 pathway and the PI3 kinase pathway. 
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The ultraviolet-B radiation-induced inhibition of interferon-gamma caused keratinocyte acti-
vation is independent of endogenous interleukin-10 and other soluble mediators but associated
with enhanced intracellular suppressor of cytokine signaling expression
R Sabat,3,2 M Friedrich,1 R Holzmann,1 H Piazena,1 W Sterry,1 K Wolk2 and K Asadullah2 1
Dermatology, University Hospital Charite, Berlin, Germany, 2 RBA Dermatology, Schering AG,
Berlin, Germany and 3 Institute of Medical Immunology, University Hospital Charite, Berlin,
Germany
Ultraviolet irradiation represents a well established treatment modality for inflammatory skin dis-
eases. The aim of this study was to investigate the mechanisms of UVB radiation (UVBR) induced
KC insentitivity towards IFN-g. Flow cytometric analyses indicated that UVBR temporarily inhibits
the IFN-g-caused activation of primary keratinocytes and HaCaT cells as measured by reduced ICAM-
1 and HLA-DR upregulation. Western blot experiments suggested that this is mediated by the UVBR-
induced inhibition of STAT-1 phosphorylation. Neither IL-10 neutralization nor IL-10 addition had
any effect on the UVBR-induced inhibition of IFN-g caused ICAM-1 expression on primary ker-
atinocytes or HaCaT cells. Furthermore the supernatant from UVB-irradiated cells failed to inhibit
the IFN-g-mediated ICAM-1 and HLA-DR upregulation in non-radiated HaCaT cells. Moreover
irradiated cells from whom the supernatant was withdrawn 4 hours after irradiation still showed a
diminished IFN-g-induced response after 24 hours. Thus no soluble but intracellular factors might
be involved in the UVBR-induced inhibition of IFN-g-caused KC activation. Therefore we ana-
lyzed the expression of members of the intracellular protein family of suppressors of cytokine sig-
naling (SOCS) molecules using a real-time PCR approach. We found a strong upregulation of SOCS
1 after UVBR with peak levels at 1 hour. Since SOCS molecules are known inhibitors of STAT
phosphorylation that is essential for IFN-g-induced ICAM-1 and HLA-DR upregulation, this may
explain the IFN-g unresponsiveness after UVBR. 
0743
Evidence that nitric oxide is an upstream mediator of FasL-mediated keratinocyte apoptosis
in toxic epidermal necrolysis
I Viard-Leveugle, J Saurat and LE French Dermatology, Geneva University Hospital, Geneva,
Switzerland
Toxic epidermal necrolysis (TEN or Lyell’s syndrome) is a severe adverse drug reaction that results
in extensive necrolysis of the skin due to large scale Fas-FasL mediated keratinocyte apoptosis. The
signaling pathways leading to the rapid upregulation of keratinocyte FasL expression in TEN are
unknown. Here we show that FasL and inducible nitric oxide synthase (iNOS), an enzyme that leads
to the production of the proinflammatory and cytotoxic molecule nitric oxide (NO), are coexpressed
in increased amounts by keratinocytes in lesional skin samples of TEN. In vitro, within 8 h of expo-
sure of keratinocytes to NO donors (NOC18 or SNP), a significant increase in FasL mRNA levels
and cell surface FasL could be detected. Cell surface FasL induced by NO donors was lytically active,
as within 8h both NOC 18 and SNP caused a 4-fold increase in keratinocyte apoptosis. The latter
was completely abolished by the caspase-8 inhibitor ZVAD, and significantly reduced by Fas:Fc
confirming that NO triggers rapid FasL-mediated keratinocyte cell death in vitro. Similarly, in an in
vitro model of human skin (EpiDerm TM, MatTek Corp.), NOC18 induced keratinocyte FasL expres-
sion, keratinocyte apoptosis and histopathological modifications reminiscent of those observed in
early biopsy specimens of TEN. In this model, keratinocyte apoptosis could be virtually completely
inhibited by the caspase-8 inhibitor Z-IETD-FMK. Taken together, our data show that iNOS via the
action of NO is likely to be an upstream trigger of FasL-mediated keratinocyte apoptosis in TEN. 
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Calcium (Ca++) signaling through a novel Ca++-binding protein in mouse keratinocyte dif-
ferentiation
M Hwang and M Morasso (SID) Developmental Skin Biology Unit, NIH/NIAMS, Bethesda, MD
The Ca++ signaling dependent systems, such as keratinocyte differentiation process, must be
responsive to rapid and transient variations in Ca++ concentration. A central role in the transduc-
tion of Ca++ signals is played by members of the Ca++-binding proteins. Calmodulin (CaM) is
the best studied of these signaling proteins that function as calcium sensors. Members of this sub-
family are small, acidic (PI 4-5) proteins that contain EF-hand motifs that bind Ca++. It is through
the binding of Ca++ by the EF-motifs that these sensor proteins are able to bind or liberate their
target interacting proteins and in this way modulate their function. Performing a Suppressive
Subtractive Hybridization (SSH) screen we obtained a partial cDNA clone (called B12) that has
homology to CaM-like proteins. Using a RACE protocol and a gene-specific oligonucleotide, we
obtained the full-length B12 cDNA. The ORF encodes a protein of 148 amino acid residues with
a PI of 4.59, predicted MW of 16.8 kDa and contains four conserved EF-hand motifs, predicted
to be Ca++-binding domains. The deduced amino acid sequence had 56% homology with mouse
CaM. Northern blot and in situ hybridization analysis showed restricted differential expression of
the B12 gene in the suprabasal layers of the epidermis. Furthermore, induction of B12 expression
was observed upon in vitro differentiation by Ca++ of primary cultured keratinocytes. The func-
tionality of B12 EF-hand domains was assayed with a radioactive Ca++-binding method, and the
quantitated data shows that B12 binds Ca++ ions 6.2 times more the CaM positive control used
in the experiments. Therefore, our preliminary data indicates that the B12 EF-hand motifs are func-
tional Ca++-binding domains. Ca++-binding proteins and CaM exert their role through specific
interaction with their target proteins. To identify B12 target protein we are performing a yeast II
hybrid screen. Identification of target proteins will help us understand the specific role of B12 dur-
ing keratinocyte differentiation. 
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Centaurin β ADP-Ribosylation Factor GTPase Activating Proteins identify novel cell mem-
brane domains in primary cultured keratinocytes
S Blakeley, MA Hawadle and TR Jackson Dermatology, University of Newcastle, Newcastle upon
Tyne, Tyne and Wear, United Kingdom
The ADP-Ribosylation Factor family of small guanine nucleotide binding proteins control mem-
brane trafficking events and regulate actin cytoskeleton mediated changes in cell morphology. β-cen-
taurins are multidomain proteins containing ARF-GTPase Activating Protein and phosphoinositide
binding Pleckstrin Homology (PH) domains. Centaurins β1 and β2 show phospholipid regulated
GAP activity with high selectivity for ARF6.  Confocal fluorescence microscopy of primary cultured
keratinocytes transfected with enhanced Green Fluorescent Protein-Centaurin β chimeras indicates
that these proteins are difusely distributed in the nucleus and cytoplasm of confluent cells. Dynamic
confocal imaging of cells cultured at lower densities and in the presence of growth factors show asso-
ciation of eGFP-centaurin β1 with lamellipodial membranes as well as intracellular circular and
tubulovesicular structures. Immunofluorescence confocal microscopy confirms that endogenously
expressed β-centaurins associate with the same subcellular structures in cells cultured at low den-
sity as well as in keratinocytes at the edge of monolayers following scrape wounding. These stud-
ies indicate a possible role for ARF and β centaurin signalling in the regulation of keratinocyte mor-
phological responses to wounding. 
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The epidermal platelet-activating factor receptor augments chemotherapeutic agent-induced
apoptosis in human carcinoma cell lines
M Al-Hassani, T Li, MD Southall, Q Yi, Y Pei, D Lewis, D Spandau and JB Travers Dermatology,
Indiana University, Indianapolis, IN
Most chemotherapeutic agents exert their cytotoxic effects in part through the induction of apopto-
sis. In addition, many chemotherapeutic agents are potent pro-oxidative stressors.  Although the lipid
mediator platelet-activating factor (1-alkyl-2-acetyl glycerophosphocholine; PAF) is synthesized in
response to oxidative stress, and many epidermal carcinomas express PAF receptors, it is not known
whether PAF is involved in chemotherapeutic agent-induced apoptosis. These studies examined the
role of the PAF system in chemotherapy-mediated cytotoxicity using model systems created by retro-
viral-mediated transduction of the PAF receptor-negative human epidermal carcinoma cell line KB
with the human PAF receptor (PAF-R), and ablation of the endogenous PAF-R in the carcinoma cell
line HaCaT with a retroviral-mediated tetracycline-inducible antisense PAF-R vector. The presence
of the PAF-R in these models resulted in an augmentation of apoptosis (as measured by caspase-3
induction and nucleosomal enrichment) induced by chemotherapeutic agents etoposide and mito-
mycin C, but not TRAIL or by C2 ceramide. The mechanism by which chemotherapeutic agents acti-
vate the epidermal PAF-R involved oxidative stress-induced PAF production, as this process was
inhibited by antioxidants, and expression of the fMLP receptor in KB cells did not affect chemother-
apeutic agent-induced apoptosis. PAF-R-mediated augmentation of chemotherapeutic agent-induced
apoptosis involved the transcription factor nuclear factor (NF)-B because etoposide and mitomycin-
C treatment of PAF-R-expressing cells resulted in increased levels of NFkappaB binding and pro-
moter activity. Moreover, NFkappaB pharmacological inhibitors and a super-repressor IkappaBM
mutant protein inhibited the PAF-R-mediated augmentation of chemotherapeutic agent-induced cyto-
toxicity. These studies provide evidence for a novel pathway whereby the epidermal PAF-R can
augment chemotherapy-induced cytotoxic effects through an NFkappaB-dependent process. 
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Co-operation of ZBP-89 and mitogen-activated protein kinase pathways in the enhancement
of matrix metalloproteinase-1 and -3 expression in dermal fibroblasts
NK Hieta,1 JL Merchant,3 J Han2 and V Kahari1 1 Centre for Biotechnology, University of Turku,
Turku, Turku, Finland, 2 Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI
and 3 Scripps Research Institute, La Jolla, CA
ZBP-89 is a widely expressed four-zinc finger transcription factor that binds to a variety of promoters
involved in growth regulation, e.g. type I collagen and stromelysin-1 (matrix metalloproteinase-3,
MMP-3). In many instances, ZBP-89 represses the promoter activity by opposing the effect of Sp1.
Here, we wanted to study the role of ZBP-89 in the regulation of collagenase (MMP-1) and MMP-
3 expression. In dermal fibroblasts, up-regulation of MMP-1 and MMP-3 by tumor necrosis factor-
α (TNF-α), but not by interleukin-1β (IL-1β), is enhanced by overexpressing wild-type ZBP-89.
Infecting dermal fibroblasts with an adenovirus for constitutively active MKK3b or MKK6b (p38
kinase) specifically activated p38 MAPK and up-regulated the expression of MMP-1 and MMP-3.
This up-regulation of MMP-1 and MMP-3 was further enhanced by co-infecting cells with wild-type
ZBP-89. Also the up-regulation of proMMP-1 and proMMP-3 production by constitutively active
MKK3b and MKK6b was enhanced by co-infection with wild-type, but not dominant negative, ZBP-
89. In contrast, the up-regulation of the expression of MMP-1 and MMP-3 by constitutively active
MEK (ERK kinase) was not altered by co-infecting cells with wild-type ZBP-89. No effect on type
I collagen expression was seen when cells were co-infected with constitutively active MEK1, MKK3b,
or MKK6b together with wild-type or dominant negative ZBP-89. These results suggest, that the
induction of MMP-1 and MMP-3 expression in dermal fibroblasts by p38 MAPK is mediated through
ZBP-89 transcription factor. 
0748
Identification of a cysteine proteinase from the itch-inducing plant Macuna pruriens
K Kounga, VB Reddy and EA Lerner Cutaneous Biology Research Center, Massachusetts General
Hospital, Boston, MA
The purpose of this study was to characterize substances from the itch-inducing plant M. pruriens.
Isolation of a pure itch-inducing substance could be used as a probe for itch receptors and lead to
new therapies for the treatment of pruritus. A putative itch ‘proteinase’ termed mucanain was described
as the active ingredient in the spicules of the seedpods of the cowhage plant M. pruriens by Shelley
and Arthur in the 1950s. This proteinase was not characterized further. We have obtained spicules
from M. pruriens and extracted material from the spicules under both acidic and alkaline conditions.
The extracts have been analyzed using a variety of biochemical approaches including HPLC and gel
electrophoresis. The spicules, extracts and the purified material lost activity at basic pH or boiling.
Pruritic activity appears to be maintained in the acidic extract and in one of several peaks from size-
exclusion HPLC separation. SDS-Page analysis of the total extract and the peaks from the size-exclu-
sion column revealed a major protein band of about 30 kDa in the active fraction. Proteinase activ-
ity was present in this fraction. This result suggested that, the active ingredient is not histamine but
rather a proteinase. N-terminal and mass spectrometry-based sequencing revealed the presence of a
cysteine protease. This proteinase may be a useful tool in determining the mechanism of itch. 
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The interleukin-6 cytokine system regulates epidermal wound repair in wild-type and IL-6-
deficient mice
X Wang,1 M Schunck,1 K Kallen,2 S Rose-John2 and E Proksch1 1 Dermatology, University of Kiel,
Kiel, Germany and 2 Institute for Biochemistry, University of Kiel, Kiel, Germany
Interleukin-6 (IL-6) is a pleiotropic cytokine that is involved in growth and differentiation in numer-
ous cell types and its synthesis is induced by IL-1 and tumour necrosis factor (TNF). In the skin it
is produced primarily by epidermal keratinocytes, whereas macrophages, Langerhans cells, and
fibroblasts in the dermis represents minor source of the cytokine. Increased levels of IL-6 have been
associated with a number of skin pathologies, such as psoriasis and lupus erythematosus. The tran-
scription factor Stat3 is activated by cytokines of the IL-6 family. In the present study we examined
the involvement of IL-6, soluble IL-6-receptor, and Stat3 in epidermal wound repair after experi-
mental permeability barrier disruption by tape-stripping. After barrier disruption in wild type mice
we found an increased expression of IL-6 and IL-6-receptor in the epidermis using immuno-histo-
chemistry at 0.5 to 5 h after treatment, peaking at 1 and 3 h, respectively. Stat3 tyrosine phosphory-
lation shown by western blotting was absent at 0.5 h, but induced at 1 h after barrier disruption. In
IL-6 deficient mice barrier repair after tape-stripping was significantly reduced at 1 to 24 h after
barrier disruption. The effect was reversed by topical application of recombinant IL-6. In wild type
mice topical application of IL-6 enhanced permeability barrier repair after wounding. Also, Hyper
IL-6, a complex of IL-6 covalently linked to the soluble IL-6 receptor, enhanced barrier repair. Top-
ical application of a soluble form of the signal transducing protein gp130, which has been shown to
act as an inhibitor of the agonist IL-6/sIL-6 receptor complex, delayed epidermal wound repair after
barrier perturbation. In summary, we found that the IL-6 cytokine system is critically involved in
epidermal wound repair. IL-6 may be used to enhance reepithelization in wound healing, whereas,
gp130 may be a useful novel therapeutic tool to block IL-6 response in diseased skin. 
0750
Oligonucleotides homologous to the telomeric 3’ overhang stimulate p21-dependent adaptive
responses to oxidative damage
MS Lee, M Yaar, MS Eller and BA Gilchrest Dermatology, Boston University School of Medicine,
Boston, MA
We reported that oligonucleotides homologous to the telomeric 3’ overhang (T-oligos) induce the
same protective responses as sublethal H2O2 exposure in human dermal fibroblasts (Fb): Fb treated
for 72 hrs with the T-oligo pTT display transient growth arrest, mRNA and protein induction of
Cu/Zn- and Mn-dependent superoxide dismutases (SODs), and resistance to oxidative damage as
determined by cell yields. We also showed that T-oligo effects are mediated in part by p53 and p21.
It is published that ROS participate in signal transduction, via activation of transcription factors or
modulation of enzyme activity, and that NADPH oxidases produce ROS in a p53- and p21-depend-
ent manner. We now report that Fb exposure to the T-oligo pGTTAGGGTTAG (40 µM) activates
p53, as determined by p53 phosphorylation on serine 15, by 24 and 48 hrs, with a 3-fold higher
response than that produced by pTT (100µM) (western blot). A dichlorofluorescein diacetate assay
revealed increases in ROS within 36 hrs of treatment with pGTTAGGGTTAG and pTT compared
to treatment with control oligonucleotides pCTAACCCTAAC and pCC or diluent alone (p<0.002).
The specific NADPH oxidase inhibitor diphenyliodonium chloride blocked ROS production and T-
oligo failed to induce ROS in p21-null mouse embryonic Fb as compared with wild-type control
cells. Within 48 and 72 hrs pGTTAGGGTTAG, but not pTT, modestly induced senescence-associ-
ated-Β-galactosidase staining, consistent with the ability of prolonged T-oligo treatment ( 7 days)
to induce Fb senescence. We conclude that in Fb, T-oligo effects depend on degree of homology with
the telomeric 3’ overhang as well as on length of treatment: only prolonged exposures lead to senes-
cence, while exposures of 72 hrs induce ROS levels in a p53- and p21-dependent manner and
induce the level of SOD enzymes. These data help elucidate adaptive responses to sublethal oxida-
tive stress mediated by low levels of ROS and the mechanism by which T-oligos mimic these responses
in the absence of initial injury. 
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Study of the involvement of Heregulin and HER family receptors of keratinocytes in epider-
mal tissue repair
IY De Potter, F Herphelin and YG Poumay Histology-Embryology, FUNDP (University of Namur),
Namur, Namur, Belgium
In human normal epidermis, Heregulin (HRG) and its heterodimeric receptors HER2/HER3 which
belong to the human EGF receptor (HER) family constitute a potent autocrine and/or paracrine sig-
naling system. Indeed, HRG is expressed by the non-differentiated keratinocytes of the basal layer,
while the receptors (HER2 and HER3) are mainly expressed by the more differentiated keratinocytes
of the suprabasal layers. During epidermal wound healing, keratinocytes near the wounded edge alter
their phenotype and rapidly initiate cell migration. In this study, we found that keratinocytes of the
wounded edge also regulate their expression of HRG and receptors, suggesting a role of this sig-
naling system in the reepithelialization process. In order to test this hypothesis, we analyzed the effect
of HRGalpha and HRGbeta on keratinocyte proliferation, differentiation and migration in serum-
free culture conditions. Firstly, we found that most HRG isoforms, especially HRGb, enhance the
proliferation of low density cultured keratinocytes. Secondly, although we have previously shown
that HRGb prevents commitment to keratinocyte differentiation, treatment of already committed dif-
ferentiating keratinocytes with HRGa or HRGb increases expression of the early differentiation
marker keratin 10. These results suggest that HRG may differentially regulate the keratinocyte phe-
notype. Thirdly, using phagokinetic tracks analysis, we found that HRGb enhances the migration of
isolated keratinocytes cultured on collagen I. Conversely, HRGa fails to promote the polymeriza-
tion of stress fibers. Together, our results suggest that the HRG-HER signaling system in epidermal
keratinocytes is involved in the control of the reepithelialization process, apparently acting on both
the control of the proliferation-differentiation balance and the migration process of keratinocytes. 
0752
4-tert-butylphenol and UVB stimulate distinct apoptotic pathways in human melanocytes
D Biddle,2 A Hanks,2 B Brouha1 and D Grossman1,2 1 Departments of Dermatology and
Oncological Sciences, University of Utah, Salt Lake City, UT and 2 Huntsman Cancer Institute,
University of Utah, Salt Lake City, UT
In previous studies we found that human melanocytes express a broad spectrum of apoptosis inhibitors
and are relatively resistant to most apoptotic stimuli, with the exception of the tyrosine analog 4-
tert-butylphenol (4-TBP). To investigate the mechanistic basis for melanocyte susceptibility to 4-
TBP-induced apoptosis, we examined apoptotic events and pathways in melanocytes optimally stim-
ulated with 0.9 mM 4-TBP or 1200 J/m2 UVB. For both stimuli, DNA fragmentation (assessed by
propidium iodide staining and flow cytometry) was detected by 24 hrs and was maximal by 48 hrs,
although the magnitude was far greater in cells treated with 4-TBP compared to UVB. There was
activation of upstream caspase-9 and terminal caspase-3 (as assessed by precursor loss and appear-
ance of cleavage fragments on Western blots) in both 4-TBP and UVB-treated cells, but activation
of upstream caspase-8 was seen only after UVB treatment. Apoptosis induced by both stimuli was
partially (50%) blocked by the pan-caspase inhibitor ZVAD. Interestingly, cells treated with 4-TBP
after 1 hr were non-adherent, and there was complete transposition of phosphatidylserine (deter-
mined by PE-Annexin V binding). Mitochondrial depolarization (JC-1 fluorescence shift) and release
of cytochrome c and Smac/DIABLO (Western blot) were also seen in 4-TBP-treated melanocytes
after only 1 hr. By contrast, melanocytes exposed to UVB generally remained adherent and did not
exhibit Annexin V binding until 24-48 hrs later. Similarly, mitochondrial depolarization and content
release did not occur in UVB-treated cells until after 24-48 hrs. These results suggest that despite
similar kinetics and partial caspase-independence of DNA fragmentation induced by 4-TBP and
UVB, distinct apoptotic pathways are stimulated. The susceptibility of melanocytes to 4-TBP-induced
apoptosis likely relates to the capacity of this compound, unlike UVB, to cause rapid cell detach-
ment, phosphatidylserine transposition and mitochondrial apoptotic events. 
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Serotoninergic and melatoninergic systems expressed in the skin
AT Slominski,1 A Pisarchik,1 B Zbytek1 and J Wortsman2 1 Pathology, University of Tennessee
Health Science Center, Memphis, TN and 2 Medicine, Southern Illinois University, Springfield, IL
We have shown in mammalian skin expression of genes for tryptophan hydroxylase, arylalkylamine
N-acetyltransferase and hydroxyindole-O-methyltransferase together with the corresponding enzy-
matic activities (FASEB J 10.1096/fj.0.1-0952fje; J Invest Dermatol 119,934-942). The enzymes are
arranged into pathways since serotoninergic and melatoninergic products were also detected, includ-
ing serotonin (5HT), N-acetylserotonin (NAS), melatonin (MT) and 5 methoxytryptamine (5 MTT)
in human skin and selected cultured skin cells (FEBS Lett 511,102-106). Currently we are showing
expression of genes coding receptors of a cutaneous serotoninergic/melatoninergic system in whole
human skin and in normal and pathologic cultured skin cells. Evaluation of 5HT, MT and MT-related
receptors (MRR) showed expression of the isoforms 5HT2B, 5HT7 and MT1 genes in almost all the
tested samples. Expression of other isoforms was less prevalent; 5HT2C, MRR and MT2 were rarely
detected. We also found novel isoforms for MT2, MRR and 5HT2B, and document RNA editing for
5HT2C. Testing for functional activity of these receptors with 5HT and MT (10-14 to 10-10 M)
showed variable effects depending on cell type and culture conditions. Thus, 5HT stimulated pro-
liferation of melanocytes in medium deprived of growth factors, while inhibiting cell growth in the
presence of growth factors. MT inhibiting apoptosis of HaCaT keratinocytes in serum-free media,
it also inhibited proliferation of cells cultured in medium supplemented with serum. MT also increased
fibroblasts survival in serum free medium. NAS and 5MTT were generally without effect on cell
proliferation. Thus, skin cells represent a target for the local serotoninergic/melatoninergic path-
way. 
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Delineating an insulin specific signaling pathway in skin proliferation: the role of protein kinase
C delta and transcriptional activation of STAT3
M Gartsbein,1 A Alt,1 T Kuroki,2 K Hashimoto,3 Y Hanakawa,3 K Nakajima4 and T Tennenbaum1
1 Faculty of Life Sciences, Bar Ilan University, Ramat Gan, Israel, 2 Gifu University, Gifu, Japan,
3 Ehime University, Ehime, Japan and 4 Osaka City University, Osaka, Japan
In our previous studies we identified a unique signaling pathway, which specifically mediates insulin
signaling in skin keratinocyte proliferation and involves PKCδ activation. In the present study we
have identified the role of the transcription factor STAT3 (Signal Transducers and Activators of Tran-
scription) in this pathway utilizing a model of skin keratinocytes in culture. STAT3 activation is a
multi-step process associated with STAT3 phosphorylation, dimerization, followed by nuclear translo-
cation and binding to target genes to induce transcription. It was found that in keratinocytes, PKCδ
but not other PKC isoforms expressed in skin is constitutivly associated with STAT3. Following
insulin stimulation, serine and tyrosine phosphorylation of STAT3 was induced followed by STAT3
nuclear translocation and transcriptional activation. Specifically, overexpression of PKCδ induced
STAT3 serine phosphorylation and its association with PKCδ. Inhibition of PKCδ activity by over-
expressing a PKCδ mutant, or pharmacological inhibition by rottlerin, abrogated insulin induced
activation of STAT3 and blocked STAT3 mediated proliferation. Moreover, overexpression of a STAT3
tyrosine mutant, inhibited insulin induced PKCδ activation and its association with STAT3. Finally,
In order to explore the significance of STAT3 serine phosphorylation to insulin signaling, a STAT3
serine mutant adenovirus was constructed. As expected, overexpression of STAT3 serine mutant
abrogated insulin induced STAT3 serine phosphorylation. However, in cells overexpressing the STAT3
serine mutant STAT3 activation was dramatically increased several folds above control levels. Over-
all, these results suggest a physical and functional link between PKCδ and serine phosphorylation
and activation of STAT3 in mediation of insulin-induced proliferation in skin keratinocytes. 
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Role of PKCδ and STAT3 activation in insulin signaling in skin keratinocytes
E Brener,1 M Gartsbein,1 T Kuroki,3 K Hashimoto,4 E Wertheimer2 and T Tennenbaum1 1 Faculty
of Life Sciences, Bar Ilan University, Ramat Gan, Israel, 2 Tel Aviv University, Tel Aviv, Israel, 3
Gifu University, Gifu, Japan and 4 Ehime University, Ehime, Japan
Insulin belongs to a family of insulin like growth factors associated with diverse biological actions.
Binding of insulin to the insulin receptor induces tyrosine phosphorylation and activation of the
receptor leading to recruitment and phosphorylation of the insulin receptor substrate (IRS) and ini-
tiation of the signaling cascade. Following phosphorylation and activation, IR and IRS become plat-
forms for other signaling molecules downstream of the Insulin signaling pathway. We have previ-
ously identified a novel pathway in keratinocyte proliferation which involves insulin induced activation
of PKCδ. Utilizing mouse primary keratinocytes we have further characterized the signaling cas-
cade associated with insulin stimulation of keratinocytes. In Insulin treated cells, IR and IRS1 are
tyrosine phosphorylated and activated in a dose and time dependent manner. In response to insulin
stimulation PKCδ physically associated with IR, but not with IRS1 or IRS2. Interestingly, overex-
pressing PKCδ induced maximal IR phosphorylation regardless of insulin stimulation. Furthermore,
overexpression of a dominant negative form of PKCδ abolished insulin induced tyrosine phospho-
rylation of IR. Insulin also induced PKCδ association with Signal Transducer and Activator of Tran-
scription (Stat3). As early as 5 minutes following insulin stimulation, Stat3 phosphorylation and
association with PKCδ was induced. Overexpressing wild type Stat3 or inhibiting Stat3 by overex-
pressing a dominant negative tyrosine mutant did not alter IR tyrosine phosphorylation in response
to Insulin. In contrast, overexpression of a Stat3 serine mutant induced constitutive phosphorylation
of IR, similarly to overexpression of PKCδ. In conclusion: PKCδ and Stat3 are down stream effec-
tors of the insulin-signaling pathway in skin keratinocytes. The ability of PKCδ and Stat3 to affect
phosphorylation of the IR suggests a role for PKCδ and Stat3 in upstream insulin signaling in skin
keratinocytes. 
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Ultraviolet irradiation induces epidermal growth factor receptor nuclear translocation in
human keratinocytes
Y Xu, Y Shao, JJ Voorhees and GJ Fisher Dermatology, University of Michigan, Ann Arbor, MI
Epidermal growth factor receptor (EGFR) plays a critical role in mediating ultraviolet (UV) irradi-
ation-induced signal transduction and gene expression in human keratinocytes (KC). EGFR activa-
tion results from increased phosphorylation on specific tyrosine residues in the C-terminal intracel-
lular domain. It has recently been reported that upon growth factor stimulation EGFR translocates
from the surface membrane to the nucleus, where it directly regulated gene transcription. We have
investigated the ability of UV irradiation to induce EGFR nuclear translocation in human KC. UV
irradiation (40mJ/cm2, UVB/A2) caused rapid nuclear translocation of EGFR. Significant accumu-
lation of EGFR in the nucleus was observed within 5 minutes of UV exposure. Maximal transloca-
tion occurred at 30 minutes post UV, and resulted in a 10-fold increase (n=5) in EGFR in the nucleus,
as determined by Western analysis of isolated nuclear extracts. Epidermal growth factor (EGF) also
caused EGFR nuclear translocation, but to a lesser extent (3-fold, n=5) than UV. Nuclear localiza-
tion of EGFR following UV irradiation or EGF was confirmed by immunofluorescence. Leptomycin
B (nuclear export inhibitor) did not alter UV-induced nuclear accumulation, indicating that the mech-
anism of nuclear localization did not involve reduced nuclear export. However, inhibition of UV-
induced EGFR tyrosine phosphorylation by the specific inhibitor PD169540 reduced nuclear translo-
cation 70%. To further explore the role of EGFR tyrosine phosphorylation, the effect of point mutation
of specific tyrosine residues on UV-induced EGFR nuclear translocation was examined. Mutation
of either tyrosine 1148 or tyrosine 1173 reduced nuclear translocation 70%, while mutation of tyro-
sine 1068 was without effect. These data demonstrate that UV irradiation stimulates rapid EGFR
nuclear translocation, which is dependent on phosphorylation of specific tyrosine residues. EGFR
nuclear translocation is a heretofore-unrecognized signaling pathway mediating UV-induced responses
in human KC. 
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The role of JAK3 and STAT3 in mastocytosis
I Chan and MD Tharp Department of Dermatology, Rush Presbyterian-St. Luke’s Medical Center,
Chicago, IL
The tyrosine kinase receptor KIT is essential for the growth and development of mast cells. Studies
have shown that a point mutation (816) in c-kit leads to tyrosine kinase autoactivation which has
been proposed as the cause of adult-onset mastocytosis. One strategy for treating mastocytosis focuses
on inhibiting the downstream KIT signaling pathways JAK3/STATs. Previous studies form our lab-
oratory have shown that the JAK3/STAT inhibitor Whi-p131 reduced the growth of two human mas-
tocytosis mast cell lines (HMC-1 and RMT) by 82±14% and 87±8% respectively. To study further
the functional role of the JAK3/STATs in mastocytosis mast cell growth, cellular extracts were ana-
lyzed for the presence of activated JAK3 and STATs by Western blots. While both cell lines expressed
significant amounts of JAK3, only low levels of STAT1, STAT5 and STAT6 were detected. How-
ever, both HMC-1 and RMT expressed high levels of the anti-apototic, phosphorylated STAT3 pro-
tein (ser727). Treatment of these cell lines with Whi-p131 for 4 hours failed to reduce the expres-
sion of either JAK3 or phosphorylated STAT3 despite the fact that this inhibitor greatly reduced the
growth of both mastocytosis cell lines. We conclude from these studies that Whi-p131 has the abil-
ity to significantly reduce the growth of mastocytosis mast cells; however, its mechanism of action
is yet to be defined. Nevertheless, this inhibitor may prove to be useful for the treatment of cutaneous
lesions of adult mastocytosis patients. 
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IL-7-diphtheria toxin fusion. DNA construction and expression
SV Shulga-Morskoy and B Rich Dermatology, Brigham and Women, Boston, MA
Constitutive expression of the IL-7 receptor is a prominent characteristic of cutaneous T cell lym-
phoma (CTCL), and it is detected in one third of the NCI-60 panel of tumor cell lines. This makes
the receptor an attractive target for fusion toxin therapy of cancer cells. Fusion toxins consist of a
high affinity ligand for a target cell surface receptors and toxin such as the A and B domains of diph-
theria toxin (DAB). DAB-IL2 selectively kills cells expressing the high affinity IL-2 receptor and is
used clinically for CTCL. A parallel toxin directed against the IL-7 receptor, DAB-IL7, has been made
in bacteria but it has been difficult to produce in sufficient quantity and quality to develop. A likely
reason for this is that bacterial methods for producing the toxin rely on denaturation and refolding:
IL-7 has 6 cysteines, which form 3 disulfides, while IL-2 has only 4 cysteines, which form 2 disul-
fides. To circumvent this we are attempting to engineer in mammalian cells to secrete active DAB-
IL7. We have isolated variants of several cell lines that are resistant to high concentrations of diph-
theria toxin and assembled expression constructs encoding DAB-IL7 and DAB-GFP that are suitable
for mammalian cells. Diphtheria toxin resistant cells transfected with DAB-GFP accumulate GFP
while toxin sensitive cells do not, demonstrating that diphtheria toxin can be made in mammalian
cells. We believe that this will prove efficient system for the production of active DAB-IL7, allowing
it to be tested in animal models of lymphoma. Characterization of DAB-IL7 produced in this system
is ongoing. 
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Conditionally active Raf1 and MEK1 inducibly alter epidermal growth and differentiation in
transgenic mice
F Scholl,1 P Dumesic,1 J Charron2 and P Khavari1 1 Dermatology, VA Palo Alto and Stanford
University, Stanford, CA and 2 Laval University, Quebec City, QC, Canada
A number of pathways exert important effects on epithelial growth and differentiation, including
the Ras/Raf/MEK/MAPK cascade. Recent work indicates that activation of oncogenic Ras in epi-
dermis promotes proliferation and opposes terminal differentiation, however, the role of the three
major specific Ras effector pathways, Raf/MEK/ERK, PI3K/Akt and RalGEF/Ral has not been
defined. To address this, we generated mice with conditionally active Raf1 and MEK1 in epidermis
via 4-hydroxytamoxifen (4OHT)-responsive C-terminal estrogen receptor fusions with Raf1 and
MEK1 kinases (K14-Raf:ER and K14-MEK1:ER mice, respectively). Induction of Raf1 and MEK1
activity in response to topical 4OHT was confirmed by enhanced phosphorylation of their down-
stream target MAP kinase (MAPKs ERK1 and ERK2). Epidermal hyperplasia and inhibited expres-
sion of some differentiation markers was observed with induction of both kinases. These changes
resembled those seen with Ras induction and indicate that Raf/MEK activation is sufficient to effect
these Ras-driven epidermal alterations. We next examined the necessity of specific members of the
Raf/MEK cascade for Ras action. Conditionally inducible epidermal Ras mice (K14-ER:Ras) were
crossed with MEK2 knock-out mice to test if MEK2 is required for Ras effects on epidermal growth
and differentiation. Induction of Ras in K14-ER:Ras/MEK2-/- mice led to proliferation and inhib-
ited differentiation that was indistinguishable in kinetics and magnitude to K14-ER:Ras/MEK2+/+
controls, indicating that MEK2 is dispensable for epidermal changes driven by oncogenic Ras. These
data indicate that induction of the Raf/MEK/ERK effector cascade is sufficient to mediate epider-
mal Ras effects on growth and differentiation and suggest that MEK1 and MEK2 are redundant in
this setting. 
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Involvement of adiponectin in the cutaneous wound healing process
Y Yamaguchi,1 H Nishizawa,3 T Funahashi,3 M Nishida,3 Y Nakatani,1,2 N Maeda,3 I Shimomura,4
S Kihara,3 T Kubo,5 G Kondoh,2 J Takeda,2 S Itami,1 K Yoshikawa1 and Y Matsuzawa3 1
Department of Dermatology, Graduate School of Medicine, Osaka University, Suita-shi, Osaka,
Japan, 2 Department of Internal Medicine and Molecular Science, Graduate School of Medicine,
Osaka University, Suita-shi, Osaka, Japan, 3 Department of Medicine and Pathophysiology,
Graduate School of Medicine, Osaka University, Suita-shi, Japan, 4 Department of Plastic Surgery,
Graduate School of Medicine, Osaka University, Suita-shi, Japan and 5 Department of Social and
Environmental Medicine H3, Graduate School of Medicine, Osaka University, Suita-shi, Japan
Adipose tissue secretes complement factors, growth factors and cytokines and participates in self-
defense responses. Adiponectin is a secretory protein exclusively produced by adipocytes. Here, we
investigated the role of adiponectin in cutaneous wound healing. In humans, adiponectin was over-
expressed in adipose tissue beneath the epithelial tongue of acute wounds. Mice lacking adiponectin
showed retardation of the wound healing process characterized by poor reepithelialization and
increased granulation tissue, compared with the wound of wild type littermates. In cultured ker-
atinocytes, adiponectin enhanced the phosphorylation of ERK1/2 and promoted proliferation and
migration of keratinocytes in a dose-dependent manner. Our results suggest adiponectin participates
in the normal wound healing process. 
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Microarray analysis of temporal changes in gene expression induced by TGFβ1 in the mouse
skin
AB Glick and A Ryscavage Laboratory of Cellular Carcinogenesis and Tumor Promotion,
National Cancer Institute, Bethesda, MD
Transforming growth factor beta 1 (TGFβ1) is an important regulator of epidermal growth and home-
ostasis. Elevated expression of this cytokine occurs frequently in a variety of pathological conditions
including cancer, in the skin and other epithelial tissues. We have utilized cDNA microarray analy-
sis in conjunction with a conditional expression model to examine patterns of TGFβ1-induced gene
expression in the intact normal epidermis. In this model active TGFβ1 is induced in the epidermis
of mice transgenic for both a keratin 5 promoter driven rTA and a tetOTGFβ1 cassette by the addi-
tion of doxycycline. RT-PCR analysis of RNA isolated from whole skin shows that within 24 hrs of
addition of doxycycline, TGFβ1 transgene mRNA is induced to near maximal levels. We have used
NCI mouse cDNA microarray slides containing 10,000 features to examine the transcriptional response
to elevated TGFβ1 at specific times after transgene induction. At each time point RNA was isolated
from the skin of 4 double and single transgenic mice from which the underlying muscle and fascia
had been removed. At least 4 comparisons from independent samples were done for each time
point. We observed 3 major patterns of gene expression in response to TGFβ1: genes that were rap-
idly but transiently induced or repressed at 24 hrs, genes whose induction or repression was sus-
tained over multiple time points, and genes with a delayed induction pattern. As expected known
TGFβ1 responsive genes were identified within the differentially regulated gene set. In addition, epi-
dermal differentiation markers such as keratins 3, 4 and 10, filaggrin and sprr were rapidly down-
regulated while muscle differentiation markers were induced.  There were significant changes in
genes involved in cell adhesion, gap junction formation, and extracellular matrix. These results point
to complex temporal patterns of gene expression in response to TGFβ1 in vivo and suggest that this
type of analysis will provide important information on the mechanism of TGFβ1 based pathologies. 
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SIRKO-the skin specific insulin receptor knockout mouse
E Wertheimer,1 R Shapira,2 S Maoz,1 C Kahn,3 J Takeda,4 T Tennenbaum5 and G Sizyakov1 1 Tel
Aviv University Sackler Medical School, Tel Aviv, Israel, 2 Mount Scopus hospital, Jerusalem,
Israel, 3 Joslin Diabetes Center, Boston, MA, 4 Osaka University, Osaka, Japan and 5 Bar Ilan
University, Ramat Gan, Israel
Impaired wound healing in diabetes is associated with high morbidity and mortality rates. However
the pathogenesis leading to this complication is not known. Previously we have demonstrated direct
involvement of insulin in regulation of normal skin physiology and shown that lack of insulin recep-
tor (IR) expression leads to abnormal skin proliferation and differentiation. However direct investi-
gation of the involvement of the IR in wound healing in vivo was not possible since the IR null mice
available die within 5-7 days after birth. To resolve this problem we developed the epidermal skin-
specific insulin receptor knockout mouse (SIRKO) driven by matings of IRflox and K5Cre mice.
The SIRKO mice exhibit an epidermal-specific reduction (> 95%) in receptor content and early sig-
naling events. This was associated with changes of the epidermis that appeared flatter and thinner
compared to the wild type skin. Similarly to the skin cells of the IR whole body knockout mouse,
the SIRKO skin cells exhibited impaired differentiation both in vivo and in vitro. However the strik-
ing change was seen in the dermis of the SIRKO mice. While there was no change in the IR content
in the dermal fibroblasts, there was a progressive thickening of the dermis due to increase in closely
packed collagen bundles and the disappearance of the subdermal adipose tissue. In wound-healing
studies being conducted, deterioration in the strength of the healed wound is detected.  These results
suggest that insulin signaling in skin keratinocytes is essential for normal skin function and fur-
thermore, impairment in its function might contribute to the impaired wound healing process char-
acteristic to diabetes. 
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Downstream signaling pathways that mediate protein kinase C-dependent keratinocyte cell
death—a novel p38δ/ERK1/2 complex
T Efimova1 and RL Eckert1,2 1 Physiology and Biophysics, Case Western Reserve University,
Cleveland, OH, 2 Oncology, Case Western Reserve University, Cleveland, OH and 3 Dermatology,
Case Western Reserve University, Cleveland, OH
It is thought that several protein kinase c (PKC) isoforms function as master controllers regulating
the processes that determine keratinocyte survival, death and differentiation. As such these kinases
are pivotal regulators of keratinocyte function. Despite this realization, the downstream signaling
pathways that mediate this action have not been clearly defined. Our present studies implicate sev-
eral mitogen-activated protein kinases (MAPKs) as downstream carriers of the death signal. Expres-
sion of PKCδ in keratinocytes causes limited cell death; however, co-expression with p38δ MAPK
produces profound alterations in cell appearance, including nuclear shrinkage, cell rounding, cell
detachment, and enhanced cornified envelope formation. Annexin V/propidium iodide staining and
Hoescht staining confirm induction of apoptosis. PARP degradation and procaspase-3 cleavage is
also observed. This highly reproducible response is absolutely specific for the PKCδ/p38δ combi-
nation, and is not observed when p38δ is replaced by p38α, or other PKC isoforms are substituted
for PKCδ. At the MAPK kinase level, this response is reproduced by co-expression of MEK6 with
p38δ, and not when MEK3 or MEK1 are substituted for MEK6. Moreover, a reduction in ERK1/2
activity appears to be an integral requirement for cell death, since PKCδ/p38δ co-expression reduces
ERK1/2 activity, and expression of constitutively-active Raf-1, which reactivates ERK1/2, prevents
cell death. These findings suggest that a PKCδ triggers keratinocyte death by activating MEK6 which,
in turn, activates p38δ. We further provide evidence that a p38δ and ERK1/2 exist as a complex and
that p38δ may directly influence ERK1/2 activity. These results indicate that PKCδ triggers cell death
by tilting the balance of p38δ and ERK1/2 activity in favor of p38δ. 
0764
Endogenous TGF-β and endothelin differentiate human skin fibroblasts into myofibroblasts
in keratinocyte co-culture: counter-regulation by endogenous IL-1
P Shephard,1 G Martin,2 G Brunner,2 S Smola,3 T Krieg1 and H Smola1,4 1 Dermatology, University
clinic of cologne, Cologne, NRW, Germany, 2 Virology, University clinic of cologne, Cologne, nrw,
Germany, 3 Tumour biology, Fachklinik Hornheide, University of Muenster, Muenster, Germany
and 4 Nestle Research Center, Lausanne, Switzerland
Epithelial-mesenchymal interactions are crucial to skin development, homeostasis and wound heal-
ing. In the latter, dermal fibroblast (DF) derived growth factors are know to contribute significantly
to the regulation of keratinocyte behaviour, yet the influence of keratinocytes on DF metabolism
remains largely unknown. We have used several co-culture and read-out systems to systematically
investigate the influence of keratinocytes on DFs: cDNA microarray screening yielded over 100
genes differentially regulated in DFs upon co-culture with keratinocytes. Numerous extracellular
matrix and smooth muscle cell associated genes were strongly up-regulated, suggesting a differen-
tiation into myofibroblasts (MF). We confirmed this by analyzing the expression of the MF marker,
α-smooth muscle actin (SMA). MF differentiation required time and close proximity between ker-
atinocytes and DFs. Exogenous growth factors were dispensable, however, MF differentiation required
both endogenous TGF-β and endothelin activity: TGF-β neutralizing mAb and an endothelin recep-
tor antagonist abolished SMA induction. Accordingly, TGF-β production and activation were increased
in co-culture, as were endothelin 1 protein and mRNA transcripts in co-cultured DFs. Blocking ker-
atinocyte derived IL-1 with IL-1ra, we could show an unexpected SMA induction in co-cultures. The
NFkB binding activity is increased in co-cultured DFs, possibly inhibiting TGF-β mediated tran-
scription. Indeed, addition of exogenous IL-1 abrogates SMA induction in co-cultured DFs and in
DFs stimulated with TGF-β1. In summary, co-culture with keratinocytes effectively differentiates
DFs into MFs via a complex interplay of positively and negatively acting factors. 
0765
Requirement of Akt/PKB for PDGF-BB-, but not collagen-, induced migration of human der-
mal fibroblasts
JH Fan,1 S Patrick,1 M Chen,1 N Hay,2 DT Woodley1 and W Li1 1 Dermatology and The Norris
Cancer Center, University of Southern California, Los Angeles, CA and 2 Microbiology, University
of Illinois at Chicago, Chicago, IL
Extracellular matrices (ECMs) and growth factors (GFs) are the two main extracellular cues that
directly influence the decision of a cell to move or stop. The optimal migration of human dermal
fibroblasts (HDFs) is driven by a collagen matrix and platelet-derived growth factor-BB (PDGF-BB)
in vitro. To understand the mechanisms of collagen and PDGF-BB signaling, we investigated the
role of Akt/PKB, a prominent downstream target for the PI-3K pathway. Both PDGF receptor and
integrin activate PI-3K. We found that PDGF-BB, but not collagen stimulation potently activated
Akt in HDFs as detected by anti-phospho-Akt antibodies. Using lentiviral infection to achieve over
95% gene transduction efficiency in primary HDFs, we studied if Akt is required for collagen and
PDGF-BB-stimulated HDF migration. The cells were infected with lentivirus carrying either a
dominant negative (Akt-K179M) or a constitutively active (Myr-Akt) mutant of human Akt1. West-
ern blot analysis showed that the level of the exogenously expressed Akt was 5-7 fold higher than
that of endogenous Akt (including Akt1, 2, 3). The results showed that the dominant negative mutant,
but not the wild type Akt, completely blocked PDGF-BB-stimulated migration, whereas it had lit-
tle effect on collagen initiation of migration. Activation of Akt appeared to be necessary but not suf-
ficient for PDGF-BB to stimulate HDF migration since overexpression of the constitutively active
Myr-Akt had no significant stimulatory effect. Furthermore, while participation of all three major
mitogen-activated protein kinase cascades, ERK1/2, p38 and JNK, were implicated in PDGF-stim-
ulated HDF migration, blockade of Akt signaling selectively inhibited the PDGF-BB-stimulated p38
activation. This suggests that the ERK1/2 and JNK pathways act in parallel with the Akt-p38 path-
way to mediate the PDGF-BB signaling. In conclusion, this study elucidates the role of Akt and its
mechanism of action in PDGF-BB-stimulated migration of HDFs. 
0766
Focal adhesion kinase but not Src plays an important role in human keratinocyte migration
D Sawcer, JH Fan, M Chen, W Li and DT Woodley Dermatology and The Norris Cancer Center,
Umiversity of Southern California, Los Angeles, CA
Signals from extracellular matrices (ECMs) and serum growth factors (GFs) are the two main extra-
cellular cues that control human keratinocyte (HK) migration. We previously showed that ECMs,
but not GFs, can initiate migration. However, along the ECM-induced migration is partial and non-
directional. We hypothesized that the interaction of HKs with ECM is permissive to migration. The
ECMs signals then work in concert with GFs to optimize motility. In this study, we further investi-
gated these dual signaling pathways. We focused upon focal adhesion kinase (FAK) and pp60Src,
two protein tyrosine kinases known to be important for integrin signaling and also linked to the
growth factor receptor signaling. We found that FAK and Src are rapidly activated in HKs migrat-
ing on collagen in the presence of GFs. As expected, blockade of FAK signaling by FAK dominant
negative mutants (R454, F397Y and FRNK) significantly decreased tyrosine phosphorylation of Src.
However, over expression of kinase-inactive Src had little effect on the activation of FAK in the same
cells. To study the importance of FAK and Src in HK migration, we inhibited either FAK or Src sig-
naling by infecting cells with lentiviral vectors containing the three FAK mutants or a kinase-inac-
tive Src mutant. The cells were then subjected to a colloidal gold migration assay on a collagen
matrix. We found that all three FAK mutants, but not their wild type (wt) counterpart, potently blocked
both collagen-initiated and GF-stimulated HK migration. In contrast, neither the wt nor the kinase-
inactivated mutant of Src had any significant effect. Taken together, this is the first report that directly
addresses the roles of FAK and Src in HK migration. We conclude that FAK and Src play distinct
roles. 
0767
E-cadherin can inhibit activation of receptor tyrosine kinases and transformation by onco-
genes
X Qian,1 A Sheppard,1 W Vass,1 T Karpova,2 J McNally2 and DR Lowy1 1 Lab Cell Oncol, Natl.
Cancer Inst., Bethesda, MD and 2 Lab Recep Biol & Gene Express, Natl Cancer Inst, Bethesda,
MD
The purpose of this study was to identify mechanisms by which the tumor suppressor gene E-cad-
herin, which is required for normal development and is frequently down-regulated in epithelial tumors
and melanomas, negatively regulates cell growth. We here present evidence that endogenous E-cad-
herin can inhibit mitogenic signaling from receptor tyrosine kinases (RTK), including EGFR, IGF1R,
and Met, by impairing the response of RTKs to their cognate ligands. E-cadherin was found to form
stable complexes with RTKs. In confluent cells, complex formation was associated with reduced
RTK mobility within the plasma membrane, as determined by FRAP (fluorescence recovery after
photobleaching), and lowered the efficiency of ligand-induced RTK dimerization and activation.
These effects, which can be abrogated by an E-cadherin function blocking antibody, appear to be
specific for RTKs, as E-cadherin did not inhibit signaling via G-protein coupled receptors. Results
from colon cancer cell lines carried out by other laboratories have attributed most of the growth
inhibitory activity of E-cadherin to the ability of its C-terminus to bind and sequester beta-catenin.
However, we have found with several other cell types (kidney epithelial cells, melanocytes, and
fibroblasts) that E-cadherin can form complexes with RTKs and inhibit RTK signaling even with-
out beta-catenin binding, since these functions are retained by E-cadherin premature termination
mutants that are deficient for binding beta-catenin. In these cell types, E-cadherin wild type and pre-
mature termination mutants can inhibit cell transformation by ras and src oncogenes, presumably
because full transformation depends on the activation of RTK pathways via serum factors and autocrine
factors. Thus, the ability of E-cadherin to suppress RTK signaling has implications for normal and
abnormal cell growth. 
0768
Lysophosphatidic acid-induced EGF receptor internalization in human keratinocytes depends
on metalloproteinase activity
SW Stoll,1 S Kansra1 and JT Elder1,2 1 Dermatology, University of Michigan, Ann Arbor, MI and 2
VA Medical Center, Ann Arbor, MI
Several recent reports showed that transactivation of the ErbB1 by G protein-coupled receptor (GPCR)
ligands requires metalloproteinase (MP) activity in several cell types. However, this process has not
previously been studied in normal human keratinocytes (NHK). Therefore, we asked whether the
GPCR ligands lysophosphatidic acid (LPA) and carbachol could also induce transactivation of ErbB1
in NHK, and whether this process could be blocked by inhibitors of MP activity. NHK were grown
until 40-50% confluent followed by incubation in growth factor-free basal medium for 48 h. Cells
were then treated with LPA, carbachol or EGF for various times in the presence or absence of the
ErbB1 receptor tyrosine kinase inhibitor (RTKI) PD158780 (1 uM) or the MP inhibitor BB2516 (20
uM). After fixation, NHK were stained with anti-ErbB1 antibodies and analyzed by immunofluo-
rescence microscopy. ErbB1 showed a well-defined cell surface staining in untreated NHK. Treat-
ments with EGF (10 min) or LPA (15 min) rapidly led to the internalization of ErbB1 as evidenced
by the development of punctate intracellular staining. Preincubation of NHK with ErbB RTKI
PD158780 blocked both EGF- and LPA-induced internalization, whereas the MP inhibitor BB2516
blocked LPA-induced, but had no effect on EGF-induced internalization. In contrast to LPA, an alter-
native GPCR ligand carbachol had no effect on ErbB1 internalization in NHK. Consistent with
rapid degradation of internalized receptors, we have consistently observed a marked (30-50%) decrease
of ErbB1 protein in NHK after 10 min of EGF stimulation. This decrease can be blocked by pre-
treatment of the cells with PD158780. These data indicate that metalloproteinase-dependent trans-
activation of ErbB1 by selective GPCR ligands such as LPA leads to rapid internalization of ErbB1. 
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p38 mitogen-activated protein kinases (MAPKs) mediate ultraviolet B (UVB)-induced COX-
2 expression and inflammation in the skin of SKH-1 hairless mice
AL Kim, Y Zhu, DR Bickers and M Athar Department of Dermatology, Columbia University, New
York, NY
MAPKs are a family of serine/threonine protein kinases including extracellular signal-regulated pro-
tein kinases (ERK), p38 MAP kinase (p38), and c-Jun NH2-terminal kinases (JNK). Signaling
pathways involving MAP kinases respond to various cytotoxins and environmental stresses includ-
ing solar radiation. UVB is a potent environmental carcinogen and a known risk factor for human
non-melanoma skin cancers (NMSC). UVB increases p38 activities, and a p38 inhibitor abrogates
UVB-induced COX-2 expression in human epidermal keratinocytes. Recently, we showed that COX-
2 is up-regulated during UVB-induced skin carcinogenesis in SKH-1 hairless mice. In this study we
assessed the effects of UVB on the p38-MAP kinase signaling pathway and determined whether
COX-2 over-expression in the skin of UVB-irradiated SKH-1 mice is downstream of this kinase.
SKH-1 mice were irradiated with a single erythema dose of UVB (360 mJ/cm2), and epidermal
homogenates evaluated for p38 MAP kinase activity. UVB induced phosphorylation of p38 and its
upstream kinases MKK3/6 in a time-dependent manner. Phosphorylation of MAPK activated pro-
tein kinase 2 (MAPKAPK-2) was also detected at both Thr222 and Thr334 residues. This increase
in phospho-MAPKAPK-2 correlated with an increase in kinase activity. MAPKAPK-2 activation
also resulted in phosphorylation of heat shock protein (hsp27), an endogenous substrate. UVB-
induced activation of the p38 MAPK cascade was inhibited by pre-treatment with a single dose of
SB-242235, a known inhibitor of this kinase prior to UVB irradiation. SB-242235 abolished MAP-
KAPK-2 kinase activity as well as phosphorylation of hsp27. UVB-induced COX-2 over-expres-
sion was simultaneously inhibited as were the pro-inflammatory cytokines IL-6 and IL-8 by SB-
242235 treatment. Our data demonstrate that UVB activates epidermal p38 MAPK and COX-2
over-expression. Inhibitors of p38 may offer a novel approach to cancer chemoprevention by dimin-
ishing UVB-induced inflammation and modulating tumor promotion. 
0771
Homeobox factors HOXA7 and HOXA5 exhibit differential regulation of keratinocyte growth,
differentiation, and apoptosis
P LaCelle and L Parker Dermatology, Box 697, University of Rochester School of Medicine,
Rochester, NY
Homeobox transcription factors regulate differentiation and cell fate during development, and in tis-
sues undergoing continuous renewal through proliferation and differentiation. We have reported
that HOXA7 inhibits differentiation in transfected primary human keratinocytes. Paralogous mem-
bers of the Class 1 homoeobox (HOX) transcrition factor family, as well as the products of neigh-
boring HOX genes, appear to share overlapping, and perhaps synergistic function. In addition, both
HOXA7 and HOXA5 exhibit downregulation in keratinocytes induced to differentiate. We therefore
have initiated a comparison of HOXA7 and HOXA5 function in human keratinocytes. A set of ade-
noviral vectors was prepared containing the HOXA7 and HOXA5 full-length cDNAs, or truncated
5’ cDNA fragments lacking code for the homeobox DNA-binding region, each in the forward and
reverse orientations. The viral vectors contain tandem cytomegalovirus promoter-driven cassettes
for simultaneous eGFP and HOX expression, allowing viral titration by GFP fluorescence. As seen
previously in transiently-transfected keratinocytes, adenoviral HOXA7 expression inhibited transg-
lutaminase type 1 gene transcription, as a marker of differentiation, and antisense HOXA7 expres-
sion resulted in stimulation of transglutaminase 1 expression. Interestingly, exogenous HOXA5
expression also downregulated the transglutaminase type 1 gene. Both HOXA7 and HOXA5 over-
expression triggered an increased rate of apoptosis absent from cells harboring the antisense con-
structs. This activation of cell death appeared to require the DNA-binding homeodomain. However,
HOXA7-transduced cultures nevertheless exhibited increased cell numbers. Antisense HOXA5
expression stimulated proliferation, an effect not seen with antisense HOXA7 expression. These
results suggest that in undifferentiated human keratinocytes, both HOXA7 and HOXA5 are poten-
tial inhibitors of differentiation, but that endogenous HOXA7 suppresses differentiation, while endo-
geous HOXA5 acts to limit cell growth. 
0773
Transgenic mice overexpressing the calcium sensing receptor express aberrant epidermal dif-
ferentiation
K Turksen and T Troy Hormones Growth and Development, Ottawa Health Research Inst., Ottawa,
ON, Canada
The regulation of growth and differentiation by calcium (Ca++) is fundamental in cell physiology.
However despite much progress in elucidating Ca++ sensitive signalling pathways, many details
coupling changes in Ca++ to biological or developmental outcomes are missing. Epidermal cells
are one cell type in which Ca++ exerts a marked effect on growth and differentiation, however it is
not understood how the cells “feel” the changes in Ca++ and initiate the differentiation process. The
recent identification of the calcium sensing receptor (CaSR), a member of the G protein-coupled
receptor family led us to ask what role it might play in epidermal differentiation. We therefore engi-
neered transgenic mice with the CaSR overexpressed via the keratin 14-(K14) promoter, which drives
expression in the basal layer. The transgenic mice displayed abnormalities in epidermal differenti-
ation with strikingly accelerated hair growth. Changes in differentiation were clearly manifested bio-
chemically as detected by aberrant expression of late epidermal differentiation markers, including
K1, filaggrin, loricrin, transglutaminase-3, and involucrin. These results provide new insights into
the role of CaSR in epithelial differentiation and hair formation. This work was supported by grant
from NSERC of Canada. 
0772
Srcasm activates src-family tyrosine kinases in vivo and modulates EGF-dependent signaling
pathways
W Li, L Mei, D Shurman and J Seykora Department of Dermatology, University of Pennsylvania,
Philadelphia, PA
Srcasm: Src activating and signaling molecule, is a substrate and in vitro activator of Src-family tyro-
sine kinases (SFKs). In this study, we demonstrate that Srcasm activates Fyn, a Src-family kinase,
in vivo and modulates the activation of molecules associated with EGF receptor signaling.  Co-trans-
fection of COS cells with Fyn and increasing amounts of Srcasm results in correspondingly higher
levels of Fyn phosphorylated at tyrosine 416, which indicates the amount of activated kinase.  To
examine the effects of Srcasm on SFK regulated signaling pathways, COS cells were tranfected
with Srcasm and the levels of tyrosine phosphorylated EGF receptor were determined by western
blotting. In quiescent and EGF stimulated cells, Srcasm promoted EGF receptor tyrosine phospho-
rylation. In addition, immunofluorescence studies demonstrate that Srcasm co-localizes with Fyn
and EGF receptor. The ability of Srcasm to promote signaling events downstream of the EGF recep-
tor was evaluated by performing serum-response element dependent luciferase transcriptional assays.
Native Srcasm can potentiate the ability of Fyn to stimulate transcription from serum-response ele-
ments while mutated forms of Srcasm cannot. Initial biological studies reveal that Srcasm promotes
cellular proliferation in A431 cells in an EGF dependent and independent manner. These studies
demonstrate that Srcasm can activate Src-family kinases and promote signaling in SFK-dependent
pathways. Together, this information suggests that Srcasm may play a role in regulating cellular
proliferation. 
0770
Active Ras upregulates pAkt and increases anti-apoptotic defenses via a PI3K-specific mech-
anism
D Marr, Y Shellman, Y Xu and DN Norris Dermatology, University of Colorado Health Sciences
Center, Denver, CO
We investigated the effects of activating Ras on the autonomous anti-apoptotic defenses in melanoma
that are mediated by PI3K. PI3K phosphorylates Akt (pAkt), which has multiple downstream tar-
gets that support cell survival. It was our hypothesis that in melanoma, activating Ras maintains
anti-apoptotic defenses by activating the PI3K pathway, and through pAkt, leads to increased activ-
ity of the transcription factor, CREB, resulting in upregulation of Bcl-2 and potentially other anti-
apoptotic regulatory mechanisms.  We used the following cell lines to investigate our hypothesis:
WM35H-Ras and WM35 N-Ras (containing a constitutively active mutant H-Ras or N-Ras onco-
gene, respectively) and WM35Neo (control). Previously, we have found that transfecting WM35
cells with an activating Ras oncogene leads to increased malignancy and confers survival advan-
tages: resistance to cell death from Fas, cisplatinum, and UVR. For our experiments, the cells were
grown as spheroid cultures thereby eliminating any survival signals due to integrin binding to tissue
culture plastic. In the absence of serum, there was no difference in the level of pAkt (Western Blot)
between the Ras transfectant lines and the control, and the level of pAkt was quite low. However,
when stimulated with 10% FBS, pAkt increased 3-fold in WM35Neo, 4-fold in WM35N-Ras, and
6-fold in WM35 H-Ras. Treating these cells with the PI3K inhibitor, LY294002, at 500uM for 24
hrs decreased pAkt to just above baseline. In addition, Bcl-2 was significantly decreased in all three
cell lines treated with PI3K inhibitor compared to serum stimulation alone.  The melanoma cell line,
WM35, when grown in spheroid culture is dependent upon serum stimulation for pAkt expression.
This effect is augmented approximately two-fold by an activating H-Ras mutation. It appears that
activating Ras activity contributes to melanoma progression, at least in part, by stimulating the
PI3K pathway, resulting in pAkt-induced upregulation of anti-apoptotic defenses, including Bcl-2,
in the melanoma cell line, WM35. 
0774
BEG4 is a novel actin binding protein expressed in hair follicles and BCCs
R Gonzalez-Quevedo, L Horng and AE Oro Program in Epithelial Biology, Stanford University,
Stanford, CA
The Shh signaling pathway plays a critical role in the development of multipotent progenitor cells,
and inappropriate induction of its target genes has been implicated in the development of BCCs of
the skin. However little is known about how Shh target genes mediate the morphogenesis associated
with development and tumorigenesis.  BEG4 is a novel Shh target gene identified through cDNA
microarray screen of human BCCs. BEG4 is a proline-rich protein with a coiled-coil N-terminal
and with a C-terminal domain that shares a conserved WH2 domain with the human Wiskott-Aldrich
Syndrome protein (WASP). WH2 domains are highly conserved motifs that bind to G-actin and act
downstream of the small Rho GTPase family to nucleate actin filaments. Our results have shown that
human BEG4 protein bind both G-actin and F-actin in vitro with a physiologic affinity of 0.4 mM
for G-actin and 0.15 mM for F-actin. Deletion mutants of the WH2 domain fail to bind G-actin but
still retain binding to filamentous actin, demonstrating the role of the WH2 domain in G-actin bind-
ing. In vitro assays have provided evidence that BEG4 promotes the creation of actin filament bun-
dles. Moreover, overexpression of BEG4 in the mouse embryonic cell line C3H10T1/2 results in an
altered actin cytoskeleton and in the production of long cytoplasmic extensions. This phenotype is
maintained when we transfect a C-terminal deletion mutant, but disappears with a transfected BEG4-
N terminal deleted protein. Taken together, these data show that human BEG4 is a novel protein
expressed in human hair follicles and BCCs that may link the Shh signaling pathway to alterations
in the actin cytoskeleton. 
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Expression of erbB receptor family proteins in human keratinocytes and their role in UVB-
induced apoptosis
DA Lewis1 and DF Spandau1,2 1 Dermatology, Indiana University School of Medicine,
Indianapolis, IN and 2 Biochemistry & Molecular Biology, Indiana University School of Medicine,
Indianapolis, IN
Irradiation of human keratinocytes with UVB leads to the ligand-independent activation of many
cell surface receptors, including erbB1 and erbB2. However, the exact nature of this activation and
the subsequent biological consequences of UVB-induced erbB receptor family activation have not
been completely described. Previous studies from our laboratory have demonstrated that simulta-
neous inhibition of both erbB1 and erbB2 tyrosine kinase activities will suppress the induction of
apoptosis resulting from UVB exposure. This protection from apoptosis was not due to the induc-
tion of keratinocytes differentiation, loss of keratinocytes viability, or inhibition of the proliferative
potential of keratinocytes. To more closely examine the role of the erbB receptor family during UVB-
induced apoptosis, we have generated keratinocytes cell lines which overexpress either erbB1, erbB2,
or erbB3 cell surface receptors. The effect of overexpression of these UVB-targeted cell surface
receptors on the response of human keratinocytes to UVB irradiation is currently under investiga-
tion. 
0776
IRS1 and IRS2 have distinct roles in primary skin keratinocytes and skin fibroblasts
M Sadagurski, G Sizyakov and E Wertheimer Pathology, Tel Aviv University Sackler Medical
School, Tel Aviv, Israel
The insulin receptor substrate (IRS) proteins are the first known substrates downstream to the insulin-
and IGF1 receptors. Previously we have demonstrated that IRS1 and IRS2 have distinct and some-
times divergent roles in primary murine skin keratinocytes and fibroblasts. We shown that IRS1 is
essential for skin differentiation while IRS2 is important for the metabolic regulation of these cells.
In the present study we aimed to elucidate the molecular mechanism underlying these differences.
IRS1 and IRS2 proteins are expressed and similarly tyrosine phosphorylated following insulin or
IGF1 stimulation in both skin keratinocytes and fibroblasts.  The next step in the signaling pathway
is interaction between the IRS proteins to downstream elements including PI-3 Kinase (PI3K),
Grb2 and more, leading to these proteins activation. To our surprise, in keratinocytes only IRS1 was
found to interact with PI3K whereas IRS2 was not found to be associated with this protein. In con-
trast, in skin fibroblasts PI3K was found to associate solely with the IRS2 protein, whereas no inter-
action with the IRS1 protein was found. PI3K activity was associated accordingly with IRS1 in ker-
atinocytes and with IRS2 in fibroblasts. In order to further elucidate the importance of this physical
interaction we studied primary cultured skin keratinocytes and fibroblasts isolated from IRS1- and
IRS2-knockout mice. We have found that the resulting consequences of the IRS1 or IRS2 inactiva-
tion were dependent on their initial interaction with the downstream elements. Whereas IRS1 inac-
tivation was associated abnormal keratinocyte differentiation, lack of IRS2 in keratinocytes results
in abnormal differentiation and a marked increased glucose uptake, whereas in fibroblasts lack of
IRS2 results in a decrease in glucose uptake in both basal, insulin- and IGF1 stimulated states. Fur-
ther identifying the unique roles of IRS1 and IRS2 in skin keratinocytes and fibroblasts will hope-
fully shed light on the complex wound healing process and the pathogenesis leading to its impair-
ment in Diabetes. 
0777
TGF-β-Smad signaling in scleroderma
Y Mori,1 S Takagawa,1 GJ Fisher2 and J Varga1 1 Rheumatology, UIC, Chicago, IL and 2
Dermatology, Universty of Michigan, Ann Arbor, MI
Scleroderma(SSc) is characterized by excessive synthesis and accumulation of matrix proteins in
lesional tissues. Transforming growth factor-β (TGF-β) plays a central role in the pathogenesis of
fibrosis by inducing and sustaining activation of fibroblasts; however, the underlying mechanisms
are poorly understood. Smads are intracellular effectors of TGF-β signaling. Smad3 together with
Smad4 functions as an inducible DNA-binding transcription factor that mediates TGF-β stimula-
tion of collagen synthesis, whereas Smad7 suppresses this response. Recently we have shown that
in SSc fibroblasts Smad3 and Smad4 were consistently localized within the nucleus in the absence
of TGF-β in contrast to control fibroblasts and it is transcriptionaly active. In the present study we
examined the levels of phosphorylated Smad2/3 and blockade of autocrine TGF-beta using dermal
fibroblasts derived from SSc patients and the expression levels and description of Smads in SSc skin
as well as bleomycin-induced murine model of SSc in-vivo. We found elevated phosphorylation of
Smad2/3 and no effect of TGF-β neutralizing antibodies or adenovirus-mediated expression of
dominant negative human Type II TGF-β receptor on Smad subcellular distribution in SSc fibrob-
lasts, suggesting that nuclear Smad import was due to alterations downstream of the TGF-β type II
receptors. Furthermore, similar with in-vitro study, both SSc patient skin and bleomycin-induced
murine model of SSc showed higher staining of phospho-Smad2/3, Smad3 and Smad4 on fibrob-
lasts and undetectable level of Smad7. To further investigate these data, transcription factor micro
array are performed and it showed high Smad activity. Together, these results demonstrate constitu-
tive activation of the intracellular TGF-β-Smad signaling as a potential mechanism contributing to
the characteristic phenotype of SSc fibroblasts, and playing a role in the pathogenesis of fibrosis. 
0778
Functions of EGFR during SOS-Dependent skin tumor development
P Tan, H Gustafson, C Frank, F Palamara, M Holcmann and M Sibilia Dermatology/DIAID,
University, Vienna, Austria
The epidermal growth factor receptor (EGFR) plays a key role in skin development and is implicated
in epithelial tumor formation. Transgenic mice expressing a truncated form of the Ras activator Son
of Sevenless (SOS-F) from the K5 promoter develop skin papillomas in an EGFR-dependent man-
ner. EGFR mutant tumors are more differentiated and display an increased number of apoptotic cells,
which is accompanied by decreased Akt phosphorylation indicating that the EGFR provides an impor-
tant survival signal during tumor formation (1). Primary keratinocytes from K5-SOS-F transgenic
mice of different EGFR backgrounds were characterized for their adhesive properties and the expres-
sion of downstream signaling molecules. We found that in K5-SOS-F transgenic keratinocytes the
protein levels of Src are increased and that the adhesive and migratory capacities are altered. More-
over, the kinase domain and the C-terminal tyrosine phosphorylation sites of the EGFR are required
for SOS-mediated tumor formation and efficient Akt activation. These results indicate that the EGFR
is essential for oncogenic transformation by components of the Ras signaling pathway and provides
a valuable target for therapeutic intervention in a broader range of tumors than previously antici-
pated. Therapies aimed to modulate either EGFR function or the immune system were employed in
vivo on K5-SOS-F transgenic mice and the results of these experiments will be presented.  (1) Sibilia
et. al., Cell 102, 211-220, 2000 
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Cultured peri-bulbar dermal sheath and dermal papilla cells induce new hair follicles from
mouse epidermis and modify the growth and cycling properties of hair follicles present through
natural embryogenesis
KJ McElwee, S Kissling, E Wenzel, A Huth and R Hoffmann Dermatology, Philipp University,
Marburg, Hessen, Germany
Mesenchyme derived dermal papilla (DP) cells control development, differentiation and cycling of
hair follicles. These cells are highly differentiated and non-proliferative in vivo. Significant progress
has been made in defining progenitor cells of the epidermal hair follicle component but the progen-
itor cell source for the DP is unknown. Transgenic GFP-expressing mouse, wildtype, and non-trans-
genic mouse vibirssa follicle cells were cultured and implanted to CBySmn.CB17-Prkdcscid/J mouse
ears. DP-derived cells and cells from the peribulbar dermal sheath “cup” (DSC) induced new hair
follicles while non-bulbar dermal sheath (DS) cells did not. Confocal microscopy revealed that GFP-
expressing DSC cells induced hair growth through the formation of a new DP, DSC and the lower
hair follicle DS, whereas DP cells only capable of forming a DP. In addition to inducing entirely
new hair follicles, DP and DSC cells also integrated with hair follicles already present through nat-
ural embryogenesis. Biochemically, DSC cells where characterized in vivo and in vitro by low alka-
line phosphatase activity in contrast to high alkaline phosphatase expression in differentiated DP
cells. Thus, transplanted autogeneic and allogeneic cells derived from adult vibrissa follicles were
capable of inducing new hair follicles from mouse epidermal cells and modified the growth and
cycling properties of hair follicles present through natural embryogenesis. We suggest that the func-
tional capacity of cultured DSC cells to form DP and DS and induce hair follicle development is an
indicator of their pluripotency. In principle, it may be possible to utilize cultured hair follicle mes-
enchyme cells as a treatment for androgenetic alopecia and other forms of hair loss. 
0780
Macrophage stimulating protein is a potent promoter of anagen stage hair follicles in vitro and
in vivo
KJ McElwee, A Huth, S Kissling, E Wenzel and R Hoffmann Dermatology, Philipp University,
Marburg, Hessen, Germany
Hepatocyte growth factor has been identified as a powerful promoter of hair follicle growth. In the
current study we examined another HGF family member, macrophage stimulating protein (MSP) for
its hair follicle modulating properties. Western blotting confirmed human dermal papilla (DP) cell
expression of MSP. Immunohistology demonstrated expression of MSP receptor RON/STK in most
epithelium derived follicular structures including the outer and inner root sheaths, differentiating hair
matrix cells, DP, arrector pili muscle, and some cells of the sweat glands. Human hair follicles from
5 donors (2 female, 3 male, mean age 27) exposed in vitro for 8 days to 0.1, 1, 10, and 100 ng/ml
MSP yielded a mean net increase in hair follicle length of 10.3% (n=16, P=0.0023), 12.9% (n=30,
P=0.0001), 9.8% (n=18, P=0.0008), and 8.4% (n=18, P=0.0072) respectively in excess of the 43.8%
mean baseline growth observed in controls (n=36). MSP was incubated with agarose beads and
injected subcutaneously into mice all 70 days old when the dorsal pelage hair follicles are in a tel-
ogen resting state after completion of the second coat generation. All 8 mice receiving 1 µg MSP,
and 4 of 8 receiving 100 ng MSP had hair growth induction at the site of bead implantation after 16
days while 8 mice implanted with PBS incubated beads had no hair growth response until necropsy,
22 days post injection. The data identify MSP as a potent modulator of hair follicle growth. 
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Photo-epilation: a potential threat to wound healing in a mouse
C Huh,1 J Oh,2 M Kim,1 C Won1 and H Eun1 1 Dermatology, Seoul National University College of
Medicine, Seoul, South Korea and 2 Rich Hair Clinic, Seoul, South Korea
Many people want to remove unwanted hair for cosmetic purposes, and photo-epilations by laser or
intense pulsed light (IPL) are being widely used in this field. However, to achieve permanent epila-
tion adjacent cells to the bulge area, which are known to be a reservoir of epidermal stem cells, should
be destroyed in addition to hair follicles. Thus, the possibility of aberrant wound healing after
photo-epilation is strongly suspected. We wished to determine whether wound heeling capability is
perturbed after photo-epilation for cosmetic hair removal. Twenty pigmented hairy C57/BL6 mice
aged 5 weeks were used in this study. After wax epilation to synchronize the hair cycle, one half of
the backs of mice were photo-epilated by IPL (Ellipse Flex®) in the early anagen stage. After the
two hair cycles of the mice to confirm the hair removal effect, 30% trichloroacetic acid was applied
to the both halves of the backs of the mice. The non photo-epilated side of the mice was shaved before
the chemical peeling. A skin biopsy was performed on both sides before and just after the injury,
and 2, 6, 9, and 14 days thereafter. The specimens were evaluated histologically after staining with
hematoxylin and eosin, Masson trichrome, and Verhoeff-van Gieson. No differences in wound heal-
ing times were evident upon gross observation by the naked eye. However, the photo-epilated hair-
less skin was observed to have a thicker epidermis and dermis than normal hairy skin by histologi-
cal evaluation. The cellularity of the healed wound was much denser in the photo-epilated skin and
nodular condensation of fibroblasts and collagen were also observed. Collagen production of the
neodermis in the normal hairy skin was first observed around the lower part of hair follicle, while it
started from the upper papillary dermis in photo-epilated skin. Photo-epilation may disturb the nor-
mal wound healing process, especially dermal wound healing, and increases the risk of producing
hypertropic scar or keloid. 
0783
Follistatin promotes the differentiation of mouse embryonic stem cells into the cells with ver-
sican promoter-driven green fluorescent protein expression
M Nakamura,1,2 R Paus2 and Y Miyachi1 1 Dermatology, Kyoto University Graduate School of
Medicine, Kyoto, Kyoto, Japan and 2 Dermatology, University Hospital Eppendorf, Hamburg,
Hamburg, Germany
Embryonic stem (ES) cells are pluripotent cells which can be differentiated into many cells in vitro.
Hair follicle development is governed by the intricate signal transduction between the epidermal
cells and mesenchymal cells. Hair mesenchymal dermal papilla (DP) cells expressing proteoglycan
versican can induce hair growth in vivo. To establish an in vitro differentiation system of mouse ES
cells into DP cells for a regenerative therapy, we have generated stably transfected mouse ES cells
with a vector containing the gene of the green fluorescent protein (GFP) under control of the versi-
can promoter. Coculture with NIH3T3 or HeLa cells induced the GFP expression in transfectants.
NIH3T3 cells and HeLa cells retained this activity even after being fixed with paraformaldehyde
(PFA). Furthermore, green fluorescence emitting transfectants were detected after four days serum-
free culture on collagen IV coated dishes. Administration of recombinant follistatin into this culture
medium significantly increased the ratio of GFP positive cells. In situ hybridization of mouse embry-
onic skin revealed the expression of follistatin mRNA most strongly in the hair placode and hair
matrix cells. Recombinant follistatin accelerated the development of hair follicles in an embryonic
mouse skin organ culture, while follistatin deficient mice showed a retardation of hair follicle for-
mation. These results may indicate an important role of follistatin as an epidermal signal for a DP
cell differentiation and hair follicle development. Our system may lead to a regenerative therapy
approach for alopecia patients using their own various stem cells grown in a certain differentiating
condition. 
0785
Hair follicles as a local reservior of skin mast cell precursors
T Kumamoto, D Shalhevet, ME Mummert, H Matsue, JV Jester and A Takashima UT
Southwestern, Dallas, TX
Hair follicles (HF) are known to serve as a “niche” for tissue regeneration. Bulge region of the outer
root sheath (ORS) contains multipotent stem cells that can generate epidermis, hair follicles, and
sebaceous glands, and can even give rise to melanocyte lineage. To test the hypothesis that HF may
also contain precursors of skin resident leukocytes, vibrissal follicles isolated from adult mice were
cultured in the presence of stem cell factor (SCF), IL-3, IL-7, GM-CSF, and Flt3 ligand. Progres-
sive expansion of CD45+ leukocytes became detectable on the top of outgrowing fibroblast layers
in 10 days. When HF samples were dissected into upper fragments containing sebaceous glands,
intermediate fragments containing bulge regions, and lower fragments containing hair bulb regions,
leukocyte growth occurred most frequently (40-70%) from the intermediate fragments. HF-derived
leukocytes showed characteristic features of mast cells: a) surface phenotype of CD45+/lineage-/c-
kit+/FcεRI+, b) proliferative response to SCF, but not other growth factors, c) metachromatic cyto-
plasmic granules, d) mRNA for mast cell proteases-1, 4, 5, and 6, and e) histamine release upon
FcεRI ligation or treatment with substance P or compound 48/80. They maintained these features
>6 months when expanded in the presence of SCF alone. When vibrissal follicles isolated from the
chimeric mice reconstituted with the GFP transgenic bone marrow cells were placed in culture,
marked expansion of GFP+ cells was observed within the HF structures and over GFP-negative fibrob-
lasts, formally validating bone marrow origin of the HF-derived mast cells. We identified c-kit+ cells
within the ORS regions of vibrissal follicles and detected constitutive SCF mRNA and protein expres-
sion in the same specimens. Thus, the HF microenvironment provides two essential factors for mast
cell development, i.e., progenitors expressing c-kit (SCF receptor) and local production of SCF. Our
results have unveiled a previously unrecognized function of HF to serve as a local and intermediate
reservoir of mast cells from bone marrow to dermis. 
0784
Zinc pyrithione delays hair growth and follicular melanogenesis
M Seiberg, M Filippi, A Ricklis, V Iotsova and CB Lin Skin Biology Research Center, Johnson &
Johnson CPWW, Skillman, NJ
Zinc pyrithione (ZnPTO) is an antibacterial and antifungal agent used in some shampoos for man-
agement of dandruff. To assess the possible effect of ZnPTO on hair growth, C57Bl/6 mice were
induced to a new synchronized hair cycle and subsequently treated with ZnPTO once daily through-
out one hair cycle.  A clear delay in hair cycle induction was observed in ZnPTO-treated mice, accom-
panied by a change in the appearance of the re-growing hair to a finer and more unruly hair. Histo-
logical evaluation confirmed the delay in hair growth. Striking differences in the treated mice were
seen as early as day 5 of the hair cycle. At day 23, when untreated mice were already in telogen, the
treated mice were still in the (delayed) growth phase. The appearance of hair pigmentation was notice-
ably delayed in ZnPTO-treated mice. Since follicular melanogenesis is strictly coupled to anagen,
we evaluated expression levels of melanogenic proteins in treated mice. Western blot analysis showed
delayed and reduced expression patterns of melanogenic genes throughout the hair cycle of treated
mice. A significant decrease in tyrosinase, tyrosinase related protein-1, and dopachrome tautomerase
was evident as early as day 5 of the hair cycle of treated mice.  Interestingly, microphthalmia, a tran-
scription factor that regulates tyrosinase family gene expression, was found to be expressed through-
out the hair cycle in both treated and control mice. However, ZnPTO treatment significantly inhib-
ited phosphorylation of microphthalmia, seen as early as day 3. The reduced phosphorylation of this
transcription factor might be responsible for the subsequent down-regulation of tyrosinase family
gene expression. Our findings suggest that ZnPTO treatment delayed the induction of a new hair
cycle, resulting in shorter hair shafts at the early re-growth stage. ZnPTO may delay hair growth
through its anti-proliferative activity and affects MITF phosphorylation in a proliferation-independent
pathway. The precise mechanism remains to be further investigated. 
0782
IFNγ-induced ectopic MHC class I expression in human hair matrix cells are down-regulated
by IGF-1, TGFβ1 and αMSH: implication for hair follicle immune privilege and alopecia areata
T Ito,1,3 N Ito,1 Y Tokura,2 M Takigawa3 and R Paus1 1 Dermatology, University Hospital Hamburg-
Eppendorf, Hamburg, Hamburg, Germany, 2 Dermatology, University of Occupational and
Environmental Health, Kitakyushu, Fukuoka, Japan and 3 Dermatolgy, Hamamatsu University
School of Medicine, Hamamatsu, Shizuoka, Japan
The anagen hair bulb displays an immune privilege (IP), since it shows low or absent MHC class I
expression on the protein level. In the current study, we show by ABC, APAAP and TSA techniques
as well as by in situ hybridization that there are substantial interindividual and location-dependent
differences in the constitutive hair bulb MHC class I expression on both the protein and gene level.
We have previously hypothesized that collapse of the MHC class I-dependent IP of the hair bulb is
a crucial element in the pathogenesis of alopecia areata (AA) as an autoimmune disease (Paus et al.,
Yale Biol Med 1994). Since IFNγ is the key up-regulator of ectopic MHC class I expression in murine
anagen hair bulbs in vivo (Rückert et al., J Invest Dermatol 1998), we have tested here whether this
is also true in organ cultured human anagen scalp hair follicles. We demonstrated IFNγ (75U/ml)
indeed strongly induced ectopic MHC class I expression (without triggering premature catagen devel-
opment). Since effective agents remain to be identified, we then investigated the effects of several
candidate down-regulators of IFNγ-induced MHC class I expression. Here we show by immuno-
histochemistry that IGF-1 (100ng/ml), TGFβ1 (30ng/ml) and αMSH (0.4µg/ml) significantly down-
regulate IFNγ-induced ectopic MHC class I expression in human anagen hair bulb. This effect was
further studied by in situ hybridization and RT-PCR on the mRNA level. IGF-1 also down-modu-
lates MHC class I pathway molecules, e.g. TAP2 and β2-microglobulin. In addition, IGF-1 down-
regulates not only MHC class I but also IFNγ-induced MHC class II expression. This is the first
report to identify effective down-regulators of ectopic MHC class I expression in human hair folli-
cles. These may prove particularly promissing therapeutic agents for the restoration of hair follicle
IP in AA. 
0786
Design and implementation of the National Alopecia Areata Registry
JN Breuer-McHam,1 A Christiano,2 M Hordinsky,3 D Norris,4 V Price5 and M Duvic1 1 MD
Anderson Cancer Center, Houston, TX, 2 Columbia University, New York, NY, 3 University of
Minnesota, Minneapolis, MN, 4 University of Colorado, Denver, CO and 5 University of
California, San Francisco, San Francisco, CA
A National Registry for Alopecia Areata (AA), an organ specific autoimmune disease resulting in
patchy to complete hair loss, was established in Sept 2000 by NIAMS. The Registry is a web-based
database for collecting epidemiology data, pedigrees, and to encode patient specimens (DNA, LB-
lines, sera) from well-characterized AA subjects: multiplex families, sib-pairs, and individuals clas-
sified as persistent AU/AT or persistent patchy AA or transient AA. The registry will further genetic
research by making these materials available to investigators. The Universities of Texas MD Ander-
son, California, Colorado, and Minnesota and Columbia University NYC are participating sites for
patient examination. US residents with any form of AA, confirmed by a dermatologist, can com-
plete a short-questionnaire about extent and duration of AA, family and autoimmunity history on
line at alopeciaareataregistry.org or by mail. Patients are screened and invited to a site for extended
questionnaires, exams, and blood sample collection. Dermatologists can also help in registering
patients not able to travel and informing AA patients about the registry. To date, the web-site has
had >44,000 hits with 800 registrants; 80% are female and 209 are children. Forty-two multiplex
families and 28 sib-pairs have registered and over 70 patients have been examined and contributed
samples. The existance of an Alopecia Areata Registry will serve as a resource for understanding of
this complex genetic trait in the future. 
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Fluorescence activated cell sorting of a Verapamil-sensitive, Hoechst-low side population of
basal keratinocytes from the cutaneous epithelium of adult mice
RJ Morris,1 CS Trempus,2 CD Bortner,4 RS Faircloth,2 G Cotsarelis3 and RW Tennant2 1
Dermatology, Columbia Univ. Coll. Phys. Surg., New York, NY, 2 National Center for
Toxicogenomics, NIEHS, Research Triangle Park, NC, 3 Laboratory of Signal Transduction,
NIEHS, Research Triangle Park, NC and 4 Dermatology, University of Pennsylvania, Philadelphia,
PA
Studies directed toward the identification and isolation of keratinocyte stem cells are expected to
yield important insights into the mechanisms of both epidermal homeostasis and pathogenesis of
skin disease. Here, we report the identification and phenotypic characterization of a Verapamil-sen-
sitive side population (SP) of living cells from adult murine epidermis and hair follicles following
staining with Hoechst 33342. Constituting 0.02 to 0.09 percent of viable cells, the SP from cuta-
neous epithelial cells is similar to that of hematopoietic stem cells and several other tissues. Pheno-
typic characterization of epithelial SP cells demonstrated that virtually all of them expressed both
keratin 14 and alpha-6 integrin proteins, indicating that they are basal keratinocytes. However,
immunocytochemistry of SP cells detected only low expression of keratin-6 (approximately 30%),
a marker of hair follicles. Although CD34 protein was not detected, CD34 message was present by
RT-PCR. We have undertaken studies to determine the stem/progenitor characteristics of epidermal
SP cells: whether they are quiescent and retain [3H] thymidine label (slowly cycling label-retaining
cells), are clonogenic in vitro, or reconstitute a graft. In summary, our initial characterization of SP
cells from the cutaneous epithelium of adult mice indicated that they are basal keratinocytes; how-
ever, the relative paucity of keratin 6 or CD34 expression suggests that some SP cells may not orig-
inate from the bulge region of the hair follicles. Thus, the SP may include both bulge and non-bulge
progenitors, a concept supported by cell kinetic studies, mathematical models, and carcinogenesis
experiments suggesting potent progenitors exist in the epidermis as well as the hair follicles. 
0788
Regulation of human hair follicle vascular responses and growth by neurokinin 1 receptor lig-
ands
S Lachgar, M Charveron and Y Gall Dermatology, Hotel Dieu Saint Jacques Hospital, Toulouse,
France
Angiogenesis is an important process in hair follicle growth. The formation of new vessels and the
remodelling of existing vessels are likely to be induced by the major endothelial cell-specific stim-
ulatory factor called VEGF. Recent reports revealed that neural mechanisms play a role in hair growth
control. It has been also demonstrated the presence of a close spatial localization of vascular net-
work and substance P in hair follicle. To understand the nature of the neural and vascular interac-
tions in human hair follicle we investigate the relationship between the neurokinin-1 (NK1) recep-
tor ligands and VEGF receptors expression in human hair follicle and the impact of these interactions
on the regulation of hair follicle growth. We demonstrated the presence of NK1 receptors in human
hair follicle cells. The anti hair loss drugs, minoxidil and finasteride, enhanced NK1 receptors pro-
tein and gene expression in human hair follicle. We also observed that substance P up-regulates VEGF
receptors in human hair dermal papilla cells (HDPC) and in isolated human hair follicles in anagen
phase. By the use of selective NK1 receptors agonist [Sar9,Met (O2)11] substance P, it was estab-
lished that the activation of NK1 receptors is most likely to mediate the angiogenic responses induced
by substance P. The angiogenic activity of SP was abolished by treatment with the selective NK1
receptors antagonist (L-732,138). Ex vivo studies indicate that NK1 receptor antagonist also inhib-
ited the rate of hair follicle growth. These results demonstrate the interactions existing between angio-
genic factors and neurokinin 1 receptor activity in hair follicle. The increase of hair growth rate in
the presence of NK1 receptor agonist is associated with a stimulation of VEGF receptors. These
data may be a key to new advances in the field of hair loss treatments with a particular emphasis on
the alopecia areata disease associated with a decrease of substance P expression. 
0789
Direct evidence that head and rod domain sequences interact to control states of assembly of
trichocyte keratin intermediate filaments
AE Kalinin,1 S Jang,1 LN Marekov,1 DA Parry2 and PM Steinert1 1 LSB, NIAMS, NIH, Bethesda,
MD and 2 Institute of Fundamental Sciences, Massey University, Palmerston North, New Zealand
Keratin intermediate filaments (KIF) are assembled in a series of hierarchical steps from: a single
protein chain; a dimer coiled-coil molecule; a tetramer consisting of a pair of antiparallel partially
staggered molecules; a unit length filament (ulf) entity consisting of about 8 tetramers aligned side-
by-side and about 20 nm wide; as the ulfs join end-to-end, the assembly begins to shrink to 10 nm
as the molecular strands entwine; and finally a uniformly-wide 10 nm KIF is formed. However, many
details of this model have yet to be proven experimentally. In particular, we want to know what is
the precise role of the head domains in these states of assembly. We replaced each arginine residue
of the type I and II trichocyte chains one at a time with a lysine, and used full-length as well as trun-
cation and deletion forms to explore molecular assemblies by cross-linking with DST (0.6 nm arm)
or BSOCOES (1.3 nm). We found that the head domain of the type I chain interacts with the 1A, L1
and early 1B segments of the rod domain. The head domain of the type II chain engaged in similar
interactions, but primarily with the late 1B, 2A-L2-early 2B rod domain segments. Thus the head
domain of the type II chain is especially important as it can adopt multiple interactions along the rod
domains of molecules in adjacent molecular strands. In stable ulf particles formed in the absence of
the beta-strand motif on the head domain of the type II chain, there were no interactions of the type
II head and 2B rod domain segments. This may be because the molecular alignments in such ulfs
are not the same as those in intact KIF. Together with previous work in which we have mapped pos-
sible functional domains on the head domains, these new data document that direct interactions
between the head and rod domain are responsible for various levels of structural hierarchy within
KIF. This will now allow modeling on how molecular strands pack within KIF. 
0790
Identification of essential motifs on head domain sequences involved in the assembly of tri-
chocyte keratin intermediate filaments
PM Steinert,1 S Jang,1 LN Marekov1 and DA Parry2 1 Laboratory of Skin Biology, NIAMS NIH,
Bethesda, MD and 2 Institute for Fundamental Sciences, Massey University, Palmerston North,
New Zealand
The head domain of intermediate filament (IF) protein chains is essential for assembly in vitro and
in vivo. For example, headless type I or II keratin or type III vimentin chains do not assemble. While
portions and structural motifs in the vimentin head domain have been described, there are few com-
parable data for keratin IF. We have made constructs with the type I and II mouse trichocyte keratin
chains. Selective truncations or deletions were made, and then used to map essential regions for
each hierarchical stage of IF assembly. The first 9 residues in either chain are not essential for assem-
bly. Residues 10-21 in both chains possess a conserved motif that is essential for unit-length fila-
ment (ulf) stability; its absence from either chain arrests KIF assembly at the tetramer-octamer stage.
Residues 22-49 (type I) or 22-31 (type II) consisting of irregular linker sequences, are similarly
required for ulf stability. Residues 32-67 (type II) contain four potential beta-turn motifs that are
essential for ulf elongation, as their absence fosters formation of stable ulf. Cross-linking studies
show these ulf consist of alternating rows of molecules in the A11 and A22 alignment modes, inter-
faced by the A12 mode, to produce the characteristic 20-nm wide ulf raft, but the A22 and A12
alignments are set further apart than in intact KIF. Thus the beta-turn motifs on adjacent type II chains
promote normal A11, A12, A22, and ACN interactions for KIF elongation. Residues 49-57 (type I)
and 70-104 (type II), containing the respective H1 regions, are required for tetramer-octamer sta-
bility, as their absence in whole or in part allows only homo- or hetero-tetramer formation. These
data offer the first systematic analysis of the roles of various portions of head domain sequences of
a keratin chain system. Similar motifs may exist on other keratins, but are not easily recognizable
due to the insoluble and refractory nature of the glycine-rich sequences. 
0791
Rules of hair cycling and skin domains revealed by Msx2 knockout mice
M Plikus and C Chuong Pathology, University of Southern California, Los Angeles, CA
We recently reported the skin phenotype of Msx2 homeobox gene knock out mice (Development
130, 379-389). Analyses demonstrated that the hair follicles of these mice have shorter anagen, longer
catagen, prolonged telogen and precocious exogen. As a result, the mice show a characteristic cyclic
alopecia phenotype with complex and dynamic alopecic and hairy skin patches. Previously researchers
analyzed hair cycling in single hair follicles, we now analyze the social behavior of hair cycling in
groups of hairs. The following rules are observed. 1) Hairs are usually distributed into domains: cra-
nial, cervical and several trunk domains. Each domain has its own hair cycle pace, asynchronous
with other domains. Domains split gradually with increasing age. In adults, the domains further
split into one central and two lateral domains. The position and shape of lateral domains are usually
bilaterally symmetric. These skin domains are not the result of Msx2 loss of function, as they also
exist in normal mice as revealed by shaving and tracking the reappearance pattern of anagen hairs.
2) For hair cycling of each domain, there is an initiation center which starts anagen, spreading wave
which occurs in all directions, and borders that are refractive to spreading. 3) The domains are not
stable. From cycle to cycle, the location of the initiation centers and the border of domains can change
even on the same mouse, suggesting stochastic events are in place. Sometimes, one domain can
have multiple initiation centers. Sometimes, two domains can fuse into one. As a result, domain maps
of different mice are similar but not identical. A time-lapse cartoon movie is prepared to show the
dynamics. 4) For hairs of the same region, anagen duration is more constant and telogen duration is
more variable. Traditional telogen can be divided into an early phase when skin is refractive to ana-
gen initiation, and a later phase when skin is responsive to anagen initiation signals. The molecular
bases of these hair follicle behaviors are undergoing current investigation. 
0792
Tiger tail banding and hair shaft abnormalities in trichothiodystrophy and other hair disor-
ders
CA Liang,1,2 V Price,4 KH Kraemer1 and JJ DiGiovanna1,3 1 BRL, NCI, Bethesda, MD, 2 Howard
Hughes Medical Institute, Bethesda, MD, 3 Dermatology, Brown Medical School, Providence, RI
and 4 Dermatology, UCSF, San Francisco, CA
Trichothiodystrophy (TTD) is a rare autosomal recessive disorder characterized by short, brittle hair
with low cystine content and alternating dark and light (tiger tail) bands under polarizing microscopy.
Some TTD patients also show ichthyosis, intellectual impairment, decreased fertility, and short stature
(IBIDS). Others have, in addition, photosensitivity (PIBIDS). TTD patients do not have a predispo-
sition to skin cancer. The findings in xeroderma pigmentosum (XP) are markedly different, with
acute sun sensitivity, lentiginous pigmentation, poikiloderma, and a 1000-fold increase of UV induced
skin cancers. Most PIBIDS patients have a mutation in either of two XP DNA repair genes: XPD or
XPB. Rarely, TTD may also occur in combination with XP. We examined hairs from 10 TTD patients
and 4 XP-TTD patients for tiger tail banding and hair shaft abnormalities. Using a rotating micro-
scope stage, virtually all hairs in 14 samples showed tiger tail banding under polarizing light. All 14
had hair shaft abnormalities but the proportion of involved hairs varied among the patients.  These
included surface irregularities (13/14), trichoschisis (12/14), and trichorrhexis nodosa-like defects
(7/14). Based on amino acid analysis, the 4 patients with XP-TTD had cystine content intermediate
between normal and TTD levels. These patients had fewer hair shaft abnormalities than 2 TTD sib-
lings with low cystine content. In contrast, an XP-D and an XP-A patient did not show tiger tail band-
ing or hair shaft abnormalities and had normal sulfur amino acid analysis. We also examined con-
trol hairs from 7 normals and 50 patients with XP-C or other dermatologic conditions, including a
variety of disorders of cornification. None of these hairs showed tiger tail banding or the described
TTD hair shaft abnormalities. Tiger tail banding on polarizing microscopy and the presence of cer-
tain hair shaft abnormalities provide a reliable method for rapid bedside diagnosis of TTD. 
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Stimulation of hair growth in a C3H/HeN mouse model by topical application of ketoconazole
R Tsuboi,2 K Ko,1 Y Kojima1 and H Ogawa1 1 Dermatology, Tokyo Medical University, Tokyo,
Japan and 2 Dermatology, Juntendo University School of Medicine, Tokyo, Japan
Ketoconazole (KCZ) is an imidazole anti-mycotic agent, and its topical application is also effective
for treating seborrheic dermatitis and dandruff. Recently, topical use of KCZ 2% shampoo was
reported clinically to have a therapeutic effect for androgenic alopecia. The present study was con-
ducted to examine statistically the stimulatory effect of KCZ on hair growth in a mouse model. Coat
hairs on the dorsal skin of seven week old male C3H/HeN mice were gently clipped, and either 2%
KCZ solution in ethanol (EtOH) or 1% EtOH was topically applied once daily for three weeks. The
clipped area was photographed every other day, and the ratio of re-grown coat area was then calcu-
lated. The results demonstrated that KCZ had a clinically significant stimulatory effect on days 15,
18 and 21 compared with the vehicle group (p<0.05, n=8). Repeated experiments showed similar
effects, confirming the efficacy of KCZ as a hair growth stimulant. Although the therapeutic mech-
anism of KCZ for hair growth is unclear at this moment, our results suggest that topical applications
of the substance are useful for treating seborrheic dermatitis accompanied by hair regression or andro-
genetic alopecia. 
0795
Bone morphogenetic protein receptor IA is expressed in developing human sebaceous gland
M Akiyama (JSID), D Sawamura and H Shimizu Department of Dermatology, Hokkaido
University Graduate School of Medicine, Sapporo, Hokkaido, Japan
BMPs comprise a family of secreted signaling molecules which have multiple functions during ani-
mal development, including mouse hair follicle morphogenesis. However, little is known about the
regulation of human fetal hair follicle morphogenesis by BMP signaling. We studied the distribu-
tion patterns of BMP 2 & 4, BMP receptor IA (BMPRIA) and several signal molecules by confocal
laser scanning microscopy in human embryonic and fetal skin specimens at 49-163 days estimated
gestational age (EGA). Strong BMPRIA labelings were seen in the human fetal sebaceous gland
(SG) primordium at 108 days EGA and after. At 135 days and after, cells of the developing arrector
pili muscle as well as SG primordium were positive for BMPRIA. In adult human hair follicle, the
SG turned to be negative for BMPRIA, although the arrector pili muscle expressed BMPRIA strongly.
High power view revealed that the BMPRIA was distributed mainly on the cell periphery and in the
perinuclear endoplasmic reticulum areas of the human fetal SG primordium cells. Smad1/5/8 was
expressed strongly in the mesenchymal cells around the SG primordium. In addition, in the SG pri-
mordium, immunolabeling of Smad1/5/8 was observed mainly in the nuclei. No apparent immunore-
activitiy for BMPRIA was seen in other portion of developing human hair follicle, including the bulb
region. No significant expression was detected for BMP2 or BMP4 throughout hair follicle devel-
opment. Lef-1 was expressed in the hair peg and in the inner root sheath of developing human fetal
hair follicles. The BMPRIA expression may suggest the binding of exogenous BMPs to the SG pri-
mordium cells, although it was not possible to detect BMPs in and around the developing SG in the
present study, most likely due to low levels of these proteins in the extracellular space. Furthermore,
smad1/5/8, the molecule in the downstream of BMP signaling, was expressed in the SG primordium
cells. Our observations suggest the involvement of BMP signaling via BMPRIA in the antiprolifer-
ative/differentiation programmes of the SG primordium cells. 
0797
Identification and expression analysis of a second domain of human high sulfur keratin-asso-
ciated protein genes on chromosome 21q23
MA Rogers,1 L Langbein,2 H Winter,1 I Beckmann,1 S Praetzel2 and J Schweizer1 1 Section of
Normal and Neoplastic Epidermal Differentiation, German Cancer Research Center, Heidelberg,
Baden-Wuerrtemberg, Germany and 2 Department of Cell Biology, German Cancer Research
Center, Heidelberg, Baden-Wuerrtemberg, Germany
Analysis of the EBI/ Genebank database using nonhuman keratin associated protein (KAP) gene
sequences as a query resulted in the identification of two domains of KAP genes on chromosome
21, one of which was recently characterized (Rogers et al. JBC 227: 48993-49002, 2002). The sec-
ond domain, a ca. 90 kb region on human chromosome 21q23 harbours sixteen KAP genes and two
KAP pseudogenes. These genes could be divided into two families, twelve members of which are
the human orthologs of the sheep KAP 10 family, and four members which are orthologs of the
mouse KAP12 family. Systematic cDNA/ 3-RACE isolation studies, as well as in situ hybridisation
analysis of all of the KAP genes identified showed the mRNA expression of a majority of the mem-
bers of both families in a narrow region of the hair fiber cuticle. 
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Towards the development of safe, topical cyclosporine derivatives as hair-growth-stimulators
S Kim,1 J Kim,1 H Lee,1 S Kim,1 H Kim,1 M Rang,1 YYoon1 and R Paus2 1 LG Household & Health
Care, Daejeon, South Korea and 2 Dermatology, Univ Hamburg, Hamburg, Germany
Since hypertrichosis is one of the leading undesired effects of systemic cyclosporine A (CsA) ther-
apy in man and since topical and systemic CsA potently induces anagen and inhibits catagen in mice,
CsA is the most attractive candidate “hair drug” for human alopecias. However, the serious side
effects associated with systemic CsA administration far outweigh the potential trichological bene-
fits. Therefore, topically applicable and, ideally, non-toxic CsA derivatives deserve to be developed
as a hair growth stimulators for clinical use. In the current studies, we have systematically explored
whether it is possible to modify the CsA molecule in such a way as to maintain its hair growth-mod-
ulatory potency while significantly reducing its unwanted nephrotoxicity, which is the major dose-
limiting adverse effect of long-term CsA administration, and immunosuppressive effects. Initially
we have screened 6 candidates, LG 40, 64-1, 70-2, 409, 432, and 474, based on the their anagen-
inducing potency in the C57BL/6 mouse model. The LG 70-2 was an equipotent anagen inducer
compared to CsA and retarded cyclophosphamide-induced massive, premature catagen development.
In organ-cultured human occipital scalp hair follicles, LG 70-2 or CsA stimulated hair shaft pro-
duction, as measured by 35S-cysteine incorporation. Oral administration of CsA caused significant
renal toxicity, evidenced by the increases in the serum creatine and urea concentration, and a decrease
in the magnesium concentration, while there were no significant changes in these parameters in rats
treated with LG 70-2 and other analogs. When CsA was administrated to 40 mice at a dose of 3g/kg
all animals were killed, while none of the mice treated with LG 70-2 and other derivatives was killed.
The MLR (mixed allogenic lymphocyte reaction) data for LG analogs widely ranged from 30 % to
less than 2 % of the IC 50 of CsA. This encourages to further explore less toxic LG analogs as the
most interesting candidates for hair drugs for topical application. 
0794
Gap junction formation in human fetal hair follicle and its bulge region
K Arita,1 M Akiyama,1 Y Tsuji,1 JR McMillan,1 RA Eady2 and H Shimizu1 1 Dermatology,
Hokkaido University Graduate School of Medicine, Sapporo, Japan and 2 Cell and Molecular
Pathology, St John’s Institute of Dermatology, London, United Kingdom
Gap junctions (GJs), composed of connexins (Cxs), are channels allowing intercellular communi-
cation, and play a key role in the regulation of cell proliferation and differentiation. The Cx expres-
sion pattern and GJ formation in human fetal hair follicle (HF), including bulge that is prominent in
fetal HF and is believed to be stem cell-rich site, have not yet been clarified. We used immunofluo-
rescent labeling to investigate the sequential expression pattern of Cx26 and Cx43 in developing HFs
in human fetuses of a series of estimated gestational age (EGA) (49-163 days). Ultrastructural GJ
formation was observed by electron microscopy and the numbers of GJs were quantitatively ana-
lyzed. Both Cx26 and Cx43 expression were observed at 88 days EGA in the hair peg. At 135 days
EGA, Cx26 was expressed in the outer root sheath (ORS) and the inner root sheath (IRS), while
Cx43 expression was chiefly in the IRS, hair matrix and sebaceous glands. At 163 days EGA, Cx26
expression in the ORS was most intense in the outermost layer, in contrast to Cx43 expression in the
inner part of ORS. In the bulge, only Cx43 was expressed in a few cells. Ultrastructurally, GJs were
observed at 102 days EGA in both the ORS and IRS. The numbers of GJs per cell were 0.03 at 102
days EGA, 0.05 at 120 days EGA and 0.11 at 152 days EGA, increasing over time. GJs were also
observed in the bulge, and the numbers per cell were 0.04 at 120 days EGA and 0.08 at 152 days
EGA, which were only about 20% to 30% less than those of ORS and IRS cells. The changing expres-
sion patterns of Cx26 and Cx43 and increasing GJ formation suggest the close association of Cx
expression and GJ formation with HF morphogenesis. In addition, the ultrastructural observations
showed that the considerable number of the bulge cells, the putative stem cells, form GJs during
human HF development. 
0798
EDA function in skin appendage formation revealed by conditional transgenic mice
C Cui,1 M Durmowicz,1 B Griggs,2 A Srivastava2 and D Schlessinger1 1 Laboratory of Genetics,
NIH/NIA, Baltimore, MD and 2 Self Research Institute of Human Genetics, Greenwood Genetic
Center, Greenwood, SC
Mutations in the X-linked EDA gene cause Anhidrotic Ectodermal Dysplasia (EDA) with lesions in
skin appendage formation; mutations in mouse EDA give similar “Tabby” phenotype. Among sev-
eral EDA splice isoforms, the longest, EDA-A1 and EDA-A2, which belong to the TNF ligand fam-
ily, activate NF-kB transcription factors through corresponding receptors, EDAR and XEDAR. To
get clues to the function of EDA in skin appendage formation, we generated Tet-regulated condi-
tionally expressed EDA-A1 and EDA-A2 isoforms as transgene in Tabby and wild-type mice. Here
we show that the expression of the EDA-A1 transgene fully restored guard hair follicles and sweat
glands, but did not restore zigzag hair, and instead strongly suppressed zigzag hair follicle forma-
tion in wild type mice. In addition, marked hyperplasia of sebaceous glands was observed in response
to high levels of EDA-A1 in transgenic Tabby mice, and was reversed when transgene expression
was turned off. In contrast to the effects of EDA-A1, the EDA-A2 transgene restored neither hair
follicles nor sweat glands, and had no effect on sebaceous glands, indicating that it likely functions
in cooperation with other isoforms. The results reveal isoform-specific actions during skin appendage
formation, and further suggest possible interactions of different EDA isoforms. 
ABSTRACTS THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
0799
The in vitro differences between hair follicle bulge stem cells and hair bulb keratinocytes
Q Tao, C Photopoulos and S Lyle Pathology, Beth Israel Deaconess Medical Center, Boston, MA
The goals of this study are to define the in vitro characteristics of keratinocyte stem cells, isolated
from the bulge region of human hair follicles, and determine how they differ from the transit-ampli-
fying (TA) cells from the hair bulb. We used telogen follicles, plucked from dispase-treated human
scalp, to generate primary keratinocyte cultures from this stem cell-enriched area. We also dissected
the bulb region of anagen follicles to obtain matrix/TA keratinocytes. We then compared the in vitro
properties of cell adhesion, cell migration, clonogenicity and in vitro life-span for these two popu-
lations. We observed epithelial outgrowths from the bulbs within two days of explant, consistent with
the active proliferation of TA cells, while telogen outgrowths appeared between 7-10 days after
explant, reflecting their normal in vivo quiescent nature. After growing for two weeks, the cells
were re-plated and analyzed. Both populations formed colonies, however the stem cells from telo-
gen follicles formed more colonies than bulb keratinocytes (147+/- 14 vs 83 +/- 9), and more colonies
> 3 mm (41% vs 23%). When the cells were sub-cultured, telogen cells formed colonies until pas-
sage 6 when they only formed terminally differentiated cells, while bulb cells terminally differenti-
ated at passage 3. On cell adhesion assays, the ratio of cells rapidly adhering to collagen IV within
10 min. was greater in stem cells vs. TA cells, 84.6% vs 55% respectively. Most strikingly, bulb ker-
atinocytes showed a 7-fold greater mobility on migration assays than the telogen bulge stem cells
(.704 vs .102 microns/min.) Our results show distinct in vitro differences between stem cells from
the telogen bulge and TA cells from the anagen bulb. These assays thus help to define the hair fol-
licle stem cell phenotype and correlate with the in vivo properties of stem cells such as permanent
residence within the stem cell niche, tightly adherent to the basement membrane. The assays can
also now be used to determine the molecular requirements which maintain the differences between
stem and TA cells. 
0800
Inhibition of PKC activity slows hair growth: possible involvement of COX2
K Shamoun, H Park and BA Gilchrest Department of Dermatology, Boston University, Boston, MA
The expression of cyclooxygenase 2 (COX2) mRNA was shown to be increased in depilation-induced
anagen phase of the hair cycle, mainly in the outer root sheath cells. Protein kinase C (PKC) appears
to regulate COX2 expression in that TPA, known to first activate and later deplete PKC, induces the
protein level of COX2 in both mouse and human keratinocytes. We have observed that the topical
application of a selective PKC inhibitor Bisindolylmaleimide (300µM) (Bis) caused shortening and
thinning of hair in mouse and guinea pigs after 5 weeks twice daily application. In order to explore
the role of COX2 in mediating this effect of PKC inhibition, sections from biopsies taken from areas
of hair regrowth on the backs of guinea pigs at end of the experiment were stained using an antibody
against COX2. COX2 staining was strongest in the outer root sheath cells, as previously reported,
but less in Bis-treated areas than in vehicle-treated areas. To further explore whether Bis-induced
changes in hair growth may involve COX2, paired cultures of primary human keratinocytes were
treated with 10-7M TPA or vehicle alone, or 100µM Bis alone or Bis plus TPA for 24 or 48 hours.
Within 24 hours of treatment, TPA induced a dramatic differentiation of keratinocytes as judged by
culture morphology, as previously reported. However, the PKC inhibitor Bis completely blocked
TPA-induced differentiation. Immunoblot analysis using cells harvested after 48 hours showed that
TPA induced COX2 protein, as previously reported, and this induction was completely blocked by
simultaneous treatment with Bis. These results suggest that initial PKC activation, rather than its
subsequent depletion by TPA, is responsible for COX2 inhibition. Further, the data suggest a role
for COX2 in regulating hair growth. 
0801
WNT signals in the initiation of epidermal appendage development
EY Chu,1 T Andl,1 J Hens,2 JJ Wysolmerski2 and SE Millar1 1 Dermatology, University of
Pennsylvania, Philadelphia, PA and 2 Internal Medicine, Yale University, New Haven, CT
Stem cells in the embryonic epidermis give rise to several types of appendages, including hair,
mammary glands and teeth, in addition to the epidermis. We have previously shown that WNT
paracrine intercellular signaling molecules are required for the initiation of hair follicle development.
We hypothesize that WNTs are generally required for embryonic epidermal stem cells to adopt an
appendageal fate. To test this hypothesis we examined WNT pathway gene expression during devel-
opment of the mammary streak and mammary buds. Of multiple Wnt genes surveyed, we found that
Wnt10b shows the earliest specific localization to the mammary region, being expressed in the mam-
mary streak epithelium and in the mammary buds as they develop. Wnt6 is strongly expressed in
mammary buds at slightly later stages, and Wnt4, Wnt5a, Wnt7a, Wnt10a, and Wnt11 are expressed
at lower levels. We find that WNT pathway genes such as beta-catenin, Kremen1, and Kremen2,
and Lmx1, a known target of Wnt7a, are expressed at early stages of bud development. To deter-
mine whether inhibition of WNT signaling blocks the initiation of mammary streak or bud devel-
opment we examined the mammary region in transgenic embryos expressing high levels of the potent
WNT inhibitor Dickkopf 1 (DKK1) in the surface epithelium. These embryos lack any histological
sign of mammary bud formation. To determine the precise stage at which mammary bud develop-
ment is arrested we examined expression of Wnt10b, beta-catenin and Fgf10, an early regulator of
mammary streak formation, in DKK1-expressing and control embryos. We find that DKK1 pre-
vents localized expression of Wnt10b and beta-catenin in the mammary region epithelium. How-
ever, expression of Fgf10 in the mesenchyme underlying the presumptive mammary streak is unaf-
fected by Dkk1 at E10. These results suggest that WNT signals are required downstream of Fgf10
for the initiation of mammary streak development, and support the hypothesis that WNTs are nec-
essary for epidermal stem cells to adopt an appendageal fate. 
0802
Identification and characterization of cornifelin, a novel cornified envelope component, related
to psoriasis
M Seishima,1 H Michibata,2 K Wakimoto,2 H Chiba,2 Y Imai2 and K Okubo3 1 Dermatology, Ogaki
Municipal Hospital, Ogaki, Japan, 2 Discovery research laboratory, Tanabe Seiyaku, Osaka, Japan
and 3 Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan
To identify psoriasis-related genes, we compared mRNA populations of normal and psoriatic skin
by random 3’-directed tag sequencing from non-biased cDNA libraries. We selected one of candi-
date genes, designated as cornifelin, which showed the increased expression in psoriatic skin. Cornife-
lin contains 112 amino acids with a predicted molecular weight of 12367 Da and is expressed only
in uterus, cervix, and fetal skin by Northern blot. Cornifelin transcript was expressed in the granu-
lar cell layers of the epidermis in uninvolved psoriatic skin, and widely detected in the upper-spin-
ous layers in psoriatic skin, but not in normal skin, by in situ hybridization analysis using a cornife-
lin riboprobe. To investigate the function of cornifelin, we established a transgenic mouse line
overexpressing human cornifelin in the epidermis using a human involucrin promoter. Cornifelin
protein was detected in both protein fractions precipitated with anti-loricrin and anti-involucrin
antibodies using the specific antibody against cornifelin, suggesting that cornifelin is directly or indi-
rectly cross-linked to other cornified envelope proteins, loricrin and involucrin. Transgenic mice of
cornifelin showed reduced expression of loricrin and enhanced expression of involucrin without
altered expressions of K6, K10, and K14 and other morphological changes compared to wild type
mice. In this study, we found a novel cornified envelope component, cornifelin, which may be involved
in the pathological processes of psoriatic epidermis. 
0803
Caspase-9 pathway is involved in the induction of apoptosis by TGF-beta: a possible catagen
mechanism in human hair cycle
T Hibino and Y Tsuji Shiseido Life Science Research Center, Yokohama, Kanagawa-ken, Japan
We have already shown that TGF-beta2 plays an essential role in the induction of the regressing
phase, catagen, during the human hair cycle. In this study, we analyzed mechanism of apoptotic cell
death induced by TGF-beta2. mRNA processed to cDNA from immortalized outer root sheath cells
(IORS) were compared with or without 25 ng/ml of TGF-beta2 at 30 h using Clontech human plas-
tic 83K array. TGF-beta2 induced variety of signal transduction molecules including kinases and
phosphatases. Proteasome componens were up-regulated, whereas matrix metallo proteases were
down-regulated. Interestingly upregulation of caspase-9 and down regulation of caspase-8 were
noticed. For the confirmation of microarray results, real-time PCR was carried our using LightCy-
cler system. Caspase-9 and caspase-3 mRNAs were gradually increased with time reaching 3-fold
increase at 48 h in the presence of TGF-beta2. Expression of caspase-8 was slightly decreased or
not altered significantly. Essentially the same results were obtained for the primary ORS cells.
Immunohistochemical study demonstrated that active caspase-9 and caspase-3 were localized in the
regressing ORS cells in the transient stages of human catagen hair follicles in vivo. Furthermore
hair follicles cultured with TGF-beta2 showed activation of these caspases in ORS cells. Collectively
our results indicate the catagen induction mechanism as follows. TGF-beta2, that is upregulated
during the transition phase, triggers synthesis and accumulation of caspas-9 and 3, resulting the
activation of intrinsic caspase network to eliminate follicular keratinocytes. 
0804
Impaired sonic hedghog signaling and defective hair germ formation and elongation in laminin
10 deficient mouse
Y Zhang,1 Y Chen,2 H Zhen,2 AE Oro,2 JH Miner,3 MP Marinkovich2 and J Li1 1 Dermatology and
Cutaneous Surgery, University of Miami, Miami, FL, 2 Dermatology, Stanford University, Stanford,
CA and 3 Renal Division and Cell Biology and Physiology, Washington University, St. Louis, MO
Mesenchymal-epithelial interaction plays a critical role during hair follicle development. The defect
of hair germ formation and elongation in laminin 10 (alpha5beta1gamma1) deficient (lam a5-/-)
mouse suggests an important role of laminin 10 in this process. Sonic hedgehog (Shh) signaling has
been implicated in hair germ invagination and elongation downwards into the dermis. In this study,
we examined the mRNA expressions of Shh and its downstream effector Gli 1 in laminin 10 defi-
cient mouse skin hair follicles using in situ hybridazation with [35S]-UTP-labeled Shh and Gli 1
specific riboprobes. Due to the fact that laminin 10 homozygous knockout (lam a5-/-) mouse embryos
die at about gestation day 16.5 (E16.5), we studied skins from the embryo E16.5 and their grafts
that had been grafted onto nude mice for 5 days. While Shh and Gli 1 expressions were observed in
wild type skin localized to hair germs in E16.5 skin and elongating hair germs in 5-day grafts, a dra-
matic decreased expression of Shh or Gli 1 was noted in mutant skin of the embryo or graft sam-
ples. Semi-quantitative and statistical analyses confirmed significant difference in the mRNA expres-
sion levels of Shh and Gli 1 in the wild type and mutant skins. Our study indicates that the defect in
the formation of hair germ and failure of hair germ elongation in laminin 10 deficient skin are likely
the direct result of impaired Shh signaling. The data also suggests that normal expression of laminin
10 may be required in part in the activation of Shh signaling pathway during hair follicle develop-
ment. 
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The zebrafish: a vertebrate genetic model for studying cutaneous biology
VH Nguyen,1 J Schumacher,2 C Yeol-Yeo,3 M Whitman3 and MC Mullins2 1 Dermatology,
University of Pennsylvania, Philadelphia, PA, 2 Cell and Developmental Biology, University of
Pennsylvania, Philadelphia, PA and 3 Harvard Medical School, Boston, MA
The zebrafish has emerged as an important vertebrate genetic model for the study of numerous devel-
opmental and biological processes. Our recent investigations have focused on neural crest specifi-
cation and scale development utilizing zebrafish mutants. Melanocytes are a derivative of the neu-
ral crest. Three zebrafish mutants exhibit interesting abnormal neural crest phenotypes: swirl
(swr/bmp2b) with greatly reduced or absent neural crest progenitors (NCP); somitabun (sbn/smad5)
with a large expansion in the number of NCP; and snailhouse (snh/bmp7) with a moderate expan-
sion. All three are members of the Bone Morphogenetic Protein (BMP) signaling pathway. We show
evidence that different residual levels of BMP signaling exist in these mutants. We propose that low
levels of BMP signaling, as is likely found throughout most of the sbn/smad5 mutant embryo, spec-
ifies NCP from presumptive naive ectoderm. We put forth a model to explain the NCP phenotypes
displayed by these mutants in terms of levels of BMP signaling. We tested this model by several
approaches: overexpression of mRNA encoding various members and inhibitor of the BMP path-
way in order to change the level of BMP signaling in mutants/wild-type embryos; antisense/Mor-
pholino technology; and Western Blot analysis using an antibody specific for the activated form of
Smad 1/5, downstream members of the BMP pathway. Our results are consistent with our proposed
model. We also have begun analyzing the development of scales in the zebrafish. Our gene expres-
sion analysis have shown evidence for various signaling pathways, including Wnt, Sonic Hedgehog,
BMP, and Notch/Delta in the development of scale placodes, as reported for hair. Analysis of a scale-
less mutant also has begun. 
0807
Development of gene-switch-Smad7 transgenic mice for studying the molecular mechanisms
of Smad7 in skin development
G Han,1 AG Li,1 W He,1 D Wang,1 P ten Dijke2 and X Wang1 1 Otolaryngology, Dermatology,
Oregon Health & Science University, Portland, OR and 2 Div. of Cell Biology, The Netherlands
Cancer Institute, Amsterdam, Netherlands
Smad7 is a signaling inhibitor of the TGFβ super family. Previously, we have generated Smad7 trans-
genic mice, using a keratin 5 (K5) promoter. K5.Smad7 mice exhibit a severe delay in hair follicle
development and die at neonatal stage. Consistently, K5.Smad7 transgenic skin exhibited reduced
β-catenin protein. However, it is not clear whether this change is directly induced by Smad7 or the
consequence of pathological changes. Additionally, the early death of K5.Smad7 founders precludes
them to be used in studying the functions of Smad7 during hair follicle development in embryos and
hair cycling in adults. Therefore, we have generated gene-switch-Smad7 mice in which Smad7 trans-
gene expression can be induced by application of RU486. At day 14 pregnancy, mice carrying gene-
switch-Smad7 embryos were injected s.c. with RU486. The embryos were dissected at E18.5. Hair
follicles in Smad7 transgenic embryos were at the stage equivalent to E14.5 in normal embryos, indi-
cating that Smad7 overexpression blocks hair follicle development at the earliest stage. Twelve hours
after single topical application of RU486 to gene-switch-Smad7 mouse skin resulted in a significant
reduction of β-catenin protein. Thus, down regulation of β-catenin is likely a direct effect of Smad7
overexpression and contributes to delayed and aberrant hair follicle development. To study the role
of Smad7 in hair cycling, Smad7 overexpression was induced at different stages of hair follicle
cycling. After Smad7 transgene induction, hair follicles exhibited a significant delay in the transi-
tion from telogen to anagen. In addition, apoptosis at the categen phase was blocked after acute
Smad7 induction, suggesting that blocking TGFβ1-induced apoptosis is one of the mechanisms by
which Smad7 delays hair follicle cycling. Our results show that the gene-switch-Smad7 transgenic
mice are a unique model to delineate the functions and molecular mechanisms of Smad7 in the skin. 
0809
Prolactin regulates onset of anagen and size of underhair follicles in mink (Mustela vison)
J Rose, S Larson and J Hunt Biological Sciences, Idaho State University, Pocatello, ID
In mink, ♠ 10-20 hair follicles develop from a common follicular canal into bundles of; G-type: one
large guard hair plus a variable number of underhairs, I-type: one intermediate size guard hair plus
a variable number of underhairs, and U-type: underhairs only. Winter anagen is correlated with
reduced serum prolactin (PRL) levels, and maximum hair density, whereas summer anagen is cor-
related with elevated serum PRL levels and minimum hair density. Our objectives were to deter-
mine if PRL has effects on anagen initiation, hair diameter and/or density, and if the effects are medi-
ated equally between fiber or bundle type (G, I or U). Mink (4/group) in telogen (Feb 20), were
treated as; Haloperidol (HAL), Melatonin (MEL), or Controls, and the dorsal skin plucked of hair
to induce anagen. Onset of anagen in HAL (Mar 27) and MEL (Mar 29) treated mink occurred ear-
lier than controls (April 9; P•0.05).  Serum PRL levels were 5.6 ± 0.91 ng/ml (Control), 7.8 ± 1.1
ng/ml (HAL; P•0.05), and undetectable in MEL-treated mink. Density of I-Guard hairs (4.93 ± 0.05
/ mm2) was greater than G-guard hairs (3.15 ± 0.05 / mm2; P•0.05), but the diameter of G-guard hairs
(127.5 ± 1.53 µm) was greater than I-type (51.0 ± 0.34 µm; P•0.01). There was no difference in
guard hair density or diameter in response to treatments. Density of underhairs in all bundle types
was reduced by HAL and increased by MEL (P•0.05). Underhair diameters did not differ between
G, I & U bundles within treatments groups, but were increased in response to HAL (18.7 ± 0.78 µm)
and decreased by MEL (9.5 ± 0.56 µm) compared to controls (14.1 ± 0.082 µm; P•0.01). Finally,
underhair diameters of mink in spontaneous summer anagen (13.0 ± 0.14 µm) were greater than
those of mink in winter anagen (10.6 ± 0.14 µm; P•0.001). We propose that during the summer,
PRL initiates anagen and increases follicular size in a portion of the underhair follicles, which results
in reduced fur density. In contrast, during winter, low PRL levels results in reduced follicular size,
but a greater number of follicles entering anagen. 
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A novel WNT agonist is required for epithelial-mesenchymal interactions in the hair follicle
R O’Shaughnessy,1 W Yeo,1 J Gautier,1 C Jahoda2 and A Christiano1 1 Columbia University, NY,
NY and 2 Durham University, Durham, United Kingdom
There is an absolute requirement for reciprocal signalling in the maintenance of epithelial-mes-
enchymal interactions during hair follicle morphogenesis and cycling. Secreted factors of the
WNT/Wingless family have been implicated in both the first epithelial message and also in mainte-
nance of inductive ability in the mesenchyme. In the adult hair follicle, anagen is maintained by the
interaction between the mesenchymal condensation known as the dermal papilla (DP) and the over-
lying proliferative matrix cells, while the dermal sheath (DS) is physically isolated from signals from
the hair follicle epithelium. We performed gene expression analysis between rat vibrissae DP and
DS with the hypothesis that genes expressed in the DP but not in the DS may be specifically deter-
mined by the interaction with the overlying epithelial cells. A number of genes are induced in the
DP as a result of the interaction, the most prominently induced gene being the uterine sensitivity
associated protein, USAG-1. During anagen, this secreted factor is expressed in a domain confined
to the region of epithelial-mesenchymal interaction in the hair follicle and by RT-PCR we show that
the expression of USAG-1 falls rapidly when the DP cells are cultured. In vivo experiments in
Xenopus laevis embryos and in vitro transfection experiments on cultured NIH3T3 cells show that
USAG-1 can enhance signalling by specific WNTs while concomitantly down regulating signalling
by the TGFb superfamily of genes. The same WNTs are expressed in the hair follicle during ana-
gen, as are their co-expressed secreted inhibitors, the secreted frizzled-related proteins (sFRPs). We
hypothesize that USAG-1 modulates the interaction between the WNTs and sFRPs to control not
only hair follicle differentiation, but epithelial-mesenchymal interactions in general. 
0806
Epithelial and mesenchymal mitogens stimulate VEGF expression in cultured dermal papilla
cells
U Kozlowska,1 U Blume-Peytavi,2 C Sommer,2 CE Orfanos,2 S Jablonska1 and S Majewski1 1
Dermatology, Warsaw Medical School, Warsaw, Poland and 2 Dermatology, University Medical
Center B. Franklin, Free University of Berlin, Berlin, Germany
Vascular Endothelial Growth Factor (VEGF) acting selectively on endothelial cells induces angio-
genesis and enhances vascular permeability. In previous studies we found, that human cultured der-
mal papilla cells synthesize VEGF, implicating its role in hair vascularisation. Moreover VEGF syn-
thesis was influenced in vitro by addition of proinflammatory cytokines suggesting possible link
between vascular supply and the development of inflammatory processes involving human hair fol-
licle. The aim of this study was to find the relationship between hair cycle regulating growth factors
and VEGF synthesis from hair papilla. Several growth factors: EGF, TGFα, TGFβ-1, bFGF, PDG-
Faa, IGF-1 and NGFβ, mitogens for various epithelial and mesenchymal cells and influencing hair
growth cycle were investigated for their effect on VEGF gene expression and protein synthesis in
cultured dermal papilla cells. VEGF mRNA expression was measured by semiquantitative RT-PCR
method and VEGF proteins by radioimmunoprecipitation. Growth factors known to be promoters
of angiogenesis like TGFβ1, PDGFaa as well as anagen-promoting IGF-I significantly stimulated
VEGF mRNA expression in dermal papilla cells. The highest VEGF mRNA levels in DPC were
observed after stimulation with EGF and IGF-1 after 2 hours. Hair cycle-dependent vascular changes
are probably regulated by the same cytokines and growth factors, which control hair growth cycle,
and are synchronized with the growth of other follicular structures. The investigation of VEGF expres-
sion in DPC in vitro may serve as a model of influencing angiogenetic processes associated with
human hair follicle, and therefore might be potentially useful in finding new treatment options of
alopecia. 
0810
TAp63α induces a squamous epithelial program but blocks terminal differentiation
MI Koster1 and DR Roop1,2 1 Program in Developmental Biology, Baylor College of Medicine,
Houston, TX and 2 Departments of Molecular and Cellular Biology and Dermatology, Baylor
College of Medicine, Houston, TX
Expression of p63, a transcription factor that is transcribed into six isoforms, is required for proper
development of stratified epithelia, such as the epidermis. To determine the role of p63 isoforms
during epidermal development, we are using in vitro and in vivo models. We demonstrated that two
p63 isoforms that contain a transactivation domain, TAp63α and TAp63γ, can induce K14 expres-
sion in cell lines and primary p63-/- keratinocytes. Since K14 is one of the first structural proteins
expressed during normal epidermal development, this suggests a role for TA isoforms in the com-
mitment of single-layered epithelia to squamous epithelial lineages. To determine the in vivo func-
tions of TAp63α and ∆Np63α in epidermal differentiation, we are using inducible mouse models in
which epidermal-specific transgene expression is achieved by topical application of RU486. Inducible
TAp63α and ∆Np63α mice were bred with mice carrying the activator construct driven by a K14
promoter (K14.Glp65). Skin biopsies from RU486-treated newborn or adult mice exhibited severe
hyperplasia in K14.Glp65/TAp63α skin while K14.Glp65/∆Np63α skin was mildly hyperplastic.
In addition, the differentiation process in K14.Glp65/TAp63α skin was perturbed as demonstrated
by a delayed onset of K1 expression. Despite the mild hyperplasia, K1 expression appeared normal
in K14.Glp65/∆Np63α skin. In addition, more BrdU-positive cells were observed in the epidermis
of K14.Glp65/TAp63α as compared to K14.Glp65/∆Np63α mice. In summary, transient expression
of TAp63α in the epidermis results in perturbed epidermal differentiation, hyperproliferation and
severe hyperplasia. Expression of ∆Np63α, however, results in mild hyperplasia without effects on
epidermal differentiation. These data suggest that although TAp63α is required for the induction of
a squamous differentiation program, it prevents terminal differentiation. Therefore, downregulation
of TAp63α and induction of other p63 isoforms may be required for normal epidermal differentia-
tion. 
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Identification of androgen-inducible TGF-beta1 from balding dermal papilla cells as a key
mediator in pathogenesis of androgenetic alopecia
S Inui, Y Fukuzato, T Nakajima, K Yoshikawa and S Itami Department of Dermatology, Osaka
University School of Medicine, Suita-shi, Osaka, Japan
We attempted establishing an in vitro coculture system by using human dermal papilla cells (DPCs)
from androgenetic alopecia (AGA) and keratinocytes (KCs) to explore the role of androgens in hair
growth regulation. Androgen showed no significant effect on the growth of KCs when they were
cocultured with DPCs from AGA. Because the expressions of mRNA of androgen receptor (AR)
decreased during subcultivation of DPCs in vitro, we transiently transfected the AR expression vec-
tor into the DPCs and cocultured them with KCs. In this modified coculture, androgen significantly
suppressed the growth of KCs by ~50%, indicating that overexpression of AR can restore the respon-
siveness of the DPCs to androgen in vivo. We found that androgen stimulated the expression of TGF-
beta1 mRNA in the cocultured DPCs. ELISA assays demonstrated that androgen treatment increased
the secretion of both total and active TGF-beta1 in the conditioned medium. Moreover, the neutral-
izing anti-TGF-beta1 antibody reversed the androgen-elicited growth inhibition of KCs in a dose-
dependent manner. Together, androgen-inducible TGF-beta1 derived from DPCs of AGA is involved
in epithelial cell growth suppression in our coculture system, suggesting a potential role of TGF-
beta1 in the pathogenesis of AGA. 
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Localization of versican in human hair follicle: implication of proteoglycan involvement in ana-
gen induction and hair elongation
T Soma, M Tajima and J Kishimoto Shiseido Life Science Center, Yokohama, Japan
Proteoglycans are present in the extracellular matrix and play multiple roles in regulating cell-cell
communication and modulating growth factor activity and turnover. Versican is a large chondroitin
sulphate proteoglycan and transgenic mouse study showed its pivotal role both in mesenchymal con-
densation and hair induction. Versican immunoreactivity has been localized in the dermal papilla
(DP) of active hair follicles (anagen) in mice but not clear in human species. We examined versican
mRNA expression in human hair follicles using the automated in situ hybridization (ISH) system
and also compared the sites of versican mRNA expression with the sites of versican immunoreac-
tivity. Human scalp skin specimens (29 years old male and 50 years old male) obtained from plas-
tic surgery were fixed with 10 % phosphate-buffered formalin and riboprobes specific to human
versican were prepared by in vitro transcription. The 2-B-1 monoclonal antibody against versican
core protein moiety was used for the immunohistochemical (IHC). Versican mRNA was expressed
in the DP cells in anagen hair follicles, but not in dermis. Expression of versican gene was appar-
ently decreased in the DP cells of catagen hair follicles and was not detectable in telogen hair folli-
cles. Consistent with ISH results, versican immunoreactivity was extended over the DP of anagen
hair follicles. This staining was diminished in the catagen phase of human hair follicles. The remain-
ing activity of the versican signals at catagen stage confined at the upper side of DP by ISH and IHC..
Versican immunoreactivity in the DP was partially lost in terminal hair follicles and almost lost in
vellus hair follicles seen in the tissue sections of male pattern baldness. Interestingly, versican
immunoreactivity was also remained around the bulge region of anagen hair follicle although no
mRNA expression was detected. Our result suggests that versican production may be important for
hair induction and maintenance of the normal growing phase of human hair follicles. 
0813
Primary cicatricial alopecia: histopathologic findings do not distinguish clinical variants
P Mirmirani,1 A Willey,1 JT Headington,4 K Stenn,3 T McCalmont2 and VH Price2 1 Dermatology,
Case Western Reserve University, Cleveland, OH, 2 University of California, San Francisco, CA,
3 Aderans Research Institute, New Jersey, NJ and 4 Private, Denver, CO
All patients with active primary cicatricial alopecia seen at the UCSF Dermatology clinic were eli-
gible. Patients with active disease had symptoms of itching, burning, or pain, had progression of
hair loss, a positive pull test, and clinical evidence of inflammation. Two 4 mm scalp biopsies (affected
and unaffected ) were done. 6 horizontal sections were cut and stained with hematoxylin and eosin
and interpreted blindly by one investigator (JTH). 20 patients (5 male/15 female) were enrolled with
an average age of 48 years and average duration of disease of 7 years. Clinical diagnosis included:
lichen planopilaris (LPP)(5), frontal fibrosing alopecia(2), pseudopelade(Brocq)(3), central cen-
trifugal alopecia(2), folliculitis decalvans(6), and tufted folliculitis(2). Histologic and clinical diag-
noses were concordant in 14/20 cases(70%). Biopsy samples of clinically uninvolved scalp had evi-
dence of disease in 11/20 patients (55%). Sebaceous glands were absent in 19/20 (95%) of the biopsies
from clinically affected lesions. Tufted folliculitis was histologically indistinguishable from folli-
culitis decalvans, and frontal fibrosing alopecia was indistinguishable from LPP. In addition, biop-
sies from LPP and frontal fibrosing alopecia were indistinguishable from other lymphocyte-medi-
ated cicatricial alopecias including pseudopelade (Brocq) and central centrifugal alopecia. We therefore
conclude that current histopathologic techinques do not distinguish clinical variants of the above pri-
mary cicatricial alopecias. A descriptive, standardized histopathologic reporting of follicular archi-
tecture, type, location, and extent of the inflammatory infiltrate, presence or absence of sebaceous
glands, presence of fibrosis, may be of most benefit to clinicians evaluating and treating patients with
primary cicatricial alopecia. 
0814
Eflornithine hydrochloride 13.9% cream alters beard hair fiber curvature and diameter in
African-American men with pseudofolliculitis barbae
S Chow, MK Hordinsky and ME Ericson Department of Dermatology, University of Minnesota,
Minneapolis, MN
This 16 week, open-label investigation evaluated the effects of eflornithine hydrochloride 13.9% top-
ical cream on ten African-American men with a two-year history of at least Grade 3 seudofolliculi-
tis barbae (PFB). Eflornithine hydrochloride 13.9% cream, an irreversible inhibitor of ornithine decar-
boxylase, has been shown to inhibit the organization of cytoplasmic actin filaments in cultured
keratinocytes. We hypothesized that application of eflornithine hydrochloride 13.9% cream would
alter the actin cytoskeleton of the beard hair follicle, cause a loss of follicle integrity, and affect hair
fiber development. A total of 1,246 pre- and post-treatment beard hair fibers were collected and
stained with rhodamine for analysis. Curvature, diameter, and cuticle scale structure and patterns
were determined using image analysis and laser scanning confocal microscopy. The PFB clinical
rating improved in 8 of the 10 subjects treated with eflornithine hydrochloride 13.9% cream. There
were no consistent changes in the cortical, medullary or cuticular structures or cuticle scale pat-
terns. However, post-treatment beard hair fibers had statistically significant higher fiber diameters
than pre-treatment fibers (135.8 microns vs. 130.7 microns, p=0.037). An increased proportion of
the post-treatment beard hair fibers also had distorted cross-section morphology compared to the cir-
cular axis of the pre-treatment fibers. No significant differences in fiber curvature were observed
between the pre- and post-treatment groups of hair fibers. However, 6 of 10 patients demonstrated
statistically significant changes of fiber curvature. Changes observed in erupted beard hair fiber cur-
vature and diameter after treatment with eflornithine hydrochloride 13.9% topical cream most likely
resulted from disruption of the actin cytoskeleton surrounding the beard hair follicle. 
0815
Epidermal hyperplasia and impaired morphogenesis of hair follicles in mice overexpressing a
soluble form of heparin-binding EGF-like growth factor
D Nanba,1,2 Y Shirakata,1 Y Nakanishi,3 Y Hieda,3 H Ishiguro,4 S Higashiyama2 and K Hashimoto1
1 Dermatology, Ehime University School of Medicine, Ehime, Japan, 2 Medical Biochemistry,
Ehime University School of Medicine, Ehime, Japan, 3 Biology, Osaka University, Toyonakashi,
Osaka, Japan and 4 Nippon Organon K.K., Osaka, Japan
HB-EGF, an EGF receptor ligand, is initially synthesized as a membrane-anchored form (proHB-
EGF), which is cleaved to produce a soluble form (sHB-EGF). The involvement of HB-EGF in ker-
atinocyte growth and migration has been well studied. However, the roles of HB-EGF and its pro-
cessing in skin development remain unclear. Therefore, we generated mice overexpressing sHB-EGF
under control of the K5 promoter and investigated its roles in skin development. The transgenic
mice showed epidermal hyperplasia and loss of hair. Histological analyses of the newborn mice indi-
cated impaired morphogenesis of follicular dermal papilla in skin overexpressing sHB-EGF. In the
embryonic period, mesenchymal aggregates under the hair placode, a precursor of the follicular
dermal papilla, make a tightly packed population of cells with little extracellular space. After cell
“compaction”, the cells separate and the extracellular space is restored in the dermal papilla after
birth. At postnatal day 1 (P1), the expression of heparan sulfate proteoglycan (HSPG), an extracel-
lular matrix molecule, was observed and the cells separated from each other in the dermal papilla of
wild-type mice. In the transgenic mice, however, HSPG was not detected and the cells tightly adhered
to one another in the dermal papilla of P1 skin, indicating that the dermal papillae of transgenic
mice remain in the compacted stage; subsequent development of the papillae and hair follicles does
not occur. The EGF receptor was detected in epidermal, but not the papilla, cells. These results sug-
gest that regulated processing of proHB-EGF is required for the organization of epidermal tissues
and dermal papilla formation in direct and indirect manners, respectively. 
0816
Localization of Myc/Mad1 protein in the hair follicle during hair cycle
N Saito, Y Hamada, Y Ohta and K Katsuoka Dermatology, Kitasato University, Sagamihara,
Kanagawa, Japan
Precise molecular mechanisms associated with transient growth/differentiation of follicular ker-
atinocyte have not been fully elucidated in the hair cycle. Resent observations have suggested that
proto-oncogene c-myc plays a pivotal role in the regulation of both apoptosis and growth in the
epithelial cells. Mad1 is a Myc antagonist that heterodimerizes with Max and functions as a tran-
scriptional repressor. Inhibition of proliferative activity subsequent to Mad1 overexpression has been
demonstrated in variety of cell types, including keratinocytes. However, little is known about the
Myc/Mad1 expression in follicular keratinocyte. (a) To elucidate whether c-Myc/Mad1 proto-onco-
genes could be involved in hair cycle, in situ expression of Myc/Mad1 protein was investigated. (b)
Immunohistochemical analysis were performed for the specimens taken from the plucking-induced
anagen hair follicle in C3H/HeNCrj mice and human anagen follicle. Antibodies against PCNA (pro-
liferating cell nuclear antigen), c-Myc, Mad1 were used. The expression of c-myc/mad1 mRNA were
semi-quantitated in different phases of hair cycle by RT-PCR. (c) Immunoreactivity for PCNA was
intensely observed both in the middle portion and matrix of hair folicle in the early anagen of pluck-
ing-induced hair regrowth in C3H mice. In mid anagen phase, PCNA positive cells were lacated only
the matrix. The expression of c-myc mRNA was detected in the mid-anagen phase, whereas mad1
mRNA was expressed in the early anagen phase. In contrast, c-Myc-positive cells were visible in
Huxley’s and Henley’s layer of inner root sheath and Mad1 was expressed in whole hair follicle by
confocal microscope. (d) These suggested that cells in mid-portion of hair follicle proliferate tran-
siently before plucking-induced anagen phase. Moreover, c-myc and mad overexpression might be
related with switching to the hair cycle. These findngs suggested that c-myc has been implicated not
only in the cell proliferation, but also in the terminal differentiation and mad has been implicated in
the cell differentiation in hair cycle 
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Post-natal acidification of stratum corneum in the neonate: functional consequences for the
neonate of a neutral pH
JW Fluhr,1,2 M Man,2,3 D Debra Crumrine,2,3 TM Mauro,2,3 PM Elias2,3 and KR Feingold2,3 1
Dermatology, Friedrich-Schiller-University Jena, Jena, Thueringen, Germany, 2 Dermatology and
Medicine, University of California, San Francisco, CA and 3 Dermatology and Medical Service,
Veterans Affairs Medical Center, San Francisco, CA
At birth, mammalian stratum corneum (SC) displays a near-neutral surface pH, which declines over
several days to weeks to an acidic pH, comparable to adults. An acidic pH is required for perme-
ability barrier homeostasis and SC integrity/cohesion. The post-natal acidification in the neonatal
rat SC where pH, as measured with a flat surface electrode, declines progressively from near-neu-
tral levels (pH 6.8) on day 0-1 post-natal to adult levels (pH 5.6) over the subsequent 5-6 days. The
basal transepidermal water loss (TEWL) is normal while acute barrier disruption by both tape strip-
ping and acetone treatment shows a delay in barrier recovery at day 0/1 compared to day 5/6. Acid-
ification experiments with “super-acids” and acid buffer systems reversed the negative impact of the
near-neutral pH at birth on permeability barrier homeostasis. On ruthenium tetroxide-stained elec-
tron-microscopy, the delay in barrier recovery was paralleled by normal lamellar body secretion,
but evidence of abnormal (=delayed) lamellar bilayer maturation. The biochemical basis for delayed
maturation could be further attributed to decreased beta-glucocerebrosidase activity. Blockade of the
sPLA2 and NHE1 pathways, previously shown to contribute to formation of an acid SC pH, pro-
voked a delay in neonatal acidification, and resulted in an impaired barrier homeostasis. Further-
more SC integrity/cohesion were impaired in either the case of a near-neutral pH at day 0/1 or fol-
lowing blockade of the sPLA2 and NHE1 pathways. The impaired SC integrity/cohesion was
associated with a decrease in corneodesmosomes and in desmoglein 1. Together, these results demon-
strate the progressively beneficial effect of the post-natal development of an acidic pH on perme-
ability barrier homeostasis and SC integrity/cohesion 
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Role of prolactin in human hair growth control: cross-connections to androgen receptor sig-
naling?
KA Foitzik,1 K Krause,1 U Ohnemus,1 M Nakamura,2 U Halsner,3 A Bettermann1 and R Paus1 1
Dept. Dermatology, University Hospital Eppendorf, Hamburg, Germany, 2 Dept. Dermatology,
Kyoto University, Kyoto, Japan and 3 Meditra, Graefelfing, Germany
Murine skin expresses prolactin (PRL), and PRL treatment induces premature catagen in murine
skin organ culture (Foitzik et al., Am J Pathol, in press), while PRL receptor (PRLR) null mice show
an altered hair follicle cycling pattern (Craven et al., Endocrinology 142:2533, 2001). Here, we
have investigated the expression of PRL and PRLR in human hair follicles (HF), and have studied
the influence of PRL on isolated human hair follicles in anagen VI. By immunohistochemistry (IH),
prolactin immunoreactivity (IR) was detected in human anagen VI HF in follicular keratinocytes,
while the dermal papilla was negative. Prolactin receptor IR showed a very similar pattern. In cata-
gen HF, prolactin and PRL receptor expression appeared to be upregulated. Contrary to a previous
report that PRL mRNA is not transcribed in human skin (Slominski et al., J Lab Clin Med 136:476,
2000), we show by RT-PCR that human hair follicles do express the PRL gene. Prl (400 ng/ml) sig-
nificantly inhibited hair shaft elongation and accelerated a catagen-like HF transformation in iso-
lated human hair follicles, where it also significantly reduced the number of proliferating and increased
the number of apoptotic cells in the hair bulb. When visualizing androgen receptors by IH, PRL-
treated hair follicles showed a substantial up-regulation of androgen receptor-IR in the hair bulb.
Currently, we are testing whether co-stimulation of human hair follicles with PRL and androgen
receptor antagonists abrogates the inhibitory influences on human hair growth in vitro, are search-
ing for target genes of PRLR-mediated signaling in the hair follicle and are investigating the influ-
ence of PRL on follicular androgen metabolism. These data support the hypothesis that PRL is a
locally generated hair growth inhibitor, possibly not only via direct, PRLR-mediated effects but also
via upregulation of androgen receptors. 
0821
17beta-estradiol, but not 17alpha-estradiol inhibits human hair growth in whole follicle organ
culture
LD Nelson,1 AG Messenger,2 R Karoo1 and J Thornton1 1 Biomedical Sciences, University of
Bradford, Bradford, West Yorkshire, United Kingdom and 2 Dept Dermatology, Royal Hallamshire
Hospital, Sheffield, United Kingdom
It has been know for a number of years that ovarian hormones can significantly influence the hair
cycle. In rats, mice and guinea pigs it has been clearly demonstrated that estrogens inhibit hair growth.
Although we have recently reported that estrogen receptors are expressed in the human hair follicle,
the role of estrogens in human hair growth is still unclear. Therefore, we have used a whole follicle
organ culture system to investigate the effect of both 17beta and 17alpha-estradiol on human hair
growth. Individual hair follicles from female occipital scalp were microdissected out from surrounding
skin and incubated individually in phenol red-free William’s E medium supplemented with L-glut-
amine, penicillin, streptomycin, 5mM glucose and either 10nM 17beta-estradiol, 10nM 17alpha-
estradiol or the vehicle control (0.0001% alcohol) (6 follicles per group). The increase in the length
of the follicles was measured sequentially with an inverted microscope fitted with an eyepiece
measuring graticule over a seven day period. Follicles in each group exhibited linear growth over
the seven day period. Follicles incubated with 17alpha-estradiol grew at the same rate as the control
group. However, follicles incubated with 17beta-estradiol grew at a significantly slower rate than
the control group (p<0.0001). These reults show that the biologically active estrogen, 17beta-estra-
diol, has a physiological effect on human hair growth in culture, which parallels the in vivo effects
seen in animals. We have previously shown that ERbeta is the receptor expressed in human hair fol-
licles in situ and that it is expressed in the cells of the dermal papilla and follicular epithelium. Stud-
ies are in progress to further elucidate the mechanism of action of estrogens and estrogen receptors
in the human hair follicle. 
0820
Expression and localisation of tight junction proteins in human hair follicles
M Stute, JM Brandner, S Kief, E Wladykowski and I Moll Department of Dermatology and
Venerology, University Hospital Hamburg-Eppendorf, Hamburg, Hamburg, Germany
Tight Junctions (TJ) are intercellular junctions selectively sealing cells and controlling the transcel-
lular pathway. They are well characterized in simple epithelia and endothelia but have only recently
been described in stratified epithelia such as epidermis. The human hair follicle comprises various
epithelial layers which are partly in morphogenical continuity with the epidermis and develop there
from during early fetal life. The barrier function of these epithelial layers seems to be important for
the universal continuity of the barrier represented by the skin. By using RT-PCR-techniques and
immunolocalization we show the presence of the TJ proteins ZO-1, occludin, and various claudins
in the hair follicle and demonstrate their heterogeneous distribution pattern within a given strata as
well as within the different epithelial layers. A colocalization of the various TJ proteins, arguing for
typical tight junction structures, can be observed especially in cell layers facing the hair shaft and
the stratum corneum, and in addition at the border between outer and inner root sheaths. Usually
they are found in close vicinity to desmosomal and adherens junction proteins. The morphological
and biological importance of these findings and the possible roles of TJ in hair follicles, e.g. in fol-
licular penetration and prevention of transepidermal water loss, are discussed. 
0818
Effect of transforming growth factor-b on the proliferation and differentiation of multipoten-
tial sphere colonies from skin
Y Kawase,1,2 Y Yanagi,1 T Takato,2 M Fujimoto1 and H Okochi1 1 Int.Med.Ctr.Jpn, Tokyo, Japan
and 2 Univ. of Tokyo, Tokyo, Japan
Skin derived precursor cells possess self-renewal and multipotential capabilities, which can give
rise to neuron, glia, smooth muscle cells (SMC) and adipocyte. Previous studies in vitro and in vivo
have demonstrated that transforming growth factor-b (TGF-b) plays a pivotal role in controlling
proliferation and differentiation of the skin cells. In this study, we investigated the effects of TGF-
b on mutipotential sphere colonies from the ear skin using a sphere forming assay, in which the mul-
tipotential cells can be grown in response to epidermal growth factor and basic fibroblast growth fac-
tor to form floating clusters of cells called sphere colonies. We found that the number, but not the
diameter, of the sphere colonies increased with an addition of TGF-b during the colony formation.
However, the capabilities of differentiation of the sphere colonies generated in the presence of TGF-
b were unaffected, as analyzed by the immunostaining of the differentiated progenies with antibod-
ies directed for neuron (b3 tubulin and neurofilament M), astroglia (Glial Fibrillary Acidic Protein)
and SMCs (a smooth muscle actin) together with an Oil red O lipid droplet staining. Similar results
were obtained when TGF-b was added after the cells were passaged, i.e. the number, but not the
diameter, of the daughter sphere colonies increased without affecting their capabilities of differen-
tiation. Interestingly, the percentage of SMCs increased when TGF-b was added after differentia-
tion was initiated, whereas the differentiation into other cell types was not perturbed. Together our
results demonstrate that the addition of TGF-b increased the number of the cells to initiate sphere
colony formation, raising the possibility that TGF-b can induce transdifferentiation of the skin cells
into immature phenotypes and the effect of TGF-b changes once a cue for differentiation is given. 
0822
Epidermal and hair follicle progenitor cells express melanoma-associated chondroitin sulphate
proteoglycan
PP Michael, L Ghali, A Quinn, S Wong, I Leigh and N Tidman Centre for Cutaneous Research,
University of London, London, United Kingdom
Basal keratinocytes in the epidermis and hair follicle are biologically heterogenous but must include
a stable subpopulation of epidermal stem cells. In animal models these can be identifed by their reten-
tion of radioactive label due to their slow cycle (label retaining cells) but human studies largely
depend on in vitro characterisation of colony forming efficiency and clonogenicity. Differential
integrin expression has been used to detect cells of increased proliferaitive potential but further stem
cell markers are urgently required for in vivo and in vitro characterisation. Using LHM2, a mono-
clonal antibody reacting with a high molecular weight melanoma associated proteoglycan (MCSP)
a subset of basal keratinocytes in both the interfollicular epidermis and the hair follicle have been
identified. Co-expression of MCSP with keratins K15 and K19 as well as b1 and a6 integrins have
been examined in adult and foetal human skin from hair bearing, non-hair bearing and palmoplan-
tar regions. Although MCSP co-expression with a subset of b1 integrin bright basal keratinocytes
within the epidermis would suggest that MCSP co-localises with epidermal stem cells, MCSP expres-
sion within the hair follicle was more complex and multiple sub-populations of basal ORS ker-
atinocytes are described. These data suggest that epithelial compartmentalisation of the ORS is more
complex than interfollicular epidermis and further supports the hypothesis that more than one hair
follicle stem cell compartment may exist. 
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The cutaneous vanilloid receptor 1 expression suggests multiple functions beyond sensory nerve
signaling
E Bodo,1,3 J Lazar,1 I Kovacs,2 G Czifra,1 L Kovacs,1 R Paus3 and T Biro1 1 Department of
Physiology, University of Debrecen, MHSC, Debrecen, Hungary, 2 Department of Pathology,
Kenezy Hospital, Debrecen, Hungary and 3 Department of Dermatology, University Hospital
Hamburg-Eppendorf, Hamburg, Germany
Vanilloid receptor 1 (VR1), a key molecular integrator of nociceptive sensory mechanisms, was
recently described to be functionally expressed in human epidermal keratinocytes. In this study, using
functional assays and immunohistochemical methods, our goal was to describe the expression of
VR1 in other cell types of human and mouse skin preparations. Both in mouse and human skin,
VR1 immunoreactivity (ir) was localized to the (mostly superficial layers of the) epidermis and to
inner and outer root sheath keratinocytes (but not to the dermal papilla fibroblasts) of hair follicles.
Furthermore, in human skin but not in mouse skin, strong VR1-ir was observed in sweat and seba-
ceous glands, in smooth muscle cells of vessels, and, as was revealed by double staining with cell-
specific markers, in mast cells and dendritic cells. Since hair follicles provide an excellent model
for exploring actions of various agents on the proliferation and differentiation of defined epithelial
cell subpopulations, we also investigated the effects of VR1 acting drugs on hair growth character-
istics. Preliminary results suggest that modification of VR1 by various vanilloid compounds (the
agonist capsaicin and the antagonist capsazepine) modulated hair shaft elongation of organ-cultured
human scalp hair follicles in a dose-dependent and VR1 receptor-mediated fashion. In summary,
VR1 is expressed in various cutaneous cell populations, and the functional presence of this recep-
tor/channel in hair follicle keratinocytes suggests that VR1-mediated signaling is involved in the reg-
ulation of follicular epithelial cell growth and differentiation. 
0824
Estrogen effects on murine and human hair follicle cycling
UG Ohnemus,1 M Uenalan,2 B Handjiski,2 M Nakamura,3 S Liotiri,1 F Conrad,1 A Bettermann1 and
R Paus1 1 Department of Dermatology, Universitiy Hospital Hamburg Eppendorf Unversity of
Hamburg, Hamburg, Germany, 2 Department of Dermatology, Charite, Humboldt University,
Berlin, Germany and 3 Department of Dermatology, Postgraduate School of Medicine, Kyoto,
Japan
Although 17 β-estradiol (E2) is a potent hair growth modulator, our knowledge of estrogen effects
on hair follicle cycling is still very limited. Here, we have investigated hair cycle-dependent estro-
gen receptor (ER) expression patterns, how E2 affects murine catagen development, and whether
E2 influences development and recovery from chemotherapy-induced alopecia in mice. Immuno-
histochemical staining (ABC-DAB, TSA) for ER α and ER β revealed that both receptor subtypes
are expressed throughout the murine hair cycle, with a maximum in telogen dermal papillae and
sebaceous gland. By RT-PCR we detected ER α, but not ER β transcripts during the entire murine
hair cycle, with a maximum in catagen and telogen skin. Female C57BL/6 mice were treated topi-
cally with E2 or with an ER antagonist (ICI 182.780) when follicles were in anagen stage VI. Stag-
ing was assessed macroscopically by dotmatrix planimetry and by quantitative histomorphometry.
We demonstrate that topical E2 induces premature catagen development while the ER antagonist had
no effects on catagen development. By promoting the dystrophic catagen pathway, topical E2 enhanced
cyclophosphamide-induced alopecia and significantly stimulated the re-growth of normally pig-
mented hair shafts. In organ-cultured human scalp hair follicles (female, temporal region), E2 (10-
6-10-9 M) slightly, but non-significantly, inhibited human hair shaft elongation in vitro and rather
prolonged the duration of the anagen phase in vitro (10-7 M). We conclude that murine pelage hair
follicles (fur coat) in vivo appear to show opposite E2 hair cycling effects compared with human




Fas and Fas-ligand are involved in the control of hair follicle response to chemotherapy
T Sharova, A Sharov, L Yelton, B Gi1chrest, and V Botchkarev Dermatology, Boston University
School of Medicine, Boston, MA
Anticancer drugs induce apoptosis in the hair follicles and hair loss, the most common side effect
of chemotherapy. Hair follicle response to cyclophosphamide is p53-dependent, and p53 mediates
chemotherapy-induced apoptosis in the hair follicle via modulating the transcription of p53 target
genes. In a C57BL/6 mouse model for chemotherapy-induced hair loss, we demonstrate that p53
targets Fas and Fas-ligand are involved in the control of hair follicle response to chemotherapy. By
semi-quantitative RT-PCR, the expression of both Fas and Fas-ligand transcripts is increased in full
thickness skin samples 24-72 hours after cyclophosphamide administration. By immunohistology,
Fas and Fas ligand are upregulated and co-localized with TUNEL in the hair matrix, outer and inner
root sheaths after cyclophosphamide treatment. In contrast to wild type mice, Fas-deficient mice
show significantly (p<0.05) reduced apoptosis in the hair follicle keratinocytes and retardation of
cyclophosphamide-induced hair follicle regression. Furthermore, administration of Fas-ligand neu-
tralizing antibody into wild type mice significantly (p<0.05) reduced a number of apoptotic cells in
the hair follicle and retarded a rate of hair follicle involution induced by cyclophosphamide. This
suggests that Fas signaling pathway is involved in apoptosis of hair follicle keratinocytes induced
by cyclophosphamide. These observations also indicate that locally administered inhibitors of Fas
signaling may be combined with p53 inhibitors to prevent or retard hair follicle response to chemother-
apy and chemotherapy-associated hair loss. 
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Scalp dermal papilla cell conditioned medium inhibits DMEM induced 3H-thymidine uptake
by epidermal keratinocytes and is modulated by estradiol and tamoxifen
J Thornton,1 LD Nelson,1 R Karoo1 and AG Messenger2 1 Biomedical Sciences, University of
Bradford, Bradford, United Kingdom and 2 Dept Dermatology, Royal Hallamshire Hospital,
Sheffield, United Kingdom
Estrogens influence the hair cycle, yet the cellular sites and mechanisms of estrogen action are still
poorly understood. Radioactive estrogens and androgens have been localised to the follicular der-
mal papilla in rodents and recently we reported that estrogen receptor beta is expressed in human
hair follicles in situ and dermal papilla cells in vitro. Since we have previously demonstrated andro-
gens stimulate cultured dermal papilla cells to secrete autocrine growth factors, we have incubated
cultured dermal papilla cells with estrogenic and non-estrogenic steroids to investigate the effect of
conditioned media on the DNA synthesis of primary cultures of epidermal keratinocytes. Primary
cultures of dermal papilla cells and epidermal keratinocytes were propagated using established meth-
ods. Primary dermal papilla cell lines (n=3) were incubated in phenol-free, serum-free DMEM in
the presence of vehicle control (0.0001% alcohol), 10nM 17β-estradiol, 10nM estrone, 10nM testos-
terone, 10nM DHT, 10nM 5α-androstane-3α, 17β-diol, 10nM 5α-androstane-3β, 17β-diol, 100nM
dexamethasone, 100nM tamoxifen or tamoxifen plus 17β-estradiol for 24h. The media was collected
and its effect on keratinocytes assayed using 3H-thymidine. Parallel dishes of keratinocytes were
incubated with unconditioned DMEM or keratinocyte serum-free medium +/- the relevant steroids.
Unconditioned DMEM significantly increased DNA synthesis by keratinocytes compared to con-
trol keratinocyte serum-free medium (p<0.0001). In contrast dermal papilla cell conditioned DMEM
significantly inhibited this response (p<0.0001). Furthermore, 17β-estradiol augmented this inhibi-
tion, which was antagonised by tamoxifen, while estradiol attenuated the stimulatory effect of tamox-
ifen. These results further amplify the role of dermal papilla cells in the regulation of epithelial cells
and provide important evidence for a role for estrogenic steroids in this process. 
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Multiple functions of Noggin in cutaneous development: leads and lessons from Noggin trans-
genic mice
A Sharov,1 L Weiner,2 T Sharova,1 F Siebenhaar,1 J Brissette2 and V Botchkarev,1 1 Dermatology,
Boston University School of Medicine, Boston, MA and 2 Cutaneous Biology Research Center,
Harvard University, Cambridge, MA
Noggin is an antagonist of bone morphogenetic proteins 2/4 (BMP-2/4), which play pivotal roles in
regulation cell proliferation, differentiation and apoptosis during development. To study the in vivo
functions of noggin in cutaneous development, transgenic mice overexpressing noggin under con-
trol of the K5 promoter were generated using C3H/HeJ mice as a background strain. K5-Noggin
transgenic mice are viable and fertile and show several cutaneous phenotypes different to the wild
type (WT) controls. Firstly, K5-Noggin mice show acceleration of hair follicle morphogenesis and
formation of enlarged hair follicles with increased proliferative activity in the hair bulb. Secondly,
K5-Noggin mice show hyperpigmented hairs with predominance of eumelanin, while agouti-type
hair pigmentation is seen in WT mice. Thirdly, K5-Noggin mice show severe alterations of ker-
atinocyte apoptosis and differentiation in the eyelids, which results in retardation of the eyelid open-
ing by 17-24 days. Reduction of apoptosis and retardation of cell differentiation seen in the eyelid
epithelium of K5-Noggin mice are associated with downregulation of expression of the apoptotic
receptors (Fas, p55 kD TNFR), Id3 protein, and keratinocyte differentiation markers (loricrin, involu-
crin). Since BMP-4, but not EGF accelerates opening of the eyelid explants isolated from K5-Nog-
gin transgenic mice and cultured ex vivo, this suggests that BMP signaling pathway operate inde-
pendently of EGF signaling in controlling eyelid opening. Thus, BMP-2/4 and noggin function as
critically important players in the control of genetic program of cutaneous development. Most impor-
tantly, noggin and BMP-2/4 regulate not only morphogenesis of skin appendages, but also control
the formation of openings in skin overlying sensory organs, such as the eye, to provide access for
environmental signals to sensory epithelia. 
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CD34 expression delineates a population of outer root sheath keratinocytes outside the bulge
area in the lower human anagen hair follicle
G Cotsarelis,1 C Trempus,2 Y Liu1 and RJ Morris3 1 Dermatology, University of Pennsylvania,
Philadelphia, PA, 2 Cancer Biology, National Center for Toxicogenomics, National Institute of
Environmental Health Sciences, RTP, NC and 3 Dermatology and Pathology, Columbia University,
New York, NY
Hair follicle bulge cells have properties of epithelial stem cells in that they are highly persistent,
rarely proliferate and can give rise to multiple cutaneous epithelial cell types in vivo. Recently, we
described CD34 as a cell surface marker for bulge cells in the mouse. To study the relevance of CD34
expression in human hair follicle stem cell biology, we immunostained tissue sections of human scalp
for CD34. Using two different anti-CD34 antibodies, we found that, unlike CD34 expression in the
mouse, CD34 was not expressed in human hair follicle bulge cells of telogen or anagen hair folli-
cles. Rather, within the cutaneous epithelium, CD34 expression was confined only to anagen hair
follicles, in the keratinocytes of the basal outer root sheath below the bulge and above the bulb. The
morphology of these cells differs from the bulge cells in that they are columnar and heavily glyco-
genated. Based on bromodeoxyuridine incorporation of human skin grafted to immunodeficient mice,
these cells proliferate more frequently than the bulge cells but less frequently than the bulb matrix
cells. Thus, CD34 expression defines outer root sheath cells within the human anagen hair follicle
that appear to have proliferative characteristics of early transit amplifying cells. Furthermore, although
bulge cells within both mouse and human preferentially express cytokeratin 15, their differing expres-
sion patterns with respect to CD34 may reflect the extremely different anagen durations of mouse
and human hair follicles. 
0831
Epidermal-specific loss of BMP receptor 1A results in dysgenesis of hair and teeth
T Andl,1 K Ahn,2 B Crenshaw III2 and SE Millar1 1 Dept. of Dermatology, University of
Pennsylvania, Philadlephia, PA and 2 Center for Childhood Communication, CHOP, Philadelphia,
PA
Several lines of evidence implicate BMP signaling in the development of epidermal appendages such
as hair and teeth. However, early lethality has precluded analysis of the effects of loss of function
mutations in BMP pathway genes on hair and tooth development. Here we have used conditional
gene targeting to reveal roles for the most widely expressed type I BMP receptor, BMPR-IA, in hair
and tooth development. We utilized several different lines of transgenic mice that express Cre recom-
binase in surface ectoderm: Brn4-Cre pedigree bcre-32, that shows ectopic Cre expression in limb
and mid-ventral ectoderm from 9.75 days post-coitum; and two mouse lines in which Cre is placed
under the control of a keratin 14 (K14) promoter that is active in surface ectoderm from embryonic
day 9.5 and subsequently in the basal layer of the epidermis, hair follicles and tooth epithelium. We
found that mice that are homozygous for a conditional allele of the Bmpr1a gene (Bmpr1a-cl) and
also carry bcre-32 survive up to 14-20 days after birth and display limb defects and a hairless mid-
ventrum. Bmpr1a-cl/Bmpr1a-cl mice carrying a highly active K14-Cre transgene die at birth with
limb defects and open eyes. However, use of a second, less active K14-Cre transgenic line prevented
perinatal lethality. These mice displayed missing or defective incisor teeth and extremely sparse,
short hair. Analysis of the histology of newborn and postnatal skin from bcre-32; Bmpr1a-cl/Bmpr1a-
cl and K14-Cre; Bmpr1a-cl/Bmpr1a-cl mice revealed an apparently normal density and spacing of
hair follicles in each case. However, differentiation of the hair shaft was severely disrupted in mid-
ventral skin from bcre-32; Bmpr1a-cl/Bmpr1a-cl mice and in ventral and dorsal skin in K14-Cre;
Bmpr1a-cl/Bmpr1a-cl mice. These results indicate that signaling through epithelial BMPR-1A is not
required for the initial stages of hair follicle morphogenesis, but plays an essential role in hair shaft
differentiation and in tooth development. 
0833
Signal transduction pathways responsible for restoring hair growth in alopecia areata mice
L Tang,1 JP Sundberg,2 S Pelech,1 H Lui1 and J Shapiro1 1 Medicine/Dermatology, University of
British Columbia, Vancouver, BC, Canada and 2 The Jackson Laboratory, Bar Harbor, ME
It has been found that mechlorethamine is the most effective therapy for alopecia areata (AA)-affected
C3H/HeJ mice and this is an ideal model system to explore the corresponding molecular mecha-
nisms of drug’s therapeutic actions on reversing autoimmune arrested follicular activity in AA. The
effects of various immuno-modulating drugs have been studied for different autoimmune disorders,
but little is known about the signaling pathways involved in their therapeutic responses. To study the
signaling pathways responsible for successful mechlorethamine therapy in AA mouse model, a West-
ern blotting-based multi-antibody proteomics assay was used. A total of 52 different protein kinases
were detected in the C3H/HeJ mouse skin and over 17 protein kinases showed significant differences
between control and mechlorethamine-treated skins. Protein kinases in the growth factor-mediated
Erk pathway (Raf1, Mek1, Erk1/2/3, S6K), the cell cycle regulatory kinases (CDK4/5/6/7), and the
multi-functional GSK-3 kinases were increased by mechlorethamine. The later have been linked to
follicular activity and also inhibit IL-2 production by T cells. Another interesting finding is that the
expression of cell adhesion mediated kinase FAK was dramatically decreased by mechlorethamine,
suggesting that this kinase might be responsible for T lymphocytes migration into targeted hair fol-
licles. Other kinases modulated by mechlorethamine are either important regulators of cell prolifer-
ation/differentiation (PKG, PKB, PKC, CK-2) or linked to immune functions (PIM1, PKB). These
signal transduction pathways may represent the initial molecular events in mouse skin upon suc-
cessful mechlorethamine treatment and will accelerate the target discovery process for treating AA.
The findings from this study may also shed light on the precise mechanism of action of
mechlorethamine on cutaneous T cell lymphoma. 
0832
Hair growth cycle modulation of the β-endorphin/µ-opiate receptor system in human follicu-
lar melanocytes
S Kauser,1 KU Schallreuter,1 AJ Thody,1 C Gummer2 and DJ Tobin1 1 Department of Biomedical
Sciences, University of Bradford, Bradford, West Yorks, United Kingdom and 2 Technical Center,
Procter & Gamble Ltd, Egham, Surrey, United Kingdom
The opiate peptide b-endorphin (b-END) is enzymatically cleaved from POMC in the skin. Cuta-
neous functions of this peptide include immunomodulation and melanogenesis, effects that are medi-
ated via opiate receptors. Unlike other POMC peptides, a role for b-END in hair pigmentation/cycling
has not been demonstrated. This study was designed to assess expression of the b-END/mu-opiate
receptor system in human hair follicle melanocytes (HFM) during the hair growth cycle. Anagen VI
was associated with a striking up-regulation of b-END expression in both melanogenically-active
bulbar melanocytes and amelanotic outer root sheath (ORS) melanocytes. b-END expression was
also marked in the epithelial compartments but was conspicuously absent in the follicular papilla.
Catagen however, was associated with down-regulation in b-END expression in residual gp-100 pos-
itive melanocytes, while strongly b-END-positive melanocytes were found in the peripheral regions
of the epithelial sac in late catagen, early telogen, and late telogen follicles. The mu-opiate receptor
also showed hair cycle-dependent change, whereby this receptor during anagen was detected only
in a sub-population of weakly melanogenic melanocytes both in the proximal/peripheral hair bulb
matrix and of amelanotic melanocytes in the ORS. In catagen and telogen melanocyte expression of
mu-opiate receptor was moderately down-regulated. Receptor expression was detected in rare non-
dendritic melanocytes located in the residual catagen bulb and also in melanocytes located in the
peripheral telogen sac. The follicular papilla and hair follicle epithelium showed prominent mu-opi-
ate receptor expression throughout the cycle. The differential expression of the b-END/ mu-opiate
receptor system in follicular melanocytes during the hair growth cycle, and the up-regulation of b-
END expression in differentiated bulbar melanocytes, suggests an important role for this opiate in
maintaining melanogenesis during hair growth. 
0830
Effect of Aldara 5% cream on anagen:telogen and terminal:vellus ratios in extensive alopecia
areata
MK Hordinsky,1 LP Steiner,1 C Boeck,1 M Deeths,2 D Whiting3 and ME Ericson1 1 Derm, U of
MN, Minneapolis, MN, 2 Derm, U of Colorado, Denver, CO and 3 Derm, U of Texas Southwestern,
Dallas, TX
In this study we asked if daily application of Aldara 5% Cream (3M Pharmaceuticals) to 1/2 of the
scalp in 12 Caucasian patients with extensive alopecia areata (AA), (5M, 7F, ages 30-68, average
disease duration 14 years)induces hair growth. Two 4-mm punch biopsy specimens were taken from
the right parietal scalp before and after treatment. 11 patients successfully completed the study. Scalp
biopsy specimens were vertically and horizontally sectioned, stained using standard techniques,
and analyzed by a dermatopathologist (DW) who was blinded to patient information. Anagen:telo-
gen ratios, terminal:vellus ratios, follicular structures per mm2 and inflammation were assessed. No
significant hair regrowth was observed; however, the number of follicular structures per mm2 increased
in 4/11 subjects; terminal:vellus ratios increased in 9/11 subjects, and anagen:telogen ratios increased
in 7/11 subjects. Lymphohistiocytic infiltrates were noted to decrease in 3/11 subjects, increase in
3/11 subjects and remain the same in 5/11 subjects. Aldara 5% cream augments interleukin-2 pro-
duction and enhances Th1 responses in the skin, changes which have been implicated in the patho-
physiology of AA. So not unexpectedly, no patient with extensive AA demonstrated a significant
clinical improvement after only 6 months of therapy. However, the surprising outcome of this study
was that the use of Aldara 5% cream did affect the hair follicle and hair cycle as noted in the skin
biopsy specimens. It is possible this immunomodulating agent may prove to have a role in the man-
agement of extensive AA if the treatment period is longer and there is histological potential for hair
regrowth at baseline. 
0834
Nestin-expressing hair follicle stem cells
L Li,1 M Yang,1 GN Enikolopov2 and RM Hoffman1 1 AntiCancer, Inc., San Diego, CA and 2 Cold
Spring Harbor Laboratory, Cold Spring Harbor, CA
The nestin gene encodes an intermediate filament protein which is selectively present in the neu-
roepithelial cells of the developing embryo and in the neurogenic areas of the adult brain. Transgenic
mice, in which nestin regulatory elements drive expression of green fluorescent protein (GFP) were
found to have nestin-expressing cells located in the permanent upper hair follicle right below the
sebaseous glands in the follicle bulge. This is the area of the follicle where the hair follicle stem
cells have been previously shown to be located. The nestin-GFP-expressing stem cells in the hair
follicle bulge give rise to the outer root sheath and possibly other structures during anagen. The
nestin-GFP cells in the hair follicle cells co-express nestin and keratins as determined by immuno-
histochemistry. These data indicate the nestin-expressing cells in the bulge area of the follicle are
the hair follicle stem cells. Nestin-driven GFP was also found to be highly expressed in an interfol-
licullar neural-like network. The common expression of nestin in neural stem cells, in hair follicle
stem cells, and in an inter-hair-follicle neural-like network suggests their common origin. This gives
rise to the possibility of the hair follicle stem cells being able to form neural cells which has many
ramifications. 
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Wnts signaling through the Β-catenin pathway maintains anagen characteristics in dermal
papilla cells
H Shimizu and B Morgan CBRC, Harvard Med/ MGH, Charlestown, MA
Purpose: We have reported previously that treatment of an enriched dermal papilla cell preparation
in vitro with Wnts 3a or 7a maintains the ability of these cells to promote hair growth when engrafted
with primary keratinocytes in vivo. The effects of these intercellular signaling molecules are medi-
ated by several different signal transduction cascades within the cell. This study was designed to
determine which pathway mediates the effects on hair growth promoting activity and to further test
approaches to restore that activity to cells that have lost it. Methods: The GFP positive population
from versican-GFP; Β-actin tva transgenic mouse pups was purified by FACS and infected in vitro
with retroviruses encoding Wnts 3a, 7a or truncated forms of Β-catenin, or treated with agents that
activate the Β-catenin pathway. Results: Forced expression of either Wnt in this partially purified
dermal population is sufficient to maintain expression of the versican GFP transgene, a surrogate
marker for the anagen DP cell state. While Wnt could function in an autocrine or paracrine fashion
in this assay, this result confirms that the activity on the GFP expressing cells is direct and not medi-
ated by secondary signaling from another cell type. Activation of the Β-catenin pathway directly
using the truncated Β-catenin construct leads to cell autonomous activation of the reporter. Hence
Wnt signaling does not lead to the expression of a second signal from DP cells that maintains gene
expression in other Dp cells. Treatment of the cells with LiCl, an inhibitor of GSK-3b that activates
the Β-catenin pathway, has a similar effect. Discussion: Different reporter assays had raised ques-
tion whether the Β-catenin pathway is normally active in dermal papilla cells in vivo and whether
the activity of Wnts observed in vitro on enriched dermal papilla cell preparations is mediated through
this pathway. This work confirms that Wnts acting through the Β-catenin pathway can maintain
gene expression characteristic of the anagen phase in dermal papilla cells. 
0836
Sox9 expression in red deer (Cervus elaphus) antler tip velvet. A potential role in hair follicle
development?
NJ Croft1,2 and VA Randall2 1 Dermatology, University of Pennsylvannia, Philadelphia, PA and 2
Biomedical Sciences, University of Bradford, Bradford, West Yorkshire, United Kingdom
Sox9 is a Sry type homeobox gene sharing a strongly conserved 79 amino acid high mobility group
box (HMG) domain. It has known expression in developing chondrocytes and teeth and also has a
role in temperature sensitive sex determination in reptile species not possessing the Sry male sex
determining gene. In Man mutations in this gene result in congenital defects with genetic males
possessing female phenotypes, as well as skeletal malformations described as campolmelic dyspla-
sia. Mutations in Sox9 are fatal with offspring surviving only a few days after birth.  In red deer
(Cervus elaphus) antlers annually undergo rapid de novo development of new bone, skin and hair
follicles. We hypothesise that Sox9 is involved in the development of antler cartilage and osseous
tissue and that it may also have a role in hair follicle development.  With the use of RT-PCR Sox9
mRNA transcripts were identified in all regions of the developing antler tip, which includes the epi-
dermis and dermis, reserve mesenchyme and developing cartilaginous and osseous tissue. Positive
control tissue (testes) showed strong expression of this gene as expected. Negative control (heart)
tissue did not express Sox9. Results were confirmed in six different deer for the antler velvet epi-
dermis and dermis; other tissues in at least two deer. In addition, expression was also identified in
bald velvet showing only very early hair follicle bud developmental stages. The sequenced transcripts
showed close similarity with the Bos taurus Sox9 gene. The findings in the developing antler tip sug-
gest that Sox9 is involved in bone development with a predicted expression within the developing
chondrocytes. In addition, we propose that Sox9 may also have a new and exciting role in the devel-
oping epidermis and hair follicles of the antler velvet. 
0837
Deregulated c-Myc diverts multipotent stem cells to a sebaceous gland lineage
KA Huntzinger1 and DR Roop1,2 1 Molecular & Cellular Biology, Baylor College of Medicine,
Houston, TX and 2 Dermatology, Baylor College of Medicine, Houston, TX
c-Myc is an oncoprotein known to induce proliferation, transformation and apoptosis in mammalian
cells. To analyze the role of c-Myc in vivo, we previously targeted the overexpression of c-Myc to
the hair follicles and basal layer of the mouse epidermis. As homozygotes, these mice (K14.myc2)
exhibit epidermal hyperplasia at postnatal day 3, are smaller than wild-type littermates, and die before
21 days of age. As adults K14.myc2 heterozygous mice develop spontaneous ulcerated lesions, which
shorten their lifespan to 5 months. We have previously documented that this phenotype occurs due
to impairment in wound healing and accelerated depletion of epidermal stem cells. These mice also
exhibit an increase in the number and size of sebaceous glands and are predisposed to develop seba-
ceous gland tumors in response to a chemical carcinogenesis protocol. To bypass the premature lethal-
ity of K14.myc2 mice, we have generated an inducible mouse model in which c-Myc expression
can be regulated by topical application of a progesterone antagonist, RU486. We observed a marked
increase in sebaceous gland number in neonates topically treated to induce c-Myc expression, which
suggests that c-Myc expression accelerates the rate of sebaceous gland development. Consistent with
this data, adult mice show an increase in sebaceous gland number and size after prolonged treatment
with RU486. In addition, we are using the inducible system to determine if c-Myc expression can
result in precocious sebaceous gland development by inducing c-Myc expression in utero. Pregnant
females were injected with RU486 and progesterone once a day from embryonic day E14.5 through
E17.5. At E19.5, sebaceous glands were difficult to detect in control littermates, however Oil Red
O staining revealed accelerated sebaceous gland development in transgenic mice. Taken together,
these results suggest that deregulated c-Myc expression may alter the fate of multipotent stem cells,
diverting them to a sebaceous gland lineage. 
0838
Differential expression of dioxin-binding Ah receptor (AhR) and AhR Nuclear Translocator
(ARNT) in mouse skin suggests the role of ARNT-independent pathway in the pathogenesis of
chloracne
M Zhang and AA Panteleyev Dermatology, Columbia University, New York, NY
The aromatic hydrocarbon receptor (AhR) is a ligand-activated helix-loop-helix transcription factor
that belongs to the family of Per-ARNT-Sim proteins and serves as a basic mediator of the toxic
effects of the environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). In the canon-
ical model of dioxin toxicity dimerization of activated AhR with ARNT is a required step. However,
recently several ARNT-independent pathways of TCDD toxicity have been identified. The role of
AhR and ARNT in skin effects of TCDD action remains unknown. As the first step in elucidation
the role of the AhR signaling pathway in chloracne, the temporal and spatial expression patterns of
AhR and ARNT1 were studied during hair follicle (HF) development and regression in the C57BL/6
mouse model. During HF morphogenesis, a gradual increase of ARNT1 immunoreactivity was found
in the dermal fibroblasts while initially low/moderate expression in HF epithelium, follicular papilla
and in the hair matrix gradually declined, and was not recognizable after stages 6-7 of morphogen-
esis. In contrast to ARNT1, at initial steps of morphogenesis, HF epithelium and epidermis were
totally negative for AhR, while strong expression was found in the dermis. At stage 5 of morpho-
genesis AhR immunoreactivity occurred in melanogenic zone and the lower IRS (Henley’s layer),
becoming very active by stage 6. With the completion of morphogenesis, AhR immunoreactivity was
evident in the epidermis and in the sebaceous gland (SG), and shifted from the Henley’s to the Hux-
ley’s layer in the IRS. With transition to telogen, expression of AhR in HF declined, remaining at
the moderate level only in the SG and epidermis. The weak and transitional expression of ARNT1
in the HF and the lack of spatiotemporal overlap with AhR expression suggest that skin effects of
TCDD toxicity may be mediated by AhR via an ARNT-independent mechanism. 
0839
Hair cycle regulation of hedgehog signal reception by regulation of Gli protein accumulation
AE Oro and K Higgins Program in Epithelial Biology, Stanford University, Stanford, CA
Proper patterning of self-renewing organs like the hair follicle requires exquisite regulation of growth
signals. Sonic hedgehog (Shh) signaling in skin controls the growth and morphogenesis of hair fol-
licle epithelium in part through regulating the Gli transcription factors. While ectopic induction of
Shh target genes leads to hair follicle tumors such as basal cell carcinomas, how Shh signaling nor-
mally functions during the cyclic process of hair development is unknown. Here we show that, dur-
ing the hair cycle, Shh expression and the ability of skin cells to respond to Shh signaling is spa-
tially and temporally regulated. Induction of Shh target genes normally occurs only in the anagen
hair follicle in response to expression of Shh. However, in patched1 heterozygous mice, putative
tumor precursors form with concomitant induction of Shh target gene transcription only during ana-
gen in follicular and interfollicular keratinocytes. Ectopic production of Gli1 accumulates Gli pro-
tein and induces Shh target genes and epithelial tumors at anagen but not other stages, pointing to a
restricted competence occurring at the level of Gli protein accumulation. Delivery and reception of
growth signals amongst multipotent cells are restricted in time and space to facilitate cyclic pattern
formation. 
0840
Embryonic development of the normal mouse nail unit
RE Seymour,1 KA Silva,1 A Buckley,1 LS Bechtold,1 P Fleckman2 and JP Sundberg1 1 The Jackson
Laboratory, Bar Harbor, ME and 2 Dermatology, University of Washington, Seattle, WA
The purpose of this study was to characterize embryonic development of normal mouse nail unit in
order to facilitate comparison with the human nail unit and to identify models for abnormal devel-
opment. Scanning electron microscopy, elemental X-ray microanalysis, histology, and immunohis-
tochemistry were used to define the process. Demarcation of digits was seen at 14.5 days post coitus
(dpc). By 15.5 dpc individual digits were distinct. By 16.5 dpc invagination of the proximal nail fold
and nail plate formation were noted. Early epidermal differentiation on the embryonic digits could
be identified using antibodies directed against specific keratins. Elemental analyses for sulfur con-
centration in the nail plate (hard keratins, ultrahigh sulfur proteins) compared with skin of the dig-
its (soft keratins, low sulfur containing proteins) revealed that the nail plate does not mature until
birth, when sulfur levels dramatically increase. This information is useful for defining developmen-
tal steps in the formation of the normal nail unit and for characterization of mutant nail phenotypes. 
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Evidence for expression of melanocortin receptors, prohormone convertases, pro-opiome-
lanortin and pro-opiomelanortin-derived peptides in human dermal papilla cells
M Eickelmann,1 TA Luger,1 U Blume-Peytavi2 and M Boehm1 1 Dept. of Dermatology, University
of Muenster, Muenster, Germany and 2 Dept. of Dermatology, University Medical Center Charite,
Humboldt University of Berlin, Berlin, Germany
Dermal papilla cells (DPC) are crucially involved in regulating the activity of the hair follicle. In
contrast to the majority of other skin cells, little is known about the expression, regulation and func-
tion of pro-opiomelanocortin (POMC)-derived peptides and their receptors in DPC. We show here
that human DPC in vitro express melanocortin-1 and -4 receptors at the RNA and protein level.
POMC was detectable at the RNA and protein level as demonstrated by RT-PCR and Western
immunoblotting using an anti-ACTH antibody that cross-reacts with POMC. Among various pro-
hormone convertases (PC) examined PC1 and PACE were undetectable while PC2, its cofactor and
chaperone 7B2, and furin convertase were expressed in DPC. We next examined the capability of
DPC to express and secrete POMC-derived peptides. As shown by radioimmune assays and enzyme-
linked immunosorbent assays, both DPC lysates and cell culture supernatants contained immunore-
active ACTH-like peptides as well as beta-endorphin while alpha-MSH was undetectable. Taken
together, our findings demonstrate, for the first time, that DPC in culture express a distinct pattern
of melanocortin receptors and express ACTH-like peptides as well as endogenous opioids. Processing
of POMC into ACTH-like peptides in DPC does not appear to be mediated by PC1 but rather by an
alternative POMC cleaving enzyme, e. g. furin convertase. Further studies are necessary to define
the exact role of melanocortin receptors and the function of detected POMC peptides in DPC in
vitro and in vivo. 
0843
Red deer (Cervus elaphus) express androgen receptors in their developing antler and antler
velvet
NJ Croft1,2 and VA Randall2 1 Dermatology, University of Pennsylvannia, Philadelphia, PA and 2
Biomedical Sciences, University of Bradford, Bradford, West Yorkshire, United Kingdom
Red deer (Cervus elaphus) antlers annually undergo rapid de novo development of new bone, skin
and hair follicles in the spring. Antler development, and a mane on the neck in the winter season,
are secondary sexual characteristics of red deer stags. Although androgens are involved, where they
actually act in the antler is unclear. Therefore, we have explored the expression pattern of the andro-
gen receptor in the developing region of antler tips in order to determine potential roles for andro-
gens in antler velvet development. Androgen receptor transcripts were identified using RT-PCR. Pos-
itive control tissues, the prostate and testes, showed strong expression of this gene, while heart
tissue did not express the androgen receptor gene. Androgen receptors were expressed in all regions
of the developing antler tip, which includes the epidermis and dermis, reserve mesenchyme, and
developing cartilaginous tissue. Results were confirmed in six different deer for the antler velvet epi-
dermis and dermis; other tissues in at least two deer. In addition, expression was also identified in
bald velvet showing only very early hair follicle bud developmental stages. Partial sequence of the
androgen receptor in deer shows close similarity with the corresponding region of the bovine (Bos
taurus) gene. The findings in the developing antler tip suggest that the androgen receptor may play
a key role in developing antler cartilaginous tissue. In addition, the androgen receptor may also have
a role in the developing epidermis and hair follicles of the antler velvet. 
0845
Human hair follicle melanocytes express α-MSH and ACTH in a hair growth cycle-dependent
manner
S Kauser,1 KU Schallreuter,1 AJ Thody,1 C Gummer2 and DJ Tobin1 1 Department of Biomedical
Sciences, University of Bradford, Bradford, West Yorks, United Kingdom and 2 Technical Center,
Procter & Gamble Ltd, Egham, Surrey, United Kingdom
Pro-opiomelanocortin (POMC) is cleaved by pro-hormone convertases (PC)1 and 2 to yield ACTH
and a-MSH respectively. These peptides are produced in skin where they participate in important
cutaneous functions including melanogenesis. While the involvement of POMC peptides in the reg-
ulation of murine hair pigmentation has been well documented, little is known about the role of a-
MSH and ACTH in human hair pigmentation/hair growth cycling. This study was designed to assess
expression of a-MSH, ACTH and PC1, PC2 and 7B2 in human hair follicle melanocytes (HFM)
during the hair growth cycle. Using a double immunofluorescence labelling technique, the expres-
sion of a-MSH, ACTH and the POMC processing machinery was strikingly absent in melanogeni-
cally-active melanocytes in anagen hair bulbs. However, expression of all markers was marked in a
sub-population of poorly differentiated gp100-positive melanocytes in the most proximal and periph-
eral hair bulb matrix and outer root sheath (ORS) melanocytes. Expression of these markers was also
prominent in the follicular papilla, and in the hair bulb matrix and ORS epithelium. The residual
bulbs of regressing catagen hair follicles continued to contain a sub-population of gp100-positive
melanocytes that expressed a-MSH, ACTH and POMC processing machinery. In telogen, marker
expression was evident in gp100-positive cells located primarily in peripheral regions of the epithe-
lial sac of telogen follicles. This study shows significant heterogeneity of POMC expression within
the follicular melanocyte pool. Moreover, this expression is coupled to the hair growth cycle, sug-
gesting relevance in follicular melanocyte biology, including melanocyte survival during the apop-
tosis-driven catagen. Finally, that POMC peptides are prominently expressed in the follicular papilla,
but absent in nearby melanogenic bulbar melanocytes, suggests that this hair follicle component may
be a local source of these peptides for adjacent pigmenting follicular melanocytes. 
0844
Desmoglein 4 is a novel desmosomal cadherin with an essential role in hair follicle keratinocyte
differentiation and is mutated in the lanceolate mouse and localized hypotrichosis in humans
A Kljuic,1 J Sundberg,2 H Bazzi,1 A Martinez-Mir,1 R O’Shaugnessy,1 K Djabali,1 M Levy,7
X Montagutelli,6 W Ahmad,8 VM Aita,1 D Gordon,3 M Mahoney,5 J Uitto,5 D Whiting,2 J Ott,3
S Fisher,1 T Gilliam,1 R Morris,1 A Panteleyev1 and AM Christiano1 1 Columbia University, NY,
NY, 2 Rockefeller University, NY, NY, 3 Jackson Laboratories, Bar Harbor, ME, 4 Thomas
Jefferson, Philadelphia, PA, 5 University of Texas Southwestern, Dallas, TX, 6 Pasteur Institute,
Paris, France, 7 Quaid-i-Azam University, Islamabad, Pakistan and 8 Baylor College of Medicine,
Houston, TX
Desmosomal cadherins are essential cell adhesion molecules present throughout the epidermis. We
have identified a novel desmoglein family member, desmoglein 4 (dsg4), using positional cloning
in two families with localized autosomal recessive hypotrichosis (LAH). Linkage was established
to chromosome 18q21, with a combined multipoint Lod score of 6.29, and comparative genomics
identified of the lanceolate mouse (lah/lah) mutation in the same region. In silico cloning revealed
several novel human and mouse desmosomal cadherin genes in this region. Among these, Dsg4 was
the only novel cadherin gene present in both human and mouse, and thus became a candidate gene
for mutations. Sequence analysis revealed an identical 5 kb intragenic deletion in the two LAH fam-
ilies which removes exons 5-8 of DSG4 in frame. Further, we identified mutations in dsg4 in two
spontaneous mouse mutations, lah and lahJ. Phenotypic analysis in lah/lah and lahJ/lahJ mutant mice
revealed a striking hair shaft defect with the appearance of a lance head within defective hair shafts.
Lah hair shafts are devoid of normal cuticle and medullary structures and reveal only a disorganized
cortex which keratinizes prematurely, resulting in multiple, periodic lance head deformities. Our data
support a crucial role for dsg4 in organizing the differentiation commitments of the keratinocytes in
the precortex region of the hair follicle. 
0842
Microarray-based gene expression profiling in alopecia areata implicates immune response,
cell cycle control, and apoptosis related genes in disease pathogenesis
R Dudda Subramanya, K Luettich, Z Xiang, H King and A Sinha Weill Medical College of Cornell
University, New York City, NY
Alopecia areata (AA) is a non-scarring inflammatory hair loss disease with an uncertain etio-patho-
genesis. It is thought to be a complex polygenic autoimmune disease involving immune deregula-
tion leading to hair loss. The precise susceptibility loci and the molecular basis for the progression
of patchy AA to alopecia totalis (AT) and alopecia universalis (AU) are not yet known. In order to
better understand the pathogenesis of AA at the molecular level, we investigated the gene expres-
sion profiles in skin samples biopsied from AA lesional (n=11) and nonlesional sites (n=11) of AA
patients (10 patchy AA and 1 AU) using Affymetrix Hu95A arrays. Hierarchical cluster analysis
showed distinct separation of 19 skin samples into disease and normal groups. The lesional AU
sample clustered generally with the lesional patchy AA samples but could be distinguished from
AA based on a subset of sequences. 87 genes were found to be differentially expressed in AA skin
compared to nonlesional skin; 29 were up-regulated and 58 were down-regulated. Validity of microar-
ray data were confirmed by real-time RT-PCR. Functional classification of the 87 differentially
expressed genes (DEGs) provides evidence for a T cell mediated immune response (SCYA17,
SCYB11, SLA, ICAM1, ITGA2), a possible humoral mechanism (IGHG3) and active antigen pro-
cessing mechanism (CPVL) in AA. We found modulation in gene expression favoring an arrest of
cellular proliferation at various levels (CDK2, FGF18, PPP2R1B, Fe65) with an impairment of DNA
repair (BLM, 14-3-3-sigma) and execution of apoptosis (ATM). Further analysis of patients with
transient (<1 year duration, n=4) and persistent (>1 year duration, n=7) disease revealed 34 DEGs
between the 2 groups (21 up and 13 down-regulated in transient AA). Hierarchical cluster analysis
clearly separates transient from persistent AA samples, indicating the existence of gene profiles
unique to the initial and later stages of the disease. 
0846
A natural canine homologue of alopecia areata in humans
DJ Tobin,1 SH Gardner,1 PB Luther,2 SM Dunston,2 NJ Lindsey1 and T Olivry2 1 Department of
Biomedical Sciences, University of Bradford, Bradford, West Yorks, United Kingdom and 2
Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University,
Raleigh, NC
Alopecia areata (AA) is thought to be an autoimmune disease directed preferentially against hair fol-
licles (HF). Recently, two rodent models of AA were described. Despite several case reports of canine
AA, it is not known whether dogs with AA could be useful as an outbred homologue of this disease
in humans. The aim of this study was to evaluate 25 dogs with AA and to compare these data with
those found in human AA. Biopsies and sera were assessed by histopathology, direct immuno- flu-
orescence, lymphocyte immunohistochemistry, indirect immuno- fluorescence and immunoblotting
analysis of circulating serum IgG, selective immunoprecipitation of HF proteins, and passive trans-
fer of purified canine IgG into naive mice. Clinical signs including alopecia, skin hyperpigmenta-
tion and leukotrichia usually developed during adulthood and were first seen on the face. Sponta-
neous remission occurred in 65% of dogs and regrowing hair shafts were often unpigmented.
Histologic examination of skin biopsy specimens revealed mononuclear cell infiltrates affecting
almost exclusively anagen HF. Direct immunofluorescence analysis detected HF-specific IgG in 73%
of dogs, while indirect immunofluorescence revealed anti-HF IgG to HF inner and outer root sheath,
matrix and pre-cortex. Immunoblotting analysis revealed IgG reactivity to 45-60 kDa proteins and
a 200-220 kDa doublet. The later was identified as trichohyalin by selective immunoprecipitation.
Purified HF-reactive IgG from AA-affected and normal dogs was injected intradermally to the ana-
gen skin of naive mice where it was associated with the local retention of HFs in an extended telo-
gen phase in AA treated skin compared to that seen in controls. In summary, these findings are very
similar to those reported for human AA patients and so supports the use of dogs with AA as a use-
ful homologue for the study of the pathogenesis of this common autoimmune disease of humans. 
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Effects of Eda on hair follicle morphogenesis
M Zhang,1 A Brancaccio,2 AA Sharov,3 VA Botchkarev,3 C Missero2 and JL Brissette1 1 Cutaneous
Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Boston,
MA, 2 Telethon Institute of Genetics and Medicine, Naples, Italy and 3 Dermatology, Boston
University School of Medicine, Boston, MA
In humans and mice, mutations in Eda (ectodysplasin-A) cause the abnormal morphogenesis of
the hair, teeth, and sweat glands. The Eda protein is a member of the tumor necrosis factor family
and known to function in a well-conserved signaling pathway. To investigate the role of Eda in the
formation of skin appendages, we generated transgenic mice that express murine Eda from the
promoter for involucrin (Ivl), a marker of terminal differentiation in the epidermis and hair follicles.
In three separate lines of transgenic mice, the Ivl-Eda construct caused abnormalities in hair folli-
cle morphogenesis. At the macroscopic level, the trangenic animals diplayed a rough coat, as the hair
shafts were disoriented with respect to the body. Within the coat, zig-zag hair was missing entirely,
and two new types of hair appeared, derived presumably from abnormal zig-zag follicles. At the his-
tological level, a sub-population of hair follicles underwent aberrant development, leading to anom-
alous follicle structures. Consistent with the Ivl expression pattern, the exogenous Eda was induced
at embryonic stage E16.5 and detected in the epidermis and hair follicles during the period of zig-
zag hair formation. In all, the results suggest that Eda affects the morphogenetic programs of spe-
cific types of hair. 
0848
The hedgehog target gene BEG4 potentiates Gli transcriptional responses
CA Callahan,1,2 TA Ofstad,1 PA Coulombe,3 L Horng,1 HH Zhen1 and AE Oro1 1 Program in
Epithelial Biology, Stanford University, Stanford, CA, 2 Pathology, Stanford University, School of
Medicine, Stanford, CA and 3 Biological Chemistry, Johns Hopkins School of Medicine, Baltimore,
MD
Hedgehog (hh) signaling has diverse, context-dependent functions while controlling the prolifera-
tion, differentiation and movement of epithelial cells during development. Additionally, unregu-
lated hh signaling has been shown to be an important contributor to carcinogenesis. The transcrip-
tional output of the hh pathway is largely governed by the Gli family of transcription factors. However,
how Gli target genes are selected in different contexts remains largely unknown. We have previ-
ously identified a novel hh target gene, BEG4, that is expressed in both human and mouse trans-
genic basal cell carcinomas. To begin to characterize BEG4s role(s) in skin carcinogenesis we
expressed BEG4 in reconstituted human skin grafts in conjunction with transcriptional activators of
hh signaling. Skin grafts ectopically expressing Sonic hedgehog demonstrate dramatic increases in
keratinocyte proliferation and invasion that are not simulated by grafts expressing Gli1, BEG4 or
EGFP alone. However, grafts expressing both hh target genes Gli1 and BEG4 recapitulate the Sonic
hedgehog phenotype and demonstrate both robust keratinocyte proliferation and invasion into the
dermis. To understand the mechanism of BEG4 action we searched for relevant candidate hh target
genes and find that Gli2 regulates the activity of the mouse keratin 17 promoter, a gene highly
expressed in hh responsive tissues in skin. Keratin 17 promoter analysis shows that BEG4 dramati-
cally enhances Gli2-dependent transcriptional activity but has no effect alone. Deletion analysis of
BEG4 demonstrates that the amino terminus, but not the WH2 domain, of BEG4 is required to poten-
tiate Gli2 transcription.  This data is consistent with a BEG4-dependent mechanism for the control
of hh target gene expression and indicates that BEG4 may play a key role(s) during organ growth
and tumorigenesis. 
0849
17β-estradiol inhibits the production of RANTES in human keratinocytes
N Kanda and S Watanabe Dermatology, Teikyo University School of Medicine, Itabashi-Ku, Tokyo,
Japan
A chemokine, regulated upon activation, normal T cell expressed and secreted (RANTES) attracts
T helper-1 cells and macrophages. The production of RANTES is enhanced in keratinocytes of pso-
riatic skin lesions, which may contribute to the inflammatory infiltrate. It is known that estrogen
regulates the natural course of psoriasis. We examined the in vitro effects of 17β-estradiol on RANTES
production by human keratinocytes. 17β-estradiol inhibited TNF-α or IL-1β-induced RANTES secre-
tion, mRNA expression, and promoter activity in keratinocytes, and these effects of 17β-estradiol
were counteracted by estrogen receptor (ER) antagonist ICI 182,780. Two NF-κB elements on
RANTES promoter were required for TNF-α or IL-1β-induced transcription and involved in the inhi-
bition by 17β-estradiol. 17β-estradiol inhibited NF-κB transcriptional activity while it did not inhibit
DNA binding of NF-κB or phosphorylation or degradation of IκBα in TNF-α or IL-1β-stimulated
keratinocytes. 17β-estradiol-induced inhibition of NF-κB transcriptional activity and RANTES
promoter activity was rescued by overexpression of a coactivator CREB-binding protein (CBP) or
NF-κB p65 but not by steroid receptor coactivator-1 or NF-κB p50. The overexpression of CBP res-
cued 17β-estradiol-induced inhibition of transcription mediated by a chimeric protein, GAL4-p65286-
551
, which contained GAL4 DNA binding domain fused to C-terminal transactivating domain of p65
(amino acids 286-551). The transfection of ERα or ERβ into ER-negative SKBR3 cells resulted in
17β-estradiol-mediated inhibition of transcription via GAL4-p65286-551. These results suggest that
17β-estradiol-bound ER may inhibit NF-κB-dependent transcription of RANTES gene by compet-
ing with p65 for limiting amounts of CBP. 
0850
CD70 is selectively expressed on Th1, but not Th2, cells and required for induction of Th1 dom-
inant-contact hypersensitiveity
T Kawamura,1,2 H Oshima,2 H Yagita,2 K Okumura2 and S Shimada1 1 Dermatology, University of
Yamanashi, Yamanashi, Japan and 2 Immunology, Juntendo University School of Medicine, Tokyo,
Japan
The interaction between the Traf-linked TNF receptor family member CD27 and its ligand CD70
provides a costimulatory signal for T cell activation. Here, we investigated the expression of CD70
on Th1 and Th2 cells, and its contribution to T cell immunity. A low level of CD70 was detectable
on resting Th1, but not resting Th2, cells derived from ovalbumin-specific T cell receptor-a/b trans-
genic mice. After stimulation with anti-CD3 and anti-CD28 monoclonal antibodies (mAbs), the
expression of CD70 increased markedly on Th1 cells but remained undetectable on Th2 cells. Sim-
ilarly, while the CD70 expression was not observed on activated human Th2 clone (D10-G4), CD70
was induced on activated human Th1 clones (28-4, HK-12). CD70 was not detectable on naive T
cells, but induced faintly after stimulation. Unlike CD70, similar levels of CD27 were expressed on
naive T, Th1, and Th2 cells. Interestingly, CD27 signaling triggered by CD70-transfected P815 cells
provided a potent costimulatory activity for naive T cell proliferation and IFN-g production, but
exhibited very low costimulatory activity for Th1 and Th2 cell proliferation and cytokine produc-
tion. We next administered anti-CD70 mAb to BALB/C mice sensitized with dinitrofluorobenzene
(DNFB) or fluorescein isothiocyanate (FITC), which has been reported to elicit Th1- or Th2-dom-
inant contact hypersensitivity (CHS), respectively. Administration of anti-CD70 mAb at induction
phase significantly decreased the frequency of hapten-specific IFN-g producing cells in regional
lymph nodes from mice treated with DNFB, but did not affect the frequency of hapten-specific IL-
4 producing cells in regional lymph nodes from mice treated with FITC. These results indicated that
CD70 is useful as a marker distinguishing Th1 from Th2 cells, and more importantly, anti-CD70
mAb abrogated the generation of Th1, but not Th2 cells, substantiating a critical role of CD27/CD70
interaction in Th1 development in vivo. 
0851
A novel dissociated 1α,25 dihydroxyvitamin D3 analog with immunosuppressive activity in T
cell-mediated skin inflammation
UA Zugel,1 A Steinmeyer,2 C Giesen3 and K Asadullah1 1 Research Bunsiness Area Dermatology,
Schering AG, Berlin, Berlin, Germany, 2 Medicinal Chemistry, Schering AG, Berlin, Germany and
3 Center of Dermatology, Schering AG, Berlin, Germany
1α,25-Dihydroxyvitamin D3 (Calcitriol), the biologically active form of vitamin D3, is a potent
immunomodulatory molecule. However, its clinical use as an immunosuppressant is limited due to
its strong effects on calcium homeostasis and the risk of associated side effects. Here, we present a
representative of a novel class of vitamin D analogs which exhibits potent immunosuppressive activ-
ity in a murine model of contact hypersensitivity (CHS) when applied systemically and is efficacious
also at non-hypercalcemic dosages. In vitro analyis revealed a binding affinity of ZK 191784 to the
vitamin D receptor comparable to Calcitriol. This compound inhibits dose-dependently lymphocyte
proliferation and secretion of TNFα and IL-12 in monocytes but with reduced potency and efficacy
than Calcitriol. Treatment of human monocytes with this analog significantly reduces expression of
MHC class II, B7.1, and ICAM-1 equipotent to Calcitriol. In vivo, as analyzed in mice the com-
pound potently inhibits the CHS when applied systemically. ZK 191784 has a clear therapeutic advan-
tage over Calcitriol by inducing immunosuppressive effects also at doses that do not cause hyper-
calcemia. ZK 191784 represents the first representative of a novel class of Vitamin D analogs which
might have therapeutic potential in T cell mediated dermatoses. 
0852
T cell receptor gene usage in desmoglein-3-specific T lymphocytes from patients with pem-
phigus vulgaris
MK Hacker, JA Fairley and M Lin Dermatology, Medical College of Wisconsin, Milwaukee, WI
Pemphigus vulgaris is an autoimmune disease mediated by autoantibodies against the target anti-
gen, desmoglein-3. From our previous observations, it is clear that both humoral and cellular autoim-
munity play essential roles in the development of pemphigus vulgaris. Recently, we identified that
T cells from PV patients proliferate in response to three antigenic fragments on the ectodomain of
desmoglein-3. These desmoglein-3-specific T cells are α/β T cells with a CD4 memory T cell phe-
notype, secreting a Th2-like cytokine profile, and responding to the autoantigen in a restriction to
HLA-DRB1*0402 or 1401 alleles. Other characteristics of these autoimmune T cells, such as the
usage of T cell receptors, however, have not yet been investigated. The purpose of this study is to
determine whether desmoglein-3-specific T cells derived from pemphigus vulgaris patients prefer-
entially utilize certain T cell receptor genes. Using an established reverse transcription polymerase
chain reaction method, we found that T cell clones responding to Dsg3 (AA 145-192) preferentially
utilize the T cell receptor Vα22Vβ13 genes, while most clones responding to Dsg3 (AA 240-303)
and Dsg3 (AA 570-614) utilize Vβ7 and Vβ17 genes, respectively. We believe that this information
will further our understanding of the properties of autoimmune T cells in patients with pemphigus
vulgaris. Future vigorous investigation, however, is required to analyze the possibility of designing
a therapeutic reagent specifically targeting these T cells. 
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Suppression of contact hypersensitivity reactions by induction of CD4+/CD25+ regulatory T
cells after targeting of antigens to immature dendritic cells by anti-DEC-205 antibodies in vivo
K Mahnke, Y Qian, J Knop and AH Enk Dpt. of Dermatology, University of Mainz, Mainz,
Germany
Dendritic cells (DC) express a distinct receptor for adsorptive endocytosis, DEC-205. To target anti-
gens to DC in vivo, we coupled the modelantigen ovalbumin (OVA) to anti-DEC-205 mAb (αDEC).
Injection of these conjugates into mice lead to efficient uptake of OVA by lymphnode DC and induced
proliferation of OVA-specific T cells. However, this expansion is shortlived, and OVA-specific T
cells isolated 8 days after injection of αDEC-OVA conjugates failed to proliferate upon restimula-
tion with OVA pulsed DC in vitro. Analysis of those anergic T cells revealed sustained expression
of CD25 and CTLA-4 and coculture with conventional CD4+ T cells in MLR assays induced sup-
pression of proliferation and IL-2 production, both of which are functional hallmarks of regulatory
T cells. In contrast, these effects were abolished when a DC-maturation stimulus such as a αCD40
antibody was simultaneously injected with αDEC-OVA, suggesting that only non-activated DC
induce regulatory T cells in vivo. To further exploit this system for a disease model we injected mice
with αDEC coupled to the contact allergen TNCB and we show, that the CD8+ T cell mediated ear
swelling reactions were markedly reduced after injection of the αDEC-TNCB conjugates. Simi-
larly, in a CD4+ T cell-driven OVA-specific DTH reaction a reduction of the footpad swelling was
obtained after application of αDEC-OVA conjugates. Thus we conclude that targeting of antigens
to immature DC via αDEC mAb, leads to induction of regulatory T cells in vivo. These studies pro-
vide the basis for a novel strategy to induce regulatory T cells for therapeutic purposes in different
autoimmune diseases in vivo. 
0855
Impact of anatomical location on the requirement of immunoglobulins and B cells for the elic-
itation of contact hypersensitivity
Y Mizukawa and T Shiohara Department of Dermatology, Kyorin University, School of Medicine,
Mitaka, Tokyo, Japan
Recent studies have uncovered an indispensable function for immunoglobulins (Ig) and B cells in
initiating the elicitation of contact hypersensitivity (CH) in mice; however, in these studies CH is
elicited by skin painting with antigen (Ag) on one anatomical location, usually the ear. It remains
unknown,therefore, whether distinct anatomical locations can respond with different types of immune
responses, particularly after chronic Ag exposure. The objective of this study was to investigate the
impact of acute or chronic Ag exposure to different anatomical locations on the development of CH.
We found that repeated elicitation of CH in the ear of Balb/c and C57BL/6 mice resulted in a shift
from a typical DTH to an early-type response with the immediate-type reaction (ITR) followed by
late phase reaction (LPR); and the shift was associated with a dramatic increase in serum IgE and
mast cell number, indicating IgE-dependent activation of mast cells in the ear. In contrast, elicita-
tion of CH in the footpad led to totally different consequences: ITR followed by LPR was already
evident in the acute phase of CH, at the time when serum IgE did not increase; and after chronic Ag
exposure there was no further increase in ITR despite an increase in serum IgE, suggesting IgE-inde-
pendent activation of mast cells in the footpad.  To examine further whether Ig and B cells can be
critically involved in the elicitation of CH on diverse locations, B cell-deficient C57BL/6 ( µ MT-/-
) mice were elicited using the same protocol. Surprisingly, even in the acute phase, µ MT-/-, only
when elicited in the footpad, developed accelerated CH responses with an early-type response and
a major DTH reaction after 24h; and after chronic Ag exposure a dramatic increase in the early-type
response was detected, indicating that neither Ig nor B cells are needed for the elicitation of CH in
the footpad. Ig and B cells indispensable for the elicitation of CH in one anatomical location may,
on the contrary, serve to inhibit the development of CH in other locations. 
0857
Engagement of the high affinity IgE receptor on human monocytes induces the secretion of sol-
uble factors that inhibit IgE production and augment IgG4 synthesis
N Katoh, F Okuda, K Masuda and S Kishimoto Department of Dermatology, Kyoto Prefectural
University of Medicine, Kyoto, Kyoto, Japan
Although exposure to inhaled allergens often induces naturally developed or immunotherapy-induced
tolerance in patients with atopy, the precise mechanism is unclear. In this presentation, we studied
the role of the high affinity IgE receptor (FcεRI) expressed on antigen presenting cells in the pro-
duction of IgE and IgG4 by B cells. Peripheral human blood monocytes were obtained from patients
with atopic dermatitis and non-atopic healthy individuals and enriched by density centrifugation.
Culture supernatant of monocytes (Sup-Fc) was harvested after 24 hr from engagement of FcεRI and
the effect of Sup-Fc on IgE and IgG4 production by peripheral blood mononuclear cells (PBMC)
and purified B cells was examined. Sup-Fc downregulated IL-4 and/or sCD40L-induced IgE pro-
duction and enhanced IgG4, IgG1-3, and IgA production by PBMC without affecting their prolif-
eration. Sup-Fc also suppressed germline and mature Cε transcripts while it augmented Cγ4 tran-
scripts in PBMC. However, Sup-Fc upregulated IL-4 and/or sCD40L-induced IgE and IgG4 production
by purified B cells. The differential effects of Sup-Fc on the IgE and IgG4 production were blocked
with neutralization antibodies against IL-10 and IL-8. These results suggest that aggregation of FcεRI
on monocytes induce the secretion of soluble factors that suppresses IgE class switching and may
explain the role of antigen presenting cells in FcεRI-mediated tolerance against inhaled allergens. 
0856
Polymorphic expression of CD158k/P140/KIR3DL2 in Sezary patients
M Philippe,3 M Laurence,3 J Francette,3 B Martine2 and B Armand2 1 Dermatology, CHU Rouen,
Seine Maritime, France, 2 INSERM 448, CHU H. Mondor, Creteil, France and 3 INSERM 532,
IRP, Paris, France
Sezary syndrome (SS) is a leukemic form of epidermotropic cutaneous T-cell lymphoma (CTCL).
No specific cell menbrane receptor has been described until now on Sezary cells. Recently, we
reported that circulating and cutaneous sezary cells express CD158k/P140/KIR3DL2. This men-
brane receptor is a member of the killer cell Ig-like receptors that inhibit NK-mediated lysis after
interaction with HLA-A. In normal individual KIR3DL2 is only detected on minor NK, and
CD3+CD8+ subsets. Until now, nine KIR3DL2 alleles have been defined. We reported the restricted
expression of KIR3DL2 008 allele from 2/2 CTCL lines derived from Sezary patients, suggesting
that expression of this allelic form could be associated to CTCL malignancies. The role of KIR3DL2
on CTCL cells is still unknown. It could be possible that KIR3DL2 polymorphism might influence
the recognition of HLA-I alleles. In order to determine whether Sezary cells express a specific
KIR3DL2 allelic form, we have determined the repertoire of KIR3DL2 expression in 14 patients
presenting SS. CDNA was PCR-amplified througg 40 cycles, with two different conditions depend-
ing on the KIR3DL2 allele specific primers.The amplification products were analysed on a 1%
agarose gel. 10/14 patients expressed two different alleles including 009/007 (1 patient), 002/005 (1
patient), 007/006 (1 patient), 002/007 (3 patients), 003/007 (3 patients), 005/007 (1 patient). Whereas
4/14 patients were homozygote including 009 (2 patients), 002 (1 patient), 001 (1 patient). None of
the patients was homozygote for KIR3DL2 008 found expressed in CTCL line. These results demon-
strate that there is no preferential allelic expression of KIR3DL2 associated with Sezary syndrome. 
0854
Antigen-specific suppression of T cell activation in allergy and autoimmune disease models by
dendritic cells genetically modified to secrete a T cell receptor mimic peptide
K Mahnke, Y Qian, J Knop and AH Enk Dpt. of Dermatology, University of Mainz, Mainz,
Germany
A T cell receptor mimic peptide (TCRpep) consists of a 8-amino acid peptide, homologous to the
transmembrane region of the T cell receptor (TCR) alpha chain. This peptide blocks T cell prolifer-
ation by preventing the assembly of an intact TCR. After transfection of Dendritic cells (DC) with
the DNA sequence encoding for the peptide, the DCs secreted the TCRpep, causing a reduced anti-
gen-specific T cell proliferation in an OVA specific, transgenic mouse model. To test the effects in
vivo, we injected mice with TCRpep transduced DC that had been pulsed with the hapten TNBS.
After 6 days mice were challenged with TNCB and ear swelling reaction was determined 24h later.
In this CD8-driven CHS model ear swelling reaction was markedly reduced in mice injected with
TCRpep transduced DCs as compared to controls. Next we tested the effect of TCRpep tranfected
DCs in an experimental autoimune encephalitis (EAE) model, a CD4 dependent murine model for
multiple sklerosis. For this, TG4 transgenic mice were injected with TCRpep transduced DC or
control DC. After 3 successive injections of DC, the EAE was induced by s.c. injection of the myelin-
basic protein emulsified in CFA. Mice in control groups showed significant symptoms of EAE, and
100% died within 3 weeks after induction. In contrast, mice that received TCRpep secreting DC had
significantly less severe EAE symptoms and 70% of the animals survived. In a therapeutic approach,
EAE was induced first followed by injection of TCRpep secreting DCs. Here EAE was symptoms
were suppressed by TCRpep transduced DCs and survival of the mice was significantly improved
as compared to controls. This effect was antigen-specific since transfected DC that did not express
the respective EAE antigen failed to convey protection. Thus these data show, that DC expressing
the TCRpep are able to prevent T cell activation in vivo and might be a useful tool to induce anti-
gen specific immune suppression. 
0858
Transfection of dendritic cells with antigen-encoding RNA generates a cellular vaccine that
induces protective CD8 T cell-dependent antiviral immunity
C Hauser,1,2 S Zarei1 and J Arrighi2 1 Allergy Unit, University Hospital, Geneva, Switzerland and
2 Dermatology, University Hospital, Geneva, Switzerland
Dendritic cells (DC) are obvious targets for antigen-specific immune intervention. Here we attempted
to introduce a CD8 T cell-dependent epitope into DC for presentation on MHC class I and induc-
tion of antiviral immunity. Bone marrow-derived DC were subjected to electroporation with RNA
transcribed in vitro from a plasmid encoding lymphocytic choriomeningitis virus (LCMV) glyco-
protein (gp) or green fluorescent protein (GFP) under the control of a T7 promotor. Cells were then
incubated with LPS to induce maturation of DC. LPS-treated GFP+CD11c+ cells upregulated MHC
class II, CD40, CD80 and CD86 as well as GFP-CD11c- cells or untreated cells from control cul-
tures, indicating preserved maturation of transfected DC. DC expressing LCMV gp but not DC
expressing GFP or untreated DC induced cell number dependent in vitro proliferation of CD8 T cells
expressing a transgenic receptor recognizing the 33-41 sequence of LCMV gp in association with
H-2K/Db, indicating correct synthesis, processing and presentation of LCMV gp by transfected DC.
Transfected DC were then injected intravenously twice in weekly intervals into naive C57/BL6
mice and challenged one week after the last DC injection with 200 PFU of LCMV intravenously.
Five days later the viral titer in the spleen from mice that received LCMVgp expressing DC but not
GFP-expressing DC or untreated control DC was 5 to 7 logs lower than in nonvaccinated but virus
challenged mice. These results indicate that targeting DC with antigen-encoding RNA can induce
antigen-specific CD8 T cell responses and more importantly protective antiviral immunity in vivo.
Targeting DC with antigen-encoding RNA may find wider application for immune intervention in
disorders such as autoimmunity and cancer in addition to vaccination for viral diseases. 
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Imbalance of CD123+ (lymphoid) and CD11c+ (myeloid) dendritic cells is critical for Th2 polar-
ization in atopic dermatitis
H Hashizume,1 Y Tokura,2 H Yagi1 and M Takigawa1 1 Dermatology, Hamamatsu University
School of Medicine, Hamamatsu, Shizuoka, Japan and 2 Dermatology, University of Occupational
and Environmental Health, Kitakyushu, Japan
Dendritic cell (DC) is a professional antigen-presenting cell in the immune system, orchestrating
the decision-making process in the differentiation of pre-Th cells into Th1 and Th2 cells. In lymph
nodes and circulation in human,two DC subsets, DC1 and DC2, are identified based on origin, phe-
notype and function. DC2 has a function to drive Th2 development and provides the milieu favor-
ing Th2-biased immune reactions. Recent reports have provided evidence that the number and bal-
ance of blood DCs reflect the host’s immune status. Atopic dermatitis (AD) has characteristic features
of marked Th2 polarization such as Th2 cytokine expression in the lesional skin and enhanced IgE
production and eosinophilia in the blood. We found that lower ratio of blood DC1/DC2 subsets in
AD as compared with psoriasis and normal subjects. The ratio was also closely associated with the
extent of Th2 polarization, as exemplified by the serum levels of total and specific IgE,Th1/Th2
cytokine production of peripheral blood cells and the disease severity estimated by SCORAD. There-
fore, the degree of DC imbalance in circulation is suggested to be one of the critical factors that deter-
mine atopic skin inflammation. 
0860
Epidermal involvement and mechanism of ulceration in the pathogenesis of cutaneous leish-
maniasis
OE Akilov and M McDowell Biological Sciences, University of Notre Dame, Notre Dame, IN
Cutaneous leishmaniasis (CL) is a vector-born disease caused by flagellated protozoa of the genus
Leishmania. We use a murine model and histoimmunofluorescent techniques to study the kinetics
of ulceration and the level of epidermal involvement during CL caused by L.major. We studied the
epidermis associated with cellular infiltrate in susceptible BALB/c mice at 7 weeks after intrader-
mal infection with 500 parasites. Following injection and a 4 week incubation period, a red-furun-
cle-like nodule appears at the site of inoculation. The nodule ulcerates two weeks later and then
enlarges. The biopsies revealed mixed infiltrates characterized by a predominance of lymphocytic
cells associated with polymorphonuclear leukocytes. The microanatomic localization of the infil-
trate was diffuse in the dermis. Ulcer development was associated with activated CD11c+CD8α-
Langerhans cell (LC) present in the place of future disruption. Each LC was surrounded by MHC
class II+ keratinocytes, in such a manner “a nest of activation” was formed. Keratinocytes in the place
of the future ulcer gradually increased MHC class II expression. At this time the exocytosis was pre-
sented, that is infiltration of mononuclear cells into the epidermis, accompanied by spongiosis. The
dominant type of the exocytotic cells were T lymphocytes (73.2%), the most part of which was CD4+
T cell producing IL-4 and TNFα. Also activated F4/80+ iNOS+ macrophages (18.3%) and CD8+ pan-
NK+ cells (8.5%) were present in the epidermis, and NK cells, macrophages and lymphocytes were
concentrated under the upper layer of papillary dermis at the same time. Furthermore, we observed
a high level of IFNγ, TNFα and IL-4 production directly under the epidermis. Immediately follow-
ing these observations, ulceration ensued. We hypothesize that up-regulation of MHC class II in this
population of keratinocytes goes parallely with down-regulation of MHC class I that is a signal of
NK cells attack, lysis and form a defect of tissue. Thus, this phenomenon emphasizes the impor-
tance of the epidermis in the immunoregulation of the disease. 
0861
Human mast cell development in mice after xenotransplantation of cord blood-derived
hematopoietic stem cells
N Kambe,1 H Hiramatsu,2 Y Miyachi1 and T Nakahata2 1 Dermatology, Kyoto University Graduate
School of Medicine, Kyoto, Kyoto, Japan and 2 Pediatrics, Kyoto University Graduate School of
Medicine, Kyoto, Kyoto, Japan
Recently stem cell factor (SCF)-dependent in vitro-derived human mast cell (MC) culture system
has been establised, which provides us wonderful opportunities for the investigation of human MC
functions. However to study the development mechanism and functional roles of human MC in our
body, the establishment of in vivo model is desired. The transplantation of primitive human cells into
immune-deficient mice is the well-established in vivo system for the investigation of human
hematopoietic stem cell (HSC) function. Although MCs are the progeny of HSCs, human MC devel-
opment after the transplantation of human HSCs into mice has never been reported. We newly
developed NOD/SCID/γc
null (NOG) mice, double homozygous for the severe combined immunode-
ficiency and IL-2 receptor common γ-chain defect mutation, and reported that NOG mice were the
excellent recipient animals for human cell engraftment. Fifty thousand of enriched CD34+ cells from
cord blood were injected into sublethally irradiated NOG mice intravenously through the tail vein.
Twelve weeks after the transplantation, approximately 42% of peripheral white blood cells repre-
sented human CD45+ in NOG mice. Compared with other reconstituted blood cells, however, the
appearance of human MCs in NOG mice was delayed; only 12 weeks after the xenotransplantation,
a very small number of human CD45+ MCs were recognized focally in the upper dermis, then they
gradually increased in a number supported by murine SCF. By immunohistochemical staining, human
MCs in the mouse dermis were chymase positive cells. Human MCs were also developed in mouse
lung and gastric tract, where MCs containing both tryptase and chymase distributed in submucosa
and around big airways, whereas MCs containing tryptase but lacking chymase located in mucosa,
just as in our human body. Xenotransplantation of human HSCs into NOG mice shows the recon-
stitution of blood cells including MCs, which is a potentially nice tool for the investigation of
human MC development and functions in vivo. 
0862
Drug specific cytotoxic CD8 T-lymphocytes as effector cells in toxic epidermal necrolysis
J Roujeau,1,2 A Nassif,2 A Bensussan,2 H Moslehi,2 M Bagot1,2 and L Boumsell2 1 Dermatology,
Paris XII University, Creteil, France and 2 INSERM U 448, Paris XII University, Creteil, France
In a patient suffering from sulfamethoxazole (SMX) related TEN, we recently reported the presence
in the blister fluid of diseased skin of CD8 cytotoxic T-lymphocytes (CTL). Like classical CTL they
killed autologous lymphocytes in a drug specific, class I restricted and perforin/granzyme mediated
pathway. We report here additional findings in a total of 6 patients. Blister fluid were collected on
admission (2 to 6 days after onset of disease) in 6 patients with TEN, 5 related to “ highly suspected
“ drugs (SMX 3, carbamazepine 2) and 1 with recent exposure to a usually non-suspected drug
(tetrazepam). In all 6 cases the cells present in blister fluids were mainly lymphocytes (40 to 75%,
which were mostly CD8+ (53% to 99%), CLA+ (54% to 83%), and often CD56+(21% to 72%) and
HLA-DR+ (20% to 85%). In 4/6 cases (3 SMX, 1 carbamazepine) blister fluid lymphocytes exhib-
ited a drug specific cytotoxicity on autologous EBV transformed lymphocytes. This was found in
the presence of therapeutic concentrations of the “ parent “ drug. Cross reactivity was observed
between SMX and some other sulfonamides (sulfamethizole, sulfadiazine and sulfapyridine), but
not between SMX and sulfasalazine or other sulfonamide related drugs (chlorpropamide, tolbu-
tamide, glyburide, hydrochlorothiazide). In addition in one case keratinocytes were obtained from
hair follicles and used as targets. After activation with interferon gamma autologous keratinocytes
were lysed by blister fluid lymphocytes in the presence of SMX. Taken together these results sug-
gest that CTLs play a major role in the widespread death of keratinocytes, which characterize TEN.
In many cases these CTLs are drug specific. In other cases it remains to determine whether another
drug, a metabolite or another antigen elicited the reaction. 
0863
Serum soluble P-selectin glycoprotein ligand-1 was up-regulated in patients with atopic
dermatitis
T Hoashi,1 K Kikuchi,1 Y Tada,1 T Kakinuma,1 K Nakamura,2 A Asahina1 and K Tamaki1 1
Dermatology, University of Tokyo, Tokyo, Japan and 2 Dermatology, Fukushima Prefectural
Medical College, Fukushima, Japan
P-selectin is expressed on endothelial cells. P-selectin ligand glycoprotein ligand-1 (PSGL-1), which
was first identified on myeloid cells, is a homodimer of two about 120 Kd subunits. PSGL-1 plays
a crucial role on the early inflammation stage, especially leukocyte rolling. Moreover, topical solu-
ble PSGL-1 (sPSGL-1) injection in mice with allergic conjunctivitis reduce the inflammation. We
studied the serum concentration of sPSGL-1 on the patients with atopic dermatitis and psoriasis
vulgaris. In the patients with atopic dermatitis, sPSGL-1 was upregulated in comparison with healthy
control (p<0.05). Moreover, there was a high correlation between the sPSGL-1 and disease activity,
SCORAD (SCORing Atopic Dermatitis). However, in the patients with psoriasis vulgaris, sPSGL-
1 showed neither significant up nor down regulation with healthy control. We thought that sPSGL-
1 might be a the disease activity marker with atopic dermatitis. 
0864
Inhibition of Th2 cytokine production by regulatory CD4+CD25+ T cells in allergic/atopic
individuals
I Bellinghausen, B Klostermann, J Knop and J Saloga Dept. of Dermatology, University of Mainz,
Mainz, Rheinland Pfalz, Germany
CD4+CD25+ regulatory T cells from human peripheral blood have been demonstrated to inhibit allo-
geneic proliferation and cytokine production of preactivated CD4+CD25- responder T cells. The aim
of this study was to analyze in an allergen-specific setting whether such regulatory CD4+CD25+ T
cells also exist and function normally in atopic individuals, especially concerning the inhibition of
Th2 cytokines. For this purpose, CD4+CD25- or CD4+CD25+ T cells from grass or birch pollen
allergic donors were stimulated in the presence of autologous mature monocyte-derived allergen-
pulsed dendritic cells and the preactivated CD4+CD25+ T cells were added to CD4+CD25- T cells
during restimulation. CD4+CD25+ T cells from the majority of the patients investigated prolifer-
ated poorly, produced less cytokines and inhibited the proliferation as well as the Th1 (IFN-gamma)
and Th2 (IL-4, IL-5) cytokine production of CD4+CD25- T cells, but not IL-10 production. The sup-
pression of CD4+CD25- T cells by CD4+CD25+ T cells was mainly antigen-unspecific and not
reversible by anti-IL-10, anti-TGF-beta or anti-CTLA-4 mAb, but by IL-2. In some atopic patients,
preactivated CD4+CD25+ T cells reproducibly showed strong proliferative responses, produced
higher amounts of IL-4 and IL-10 than CD4+CD25- T cells and suppressed only the IFN-gamma
production of CD4+CD25- T cells. These data indicate that regulatory CD4+CD25+ T cells are pres-
ent and functional in most atopic patients with allergic rhinitis and are able to inhibit Th1 as well as
Th2 cytokine production. 
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PGE2 produced by DCs acts T cells to enhance differentiation into Th1 and Tc1 cells in con-
tact hypersensitivity
M Nagamachi,1,2 K Kabashima,1,2 S Narumiya2 and Y Miyachi1 1 Kyoto University, Dermatology,
Kyoto, Kyoto, Japan and 2 Kyoto University, Pharmacology, Kyoto, Japan
Prostaglandin (PG) E2 mediates its physiological role through EP1, EP2, EP3, and EP4. In immune
system, only EP2 and EP4 are known to suppress T cell function. Here we found that mRNA of EP1
was also abundantly expressed on CD4+, CD8+, and CD11c+ cells using RT-PCR. However, the
role of EP1 in immune system remains completely unknown. To evaluate this issue, we used newly
generated EP1knockout(KO) mice and EP1 selective compounds. In contact hypersensitivity (CHS)
model, EP1KO mice showed significant suppression in both ear swelling and total cell counts of
cervical lymphocytes after challenge with DNFB compared to control C57BL/6 mice. The number
of IFN-γ producing CD4+ and CD8+ cells from regional lymph nodes after challenge were also
decreased in EP1KO mice. Moreover, when draining lymph node cells after sensitization were stim-
ulated with DNBS in vitro, the level of IFN-γ in culture medium was significantly decreased in
EP1KO mice. Suppression of CHS response was reproduced pharmacologically when the EP1 antag-
onist was administered during the sensitization phase to control mice. Consistently, mRNA of PGE
synthase was elevated in regional lymph nodes 1-5 days after sensitization and the level of PGE2
were abundant in the culture medium of DCs. When we evaluated the function of DCs using FITC-
induced Langerhans cell migration and mixed lymphocyte reaction assay, the EP1 selective com-
pounds did not modulate the migration and T cell stimulation activity of DCs. Therefore, we then
assessed the effects of EP1 on T cell function. Naive CD4+ and CD8+ cells were stimulated with
anti-CD3 under Th1 (IL-2, IL-12 and anti-IL-4 Ab) or Th2 (IL-2, IL-4 and anti-IL-12 Ab) driving
condition, the EP1 selective agonist increased the number of IFN-γ cytokine but decreased the num-
ber of IL-4 cytokine producing CD4+ or CD8+ cells. These results suggest that PGE2 produced by
DCs in the regional lymph nodes during sensitization phase of CHS acts T cells in situ to enhance
differentiation into Th1 and Tc1 cells. 
0867
PKC and MMP inhibitors as potential modulators of Langerhans cell migration following hap-
ten-induced sensitization
P Nathalie,1 P Antoine,1 M Philippe,1 S Daniel2 and S Marie-Jeanne2 1 R&D, Laboratoires
Expanscience, Epernon, France and 2 INSERM 346, Lyon, France
Langerhans cell (LC) migration from the epidermis to draining lymph nodes is a critical first step
for the sensitisation as well as for the initiation of contact hypersensitivity. Among the intracellular
mechanisms which mediate LC migration from the skin, pro-inflammatory cytokines, protein kinase
C (PKC) and Matrix Metallo Proteinases (MMP) activation seem to play a pivotal role. In the pres-
ent work, we have investigated the efficiency of different PKC inhibitors alone, or in association with
an MMP inhibitor in modulating the migration of activated LC. The migratory capacity of freshly
isolated LC was assessed using a reconstituted basement membrane assay (Matrigel) mimicking the
prerequisite passage through the dermal-epidermal junction on the way to lymph nodes. Suspensions
highly enriched in Langerhans cells were treated for 1h with different concentrations of inhibitors
of PKC and/or MMP inhibitor before being exposed to a strong sensitizer, DNBS, and subjected to
migration using modified Boyden chambers. Our results demonstrate that all the PKC inhibitors
(with large or narrow specificity) as well as the MMP inhibitor are per se potent modulators of acti-
vated LC migration. Moreover, these two kind of compounds seems to act in an additive way. Indeed,
in the presence of both inhibitors, activated LC migration rate is comparable to those of non acti-
vated cell. Thus, PKC and MMP inhibitors can act as potentially important modulators of contact
hypersensitivity. LC migration is also under the control of pro-inflammatory cytokines such as IL-
1b and TNF-a. The cytokine profile of activated LC treated with both type of inhibitors is under
investigation. 
0869
Blockade of skin dendritic cell migration by topical application of MMP- and PKC- inhibitors
B Frederique,2 S Pierre,2 C Cyril,2 B Sophie,2 P Nathalie,1 P Antoine,1 M Philippe1 and N Jean
Francois2 1 R&D, Laboratoires Expanscience, Epernon, France and 2 INSERM 503, Lyon, France
Epidermal langerhans cells (LC) and skin dendritic cells (DCs) are potent antigen presenting cell
(APC) in the induction of primary T cell-mediated immune responses in the skin. They capture for-
eign antigens (Ags) and migrate to regional lymph nodes (LNs) to carry and present this antigen to
naive T cell. This mechanism is critical in the initiation of different cutaneous pathology such as Pso-
riasis, Contact Dermatitis or Contact Hypersensitivity (CHS). Several molecules regulate the migra-
tion of skin DC, among which metalloproteinase (MMPs) and proteine kinase C (PKC). The aim of
this study was to evaluate the participation of MMPs and PKC in the in vivo migration of murine
skin DCs, using topical inhibitors for MMP and PKC. Mice were ear painted with FITC and DC
migration to auricular LNs was assessed 24 hrs later by flow cytometry quantification of FITC+,
CD86+, MHC class II high positive cells. Topical application of MMP or PKC inhibitors on the skin
once a day for 4 consecutive days induced a dose-dependant reduction in the number of FITC+
migrating DC (around 30% of inhibition for the optimal dose), compared to placebo application.
When PKC and MMP inhibitors were mixed in the same ointment, the inhibitory effect was more
pronounced (86% of inhibition), suggesting a synergistic action. These data indicate that, topical
use of inhibitors of PKC plus MMPs, could inhibit skin DC migration, which could have strong
therapeutic implications in the treatment of skin inflammatory dermatoses. 
0868
Pimecrolimus protects mice from developing T cell-induced inflammatory bowel disease with-
out systemic immunosuppression, in contrast to tacrolimus or cyclosporin A
HD Moore, M Tyldesley, A Martland, M Edjlalipour and M Pfann Pharmacology, Novartis
Research Institute, Vienna, Austria
Oral pimecrolimus is active in patients with psoriasis or atopic dermatitis, inflammatory skin dis-
eases which share many pathogenic features of inflammatory bowel disease (IBD). Using a T cell
induced mouse model of severe IBD, we compared the activity of calcineurin inhibitors, pime-
crolimus, tacrolimus and cyclosporin A (CyA). SCID mice were reconstituted with 2x105
CD4+CD45RBHi T cells and treated orally once a day for 4 weeks with pimecrolimus (30, 60 or
100mg/kg/d), tacrolimus (3, 10 or 30mg/kg/d) or vehicle. CyA (Sandimmun®) was administered
continuously via s.c. mini-pump (15, 30 or 60mg/kg/d). We measured body weight, serum hapto-
globin, neutrophil (Ly-6G+ cells) and T (CD3+CD4+) cell numbers by FACS analysis of single cell
suspensions from blood, spleen and mesenteric lymph nodes (MLN). Colitis was assessed histo-
logically. All doses of pimecrolimus tested prevented, whilst tacrolimus and CyA accelerated the
severe weight loss. Colon sections showed a significant (p<0.01) reduction in inflammation in
pimecrolimus (60 and 100mg/kg/d)- relative to vehicle-treated mice. A significant reduction in coli-
tis in tacrolimus-treated mice was only achieved consistently with the side-effect inducing dose of
30mg/kg/d. CyA treatment, whilst toxic, was effective (p<0.01) at 60 but not at 30mg/kg/d. All 3
inhibitors significantly reduced serum haptoglobin levels and neutrophilia in blood and spleen. Pime-
crolimus, at the high dose of 100mg/kg/d, caused no significant reduction in T cell numbers in the
blood (-19.6±20.0; n=3 separate studies) or spleen (23.7±13.0) but induced a 61.0%±7.3 reduction
in MLNs. In contrast, tacrolimus (10mg/kg/d) reduced T cell numbers in blood, spleen and MLN by
72.3%, 83.1% and 80.2%, respectively, compared to an 85.1%, 68.1% and 63.6% reduction by CyA
(30mg/kg/d). In conclusion, these data suggest that pimecrolimus prevents IBD by selectively reg-
ulating the intestinal immune system whilst tacrolimus and CyA induce general immunosuppres-
sion and severe side effects. 
0866
Prostaglandin E2-EP4 signaling is critically involved in migration and maturation of Langer-
hans cells in the initiation phase of contact hypersensitivity
K Kabashima,1,2 S Narumiya2 and Y Miyachi1 1 Dermatology, Kyoto University, Kyoto, Kyoto,
Japan and 2 Pharmacology, Kyoto University, Kyoto, Japan
The antigen-specific immune response in the skin is initiated by antigen ingestion by Langerhans
cells (LCs) in the epidermis and their migration to draining lymph nodes. While prostaglandin (PG)
E2 is produced abundantly during antigen exposure and accompanying inflammation in the skin,
the role of PGE2 in the initiation process remains unknown. We examined this issue by using mice
deficient in four subtypes of PGE receptor, EP1 to 4, individually, and EP subtype-selective drugs.
We found that, while LCs expressed all EP subtypes, the number of LCs that migrated to the regional
lymph nodes after FITC application was significantly decreased only in EP4KO mice. The decreased
LC migration was mimicked in C57BL/6 mice treated with an EP4-selective antagonist. Consis-
tently, an EP4 agonist increased the number of LCs that migrated to the culture medium from the
mouse skin explants, and the number of migrated LCs towards CCL19, as a CCR7 ligand, through
a trans-well. Moreover, an EP4 agonist significantly increased expression of co-stimulatory mole-
cule of LCs in the organ culture, and acted on LCs in mixed lymphocyte reaction assay to enhance
allogeneic T cell proliferation and activation. On the other hand, the morphology and density of LCs
in epidermal sheets in the steady state, and the endocytotic activity using FITC-dextran are compa-
rable between EP4WT and EP4KO mice. Finally, in vivo in the contact hypersensitivity model, the
delayed-type hypersensitivity response was significantly impaired in EP4KO mice compared to
EP4WT mice. This impaired response was reproduced in C57BL/6 mice treated with the EP4 antag-
onist during sensitization period. The antigen-specific T cell proliferation and Th1 cytokine pro-
duction was also significantly reduced in cells form the regional lymph nodes of EP4KO mice. Taken
together, our results suggest that the PGE2-EP4 signaling is critical in migration and maturation of
LCs in the initiation phase of CHS. 
0870
LFA878: a statin-derived leukocyte function-associated antigen-1 inhibitor with high potency
against rodent allergic contact dermatitis
JG Meingassner,1 W Bauer,2 K Welzenbach,2 K Baumann1 and G Weitz-Schmidt2 1 Novartis
Research Institute Vienna, Vienna, Vienna, Austria and 2 Novartis Pharma AG, Basle, Switzerland
Leukocyte function-associated antigen-1 (LFA-1, CD11a/CD18) is a member of the β2 integrin fam-
ily which is expressed on all leukocytes. The interaction of LFA-1 with its most important counter-
receptor ICAM-1, mediates cellular interaction in the immune system and extravasation/migration
of leukocytes to sites of inflammation. Blocking the LFA-1/ICAM interaction, therefore, is consid-
ered to be a therapeutic strategy in inflammatory diseases. Clinically, this approach is followed by
the parenteral use of anti-LFA-1 antibodies in patients with psoriasis. An in-house in vitro screen-
ing revealed the HMG-CoA reductase inhibitor lovastatin as a weak inhibitor of the LFA-1/ICAM-
1 interaction. This finding prompted the synthesis of lovastatin- derived molecules including LFA878
which potently inhibit LFA-1 but lack the effect of HMG-CoA reductase. LFA878 selectively inhibits
in vitro the LFA-1/ICAM-1 interaction with IC50s of 50 ± 2 nM (cell-free binding assay) and 300
± 150 nM (cell-based adhesion assay). LFA878 up to 100 µM did not affect binding mediated by
the closely related β2 Mac-1 (CD11b/CD18) and the β1 integrin VLA-4 (CD49d/CD29). Parenteral
administration of anti-LFA-1 antibodies has been shown to inhibit contact hypersensitivity in mice.
Therefore, this disease has been used as a model of T-cell mediated skin diseases for profiling LFA878
in rodents. The compound potently inhibited contact hypersensitivity at minimal effective oral
doses of 0.1 mg/kg in mice and 0.8 mg/kg in rats, respectively. Since findings in this model are very
predictive for the human situation, LFA878 is considered to be a potential drug candidate for oral
treatment of allergic contact dermatitis and other T cell dependent skin diseases such as psoriasis. 
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Pimecrolimus potently inhibits established severe disease in SCID mice with T cell-induced
inflammatory bowel disease
H Moore, M Tyldesley, A Martland, M Edjlalipour and M Pfann Pharmacology, Novartis Research
Institute, Vienna, Austria
Oral pimecrolimus is therapeutically active in patients with psoriasis or atopic dermatitis, diseases
sharing many pathogenic features of inflammatory bowel disease (IBD). Using a mouse model of
severe, established T cell induced IBD we show that pimecrolimus possesses potent therapeutic activ-
ity. SCID mice were reconstituted with 2x105 CD4+CD45RBHi T cells. Pimecrolimus (100mg/kg/d),
or vehicle, was given orally to mice from day 7, 14 or 21 after T cell transfer and then daily until
day 30. We measured body weight (BW), serum haptoglobin, neutrophil (Ly-6G+ cells) and T
(CD3+CD4+) cell numbers by FACS analysis of cell suspensions from blood, spleen and mesen-
teric lymph nodes (MLN). Colitis was assessed histologically and myeloperoxidase (MPO) was
assayed in colon homogenates as a marker of neutrophil infiltrate. Initiating pimecrolimus treat-
ment on day 21 post T cell transfer rapidly reversed the loss in BW. Starting treatment earlier pre-
vented BW loss. In untreated mice the colon inflammation by day 21 is usually scored as severe.
When pimecrolimus treatment was started on day 21, the mean score by day 30 was significantly
(p<0.01) reduced to moderate, and when starting on day 7, to low scores describing only mild inflam-
mation. The neutrophil infiltrate, measured as MPO activity, in diseased colons of the 21d delayed
mice was potently reduced by 68% relative to the vehicle-treated group by day 30. Pimecrolimus
reduced both the serum haptoglobin levels (by 86 and 97%, n=2 studies) and nearly totally inhib-
ited the disease-induced neutrophilia in the blood and spleen of severely diseased mice. FACS analy-
sis showed that pimecrolimus was not preventing activated T cells from proliferating as numbers
were not reduced in the pimecrolimus- relative to vehicle-treated mice. Pimecrolimus is highly effec-
tive in a therapeutic setting, strongly inhibiting some of the downstream systemic inflammatory reac-
tions. The data from this severe chronic model of IBD lead us to expect pimecrolimus to be effec-
tive in IBD in man. 
0872
Development of a novel strategy to generate mice lacking dendritic cells
DH Kaplan, WD Shlomchik and MJ Shlomchik Dermatology, Yale University, New Haven, CT
Dendritic cells (DCs) occupy a central location in immune regulation and are responsible for both
the development of immune responses and the generation of peripheral tolerance. Dissecting their
precise role in immune regulation, however, has been hampered by the absence of a mouse model
specifically lacking dendritic cells. We are in the process of developing a murine model with a spe-
cific defect of dendritic cells. The first step of the strategy is to generate transgenic (Tg) mice from
unmodified human Bacterial Artificial Chromosome (BAC) DNA that contains a putative DC-spe-
cific gene and document that Tg expression is indeed specific for DCs using antibodies to the human
proteins. BACs containing DC-specific genes will then be modified to express diphtheria toxin and
the modified BAC used to make a second round of Tg mice. These Tg mice should lack DCs or DC
subsets owing to the expressing of diphtheria toxin from the Tg. We have generated two lines of Tg
mice using an unmodified human BAC containing the gene for DC-SIGN and another line contain-
ing the gene for Langerin. DC-SIGN is expressed on all immature human DC lineages but is absent
from macrophages and Langerhan cells. Langerin is expressed primarily on epidermal Langerhan
cells. FACS analysis of bone marrow derived DCs and peripheral lymph nodes from DC-SIGN Tg
mice reveals huDC-SIGN expression on a subset of CD11c+ cells. By immunohistochemistry, the
huDC-SIGN Tg is expressed on a large number of cells with dendritic morphology in the T cell area
of the lymph node and on rare cells in the dermis and colonic adventitia. These cells are primarily
of the “myeloid” DC type and are CD11b+, CD4+, and CD8-. Preliminary analysis of the Langerin
Tg mice shows strong expression of the human Langerin Tg in Langerhan cells but not in dermal
DCs. Thus, human BAC DNAs containing Langerin or DC-SIGN appear able to confer specific Tg
expression in particular DC subsets. We have successfully modified the BACs containing Langerin
and DC-SIGN to express diphtheria toxin and are in the process of generating new Tg lines with
these modified BACs. 
0873
Characteristics of antibody responses to a polyvalent melanoma vaccine
DA Kiken,1 SR Reynolds,1 J Mojzes,1 RL Shapiro,2,3 DF Roses,2,3 MH Harris2,3 and J Bystryn1,3 1
Dermatology, NYU School of Medicine, New York, NY, 2 Surgery, NYU School of Medicine, New
York, NY and 3 NYU Cancer Institute, NYU Medical Center, New York, NY
There is increasing interest in constructing cancer vaccines from multiple tumor antigens to improve
their effectiveness. Little is known about the characteristics of the antibody responses induced by
such vaccines. The following study was conducted to address this question. The study was conducted
on 188 pts with resected stage IIb-IV melanoma who were immunized with a polyvalent, shed anti-
gen, melanoma vaccine. 62% had AJCC stage IIb or IIIa, 21% had stage IIIb, and 17% had stage IV
melanoma. Immunizations were given intradermally q2-3 wks x 4 and then monthly x 3. IgM and
IgG antibodies to antigens in a detergent extract of melanoma cells were measured by western
immunoblotting at baseline and following 4 (IgM responses) or 7 (IgG responses) immunizations.
Vaccine-induced antibody responses were defined as a new or enhanced response following immu-
nization compared to baseline in the same pt. Fifty two percent of pts had a vaccine-induced anti-
melanoma IgM and/or IgG response. IgM and IgG responses were induced in a similar proportion
of pts (31% vs 32%). There was no relation between stage of disease and the frequency or class of
response. The responses were directed to one or more antigens ranging in size from 35 to 185 kds.
There was considerable heterogeneity in the pattern of antigens recognized by individual pts and no
antigen was clearly immunodominant. In the majority of responding pts (76%) the responses con-
sisted of an increase in the level of a melanoma antibody that was already present prior to vaccina-
tion, rather than the induction of a new antibody response. These results indicate that antibody
responses to polyvalent vaccines are complex and directed to a broad range of antigens. Different
pts develop responses to different sets of these antigens. Immune responses do not decrease in more
advanced disease. The most novel finding was that immunization enhanced pre-existing anti-melanoma
antibody responses rather than induce new responses. 
0874
Regulation of human β-defensin 3 in human keratinocyte (HaCaT) cell lines
BJ Kim, SJ Seo, YJ Kim and CK Hong Dept. of Dermatology, College of Medicine, Chung-Ang
University, Seoul, South Korea
The large surfaces of the skin are often initial site of contact between microorganism and human.
Recent studies introduce us new peptides with antimicrobial activity such as β-defensins and cathe-
licidins. They are expressed on the epithelia and polymorphonuclear leukocytes, which are first
lines of defence from various invasive environments. Futhermore, they are considered very inter-
esting and important endogenous antibiotics. Our previous study has shown that the expression of
human defensin(hBD)-2 mRNA, which is potent antibiotic peptide against Gram-negative bacte-
ria(P. aeruginosa), was upregulated with ultraviolet(UV) irradiation, tumor necrosis factor-α(TNF-
α) and lipopolysaccharide(LPS) in HaCaT cells. A novel hBD-3, 5-kDa, nonhemolytic antimicro-
bial peptide, was demonstrated a salt-insensitive broad spectrum of potent antimicrobial activity
against many potentially pathogenic microbes in especially, multiresistant S. aureus. We have ana-
lyzed the expression patterns of hBD-3 in HaCaT cell lines. This research has done in order to eval-
uate the expression and regulation of hBD-3 mRNA in human keratinocyte cell lines. HaCaT cell
lines were used to all culture experiments. Cultured human keratinocytes were stimulated with UV
irradiation or TNF-α or LPS to determine whether hBD-3 mRNA production occurred. Reverse tran-
scription-polymerase chain reaction (RT-PCR) was performed to amplify hBD-3 cDNA from stim-
ulated keratinocytes in a time dependant manner, and densitometry was used to verify the speci-
ficity of RT-PCR amplication products. Expression of hBD-3 was upregulated with UV irradiation,
TNF-α and LPS in HaCaT cells compared to control. Human keratinocytes are capable to induce
hBD-3 mRNA, as well as hBD-2, in response to UV irradiation, TNF-α and LPS suggesting that
these cells could play an important role against the bacterial infection and UV light damage in human
skin. 
0875
Differential expression and function of toll-like receptor in murine Langerhans cells: com-
parison with splenic dendritic cells
H Mitsui, T Watanabe, H Saeki, H Fujita, A Asahina and K Tamaki Department of Dematology,
University of Tokyo, Tokyo, Japan
We purified murine resident epidermal Langerhans cells (LC) using panning method and studied
the expression pattern and functions of Toll-like receptors (TLRs) of LC. We found the following:
(1) LC expressed TLRs 2, 4, 9, but not 7, the pattern of which suggest LC are the closest to one of
the splenic dendritic cell (DC) lineage, CD11c+11b+8αα-4-; (2) TLR4 and its accessory molecules
CD14 and Rp105 (CD180) are more highly expressed on splenic DC than on LC; (3) murine LC,
similar to human LC, overall produced Th1 cytokines including IL-12p40 and IP-10 on stimulation
to each expressed TLR, namely, to TLR2 with Staphylococcus aureus Cowan I (SAC), to TLR4
with lipopolysaccharide (LPS), and to TLR9 with unmetylated CpG; only exception was IL-12p40
unresponsiveness on stimulation with LPS; (4) on the other hand, the production of Th2 cytokine,
TARC/CCL17 was decreased on stimulation with these TLR stimulations; (5) the IL-6 production
by LPS-stimulated LC was significantly lower than that by LPS-stimulated DC, whereas the TARC
production was higher in LC than in DC. The difference in the responsiveness to LPS between epi-
dermal LC and splenic DC might be due to the deviated expressions of TLR4 and its accessory mol-
ecules. These results may represent the heterogeneity of DC lineages and functions. 
0876
Classification of immunoregulatory stimuli by dendritic cell-based biosensor
N Mizumoto, F Hui, H Matsue, D Edelbaum, D Shalhevet and A Takashima UT Southwestern,
Dallas, TX
Dendritic cells (DC) are uniquely equipped with many receptors, including Toll-like receptors (TLR)
and P2 receptors (P2R), to recognize molecular patterns produced by microorganisms, endogenous
“danger” signals, and various soluble and membrane-associated immunoregulatory molecules. Lig-
ation of these receptors triggers rapid and dynamic reprogramming of gene expression and cellular
functions, the process known as DC maturation or activation. We reasoned that any agent that turns
on particular transcription regulatory pathway(s) by binding to DC-associated receptors must alter
DC function in a predictable manner. To test this concept, we created a multi-channel, DC-based
biosensor system by transducing XS106 DC line with Luc reporter constructs driven by each of 12
different cis-enhancer elements. By measuring Luc activities following exposure to test samples,
we have identified a diverse array of DC-stimulating agents, including TLR ligands (LPS and CpG
oligonucleotides), other microbial products (muramyl dipeptide, D-mannose, and Protein A), P2
receptor ligands (ATP and ADP), skin irritant chemicals (croton oil and ethyl phenylpropiolate),
pharmacological agents (PMA and Forskolin), immuno-modifiers (cytokines), crude biological mate-
rials (necrotic keratinocytes), and physical stimulus (phagocytosis of latex beads). The system has
further allowed us to classify these agents based on the unique activation profiles of transcription
regulatory pathways (e.g., NFkB and AP1 activation by TLR ligands and NFAT activation by P2R
ligands). Moreover, agents classified in different categories produced distinct “signatures” in DC in
terms of gene expression profiles, cytokine and chemokine profiles, and surface phenotypes. These
results unveil a mechanism by which DC acquire striking plasticity upon exposure to different stim-
uli. Our DC-based biosensor system should serve as a useful platform to dissect the DC activation
process and to discover novel vaccine adjuvants and immunotherapeutics that selectively activate
desired transcription regulatory pathways in DC. 
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Correlation between changes in serum high-molecular weight melanoma-associated antigen
levels and clinical outcome in melanoma
BD Wainwright,1 SR Reynolds,1 S Ferrone,4 RL Shapiro,2,3 DF Roses,2,3 MN Harris,2,3
A Zeleniuch-Jacquotte3 and J Bystryn1,3 1 Dermatology, NYU School of Medicine, New York, NY, 2
Surgery, NYU School of Medicine, New York, NY, 3 NYU Cancer Institute, NYU School of Medicine,
New York, NY and 4 Immunology, Roswell Park Cancer Institute, Buffalo, NY
There is a need for improved markers to monitor the course of malignant melanoma and its response
to therapy, as the time required to reach conventional end-points of disease recurrence and overall
survival considerably increases the time and expense required to evaluate new therapies. This study
was conducted to examine whether treatment associated changes in levels of the high-molecular
weight mlanoma-associated antigen (HMW-MAA) are related to clinical outcome. We measured
serum levels of the HMW-MAA in 96 patients with resected AJCC Stage IIb or IIIa melanoma before
and following therapy with a polyvalent, shed antigen, melanoma vaccine using a double-sandwich
ELISA. The normal range was determined utilizing sera of 33 healthy individuals. Assay for HMW-
MAA was quantitative and was reproducible. Elevated baseline levels of HMW-MAA were detected
in 31% of patients. Following vaccine therapy, 12 (12.5%) patients had a decrease in antigen level
and 11 (11.5%) an increase. Median 75% percentile recurrence free survival RFS was significantly
longer in patients whose HMW-MAA level decreased compared to those whose antigen level increased
i.e., 23.2 months vs. 3.5 months (p=0.006). Melanoma recurred within 12 months in 73% of patients
with increasing HMW-MAA levels compared to 25% of those with decreasing levels (p=0.02). In
the remaining 73 (76%) patients HMW-MAA was negative at both time points or remained positive
without significant change, and their median 75% RFS in patients was 8.6 months. These results
suggest that changes in serum level of HMW-MAA may provide an early marker of the progression
and/or response to therapy of malignant melanoma. 
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Elevated serum cutaneous T cell-attracting chemokine (CTACK/CCL27) levels in patients with
atopic dermatitis and psoriasis vulgaris
T Kakinuma,1 H Saeki,1 Y Tsunemi,1 H Fujita,1 N Asano,1 H Mitsui,1 Y Tada,1 M Wakugawa,1
T Watanabe,1 H Torii,1 M Komine,1 A Asahina,1 K Nakamura2 and K Tamaki1 1 Department of
Dermatology, University of Tokyo, Tokyo, Japan and 2 Fukushima Medical University, Fukushima,
Japan
Both atopic dermatitis (AD) and psoriasis vulgaris (PsV) are characterized as chronic and relapsing
inflammatory skin diseases associated with various immunologic abnormalities. CTACK/CCL27
(cutaneous T cell-attracting chemokine) is a member of the CC chemokines and a functional ligand
for CC chemokine receptor 10 (CCR10). The epidermal keratinocyte is a main source of CTACK,
suggesting the involvement of various inflammatory skin diseases. The purpose of this investigation
was to clarify whether or not CTACK produced by keratinocytes is detected in sera of patients with
AD and PsV and to examine the correlation between the serum CTACK levels and disease activity
of patients with AD and PsV. We measured the serum CTACK levels in 50 patients with AD, 30
patients with PsV and 22 healthy control subjects. We also divided 50 patients with AD into three
groups; mild, moderate and severe, and compared them among three categories. Moreover, we com-
pared the serum CTACK levels of patients with AD and PsV with clinical or laboratory data. Immuno-
histochemical staining of CTACK and IP-10/CXCL10 was performed in the lesional skin of patients
with AD and PsV. The serum CTACK levels in patients with AD and PsV were significantly higher
than those in healthy control subjects. The serum CTACK levels in patients with AD significantly
correlated with SCORAD, serum sIL-2R, sE-selectin, TARC and MDC levels. Those in patients with
PsV significantly correlated with the serum IP-10 levels, but not with the PASI score. Immunohis-
tochemical staining showed CTACK was strongly expressed in lesional keratinocytes of patients with
AD and PsV whereas IP-10 was strongly expressed in those of patients with PsV and focally in
those with AD. These results suggest that CTACK may be one of the important chemokines for the
pathogenesis of AD and PsV. 
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Epidermal Langerhans’ cell migration in psoriasis
CE Griffiths,1 M Cumberbatch,2 RJ Dearman,2 H Young1 and I Kimber2 1 Dermatology Centre,
University of Manchester, Manchester, United Kingdom and 2 Immunology Group, Syngenta CTL,
Macclesfield, United Kingdom
Epidermal Langerhans’ cell (LC) migration is in part dependent upon signals provided by tumour
necrosis factor-a(TNF-a). For instance, intradermal administration of homologous recombinant TNF-
a results in a significant reduction (approx 25%) in LC numbers in normal epidermis within 2 hours
of treatment. By contrast the characteristics of epidermal LC migration in psoriasis are poorly under-
stood. Thus we examined the migration of epidermal LC in patients with a range of severities of
chronic plaque psoriasis following exposure to TNF-a. 4 healthy volunteers (20-55 years) and 8
patients with psoriasis (27-53 years), each received 50 249.3 LC/mm2; mean ± SD for n=4 normal
subjects and 1055.2 ± 125.7 LC/mm2; mean ± SD for n=8 psoriasis subjects). However, whereas
TNF-a provoked a marked reduction in CD1a+ LC numbers in normal subjects at both concentra-
tions tested (mean reduction 27% for 200U, n=2, and 24% for 500U, n=2), TNF-a failed to stimu-
late LC migration in patients with psoriasis (mean reduction 0.8% for 200U, n=5; and 1.0% for 500U,
n=3). In 4 other patients with psoriasis (27-52 years), LC frequency was measured as a function of
HLA-DR expression. HLA-DR+ LC densities at saline treated sites were within the range of values
for control sites stained for CD1a (989.9 ± 273.1 LC/mm2; mean ± SD) and no change (mean reduc-
tion: 0.05%) in LC numbers was observed in response to 500U TNF-a. These results suggest that in
psoriasis there is a functional abnormality in the epidermal LC population that manifests as a lack
of migratory response to TNF-a. 
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T helper type 2-dominated response in lck-GATA-3-transgenic mice up-regulates the contact
hypersensitivity reaction
Y Amo,1 H Tamauchi,2 Y Hamada,1 K Hozumi,3 S Habu,3 M Masuzawa1 and K Katsuoka1 1
Dermatology, Kitasato University School of Medicine, Sagamihara, Japan, 2 Immunology,
Kitasato University School of Medicine, Sagamihara, Japan and 3 Immunology, Tokai University
School of Medicine, Isehara, Japan
Contact hypersensitivity is thought to be mainly associated with the activation of Th1 cells. How-
ever, there is also evidence that Th2 cells and Th2 cytokines play a role in the development of con-
tact hypersensitivity. In the present study, we set out to determine the Th2 response in contact hyper-
sensitivity reaction to 2,4,6-trinitrochlorobenzene (TNCB) in lck-GATA-3-transgenic mice.
TNCB-challenged lck-GATA-3-transgenic mice had significantly greater ear-swelling responses than
TNCB-challenged wild-type (wt) mice. The dermis in the challenged skin in lck-GATA-3-transgenic
mice was the very severe inflammatory response with the lesional inflammation of both eosinophils,
monocytes/macrophages and mast cells compared with wt mice. The expression of Th2 cytokines
(IL-5 and IL-13) in TNCB-challenged skin tissues and the IgE response after chalenge were pro-
foundly increased in lck-transgenic mice, whereas the expression of interferon-γ was the same in
lck-GATA-3 trasgenic mice and wt mice after challenge. TNCB-challenged lck-GATA-3 transgenic
mice appeared to mimic the reaction of Th2 cells and Th2 cytokines occurring within the lesional
skin in atopic dermatitis (AD) patients. These results suggest that GATA-3-induced Th2-dominated
responses play a critical role in the pathogenesis of allergic dermatitis such as AD. 
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Expression of IP-10 is strongly induced during mouse Langerhans cell maturation and its
production is differentially regulated by various stimuli compared with that of TARC and MDC
H Fujita, A Asahina and K Tamaki Department of Dermatology, University of Tokyo, Tokyo, Tokyo,
Japan
Th1 and Th2 cells express different types of chemokine receptors. CXC chemokine receptor
3(CXCR3) is predominantly expressed on Th1 cells, and its ligand IFN-inducible protein-10(IP-10)
promotes migration of Th1 cells. On the other hand, CC chemokine receptor 4(CCR4) is predomi-
nantly expressed on Th2 cells, and its ligands thymus and activation-induced chemokine(TARC) and
macrophage-derived chemokine(MDC) promote migration of Th2 cells. It is well known that IP-10,
TARC and MDC are produced by antigen presenting cells(APC) including dendritic cells(DC).
Langerhans cells(LC) are APC localized in epidermis, and they belong to DC lineage. It is reported
that LC express TARC and MDC during maturation. However, it is not well documented whether
LC can express IP-10 and how the production of these Th1/Th2 chemokines is modulated by vari-
ous stimuli in LC. Recently, using the panning method, we succeeded in isolating highly purified
LC(>95%) from BALB/c mouse skin. In this study, mRNAs of freshly isolated LC and cultured LC
were analyzed by RT-PCR to detect the mRNA expression of these Th1/Th2 chemokines. Second,
to examine the regulation of the production of these chemokines, the amount of each chemokine
was measured by ELISA using the supernatant of 48h cultured LC with or without various stimuli.
We show here that: (1) mRNA of IP-10, as well as TARC and MDC, is strongly induced during mat-
uration in mouse LC. (2) Production of TARC and MDC in LC is either greatly enhanced or inhib-
ited according to the various kinds of stimuli used, but only limited kinds of stimuli can regulate the
production of IP-10. These results indicate that IP-10-CXCR3 system is operative only in special
microemvironment compared with TARC/MDC-CCR4 system in the skin immune system. 
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Adaptive immunity relies on distinct B cell recruitment for antigen presentation in murine
leukocyte adhesion deficiency 1
T Peters,1,4 W Bloch,2 S Grabbe,3 D Kess,4 R Hinrichs,4 T Krieg,1 W Muller5 and K Scharffetter-
Kochanek1,4 1 Dermatology / Center for Molecular Medicine, University of Cologne, Cologne,
Germany, 2 Anatomy, University of Colgne, Cologne, Germany, 3 Dermatology, University of
Muenster, Muenster, Germany, 4 Dermatology, University of Ulm, Ulm, Germany and 5
Experimental Immunology, GBF, Braunschweig, Germany
Leukocyte adhesion deficiency type 1 (LAD1) is a severe primary immunodeficiency syndrome
caused by a lack of functional β2 integrins. LAD1 patients suffer from recurrent bacterial infections,
impaired wound healing and skin ulcers. Weak or absent vaccine responses are concurrent. We inves-
tigated the role of β2 integrins in adaptive immune responses towards T-dependent antigens in β2
integrin-deficient (CD18-/-) mice. Immunohistochemistry and ultrastructural analyses revealed a defi-
ciency in forming morphologic corner stones of secondary lymphoid tissue such as germinal cen-
ters and immunological synapses. Upon immunization with tetanus toxoid (TT), CD18-/- mice gen-
erated only weak primary and secondary IgG responses, paralleling reports on human and bovine
LAD1. To specifically amplify the capacity of antigen presentation, CD18-/- and wild-type mice were
immunized with densely haptenated, (4-hydroxy-3-nitrophenyl) acetyl- (NP-) coupled antigens (NP-
chicken γ globulin, NP-TT). Despite pronounced morphological alterations, and the failure to respond
to TT, we found that CD18-/- mice mounted full primary and secondary immune responses when
immunized with haptenated antigens. These were not dependent on the prevailing high interleukin-
6 (IL-6) serum concentrations in CD18-/- mice, as could be demonstrated by the generation of a CD18-
/- IL-6-/- mutant. Since haptens have the distinct ability to recruit additional B cells with hapten
specificity into antigen presentation, they thus increase the pool of antigen presenting cells. This is
crucial for the successful elicitation of adaptive immune responses in LAD1. These findings may
argue in favour of a modification of vaccination strategies in immunodeficient individuals. 
ABSTRACTS THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
0883
Prevention of generalized autoimmune skin disease by transferring regulatory T cells
H Azukizawa, H Kosaka, S Sano and S Itami Department of Dermatology,Course of Molecular
Medicine, Osaka University, Graduate School of Medicine, Suita, Osaka, Japan
We established a model mouse of spontaneous generalized autoimmune skin disease mimicking toxic
epidermal necrolysis (TEN) affected by extrathymically developed cytotoxic T lymphocytes (CTL).
Double transgenic mice carrying both the transgene of ovalbumin (OVA) expressed selectively in
the keratinocytes under the keratin 5 (K5) promoter (K5-mOVA) and the Kb-restricted OVA-specific
TCR transgene(OT-I) spontaneously developed TEN-like skin phenotype in athymic nude mice back-
ground. In contrast, the double transgenic mice in euthymic mice background never developed the
skin phenotype. The number of OT-I cells was extremely decreased in euthymic double transgenic
mice because of clonal deletion by OVA-expressing thymus in which K5 was active. However,
when the OT-I cells purified from the lymph node of euthymic double transgenic mice were trans-
ferred into K5-mOVA single transgenic athymic nude mice, they vigorously attacked the skin bear-
ing OVA antigen, resulting in TEN-like skin damage. These results strongly suggested that toler-
ance of OT-I cells might be induced by thymus-derived cells in the euthymic mice. To demonstrate
the existence of tolerogenic immune system, we transferred CD8 (-) lymph node cells of euthymic
double transgenic mice into athymic double transgenic mice at day 10 of age. Although athymic dou-
ble transgenic mice usually developed severe skin disease at 8-12 weeks of age, transferred mice
were completely rescued from skin phenotype at more than 24 weeks of age. Moreover, depletion
of CD4 (+) cells from inoculating cells resulted in failure of tolerance induction in athymic mice.
These results indicate that so-called regulatory T cells strictly prevent the cytotoxicity of OT-I cells
in euthymic double transgenic mice, and that antigen expressed under control of K5 promoter in the
thymus not only induces clonal deletion but also generates regulatory T cells preventing autoimmune
skin disease. 
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Priming with formaldehyde-treated tumor cells broke tolerance and induced anti-tumor
immune response in murine melanoma models
C Obata,1 M Yoichi,1 K Urabe,1 T Koga,1 K Himeno2 and M Furue1 1 Department of Dermatology,
Kyushu University, Fukuoka City, Fukuoka-ken, Japan and 2 Parasitology, Kyushu University,
Fukuoka City, Japan
Tumor antigen-specific immune responses are often not evoked in tumor-burden mice. At first
tumor antigens induce specific immunologic tolerance in lymph organs. In addition, the products of
tumor cells may suppress immune responses of antigen presenting cells (APC) and/or lymphocytes.
Therefore, we modified murine melanoma cells, B16F1, to create the following: (1) 1% formalde-
hyde-treated cells (fixed), (2) sonicated fixed cells, and (3) frozen and thawed cells (F&T). We then
determined which modified tumor cells elicited the strongest anti-tumor immunity. C57BL/6 mice
were intradermally immunized three times at one-week intervals with the modified melanoma cells
before or after challenge with syngeneic melanoma. Some mice were transfected with 6µg IL-12
p35/p40 expression plasmid DNA (IL-12) into the skin around the tumor-immunization site with
the gene gun. In the preventative assay, in over 60% of the mice primed with fixed tumor followed
by IL-12 administration, tumor establishment was completely rejected. In the therapeutic assay,
tumor size decreased in mice primed with fixed tumor but not in those primed with sonicated fixed
tumor. IL-12 administration enhanced anti-tumor immunity both in mice primed with fixed and
sonicated fixed tumor compared with mice only administered IL-12. The lymphocyte depletion assay
demonstrated that both CD4+ and CD8+ T cells played critical roles in the protection against
melanoma. In this experiment, melanoma-specific proliferation in lymphocytes was enhanced only
in mice primed with fixed tumor. In conclusion, priming with fixed tumor cells can elicit significant
anti-tumor immunity both in preventative and therapeutic models. The activation of dendritic cell
might be critical to this enhanced anti-tumor immunity, because fixed melanoma cells should be
phagocytosed, processed and antigen-presented by APC as non-treated cells. Fixed tumor cells can
be a potential antigen source in several immune therapeutic strategies against tumors. 
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CD4+CD25+ regulatory T cells and the regulation of cutaneous antigen-specific inflammation
in humans in vivo
JR Reed,1 M Vukmanovic-Stejic,1 M Salmon,2 M Rustin1 and A Akbar1 1 Clinical Immunology,
Royal Free & University College Medical School, Hampstead, London, United Kingdom and 2
MRC Centre for Immune Regulation, University of Birmingham, Birmingham, United Kingdom
The resolution of antigen-specific inflammation is dependent on mechanisms to switch off the immune
response. CD4+CD25+ regulatory T cells exhibit suppressive activity and are anergic. Evidence sug-
gests that regulatory T cells are highly differentiated cells with short telomeres and low expression
of CD45RB. We have used the Mantoux test (MT) to investigate the role that regulatory T cells may
play in controlling an immune response in vivo. CD4+ T cells isolated from the peripheral blood
(PB) and skin suction blisters raised over MTs have been analysed. Antigen-specific telomere length
was measured using a novel 3-colour flow FISH technique. The clinical peak of the MT is at day 3
and is associated with a low proportion of antigen-specific CD4+ T cells (1.6%). The peak of infil-
trating T cells, however, is at day 7 and is marked by a significant increase in antigen-specific cells
(12%). This increased to 27% by day 21. PPD-specific CD4+ T cells isolated from the skin at day
21 had shortened telomeres compared to PB PPD-specific cells (MFI 85 vs 152 respectively). Sig-
nificant shortening was not detected at days 3 and 7. CD45RB expression was also significantly
decreased in skin memory CD4+ T cells by day 21. This points to the on-going differentiation of
cells within the skin, which results in a highly differentiated antigen-specific population of cells phe-
notypically similar to regulatory T cells. There was, however, no accumulation of CD4+CD25+ T
cells during the course of the MT and no change in the proportion of PPD-specific cells capable of
IL-2 secretion. Furthermore, CD4+ T cells isolated from the skin during resolution were hyperpro-
liferative compared to PB CD4+ T cells and did not suppress PB CD4+CD25- T cell proliferation.
Lack of significant suppressive activity at day 21 suggests that regulatory T cells do not play an
important role in the resolution of cutaneous inflammation. 
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Improved responsiveness of Langerhans/dendritic cells to allergens
S Ayehunie , SK Lamore, RS Lappen, KL Bellevance, J Kubilus, JE Sheasgreen and M Klausner
R & D, MatTek Corporation, Ashland, MA
Langerhans cells (LC) are immature dendritic cells (DC) that are highly specialized antigen-pre-
senting cells (APC) located in the skin, mucosa, and lymphoid tissues. LC play a key role in the
induction phase of contact allergenicity, and hence it may be possible to develop an in vitro LC-based
assay for contact sensitization.  The difficulty in harvesting and the short survival time of LC in cul-
ture have prevented researchers from widespread experimental use of LC. Although improvements
have been made, generating large number of cells remains a limiting factor and the functionality
and cytokine production capacity of cells in response to different stimuli is not consistent. Here we
report a new method of generating LC from CD34+ progenitor cells harvested from umbilical cord
blood. The generated LC were expanded 200 fold and expressed CD1a and HLA-DR, characteris-
tic of LC. LC were cultured for up to 41 days with no significant changes in CD1a and HLA-DR
expression. Transmission electron microscopy showed the presence of Birbeck granules, a key
ultrastructural marker of LC. Upon stimulation with lipopolysaccharide and phorbol 12-myristate
13-acetate, the LC showed a reproducible (n = 4), high level of gene and protein responsiveness in
terms of IL-12, MIP-1α, MIP-3α, IL-6, and TNF-α expression. The generated cells were infectable
with HIV and they were able to stimulate allogeneic T cells. In conclusion, we have developed a
method to harvest and culture functional LC expressing key LC markers. These cells have longer
life span in culture and can be used in: 1) allergenicity, 2) viral infection, 3) antigen presentation, 4)
immuno-therapeutic, and numerous other studies. 
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Telomere shortening and down-regulated telomerase activity during resolving cutaneous T cell-
mediated inflammation in humans in vivo
M Vukmanovic-Stejic,1 JR Reed,1 GR Foster,3 M Salmon,2 MH Rustin1 and AN Akbar1 1 Clinical
Immunology, Royal Free & University College Medical School, Hampstead, London, United
Kingdom, 2 MRC Centre for Immune Regulation, University of Birmingham, Birmingham, United
Kingdom and 3 Department of Medicine, Imperial College School of Medicine, London, United
Kingdom
The Mantoux test (MT) is a CD4 T cell mediated recall immune response that represents an excel-
lent model of resolving cutaneous inflammation in humans. The skin suction blister technique has
allowed us to characterise the course of MT response and follow the on-going differentiation of
cells in humans in vivo. One consequence of T cell proliferation and differentiation is telomere short-
ening. We have previously established that the MT peaks cliniclly at day 3 while the peak of infil-
trating T cells and proliferation occurs at day 7. Cells were collected from blisters at various time-
points during the induction, peak and resolution phases of the response and compared to cells derived
from peripheral blood. We observed an increase in the proportion of highly differentiated CD45RBlow
memory CD4+ T cells in the skin at day 21 compared to blood (65% and 87% respectively, p<0.001).
PPD-specific CD4+ T cells isolated from the skin at day 21 had significantly shorter telomeres com-
pared to PPD-specific cells in the blood (telomere MFI 85 vs 152 respectively). Heteroduplex analy-
sis confirmed the presence of the same clones throughout the response. This indicates that prolifer-
ation and differentiation of CD4+ T cells occurs in situ during the MT. The shortening of telomeres
observed within the antigen specific population of CD4+ T cells in the skin may be explained by a
low level of telomerase activity situ. Our data suggests that telomerase activity is only present tran-
siently early in the response. At the peak of proliferation at day 7 telomerase activity was at unde-
tectable levels. Our preliminary data suggest that the lack of telomerase function may be explained
by the increased levels of interferonα observed in blister fluids at day 3. 
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Ligation of CD86 increases dendritic cell capture of naive T cells and up-regulates CD40 and
MHC II expression
AR Cardones, T Murakami, H Fang and ST Hwang Dermatology Branch, NCI, NIH, Bethesda, MD
CD86 is expressed by maturing DC, including Langerhans cells, and modulates T cell function when
it binds to CD28 and CTLA4 on T cells, but the effects of CD86 ligation on DC are unclear. Herein,
we address whether CD86-mediated signaling modulates DC function and surface receptor expres-
sion. To crosslink CD86 (or other cell surface markers for comparison), murine bone marrow-derived
DC (BMDC) were added to tissue culture plates that had been coated with anti-CD80, anti-CD86,
or control monoclonal antibodies (mAb). After 12 hr at 37 deg C, BMDC were then analyzed by
flow cytometry for CD40 and MHC class II expression. 51% of CD86-ligated BMDC had a fluo-
rescence intensity (FI) for CD40 of >800, compared with only 0.62% and 2% for anti-CD80 and
isotype mAb-treated BMDC, respectively. 47% of CD86-ligated BMDC had an FI for MHC Class
II above 6000, compared with 16% of CD80-ligated and 3% of isotype mAb-treated BMDC. By
quantitative RT-PCR analysis, ligation of CD86, but not CD80, increased mRNA expression of the
T cell chemoattractants, CCL5 (RANTES) and CCL17 (TARC), by 5 and 4.2 fold, respectively, com-
pared to isotype mAb.  To evaluate DC adhesion to T cells, naive T cells isolated from mouse periph-
eral LN were introduced into a parallel plate flow chamber containing BMDC that had been immo-
bilized on anti-CD80, CD86, and CD40 mAb-coated tissue culture plates for 2 hr at 4 deg C and
then 1 hr at RT prior to assay. Interestingly, anti-CD86-immobilized BMDC captured naive T cells
two-three fold better than BMDC immobilized by CD40 or CD80 mAb (p<0.0001). DC from mouse
skin explants showed similar enhancement of T cell binding after CD86 ligation. Thus, in vitro
engagement of CD86 on DC up-regulates DC maturation markers, chemokines that can attract T
cells, and DC capture of T cells. Interestingly, these effects were not seen when CD80 (another mem-
ber of the B7 family) was crosslinked. These results suggest that engagement of CD86 on DC may
play a selective role in regulating DC-T cell binding and antigen presentation in vivo. 
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The malignant cells of cutaneous T cell lymphoma retain properties of the immunoregulatory
precursors from which they derive and are responsive to common CTCL antigens
CL Berger, D Hanlon, J Cohen, K Marinalla, N Wang, W Yuan and R Edelson Dermatology, Yale
University, New Haven, CT
We have demonstrated that the growth of cutaneous T cell lymphoma (CTCL) is driven by class II
presentation of peptides endogenous to the CTCL cells themselves. CTCL cells stimulated by auto-
antigen develop a T-regulatory (T-reg) phenotype. We now demonstrate that this antigen, when pre-
sented by autologous dendritic cells (DC), induces a T-reg phenotype in both allogeneic CTCL cells
and normal CD4 T cells. CTCL cells, DC and normal CD4 T cells were expanded with GMCSF/IL4
and IL2/IL7. Purified CTCL cells were rendered apoptotic by incubation with CD3 antibody prior
to being internalized by autologous or allogeneic DC. The phenotype of CTCL cells or normal CD4
T cells, after addition to autologous pulsed DC, was assessed. Purified CTCL cells that adopted a T-
reg phenotype were added as third-parties to measure suppression of a normal control mixed leuko-
cyte culture (MLC). After stimulation by tumor-loaded DC, CTCL cells or normal control CD4 T
cells expressed a T-reg phenotype (>20% membrane CD3, CD4, CD25+/cytoplasmic CTLA4+). In
contrast, neither CD4-treated CTCL cells, normal CD4 T cells, autologous DC alone, nor unpulsed
allogeneic DC induced expression of a T-reg phenotype (<5% + cells). Adoption of a T-reg pheno-
type depended on the concentration of CTCL-loaded DC (38% CTLA4+/105DC) and the number
of apoptotic CTCL cells used to load the DC (106 CTCL cells:38% CTLA4+). CTCL cells that
adopted a T-reg phenotype were functional third-party suppressors of a normal MLC response (51%
T-reg CTCL mediates 63% MLC suppression). These results suggest that CTCL is a malignant expan-
sion of a normal clone of T-reg cells. The common CTCL antigen(s) is recognized by autologous,
and allogeneic CTCL cells, as well as normal CD4 T cells. Since the antigen is endogenous to
CTCL cells from multiple sources, but not normal CD4 T cells, it may reflect a protein with an eti-
ologic relationship to the malignancy. 
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A TLR2-ligand induces pro-inflammatory cytokines and release of an antimicrobial peptide
in human mast cells: role of mast cells in innate immunity of the skin
MT Ochoa,1 TH Rea2 and RL Modlin1 1 Dermatology, UCLA, Los Angeles, CA and 2
Dermatology, University of Southern California, Los Angeles, CA
Mast cells (MC) have for decades been viewed as effector cells in the immune response associated
with Th2 cells and IgE, including urticaria and atopic dermatitis. However, recent studies in mouse
models have shown that mast cells express TLR-receptors and can contribute significantly to the
innate immune response against infectious agents. MC can rapidly respond to the infectious microor-
ganisms, by releasing immunoregulatory mediators, cytokines and recruiting neutrophils. We sought
to investigate if human MC play a role in the innate immunity of the skin, using leprosy as a model.
We found numerous mast cells in the skin lesions of the leprosy patients. A human MC line (HMC-
1) express TLR2 and can be activated by 19kD mycobacterium lipopeptide, releasing pre-formed
TNFα and IL-8. Cathelicidin - a novel antimicrobial peptide - was detected by real-time PCR and
confirmed at the protein level by FACS analysis and confocal microscopy after TLR-ligation in the
HMC-1 and in the lesions of the leprosy patients. We also found that stimulation of the HMC-1 with
the 19kDa lipopeptide, upregulates the expression of TLR1, a TLR that forms heterodimers with
TLR2 and can confer unique ligand recognition patterns in comparison to TLR2 alone. Our data indi-
cate that MC can be activated via pattern recognition receptors to increase antimicrobial mediators
and suggest that MC can contribute to the antimicrobial host response in the skin. 
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Keratinocyte extract enhances IgE production and epsilon germline transcription in vitro
K Morimoto, Y Nabeshima, M Mochizuki and M Hide Dermatology, Division of Molecular
Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences,
Hiroshima University, Hiroshima, Hiroshima, Japan
[Objective] Serum IgE level of atopic dermatitis patient is correlative to the severity of skin lesion.
We hypothesized that destruction of keratinocyte enhances IgE production and have reported that
serum IgE level of BALB/c mouse increased when injected with PAM212 (keratinocyte cell-line of
BALB/c mouse) extract. (Yamamoto T. et al. Arch Dermatol Res 294:117, 2002 ) Here, we exam-
ined the effect of PAM212 extract on IgE production and B-cell class switching in vitro. [Method]
PAM212 cells were cultured and homogenized by sonication. The soluble fraction was obtained by
centrifugation (105,000 g)(PAM extract). Splenic lymphocytes were obtained from BALB/c mouse
and cultured with or without IL-4, anti-CD40 antibody, and PAM212 extract. Supernatant IgE level
was measured by ELISA. Epsilon germline transcription in cultured cells was measured by semi-
quantitative RT-PCR from mRNA. [Result] PAM extract increased supernatant IgE level and enhanced
epsilon germline transcription in dose-dependent manner. Both IL-4 and anti-CD40 antibody were
required for these effects of PAM extract. [Conclusion] PAM extract enhances IgE production by
splenic lymphocytes via the enhancement of class-switching to IgE. 
0892
Four-dimensional (x,y,z, time) imaging of Langerhans cell movement in living tissues
JV Jester, B Ward, D Shalhevet, T Kumamoto, WM Petroll, HD Cavanaugh and A Takashima UT
Southwestern, Dallas, TX
Langerhans cells (LC) are strategically located at the environmental interfaces (e.g., skin and cornea),
where they serve as primary Ag presenting cells. Although LC migration from these tissues to drain-
ing lymph nodes have been documented by immunohistochemical analyses of fixed specimens, actual
behaviors of LC in living tissues remain unknown. In this study, we have created chimeric mice by
injecting bone marrow cells isolated from the green fluorescence protein (GFP) transgenic mice
into lethally irradiated B6 recipient mice. When tested 2-3 months after bone marrow reconstitu-
tion, >90% of IA+ dendritic cells in the epidermis and the cornea epithelium expressed GFP. Con-
versely, >80% of GFP+ dendritic cells expressed LC markers (i.e., IA and DEC205) in both tissues.
Ear skin and corneal samples harvested from the chimeric animals were then examined by multi-
photon confocal microscopy (Leica SP2/Coherent Ti:Sapphire femtosecond pulsed laser). Tissue
was mounted on a tissue slice adapter with temperature and media flow rate control. After tissue sta-
bilization (∼1 hr), 3D data sets were collected every 2-5 min for 1-3 hr. Images were then recon-
structed to evaluate cell movement in xyt, xzt and yzt, simultaneously. The time lapse confocal analy-
ses revealed striking mobility of GFP+ LC in both epidermis and cornea. Virtually all GFP+ cells
showed rhythmic and synchronized movement of their dendrites, primarily composed of repeated
projection/retraction cycles with an interval of 33 ± 5 min/cycle and speeds of 1.5 ± 0.2 µm/min (pro-
jection) and 2.0 ± 0.6 µm/min (retraction). Some (∼5%) of the GFP+ cells showed rapid migration
through the epithelial layer at a speed of 4.6 ± 3.8 µm/min with snaking of dendritic processes around
and between adjacent keratinocytes. Some vertical migration through the lamina propria was also
noted. This is the first report showing real-time 3D images of LC movement in living tissues and
unveiling a peculiar dendrite projection/retraction cycle. 
0890
Allergen-DNA-transfected dendritic cells as a tool to influence the human allergic immune
response
B Klostermann,1 I Bellinghausen,1 I Boettcher,1 A Petersen,2 W Becker,2 J Knop1 and J Saloga1 1
Department of Dermatology, University of Mainz, Mainz, Rheinland Pfalz, Germany and 2
Biochemical and Molecular Allergology, Research Center Borstel, Borstel, Germany
Atopic/allergic diseases are characterized by TH2 dominated immune responses resulting in IgE pro-
duction. DNA-based immunotherapies have been shown to shift the immune response towards TH1
in animal models. The aim of the study was to analyze wether DC transfected with allergen-DNA
are able to stimulate human autologous CD4+ and/or CD8+ T cells from atopic individuals to pro-
duce TH1 cytokines instead of TH2 cytokines. For this purpose, human mature DC from atopic
donors were transfected with an adenovirus encoding the allergen Phl p 1. Autologous CD4+ and
CD8+ T cells were stimulated with these transfected DC and proliferation and cytokine production
were measured. Using an adenoviral vector a transfection rate of 92% could be achieved. The pro-
liferative response of CD4+ T cells stimulated with autologous transfected DC was dose dependent
and almost as high as that of T cells stimulated with mature allergen pulsed DC. The proliferation
of CD8+ T cells stimulated with transfected DC however, was higher than that of cells stimulated
with allergen pulsed DC. The cytokine pattern showed a shift towards a TH1 immune response
compared with T cells stimulated with allergen-pulsed DC. Human DC can be transfected with aller-
gen-DNA very efficiently using an adenoviral vector yielding DC with high T cell stimulatory capac-
ities directing the atopic/allergic immune response from TH2-dominance towards TH1. 
0894
Primary lymphocyte activation during induction of contact hypersensitivity is potently inhib-
ited in mice by tacrolimus but not by pimecrolimus
A Bavandi, H Fahrngruber, JG Meingassner and F Kalthoff Novartis Forschungsinstitut Wien,
Vienna, Vienna, Austria
Contact hypersensitivity (CHS) is a T cell-mediated, antigen-specific dermatitis which is elicited in
sensitized individuals by epicutaneous exposure to the antigen. Oral pimecrolimus (PI) and oral
tacrolimus (TA) have been shown to inhibit the elicitation of CHS with similar activity in mice sen-
sitized against oxazolone. Interestingly, the induction phase (sensitization) associated with hyper-
plasia of local lymph nodes (LLN) was inhibited significantly by TA only, even at one third of the
highest PI dose tested. This striking difference prompted us to analyze phenotypes and kinetics of
activation-associated surface markers of lymphocytes of LLN. BALB/c mice were treated orally with
30 mg/kg TA or 90 mg/kg PI 2 hrs before, 4, 24, and 48 hrs after sensitization and dissected 48 or
96 hrs after sensitization. LLN cells were prepared and subjected to analysis by flow cytometry. LLN
from placebo-treated sensitized mice (controls) and from normal mice were prepared similarly for
comparison. At 48 hrs (24 hrs after the third dosing) a higher proportion of LLN cells from controls
expressed activation antigens such as CD25 (5.6%), CD69 (41.7%) and CD134 (9.6%) than in nor-
mal mice. TA significantly decreased the number of activated lymphocytes bearing these markers
(2.7, 21.2 and 5.3%, respectively) whereas the changes by PI vs controls were not statistically sig-
nificantly different. At 96 hrs (48 hrs after the fourth dosing), 41.7% of all LLN cells were B cells
(B220+/CD19+) in controls vs 25.6% in normal mice. B cells showed an activated phenotype as
assessed by double staining for B220/CD95 (41.7%) and B220/CD40 (39.7%). TA, in contrast to
PI, significantly reduced the number of activated B cells as shown for B220/CD95 cells (TA:30.7%
vs PI:41.7%) and for B220/CD40 (TA:29.3% vs PI:42.1%). Taken together, our results indicate that
treatment of mice with TA, opposed to the treatment with PI, results in a potent inhibition of lym-
phocyte activation in LLN during sensitization. 
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ATP enhances cutaneous immunity by modulating Langerhans cell function
W Ding,1 S Kodali,1 A Holzer,1 K Seiffert,1 JA Wagner2 and RD Granstein1 1 Dermatology, Weill
Medical College of Cornell University, New York, NY and 2 Neurology, Weill Medical College of
Cornell University, New York, NY
ATP can signal through cell surface receptors that are either ionotrophic (P2X) or G-protein linked
(P2Y) and ATP has been shown to modulate some aspects of dendritic cell function. Langerhans
cells (LCs) are a class of dendritic antigen presenting cells that reside in the epidermis and are believed
to play an important role in the initiation and expression of cutaneous immune responses. The response
of LCs to ATP has not been studied. In this study, we have examined the effects of ATP on func-
tional properties of LCs using the murine LC-like cell line, XS106A, derived from neonatal A/J (H-
2a) epidermis as a surrogate for LCs. XS106A cells were cultured in graded concentrations of ATP.
ATP (10 µM to 1000 µM) augmented cell surface expression of CD80 and CD86 at 24 hrs and
increased expression of I-A at 48 hrs as measured by flow cytometry. Culture in ATPγS, a stable
analogue of ATP, modified cytokine expression. It significantly enhanced secretion of IL-1β induced
by lipopolysaccharide, but significantly decreased secretion of IL-10, as measured by ELISA. We
then examined whether exposure to ATPγS would modulate antigen presenting ability.  Culture in
ATPγS (1 µM to 1000 µM) followed by thorough washing significantly augmented the ability of
BALB/c (H-2d) epidermal cells to present antigen (KLH) to a responsive T cell clone [HDK1 (H-
2d)]. To test whether ATP might also enhance cutaneous immunity in vivo, we studied the effect of
ATPγS on contact hypersensitivity (CHS). Intradermal injection of ATPγS significantly enhanced
induction of CHS to dinitrofluorobenzene applied topically at the injected site. Finally, by RT-PCR,
XS106A cells were found to express mRNA for both P2X and P2Y receptors. These data suggest
that local production of ATP, and possibly other nucleotides, may play an important role in regulat-
ing the ability of the epidermis to initiate or express an immune response through interaction of
nucleotides with a specific receptor(s) on the surface of resident LCs. 
0896
Epinephrine regulates TNF-α expression in the Langerhans cell-like cell line XS106A
K Seiffert, J Hosoi, H Torii, W Ding, S Kodali, JA Wagner and RD Granstein Weill Medical College
of Cornell University, New York, NY
Epidermal Langerhans cells (LC) express adrenergic receptors and agonist-binding to these recep-
tors regulates LC function. Exposure of purified LC to epinephrine (EPI) and norepinephrine (NE)
in vitro inhibits presentation of a defined antigen to a responsive T cell clone. They also inhibit elic-
itation of delayed-type hypersensitivity by epidermal cells in a β-receptor-mediated fashion, and
intradermal injection of EPI inhibits the induction of contact hypersensitivity. To examine possible
mechanisms for these activities, we studied the effect of EPI on LPS-induced expression of mRNA
for IL-12 by semiquantitative RT-PCR as well as production of TNF-α, IL-1β, IL-10, and IL-12
protein (assessed by ELISA) by the LC-like cell line XS106A . Cells were plated at 106/ml and
incubated with or without EPI 3 h prior to stimulation with 0.1 mg LPS. In a subgroup of experi-
ments, cells were incubated with the β-adrenergic antagonist propranolol or the α-adrenergic antag-
onist phentolamine 1 h prior to EPI treatment. Without LPS-stimulation cells did not produce detectable
levels of TNF-α. In supernatants collected 3h after addition of LPS, TNF-α was strongly upregu-
lated [225+/-31 (SD) pg/ml]. This effect was significantly inhibited by pretreatment with EPI 10-7
M (157+/-21 pg/ml). Propranolol 10-6 M prevented the EPI-induced inhibition (233+/-15 pg/ml),
while phentolamine had no effect (173+/-8 pg/ml). In 24 h supernatants, IL-1β and IL-10 produc-
tion was upregulated after stimulation with LPS. Preliminary data suggest that EPI may reduce the
upregulation of IL-1β while it may increase the production of IL-10. Preliminary experiments indi-
cate an upregulation of IL-12 mRNA expression 8h after addition of LPS and protein production 24
h after LPS addition, both of which are also inhibited by EPI. Our findings indicate that catecholamine-
induced suppression of cutaneous immunity may be mediated, in part, by changes in cytokines
secreted by LC upon stimulation. 
0897
Hapten application induces the production of IL-16 by epidermal cells in induction and elici-
tation phase of contact hypersensitivity reaction
K Masuda, N Katoh, F Okuda and S Kishimoto Dermatology, Kyoto Prefectural University of
Medicine, Kyoto, Kyoto, Japan
Interleukin (IL)-16 is a chemoattractant cytokine for CD4 positive leukocytes and is synthesized by
a variety of immune (T cells, eosinophils, and dendritic cells) and non-immune (fibroblasts, epithe-
lial cells, and neuronal cells) cells. Because contact hypersensitivity reaction is mediated by T helper
1 cells, we have investigated the involvement of IL-16 in the contact hypersensitivity reaction in
which CD4 positive T cells may be chemoattracted by IL-16. Trinitrochlorobenzene was applied to
the skin of male BALB/c mice and the expression of IL-16 was estimated at various times. ELISA
analysis exhibited the release of IL-16 from the epidermis and the dermis in elicitation phase in a
dose-dependent fashion. Interestingly, hapten application alone also induced IL-16 production both
in the epidermis and the dermis in induction phase. RT-PCR analysis also demonstrated IL-16 mRNA
to be detected in the epidermal cells of the mice not only in elicitation phase, but also in induction
phase. No IL-16 mRNA was detected in those of control mice applied vehicle alone. Flowcytomet-
ric analysis using monoclonal antibody against I-Ad indicated that IL-16 was produced mainly by
keratinocytes after single application of trinitrochlorobenzene. These results suggest that IL-16 may
play a role in induction and elicitation phase of contact hypersensitivity reaction. 
0898
Immunophenotyping of inflammatory cells in skin lesions of atopic dermatitis: more similar-
ities than differences between extrinsic and intrinsic forms
N Rho,1 D Lee,1,2 J Lee,1 E Lee1 and J Yang1,2 1 Department of Dermatology, SungKyunkwan
University School of Medicine Samsung Medical Center, Seoul, South Korea and 2 Samsung
Biomedical Research Institute, Seoul, South Korea
It is well known that atopic dermaititis is divided into several subgroups-extrinsic, intrinsic or inde-
terminate types-according to the presence or absence of allergy. Although the previous studies have
demonstrated differences in the cytokine profile between the two subtypes, the precise pathogene-
sis of both extrinsic and intrinsic forms of atopic dermatitis is obscure. To find out the potential dif-
ferences in the inflammatory micromilieu of both extrinsic and intrinsic atopic dermatitis, we per-
formed immunophenotyping of inflammatory cells in skin of 18 extrinsic and 17 intrinsic type of
atopic dermatitis. The results revealed a predominance of CD4+ T cells in the dermal infiltrate with
a similar CD4/CD8 ratio between two subtypes. Expression of other T cell markers and epidermal
Langerhans cells including CD30 and HLA-DR was also prominent in both types of atopic der-
matitis. Although the dermal T cell immunoprofile was simialr between two subtypes, tissue infil-
tration of EG2+ and MBP+ eosinophil granular proteins was markedly prominent in extrinsic type
compared to intrinsic type. Furthermore, lesional eotaxin immunoreactivity was significantly higher
in extrinsic subgroup. Our data suggest that although overall inflammatory microenvironment appears
to be similar in two subtypes, differences of cytokine productions in the T cell may contribute to the
differential degree of tissue eosinophilia in extrinsic and intrinsic form of atopic dermatitis. 
0899
Differential in vivo cytokine mRNA expression in lesional skin of intrinsic versus extrinsic atopic
dermatitis patients using semiquantitative RT-PCR
C Jeong,1 K Ahn,2 N Rho,1 Y Park,2 D Lee,1,2 J Lee,1 E Lee1 and J Yang1,2 1 Dermatology,
Sungkyunkwan University School of Medicine Samsung Medical Center, Seoul, South Korea and 2
Samsung Biomedical Research Institute, Seoul, South Korea
A small subgroup of atopic dermatitis (AD) patients with normal serum IgE levels and without spe-
cific IgE sensitization has been termed intrinsic type of AD (ADi) as a counterpart to the term
extrinsic type of AD (ADe). But, there are neither molecular makers nor clinically diagnostic tools
for distinguishing between ADi and ADe. To clarify the pathogenesis and in vivo cytokine microm-
ilieu of ADi patients in comparison with ADe patients, we used semiquantitative RT-PCR to inves-
tigate the expression of various cytokines and checked the tissue eosionphil counts in skin biopsies
from both types of AD patients. Although there was no significant difference of cellular infiltrates
in the lesional skin between ADe and ADi patients,ADe had significantly increased tissue eosinophilia
than ADi. Based on our RT-PCR, the expression patterns of cytokines could be categorized into four
groups. First group includes IL-5, IL-13 and IL-1β whose levels of mRNA expression were higher
in both types of AD patients than non-atopic (NA) and even higher in ADe patients than ADi patients.
Second group includes IFN-γ, IL-12, GM-CSF, IL-4, and IL-10 whose levels of mRNA expression
were elevated in both types of AD patients without differences between ADe and ADi patients.
Third group includes TNF-α whose mRAN expression was more decreased in both types of AD
patients than NA. And the fourth group includes IL-6 and TGF-β, which did not show any differ-
ences among three groups. Thes current data demonstrate that the expression of cytokine IL-5, IL-
13, and IL-1β mRNA and numbers of dermal infiltrating eosinophils are increased in ADe patients,
compared to ADi patients. 
0900
Natural anti-keratin autoantibody is encoded by germline gene
F Meng, L Wei, W Gang, L Yufeng, G Tianwen and L Chengxin Xijing Hospital, Xi, Shanxi, China
Anti-keratin autoantibody(AK autoAb), the circulating autoantibody binding to keratin polypep-
tide, has been detected in all healthy individuals. Although some progresses have been made in deter-
mining its functions and significances, the mechanism of natural AK autoAb production remains an
enigma. According to Clone tolerance theory, B lymphocytes with self-reactivity should be deleted.
The presence of AK autoAb seems to collide with the clone tolerance theory . The present study
aimed at obtaining and analyzing the variable region gene sequence of natural AK autoAb. Keratin
purified from newborn mice skin was used to screen hybridomas secreting anti-keratin mAb . Fusions
were performed between Sp2/0 cell lines and spleen cells of normal SPF(Specific Pathogen Free)
BALB/c mice. Total RNA was isolated from hybridoma and cDNA was synthesized. VH and VK
ds-cDNA were generated by PCR using the cDNA as template, two pairs of primers complemen-
tary to the cDNA in J or FR1 regions of VH and VK. DNA fragments were sequenceed and aligned
to Entrez databases of NCBI. Three hybrydomas strains secreting IgG anti-keratin mAb were obtained
and denominated as 2H8, 3B4 and 4G2. The results of immunohistochemistry and Western blot
showed that three mAbs could bind to keratin specially. The VH or VK sequences differed extremely
from each other except VH of 2H2 and 4G2. The disparity of three VH or VK may be due to the dif-
ferent binding epitope and affinity .Both the VH and VK were homologus to germline gene in data-
bases of NCBI, with the highest identity up to 99%. The nucleotide substitutions may be due to
somatic mutation. Because all three VH correspond to J558 family, the usages of VH seem to be
restrict to VH1 J558 family. With regard to the JH and JK, quite a few nucleotide substitutions could
be found when compared with JH and JK germline genes. No suitable germline gene matched DH
. These results strongly indicate variable region genes of natural AK autoAb are derived from germline
genes . It will be helpful to elucidate the mechanisms of natural AK auto Ab production. 
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Pituitary adenylate cyclase activating polypeptide inhibits cutaneous immune function
S Kodali, I Friedman, W Ding, K Seiffert, JA Wagner and RD Granstein Weill Medical College of
Cornell University, New York, NY
Pituitary adenylate cyclase activating polypeptide (PACAP) is present in cutaneous nerves. Previ-
ous evidence has demonstrated that cutaneous nerves are closely associated with Langerhans cells
(LC) and that LC express mRNA for the PACAP receptors VPAC1 and VPAC2.  Previously, we
have demonstrated that exposure of murine epidermal cells to PACAP in vitro inhibits the ability of
these cells to present antigen to a responsive T cell clone and that PACAP inhibited the induction of
contact hypersensitivity when injected intradermally into mice prior to sensitization with a contact
sensitizer at the injected site. We have now further characterized the regulatory effects of PACAP on
cutaneous immunity. To examine the effects of PACAP on presentation of antigen for induction of
delayed-type hypersensitivity (DTH), CAF1 (H-2a/d) epidermal cells were enriched for LC content
(eEC) by deletion of Thy 1+ cells. These cells were then incubated with or without PACAP prior to
being pulsed with soluble tumor antigens (TAA) from the S1509a spindle cell tumor (H-2a). These
eEC were then injected into a hind footpad of mice previously immunized against S1509a cells and
24 hr footpad swelling was measured. Mice injected with eEC preincubated with PACAP prior to
TAA pulsing showed a significantly decreased DTH response compared to the response elicited by
cells not exposed to PACAP [11.9 +/- 4 (SD) mm-2 vs 21.3 +/- 7, p=0.002].  To examine possible
regulatory effects of PACAP on cytokine expression by LC, we employed the murine LC-like cell
line XS106A (derived from neonatal A/J epidermis) as a surrogate for LC. In these cells, PACAP
significantly inhibited the LPS and GM-CSF-induced stimulation of IL-1β and IL-12 secretion, while
significantly augmenting the production of IL-10. We hypothesize that the effect of PACAP on LC
antigen presentation may be due to modulation of cytokine production, resulting in downregulation
of cell-mediated immunity. 
0903
Vasoactive intestinal polypeptide regulation of cytokine production in the Langerhans cell-like
line XS106A
S Kodali,1 W Ding,1 K Seiffert,1 JA Wagner2 and RD Granstein1 1 Dermatology, Weill Medical
College of Cornell University, New York, NY and 2 Neurology, Weill Medical College of Cornell
University, New York, NY
Vasoactive intestinal polypeptide (VIP) is found in cutaneous nerves and its receptors VPAC1 and
VPAC 2 are expressed in Langerhans cells (LCs) and the murine LC-like cell line XS106A, derived
from neonatal A/J epidermis. Previous work by our group has shown that neuropeptides released by
cutaneous nerves affect LC antigen presentation. In order to determine if VIP regulates cutaneous
immune function, we employed XS106A cells as surrogates for LCs and determined the effect of
VIP on XS106A cytokine production. XS106A cells were preincubated with varying concentra-
tions of VIP for 3 hours prior to addition of LPS and GM-CSF for stimulation of the cells. Super-
natants were collected 24 hours later and analyzed by ELISA for IL-10 and IL-1β production. Since
IL-12 levels were not easily detectable by ELISA, the effect of VIP on IL-12 expression was assessed
at the mRNA level. Cells were treated as above, but harvested for mRNA 6 hrs after addition of LPS
and GM-CSF. Semi-quantitative PCR was utilized to determine changes in IL-12 mRNA expres-
sion using GAPDH as an internal control. VIP suppressed the LPS and GM-CSF-induced produc-
tion of IL-1β at 10-6 M [88 +/- 6 (SD) pg/ml for 10-6 M VIP vs 106 +/- 5 pg/ml without VIP, p=0.01].
Preliminary data also suggests that VIP at 10-6 M inhibits induction of IL-12 mRNA in XS106A
cells. In contrast, VIP augmented the secretion of IL-10 in stimulated XS106A cells at concentra-
tions of 10-8, 10-7, and 10-6 M (779 +/- 18 pg/ml for VIP 10-6 M vs 583 +/- 10 pg/ml without VIP,
p<0.001). VIP may regulate cutaneous immune function by modulating LC cytokine expression. 
0905
Systemic treatment with anti-SHPS-1 antibody suppresses contact hypersensitivity response
via inhibiting Langerhans cell migration at the sensitization phase
A Fukunaga, H Nagai, M Ichihashi and T Horikawa Division of Dermatology, Kobe University
Graduate School of Medicine, Kobe, Japan
Src homology 2 domain-containing protein tyrosine phosphatase substrate 1 (SHPS-1) is a member
of the signal regulatory protein family, which plays an important role in cell motility and is expressed
in myeloid cells including monocytes, macrophages, and dendritic cells. Here we demonstrate that
murine epidermal Langerhans cells (LCs) express SHPS-1 and in vivo treatment with monoclonal
antibodies (mAbs) to SHPS-1 reduced contact hypersensitivity (CHS) response. FACS and immuno-
fluorescent studies using mAbs to SHPS-1 and Ia molecules revealed that Ia-bearing LC express
SHPS-1. The in vivo treatment with mAbs to SHPS-1 before sensitization, but not before elicitation,
reduced CHS reponse to DNFB in C57BL6 mice. We further investigated if anti-SHPS-1 mAbs can
inhibit LC migration. First, in vivo adminitration of anti-SHPS-1 mAbs reduced LC migration to the
regional lymphnodes after FITC application to skin. Second, in vivo mAb treatment significantly
suppressed a decrease of LC number in the epidermis with hapten application. Third, migration of
the dendritic cells expressing Ia molecules from skin explants into the culture media was reduced
by the addition of anti-SHPS-1 mAb into the culture media. These results indicates that anti-SHPS-
1 mAb inhibited the migration of LC at the sensitization phase and thereby suppressed CHS reponse. 
0904
In vivo transfection of cis element “decoy” against signal transducers and activators of tran-
scription 6 binding site ameliorates IgE-mediated late phase reaction in atopic dermatitis model
mouse
H Yokozeki,1 M Wu,1 K Sumi,1 T Satoh,1 K Nishioka,1 I Katayama2 and Y Kaneda3 1 Dermatology,
Tokyo Medical and Dental University, Tokyo, Tokyo, Japan, 2 Dermatology, Nagasaki University,
Nagasaki, Nagasaki, Japan and 3 Gene Therapy, Osaka University, Suita, Osaka, Japan
Signal Transducers and Activators of Transcription 6 (STAT6) plays a crucial role in the transacti-
vation of IL-4, IL-13 that might be involved in the pathogenesis of atopic dermatitis (AD). We reported
here that IgE mediated late phase reaction was significantly reduced in STAT6 deficient (STAT6-/-
) mice in AD model mouse induced by intravenous injection of monoclonal anti-DNP-IgE antibody
and subsequent skin testing with dinitrofluorobenzene (DNFB). Therefore, we hypothesized that
synthetic double-stranded DNA with high affinity for STAT6 could be introduced in vivo as decoy
cis elements to bind the transcriptional factor and to block the activation of genes mediating AD,
thus providing effective therapy for AD. Treatment by transfection of STAT6 decoy oligodeoxynu-
cleotides (ODN), but not scramble decoy ODN after the sensitization by anti-DNP-IgE antibody,
had a significant inhibitory effect on not only STAT6 binding to nuclear but the anti-DNP-IgE anti-
body induced late phase response.  The histological analysis revealed that both edema and the infil-
tration of neutrophils and eosinophils were significantly reduced in STAT6 decoy ODN transfected
mice.  To examine the mechanism of the in vivo effect of STAT6 decoy ODN, we employed an in
vitro mast cell culture system. After IgE receptor engagement, bone marrow cells tranfected by STAT6
decoy ODN exhibited normal histamine release, but their cytokine release (TNF-a, IL-6 ) was markedly
reduced. Here, we reported that the first successful in vivo transfer of STAT6 decoy ODN to reduce
the late phase reaction providing a new therapeutic strategy for atopic dermatitis. 
0902
Sensitization or tolerization by DNTB in humans?
PS Friedmann,1 C Pickard,1 M Cumberbatch,2 R Dearman2 and I Kimber2 1 Dermatopharmacology
Unit, Southampton General Hospital, Southampton, United Kingdom and 2 Syngenta Central
Toxicology Laboratory, Macclesfield, United Kingdom
Dinitrothyocyanobenzene (DNTB) has been reported to tolerize mice to subsequent sensitization
by dinitrochlorobenzene (DNCB) so we examined whether DNTB modified subsequent responses
to DNCB in humans. To show whether responses to DNCB are altered by prior treatment with DNTB
the “reference response” to DNCB was first established in 10 volunteers sensitised by application
of the challenge regimen of 4 doses of DNCB (6.25, 8.8, 12.5, 18.8µg) which is itself a moderately
potent sensitizing stimulus. Four weeks later the same 4 doses were applied to the other arm and
48h responses quantified as thickness with calipers. The mean response to DNCB (AUC obtained
from the sum of responses at each challenge dose) was 5.9±1.02(SEM). To examine whether DNTB
could sensitize, the same regimen but with DNTB was used in a second group (N=7). Responses to
challenge were uniformly negative so DNTB appeared not to sensitize. To see if priming with DNTB
altered subsequent reponses to DNCB, 4 DNTB challenge doses were applied 4 weeks before expo-
sure to the “reference regimen” of sensitization and challenge with DNCB. Responses to the final
DNCB challenge were similar to those for the reference group (AUC=4.3±1.6; P>0.05). However,
initial priming with a single high dose (35µg) of DNTB followed by the “DNCB reference regi-
men” resulted in much greater responses to DNCB (AUC 13.4±6.02; N=6). Thus, DNTB appears to
act as a weak sensitizer, being unable to prime for responsiveness to itself, but able to prime for aug-
mented responses to DNCB. This result could possibly reflect poor penetration rather than weak
inherent sensitizing potency. Therefore, a group previously sensitized and challenged with DNCB
were challenged with DNTB which elicited strong responses, comparable to those evoked by DNCB
itself. Thus, DNTB can be recognised by DNCB-primed T lymphocytes but it appears poorly able
to induce activation of naive T cells. However, in humans, it is not a tolerizer for subsequent reac-
tivity to DNCB. 
0906
Cutaneous CD25+CD4+ T lymphocytes regulate nickel-specific T cell responses
A Cavani, F Nasorri, C Ottaviani, S Sebastiani and G Girolomoni Laboratory of Immunology, IDI,
Rome, Italy
A specialized subset of regulatory CD4+ T cells that constituively express the CD25 antigen has
been recently characterized. CD4+CD25+ lymphocytes are anergic in vitro when engaged through
the TCR, express high levels of CTLA-4 antigen, and suppress T cell responses through a mecha-
nism requiring cell-to-cell contact. CD25+ cells are critical for the maintenance of peripheral toler-
ance to self-antigens. However, their role in the control of T cell responses against exogenous anti-
gens is still unknown. We found that approximately 20% of CD4+CD25+ T cells purified from
peripheral blood of healthy, non allergic donors (n 6), express the cutaneous lymphocyte-associated
antigen (CLA), a marker for skin-seeking T lymphocytes. CD4+CD25-, depleted from CD25+
cells, displayed 50-80% increased responses to nickel, compared to the whole CD4+ population,
both in terms of proliferation and IFN-γ release. In contrast, the CD25+ fraction was anergic to nickel
in 5 out of 6 non allergic individuals, failed to release cytokines, but up-regulated CTLA-4 upon
nickel exposure. CD25+ T cells dose-dependently inhibited the proliferation to nickel and the cytokine
released by autologous CD4+CD25- T cells. Inhibition was not mediated by IL-10 or TGF-β, and
was mostly, but not exclusively, mediated by the CD25+CLA+ population. Punch biopsies taken
from the site of negative patch tests to nickel in non allergic subjects, showed the presence of an
heavy CLA+CD4+ T cell infiltrate with fewer CD8+ T cells, and a substantial number of CD25+
lymphocytes. T cells isolated from the biopsies contained about 20% of CD25+ cells, failed to respond
to nickel in vitro, and strongly inhibited the proliferation of blood CD4+CD25- T cells to the metal.
These results indicate that CD4+CD25+ cells can regulate peripheral immune responses to haptens
in non allergic individuals, and they may have a role in preventing the development of undesired skin
allergies. 
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Role of CC- chemokines, chemokine receptors and polymorphism in promoter regions of
RANTES among patients with atopic dermatitis in Taiwan
Y Huang,1 S Shen,2 C Hu2 and W Lee1,3 1 Dermatology, Taipei Medical University Hospital,
Taipei, Taiwan, 2 Dermatology, Taipei Wan-Fang Municipal Hospital affliated to Taipei Medical
University, Taipei, Taiwan and 3 Institute of Medical Sciences, Taipei Medical University, Taipei,
Taiwan
CC- chemokines are potent proinflammatory molecules which play an important role in the patho-
physiology of atopic dermatitis (AD) and allergy. We determined the plasma level of CC- chemokines
in AD and controls by ELISA and used flow cytometry to evaluate the expression of chemokine
receptors on peripheral blood mononuclear cells (PBMC) in both groups. We graded clinical sever-
ity of AD according to the SCORAD index. Plasma levels of RANTES, MIP-1 and eotaxin were
increased in severe AD patients (n=19), but not in moderate AD (n=32) and mild AD (n=13) com-
pared with normal controls (n=23). MCP-1 level is the samte in both groups. Chemokine receptor
CCR3 were overexpressed in patients with severe atopic dermatitis as compared with controls, but
not CCR2 and CCR5. In addition, polymorphisms in the promoter region of RANTES have been
found and associatecd with overexpression of these chemokines. Different studies showed various
roles of RANTES polymorphism in German and Hungarian children with atopic dermatitis. So we
have also investigated whether the presence of these polymorphisms was associated with atopic der-
matitis in Taiwanese children. Sixty-five atopic dermatitis patiens and twenty six controls of com-
parable ages were screened for genotype with PCR and direct sequencing- based assay. No signifi-
cant difference in the frequency of the polymorphisms between atopic dermatitis patients and controls
was detected. Our finding suggests augmented production of some CC- chemokines such as RANTES,
MIP-1 eotaxin and chemokine receptor CCR3, but no MCP-1, CCR2 and CCR5 correlate with clin-
ical severity of atopic dermatitis. In Taiwanese children, there was no association between -28G and
-403 A alleles in the RANTES promoter and atopic dermatitis. 
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Pollen-associated lipid mediators modulate dendritic cell function leading to a reduced capac-
ity to initiate Th1 responses
C Traidl-Hoffmann,1 T Jakob,1 V Mariani,1 H Hochrein,2 MJ Mueller,3 H Wagner,2 J Ring4 and
H Behrendt1 1 Division of Environmental Dermatology and Allergy GSF/TUM, ZAUM-Center for
Allergy and Environment, Munich, Germany, 2 Institute of Medical Microbiology, Immunology and
Hygiene, Munich, Germany, 3 Julius von Sachs Institute, Wuerzburg, Germany and 4 Technical
University, Department of Dermatology and Allergy, Munich, Germany
The primary site of exposure to pollen grains is the epithelium of the upper respiratory tract, which
is densely populated by immature dendritic cells. We recently demonstrated that pollen grains not
only function as allergen carriers but are also a rich source of bioactive lipid mediators. Aqueous
extracts from phleum pratense and betula alba pollen (APE) contained predominantly monohy-
droxylated derivatives of linoleic and linolenic acid. In addition, GC-MS analysis of betulla alba
APE demonstrated the presence of phytoprostanes E1, F1, A1/B1. Since DC critically influence the
outcome of the ensuing T cell polarization, we investigate the biological activity of APE on imma-
ture DC. Human pB monocytes-derived DC displayed morphology and phenotype of immature DC
(CD1a+, MHC IImed, mannose receptor+, CD14neg., CD83neg., CD86neg.). Exposure to phleum
pratense or betula alba APE induced DC maturation as documented by upregulation of MHC class
II, CD83, CD86 and increased allostimulatory activity. APE induced DCs to release significantly
less IL-12 p40 and p70, as compared to LPS. In addition, APE inhibited dose-dependently the LPS-
induced IL-12 p70 release and IL-12 p40 (but not p35) mRNA levels (real time PCR), while no effect
on LPS induced IL-6 release was observed. Consistent with that, APE-activated DCs induced sig-
nificant less IFN-g production in allogeneic naive CD45RA+, CD4+ T cells. These results suggest
that pollen associated lipid mediators (PALMs) act as important regulatory signals that modulate DC
function in a fashion that favours a reduced Th1 polarization. C.T.-H. and T.J. contributed equally 
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A reciprocal interplay of tolerogenic APCs and T suppressor cells accounts for the spread of
nickel tolerance in vivo
K Roelofs, X Wu, M Nowak and E Gleichmann Environmental Health Research Institute (IUF) at
Heinrich-Heine-University, Duesseldorf, NWF, Germany
We have reported that Ni2+ ions need to be administered together with adjuvant, such as H2O2 (1%),
in order to induce de novo sensitization to nickel (Ni) in mice and that tolerance can be induced by
a 4-week course of 10 mM NiCl2 in the drinking water. In adoptive transfer assays, as few as 10
2
splenic T cells, containing both CD4+ and CD8+ cells, from orally tolerized donors prevented de novo
sensitization to Ni of the recipients. In vitro, these Ni-specific T suppressor (Ts) cells were anergic.
Here, we analyzed the mechanism underlying Ni tolerance. We found that 103 CD4+CD25+ T cells
from orally tolerized donors failed to transfer Ni-tolerance, whereas, 102 APCs, i.e., T cell-depleted
spleen cells and even 103 purified B cells, which were devoid of DCs, of these donors were perfectly
able to do so. This tolerance cannot be explained by a simple passive transfer of Ni. Compared with
APCs from untreated donors, the APCs from orally tolerized donors showed a reduced allostimula-
tory capacity in vitro and displayed a tolerogenic phenotype, namely an increased expression of
DEC-205 on DCs, and a decreased expression of CD40 on B cells and DCs. Serial adoptive trans-
fers, using orally tolerized Ly5.1+ donors into two successive sets of Ly5.2+ recipients, revealed a
spread of tolerance from donor T cells to host T cells. However, this infectious spread of tolerance
required participation of the recipients, APCs. The Ni-specific donor Ts cells apparently modified
Ni-presenting APCs of the recipient into tolerogenic APCs which, in turn, induced Ni tolerance in
the naive T cells of the recipient. The spread of Ni tolerance from donor Ts cells to host APCs required
challenge with both Ni2+ ions and H2O2, indicating that the Ni-specific donor Ts cells need to be re-
activated in order to render the host,s APCs tolerogenic. Hence, restimulation of Ni-specific Ts cells
not only prevented Ni sensitization of the host, but, paradoxically, enhanced Ni tolerance by the pow-
erful mechanism of infectious tolerance. 
0910
Blockade of lymphotoxin signaling inhibits the clinical expression of murine graft-versus-host
skin disease
Q Wu and RD Sontheimer Dermatology, Univ. of Iowa College of Medicine, Iowa City, IA
Early murine GVHSD can serve as an experimental (exp) model for the human cutaneous lichenoid
tissue reaction (LTR), a pattern seen in human skin diseases such as lupus erythematosus, dermato-
myositis, and lichen planus. As interaction of membrane LTα1Β2 (LTα) with its receptor, LTαR, is
essential for normal immune functioning, we questioned whether LTα signaling might play a role
in the expression of GVHSD. Bone marrow and spleen cells (4 million splenocytes) from 6-8 week-
old female LP/J mice (H-2b) were transplanted by retro-orbital vein infusion into a panel of 5 lethally-
irradiated 8-12 week-old female C57BL/6 (H-2b) recipient mice. At day 0 and 7 after-transplant (A-
T), recipient mice were injected by retro-orbital vein with 75mg of LTΒR-Ig, a LTΒ receptor decoy
fusion protein know to inhibit LTα signaling (exp group [exp grp]) or 75mg of human-Ig (control
group [cnt grp]). This same exp was replicated twice with similar results. Posterior neck skin biop-
sies from the cnt grp on day 20 A-T revealed ~ 40% increase in epidermal thickness and ~200%
increase in dermal thickness due largely to prominent mononuclear cell (MC) infiltration of the der-
mis and epidermis. Skin biopsies at the same point in the exp grp demonstrated only low levels of
MC infiltration and normal architecture overall. By 40 days A-T, 50% of the cnt grp had developed
clinically-obvious, severe skin lesions (les) consisting of varying elements of blistering, erosion,
crusting, hyperkeratosis, and alopecia on the face, ears, neck and abdomen. However, the exp grp
had not developed clinical skin les at this time point. Analysis of skin and spleen T cells by immuno-
chemistry and flow cytometry revealed that LTΒR-Ig treatment inhibited T cell infiltration into skin
but and spleen T cell activation. We conclude that inhibition of LTα signaling via LTΒR-Ig treat-
ment can ameliorate skin les in murine minor H2 antigen mismatch GVHSD probably by inhibiting
T cell activation and homing to skin. The LT signaling pathway could play an important role in the
pathogenesis of the human LTR. 
0911
Diphenylcyclopropenone sensitization and therapeutic failure in alopecia areata
JM Hales, N Patel and RD Camp Dermatology, University of Leicester, Leicester, United Kingdom
The mechanism of action of topical diphenylcyclopropenone (DCP) in the treatment of alopecia
areata (AA) and reasons for the highly variable therapeutic successes, are unclear. Because there are
few reports of the in vitro immunologic properties of DCP, we explored its effects on peripheral blood
mononuclear cells (PBMC) from topically treated donors. Preliminary experiments showed that
PBMC responses to DCP were dependent on the presence of a >50 kDa ultrafiltration fraction pre-
pared from fresh autologous serum, but were not enhanced by addition of stratum corneum extract
as a source of putative hapten binding proteins. Reversed phase HPLC analysis showed that DCP
was converted to a major, non-polar, biologically inactive metabolite by liver and skin microsomes,
the latter almost completely converting saturating concentrations of DCP to this metabolite in 4 hours.
These preliminary experiments established that 5-day proliferation assays with PBMC, 10% fresh
autologous serum and a range of DCP concentrations up to 20 µM (limit of water solubility approx-
imately 200 µM), provide a reliable indication of the level of sensitization to DCP. Analysis of the
PBMC responses of patients who had undergone weekly topical DCP treatment of AA for at least 5
months, indicated that DCP-induced PBMC proliferation was significantly greater in the minority
of patients who were therapeutic responders (maximum stimulation index [mSI] 13.7 ± 8.6, n=5)
than in the therapeutic non-responders (mSI 2.5 ± 1.3, n=9; means ± SD, p=0.009, Mann-Whitney
test). Almost 70% of the latter were not sensitized to DCP as shown by the PBMC proliferation
assays. In spite of the in vitro immunologic differences, inflammation in treated skin, measured by
a defined scoring system, was not different in therapeutic responders and non-responders. These
results associate therapeutic failure with failure of DCP sensitization, and suggest that skin inflam-
mation during DCP treatment is not a good measure of DCP allergy. Metabolism by skin microso-
mal enzymes may also be a mechanism for inactivation of DCP during therapy. 
0912
Morphological evidence of neuropeptide release and mast cell degranulation in tacrolimus (FK
506) and pimecrolimus (SDZ ASM 981) treated murine skin
S Staender, M Steinhoff, H Staender and TA Luger Dermatology, University of Muenster,
Muenster, Germany
Topical therapy of atopic dermatitis with the calcineurin inhibitors pimecrolimus and tacrolimus
has proven to be a very effective novel approach. However, following tacrolimus and to a lesser extent
also after pimecrolimus application many patients experience transient, adverse events such as
burning and itching. Since the neuropeptides substance P (SP) and calcitonin gene-related peptide
(CGRP) are the major cutaneous mediators of pain and pruritus the effect of topical calcineurin
inhibitors on neuropeptide release was investigated. Healthy Balb/c mice were treated on the shaved
back twice daily with either 0.1% tacrolimus ointment or 1% pimecrolimus cream for 2, 4 and 8 days
respectively. Untreated or vehicle-treated mice served as controls. Skin specimens were investi-
gated by light, immunofluorescence and electron microscopy. Following pimecrolimus application
hyperplasia of the epidermis and a dense dermal inflammatory infiltrate was observed. In contrast,
these changes were not seen after tacrolimus application. Mast cells often in close vicinity to nerve
fibers were found to be degranulated following 2 and 4 day tacrolimus application and only after 8
day pimecrolimus application. Immunofluorescence revealed a reduced staining with SP and CGRP
in papillary nerve fibers after the application of pimecrolimus or tacrolimus. At the ultrastructural
level, nerve fibers were found to be regular without signs of degeneration or inflammation in tacrolimus
or pimecrolimus treated skin. These data indicate that topical application of calcineurin inhibitors is
followed by the release of neuropeptides possibly leading to mast cell degranulation. However, the
potency of tacrolimus to affect mast cells and nerve fibers appears to be more pronounced in com-
parison to pimecrolimus. Therefore, the release of mast cell mediators after topical application of
calcineurin inhibitors leading to the release of neuropeptides in peripheral nerves may provide an
explanation for the transient observation of burning and pruritus. 
VOL. 121. NO. 1 JULY 2003 ABSTRACTS
0913
Identification of a T cell epitope in the immunodominant NC16-A region of BP180 in bullous
pemphigoid
S- Thoma-Uszynski,1 S Schwietzke,1 L Borradori2 and M Hertl1 1 Dermatology, University of
Erlangen, Erlangen, Germany and 2 Dermatology, University of Geneva, Geneva, Switzerland
Autoreactive T cells are attributed a key role in the pathogenesis of bullous pempghigoid (BP) by
triggering antibody (Ab)-formation directed against the hemidesmosomal adhesion molecule BP180
and induction of dermoepidermal loss of adhesion. Our study objective was to identify BP180 T cell
epitopes. Using baculovirus-expressed BP180 proteins we investigated autoreactive T cell responses
in patients with active BP (n=20). Autoreactive T helper cells preferentially recognized epitopes
within the immunodominant NH2-terminal region of the extracellular domain (ECD) of BP180, but
in about 50% of BP patients T cell epitopes were also located throughout the ECD of BP180. T cell
lines were cloned by limiting dilution and tested against overlapping 17mer BP180-derived peptides.
With this approach, we identified a T cell peptide within the NC16-A domain of the ECD of BP180
which is also immunodominant for auto-Ab. This stimulatory BP180-pepitide was recognized in
association with HLA-DRB1*1301 by an autoreactive CD4+ T helper cell clone. Application of trun-
cated peptides and alanine substituted altered peptide ligands abrogated the peptide response specif-
ically and revealed a 12mer core peptide with essential peptide residues at positions 1, 4-7, 9-11.
This autoreactive T cell clone exhibited a Th0- mixed cytokine pattern with high levels of IL-5, but
also IL-4, IL-10, TNF-a and IFN-g upon specific stimulation. The identification of this BP180-spe-
cific peptide supports the functional relevance of T cell responses in the pathogenesis of BP and rep-
resents the basis for the development of immunomodulatory strategies in BP. 
0915
The role of mature and immature dendritic cells in the induction and elicitation of contact
hypersensitivity
H Xu, G Zu, H Guan, H Kim and C Elmets Dermatology, University of Alabama at Birmingham,
Birmingham, AL
Dendritic cells (DC) are not only potent antigen presenting cells for the development of immune
responses but also play important roles in the induction of immune tolerance. A crucial factor which
decides immunogenic or tolerogenic potentials of DC is their maturation or activation status. Although
the role of DC in hapten induced contact hypersensitivity (CHS) responses has been well demon-
strated, the effect of DC maturation in the induction and elicitation of the response remains to be
identified. In the current study, mature and immature bone marrow derived DC were isolated and
applied in vivo to address this issue. We found that hapten labeled mature DC, but not immature
DC, could induce CHS responses. However, the immunization with hapten labeled immature DC
did not tolerize mice; a normal CHS response occurred when the mice were re-sensitized epicuta-
neously with the same hapten. Further experiments exhibited that immunization of animals with
mature DC activated hapten specific T cells in the draining lymph nodes while hapten presentation
by immature DC resulted in a very low level of T cell activation. During the elicitation phase, intra-
auricular application of hapten labeled mature or immature DC resulted in similar levels of CHS
responses in pre-sensitized mice. In vitro stimulation of hapten primed T cells with hapten labeled
DC demonstrated that mature and immature DC induced a similar level of IFN-γ production by CD8+
T cells. Our studies indicate that hapten presentation by immature DC is ignored by na&iuml;ve T
cells, which may represent a mechanism for unresponsiveness of the immune system to cutaneous
antigens under steady state in which DC do not undergo maturation. However, immature DC can
activate primed T cells and elicit inflammatory reactions during the elicitation phase of CHS responses.
These data have implications for both the immune responses to cutaneous antigens and for trials
employing DC for vaccination. 
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Mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial pep-
tide
A Di Nardo,2,1 A Vitiello3 and RL Gallo1 1 Dermatology, UCSD and VA Medical Center, San Diego,
CA, 2 San Gallicano Dermatological Institute (IRCCS), Rome, Italy and 3 Infectious Disease,
Johnson & Johnson Pharmaceutical Research and Development, San Diego, CA
Mast cell (MC)-mediated activity against bacteria has surfaced as an important mechanism of innate
immunity. Cathelicidins (Caths), a family of antimicrobial peptides with activity against bacteria,
fungi, viruses and protozoa, are present in MCs of humans and mice. To test the function and regu-
lation of Cath in MC, we challenged connective tissue-type MCs derived in vitro from mouse bone
marrow with lipopolysaccharide (LPS), lipid A, and lipotechoic acid (LTA). In LPS-treated MC, the
expression level of mouse Cath (CRAMP) mRNA determined by quantitative real-time PCR was 6-
fold higher after 3 h than that found in controls. To verify that increased CRAMP mRNA would also
result in expression of CRAMP protein, we challenged MCs with the same bacterial products and
measured the amount of intracellular CRAMP by flow cytometry with an anti-CRAMP antibody.
FACS showed an increase in CRAMP protein in MCs 48 hr after challenge with all bacterial extracts.
Western blot analysis showed MCs contain the (CRAMP) localized in granules as the full length pre-
cursor form, but can process some to active peptide. To test the functional significance of these find-
ings, the ability to directly kill Group A Streptococcus (GAS NZ131) by MCs from wild-type 129SvJ
mice (MCswt) was compared to MCs derived from littermate CRAMP knockout mice (MCs-/-).
MCs-/- showed a 50% reduction in the efficiency of bacterial clearance when compared to MCswt.
Moreover, both wt and -/- MCs expressed mRNA for mouse beta-defensin 4 (mBD4). These find-
ings, and the normal perivascular location of MCs in dermis, suggest the possibility that MCs may
use multiple antimicrobial peptides to defend against systemic microbial invasion through the skin,
and that Cath is a vital effector molecule in this process. 
0916
Effect of tacrolimus and CD4+CD25+ regulatory T cells on T cell activation and proliferation
CA MacGregor,1,2 M Vukmanovic-Stejic,2 M Rustin1 and A Akbar2 1 Dermatology, Royal Free
Hospital, London, United Kingdom and 2 Immunology, Royal Free Hospital, London, United
Kingdom
Atopic dermatitis is characterised by a persistent T cell infiltrate in the dermis. A subset of CD4+
cells (CD4+CD25+) has been isolated in humans and has been shown to have the ability to suppress
T cell proliferation in vitro. Topical tacrolimus has been shown to be an effective treatment for atopic
dermatitis. This study aims to explore whether addition of tacrolimus and CD4+CD25+ cells to cul-
tured CD4+CD25- cells can have additive or synergistic effects in their suppression, as seen when
used alone. CD4+CD25- and CD4+CD25+ were isolated from blood of healthy volunteers by MACS
bead separation. CD4+CD25- cells were stimulated to proliferate with anti CD3 and irradiated blood
mononuclear cells. Tacrolimus was added in varying concentrations and CD4+CD25+ in varying
numbers to CD4+CD25- cells in culture. Proliferation was measured by radioactive thymidine incor-
poration and CD69 expression as a marker of cell activation was measured by FACS analysis.
Tacrolimus induced a dose dependent inhibition of CD4+CD25- proliferation, indicating that
CD4+CD25+ cells are not needed for the suppressive effects of tacrolimus. Tacrolimus and
CD4+CD25+ cells have an additive effect on the percentage inhibition of proliferation of CD4+CD25-
cells 61% (tacrolimus alone) vs 82% (1:0.25 ratio CD25-:CD25+) vs 92% (tacrolimus and 1:0.25
ratio CD25-:CD25+). Both tacrolimus at the IC50 and CD4+CD25+ cells inhibit activation as seen
by CD69 expression in stimulated CD25- T cells (54.8% vs 30.8%). However when added together
they do not appear to have an additive effect. The additive effect seen on inhibition of proliferation
of CD4+CD25- cells with both tacrolimus and CD4+CD25+ cells suggest that they mediate their
suppressive effects via inhibiting different stimulatory pathways. 
0914
Toll-like receptor 4 in Th2 responses induced in the skin and airway
CA Herrick,1,2 S Eisenbarth2 and K Bottomly2,1 1 Dermatology, Yale School of Medicine, New
Haven, CT and 2 Immunobiology, Yale School of Medicine, New Haven, CT
The factors governing initiation of Th2 responses to environmental allergens are not well defined.
We have identified distinct requirements for Th2 activation at two sites of natural allergen exposure;
Th2 responses induced by inhaled (i.n.) ovalbumin (OVA) are IL-4 dependent, while those gener-
ated by epicutaneous (e.c.) OVA rely on IL-13. Recently, we have shown that Th2 induction by i.n.
OVA requires innate immune system signals, being impaired in TLR4 deficient (TLR4d) mice or in
the absence of LPS. Given its presence on keratinocytes and mast cells, we asked if TLR4 was also
required for Th2 induction in the skin. Wildtype (WT) and TLR4d BALB/C mice were exposed to
e.c. OVA (100 µg) on day 0 and challenged 2 weeks later with i.n. OVA. Both WT and TLR4d mice
had equally robust Th2 responses, with equivalent OVA-specific IgG1 (274±60 vs. 363±117 µg/ml,
respectively), total IgE (1130±147 vs. 1500±348 ng/ml), and airway eosinophils following i.n. OVA
challenge (6.7±0.6 vs. 9.5±2.2 x105 ). Thus, Th2 responses generated in the skin were TLR4 inde-
pendent. Given that Th2 responses induced by e.c. OVA are uniquely dependent on IL-13, we hypoth-
esized that IL-13 in the cutaneous environment was bypassing the need for TLR4. If so, addition of
IL-13 to TLR4d mice might restore inhalational Th2 sensitization. TLR4d mice were exposed to i.n.
OVA (100 µg) ± IL-13 (5 ng), or PBS alone, on days 0-2 and challenged 2 weeks later with i.n.
OVA. TLR4d mice initially exposed to i.n. OVA alone had no increase in airway eosinophils com-
pared to PBS controls. However, TLR4d mice that received i.n. OVA+IL-13 during priming, versus
OVA alone, had a significant increase in airway eosinophils (34±7 vs. 0.04±0.02 x105 ; p=.01), as
well as OVA-specific IgG1 (126±23 vs. 2.5±2.0 µg/ml, p=.007) and IgE (235±122 U/ml vs. unde-
tectable, p=.003). Thus, addition of IL-13 restored inhalational Th2 sensitization in TLR4d mice.
The data suggest that IL-13 in the cutaneous environment may allow Th2 sensitization in the absence
of innate immune system signals. 
0918
Photopheresis inhibits subcutaneous T cell tumor growth via a cellular immuno-regulatory
mechanism
D Peritt,1 K Campbell,1 C Napier,2 J Morris,2 B Holister,2 K Meshaw2 and G Harriman1 1 Therakos,
Exton, PA and 2 Piedmont Research Center, Morrisville, NC
Extracorporeal photopheresis (ECP) is approved for the palliative treatment of cutaneous T cell lym-
phoma but its underlying mechanism of action remains unresolved. ECP involves the reinfusion of
peripheral blood leukocytes exposed ex vivo to 8-methoxypsoralen (8MOP) and UVA light. It has
been suggested that ECP induces differentiation of monocytes to dendritic cells due to physical per-
turbation. Subsequent phagocytosis of apoptotic T cells by dendritic cells and presentation of anti-
idiotypic tumor cell determinants to CD8+ T cells mediates direct cytotoxic activity against the
offending tumor cells. We present data suggesting that monocytes do not differentiate into dendritic
cells following overnight incubation after ECP.  We further demonstrate that all cells including lym-
phocytes, monocytes and dendritic cells die via apoptosis after ex vivo 8MOP/UVA treatment with
no preferential death of activated T cells. Most importantly, 8MOP/UVA treated leukocytes alone
(no tumor cells) inhibit subsequent tumor challenge. This is consistent with our findings that ECP
treatment of humans and animals is effective even before the introduction of antigen (BMT and
solid organ transplantation) suggesting promotion of a more generalized immuno-suppressive state
that does not rely on the presence of pathogenic cells during treatment. We have further character-
ized this suppression and found it to be antigen specific and of a cellular nature as it is transferable
to a naive animal (also see Maeda & Schwarz abstract). Our current hypothesis is that ECP gener-
ates tolerogenic antigen presenting cells, which induce antigen specific regulatory cells. We are cur-
rently investigating the nature of this antigen specific cell-mediated tolerance. 
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B cells are not required as antigen presenting cells during the induction of low zone tolerance
to contact allergens
W Seidel-Guyenot, R Alt, S Perschon, J Knop and K Steinbrink Department of Dermatology,
University of Mainz, Mainz, Germany
Hapten-specific low zone tolerance (LZT) induced by epicutaneous application of low doses of
contact allergens is mediated by CD8+ suppressor T cells inhibiting the development of contact hyper-
sensitivity reactions. Several factors have been shown to affect the generation of peripheral tolerance
but the responsible APC of tolerance reaction to epicutaneously applied contact allergens has not
yet been identified. To evaluate the role of B cells as APC in the induction of low zone tolerance to
contact allergens, we studied µMT mice, characterized by a nonsense mutation of the IgM heavy
chain resulting in total deletion of B cells. Tolerizing doses of the contact allergen TNCB (0.45 or
4.5 µg per site, 5 times per mouse) were applied epicutaneously. Subsequently, for the assessment
of tolerance induction the inhibition of the contact hypersensitivity reaction was measured by ear
swelling. Performing this protocol resulted in robust LZT in WT and B cell deficient mice, indicat-
ing that B cells are not required for the induction of LZT. These data were confirmed by hapten-spe-
cific restimulation experiments: lymph node cells (LNC) or purified T cells from tolerized WT and
B cell deficient mice showed markedly reduced antigen-specific proliferative responses, as com-
pared to LNC or T cells derived from sensitized control animals. Analysis of Th1/Tc2 cytokines
produced by LNC obtained from tolerized µMT mice showed a typical Tc2 cytokine pattern of LZT
with high IL-4 and IL-10 and reduced IL-2 and IFN-γ production. Furthermore, adoptively trans-
ferred CD8+ T cells from tolerized µMT mice induced a significant tolerance reaction in WT recip-
ients, demonstrating the development of hapten-specific effector CD8+ T cells of LZT in B cell defi-
cient mice. These results demonstrate that B cells are not mandatory for the induction of low zone
tolerance to contact allergens. 
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IgE-facilitated allergen presentation in atopic dermatitis
DL Cooper, JM Hales and RD Camp Dermatology, University of Leicester, Leicester, United
Kingdom
The pathogenic importance of allergen-specific IgE in atopic dermatitis (AD) is controversial. Pre-
vious reports showed that IgE bound to Fcε receptors on antigen presenting cells (APC), enhanced
T cell activation by a process of facilitated allergen presentation (FAP). However methods were
selected to maximise IgE-FAP, and included use of purified APC populations, allergen specific T
cell clones or lines, haptenised allergen, and chimeric, hapten specific IgE. The clinical relevance of
IgE-FAP has therefore been uncertain. We investigated the effects of medium supplemented with
10% fresh, IgE-containing autologous serum on the proliferation of peripheral blood mononuclear
cells (PBMC) incubated with Dermatophagoides pteronyssinus (Der p) extract. PBMC from 13 AD
patients responded in a dose-dependent manner to Der p with maximal stimulation indices (mSI) of
4.1-100.0, whereas normal donors did not respond (mSI <2.6, n=5). Heating of autologous serum
at 56 C for 60 minutes, which irreversibly denatures IgE, caused major reduction of PBMC responses
in 12/13 atopic samples (p=0.003, paired t test). Incubation of PBMC with blocking monoclonal
antibodies 3G6 and MHM6 against the high and low affinity IgE receptors (FcεRI and FcεRII) respec-
tively, produced inconsistent inhibition of PBMC responses to Der p in the presence of fresh autol-
ogous serum (n=6), probably because IgE bound to its high affinity receptor is not reproducibly dis-
placed by blocking antibody. Flow cytometry confirmed that 3G6 blocking antibody cannot displace
IgE from monocytes in short term (2 hour) cultures, and displacement of IgE by 3G6 in 3-day cul-
tures could not be determined because FcεRI expression on monocytes diminishes with time. Finally,
atopic serum was depleted of IgE by using rabbit anti-IgE-coupled Dynabeads. Autologous PBMC
responses to Der p in cultures containing 10% IgE-depleted serum were reduced by 55-62% in
comparison with cultures containing control serum (n=3). These experiments are the first that use
serum IgE depletion to indicate the clinical relevance of IgE-FAP in atopy, and further validate IgE-
FAP as a therapeutic target. 
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Dysfunctional CD4+CD25+ regulatory T cells in psoriasis
H Sugiyama,1,2 R Gyulai,1,3 S Shimada,2 S Stevens,1,4 T McCormick1 and K Cooper1,4 1
Dermatology, Case Western Reserve Univ., Cleveland, OH, 2 Dermatology, Univ. of Yamanashi,
Yamanashi, Japan, 3 Dermatology, Univ. of Szeged, Szeged, Hungary and 4 VA Medical Center,
Cleveland, OH
In murine models of autoimmunity, CD4+CD25+ regulatory T cells (Tr) are key elements in the main-
tenance of peripheral tolerance toward self-proteins. Because psoriasis is sustained by the ongoing
activation of T cells responding to antigens in the skin, we asked if psoriatic T cell reactivity could
be due to insufficient regulation by Tr. We found that total and skin homing (CLA+) CD4+CD25high
Tr are present in equal proportions in normal and psoriatic PBMC. However, psoriatic Tr showed a
markedly decreased capacity to suppress autologous CD4+CD25- responder T cell (Tresp) prolifer-
ation following antigen specific stimulation (p=0.0001, n=9), as well as polyclonal TCR stimulation
(p=0.015, n=3). To determine if this is due to Tr-resistant hyper-proliferative Tresp, we performed
“criss-cross” experiments. Whereas normal Tr were fully capable of suppressing the proliferation of
hyper-reactive psoriatic Tresp by > 78%, psoriatic Tr could only suppress normal Tresp by < 39%
(p=0.016, n=2). These data clearly map the defect to psoriatic Tr. We next performed analytic and
functional analyses of CD4+CD25+CTLA-4+ Tr in psoriatic skin. By flow cytometry, the ratio of Tr:
Tresp in psoriatic dermis and epidermis was calculated as 1:6 and 1:3, respectively. Using purified
psoriatic dermal Tr, we found that, as in blood, the 1:6 ratio provided < 20% Tresp suppression,
(whereas normal Tr suppress > 50% at 1:8). These data demonstrate for the first time that Tr are pres-
ent in an inflamed target organ, and are functionally impaired in a human disease. The observations
that the numbers and functionality of Tr in psoriatic skin are insufficient to restrain hyper-reactive
psoriatic Tresp are also novel, and may explain chronic T cell activation in peripheral organs of
inflammatory/autoimmune diseases such as psoriasis. 
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Hyaluronic acid glycosaminoglycans are direct stimulants of endothelial cell activation
K Taylor,1 J Trowbridge,1 J Rudisill,1 C Termeer,2 J Simon2 and RL Gallo1 1 Dermatology,
University of California, San Diego and VA Medical Center, San Diego, CA and 2 Dermatology,
University of Freiburg, Freiburg, Germany
Endothelial cells (ECs) respond to injury by release of a repertoire of cytokines and chemokines,
and expression of cell surface adhesion molecules. Various endogenous proteins and pathogen com-
ponents can activate this innate immune response. Additionally, glycosaminoglycans (GAGs) such
as dermatan sulfate that are released by injury of the extracellular matrix may serve as signals to the
EC of tissue damage. This study sought to determine how ECs respond to the unsulfated GAG
hyaluronic acid (HA). Microarray analysis of primary cultures of human dermal microvascular EC
identified 40 genes that are up-regulated at least 3-fold after 6h stimulation with purified 4-8 disac-
charide HA fragments (sHA). The cytokine IL-8 was prominent among those responding, (44 fold
increase). This increase in IL-8 mRNA was further confirmed by ELISA of protein in culture super-
natants and shown to be time and concentration dependent with increases of 117-fold over a 72 hour
period in response to 20 ug/ml sHA. IL-8 induction was abolished by digestion of HA with
hyaluronidase, thus verifying dependence on HA and not contaminants undetectable by HPLC. To
confirm these in vitro data, mice were injected IP with 100ug sHA and serum soluble ICAM-1 and
MIP-2 (mouse IL-8 homolog) measured by ELISA. sHA induced MIP-2 and ICAM-1 in treated mice
compared to the PBS control injections. These data illustrate a potential mechanism by which exoge-
nous extracellular matrix components can stimulate EC expression of factors critical to the initial
stages of the inflammatory response. Importantly, this can occur in the absence of microbial prod-
ucts. Recognition of GAGs may therefore occur through stimulation of similar pattern recognition
events previously thought to be specific to microbial pattern recognition. 
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Dendritic cells distinguish fungal yeast from hyphae by selective binding of dectin-2 to
mannan-like carbohydrates on hyphae and by up-regulating IL-4 and IL-10 expression
T Yudate,1 M Bonkobara,1 I Dougherty,1 T Tezuka,2 P Cruz Jr1 and K Ariizumi1 1 Dermatology, UT
Southwestern Med Ctr, Dallas, TX and 2 Kinki Univ, Osaka, Japan
Having discovered that Langerhans and dendritic cells (DC) express the C-type lectin receptors,
dectin-1 and dectin-2, and since dectin-1 was reported to recognize β-glucan on yeasts, we posited
that dectin-2 may recognize carbohydrates on fungi. To identify such ligands using fluorescence
and 125I-Fc binding assays, we made a recombinant protein for each receptor (Dec1-Fc; Dec2-Fc)
consisting of the extracellular domain and IgG Fc. Dec1-Fc bound the yeast forms of Candida albi-
cans, whereas Dec2-Fc did not. By contrast, Dec2-Fc bound hyphal forms of Candida with 10-fold
greater affinity than Dec1-Fc. Similar results were obtained using yeast vs hyphal forms of Aspergillus
and dermatophytes (M. audouinii, T. rubrum, E. floccosum). Neither β-glucan nor Dec1-Fc disrupted
binding of Dec2-Fc to hyphae, indicating that dectin-1/dectin-2 possess disparate ligands. By con-
trast, EDTA blocked binding of Dec2-Fc to hyphae (but not Dec1-Fc to yeast), indicating that recep-
tor function of dectin-2 (but not dectin-1) is Ca++-dependent. In similar assays, we screened carbo-
hydrates for ability to block binding of Dec2-Fc to hyphae: mannan was most potent (100% block),
followed by mannose and fucose (75%). Dec2-Fc itself bound to mannan-coupled agarose beads.
Similar data resulted using dectin-2 gene-transfected COS-1 cells as binding substrates. Finally, we
used RT-PCR to examine cytokine mRNA of mouse DC after culture with Candida yeast or hyphae.
Constitutive expression of IL-4, IL-10, IL-12, and IFN-γ was not altered by yeast. By contrast, IL-
4 and IL-10 were upregulated 5-10-fold by hyphae, with no change in IL-12 and INF-γ. We con-
clude that DC can distinguish fungal yeast from hyphae by selective binding of dectin-2 to mannan-
like moieties on hyphae and by upregulating Th2 cytokine expression. Our findings support the
concept that differential recognition of microbial components by APC may condition immunity
generated against infection. 
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Polymorphism of CTLA4 gene in the patients with pemphigus
J Narbutt,1 JD Torzecka,1 A Sysa-Jedrzejowska,1 I Kubryn2 and W Mlynarski2 1 Dermatology,
Medical University, Lodz, Poland and 2 Immunopathology, Clinic of Pediatrics, Medical
University, Lodz, Poland
Pemphigus is an autoimmune, intraepidermal blistering disease. In addition to pathogenic autoanti-
bodies, other mechanisms seem to be of importance in the disease development. Some reports sug-
gesting that activated T cells may contribute to the pathogenesis of pemphigus have been published
recently. The cytotoxic T-lymphocyte antigen 4 (CTLA4) is known to be an important modifier of
T-cell activation with down-regulatory properties upon B7 engagement. The human CTLA4 gene
contains an A/G dimorphism at position +49 in exon 1. It was proven that various autoimmune dis-
eases are associated with this polymorphism in CTLA4, however, it has not been examined in pem-
phigus so far. The aim of our study was to analyze the association of the CTLA4 gene variation with
pemphigus in a Polish population. Analysis of the CTLA4 gene polymorphism within exon 1 (A∅G
transition, +49) was studied in 44 patients with pemphigus (27 with PV and 17 with PF, 25 women,
19 men) and in 223 unrelated healthy individuals. All studied subjects were of Polish origin and were
also genotyped for HLA-DRB1, DQA1 and DQB1 genes. PCR, followed by RFLP (Ital), was applied
to define respective alleles of the CTLA4 gene. Genotype GG was found to be more frequent in
patients (20.4%) vs. controls (7.6%) (p=0.043; OR=2.68 with CI95%=1.12-6.41). The G-allele fre-
quency was also slightly higher in pemphigus patients (42.0 vs. 33.4%). Moreover, the genetic asso-
ciation of the CTLA4 polymorphism with pemphigus seems to be independent of the HLA class II
genes. Obtained results support the hypothesis about the complex inherited component in pemphi-
gus development. 
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CD4+ and/or CTLA-4+ T cells are key regulatory cells in peripheral tolerance
A Sato, A Shibaki and SI Katz Dermatology, NIH/NCI, Bethesda, MD
We have previously reported that both single [K14-mOVA] transgenic (Tg) and double Tg [K14-
mOVA X OT-I that have a T cell receptor that recognizes OVA peptide in association with MHC
class I] mice express membrane-associated ovalbumin (mOVA) under the control of a K14 promoter.
When injected with CD8+ TCR Tg T (Vα2Vβ5+) cells from OT-I mice, single Tg mice developed
a graft vs. host disease (GvHD), whereas double Tg mice did not develop disease. These results sug-
gest that, in double Tg mice, regulatory mechanisms prevent infused OT-I cells from inducing GvHD.
To determine why OT-I cells fail to induce GvHD, we assessed the ability of various antibodies to
reverse this peripheral tolerance. Double Tg mice treated with anti-CTLA-4 mAb or with anti-CD4
mAb developed GvHD after transfer of OT-I cells. However, anti-CD25 mAb or anti-CD8 mAb did
not reverse this peripheral tolerance. We then analyzed the phenotype of Vα2Vβ5+ T cells in super-
ficial lymph nodes (LN) of double Tg mice after OT-I cell transfer. Before injection, double Tg mice
expressed 3 different CD3+ (Vα2Vβ5+) T cell populations in LN: CD3+CD8-CD4-(42%),
CD3+CD8+CD4-(8%), and CD3+CD8-CD4+(50%). 7 days after injection of OT-I cells, Vα2Vβ5+
T cells were unchanged from baseline even when the mice were treated with the anti-CTLA-4 mAb,
but the percentage of CD8 positive cells (75% of Vα2Vβ5+ T cells) was dramatically increased and
they exhibited a CD62Ldim (57%) activated phenotype. In contrast, in non-antibody treated double
Tg mice, 80% of T cells exhibited a resting (CD62Lbright ) phenotype. In double Tg mice, 4.9% of
LN T cells were CD4+CD25+ T cells before injection. Although treatment with anti-CTLA-4 mAb
induced GvHD in the double Tg mice, the population of CD4+CD25+ T cells did not change after
injection. Thus, we could not identify a CD4+CD25+ regulatory T cell population in these mice.
Together, our results indicate that, in double Tg mice, CD4+ and/or CTLA-4+ T cells prevent infused
OT-I cells from inducing GvHD. Further elucidation of the mechanism(s) responsible for protection
from GVHD in this model may provide new insights into peripheral tolerance. 
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The predisposing and protective effect of HLA-DRB1 alleles on pemphigus development in
patients of Polish origin
JD Torzecka,1 J Narbutt,1 A Sysa-Jedrzejowska1 and W Mlynarski2 1 Dermatology, Medical
University, Lodz, Poland and 2 Immunopathology, Clinic of Pediatrics, Medical University, Lodz,
Poland
Pemphigus is an autoimmune blistering disease characterized by the presence of antidesmoglein
autoantibodies. Both genetic and environmental factors probably play an important role in its etiopatho-
genesis. Various studies have shown that the HLA-DRB1*04 and -DRB1*14 alleles confer strong
susceptibility to pemphigus in different ethnic groups. The genotyping for HLA class II has not
been performed in Polish pemphigus patients so far. Our study comprised 44 patients (27 with pem-
phigus vulgaris, 17 - with pemphigus foliaceus), the control group included 100 healthy unrelated
individuals of Polish origin. The genotyping of HLA-DRB1 alleles was done using the Dynal Reli
SSO HLA-DRB test (Dynal, Norway). The chi-square statistic was applied to determine differences
in alleles and genotype distribution between groups. P-values were corrected according to Bonfer-
roni method for multiple comparison. All computational studies were done using SAS Genetics soft-
ware. Alleles DRB1*04 and *14 were significantly increased in patients as compared to controls
(29.5% vs. 1.0%, pcor<0.04 and 11.5% vs. 3.5% pcor=0.063; respectively). Moreover, the DRB1*04-
DRB1*14 genotype occurred dramatically more frequent in pemphigus individuals (11.4% vs.
1.0%,pcor<0.05, OR(95%CI)=11.4(1.3-100.1)), which suggests synergic effect of both alleles. A
significantly lower frequency of HLA-DRB1*15 genotype was observed in patients compared to
controls (2.3% vs. 15.0%, respectively, pcor<0.05). However, since one of the studied patients car-
ries the DRB1*04-DRB1*15 genotype, the predisposing effect of the DRB1*04 seems to override
the protective role of DRB1*15. The results confirm literature data concerning susceptibility to pem-
phigus linked to the DRB1*04 and DRB1*14 alleles. However, some protective effect of the HLA-
DRB1*15 allele needs further evaluation. 
0929
The role of endothelin-1 on cutaneous mast cells: implications for tissue-remodeling and inflam-
mation
H Matsushima, N Yamada and S Shimada Department of Dermatology, University of Yamanashi,
Yamanashi, Japan
Endothelin-1 (ET-1) is the most potent and long-lasting vasoconstrictor produced by numerous cell
types including endothelial and epithelial cells. Although ET-1 and mast cells have been reported to
relate with vascular, inflammatory and fibrotic disease states, the effect of ET-1 on cutaneous mast
cells has been unclear. This study aimed to determine whether ET-1 regulates functions of skin-
associated mast cells. We utilized murine fetal skin-derived cultured mast cells (FSMC) for this pur-
pose because of their strong resemblance to cutaneous mast cells. FSMC constitutively expressed
ET-1 and its expression was further up-regulated by ionomycin or Toll-like receptor ligands, includ-
ing LPS and peptidoglycan. Previously, we identified the expression of Toll-like receptor (TLR) 3
and 9 on FSMC but not murine bone marrow-derived cultured mast cells (BMMC) that represent
immature mast cells. Interestingly, poly(I:C) (TLR3 ligand) and CpG DNA (TLR9 ligand) up-reg-
ulated ET-1 expression on FSMC but not BMMC. FSMC also expressed both ETA and ETB recep-
tors. Whereas ET-1 did not cause degranulation of BMMC, ET-1 potently caused degranulation of
FSMC in a dose-dependent manner (10-6 -10-8M), which was completely ihnhibited by BQ-123 (an
ETA antagonist) but not by sarafotoxin 6c (an ETB antagonist). Thus ETA mediates degranulation
of FSMC in response to ET-1. Furthermore, pretreatment with monomeric IgE up-regulated degran-
ulation of FSMC in response to ET-1. On the other hand, pretreatment with low dose of ET-1 (10-
9-10-10M) significantly down-regulated degranulation of FSMC induced by crosslinking of FceRI.
This down-regulation was again inhibited by BQ-123. Finally, ET-1 remarkably induced expression
of TGF-beta1 and VEGF by FSMC. Thus ET-1 controls functions of cutaneous mast cells in many
aspects. Such association of ET-1 and mast cells may play important roles in various cutaneous
inflammation and tissue-remodeling. 
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Activation of the platelet-activating factor (PAF) receptor: crucial molecular step in pso-
ralen+UVA-induced immune suppression
P Wolf,1,2 DX Nghiem,2 JP Walterscheid,2 Y Matsumura,2 N Kazimi,2 P Khaskina,2
HN Ananthaswamy2 and SE Ullrich2 1 Dermatology, Karl-Franzens-University, Graz, Styria,
Austria and 2 Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX
PUVA has been used for many years as a very effective treatment modality for various skin diseases
such as psoriasis and early stages of cutaneous T cell lymphoma. The mechanisms by which PUVA
leads to clearance of skin lesions are not well understood. However, PUVA has immunosuppressive
properties, which in turn may contribute to or even be totally responsible for its therapeutic effects.
Work from our laboratory (Walterscheid et al, J Exp Med 195, 2002) has disclosed PAF, a potent
phospholipid mediator, as one of the first molecular events for UV-induced immune suppression. In
this study we used a specific PAF receptor antagonist and a selective COX-2 inhibitor to study the
possible role of the PAF pathway in PUVA-induced systemic immune suppression in the model of
delayed-type hypersensitivity (DTH) to Candida albicans. Six to 8 wk old C3H/HeNCr mice were
painted on the their shaved backs with 8-methoxypsoralen (100 ug/100 ul ethanol) 30 min before
exposure to 50 kJ/m2 UVA. At day 5, the mice were immunized by injecting 2 x 108 formalin-fixed
Candida albicans into each flank, and at day 14 they were challenged by injecting 50 ul of Candida
antigen into each hind footpad. The intraperitoneal injection of both the PAF receptor antagonist
PCA-4248 or the selective COX-2 inhibitor SC-236 (0.2 ug/100 ul each; 15 min before UVA treat-
ment) abrogated PUVA-induced immune suppression. These results indicate that the pathway of
PUVA-induced immune suppression follows that of UV(B) radiation, in which PAF induction is
followed by the production and release of prostaglandin E2 and immunosuppressive cytokines such
as interleukin-10. A better understanding of the early molecular events after PUVA exposure may
offer the opportunity to dissect the beneficial (i.e. therapeutic) from the detrimental (i.e. tumorigenic)
effects of this treatment modality. 
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Vasoactive intestinal peptide stimulates nitric oxide production in psoriasis vulgaris fibro-
blasts-mast cell co-culture
A Zalewska,1 J Wyczolkowska2 and A Sysa-Jedrzejowska1 1 Dermatology, Medical University,
Lodz, Poland and 2 Biogenic Amines, Polish Academy of Science, Lodz, Poland
Nitric oxide (NO) seems to play some role in many physiological and pathological processes includ-
ing psoriasis vulgaris (PV) lesions development. There are some reports demonstrating skin fibrob-
lasts involvement in psoriatic processes triggering and maintenance. It is generally accepted that neu-
ropeptides are important in the course of psoriasis. So, the aim of our study was to evaluate NO levels
in fibroblasts cultures obtained from lesional skin of PV patients and healthy subjects co-cultured
with human leukaemic mast cell line (HMC-1) - stimulated with different concentrations of vasoac-
tive intestinal peptide (VIP - 10-6, 10-7, 10-8, 10-9 M). Fibroblasts from pasages 1-3 were used.
NO levels were evaluated by Griess method after 72 h of culture in the medium devoid of phenol
red and serum. It was observed that VIP inhibited NO production by PV fibroblast and HMC-1 mono-
cultures in comparison to spontaneous NO production - at 10-9M of VIP NO production was mean
1.31 µM and 1.14 µM in comparison to 1.93 µM and 1.79 µM, respectively. No production was dose-
dependent as for both monocultures and co-cultures. The higher the VIP concentration the bigger
NO production in all cultures studied was observed. What is more VIP inhibited NO production in
normal fibroblasts - HMC-1 co-cultures whereas stimulated NO production in PV fibroblasts - HMC-
1 ones: VIP concentration (10-9 M)- 1.46 vs. 1.93 µM. our results point out at VIP importance in
PV fibroblasts and mast cell interactions. 
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Heat killed mycobacterium vaccination completely suppressed severe dermatitis in AD-model
mouse converting Th2 into Th1 cytokine profile
T Murakami,1 K Yamanaka,1 K Yamanishi,1 Y Yasutomi2 and H Mizutani1 1 Dermatology, Mie
University, Tsu, Mie, Japan and 2 Bioregulation, Mie University, Tsu, Mie, Japan
Atopic dermatitis (AD) is a chronic inflammatory disease based on T-helper cell2 (Th2) immune
responses. The recent increase of the prevalence of AD has been suggested caused by a cleaner envi-
ronment and fewer childhood mycobacterium infections. While topical and systemic immunosup-
pressive medicine improved AD clinically, the reconstitution of the balance between Th2 and Th1
is an ideal therapy for AD. Here we report significant effect of a heat killed BCG vaccine in AD
model mouse (Caspase-1Tg). Caspase-1Tg express severe itching dermatitis with elevated plasma
histamine, IgE, IL-18, cutaneous mastocytes counts and lesional IL-4, IL-5 and IL-10 mRNA expres-
sion. After weekly vaccination with 20 micrograms of heat killed BCG suspension for 10 weeks, all
the cutaneous manifestations were completely suppressed. According to improvement of the cuta-
neous manifestation, levels of plasma histamine, IgE, and IL-18 were normalized. The lesional IL-
4, IL-5 and IL-10 expression were suppressed, but IFN-g mRNA was augmented. No relapse of the
cutaneous nor laboratory manifestations of AD was observed over 6 months following-up after dis-
continuance of this therapy. No particular side effects was observed in this study. Thus, the heat-
killed BCG vaccination is a highly potential therapy for AD, performing an essential role in AD
therapy with restoring the balance of Th1/Th2 cells. 
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DCIR & DCAR: antigen presenting cells expressing lectin-type paired immunoreceptors
N Kanazawa,1 K Tashiro,2 K Inaba3 and Y Miyachi1 1 Department of Dermatology, Graduate
School of Medicine, Kyoto University, Kyoto, Kyoto, Japan, 2 Center for Molecular Biology and
Genetics, Kyoto University, Kyoto, Kyoto, Japan and 3 Laboratory of Immunobiology, Division of
Systemic Life Science, Graduate School of Biostudies, Kyoto University, Kyoto, Kyoto, Japan
Dendritic cells (DC) play a central role on antigen specific immune response. Therefore regulating
DC activation has been a major interest as for induction of tumor immunity and inhibition of autoim-
munity. DCIR (DC immunoreceptor), which we have isolated from murine mature DC, is a type II
membrane protein having extracellular C-type lectin domain and cytoplasmic ITIM (immunoreceptor
tyrosine-based inhibitory motif). Furthermore, we have obtained two isoforms of a gene similar to
DCIR, by RT-PCR from murine splenic mRNA. These isoforms were named as DCAR (DC immuno-
activating receptor) α and β, and β isoform lacks the neck domain. The extracellular lectin domain
of DCAR is highly homologous to that of DCIR (91% identity), but the short cytoplasmic to trans-
membrane portion is rather homologous to that of dectin-2. Genes of DCAR, DCIR and dectin-2 are
closely located on murine chromosome 6 near the NK gene complex. By RT-PCR using specific
primer pairs, expression of DCAR mRNA was observed high in lung and spleen and low in lymph
node and skin, while DCIR high in both spleen and lymph node. DCAR expression reached maxi-
mum on day 8 during maturation of bone marrow-derived DC, while DCIR on day 10. FACS analy-
ses demonstrated the expression of those receptors on MHC class II positive antigen-presenting cells
(APC) but not on T cells. Experiments using chimeric receptor of cytoplasmic DCIR and extracel-
lular Fc γ receptor IIB revealed the ITIM-dependent inhibitory function of DCIR. In contrast, co-
transfection experiments indicated that surface DCAR expression was induced only in direct asso-
ciation with Fc receptor γ chain, and the experiments using chimeric receptor of DCAR and Fc γ
receptor revealed the activatory function of DCAR which was dependent on ITAM (immunorecep-
tor tyrosine-based activatory motif) of γ chain. Thus, a pair of DCIR and DCAR can possibly regu-
late APC function. 
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Epidermal cytokine mRNA expression profiles in allergic and irritant contact dermatitis
S Kim, J Kim, Y Chung and I Lee Dermatology, Yonsei University College of Medicine, Seoul,
Seoul, South Korea
Although pathogesis of allergic contact dermatitis (ACD) and irritant contact dermatitis (ICD) seem
to be distinct, comparative studies of ACD and ICD suggest that both the histologic and clinical fea-
tures of ACD and ICD are strikingly similar. Immunohistochemistry studies of the expression of
accessory molecules such as ICAM-| and B7-1 also do not show a consistent feature that will dis-
tinguish ACD from ICD. In this study, we studied epidermal cytokine mRNA expression profiles in
ACD and ICD in an effort to distinguish these two contact dermatitis. ACD and ICD were induced
in mice ear by dinitrofluorobenzene and benzalkonium chloride, respectively. Histologically, ACD
and ICD have in common intra-and intercellular edema, edema of the papillary dermis, and dermal
mixed inflammatory-cell infiltrates; however eosinophilic infiltrate is more prominent in ACD. We
separated epidermis from dermis using 20mM EDTA solution, and performed reverse transcriptase-
polymerase chain reaction and RNase protection assay to study cytokine mRNA expression. The
expression of IL-1β, IL-2, IL-4, IL-10, and CC chemokines(eotaxin, TARC, RANTES, JE) were
increased in ACD, while the expression of TNF-α, IFN- γ, IL-12p40, IL-18 and CXC chemokines
(IP-10, KC, MIP-2) were increased in both ACD and ICD. IL-1β, IL-4, IL-10 and CC chemokines
might be considered as biomarker to distinguish ACD and ICD. In conclusion, the cytokine expres-
sion profiles between ACD and ICD are different, and some cytokines have been considered as bio-
markers to distinguish these two contact dermatitis. In addition, the difference of chemokine expres-
sion profiles in ACD and ICD support the explanation of difference of leukocyte infiltration in ACD
and ICD. 
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Regulation of toll-like receptor-2 expression by adapalene: implications for the treatment of
inflammatory acne
B Vega, C Ferret, A Jomard and S Michel Department of Research, Galderma R&D, Sophia
Antipolis Cedex., France
The Toll-like receptors (TLRs) are implicated in directing recognition of microbial pathogens by
cells of the immune system such as monocytes, macrophages. In particular, TLR2 recognizes the
cell wall components of Gram+ bacteria, whereas TLR-4 mediates the response to the lipopolysac-
charides (LPS) of Gram- bacteria. Upon activation, these receptors can trigger the release of pro-
inflammatory cytokines. Activation of macrophages TLR-2 by components of P. acnes might con-
tribute to the development of inflammatory acne lesions. Natural and synthetic retinoids, such as
adapalene, are currently being used for the treatment of acne and we asked the question whether
these drugs could have an effect on the regulation of TLR-2 expression by monocytes. Here we
show that adapalene inhibits the expression of TLR-2 without affecting that of TLR-4. This effect
was also observed with retinoic acid. The action of adapalene was dose dependent with an IC50 of
10nM. An antagonist of the retinoic acid receptors (RARs) completely inhibited the effect of ada-
palene showing that its action on TLR-2 expression is mediated by its interaction with RARs. Ada-
palene had no effect on the expression of other myeloid markers such as CD14 and HLA-DR. In
addition, stimulation of monocyte TLR-2 by P. acnes induced the production of IL-12 and TNF-α
and this induction was abolished by adapalene. Inhibition of TLR-2 expression may provide a novel
mechanism by which adapalene exerts its beneficial effect on the treatment of inflammatory acne
lesions. 
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Stress affects atopic dermatitis possibly involving neurogenic pathways
EM Peters, A Peter, B Klapp and PC Arck Psychoneuroimmunology, Charite Campus Virchow
Clinics, Humboldt-University of Berlin, Berlin, Germany
Stress may exacerbate atopic dermatitis. Respective research has largely focused on activation of
the hypothalamus-pituitary-axis. Alterations in the nervous system have also been reported. E.g. the
neuropeptide Substance P (SP) has been detected with contradictory results in patients with atopic
dermatitis. SP has been shown to induce interferon-γ (IFN-γ) expression in T-Lymphocytes which
normally express a TH-2 like cytokine pattern in vitro. TH-2 predominance is characteristic in acute
atopic dermatitis in vivo, while IFN-γ expression is associated with the chronification of atopic der-
matitis. However, local interactions between the nervous and the immune systems, especially under
perceived stress, has never been reported in the context of atopic dermatitis. Here we show for the
first time, that 48h after intradermal provocation with ovalbumin to induce a TH-2 dominated der-
matitis and additional sonic stress exposure over 24 h, dermal infiltration e.g. by CD4+ T-lympho-
cytes is increased in the back skin of C57BL/6 mice. At the same time the number of SP-immunore-
active nerve fibers is decreased in the acute lesion. Stress without intradermal provocation with
ovalbumin does not produce an atopic dermatitis-like infiltrate and alters the cutaneous innervation
patterns only mildly, while provocation alone produces a milder infiltrate and mild alteration of the
cutaneous innervation pattern. Sonic stress also increased IFN-γ levels, as determined by flow cytom-
etry of peripheral lymphocytes. Thus we conclude, that SP-immunoreactive nerve fibers disappear
from acute atopic dermatitis-like skin lesions due to the release of SP, especially under perceived
stress. This may lead to an increased infiltration by immunocytes, which in turn is associated with
a switch in cytokine-expression normally seen in chronic atopic dermatitis and provides first evi-
dence for stress-induced exacerbation and phenotype-switch of cutaneous inflammatory diseases
such as atopic dermatitis by interaction of the nervous and immune system. 
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Human keratinocytes express functional IL-10 receptor after prolonged treatment with
IFN-γ
ML Giustizieri, C Scarponi, C Albanesi and G Girolomoni Laboratory of Immunology, Istituto
Dermopatico dell, Rome, Italy
IL-10 is a promising candidate for the treatment of Th1-mediated cutaneous disorders such as pso-
riasis and allergic contact dermatitis (ACD). IL-10 possesses established immunosuppressive activ-
ities on professional antigen presenting cells, but it is still unclear whether IL-10 has direct effects
on epidermal keratinocytes. The aim of this study was to investigate the presence of functional IL-
10 receptor (IL-10R) in human keratinocytes isolated from healthy individuals and psoriatic sub-
jects. Keratinocytes of healthy skin did not stain for IL-10R whereas ACD and, at lower extent, pso-
riatic epidermis showed an evident IL-10R reactivity in both basal and suprabasal epidermal layers.
Primary cultures of resting and IFN-γ-activated keratinocytes obtained from normal and psoriatic
donors were assayed for the mRNA expression of IL-10R α and β chains, and IL-10 binding capac-
ity. RT-PCR analysis revealed the constitutive presence of IL-10Rβ mRNA and the absence of IL-
10Rα mRNA in both normal and psoriatic keratinocytes. Cultures exposed for prolonged time (24-
36 h) to IFN-γ expressed the IL-10Rα mRNA, which was present at higher levels in healthy
keratinocytes compared to psoriatic keratinocytes. In contrast, IL-10Rβ mRNA levels were not influ-
enced by IFN-γ. A significant IL-10-binding activity was measured on IFN-γ-stimulated, but not on
resting cells, with healthy keratinocytes showing a higher avidity for biotin-labeled IL-10 compared
to psoriatic keratinocytes. To test whether IFN-γ-induced IL-10R complex on keratinocytes was func-
tional, we analyzed the IL-10-promoted early gene products, suppressors of cytokine signaling
(SOCS). IL-10 induced a strong and sustained SOCS3 and some SOCS1 mRNA expression in ker-
atinocytes pre-treated with IFN-γ for 36 h, but not in unstimulated cells. In aggregate, our results
demonstrate that keratinocyte responsiveness to IL-10 can be obtained only after prolonged treat-
ment with IFN-γ, which is mandatory for expression the IL-10R complex. 
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A probable role of secretary IgA antibody to Candida in patients with severe type of atopic
dermatitis and high tiers of IgE antibdy to Candida
T Utida, H Kitajima, K Shimamura, Y Fukunaga, H Osuna, S Matsukura, T Kambara and
Z Ikezawa Dermatology, Yokohama city university school of medicine, Yokohama, Kanagawa,
Japan
Recently, we have already reported that an impaired immune system to Candida of normal intestinal
flora may be related to the deterioration of atopic dermatitis (AD), because the severity of the AD
has correlated with IgE-RAST titers to Candida and many cases of the refractory AD has been
improved by oral antifungal agents. The mucosal immune system is supposed to defence the mucosal
invasion of Candida in healthy individuals, while its impairment permits their invasion and induces
an increase in production of IgE antibodies to Candida. Then, as an indicator of the mucosal immune
responsiveness to Candida, we measured the saliva levels of the secretory IgA (S-IgA) antibody
specific to Candida and compared them with the serum levels of IgE-RAST titers to Candida in
patients with AD and normal individuals, and analyzed their relationships to the severity of AD. The
values of total sIgA and the sIgA specific to Candida fluctuated by sampling times. These fluctua-
tions are supposed to be attributed to the water content of each collected saliva. We calculated,
therefore, the ratios of Candida-specific sIgA to total sIgA, in order to get the individual values with
little fluctuation. The results showed that the individual values thus obtained had little fluctuations.
Therefore, we employed this ratio as the sIgA value specific to Candida for individual patients. The
results indicated that the saliva levels of S-IgA to Candida in the severe AD patients were main-
tained within the lower ranges, while those in the mild showed frequently high values. On the oth-
erhand, the saliva levels of S-IgA to Malassezia of normal skin flora were very low in either mild
AD patients or not. These results indicate that the mucosal immune system to Candida appears to
normally function in the mild patients, but dose not in the severe, suggesting that the impairment of
the mucosal immune system may be involved in deterioration of AD at least as one of the important
etiologic factors. 
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The analysis of immune regulation of antinuclear antibody production induced by the injec-
tions of gold thiomalate in H-2 congenic mice and beige mouse
Y Ikezawa,1 M Nakazawa,2 K Takahashi,1 M Minami2 and Z Ikezawa1 1 Dermatology, Yokohama
City Uni. School of Medicine, Yokohama, Japan and 2 Dpt. of Immunology, Yokohama, Japan
The system has established that in susceptible mouse strains, H-2s, injections of goldthiomalate
induce high serum titers of antinuclear antibody(ANA).The ANA produced reacts with fibrillarin as
well as ANA detected in some patients with systemic scleroderma and mercuric chloride-induced
ANA which we demonstrated recently.This is so called a hapten-induced autoimmunity model, of
which mechanism of ANA production is still obscure. First, we tested ANA titers of three different
genetic background of mice with H-2s haplotype and eight H-2 congenic strains on B10 genetic
background. The results showed that all strains bearing H-2s(AsEo) were high responders, whereas
AsEs, AsEk, AbEo, AkEo, ArEo were low or nonresponders. Then we searched other strain with I-
E molecule lacked, and discovered beige mouse(bg) as a high responder. The bg has same genetic
background of C57BL/6(AbEo) but differs from it only in a mutation of beige locus. Therefore, this
beige locus is suggested to immunoregulate ANA production in this case. These results indicate the
possibility that lack of I-E molecule and mutation of beige gene may be involved in an increase of
ANA production. Treatment of anti-IL-4 against A.SW(H-2s) partially inhibited the increase in
total ANA, but anti-IFN-r made them promote a week earlier than untreated one, indicating that Th2
cells preferentially play a role in this system. The ANA production induced by AuTM in A.SW was
higher under the conventional condition rather than clean, indicating that enviromental factors are
also related with ANA production as well as genetic factors like haplotype of I-A allele, lack of I-E
molecule and mutation of beige locus. 
0939
IL-23 production by cosecretion of endogenous p19 and transgenic p40 in K14/p40 transgenic
mice. Evidence for enhanced cutaneous immunity
T Kopp,1 P Lenz,4 C Bello-Fernandez,1 RA Kastelein,2 TS Kupper3 and G Stingl1 1 Dermatology,
DIAID, University Hospital of Vienna, Vienna, Vienna, Austria, 2 DNAX, Palo Alto, CA, 3 Harvard
Skin Disease Research Center, Boston, MA and 4 NCI, Bethesda, MD
The proinflammatory cytokine interleukin 12 (IL-12), a p35/40 heterodimer, is produced by resi-
dent cells in skin and has been implicated as a pathogenic factor in T cell-mediated skin diseases.
To investigate the effect of local IL-12 inhibition in cutaneous immunity, we generated mice which
constitutively produce the IL-12 antagonists p40 and p40/40, but not p35/40, in basal keratinocytes
(KC). Surprisingly, these mice spontaneously developed an eczematous skin disease. To identify the
proinflammatory activity of transgenic (TG) p40, we searched for the presence of a moiety distinct
from p35 which forms a proinflammatory cytokine with TG p40. Here we show that TG KC endoge-
nously express p19, which, by cosecretion with TG p40 results in IL-23 (p19/p40) production.
Repeated injections of recombinant IL-23 in littermate (LM) mice resulted in an inflammatory skin
disease similar to that of p40 TG mice, confirming the proinflammatory activity of IL-23. Further-
more, IL-23 secretion by p40 TG KC induced elevated numbers of Langerhans cells (LC) with a
marked upregulation of costimulatory molecules indicative of advanced maturation of K14/p40 LC
when compared to LM LC. At the functional level, freshly isolated K14/p40 LC greatly exceeded
LC from LM animals in their capacity to stimulate allogeneic T cell proliferation. To assess whether
IL-23 regulates cutaneous immune responses in vivo, we used an allogeneic skin transplantation
model. Full thickness skin grafts from K14/p40 donors (H-2q), transplanted across a MHC class I
and class II barrier onto BALB/c (H-2d) recipients, were rejected in a significantly accelerated fash-
ion (mean survival time [MST]: 8.8 days) when compared to skin grafts from non-TG LM (H-2q)
(MST: 10.7 days, p<0.01). Based on these results, we propose that IL-23 may be a major player in
cutaneous immune responses. 
0941
Densities, distribution and phenotypic expression of T cells in human fetal skin
S Di Nuzzo, P Pavanello and G De Panfilis Dermatology, University of Parma, Parma, Italy
T cells, which are at the heart of most adaptive skin immune responses, are present in normal human
skin, but their occourrence in human fetal skin is poorly understood. T cell and Langerhans cell
(LC) populations were studied, in human fetal skin, using single or double immunohistochemical
stainings on cryostat section. Forty samples derived from different body regions of 13 individuals,
ranging from 18 to 30 weeks estimated gestational age, were examined. In all specimens but one,
we did not find any epidermal T cell. By contrast, dermal CD3+ T cells were present in all samples,
mainly distributed in the perivascular compartment, with a statistically equivalent density, namely,
a mean of 8 cells/centimetre linear section. Double-stainings showed that such CD3+ T cells were
predominantly CD4+/CD45RA+/CLA-. On the other hand, LC, as assessed by CD1a expression,
were evenly distributed within the interfollicular epidermis at all gestional ages, with an average den-
sity of 25 cell/centimetre linear section. Analysis of T cells and LC in different body regions did not
show topographic differences in number and composition. We suggest that lack of epidermal T
cells, although the LC network is fully represented, might reflect the scarce opportunity of fetal LC
to contact foreign antigens in utero. Furthermore, the predominance of CD4+/CD45RA+/CLA- T
cells in the dermis may reflect a random recruitment from the circulation. 
0940
Antitumor immunity utilizing melanoma cells fused with dendritic cells derived from MHC
class I & II knockout mice
Y Takagi,1,2 T Kikuchi,2 T Ohno2 and M Niimura1 1 Dermatology, Jikei University School of
Medicine, Tokyo, Japan and 2 Department of Oncology, The Institute of DNA Medicine, Jikei
University School of Medicine, Tokyo, Japan
Antitumor effects of dendritic cells(DCs) fused to mouse B16 melanoma cells have been reported
previously. MHC class I & II in addition to tumor associated antigen,co-stimulatory molecules are
known to be involved in crosstalikng between tumor cells and DCs. To assess whether MHC play
an important role in induction of antitumor immunity by DCs,DCs derived from MHC knocked out
mice as well as wild type were fused to B16 .FACS analysis demonstrated that levels of surface mark-
ers and phagocytosis of both wild and MHC knock out DCs were not significant.Animals were immu-
nized by wild type or knocked out DCs fused to B16 twice every week followed by challenging of
B16 melanoma cells.Outgrowth of implanted B16 was not significant between wild type and knocked
out DCs.These results suggest that the levels of MHC may not have any effects on fusion cells based
antitumor immunotherapy. 
0938
From phenotype to genotype: Functional analysis and chromosomal mapping of a hyper IgE
mouse mutant generated by genome wide mutagenesis
T Jakob,1 D Soewarto,2 G Koellisch,1 M Howaldt,6 E Kremmer,3 M Hrabe de Angelis,2 R Balling,4
H Behrendt,1 J Ring,1 K Pfeffer,5 E Wolf6 and H Flaswinkel6 1 Division of Environmental
Dermatology and Allergy TUM/GSF National Research Center for Environment and Health,
Munich, Germany, 2 Institute of Exp. Genetics, GSF, Munich, Germany, 3 Institute of Molecular
Immunology, GSF, Munich, Germany, 4 Gesellschaft fuer Biotechnologische Forschung mbH,
Braunschweig, Germany, 5 Institute of Medical Microbiology, Heinrich-Heine-University,
Duesseldorf, Germany and 6 Institut of Molcular Animal Breeding, Gene Center LMU, Munich,
Germany
Laboratory animals carrying genetic mutations are of great value to study the biological function of
genes. The ENU-Mouse-Mutagenesis Project aims at a large scale systematic production of mouse
mutants using the mutagen ethylnitrosourea (ENU). Using this approach, we have identified mouse
mutants with increased plasma IgE levels. One of these hyper IgE mutants displays additional immuno-
logical abnormalities. Flowcytometric analysis of peripheral blood and spleen lymphocyte subpop-
ulations revealed dramatically reduced T cell numbers, while B cell counts were normal. Thymo-
cyte analysis of mutants indicate a block in late T cell differentiation where numbers of CD4, CD8
double positive cells appeared to be normal, while single positive cells where almost absent. Bone
marrow analysis of B cell development revealed an incomplete block of early B cell development at
the stage of pre-B cells. Chromosomal mapping revealed a link to a 2.1 cM region localized on
chromosome 1. Differential mRNA expression profiling of selected tissues using genome wide cDNA
array technology is employed to narrow down potential candidate genes. Selected candidate genes
are currently sequenced to identify relevant mutations. In conclusion, we have identified a novel
mouse mutant with a combined phenotype of hyper IgE, a late block in T cell differentiation and an
early block in B cell development. Chromosomal mapping and sequencing of candidate or novels
genes will allow us to establish new gene/function/phenotype relations and may lead to novel ani-
mal models for human disease. 
0942
Contact hypersensitivity was attenuated in T-bet knockout mice
M Shibata,1,2 RC Fuhlbrigge,1 R Moreno,1 LH Glimcher3 and TS Kupper1 1 Dermatology, Harvard
Skin Disease Research Center, Brigham and Women’s Hospital, Boston, MA, 2 Dermatology,
Cutaneous Biology Research Center, MGH/Harvard Medical School, Charlestown, MA and 3
Harvard School of Public Health and Harvard Medical School, Boston, MA
T-bet is a Th1-specific T-box transcription factor that controls the expression of IFN-γ in Th1 cells
and NK cells. Mice engineered for deletion of T-bet have been shown to be have a Th2-dominant
immune response and show a phenotype reminiscent of human asthma when stimulated with metha-
choline aerosol (Finotto et. al, Science 295: 336-338, 2002). We evaluated the contact hypersensi-
tivity response to trimellitic anhydride (TMA), a hapten known to cause asthma-like responses when
inhaled, in T-bet knockout mice on both Balb/c and C57BL/6 backgrounds as well as in wild-type
control animals. Mice were sensitized by topical application on the shaved abdomen of 100 µl 50%
TMA on day 0 and 50 µl of 25% TMA on day 7. Contact hypersensitivity was elicited on day 14 by
application of 10 µl of 10% TMA to both sides of the right ear. Ear swelling was assessed with a
digital micrometer at various time points and the ears were removed for cytokine gene expression
and histological examination. Total RNA was obtained using a freeze-smash technique and cytokine
expression was quantitated by real-time PCR. Ear swelling in response to TMA was reduced 37%
and 38% in T-bet -/- mice in comparison with wild-type Balb/c and C57BL/6 mice, respectively.
The degree of inflammatory cell infiltrate and the presence of microabcesses were also reduced in
T-bet -/- ear skin compared with wild type controls. IL-4 mRNA was increased in TMA sensitized
ear skin of both T-bet -/- and wild-type animals. These results suggest that Th1 cells partially medi-
ate contact hypersensitivity to TMA, but that Th2 cells also contribute to this reaction. 
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Dendritic cells in allergic contact dermatitis--the widening spectrum
C Bangert, G Stingl and T Kopp Department of Dermatology, DIAID, University Hospital of
Vienna, Vienna, Vienna, Austria
The nature of the pathogenetically relevant antigen-presenting cells in the effector phase of contact
hypersensitivity (CHS) is still unknown. To address this issue, we examined, by immunofluores-
cence, biopsies from positive 72h epicutaneous patch tests (EPTs; n=10) and normal human skin
(NHS; n=5) for the presence of different members of the dendritic cell (DC) family. CD1a was used
as marker for Langerhans cells (LCs), CD1c for dermal dendritic cells (DDCs) and CD123/BDCA-
2 for plasmacytoid DCs (pDCs). \HS contained CD1a+ and CD1c+ cells in both the epidermal
(19.3/mm- and 4.3/mm basement membrane, respectively) and dermal (16.2/mm2 and 28.6/mm2,
respectively) compartment. In EPTs the number of dermal CD1a+ cells (47.5/mm2) was clearly
increased at the expense of their epidermal counterpart (12.6/mm basement membrane). We obtained
similar results for CD1c+ cells of EPT specimens (15.7 epidermal CD1c+ cells/mm, and 100.8 der-
mal CD1c+ cells/mm2). In contrast to NHS, a substantial proportion of epidermal (28%) and dermal
(38%) CD1a+ cells in EPT lesions expressed the activation marker CD83, whereas the majority of
the CD1c+ cells in EPTs remained unactivated. These findings may speak for distinct maturational
events of LC and DDC in ACD. We also detected a small number of the newly defined CD123+BDCA-
2+ pDCs in the dermal, but not in the epidermal compartment of NHS (2.9/mm2). Notably, these cells
represented a substantial proportion of the entire dermal DC infiltrate in EPT lesions. They were
numerically increased already in 6h EPTs and peaked in 72h reactions (1.6 epidermal cells/mm, and
50 dermal cells/mm2). FACS analysis of EPT reactions revealed that approximately 90% of
CD123+MHCII+ cells bear BDCA-2. In summary we find that, in contrast to NHS, EPT lesions not
only contain increased numbers of LCs and DDCs, but also a significant population of pDCs. It
remains to be determined whether the attraction of pDCs to the site of hapten-challenge represents
a bystander phenomenon or, alternatively, contributes to the evolution or resolution of the ACD. 
0944
Neonatal epidermal cells impair the maturation of adult Langerhans cells in vitro
S Chang-Rodriguez, S Meindl, G Stingl and A Elbe-Buerger DIAID, Department of Dermatology,
University of Vienna Medical School, Vienna, Austria
We and others have previously shown that the fetal and neonatal epidermis contains ADPase+, CD45+,
MHC class II+/-, DEC-205- dendritic leukocytes which are defective in their capacity to stimulate
antigen-specific T cell proliferative responses. Cells with a Langerhans cell (LC) phenotype (MHC
class II+, DEC-205+, Langerin+) appear only 3-5 days after birth. In the present study we tested
whether a different cytokine milieu in the neonatal epidermal microenvironment compared to adult
epidermis may be responsible for the immature phenotype of resident leukocytes. We therefore com-
paratively assessed the cytokine pattern of neonatal and adult cultures by testing epidermal cell
(EC) supernatants for the presence of keratinocyte-derived cytokines known to promote survival
and maturation of LC. While similar amounts of GM-CSF were measured in both culture super-
natants during the entire culture period of 72 hours, the levels of TNF-α in the supernatants of neona-
tal-EC cultures far exceeded ( 10) those secreted by EC from adult animals. In coculture experiments
we tested whether this finding may have any consequences for the maturation capacity of LC. Indeed,
results obtained revealed that the presence of neonatal EC not only hampered the upregulation of
costimulatory molecules (e.g. CD40, CD86) on syngeneic and allogeneic adult LC but also the expres-
sion of DEC-205. In contrast, adult EC failed to influence the phenotype of neonatal dendritic epi-
dermal leukocytes. These findings may have important implications for our understanding of mech-
anisms underlying neonatal tolerance. 
0945
The expression of Toll-like receptors, MD-2 and CD14; in mouse keratinocytes
PI Song,1 R Prado,1 N Neparidze,1 L Jaiani,1 J Wang,2 P Dotto,2 CA Armstrong1 and JC Ansel1 1
Dermatology, Northwestern University, The Feinberg School of Medicine, Chicago, IL and 2
Cutaneous Biology Research Center, Harvard Medical School and Massachusetts General
Hospital, Charlestown, MA
Toll-like receptors (TLRs), MD-2 and CD14 have been known to play an important role in innate
immune responses to various microbial derived agents. Recently, we have demonstrated that
lipopolysaccharide (LPS) and lipoteichoic acid (LTA), major biologically active components derived
from gram-negative and positive bacteria, respectively, can activate human keratinocytes by CD14
and TLR4 dependent mechanism. However, the expression and biological function of TLRs, MD-2
and CD14 in mouse keratinocytes remains unclear. In this study we examined the expression of
TLR2/4, MD-2 and CD14 in primary mouse keratinocytes and in the murine keratinocyte cell line
PAM212. Our results indicate that TLR2/4, MD-2 and CD14 mRNA was constitutively expressed
in primary mouse keratinocytes and PAM212 cells. The differentiation state of the murine ker-
atinocytes had a significant effect on TLR2/4 and CD14 expression. Under high calcium culture con-
ditions for 1 to 6 days there was a time dependent increase in murine keratinocytes TLR2, TLR4
and CD14 mRNA with differentiation. The results of these studies indicate that murine keratinocytes
express TLRs and support the potential of a murine model system in examining the role of ker-
atinocytes in mediating innate immunological responses to cutaneous infections. 
0946
Profound defects in dendritic cell function in Sezary syndrome: correction with CpGs and
CD40 ligand
M Wysocka,1 BM Benoit,1 L French,3 J Budgin,1 S Richardson,1 J Moore2 and AH Rook1 1
Dermatology, University of Pennsylvania, Philadelphia, PA, 2 Pathology, University of
Pennsylvania, Philadelphia, PA and 3 Dermatology, University of Geneva, Geneva, Switzerland
Patients with Sezary syndrome (SS) exhibit profound defects in cell mediated immunity partially
resulting from marked deficiencies in the numbers of peripheral blood dendritic cells (DCs) and in
their capacity to make the immune augmenting cytokines interferon α (IFNα) and interleukin-12
(IL-12). In an effort to enhance DC function of SS patients, we investigated the effects of several
immunostimulatory compounds including repeat CpG nucleotides, which activate DCs following
binding to Toll like receptor (TLR) 9 and soluble recombinant CD40 ligand (CD40L) which acti-
vates DCs following ligation of CD40. Initial studies indicated that TLR 9 and CD40 expression on
DCs of SS patients was normal. Culture of patient peripheral blood cells with of CpG 2216 resulted
in significant activation of DCs characterized by enhanced expression of CD83 and production of
IFNα comparable to normals. Production of IFNα correlated with enhanced natural killer cell func-
tion in vitro. Following priming with low concentrations of IFNγ, culture of cells with CD40L induced
high levels of IL-12 production, while IFNγ alone induced no IL-12. Thus, CpGs and CD40L, by
virtue of IFNα and IL-12 induction, appear capable of activating both major families of DCs within
the blood of SS patients. Because IFNα and IL-12 each exhibit therapeutic efficacy for SS, these
findings have profound implications for the enhancement of anti-tumor immunity among SS patients. 
0947
Identification of gene expression profiles that segregate patients with distinct primary cuta-
neous large B cell lymphoma
M Vermeer, R Dijkman, JJ Hoefnagel, R Willemze and CP Tensen Dermatology, LUMC, Leiden,
The Netherlands
Primary cutaneous large B-cell lymphomas (PCLBCL) account for 20% to 25% of all primary cuta-
neous lymphomas. Most PCLBCL are primary cutaneous follicle center cell lymphomas (PCFCCL)
that present with nodules and tumors on a restricted area on the head and trunk. These lymphomas
are highly responsive to radiotherapy and have an excellent prognosis (5-year survival 95%). In
contrast, the PCLBCL of the leg have a higher relapse rate and a more unfavorable prognosis (5-
year survival 58%). Methods: Using Affymetrix oligo-arrays (U95Av2) we determined gene expres-
sion profiles in biopsies from PCLBCL of the leg (n=7) and PCFCCL (n=4) containing more than
80% tumor cells Results: On average 55% of the genes were expressed in all biopies. Using unsu-
pervised hierarchical cluster analysis, PCLBCL of the leg (n=7) and PCFCCL (n=4) are classified
in two distinct clusters. Within these separate clusters gene expression profiles are relatively homo-
geneous. More detailed analysis (supervised clustering) revealed increase of 67 genes and decrease
of 84 genes in all PCLBCL of the leg compared to all PCFCCL. In patients with PCLBCL of the leg
38 genes are associated with a detrimental clinical outcome (13 increased and 25 decreased expres-
sion) including genes involved in cell adhesion and proliferation. Discussion The differences in gene
expression between PCLBCL of the leg and PCFCCL support the EORTC classification of PCLBCL.
In addition, differentially expressed genes can provide insight in lymphomagenesis in PCLBCL and
serve as prognostic and diagnostic markers as well as therapeutic targets. 
0948
In vitro induction of specific Th1 cells using MVA-hTyrosinase infected dendritic cells
K Ghoreschi,1 I Drexler,2 C Weigert,1 H Braumueller,1 G Sutter2 and M Roecken1 1 Dermatology,
Eberhard Karls University, Tuebingen, Baden-Wuerttemberg, Germany and 2 Molecular Virology,
GSF-Institute, Munich, Bavaria, Germany
Since the incidence of invasive malignant melanoma is still increasing new vaccination strategies
for tumor prevention and therapy are needed. Recently we could show in a mouse model that tumor-
specific IFN-γ-producing Th1 cells are highly effective in tumor prevention and therapy of estab-
lished disseminated lymphoma. In humans the use of gen-transfected dendritic cells (DC) seems to
be more effective than the use of peptide pulsed DC for priming naive T cells. Gen-transfected DC
can stimulate T cells independently from HLA-restriction and limited epitope sequences. Tyrosinase
is expressed on more than 90% of malignant melanomas, and is an immunogenic target in autoim-
mune disease. Therefore we used a modified vaccinia virus ankara encdoing the human tyrosinase
gen (MVA-hTyr) for gen-transfer in DC. Monocyte derived DC can be infected with a efficiency of
more than 60% and express tyrosinase. Surprisingly, MVA-hTyr infection of DC abolished their
capacity to stimulate autologous T cells in vitro even in presence of superantigen and IL-2. Pheno-
type analysis showed a decline of costimulatory molecules and induction of apoptosis in DC. In
vivo vaccination with MVA leads to a potent immune protection in mice and human. This can be
explained by phagocytosis of apoptotic DC by other DC for effective presentation. Thus, coculture
of infected DC with non-infected DC restores the stimulatory capacity of DC in superantigen trig-
gered T-cell stimulation. Incorporation of apoptotic DC by other DC could be shown using MVA-
GFP. Three rounds of stimulation of autologous CD4+ T-cells by DC-DC-MVA-hTyr led to genera-
tion of MVA-hTyr specific CD4+ T-cells as shown by proliferation and cytokine production.
Importantly, this in vitro generated Th cells presented an IFN-γ producing Th1 phenotype. 
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Analysis of host-melanoma interaction of transgenic mouse melanoma model
M Fujita,1,2 DA Norris,1 C Yee2 and J Takao1 1 Dermatology, University of Colorado Health
Sciences Center, Denver, CO and 2 Clinical Research Division, Fred Hutchinson Cancer Research
Center, Seattle, WA
The immune system is not efficient enough to control melanoma progression despite the fact that it
can recognize melanocyte differentiation antigens expressed by melanoma cells. Several oncogenes
and tumor suppressor genes are implicated in melanoma progression. Of particular, the Ras-signal-
ing pathway and Cdkn2a encoding Ink4a/Arf play major roles in development of melanoma not only
in humans but also in the mouse melanoma model as described by Chin et al.. In order to elucidate
host-melanoma interactions, we analyzed this model. Following Chin’s method we crossed Tyr-Hras
transgenic mice with Ink4a/Arf knockout mice twice to generate the mice with melanocyte-specific
H-rasG12V expression on an ink4a/Arf-deficient background. The mice develop spontaneous cuta-
neous and ocular melanomas around several months of age. Cutaneous melanomas form fairly-cir-
cumscribed tumors in the upper dermis, extending through deep tissues and are associated with epi-
dermal hyperplasia. RT-PCR analysis of the tumor reveals transcripts of melanocyte differentiation
antigens including mTRP-1, mTRP-2 and mMART-1. Immunohistochemical analysis reveals mild
to moderate CD3 T cells infiltrating mainly at the periphery of tumor mass with scattered cells among
the tumor. Scattered B220 cells (B cells and NK cells) are also seen at the periphery of tumor. More
detailed analysis of host-tumor interaction and tumor escape from immune recognition is under inves-
tigation. 
0951
The percentage and activation phenotype of circulating CLA+ T cells in acute psoriasis sug-
gest sequestration of skin-homing T cells to tissue
A Gimenez-Arnau,1 M Pont,2 J Beleta,2 R Pujol1 and LF Santamaria-Babi2 1 Almirall Prodesfarma,
Barcelona, Spain and 2 Department of Dermatology, Hospital del Mar, Barcelona, Spain
The CLA antigen distinguishes memory effector T cells with cutaneous tropism. CLA+ T cells are
important in the T cell mediated immune response in different cutaneous diseases like atopic der-
matitis, drug induced allergic reactions and herpes infection. The purpose of this study was to deter-
mine by flow cytometry the percentage and activation stage of CLA+ T cells (both CD3 and CD4)
in the PBMCs of psoriasis patients in acute phase, chronic phase, or in healthy controls. Psoriatic
patients in the acute phase of their disease presented significantly the lowest percentagesof circu-
lating CLA+ T cells of the three groups. Patients with acute psoriasis also presented the highest per-
centages of HLA-DR expression within the CLA+CD3+ or CLA+CD4+ circulating pool. The lev-
els of CD25+CLA+ T cells were also the highest in the patients with acute psoriasis. There were no
significant differences regarding the percentages of cells expressing HLA-Dr or CD25 within the
CLA negative T cell subset in the 3 groups studied. In addition, purified CLA+ T cells from PBMCs
of acute phase psoriasis patients incorporated Brdu and proliferated to exogenous IL-2 in the absence
of TCR stimulation, in contrast to the CLA negative subset. Our data suggest that there is a decrease
in the percentage of circulating CLA+ T celsl in acute psoriasis possibly due to a sequestration of
circulating skin-homing T cells. Also that some circulating CLA+ T cells from PBMCs of acute
psoriasis patients have been activated in vivo and probably come from cutaneous lesions. The dif-
ferences in the percentages and activation state of skin-homing T cells within different stages of
psoriasis are compatible with an early involvement of those cells in the pathogenesis of psoriasis. 
0953
Corticosteroids but not pimecrolimus affect the viability of murine L Langerhans cells in vivo
W Hoetzenecker,1 JG Meingassner,2 R Ecker,3 A Stuetz2 and A Elbe-Buerger1 1 DIAID, Dept. of
Dermatol., Vienna, Austria, 2 Novartis Research Institute, Vienna, Austria and 3 BMT, Vienna,
Austria
Given the importance of dendritic cells for immune functions, we investigated the effect of pime-
crolimus, a novel anti-inflammatory drug for the topical treatment of atopic dermatitis, on the integrity
and survival of Langerhans` cells (LC) in comparison with corticosteroids (CS). BALB/c mice were
treated twice on one day on both sides of the ears and the tail with ethanolic solutions of the test
compounds at their clinically used concentrations [1% hydrocortisone (HC), 0.05% clobetasol pro-
pionate (CL), 1% pimecrolimus] which inhibit efficaciously contact hypersensitivity responses in
mice. Controls were treated with ethanol (vehicle) alone. Twenty four – 72 h after the last applica-
tion, we observed an upregulation of Fas expression, induction of caspase-3 activity and fragmented
DNA in most LC from mice treated with CS as determined by flow cytometry of epidermal cell
(EC) suspensions and TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick-end
labeling) staining of epidermal sheets. In contrast, no such changes were observed in LC of pime-
crolimus- or vehicle-treated animals. When we tested whether the topical application of CS blocks
the secretion of soluble factors which are required for LC survival and maturation, we found that
CS-EC supernatants but not pimecrolimus-EC supernatants contained significantly lower amounts
of GM-CSF, TNF-α, and IL-1α than EC supernatants from vehicle-treated mice. The addition of
GM-CSF to EC suspensions prepared from CS-treated mice greatly improved LC viability. In con-
clusion, these data show that CS but not pimecrolimus induce apoptosis in LC. This most likely
occurs via both a direct and indirect mechanism. This confirms that pimecrolimus has a more selec-
tive mode of action than CS supporting a higher safety of topical pimecrolimus in the treatment of
inflammatory skin diseases. 
0952
Heat shock proteins-27 and -70 are present in the epidermis and are important for the induc-
tion of allergic contact hypersensitivity
N Yusuf, CE Huang, H Xu, DC Tang, SK Katiyar and CA Elmets Dermatology, UAB, Birmingham,
AL
Heat shock proteins (HSPs) refer to a large family of molecular chaperones. Their presence in the
skin and their role in the pathogenesis of skin disease have received little attention. The purpose of
this study was to determine which HSPs were present in the skin and to examine their participation
in allergic contact hypersensitivity. Initial studies employed a proteomic approach to separate skin
proteins from C3H/HeN and BALB/c mice. On 2-D gel electrophoresis spots with a Mr of 27.0 and
a pI of 6.1 and a Mr of 71.23 and pI of 5.07 were noted. Protein identification by MALDI-TOF mass
spectroscopy demonstrated that these spots had the characteristics of HSP-27 and HSP-70. Immuno-
histochemical staining of mouse skin with antibodies to HSP-27 showed that it was expressed through-
out the superficial portion of the epidermis. To assess the functional role of HSP-27 and HSP-70,
blocking antibodies were applied to the shaved abdominal skin of C3H/HeN mice. Two hours later,
the animals were contact sensitized to DNFB and ear challenged five days after that. Animals in
which sensitization was attempted through HSP antibody treated skin developed a reduced contact
hypersensitivity response compared to mice that were not pretreated with antibody and to mice treated
with an isotype specific control antibody. HSP-27 had a more profound inhibitory effect (48%) than
HSP-70 (33%). When both antibodies were applied at the same time an additive inhibitory effect
was observed (75% inhibition). The findings indicate that HSPs are present in murine skin and are
important contributors to the development of contact hypersensitivity reactions. 
0950
Corticosteroids down-regulate murine Langerhans cell function in vitro in contrast to pime-
crolimus
A Elbe-Buerger,1 W Hoetzenecker,1 JG Meingassner,2 A Stuetz2 and G Stingl1 1 DIAID, Dept. of
Dermatol., Vienna, Austria and 2 Novartis Research Institute, Vienna, Austria
Topically applied CS as well as the novel ascomycin derivative pimecrolimus are highly effective in
the treatment of atopic dermatitis. To determine their effects on the immune functions of resident
skin leukocytes, we comparatively assessed their influence on LC-driven T cell responses. BALB/c
mice were topically treated with ethanolic solutions of the test compounds at their clinically used
concentrations [1% hydrocortisone (HC), 0.05% clobetasol propionate (CL), 1% pimecrolimus]
which inhibit efficaciously CHS responses in mice. Controls were treated with ethanol (vehicle)
alone. Forty eight hours after the last application, epidermal cell (EC) suspensions were prepared
from auricular and tail skin and cultured. After 2 days, nonadherent EC were counted and tested for
viability, phenotype and function. While the viability of EC prepared from pimecrolimus- and vehi-
cle-treated skin areas was greater than 70%, the percentage of trypan-blue positive EC from HC-
and CL-treated mice was 45 and 61%, respectively. FACS phenotyping revealed comparable levels
of surface-bound MHC class II molecules on LC from all groups. In contrast, the expression of CD25,
CD205 and costimulatory molecules was significantly higher on LC derived from pimecrolimus-
and vehicle-treated mice than on those of CS-treated animals. In line with this, LC-enriched EC
(adjusted to equal numbers of LC) from pimecrolimus-treated mice induced a vigorous allogeneic
T cell response comparable to that evoked by LC-enriched EC from vehicle-treated mice. In con-
trast, LC-enriched EC from CS-treated skin areas were greatly hampered in this capacity. These
results show that, in contrast to CS, pimecrolimus does not interfere with the maturation and immune
function of LC and immune function of EC. 
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Serum complement activation and T cell responses to whole microbes
DS Cundell,1 JM Hales,1 PP Freestone2 and RD Camp1 1 Dermatology, University of Leicester,
Leicester, United Kingdom and 2 Microbiology and Immunology, University of Leicester, Leicester,
Leicestershire, United Kingdom
Complement activation is implicated as a proinflammatory process in autoimmune and inflamma-
tory diseases of the skin and other organs. However, during investigations into the role of commen-
sal and pathogenic skin bacteria as immunologic targets in atopic dermatitis, we have unexpectedly
shown that complement activation is associated with decreased T cell responses. Whole, formalin-
killed, washed Staphylococcus (S) aureus, S capitis and S epidermidis were incubated for 5 days
with autologous peripheral blood mononuclear cells (PBMC) in medium with 10% fresh, unmodi-
fied serum or serum that had been heated under complement-inactivating conditions. All samples
caused substantial, dilution-related PBMC proliferation, but the maximum stimulation index (mSI)
was significantly greater with heat-inactivated serum (123 ± 54) than with unheated serum (43 ± 22;
means ± SD, n=18, p<0.0001, paired t test). Soluble subcellular fractions of the S species, prepared
by lysostaphin digestion, sonication and centrifugation, also caused PBMC proliferation, but mSI
values in the presence of 10% unheated and heat-inactivated serum were similar (54 ± 77 versus 57
± 79 respectively; mean ± SD, n=42, p=0.25, paired t test). Because complement activation prod-
ucts were likely to be generated in unheated serum by whole bacteria via the lectin pathway, but not
by soluble subcellular fractions, we asked whether complement fragments might inhibit T cell acti-
vation. Accordingly, PBMC proliferation in response to whole S aureus was shown to be consider-
ably greater in medium with 10% C3-deficient serum (prepared by immunoaffinity depletion) than
control serum (maximum counts per min 19,064 ± 2,600 versus 10,637 ± 3,164, means ± SD, n=4,
p=0.006, paired t test). We propose that certain complement fragments downregulate T cell activa-
tion, and may serve to control post-infective autoimmune responses. Whether these effects are due
to iC3b-dependent IL-10 production, C5b-9-mediated immunocyte apoptosis or other mechanisms,
remains to be determined. 
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Topical application of adenovirus-vectored anthrax vaccine
Z Shi, J Zhang, G Yang, E Jex, C Elmets and D Tang Dermatology, UAB, Birmingham, AL
Anthrax caused by Bacillus anthracis is usually a cutaneous disease in nature. However, based on
the rapidly fatal hemorrhagic mediastinitis resulting from inhaling spores, the threat of intentional
use of anthrax as a biological weapon has engendered great public panic. The two toxins secreted
by B. anthracis are composed of binary combinations of three proteins: protective antigen (PA), lethal
factor (LF), and edema factor (EF). The PA component binds to a specific cell surface receptor and
causes internalization and translocation of LF and EF. The contemporarily licensed anthrax vaccine
in the US was made from cell-free filtrate of a nonencapsulated attenuated strain of B. anthracis and
is given as 6-dose subcutaneous administration within 18 months. The principal antigen responsi-
ble for inducing immunity is the PA, but there have been concerns over the safety and efficacy of
protective antigen vaccine. By taking advantage of potent immunological induction property of skin,
we have successfully developed a skin-targeted immunization system by topical application of a
recombinant adenovirus which encodes foreign antigen. In the present study, recombinant aden-
ovirus encoding PA (Ad-PA) or LF (Ad-LF) were constructed and were topically applied onto the
skin of different mouse strains. The antibody response to PA and LF were examined by ELISA after
topical immunization. High titers of antibody to PA and LF were observed in mice topically immu-
nized with both Ad-PA and Ad-LF and were dose-dependent. In contrast, immunization with either
Ad-PA or Ad-LF resulted in weak antibody responses. The efficacy of this novel anthrax vaccina-
tion approach will be examined by protection study. We hypothesize that vaccination against anthrax
may be achieved in a simple, effective, economical, painless, and safe mode by inoculation of expres-
sion vectors encoding PA and LF in a needle-free manner. This approach potentially could immu-
nize a large number of people against anthrax-based biological weapons in an emergency setting
during a terrorist attack. 
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Increasing the number of Langerhans cells in the dermis as an approach to augmenting the
immunogenicity of cancer vaccines
CM Berger,1 R Underwood,1 R Ahlquist,2 L Muffley,1 JE Olerud1 and ML Disis2 1 Dermatology,
University of Washington, Seattle, WA and 2 Oncology, University of Washington, Seattle, WA
Cancer vaccines must be developed to target multiple antigens. Plasmid DNA vaccines, easily tai-
lored to deliver multiple antigens, have been only moderately successful in their translation to human
clinical use. One strategy to make plasmid DNA immunizations more effective may be by targeting
the reservoir of professional APC in the skin, i.e. skin Langerhans cells (LC), and improving in vivo
transduction of these cells. We evaluated whether local application of LC recruiting agents could
result in increased numbers of LC in the epidermis, the cutaneous reservoir of LC, and in the der-
mis, where DNA vaccines would be administered. Application of cytokines such as GM-CSF and
TNF were compared with the effects of imiquimod, a newer topical immunomodulator. Mouse ears
were treated with intradermal GM-CSF, TNF, or topical imiquimod daily for three days, then ears
were harvested at 24, 48, or 72 hours after the end of the applications (days 4, 5 and 6, respectively).
IAd-immunolabeled LC in the dorsal ear epidermal sheets were counted and compared to IAd label-
ing in the underlying dorsal dermal sheets. The kinetics of epidermal LC recruitment and migration
varied significantly between reagents. At baseline, epidermal sheets contained 862 LC/mm2.
Imiquimod resulted in an initial fall in epidermal LC numbers to 564 LC/mm2 on day 4, then an
increase to baseline by day 5. GM-CSF and TNF treated ears revealed decreased epidermal LC counts
of 405 and 326 LC/mm2 by day 5. The kinetics of dermal inflammation was also different between
groups. Dermal inflammation in the imiquimod group increased progressively over time, whereas
inflammation in GM-CSF and TNF treated dermis initially peaked on day 4 and then subsequently
fell. These results suggest that LC activators may have variable effects at increasing and maintain-
ing LC in the dermis for in vivo transfection with DNA vaccines. 
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Langerhans cell precursors are present in spleen, peripheral blood and thymus
S Takeuchi and SI Katz Dermatology Branch, NCI, Bethesda, MD
More than two decades have passed since Langerhans cells (LC) were shown to be bone marrow-
derived. A recent study reported that epidermal LC are very long lived and, under normal conditions
and without perturbations, either proliferate or are replenished from LC precursors in skin. The pur-
pose of this study was to determine whether LC can also be derived from cellular sources other than
bone marrow or skin. Cell suspensions from F1 (H-2bxd) mice were prepared from peripheral blood,
skin-draining lymph nodes (LN), mesenteric LN, spleen, thymus and bone marrow (positive con-
trol), and injected IV into sublethally X-irradiated (8.5Gy) parent (H-2b) recipient mice. To accel-
erate LC engraftment by depleting host LC, we painted ears with 1.5% trinitrochlorobenzene (TNCB)
at the time of cellular reconstitution. Donor-origin cells were detected with anti-MHC class II anti-
body (anti-I-Ad), by counting LC in epidermal sheets manually or by flow cytometry of spleens to
determine the extent of chimerism at days 11, 14 and 28 after cell transfer. Splenocytes, peripheral
blood cells, and thymocytes, but neither of the LN preparations, gave rise to epidermal LC. After
splenocyte infusion, long-lasting and almost total chimerism (64, 58, and 94% at day 11, 14 and 28)
was observed in recipient spleens and increasing LC engraftment was observed (0, 415 and 3036/ear
sheet of donor-origin LC in non-TNCB treated ears and 577, 2584 and 3467 in TNCB-painted ears),
indicating the existence of LC progenitors in the spleen. Chimerism was also seen in mice infused
with bone marrow (97, 96, and 98% in spleen, and 983, 2178, and 9037 LC in non-TNCB treated
ears and 10765, 10843, and 38782 LC in TNCB-painted ears). LC engraftment was more evanes-
cent when peripheral blood cells were infused (1.3, 1.9, and 0.8% in spleen, and 0, 0, and 0 in non-
TNCB treated ears and 23, 115, and 19 in TNCB-painted ears) or when thymocytes were infused
(5.8, 2.4 and 2.7% in spleen, 0, 16, and 0 in non-TNCB painted ears and 66, 128, and 0 in TNCB-
painted ears). Taken together, these studies demonstrate that LC precursors are present in spleen,
peripheral blood and thymus. 
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A single nucleotide polymorphism in the DEFB1 gene associated with antimicrobial peptide
expression and oral Candida carriage
BA Dale-Crunk,1,2 LP Fredericks,1 RJ Jurevic1 and RB Presland1,2 1 Oral Biology, Univ. of
Washington, Seattle, WA and 2 Medicine/Dermatology, Univ. of Washington, Seattle, WA
Human β-defensin-1 (hBD1) is a constitutively expressed cationic antimicrobial peptide that may
have a role in innate immune defense against the adherence and carriage of oral Candida. We pre-
viously identified multiple single nucleotide polymorphisms (SNPs) in the DEFB1 gene encoding
hBD1 and showed that a SNP in the 5’ untranslated region (UTR) of hBD1 is associated with pro-
tection from oral Candida. This SNP is a C to G change at position -44 relative to the ATG start site.
The frequency of this SNP is 20% in the overall population, but 6% in diabetics with high Candida
carriage and 58% in those with low Candida giving statistically significant odds ratios for a protec-
tive effect. Two closely flanking SNPs (-20 and -52) result in several haplotypes. Because the 5’UTR
has been shown to modulate transcription, we tested the causal effect of the -44 SNP on gene expres-
sion. Chloramphenical acetyltransferase (CAT) reporter plasmids with the hBD1 5’ UTR or control
plasmids were constructed and transfected into COS cells. CAT expression was measured by a radioac-
tive assay normalized to β-galactosidase expression. The experimental plasmid with the most com-
mon haplotype containing the -44 SNP (GGG) was compared to constructs containing the three most
common haplotypes with a C allele at the -44 position (GCG, ACG, or GCA). The CAT reporter
activity of the -44 SNP G allele was twice that of the identical haplotype with C at -44 (p<0.01), and
about 30% higher than the other two haplotypes. The results suggest that the -44 SNP increases pro-
tein expression and may yield more hBD1 peptide, providing a protective effect against Candida.
This could be critical in immunocompromised patients, in which innate immune responses may have
an important role in preventing commensal organisms from becoming opportunistic pathogens. Stud-
ies on genetic polymorphisms in markers of innate immunity may enable innovative approaches to
investigations of susceptibility to opportunistic infections. 
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Effect on basal cell carcinoma tumor defense mechanisms after treatment with imiquimod
5% cream
M Urosevic,1 J Bichel,2 G Burg1 and R Dummer1 1 Dermatology, Universitatsspital, Zurich,
Switzerland and 2 3M Medica, Borken, Germany
Superficial basal cell carcinoma (sBCC) tumor defense mechanisms were evaluated before and
after treatment with imiquimod to assess changes in avoidance of tumor immune destruction. Six
subjects with 1 biopsy-confirmed sBCC tumor applied imiquimod once daily 5 days/week until signs
of initial tumor erosion; baseline and midregression biopsies were examined by immunohistochemistry
(ICH) and quantitative polymerase chain reaction (PCR). Increased cellular infiltrate density was
observed in all 6 subjects. B-cell lymphoma-2 protein (Bcl-2) staining of tumor cells decreased in
4 of 6 subjects after 2 to 5 days of imiquimod treatment; Bcl-2 staining was negative on tumor cells
in 2 subjects. Intercellular adhesion molecule-1 (ICAM-1), interleukin (IL)-10, Fas-ligand (Fas-L),
and transporter associated with antigen processing (TAP)-1 ICH staining tended to be unchanged or
somewhat decreased following 2 to 14 days of treatment with imiquimod. On local endothelial
cells, rapid cellular infiltrates associated with enhanced expression of ICAM-1 adhesion molecules
were observed. Early lymphocyte responses were mixed cluster determinant (CD)4 and CD8 in
nature. The CD4/CD8 messenger ribonucleic acid (mRNA) ratios decreased or remained unchanged
in 5 of 6 subjects, and lower CD4/CD8 ratios tended to be associated with production of interferon
gamma (IFN-γ;). Cellular infiltrates were associated with increases in IL-10. An increased infiltrate
density of CD68+ cells was noted in the midregression biopsies. Of the 18 adverse events reported
during the study, 11 (61.1%) were coded by the investigator as mild in intensity and 7 (38.9%) were
coded as moderate. The study findings suggest that topical treatment of sBCC with imiquimod may
have a direct or indirect effect on tumor defense mechanisms, most notably Bcl-2 expression. Treat-
ment with imiquimod was associated with local immune activation, including the cells of the adap-
tive immune system. Imiquimod, approved for treatment of external genital warts, is under investi-
gation for treatment of BCC and actinic keratosis. 
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Cytotoxic drugs improve the effectiveness of IVIg in pemphigus
J Bystryn and D Jiao Dermatology, NYU School of Medicine, New York, NY
Intravenous immunoglobulin (IVIg) treatment of pemphigus vulgaris (PV) causes a rapid decrease
in circulating pemphigus antibodies. This suggests that a rebound in the level of these antibodies, as
occurs following their depletion in plasmapheresis, may limit the effectiveness of IVIg and that sup-
pression of the rebound with cytotoxic drugs may improve the effectiveness of the procedure. To
evaluate this possibility we examined the effects of IVIg on serum levels of intercellular (IC) anti-
bodies and on clinical response in patients with active PV treated identically with IVIg given with
or without an effective dose of cytotoxic drug. Twelve pts with active PV unresponsive to conven-
tional therapy with systemic steroids were treated with a single cycle of IVIg (400 mg/kg/day for 5
days). Nine of the patients were concurrently given cyclophosphamide (n=8) or azathioprine (n= 1)
at 50 mg/TID. Three patients were treated similarly with IVIg but given no (n=1) or inadequate doses
(n=2) of these agents. Serum levels of IC antibodies decreased by an average of 73% from baseline
level within 1 week of initiating IVIg in the 9 pts given a cytotoxic drug compared to 0% decline in
the 3 pts given none or an inadequate dose. One of the patients treated without a cytotoxic drug, IC
antibodies decreased by 50% within 1 week when IVig was repeated together with cytoxan. Two
wks following initiation of IVIg, skin lesions were healed by approximately 80% in pts treated with
a cytotoxic drug vs 17% in pts that received an inadequate dose. These results suggest that cytotoxic
drugs improve the ability of IVIg to rapidly lower pemphigus antibodies and to control active PV
unresponsive to conventional therapy. 
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Application of human papillomavirus type 5 virus-like particles may partially overcome a
specific immune defect in patients with epidermodysplasia verruciformis
S Majewski,1 M Malejczyk,1 K Padlewska,1 M Favre,2 G Orth2 and S Jablonska1 1 Department of
Dermatology and Venereology, Warsaw School of Medicine, Warsaw, Mazowieckie, Poland and 2
Unite des Papillomavirus, Pasteur Institut, Paris, France
Recently it was shown that epidermodysplasia verruciformis (EV) is caused by nonsense mutations
of two adjacent novel genes on chromosome 17qter (EVER1 and EVER2) (Ramoz et al. Nature
Genet 2002). These genes are probably involved either in regulation of HPV-keratinocyte interac-
tion or in the control of immune surveillance against EV-HPVs since EV patients do not respond to
EV-HPV antigens. The aim of the study was to find out whether immunogenic booster by adminis-
tration of specific HPV5L1 virus-like particles (VLPs) could stimulate local and systemic cell-medi-
ated and humoral immunity in EV patients with confirmed mutations of EVER2. All 4 EV patients
studied were found anergic to HPV5 VLPs as measured by T cell proliferation assay and IFNg pro-
duction. The PBMC stimulated with HPV5 VLPs generated high amounts of IL-10, but normal
amounts of IL-18. Highly purified HPV5L1 VLPs, with no detectable DNA contamination, were
applied intradermally at increasing doses: 75mcg, 150mcg and 300mcg at 1, 2, 6 monthly intervals.
Antibodies to HPV5L1 VLPs were evaluated by ELISA using the same antigen. A seroconversion
was observed in two of four cases, both familial EV, one with widespread skin involvement and the
other a 17-year-old girl with plane wart-like lesions since the age of 3, in whom the lesions partly
regressed after the 5th VLP administration and entirely disappeared, amid a slight inflammatory reac-
tion, after the 6th VLP application. In two remaining patients with widespread lesions and several
carcinomas there was a slight increase in antibody titres and some flattening of wart-like changes.
In one of them, after 5th VLP administration, local skin reaction of delayed type to VLPs became
positive and IFNg production by VLP-stimulated PBMC increased. Our study suggests that stimu-
lation with EV-HPV VLPs couls partially overcome the specific immune defect in EV patients. 
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In vivo transfection of cis element “decoy” against signal transducers and activators of tran-
scription 6 binding site ameliorates contact hypersensitivity
K Sumi,1 H Yokozeki,1 M Wu,1 T Satoh,1 Y Kaneda2 and K Nishioka1 1 Environmental
Immunodermatology, Tokyo Medical & Dental University Postgraduate School, Bunkyo-ku, Tokyo,
Japan and 2 Gene Therapy, Osaka University, Suita, Osaka, Japan
We previously demonstrated that Signal Transducers and Activators of Transcription 6 (STAT6) plays
a crucial role in the induction of contact hypersensitivity (CHS) (J Exp Med, 191; 995, 2000). Fur-
ther, repeated elicitation of CHS has been reported to induce a shift in cutaneous cytokine milieu
from Th1 to Th2. Therefore, we hypothesized that synthetic double-stranded DNA with high affin-
ity for STAT6 could be introduced in vivo as decoy cis elements to bind the transcriptional factor
and to block the induction of not only single elicitation of CHS (acute CHS) but also repeated (12
times) elicitation of CHS (chronic CHS), thus providing effective therapy for CHS. Treatment by
transfection of STAT6 decoy oligodeoxynucleotides (ODN), but not scrambled decoy ODN, after
the sensitization by application of 5% 2,4,6-trinitrochlorobenzene (TNCB), had a significant inhibitory
effect on both the induction of acute CHS and chronic CHS. Histological analysis revealed that
edema, infiltration of eosinophils, and degranulation of mast cells were all significantly reduced in
STAT6 decoy ODN transfected mice at both acute CHS and chronic CHS. To examine the mecha-
nism of the in vivo effect of STAT6 decoy ODN, we assessed the cytokine level of challenged skins
by ELISA. Expression of IL-4 was reduced by transfection of STAT6 Decoy but not scrambled Decoy.
This is the first successful in vivo transfer of STAT6 decoy ODN to inhibit the induction of single
or repeated elicitation of CHS providing a new therapeutic strategy for not only CHS but also atopic
dermatitis. 
0965
All trans-retinoic acid induces production of IL-8 in human keratinocytes via increased phos-
phorylation of IκBα in the NFκB pathway
X Dai, K Yamasaki, Y Yahata, S Tokumaru, M Tohyama, Y Shirakata, K Sayama and K Hashimoto
Dermatology, Ehime University School of Medicine, Onsen-gun, Ehime, Japan
All trans-retinoic acid has various biological effects on the skin. Several groups have reported that
all trans-retinoic acid causes skin inflammation. This led us to hypothesize that all trans-retinoic acid
induces the production of inflammatory chemokines or cytokines in human keratinocytes. First, we
examined whether all trans-retinoic acid enhances mRNA expression of various chemokines in cul-
tured normal human keratinocytes. We found that 10-9 to 10-5 M all trans-retinoic acid induced IL-
8 mRNA expression in a dose-dependent manner. The optimum increase was 5.5-fold at 10-5 M com-
pared to vehicle control after 24 h. The amount of IL-8 protein in culture medium was measured by
ELISA. All trans-retinoic acid induced IL-8 protein production by human keratinocytes, 25 pg/ml
at 10-6 M and 150 pg/ml at 10-5 M. IL-8 is reported to be produced by IL-1 via the NFκB pathway
in human keratinocytes. Therefore, we examined the effect of all trans-retinoic acid on the NFκB
pathway. Interestingly, 10-9 to 10-5 M all trans-retinoic acid increased the phosphorylation of IκBα
in a dose-dependent manner, optimally 1.7-fold at 10-5 M, whereas all trans-retinoic acid had no
effect on the amount of IκBα protein. IκBα binds to NFκB and prevents the translocation of NFκB
to the nucleus until it is phosphorylated. An adenovirus vector expressing a mutant IκBα was used
to block the NFκB pathway. This mutant IκBα cannot be phosphorylated and prevents translocation
of NFκB to nucleus. The mutant IκBα almost completely inhibited IL-8 production induced by 10-
6 M all trans-retinoic acid for 48 h. Combined, these data demonstrate that all trans-retinoic acid
induces IL-8 production by increasing the phosphorylation of IκBα in the NFκB pathway. 
0964
High efficient transgene expression after terminal differentiation of DNA transfected dendritic
cells
A Larregina,1 A Morelli,2 O Tkacheva,1 G Erdos,3 A Thomson2 and L Falo1 1 Dermatology,
University of Pittsburgh, Pittsburgh, PA, 2 Surgery, University of Pittsburgh, Pittsburgh  and 3 West
Penn Allegheny Health System, Pittsburgh, PA
Dendritic cells (DC) play critical roles in the development and control of immunity. For evolving
immune therapies ranging from vaccine development to tolerance induction, the use of in vitro gen-
erated DCs is an attractive strategy for immunomodulation. Efficient non-viral transfection of DCs
would significantly contribute to these efforts by enabling genetic engineering of DC populations,
but has not yet been achieved. In the present study, we analyzed the mechanisms involved in effi-
cient transgene expression by murine DCs. Using biolistic delivery of plasmid DNA encoding reporter
proteins such as firefly luciferase and EGFP under the control of the human CMV promoter, we
demonstrate that transgene expression increases dramatically in DCs terminally differentiated through
CD40, or DC-T cell interaction mediated differentiation. Under these conditions up to 75% of trans-
fected DC expressed transgenic proteins and peptides. We demonstrate that induction of high trans-
gene expression was due to signaling occurring during the interaction between transfected DC and
CD4 T cells or through DC-DC homotypic aggregation. Signaling of DC through terminal differ-
entiation resulted in the translocation of the nuclear factors -kBeta (NF-kB), activator of protein-1
(AP-1) and cAMP responsive element (CRE) to the cell nucleus of DC and enhanced gene expres-
sion was blocked by inhibition of these factors or by blocking adhesion molecules involved in DC-
T cell interaction. Importantly terminal differentiation of DC favored the loading of transgenic anti-
genic peptides into MHC-class I molecules that resulted in induction of strong CTL response. Taken
together, these studies demonstrate that highly efficient transgene expression by DCs can be achieved
by combining an appropriate DNA delivery method with appropriate DC signaling stimulus able to
translocate the transcription factors required by the transpromoter being employed into the nuclei of
DCs. 
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Tissue-specific tumor immunity is mediated by trafficking-related molecules fucosyl trans-
ferase VII and b7 integrin
D Hurwitz,1,2 M Yoshida,3 S Richardson,1,2 R Moreno,1,2 R Fuhlbrigge,1,2 B Rich,1,2 R Blumberg3
and T Kupper1,2 1 Dermatology, Brigham and Women, Boston, MA, 2 Harvard SDRC, Boston, MA
and 3 Gastroenterology, Brigham and Women, Boston, MA
Inflammatory stimuli generate tissue-specific patterns of selectins, chemokines and cell adhesion
molecules by which memory / effector T cells preferentially home back to the tissue in which they
first encountered their cognate antigen (anatomic memory). Fucosyltransferase VII (FucTVII) reg-
ulates leukocyte homing via the generation of selectin ligands. Cutaneous lymphocyte antigen (CLA)
is a FucTVII -dependent carbohydrate epitope that serves as an E -selectin ligand on human T cells.
FucTVII appears to play a similar role in mice, although a murine CLA homolog has not been iden-
tified. In a similar fashion, b7 integrin plays a key role in gut homing. Both a4b7 and a(iel)b7 inte-
grins, which interact with MadCAM expressed on gut endothelium, mediate homing into gut-asso-
ciated inflammatory sites. We hypothesized that tissue-specific homing is important in anti-tumor
immunity. To test this hypothesis, we examined rejection of allogeneic tumors transplanted into the
skin and gut of wild-type C57BL/6 mice, as well as C57BL/6 mice deficient in FucTVII or b7 inte-
grin. Wild-type C57BL/6 mice are able to reject allogeneic J558L tumors transplanted into skin or
gut. We found that FucTVII -/- mice showed delayed rejection of J558L tumors transplanted into
skin but normal rejection of identical tumors transplanted into gut. b7 integrin -/- mice, in contrast,
showed delayed rejection of J558L tumors transplanted into gut but normal rejection of identical
tumors transplanted into skin. Transfer of C57BL/6 T cells expressing wild-type FucTVII ablated
skin tumor rejection defects in FucTVII -/- mice. In summary, mice deficient in skin or gut traf-
ficking-related adhesion molecules showed defective T cell mediated allogeneic tumor rejection in
the corresponding tissues. From these results we conclude that tissue-specific homing of T cells is
an important element of anti-tumor immunity. 
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Toll-like receptor-2 up-regulates IL-4-induced eotaxin production through signal transducers
and activators of transcription (STAT)-6 activation in dermal fibroblasts
S Bae,1 H Murota,1 I Katayama,1 Y Sumikawa,2,3 S Itami2 and S Akira3 1 Department of
Dermatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 2
Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan and 3
Research Institute for Microbial Diseases, Osaka University, Osaka, Japan
Innate immunity acts as first-line host defense to multi-cellular organisms. Many recent reports
have revealed the new roles of toll like receptors (TLRs) in mammalian immune system including
TLR-2 mediated activation of mast cells. It is wellknown that CCR3 chemokine, eotaxin plays a cen-
tral role in the development of Th2 allergic diseases, including atopic dermatitis, asthma, and nasal
allergy. To clarify the role of innate immunity in Th2 allergic diseases, we investigated whether TLRs
could modulate IL-4 and/or TNF alpha -induced eotaxin production by fibroblasts derived from
atopic dermatitis patients and TLR-/-mice. As results, eotaxin production and mRNA expression
were significantly upregulated in atopic fibroblasts in contrast to normal fibroblasts after IL-4 stim-
ulus. TLR2, 4 and 9 were identified by human fibroblasts at mRNA. Pretreatment of fibroblasts by
TLR-2 neutralizing antibody (Ab) inhibited about 30% of eotaxin production and mRNA expres-
sion in both fibroblasts. Westhern blot showed that STAT-6 phpsphorylation was also down-regu-
lated in TLR-2 Ab treated fibroblasts, whereas NF kappa B expression was unchanged. Luciferase
assay demonstrated TLR-2 Ab treatment had no effect on NF kappa B activation in both fibroblasts
stimulated with IL-4 and TNF alpha. To confirm the action of TLR-2 on IL-4 signaling, fibroblasts
of TLR-2 -/- mice were stimulated with IL-4 and TNF alpha. TLR-2 -/- mice fibroblast showed a
markedly lower STAT-6 expression than wild type after both stimuli. Taken together, our studies pro-
vide new evidences that TLR-2 expressed in dermal fibroblasts regulates eotaxin production via
STAT-6 signaling. Theses finding could suggest that TLR-2 plays a novel role in Th2 allergic inflam-
mation of the skin. 
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Differential effects of immunosuppressive drugs on TARC/CCL17 production in PBMC of
atopic dermatitis
K Nakamura,1 H Furukawa,1 H Akiba,1 A Nishibu,1 N Oyama,1 M Tojo,1 F Kaneko,1 Y Tsunemi,2
T Kakinuma,2 H Saeki2 and K Tamaki2 1 Dermatology, Fukushima Medical University, Fukushima,
Fukushima, Japan and 2 Dermatology, Tokyo University, Tokyo, Japan
Thymus- and activation- regulated chemokine (TARC / CCL17) is a Th2 chemokine which chemoat-
tacts CCR4+ memory T cells. Atopic dermatitis (AD) is an inflammatory skin disease characterized
by the predominance of Th2 type cytokines such as IL-4 or IL-5 in peripheral blood. We previously
showed high levels of serum TARC of patients with AD. However, little is known about the regula-
tion of TARC production in peripheral blood mononuclear cells (PBMC) of AD. We first examined
TARC production in PBMC of AD patients or healthy controls with or without stimulation by dust
mite allergens extracts during 7 days in vitro. Cultured PBMCs in AD patients without stimulation
of DME for 7 days spontaneously produced TARC protein (603.7pg/ml), which was significantly
higher than that of healthy controls (24.4pg/ml). When PBMCs were stimulated with DME, cul-
tured PBMC of AD showed strong enhancement of TARC production during 7 days up to 1576.1pg/ml,
which was higher than that of healthy controls (159.8pg/ml). RT-PCR experiments revealed that the
subtypes of TARC producing cells in PBMCs after the stimulation of DME were CD4+ T cells, CD8+
T cells and monocyte derived dendritic cells. We next examined the effects of various immunosup-
pressive drugs (Tacrolimus, Cyclosporine (CyA), Dexamethasone (Dex)) on TARC production by
cultured PBMCs with DME stimulation. When PBMCs were co-cultured with DME and immuno-
suppressive drugs, TARC production of PBMC from AD patients were inhibited at protein levels in
a dose dependent manner of these drugs. RT-PCR experiments showed that these immunosuppres-
sive drugs inhibited TARC mRNA expression by PBMC. Gel shift analysis revealed NFkB activity
was differentially inhibited by these immunosuppressive drugs. We suggest that TARC signaling
could be the target for the future treatment of AD. 
0968
Expression and regulation of CD1d in keratinocytes
AI Koreck,1 M Szell,2,1 A Pivarcsi,2,1 E Sonkoly,1 C Szeg,1 Z Bata-Csorgo,1,2 R Olariu,3 A Dobozy1,2
and L Kemeny1,2 1 Dermatology and Allergology, University of Szeged, Hungary, Szeged,
Csongrad, Hungary, 2 Dermatological Reseach Group of the Hungarian Academy of Sciences,
University of Szeged, Szeged, Csongrad, Hungary and 3 Dermatology, University of Timisoara,
Timisoara, Timis, Romania
CD1d is a non-polimorphic antigen-presenting molecule that has been suggested to play a role in
immunosurveillance. The aim of the present study was to examine the expression of the glycosy-
lated and nonglycosylated forms of CD1d in keratinocytes and to establish if they have distinct roles
in psoriasis. The expression of CD1d was examined in synchronised HaCaT keratinocytes by real-
time PCR and Western blot using clone 51.1.3. We found that the expression of the glycosylated
form was maximal in proliferating cells, while the nonglycosylated form was detectable especially
in differentiated cells. Investigation of CD1d gene expression by real-time PCR in healthy skin,
psoriasis and atopic dermatitis revealed that CD1d is overexpressed only in psoriasis. Immunohis-
tochemical staining of skin sections was performed using clone NOR 3.2 and 51.1.3. The NOR 3.2
clone stained the differentiated, subcorneal keratinocytes in healthy skin and atopic dermatitis and
the whole epidermis in psoriatic skin. The 51.1.3 clone showed a diffuse staining in all skin sam-
ples, and was much stronger in psoriatic skin. Since the high resistance to infections in psoriasis
might be partly explained by increased CD1d expression, the effect of pathogens and proinflamma-
tory cytokines was also studied. We found that staphylococcal peptidoglycan, Candida albicans, IL-
8 and IFN-gamma strongly induced CD1d mRNA expression. Lipopolisaccharide and tuberculin
had no effect and human herpes virus 1 down regulated the expression of CD1d gene in a dose depend-
ent manner. These results showed that the two forms of CD1d are expressed in different stages of
keratinocyte maturation and both are overexpressed in psoriasis. CD1d may have a role in host defense
against certain pathogens and the high expression of the nonglycosylated form in psoriasis compared
to atopic dermatitis may be responsible for less frequent skin infections. 
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In vivo elimination of CD25+ regulatory T cells leads to tumor rejection of B16F10 melanoma
when combined with interleukin-12 gene-transfer
H Nagai, T Horikawa, A Fukunaga and M Ichihashi Dermatology, Kobe University School of
Medicine, Kobe, Hyogo, Japan
CD4+CD25+ T cells are an important population that play a critical role in the maintenance of periph-
eral self-tolerance. Recently, it was shown that the elimination of these cells by in vivo administra-
tion of anti-CD25 mAb caused the regression of highly immunogenic tumors in syngeneic mice. In
this study, we examined whether B16F10 melanoma cells regressed with the elimination of CD25+
regulatory T cells. We found the melanoma cells were not affected at all by in vivo anti-CD25 mAb
administration alone but tumor rejection resulted in all mice when the administration was combined
with IL-12 gene transfer to tumor cells. In vivo depletion of NK cells or CD8+T cells cancelled the
tumor rejection. NK cell depletion allowed IL-12-transfected B16F10 melanoma (B16/IL12) to grow
from an early stage and resulted in a more rapid tumor growth of B16/IL12 than that in mice with-
out administration of anti-CD25 mAb. On the other hand, CD8+T cell depletion did not affect the
tumor growth in the early phase but allowed B16/IL12 to grow in rather a late phase and resulted in
almost the same degree of tumor growth as in mice without administration of anti-CD25 mAb. In a
previous study, we showed that the elimination of CD4+T cells enhanced the antitumor effect of
B16/IL12 and induced vitiligo-like coat color alteration. Therefore, we also examined the frequency
of the change to a vitiligo-like coat color in mice showing tumor rejection caused by CD25+ T cell
elimination to compare with the mechanism enhancing the antitumor effects by CD4+ T cell elim-
ination. The elimination of CD25+T cells did not induce vitiligo-like coat color changes, though
that of CD4+T cells induced the change in 60% of mice. These results indicate that in vivo deple-
tion of CD25+ regulatory T cells is a potent useful adjuvant in immunotherapy of B16F10 melanoma
when combined with IL-12 gene-transfer. 
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Differentiation-regulated expression of TLRs in human epidermal keratinocytes
A Pivarcsi,1,2 L Bodai,2 A Koreck,2 M Szell,1,2 AS Kenderessy,2 C Szeg,2 ZC Bata,1,2 A Dobozy1,2
and L Kemeny1,2 1 Dermatological Research Group of the Hungarian Academy of Sciences,
University of Szeged, Szeged, Szeged, Hungary and 2 Department of Dermatology and Allergology,
University of Szeged, Szeged, Hungary
Recent investigations have demonstrated that keratinocytes express toll-like receptors (TLRs) that
might have an important role in host defence. The aim of our study was to investigate whether the
proliferation and differentiation state of keratinocytes modulate the expressions of TLR2 and TLR4.
The expressions of TLR2 and TLR4 were examined in cultured keratinocytes, HaCaT cells and in
normal human epidermis using quantitative real time RT-PCR (Q-RT-PCR), western blot analysis
and immunohistochemistry. As differentiation models, 1.2 mM Ca2+-treated cultured keratinocytes
and synchronised, contact inhibited HaCaT keratinocytes were used. In the normal human epider-
mis anti-human TLR2 antibodies stained the suprabasal layer, while anti-human TLR4 antibodies
stained the whole epidermis. In order to examine whether differentiation could lead to the increased
expression of TLR2 in the suprabasal keratinocytes, the expressions of TLR2 and TLR4 were com-
pared in Ca2+-treated and untreated keratinocytes both at mRNA and at protein levels. Q-RT-PCR
analyses showed that Ca2+ upregulated the expression of both TLR2 and TLR4. Western blot analy-
sis showed increased expression of TLR2 isoforms but not that of TLR4 in keratinocytes treated with
Ca2+. In an in vitro differentiation model, proliferating HaCaT keratinocytes were grown to conflu-
ency and the expressions of TLR2 and TLR4 were monitored at 24, 96 and 124 hours after reach-
ing confluent state. During the 124 hours differentiation period, the expression of TLR4 increased
while the expression of TLR2 remained unchanged. These results suggest that differentiation and
proliferation state of keratinocytes modulate the expression of TLRs that might be involved in dis-
eases characterised by disturbed KC proliferation and differentiation. 
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Impaired function of STAT1 involves hyperproliferation of keratinocyte in psoriatic lesions
despite the elevated presence of IFN-γ
H Hwang, W Bae, S Kim, S Byun and T Kim Dermatology-Immunology, Catholic Medical
College, Seoul, South Korea
Psoriasis is an inflammatory skin disease characterized by hyperproliferation of keratinocytes.
Although the exact pathogenesis of psoriasis remains to be elucidated, it is likely to be mediated by
activated T cells, which primarily release IFN-γ. The keratinocytes in the psoriatic lesions are highly
proliferating despite the presence of IFN-γ, a potent antiproliferative cytokine, suggesting that there
may be a defect in the IFN-γ signaling pathway in psoriasis. In an attempt to investigate the mech-
anism by which psoriatic keratinocytes are less sensitive to the antiproliferative effect of IFN-γ, we
examined the IFN-γ signaling pathway in both human keratinocyte derived HaCaT cells and the
psoriatic keratinocytes. We detected in the IFN-γ treated HaCaT cells the elevated production of
STAT1, which is a transcription factor responsive to IFN-γ, and phosphorylation of STAT1 at the
tyrosine residue Y701. This in turn increased expression of IRF-1, IP-10, and MCP-1, which are
crucial genes regulated by STAT1 in the IFN-γ signaling pathway, indicating that the IFN-γ signal-
ing in the HaCaT cells occurs normally. In contrast, the phosphorylation of STAT1 at the tyrosine
residue was undetectable in the psoriatic lesions, even though the STAT1 expression highly increased
in the psoriatic lesions where elevation of the IFN-γ expression was confirmed. IFN-γ and STAT1
were hardly detectable in the non-lesions and the skin biopsies from healthy individuals. We exam-
ined if the absence of the phosphorylated STAT1 was associated with the SH-PTP2, which dephos-
phorylate the phosphorylated STAT1, but did not detect any significant difference in its expression
level between lesions and non-lesions. We have further demonstrated that transcription of the IFN-
γ/STAT1 responsive genes such as IRF-1, IP-10, and MCP-1 remained unchanging in the psoriatic
lesions compared to those in non-lesions. These data suggest that impaired function of STAT1 to
IFN-γ in the psoriatic lesions may give rise to the hyperproliferative feature of psoriasis. 
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Large scale transcriptional analysis of mechanisms of contact hypersensitivity in rats
B Hartmann,1 JG Meingassner1 and J Kehren2 1 Novartis Forschungsinstitut Wien, Vienna, Vienna,
Austria and 2 Novartis Pharma AG, Basle, Switzerland
The contact hypersensitivity (CH) in laboratory animals is a commonly used model of an immuno-
logically mediated inflammatory skin disease. However, the underlying cellular events are not fully
elucidated. We have, therefore, examined transcriptional alterations in rat skin during the elicitation
phase of CH. Female Sprague Dawley rats, sensitized against 2,4-dinitrofluorobenzene (DNFB),
were challenged with 0.5% DNFB on the flanks and the skin dissected 8 or 24 hrs after the chal-
lenge. The RNA from the challenged sites and from similar sites of sensitized animals without chal-
lenge (controls) was extracted and hybridized on GeneChip microarrays (Affymetrix RU34A). Genes
which differed significantly (p: < 0.001) by > 40% in expression at 8 or 24 hrs from controls were
analysed. Among the 414 genes retrieved, heat shock protein Hsp70, metallothionein, alpha 2u-
microglobulin, caspase 6, Gadd153, p53, iNOS, ICAM-1, Gro-1 and MCP-1 (genes related to cel-
lular stress, apoptosis, cellular migration or inflammation) were strongly expressed as early as at
8hrs. IL-4 receptor, histidine decarboxylase and mast cell protease 8 were upregulated at both time
points and may have revealed mast cell activation. A similar expression profile exhibited the genes
of IL-6, CD14, MRP8, MRP14, MIP1 beta and MIP2 indicating an early infiltration of macrophages.
Expression of genes associated with homeostasis of dermal and epidermal structures were either
induced (matrix metalloproteases MMP3 and MMP12) or reduced (collagen 1a, collagen 3, claudin
3, profilaggrin) 8 and 24 hrs after challenge. These differences may have been associated with his-
tomorphological changes. In conclusion, this type of analysis proves to be a powerful tool to obtain
a broad and detailed description of the diverse molecular cascades involved in contact hypersensi-
tivity. 
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The aberrant expression of toll-like receptor 9 in the peripheral blood mononuclear cells of
patients with psoriasis vulgaris
E Muroi, S Bae, H Murota, K Shimizu and I Katayama Dermatology, Nagasaki University,
Nagasaki, Nagasaki, Japan
It is well known that the pathogenesis of psoriasis vulgaris is related to various factors, including
genetic, and environmental elements. Such as bacterial infection occasionally exacerbating the clin-
ical manifestation in severe psoriatic eruption. Toll-like receptors (TLRs) are proteins that stimulate
proinflammatory cytokine gene transcription in response to various microbial ligands. The regula-
tion of TLR2 and TLR4, TLR9 is known to be an important factor in the cell mediated immune
responses to bacteria, but the participation of TLR9 has not been yet studied profoundly enough in
psoriasis patients. In this study, we examined the expression level of TLR2 and TLR9 mRNA in
peripheral blood mononuclear cell (PBMC) obtained from psoriatic patients and healthy controls.
TLR9 mRNA was significantly increased in psoriatic patients, whereas TLR2 mRNA was not.
Next, we investigate the expression level of TLR9 level in PBMC obtained from psoriatic patients
and healthy control, using flow cytometric analysis. As results, we observed that the expression of
TLR9 in the cell surface was very similar in both normal and psoriatic PBMC. In contrast, surpris-
ingly, the expression of TLR9 in the PBMC from psoriasis patients was significantly increased in
the cytoplasmic fraction compared to the normal controls. These aberrant distribution patterns of
TLR9 in psoriatic patient PBMC might suggest that bacterial derived factors such as TLR9 ligand,
CpG DNA play important role in induction of psoriasis. 
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Imiquimod treatment of cutaneous T cell lymphoma
J Muche,1 A Born,1 A Marchand,2 S Gellrich,1 W Sterry1 and A Lukowsky1 1 Dermatology and
Allergy, Charite Berlin, Berlin, Germany and 2 Dermatology, Vivantes Hospital Berlin-Spandau,
Berlin, Germany
The neoplastic cells of cutaneous T cell lymphomas (CTCL) express type 2 cytokines and are attacked
by type 1 cytokine expressing reactive lymphocytes. Since imiquimod induces IFNa, IFNg and
IL12 and down-regulates IL4 and IL5, we asked whether it would be effective in CTCL treatment.
Ten patients suffering from MF stage IA-IIA were treated by application of 5% imiquimod oint-
ment (one lesion of 20 cm2, 5 times per week for 12 weeks). Effects were assessed clinically and
by evaluation of skin biopsies taken before and 4 weeks after treatment (treated and untreated lesion).
Of the 7 patients completing the study, two developed a clinical response (1 CR, 1 PR). Two addi-
tional patients showed complete clearing of the treated lesion. Histological evaluation revealed an
increase in CD8+ cells paired with a reduced number and a loss of epidermotropism of CD4+ cells
in the responding lesions. Assessment of the lesional mRNA expression of IFNg and IL4 by real-
time PCR revealed a strong reduction of both, IFNg and IL4 in treated and untreated lesion of the
complete responder, thereby indicating complete clearing of the lesions. In treated lesions of local
responders, an induction of IFNg mRNA paired with only slight reduction of IL4 was observed. This
may correlate with failure to induce a sufficient anti-tumour response despite induction of type 1
cytokines. The increase of IL4, found in treated and untreated lesions of non-responders, may indi-
cate ongoing proliferation of type 2 tumour cells. In summary, our data prove principle and efficiency
of topical imiquimod therapy in CTCL. With regard to the low overall response despite satisfactory
local effects in our patients, treatment should be extended to at least one lesion per skin region. 
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CCR10 expression by malignant melanoma cells: implications for tumor growth and metas-
tasis
A Mueller,2 SN Wagner,3 EP Bowman,5 T Ruzicka,4 A Zlotnik1 and B Homey4 1 Radiation
Oncology, Heinrich-Heine-University, Duesseldorf, NRW, Germany, 2 Dermatology, University of
Vienna, Vienna, 3 DNAX Research Inc., Palo Alto, 4 Dermatology, Heinrich-Heine-University,
Duesseldorf, NRW, Germany and 5 Eos Biotechnology, South San Francisco, CA
Malignant Melanoma shows aggressive primary tumor growth and metastasizes into local draining
lymph nodes, lung, liver, brain and bone marrow. In contrast to other malignancies, malignant
melanoma also shows a high frequency of skin metastases. Recently, we showed that chemokine
receptors such as CXCR4 are involved in the development of organ-specific metastasis to lymph
nodes and lung. Furthermore, we identified the novel skin-associated chemokine CCL27(CTACK,
ALP, ESkine) and its receptor CCR10(GPR-2) which specifically mediate the recruitment of lym-
phocytes into the skin. In the present study, we demonstrate that malignant melanoma cell lines as
well as primary malignant melanoma tumors express high levels of CCR10 mRNA. Notably, skin
metastases of malignant melanoma show significantly increased CCR10 mRNA expression com-
pared to primary tumors suggesting the selection for CCR10-high expressing malignant clones.
Immunohistochemical analyses confirmed CCR10 expression by MelanA-positive melanoma cells.
In vitro, CCR10 signaling mediated migration and invasion of malignant melanoma cells and sig-
nificantly induced their proliferation. In vivo, neutralization of mCCL27 resulted in delayed primary
tumor growth of human melanoma cells in a SCID mouse model. Taken together, our findings sug-
gest that CCR10 expression by malignant melanoma cells plays a role in primary tumor growth and
the development of skin metastases. 
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Rho proteins regulate ICAM-1 (CD54) expression in Hs294T melanoma cells
C Hofmann,1 U Goehring,3 Y Herouy,1 JM Becker,2 E Wagner,4 K Aktories3 and J Norgauer1 1
Department of Dermatology, University Hospital, Freiburg, Germany, 2 Department of
Dermatology, University Hospital, Wuerzburg, Germany, 3 Department of Pharmacology,
University Hospital, Freiburg, Germany and 4 Department of Biology, University Hospital,
Freiburg, Germany
The expression of intercellular adhesion molecule 1 (ICAM-1, CD54), a molecule pivotal in many
inflammatory and immune paracrine interactions, has been highly correlated with malignant melanoma
progression. In the current study we investigated the involvement of Rho GTPases in ICAM-1 expres-
sion in Hs294T melanoma cells. Treatment of melanoma cells with Clostridium difficile toxin B
covalently modified Rho GTPases in vivo by UDP-monoglucosylation and almost completely inhib-
ited interferon-γ(IFNγ) induced ICAM-1 expression. Western blot and RT-PCR experiments revealed
in Hs294T melanoma cells protein expression of RhoA, RhoB, RhoG, Rac1 and Cdc42 as well as
mRNA expression of RhoC and TC10, respectively. Overexpression of constitutive activated forms
of Rho proteins such as RhoGV12, Rac1V12 and Cdc42V12 increased significantly constitutive
expression of ICAM-1, whereas INFγ{induced ICAM-1 expression was significantly inhibited in
dominant negative RhoCN19, Rac1N17 and CdcN17 transfectants and potentiated in constitutively
activated RhoCV14, RhoGV12 and TC10V26 transfectants. ICAM-1 protein cell surface expression
in transfectants was paralleled by alterations in ICAM-1 mRNA steady state levels as detected by
Northern blot and cell surface expression of ICAM-1 protein in transfectants could be blocked by
actinomycin D. In summary, the present study suggests that RhoC, RhoG, Rac1, Cdc42, TC10 con-
trol expression of ICAM-1 in melanoma. These observations suggest that disturbances in Rho GTPases
function are a critical event in melanoma progression. 
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The serotoninergic receptors of human dendritic cells: identification and coupling to cytokine
release
J Norgauer,1 E Panther,1 F Di Virgilio,2 Y Herouy,1 D Ferrari2 and M Idzko3 1 Department of
Dermatology, University Hospital, Freiburg, Germany, 2 Experimental and Diagnostic Medicine,
University of Ferrara, Ferrara, Italy and 3 Dpartment of Pneumology, University of Freiburg,
Freiburg
The neurotransmitter 5-hydroxytryptamine (5-HT), commonly known as serotonin, is stored at periph-
eral sites in mast cells and released from this peripheral source upon IgE cross-linking. Here we
investigated the expression of serotoninergic receptors (5-HTR), signal pathway coupling and bio-
logical activity of 5-HT of human dendritic cells (DC), showing that immature and mature DC
expressed mRNA for different serotoninergic receptors. Thereby, the mRNA of 5-HTR1B, 5-HTR1E,
5-HTR2A, 5-HTR2B, two splicing variants of the 5-HTR3, 5-HTR4 and the 5-HTR7 receptor were
detected. Immature DC preferentially expressed mRNA for the heptahelical receptors 5-HTR1 and
5-HTR2, while mature DC mostly expressed 5-HTR4 and 5-HTR7. The mRNA expression level of
the ligand-gated cation channel 5-HTR3 did not significantly change during maturation. Isotype-
selective receptor agonists allowed us to show that 5-HT stimulated 5-HTR3-dependent Ca2+ influx
in immature and mature DC. Moreover we revealed that 5-HTR1 and 5-HTR2 receptor stimulation
induced intracellular Ca2+ mobilization in immature, but not in mature DC. Ca2+ transients were
mediated via Gi/o proteins activation. Activation of 5-HTR4 and 5-HTR7 induced cAMP elevation
in mature DC. Functional studied indicated that 5-HTR regulate the proinflammatory activity of DC
controlling the release of the cytokines interleukin (IL)-1β and IL-8. In summary, our study impli-
cate that 5-HT stimulated in a maturation-dependent manner, different signal pathways in DC. These
data would point for a role for 5-HT in regulating the immune response at peripheral sites. 
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Inosine stimulates chemotaxis, Ca2+-transients and actin polymerization in immature den-
dritic cells via pertussis toxin-sensitive mechanism independent of adenosine receptors
M Idzko,2 E Panther,1 HC Bremer,2 S Sorichter,2 Y Herouy1 and J Norgauer1 1 Department of
Dermatology, University Hospital, Freiburg, Germany and 2 Department of Pneumology,
University of Freiburg, Freiburg, Germany
Inosine is an endogenous purine nucleoside which is formed by adenosine deaminidase during adeno-
sine breakdown and is released into the extracellular space from the sympathic nervous system or
metabolically stressed cells. Here, we studied the biological activity of inosine on human dendritic
cells (DC) which are specialized antigen presenting cells characterized by their ability to migrate
into target sites and secondary lymphoid organs in order to initiate an adaptive immune response. In
immature DC inosine stimulated Ca2+ transients, actin polymerization and chemotaxis. During the
maturation process DC lost their ability to respond towards inosine with these activities. Experiments
with adenosine receptor antagonists and pertussis toxin as well as desensitization studies suggested
that the activity of inosine is mediated by a G protein-coupled receptor pathway independent of
adenosine receptors. In summary, our study implicates that inosine might be another member of the
trafficking controlling system of immature DC and mediates its chemotactic activity by pertussis
toxin-sensitive mechanism independent of adenosine receptors. 
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Human keratinocyte regulation of CD1d cell surface expression during terminal differentia-
tion is post-translational, and is not limited by its association with beta2 microglobulin
AA Gaspari,1 R Fishelevich,1 A Malinina1 and SA Porcelli2 1 Dermatology, University of
Maryland, Baltimore, MD and 2 Microbiology & Immunology, Albert Einstein College of
Medicine, New York, NY
CD1d is a major histocompatibility (MHC)-like molecule that serves as a recognition element for
the presentation of glycolipids to NKT-cells. This molecule is expressed by human epidermal ker-
atinocytes (KC) in normal human skin in the subcorneal layer of the epidermis, but there is no infor-
mation about the regulation of expression of CD1d during KC terminal differentiation. Cultured
human KC that were terminally differentiated (DIFF), expressed CD1d on their cell surface, whereas
undifferentiated (UNDIFF), cultured KC expressed CD1d in the cytoplasm and not on the cell sur-
face, as detected by confocal microscopy. This indicates that cultured KC recapitulate differentia-
tion-associated regulation of CD1d expression in vitro. RT-PCR was utilized to study KC CD1d gene
expression, and indicated equivalent mRNA steady-state levels in both cell types. As well, western
blotting of DIFF and UNDIFF KC indicated equivalent expression of the 45kD mature form of CD1d
by both cell types, despite increased expression of involucrin by DIFF KC. Because the 45kD form
of CD1d is dependent on beta2 microglobulin (B2M) for membrane expression in other cell types,
the association of this molecule with CD1d in DIFF and UNDIFF KC was studied by immunopre-
cipitation with monoclonal antibodies specific for CD1d or MHC class I, followed by immunoblot-
ting with a B2M specific monoclonal antibody. 12kD B2M was equally associated with both CD1d
and MHC class I in both DIFF and UNDIFF KC. These data indicate that during terminal differen-
tiation, normal human KC regulate membrane expression of CD1d by a post-translational mecha-
nism, which is not limited by its association with B2M, and suggests other factors, such as lipids,




Characterizing the inhibition of squamous cell carcinoma growth by αβ T cells
M Girardi,2 D Oppenheim,1 C Pollit,1 E Glusac,2 R Filler,2 R Tigelaar2 and A Hayday1 1
Dermatology, Yale University, New Haven, CT and 2 Immunobiology, GKT Guy’s Hospital,
London, United Kingdom
We previously showed that intradermal injection of the squamous cell carcinoma (SCC) line, PDV,
elicits markedly increased tumor incidence and decreased tumor latency in T cell receptor-β knock-
out (TCRβ-KO) mice, relative to wild-type (WT) C57BL/6 recipients. Adoptive transfer studies
showed that both CD8+ and CD4+ cells were required for optimal tumor immunity. CD4-KO, inter-
feron (IFN)γ-KO, and β2-microglobulin (β2m)-KO mice also showed increased tumor incidence and
decreased tumor latency. Thus, this is a powerful model for the better characterization of αβ T cell-
mediated inhibition of tumor growth. To investigate the influence of the immune system on the growth
of PDV SCC tumors in vivo, an investigation was made of the gene expression patterns of tumors
growing in immunocompetent vs immunocompromised hosts. By real-time qRT-PCR, all tumors
growing in TCRβKO mice expressed much higher levels of Rae-1, a MHC-IB gene known to be up-
regulated in SCC, and a target for cytolytic T and NK cells, relative to tumors growing in WT mice
(5.2±0.8 vs 11.3±1.3; p≤0.001). To identify other genes that might be altered in their expression pat-
terns in tumors according to the immunocompetence of the host, we performed cDNA microarray
analysis. This identified several genes of which 5 were selected for further analysis on a broad panel
of tumors harvested directly from growth in WT, TCRβ-KO or IFNγ-KO mice. Strikingly, 3 genes
(osteopontin, semaphorin-IIIA, and syndecan-1) showed consistent up-regulated expression by semi-
quantitative RT-PCR in tumors explanted from immunodeficient mice (p≤0.01 for each gene). While
these findings do not assign the expression of the up-regulated genes to either the tumor cells or to
the supporting stroma, they nonetheless demonstrate that the growth of SCC cells as a tumor in vivo
is under immunological influence that is reflected in reproducible changes in the expression of par-
ticular genes. The expression of particular genes may act as a marker of the status of immunologi-
cal pressure on a growing tumor. 
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CpG oligonucleotides inhibit tumor growth in a human melanoma NOD/SCID xenotrans-
plantation model
C Krepler,2,1 V Wacheck,1 S Strommer,1 G Hartmann,3 K Wolff,2 H Pehamberger2 and B Jansen2,1
1 Dep. of Dermatology, Univ. of Vienna, Vienna, Austria, 2 Dep. of Clinical Pharmacology, Univ.
of Vienna, Vienna, Austria and 3 Dep. of Clinical Pharmacology, Univ. of Munich, Munich,
Germany
For patients with advanced malignant melanoma, the 5 year survival rate with current treatment
modalities is less than 5%. Melanoma is a prime example of a malignancy resistant to chemother-
apy. Therefore new strategies for its treatment are greatly needed. One approach is to stimulate the
immune system using CpG oligonucleotides into mounting a response against tumor cells. CpG
oligonucleotides are distinct oligonucleotides containing non-methylated cytidine residues in cyti-
dine-guanosine dinucleotides with particular flanking bases (CpG motifs) and are capable of strong
immune stimulation by mimicking bacterial DNA. We evaluated the in vivo antitumoral effects of
CpG oligonucleotides against human melanoma xenografts in NOD/SCID mice. CpG oligonucleotides
administered in single peritumoral s.c. injections three times per week resulted in increased num-
bers of dendritic cells in draining lymph nodes, increased plasma levels of IL-12 and significantly
inhibited the growth of established tumor xenografts by 60% (p< 0.016) as compared to the saline
control. We also identified a significant increase of F4/80 + cells in the CpG oligo treated tumors by
immunostaining. Our findings demonstrate the anti-tumor activity of oligonucleotides containing
immune stimulatory CpG motifs in a xenotransplantation model with absent B-, T- and NK cell func-
tion. As NOD/SCID mice lack NK1.1 + cells, the increase of F4/80+ cells in the tumor tissue points
toward macrophages as the possible effector cells involved in the growth inhibition of melanoma
xenotransplants. 
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Differential splicing of cTAGE genes leads to two tumor-specific antigens
S Eichmuller, D Usener and D Schadendorf Skin Cancer Unit, German Cancer Research Center,
Heidelberg, Germany
cTAGE-1 is a cutaneous T-cell lymphoma (CTCL)-specific tumor antigen which we have recently
identified by SEREX (PNAS 98(2):629). The present study was aimed to identify related genes and
to evaluate their value as tumor targets. RACE-PCR and DNA screening of a testicular cDNA phage
library led to 5 new members of this gene family (cTAGE-2, -3, -4, -5A, and -5B), which could be
ascribed to 4 different genes localized on chromosomes 7, 13, 14, and 18. Two of these genes were
found as different splicing variants: cTAGE-1 and -2 (chromosome 18p11.2) and cTAGE-5A and -
5B (chromosome 14). Sequences from public EST and mRNA databases could be ascribed as fur-
ther splicing variants to cTAGE-1 (-1B and -1C) and cTAGE-5 (-5C and -5D). Expression analysis
using gene-specific RT-PCR revealed cTAGE-1, -1B and cTAGE-5A expression was restricted to
testis and tumor tissues, whereas the other cTAGE-members were found in few (2 to 8) other con-
trol tissues (27 tissues tested). Tumor-specific protein expression of cTAGE-5A, -C and -D was con-
firmed by Western blotting. Sero-reactivity against cTAGE-1, -4, -5A and -5B was found only in
tumor-patients (CTCL and melanoma), while cTAGE-3 was also perceived in 1/10 control sera. The
immunogenic epitope of cTAGE-1 was determined by using epitope mapping and sera of two CTCL
patients. Moreover, cTAGE-1, -4, -5A and -5B could be detected in most types of tumor tissues and
cell lines, but to variable frequencies. Particular cTAGE-members showed a widespread expression
profile in specified tumor entities, e.g. cTAGE-1 in CTCL (11/24) and mamma carcinoma (10/23),
cTAGE-5A in CTCL (8/18), in melanoma (5/25), and in colon carcinoma (13/39). We conclude,
that cTAGE-1 and cTAGE-5 are new cancer testis antigens and that tumor-specific splicing of cTAGE
genes may lead to further new candidate proteins for specific immunotherapy of CTCL and other
malignancies. 
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Cellular infiltrates in superficial basal cell carcinoma after treatment with imiquimod 5%
cream suggest a cell-mediated immune response
R Barnetson, G Halliday, A Satchell and L Zhuang Royal Prince Alfred Hospital at University of
Sydney, Sydney, NSW, Australia
Early immune responses in superficial basal cell carcinoma (sBCC) tumors were examined to deter-
mine if cell-mediated immunity (CMI) is responsible for imiquimod-induced regression of sBCC.
Sixteen subjects with a clinically-diagnosed sBCC tumor participated in an open-label, nonran-
domized, mechanism of action study; 12 subjects applied imiquimod 5 days/week for either 1, 2, or
4 weeks and 4 subjects applied placebo cream 5 days/week for 2 weeks. After treatment, excised
tumors were evaluated for confirmation of sBCC and were verified for tumor-negative margin;
immunohistochemical analysis was used to evaluate immune cell type and number. Infiltrates were
consistent among subjects with verified sBCC (n=8). Cluster determinant (CD) 4-positive (CD4+)
T cells were present by week 1 and remained at comparable levels through week 4. CD8+ T cells
infiltrated at a slower rate than CD4+ T cells, with the highest level measured at week 4. Dendritic
cell counts increased with time. Macrophage counts were highest at week 1 and declined slightly at
weeks 2 and 4. Fewer neutrophils and γδ T cells were present compared with CD4+ T cells, CD8+
T cells, and dendritic cells, but there was a general increasing trend in neutrophil and γδ T cell
counts over time. Application site reactions were the most frequently reported adverse event with 8
(57.1%) of 14 subjects in the imiquimod group reporting at least 1 such event. The most commonly
reported application site reactions were inflamed papules surrounding treatment site (n=3); redness
at treatment site (n=3); and itching at treatment site (n=3). In conclusion, imiquimod-induced regres-
sion of clinically diagnosed sBCC is associated with infiltration of CD+ T cells and dendritic cells
by week 1. The results of this pilot study indicate that imiquimod may facilitate tumor destruction
by an immune-mediated mechanism similar to classic CMI in the skin. Imiquimod, approved for the
treatment of external genital warts, is under investigation for the treatment of BCC and actinic ker-
atosis. 
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Expression and sero-reactivity of tumor-specific antigens in cutaneous T cell lymphoma
D Usener, D Thiel, D Schadendorf and S Eichmuller Skin Cancer Unit, German Cancer Research
Center, Heidelberg, Germany
Cutaneous T-cell lymphoma (CTCL) is a heterogeneous group of extra-nodal non-Hodgkin lym-
phomas with primary manifestation in the skin with poor treatment options in the advanced stages.
As basis for future immune-therapeutic strategies we have investigated the possible expression of
tumor-specific targets in CTCL focusing mainly on so-called cancer-germline genes. cDNAs derived
from 20 CTCL tissues and 4 CTCL cell lines were tested with 15 gene- and 4 gene family-specific
primers by RT-PCR and confirmative Northern blotting. The most frequently detected mRNAs were
LAGE-1 (55% with only partial coexpression of the splicing variants), cTAGE-1 (35%), MAGE-A9
(27%), and the GAGE-3to7 group (35%). Furthermore, we could detect NY-ESO-1 (21%) and a
MAGE-A subgroup (15%), while sub-specification of the latter proved absence of MAGE-A1, -A2,
-A3, -A6, and -A12. SCP-1 was found in only one specimen and a several antigens could not been
detected in any tumor tissue or cell line (MAGE-B, GAGE-1,2,8, and all four RAGE genes). 95%
of all CTCL samples were positive for at least one of the frequent mRNAs in RT-PCR (LAGE-1,
NY-ESO-1, cTAGE-1, MAGE-A9, and/or GAGE-3to7). Using a secondary SEREX approach we
could detect sero-reactivity in sera of CTCL patients against recombinant cTAGE-1 (10/29), GAGE
(3/19), MAGE-A1 (1/18), -A3 (1/18), -A6 (2/18), and -A9 (4/18) protein, but not against LAGE-1b,
MAGE-A4b or MAGE-A12 protein (n=19). We conclude, that certain cancer-germline genes can
be detected frequently in CTCL and are able to elicit a systemic immune response. These candidate
genes might therefore be promising targets for immunotherapeutic interventions in CTCL. 
0987
Caspase-1 recruitment domain protein expression in psoriasis
KL Agnew, JB Mee and RW Groves Academic Dermatology, Imperial College, London, United
Kingdom
The cysteine protease caspase-1 is responsible for cleavage of the inactive precursors of IL-1β and
IL-18 into mature, pro-inflammatory cytokines. It is synthesised as a zymogen which, on receipt of
an appropriate signal, undergoes oligomerisation and autoprocessing. A number of molecules have
been described recently which bind caspase-1 and possess a caspase recruitment domain (CARD),
through which association occurs. The CARD proteins RICK, ASC and IPAF induce cleavage of
caspase-1 on binding, whereas ICEBERG, COP and CARD-8 antagonise this process. We have pre-
viously shown that a) human keratinocytes produce proIL-1b and proIL-18 constitutively, b) ker-
atinocyte caspase-1 is normally present in an unprocessed form and c) keratinocytes synthesise all
six CARD proteins in vitro. Given the potential importance of caspase-1 processing in the regula-
tion of inflammation, we were interested to determine whether epidermal CARD proteins could be
detected in vivo and whether their expression was altered in inflamed skin. Lesional and non-lesional
shave biopsies from six untreated chronic plaque psoriasis patients were snap-frozen. Total RNA
was prepared and semi-quantitative reverse transcription (RT) PCR was performed to determine
CARD protein mRNA levels relative to a housekeeping transcript. Whilst both non-lesional and
lesional epidermis expressed mRNA for the pro-cleavage CARD ASC, there was no significant dif-
ference in relative levels. Interestingly, despite abundant keratinocyte expression in vitro, RICK
mRNA was absent from all samples tested. Analysis of anti-cleavage CARD molecules demonstrated
no difference in levels of COP, very low expression of CARD-8 but a significant upregulation of
ICEBERG mRNA expression in lesional psoriatic epidermis. These findings indicate a complex reg-
ulatory mechanism for caspase-1 activation in human keratinocytes in vivo involving at least 5 CARD
proteins and suggest a net suppression of caspase-1 activation is maintained in lesional psoriatic
epidermis, possibly as part of a counter-regulatory feedback mechanism.  
0989
Critical role of IL-10-dependent preventive T cells, a novel subclass of regulatory T cells, in
tolerance to contact allergens
M Maurer, W Seidel-Guyenot, M Metz, J Knop and K Steinbrink Department of Dermatology,
University of Mainz, Mainz, Germany
The induction of hapten-specific low zone tolerance (LZT) by epicutaneous application of low doses
of contact allergens is mediated by CD8+ suppressor T cells (Tc2) that secrete immunosuppressive
cytokines such as IL-4 and IL-10. Here, we used IL-10-deficient (IL-10-/-) mice and normal wild
type (+/+) animals, to better characterize the role of IL-10 in the induction of LZT. Tolerizing doses
of the contact allergen TNCB (0.45 or 4.5 µg per site, 5 times per mouse) were applied epicuta-
neously. Tolerance induction was assessed by measuring the inhibition of a contact hypersensitivity
reaction (ear swelling). We found that the induction of low zone tolerance (LZT) is IL-10-depend-
ent as IL-10-/- mice failed to develop LZT unless IL-10 was injected during the induction phase of
LZT, whereas IL-10 reconstitution during the effector phase did not normalize LZT responses in
these mice. IL-10 induced LZT by promoting LZT effector T cell development, as T cells from
tolerized IL-10+/+ mice, but not IL-10-/- mice, adoptively transferred LZT to naive mice and pre-
vented Tc1-skewing as well as clonal expansion of allergen-specific T cells. During the induction
of LZT, CD4+ T cells were the only lymph node or skin cells that produced relevant amounts of IL-
10. Thus, CD8+ LZT effectors are unique regulatory T cells, best classified as preventive T cells
(Tprev), as they require IL-10 to develop, but prevent immune responses independent of IL-10. As
Tprev-dependent LZT responses can be improved by IL-10 in normal mice, these T cells may prove
to be useful targets of strategies aimed at avoiding the development of allergies and other harmful
immune responses. 
0988
PAX3 as a new melanoma-associated tumor antigen: identification of HLA-A2 restricted T cell
epitopes
A Tassis,1 L Heinzerling,1 B Schafer,2 T Kundig,1 R Dummer,1 G Burg1 and F Nestle1 1
Dermatology, University Hospital, Zurich, Switzerland and 2 Childrens Hospital, University of
Zurich, Zurich, Switzerland
Melanoma is a prime candidate for antigen specific vaccination strategies. One reason for failure of
vaccination might be the use of inappropriate targets on melanoma cells. PAX-3 is a developmen-
tally regulated transcription factor with expression in 77% of cultured malignant melanoma cell lines
and the corresponding tissues. Since PAX-3 expression is restricted to embryogenesis and certain
tumors such as melanoma, it might be a suitable vaccine target. We used the technique of inverse
immunology to design Pax3 peptides. According to the theoretical binding scores of this peptides to
HLA-A*0201, three natural and two heteroclitic peptides were synthesised. From their ability to sta-
bilise MHC class I molecules on the surface of T2 cells we could show that the practical and theo-
retical peptide binding is comparable. To screen the T cell repertoire of healthy donors we raised T
cell lines against the five peptides in presence of IL2 and IL7. The presence of peptide specific T
cells was detected by HLA-A*0201 tetramers folded around one of the heteroclitic peptides. More-
over, T2 cells loaded with four of the five peptides could be killed by these CTLs. CTLs of melanoma
patients raised against the PAX3 peptides could also kill the autologous melanoma cells e.g. were
able to recognize the naturally processed peptides. HLA-A*0201 transgenic H2 class I-deficient
(HHD) mice were used to analyse the immunogenicity of the PAX3 peptides in vivo. Ex vivo spleen
cells from HHD mice immunised with the strongest HLA-A*0201 binder peptide could kill T2 cells
loaded with the vaccinated peptide. Thus, PAX3 derived peptides define a new group of tumor anti-
gens and are potential new targets for antigen specific melanoma vaccination. 
0986
Intradermal genetic vaccination: role of bone marrow-derived antigen presenting cells
A Schneeberger, P Luehrs, R Kutil, C Wagner, G Stingl and SN Wagner Dpt of Dermatol, Univ
Vienna Medical School, Vienna, Vienna, Austria
We have recently shown that intradermal (i.d.) injection of pDNA coding for the autologous form
of Pmel17 induces a specific T cell response capable of protecting DBA/2 mice against a challenge
with a lethal dose of Pmel17-expressing melanoma cells. In the present study, we attempted to explore
the mechanism(s) of this protective response. To this end, we used β-galactosidase (βgal) as a sur-
rogate antigen. A single i.d. injection of a CMV-driven VR1012 vector engineered to express the lacz
gene led to the activation of βgal-specific CD4+ and CD8+ T cells as well as antibodies. Excision
of the VR1012 injection site at defined time points after vaccination (d1, 4, 6, 8, 11, 13) revealed
that, for a specific immune response to occur, the i-site has to stay intact for 8 days. To test whether
migratory antigen presenting cells (APC) or resident non-leukocytic cells are the critical sensitizing
cell population, bone marrow chimeras were employed. F1 (C57BL/6 x BALB/c) mice that had been
reconstituted with either BALB/c or F1 bone marrow were used 3 months after transplantation, i.e.
at a time when >95% of migratory skin DC were of donor origin. Following i.d. application of
50mg VR1012lacz, BALB/c-reconstituted F1 were found to harbor T cells that recognized an H-
2Ld-restricted peptide epitope but none that reacted against an H-2Kb epitope potentially presented
by resident skin cells which express both H-2d and H-2b MHC molecules and recognized by the T
cells that had been educated in an H-2d/b thymic microenvironment. Our results suggest that crossp-
resentation by bone marrow-derived APCs is critical for the induction of antigen-specific, protec-
tive T cell responses following intradermal DNA application. 
0990
Comparison of B7-DC expression with B7.1 and B7.2 as well as TNF family costimulatory
molecules on Langerhans cell-like XS52 cells
B Wang,1 I Freed,1 H Watanabe,1 AJ Mamelak,1 D Pardoll2 and DN Sauder1 1 Dermatology, Johns
Hopkins University, Baltimore, MD and 2 Oncology, Johns Hopkins University, Baltimore, MD
Dendritic cells (DCs) present antigens to T cells and initiate immune responses. T cell activation
requires at least two signals: one delivered by the interaction between MHC-peptide complex on
DCs and T cell receptor (TCR), and the other released by interaction of costimulatory molecules on
DCs with their receptors on T cells. Costimulatory molecules consist of 2 superfamilies: the B7
superfamily (B7.1, B7.2, B7-H1, B7-H2, B7-3 and B7-DC) and the TNF superfamily (CD40, OX40L,
CD27, Light and 4-1BBL). Langerhans cells (LCs) are the DCs residing in the epidermis. It has been
demonstrated that resident LCs express little B7 molecules, however following LC migration and
maturation B7.1 and B7.2 are significantly upregulated. In addition, we have recently demonstrated
that the novel B7 family member B7-DC is expressed on migratory mature LCs as well. To further
compare LC B7-DC expression with classic B7.1 and B7.2 as well as with TNF family costimula-
tory molecules, we analyzed B7.1, B7.2, B7-DC, CD40, OX40L and 4-1BBL expressions on LC-
like XS52 cells. Since XS52 cells are early precursor immature DCs, LPS was utilized to induce
their maturation via triggering Toll-like receptor 4 (TLR4). XS52 cells were cultured in RPMI medium
containing LPS (1 µg/ml) or medium alone for 24 hours, and then immunolabeled with various mon-
oclonal antibodies. FACS analysis showed that unstimulated XS52 cells expressed low to moderate
levels of B7.1, B7.2, B7-DC, and 4-1BBL, but not CD40 and OX40L. After 24 h-LPS stimulation,
B7.1, B7.2, B7-DC, and 4-1BBL levels were markedly increased. By contrast, CD40 and OX40L
expressions were only minimally upregulated. Our observations suggest that in addition to the clas-
sic B7.1 and B7.2 molecules, B7-DC and 4-1BBL are two new maturation markers for murine LCs. 
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Antigen-specific modulation of experimental bullous pemphigoid induced by active immu-
nization
M Zhao, LA Diaz and Z Liu Dermatology, University of North Carolina at Chapel Hill, Chapel
Hill, NC
Bullous pemphigoid (BP) is a subepidermal blistering skin disease associated with autoantibodies
against the hemidesmosomal proteins, BP180 and BP230. Experimental autoimmune BP (EABP)
in mice can be induced by active immunization with murine BP180 autoantigen (mBP180). We
have showed that EABP is dependent on both T and B cells and is mediated by anti-mBP180 autoan-
tibodies. In this investigation, we studied peripheral tolerance induction as a strategy to prevent EABP
and the mechanisms underlying this effect. We found that subcutaneous administration of mBP180
antigen suppressed EABP in C57BL/6J mice (n=10 for testing and control group). Protection from
BP development was associated with a significant reduction in mBP180-specific cellular and humoral
responses. Tolerance treatments resulted in suppressed lymphocyte proliferation induced by mBP180
antigen and antigen-specific B cell expansion. The change of antigen-specific B cell population in
control mice increased from 15% after the first immunization to 41% after the boosting immuniza-
tion, while no significant change of antigen-specific B cell population in testing group oft mice was
observed (18% to 22%). The protective effect induced by mBP180 antigen was mediated by reduced
number of IL-4-producing T cells, suggesting that a shift from a Th2 to a Th1 response could be the
underlying mechanism for the antigen-induced tolerance. ELISA assay revealed that circulating anti-
mBP180 autoantibody levels were significantly lower in mice with tolerance treatment than in the
control mice. Therefore, peripheral tolerance induced by mBP180 is effective in suppressing EABP
and represents a potential antigen-specific immunotherapy for BP. 
0992
Granulysin and cathelicidin have antimicrobial activity against Propionibacterium acnes
S Wang,1 S Kafaja,1 RL Gallo,2 RL Modlin1 and J Kim1 1 Division of Dermatology, David Geffen
School of Medicine at UCLA, Los Angeles, CA and 2 Dermatology Section, University of
California San Diego School of Medicine, San Diego, CA
Acne vulgaris is one of the most common dermatology diseases. Current treatments with antibiotics
and retinoids have several disadvantages including severe side effects. In addition, the overuse of
antibiotics has resulted in resistant strains of P. acnes. Therefore there is a need for development of
more effective therapy for acne. Antimicrobial peptides are evolutionarily conserved proteins that
are part of the innate immune system and have been found to be active against a variety of microor-
ganisms. We sought to determine if these naturally occurring peptides are effective against Propi-
onibacterium acnes. Antimicrobial peptides including granulysin, human cathelicidin peptide LL-
37, and dermcidin were incubated with P. acnes and colony-forming units were determined. Granulysin
killed P. acnes in a dose-dependent manner with 70% of bacteria killed at a concentration of 10µM
and 98% of bacteria killed at a concentration of 15µM. LL-37 also killed P. acnes in a dose-depend-
ent manner with 93% of bacteria killed at 4µM. In contrast, dermcidin, a recently identified antimi-
crobial peptide found in eccrine glands was found to be ineffective in killing P. acnes. In addition,
smaller granulysin peptides were synthesized and tested against P. acnes. Peptides that contained a
helix-loop-helix structure were effective against P. acnes while those peptides that did not contain
this secondary structure were ineffective. Finally, a colorimetric MTT (tetrazolium) assay demon-
strated that granulysin and cathelicidin are not toxic to human keratinocytes and peripheral blood
mononuclear cells. Our data indicate that naturally occurring antimicrobial peptides such as gran-
ulysin and cathelicidin are effective in killing P. acnes and are not toxic to human cells and there-
fore may have therapeutic applications for the treatment of acne vulgaris. 
0993
E-selectin and ICAM-1 co-localize in mid to upper dermal vessels in non-inflamed human skin:
a means for cutaneous immunosurveillance
B Chong, J Murphy, TS Kupper and RC Fuhlbrigge Dermatology, Brigham and Women, Boston,
MA
The efficient recruitment of leukocytes to areas of trauma and infection underlies the success of the
cutaneous immune system. Inflammation initiates a complex series of steps that draw leukocytes to
tissue sites. Skin-homing leukocytes expressing CLA (cutaneous lymphocyte antigen) bind to E-
selectin located on endothelium, inducing their tethering and rolling. Firm arrest of these leukocytes
on the vessel wall, mediated by LFA-1 (lymphocyte function-associated antigen-1) and ICAM-1
(intercellular adhesion molecule-1)), is required for transmigration into the skin. While the multi-
step process of leukocyte-endothelial interactions has been well established in inflammatory mod-
els, its involvement in a skin-specific immunosurveillance system has been controversial. E-selectin
and P-selectin are generally considered to be absent in non-inflamed skin and upregulated during
inflammation. Several animal models, however, have shown spontaneous rolling of leukocytes in
postcapillary venules in skin, which has been attributed to the constitutive presence of E- and P-
selectin. To determine whether a similar process occurs in humans, we performed immunohisto-
chemical stainings of E-selectin on non-inflamed human skin removed from cosmetic surgeries.
These surgeries showed a small subset of mid to upper dermal vessels with non-contiguous E-selectin
expression. Double immunofluorescence stainings of E-selectin and CD31 confirmed E-selectin
staining in vessels and demonstrated a larger distribution of dermal vessels that stained only with
CD31. Using confocal microscopy, we also demonstrated co-expression of E-selectin and ICAM-1
in these dermal vessels. Thus, the constitutive presence of E-selectin and ICAM-1, which should be
necessary and sufficient to induce extravasation of circulating activated CLA+ T-cells, could pro-
vide the foundation of a cutaneous immunosurveillance system. Manipulating the expression of these
molecules could enhance treatment of inflammatory and malignant skin diseases. 
0994
The topical immune response modifier imiquimod induces Langerhans cell migration in human
skin explants
I Freed, B Wang, D Bilu, H Watanabe, AJ Mamelak and DN Sauder Dermatology, Johns Hopkins
University, Baltimore, MD
Imiquimod (R-837), an imidazoquinoline amine, is an immune response modifier that can induce
the synthesis of IFN-α and other cytokines in a variety of cell types including monocytes, macrophages
and dendritic cells (DCs). Imiquimod has been shown to have potent anti-viral and anti-tumor prop-
erties, and clinically this compound has been used for the treatment of external genital warts and
perianal warts. Recently, it has been demonstrated that imiquimod activates immune cells via the
Toll-like receptor 7 (TLR7)-MyD88-dependent signaling pathway. Studies have demonstrated that
three members of the TLR family can trigger DC migration and maturation: TLR4 interaction with
LPS, TLR3 interaction with dsRNA, and TLR9 interaction with CpG motifs. Previous studies demon-
strated that imiquimod stimulates migration of murine Langerhans cells (LCs), which are DCs resid-
ing in the epidermis. In this study we examined the effects of imiquimod on human LCs using a skin
explant ex-vivo culture system. We hypothesized that TLR7 plays a role in DC migration and mat-
uration. Five percent imiquimod cream or vehicle cream as a control was applied on the epidermal
surface of skin explants and cultured in medium at 37 C for 1-7 days. Epidermal sheets were then
prepared and immunolabelled by anti-CD1a/FITC. No change in LC density was demonstrated at
24 h and 48 h, however, morphologically imiquimod-treated LCs appeared larger and brighter when
compared with vehicle treated LCs. After a seven day-treatment with imiquimod, the density of epi-
dermal LCs was significantly lower than that of the controls, suggesting that the LCs migrated from
the explant. Our observations suggest that imiquimod induces TLR7 activation and may play a role
in DC migration. 
0995
Production of human T cells from bone marrow progenitor cells using a skin-derived thymic
construct
RA Clark2,1 and TS Kupper2,1 1 Dermatology, Brigham and Women’s Hospital, Boston, MA and 2
Harvard Medical School, Boston, MA
The development of T cells requires a period of specialized education in the thymus, an organ that
largely undergoes involution during late adolescence. This requirement for thymic education has
been a barrier to the laboratory production of T cells that can be given to immunocompromised
patients to treat infection or malignancies. In vitro systems for T cell development have thus far
required the use of either human or animal thymus tissue, preventing their use in adult human patients.
Utilizing the natural similarities between skin and the thymus, we have developed a system in which
cells from the skin are reprogrammed to act as a surrogate thymus, supporting the in vitro develop-
ment of mature T cells from bone marrow precursor cells. Keratinocytes and fibroblasts from adult
human skin were expanded separately in culture and then seeded onto a three-dimensional tantalum
coated carbon framework. AC133+ (CD133+) human bone marrow precursors cells were then added
and the resultant construct was cultured for 3 to 4 weeks. Cells produced by the construct were ana-
lyzed by flow cytometry and T cell recombination excision circles (TREC) analysis. Using this sys-
tem, we have produced T cells that have surface markers consistent with mature, functional T cells.
The cells were CD3hi, either CD8 or CD4 single-positive, and a significant proportion were CD45RA+,
suggesting a naive phenotype. Input hematopoetic precursor cells were negative for CD3 and for
TREC expression, while output cells were CD3+ and positive for TREC expression, indicating that
these cells are newly developed T cells. A comprehensive phenotypic and functional analysis of these
cells is underway. The ultimate goal of this project is to develop a method by which newly gener-
ated T cells, either naive or with engineered T cell receptors, can be produced for the treatment of
diseases of individual patients using autologous bone marrow and skin biopsies. 
0996
Rapid generation of functional dendritic cells from monocyte precursors
DJ Hanlon,1 C Berger,1 R Edelson1 and B Smith2 1 Dermatology, Yale School of Medicine, New
Haven, CT and 2 Laboratory Medicine, Yale, New Haven, CT
Current protocols for the generation of human dendritic cells from blood monocytes involve a vari-
ety of time-consuming physical manipulations as well as extended incubations with cytokine cock-
tails designed to both differentiate and mature monocyte precursors. Our group has previously reported
that the extracorporeal treatment of peripheral blood in a closed cast acrylic flow system, as part of
a therapy termed “photophoresis”, could lead to the comparatively rapid conversion of blood mono-
cytes to functional DC. Factors identified as critical to this conversion included both transient inter-
action of monocytes with the device’s plastic surface under defined flow conditions and the pres-
ence of apoptotic tumor cells as phagocytic targets. Here we describe a modification of this system
that appears to drive this rapid differentiation to a DC phenotype by utilizing a blood/device inter-
phase of improved physical characteristics and controlled flow dynamics. We report that the appear-
ance of DC-associated markers could be induced after an extremely short (30 min.) exposure of
PBMC to the modified device followed by a brief overnight incubation at 37 degrees. As a measure
of monocyte differentiation post-treatment, we monitored the loss of expression the monocyte asso-
ciated marker CD14 as well increased expression of cell surface MHC Class II, CD36 and intracel-
lular CD83, hallmarks of transition to a DC phenotype. We are presently testing the functional sta-
tus of these reagents in phagocytosis and antigen presentation assays. These results indicate that
functional DC can potentially be generated extracorporeally without the need for apoptotic stimuli
and without the expense and time investment of current protocols. Study of dendritic cell differen-
tiation utilizing this new blood/biomaterial interphase may result in both enhanced understanding
of the physiologic determinants of DC biology and also suggest improved pragmatic methodologies
for generating cellular reagents for DC-based therapies. 
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Clonal γT cell DNA in the lymphoid infiltrate of lichen sclerosus
S Regauer and C Beham-Schmid Pathology, University of Graz, Graz, Austria
Lichen sclerosus (LS) is chronic sclerosing lymphocyte-mediated skin disease with a strong autoim-
mune association. Well developed LS during high disease activity is characterized by a dense lym-
phocytic tissue infiltrate. Low density infiltrates can be observed in early and late atrophic disease
stages.  About 50% of LS of all stages have been described to contain T-cells with a monoclonally
rearranged γ-chain of the T-cell receptor (mγTCR) as evidenced in conventional PCR analysis. For
a better understanding of these observations we further investigated 10 vulvar and penile LS with
mγTCR by a PCR-based fluorescent fragment GeneScan analysis (PCR-GSA) which combines the
advantages of high sensitivity with accurate quantification and size determination of PCR products
on high resolution polyacrylamide gels.  Clonal T-cells as low as 1% within a low density inflam-
matory background can be identified with the γTCR-PCR-GSA. We further analyzed the the infil-
trate immunohistochemically with antibodies to CD3, CD4, CD8, cytotoxic granula granzyme-B
and TIA-1, and to γδT-cells. In all cases with a mγTCR in the conventional PCR analysis we iden-
tified a single monoallelic peak in the GeneScan analysis. The percentage of monoclonal γTCR DNA
contained within the peak was calculated and ranged from 1.4% to 20.5% of total DNA analyzed.
The size of the clonal DNA ranged from 52 to 68 base pairs (bp), with several cases of LS contain-
ing clonal γ TCR DNA of 62 bp.  The immunohistochemical search for T-cells corresponding to the
low percentage of clonal γTCR DNA identified γδ-T-cells together with granzyme-B and TIA-1 con-
taining cytotoxic T-cells as most likely candidates.  The low percentage of clonal γTCR DNA in the
inflammatory infiltrate speaks against a systemic neoplastic disease, and further supports the theory
of a local antigen-dependent proliferation of T-cells and an antigen-related immune process in LS.
Asγδ-T-cells are involved in primary immune responses to (foreign) antigens / pathogens, the pre-
sented findings allow to speculate that the LS-associated antigen may be an infectious agent. 
0999
Innervation and expression of sensory neuropeptides in murine contact allergy
H Elnour,1 L Lundeberg,1 A Boman,1 E Theodorsson2 and K Nordlind1 1 Department of Medicine,
Karolinska Institutet, Stockholm, Stockholm, Sweden and 2 Unit of Neurochemistry, University of
Linkoping, Linkoping, Sweden
The density of nerve fibers, using markers for protein gene product (PGP)9.5, growth associated pro-
tein (GAP)-43, as well as expression of sensory neuropeptides, substance P (SP) and calcitonin gene-
related peptide (CGRP), was determined in a murine model of contact allergy using immunohisto-
chemistry and RIA. Sixteen female Balb/c mice were used. Eight mice were sensitized with oxazolone
and 6 days later challenged on dorsal surface of the ears, control mice received the vehicle. One ear
was taken after 24 hours and fixed in 4% formaldehyde, or 10% formalin with 0.2% picric acid, sec-
tioned at 14 micrometer and processed for staining using a biotinylated fluorescence technique, while
the other ear was frozen and processed for RIA. Image analysis or manually counting was used.  PGP
9.5 immunoreactive nerve fibers in inflamed ears were 1.6+-0.7 mm/section compared to control
ears at 1.3+-0.9 mm/section, in the epidermis, and 4.8+-1.2 mm/section and 4.5+-2.9 mm/section,
in the dermis. GAP-43 positive fibers in the epidermis were increased (p<0.01), 2.7+-1.0 mm/sec-
tion in inflamed ears, compared to 1.3+-0.8 mm/section in control ears, also the case for the dermal
fibers, 9.7+-3.2 mm/section compared to 5.5+-2.5 mm/section. Total number of SP and CGRP
nerve fibers tended to increase in the inflamed skin, at 23.9+-13.6/section and 56.0+-29.3/section,
respectively, in contrast to 16.2+-4.9/section and 51.0+-21.4/section, respectively, in control skin.
RIA demonstrated a tendency to a decrease in SP concentration, 2.6+-0.5 pmol/g in the eczematous
compared to 3.0+-0.4 pmol/g in control ears. CGRP concentration was significantly lower (p<0.05)
in the inflamed ears, 11.5+-3.8 pmol/g, compared to controls, 16.0+-2.1 pmol/g. Our results indi-
cate that nervous system plays a role in contact allergy. 
1001
Development of dendritic cell therapies for cutaneous T cell lymphoma
A Kingston, L Geskin, J Plowey, M Robb, S McCann and LD Falo Dermatology, University of
Pittsburgh School of Medicine, Pittsburgh, PA
The aims of this study were to investigate whether Dendritic Cells (DCs) could be generated from
peripheral blood monocyte precursors obtained from patients with Sezary Syndrome (SS), loaded
with autologous tumor antigens, and induced to express potent antigen presenting cell function
characteristic of activated or “matured” DCs, as a direct prelude to clinical trials.  Peripheral blood
monocytes isolated from SS patients were cultured for 5 days in the presence of GM-CSF and IL-4
and then loaded with autologous tumor antigens by either fusion or co-culture to create DC-tumor
cell conjugate vaccines. DC-tumor cell conjugates were then matured or activated using a proin-
flammatory cytokine “maturation” cocktail. DCs generated from SS patients expressed phenotypic
and functional properties consistent with potent antigen presentation and comparable to those of DCs
generated from normal volunteers. This included expression of DR, CD86, CD80, CD83 and CCR7,
and the exhibition of potent T-cell stimulatory function as measured in mixed lymphocyte reactions.
DCs were efficiently loaded with tumor derived proteins as evaluated by confocal microscopy and
quantitated by flow cytometry. Generally, co-culture DCs with autologous tumor cells resulted in
approximately 40% of DCs internalizing significant quantities of tumor derived proteins. DC-tumor
cell fusion efficiencies approached 70-90%. In comparison to DC-tumor cell co-cultures, some
inhibition of DC maturation was observed in DC-tumor cell fusion vaccines for some phenotypic
markers evaluated.  Our results demonstrate that functional DCs can be generated from peripheral
blood monocyte precursors of SS patients. These DCs can be efficiently loaded with autologous
tumor antigens, and “matured” or activated in vitro. They suggest that the method of antigen-load-
ing could influence subsequent DC function. Taken together, these studies demonstrate feasibility
for the design of clinical trials to evaluate the efficacy of DC-tumor cell conjugate vaccines for the
immunotherapy of Cutaneous T-Cell Lymphoma. 
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Evidence for viral and autoimmune contributions to cutaneous T cell lymphoma
D Jones, N Yawalkar, K Yamanaka, S Sadat and TS Kupper Dermatology, Brigham and Women,
Boston, MA
Cutaneous T cell lymphomas (CTCL) are a group of clinical syndromes resulting from abnormal
proliferation of skin-homing T cells. A viral etiology has long been suspected, and some studies
suggest involvement of HTLV-1, but these are highly controversial. We here present new evidence
for the involvement of HTLV-1 tax protein in CTCL and also demonstrate molecular mimicry between
tax and human keratin. Our experiments to screen for CTCL tumor antigens using expression cloning
show that hnRNP-A1 is a candidate antigen with reactivity in 32% of CTCL sera compared with 7%
of healthy controls. Because hnRNP-A1 is known to be a pathogenic autoantigen in HTLV-1-asso-
ciated myelopathy via direct cross-reactivity to HTLV-1 tax protein, we then hypothesized that patients
reactive with hnRNP-A1 would also react with tax. Analysis of patient serum samples shows tax-
reactive antibodies in 46% of patients and 15% of healthy controls with a strong correlation between
hnRNP-A1-reactive and tax-reactive samples. In one serum sample containing relatively strong reac-
tivity to both proteins, direct cross-reactivity is demonstrated using immunoprecipitated antibodies.
Furthermore, examination of the T cell receptor CDR3 binding domains of patients with advanced
CTCL and dominant peripheral blood clones reveals structural motifs which match those seen in tax-
binding T cell clones from HTLV-1 infected patients with adult T cell lymphoma. An additional find-
ing is that the antibodies which bind hnRNP-A1 and tax also bind human keratin 13, which we have
previously demonstrated to be a skin autoantigen. In summary, these data suggest that either HTLV-
1 or a related virus may play a role in CTCL and that there is molecular mimicry between tax and
keratin which could be related to the skin tropism characteristic of CTCL. 
0998
Gene expression profiling of blood-derived dendritic cells following exposure to a contact aller-
gen
C Ryan,1 B Hulette,1 L Gildea,1 R Dearman,2 I Kimber2 and F Gerberick2 1 The Procter & Gamble
Company, Cincinnati, OH and 2 Syngenta CTL, Macclesfield, Cheshire, United Kingdom
Langerhans cell activation and subsequent migration from the skin are critical steps in the induction
of allergic contact dermatitis. Therefore, to gain a fuller understanding of these early events, changes
in the gene expression profile of human peripheral blood-derived dendritic cells (DC) were exam-
ined following exposure to a contact allergen. DC were generated from the adherent cell fraction of
peripheral blood mononuclear cells by culture in the presence of granulocyte/macrophage-colony
stimulating factor and interleukin (IL)-4 for 7 days. The resulting immature DC were treated for 24
hours with either 1 mM or 5 mM dinitrobenzene sulfonic acid (DNBS), the water-soluble analog of
the strong contact allergen dinitrochlorobenzene. Total RNA was obtained and changes in gene
expression were analyzed using Affymetrix U95Av2 Genechips®. Pairs plots indicated good corre-
lation between replicates for the treated and untreated cultures. In the principal component (PC)
analysis, a treatment related effect was clearly observed for the first PC (the component represent-
ing the highest source of variance). Comparison of mean signal values from the replicate cultures
revealed 185 genes that were significantly different (p0.001)between DC treated with 1 mM DNBS
versus untreated control DC and 1340 significant gene changes between 5 mM DNBS treated DC
and untreated DC. Significantly up-regulated genes included cytokine/chemokine genes (IL-8, IL-
1RA) and genes associated with T-cell co-stimulation (CD86), protein modification (pro-cathepsin
L) and transcription (TGF induced factor). Significant down-regulation was observed in some
chemokine (CCL4, CCL2) and immune function (FcεRα, lectin receptor) genes. Information gained
by this gene expression profiling will be used in the development of endpoint measures that can serve
as the basis of an in vitromethod for identifying potential skin sensitizing chemicals. 
1002
Disperse blue 124 is a strong sensitizing material
M Sugiura,1 R Hayakawa 1 and K Sugiura1,2 1 Environmental Dermatology, Nagoya University,
School of Medicine, Nagoya, Aichi, Japan and 2 Division of Pathological Cytology, Institute for
Comprehensive Medical Science, Fujita Health University, Kutsukake-cho, Toyoake, Japan
(Objective) In this study, we investigated skin sensitization potential of disperse blue 124 using a
guinea pig maximization test. (Materials) [Animals] Female Hartley strain albino guinea pigs were
introduced at 4 weeks of age. [Test materials] We selected refined disperse blue 124.  (Methods) [Pri-
mary irritation study] The optimal concentrations for inductions and challenges were investigated
preliminarily. We used 3 animals for each test substance. We conducted intracutaneous and 24 hours
open testing of disperse blue 124 (5, 2.5, 1.0, 0.5, 0.25, 0.1, 0.05% ac.). [Procedure]The procedure
of the Magnusson & Kligman’s guinea pig maximization test was followed for induction. Ten ani-
mals were included in the sensitization group and the control group. [Readings] Reactions were made
at 24, 48, 72 hours after the challenge, according to the Draize’s criteria. A summation of numeri-
cal scoring of more than 2 was judged as a positive reaction. (Results) [Primary irritation study] We
judged 5, 2.5, 1.0, 0.5% ac. were strong necrosis reactions and 0.25, 0.1, 0.05% ac. were weak necro-
sis reactions in intracutaneous testing. We decided 0.25% ac. as intracutaneous sensitizing concen-
tration. We judged 5, 2.5% ac. were 1 point of erythema and 1% ac. was negative in 24hours open
testing. We decided 5% ac. as percutaneous sensitizing concentration and 1% ac. as challenge con-
centration. [The guinea pig maximization test ] The positive reactions were observed in all animals
with 1 and 0.5% ac., 5 out of 10 animals with 0.1% ac., 4 out of the 10 animals with 0.05 and 0.01%
ac. and 0 out of 10 animals with 0.005% ac. in the sensitization group. All animals were negative in
the control group. (Conclusion) We concluded disperse blue 124 was a strong sensitizing material. 
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Selective inactivation of the interleukin-10 gene in T cells results in enhanced contact hyper-
sensitivity reactions
A Roers,2 L Ntambi,2 E Strittmatter,2 M Deckert,1 W Stenzel,1 CB Wilson,4 T Krieg,2 K Rajewsky3
and W Mueller5 1 Department of Dermatology, University of Cologne, Cologne, Germany, 2
Department of Neuropathology, University of Cologne, Cologne, Germany, 3 Department of
Immunology, University of Washington, Seattle, WA, 4 Center for Blood Research, Harvard
Medical School, Boston, MA and 5 Gesellschaft fur Biotechnologische Forschung, Braunschweig,
Germany
Interleukin-10 (IL-10) is a potent suppressor of T helper 1 responses. It is secreted by activated
macrophages, but also by the epithelia lining inner and outer body surfaces as well as by T and B
lymphocytes. In order to elucidate the function of T cell derived IL-10, we have generated mice
with selective deficiency for IL-10 only in T cells by means of the Cre lox-recombination system.
Unexpectedly, the T cell specific IL-10 mutants spontaneously developed inflammatory bowel dis-
ease. The mutants also show enhanced contact hypersensitivity reactions as compared to control
animals, while responses to nonspecific irritation of the skin are not enhanced. Furthermore, the T
cell specific IL-10 mutants succumb to infection with an avirulent strain of T. gondii which is not
harmful for wildtype animals. This phenotype is very similar to that of conventional IL-10 k.o. mice
which lack IL-10 in all cell types and is probably a result of unbalanced T helper 1 responses. These
results show that T cell derived IL-10 serves important regulatory functions which cannot be sub-
stituted for by IL-10 released from other cell types. Future experiments will aim at defining T cell
subsets carrying the IL-10 dependent regulatory function. 
1004
Decreased clearance of apoptotic cells and enhanced cross-presentation in milk fat globule-E8
(MFG-E8) deficient mice
GF Hofbauer,1 F Melchionda,2 MA Wilson3 and MC Udey3 1 Dermatology, University Hospital,
Zuerich, Switzerland, 2 Dermatology Branch, National Cancer Institute, Bethesda, MD and 3
Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD
Milk fat globule-associated protein MFG-E8 is produced in large amounts in lactating and involut-
ing breast and by thioglycollate-elicited macrophages, and MFG-E8 mRNA is abundant in imma-
ture dendritic cells. Known to bind av integrins via its RGD-containing amino terminus and phos-
phatidyl serine via its carboxy terminus, the predicted involvement of MFG-E8 in ingestion of
apoptotic cells by macrophages in vitro has recently been confirmed. We generated MFG-E8-defi-
cient (MFG-E8-/-) mice to assess the role of MFG-E8 in clearance of apoptotic cells and in cross-
presentation in vivo. MFG-E8-/- mice were indistinguishable from normal littermates and were fer-
tile. Although no gross morphologic or routine histological abnormalities were detected, the number
of TUNEL-positive thymocytes in resting and dexamethasone-stressed thymi of adult MFG-E8-/-
mice exceeded that found in controls. In vitro studies suggested that resident, but not thioglycollate-
elicited, peritoneal macrophages from MFG-E8-/- mice ingested apoptotic thymocytes less efficiently
than control macrophages. In an assay if cross-presentation, immunization of female 129Sv/B6 MFG-
E8-/- mice with beta-2 microglobulin-deficient male C57BL/6 splenocytes resulted in more vigor-
ous immune responses than immunization of wild-type littermate control mice. We conclude that
MFG-E8 plays a role in clearance of apoptotic cells by resident macrophages and that MFG-E8 is
not essential for cross presentation. 
1005
Regulation of CTLA-4 Expression in Human CD4 T cells
HK Wong, B Aufiero, H Carrie, M Hafner and A Wilson Dermatology, Henry Ford Health System,
Detroit, MI
In a search for genes that are differentially regulated in human naive, CD45RA, and memory, CD45RO,
CD4 T cells, we have identified CTLA-4 as a gene that is preferentially upregulated in the CD45RO
T cell subset. CTLA-4 is a member of the co-stimulatory molecule, which negatively regulates T
cell activation. In contrast to CD28, which is expressed constituitively, the expression of CTLA-4 is
highly regulated. To characterized CTLA-4 regulation, we analyze the expression of CTLA-4 in T
cell subsets. In CD4 T cells, we show that CTLA-4 can be induced rapidly in 50% of the cells in
response to T cell activators. This pattern suggests that CTLA-4 is not restricted to traditional reg-
ulatory T cells, nor CD8 T cells. Indeed, CTLA-4 can be induced to a higher level in CD4 T cells
than in CD8 T cells. We confirm the differential regulation of CTLA-4 expression in CD45RA and
CD45RO T cells by demonstrating that stimulation through the T cell receptor using anti-CD3 and
anti-CD28 results in 30% of CD45RO T cells expressed CTLA-4, whereas less than 3% of CD45RA
cells expressed CTLA-4. This is supported by mRNA analysis of CTLA-4 transcripts. To futher
investigate the mechanism of CTLA-4 expression, 6kb of the human CTLA-4 promoter was cloned
into reporter constructs to analyze the region necessary for transcriptional regulation. Successive
5’-promoter deletion constructs were created to determine the region necessary for transcription reg-
ulation. In transient lucuferase reporter assays in T cells, we find that the first 500 base pairs of the
5’-promoter contained regions that yielded the highest level of luciferase expression. This region is
important for mediating induction by T cell activators such as phorbol esters. We are presently iden-
tifying the protein factor(s) that interact with this promoter region to up regulate CTLA-4 expres-
sion. Understanding the mechanism of transcriptional regulation of CTLA-4 will contribute to insight
into mechanisms for differential gene regulation in CD45RA and CD45RO T cells. 
1006
Separating acute from chronic delayed-type hypersensitivity reactions with radiolabeled
RGD-peptides
B Pichler,3 M Kneilling,1 L Hueltner,4 R Mailhammer,4 H Braumueller,1 C Sander,2 W Weber,3
R Haubner3 and M Roecken1 1 Dermatology, Eberhard Karls University Tuebingen, Tuebingen,
Germany, 2 Dermatology, Ludwig-Maximilians-University, Munich, Germany, 3 Nuclear
Medicine, Technical University, Munich, Germany and 4 Molecular Biology and Tumor Genetics,
GSF, Munich, Germany
Chronic and recurrent inflammation can lead to tissue destruction and regenerative processes while acute
episodes may resolve without scar formation. Angiogenesis plays a major role in organ-specific autoim-
mune diseases caused by delayed type hypersensitivity reactions (DTHR) and contact hypersensitivity
reactions (CHSR). To better understand the mechanisms leading to chronic inflammation, we investi-
gated the activation of αvβ3-integrin in acute- (A-CHSR, one episode of inflammation) and chronic con-
tact hypersensitivity reactions (C-CHSR, recurrent episodes), as this intergrin is selectively induced
during angiogenesis. We quantified αvβ3-integrin in vivo, using a RGD-peptide which selectively
binds to αvβ3-integrin. Mice were sensitized and challenged with TNCB to induce and elicit CHSR.
Twelfe hours later we injected animals either [18F]Galacto-RGD or [125I]Gluco-RGD peptide and scanned
mice in vivo with the small animal positron emission tomograph MADPET or determined uptake by
autoradiography. In vivo MADPET images showed intense RGD peptide uptake in C-CHSR but not in
A-CHSR. This was specific as unlabeld RGD peptide completely blocked the uptake during C-CHSR.
Uptake ratio between treated and untreated ear was 2.9 for C-CHSR. In sharp contrast to C-CHSR,
[18F]Galacto-RGD binding did not increase in A-CHSR. The uptake of labelled RGD peptide increased
linearly with the episodes of inflammation. Immunohistochemistry confirmed that β3 expression increased
exclusively in C-CHSR. TNF-/- and IL-4-/- mice had normal αvβ3-integrin expression and developed
unaltered angiogenesis in C-CHSR. This suggests that angiogenesis during C-CHSR is independent of
these two cytokines. Thus, angiogenesis and αvβ3-integrin plays are critically involved in C-CHSR but
not in A-CHSR. Our data represent a new model for quantifying angiogenesis in vivo and thus may help
to bring to elucidate the mechanisms underlying T cell mediated inflammation and tissue destruction. 
1007
Up-regulated expression of CXCR3 but not CLA in skin-infiltrating malignant T cells
regulates epidermotrophism in CD8-positive Sezary syndrome
H Yagi,1 Y Tokura2 and M Takigawa1 1 Dermatology, Hamamatsu University school of medicine,
Hamamatsu, Japan and 2 Dermatology, University of Occupational and Environmental Health,
Kitakyushu, Japan
We have previously shown that a T-cell line (CD8SzCL) was established from blisters arising on skin
of a patient with CD8+ Sezary syndrome. The malignant cells were CD3lowCD8+CD45RA+CD56+
and expressed mRNA for IL-10 and IFN-γ. Biopsies showed marked epidermotropism of the tumor
cells. In this study, we further elucidated the mechanisms of migration of the tumor cells. The
malignant cells in the PB were CXCR3-, while the cells in the blister expressed it. CXCR3 on PB
tumor cells was changed to positive when they were cultured in the medium. CXCR3 expression was
reversibly downregulated by the addition of patient’s serum to the culture. The tumor cells from
both blisters and PB constantly expressed CLA and its intensity was unchanged. In addition, the cells
freshly isolated from blisters expressed a high level of granzyme B, while the expression level of
this molecule was lower in the PB tumor cells. We next performed chemotaxis assay using a Tran-
swell plate. CD8SzCL (CLA+CXCR3+) showed increases in movement in response to IP-10, but
not to CCL27. When cultured patient’s PBMC, including CLA+CXCR3+ tumor cells, were placed
in the top chamber, the percentage of tumor cells was significantly increased after passage of the
membranes, demonstrating selective attraction of the tumor cells by IP-10. Such selectivity was not
seen when fresh PBMC were applied. Neither fresh nor cultured PBMC migrated with CCL27 added
to the lower unit. These findings suggest that CXCR3, but not CLA, plays a major role for tumor
cell migration into the skin. Although the tumor cells are capable of expressing CXCR3 and cyto-
toxic molecules, they are strongly downmodulated in the PB. Once the cells infiltrate into the skin,
they bear CXCR3 and migrate toward epidermis by virtue of keratinocyte-derived IP-10. Further-
more, IFN-γ produced by the tumor cells may stimulate the production of IP-10, which might exag-
gerate epidermotropism. 
1008
Activated neutrophils exert anti-tumor activity against human melanoma cells: reactive oxy-
gen species-induced mechanisms and their modulation by GM-CSF
J Dissemond,2 T Weimann,2 LA Schneider,3 A Schneeberger,1 K Scharffetter-Kochanek,3 M Goos2
and SN Wagner1 1 DIAID, Dept. of Dermatology, University School of Medicine, Vienna, Austria,
2 Dept. of Dermatology, University School of Medicine, Essen, Germany and 3 Dept. of
Dermatology, University School of Medicine, Ulm/D., Germany
Rapid and marked infiltration of polymorphonuclear cells (PMN) into tumors genetically modified
to produce cytokines (e.g. GM-CSF) has been observed in several preclinical cancer vaccine mod-
els. A similar phenomenon has also been described in melanoma patients after direct intralesional
injection of a GM-CSF/vaccinia construct or vaccination with GM-CSF-transduced tumor cells. To
date, it is still unclear whether PMN contribute to melanoma rejection by virtue of direct tumorici-
dal activity. Therefore we established a co-culture model of human melanoma cells with N-formyl-
methionyl-leucyl-phenylalanine (FMLP)-activated PMN. Whereas FMLP-activated PMN had no
direct effects on the viability of melanoma cells (as determined by MTT-assay), GM-CSF priming
of FMLP-activated PMN induced significant dose- and time-dependent reduction of melanoma cell
viability with induction of apoptosis. PMN can exert their tumoricidal activity by generation of
reactive oxygen species (ROS). We therefore analyzed the release of superoxide anion (SOA) and
found significantly enhanced release of SOA after GM-CSF priming of FMLP-activated PMN.
Generation of SOA is known to represent the first step in a cascade of potential cytotoxic interme-
diate-products including hydroxyl radicals. Release of SOA is the first step in a cascade leading to
the generation of potential cytotoxic reactive oxygen intermediates including hydroxyl radicals.
Direct and indirect inhibition of hydroxyl radical generation with combinations of superoxide anion
dismutase and catalase, the hydroxyl radical quencher dimethylsulfoxamide or the nitric oxide inhibitor
NG-monomethyl-L-arginine resulted in nearly complete protection of melanoma cells against the
tumoricidal effects of cytokine-primed PMN. These results support the assumption that cytokine-
primed PMN can exert direct anti-tumor activity against melanoma cells via release of hydroxyl
radicals. 
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L-selectin and CCR7 expressing T cells represent the minority of skin T cells in normal and
diseased skin
K Ferenczi, RC Fuhlbrigge and TS Kupper Dermatology, Brigham and Women’s Hospital, Harvard
Skin Disease Research Center, Boston, MA
Molecules reported to have key role in T cell homing to the skin include CLA and CCR4. We have
previously shown increased expression of the skin homing molecules CLA and CCR4 in the periph-
eral blood of cutaneous T cell lymphoma (CTCL) patients compared to healthy subjects and showed
increased expression of these molecules in both normal and CTCL skin. While CLA and CCR4 play
important role in T cell homing to the skin, L-selectin and CCR7 have been shown to participate in
T cell entry to the lymph nodes. Although there is data in the literature suggesting that these L-
selectin+CCR7+ central memory T cells do not enter tissues, our results indicate that a large per-
centage of peripheral blood T cells expressing CLA and CCR4 also express L-selectin and
CCR7.These T cells have features of both central and effector memory T cells. In this study we ana-
lyzed the expresion pattern of the lymph node homing molecules in the blood and skin of CTCL
patients and healthy controls. Our results demonstrate that while the majority of T cells in the cir-
culation of both patients and controls express L-selectin and CCR7, skin T cells (normal and dis-
eased)express low levels of these molecules. This is in contrast to the expression pattern of CLA and
CCR4, which are expresed on a small subset of blood T cells and the majority of skin lymphocytes.
Our data indicate that the very high ratio of lymph node/skin homing molecules found in the periph-
eral blood (normal and CTCL)shows an inverse pattern in the skin.Interestingly, particularly low lev-
els of L-selectin and CCR7 co-expressing T cells were detected in CTCL skin lesions even when
most malignant T cells expressed these molecules in the blood. These data suggest that from the pool
of circulating T cells, the majority of which express lymph node homing molecules, the L-
selectin/CCR7 negative, CLA/CCR4 positive T cells are recruited to the skin. Alternatively, it is
also possible that L-selectin and CCR7 are downregulated in the skin microenvironment. 
1011
Propionibacterium acnes induces antimicrobial pathways through toll-like receptor 2 in human
neutrophils
S Kafaja, H Lin, S Wang, R Modlin and J Kim UCLA Division of Dermatology, Los Angeles, CA
One of the factors that contribute to the pathogenesis of acne is Propionibacterium acnes. Although
the entire mechanism by which the immune system defends against this pathogen is not understood,
it is believed that innate immune system plays a critical role. Neutrophils, an integral part of innate
immunity, control infection through a number of different antimicrobial mechanisms including the
release of cytokines, reactive oxygens, and antimicrobial peptides such as Human Neutrophil pep-
tide (HNP). In acne lesions there are abundant neutrophils infiltrating around the pilosebaceous fol-
licles at the site of the disease suggesting that neutrophils play a role in host defense. Recent stud-
ies have demonstrated that granulocytes express Toll-like receptors (TLRs) and mediate responsiveness
to a variety of molecular structures from microbial pathogens. Therefore, the present study was
devised to elucidate the mechanism by which P. acnes induces antimicrobial activity in neutrophils.
Using confocal microscopy, we found that neutrophils are abundant in acne lesions and that they
expressed TLR2. Using human peripheral blood, we isolated neutrophils and demonstrated that
they expressed TLR2. We found that these neutrophils could be activated by P. acnes to induce the
release of reactive oxygens and HNP. Interestingly, the release of reactive oxygens could be blocked
by using anti-TLR2 antibody. Our data suggest that TLR2 is the direct mediator of signaling by P.
acnes in neutrophils and may initiate antimicrobial response of neutrophils against P. acnes. As
such, TLR2 agonists may provide a novel target for treatment of this common skin disease. 
1013
Human keratinocytes and airway epithelial cells express a number of CC and CXC chemokine
receptors
JW Loveless, ME Brummet, B Dailey, CS Stellato and LA Beck Dermatology, Johns Hopkins,
Baltimore, MD
Chemokine receptors are recognized for their role in leukocyte recruitment to tissues under both
homeostatic and inflammatory settings. More recently, they have been discovered on non-hematopoi-
etic cells. Their function on these cells extends beyond chemotaxis and cell activation to include pro-
liferation, adhesion molecule expression, organogenesis, and viral entry. Human keratinocytes have
been shown to express CCR1, CCR3, CXCR1, CXCR2, and CXCR4 at the protein level. Our pur-
pose was to study the constitutive expression of chemokine receptors on human epithelial cells. The
surface expression of CCR1-CCR10 and CXCR1-CXCR5 was characterized on the epidermoid
carcinoma A431 cell line, primary human neonatal foreskin keratinocytes (PHFK), and the human
bronchial epithelial cell line (BEAS-2B) by flow cytometry. There was statistically significant con-
stitutive chemokine receptor expression on A431 cells (n=3) for
CCR9>CXCR4 CCR3>CCR5>CXCR5>CCR1 and PHFK(n=3) for
CCR3 CXCR4>CCR9>CCR5>CXCR5>CCR6. In contrast, BEAS-2B (n=7-12;
CCR5>CXCR4>CCR9>CCR3) expressed fewer chemokine receptors. The CCR3 expression on
human keratinocytes (PHFK; net MFI=35.2±12.5) in contrast to airway epithelial cells (BEAS-2B;
net MFI=4.0±0.6), was even greater than that observed on purified human eosinophils (net
MFI=24.9±4.0). Eotaxin (100ng/ml x18hr) stimulation of primary bronchial epithelial cells (n=3)
enhanced the surface expression of CCR3 suggesting that there may be an autocrine feedback loop.
In conclusion, we have identified numerous chemokine receptors on epithelial cells. The expression
is more remarkable on cutaneous epithelial cells with CCR3, CCR9, and CXCR4 as the most abun-
dant receptors. Since epithelial cells have been identified as potent sources of the ligands for these
receptors it is logical to speculate that this may be an important autocrine regulatory loop. Current
studies are focusing on what regulates the expression of these chemokine receptors and on functional
studies aimed at identifying the role they play in human disease. 
1012
Development of a unique CD4+ T cell phenotype via α5 integrin modulation of CD3/CD28
signaling
AR Swick,1,2 TS McCormick1,2 and SR Stevens2,3 1 Dermatology, Case Western Reserve
University, Cleveland, OH, 2 Dermatology, Univ. Hospitals, Cleveland, OH and 3 Dermatology,
V.A. Medical Center, Cleveland, OH
We previously showed that activation of CD4+ T cells by tolerogenic macrophages infiltrating UV-
exposed human skin (UV-Mph) differs from activation by Langerhans cells (LC). This includes defi-
cient expression of IL-2 receptor alpha chain (CD25) and induction of Th2 cytokines by the UV-
Mph. Relative to LC, UV-Mph while deficient in their expression of B7-1 and 2, nonetheless stimulate
T-cell proliferation. Blocking T-cell α5 integrin (A5) inhibits UV-Mph, but not LC mediated T-cell
growth. We asked whether A5 signals can compensate for deficient CD28 signaling and provide syn-
ergistic costimulation to activate T-cells, such as is induced by tolerogenic UV-Mph. We now char-
acterize this unique CD4+ T-cell by in vitro activation. To model activation by either LC (anti-
CD3/high anti-CD28) or UV-Mph (anti-CD3/ anti-A5 with low anti-CD28) Ag presentation, purified
CD4+ T-cells were added to antibody coated plates. With equal T-cell proliferation, CD69 was equiv-
alent while CD25 expression was reduced 30% in the UV-Mph model. Th1/Th2 cytokine array of
Il-2, Il-4, Il-6, Il-10, IFNγ and TNFα analysis showed that the LC model produces a robust cytokine
production that favors a Th1 type profile, while cytokine production in the UV-Mph model was
reduced 30 to 50%. Further, in the UV-Mph model IL-10:IFNγ was twice the LC model, indicative
of Th2 skewing. Subsequently, we examined other markers of T-cell differentiation and found that
the UV-Mph model exhibited twice the ccr4 (associated with both Th2 and regulatory cells) and
half the CD40L (associated with Th1 cells) surface expression. These results demonstrate that acti-
vation of T-cells through A5 can result in a distinct phenotype that is relevant to the induction of tol-
erance by the UV-Mph; reduced cytokine production with a skewing towards a Th2 cytokine pro-
file, and expression of surface markers characteristic of non-Th1 type cells capable of down regulating
cell mediated immunity. 
1010
NKT cell subsets in the peripheral circulation of patients with psoriasis
N Pejnovic,2 R Groves,1 J Mee1 and W Chan2 1 Dermatology, Imperial College London, London,
United Kingdom and 2 Biochemical Pharmacology, Queen Marys School of Medicine, London,
United Kingdom
Despite evidence of the presence of NK, NKT and T cells in psoriatic plaques, the specific lym-
phocyte subset(s) responsible, their regulation and mechanistic role remain unresolved. Following
the recent identification of two stably expressed cell surface markers, IL-18R and ST2L, which are
selectively expressed on the surface of Type 1 and Type 2 NKT subsets respectively, we were inter-
ested to determine how these subsets were distributed in patients with inflammatory skin disease.
The ratio of Type 1 and Type 2 lymphocytes in PBMC of patients with mild to severe psoriasis (n=20)
or atopic eczema (n=14) were examined by three colour flow cytometry for cell surface expression
of ST2L or IL-18R together with CD3 or invariant TCRa chain Va24JaQ and CD4, CD8, CD56 or
CD161. There was no significant difference in the proportion of CD4+ or CD8+ T cell subsets in
patients with psoriasis compared to those with eczema or to normal controls (n=10). In contrast,
NKT cells expressing CD161 and TCR Va24 were significantly increased in patients with psoriasis
compared to healthy controls and to those with atopic dermatitis. Importantly, we found a predom-
inance of STL2+ NKT2 cells over IL-18R+ NKT1 cells in PBMC of patients with mild to moder-
ate psoriasis (N = 12, p = 0.005) but not in normal individuals or patients with atopic dermatitis. In
contrast, there was a significantly higher proportion of Type 1 to Type 2 NKT cells in people with
severe psoriasis (N = 8). These observations suggest that NKT cell subset imbalance may play a role
in the pathogenesis of psoriasis. Interestingly, NKT2 cells typically co-express IL-4 and IFNγ, two
cytokines previously identified in T-cells derived from patients with psoriasis. Moreover, they can
bind to the non-classical MHC-like CD1d antigen that is known to be expressed by keratinocytes in
lesional plaque psoriasis. The ability to distinguish functional NKT-cell subsets will be invaluable
in further defining the role of these cells in the pathogenesis of psoriasis. 
1014
Identification and characterization of CD43 as a novel ligand for E-selectin on skin-homing T
cells
RC Fuhlbrigge,2 SL King,2 JV Yee,2 R Sackstein1 and TS Kupper2 1 Dermatology, Brigham and
Women’s Hospital, Boston, MA and 2 Medicine, Brigham and Women’s Hospital, Boston, MA
Memory T cell recruitment to skin is a critical feature of the immune response to pathogen invasion
and to immune surveillance of uninflamed skin. Trafficking of T cells to skin has been linked with
expression of the cutaneous lymphocyte-associated antigen (CLA), a carbohydrate epitope recog-
nized by the unique monoclonal antibody, HECA-452. We have shown previously that P-Selectin
Glycoprotein Ligand-1 (PSGL-1) can be differentially decorated with the CLA epitope to serve as
both an E-selectin and a P-selectin ligand on T cells. Using real-time, direct observation of adhesive
interactions between selectin-bearing cells in shear flow and Western blots of CLA+ human T cells
lysate, we have identified T cell E-selectin ligands with apparent molecular weights of 240 kD, 140
kD, 125 kD, 110 kD and 100 kD. The 240 kD and 140 kD bands correspond to the previously described
dimer and monomer forms of PSGL-1, respectively, and support binding via both E-selectin and P-
selectin. The 125 kD and 110 kD bands represent two isoforms of the sialomucin CD43 (leukosialin).
The biochemical features of CD43 from CLA+ T cells and its properties as a E-selectin specific lig-
and were confirmed by immunopurification of CD43 and antigen capture flow analysis. The 125 kD
CD43 component bears core-2 modified O-linked sialoglycans decorated with the CLA epitope and
functions as a ligand for E-selectin, but not for P-selectin. The 110 kD CD43 component, in con-
trast, is not modified by core-2 glycans, does not bear CLA epitope and does not have selectin lig-
and function. The identification of CD43 as a T cell E-selectin ligand distinct from PSGL-1 sug-
gests that the regulation of T cell homing to skin is more complex that previously appreciated.
Although CD43 shares structural homology with PSGL-1, its expression and post-translational mod-
ification pathways are distinct and suggest a unique or synergistic role for CD43 in the trafficking
of T cells to skin. 
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Heme oxygenase-1 expression in the skin: low expression pattern in malignant skin tumors but
high in benign tumors and psoriasis
NM Khaskhely, S Ramzi, M Maruno, M Abul Kasem Khan, A Takamiyagi, H Uezato and
S Nonaka Department of Dermatology, University of the Ryukyus, Nishihara, Okinawa, Japan
Heme oxygenase-1 (HO-1) is a heat-shock protein that is induced by stressful stimuli such as arsen-
ite, hydrogen peroxide, nitric oxide heavy metals organic chemicals and UV radiation. HO-1 over
expression in renal cell carcinoma and oral SCC has been reported. But noting is reported about the
expression pattern of HO-1 in skin malignant and benign tumors. The expression pattern of HO-1
in above diseases was studied by immunohistochemistry. Thirty three cases of squamous cell carci-
noma (SCC), 25 cases of basal cell carcinoma (BCC), 26 cases of actinic keratosis (AK), 32 cases
of Bowen’s disease (BD), 33 cases of seborrheic keratosis (SK) and 26 cases of psoriasis, were eval-
uated. Three (9.09%) of the 33 SCC cases, 7 (28.00%) of the 25 BCC cases, 24 (92.31 %) of the 26
AK cases, 21 (65.60%) of the 32 cases of BD, 19 (57.58%) of the 33 SK cases and 26 (100.00%) of
the 26 psoriasis cases showed positive results for HO-1. Twenty (60.60%) of the 33 SCC cases, 9
(36.00%) of the 25 BCC cases showed positive-epidermal expression in normal area around the tumor
nest and also  cells around the tumors. The upregulation of HO-1 expression in pre-malignant, benign
and inflammatory skin diseases, suggest an important role for HO activity in skin repair and dis-
ease. We hypothesized that the increased HO-1 activity could be a defense mechanism of cells in
damaged/inflammed tissues, which might lead to a blockage of the carcinoma/inflammatory process. 
1016
Promastigote and amastigote stage-specific monoclonal antibodies against Leishmania major
ST Ramzi,1,2 NM Khaskhely,1 M Maruno,1 MA Khan,1 Y Tanaka,2 H Uezato1 and S Nonaka1 1
Dermatology, Univ. of the Ryukyus, Nishihara, Okinawa, Japan and 2 Immunology and Infectious
Disease, Okinawa-Asia Pacific Research Center for Medical Science,Univ. of the Ryukyus,
Nishihara, Okinawa, Japan
The etiologic agents of leishmaniasis include many complex and epidemiological diverse species
from the genus Leishmania. Monoclonal antibodies specific to the infective stage promastigotes
and amastigotes of Leishmania are needed for accurate, rapid and early clinical diagnosis, and effi-
cacy of drug therapy against Leishmania infection. Female BALB/c, 6-8 weeks old mice were immu-
nized subcutaneously and intramascularly with fusion protein, obtained from 1 x109 promastigotes
forms of L. major. The sensitized spleen cells were fused with a mouse myeloma cell line, SP2/0-
Ag14, using polyethylene glycol 1500, 3 days after a final booster immunization of sonicated L.
major promastigote alone by the intraperitonial route.Hybridomas producing Mab reactive with L.
major were screened indirect immunofluorescence staining using L. major promastogotes alone, and
differentiated THP-1, J774 cell line infected with L. major. The hybridomas (5x 105) producing Mab
(W-2 and W-10) against L. major promastigotes and amastigotes, were injected to SCID mice,
intraperitoneal. After 8-14 days mice were sacrificed and peritoneal fluid was collected from peri-
toneal cavity and processed for purification. Mab efficacy was analyzed by flow cytrometric analy-
sis, western blotting, indirect immunofluorescence staining. On western blotting the Mab (W-10,
W-2) showed a positive band at 62 kDa. On indirect immunofluorescence staining the promastig-
otes showed positivity on parasite surface and cytoplasm. Amastigotes, phagocytosed by macrophages,
showed positivity in the cytoplasm. On flow cytometry both antibodies identified intracellular amastig-
otes and more than 60% cells showed positivity. Monoclonal antibodies are expected to be useful
for the diagnosis epidemiology of cutaneous leishmaniasis caused by L. major. Monoclonal anti-
bodies can also be useful to evaluate the efficacy of new drug therapy against L. major. 
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Soluble glycoprotein factor/s secreted by Candida albicans inhibit human monocytic interleukin
12 production by targeting ERK MAP kinase
N Tang,1 K Kang,1 PK Mukherjee,1,3 L Liu,1 MA Ghannoum2,3 and KD Cooper1,2 1 Dermatology,
The Research Institute of University Hospital of Cleveland, Cleveland, OH, 2 Dermatology, VA
Medical Center, Cleveland, OH and 3 Center for Medical Mycology, University Hospital of
Cleveland, Cleveland, OH
Our previous data have shown that C.albicans (CA) inhibition of induce–interleukin 12 (IL–12)
production by human monocyte can be mediated by soluble factor/s released from CA but not the
nonpathogenic S. cerevisiae. The data also showed that the soluble factor/s is greater than 30kDa
and heat–resistant. To better understand the mechanism underlying this IL–12 inhibition, the mito-
gen–activated protein kinase (MAPK) signaling transduction pathway was studied. We found that
CA supernatant markedly induced phosphorylation of ERK1/2 MAPK (P<0.005, n=5), but not p38
and SAPK, at 1 min (very early time point). Since interferon–γ (IFNγ, 1ng/ml) plus lipopolysac-
charide (LPS, 100ng/ml) were used to stimulate IL—12 production by monocytes, we also observed
and found, however, that IFN γ +LPS did not significantly affect supernatant–induced ERK MAPK
activity. Specific inhibitor for ERK MAPK, PD98059 (20µM), significantly blocked CA super-
natant–induced ERK MAPK expression(P<0.05). Interestingly, Our data also showed that induc-
tion of ERK MAPK is inreversely correlated with IL–12 production by monocytes, and that the
inhibition of ERK MAPK led to restoration of the IL–12 levels (P<0.01). These data indicated that
CA secretes factors inhibiting human monocytic IL–12 production in which MAP Kinases signal-
ing pathway is critically involved.  Additionally, we further characterized CA supernatants by treat-
ment of the supernatants with proteinase K (20µg/ml) or alkaline hydrolysis (0.2N NaOH), both led
to abrogation of the inhibitory activity relative to their controls: inactivated proteinase K or expo-
sure to blank alkine dialysate, suggesting that the inhibitor/s in CA supernatant is proteinacious and
glycoprotein in nature. Further fractation and characterization of CA supernatants is needed to elu-
cidate the biochemical characteristics of the inhibitor/s. 
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Recombinant expression and functional analysis of the protein encoded by Mce1A region of
Mycobacterium leprae
N Sato,1 T Fujimura,1 M Masuzawa,1 K Katsuoka,1 M Kanou,1 Y Yogi2 and M Matsuoka2 1
Department of Dermatology, Kitasato University, Graduate School of Medical Sciences,
Sagamihara, Kanagawa, Japan and 2 Leprosy research center, National Institute of Infectious dis-
eases, Higashimurayama, Tokyo, Japan
Mycobacterium cell entry protein (MceP) is a protein associated with epithelial cell entry, and is
only expressed among members of the M. tuberculosis (MTB) complex. On the other hand, it is
known that mce1A region of M. leprae has a high degree of homology with MceP encoding sequence.
In our new study, the recombinant (r-) Mce1A proteins (45kDa, 37kDa, 27kDa and 19kDa), which
were deleted at N-terminus and/or C-terminus amino acid residues of full length 47kDa Mce1A,
were expressed and purified using r-E. coli systems and these characteristics were examined. Attach-
ment and entry into epithelial cells was investigated using 45kDa r-Mce1A-coated FITC labeled
polystyrene microsphere beads associating with HeLa cells. The attachment and entry of both 45kDa
r-Mce1A and MTB r-MceP into HeLa cells were identical as well. In addition, 45kDa r-Mce1A
reacted with anti-mouse MTB r-MceP polyclonal antibody. These results suggest that 45kDa r-Mce1A
protein has an activity of entry into epithelial cells as well as MTB r-MceP and has an antigenic sim-
ilarity with MTB MceP. These suggest that the mce1A cording protein is an important virulence
factor associated with epithelial cell entry. Since percutaneous thick contact or airborne infection
are important infective pathways for Hansen disease, we continue examining the role of Mce1A in
the entry of M. leprae into skin and nasal mucosa. 
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Epifluorescent microscopic visualization of an in vitro biofilm formed by a Pseudomonas aerug-
inosa wound isolate and of an in vivo polymicrobial biofilm obtained from an infected wound
CA Ricotti, A Cazzaniga, A Feiner, SC Davis and PM Mertz Dermatology and Cutaneous Surgery,
University of Miami, Miami, FL
Our lab has demonstrated that wound pathogenic bacteria establish biofilms in vitro, and in acute
and chronic infected wounds. To broaden our current understanding of biofilm morphology in wounds,
we used epifluorescent microscopy to visualize wound pathogenic bacterial biofilms. In-vitro wound
pathogenic Pseudomonas aeruginosa biofilms, and polymicrobial biofilms obtained from chronic
infected wounds in humans were examined. Pseudomonas aeruginosa was grown in Tryptic Soy
Broth while shaking at 37 C (48 hrs). This sample was smeared onto a slide, fixed with 2.5% for-
malin and stained with ethidium bromide (1mg/L; Sigma). It was then washed with distilled water,
and stained with calcofluor white (75 mg/L). The bacterial DNA, stained with ethidium bromide,
was revealed by red fluorescence. The exopolysaccharide (EPS) appeared as a blue fluorescence. A
swab smear was taken from a chronic venous leg ulcer and fixed with 2.5% formalin and stained
with only calcofluor white that enabled visualization of the wound biofilm EPS. Images obtained
using epifluorescent microscopy demonstrate the complex nature of wound pathogenic bacterial
biofilms both in vitro and in vivo. The understanding of the histology of bacterial biofilms in chronic
infected skin wounds will provide us the fundamentals to determine its role in wound healing. 
1020
Demonstration of Staphylococcus aureus biofilms in acute partial thickness wounds in pigs
using electron microscopy
E Welsh, A Cazzaniga, SC Davis and PM Mertz Dermatology and Cutaneous Surgery, University
of Miami, Miami, FL
Biofilms are groups of microorganisms that adhered to surfaces and form a polysaccharide matrix.
These microorganisms exchange genetic information, nutrients, virulence and growth factors. We
have confirmed the presence of biofilm formation in wounds using a modified Congo red stain. The
purpose of this study was to examine the formation of biofilms in acute wounds over time using a
scanning electron microscopy. Partial thickness wounds were made on the backs of swine. Wounds
were inoculated with Staphylococcus aureus or left un-inoculated to serve as controls. All wounds
were covered with a polyurethane film. Biopsies were taken from each wound at 0, 24, 48, or 72
hours. The biopsies were processed for scanning electron microscopic analysis using a modified
technique. At time 0, wounds that were not inoculated, had no evidence of biofilm formation. Slight
biofilm formation from normal flora was seen with wounds that were not inoculated (24, 48, and 72
hours). Inoculated wounds demonstrated a progressive biofilm formation over time with more promi-
nent structure seen at 48 and 72 hours. The benefit of this model will allow the visualization of S.
aureus living in biofilms and could be used to assess the efficacy of therapeutic modalities. 
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Efficient anti-MRSA barrier and lytic action of nanocrystalline silver dressings: a preclinical,
in vitro study
R Strohal,1 G Hartmann,2 U Gruber2 and F Offner2 1 Dermatology, Federal Academic Hospital of
Feldkirch, Feldkirch, Austria and 2 Pathology, Federal Academic Hospital of Feldkirch, Feldkirch,
Austria
In the light of an increasing problem of drug resistant, nosocomial infections, we have looked at the
antimicrobial property and/or barrier function of Acticoat, a three layers wound dressing consisting
of an absorbent inner core sandwiched between outer layers of silver coated polyethylene nets. Mois-
turized with sterile water, the lower nanocrystalline silver site was put on Columbia agar (Biomerieux,
Paris, France) plates saturated either with methicillin-resistant Staphylococcus aureus(MRSA) solu-
tions (s, Mac Farland: 0.5), or colonies (c, density: 107). After incubating different plates at 37oC for
1 hour (h), 1 day (d), 2d and 3d, respectively, the numbers of colony forming units (cfu) on the Acti-
coat upper site (upA), lower site (loA) and the Acticoat -covered area of the plate (pA) were delin-
eated. All test plates were further cultured after removal of Acticoat for 3 d to test potential re-col-
onization at pA (post-antimicrobiotic effect). At every site, Acticoat killed at least 99.99% (-log6)
of bacteria after 1d. MRSA reduction to undetectable levels were found at pA of s-MRSA plates
already after 1h. With regard to c-MRSA this cidal effect needed 1d. 2d and 3d cultures of s- as well
as c-MRSA plates were also MRSA free. Lack of re-colonization during the post-antimicrobiotic
test phase confirmed the complete lytic activity of Acticoat. Additional analysis of Acticoat`s bar-
rier property revealed a log6 reduction of bacteria in upA s-MRSA sites, but no reduction in c-MRSA
plates after 1h. In 1d as well as 2d, 3d cultures bacteria decreased under detection levels. Based on
the absorbent effect of Acticoat, loA sites always presented with the highest amounts of bacteria (s-
MRSA: 1h/no reduction, 1d,2d/-log7; c-MRSA: 1h/no reduction, 1d,2d/-log6) with undetectable lev-
els of MRSA in 3d cultures only. Taken together, we were able to show that nanocrystalline silver
dressings have the potency to serve as efficient barrier/antimicrobiotic agent against MRSA in-
vitro. Further clinical studies have already been initiated. 
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Distinct distribution of KSHV subtypes and VEGF-R expression in Kaposi’s sarcoma in Cen-
tral Europe
K Nagy, B Kemeny, F Harmos and A Horvath Dept. Medical Virology, National Institute of
Dermato-Venerology, Budapest, Hungary
Classic Kaposi’s sarcoma (KS) is relatively more common in Central Europe but AIDS-associated
KS even in untreated cases is less frequent (e.g. ~7% in Hungary) than that in Western Europe.To
study the underlying pathomechanism of tumorigenesis, genotyping of KS associated herpesvirus-
KSHV viral subtypes and co-expression of KSHV latency associated nuclear antigen-LANA and
cytokines involved in KS tumorigenesis such as VEGF-R (vascular endothel growth factor recep-
tor) and bFGF (basic fibriblast growth factor) were compared in classic, AIDS-associated, iatrogenic
KS and pseudo-Kaposi samples. Presence and diversity of open reading frame K1 of KSHV was
studied by nested PCR amplification and direct DNA sequencing of variable regions of K1. In thin
section of tumors KSHV LANA was detected by LN53 mcab, VEGF-R by rhFlt-4 mcab and bFGF
by rhFGFb mcab using Vectastain immuneperoxidase staining. Permanent KS cell line (KS-imm)
was inoculated sc. into SCID mice an the tumors developed were also analyzed. Genetic analysis
defined a narrow distribution of KSHV viral subtypes as:
A,A1,A1’,A3,A4,A1/C3’,A1/C6,C,C2,C3,C3/C3’, showing a close phylogenetic relationship between
subtypes A and C in this geographical region. The majority of samples were clustering as A1’. Where
expressed, KSHV LANA could be detected in spindle cells of tumor recesses with nuclear local-
ization. Highest level of expression was found in AIDS-associated KS saple. Co-expression of VEGF-
R and bFGF was observed in all cases independently of the presence of KSHV subtypes demostra-
trating that initiating effect of KSHV on cell proliferation is unlikely. KS tumor samples from SCID
mice as well as two iatrogenic KS cases and pseudo-Kaposi samples were KSHV negative by PCR.
These observations suggest that possible role of KSHV in the pathogenesis of KS may not be the
initiation but the maintenance of cell proliferation. 
1025
Quantification of Biofilm formation by Pseudomonas aeruginosa chronic wound isolates in vitro
A Cazzaniga and PM Mertz Dermatology and Cutaneous Surgery, University of Miami, Miami, FL
Pseudomonas aeruginosa infections are a major threat to patients with chronic wounds and burns.
Some strains grow as planktonic cells while others attach to surfaces and form biofilms, a combi-
nation of microorganisms and extrapolysaccharides (EPS) matrices. Once biofilms are established,
phagocytosis and diffusion of antibiotics are impaired thus facilitating colonization and persistent
infections. The purpose of this study was to assess EPS formation of wild type Pseudomonas aerug-
inosa isolates from chronic leg ulcers. Biofilm forming ATCC isolates were used as controls. Bac-
terial suspensions in Tryptic soy broth were grown in polystyrene wells and incubated. At 48 hours,
the bacteria suspensions were removed and discarded. Wells were gently washed with PBS, air
dried and heat fixed. Wells were stained with Huckers crystal violet solution to visualize the EPS.
Excess stain was rinsed off with PBS and Tween 80 was added to wells. The stained EPS was removed
by sonication, and their optical density quantitated. All strains developed EPS of varying intensities
indicating different amounts of biofilm formation. This study demonstrated that chronic wound
Pseudomonas aeruginosa isolates vary in their abilities to produce EPS which may in turn affect
biofilm formation and therapeutic outcomes in persistent infections. 
1024
The role of human papillomavirus in squamous cell carcinomas
MM Asgari,1,3 C Critchlow,3 G Raugi,2 P Odland1 and N Kiviat4 1 Dermatology, University of
Washington, Seattle, WA, 2 Epidemiology, University of Washington, Seattle, WA, 3 Dermatology,
VA Puget Sound, Seattle, WA and 4 Pathology, University of Washington, Seattle, WA
Although the role of human papillomavirus (HPV) in the pathogenesis of cervical squamous cell
carcinomas (SCCs) is firmly established, the evidence supporting a similar role in cutaneous SCCs
remains speculative. HPV DNA, especially from epidermodysplasia verruciformis (EV) subtypes,
has been detected in cutaneous SCCs arising in immunosuppressed individuals, suggesting a path-
ogenic role for these HPV subtypes; however, results concerning HPV prevalence in lesions from
immunocompetent individuals have been mixed. These discrepancies may be due, in part, to differ-
ences in the specificities and sensitivities of techniques used to detect HPV in the skin. We used a
degenerate nested PCR technique with the capacity to detect a broad spectrum of cutaneous, mucosal,
and EV HPV types to detect HPV DNA in cutaneous SCCs (lesional) and in adjacent, clinically unin-
volved (perilesional) skin. We found, among 61 immunocompetent subjects with histologically
confirmed cutaneous SCCs, that 38 (62%) had HPV DNA isolated from lesional tissue and 28
(46%) had HPV detected in perilesional tissue. The HPV subtypes present were predominantly EV-
associated. These results will be compared to those from skin biopsies taken from sun-exposed
areas from age and sex-matched immunocompetent control subjects without a history of skin can-
cer (results of these analyses are pending). The difference in HPV prevalence between lesional, per-
ilesional and control tissue will help clarify the role of HPV in cutaneous carcinogenesis, specifi-
cally in relation to the potential for involvement of other co-factors. 
1022
The Kaposi’s sarcoma-associated herpesvirus latency-associated nuclear antigen induces expres-
sion of Id-1, a critical cell cycle regulatory protein, in human endothelial cells
J Tang,1 GM Gordon,1 MG Mueller,1 M Dahiya2 and KE Foreman1 1 Pathology/Cancer Center,
Loyola University Medical Center, Maywood, IL and 2 Pathology, Beth Israel Deaconess Medical
Center, Boston, MA
The Kaposi’s sarcoma (KS)-associated herpesvirus (KSHV, or human herpesvirus 8, HHV-8) is
believed to be the etiologic agent responsible for KS. The pathogenesis of this potentially life-
threatening neoplasm is complex and unclear, and it is currently unknown how KSHV causes KS.
Id-1 (Inhibitor of DNA Binding-1 or Inhibitor of Differentiation-1) is a naturally occurring domi-
nant negative inhibitor of basic helix-loop-helix transcription factors. Id-1 has been shown to inhibit
cellular differentiation, promote cell cycle progression, and has recently been associated with immor-
talization and tumorigenesis. In this report, we demonstrate that Id-1 is expressed at high levels in
KS tumor cells both in vitro and in vivo, but is expressed at relatively low levels in endothelial cells
(ECs), the precursor of the KS tumor cell. KSHV infection of the progenitor cells may be responsi-
ble for Id-1 induction as KSHV infection of EC in vitro results in a 27-fold increase, on average, in
Id-1 protein expression under our experimental conditions. Furthermore, we demonstrate that the
KSHV-encoded latency associated nuclear antigen (LANA) appears to be involved. Expression of
LANA in ECs results in Id-1 induction similar to that seen in KSHV infected ECs. In contrast, KSHV
encoded viral cyclin only modestly induced Id-1 expression (average: 5-fold) and KSHV encoded
viral FLIP had no effect on Id-1 expression. These results demonstrate the overexpression of Id-1 in
KS tumor cells and indicate the KSHV-LANA protein may be responsible for Id-1 induction in ECs.
As Id-1 promotes cell cycle progression and has been associated with tumorigenesis in other cell
systems, the induction of this critical protein by LANA may be an important mechanism by which
KSHV allows infected ECs to escape normal cell cycle regulation ultimately leading to the devel-
opment and/or progression of KS. 
1026
Histological evidence of nuclear factor kappa B p65 activation in skin infectious diseases
T Koga, H Duan, Y Moroi, K Urabe and M Furue Dermatology, Kyushu University, Fukuoka,
Japan
The NF-kappa B family consists of a group of inducible transcription factors which regulate immune
and inflammatory responses. A number of signal transduction cascades can activate the NF-kappa
B pathway to result in the translocation of the NF-kappa B proteins from the cytoplasm to the nucleus
where they activate the transcription of specific cellular genes. It would be interesting to know the
extent to which NF-kappa B actually is present in the tissues of skin infectious diseases in vivo.
Skin biopsy samples from patients with various skin infectious diseases were obtained. We investi-
gated the localization of the NF-kappa B (active p65 subunit) immunohistochemically by light
microscopy and examined using a confocal microscope to confirm nuclear staining. The p65 sub-
unit of NF-kappa B was found in the cytoplasm of some inflammatory cells and it was also local-
ized in the nucleus of a small amount of inflammatory cells. Nuclear staining was observed under a
confocal microscope. In our study, the nuclear localization of NF-kappa B, which is equivalent to
NF-kappa B activation, was clearly seen in skin infectious diseases. The demonstration of the acti-
vation of NF-kappa B may be helpful in defining the identity and role of gene products that con-
tribute to pathogenesis of skin infectious diseases. 
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Analysis of antibiotic susceptibility patterns from two large cohorts of pediatric impetigo
patients: Puerto Rico versus South Africa
JE Greenberg,2 PM Mertz,2 L Chase,2 G Todd,1 Y Piovanetti3 and WH Eaglstein2 1 Dermatology
and Cutaneous Surgery, University of Miami, Miami, FL, 2 Dermatology, Goote Schuur Hospital,
Cape Town and 3 University of Puerto Rico, Puerto Rico, Puerto Rico
Impetigo, a common skin infection in children, is caused primarily by Staphylococcus aureus and
Group A beta-hemolytic streptococci.  Isolates from 450 patients in Puerto Rico and 593 patients in
South Africa were identified and then tested for sensitivity and resistance to antibiotics. Data was
examined for percent resistance to antibiotics for staphylococcus isolated alone and in co-infection
with streptococcus. S .aureus isolated alone was most common in Puerto Rico, 52.44%, while co-
infection of staphylococcus and streptococcus was most common in South Africa, 55%. In both coun-
tries there was an increase in resistance to a number of antibiotics when staphylococcus was found
in co-infection with streptococcus. Approximately 95% of the cultures in South Africa were resist-
ant to penicillin versus 50% in Puerto Rico. In Puerto Rico there were higher rates of resistance to
erythromycin as compared to South Africa. Oxacillin resistance was also higher in Puerto Rico
compared to South Africa. Different antibiotics were tested in the two regions therefore direct com-
parison was not possible. More information on antibiotic prescribing practices and use in both places
is needed to assess the significance of these patterns of resistance and the possible impact on the
treatment of impetigo. 
1028
Vaccination with TAT-LACK fusion protein protects against murine leishmaniasis
K Moelle,1 N Shibagaki,2 S Lopez,1 J Knop,1 MC Udey2 and E von Stebut1 1 Dermatology, Joh.
Gutenberg-University, Mainz, Germany and 2 Dermatology Branch, NIH, Bethesda, MD
Cutaneous leishmaniasis is a major health problem with significant morbidity. An efficacious vac-
cine does not exist. Protective immunity depends on IFNγ+, antigen-specific Th1- and/or CD8+
cells. In vitro treatment of dendritic cells (DC) with antigens containing the protein transduction
domain of HIV-TAT leads to enhanced MHC-class-I- and II-dependent antigen presentation. We
utilized recombinant proteins comprised of TAT PTD and the Leishmania antigen LACK as a com-
ponent of a vaccine. Bone marrow-DC were transduced with TAT-containing or TAT-deficient LACK
and injected i.d. on d-7 into Leishmania-susceptible BALB/c mice. On d0, infections were initiated
with L. major using high dose (2x105) as well as low dose (1x103) inocula. In all experiments, admin-
istration of TAT-LACK-pulsed DC was more protective than injection of DC loaded with LACK
alone. Furthermore, TAT-LACK + DC-mediated protection was comparable to that achieved with
soluble Leishmania-antigen + CpG ODN treatment. 7 wks after high dose infection, lesions in TAT-
LACK + DC-treated mice were 33% smaller than those in PBS-treated mice. In contrast, LACK +
DC treated mice showed a 22% increase in granuloma size. In low dose infections, lesion sizes were
decreased by 50% in TAT-LACK- and 2% in LACK-treated mice (10 wks). We also directly assessed
the immunogenicity of TAT-LACK after direct injection (8 µg protein i.d.). Co-injection of CpG as
adjuvant was necessary to obtain protective immunity, and protection was comparable to responses
achieved with TAT-LACK transduced DC. LACK alone was ineffective, even in the presence of adju-
vant. These results suggest that priming of L. major-reactive CD8+ cells utilizing TAT-LACK enhances
protection against disease. These proof of principle experiments establish the basis for a novel vac-
cine against murine leishmaniasis. Future studies will explore the potential of TAT-LACK as a treat-
ment for, as well as a therapeutic vaccine against, the infectious disease. 
1029
In vitro antifungal activity of membrane-active peptides against dermatophytes and yeasts
using broth microdilution method
S Choi,1 J Sung,2 J Kim,3 D Lee,1,2 J Lee,1 E Lee1 and J Yang1,2 1 Dermatology, Sungkyunkwan
University School of Medicine Samsung Medical Center, Seoul, South Korea, 2 Samsung
Biomedical Research Institute, Seoul, South Korea and 3 Dermatology, Seoul National University
College of Medicine, Seoul, South Korea
The recent emergence of fungal infections with resistant strains has stimulated the development of
antifungal drugs with different mechanisms. Recently, novel membrane-active peptide (MAP)s
have been developed and reported to inhibit the growth of various pathogenic fungi at concentration
of 2 to 32µg/ml. We examined the susceptibility of MAPs to dermatophytes and yeasts using a mod-
ification of the NCCLS M27-A broth microdilution method, and compared the minimal inhibitory
concentration (MIC)s of MAPs with those of terbinafine and fluconazole. The MICs of MAPs for
dermatophytes ranged from 1 to 10µg/ml. Terbinafine inhibited the growth of most species at the
very low concentration under 0.005µg/ml. The MICs of fluconazole were over 0.5µg/ml for all strains.
Obviously MAPs have fungistatic activity, although they could inhibit the fungal growth at the rel-
atively higher concentrations than terbinafine and fluconazole in our experiment. This fact suggests
the possibility that MAP may be a candidate for the new antifungal agent in the future. 
1030
Decline of Th2 response in senescence can lead to Th1 response in L. major infected BALB/c
mice
C Sunderkoetter,1,2 J Ehrchen,3,2 S Grabbe,2 C Sorg3 and K Scharffetter-Kochanek1 1 Dermatol.,
Muenster, Germany, 2 Dermatol., Ulm, Germany and 3 Exp. Dermatol., Muenster, Germany
Ageing is associated with an altered immune response and increased susceptibility to infections. The
senescent immune system shows e.g. dysregulated macrophage functions and deficits of T cells, incl.
a decrease in mounting a Th2 response. We wondered if in experimental leishmaniasis this decrease
would lead to a less severe infection in aged BALB/c mice, or if changed macrophage functions
would lead to deterioration in resistant C57Bl/6 mice. When comparing bone marrow-derived
macrophages from BALB/c or C57Bl/6 mice there was no significant difference in NO production
and phagocytosis or killing of L.major between 2-month old and 18-month old (=senescent) mice.
After infection of C57Bl/6 mice in vivo, aged and young mice showed a resistant course. However,
in BALB/c mice ulceration of infected footpads progressed slower in aged mice and, surprisingly,
in 6 of 8 aged mice ulcers healed. These mice also showed low or absent dissemination of L.major
into visceral organs, and their CD4+ T cells released Th1 instead of Th2 cytokines in response to
L.major Ag. When looking at possible reasons for this reversed immune reaction we found that
macrophages from aged, but not from young BALB/c mice revealed constitutive release of low
amounts of IL12. Also, when ageing mice were kept in conditions free of specific pathogens (SPF)
they did reveal decreased parasite load after infection, but no more Th1-determined resistance. We
conclude i) that in ageing mice a decreased ability to mount a Th2 response can lead to emergence
of a Th1 response in BALB/c mice, while the immune response in C57Bl/6 mice remains unchanged,
ii) that constitutive release of IL12 in ageing mice may favour the decline of Th2 response, and iii)
that for full reversal into a Th1 response during ageing the immune system may need to be contin-
uously stimulated, e.g. by exposure to microbes. 
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Involvement of granulysin-producing T cells in the development of superficial microbial fol-
liculitis
T Oono, O Yamasaki, W Huh, H Akiyama and K Iwatsuki Dermatology, Okayama University
Graduate School of Medicine and Dentistry, Okayama, Okayama, Japan
Folliculitis is a common skin disease with inflammation of the hair follicle. Staphylococcus aureus
and S. epidermidis are often cultured from the lesions. In the previous report, we showed that human
beta-defensin 2 and human neutrophil peptides were expressed in superficial folliculitis. These obser-
vations indicate that these antimicrobial peptides play an important role in innate immunity against
bacterial invasion. In addition to neutrophilic infiltration, many CD45RO+ T cells were infiltrated
in the lesion of folliculitis. However, the role of lymphocytes in the infectious skin disease is not
well investigated. Granulysin, an antimicrobial protein expressed by cytolytic T lymphocytes and
NK cells possesses lytic activity against a broad range of microbes including S. aureus. In the pres-
ent study, we assessed the localization of granulysin in the lesional skin and the cell types produc-
ing granulysin. Immunoperoxidase labeling of seven samples of superficial folliculitis was performed
using mouse anti-granulysin monoclonal antibody (a kind gift from Dr. RL Modlin, Los Angeles,
CA) and anti-human antibodies against CD markers. Double-immunofluorescence was also per-
formed and secitons were examined by confocal laser microscopy. Cells positive for granulysin were
abundant in pustules and perilesional dermis of all tested samples. We identified CD3+, CD4+ and
CD8+ T cells in the lesions. CD20+ and CD56+ cells were not observed. Confocal laser microscopic
examination indicated that the granulysin-producing cells were of CD3+, CD4+ T cells but not CD8+
T cells. Our observations indicate that granulysin produced by T cells may play a pivotal role in host
defense against microbial invasion in the lesions of superficial folliculitis. 
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Detection of human papillomavirus in callus of diabetic foot ulcers by polymerase chain reac-
tion method
L Li,2,1 E Badiavas2,1 and V Falanga2,1 1 Dermatology, Roger Williams Medical Center, Providence,
RI and 2 Boston University School of Medicine, Boston, MA
Callus is an important risk factor in the development of diabetic neuropathic foot ulcers. The pro-
posed mechanism for callus formation involves the pressure and stress that occur in the diabetic foot
as a result of neuropathy. Moreover, once formed, the callus contributes to skin breakdown and ulcer-
ation by increasing the pressure at the site. However, the observation that callus often forms in
seemingly compliant patients and despite appropriate off-loading has led us to evaluate alternative
pathophysiologic explanations. Since calluses in the diabetic foot often clinically and histopatho-
logically resemble lesions induced by HPV, we have hypothesized that HPV may play a role in the
formation of calluses in diabetic patients. Tissue samples were obtained by shave biopsy of callus
from the edge of diabetic foot ulcers. DNA was extracted from 11 tissue samples from 6 patients for
PCR amplification, using primers that cover HPV-1, 2, 3, 4, 6, 10, 11, 16, 18, 28, 29, 41, 48, 50, 57,
60, 63, and 65. RESULTS: No HPV DNA was detected in any of the samples, and the validity of
these observations was confirmed with positive and negative controls. HPV infection is unlikely to
be the cause of callus formation in diabetic foot ulcers. Other etiologies may need to be pursued. No
previous publication has addressed this issue using PCR methodology. The key to the validity of
this study is the choice of the primers, which have detected HPV in multiple studies, and therefore
proven to be sensitive and specific. However, the possibility of an unusual type of HPV dominating
in diabetic foot, and/or HPV causing only a small fraction of the diabetic calluses, cannot be ruled
out completely. 
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The dominant-negative HSV-1 recombinant CJ83193 can serve as a safe and effective vaccine
against wild-type HSV-1 infection in mice
D Hoeller, H Augustinova and F Yao Div. of Plastic Surgery, Brigham & Women, Boston, MA
Despite the availability of antiviral therapies, the spread of herpes continues to increase worldwide.
The use of HSV replication-defective viruses and neuroattenuated mutants as vaccines has been eval-
uated. The ability of these vaccines to establish life-long latent infection and the fact that they are
replication competent when encounted with the wild-type HSV, raise concerns about their safety.
We recently generated an anti-HSV-specific HSV-1 recombinant CJ83193, which can inhibit its
own replication, as well as the replication of wild-type HSV-1 and -2 in co-infected cells. In this
study we examined whether CJ83193 can serve as a vaccine agains t HSV-1 in mice, as compared
to wild-type HSV, strain KOS and ICP27 deletion mutant D27. We demonstrate that CJ83193 can-
not initiate acute productive infection in the corneas of infected mice, nor can it reactivate from the
trigeminal ganglia of mice latently infected by CJ83193 in a mouse ocular model. Immunization
with CJ83193 prevents the development of keratitis and encephalitis induced by corneal challenge
with wild-type HSV-1 strain mP and reduces the yields of challenge HSV in the eyes and trigemi-
nal ganglia significantly. Moreover, Mice immunized with CJ83193 are capable of developing strong
HSV-1 neutralizing antibodies at levels similar to KOS immunized mice, 4-8 fold higher than titers
induced by D27, and induces cell-mediated immune response at levels similar to mice immunized
with KOS. Antibody titers and immune response are detectable at high levels up to six month, while
response induced by D27 is reduced six month after vaccination. These results shed new light on the
development of safe and effective HSV viral vaccines that encode a unique safety mechanism capa-
ble of inhibiting its own replication and replication of wild-type virus. 
1035
NF-kB activation by Candida albicans in human keratinocytes: possible involvement of toll-
like receptor (TLR) 2 but not TLR4
K Tani,1 M Adachi,1 A Hasegawa,2 N Kanda1 and S Watanabe1 1 dermatology, Teikyo Univ., Tokyo,
Tokyo, Japan and 2 Pathobiology, Nihon University School of Veterinary Medicine, Fujisawa,
Kanagawa, Japan
The epidermis of the skin is largely composed of keratinocytes which does not only play an impor-
tant structural part in forming a physical barrier to foreign microorganisms but also are important
functionally in mediating cutaneous immune reactions. Candida albicans (CA), a most common
cause of superficial candidiasis, induces cytokine productions from keratinocytes. No detailed inter-
action between CA and human keratinocytes has been studied previously, but it may involve acti-
vation of NF-kB, a transcriptional activator of multiple host defense genes involved in immune and
inflammatory responses. Here, we show that CA activates NF-kB in normal human epidermal ker-
atinocytes (NHEKs). Interleukin-8 production by NHEK stimulated with CA was increased in time-
dependent manner. Westernblot analysis revealted that CA induced IkBa phosphorylation and degra-
dation in NHEKs. Dual-luciferase reporter assay revealed that CA activated NF-kB and that the
activities were blocked by inhibitors against IkB kinase (IKK) and NF-kB. Furthermore, we show
that toll-like receptor (TLR) 2 but not TLR4 may be required for CA induced NF-kB activation. After
stimulation with CA, TLR2 mRNA expression was up-regulated. However, we failed to detect TLR4
mRNA expression in NHEK with or without CA stimuli. Also, anti-TLR2 antibody inhibited IL-8
production by NHEKs with CA stimuli. Taken together, our results demonstrate that CA activates
NF-kB via TLR2 but not TLR4 in NHEKs. 
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Susceptible gene analysis of herpes zoster and postherpetic neuralgia within HLA region
H Shinagawa,1 T Mabuchi,1 T Naruse,2 N Sugita,2 E Kikkawa,2 M Nakashima,2 T Anzai,2 M Sato,4,6
M Ota,5 T Yabe,6 Y Ishikawa,6 K Hanaoka,4 K Tokunaga,3 M Iizuka,1 Y Umezawa,1 T Matsuyama,1
H Inoko2 and A Ozawa1 1 Department of Dermatology, Tokai University School of Medicine,
Isehara, Kanagawa, Japan, 2 Department of Molecular Life Science, Tokai University School of
Medicine, Isehara, Japan, 3 Department of Human Genetics, Tokyo University School of Medicine,
Tokyo, Japan, 4 Department of Anesthesia, Tokyo University School of Medicine, Tokyo, Japan, 5
The Metro Tokyo Red Cross Blood Center, Tokyo, Japan and 6 6Department of Legal Medicine,
Shinshu University School of Medicine, Nagano, Japan
HLA region is known to have an important role in the immune response against foreign antigen in
patients with infectious diseases. In the present study, we have analyzed polymorphisms of HLA
genes and 11 sets of microsatellite markers located in the HLA region to investigate precise loca-
tion of the susceptibility gene for herpes zoster and postherpetic neuralgia (PHN). A total of 162
Japanese patients with herpes zoster (including 102 patients with PHN), 52 patients without herpes
zoster and 136 healthy controls were genotyped by the sequence based typing (SBT) method for the
class I loci (HLA-A, B, C), and the PCR-restriction fragment length polymorphism (PCR-RFLP)
method for the class II loci (HLA-DRB1, DQA1, DQB1). We recognized (1) positive associations
of the development of PHN with the HLA class I and II antigens HLA-A*3303,B*4403,DRB1*1302
haplotype, (2) negative associations of the development of PHN with the HLA class I antigen HLA-
B*4001 and (3) negative associations of the development of herpes zoster with the HLA class I anti-
gen HLA-B*5101. Interestingly, these associations were recognized also by microsatellite analysis
as their markers located around HLA-B were significantly associated in each patients group com-
pared with 248 healthy controls. These findings suggest that the susceptibility gene of PHN and her-
pes zoster might existed in the HLA class I region rather than class II. 
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Peptiodoglycan up-regulates expression of various components of the microbial recognition
receptor complex, TLR2, TLR4, CD14, and CD11b/CD18 in human and mouse keratinocyte
cell lines
H Jang1 and CL Reardon2 1 Dermatology, Pusan National University Hospital, Pusan, South Korea
and 2 Dermatology and Immunology, University of Colorado Health Sciences Center, Denver, CO
Peptidoglycan (PGN) is an essential cell wall component of all types of bacteria and thus is an
excellent target for recognition by the innate immune system. PGN induces clinical manifestations
of infection by activation of macrophages leading to secretion of cytokines. Toll-like receptor (TLR)2
and CD14 are well known to be primary signal-transducing receptors for PGN in macrophages.  How-
ever, little is known about the response of keratinocytes to PGN. By using the human macrophage
cell line, U937, as a positive control, expression and regulation of microbial receptors and cytokine
production following 24 hr stimulation by PGN were investigated in human keratinocyte cell lines,
A431, HaCaT, CL-22, and mouse keratinocyte cell lines, Balb/MK, PAM 212.  PGN increased
cytokine production and induced upregulation of TLR2 and TLR4 in human and mouse keratinocytes.
Because TLR4 is well known to be a primary signal-transducing receptor for lipopolysaccharide
(LPS), cells were stimulated by PGN in the presence of polymyxin B, a well-known lipid A-neu-
tralizing agent to exclude possible LPS contamination effects.  Although Polymyxin B blocked the
ability of LPS to stimulate cytokine production, it did not inhibit PGN stimulation in keratinocytes.
In addition, antibody blocking of TLR2 decreased PGN-mediated cytokine production in keratinocytes,
whereas blocking of TLR4 had no effects on cytokine production.  Therefore, these data indicate that
PGN stimulation occurs through TLR2, but TLR4 upregulation by PGN might be induced indirectly
by TLR2 signaling in keratinocytes.  In addition to TLR2 and TLR4, CD14 and CD11b/CD18 were
also upregulated by PGN stimulation. Antibody blocking of CD14 and CD11b/CD18 also reduced
cytokine production in keratinocytes.  Our results suggest that PGN stimulation in keratinocytes is
mediated through the activation and cooperation of microbial receptors within this receptor com-
plex. 
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Cathelicidins are effector molecules in the direct antimicrobial action of keratinocytes
MH Braff and RL Gallo Dermatology, University of California, San Diego and VA Medical Center,
San Diego, CA
Cathelicidins (caths) are antimicrobial peptides vital to the innate immune response of skin. Caths
are made by keratinocytes during inflammation and are also deposited at sites of injury by neu-
trophils. This investigation sought to determine how keratinocytes store and process caths, and whether
the expression of caths by keratinocytes is necessary for skin antimicrobial function. Cath localiza-
tion was evaluated using immunocytochemistry and confocal microscopy with polyclonal antibod-
ies against either the prepro- cathelin domain or the antimicrobial C-terminal peptide. Cath function
was determined by analysis of microbial killing following coculture of keratinocytes with bacteria.
In cultured undifferentiated HaCaT cells and primary keratinocytes, human cath (LL-37) was dis-
tributed in a perinuclear pattern and localized in the Golgi apparatus. In whole epidermis, mouse
cath (CRAMP) was detected in lamellar granules by immunogold electron microscopy, and by
immunoblot in lamellar granules isolated by metrizamide density gradient fractionation. Coculture
of keratinocytes with heat-killed, TRITC-labeled E. coli BioParticles, followed by immunostaining
and confocal microscopy, showed intracellular colocalization of bacteria with caths. Analysis of
survival of Staphylococcus aureus, particularly the cathelicidin-sensitive mprF strain, suggested
that keratinocytes from wild-type mice kill S. aureus more efficiently than those isolated from cath
knock-out mice. This effect was rescued by adding synthetic CRAMP. Further, inhibition of cath
activation by protease inhibitors reduced the ability of keratinocytes to kill S. aureus. Thus, ker-
atinocytes phagocytose bacteria and use caths as a mechanism for direct antimicrobial action. Caths
present at basal levels in cultured keratinocytes are capable of killing bacteria, and storage of cath
in lamellar bodies may facilitate release in vivo. This process enables proteolytic cleavage of stored
cath to active antimicrobial peptide, an essential event in the innate immune defense of skin. 
1038
The role of DC-SIGN in HIV sexual transmission
M Pion,1 J Arrighi,1 J Escola,1 F Leuba,1 Y VanKooyk2 and V Piguet1 1 Dermatology and
Venerology, University Hospital of Geneva, Geneva, Geneva, Switzerland and 2 Molecular Cell
Biology, VUMC Amsterdam, Amsterdam, Switzerland
Since new HIV infections occur primarily through sexual transmission, small amounts of virus have
to cross the mucosal barrier and reach replication-competent sites. Evidence has accumulated that
a specific cell subtype, called Langerhans/dendritic (DC) cells, plays a crucial role in the early events
of entry into the host (reviewed in Piguet and Blauvelt, JID, 2002). Th receptor DC-SIGN at the sur-
face of DC can capture small amounts of virus in the periphery and transfer it efficiently to T cells,
where massive viral replication occurs. Our results demonstrate that DC-SIGN, a receptor that
binds HIV with a higher affinity than CD4, is rapidly internalized from the cell surface of DC and
targets antigens to the lysosomes, where they are degraded. Furthermore, DC-SIGN internalizes anti-
gens for presentation to T cells. However, HIV is able to escape DC-SIGN-mediated antigen pres-
entation, by dissociating from this receptor early after internalization from the cell surface. In absence
of viral replication, this pool of virus is stabilized inside a DC for up to 10 days, whereas free virus
in medium looses infectivity in less than three days. We will demonstrate where the virus resides for
prolonged periods of time and remains highly infectious with a combination of morphological and
virological methods. In order to disturb the early events of HIV infection and the pool of virus hid-
ing in DC, we have developed lentiviral vectors expressing stably small interfering RNA (siRNA)
targeting DC-SIGN. Our results demonstrate that siRNA targeting DC-SIGN can suppress up to 97%
of the surface expression of DC-SIGN. Using this tool we are analyzing the contribution played by
this receptor in the overall pathogenesis of HIV early steps of infection. Furthermore, lentiviral vec-
tors expressing stably siRNA that inhibit DC-SIGN expression could prove to be a novel weapon
against HIV infection. 
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T cell-mediated induction of Epstein-Barr virus oncogene expression in patients with hyper-
sensitivity to mosquito bites and EBV-infected NK cell lymphocytosis
H Asada,1 S Suguri,2 Y Tokura,3 K Iwatsuki 4 and S Miyagawa1 1 Dermatology, Nara Medical
University, Kashihara, Nara, Japan, 2 Medical Zoology, Kagawa Medical University, Kida,
Kagawa, Japan, 3 Dermatology, University of Occupational and Environmental Health,
Kitakyushu, Fukuoka, Japan and 4 Dermatology, Okayama University Graduate School of
Medicine, Okayama, Okayama, Japan
NK cell lymphocytosis associated with Epstein-Barr virus (EBV) infection often shows severe hyper-
sensitivity to mosquito bites (HMB) characterized by intense local skin reactions and systemic symp-
toms such as high fever, lymphadenopathy, and hepatosplenomegaly. We previously demonstrated
that CD4+ T cells of the patients proliferated well in response to mosquito salivary gland extracts
and played a key role in EBV reactivation from latent state in NK cells. Here we investigated whether
CD4+ T cells have any influence on EBV oncogene expression in patients’ NK cells and immortal-
ization of these cells. Peripheral blood mononuclear cells were taken from the 5 cases of HMB, and
purified CD4+ T and NK cells were cocultured in the presence of mosquito salivary gland extracts
(4ug/ml). Before and 12, 24, 72, and 120 hours after starting coculture, viral oncogene expression
was assessed by RT-PCR and immunostaining. In result, expression of the oncoprotein LMP1 was
remarkably increased at 12-72 hours, while another oncoprotein EBNA2 expression was not detected.
In contrast, no or little change of LMP1 expression was observed in coculture without mosquito
extracts. Furthermore, to investigate whether humoral factors of the CD4+ T cells can induce LMP1
expression, we transferred the supernatants from the culture of CD4+ T cells stimulated with mos-
quito extracts into the NK cell culture. We observed an increase of LMP1 mRNA expression in the
NK cells and proliferation of these cells. These results suggest that the humoral factors from CD4+
T cells stimulated with mosquito extracts can induce expression of oncoprotein LMP1 in the NK
cells and is involved in NK cell lymphocytosis. 
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Selective proliferation of Epstein-Barr virus-infected NK cell clones in the cutaneous lesions
of hypersensitivity to mosquito bites
K Iwatsuki, T Yamamoto, K Fujii, K Tsuji and T Oono Dermatology, Okayama University
Graduate School of Medicine and Dentistry, Okayama, Japan
Hypersensitivity to mosquito bites(HMB) is a disease of Epstein-Barr virus (EBV)-associated NK/T
lymphoproliferative disorders, characterized by skin ulcers, high-grade fever, liver damage and
lymphadnopathy with the subsequent development of lymphoma. In the current study, we investi-
gated cytological and genotypic profiles of the circulating and skin infiltrating EBV+ NK cells in 2
patients with HMB and an established EBV+ NK cell line, using immunohistological and molecu-
lar probes. EBV+ NK cells determined by the presence of EBV-encoded small nuclear RNAs (EBER)
were increased in number up to 50-55% of the peripheral lymphocytes, and infiltrated in the skin,
bone marrow and lymph nodes. The NK cells showed surface phenotypes of CD11b+,16+,56+ in
case 1, and CD11b+16-56+ in case 2. Many cytotoxic T-cells (CTLs) expressing TIA-1 and granzyme
B were present in the skin lesions. Southern blotting studies using an EBV-terminal repeat probe
demonstrated no clonal proliferation of EBV+ cells in the peripheral blood or bone marrow in both
cases, but 2 distinct EBV+ NK cell clones were detected in the different cutaneous lesions in case
2. An EBV-infected NK cell clone (NOY-1) established from the peripheral blood was of the same
origin as one of the 2 clones detected in the cutaneous lesions. The NOY-1 cells were capable of
producing IFN-γ, possessed 7.5 copies of EBV-DNA per cell as determined by quantitative PCR,
and expressed only EBNA-1 by usage of Qp promoter without LMP-1 or any other EBNAs, sug-
gesting latency I or II infection pattern. These findings indicate that patients with HMB have oligo-
clonal EBV+ NK cells in the peripheral blood in which selective clones become dominant in the skin
following mosquito bites. Although CTLs are infiltrated in the skin lesions, EBV+ NK cells may
minimize the expression of the latency-associated viral antigens which might favor cell survival,
evading the host immune surveillance. 
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Autoreactive T cells and HSV DNA transport in HAEM pathogenesis
F Ono,1 T Gyotoku,1 JW Burnett2 and L Aurelian1 1 Pharmacology, University of Maryland,
Baltimore, MD and 2 Dermatology, University of Maryland, Baltimore, MD
HSV DNA transport to the skin and restricted TCR repertoire usage are significant factors in HAEM
pathogenesis. To determine the HSV-specificity of T cells in HAEM lesions, epidermal T cells were
cultured with autologous PBMC (106/well) and HSV antigen (400µg/ml). Single cell clones were
established by limiting dilution in medium with PHA-P (200ng/ml), human IL-2 (40U/ml), IFN-γ
(25ng/ml) and GM-CSF (25ng/ml), autologous PBMC and HSV antigen. T cell lines/clones from
HSV patients proliferated in response to HSV antigen. T cell lines from HAEM patients were HSV-
specific only at 30 hrs after lesion onset, and only 4/25 (16%) clones recognized HSV antigens.
Lines/clones established from HAEM patients at 4-6 days after lesion onset recognized cellular
antigens, suggesting that they are autoreactive and could be induced by molecular mimicry or self-
antigens released during the earlier virus-specific inflammatory response. To examine HSV DNA
transport, PBMC from 8 HAEM and 8 HSV patients were fractionated with the Direct CD34 Prog-
enitor Cell Isolation Kit, infected with HSV and cultured without or with GM-CSF and IL-4 to stim-
ulate CD34+ cell differentiation into immature dendritic cells (DC). They were assayed for HSV
DNA (by PCR) on days 1-7 in culture. CD34+ cells were enriched to 82-94% purity and their fre-
quency was similar in HAEM and HSV patients (0.26 ± 0.05% and 0.22 ± 0.1%, respectively). CD34-
populations had 20-40% CD14+ cells. HSV DNA was seen in infected CD34- cells from both HAEM
and HSV patients. HAEM patients differed from their HSV counterparts without HAEM in that their
CD34+ cells retained the HSV DNA at 5-7days p.i. The higher stability of HSV DNA was also seen
in CD34+ cells from HAEM patients cultured without cytokines or with TNF-α (to generate mature
DC). The data suggest that HAEM is a virus-induced disease with an autoreactive component and
HSV DNA is transported to the skin by immigrating CD34+ cells. 
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Dendritic cells take up Leishmania parasites via Fc-receptors: implications for resulting immune
responses
F Woelbing,1 C Sunderkoetter,2 Y Belkaid,3 A Nigg,1 J Knop1 and E von Stebut1 1 Dermatology,
Joh. Gutenberg University, Mainz, Rheinland-Pfalz, Germany, 2 Dermatology, University,
Muenster, Rheinland-Pfalz, Germany and 3 Laboratory of Parasitic Diseases, NIH, Bethesda, MD
Previously, we demonstrated that L. major-infected dendritic cells (DC) - unlike macrophages (MΦ)
- release IL-12 and effectively vaccinate against progressive disease. Additionally, we observed that
i) skin-DC take up only L. major amastigotes, whereas MΦ efficiently phagocytose amastigotes as
well as promastigotes, and ii) the kinetics of L. major uptake was much slower in DC than in MΦ.
These differences could partially be related to differences in the involved receptors. In this study, we
initially confirmed that bone marrow-DC (BMDC) - like skin-DC - efficiently take up amastigotes
(isolated freshly from infected tissues), but not cultured promastigotes (30±10 vs. 2±1 % infected
DC/18 hrs, p<0.005). We then analysed the receptors involved in amastigote uptake by BMDC. We
have previously shown that uptake of parasites by CD18-(thus CR3-)deficient MΦ is dramatically
reduced. In contrast, CR3-deficient BMDC generated from CD18-/- mice showed no alterations in
L. major phagocytosis. We next studied if opsonization by Ig is involved in Leishmania uptake.
Amastigotes isolated from B-cell (µMT) or T- and B-cell deficient (SCID) mice devoid of surface
Ig were not phagocytosed (3±2 and 4±2 %, p<0.02) compared to amastigotes isolated from BALB/c
mice. When, however, promastigotes were preincubated with Ig-containing serum or isolated IgG
from infected mice, they were efficiently taken up by DC (11±4 %, p<0.05). Similar to unopsonized
promastigotes, promastigotes opsonized with normal mouse serum were not phagocytosed. Our data
suggest, that parasite uptake by DC is dependent on Fc-receptors, whereas MΦ take up Leishmania
via CR3, and explain why Leishmania-infected DC - in contrast to MΦ - release IL-12. Our data
may also explain why MΦ phagocytosis of the parasite leads to MHC class II-restricted antigen pres-
entation, and in DC class I and II-dependent presentation of L. major-antigens is observed resulting
in efficient CD4+ and CD8+ T-cell priming. 
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Production of MIP-1α/ CCL3 is mediated via toll-like receptor 3 in human keratinocytes
M Tohyama, Y Shirakata, K Yamasaki, K Sayama, T Tsuda, E Tan and K Hashimoto Dermatology,
Ehime University School of Medicine, Ehime, Ehime, Japan
MIP-1α is a chemokine that binds to CCR1 and CCR5. MIP-1α induces monocytes and Th1 lym-
phocytes, and plays an important role in skin immune reactions. It has been reported that TNF-α,
IL-1, and IFN-γ cannot induce MIP-1α production by keratinocytes. Interestingly, MIP-1α was
detected in vesicular fluids in herpes simplex infection. Recently, we found that Toll-like receptor 3
(TLR3) was strongly expressed in cultured human keratinocytes. Several groups showed that TLR3
is a receptor for virus-associated double-stranded RNA (dsRNA). This led us to hypothesize that ker-
atinocytes synthesize MIP-1α via TLR3 by dsRNA. First, we examined the effect of poly(I;C), a
synthetic ligand for TLR3, on normal human keratinocytes. Poly(I;C) induced keratinocytes to express
MIP-1α mRNA and produce MIP-1α at 1, 3, and 10 mg/ml in a dose-dependent manner, optimally
4.1 ng/ml at 10 mg/ml. Next, we studied the intracellular signaling pathway of MIP-1α production.
We added 3 mg/ml poly(I;C) to keratinocyte culture and examined the effect of inhibitors for the
NFκB, JNK, and p38 signaling pathways. Adenovirus vector expressing a mutant IκBα was used to
block the NFκB pathway. This mutant IκBα cannot be phosphorylated and prevents translocation
of NFκB to the nucleus. The mutant IκBα had no effect on MIP-1α production by keratinocytes.
SP600125, an inhibitor of the JNK pathway, also had no effect on MIP-1α production by keratinocytes.
However, SB203580 and SB202190, p38 pathway inhibitors, inhibited poly(I;C)-induced MIP-1α
production by keratinocytes almost completely. Combined, normal human keratinocytes can pro-
duce MIP-1α via TLR3 and the p38 pathway. This is the first report that MIP-1α is produced by
keratinocytes. 
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Epidermal differentiation regulates the production of innate antimicrobial peptides in the skin
K Sayama,1 H Komatsuzawa,2 K Yamasaki,1 Y Shirakata,1 X Dai,1 M Sugai,2 H Ichijo3 and
K Hashimoto1 1 Dermatology, Ehime University School of Medicine, Shigenobucho, Ehime, Japan,
2 Hiroshima University, Hiroshima, Hiroshima, Japan and 3 Tokyo University, Bunkyo, Tokyo,
Japan
Previously, we showed that apoptosis signal regulating kinase-1 (ASK1) is an intracellular regula-
tor of keratinocyte differentiation, especially late phase differentiation. We hypothesized that epi-
dermal differentiation regulates innate immunity, since epidermal differentiation is thought to pro-
tect the body from the outside environment. In this study, we clarified the role of ASK1 in epidermal
innate immunity. Epidermal keratinocytes produce the human antimicrobial peptides beta-defensin-
1 (hBD1), hBD2, and hBD3. Direct contact of S. aureus with cultured normal human keratinocytes
triggered the production of hBD2 and hBD3. Then, we examined the effect of ASK1 on the pro-
duction of BDs. Transfection of the constitutively active form of ASK1 to normal human keratinocytes
using adenovirus vector markedly enhanced hBD1, hBD2, and hBD3 mRNA expression, 2.9-, 22-,
and 44-fold compared to controls, respectively, as analyzed by ribonuclease protection assay. This
induction was almost completely abolished by the addition of p38 inhibitors: SB203580 and
SB202190. Next, we analyzed the role of ASK1 in BD production in mouse keratinocytes obtained
from ASK1-/- mice. Direct contact between heat-inactivated S. aureus and cultured ASK1+/+ mouse
keratinocytes for 18 h enhanced mBD2 and mBD6 mRNA expression, 3.8- and 1.6-fold compared
to controls, respectively. In contrast, ASK1-/- mouse keratinocytes did not induce mBD2 or mBD6
mRNA (1.1- and 0.9-fold, respectively). These data demonstrate that activation of ASK1 induces
BD production and the absence of ASK1 results in the failure of BD production in response to S.
aureus. Furthermore, peritoneal injection of bacteria resulted in significantly lower survival rate in
ASK1-/- mice than in ASK+/+ mice. In conclusion, this is the first report that the ASK1-p38 MAP
kinase pathway plays an essential role in skin innate immunity. 
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Lymphatic dysfunction in Kaposi’s sarcoma-associated herpesvirus k-cyclin transgenic mice
M Sugaya,1 T Watanabe,1 A Yang,1 AM Atkins,1 EA Aquilino,1 DL Borris,1 M Bryant2 and
A Blauvelt1 1 Dermatology Branch, National Cancer Institute, Bethesda, MD and 2 Office of the
Director, National Institute of Health, Bethesda, MD
Vascular endothelial growth factor receptor (VEGFR)-3 is expressed by lymphatic endothelial cells
in adults. In addition, KSHV-infected tumor spindle cells within Kaposi’s sarcoma (KS) lesions
express VEGFR-3, supporting the hypothesis that KS is derived from lymphatic endothelial cells.
To further understand KS pathogenesis, we generated transgenic (Tg) mice that express KSHV k-
cyclin within lymphatic endothelial cells under the control of the murine VEGFR-3 promoter. k-
cyclin is a cellular cyclin D2 homolog that is expressed within KS spindle cells. In the Tg line that
demonstrated the highest level of k-cyclin expression, all heterozygous mice died prematurely within
6 months of age. Both male and female k-cyclin Tg mice were noted to be slightly heavier when
compared with wild-type littermates (at 16 wks, 26.5±3.2 g vs. 23.7±2.8 g, p=0.076). Rapid and shal-
low respirations were regularly observed in Tg mice just prior to death. Necropsy of Tg mice revealed
0.25-1.5 ml of chylous fluid within pleural cavities. Histologically, lungs showed diffuse atelectasis
and severe congestion. Footpads and ears of Tg mice were edematous and erythematous, and histo-
logically showed dermal edema and extravasated erythrocytes. Other tissues also showed signs of
edema. Interestingly, when assessed quantitatively by real-time RT-PCR, k-cyclin expression corre-
lated with VEGFR-3 expression within a variety of tissues, and was highest in lungs. Functionally,
defects in lymphatic drainage were observed in k-cyclin Tg mice following intradermal injection of
either Evans Blue dye or FITC-dextran. In summary, lymphatic dysfunction with premature death
secondary to pleural effusion was observed in KSHV k-cyclin Tg mice. These mice provide a small
animal model for assessing the in vivo function of KSHV genes. Thus, they should prove useful in
further understanding the pathogenesis of KS and other diseases associated with KSHV infection. 
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Virus-like particles of human papillomavirus type 92, a new type isolated from a basal cell
carcinoma
A Handisurya,1 S Shafti-Keramat,1 O Forslund2 and R Kirnbauer1 1 Lab. of Viral Oncology, DIAID,
Dermatology, Univ. of Vienna Medical School, Vienna, Austria and 2 Med. Microbiol., Malmoe
Univ. Hospital, Malmoe, Sweden
Human papillomavirus (HPV) genomes, in particular DNA sequences related to HPV types found
in epidermodysplasia verruciformis (EV), have been demonstrated in malignant and benign skin
lesions and in hairs from renal transplant- and immunocompetent patients. An etiologic role of HPV
in the development of non-melanoma skin cancer is still unclear. Recently, a novel HPV type, des-
ignated candidate HPV92, has been isolated from a basal cell carcinoma. HPV92 showed highest
similarity to HPV49 (72%) and phylogenetically was distantly related to other types (e.g. 5, 8) in
the B1-group of EV-types. To study functional properties of the HPV92 late region we cloned the
L1 major capsid protein ORF into a baculovirus expression vector. Sf9 insect cells were co-trans-
fected with AcMNPV DNA, recombinant baculoviruses were plaque purified and high titer virus
stocks generated. By SDS-PAGE and Coomassie staining of whole cell lysates of infected Sf9 cells
the L1 protein migrated as a 50-55 kD band similar to the L1 of other HPV types. By western blot-
ting HPV92 L1 was recognized by a polyclonal antiserum raised against HPV5 L1 virus-like parti-
cles (VLP) reflecting their deduced protein homology. To provide further evidence for the structural
integrity of the L1 protein high-MW complexes from L1 expressing insect cell lysates were purified
by density gradient centrifugation and analyzed by transmission electron microscopy. Electron micro-
graphs demonstrated spherical particles indicating that L1 of HPV92 is able to self-assemble into
capsomeric VLP. Studies are under way to determine whether immunization with HPV92 VLP can
elicit (neutralizing) antibodies to conformational capsid epitopes and whether these cross-react with
other cutaneous HPV types. HPV92 VLP might be a useful reagent for serology and prophylactic
and therapeutic vaccination strategies aimed against a spectrum of cutaneous HPV types potentially
associated with non-melanoma skin cancer. 
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Single gene encodes dual antimicrobial peptides, multiple functions of the cathelicidin
(hCAP18/LL-37)
M Zaiou,1 V Nizet2 and RL Gallo (SID)1,2 1 Dermatology, University of California, San Diego and
VA Medical Center, San Diego, CA and 2 Pediatrics, University of California, San Diego, San
Diego, CA
As resistance of pathogenic microbes to antibiotics increases, endogenous antibiotic peptides are
being considered as a source for new treatments of infectious diseases. Cathelicidins are a class of
small cationic peptide antibiotics that are an active component of mammalian innate immunity.
Human cathelicidin (hCAP18/LL-37) consists of a conserved prosequence called the cathelin-like
domain and a C-terminal peptide named LL-37. To study the role of the conserved prosequence, we
produced recombinant cathelin-like domain alone and full-length hCAP18 in E. coli. Since cathe-
lin-like protein is similar to cystatins, a family of cysteine protease inhibitors, we analyzed the
effect of the cathelin-like domain on the lysosomal cysteine protease cathepsin L. Cathelin-like pro-
tein inhibited cathepsin L proteolytic activity by 46% vs. control. Next, we tested cathelin-like pro-
tein for antimicrobial activity using solid phase radial diffusion and liquid phase killing assays. The
cathelin-like domain, but not full-length hCAP18, inhibited growth of E. coli and methicillin-resist-
ant Staph. aureus at concentrations of 16-32uM. This activity was distinct from LL-37. To under-
stand how pathogens might overcome this element of innate immunity, we tested the effect of a bac-
terial proteinase on full-length hCAP18. Group A Streptococcus producing proteinase SpeB (a
virulence factor) degraded hCAP18but mutants lacking SpeB did not. Together, these findings sug-
gest that after processing from the full-length cathelicidin precursor, the cathelin-like domain con-
tributes to host defense by inhibition of bacterial growth and limitation of cysteine proteinase-medi-
ated tissue damage. These dual functions of the cathelin-like domain are complementary to the
antimicrobial activity of the mature LL-37 peptide. We conclude that human cathelicidin gene encodes
at least 2 distinct antimicrobials, and therefore represents an elegant multifunctional effector mole-
cule of skin innate immune defense. 
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Detection of cholera toxin bioweapons via melanophores
AO Iuga, VB Reddy, K Kounga and EA Lerner Cutaneous Biology Research Center, Massachusetts
General Hospital, Boston, MA
There is a pressing need for methods to detect substances associated with bioterrorism. We demon-
strate that melanophores provide a method for the rapid and sensitive detection of cholera toxin
from V. cholerae. Melanophores are pigment cells, analogous to human melanocytes, found in lower
vertebrates, such as frogs and chameleons. Stimulation of G-protein coupled receptors (GPCRs) on
these cells by ligands such as light or hormones, results in alterations in the levels of intracellular
second messengers. Changes in the level of these second messengers cause the melanosomes in the
melanophores to rapidly aggregate or disperse such that the cells appear to change color between
white and black. This color change can be visualized by eye and measured with a plate reader or
digital imaging system. The GPCRs can be bypassed by compounds that directly effect G-proteins.
One such compound is cholera toxin. This toxin ADP-ribosylates the Gs protein. Ribosylation inhibits
the GTP-ase activity of Gs, and stimulates cAMP production. We demonstrate that cholera toxin, in
the low nanomolar range, rapidly causes pigment dispersion in Xenopus melanophores. Melanophores
can thus be linked to an imaging system to provide a rapid and sensitive indicator for the detection
of cholera toxin. 
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Role of syndecan and glypican proteoglycans in early events of human papillomavirus (HPV)
infection
S Shafti-Keramat,1 A Handisurya,1 E Kriehuber,2 K Slupetzky1 and R Kirnbauer1 1 Lab. of Viral
Oncology, DIAID, Dermatology, Univ. of Vienna Medical School, Vienna, Austria and 2 CEMM,
Austrian Academy of Science, Vienna, Austria
Heparan sulfate (HS) proteoglycans (HSPG) are required for attachment of papillomavirus capsids
to the cell surface and pseudovirion infection. However, receptor proteins involved in early events
of infection have not been identified. To characterize the HS carrying cell surface protein(s) ker-
atinocytes were treated with heparitinase I or PI-specific phospholipase C. Removal of cell surface
HS by heparitinase I inhibited HPV16 virus-like particle (VLP) binding in a dose dependent man-
ner, whereas treatment with PI-PLC had no effect suggesting transmembrane syndecans, rather than
GPI-anchored glypicans as VLP-binding structure. To directly assess the role of specific HSPG, K562
cells stably transfected with syndecan-1, syndecan-4, glypican-1 or empty vector control cells (G.
David) were analyzed for their ability to bind purified HPV16 VLP. Binding was stronger to syn-
decan-1 K562 cells as compared to the remaining transfectants and was correlated with the total
amount of HSPG cell surface expression. In addition, susceptibility for infection was analyzed by
in vitro infectivity assays using authentic virions of bovine papillomavirus (BPV) or human papil-
lomavirus (HPV) type 11 isolated from bovine skin and human genital warts. With the appearance
of spliced viral mRNA as a readout (RT-PCR) all stable transfectants were permissive for infection
with native virions. These results indicate that the amount of HSPG expressed on K562 cell surface
determines the capacity for papillomavirus binding and infectivity. Since syndecan-1 is the major
HS carrying surface protein of human keratinocytes and specifically induced in basal cells of injured
epithelia we propose a model implicating syndecan-1 as the primary cellular receptor in natural papil-
lomavirus infection. 
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Exposure to nevirapine in Stevens-Johnson syndrome and toxic epidermal necrolysis
J Fagot,1 M Mockenhaupt,2 J Bouwes-Bavinck,3 L Naldi,4 C Viboud1 and A Flahault1 1 Inserm
U444, Paris, France, 2 EuroSCAR Study Group, Freiburg, Germany, 3 EuroSCAR Study Group,
Leiden, Netherlands and 4 EuroSCAR Study Group, Bergamo, Italy
HIV and AIDS are known risk factors for drug reactions. Nevirapine (NVP), a non nucleoside anti-
retroviral drug has been already reported as inducing SJS or TEN and we previoulsly raised an alert
after having observed 15 cases related to NVP in the first 18 months of a European case control study.
We report here the final data of this study after 24 more months of inclusion. Among 441 cases of
SJS or TEN enrolled from Apr 1997 to Dec 2001, 36 were known to be infected by HIV-1 (8.1%)
They were 12 F and 24 M, aged 21 to 62 years (median 36). 12 SJS, 13 SJS/TEN overlap and 11
TEN. Six of 36 (16.6%) died. 24 of 36 patients (66.7%) had been exposed to nevirapine. All but one
received simultaneously other antiretroviral agents but no specific drug combination emerged.
Since only 3 of 1505 controls were HIV infected (0.2%) a classical case control analysis was not
feasible. We used a case-crossover analysis where each case served as his/her own matched control,
by comparing exposure during a case period (one week before onset of the disease) and a control
period (3 weeks before). In this analysis, relative risk associated with various antiretroviral drugs
was raised significantly for nevirapine (RR=infinite [95% CI: 4.7-infinite]), but not for other non
nucleoside reverse transcriptase inhibitors. Intake of NVP was stopped before the probable onset of
disease for 4 cases, the day of onset for 7 cases, and after the onset for 13 cases. The later the drug
was stopped, the more severe was the disease with 0%, 14% and 46% of patients respectively hav-
ing detachment of epidermis on more than 30% of the body surface area (p<0.05). Considering the
high risks of SJS or TEN associated with NVP, the existence of alternative drugs with lower risks,
and the incresed severity of skin reactions if NVP is stopped late, we suggest to withdraw nevirap-
ine if any cutaneous eruption occurs in the first month of treatment. 
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Interferometric biosensors for diagnostic applications
F Taghizadeh,4,2 SR Horner,5,2 J Lv,3,2 LJ Rothberg3,2 and BL Miller1,2 1 Dermatology, U. of
Rochester, Rochester, NY, 2 Center for Future Health, U. of Rochester, Rochester, NY, 3 Biochem.
Biophys., U. of Rochester, Rochester, NY, 4 Chem., U. of Rochester, Rochester, NY and 5 Surgery,
U. of Rochester, Rochester, NY
Rapid diagnostic aids have considerable potential for improving clinical practice. We have devel-
oped a new biosensor that relies on changes in the reflectivity of a silicon substrate, to which a
probe molecule is attached. The device is able to specifically detect the presence of bacteria directly
from culture, without any intervening lysis or amplification. In the first example, DNAs are used to
selectively detect Pseudomonas aeruginosa. Two rDNAs specific to P. aeruginosa and one rDNA
specific to E. coli were obtained in 5’-biotinylated form. These were individually spotted on strep-
tavidin-coated silicon wafers. Treatment of these spotted substrates with P. aeruginosa in LB for 5
to 45 minutes, followed by thorough rinsing of the chip, led to changes in reflectivity at locations
corresponding to the Pseudomonas-derived rDNA spots. Treatment with LB media alone, or E. coli
in LB media, produced little to no change in the reflectivity. In the second example, Tir, an E. coli
0157:H7 protein responsible for its pathogenicity, was attached to a silicon surface. When exposed
to a solution of purified Intimin, an 0157:H7 protein known to bind Tir, changes in the surface reflec-
tivity consistent with Intimin-Tir binding are observed. Exposure to a culture of E. coli overexpressing
Intimin produces analogous changes in the surface reflectivity, while exposure to E. coli lacking the
ability to produce Intimin does not. These results suggest that reflective/interferometric devices using
DNA or polypeptide probes may have general utility in the rapid and specific detection of patho-
genic organisms. 
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In Vivo Evaluation of the Bactericidal Activity of Three Wound Antiseptics on Biofilms of Com-
mon Wound Pathogens
A Drosou, A Cazzaniga, S Davis, J Silver and PM Mertz Dermatology and Cutaneous Surgery,
University of Miami, Miami, FL
Biofilms, associations of adherent bacteria living in an exopolysaccharide matrix, have been found
in wounds. The purpose of this evaluation was to investigate the effect of wound antiseptics on
biofilm-living bacteria of common wound pathogens in a pig wound model. Partial thickness wounds
were created and inoculated with Pseudomonas aeruginosa and Staphylococcus aureus. Wounds were
covered with a film dressing for 24 hours to allow for biofilm formation. The wounds were treated
with povidone-iodine, hydrogen peroxide, chlorhexidine or PBS. After 10 or 20 minutes, planktonic
or biofilm bacteria were recovered and quantitated following neutralization of antiseptics. P. aerug-
inosa: Planktonic cells were reduced by 2.1 and 2.9 logs from the control value after 10 and 20 min-
utes of PI treatment and by 3.1 and 5 logs after chlorhexidine treatment, whereas the cells in biofilms
were reduced by less than 1.5 logs after PI and chlorhexidine treatment. Hydrogen peroxide failed
to reduce both the planktonic and biofilm bacteria. S. aureus: Planktonic cells were significantly
reduced after PI and chlorhexidine treatment at all time periods by 2-3 logs, while biofilm-living
bacteria were reduced after 20 minute chlorhexidine treatment by 1.4 logs and 10 or 20 minute PI
treatment by 0.9 or 4.6 logs. Hydrogen peroxide did not reduce either planktonic or biofilm bacte-
ria. We concluded that none of the antiseptics we examined were completely effective in-vivo in
eliminating planktonic or biofilm-living S. aureus or P. aeruginosa during a short treatment time.
Povidone-iodine is the most efficient agent against biofilm-living S. aureus, while biofilm-living P.
aeruginosa is much more resistant to the tested antiseptics. 
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Leishmania infection in murine ears following UVB-induced immunosuppression
Z Darejeh,1,2 FP Heinzel,2,3 KD Cooper,1,3 AC Gilliam1 and TS McCormick1,3 1 Dermatology, Case
Western Reserve Univ., Cleveland, OH, 2 Geographic Medicine, Case Western Reserve Univ.,
Cleveland, OH and 3 VA Medical Center, Cleveland, OH
Leishmania major (L. major) commonly involves sun-exposed skin, raising the possibility that the
course of infection may be affected by UV immunosuppression. However, UVB irradiation effects
have not been addressed in L. major models using ear infections to assess outcomes. Therefore, we
sought to establish a model using murine ears, which serve as an ideal site for combined infec-
tion/irradiation studies. The effect of UVB irradiation was examined in the course of L. major infec-
tion in the ears of C57BL6/J mice. The ears of mice were irradiated with 120mj/cm2 using Kodacel
filtered FS40 sunlamps 48 hours before intradermal injection of 2x106 promastigotes/ear pina. Irra-
diation was continued every 3 days for 2 weeks (wks) post infection with 30mj/cm2 (53% immuno-
suppression, as determined by DNFB sensitization and challenge). Ear thickness was measured before
infection and weekly thereafter. Infected-only animals developed well defined 2-3mm erythema-
tous nodules on pinas, by 3 wks post-infection. No visible or palpable lesions were noted in either
the irradiated-infected or the irradiated-only groups. Ear thickness measurements showed no differ-
ence between the irradiated-infected group and infected-only group at 3 or 8 wks post infection
(p>0.1). However irradiation alone may account for this observation since the irradiated-only group
ears were thicker than the infected-only group by 3 wks post-infection (P=0.002). By 8 wks post-
infection this difference declines (p>0.1). During the resolution phase of ear swelling, at 7-8 wks
post infection, histopathological exam showed diffuse and deep immune cell infiltration with intra-
and extra-cellular parasites in both infected-only and the irradiated-infected groups, but was negli-
gible in the irradiated-only group. Although UVB irradiation does not block immune cell infiltra-
tion, it may prevent ear nodule formation. Establishing the combination of L. major ear infection and
UVB exposure allows for assessment of immunological outcomes. 
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Staphylococcus aureus infection of primary cultured human keratinocytes: a morphological
approach
Z Duanmu, D Yao, B Aufiero and G Murakawa Dermatology, Wayne State Univeristy, Detroit, MI
Staphylococcus aureus is the most common cause of skin infection, yet, little is known about the
mechanisms that underlie the infectious process. The skin is composed of many cell types of which
keratinocytes predominate. In our previous studies using bacterial plate assays, we found that S.
aureus adhered to keratinocytes efficiently and rapidly (40% five minutes post infection), invaded
the cells poorly (2-4% in 4 hours), and upon invasion replicated intracellularly. To further investi-
gate the interaction of keratinocytes with S. aureus, immnuofluorescence assays were performed on
human primary keratinocytes infected with S. aureus RN1, a strain of S. aureus that contains a plas-
mid that constitutively expresses green fluorescent protein (GFP). Successful penetration of bacte-
ria into keratinocytes was observed by fluorescent microscopy. Inside-outside antibody stains con-
firmed the presence of intracellular bacteria. GFP-tagged bacteria were seen in the cytoplasm of
keratinocytes. Intracellular bacteria were first observed within 30 minutes after infection, and the
number of infected cells and the number of intracellular bacteria increased in a time dependent fash-
ion. In general, bacteria entered as singlets or doublets and their number appeared to increase over
time, indicative of intracellular replication. To determine whether the intracellular bacteria popula-
tion increased, infected cells were studied over time by adding lysostaphin, an endopeptidase, to
eliminate extracellular bacteria at the end of 4 hours. At 4 hours, infected cells contained few bac-
teria, mainly singlets and doublets with < 5% containing ten or more bacteria. At 6 hours, most of
the infected cells contained clusters of ten or more bacteria. At 24 hours, all of the infected cells were
filled with bacteria in the cytoplasm. These results indicated that S. aureus invasion occurs at an early
stage of infection followed by replication inside the cells. 
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Immediate inflammatory responses to bacterial toxins are reduced, whereas their toxic effects
are greatly increased in the absence of mast cells
M Magerl,1 M Metz,1 I Walew,2 J Knop,1 S Bhakdi2 and M Maurer1 1 Department of Dermatology,
University Hospital Mainz, Mainz, Rheinland-Pfalz, Germany and 2 Inst. of Med. Microbiology
and Hygiene, University Hospital Mainz, Mainz, Rheinland-Pfalz, Germany
Mast cells (MC) are critical effector cells in the induction of protective immune responses to bacte-
ria. Little is known, however, about how MC are activated and how MC provide host protection in
the context of bacterial infections. Virulence of bacteria is, at least in part, attributed to bacterial tox-
ins (BT) such as streptolysin O (SLO) from Streptococci or alpha toxin (AT) from Staphylococci.
Thus, we asked whether SLO or AT can activate MC and whether MC can downmodulate the toxic
effects of these BT. Both SLO and AT dose dependently induced degranulation of murine peritoneal
MC as assessed by quantification of serotonin release. In addition, intracutaneous injections of SLO
or AT into the ears of C57BL/6 mice resulted in pronounced ear swelling responses within the first
hour after injection, suggesting that activated MC had increased extravasation by releasing vasoac-
tive mediators including histamine. Interestingly, genetically MC-deficient KitW/KitW-v-mice injected
with BT developed markedly impaired early inflammatory responses as compared to normal Kit+/+
mice. Indeed, SLO only induced ear swelling in KitW/KitW-v-mice that had been reconstituted with
MC prior to injection, indicating that MC activation is required for the development of early inflam-
matory reactions to BT. Most notably, ears of KitW/KitW-v-mice injected with AT exhibited dramati-
cally increased toxic damage, i.e. increased ear thickness on day 10 post injection, as compared to
Kit+/+ mice (543±48µm vs. 252±62µm, p<0.01). These findings suggest that the early activation of
cutaneous MC by BT after infection results in increased extravasation and recruitment of other proin-
flammtory cells, which helps to protect the host from toxin-induced morbidity. Ongoing investiga-
tions will clarify the significance of our findings in skin infections by Streptococci and Staphylo-
cocci and may explain how MC limit the pathogenic effects of BT. 
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Staphylococcus aureus invade and replicate in epidermal and dermal cells
BM Aufiero, D Yao and G Murakawa Dermatology, Wayne State University, Detroit, MI
Staphylococcus aureus is the most common cause of cutaneous infection. In order for S. aureus to
establish skin infection, the bacteria must attach, invade and replicate. However, the skin is com-
posed of several cell types and the relative risk of infection to each cell type is unclear. Therefore,
five cell types found within skin (macrophages, Langerhans cells, endothelial cells, fibroblasts and
keratinocytes) were grown in culture and tested for their ability to host S. aureus infection. Adhe-
sion and invasion, critical steps for the establishment of an infection, were assayed in all cell types.
For adhesion assays, bacteria were co-incubated with mammalian cells for 30 minutes and adherent
bacteria were counted. Greater than 50% of input bacteria adhered to all cell types studied. In inva-
sion assays, bacteria and mammalian cells were co-incubated between 30 minutes and 4 hours. Intra-
cellular bacteria were harvested from lysed cells and counted. By one hour, 40-70% of bacteria
invaded macrophages and Langerhans cells. In contrast, intracellular bacteria in fibroblasts and ker-
atinocytes were first detected in 4 hours at a level of 2-4% of bacteria. Endothelial cells gave an inter-
mediate phenotype; 20% of bacteria invaded within 4 hours. Interestingly, the proportion of bacte-
ria detected in adhesion and invasion assays was similar regardless of multiplicity of infection.
Cytochalasin D, an inhibitor of actin polymerization, effectively blocked invasion in all cell types
but had no effect on adhesion rates. Keratinocytes, the predominant cell type found in the epidermis
were tested for the ability of bacteria to replicate intracellularly upon invasion. At eight hours post-
invasion, bacteria multiplied 50 times in keratinocytes. Similar results were obtained in all cells stud-
ied. In summary, we found that all cell types served as efficient hosts and, therefore, should be con-
sidered potential targets for S. aureus infection of the skin. 
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The Cell Sorted skin equivalent as a model for the study of HPV
D Finlay, S Purdy, J Lievers and W Hoeffler Xgene Corporation, San Carlos, CA
Human papilloma virus (HPV) infections are difficult to model because the viral lifecycle is depend-
ent upon differentiation of the epidermal host cells. The use of raft cultures has been crucial, but
limitations in the size and reproducibility of these systems has impaired some studies. Here we
show that our novel method of modeling human skin, the Cell Sorted skin equivalent (CeSSE) can
be adapted as an effective tool in HPV research. CeSSE relies on the inherent cell adhesive proper-
ties of keratinocytes and dermal fibroblasts to sort-out into distinct layers from amixed cell slurry.
(J Invest Derm 2000, 114:674). Here using our CeSSE system along with a keratinocyte cell line
persistently infected with HPV-18 we demonstrate a model that forms normal human skin that is per-
missive for viral reproduction. To establish an in vivo HPV activity assay using SCID mice we show
that the HUC18 cell line that is persistently infected with HPV18 will generate in vivo CeSSE skin
when combined with normal fetal fibroblasts. Positive staining with anti-filaggrin antibodies estab-
lished these cells as forming morphologically correct skin that sufficiently differentiated to support
virus production. We document the presence of the virus in this in vivo CeSSE skin system by immuno-
histochemical staining for E2, E7, and L1 expression, as well as by electron microscopic detection
of virions in the HUC18-CeSSE.  Lastly we present initial results demonstrating the use of HPV
incorporation into our in vitro self-sorting skin equivalent model, Accuskin.  We feel we have suc-
cessfully developed a working HPV in vivo CeSSE model of virus reproduction that may aid in test-
ing anti-HPV compounds. 
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Oral Polypodium leucotomos extract inhibits PUVA-induced phototoxicity of human skin
M Middelkamp-Hup,1 M Pathak,1 C Parrado,1 T Garcia-Caballero,2 F Rius-Diaz,1 T Fitzpatrick1
and S Gonzalez1 1 Mass General Hospital, Harvard Medical School, Boston, MA and 2
Morphological Sciences Dept., Santiago de Compostela University, SC, Spain
PUVA [psoralens and ultraviolet radiation A (UVA, 320-400 nm)] is an effective therapy for over
20 skin disorders, and its clinical use has been limited by problems related to acute phototoxicity
and potential long-term carcinogenecity. An extract of the fern plant Polypodium Leucotomos (PL)
has been shown to exhibit strong anti-oxidant, photoprotective and immunomodulatory properties.
We investigated whether oral intake of PL could reduce the acute PUVA-induced phototoxicity on
a clinical and histological level. Normal skin of 10 healthy volunteers with skin types II and III was
exposed to PUVA with UVA and oral 8-methoxypsoralen (0.6 mg/kg) alone and to PUVA after oral
administration of PL (7.5 mg/kg). Erythema and edema of all skin sites was evaluated with a visual
scoring system. Biopsies were taken from sites exposed to the 2x minimal phototoxic dose (MPD)
without and with PLE after 48 and 72 hours. H&E staining and immunohistochemistry for detec-
tion of sunburn cells and CD1a, CD31, Ki 67 and tryptase positive cells was performed. Clinically,
PUVA plus PL resulted in a significant reduction of the erythema and edema associated with acute
PUVA-induced phototoxicity (p≤0.0004) and also in a reduction of the development of pigmenta-
tion after PUVA when compared to PUVA alone. Histologically, PUVA plus PL showed a signifi-
cant reduction of sunburn cells (p=0.05) and numerical preservation of Langerhans cells (p=0.007)
and preservation of their morphology, as well as a significant decrease of vasodilation (p≤0.0001)
and dermal mast cell infiltration (p=0.038). PL treated skin biopsies also revealed less epidermal
phototoxicity. No difference was found in Ki 67 positive cells. In conclusion, oral PL appears to be
an effective systemic chemopreventive agent in reducing PUVA-induced phototoxicity. These find-
ings have important implications as they may indicate a beneficiary effect such as reduction of the
chance of developing skin cancer in the future. 
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Attenuation of UVA-induced human skin keratinocytes damage by (-) epigallocatechin-3-gal-
late (EGCG)
J Xia,1 X Song,1 Z Bi1 and Y Wan2 1 Nanjing Medical University, Nanjing, China and 2 Providence
College, Providence, RI
Cellular effects of UV irradiation are implicated in human skin photoaging. Previous studies indi-
cated that UV irradiation induces generation of reactive oxygen species leading to skin cell damage.
EGCG is the major constituent of tea catechin with antioxidant activity. In this study, the protective
effects of EGCG on UVA irradiated human keratinocytes (HaCat cells) were investigated with detec-
tion of cell proliferation and apoptosis. Expression of matrix metalloproteinases (MMPs) that are
responsible for the degradation of collagen knowingly leading to cutaneous aging was also meas-
ured. EGCG was applied to the cell culture medium immediately after UVA (1.98 and 3.96 mJ/cm2)
and UVB (21, 42 and 126 mJ/cm2) irradiation. The final concentration of EGCG was 0.3, 1.5, and
3 mM. MTT dye assay was used at 24 hours post UV irradiation to determine cell proliferation.
Apoptotic and dead cells and bcl-2 protein were detected by FACS analysis. RT-PCR was utilized
to measure the expression of MMP1 and MMP3 mRNA. The results showed that UVA and UVB
significantly induced apoptosis, inhibited cell proliferation, reduced bcl-2 protein level, and up-reg-
ulated mRNA expression of MMP1 and MMP3 in cultured human keratinocytes. In all UV-exposed
then EGCG-treated (0.3 mM) groups, cell proliferation, apoptosis rate, and bcl-2 level were restored
to the level of non-irradiated groups. The mRNA expression of MMP1 and MMP3 were also com-
parable to that of unexposed groups. These results suggest that EGCG can be applied to attenuate
UV-induced skin cell damage due to its effect on reduction of apoptosis, restoration of cell prolif-
eration and inhibition of MMP expression. 
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Nitric oxide and genetic damage are mediators of ultraviolet radiation-induced immunosup-
pression in humans
GM Halliday, JM Kuchel and RS Barnetson Dermatology, University of Sydney, Sydney, NSW,
Australia
The aim of this study was to examine the mechanism by which solar-simulated ultraviolet radiation
(ssUVR) causes immunosuppression in humans. We studied suppression of recall responses to nickel
in allergic human volunteers. NG-methyl-L-arginine (L-NMMA) was used to inhibit nitric oxide
(NO) production, 2,2-dipyridyl was used to reduce hydroxyl radical formation, and T4N5 lipo-
somes which contain the DNA repair enzyme T4 endonuclease V encapsulated in microscopic lipid
membrane vesicles were used to enhance DNA repair. Each substance was applied to a separate group
of 15 volunteers. Skin was irradiated with a 1000W Oriel xenon-arc lamp. Two, six cm squares on
the lower back of each volunteer was randomized to receive either the active or base lotion daily for
four consecutive days and these squares were subdivided into smaller areas which received differ-
ent doses of ssUVR. After the final irradiation, nickel patches were applied to each test site for 48
h. Contact hypersensitivity-induced erythema was measured with a reflectance spectrometer 24 h
after patch removal. Both antioxidants but not the T4N5 liposomes provided only marginal, signif-
icant protection from sunburn. Low, sub-erythemal doses of ssUVR caused local immunosuppres-
sion in a dose-dependent manner. L-NMMA and the DNA repair enzymes but not 2,2-dipyridyl
protected the immune system from suppression, suggesting that NO and DNA damage, but not iron-
catalyzed production of hydroxyl radicals, are involved in UV-induced immunosuppression in humans.
Immunostained frozen sections of biopsies from the treated sites suggested that inhibition of UV-
induced migration of dendritic cells from the epidermis was responsible for prevention of immuno-
suppression by both the NO inhibitor and the DNA repair enzymes. 
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Does survivin play a role in chemoprevention of ultraviolet exposure-mediated cutaneous dam-
ages in SKH-1 hairless mouse by resveratrol?
MH Aziz, F Afaq and N Ahmad Dermatology, University of Wisconsin, Madison, WI
Ultraviolet (UV) B radiation from the sun elicits many adverse effects on skin and is the major
cause of skin cancer; and chemoprevention by naturally occurring agents may be a useful strategy
for its management. We earlier showed that resveratrol (trans-3, 5, 4’-trihydroxystilbene), a polyphe-
nolic antioxidant present in grapes and red wines, imparts protection from UVB-mediated cutaneous
damages in SKH-1 hairless mice. The mechanism of the action of resveratrol is not well-under-
stood. This study was aimed to define the involvement of Survivin, a member of the inhibitor of
apoptosis protein (IAP) family that is expressed in many cancers, in skin cancer chemopreventive
effects of resveratrol. Because multiple UV exposure increases the skin cancer risk in individuals,
we evaluated the effect of resveratrol on multiple UVB (180 mJ/cm2 x 7 in 2 wks) exposures in SKH-
1 hairless mice. The animals were subjected to UVB exposures alone or in combination with resver-
atrol (10µ mole/0.2 ml acetone/mouse), topically applied on mouse-skin prior (30 min) to UVB expo-
sure. The mice were sacrificed at 24 h following the last exposure, and studies were performed. Our
data demonstrated that UVB exposure resulted in a significant up-regulation in the mRNA and pro-
tein levels of survivin, as assessed by RT-PCR and immunoblot analysis, respectively. Further, resver-
atrol-treatment was found to inhibit the UVB exposure-mediated increase in bi-fold skin thickness,
skin edema and infiltration of leukocytes. Resveratrol treatment was also found to cause a down-
modulation in UVB exposure-mediated increases in cyclooxygenase (COX)-2, ornithine decar-
boxylase (ODC) and proliferating cellular nuclear antigen (PCNA), the known markers of cellular
proliferation and tumor promotion. Our data suggested that the chemopreventive effects of resver-
atrol might be mediated via modulation in the expression of survivin, and the associated events. To
our knowledge, this is the first study showing the modulation of survivin as a mechanism of pre-
vention of photo-damage by a chemopreventive agent. 
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High DNA repair efficiency in keratinocytes is mediated through strong expression and acti-
vation of p53 that induces downstream effectors p48, GADD45, and β-polymerase
C Chung, GZ Li, BA Gilchrest and TM Ruenger Dermatology, Boston University, Boston, MA
We recently reported that primary human keratinocytes repair DNA photoproducts and oxidative
DNA damage 2- to 12-fold more efficiently than primary fibroblasts or melanocytes. This differ-
ence was demonstrated in cells from 5 - 17 different donors, including all three cell types from a sin-
gle donor, and was independent of keratinocyte differentiation. In order to elucidate the mechanism
of this difference in DNA repair efficiency, we first determined levels of several DNA repair pro-
teins of the nucleotide- and base-excision repair pathways (NER and BER: XPA, ERCC1, hOGG1,
and APE-1) in extracts of primary keratinocytes, fibroblasts, and melanocytes from one donor. No
significant differences in expression were found. However, a very strong baseline expression of p53
and activated p53 (serine15-p53) was observed in keratinocytes, while fibroblasts and melanocytes
exhibited only weak expression of p53 and activated p53. The high expression of p53 and serine15-
p53 was independent of keratinocyte differentiation evident from comparison of keratinocytes cul-
tured in high (1.8 mM), intermediate (0.15 mM), and low (0.05 mM) calcium concentrations. The
high expression of p53 and activated p53 provides a very good explanation why both DNA repair
pathways, NER for photoproducts and BER for oxidative DNA damage, are more efficient in ker-
atinocytes. In recent years, p53 has been identified to induce both global genome-NER and BER.
The effect of p53 on NER is mediated by transcriptionally inducing p48XPE and GADD45, and the
effect on BER is mediated by inducing β-polymerase. Consistent with these effects, we found ele-
vated levels of these proteins in keratinocytes, as compared to fibroblasts or melanocytes. The data
suggest that keratinocytes have adapted to their increased exposure to environmental mutagens by
upregulating excision repair pathways through p53 and its downstream effectors. The data also offer
an additional explanation to the central role of p53 mutation in keratinocyte-derived malignancies. 
ABSTRACTS THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
1063
Aloin treatment attenuates membrane lipid peroxidation and over-expression of cytokines in
cultured human dermal fibroblasts exposed to UVA irradiation
X Song,1 J Xia,1 Z Bi1 and Y Wan2 1 Nanjing Medical University, Nanjing, China and 2 Providence
College, Providence, RI
Accumulating evidence indicates that reactive oxygen species generated by ultraviolet irradiation
(UV) play important roles in cellular damage leading to apoptosis in human skin. UV irradiation also
elevates expression of proinflammatory cytokines such as TNFαand IL-1βwith a result of skin inflam-
mation or sunburn. Aloin has been shown to bear photo protective properties, and yet the molecular
mechanisms of its action remain to be elucidated. Using cultured human skin dermal fibroblasts we
investigated the protective effects of Aloin on UVA-induced cell damage. FACS analysis with Pro-
pidium and Hoechst dye revealed that apoptosis rate increased 38% after UVA irradiation (30 KJ/m2).
UVA treatment induced accumulation of Malondialdehyde (MDA) (280 nmol/ml), indicating that
UVA-induced damage was associated with lipid peroxidation. Pretreatment with Aloin (10-5M) prior
to UVA irradiation reduced apoptosis to 7.5% and the MDA level was reduced to 116 nmol/ml. The
results showed that the protective effect of Aloin (10-6 to 10-4M) was dose dependent. RT-PCR
results also showed that UVA irradiation caused 2.1 fold increase of TNFαmRNA and 3 fold increase
of IL1βmRNA in cultured dermal fibroblasts. Pretreatment of Aloin significantly reduced UAV-
induced TNFαand IL1βexpression (p<0.01). Taken together, our data indicate that Aloin is an effec-
tive inhibitor of membrane peroxidation and can thus be used at appropriate concentration for the
prevention of UVA-induced apoptosis, and Aloin may also be applied to prevent UVA-induced skin
inflammation. 
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Polypodium leucotomos extract is an oral photoprotective agent against ultraviolet-induced
damage to human skin
M Middelkamp-Hup,1 M Pathak,1 M Mihm,2 D Goukassian,3 C Parrado,1 K Swindells,1 F Rius-
Diaz,1 T Fitzpatrick1 and S Gonzalez1 1 Wellman Lab of Photomedicine, MGH, Harvard Medical
School, Boston, MA, 2 Dermatopathology Unit, MGH, Harvard Medical School, Boston, MA and
3 Dermatology Unit, Boston University, Boston, MA
Exposure of unprotected skin to solar ultraviolet radiation (UVR) induces acute epidermal and der-
mal damage that can subsequently lead to long-term changes such as photoaging and skin cancer.
Currently the most widely accepted method of photoprotection is the usage of topical sunscreens.
An oral photoprotective agent acting against photooxidative stress of UVR would have substantial
benefits over topical photoprotection in the prevention of solar UVR damage. Polypodium Leuco-
tomos (PL) is a natural plant extract endowed with immunomodulating and antioxidative properties,
and its oral administration may lead to photoprotection of skin. Ten healthy subjects of skin types
II-III were exposed to varying doses of UVR from a solar simulator without and after administra-
tion of oral PL (7.5 mg/kg). Clinical evaluation of all skin sites was performed 24 hours (hrs) later.
Biopsies were obtained from skin sites exposed to the 2x minimal erythema dose (MED) from PL-
treated and non-treated skin after 24 or 72 hrs. Clinically, there was a significant decrease in ery-
thema response in skin exposed within 2 hrs after oral administration of PL (p≤0.001). Histologi-
cally, there was a significant decrease in sunburn cells in H&E stained sections (p=0.03) and DNA
damage analyzed by antibodies against thymine dimers (p≤0.0001) at 24 hrs, and also of prolifera-
tion visualized by Ki 67 at 72 hrs (p≤0.001). In total, more than 50% of all biopsies showed Langer-
hans cells preservation, and this was seen in all biopsies taken at 72 hrs. In conclusion, oral PL appears
to be an effective photoprotective agent by decreasing acute UVR induced skin damage such as DNA
damage and Langerhans cells depletion. This short-term observation may indicate that oral PL
could serve to be effective in the amelioration of short-term UVR damage and this may contribute
to prevention of skin cancer or photoaging changes of skin. 
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Low dose ultraviolet B irradiation up-regulates thrombomodulin via p38 MAP kinase path-
way in human epidermal keratinocytes
H Kawabata,1,2 T Kanekura,1 K Kawahara,2 T Kanzaki1 and I Maruyama2 1 Department of
Dermatology, Kagoshima University Faculty of Medicine, Kagoshima, kagoshima, Japan and 2
Laboratory and Molecular Medicine, Kagoshima University Faculty of Medicine, Kagoshima,
Kagoshima, Japan
Thrombomodulin (TM), an endothelial cell surface anticoagulant glycoprotein, acts as a cofactor
for protein C. TM was initially identified as an endothelial cell surface protein, however it has been
also identified in epidermal keratinocytes, especially in Malpighian- layer kerationocyte, and has
been recognized as a keratinocyte differentiation marker. It is thought that TM expressed in epider-
mal kerationcyte may modulate collagen reconstitution of the wound matrix. However, the role of
TM expressed in the epidermal keratinocyte are not fully characterized. In the present study, we
examined TM expression in response to ultraviolet (UV) B irradiation in immortalized human epi-
dermal keratinocyte cell line, HaCaT. TM expression decreased 2 hours and consequently recov-
ered 16 hours after low dose (100 J/m2) ultraviolet B (UVB) exposure. Message RNA (mRNA) was
up-regulated within 1 hour after low dose UVB irradiation. The mRNA of TM decreased with the
increasing doses of UVB radiation. A low dose of UVB induced p38 mitogen-activated protein kinase
activation rather than c-Jun NH(2)-terminal kinase activation. SB203580, a specific inhibitor of p38
down-regulated TM mRNA level after UVB irradiation and inhibited UVB induced CREB activa-
tion. Introducing TM antisense oligonucleotide to HaCaT cells resulted in reducing cell viability
after low dose UVB irradiation. Thus, our results altogether suggest that activation of p38-CREB
signaling pathway is required for UVB induced TM expression and TM plays important role in
early response to UVB irradiation which associated with keratinocyte survival. 
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Spectral responses of melanin to UVA irradiation
H Ouyang, G Stamatas and N Kollias Johnson and Johnson, Skillman, NJ
Exposure of human skin to UVA can result in pigment darkening. This pigment shows different spec-
tral characteristics compared to normal epidermal melanin or UVB induced pigments. The purpose
of this investigation was to study the spectral features of UVA induced pigmant both in an in vitro
model system and in vivo. UV-Vis absorbance spectra were measured for dopa-eumelanin and pheome-
lanin solutions of different concentrations before and after UVA (range from 10-120 J/cm2) expo-
sure. 10 human subjects were irradiated with UVA (40-80J/cm2) on their back and diffuse reflectance
spectra were collected for both irradiated sites and normal skin to calculate the spectra of UVA
induced pigment. The difference spectra in solution reveals that following UVA exposure the
absorbance increases exponentially from 800nm to 450nm in addition to a prominent decrease of
absorbance in the UVA range. This change of spectral features depends on both UVA doses and
melanin concentrations. The increase of visible absorbance, which may be considered as a marker
for new pigment formation, correlates with the decrease of UVA absorbance. Photo-oxidation of
pheomelanin solutions presents a distinctively different spectral response as the absorbance in the
visible range decreases as well as the absorbance in the UVA range. This change of spectral absorbance
is also dose dependent and concentration dependent. In vivo diffuse reflectance spectra show that
the UVA induced pigment has a similar spectral characteristic as the in vitro system. For all the vol-
unteers, the increase of absorbance in the visible wavelengths accompanies a fall of absorbance in
the UVA range. We conclude that the UVA induced pigmentation produces significant photochem-
ical alterations in the skin witnessed by increased photoprotection in the visible and reduced pro-
tection in the UVA. The spectral characteristics are consistent with the in vitro soluble melanin model
system, indicating only part of the epidermal melanin may be associated with UVA photodegrada-
tion. We also suggest that eumelanin and pheomelanin could be differentiated according to their spec-
tral responses to UVA irradiation. 
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UV-induced T suppressor cells inhibit the effector phase of contact hypersensitivity upon local
injection
A Schwarz, A Maeda, K Kernebeck and T Schwarz Department of Dermatology, University
Muenster, Muenster, Germany
Epicutaneous application of haptens onto UV-exposed skin induces hapten-specific tolerance. This
is mediated via T suppressor cells (Ts), now renamed regulatory T cells, since intravenous (i.v.) injec-
tion of T cells from UV-tolerized mice into naive animals renders the recipients unresponsive to the
hapten. When T cells from UV-tolerized mice are injected i.v. into mice which were already sensi-
tized, contact hypersensitivity (CHS) is not suppressed, suggesting that UV-induced Ts inhibit the
induction but not the elicitation of CHS and are inferior to T effector cells. Since sensitization takes
place in the regional lymph nodes, while elicitation in the area of challenge, we postulated that Ts
injected i.v. locate to the lymph nodes and not to the periphery and thus only suppress the induction
but not the elicitation of CHS. Hence we studied whether Ts inhibit the elicitation of CHS when
injected into the area of the challenge. Splenocytes and lymph node cells were obtained from mice
which were UV-tolerized against dinitrofluorobenzene (DNFB). I.v. injection of cells into naive mice
inhibited sensitization against DNFB in the recipients, but had no suppressive effect when injected
i.v. into DNFB-immunized recipients. In contrast, injection of cells into the ears of DNFB-sensitized
mice inhibited ear challenge with DNFB. Inhibition of challenge was hapten-specific since intracu-
taneous injection of DNFB-specific Ts into the ears of oxazolone (OXA)-sensitized mice did not
affect challenge with OXA. When ears of OXA-sensitized mice were injected with DNFB-specific
Ts and painted with DNFB before OXA challenge, CHS was suppressed. The inhibitory effect cor-
related with the local expression of interleukin-10 as shown by PCR. The data demonstrate that UV-
induced Ts can suppress the effector phase of CHS provided they are present in the area of challenge.
In addition, the activation of Ts is hapten-specific but once they are activated their suppressive activ-
ity is non-specific. This by-stander suppression seems to be mediated via the release of interleukin-
10. 
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The total amount of DNA damage determines ultraviolet radiation induced cytotoxicity after
uniform or localized irradiation of human cells
K Imoto,2,1 N Kobayashi,2 S Katsumi,2 Y Nishiwaki,2,1 S Miyagawa2 and T Mori1 1 Dermatology,
Nara Medical University, Kashihara, Nara, Japan and 2 Radioisotope Research Center, Nara
Medical University, Kashihara, Nara, Japan
We have recently developed a micropore ultraviolet irradiation technique. An isopore membrane fil-
ter with 3 um diameter pores shields ultraviolet C radiation from cultured human fibroblasts, lead-
ing to partial irradiation within the cells with an average of about 3 exposed areas per nucleus. This
study addressed the question of whether the spatial distribution of DNA damage within a cell nucleus
is important in triggering ultraviolet-induced cytotoxicity. We have examined whether there are dif-
ferences in cytotoxicity between partially ultraviolet-irradiated cells and uniformly irradiated cells
after equal amounts of DNA damage were induced in the cell nuclei. We first determined DNA
damage formation in normal human fibroblasts using an enzyme-linked immunosorbent assay. We
found that 5 J per m2 ultraviolet irradiation produced an equivalent amount of cyclobutane pyrimi-
dine dimers and (6-4) photoproducts per cell as 100 J per m2 with the membrane filter shield. At
those doses, we found that both types of ultraviolet irradiation induced similar levels of cytotoxic-
ity as assessed by a 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-
2H-tetrazolium assay. Both types of ultraviolet-irradiated cells also had similar cell-cycle distribu-
tion and apoptosis as measured by flow cytometry. Moreover, no significant differences in repair
kinetics for either type of photolesion were observed between the two different ultraviolet treatments.
Similar results were obtained in Cockayne syndrome cells that are defective in transcription-cou-
pled nucleotide excision repair. Present results indicate that in the range of photoproducts studied,
the spatial distribution of DNA damage within a cell nucleus is less important than the amount of
damage in triggering ultraviolet -induced cytotoxicity. 
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Comparison of minimal erythema dose and minimal melanogenic dose induced by different
wave-lengths of ultraviolet radiation
M Jang, K Doh, K Suh and S Kim Department of Dermatology, Kosin Medical College, Busan, .,
South Korea
The erythema and tanning responses of human skin to UV radiations which are used as diagnostic
phototest and guideline of phototherapy, are different accordings to skin phototype and wave-lengths.
Minimal erythema dose (MED), barely perceptible minimal melanogenic dose(MMDb) and well-
defined border melanogenic dose(MMDw) of broad band UVA(BBUVA), UVA-1, broad band
UVB(BBUVB), narrow band UVB(NBUVB) have not been reported. This study was done to meas-
ure the MED, MMDb and MMDw of different wave-lengths of UV radiation. Ten healthy volun-
teers were selected. the MED, MMDb and MMDw of the skin were assessed visually at 24 hours
and 7 days after irradiation, respectively. The result were as follows: 1) The MMDb and MMDw
induced by BBUVA and UVA-1 are less than MED. 2) The MED induced by BBUVB and NBUVB
is less than MMDb and MMDw. 3) In BBUVB, the MED for photoskin type IV was the similar as
the MMDb. Thease results suggest that the erythema and tanning response of the skin to UV radia-
tions are different according to UV wave-lengths. 
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Vitamin A exerts a photoprotective action in mouse and human skin by filtering UVB radia-
tions
C Antille, C Tran, O Sorg, L Didierjean and J Saurat Dermatology, University Hospital, Geneva
14, Geneva, Switzerland
Vitamin A is present in the skin, in particular the epidermis, mostly under retinyl esters, a storage
form that can be converted into all endogenous forms of vitamin A. Retinyl esters absorb UV light
between 300 and 350 nm, corresponding to a part of the sunlight received on the earth surface. We
thus wondered whether retinyl palmitate - the predominant endogenous retinyl esters - was able to
prevent biological actions of UVB due to its filter properties. We first used an in vitro model (Pho-
tochem. Photobiol. 75, 1-5 (2002)) to compare the photoprotective properties of retinyl palmitate to
those of the sunscreen octylmethoxycinnamate, then we applied topical retinyl palmitate on the
back of hairless mice, as well as on the buttocks of human volunteers, before exposing them to
UVB. Thymine dimers, an index of DNA damage, were visualised in mouse epidermis and human
punch biopsies by immunohistochemistry and quantified by immuno dot blots followed by densit-
ometric analysis; the intensity of erythema 24 hours after UVB was analysed in human volunteers
using a chromameter. In vitro, retinyl palmitate was shown to be as efficient as octylmethoxycinna-
mate in preventing UV-induced fluorescence or photobleaching of fluorescent markers, indicating
a filter effect on UVB. In vivo, topical retinyl palmitate was as efficient as a sunscreen with SPF 20
in preventing both the formation of thymine dimers and the development of erythema in human skin
exposed to 4 MED UVB, and significantly inhibited the formation of thymine dimers in mice exposed
to 1 J/cm2 of UVB. Taken together, these results demonstrated that an endogenous form of epider-
mal vitamin A acts as a UV filter, and thus decreases the available UV energy that could destroy
other epidermal biological molecules with deleterious consequences. 
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Exceptionally high protection of photocarcinogenesis by topical treatment of green tea polyphe-
nol (-)-epigallocatechin-3-gallate in hydrophilic ointment to SKH-1 hairless mice
SK Katiyar, A Mittal, PK Vayalil and CA Elmets Dermatology, University of Alabama at
Birmingham, Birmingham, AL
The use of botanical supplements with substantial antioxidant properties has received considerable
interest to protect human skin from adverse effects of ultraviolet (UV) radiation. The green tea
polyphenols are one of them. Here, we tested a cream based formulation of (-)-epigallocatechin-3-
gallate (EGCG) in hydrophilic ointment (10%,w/w) for skin photoprotection in SKH-1 hairless mouse
model. Topical treatment of EGCG (<1mg/cm2 skin area) before UVB irradiation (180mJ/cm2) -
induced initiation and promotion stages of carcinogenesis protocol resulted in exceptionally high
protection of photocarcinogenesis in terms of tumor incidence (70%), tumor multiplicity (82%) and
tumor size (66%) in comparison to all previous studies conducted with EGCG. Treatment of EGCG
also resulted in markedly high prevention of malignant conversion of papillomas into carcinomas.
The treatment of EGCG also resulted in prevention of multiple UVB irradiation (90mJ/cm2 on
alternate days for one month)-induced depletion of glutathione peroxidase (78%), catalase (89%)
and glutathione level (85%) concomitant with reduction in UVB-induced lipid peroxidation (76%)
and protein oxidation (67%) in the skin. Because expression of matrix metalloproteinases (MMPs)
have been shown to be associated with the invasion and metastasis potential of skin cancer, in addi-
tional experiments using gelatin zymography and Western blotting, treatment of EGCG resulted in
marked inhibition of multiple UVB irradiation-induced expression of MMP-3 (47%), MMP-7 (88%)
and MMP-9 (86%). Together, for the first time a cream based formulation of EGCG was tested to
explore the possibility of its maximum photoprotective capability, and the data from this study sug-
gest that EGCG could be useful to attenuate solar UVB radiation-induced risk of nonmelanoma
skin cancer and other skin disorders in humans. 
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Topical tacrolimus decreases UVB-induced DNA damage in mouse skin
C Tran, J Lubbe, O Sorg, P Carraux, L Didierjean and J Saurat Dermatology, University Hospital,
Geneva 14, Geneva, Switzerland
Squamous cell carcinomas on sun-exposed sites are a well known long-term complication in patients
undergoing post-transplant immunosuppression with cyclosporin and/or tacrolimus (FK506). Recently,
topical tacrolimus has been introduced for the treatment of atopic dermatitis. UV-induced cutaneous
photocarcinogenesis is of theoretical concern in the setting of long-term treatment of sun-exposed
skin sites in these patients. The aim of the present study was to investigate the in vivo effects of
UVB on mouse skin treated with topical tacrolimus (Protopic 0.1%). Tacrolimus has an absorption
peak at 290 nm, and a UV-filtering effect can be demonstrated using a liposomal model (Tran et al.,
Photochem. Photobiol. 75, 1-5 (2002)). After topical treatment once daily for 10 continuous days,
hairless mice were exposed to 1 J/cm2 UVB, and sacrificed 1 or 24 hours after irradiation. Thymine
dimers in epidermal DNA were visualised by immunohistochemistry, and quantified by immuno
dot blots. Mice treated with either topical tacrolimus or vehicle but not exposed to UVB did not show
any epidermal DNA damage. One hour following UVB-irradiation, vehicle-treated mice showed
many positive nuclei for thymine dimers in histological slices, and immuno dot blots from epider-
mal DNA were strongly labeled for thymine dimers (pixel density of 100%). In contrast, mice treated
with tacrolimus showed much less positive nuclei and the pixel density of immuno dot blots from
epidermal DNA were only 16% of that of vehicle treated counterparts. These results suggest that
0.1% topical tacrolimus inhibits the formation of thymine dimers in UVB-exposed mouse skin, pos-
sibly via a UVB filter effect, for which tacrolimus has an absorption peak at 290 nm. 
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Changes in cytokine network after UVB exposure on HaCaT, HKC-N6 and primo cultures
K Nickova and J Ruzickova CPN, Usti nad Orlici, Czech Republic
Responses to UVB irradiation and grade of activation of keratinocyte cell line HaCaT, HKC-N6 and
primo cultures were monitored by the production of cytokines (IL1β, IL6, IL8, IL10, IL12 and TNFα)
and keratins K1/K10 and K5/K14. UVB doses 0.6; 0.8; 1.0; 1.5; 3.0; 5.0 and 10.0 mJ.cm-2 caused
significant changes in cytokine production after 24h, 0.8 to 1.0 mJ.cm-2 particularly stimulated an
increased production of IL6, IL8 and IL1β. Further TNFα was highly produced after 10.0 mJ.cm-
2. Otherwise concentrations of total IL12 and NO production were not significantly changed. IL10
responsible for immune suppression after UVB exposure increased after 0.6 mJ.cm-2 or 0.8 mJ.cm-
2, higher doses of UVB inhibited.its production. Production of the keratins K1/K10 and K5/K14 was
monitored by RT-PCR. The only distinguishable keratin was K14 after 10.0 mJ.cm-2 in primo cul-
tures. We can therefore see that UVB irradiation caused significant changes to the production of
cytokines and keratins in the tested keratinocytes. 
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Different effects of PUVA and narrow-band UVB on human melanocyte regeneration
H Yu, C Wu  and C Wu Department of Dermatology, Kaohsiung Medical University, Kaohsiung,
Taiwan
Both psoralen plus UVA (PUVA) and narrow-band (311nm) UVB radiation are effective treatments
for vitiligo vulgaris. However, the mechanisms for PUVA and narrow-band UVB in repigmentation
are not thoroughly clarified. Narrow-band UVB irradiation stimulated a significant increase in human
cultured melanocytes migration. Nevertheless, PUVA demonstrated no significantly stimulatory
effect on human melanocytes migration. Both treatments could stimulate a significant increase in
interleukin 8 (IL-8) release from human melanocytes. The expression of phosphorylated p125FAK on
narrow-band UVB-irradiated melanocytes were more prominent as compared to PUVA-treated
melanocytes. Matrix metalloproteinase 2 (MMP-2) and matrix metalloproteinase 9 (MMP-9) activ-
ity in supernatants by narrow-band UVB-irradiated melanocytes and keratinocytes were significantly
increased as compared to PUVA-treated group. Supernatant derived from narrow-band UVB-irra-
diated keratinocytes, but not PUVA-treated keratinocytes, could stimulate the proliferation of human
melanocytes. Moreover, narrow-band UVB induced a significant increase in basic fibroblast growth
factor (bFGF) and endothelin 1 (ET-1) release from keratinocytes.These results suggested that the
mechanisms of PUVA and narrow-band UVB on melanocyte regeneration were different. 
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Induction of UVB-induced tolerance does not only induce T regulatory cells but also T effec-
tor cells
Y Aragane,1 A Maeda,1,3 T Tezuka,1 K Ariizumi2 and T Schwarz3 1 Dermatology, Kinki University
School of Medicine, Osakasayama, Osaka, Japan, 2 Southwestern Medical Center, University of
Texas at Dallas, Dallas, TX and 3 University of Muenster, Muenster, Germany
Ultraviolet B light (UVB) induces tolerance which is due to the induction of hapten-specific T reg-
ulatory cells (Treg). Since sensitization results in the induction of both T effector cells and Treg we
asked whether induction of tolerance by UVB does not only result in the induction of Treg but also
of T effector cells. C3H/HeN mice were first tolerized by painting dinitrofluorobenzene (DNFB)
onto UVB-exposed skin. In addition, we utilized a soluble form of the protein Dectin-2 (sDec2).
Dectin-2 is a co-stimulatory molecule expressed selectively on dendritic cells which appears to play
a pivotal role in UVB-induced tolerance. sDec2 binds to UVB-induced Treg since depletion of sDec2-
bound T cells obtained from UVB-tolerized mice results in the loss of transfer of suppression.
FACS analysis of T cells obtained from UVB-tolerized mice revealed that sDec2 only bound to
CD4+T cells. sDec2-bound CD4+T cells were mainly positive for CD25, a phenotype similar to Treg.
CD4+ T cells from UVB-tolerized mice were further fractionated into sDec2-bound T cells and
injected i.v. into naive syngenic mice. Recipients receiving sDec2-bound T cells could not be sensi-
tized against DNFB, indicating that sDec2-bound, CD4+CD25+ T cells transfer UVB-induced tol-
erance. In contrast, recipients receiving sDec2-unbound T cells could be normally sensitized. Even
more importantly, a specific ear swelling response could be induced in the recipients of sDec2-
unbound T cells when the animals were not sensitized but only challenged with DNFB. This indi-
cates that the fraction of sDec2-unbound T cells obtained from UVB-tolerized mice must contain
DNFB-specific T effector cells. Together, these data indicate that induction of tolerance by UVB
does not only induce Treg but also causes the induction of T effector cells. 
1076
EGF receptor activation by UV irradiation is mediated via HB-EGF shedding in human ker-
atinocytes
S Tokumaru, Y Shirakata, K Yamasaki, Y Yahata, M Tohyama, K Sayama and K Hashimoto
Dermatology, Ehime University School of Medicine, Ehime, Ehime, Japan
UV irradiation has various biological effects on skin. One is EGF receptor (EGFR) phosphorylation
and the subsequent activation of MAP kinase, including JNK and ERK. However, the cross-talk
mechanism linking UV irradiation and EGFR phosphorylation remains unknown. Recently, it was
reported that EGFR transactivation by G-coupled-protein receptors and their ligands is mediated
via HB-EGF shedding, the conversion of HB-EGF from a membrane-anchored form to a soluble
form. This led us to hypothesize that UV irradiation-induced EGFR phosphorylation is mediated
via HB-EGF shedding. First, we examined the effect of UV irradiation on EGFR phosphorylation
in human keratinocytes. UV irradiation (30 mJ/cm2) induced EGFR phosphorylation in a time-depend-
ent manner, optimally 2.1-fold at 20 min. Next, we studied whether UV irradiation is able to induce
HB-EGF shedding from the keratinocyte cell surface. Biotinylated membrane-anchored HB-EGF
on the keratinocyte cell surface disappeared almost completely 10 min after UV irradiation. The
soluble form of EGFR ligands in culture medium was measured by bioassay using the EP170.7 cell
line, which is a stable transformant expressing EGFR. Soluble EGFR ligands in culture medium
increased optimally 1.5-fold at 5 min after UV irradiation. An inhibition assay using anti-HB-EGF
blocking antibody identified 77% of the soluble EGFR ligands as HB-EGF. Furthermore, KB-R8301,
a specific inhibitor of HB-EGF shedding, inhibited the UV irradiation-induced HB-EGF shedding
almost completely at 1 µM. Finally, we studied the effect of KB-R8301 (1 µM) and anti-HB-EGF
blocking antibody (10 µg/ml) on EGFR phosphorylation induced by UV irradiation. Both inhibited
UV irradiation-induced EGFR phosphorylation almost completely. Combined, these data demon-
strate that UV irradiation-induced EGFR phosphorylation is mediated via HB-EGF shedding, the
conversion of HB-EGF from a membrane-anchored form to a soluble form. 
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Studies of 8-MOP/UVA influence on formation of skin photoaging
L Zhongrong1 1 Dermatology, Dermatology Center of Chinese PLA, Xijing Hospital,, Xian,
Shangxi, China and 2 Dermatology, Xijin Hospital, Xian, Shangxi, China
There are more and more evidences that longwave ultraviolet (UV) radiation (UVA; 320-400 nm)
plays an important role in the pathogenesis of photoaging and large-scale mtDNA deletions in UVA
radiation-induced is believed to be involved in.But there is lack of a reliable and practical human
model for research of its possible mechanisms yet. Appearance of premature aging of the skin is the
prominent side effect of photochemotherapy with psoralnes and ultraviolet A (PUVA) in dermatol-
ogy,it is possible that the combined treatment of 8-MOP and UVA would provide models in vivo
and in vitro for study of skin photoaging.In our studies, the skin photoaging-characteristic biologi-
cal markers such as histopathology of skin dermis; expression of SA-beta-galactosidase; expression
of p16 protein; expression of matrix metalloproteinases (MMPs) and their tissue inhibitor of matrix
metalloproteinases(TIMP-1); accumulations of mutations of mtDNA, are observed in biopsies of the
non-lesion back skin of vulgar psoriatic patients who had been treated by PUVA and the cultured
foetus dermal fibroblasts combined treatement with 8-MOP and UVA. With combined treatment of
8-MOP and UVA, the photoaging-characteristic biological markers of the dermal fibroblasts in vivo
and in vitro were changed as follows: 1. with a permanent switch of mitotic to stably postmitotic
phentypes, fibroblasts displayed growth suppression and morphological changes of cell senescence;
2. increased expression of SA-beta-galactosidase; 3. increased expression of p16 protein; 4. contin-
uous up-regulation of mRNA of MMP-1 and MMP-3,while the protein of TIMP-1 is only slightly
induced; 5. high levels of the 4977bp deleted mtDNA accumulated in dermis and cultured fibrob-
lasts.These results suggested that the in vivo and in vitro models may serve as useful tools for the
research of the mechanisms of photoaging,and also may serve as useful tools for research of the
mechanisms of mutations of mtDNA in skin photoaging. 
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Photoaged skin showed lower ERK and higher JNK/p38 activities than intrinsically aged skin
of the same individuals
M Shin, J Chung, G Rhie, C Park, O Kwon, K Cho, K Kim and H Eun Seoul National University
College of Medicine, Seoul, South Korea
Many of the molecular alterations resulting from chronological aging and exposure to UV irradia-
tion are believed to arise largely from oxidative stress. Previously, we have demonstrated decreased
extracellular-signal-regulated kinase (ERK) and increased stress-activated MAP kinase activities
(JNK and p38) in intrinsically aged human skin in vivo, compared with young skin. In this study,
MAP kinase signaling between photoaged and intrinsically aged skin of the same individuals was
compared. Interestingly, ERK activity in the photoaged skin was decreased more, and activities of
JNK and p38 were increased more than intrinsically aged skin of the same individuals, respectively.
c-Jun expression and AP-1 activity in photoaged skin tended to be higher than intrinsically aged
skin of the same individuals. We also demonstrated that catalase activity in the dermal fibroblasts
was decreased with skin aging, and H2O2 was accumulated in aged human dermal fibroblasts. Treat-
ment of catalase reversed the aging-dependent changes of MAP kinases in cultured aged fibroblasts.
Catalase increased ERK activity and inhibited JNK and p38 activities in aged fibroblasts. Our results
suggest that the changes of MAP kinase pathways resulting from skin aging and photoaging may
arise largely from accumulation of reactive oxygen species due to lower level of catalase. This cen-
tral role of oxidative stress may explain in part the observed similarity of signaling changes involved
in photoaging and chronological skin aging. 
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Polypodium leucotomos extract (Fernblock) inhibits photoisomerization and photodescom-
position of trans-urocanic acid
G Panizo, A Brieva, J Alonso-Lebrero and JJ Pivel Research and Development, Industrial
Farmaceutica Cantabria, Madrid, Madrid, Spain
Trans-urocanic acid (t-UCA) is an epidermic pigment derivated from histidine endowed with pho-
toprottective and antiradicalary properties due to the imidazole moiety. UVB induces photoisomer-
ization to cis-UCA (probably to which skin immunosuppression is due); moreover, when UVB acts
in presence of H202 or free radicals, photodescomposition is produced. To the breakdown products
are also immunosupression activities atributed. It is to remark that in the presence of solar irradia-
tion (UVA+UVB) and a photosensitizer, UVB+ROS acting together could generate either isomer-
ization or descomposition of trans-urocanic acid. Polypodium leucotomos extract (Fernblock) has
shown in several assays its antioxidative and immunoprotective activity. In this work, we study the
effect of fernblock on tUCA when irradiated with UVB in absence or presence of oxidative agents.
t-UCA was irradiated by UVB light and photoisomerization to cis-UCA was monitorized by reverse
phase HPLC (RP-HPLC). When irradiated in the presence of H202 the breakdown profile was also
analyzed by RP-HPLC. In both cases a very clear protective activity was found. We are showing a
very simple in vitro model, which allows to demonstrate that Fernblock protects t-UCA from UVB
irradiation effects ever in oxidative conditions. These properties may be of importance to its pho-
toimmunoprotective activity. 
1080
Flashlamp pumped dye laser did not cure papulo-pustolar rosacea
M Berg,1 DW Edstrom2 and A Ros2 1 Dermatology, Malar Hospital, Karolinska Institutet,
Eskiltstuna, Sweden and 2 Dermatology and Venereology, Karolinska Hospital, Karolinska
Institutet, Stockholm, Sweden
Patients with both the erythematotelangiectatic and the papulopustular type of rosacea were treated
with FPDL until telangiectases disappeared. The aim of the study was to see if the treatment result
might be effective on the papules and the pustules. Ten women were treated (mean age 45 years,
range 33-74) on one side of the face with FPDL (wavelength 585 nm, spot size 5 mm, pulse dura-
tion 0.45 ms) in average 2,4 treatments (range 1-4). Before treatment each side of the face was esti-
mated with regard to erythema, telangiectases, papules, pustules or swelling with a scale 0-3 (0=absent,
1=mild, 2=moderate, 3=severe). The final evaluation was performed blind in average 10 months
(range 3-28) after the last treatment with a scale 1-5 (1=worse, 2=unchanged, 3=slightly improved,
4=much improved, 5=cured/no efflorescenses). No other treatment was allowed during the treatment
and follow-up period. Two of the patients had significantly less papulopustular lesions after treat-
ment, three had slightly less, three were unchanged and two had more lesions. Our conclusion from
this rather small sample of patients is that FPDL has a good effect on erythematotelangiectatic rosacea,
but limited value on papulopustular lesion. This means that the origin to rosacea is probably not
only vascular. 
VOL. 121. NO. 1 JULY 2003 ABSTRACTS
1081
Anti-pruritic mechanism of PUVA therapy to patients with atopic dermatitis
K Nakada, M Toyoda and M Morohashi Depertment of Dermatology,Faculty of Medicine,Toyama
Medical and Pharmaceutical University, Toyama, Toyama, Japan
There is a recent increase in the number of patients with atopic dermatits (AD),especially severe
and refractory cases to the standerd therapies for AD such as steroid ointment. Psoralen pho-
tochemotherapy with UVA (PUVA) has been reported to be successfully substitutional for,or an
adjunct to,conventional treatment in AD patients. We examined effects of PUVA on cutaneous neu-
rologic factors,especially on substance P (SP) and neurokinin receptor (NK-1R),in AD. Topical PUVA
therapy for 12 AD patients resulted in the rapid improvement of disease severity and of itch inten-
sity. Immunohistochemical study revealed decreases in intraepidermal innervation of NK-1R on vas-
cular endothelial cells as well as on keratinocytes in AD lesional skin. Densitometrical analysis of
NK-1R expression on endothelial cells demonstrated approximaterly 75% reduction of endothelial-
expression of NK-1R and total UVA dose-dependent reduction of NK-1R immunoreactivity. Ultra-
structurally,degenerative changes of nerve endings were observed just beneath the epidermis. Although
mast cells in AD lesional skin possess a larger amount of SP within their specific granules compared
with the controls,after PUVA therapy,there were significant decrease in SP-containing mast cell gran-
ules and in SP-binding gold particles per a granule at the immunoelectron microscopic level. In
vitro studies using cultured human neural cells showed cell damage represented by disappearance
of neurites in neural cells and disappearance of NK-1 mRNA expression in vascular endothelial cells.
These results suggest that a variety of anti-pruritic mechanisms may lead to successfultherapeutic
efficacy of PUVA for AD,which include decrease in the density of SP-containing nerve fibers and
in the amount of SP within mast cells,degenrrationof nerves,inhibition of mast cells degranulation,the
modulation of NK-1R,and so on,which may in turn contribute to a marked relief of itch intensity in
severe cases of AD. 
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Polypodium leucotomos extract (Fernblock) antagonizes ultraviolet-induced free radicals hyper-
production produced in presence of titanium dioxide
G Panizo, A Brieva, JL Alonso-Lebrero and JP Pivel Research and Development, Industrial
Farmaceutica Cantabria, Madrid, Madrid, Spain
Titanium dioxide (TiO2) is a photocatalitic reactive due to its semiconductor condition, with elec-
tronic transition promoted by UVA light (photoexcitation). Despite this fact, it is widely used in
sunscreen formulations. It is possible to evaluate its photocatalytic capacity by using different bio-
logical models: non-cellular (enzymes) or cellular models. The aim of this work is to show how a
Polypodium leucotomos extract (Fernblock), an antioxidative and photoprotective natural extract is
able to protect either enzymes or cellular system against UVA/TiO2 induced damage. We used as
enzymatic system horseradish peroxidase. Photolysis was induced by UVA irradiation in presence
of TiO2. As a consequence of oxidative damage, the enzyme denatured. This enzyme denaturation
was evaluated by measuring enzymatic activity using H202 and ABTS as sustrate. Additionally,
human erytrocytes and fibroblast cells were used as cellular system and UVA irradiation was per-
formed in presence or absence of TiO2 or Fernblock. Damage in human red cells was evaluated by
hemolysis, monitorized at 540 nm; in the case of fibroblasts by analyzing survival by the MTT
method. As expected TiO2 potentiates UVA induced damage in enzymatic or cellular system. Fern-
block is able to antagonize the effect of the UVA and moreover the effect the UVA+TiO2: preser-
vation of enzymatic activity, reduction of hemolysis (red cells) and survival (fibroblasts) up to 100%.
In conclusion, Fernblock significantly minimize the hyperproduction of free radicals induced by
UVA in presence of TiO2. This antiradicalary property is demonstrated in cellular and non-cellular
system. Therefore, Fernblock may be a excellent adjunct to TiO2 in sunscreen formulations. 
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The in vitro effect of UVB on nitric oxide production in human telomerase immortalized ker-
atinocytes
SC Golden,1 Y E,1 W Lee,1 AR Shalita1 and M Matsui2 1 Dermatology, SUNY-Downstate Med Ctr,
Brooklyn, NY and 2 Bioresearch, Estee Lauder Companies, Melville, NY
Nitric oxide has already been proven to be a critical biological mediator with many physiologic and
patho-physiologic functions. The role in inflammation has important dermatologic implications but
the exact mechanism of UVB induction of nitric oxide has not yet been elucidated. Both eNOS and
iNOS have been immunohistochemically localized in keratinocytes. The purpose of this study was
to determine what effect increasing doses of UVB irradiation had on nitric oxide production in human
telomerase immortalized keratinocytes (hTERT). Futhermore, we intended to determine any rela-
tionship between eNOS and nitric oxide production. In the first part of the experiment hTERT cells
were irradiated with UVB at doses ranging from 0-100 mJ/cm2. Cell associated and supernatant
nitric oxide was measured with Griess assay. In the second part of the experiment hTERT cells were
irradiated with a similar range of UVB doses and eNOS mRNA was measured with ELISA at 12,
24, and 48 hours after stimulation. Our results showed that UVB induced nitric oxide production at
all doses over non-treated cells. At 12 hours the quantity of eNOS mRNA was greater than baseline
with all doses of UVB. At 24 hours there was no significant increase of eNOS mRNA over non-
treated cells at any dose of UVB. At 48 hours eNOS mRNA was increased again over baseline at all
doses of UVB. In conclusion, these results show that UVB does play a role in nitric oxide produc-
tion in hTERT keratinocytes and although eNOS is a constitutive enzyme, UVB at varying doses
appears to affect the amount of eNOS mRNA that is present. There seems to be a biphasic upregu-
lation of eNOS mRNA, increasing at 12 and then 48 hours. Consequently, eNOS might be respon-
sible for an increase in nitric oxide during UVB stimulation during both short and long periods after
exposure and ultimately play an important role in inflammation. 
1084
PUVA arrests cell cycle progression exclusively in S-phase by activating a caffeine sensitive
DNA damage checkpoint
C Joerges, I Kuntze and T Herzinger Dermatology, University of Munich, Munich, Bavaria,
Germany
Induction of interstrand crosslinks (ICLs) in chromosomal DNA is considered a major reason for
the anti-proliferative effect of psoralen plus ultraviolet A (PUVA). Our understanding of how these
ICLs inhibit cell proliferation is incomplete. In order to maintain genomic stability, cells halt cell
cycle progression at certain checkpoints in response to DNA damage to prevent replication of dam-
aged DNA templates or segregation of broken or incompletely replicated chromosomes. Here we
show that HaCaT keratinocytes treated with PUVA arrest with S-phase DNA content. Cells that had
completed DNA replication (G2 cells) were not perturbed by PUVA and passed through mitosis.
Likewise, cells PUVA treated in G1 progressed normally until initiating DNA replication. The repli-
cation arrest was overridden by caffeine, a known inhibitor of the ATM/ATR checkpoint kinases.
PUVA induced rapid phosphorylation of the ATM substrate Chk1 at Ser345 and a concomitant
decrease in Cdc25A levels. Phosphorylation of Chk1 and the decrease of Cdc25A levels were both
abolished by caffeine. Our results suggest that PUVA induced ICLs are sensed as a relevant DNA
damage only during ongoing replication (S-phase). The sensitivity to caffeine further suggests that
active checkpoint signaling rather than mechanical blockage of replication forks by ICLs causes the
PUVA induced growth arrest. 
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Artemia extract significantly down-regulates ATRA-induced IL-1 after UV exposure in human
fibroblasts
E Bauza, K Cucumel, E Roux, C Dal Farra and N Domloge Research Center, Vincience, Sophia
Antipolis, Sophia Antipolis, France
IL-1 is an important pro-inflammatory cytokine that exhibits pleiotropic activities. IL-1 is synthe-
sized by a large number of cells, including skin cells, and exists under two forms, IL-1 alpha, and
beta. Retinoic acid and its derivatives have been widely used in topical skin care products for ther-
apeutic and cosmetic purposes. Our prior studies have shown that Artemia extract (AE) administra-
tion to cells treated with ATRA for a short time, down-regulated IL-1 expression in these cells. As
ATRA-treated skin is known to be fragile toward UV stress, we were therefore interested in inves-
tigating the effect of AE on long-term ATRA-treated cells, with and without UV stress. Intra IL-1
beta level was assessed in the following ELISA studies on cultured human fibroblasts treated with
ATRA 100 nM, for a long time (up to 2 months), with and without UV irradiation with 100 mJ/cm2.
ELISA was performed at different time points during the test period and the results were submitted
to statistical analysis using the Mann-Whitney test which compares the AUC scores under different
conditions, and also compares the findings at different time points. Our results show that in UV-irra-
diated cells (AUC +46%), AE significantly reduced IL-1 beta at different time points in the study
(AUC -60%), confirming that AE down-regulates UV-induced inflammatory cytokines. Furthermore,
cells treated with ATRA and irradiated with UV exhibited a consistently higher level of IL-1 than
control cells (+22.35% increase of AUC over control UV). Interestingly, AE administration to ATRA-
treated cells significantly decreased UV-induced IL-1 in the cells at different time points in the
study (AUC -44%). Moreover, this effect of AE on ATRA-treated and irradiated cells was remark-
able and IL-1 level reached lower levels than in the UV control cells. These results suggest a very
interesting application for Artemia extract, in association with long-term Retinoids therapy of the
skin, in increasing skin comfort especially toward UV stress 
1086
Dietary feeding of procyanidins from grape seeds prevents photocarcinogenesis in mouse skin:
prevention of photocarcinogenesis associated with the inhibition of ultraviolet radiation-induced
oxidative stress and cellular signaling
A Mittal, CA Elmets and SK Katiyar Dermatology, University of Alabama at Birmingham,
Birmingham, AL
There is considerable interest in the use of dietary botanical supplements with substantial antioxi-
dant activity as a complementary and alternative medicine to protect skin from the adverse biolog-
ical effects of solar ultraviolet (UV) radiation. Procyanidins isolated from grape seeds (GSP) have
been shown to have antioxidant properties. In the present study, we tested whether dietary feeding
of GSP to SKH-1 hairless mice prevented photocarcinogenesis by employing long-term animal tumor
protocol concomitant with the mechanism of protection by GSP treatment. Dietary feeding of GSP
(0.2% and 0.5%, w/w) when administered during a UVB (180mJ/cm2)-induced multistage car-
cinogenesis protocol prevented skin tumorigenesis in terms of tumor incidence (20-30%), tumor
multiplicity (45-57%) and tumor size (56-75%). Feeding of GSP (0.5%, w/w) also inhibited malig-
nant conversion of papillomas to squamous cells carcinomas concomitant with reduction in carci-
noma incidence (45%), carcinoma multiplicity (67%) and size of the carcinoma (79%). Dietary feed-
ing of GSP also prevented chronic UV exposures-induced depletion of antioxidant defense enzymes
such as glutathione peroxidase (202%), catalase (81%) and glutathione content (43%), and inhib-
ited UVB-induced lipid peroxidation by 70%. Further, inhibition of UVB-induced oxidative stress
by GSP was delineated with cellular signaling of mitogen-activated protein kinase (MAPK) path-
ways. Western blot analysis revealed that dietary intake of GSP (0.5%, w/w) inhibited UVB radia-
tion-induced phosphorylation of ERK1/2 (45%), JNK (58%) and p38 (86%) proteins of MAPK fam-
ily. The results of this study provide evidence that GSP possesses anti-photocarcinogenic effects,
which may be associated with the prevention of UVB-induced oxidative stress and/or diminution of
activation of cellular signaling cascade of MAPK pathways in vivo mouse skin. 
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Reinforcing properties of UV light in frequent indoor tanners
A Liguori, M Kucenic, SR Rapp, AB Fleischer, W Lang, M Kaur and SR Feldman Wake Forest
University Health Sciences, Winston-Salem, NC
Use of tanning beds is a widespread behavior that is injurious to skin. The purpose of this study was
to assess whether tanning has reinforcing properties that contribute to the behavior. Fourteen fre-
quent tanners were enrolled in a controlled, single-blind, repeated-choice trial of UV exposure for
a six-week study period.  Subjects underwent UV and non-UV exposures in a commercial tanning
apparatus on Monday and Wednesday. Subjects could not discriminate the UV/non-UV filters on
the basis of appearance. After the exposures on Wednesday, their bed preference was recorded. On
Friday, they were given the opportunity to choose to tan in either (or both) of the two beds. 13 of 14
subjects consistently preferred the UV exposure to the non-UV exposure stimulus. In 12 subjects
that chose additional tanning exposure, 11 consistently chose the UV bed for that exposure. The clear
behavioral choice of UV stimulus was mirrored by the reported preference for the UV bed. Greater
“relaxation” was reported after UV exposure compared to after non-UV exposure (p<0.05). These
data support a UV induced mechanism that alters mood and sensation in frequent tanners. This rein-
forcing phenomenon may be an important contributor to tanning behavior in frequent tanners. 
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Efficacy of topical white tea against UV-induced Langerhans cell depletion and DNA damage
in human skin
ED Baron,1 FR Swain,1 M Matsui,2 K Marenus,2 D Maes,2 KD Cooper1 and SR Stevens1 1
Dermatology, University Hospitals of Cleveland/Case Western Reserve University, Cleveland, OH
and 2 Estee Lauder Companies, Melville, NY
There is growing interest in the cutaneous photoprotective effects of antioxidants. Previous studies
show that topical green tea polyphenols decrease damage induced by UVR. White tea, the least
processed of all tea formulations, has not been investigated for photoprotective effects. We aimed to
determine the effects of four compounds: 0.5% green tea polyphenol, 2% white tea extract, 0.2%
white tea powder, and 3% bioconverted white tea, on solar-simulated radiation (SSR)-induced ery-
thema, depletion of CD1a+ Langerhans cells, thymidine dimer formation, and oxidative DNA dam-
age via 8-OHdG levels, in normal human skin. The compounds were applied over gluteal skin in 10
volunteers, 15 minutes before and immediately after 2 MED of SSR exposure. Colorimetric evalu-
ation of erythema was performed and punch biopsies obtained for immunohistochemistry. All four
compounds decreased erythema, although green tea alone resulted in statistically significant reduc-
tion, relative to untreated unirradiated skin. All tea formulations resulted in significant reversal of
Langerhans cell depletion (32-61%), as well as reduction of thymidine dimer (33-69%) and 8-OHdG
(28-47%) levels. These results confirm the photoprotective benefits of green tea polyphenols and
demonstrate for the first time the comparable efficacy of more cosmetically acceptable white tea
formulations in preventing UV-induced damages. 
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Xeroderma pigmentosum group A gene-deficient, stem cell factor-transgenic mice with epi-
dermal melanin are resistant to UV-induced immunosuppression and carcinogenesis
F Yamazaki,1 H Okamoto,1 H Hashimoto-Miyauchi,1 K Tanaka,2 T Kunisada3 and T Horio1 1
Dermatology, Kansai Medical University, Moriguchi, Osaka, Japan, 2 Human cell Biology Group,
Osaka University, Suita, Osaka, Japan and 3 Regeneration Medicine and Bioethics, Gifu
University, Gifu, Gifu, Japan
Xeroderma pigmentosum group A gene-deficient (XPA(-/-)) mouse is a useful model of XP. How-
ever, they have no melanin and melanocytes in the interfollicular epidermis. In the present study, we
developed XPA (-/-), stem cell factor transgenic (SCF(+/-)) mice, which have a defect in nucleotide
excision repair and have epidermal melanocytes and melanin. Using this animal, we investigated
the protective effects of epidermal melanin on the cutaneous changes induced by DNA injuries.
XPA(-/-), SCF(-/-) mice showed a significant ear swelling response (ESR) after UVB radiation or
DMBA application, by which DNA damage is not repaired in XPA(-/-) mice. However, XPA(-/-),
SCF(+/-) mice developed ESR by DMBA but not by UVB. The induction of apoptotic cells and
cyclobutane pyrimidine dimmers (CPD) by UVB radiation were also highly suppressed in XPA(-/-
), SCF(+/-) mice. Contact hypersensitivity (CHS) was not inhibited in XPA(-/-), SCF(+/-) mice. On
the other hand, when mice were treated with DMBA, there were no significant differences in ESR,
apoptotic cell induction, CPD formation, and immunosuppression of CHS between XPA(-/-), SCF(-
/-) and XPA(-/-), SCF(+/-) mice. In XPA(-/-), SCF(-/-) mice, skin tumors were easily induced by
UVB radiation at a total dose of 1J/cm2 or DMBA application. However, in XPA(-/-), SCF(+/-) mice,
skin tumors did not develop even with a total dose of 72J/cm2 of UVB radiation. In contrast, DMBA
treatment induced skin tumors in XPA(-/-), SCF(+/-) mice as well as XPA(-/-), SCF(-/-) mice. These
findings indicate that epidermal melanin has a high ability to protect DNA damages by UVB radi-
ation, and thereby, prevents UV-induced inflammation, immunosuppression and carcinogenesis.
These mice are a useful animal to investigate a role of melanin in UV-protection, since they have
melanocytes in the epidermis similarly to human. 
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Spatial confinement of 5-aminolevulinic acid-based photodynamic therapy by thermal and
chemical inhibition
EK Joe, RR Anderson and BJ Ortel Dermatology, Wellman Laboratories of Photomedicine,
Massachusetts General Hospital, Boston, MA
Topical application of aminolevulinic acid (ALA) results in the accumulation of protoporphyrin IX
(PpIX) in the epidermis and in cutaneous adnexal structures, including hair follicles and sebaceous
glands. ALA-photodynamic therapy (PDT) has been shown in preliminary studies to be an effective
modality for hair removal and for the treatment of acne. However, PDT-induced side effects in the
epidermis—such as superficial exfoliation, crusting, and hyperpigmentation—limit clinical appli-
cations. To improve current methods for PDT, we explored the spatial confinement of ALA-induced
PpIX formation by both thermal and chemical inhibition. PpIX formation was demonstrated to
increase quasi-exponentially with temperatures between 15 and 40 C in a rat epidermal keratinocyte
(REK) cell line. Incubation of REK cells with 0.25 mM ALA at 25 C for 3 hours compared to incu-
bation at 37 C resulted in a 5-fold (80%) decrease in PpIX formation (p < 0.001); incubation at 20 C
compared to 37 C resulted in a 17-fold (94%) decrease (p < 0.001). Chemical inhibition was achieved
by co-exposure of REK cells to ALA and 4,6-dioxoheptanoic acid (DOHA); greater than 90% inhi-
bition of PpIX formation occurred with 1 µM DOHA. Both thermal and chemical inhibition strate-
gies were successfully employed on human skin. Topical application of a 5% ALA solution for four
hours resulted in epidermal fluorescence that could be focally suppressed both by local contact
cooling of the epidermis to 17 C and by local application of a 0.3% DOHA solution. These results
provide promising evidence for two approaches to spatially confine the formation of PpIX that may
lead to improved methods for PDT. By suppressing the formation of PpIX in the epidermis, PDT-
induced side effects may be diminished sufficiently while allowing deeper-lying targets to receive a
therapeutic PDT dose. Practical applications of these techniques include PDT for hair removal and
for the treatment of acne. 
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Lomefloxacin enhances UVA-induced skin tumors in xeroderma pigmentosum group A gene-
deficient mice
I Taketo,1 H Hiroko,1 T Kiyoji2 and H Takeshi1 1 Dermatology, Kansai Medical University,
Moriguchi, Osaka, Japan and 2 Human Cell Biology Group, Osaka University, Suita, Osaka, Japan
Lomefloxacin, a fluoroquinolone antibacterial agent,is phototoxic and phototumorigenic in mouse
skin. The mechanisms of phototumorigenesis of quinolone drugs have not been fully elucidated,while
those of phototoxic reaction have been well studied.Formation of cyclobutane pyrimidine dimers(CPD)
by UVB radiation is primarily involved in carcinogenesis. On the other hand,UVA region is mainly
responsible to photobiologic reactions of quinolone drugs. Then, we investigated phototumorigen-
esis of lomefloxacin using xeroderma pigmentosum group A gene-deficient (XPA(-/-))mouse,which
is defective in nucleotide excision repair. XPA(-/-)mice and XPA(+/+) mice were irradiated to dose
of 5J/cm2-UVAthree times a week with or without lomefloxacin.In XPA(-/-),the first skin tumor
appeared after 5 weeks. The majority of skin tumors were squamous cell carcinomas.In XPA(+/+),the
first tumor appeared after 23 weeks.The number of tumors developed was much more in XPA(-/-)
than in XPA(+/+) mice. Immunohistochemically,CPD formation was obserbed after UVA-exposure
in skin of XPA(+/+) and XPA(-/-) mice which had been given lomefloxacin. However, the CPD dis-
appeared earlier from XPA(+/+) mice than and XPA(-/-) mice.These results indicate that lomefloxacin
and subsequent UVA exposure induces DNA damage,and exerts its phototumorigenesis. 
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Ultraviolet B radiation mediates nuclear translocation of the aryl hydrocarbon receptor
E Fritsche, U Huebenthal and J Abel IUF, Duesseldorf, Germany
The aryl hydrocarbon receptor (AhR) is a ligand activated transcription factor/nuclear receptor that
mediates toxicity of various exogenous chemicals like Dioxin and polycyclic aromatic hydrocarbons
by translocation into the nucleus. There it dimerizes with its partner ARNT before it binds to spe-
cific DNA recognition sequences (XREs) and subsequently activates genes of the AhR gene battery.
This gene battery includes genes that are involved in drug metabolism (e.g. cytochrome P450 ) as
well as xenobiotic metabolism unrelated genes (e.g. TGF-alpha, IL-1beta). UV B radiation is a well
know modulator of the expression of several of these genes in human keratinocytes and an induc-
tion of CYP dependent monooxgenases has been demonstrated in UVB-irradiated human skin. In
the present study we have tested the hypothesis that the AhR is a molecular target for UVB. Accord-
ingly, we transiently transfected cells from the spontaneously immortalized keratinocyte line HaCat
with a green fluorescent protein (GFP) coupled AhR. Fluorescence microscopy revealed that in these
cells, translocation of the GFP-AhR protein from the cytoplasm into the nucleus could be observed
upon stimulation with the AhR ligand Benzo(a)pyrene which served as a positive control. In con-
trast, no nuclear translocation was observed if cells were sham-irradiated or exposed to UVA (340-
400 nm) radiation at dose levels (30 J/cm2) which were sufficient to induce CYP1A1 mRNA expres-
sion. In contrast to UVA radiation, UVB irradiation (10 mJ/cm2) shuttled the AhR into the nucleus
in a time dependent. This nuclear translocation was associated with a 2-fold upregulation of CYP1A1
mRNA steady state levels 6 hours after UVB radiation exposure. These studies demonstrate that
UVB radiation affects AhR signaling in human keratinocytes. To the best of our knowledge this is
the 1st report indicating that UVBR has the capacity to induce the translocation of a nuclear recep-
tor in mammalian cells. Ongoing studies are directed at the identification of the putative physiologic
ligand of the AhR in UVB-irradiated keratinocytes. 
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Effects of ultraviolet radiation on hairless rats: parameters related to oxygen free radicals
and Langerhans cells
J Mallol,1 M Mulero,1 M Romeu,1 MR Nogues,1 J Folch,1 A Fortuno,1 M Carreras,2 FX Sureda1 and
M Giralt1 1 Pharmacology, School of Medicine, REUS, Tarragona, Spain and 2 Research, Novartis
CH, Barcelona, Barcelona, Spain
Using the hairless rat model (Romeu et al., Life Sciences, 2002), we studied the effects of UV radi-
ation (UVR) on 1) parameters related to oxygen free radicals (OFR) in epidermis and blood and 2)
on Langerhans cells (LC). Two groups of rats (n=7 each) received two UV doses (2.14 J/cm2 at an
interval of 24h; UVB/UVA =0.83) on half of their dorsal skin while the other half was protected.
Animals were sacrificed at 72h and at 120h after the second dose of UV. A third group (C) was sham
irradiated. In erythrocytes and epidermis we determined: catalase (CAT), glutathione peroxidase
(GPx), reduced (GSH) and oxidized (GSSG) glutathione, GSH reductase (GR), GSH transferase
(GST), superoxide dismutase (SOD) and thiobarbituric acid reactive substances (TBARS). GSH,
GSSG and TBARS were also analyzed in plasma. In comparison with group C, after UVR, GSH
decreased by 60% at 72h and GSSG decreased by 54% at 72h and 120h in irradiated epidermis; in
erythrocytes, GST increased by 49% and GPX decreased by 26% at both 72h and 120h, and CAT
increased by as much as 35% at 72h and was partially restored at 120h. In irradiated epidermis,
GSSG, GSH and the GSH/GSSG ratio were lower (20%, 37% and 21% respectively) at 72h whereas
CAT was higher (21%) than in the non-irradiated epidermis of the same animal. ATP-ase positive
LC decreased significantly (p=0.010) in irradiated epidermis in comparison with non-irradiated epi-
dermis (21% at 72h and 17% at 120h). Multiple linear regression analysis showed that epidermal
GSSG, GR and GPx were good predictors of the LC number. In an additional study, rats pretreated
with a sunscreen (SPF around 15) with active anti-OFR ingredients received a total UVR dose equiv-
alent to 15 times the minimal erythemal dose. Despite a slight erythema, the number of LC did not
decrease in comparison with control rats. This suggests that erythema and the immunosuppresive
effects of UVR can be prevented independently. 
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Repetitive UV irradiation of cultured skin cells to generate the mitochondrial DNA common
deletion
KJ Krishnan, M Lusher, J Lindsey and MA Birch-Machin University of Newcastle, Newcastle upon
Tyne, Tyne and Wear, United Kingdom
We have shown that an increased incidence of the 4977bp common mitochondrial DNA (mtDNA)
deletion has been strongly associated with increased ultraviolet radiation (UVR) exposure in human
skin. A single study has also shown that the common deletion (CD) can be generated through repet-
itive doses of UVA in cultured skin fibroblasts. The aims of our study were 1) to induce the CD in
cultured skin cells using a UV light source with an output closer to that found in sunlight; 2) to pro-
vide an acccurate and reliable means of measuring low-levels of the CD generated in the cells by
UVR. Using a UVA+UVB light source (Helarium 40W lamp (Wolff B1.01), 290-400nm, peak emiss-
sion at 325nm), we tested a whole series of repetitive UV dose regimes to generate the CD in a cul-
tured HaCaT cell line. The optimal strategy used an alternative daily dose of 500mJ/cm2, which
generated the CD over a period of approximately 35-40 days. The levels of the CD were too low for
accurate determination by our previously used 3-primer PCR assay. Therefore, we compared an
established and reliable, but time consuming, serial dilution PCR method for measuring the CD, with
a nested PCR strategy that was relatively simple to perform as detailed in a previous in vitro study
using UVA (Berneburg et al., J Biol Chem, 274, 15345-9, 1999). Using the serial dilution PCR
method, the first detectable sign of the CD occurred after 17 repetitive doses of 529 mJ/cm2 UVR.
Two further UVR doses caused a 500-fold increase in the level of the CD. In contrast, the nested
PCR technique failed to detect any differences in the levels of the CD from the same DNA samples
and should not be used for accurate determination of the CD. This is important because once a cer-
tain threshold of damage is achieved, it will impair mitochondrial respiratory function, thereby affect-
ing skin biology through the induction of apoptosis and reactive oxygen species. 
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Crosstalk of ultraviolet (UV) B and UVA radiation-induced signaling: a complex relationship
SM Schieke,1,2 K Ruwiedel,1 S Grether-Beck1 and J Krutmann1 1 Institut fuer umweltmedizinische
Forschung (IUF) at the Heinrich-Heine-University, Duesseldorf, North-Rhine-Westfalia, Germany
and 2 Department of Dermatology, Heinrich-Heine-University, Duesseldorf, Germany
In previous years, the signaling pathways responsible for UVB and UVA radiation-induced gene
expression have been characterized in great detail. In particular, UVBR-induced gene expression in
human epithelial cells requires the activation of the MAPKs ERK1/2, p38 and JNK, whereas UVAR-
induced gene expression is initiated by second-messenger ceramide and subsequently mediated by
activation of transcription factor AP-2. Since human skin is mainly exposed to UV radiation from
natural sunlight that consists of both UVB and UVA radiation, we have asked in the present study
whether these two signaling pathways are independent of each other or whether and how they can
interact. We have observed that the strong activation of ERK1/2 in UVB-irradiated primary human
keratinocytes can be completely blocked if the cells are preirradiated with UVAR. In contrast, UVBR-
induced activation of p38 and JNK was significantly enhanced by preirradiation with UVA. Identi-
cal results were obtained if the sequence of irradiations was reversed, i.e. if UVB irradiation was
followed by UVA exposure. The observed crosstalk between UVA and UVB-induced signaling was
most likely mediated by second-messenger ceramide, since pretreatment of cells with cell-perme-
able C2-ceramide was capable of mimicking the UVA effect on the UVB response, i.e. attenuation
of ERK1/2 activation and stimulation of p38 and JNK activation. These studies demonstrate for the
first time a crosstalk between UVB and UVA radiation-induced signaling in human cells. We believe
that our observations provide the molecular basis for previous and contradictory reports on agonis-
tic and antagonistic effects of combined UVA and UVB irradiations. Further analysis of this crosstalk
will be of critical importance for the judgement of widely used photoprotective strategies such as
modern broadband sunscreens. 
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The platelet-activating factor pathway is involved in psoralen+UVA (PUVA)-induced skin dam-
age and apoptosis
P Wolf,1,2 DX Nghiem,2 Y Matsumura,2 JP Walterscheid,2 CD Bucana,3 SE Ullrich2 and
HN Ananthaswamy2 1 Dermatology, Karl-Franzens University, Graz, Styria, Austria, 2
Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX and 3 Cancer
Biology, The University of Texas MD Anderson Cancer Center, Houston, TX
PUVA photochemotherapy is one of the most effective treatment modalities for a large variety of
skin diseases. However, long-term exposure to PUVA (as often needed in psoriasis) has serious side
effects, such as the formation of skin cancers and promoted skin aging. The exact molecular mech-
anisms by which PUVA results in acute and chronic skin damage are not exactly defined, however,
we hypothesized that the proinflammatory PAF pathway (Walterscheid et al, J Exp Med 195, 2002)
may be involved. We investigated whether the intervention in the PAF pathway by application of a
specific PAF-receptor antagonist or a selective COX-2 inhibitor can abrogate PUVA-associated short-
term skin damage. Six to 8 wk old C3H/HeNCr mice were painted on their shaved backs with 8-
methoxypsoralen (100 ug per 100 ul ethanol) 30 min before exposure to 1 minimal phototoxic dose
of UVA (i.e. 50 kJ/m2). The inflammatory response to PUVA was monitored by skin swelling meas-
urements and skin samples were taken from the PUVA-exposed dorsal skin of mice at day 1, 2, 3, 5
and 15 after exposure for microscopic examinations, including H/E, TUNEL, and immunohisto-
chemical p53 stainings. The intraperitoneal administration of both the PAF receptor antagonist PCA-
4248 or the selective COX-2 inhibitor SC-236 (0.2 ug/100 ul each; 15 min before UVA treatment)
were highly effective in preventing PUVA-induced phototoxic skin swelling response. Both drugs
also inhibited PUVA-induced sunburn cell formation, cellular skin infiltration, and epidermal hyper-
plasia. In addition, both drugs partially inhibited PUVA-induced p53 upregulation and apoptosis (i.e.
markers of cellular damage). These results indicate that the PAF pathway is involved in PUVA-asso-
ciated skin damage and apoptosis. The intervention in the PAF pathway may offer new avenues in
preventing the undesired side effects of PUVA. 
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Experimental photopheresis induces cells with regulatory/suppressor activity
A Maeda,1 A Schwarz,1 K Kernebeck,1 D Peritt2 and T Schwarz1 1 Department of Dermatology,
University Muenster, Muenster, Germany and 2 Therakos, a Johnson & Johnson company, Exton,
PA
The basis of extracorporeal photopheresis is the reinfusion of leukocytes, which have been exposed
to 8-methoxypsoralen (8MOP) and UVA. Besides its beneficial effect in cutaneous T cell lymphoma,
photopheresis has shown evidence of benefit for the treatment of autoimmune diseases, solid organ
transplant rejection, GvHD and atopic dermatitis. The underlying mechanism for this effect remains
unresolved. Since UV radiation of the skin exhibits the capacity to induce tolerance (in this case via
regulatory T cells), we asked whether photopheresis might induce a state of tolerance following extra-
corporeal treatment. For this study we utilized a murine model of contact hypersensitivity. Spleno-
cytes and lymph node cells which were sensitized with dinitrofluorobenzene (DNFB) were exposed
to 8MOP plus UVA in vitro. 8MOP/UVA-treated cells were injected i.v. into naive mice which were
subsequently skin sensitized with DNFB and ear thickening measured following ear challenge. Ani-
mals which had received 8MOP/UVA-treated cells were significantly suppressed in their contact
hypersensitivity (CHS) response. In contrast, mice which received cells which were untreated or
exposed to UVA or 8MOP alone were not suppressed in their CHS response. This suppression was
cell-mediated and antigen specific as demonstrated by the ability to transfer the tolerance to a naive
animal which could, however, properly respond to the unrelated hapten oxazalone. Taken together,
these data suggest that infusion of 8MOP/UVA-treated cells from sensitized mice induces a state of
tolerance which is antigen-specific and cell mediated. Additional studies are underway to determine
which type of regulatory T cells mediate this effect. 
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UVB-induced oxidative DNA base damage in primary normal human epidermal keratinocytes
E Pelle,1 X Huang,2 K Marenus,1 D Maes1 and K Frenkel2 1 Skin Biology, Estee Lauder Res Labs,
Melville, NY and 2 Environmental Medicine, New York University School of Medicine, New York,
NY
To evaluate the effects of ultraviolet-induced environmental trauma on human skin cells, primary
normal human epidermal keratinocytes (NHEK) were exposed to ultraviolet B radiation (UVB;
290–320 nm). We found that relatively low doses of UVB (62.5–500 mJ/cm2) caused dose-depend-
ent increases in 8-oxo-7,8-dihydro-2′-deoxyguanosine (8-oxo-dG), a biomarker of oxidative DNA
damage. Unirradiated NHEK contained 1.49 (+ 0.11 SEM) 8-oxo-dG/106 2′-deoxyguanosine (dG)
residues in cellular DNA, which increased linearly to as high as 6.24 (+ 0.85 SEM) 8-oxo-dG/106
dG after irradiation with 500 mJ/cm2.  Further, this oxidative damage was reduced by 60.7% when
the cells were pre-treated with 1 mM mannitol. Since hydrogen peroxide (H2O2) is known to be
generated during oxidative stress, its accumulation in UVB-irradiated NHEK was also assessed and
correlated to 8-oxo-dG formation. An UVB-induced increase in H2O2 was observed in NHEK and
its production was inhibited by the addition of catalase. Based on the ability of a neutral molecule
like H2O2 to permeate membranes, our data indicate that, after UVB irradiation, H2O2 migrates
from the cytosol to the nucleus where it participates in a Fenton-like reaction that results in the pro-
duction of hydroxyl radicals (OH.) which may then cause 8-oxo-dG formation in cellular DNA.
This conclusion is supported by our data showing that OH. scavengers, such as mannitol, are effec-
tive inhibitors of oxidative DNA base damage. 
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Prevention of UV-induced immune suppression in humans by T4 liposomes, RNA and a mul-
tiagent lotion
ED Baron,1 FR Swain,1 M Matsui,2 T Mammone,2 K Marenus,2 D Maes,2 KD Cooper1 and
SR Stevens1 1 Dermatology, University Hospitals of Cleveland/Case Western Reserve University,
Cleveland, OH and 2 Estee Lauder Companies, Melville, NY
DNA damage is involved in UV-induced immune suppression and carcinogenesis. Sunscreens atten-
uate the UVR that reaches the skin. Once DNA damage ensues, other agents may help in the repair
process. T4 endonuclease liposomes excise UV-induced CPDs and have shown efficacy in reducing
neoplasia among skin cancer-prone individuals. RNA fragments have not been utilized for photo-
protection although previous reports show that DNA fragments are photoprotective. The benefits of
antioxidants have also been reported. We aimed to compare the effects of three formulations con-
taining either T4 liposomes, RNA fragments, or a lotion with multiple photoprotective agents, on
the prevention of UV-induced contact hypersensitivity (CHS) suppression in humans. 100 volun-
teers, FST I-III, were randomized into 5 groups which received no treatment, vehicle, or one of the
above preparations. Products were self-applied on gluteal skin once daily for 6 days. Half of the
subjects per group received solar simulated radiation (SSR) at 0.75 MED on day 3 of product use.
DNCB sensitization followed 3 days post irradiation. CHS response was measured via the increase
in skin fold thickness over 5 elicitation sites on the arm, 2 weeks after sensitization. Unprotected
SSR irradiation resulted in 65% CHS suppression. Suppression was reduced to 35% by T4 endonu-
clease, and 23% by RNA fragments. CHS response was enhanced by 29% in the group treated with
photoprotective lotion, which contained sunscreen, antioxidants and RNA. These results introduce
RNA as a photoprotective agent with efficacy against UV-induced immunosuppression that is greater
than T4 endonuclease alone, but not as great as a multiagent formulation containing RNA fragments. 
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Endogenous tissue autofluorescence accentuates nonmelanoma skin cancer margins
JH Tu,1 L Brancaleon,2 A Durkin,4 GM Menaker5 and N Kollias3 1 Dermatology, University of
Rochester, Rochester, NY, 2 Photobiology Unit, University of Dundee, Dundee, Scotland, United
Kingdom, 3 Beckman Laser Institute, Irvine, CA, 4 Dermatologic Surgery Unit, Evanston
Northwestern Healthcare, Skokie, IL and 5 Consumer Products Division, Johnson and Johnson,
Skillman, NJ
Tissue fluorescence in the absence of exogenous photosensitizing agents is termed autofluores-
cence (AF). Normal human skin and nonmelanoma skin cancers (NMSCs) exhibit different patterns
of AF when irradiated under defined light conditions. NMSC are associated with increased levels of
extracellular matrix proteinases, which may explain their biologic behavior. When lesions are early
or previously biopsied or treated, they may be difficult to discern from surrounding normal skin.
Biopsy proven NMSC lesions [basal cell carcinoma (BCC), squamous cell carcinoma (SCC)] were
irradiated in situ with narrowband near-UV visible light [λexcitation=λex=400-550 nm]. Resultant AF
images were digitally recorded through highband pass filters [λemission=λem>450-500 nm] to remove
specular reflection and record AF emissions. NMSC lesions were associated with areas of decreased
or absent AF against the relatively bright background AF of normal skin. Bacterial porphyrins inci-
dentally highlighted sebaceous structures. AF images were analyzed digitally to determine approx-
imate putative tumor areas. Calculated areas were correlated with post-excision defect sizes prior to
repair. λex-λem matrices suggested optimum delineation of apparent NMSC tumor margins at
λex=400±10 nm and λem>500±10 nm. Physiologic rationale and potential applications in manage-
ment of NMSC are discussed. 
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Systemic administration of the phototumorigenic flouroquinolone antibiotic lomefloxacin pho-
tosensitises thymine dimer formation in mouse skin
Y Chatelus, RE Watson and NK Gibbs Dermatology Centre, University of Manchester, Manchester,
M6 8HD, United Kingdom
The fluoroquinolones (FQ) are systemic antibiotics used against a broad spectrum of organisms,
including B.anthracis. Lomefloxacin (LOM) photosensitises human skin to solar UVA radiation
(315-400nm) and we have previously shown that a single systemic treatment with 0.1mg LOM is
phototumorigenic in mouse skin exposed to UVA. Many LOM photosensitised tumours contained
CT or CCTT mutations in p53 which are indicative of thymine dimer (T^T) formation normally
associated with UVB (280-315nm) exposure. Although we have shown that LOM is capable of pho-
tosensitizing T^T in human skin cells in vitro, it is not known whether this occurs after systemic
administration of the drug in vivo. Hairless albino (Skh-1) mice (n=4) received a single i.p. injec-
tion of 0.1mg LOM and their dorsal skin was exposed to 20 J/cm2 UVA (Waldmann PUVA source).
Control animals were exposed to UVA alone (n=4) or to 250 mJ/cm2 UVB (Philips TL-12; ~270-
340nm). Immediately after irradiation dorsal and ventral skin samples were snap-frozen. T^T were
visualized in 10µm frozen sections using the H3 monoclonal antibody and standard immunoperox-
idase techniques. Sections were randomized, blinded and scored on a 5-point ordinal scale (0= no
stain, 4=heavy staining in all epidermal nuclei). The range of mean T^T levels in the ventral (pho-
toprotected) skin of all groups of animals was 0.55-0.61 whilst the UVB irradiated skin scored
2.96±0.18 (mean ± s.e.). UVA alone produced some T^T (0.72±0.05) but this was significantly
increased to 1.74±0.12 by systemic LOM (p<0.0001). Our results suggest that systemic LOM can
reach epidermal DNA and photosensitise T^T lesions which have mutagenic consequences for p53
and other loci associated with skin tumour development. It is not known whether this will also occur
in humans but with recent large-scale prophylactic use of FQ, it is advisable that sun avoidance meas-
ures should be adhered to. 
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Topical DNA oligonucleotide treatment down-regulates constitutive and UV-induced COX-2
expression in cultured cells and in mouse and human skin in vivo
R Atoyan,1 D Goukassian,1 S Arad,1 E Helms,1 R Der Sarkissian2 and B Gilchrest1 1 Dermatology,
Boston University School of Medicine, Boston, MA and 2 Plastic and Reconstructive Surgery,
Boston University School of Medicine, Boston, MA
Overexpression of COX-2 has been demonstrated in chronically irradiated murine skin and inhibi-
tion of COX-2 reduces photocarcinogenesis in mice. p53 is reported to regulate COX-2 expression
both positively and negatively, with discrepancies likely related to protein activity under different
experimental conditions. We have previously reported that DNA oligonucleotides homologous to the
telomere sequence (T-oligos) enhance DNA repair capacity (DRC) and induce multiple cancer pre-
vention responses, effects mediated at least in part through up-regulation and activation of p53. To
determine if T-oligos affect COX-2 expression, human newborn fibroblasts were pretreated with T-
oligos (pTT and GAGTATGAG) or diluent alone for 24 hours, then UV irradiated and processed for
western blot analysis. Within 24 hrs T-oligos markedly down-regulated baseline COX-2 expression,
coincided with activation of p53 (shown by p53 serine 15 phosphorylation). After irradiation, COX-
2 was comparably decreased in diluent and T-oligo-treated samples at 24 hrs. Interestingly, 96 hours
post-UV the level of COX-2 was higher in diluent treated cells than in T-oligo-treated cells, this was
inversely correlated with p53 levels. To examine the effect of T-oligos on COX-2 expression in vivo,
mice were pretreated topically with T-oligo or diluent alone and 24 hrs later UV irradiated. Human
skin explants were provided with T-oligo or diluent alone in culture medium and irradiated 24 later.
Compared to controls, T-oligo down-regulated constitutive COX-2 immunohistochemical staining
in murine and human skin. Pretreatment with T-oligos down-regulated COX-2 expression in irradi-
ated skin (mouse through 16 hours and human skin through 48 hours). We conclude that T-oligos
treatment down-regulates constitutive and UV-induced COX-2 expression by activating and up-reg-
ulating p53. This effect may contribute to the T-oligo’s ability to reduce ptotocarcinogenesis. 
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The local immune suppressive effect of experimental UVB phototherapy correlates with the
increase of CGRP in UVB-exposed murine skin
FJ Legat,1,3 LT Jaiani,2 P Wolf,1 R Lang,4 T Abraham,4 M Wang,3 CA Armstrong,2 JD Glass3 and
JC Ansel2 1 Dermatology, Karl-Franzens University, Graz, Austria, 2 Dermatology, Northwestern
University, Chicago, IL, 3 Neurology, Emory University, Atlanta, GA and 4 Dermatology, Emory
University, Atlanta, GA
UVB is an effective treatment for skin disorders like psoriasis, in which the cutaneous neurosensory
system (CNSS) is suggested to play a pathogenetic role. UVB also induces immune suppression,
which may be part of its therapeutic effect. CGRP mediates a range of immunosuppressive effects
including suppression of contact hypersensitivity (CHS). We investigated the effects of UVB pho-
totherapy on the CNSS and on CHS to DNFB in hairless mice, and the ability of a broad-spectrum
sunscreen to prevent these effects. Skh-1 mice were repeatedly exposed to subinflammatory UVB
thrice weekly for 4 weeks. At 1, 3, or 7d after the last UVB exposure mice were sacrificed and the
number of intraepidermal nerve fibers (ENF) immunoreactive (IR) for CGRP, SP, or PGP 9.5 was
counted, as well as the skin content of CGRP and SP determined by ELISA. At the same time
points, other mice were sensitized to DNFB on exposed back skin, challenged on abdominal skin
5d later, and the immune response (i.e. skin swelling) was determined at 24h after challenge. While
the number of ENF positive for the common neuronal marker PGP 9.5 in exposed back skin did not
change, UVB significantly increased the number of CGRP-IR and SP-IR ENF. The increase in neu-
ropeptide was maximal at 1d after the last UVB exposure and declined thereafter. At all time points,
the number of CGRP-IR ENF was 4-5x that of SP. The skin content of CGRP, but not SP, was also
significantly increased at 1d after the last UVB exposure. At all time points, CGRP content was 10x
that of SP. In addition, UVB significantly reduced CHS to DNFB, also maximal when mice were
sensitized at 1d after the last UVB exposure. Sunscreen pretreatment inhibited the effects of UVB
on CNSS and CHS. These data indicate that UVB exposure and the resulting increase of CGRP com-
pared to SP in UVB exposed skin may play an important role in the immune suppressive effect of
chronic UVB. 
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Spatially selective two photon induction of oxidative damage in fibroblasts
BA King1 and DH Oh1,2 1 Department of Dermtology, University of California, San Francisco, San
Francisco, CA and 2 Dermatology Research Unit, San Francisco VA Medical Center, San
Francisco, CA
Most methods for studying and treating living skin do not readily discriminate among the three-
dimensionally distinct distribution of cutaneous tissue layers and cells. We have previously demon-
strated that near-infrared two photon excitation of psoralen can produce DNA adducts in cells as well
as in a spatially preferential manner. The method has now been extended to produce reactive oxy-
gen species (ROS) using exogenous photosensitizers. Human dermal fibroblasts grown as mono-
layer cultures were treated with dichlorodihydrofluorescein diacetate (H2DCFDA) which acts as both
a photodynamic agent as well as a fluorescent sensor of ROS. Individual cells were irradiated with
a focused, high intensity 800 nm pulsed laser beam through a microscope objective and then probed
to detect fluorescence. Irradiated cells generated significant amounts of ROS relative to background
and unirradiated cells. Subcellular irradiation, in which only a fraction of the cytoplasm or the nucleus
was irradiated, produced fluorescence throughout the cell during the several minute time scale of
the experiment, indicating that focally generated ROS rapidly diffuse throughout the cell and across
the nuclear membrane. Finally, to demonstrate the principle that ROS can be spatially controlled in
a macroscopic tissue, fibroblasts embedded in a three-dimensional collagen lattice were treated
with H2DCFDA and the photosensitizer doxycycline. The near-infrared laser was focused and scanned
in a plane toward the rear of the lattice, and integrated fluorescence from 10 planes throughout the
lattice was subsequently quantified. An approximate doubling of ROS near the focal plane of the
lattice was observed as compared with the front out-of-focus plane. These preliminary results sug-
gest that two photon excitation may be useful in studying ROS and photodynamic mechanisms in
cells and intact tissue, and may eventually be useful in refining the specificity of photodynamic
therapy in skin. 
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Neuropeptide induction of nitric oxide in human keratinocytes in vitro
Y E,2 S Golden,2 W Lee,2 AR Shalita2 and MS Matsui1 1 BRD, The Estee Lauder Companies, Inc.,
Melville, NY and 2 Dermatol, SUNY, Brooklyn, NY
Nitric oxide (NO) is an important signaling molecule in both the CNS and the periphery, where it is
involved with neurotransmission, vascular and bronchial tone, inflammation and cutaneous immune
function. Recently it has been suggested that NO participates in UV-induced immune suppression
by mediating Langerhans cell depletion from the epidermis (Yuen KS et. al., 2002). It is not clear,
however, by what mechanism NO might do this or how NO interfaces with other UV-induced sig-
naling mediators known to be involved in UV-induced immune suppression such as UV-induced IL-
10, CGRP, and TNF-α. For example, CGRP has been shown to be involved in UV-induced immune
suppression and erythema. The goal of these experiments was to investigate the possibility that CGRP,
known to be upregulated in response to UV exposure, stimulates NO production by epidermal ker-
atinocytes. Exposure of telomerase immortalized keratinocytes to either UVB or CGRP induced NO,
but the time course of NO production was different between the two treatments. CGRP from 0.01nM
to 10nM was as potent as 1 to 100ng/ml LPS at inducing NO when measured at time points earlier
than 24hr. SP and VIP (0.1 to 100nM) were less potent, as was TNF-α. UVB(10-50mJ/cm2, CGRP
and SP(0.1-10 nM) were capable of inducing NO without accompanying apoptosis. NO production
resulting from CGRP treatment occurred before iNOS induction. Exposure of keratinocytes to either
UVB or CGRP induced iNOS and eNOS but CGRP upregulation of NOS was much less marked
than UVB. We conclude that CGRP can stimulate production of NO by two separate mechanisms:
an early phase which is independent of iNOS or eNOS protein synthesis, and a later phase which
results from iNOS and eNOS upregulation. In vitro, CGRP treated keratinocytes display a time course
of NO induction that contrasts to keratinocytes exposured to UVB. Therefore, CGRP stimulation of
NO may contribute to UV-induced erythema and immune suppression following UV stimulation of
neuronal CGRP release. 
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The osmolyte strategy of human keratinocytes
S Grether-Beck,1 U Warskulat,2 A Reinen,2 J Krutmann1 and D Haussinger2 1 Institut fuer
umweltmedizinische Forschung (IUF) at the Heinrich-Heine-University, Duesseldorf, Germany
and 2 Department of Gastroenterology, Hepatology and Infectiology, Heinrich-Heine-University,
Duesseldorf, Germany
Organic osmolytes, such as betaine, myo-inositol and taurine, are accumulated or released in response
to hyperosmotic cell shrinkage or hypoosmotic cell swelling, respectively, to maintain cell volume
homeostasis. Osmolyte uptake is important for protection, e.g. against oxidative stress. This so called
osmolyte strategy requires the expression of specific osmolyte transporting systems such as the
betaine-/g-amino-n-butyric acid transporter BGT-1, the sodium-dependent myoinositiol transporter
SMIT and the taurine transporter TAUT. Osmolyte strategies have been characterized in detail in
liver, kidney and neural cells and found to be tissue-specific. In contrast, nothing is known about
osmolytes in the skin. Here we report that primary normal human keratinocytes (NHK) express
mRNA specific for BGT-1, SMIT and TAUT. In comparison to normoosmotic (305 mosmol/l) con-
trols, which only expressed TAUT mRNA, significant induction of BGT-1 and SMIT mRNA expres-
sion was observed 6h and 24h after hyperosmotic exposure (405 mosmol/l). Expression of osmolyte
transporters was associated with an increased uptake of radiolabeled osmolytes. Conversely, hypoo-
somotic (205 mosmol/l) stimulation induced an efflux of osmolytes. Identical data were obtained in
HaCaT cells. Cellular hydration can change after oxidative stress. Since UVB is a source of oxida-
tive stress and UVB and osmotic stimulation induce similar signaling events we next assessed the
influence of UVB on osmolyte transport. Exposure to UVB (0-100 J/cm2) significantly stimulated
myo-inositol and taurine uptake in NHK and taurine and betaine uptake as well as mRNA expres-
sion for BGT-1 and TAUT in HaCaT cells. Osmolyte efflux was not affected by UVB in either cell
type. These studies for the first time demonstrate that NHK possess an osmolyte strategy, which is
important for their capacity to maintain cell volume homeostasis and seems to be part of their response
to UVB. 
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New development in photoprotection: Oral supplementation in healthy volunteers prevents
the oxidative, inflammatory and immune UV-responses in blood cells
N Castex-Rizzi, C Vaissiere, M Haure, M Aries, C Baudouin, M Charveron and Y Gall Pierre Fabre
Research Institute, Toulouse, France
Sunlight ultraviolet radiation is involved in several types of skin damages including sun burn, pho-
toaging, photoimmunosuppression and photocarcinogenesis that are partly mediated through oxida-
tive pathways. The purpose of this study was to search new ways for photoprotection and to evalu-
ate an oral photoprotective preparation (PP), composed of antioxidants and essential fatty acids. In
order to mimic oxidative stress involved in the cellular aging, we treated the peripheral blood lym-
phocytes of volunteers by TNFaα (50ng/ml)or UVA (15J/cm2) in vitro. Then, we analyzed the acti-
vation of the transcription factor NFkκB and the generation of DNA damage, 8-oxo-7,8-dihydro-2’-
deoxyguanosine (8-OxodG). Our results clearly show the antioxidant properties of the oral PP
supplementation: it significantly decreased the UVA-induced 8-OxodG level (8-OxodG/105dG were
0.23 and 0.46 for the PP and placebo group, respectively) and limited also the TNFαa-induced NFκkB
activation (O.D. NFkκB were 0.20 and 0.26 for the PP and the placebo group, respectively). As
regards skin immunosuppression, we investigated the PP effect on monocyte-derived Langerhans
cells (MoLCs) generated in vitro from purified monocytes of volunteers: we focused on the expres-
sion of CD86 co-stimulatory molecule which is of crucial importance in the antigen-presenting func-
tion of Langerhans cells. Before 15J/cm2 UVA irradiation, MoLCs were supplied or not with PP
and then stimulated by 100ng/ml IFNgγ. FACSCalibur flow cytometer analysis demonstrated the
restoration by the PP of the UVA-induced inhibition of CD86 expression (100% positive effect for
cell cultures; 78% positive effect for oral treatment) illustrating its immunoprotective properties.
This systemic photoprotection limits the deleterious effects of UV for endpoints biological responses
that differ from sun burn. In combination with UV filters, this oral supplementation could provide
better photoprotection for human skin relevant to prevent photocarcinogenesis and photoaging. 
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Rinse-off-products containing alpha-tocopherol: an efficient strategy of supplementing the skin
barrier with vitamin E and protecting it from photooxidative damage
S Ekanayake Mudiyanselage,1 A Tavakkol,2 T Polefka,2 P Elsner1 and JJ Thiele1 1 Dept. of
Dermatology, Friedrich Schiller University, Jena, Thuringia, Germany and 2 Colgate Palmolive,
Piscataway, NJ
α-Tocopherol, the major biologically active vitamin E homologue, is generally regarded as the most
important lipid soluble antioxidant in human tissues. Several studies demonstrated the protective
effects of topically applied α-tocopherol leave-on formulations against immunosuppression, DNA
damage, and carcinogenesis. Only little is known about the penetration characteristics and efficacy
of α-tocopherol in rinse-off products. The objective of this study was to investigate whether the sin-
gle use of an α-tocopherol enriched rinse-off product provides i) effective deposition of α-tocopherol
and ii) photoprotection of skin surface lipids. To test this, forearm skin of 13 volunteers was washed
either with an α-tocopherol enriched rinse-off product (TP) or with an α-tocopherol free vehicle con-
trol (CP; contralateral arm) using a standardized wash protocol. Thereafter, skin surface lipids were
extracted with pure ethanol at t=0h or 24h. Additionally, some volunteers were subjected to a single
irradiation of their forearms with low-dose UVA(8 J/cm2) before lipid extraction (n=6). Skin lipid
extracts were analyzed by HPLC using electrochemical detection for vitamin E and UV-detection
for squalene and squalene monohydroperoxide (SqmOOH). Remarkably, the results of this in vivo
study demonstrate that 1)CP treatment lowers, TP treatment strongly increases α-tocopherol levels
of skin surface lipids 2)increased vitamin E deposition effects were maintained for a period of at
least 24 h, and 3)TP treatment provided significant photoprotection of the skin surface lipid squa-
lene. Thus, the use of α-tocopherol enriched rinse-off products may help to maintain the integrity
of the environmentally exposed skin barrier. 
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Fructose 1,6-diphosphate prevents UV-induced photoaging in normal human fibroblast and
human skin in vivo
S Ahn,1 J Kim,1 J Lee,1 B Lee,1 J Chung2 and I Chang1 1 Skin Research Institute, Amore-Pacific
R&D Center, Yongin-si, Gieonggi-do, South Korea and 2 Dermatology, College of Medicine, Seoul
National University, Seoul, South Korea
Exposure of human skin to ultraviolet(UV) irradiation, the major environmental factor that affects
the structure and function of skin, including sunburn, immune suppression, inflammation, cancer
and photoaging. The mechanism responsible for skin damage caused by ultraviolet irradiation is not
fully understood, however. Oxidative stress is discussed as one of the major contributors. Fructose-
1,6-diphosphate(FDP), a glycolytic metabolite, is reported to have cytoprotective effects against
ischemia and postischemic reperfusion injury of brain and heart, presumably by augmenting anaer-
obic carbohydrate metabolism. Recently, we showed that FDP reduced UVB-induced increase in
cellular ROS level although it did not show direct radical scavenging effect in the experiment using
1,1-diphenyl-2-picrylhydrazyl(DPPH) and preserved the cellular antioxidant capacity including cata-
lase activity and GSH content after irradiation. On these premises, we examined whether FDP have
protective effects on UV-induced photoaging in normal human fibroblast culture model and human
skin in vivo. UV irradiation increased MMP-1 expression and decrease of collagen expression in
fibroblast and human skin, which was significantly blocked by FDP although it did not have direct
radical scavenging and UV absorbing effect. And FDP prevents UV induced decrease of cellular
GSH contents. It also prevents UV induced NFκB translocation, which are activated by cellular
oxidative signal. Our results indicate that FDP has protecting effects in UV-injured skin aging by
decreasing UVB-induced MMP-1 expression and procollagen depression, which are possibly through
blocking intracellular oxidative stress. Therefore, FDP may be useful as anti-aging agent for cos-
metic purpose. 
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Repetitive heat shock does not lead to accomodation in human keratinocytes and protects from
UVB-induced cell death
F Trautinger,1 C Kokesch,1 G Klosner,1 R Knobler1 and M Matsui2 1 Department of Dermatology,
University of Vienna, Vienna, Austria and 2 The Estee Lauder Companies, Melville, NY
It has been demonstrated that hyperthermia protects keratinocytes from UVB-induced cell death in
culture and in vivo. This effect is mediated by the anti-apoptotic effect of heat shock proteins that
are transiently induced after exposure to heat at sublethal temperatures. The aim of this study was
to investigate whether repeated exposure to hyperthermia leads to adaptation of the cells, attenua-
tion of the heat shock response, and abrogation of the protective effect. Cells (A431, normal human
epidermal keratinocytes) were exposed to 42 C/4 h at 24 h intervals for 4 consecutive days. The intra-
cellular level of the 72 kD heat shock protein (HSP72) was determined prior to and after each heat
shock by ELISA. Immediately after the first and the last heat shock cells were exposed to UVB
from a metal halide source (400 and 600 mJ/cm2) and survival was determined 24 h after exposure
by an MTT assay. Our results demonstrate that (i) NHEK and A431 are not significantly different
with respect to the response to repeated heat shock; (ii) repetitive heat shock has no influence on
cell growth over a period of 4 days; (iii) hsp72 is strongly induced after 4 h at 42 C and is still above
baseline at 24 h; (iv) re-exposure leads to a superinduction without attenuation of the absolute increase
in hsp72 and of its UVB-protective effect. Induction of hsp by heat shock and other inducers has
been proposed as a novel means of photoprotection. However, with daily UVB-exposure of human
skin in vivo this approach would be less useful if keratinocytes would become less sensitive to hsp-
induction with repeated exposure to the inducing agent. Here we show that adaptation does not occur
over a period of 4 days in culture, thus providing a basis for the development of non-toxic hsp-
inducers that can be repeatedly applied without loss of effect. 
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Initial Vienna experience with extracorporeal photochemotherapy in refractory lung trans-
plantation patients: a pilot study
RM Knobler,1 S Mazhar,2 P Jaksch,2 H Nahavandi,1 M Czerny,2 C Aigner,2 F Trautinger,1
W Wisser2 and W Klepetko2 1 Dermatology, University of Vienna, Vienna, Austria and 2
Cardiothoracic Surgery, University of Vienna, Vienna, Austria
Because photopheresis(ECP) has been described as an immunomodulatory therapy that can signif-
icantly decrease the risk of cardiac transplant rejection without increasing the incidence of infec-
tion,a pilot study was designed to evaluate its efficacy to similarly control refractory chronic lung
transplant rejection. Patients who were undergoing ongoing refractory lung transplant rejection or
bronchiolitis obliterans syndrome were included. In the four patients (mean age 50 +/- 16.3yrs)included
in this study ECP was performed on two consecutive days in intervals of two weeks until response
was noted or could not be achieved (8 month limit). Response was evaluated by lung function tests
including forced expiration volume in one second after maximal inspiration (FEV1), flow after 50%
of forced vital capacity or maximal expiratory flow (MED-50) as well as blood gases and repeat lung
biopsies as needed. Within the deliniated treatment period limits (2 to 8 months) improvement of
lung function was achieved in the first two patients with significant increases in FEV1 169.2% +/-
38.1 and MEF50: 298.3% +/- 16.2; stabilization was observed in the third patient and diminished
but continued deterioration in the fourth patient. This small pilot study confirms previous studies and
suggests that further evaluation of ECP in larger patients cohorts is justified.A planned prospective,
randomized, multicenter study should help confirm these initial positive observations. 
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A comparison of photosensitivity disorders in African-Americans and Caucasians
HA Kerr,1 A Raheja2 and HW Lim1 1 Dermatology, Henry Ford Health System, Detroit, MI and 2
Wayne State University School of Medicine, Detroit, MI
This study was designed to evaluate and compare the distribution of photosensitivity disorders in
African-Americans and Caucasians in an academic medical center. The charts of 148 consecutive
African-American or Caucasian patients with the diagnosis of a photosensitivity disorder or patients
who had phototesting performed over a five-year period were reviewed. There were 74 African-
Americans and 74 Caucasians with photosensitivity disorders. In African-Americans and Caucasians
the distribution of diagnoses was: polymorphous light eruption (57%, 40.5% respectively), sys-
temic phototoxicity to therapeutic agents (21.5%, 11%), chronic actinic dermatitis (15%, 7%), solar
urticaria (2.5%, 11%), porphyria (0%, 23%), solar pruritus (0%, 4%), photocontact dermatitis (0%,
3%), juvenile spring eruption (0%, 3%), and nonspecific photosensitivity disorder (4%, 1%). The
distribution of photosensitivity disorders in African Americans and Caucasians is different. The most
common photosensitivity disorder in both races was polymorphous light eruption. African Ameri-
cans had a higher proportion of systemic phototoxic reactions to therapeutic agents and chronic
actinic dermatitis. Solar urticaria and porphyria was seen more commonly in Caucasians. 
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Squalene monohydroperoxides induce apoptosis in HaCaT cells
F Ogawa,1 W Oehrl,1 S Ekanayake Mudiyanselage,1 P Elsner,1 M Hamburger2 and JJ Thiele1 1
Dept. Dermatology, Friedrich Schiller University, Jena, Thuringia, Germany and 2 Dept. of
Pharmacytical Biology, Friedrich Schiller Univerity, Jena, Thuringia, Germany
Squalene monohydroperoxides (SqmOOH) have recently been identified as the most sensitive in
vivo marker of human skin surface lipid photooxidation. To date, the effects of SqmOOH on epi-
dermal target cells such as keratinocytes are poorly understood. The present study was undertaken
to investigate the effects of SqmOOH on intracellular signal transduction processes involved in cell
growth and apoptosis. To investigate this, HaCaT cells were stimulated with varying concentrations
of SqmOOH or non-peroxidized squalene. Then, the activation of intracellular signaling pathways
regulating cell growth and differentiation as well as apoptosis were assessed by propidium iodine
and Hoechst 33343 staining as well as by Western blotting. It was demonstrated that high doses of
SqmOOH exhibited cytotoxic effects on HaCaT cells, while low doses promoted cell proliferation.
SqmOOH induced apoptosis, as assessed by PARP cleavage, by activating a mitochondrial apopto-
sis pathway involving Caspase 9 and its effector Caspase 3, in a dose- and time-dependent manner.
Moreover, it could be demonstrated that ERK and by p38 MAPK pathways were activated by
SqmOOH, while the JNK pathway was unaffected. Importantly, the effects of ERK and p38 MAPK
inhibitors suggested that these MAPKs are involved in the induction of SqmOOH-induced apopto-
sis. In conclusion, SqmOOH induce a well defined mitochondrial apoptosis pathway in keratinocytes.
Previously described pathways of UVB or UVA induced apopotosis have focused on direct effects
initiated in epidermal cells at the site of the cell membrane (death receptor activation), cytosol
(reactive oxygen species) or the nucleus (DNA damage). Our data suggest an additional apoptosis
pathway with relevance for human skin, which is initiated by the formation of specific photooxida-
tion products at the site of skin surface lipids and, subsequently, their penetration into adjacent cel-
lular layers of the epidermis. 
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Keratinocyte proliferative and apoptotic responses to ultraviolet light (UV) in cyclooxyge-
nase-1 (COX-1) knockout mice
JB VanBuskirk, C Tanck and AP Pentland (SID) Dermatology, University of Rochester, Rochester,
NY
Skin cancer results when keratinocyte proliferation becomes dysregulated and sustained in the epi-
dermis. Prostaglandin E2 is a key regulator of epidermal growth produced by COX-1 & -2. Selec-
tive COX-2 inhibitors very effectively suppress ultraviolet (UV)-induced tumor development and
progression. Paradoxically, overexpression of COX-2 in epidermis can suppress chemically induced
tumors. Clearly, these studies show prostaglandin (PG) regulation is a prominent mechanism regu-
lating tumor development. These findings also raise the possibility that COX-1, the constitutive
enzyme for PG formation has a role in keratinocyte - derived cancer formation. To understand the
role of COX-1 in keratinocyte tumor growth, we studied transgenic mice lacking the COX-1 gene.
An experiment was done in which COX-1 -/- transgenic hairless SKH mice were chronically irra-
diated using UVA-340 sun lamps for 15 weeks, 3 times a week for a total dose of 3.81 x 10 3 mJ
UVB. Tumor incidence was monitored. An acute experiment was also done wherein transgenic
mice were irradiated once with 180 mJ UVB (equal to an hour of summer sun at noon in Rochester,
NY). Keratinocyte proliferation and apoptosis in control and irradiated mice were evaluated in both
experiments. The results showed that COX-1 -/+ and -/- animals were more susceptible to UV-induced
squamous cell cancer, with onset of tumors occurring 6 weeks earlier than in control mice. Apopto-
sis, measured by TUNEL staining, was decreased 10 fold in these animals while proliferation was
less strikingly affected. We conclude that COX-1 -/- & -/+ animals are more prone to develop UV-
induced skin cancer due to misregulation of apoptotic and proliferative mechanisms needed in UV
repair. The possibility that similar mechanisms may play a role in humans suggests signalling path-
ways modulated by PGE2 may be important to skin cancer prevention. 
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All-trans-retinoic-acid increases UVB-induced apoptosis of keratinocytes in in vitro recon-
structed human epidermis
P Mrass,1 M Rendl,1 M Mildner,1 C Ballaun,1 B Lengauer1 and E Tschachler1,2 1 Department of
Dermatology, Division of Immunology, Allergy, and Infectious Diseases, University of Vienna
Medical School, Vienna, Vienna, Austria and 2 CE.R.I.E.S, Neuilly, France
We have shown in the past, that all-trans-retinoic-acid (ATRA)-treatment of primary keratinocytes
(KC) in monolayer-culture leads to an upregulation of several pro-apoptotic caspases, without induc-
ing apoptosis. However, in contrast to untreated KC, KC after ATRA-treatment were highly sus-
ceptible to UV-induced apoptosis. Because retinoids may act differently in vitro and in vivo, we stud-
ied their effect on differentiating KC-cultures mimicking the in vivo situation. ATRA-treatment of
these skin equivalents (SE) by itself induces apoptosis in up to 30% of the cells. UVB-irradiation
(30 mJ/cm2) of ATRA-treated SE further increased KC-apoptosis up to 100%. By contrast, in DMSO-
treated SE only about 10% apoptotic KC, restricted to the basal layer, were observed after irradia-
tion. Because p53 plays a central role in UVB-induced apoptosis, we investigated whether ATRA
also influences p53-expression of KC. In DMSO-treated SE, p53 was found almost exclusively in
basal KC, while after ATRA-treatment p53 could be also detected in suprabasal layers, both before
and after UVB-irradiation. This expression-pattern correlated to the distribution of apoptotic KC
observed after UVB-treatment. Furthermore, both the p53-inhibitor alpha-pifithrin, and the pan-
caspase-inhibitor zVAD strongly reduced UVB-induced apoptosis, indicating that regulation of p53-
expression participates in the ATRA-mediated sensitization to UVB. Taken together, our data sug-
gest that in SE suprabasal KC lose their potential to undergo UVB-induced apoptosis. Furthermore,
we show that ATRA-treated KC of all epidermal layers are sensitized to UVB-mediated apoptosis,
probably via upregulation of p53-expression. 
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In vivo evidence for increased oxidative stress in localized scleroderma lesions
CS Sander, S Kleemann, P Elsner and JJ Thiele Dept. Dermatology, Friedrich Schiller University,
Jena, Thuringia, Germany
The pathopysiology of localized scleroderma is believed to involve damage to the vasculature, immune
activation and connective tissue dysregulation. Oxidative stress is discussed as one of the major
contributors, but convincing in vivo evidence is still lacking. We hypothesized that the natural redox
balance is disturbed in scleroderma lesions and results in accumulation of lipid peroxidation prod-
ucts (LPO) and oxidative DNA damage. LPO products, such as malondialdyde (MDA) or 4-hydrox-
ynonenal (4-HNE) tie spontaneously to DNA, RNA or proteins and thus lead to oxidative tissue dam-
age. 8-hydroxyguanosin (8-OHG) is a commonly used parameter of oxidative DNA damage. Biopsies
of patients with localized scleroderma (n=16) were compared to healthy skin of age-matched patients
(n=16). Expression of the antioxidant enzymes copper-zinc superoxide dismutase (CuZnSOD), man-
ganese SOD (MnSOD) and catalase (CAT) was analyzed by immunohistochemical techniques. To
detect LPO products and oxidative DNA damage, protein-bound MDA, 4-HNE, and 8-OHG were
investigated. In all cases, stained sections were analyzed using densitometric image analysis. In
human scleroderma biopsies, a significant overexpression of the antioxidant enzyme catalase was
found within the epidermis and dermis when compared to age- and site-matched control tissue.
Notably, the lipid peroxidation markers MDA and 4-HNE were significantly increased in sclero-
derma tissue. LPO products were found not only in epidermal keratinocytes cells, but also occurred
in dermal collagen tissue. Furthermore, 8-OHG was significantly overexpressed within the epider-
mis of scleroderma lesions.The activation of the enzymatic antioxidant catalase as well as the accu-
mulation of lipid peroxidation products and oxidative DNA damage found in localized scleroderma
indicate severe oxidative damage. Thus, oxidative stress is very likely to play a pathophysiological
role in the progression of localized scleroderma. 
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Collagen degradation in UV-exposed human skin: MMP-1 is the major collagenolytic enzyme
and high molecular weight fragments are the major degradation products
J Varani,1 M Brennan,1 H Bhatti,1 K Nerusu,1 N Bhagavathula,1 GJ Fisher,2 S Kang2 and
JJ Voorhees2 1 Pathology, Univ. of Michigan, Ann Arbor, MI and 2 Dermatology, Univ. of Michigan,
Ann Arbor, MI
Punch biopsies of human skin were obtained one day after irradiation with two minimal-erythema
doses from a UVB/UVA2/UVA1 light source and incubated in organ culture for 72 hours. Organ cul-
ture fluids obtained at 24, 48 and 72 hours were analyzed for collagenolytic activity and for reac-
tivity with antibodies to matrix metalloproteinase-1 (MMP-1; interstitial collagenase), MMP-8 (neu-
trophil collagenase) and MMP-13 (collagenase-3). High levels of collagenolytic activity were seen
in organ culture fluid from UV-exposed skin. MMP-1 was induced in parallel, increasing from less
than 100 ng/ml in organ culture fluid from control skin to approximately 1.8 µg/ml in culture fluid
from UV-treated skin. While virtually 100% of the detectable MMP-1 in control culture fluid was
represented by the latent form of the enzyme, 50% of the enzyme was present as the active form in
organ culture fluid of UV-exposed skin. In contrast, there was little MMP-8 or MMP-13 in control
organ culture fluid and only a slight increase following UV exposure. Neutralization studies with a
blocking antibody to MMP-1 removed 94+±2% of the collagenolytic activity in the organ culture
fluid from UV-treated skin. Additional studies demonstrated the presence of MMP-2 (gelatinase A),
MMP-9 (gelatinase B) and TIMP-1 (tissue inhibitor of matrix metalloproteinase-1) in control cul-
ture fluids but not TIMP-2. Levels of MMP-9 and TIMP-1 were increased following UV-exposure,
and MMP-9 was activated. When intact type I collagen was exposed to organ culture fluid from UV-
treated skin, the major degradation products were high molecular weight fragments. These findings
strongly implicate MMP-1 as the major collagenolytic enzyme responsible for collagen damage in
UV-treated skin. The failure of MMP-9 to further degrade collagen fragments may reflect the high
affinity of TIMP-1 for this enzyme. 
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Protection from UVB-induced apoptosis—a novel activity of the neuropeptide alpha-melanocyte
stimulating hormone
M Boehm, TA Luger, T Schwarz and A Schwarz Dept. of Dermatology, University of Muenster,
Muenster, Germany
UVB-induced apoptosis is a tightly regulated and complex biological response which eliminates
DNA-damaged cells. Thus, disruption of this process may lead to cellular transformation. We demon-
strate that the neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) suppresses UVB-
induced apoptosis in cultured normal human melanocytes as shown by reduced amounts of oligo-
and mononucleosomes and reduced annexin V staining. This effect was not related to enhanced
melanogenesis as keratinocytes but not melanoma cells were likewise protected by alpha-MSH
from UVB-induced apoptosis. Colony assays revealed that alpha-MSH or its superpotent analogue
NDP-MSH did not delay UVB-induced cell death but indeed promoted long-term survival of
melanocytes. To elucidate the mechanism of the anti-apoptotic activity of alpha-MSH, we performed
DNA content and cell cycle analysis. Alpha-MSH treatment of UVB-irradiated melanocytes did not
alter the percentage of cells in any phase of the cell cycle as compared to cells treated with UVB
alone ruling out that the suppression of UVB-induced apoptosis by alpha-MSH is due to G1 or G2
phase delay. Alpha-MSH also did not change the protein expression of Fas (APO-1/CD95), Bcl-2
and Bcl-X while Fas ligand was undetectable in normal human melanocytes. In contrast, alpha-MSH
treatment of UVB-irradiated melanocytes resulted in a marked reduction in the formation of pyrim-
idine dimers as shown by South Western dot blot. Our results highlight a novel biological activity
of alpha-MSH in pigment cell biology. Moreover, these findings may explain the biological conse-
quences of the recently reported loss of function mutations of the melanocortin-1 receptor in patients
with red hair and light skin and melanoma, respectively. 
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Inducible DNA repair responses in keratinocytes following differentiation and UV radiation
K Yeh2 and DH Oh1,2 1 Department of Dermtology, University of California, San Francisco, San
Francisco, CA and 2 Dermatology Research Unit, San Francisco VA Medical Center, San
Francisco, CA
Repair of damaged DNA is important for replicative fidelity and successful gene expression. Although
differentiating keratinocytes no longer replicate, we have hypothesized that these cells must still
maintain global DNA repair mechanisms to ensure all necessary genes are expressed to complete
differentiation. Using an immunoblot assay, we have demonstrated that, well after Ca2+-induced ter-
minal differentiation has begun, cultured human keratinocytes maintain global genomic repair of
UV-induced cyclobutane pyrimidine dimers and 6-4 photoproducts that is as efficient as in undif-
ferentiated cells. To elucidate mechanisms responsible for the persistence of repair in the differen-
tiating state, we used Western immunoblotting to measure levels of p53, a key mediator of global
genomic nucleotide excision repair. In contrast to undifferentiated cells, basal levels of p53 were sig-
nificantly reduced and not detectably induced in the first 24 hours following 10 J/m2 UVC in dif-
ferentiated keratinocytes. Using quantitative real-time RT-PCR, we next quantified mRNA encod-
ing nucleotide excision repair proteins involved in global genomic repair. In undifferentiated
keratinocytes, XPA, XPC and DDB2 mRNA were induced by 1.4-, 1.4, and 2-fold, respectively in
the first 24 hours following UV, and gradually decreased thereafter. In differentiated keratinocytes,
XPA, XPC and DDB2 mRNA were also comparably induced, although the basal levels were reduced
relative to total RNA. These results indicate that both undifferentiated and differentiated keratinocytes
induce mRNA encoding key DNA repair proteins involved in damage recognition following UV
radiation.  Unexpectedly, efficient global genomic nucleotide excision repair and induction of repair
proteins in differentiated keratinocytes occur in spite of a severe reduction of p53, suggesting other
pathways may exist to induce and maintain nucleotide excision repair in the differentiated state. 
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Cockayne syndrome A and B proteins are present in mitochondria and involved in the repair
of oxidative mtDNA damage
M Fousteri,2 V Kuerten,1,3 T Ruzicka,1 L Mullenders,2 J Krutmann3 and M Berneburg1,3 1 Heinrich-
Heine-University, Molecular Oncology & Aging, Dept of Dermatology, Duesseldorf, NRW,
Germany, 2 Radiation Genetics & Chemical Mutagenesis, Leiden University Medical Center,
Leiden, Netherlands and 3 Institut fuer Umweltmedizinische Forschung, Duesseldorf, Germany
Cockayne Syndrome (CS), showing neurodegeneration, photosensitivity and premature aging, is
caused by mutations in the CSA and CSB gene. Recent evidence suggests that the CSB protein par-
ticipates in the repair of oxidative DNA damage in the nucleus. Mitochondria (mt) are the cells
locus with the highest turnover of reactive oxygen species (ROS). ROS-induced mutations of mtDNA
play a role in (i) the normal aging process and (ii) neurodegenerative mt-syndromes similar to CS.
We have assessed if the CSA and CSB protein are localized in the mt and whether they may play a
role in protecting the mt genome against oxidative stress. Western blot analysis of protein extracts
from mitochondria, purified from normal human fibroblasts and free of nuclear contaminants, revealed
that the CSA and CSB proteins were detectable in the mt. In marked contrast, CSA and CSB were
undetectable in mt-extracts of CSA and CSB patients. We previously demonstrated that mt DNA
mutations can be induced in human fibroblasts by repetitive exposure to UVA radiation as a source
for oxidative stress. To assess the potential relevance of CSA and CSB proteins for protection of the
mt genome we compared the generation of mt DNA mutations in UVA-irradiated fibroblasts from
normal individuals and CS patients. UVA irradiation induced mtDNA mutations after 36 repetitive
exposures in normal controls, whereas only 12 irradiations were required in CSA and CSB cells.
Moreover, stable transfection of the CSB protein into CSB-deficient cells not only restored pres-
ence of the CSB protein in their mt, but also normalized their susceptibility towards UVAR-induced
mtDNA-mutagenesis. These results indicate a role of the CSA and CSB protein in the repair of oxida-
tive damage in mtDNA and provide the first evidence for their role in the process of aging. 
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Induction of p53 and apoptosis in peripheral blood mononuclear cells by different wavebands
of ultraviolet A radiation
A Tanew,1 W Jerney,1 M Hilgarth,2 E Hofstaetter,1 K Schulmeister,3 J Schwarzmeier2 and
H Hoenigsmann1 1 Division of Special & Environmental Dermatology, University of Vienna,
Vienna, Austria, 2 Department of Hematology, University of Vienna, Vienna, Austria and 3 Austrian
Research Centers, Seibersdorf, Austria
UVA1 radiation (340-400 nm) is increasingly employed to treat T-cell mediated skin diseases and
induction of T-cell apoptosis was shown to be a key mediator of the therapeutic effect. In the pres-
ent study we addressed the question whether this effect is specific for UVA1 radiation or can also
be induced by biologically equivalent doses of UVA (315-400 nm) or UVA2 (315-340 nm) radia-
tion. A high pressure UV metal halide lamp with different filter combinations was used to generate
UVA, UVA1 or UVA2 radiation. Irradiance and relative spectral intensity were determined with a
double monochromator. All experiments were done on freshly isolated PBMC of healthy volun-
teers. Dose response curves for cytotoxicity as determined by MTT assay were constructed for each
of the three UVA spectra. The cells were then irradiated with equitoxic doses (LD10, LD25 and
LD50) of UVA, UVA1 and UVA2. Sham irradiated cells served as a control. Quantitative analysis
of apoptotic and dead cells was performed by flow cytometry and double staining of cells with annexin
V and propidium iodide. Expression of p53 was determined by Western blot analysis. Time course
experiments revealed significant apoptosis occuring as early as 2 hours after irradiation. Maximum
numbers of apoptotic cells were observed between 6 to 12 hours after irradiation with UVA1 induc-
ing much higher yields of apoptotic cells than UVA or UVA2 at all applied doses. P53 expression
was increased at a similar level by all wavebands. Our data indicate that different bands of UVA radi-
ation are all capable of inducing apoptosis in PBMC. However, given in biologically equivalent doses
UVA1 appears to be substantially more effective in triggering apoptotic cell death than UVA or UVA2. 
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Induction of photoaging-associated mitochondrial DNA mutations by repetitive UVB irradi-
ation in normal human keratinocytes
M Berneburg,1 T Gremmel,2,1 T Ruzicka1 and J Krutmann2 1 Institut fuer Umweltmedizinische
Forschung, Duesseldorf, Germany and 2 Heinrich-Heine-University, Molecular Oncology &
Aging, Dept of Dermatology, Duesseldorf, NRW, Germany
Mutations of mitochondrial (mt) DNA play a role in the process of photoaging. The most frequent
mutation of the mtDNA, the so called common deletion (CD), which is considered to be a marker
for mtDNA mutations, has been reported to be induced in-vivo in the dermal compartment of nor-
mal human skin as well as in-vitro in normal human fibroblasts by repetitive exposure to ultravio-
let (UV) A radiation. Since it is known that pathways relevant for the process of photoaging can also
be induced by UVB radiation in normal human keratinocytes, we asked the question whether low
dose repetitive UVB exposure of these cells also leads to the generation of the CD. To determine
sublethal conditions for repetitive in-vitro UVB radiation exposure, foreskin-derived normal human
keratinocytes were irradiated with doses of UVB radiation ranging from 0, 3, 6, 12, to 24 mJ/cm2
three times daily at four consecutive days per week. Cells exposed to 12 and 24 mJ/cm2 UVB showed
a significant decrease in cell number and viability whereas doses of 6 mJ/cm2 and below did not
affect the viability of irradiated cells. In the following experiments cells were therefore repetitively
exposed to 6mJ/cm2 of UVB radiation. The presence of the CD was determined by semiquantita-
tive nested PCR and subsequent Phosphorimager analysis after each week of repetitive UVB expo-
sure. Repetitive irradiation of normal human keratinocytes three times daily, four times per week
with 6mJ/cm2 of UVB lead to the induction of the CD after the first week of UV exposure with sig-
nal intensities increasing up to the 3 weeks timepoint. These stduies for the first time demonstrate
that the CD can be induced in normal human keratinocytes by repetitive UVB irradiation. This obser-
vation indicates that mt DNA mutations are not only involved in the process of photoaging induced
by UVA but also by UVB radiation. 
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Ultraviolet irradiation activates NF-κB pathway via association of IκB kinase-γ/NEMO with
IκB kinase-β and IκB-α in human keratinocytes
GJ Fisher, T Quan, T He,Y Shao and JJ Voorhees Dermatology, University of Michigan, Ann Arbor,
MI
Gene expression of primary cytokines IL-1β and TNF-α is transcriptionally regulated by the tran-
scription factor NF-κB. NF-κB activity is sequestered in the cytosol by its association with inhibitory
protein IκB. NF-κB activation by soluble inflammatory mediators involves phosphorylation of IκBα
(the major IκB protein in human keratinocytes) by IκB kinase-β (IKK-β), which targets IκBα for
degradation, and allows NF-κB to localize in the nucleus. Phosphorylation of IκB by IKK requires
the scaffolding protein IKK-γ/NEMO.  We have investigated the role of NF-κB in UV-induced IL-
1β and TNF-α expression and the mechanism by which UV activates NF-κB pathway in human
keratinocytes. UV irradiation (30mJ/cm2, UVB/A2 source) induced IL-1β and TNF-α mRNA in
human skin in vivo (8-10 fold, n=6) and keratinocytes in vitro (3-5 fold, n=4) within four hours.
This induction, in keratinocytes in vitro, was completely inhibited by adenovirus-mediated expres-
sion of dominant IKK-β, or IκBα, indicating that the NF-κB pathway is required for UV induction
of IL-1β and TNF-α. Paradoxically, unlike soluble inflammatory mediators (positive control), UV
irradiation did not cause detectable IKK-α or IKK-β activation (measured by IP kinase assay),
IκBα phosphorylation or degradation (measured by Western blot), or NF-κB nuclear translocation
(measured by immunohistology), or DNA binding (measured by EMSA). However, Western analy-
sis of scaffolding protein IKK-γ/NEMO immunoprecipitates revealed that UV increased association
of IKK-β and IκBα (2-fold, n=4, measured by Western blot). The amount of IκBα complexed with
IKK-β and IKK-γ/NEMO was a minor fraction of total IκBα. These data indicate that NF-κB path-
way is required for UV induction of IL-1β and TNF-α. UV activation of NF-κB pathway, in con-
trast to activation by soluble inflammatory mediators, is difficult to detect because it is mediated
through physical association of a small fraction of IκBα and IKK-β with IKK-γ/NEMO. 
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Topical DNA oligonucleotide treatment enhances UV-induced DNA repair capacity in human
skin in vivo
D Goukassian,1 S Arad,1 R Der Sarkissian2 and BA Gilchrest1 1 Dermatology, Boston University
School of Medicine, Boston, MA and 2 Plastic and Reconstructive Surgery, Boston University
School of Medicine, Boston
UV irradiation causes DNA mutations in skin that may lead to skin cancer. We have shown that treat-
ment of human cells with DNA oligonucleotides homologous to the telomere sequence (T-oligos)
increases DNA repair capacity (DRC) through up-regulation of nucleotide excision repair (NER)
proteins. To investigate in vivo the effect of topical T-oligos (pTT and pGAGTATGAG) on DRC, T-
oligos were added to culture medium of human skin explants (obtained from sun protected areas)
from donors of different ages (24-77 y.o.). After 24 hrs, explants were UVB irradiated and processed
for histologic analysis. Routine histology revealed no changes in unirradiated, T-oligo- or diluent-
treated skin for up to 160 hrs. In UV irradiated skin by 16 to 48 hrs TUNEL (+) cells indicating apop-
tosis were comparable in diluent-treated and T-oligo-treated UV irradiated skin. There was no dif-
ference in the number of TUNEL (+) cells in diluent vs T-oligo treated skin. Maximum and comparable
cyclobutane pyrimidine dimers (CPDs) were detected by antibody staining immediately after UV
irradiation (time 0) in diluent-treated vs T-oligos-treated skin, suggesting no sun screen effect of top-
ical T-oligos. Within 24 hrs 51±9% of cells were CPDs (+) (an average of 3 x40 visual fields) in
diluent-treated skin vs 25±5% and 29±2% in pTT and pGAGTATGAG-treated skin, respectively
(p<0.001). The decrease in CPDs (+) cells persisted for the T-oligos-treated skin and it was also evi-
dent by 48 hrs post-UV 7±7 and 4±1 vs 12±2% in diluent-treated (p<0.05) and at 72 hrs 0 and 0 vs
7±2% (p<0.001). We conclude that topical T-oligo treatment of intact human skin enhances DRC,
leading to accelerated CPD removal following UV irradiation. Our studies suggest that topical oligonu-
cleotide therapy of human skin may ultimately prevent UV-induced cutaneous malignancies. 
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CHOP/gadd153 expression, caspase-3 activation, and sunburn cell formation (apoptosis) are
up-regulated concurrently following UVB irradiation of murine skin
E Chakrabarti, H Kawamura and EV Maytin Dermatology and BiomedicalEngineering, Cleveland
Clinic Foundation, Cleveland, OH
CHOP/gadd153 (or simply CHOP) is a transcription factor, known to be induced by stresses and tox-
ins that damage membranes and cause protein unfolding in the ER. CHOP expression is induced by
the same spectrum of damaging agents (toxins, chemotherapeutics, and UV light) that also kills cells
by apoptosis, and forcible overexpression of CHOP in cultured keratinocytes and other cell types
has been shown to induce apoptosis directly (Maytin et al., Exp. Cell Res. 267:193-204, 2001). We
wondered whether CHOP after UVB exposure may participate in UVB-induced apoptosis in vivo.
We exposed SKH-1 hairless mice to single doses of UVB (80 mJ/cm2), and the time course of CHOP
expression was followed in frozen sections using anti-CHOP antisera and a Cy3-conjugated sec-
ondary antibody. CHOP increased slightly at 30 min, more at 4 h, and very strongly at 24 h as com-
pared to the sham-irradiated flank of the same animal. This time-course corresponded closely to
that for increased epidermal SBC. These changes were confirmed in paraffin-fixed skin sections,
after epitope unmasking with Retrieval-All solution (Signet Labs; pH 9.5, 30 min, 95 C), which also
confirmed the nuclear location of CHOP. Previous studies in keratinocytes in vitro had shown UVB-
induction of CHOP mRNA, but our results now demonstrate CHOP induction at the protein level in
the intact epidermis. If CHOP has a role in epidermal apoptosis, it might be expected to affect one
or more caspases in epidermal cells. Using an antibody that detects cleaved caspase-3 (but not the
proenzyme) in paraffin sections, we observed an increase in activated caspase-3 at doses and times
similar to those for CHOP and SBC. Caspase-3 represents a downstream target for several caspase
pathways, which suggests that UVB-induced apoptosis may be mediated, at least in part, through a
mechanism in which CHOP acts via one or more caspase pathways. 
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UVA and UVB decrease the expression of CD44 and hyaluronate in mouse epidermis which is
counteracted by topical retinoids
E Calikoglu,2 O Sorg,1 P Carraux,1 JH Saurat1 and G Kaya1 1 Dermatology, University Hospital of
Geneva, Geneva, Switzerland and 2 Dermatology, Fatih University Medical School, Ankara
CD44 is a transmembrane glycoprotein and the principal cell surface receptor of hyaluronate (HA).
In a recent study we have shown that two major functions of CD44 in the mouse skin are the regu-
lation of keratinocyte proliferation in response to extracellular stimuli and the maintenance of local
HA homeostasis. Recently we have shown that the topical application of retinaldehyde (RAL) resulted
in an epidermal hyperplasia and a marked increase of CD44 expression in the epidermis of C57BL/6
and SKH1 hairless mice. Our previous studies have also shown that topical RAL prevented the gen-
eration of oxidative stress induced by UVA and UVB irradiation in SKH1 mice. In this study we
examined, by anti-CD44 antibody and hyaluronate binding protein (HABP) stainings, the expres-
sion of CD44 and HA in mouse epidermis pretreated topically by 0.05% RAL, 0.05% retinoic acid
(RA) and 0.05% retinol (ROL) for 3 days and irradiated with UVB, and pretreated by RAL and irra-
diated with UVA. We also explored the RNA expression of CD44 by Northern blot. Immunostain-
ing of vehicle-treated back skin of SKH1 mice revealed the standard membrane localization of CD44
and HA in basal and suprabasal keratinocytes. CD44 expression was significantly reduced in the
membrane and became cytoplasmic 2h after UVA (10 j/cm2) or UVB (1 j/cm2) irradiation and recon-
stituted within 8 or 24 h for UVA and UVB, respectively. HA staining and CD44 RNA expression
showed a similar pattern of decrease and reconstitution. Topical application of RAL significantly
increased the epidermal thickness and the membrane staining of CD44 and HA in follicular and inter-
follicular keratinocytes and prevented the decrease of CD44 and HA in the epidermis induced by
UVA and UVB irradiation. RA and ROL, as RAL, increased the expression of epidermal CD44 at
the protein level and of epidermal HA. The role of retinoid-induced increase of epidermal CD44
and HA in the protection of oxidative stress induced by UVA and UVB irradiation is yet to be elu-
cidated. 
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Ultraviolet irradiation induction of Smad7 via activation of transcription factor AP-1 con-
tributes to loss of procollagen gene expression in human skin fibroblasts
T Quan, T He, JJ Voorhees and GJ Fisher Dermatology, University of Michigan, Ann Arbor, MI
Smad7 functions as an endogenous negative regulator of TGF-β/Smad signaling, which promotes
collagen production. Reduced expression of Smad7 is associated with increased TGF-β/Smad activ-
ity in fibrotic skin diseases such as scleroderma. UV irradiation impairs TGF-β/Smad signaling and
reduces expression of procollagen in human skin in vivo and cultured human skin fibroblasts. We
investigated the role of Smad7 in UV impairment of TGF-β/Smad signaling and reduced procolla-
gen expression. UV irradiation (solar simulator, 2MED) induced Smad7 mRNA and protein in human
skin in vivo and cultured human skin fibroblasts. Maximal induction of Smad7 mRNA (2.5-fold,
n=3) and protein (3-fold, n=3) was observed within 5 hours post UV. Smad7 protein remained ele-
vated for at least 24 hours after UV. UV irradiation of cultured human skin fibroblasts stimulated
Smad7 gene transcription, as determined by Smad7 promoter reporter assay. Smad7 promoter con-
tains both AP-1 and Smad3 response elements. UV irradiation induced protein binding to the AP-1
element, but not the Smad3 element, in electrophoretic mobility shift assays. Increased AP-1 bind-
ing resulted from UV induction of AP-1 components c-Jun and c-Fos. Deletion of AP-1 binding site
of the Smad7 promoter abolished UV-activation of Smad7 transcription. Over-expression of domi-
nant negative c-Jun also substantially reduced UV induction of Smad7 transcription. Finally, over-
expression of Smad7 in human skin fibroblasts resulted in near total inhibition of TGF-β-induced
type I collagen α2 promoter activity. Taken together, these data indicate that UV irradiation induces
Smad7 via activation of transcription factor AP-1 and that Smad7 contributes to reduction of pro-
collagen gene expression observed in UV-irradiated human skin. 
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Photomodulation of human skin fibroblast activity in vitro and in vivo
DH McDaniel,1 R Weiss,3 R Geronemus4 and J Newman1 1 Anti-Aging Research and Consulting,
Virginia Beach, VA, 2 Eastern Virginia Medical School, Norfolk, VA, 3 Maryland Laser Skin & Vein
Institute, Hunt Valley, MD and 4 Laser & Skin Surgery Center of New York, New York, NY
This study evaluated the effects of light emitting diode (LED) photomodulation of human fibroblast
cells in tissue culture and also correlated these findings with skin biopsies from subjects who received
the same LED photomodulation in a multi center clinical trial. Control and treated fibroblast cells
were evaluated using ELISA, microarrays and RT-PCR. Skin biopsies from the faces of photoaged
female subjects were obtained at intervals of 1, 4, 8, 12 and 16 weeks past completion of LED pho-
tomodulation and established using immunofluorescence. Blinded expert grader of clinical photog-
raphy, digital skin profilometry and high-resolution ultrasound were also performed to objectively
correlate the changes in the clinical appearance of the skin with the structural changes observed
with the histopathology. One week after final treatment, the global improvement in appearance of
skin in periorbital region was 62% and upper lip improvement was 36%. Other observations in peri-
orbital area included reduction of 27% in skin roughness, 30% in elastosis, 14% in pore size, and
25% in redness. Immunofluorescence showed changes in a variety of structural proteins such as col-
lagen I and procollagen I. Increases of these proteins were observed in both skin biopsies and fibrob-
last tissue culture while MMP-1 was decreased. Increases in collagen I and decreases in MMP-1
were observed diffusely throughout the dermis. This is in contrast to the upper dermal grennz zone
typically associated with ablative thermal photorejuvenation. Traditional non-ablative and intense
pulsed light skin photorejuvenation procedures produce a thermal injury to the dermis, however LED
photomodulation operates via a non-thermal process. The implications of data from these in vitro
and in vivo studies and photomodulation cell signaling theory and clinical skin rejuvenation will be
summarized. 
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Skin protection by inhibitors of photosensitization reactions
EL Jacobson,1,3 GT Wondrak,1,2 M Roberts,1,2 D Cervantes-Laurean1,2 and MK Jacobson1,2 1
Pharmacology & Toxicology, University of Arizona, Tucson, AZ, 2 Arizona Cancer Center,
University of Arizona, Tucson, AZ and 3 Niadyne, Inc., Tucson, AZ
Reactive oxygen species (ROS) are widely accepted as crucial mediators of skin phototoxicity but
the targets of solar radiation leading to the generation of ROS are still poorly understood. We have
identified two potentially important targets that interact with UVA to generate ROS within human
skin, namely protein-bound advanced glycation endproducts (AGE) and enzymatically formed extra-
cellular matrix (ECM) chromophores such as the collagen crosslink pyridinoline. Generation of the
ROS superoxide and hydrogen peroxide was driven by solar simulated irradiation (SSL; 2.30 J/cm2
UVA, 0.12 J/cm2 UVB) of skin proteins that included type I collagen and elastin, resulting in pro-
nounced inhibition of proliferation of cultured human HaCaT keratinocytes and CF3 fibroblasts.
Glycation also strongly enhanced the sensitization potency of ECM-proteins. Most of the photo-
sensitization was attributed to the UVA-component. We hypothesize a complex synergism between
UVA-irradiation and skin chromophores that are present endogenously or result from glycation that
results in a vicious cycle of ROS generation underlying skin pathology. The involvement of AGE
and other skin chromophores as key mediators of skin photodamage makes them novel targets for
therapeutic intervention. In an effort to facilitate the pharmacological development of compounds
for topical skin photoprotection, we have developed assays for the identification of promising com-
pounds that can prevent UVA induced generation of different classes of ROS. Two classes of com-
pounds have been identified that confer photoprotection by inhibiting protein glycation or by directly
quenching photoexcited states that result from the interaction of chromophores with UVA. The top-
ical delivery of these compounds as novel classes of photoprotective agents could have impact in
limiting various skin pathologies including chronological aging, photoaging, diabetic complications,
and cancer. 
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Structural identification and biological significance of a novel UVB-generated platelet-acti-
vating factor activity
JB Travers,1 C Johnson,2 SD Billings,1 MD Southall,1 D Spandau,1 RC Murphy,2 T McIntyre3 and
G Marathe3 1 Indiana University, Indianapolis, IN, 2 National Jewish Center, Denver, CO and 3
University of Utah, Salt Lake City, UT
Through its ability to stimulate cytokine production and cytotoxicity, ultraviolet B radiation (UVB)
has profound effects on human keratinocytes. UVB can also act as a pro-oxidative stressor. Platelet-
activating factor (1-alkyl-2-acetyl glycerophosphocholine [GPC]; PAF) is a lipid-derived mediator
with many biological effects synthesized by the subsequent actions of phospholipase A2 and acetyl-
transferase in response to many stimuli. In addition to this enzymatic pathway, recent studies sug-
gest that oxidative stress can directly act on GPC resulting in the formation of GPC with short sn-2
fatty acids, which act as potent PAF-R agonists. We have previously shown that UVB-mediated pro-
duction of the cytokines TNF and IL-8, as well as UVB-induced cytotoxicity is enhanced by the
epidermal PAF-R (J. Biol. Chem. 273:18891; 274:26917). Thus, the objective of the present stud-
ies was to structurally characterize UVB-induced PAF activity and define its biological signifi-
cance. Retroviral-mediated overexpression of the PAF-R in primary cultures of human keratinocytes
resulted in enhanced UVB-induced apoptosis both in vitro, as well as in vivo using xenografts of
transduced cells grown in SCID mice. To characterize UVB-induced PAF agonistic activity, we
subjected lipid extracts from UVB-irradiated epidermal cells to gas chromatography-mass spectro-
metric analysis. Significant levels of 1-hexadecyl 2-acetyl GPC (PAF), as well as 1-hexadecyl-2-
butanoyl and 2-butenoyl GPC were found in epidermal cells following UVB treatment. Finally, UVB
treatment of purified 1-hexadecyl-2-arachidonoyl-GPC generated the same molecules directly, indi-
cating a non-enzymatic process. These studies suggest that the PAF system in human skin is a tar-
get for UVB, resulting in enhanced cytokine production and apoptosis through the production of
novel PAF agonists. 
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Differential effect of NFκB on the response of normal and immortalized human keratinocytes
to UVB irradiation
S Hengeltraub,2 DA Lewis,2 MA Horine2 and DF Spandau2,1 1 Dermatology, Indiana University
School of Medicine, Indianapolis, IN and 2 Biochemistry & Molecular Biology, Indiana University
School of Medicine, Indianapolis, IN
The transcription factor NFkB has been implicated in the survival of cells following cytotoxic
stress. We have examined the role of NFkB in human keratinocytes in response to UVB irradiation.
We demonstrate that UVB irradiation induces NFkB activation in a dose-dependent manner. NFkB
activation was analyzed by in vitro DNA-binding assays and functionally by in vivo reporter gene
assays. UVB activated NFkB in both normal human keratinocytes and immortal HaCaT keratinocytes
in a similar manner. The role of NFkB in the response of keratinocytes to UVB irradiation by the
introduction of the mutant super repressor IkB gene (IkBsr) into the keratinocytes. The IkBsr pre-
vents the activation of NFkB following cell stress. Suppression of NFkB activity in normal ker-
atinocytes and HaCaT cells resulted in differing effects following UVB-irradiation. As previously
described for other cell systems, inactivation of NFkB activity in normal human keratinocytes resulted
in an increase in sensitivity to UVB-induced apoptosis. In contrast to these data, inactivation of NFkB
in HaCaT cells protected cells from UVB-induced apoptosis. As the induction of NFkB activity by
UVB in each cell type was similar, differences in downstream effectors of the NFkB pathway results
in pro-apoptotic pathways in immortal keratinocytes and pro-survival pathways in normal ker-
atinocytes. 
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8-methoxypsoralen photoadducts mapping of p53 gene in the fibroblasts treated with PUVA
D Suh,1 AE Peritz,2 J Youn,1 FP Gasparro2 and J Uitto2 1 Dermatology, Seoul National University
College of Medicine, Seoul, South Korea and 2 Dermatology and Cutaneous Biology, Jefferson
Medical College and Jefferson Institute of Molecular Medicine, Thomas Jefferson University,
Philadelphia, PA
Photochemotherapy with 8-methoxypsoralen (8-MOP) and ultraviolet A (UVA) radiation (PUVA)
has been used for many years as an effective treatment for psoriasis. However, prolonged use is
associated with an increased risk of squamous cell carcinoma (SCC). Analysis of mutations in the
p53 gene in DNA isolated from these SCCs revealed a prevalence of non-PUVA type mutations. To
resolve the apparent lack of a link between PUVA type DNA damage, the observed mutations and
the increased incidence of SCC, 8-MOP photoadducts were mapped at nucleotide resolution using
single strand ligation mediated PCR (sslig-PCR). Primary human fibroblasts were treated with 8-
methoxypsoralen and either ultraviolet radiation or visible light. Genomic DNA was isolated and
exons 5 and 7 of the p53 gene were mapped. Photoadducts were detected at twenty nucleotide sites
in exon 5 and at seventeen nucleotide sites in exon 7. In contrast to previous observations that 5’-
TpA-3’ was the preferential site for photoadduct formation in DNA fragments when dissolved in
aqueous solutions, we found that there is a diverse distribution of sites for photoadduct formation at
pyrimidines as well as purines. 
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Contribution of pyrimidine dimers to UVA mutagenesis
UP Kappes and TM Ruenger Dermatology, Boston University School of Medicine, Boston, MA
While it is well established that UVA is a mutagen and skin carcinogen, its mechanisms of mutation
formation are not well understood. Since UVA, in contrast to UVB, is limited in its ability to gen-
erate pyrimidine dimers, UVA-induced oxidative DNA damage has been suggested to mediate UVA-
mutagenesis. However, a detailed analysis of UVA- and UVB-induced somatic mutations has not
been described in human cells. In order to investigate mutation formation by UVA and UVB, we
used the HPRT-mutagenesis assay with primary human fibroblasts. This assay measures the fre-
quency of spontaneous or induced hprt-mutations by selection for 6-thioguanine-resistance. In 3 to
5 independent experiments, we found a mutation frequency of 54 ± 17 hprt-mutants/106 cells with
20 J/cm2 UVA1 and of 20 ± 9 hprt-mutants/106 with 20 mJ/cm2 UVB. To further characterize UVA1-
and UVB-induced mutations, we performed nested RT-PCR and sequence analysis of the hprt-gene
of UVA1- and UVB-induced hprt-mutants. All mutations were confirmed by sequencing the hprt
cDNA in two directions. In a total of 29 sequenced independent mutants, 90 % carried single base
substitution mutations, the remaining deletions. 70 % of UVB-induced point mutations were C to T
or CC to TT transitions. This is consistent with a predominant role of pyrimidine dimers in UVB-
mutagenesis, as these mutations are considered ‘signature mutations’for pyrimidine dimers. A hotspot
with 12 C to T transitions was observed at bp 659, which is located within a pyrimidine run of
CCTTTT, a likely target for pyrimidine dimer formation. Surprisingly, at the same hotspot, UVA1
generated C to T transitions with a similar high frequency (89 %). This points to a mutagenic role
of pyrimidine dimers also with UVA1. The second most common mutation was a T to C transver-
sion, possibly arising from thymine oxidation. It was also seen in similar frequency with UVB and
UVA1 (20 and 17 %). Our data suggest similar mechanisms of mutation formation, including a promi-
nent role of pyrimidine dimers, with UVA1 and UVB. 
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Identification of novel genes encoding melanocyte/melanoma-specific proteins using GeneChip
T Inozume,1,3 Y Suzuki,1 S Shimada,3 H Aburatani2 and Y Kawakami1 1 Division of Cellular
Signaling, Institute for Advanced Medical Research, Keio University School of Medicine, 2
Genome Science Division, RCAST, The University of Tokyo, Tokyo, Japan and 3 Dermatology,
Yamanashi University, Yamanashi, Japan
For understanding of biology of melanocytes and development of diagnostic and therapeutic meth-
ods for hereditary and acquired pigment disorders as well as melanoma, we have attempted to iden-
tify melanocyte specific molecules systematically using DNAChip. cDNA profiles of various tissues
and cell lines including primary cultured melanocytes and highly pigmented melanoma cell line,
SKmel23, produced with GeneChip containing 42,000 probes were compared. The 603 genes that
expressed in primary cultured melanocytes more than 3 times than other normal tissues were first
selected. Among 603 genes, 44 genes predominantly expressed in cDNA libraries made from
melanocyte-containing tissues in NCBI database were selected, and actual tissue expression was
evaluated by RT-PCR. Two uncharacterized genes (FCRL/FREB and novel gene, MLG: MDR like
gene) were preferentially expressed in primary cultured melanocytes, melanoma cell lines, and
melanoma tissues. FCRL/FREB has recently been reported to be a member of the Fc receptor fam-
ily and expressed predominantly in B cells in germinal center. We found that the FCRL/FREB was
also expressed in some of the melanoma cell lines and tissues by immunohistochemical analysis with
murine polyclonal Ab specific for FCRL/FREB that we have generated. The FCRL/FREB protein
made by bacterial and mammalian expression systems were recognized by IgG Ab in sera of melanoma
patients and healthy individuals. The other identified novel gene, MLG, appears to encode a 131 aa
protein homologous to multi drug resistant gene 1 (MDR1) containing a ATP binding site. The GFP
fused protein is localized in nucleus of melanoma cell lines. These molecules preferentially expressed
in pigment cells may be useful for further understanding of melanocyte biology and development of
diagnostic and therapeutic methods for pigment disorders. 
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A double-blind randomized trial of 5% ascorbic acid versus 4% hydroquinone in melasma
LE Espinal-Perez, B Moncada and J Castanedo-Cazares Dermatology, UALSP, San Luis Potosi,
San Luis Potosi, Mexico
Melasma is an acquired hyperpigmentation of difficult treatment. Sixteen female with idiopathic
melasma were included in our trial. After randomization from another clinician they were instructed
to use at night, for sixteen weeks, 5% ascorbic acid cream in one side of the face and in the other
side, 4% hydroquinone cream. Sunscreen was applied daily throughout the period of observation.
They were evaluated every month with colorimetry, digital photography and regular color slides.
Subjective evaluation by each patient was taken in account. The best subjective improvement was
observed on the hydroquinone side with 93% of good and excellent results compared with 62.5%
on the ascorbic side (p≤0.05), with colorimetric measures there were no statisfical differences. Side
effects were present in 68.7% with hydroquinone vs 6.2% with ascorbic acid. Even though hydro-
quinone showed the best response, ascorbic acid may play a role in the therapy of melasma since it
is almost devoid of side effects or it may be part of a combined therapy. 
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Human epidermal melanocytes function in reconstructed mouse hair model
M Tsunenaga and R Ideta Shiseido Research Center, Yokohama, Kanagawa, Japan
Undifferentiated epidermal cells and dermal cells from newborn mice reconstruct hair follicles effec-
tively when transplanted to the back skin of immunodeficient mice (nude mice: Balb-c nu/nu). Uti-
lizing this system, we investigated whether xenografted human melanocytes are functionally incor-
porated in murine hair follicles. About three weeks after the grafting of epidermal and dermal cells
derived from albino mice (ICR), white hairs were observed on the recipient nude mice. When nor-
mal human epidermal melanocytes (NHEM) were added to the above grafting mixture, the recon-
structed hairs became gray. Histochemical and immunohistochemical analysis revealed melanin pig-
ments in the reconstructed epidermis and hair follicles, and xenografted human melanocytes were
observed around mouse dermal papilla by using human-specific antibodies. Addition of large amounts
of NHEM in the grafting mixture darkened reconstructed hairs. NHEM from different donors showed
different tyrosinase activity. When these NHEM were grafted, it seemed that the darkness of recon-
structed hairs correlated with the tyrosinase activity. However, the melanocytes were not able to
change the gray color of reconstructed hairs to black, as in C57/black mouse. Measurement of the
melanin content of reconstructed hair suggested that hair color might depend on the melanin con-
tent per g of hair. These results indicate that NHEM functioned in the murine reconstructed hair fol-
licles, and their tyrosinase activity and their numbers in the grafting mixture influenced on the degree
of hair follicle pigmentation. This reconstructed hair model should be useful for studying interac-
tions between melanocytes, keratinocytes and dermal papilla cells in hair follicles. 
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Only magnesium ascorbyl phosphate and copolymer complexed vitamin C affect in vitro
melanocyte morphology and in consequence the melanin transfer into keratinocytes
M Regnier,1 B Biatry,2 E Lheureux,2 J Simonnet2 and R Schmidt1 1 Skin Care Biology Group,
L’Oreal, Clichy, France and 2 Headgalenic Applied Research, L’Oreal, Chevilly-larue, France
The addition of stable vitamin C derivative magnesium ascorbyl phosphate to the culture medium
of reconstructed epidermis modifies lipid synthesis and in consequence improves its barrier func-
tion. When under such conditions, melanocytes are integrated into the epidermal reconstruct they
exhibit a round morphology with very little melanin transferred into the neighbouring keratinocytes,
whereas in the absence of the stable vitamin C, a normal epidermal melanin unit is restored with
dark, melanin transferring melanocytes. To study in more detail the effect of vitamin C on melanocyte
morphology and melanin transfer, we evaluated the effect of ascorbic acid, magnesium ascorbyl
phosphate, a stable derivative, and two vitamin C/copolymer complexes: vitamin C/vinyl pyrroli-
done -vinylimidazole copolymer and vitamin C/sodium stryrene-maleic anhydride copolymer, both
at a weight ratio of 5/1 at pH6.Treatment of keratinocyte-melanocyte co-cultures with the two vita-
min C copolymer complexes resulted in a dose-dependent reduction of melanocyte dendricity.
Melanocytes adopted a bipolar morphology and transferred considerable less melanin into the ker-
atinocytes. Similar observations were made after the addition of magnesium ascorbyl phosphate.
Treatment of reconstructed epidermis with these compounds induced a measurable reduction of
pigmentation. In all cases, removal of the compounds from the culture medium restored a functional
epidermal melanin unit. Under our experimental conditions, ascorbic acid had no effect. These results
demonstrate for the first time a mode of action for stable vitamin C compounds on melanocytes that
explain at least in part its known depigmenting activity. 
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Eumelanin and pheomelanin contents of depigmented and repigmented skin of vitiligo patients
D Parsad,1 K Wakamatsu,2 B Kumar1 and S Ito2 1 Dermatology, Postgraduate Institute of Medical
Education and Research, Chandigarh, Chandigarh, India and 2 Chemistry, Fujita Health
University, Nagoya, Nagoya, Japan
There are two chemically distinct types of melanin: the red yellow phaeomelanin and the brown
black eumelanin. Both types of melanin have been detected in human hair, epidermis and cultured
melanocytes. We conducted this preliminary study to quantify levels of both eumelanin and phaeome-
lanin in depigmented as well as repigmented patches of vitiligo on various treatments. We enrolled
five patients of vitiligo for this study. We took biopsies from depigmented as well as repigmented
lesions after PUVA therapy. The eumelanin and phaeomelanin contents of the skin biopsies were
quantified by high performance liquid chromatography (HPLC). The overall mean concentrations
in depigmented lesions were 28.56 ng/piece of AHP and 4.33 ng/piece of PTCA (average AHP/PTCA
ratio 5.5). In repigmented lesions mean concentration of AHP was 8.27 and that of PTCA was 10.36
(average AHP/PTCA ratio was 0.85). Depigmented lesions showed predominantly phaeomelanin
whereas repigmented lesions after PUVA showed predominantly eumelanin. In complex sequence
of events leading to death/inactivation of melanocyte, decreased tyrosinase activity or other factors
leading to switch to phaeomelanin must be playing a vital role in pathogenesis of vitiligo. We could
detect melanin in depigmented lesion of vitiligo of 5 years duration. It seems some residual
melanocytes are still active in depigmented lesions. 
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Characterization of melanosomes in murine strains with defective organelle biogenesis
ML Wei,1 T Nguyen,1 EK Novak,2 E Seong,3 M Burmeister3 and RT Swank2 1 Dermatology,
University of California, San Francisco, CA, 2 Molecular and Cell Biology, Roswell Park Cancer
Institute, Buffalo, NY and 3 Mental Health Research Institute, University of Michigan, Ann Arbor,
MI
Hermansky-Pudlack Syndrome is a disease that exhibits genetic and clinical heterogeneity and is
characterized by pigment dilution and prolonged bleeding. There are at least 17 murine genes which
when defective cause HPS, and in humans 4 genes have been identified. The functions of most of
the HPS genes are unknown, but are thought to function in melanosome biogenesis/maturation and
secretion. As a step towards understanding HPS gene function, we previously reported our analysis
of melanosomes in 10 murine strains that are the models for the Hermansky-Pudlack Syndrome
(HPS), and demonstrated that the mutations in HPS cause charactieristic blocks in melanosome bio-
genesis or secretion. Here we analyzed melanosomes in the skin of the 7 remaining known murine
HPS strains (buff, misty, ashen, subtle gray, sandy, muted and mocha) using transmission electron
microscopy. We find that most of these strains also have increased proportions of immature
melanosomes. The exception is ashen, which appears to have normal melanosomes, but, in agree-
ment with previous studies in cultured melanocytes, has an accumulation of melanosomes intracel-
lularly. We also find that the severity of the defects in melanosome biogenesis varies from no defect
to smaller organelle size to severe defects in pigment organization and organelle fusion/fission. We
present the additional morphological findings here along with a model, incorporating all of the murine
HPS strains, postulating which step of melanosome maturation and secretion each defective HPS
gene product affects. 
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The expressions of melanogenic proteins in human skin after ultraviolet irradiation
M Cho,1 T Kim,1 J Lee2 and K Whang1 1 Dermatology, Soonchunhyang University Hospital, Seoul,
South Korea and 2 Dermatology, Soonchunhyang ChunAn Hospital, ChunAn, South Korea
It has been known that mutual responses between melanocytes and keratinocytes play a crucial role
in the UV-induced melanogenesis in human skin. Keratinocytes secrete specific factors, such as α-
MSH, ACTH, and PGE2, responsible for melanocyte activation. They activate the cAMP pathway
in melanocyte and so increase MITF expression. MITF is known to bind the M box and E box
motifs and to stimulate tyrosinase family gene promoter. However, it is not known that how long
tyrosinase and TRP-1 activities continue after UV irradiation in vivo. In this study, we established
an immunohistochemical staining for specimens which were obtained from UV-irradiated skin in
five healthy Korean males on 2nd, 5th, 7th, 28th, 56th days after UV irradiation. As a result, with
time tyrosinase, TRP-1, and MITF activities increased until 7 days after UV irradiation and fell down
to the basal constitutive level 4 and 8 weeks later. We also showed that tyrosinase increased prior to
TRP-1, interestingly. This study provide important informations for the clinical evaluation of the
effectiveness of whitening agents. 
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Effect of co-culture of melanocytes and endothelial cells on melanogenesis
E Kraus, DB Yarosh and DA Brown AGI Dermatics, Freeport, NY
Melanocytes are found in the basal layer of the epidermis often near microvascular endothelial cells
in the dermis. In order to investigate what role endothelial cells might play in melanogenesis, co-
culture systems were developed in which human epidermal melanocytes were grown in culture
together with human micro-vascular endothelial cells (HMVEC). Interestingly, in the presence of
HMVEC, the melanocytes became more differentiated as indicated by greater length and number of
dendritic extensions. Analysis of the secreted melanin content, after 9 days in culture, revealed a 2-
3 fold increase in the amount of secreted melanosomes in co-cultures compared to melanocyte mono-
cultures. In addition there was a 2 fold increase in the number of melanocytes after 9 days in co-cul-
ture. Nitric oxide (NO) is a product of endothelial cells and also stimulates melanogenesis. When
co-cultures were incubated in the presence of a NO scavenger (Carboxy PTIO) there was no increase
in melanocyte growth or melanogenesis. Together, the data demonstrated that co-culturing of
melanocytes with endothelial cell increased both the growth rate of the melanocytes as well as the
secretion of melanin per cell and that this process is NO dependent. This is the first demonstration
of the effect of endothelial cells on melanogenesis. This suggests a role for endothelial cells in melano-
genesis since the UV-A component of sunlight reaches endothelial cells in skin and is capable of
inducing NO production by endothelial cells. 
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An examination of photoadaptive response using UV transmission spectroscopy
A Hennessy, C Oh and J Rees  Dermatology, University of Edinburgh, Edinburgh, Scotland, United
Kingdom
A study has been carried out in an attempt to characterise the relative contributions of pigmentation
and hyperplasia in the photoprotection of skin. UV transmission spectroscopy was used to collect
transmission data in the region 250nm − 400nm. Suction blisters were removed from the lower back
of volunteers, and inserted into a thin saline filled cavity within a quartz cuvette. This experimental
setup was used to minimise the effects of dehydration. Several skin types were examined, and the
transmission spectrum of a tanned area was compared with an adjacent control area in each case.
Preliminary transmission data showed a wavelength dependent change in the spectra, with decreases
in transmission of the tanned skin compared with the control in both low and high wavelength regions.
Decreases in the transmission at wavelengths between 250nm and 260nm indicated increases in the
levels of DNA, proteins and amino acids, associated with hyperplasia. Decreases in the transmis-
sion at wavelengths above 320nm indicated increases in melanin levels, associated with hyperpig-
mentation. The transmission T of forward directed radiation of wavelength λ through excised epi-
dermis of thickness t can be expressed as: T(λ,t)=exp[-{Ka(λ)+c.Km(λ)}.t]+S(λ,t) equation 1 where
Ka(λ) is the absorption coefficient of aromatic amino acids at wavelength λ, and Km(λ) is the corre-
sponding coefficient for melanin; c is the melanin concentration, and S(λ,t) is a scattering function.
The scattering function could be estimated by measuring the transmission through skin containing
no melanin, i.e. vitiliginous skin. The absorption by amino acids, a(λ), is effectively zero between
330nm and 400nm, and the function c.K
m
(λ)t could be calculated in this region for each epidermal
sample.  The absorption spectrum for melanin is well known, hence the constant (c x t) could be
estimated. It was then possible to calculate Ka(λ)t by substitution into equation 1. In this way, the
respective contributions to photoadaption by pigmentary and non-pigmentary factors could be esti-
mated. 
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A novel dose-response assay for pigment studies
C Oh, T Ha, A Hennessy, R Weller and J Rees  Dermatology, University of Edinburgh, Edinburgh,
Scotland, United Kingdom
To determine the physiological role of genes such as MC1R in pigmentation, quantitative measures
of pigmentation are required. We wish to define 1) time course of photoadaptation, 2) pigmentary
dose-response to UVB, 3) time course of pigmentary response and 4) how redheads and non-red-
heads respond to the same dose of UVB. In determining time course of photoadaptation, an exper-
iment (n=9) showed that an area of skin photoadapted daily on 3 consecutive days with UVB pro-
duced less flux (contact laser Doppler) compared to unadapted skin after a 100mJ/cm2 UVB challenge.
Mean % reduction in flux was noted on days 3-4 (40% SEM=13.1), day 6 (66% SEM=10.0), days
10-13 (65% SEM=10.7), day 17 (70% SEM=6.1), days 19-20 (26% SEM=18.4) and days 24-27
(18% SEM=13.8). To determine pigment response, 24 subjects were given 4 doses of UVB deliv-
ered on 1 occasion to the lower back. Readings up to 9 weeks were performed using the L*a*b* sys-
tem (Minolta chromameter). A novel approach was employed by first iontophoresing irradiated areas
with noradrenaline to exclude confounding influence of erythema. Contact laser Doppler flowme-
try then ensured satisfactorily low flux prior to L* readings. Results showed that higher doses of
UVB produced darker L* readings. At 1 week, 28, 56, 112, 160mJ/cm2 UVB produced a mean
increase in L* units of 0.62 (SEM=0.19), 2.55 (SEM=0.45), 6.19 (SEM=0.73) and 7.99 (SEM=0.84)
respectively. Time of maximal pigmentation was 1 week when mean increase was 7.99 L* units (to
160mJ/cm2). By week 5, the mean increase had fallen to 2.52 L* units (SEM=0.5),(lighter). Com-
paring redheads and non-redheads 1 week post-irradiation with 160mJ/cm2, non-redheads dark-
ened by 9.78 L* units (SEM=1.17) while redheads only darkened by 6.04 units (SEM=0.93)(p=0.02);
redheads were ~40% less pigmented than non-redheads. There was no difference between the 2
groups at 28mJ/cm2 (p=0.16). In conclusion, photoadaptation was maximal on days 6-17 post-
adaptation, with 65%-70% reduction in erythema, demonstrating a dose-response to UVB with max-
imal pigmentation at 1 week. We have demonstrated a novel dose-response assay for pigment stud-
ies. 
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Photoadaptation is dose dependent, but not site dependent
KM Waterston, TK Ha, L Naysmith, R Weller and J Rees Dermatology, Edinburgh University,
Edinburgh, Scotland, United Kingdom
We have previously demonstrated the presence of clear person and body site factors for ultraviolet
induced erythema (ANOVA model), and that there is a greater variation between body sites within
one individual than between individuals (p<0.01). In this study we looked at how photoadaptation
affects this variability and how much protection against acute erythema is created by facultative pho-
toadaptation. 15 healthy volunteers were exposed to 5 incremental doses of narrow band UVB (Wald-
mann 108) 0.3J/cm2–0.43J/cm2 daily for 5 days to 3 body sites — upper back, inner forearm and
outer calf. 96hrs after the final dose, the photoadapted sites plus adjacent non-adapted sites were
challenged with 5 (21/3) incremental doses of UVB, 119–300mJ/cm2 to arm and back, and
238–600mJ/cm2 to outer calf. Erythema induced by the challenge was measured at 24hrs using
contact laser doppler (Moor). Baseline erythema measurements were also taken from unchallenged
adapted and non–adapted sites. Although challenge erythema varied between body sites, there was
no variation in the percentage reduction of erythema in adapted vs non–adapted skin at each site at
each UV challenge dose. This difference was inversely related to the challenge dose (47 ± 7% at
300mJ/cm2, 57 ± 1.35% at 238mJ/cm2, 67 ± 5.51 at 189mJ/cm2). There was no significant differ-
ence in baseline erythema between unchallenged photoadapted and non–adapted sites. We conclude
that the amount of protection against erythema offered by facultative photoadaptation is dose depend-
ent but not site dependent. 
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Accumulation of tyrosinase in the endolysosomal compartment is induced by U18666A
AM Hall, L Krishnamoorthy and SJ Orlow Ronald O. Perelman Department of Dermatology, NYU
Medical Center, New York, NY
U18666A, progesterone, and several cationic amphiphilic drugs have been shown to alter the traf-
ficking of a number of intracellular membrane proteins including CD63/Lamp3, insulin growth fac-
tor 2/mannose 6-phosphate receptor (IGF2/MPR), and the Niemann-Pick C1 gene product (NPC1)
as well as ganglioside GM1. We have examined the effects of these compounds on cultured
melanocytes at concentrations that have been shown to effectively alter intracellular trafficking. Treat-
ment of melanocytes with U18666A (2.5uM) or progesterone (15 uM) for 96 hours decreased melanin
content an average of 67% as compared to control without lowering the total cellular tyrosinase activ-
ity. Steroidal alkaloids that preferentially act on the Sonic Hedgehog signaling pathway showed no
related specificity in their ability to decrease pigmentation. In melanocytes treated with U18666A,
tyrosinase accumulates in a compartment that contains both lysosome-associated membrane pro-
tein-1 (Lamp 1) and mannose 6-phosphate receptor (MPR), and stains with filipin, consistent with
cholesterol-laden late endosomes/lysosomes. Our results suggest that tyrosinase, like the NPC1 gene
product, traverses a U18666A-sensitive trafficking pathway. 
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The proteinase-activated receptor-2 mediates phagocytosis in a Rho-dependent manner in
human keratinocytes
G Scott,1 S Leopardi,1 L Babiarz,3 M Seiberg3 and R Han2 1 Dermatology, University of Rochester,
Rochester, NY, 2 Johnson and Johnson Skin Research Center, Johnson and Johnson, Skillman, NJ
and 3 Pathology, University of Rochester School of Medicine, Rochester, NY
The process of melanosome uptake by human keratinocytes (HK) is poorly understood. Recent work
shows that proteinase activated receptor-2 (PAR-2) activates signals that stimulate melanosome uptake
in HK and that PAR-2 expression is regulated by UV irradiation in vivo. The Rho family of GTP-
binding proteins is involved in receptor-mediated cytoskeletal remodeling during phagocytosis. Using
Nile red beads in a melanosome uptake model, we show that phagocytosis in HK is Rho-dependent
because treatment with toxin B (inhibitor of all Rho proteins), C3 exoenzyme (specific Rho inhibitor)
and Y27632 (Rho kinase inhibitor) blocked uptake of Nile red beads in HK. We show that PAR-2
mediated phagocytosis is Rho dependent because Rho kinase inhibitor (Y27632) blocked PAR-2
stimulated phagocytosis in HK. Affinity purification of GTP-Rho (activated Rho) from HaCat treated
with PAR-2 activating peptides or trypsin (which activates PAR-2) revealed a rapid activation of Rho
(>3 fold). We explored PAR-2 signaling in HK and show that activation of PAR-2 elevates cAMP
in a dose and time dependent manner and is pertussis toxin (PT) sensitive. PAR-2 mediated Rho
activation was independent of PKA because two PKA inhibitors (H-89 & Rp-8-Cl-cAMP) failed to
block PAR-2 dependent Rho activation. The Gα12/Gα13 PT- insensitive G-coupled proteins are
known to activate Rho in other cell types. We show that HK express Gα12/Gα13 and that PAR-2
mediated Rho activation is resistant to PT. Microinjection of antibodies to Gα13 block Rho-depend-
ent stress fiber formation in HK suggesting that Gα12/Gα13 might link PAR-2 with Rho. These
data are the first to show that PAR-2 mediated phagocytosis is Rho dependent and that PAR-2 sig-
nals downstream to Rho and cAMP. These data shed light on the mechanisms of PAR-2 mediated
melanosome uptake by HK and point to Rho as a central signaling molecule in skin pigmentation. 
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Using cDNA microarray analysis to understand pathways related to Waardenburg syndrome
and pigmentation
SR Lipner,1 L Kochilas,3 J Epstein,3 BE Morrow2 and A Skoultchi1 1 Cell Biology, Albert Einstein
College of Medicine, Bronx, NY, 2 Molecular Genetics, Albert Einstein College of Medicine, Bronx
and 3 University of Pennsylvania Medical School, Philadelphia
Waardenburg syndrome (WS) is an autosomal dominant disorder with an incidence of 1 in 40,000
live births. Patients with WS have sensorineural deafness, pigmentation anomalies, cardiac and skele-
tal abnormalities and neural tube defects. Many patients have loss of function mutations in Pax3.
Mutations of Pax3 have been identified in splotch (sp) mouse strains and these mice have charac-
teristics similar to WS patients. Many of the organs and tissues that are affected in WS patients and
splotch mice are derived from neural crest cells. Another mouse strain that has defects in tissues
derived from the neural crest is the Hoxa3 knockout mouse. Because mice homozygous for Pax3
and Hoxa3 mutations have very similar phenotypes, we investigated whether Pax3 and Hoxa3 lie in
the same pathway and regulate some of the same genes. We used semi-quantitative RT-PCR and
cDNA microarrays to study specific mRNA levels in pools of embryos derived from Pax3 and Hoxa3
mutant mice. Using RT-PCR, we observed that Hoxa3 was downregulated in Pax3 mutant embryos,
while Pax3 was unchanged in Hoxa3 mutant embryos. cDNA microarray analysis revealed that the
melanocyte gene, Tyrosinase related protein 2 (Trp-2) is downregulated in both types of mutant
embryos. We also observed expression of Hoxa3 in the B16 melanoma line and in melb-a, a
melanoblast line. These results suggest that Hoxa3 lies in a pathway downstream of Pax3, and unex-
pectedly, it may play a role in pigmentation. 
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Molecular mechanisms underlying interrupted melanosome transfer in pigmented basal cell
epithelioma
K Sakuraba,1 M Kawashima1 and G Imokawa2 1 Department of Dermatology, Tokyo Women,
Tokyo, Japan and 2 Biological Science Laboratories, Kao Corporation, Tochigi, Japan
In pigmented basal cell epithelioma (BCE), there is the abnormality of the transfer of melanized
melanosomes from proliferative melanocytes to basaloid tumor cells. In this study, to determine
molecular mechanisms underlying the disrupted transfer, we used immunohistochemistry and reverse
transcription polymerase chain reaction (RT-PCR) to examine the role of microtubuli-associated
motor proteins (MAMP) in melanocytes and of phagocytic receptor, the protease-activated receptor
(PAR)-2 on basaloid tumor cells. Electron microscopic analysis revealed that basaloid tumor cells
have a significantly lower population of melanosomes than do normal keratinocytes located in the
non-lesional epidermis, indicating interrupted melanosome transfer. RT-PCR analysis demonstrated
that while MAMP in melanocytes including dynein and kinectin, but not fascin, are markedly down-
regulated in BCE, phagocytic receptor on keratinocytes, PAR-2 is also slightly, but substantially
decreased compared with the non-lesional epidermis. Immunohistochemistry using antibodies to
MAMP and PAR-2 demonstrated that melanocytes localized in BCE express no or less immuno-
reactivity with antibodies to dynein, kinesin and fascin, while basaloid cells exhibit less immunos-
taining with antibody to PAR-2 than in the non-lesional epidermis. These findings suggest that the
decreased expression of these MAMPs in melanocytes as well as PAR-2 in basaloid cells may be
associated with the observed interruption of melanosome transfer in BCE. 
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Effect of stem cell factor and endothelin-1 on pigmentation in human skin grafted onto SCID
mice
A Ohuchi,1,2 P Sriwiriyanont2 and RE Boissy3 1 Biological Sciences Americas laboratory, Kao
Corporation, Cincinnati, OH, 2 The Skin Science Institute, Cincinnati Children’s Hospital Medical
Center, Cincinnati, OH and 3 Dermatology, University of Cincinnati, Cinvinnati, OH
It is known that UVB irradiation causes skin tan, via increasing the activity and number of melanocytes
in the epidermis. Previous reports suggest that both stem cell factor (SCF) and endothelin-1 (ET-1)
are critically involved in the biological mechanism in this process. In cultured melanocytes, ET-1
and SCF synergistically increase DNA synthesis via induction of MAPK phosphorylation. Nonethe-
less, little is known pertaining to the mechanism of action of these cytokines in intact skin in vivo.
The object of this study was to demonstrate the potential effects of SCF and ET-1 on human skin
pigmentation using an in vivo model, i.e.) human skin grafted onto the severe combined immunod-
eficient (SCID) mice. We initially examined the effect of the individual cytokines on skin color. Either
SCF or ET-1 was injected into the grafted human skin subepidermally at different doses daily for 3
days. To monitor the gross skin color change, L values were measured using image analysis from
magnified polarized pictures taken on day 0 before cytokine injection and day 4 before sacrifica-
tion. SCF injection induced skin darkness significantly in a dose dependent manner. In contrast, ET-
1 did not demonstrate a significant effect on gross skin darkness. To determine the synergic or addi-
tional effect of SCF and ET-1, both cytokines were injected simultaneously and compared with the
effect of individual injections. Neither SCF 0.2µg nor ET-1 0.1µg alone has significantly effected
skin darkness. However the combination of both cytokines induced skin darkness significantly. To
quantitate melanogenseis, the numbers of dopa-positive melanocytes of treated epidermal sheet were
determined. The combined injection of ET-1 and SCF synergistically increased a melanocyte num-
ber. In conclusion, these data demonstrated that the SCF and ET-1 synergistically increase human
skin pigmentation. 
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Fibroblasts play a stimulatory role in keratinocyte proliferation but an inhibitory role in
melanocyte growth and pigmentation in a skin equivalent system from skin type 4
D Lee,1,2 J Lee,1 E Lee,1 K Cho3 and J Yang1,2 1 Department of Dermatology, Sungkyunkwan
University School of Medicine Samsung Medical Center, Seoul, South Korea, 2 Samsung
Biomedical Research Institute, Seoul, South Korea and 3 Dermatology, Seoul National University
College of Medicine, Seoul, South Korea
There have been conflicting results regarding the influence of fibroblasts on melanocytes. In this
study we investigated the effects of fibroblasts on the number of melanocytes and melanin pigemn-
tation in a skin equivalent model derived from skin type 4. In addition, the effect of fibroblasts on
the proliferation of melanocytes in monolayer culture was evaluated using the MTT assay. The skin
color in the skin equivalent with fibroblasts (SEF) was much lighter macroscopically than in the
skin equivalent without fibroblast (SENF). Histologically, both the SEF and the SENF produced a
multilayered epidermis with a compact horny layer. Less melanin, however, was found in the SEF
than in the SENF. Immunohistochemical staining with a melanocyte-specific antibody (MEL-5)
revealed that the number of melanocytes in the SEF was much smaller than in the SENF. However,
in the SEF, the number of Ki-67-positive keratinocytes was increased compared to the number in
the SENF. In the monolayer culture, absorbance in the MTT assay by melanocytes with fibroblast
conditioned medium was significantly increased compared with that of melanocytes in control cul-
ture, suggesting that some types of fibroblast-derived factors may have positive effects on the growth
of melanocytes in monolayer systems. Our results show that in a skin equivalent, fibroblasts stimu-
late proliferation of keratinocytes while reducing the number of melanocytes and suppressing melanin
pigmentation, and that in monolayer culture, fibroblasts at least do not suppress melanocyte growth
directly. 
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Tyrosinase in melanogenic cells might have a protective role against dopamine cytotoxicity
J Matsunaga,1 I Takeuchi,1 Y Kusakari,1 Y Yoshino,1 H Andoh,2 V Hearing2 and H Tagami1 1
Department of Dermatology, Tohoku University, School of Medicine, Sendai, Miyagi, Japan and 2
Laboratory of Cell Biology, National Cancer Institute, National Institute of Health, Bethesda, MD
Tyrosinase is a multifunctional enzyme in the melanin biosynthetic pathway and is primarily expressed
in melanocytes. Tyrosinase catalyzes the conversion of tyrosine to 3,4-dihydroxyphnylalanine (L-
Dopa) and oxidizes L-Dopa to form Dopa quinone. In addition, it is known that tyrosinase also oxi-
dizes dopamine (DA) to form melanin rapidly via DA quinone. Although the catecholamines DA,
norepinephrine, and epinephrine are predominantly synthesized in selected central and peripheral
neurons and in the adrenal medulla, human keratinocytes also express tyrosine hydroxylase, which
is the first and rate-limiting enzyme in catecholamine synthesis. Therefore catecholamines could be
directly produced in the human epidermis by keratinocytes. The pathogenesis of vitiligo has not been
completely defined and even the process of melanocytes disappearance from involved skin. Evidence
has been accumulated on the role of oxidative stress as the initial event in melanocyte degeneration,
and an increase in catecholamine discharge or synthesis has been associated with disease activity.
In this study, we explore the physiological role of the tyrosinase enzyme activity toward dopamine.
Here we show that 10 µM of DA is significantly cytotoxic to the mouse melanoma cells (B16F10)
and that phenylthiourea (PTU), an inhibitor of tyrosinase, dramatically enhances the DA cytotoxic-
ity. We also presents that DA is incorporated into the cells in the time- and temperature-dependent
manner. Our results indicate that tyrosinase expressed in melanocytes might have a protective role
against dopamine cytotoxicity in the epidermis. 
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A new continuous spectrophotometric assay method for DOPA oxidase activity of tyrosinase
Y Park,2 J Lee,3 K Park,3 M Hahn3 and J Yang1,2 1 Dermatology, Sungkyunkwan University School
of Medicine Samsung Medical Center, Seoul, South Korea, 2 Samsung Biomedical Research
Institute, Seoul, South Korea and 3 Molecular Cell Biology, Sungkyunkwan University School of
Medicine, Seoul, South Korea
Tyrosinase is a key enzyme in the production of melanin pigment and catalyzes several steps in
melanosynthetic pathway. Sensitive assay methods for tyrosinase activity are essential not only for
the understanding the process of pigment production but also for the development of effective inhibitors
of tyrosinase. To develop an efficient assay method, we applied thymol blue, a pH-dependent indi-
cator, to reaction mixtures. Ultraviolet-visible absorption spectra studies showed that the extent of
absorbance change of the thymol blue-applied method was several fold greater than the DOPAchrome
formation method. The enzyme kinetic study revealed that DOPA oxidase activity of tyrosinase in
thymol blue-applied reaction system was more sensitively measured, even under lower enzyme units
compared with the previous report with significant enhancement of Vmax while affinity change on
substrate was not observed. To test whether this method could be applicable to the inhibition and the
inactivation kinetic study of tyrosinase, the effect of kojic acid, a well-known tyrosinase inhibitor,
and sodium chloride respectively, have been studied. Kojic acid showed an inhibitory effect with a
Ki value similar to previous reports on tyrosinase activity and sodium chloride inactivated this sys-
tem in a dose-dependent manner. Conclusively, thymol blue method can assay tyrosinase activity
with sensitivity and is applicable to the inhibition and the inactivation study of tyrosinase. 
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Non-enzymatic polymerization of melanogenic monomers in keratinocytes by ultraviolet A
radiation
K Sato, T Ono and M Hatao Shiseido Co., Yokohama, Kanagawa, Japan
Human skin irradiated with ultraviolet A radiation (UVA) exhibits grayish brown colored pigmen-
tation, which fades rapidly when UVA irradiation is stopped. If the amount of irradiated UVA reaches
a certain level, the pigmentation persists more than several hours and the color changes to brown.
Some hypotheses were proposed to explain the mechanism of these UVA-induced pigmentations,
but it has not yet been clearly elucidated. To know what happened in the skin by UVA irradiation,
we excised human skin three hours after UVA irradiation, and found the deposition of melanin in
the keratinocytes. Thus we postulated that mechanism of the persistent pigment darkening induced
by UVA is photo-polymerization of melanogenic monomers accumulated in the keratinocytes since
the reaction occurred in rather a short time. Culture supernatant from normal human melanocyte cul-
ture was analyzed using thin-layer chromatography and high performance liquid chromatography.
A few colorless spots on a thin-layer chromatography plate turned brown in color responding to
UVA. These spots were identified as 5,6-Dihydroxyindole-2-carboxylic acid, 5,6-dihydroxyindole,
and their metabolites. We also confirmed that these compounds synthesized chemically were easily
turned into melanin by UVA. In vitro study using normal human keratinocytes, co-cultured with
melanocytes, showed that UVA induce the darkening of the keratinocytes. These results suggest that
melanogenic monomers produced by melanocytes are accumulated in keratinocyte, and polymer-
ized to melanin by UVA irradiation. This reaction might be related to the persietent skin darkening
induced by UVA. 
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Modulation of heat shock protein 47 expression in aged and photo-aged normal human fibro-
blasts by Salix Alba extract
C Nizard,1 M Moreau,1 E Noblesse,1 A Faussat2 and S Schnebert1 1 Laboratoire Sciences du Vivant,
LVMH R&D Branche Parfums & Cosmetiques, Saint Jean de Braye, Loiret, France and 2 IFR 58,
Institut des Cordeliers, Paris, France
HSP 47 is a specific chaperone of pro-collagen. This heat shock protein is responsible for the cor-
rect 3-dimentional organization of pro-collagen and its control-quality prior secretion. The aim of
the study is to evaluate the level of HSP47 in aged, photoaged and senescent fibroblasts and its mod-
ulation by a plant extract (Salix Alba). We measured the level of HSP47 and/or pro-collagen expres-
sion in fibroblasts by real time RT-PCR (mRNA transcripts) and by flow cytometry (immuno-chem-
istry technique for measurement of arbitrary fluorescence intensity). We used immuno-chemistry
techniques and confocal microscopy to vizualized the cellular localization of HSP 47 and pro-col-
lagen. These parameters were compared with different age-donors, non senescent and senescent
fibroblasts. Fibroblasts were irradiated by a non cytotoxic dose of UVA (6 J/cm2) and HSP 47 level
was evaluated. Salix Alba extract was tested for its capacity to modulate HSP 47 expression. We
showed colocalization of HSP47 and procollagen by confocal microscopy, indicating that HSP47
could play a role of procollagen molecular chaperone in our cellular model. We showed that HSP47
level is decreased in old-donor cells, senescent and irradiated cells. This decrease can be modulated
by a salix alba extract (polyphenols rich) in a dose dependent manner. The evaluation of HSP 47
expression in our experimental conditions can lead to a new approach of aging and photoaging point-
ing out the implication of this chaperone in these pathophysiologic phenomenons. Modulation of
HSP 47 expression by molecules family could be of cosmetic and/or dermatologic interest. 
1157
MITF regulates PKC-Β transcription
H Park, J Gasparino and BA Gilchrest Department of Dermatology, Boston University, Boston, MA
MITF has been implicated as the master gene for pigment cells. MITF is required for maintenance
and survival of melanocytes and is a major transcription factor for the rate limiting melanogenic
protein tyrosinase. The promoter region of tyrosinase contains M-box and E-box sequences known
to bind MITF, allowing gene transcription. MITF expression and function were shown to be increased
by a-melanocyte stimulating hormone (α-MSH); and α-MSH or other cAMP elevating agents were
shown to increase expression of tyrosinase at least in part by increasing tyrosinase transcription in
an MITF-dependent manner. Protein kinase C-Β (PKC-Β) also plays a critical role in melanogene-
sis by phosphorylating (activating) tyrosinase protein. To determine whether MITF might also reg-
ulate melanogenesis via PKC-Β, paired cultures of human melanocytes were transfected with dom-
inant negative MITF (DN-MITF) or control vector and processed for western blotting. PKC-Β protein
was reduced by 50% within 48 hours in cells transfected with DN-MITF. Tyrosinase activity, meas-
ured in parallel, decreased proportionately in DN-MITF transfected vs control cells (5,162 ± 2,467
vs 10,170 ± 604 cpm/µg/hr). Also consistent with a role for MITF parallel to its role in tyrosinase
regulation, treatment of melanocytes with the cAMP elevating agent IBMX (100µM) for 48 to 72
hours increased the PKC-b protein level by 2-3 fold. The published sequence of the PKC-Β promoter
contains an E-box. To further determine if MITF transcriptionally regulates PKC-Β, a PKC-Β pro-
motor-CAT construct was co-transfected with an MITF expression vector or empty vector into Cos
cells that have an undetectable basal level of MITF. Cells were harvested 48 hours later and CAT-
assay was performed. Co-transfection of the MITF expression vector compared to the control vec-
tor dramatically (60 fold) increased the activity of the PKC-Β promoter-CAT construct (8,000 ± 120
vs 120 ± 50 cpm acetylated protein per µg protein in the cell lysate). These results demonstrate that
MITF is a transcription factor for PKC-Β and support a central role for PKC-Β in melanogenesis. 
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Mechanisms underlying dysfunction of melanocytes in vitiligo epidermis: role of SCF/c-kit lin-
eage and its downstream MITF-M
R Kitamura,1 K Harada,1 A Shimizu,1 S Shimada,1 K Tsukamoto2 and G Imokawa3 1 Dermatology,
University of Yamanashi Faculty of Medicine, Yamanashi, Japan, 2 Yamanashi Prefectural Central
Hospital, Yamanashi, Japan and 3 Kao Biological Science Laboratories, Tochigi, Japan
Little is known about mechanisms involved in dysfunction of melanocytes in vitiligo epidermis. We
hypothesize that some of cytokine/receptor lineage may be affected, resulting in melanocyte dys-
function and/or loss in the vitiligo epidermis. In this study, we have compared the expression of ET-
1, GM-CSF, SCF, c-kit, tyrosinase, S-100α, ETB receptor and MITF-M between the lesional and
the non-lesional epidermis using RT-PCR, immunohistochemistry and western blotting. Analysis
by RT-PCR and western blotting for ET-1 and SCF indicated rather up-regulated cytokine produc-
tion by the lesional vitiligo epidermis. Immunohistochemistry with antibodies to melanocytic mol-
ecules revealed that in the edge of the lesional epidermis, there are still remaining melanocytes
expressing tyrosinase, S-100α and ETB receptor, but not melanocytes with c-kit or MITF-M mole-
cules. Quantitation of the number of immuno-positive cells over 200 basal cells revealed a slight or
moderate decrease in the number of S100α, tyrosinase and ETB receptor immuno-positive cells at
the edge of the lesional epidermis. In contrast, the number of cells expressing c-kit markedly decreases
at the edge of the lesional epidermis compared with the non-lesional epidermis. In the center of the
lesional epidermis, there is the complete loss of melanocytes showing c-kit/S-100α/ETB recep-
tor/tyrosinase immuno-positive reactivity. Western blotting using antibodies to c-kit and MITF-M
revealed that the vitiligo epidermis is associated with down-regulated expression of c-kit and MITF-
M proteins in the edge of the lesional epidermis. These findings suggest that the deterioration of the
expression of c-kit on melanocytes and its downstream including MITF-M may be associated with
the dysfunction or loss of melanocytes in the vitiligo epidermis. 
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A novel model for post-inflammatory pigmentation
A Kitawaki, Y Tanaka and K Takada Biological Science Research Center, Lion Corporation,
Odawara, Kanagawa, Japan
The post-inflammatory pigmentation (PIP) is frequently observed, but very little is reported on the
mechanism of formation because of no experimental model. The pigmentation occurring after acne,
as a type of PIP, is a serious concern with regard to appearance. It may be considered to be repre-
sentative of PIP. Therefore, in order to investigate the mechanism of the PIP, we designed a model
by using oleic acid, which is one of the main fatty acids being responsible for acne. First, oleic acid
(15%) was applied to the back of brownish guinea pig (1 time/day) for 8 days. Inflammatory con-
dition and color of the skin were observed. Application of oleic acid induced erythema within a day,
then desquamation and crust formation occurred. At the day 15 after the application, significantly
severe pigmentation in color was observed. At the same time, substantial levels of melanin were
detected in the epidermis by Fontana-Masson staining. In addition, levels of prostaglandin E2 (PGE2),
an inflammatory mediator, increased at the tested portion of the skin soon after the first application
of oleic acid. Then, we conducted in vitro experiments using keratinocytes (KC) and pigment cells
(PC) in order to study the mechanism of melanogenesis. We investigated the effects of the oleic acid
on PC via KC because it was reported that oleic acid directly inhibited melanogenesis in PC. Melano-
genesis in PC was enhanced when KC was cultured with oleic acid and culture medium of KC was
added to PC medium. Chemical mediators such as PGE2 were detected in KC medium. We there-
fore speculated that these mediators stimulated PC and enhanced melanogenesis. These results indi-
cate that PIP is raised by several chemical mediators which are produced in KC after oleic acid
stimulation. 
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Bone morphogenetic protein 4: a novel modulator of melanogenesis
M Yaar, H Park, V Botchkarev, K Stewart, I Panova, M Kosmadaki and BA Gilchrest Dermatology,
Boston University School of Medicine, Boston, MA
Bone morphogenetic proteins (BMP), members of the transforming growth factor (TGF)-Β family,
signal in many cells including neural precursors. Two receptors (R1 and R2) coordinately mediate
BMP signaling. BMPR1 binds BMP and BMPR2 transduces the signal. BMPR1 has two forms: A
and B. Among neural precursors BMPR1A promotes proliferation and BMPR1B promotes differ-
entiation. Using RT-PCR we found that neural crest derived human melanocytes (Mc) express
BMPR1A, BMPR1B and BMPR2 and that Mc and keratinocytes (Kc) express BMP4. Furthermore,
BMP4 supplementation of Mc decreased melanin/cell by 75±1% (p<.005) and increased Mc yield
by 300% (p<.03). In Mc, BMP4 also decreased tyrosinase and PKC-Β mRNAs and proteins within
hrs of stimulation. BMP is known to act through phosphorylation of cytoplasmic Smad proteins that
translocate to the nucleus to interact with proteins like AP-1 to affect gene transcription. Interest-
ingly, the published tyrosinase promoter contains sequences recognized by Smad1 and Smad5 and
an AP-1 recognition site flanks the Smad5 site, suggesting that BMP4 down-regulates tyrosinase
transcription. To determine BMP4 effect on tyrosinase transcription, AN melanoma cells that, like
Mc, express BMP receptors, were transfected with tyrosinase-CAT plasmid construct carrying the
full tyrosinase promoter (6.1 Kb).  BMP4 decreased CAT activity by 48%±16% (mean±SEM).  Also,
as known for TGF-Β, within 10 min of BMP4 stimulation of Mc, NFΚB translocated to nuclei as
determined by immunohistochemical analysis and confocal microscopy. Since UV irradiation is the
best-recognized environmental stimulator of melanogenesis, Mc and Kc were separately sham or
UV irradiated with a solar simulator (20mJ/cm2 measured at 285±5nm). Within 24 hrs, UV sub-
stantially downregulated the mRNAs of the three BMP receptors (Mc) and BMP4 (Mc and Kc) to
hardly detectable levels. Within 48 hrs the expression of all mRNAs returned to baseline levels. Our
data provide evidence of a novel signaling pathway that influences melanogenesis in human skin. 
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Ultraviolet radiation-induced melanogenesis in human skin of different racial/ethnic origin
Y Yamaguchi,1 T Tadokoro,1 JZ Beer,2 BZ Zmudzka,2 SA Miller2 and VJ Hearing1 1 Pigment Cell
Biology Section, Laboratory of Cell Biology, National Cancer Institute, NIH, Bethesda, MD and 2
Center for Devices and Radiological Health, Food and Drug Administration, Rockville, MD
We are studying the mechanisms of skin color variation and of pigmentation induction following
exposure of human skin of different racial/ethnic origin to ultraviolet radiation (UVR). Previously,
we evaluated the usefulness of biomarker methods in response to UVR, including the measurement
of UV damage as cyclobutane pyrimidine dimers and 6-4 photoproducts. In this study, we measured
the production of melanin by Fontana Masson staining and the expression of various melanocyte
specific proteins, including tyrosinase, TYRP1, DCT, MART1, GP100, and MITF, by immunohis-
tochemical staining in response to UVR. Using these biomarkers, we quantified the proliferation of
melanocytes, the expression of melanogenic genes, and the production of melanin in different types
of skin. Melanocytes did not proliferate significantly within 1 week after UVR. Levels of melanin
were approximately 4-fold higher in darker skin than in lighter skin, and increases in distribution of
melanin particles following UVR could be seen after 1 week in all types of skin. Tyrosinase was
most effectively stimulated by UVR, and its expression closely mirrored the increases in melanin
content in all racial/ethnic groups. The magnitude of the increased tyrosinase expression 1 day after
UVR was higher in darker skin type individuals. Expression of MART1 and GP100 was also stim-
ulated by UVR, and their magnitude was higher in lighter skin type individuals. The intensity of
TYRP1, DCT, and MITF did not increase remarkably in any racial/ethnic group, but their magni-
tude was again higher in lighter skin type individuals. We conclude that these biomarkers are useful
to investigate the basis of variation in skin color and responses to UV within different racial/ethnic
groups. 
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Galectin 3 localizes to melanosome membranes in normal human melanocytes
SZ Torabian, JC Grahn, F Liu and R Isseroff Dermatology, University of California,Davis, Davis,
CA
The mechanisms that regulate melanosome transfer from the melanocyte and its engulfment in the
keratinocyte are not fully understood, but are believed to be Rab-dependent and to involve cell sur-
face carbohydrates and their cognate binding lectins. In particular, galactose residues are implicated
in the process, since isolated melanocyte vesicular membranes bind galactosyl-linked proteins, and
conversely, addition of galactosyl -linked proteins inhibits melanosome transfer to keratinocytes.
Since galectin 3 (Gal3) is a lectin that specificially binds galactosyl- glycoproteins, we initiated an
investigation of its role in this process. Both human keratinocytes and melanocytes express Gal3 in
vivo and in culture. Gal3 is homogenously distributed in the cytosol of cultured keratinocytes, and
appears to be associated with vesicular organelles within cultured melanocytes. When melanocytes
and keratinocytes are co-cultured, the melanocytes stand out as much more brightly immunostained
with antibodies to Gal3. Immunoblot analysis of cell lysates reveals that melanocytes have 5 times
more Gal3 than do keratinocytes. Finally, using confocal microscopy, we demonstrate that Gal3 co-
localizes with both stage I and II melanosomes (recognized by the polyclonal antibody αPEP1h,
against the carboxy terminal of the melanosome specific tyrosinase related protein 1) as well as pre-
melanosomes (recognized by the antibody NK1-beteb against the gp-100 component of the preme-
lanosome and melanosome membrane), present both in the perinuclear and distal dendrite areas of
the melanocyte. Thus, we present preliminary evidence of preferential localization of Gal3 in human
melanosomes, supporting the hypothesis implicating Gal3 in melanosome recognition and internal-
ization by keratinocytes. 
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AIM-1 gene, OCA4, is one of major loci for Japanese oculocutaneous albinisms
Y Tomita,1 T Suzuki,1 K Inagaki,1 Y Miyamura1 and H Shimizu2 1 Dermatology, Nagoya
University Graduate School of Medicine, Nagoya, Aichi, Japan and 2 Dermatology, Hokkaido
University Graduate School of Medicine, Sapporo, Hokkaido, Japan
Oculocutaneous albinism (OCA) is an autosomal recessive disorder caused by mutations of
melanogenic genes such as tyrosinase (OCA1), P protein (OCA2), and DIHCA oxidase (OCA3). In
2001, a novel melanogenic gene named AIM-1 (AF172849) encoding the membrane-associated trans-
porter protein was identified as the fourth pathological gene in a Turkish patient with OCA, and
termed OCA4. At present, no other OCA4 patient has been reported. We have reported that half and
8% of Japanese OCA patients could be classified into OCA1 and OCA2, respectively, but the remain-
ing 33 patients could not be unclassified. In order to clarify the OCA type of 33 patients, we tried
to find pathological mutations of the AIM-1 gene. As a result, seven novel mutations in 17 Japanese
OCA patients were detected by PCR-SSCP/heteroduplex screening and direct sequencing of the
AIM-1 gene. These included four missense substitutions (P58S, D157N, G188V, V507L), two dele-
tion mutations (S90del.CG+A91del.CA, V469del.G), and one insertion mutation (V144ins.AAGT).
All of the four missense mutations were found at the amino acid residues conserved among medaka
fish, mouse, and human. We examined the frequency of seven mutant alleles in 104 unrelated nor-
mally-pigmented Japanese subjects (208 alleles), and no allele was detected, indicating that these
seven mutant alleles are rare in the Japanese population and can be statistically defined as patho-
logical. These results indicate that AIM-1 gene, OCA4, is one of the major loci for Japanese OCA. 
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New strategy for vitiligo treatment: transplantation of genetically-altered melanocytes
V Alexeev and K Yoon Dermatology and Cutaneous Biology, Thomas Jefferson University,
Philadelphia, PA
Vitiligo is an acquired pigmentary disorder characterized by white patches of skin due to the absence
of pigment-producing cells in the epidermis. Its nature and particular causative remain unknown.
Nevertheless, non-surgical and surgical procedures including transplantation of autologous
melanocytes have been used in clinical practice. Although successful transplantations of melanocytes
have been reported, their survival rate, migration and proliferation potential are unknown. Also the
duration of repigmentation after transplantation is questionable, because transplanted melanocytes
are fully differentiated and have a limited lifespan. Also in a progressive form of the diseas even sur-
gical approaches are not favorable. Previously we reported simultaneous targeted alteration of the
tyrosinase and c-kit genes in albino mouse melanocytes. We attempted to characterize c-kit altered
pigment-producing cells in tissue culture conditions and to transplant these cells into the skin of
albino animals. Our results indicate that melanocytes with constitutively active Kit receptor do have
certain advantages over normal mouse pigment-producing cells: In vitro cells with constitutively
activated Kit tyrosine kinase can migrate; proliferation rates of these cells are higher than that of nor-
mal melanocytes. In vivo, after transplantation, cells survived in mouse skin for more than 2 months
and continue to produce melanin; transplanted, Kit- altered cells, did not possess any tumorigenic-
ity; migration of some cells toward hair follicles and epidermis was also detected. Drawing from
these observations, we hypothesize that genetically modified, Kit activated human melanocytes could
be used for transplantation via injection for localized treatment of vitiligo and other disorders asso-
ciated with depigmentation. 
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Disruption of the telomere loop induces pigmentation in normal human melanocytes
MS Eller, J Liou and BA Gilchrest Dermatology, Boston University School of Medicine, Boston,
MA
Experimental disruption of the telomere loop structure by ectopic expression of a dominant-nega-
tive telomere repeat binding factor, TRF2DN, induces a DNA damage response leading to apoptosis,
cell cycle arrest or senescence, depending on signal intensity and cell type. Normal human melanocytes
respond to DNA damage and senescence by increasing their pigmentation, a protective response
against further DNA damage. We and others have shown that small DNA oligonucleotides homol-
ogous to the telomere 3’ overhang also induce these damage responses in melanocytes, in part by
transcriptionally upregulating tyrosinase, and hypothesize that exposure of this overhang following
telomere disruption by TRF2DN, critical shortening during aging or after acute DNA damage is a
physiological signal for increased pigmentation. In order to examine the effect of telomere disrup-
tion on pigmentation, cultured normal human melanocytes were infected with an adenovirus con-
struct expressing TRF2DN (AdTRFDN) or a control virus expressing green fluorescent protein (AdGFP).
Microscopic analysis of the AdGFP-infected melanocytes demonstrated an infection efficiency of
90-95%. The pigmentation response was qualitatively and quantitatively assessed by a melanin assay.
Compared to melanocytes treated with diluent or AdGFP, those treated with AdTRF2DN decreased
their growth rate, became more dendritic and more pigmented as assessed by light microscopy and
silver staining, and increased their melanin content over 6 days to 184% of control cells (77 ± 1 vs
42 ± 2 pg/cell), (p< 0.05). Finally, we wished to examine the regulatory proteins involved in the pig-
mentation response. AdTRF2DN specifically increased the protein levels of both tyrosinase and p53,
known to regulate tyrosinase, when compared to diluent- or AdGFP-treated melanocytes. In sum-
mary, these data demonstrate that experimental disruption of telomere loop structure in cultured
normal human melanocytes induces DNA damage responses and suggest that telomere disruption
during aging or from exposure to UV light contributes to the tanning response 
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19D7 monoclonal antibody identifies immature melanoma cells
JA Burch,1 AM Benitez-Graham,1 SE Miller,2 RM Searce1 and JM Grichnik1 1
Medicine/Dermatology, Duke University Medical Center, Durham, NC and 2 Pathology, Duke
University Medical Center, Durham, NC
We believe melanocytic neoplasias (benign and malignant) are derived from mutations first occur-
ring in melanocytic/neural crest stem cells. One of our current goals is to develop markers for these
early cells. We have identified a melanoma line that has characteristics anticipated for melanocytic
precursor/stem-like cells including the capacity to spontaneously give rise to cells with increased
proliferative capacity and increased melanin production. We generated monoclonal antibodies against
the tumor line and selected for antibodies with increased staining for the immature cell phenotype.
The resultant monoclonal antibody, 19D7, was tested against a wide variety of formalin fixed tissue
sections of human skin and other organs. It was found to stain a vesicular component of immature
melanocytic cells, cells concentrated near nerve and vascular bundles, bone marrow, liver, and the
luminal surface of glands. Dermal cells of nevi and melanomas were strongly positive, while
melanocytes and melanized tumor cells were largely negative. The antigenic target of 19D7 is between
3 and 10 kDa but also exists in a greater than 50 kDa form. By electron microscopy the antigen
appears to be present on the cytoplasmic surface of small vesicular structures. Histologic staining
patterns are different than those of HMB-45, TRP-1, DCT, KIT, S100b, and MART. 19D7 appears
to identify an antigen present in melanocytic cells prior to their full differentiation and identifies a
population of presumptive melanocytic/neural crest stem cells in human skin. 
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Tyrosinase-related protein 1 and 2 selectively inhibit cytotoxicity and cell death of melanocytes
and melanoma cells occurring in tyrosinase-mediated melanogenesis
J Kowichi,1 RH Hesamaddin,1 Y Toshiharu,1 J Hai Ying,1 H Kuninori,1 W Kazumasa2 and
I Shosuke2 1 Department of Dermatology, Sapporo Medical University, School of Medicine,
Sapporo, Japan and 2 Department of Chemistry, Fujita Health University School of Health
Sciences, Toyoake, Japan
Melanin synthesis by tyrosinase involves the production of cytotoxic free radicals. This study exam-
ines the biological function of tyrosinase related proteins (TRP-1 and 2) by using the recombinant
adenoviruses that express tyrosinase, TRP-1 or TRP-2. High-level expression of tyrosinase intro-
duced not only the synthesis of new melanin but also the cell death in both of the melanocytic and
non-melanocytic cells. This cell death was found to be non-apoptotic through FACS analysis. When
TRP-1 or TRP-2 was co-expressed with tyrosinase, this cell death was significantly reduced in
melanocytic cells, but not in non-melanocytic cells. Western blot analysis revealed that TRP-1 does
not affect the amount of co-introduced tyrosinase and TRP-2, the amount of melanin and/or eume-
lanin (not pheomelanin) increased substantially more than that in cells expressing tyrosinase alone.
By double immunostaining of tyrosinase and TRP-1, the two proteins were co-localized in melanocytic
cells but not in non-melanocytic cells. Our findings indicate that TRPs play an essential role in inhibit-
ing tyrosinase-mediated cytotoxicity in melanocytic cells, possibly through the compartmentaliza-
tion of new melanogenesis in melanosomes without altering melanin production. 
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Β1,6-branched N-glycans and coarse vesicles in melanoma progression
T Handerson, V Klump and JM Pawelek Dermatology, Yale University School of Medicine, New
Haven, CT
Β1,6-branched N-glycans, catalyzed by GNT-V, predict poor survival in animal and human cancer,
yet little is known on a histopathologic level. Is upregulated GNT-V associated with a cellular phe-
notype? We studied Β1,6-branching and cell morphology in 57 human melanomas (18 in situ, 26
vertical phase, 13 metastatic), and 60 primary tumors of diverse origin. Melanin was decolorized and
sections stained with the lectin LPHA (Β1,6-branched N-glycans) and anti-CD63. Both stains co-
localized to vesicular structures, which, in melanized regions of melanomas, were present as coarse
melanin. Similar LPHA-positive vesicles but lacking melanin were found in amelanotic tumor cells.
When melanomas were scored for % LPHA-positive, vesicular cells/section, primary tumors were
heterogeneous, ranging from 0-100% of the cells being positive. Using micro-tissue array, LPHA-
positive vesicles were also observed in 55 of 60 primary tumors of diverse origin, including carci-
nomas of the lung, breast, prostate, and colon, again with LPHA staining from 0-100% of tumor
cells. In contrast, melanoma metastases were more homogeneous, with vesicular, LPHA-positive
cells comprising 75-100% of each section examined. Increased LPHA positivity in metastases vs
primary tumors was significant (p=.0080). Thus, a study of LPHA staining in melanomas and other
tumors revealed a previously unrecognized phenotype: co-expression of cytoplasmic coarse vesi-
cles and Β1,6-branched N-glycans. This phenotype was detected in primary tumors, but was most
prominent in metastases. A recent report from others showed that GNT-V, when transfected into mink
lung cells, elicited formation of LPHA-positive vesicles (Hariri et al., Mol Biol Cell, 11:255-268
2000). Thus, it is possible that the vesicles in tumors here were induced by elevated GNT-V. Our
findings are also in line with known correlations between increased GNT-V expression and metas-
tasis, and as such could provide a new understanding of the biology of this process, particularly
regarding the role of Β1,6-branching and aberrant N-glycosylation. 
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Characterization of the molecular defects in RAB27A, caused by RAB27A missense mutations
found in patients with Griscelli syndrome
P Bahadoran,1 R Busca,1 C Chiaverini,1 W Westbroek,2 J Lambert,2 K Bille,1 G Valony,1
M Fukoda,3 J Naeayert,2 R Ballotti1 and J Ortonne1 1 INSERM385, Nice, France, 2 University
Hospital, Gent, Belgium and 3 Riken, Saitama, Japan
Griscelli syndrome (GS) is a rare genodermatosis, characterized by an accumulation of melanosomes
in melanocytes resulting in pigmentary dilution. Mutations of the myosin-Va and Rab27a genes have
been identified in GS patients. On the other hand, mutations of the melanophilin gene account for
the pigmentary dilution observed in the leaden mouse. It has been shown that melanophilin, Rab27a
and myosin-Va constitute a tripartite complex that controls melanosome distal transport and dendrite
targeting. Interestingly, three GS patients present single homozygous, missense mutations, W73G,
L130P and A152P. First, we studied the effect of overexpression of these mutants on melanosome,
melanophilin and myosin-Va localization in B16 melanoma cells. Then, we evaluated several key
parameters for Rab27a function, including GTP binding activity, interaction with melanophilin and
with myosin-Va. Our results showed that Rab27a-L130P cannot bind GTP and consequently cannot
interact with melanophilin. Rab27a-L130P acts as dominant-negative mutant since its overexpres-
sion alters melanosome, melanophilin and myosin-Va localization in B16 cells. Interestingly, Rab27a-
W73G binds GTP, but does not interact with melanophilin. Rab27a-W73G does not interfere with
endogenous Rab27a and does not impair melanosome transport when overexpressed in B16 cells.
In the GS patient with homozygous W73G mutation, impairment of melanosome transport can be
explained by the exclusive expression of Rab27a-W73G. Finally, Rab27a-A152P binds both GTP
and melanophilin. However Rab27a-A152P acts as a dominant negative mutant since its overex-
pression, in B16 melanoma cells, blocks melanosome transport and mimics a GS phenotype. We
have not been able to identify the molecular defect in Rab27a-A152P, but our results point out to the
importance of the Alanine 152 in a Rab27a function other than GTP binding or melanophilin inter-
action. 
1168
Chemical genetic approach to mammalian pigmentation
JR Snyder,1 A Hall,1 S Khersonsky,2 D Dodov,2 D Walsh,2 Y Chang2 and SJ Orlow1 1 Dermatology
& Cell Biology, New York University, New York, NY and 2 Chemistry, New York University, New
York, NY
Chemical genetics is an approach used to investigate cellular pathways and to identify novel gene
products by conditionally modulating protein function through the use of small molecules. This can
be achieved with remarkable specificity by designing large and structurally diverse chemical libraries
that are subsequently screened for a desired cellular phenotype. The purpose of our investigation was
to identify a new class of pigment enhancing compounds from a triazine based chemical library
with the intention of utilizing these molecules bound to an affinity matrix to study proteins involved
in pigmentation. We report the synthesis and screening of an initial 1,600 novel small molecules and
the identification of a class of similar chemicals that augment pigmentation in cultured melan-A
melanocytes. Active compounds were structurally derivatized to maximize their cellular effective-
ness. One molecule enhanced pigmentation by as much as 500% at a concentration of 5uM. This
new class of chemicals increases melanin production, tyrosinase activity and tyrosinase, TRP-1,
TRP-2, protein levels in a dose-dependent manner at nontoxic effective concentrations. Treating
melanocytes with these chemicals in combination with the known promoter IBMX results in a dra-
matic increase in melanin production, tyrosinase activity and tyrosinase, TRP-1, TRP-2, protein
levels. Phenotypic analysis of treated cells suggests that the active compounds and IBMX enhance
pigmentation by different mechanisms. The most active lead molecules have been used to create
agarose bead affinity matrices for protein target isolation. In conclusion we demonstrate that apply-
ing a chemical genetic approach to pigmentation yields a valuable class of reagents that have been
structurally manipulated to maximize their cellular effects and to facilitate protein target identifica-
tion. We believe these chemicals work to enhance melanin production by molecular mechanisms dis-
tinct from those stimulated by IBMX. 
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Phenotypic expression of melanocortin-1 receptor mutations in Black Jamaicans
CA McKenzie,1 RM Harding,2 J Brown-Tomlinson,3 AJ Ray,4 K Wakamatsu5 and J Rees 6 1
Tropical Metabolism Research Unit, University of the West Indies, Kingston, Jamaica, 2 Institute
of Biological Anthropology, Oxford University, Oxford, United Kingdom, 3 Ministry of Health,
Kingston, Jamaica, 4 University of Newcastle, Newcastle upon Tyne, United Kingdom, 5
Chemistry, Fujita Health University School of Health Sciences, Toyoake, Japan and 6
Dermatology, University of Edinburgh, Edinburgh, Scotland, United Kingdom
The melanocortin 1 receptor (MC1R) is the only gene identified that explains substantial variation
in hair colour. Although there has been interest in studying the evolution of the MC1R, genotype/phe-
notype relationships outwith European populations are limited. We recently studied persons with red
hair but who self identify themselves as Black. In Jamaica there are persons who self-identify them-
selves as Black who have auburn/reddish hair, freckles, and a ‘rust-coloured’ complexion (some-
times called ‘red Ibos’). As part of an investigation of the phenotypic expression of MC1R variants
in a Black population we have examined MC1R sequence and hair melanins in 4 Jamaican’redheads’.
Samples were obtained from four redheads (ages 3, 11, 30 and 32 years; 2 boys and 2 women respec-
tively) and also from the mothers of the 2 boys. Sequencing of MC1R revealed that all of the red-
heads were compound heterozygotes for variants that are either known, or predicted to disrupt MC1R
function. MC1R genotypes were as follows (variant positions compared to human consensus sequence:
GenBanK X65634): subject #1: Gly89Arg/Arg151Cys (his mother is heterozygous for the Arg151Cys
variant); subject #2: 23 STOP/Arg160Trp (his mother is heterozygous for the 23 STOP variant); sub-
ject #3: Asp294His/frameshift at codon 195; subject #4: 23 STOP/Arg151Cys. Hair melanins for
subjects #1, #2 and #3 were as follows: log eumelanin 8.3, 8.3, 7.6; log pheomelanin 4.2, 6.6, 6.5.
All of these values are within the range of values seen in a white UK sample of MC1R homozygotes
selected on the basis of the red hair phenotype (log eumelanin mean 7.5 (standard deviation, SD 0.6);
log pheomelanin 6 (SD 0.9). 
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Genetic determinants of dermal and epidermal melanocytosis
KA McGowan,1 CD van Raamsdonk,2 KR Fitch2 and GS Barsh2,1 1 Genetics, Stanford University,
Stanford, CA and 2 Pediatrics, Stanford University, Stanford, CA
Melanocytes undergo a series of genetically controlled behaviors during development as they migrate
from the neural crest, through the embryonic dermis, and finally to specialized structures in the epi-
dermis. Some of the molecular pathways involved in these processes have been identified and stud-
ied using mutations that cause white spotting. Recently, however, large-scale mutagenesis projects
in mice have enabled us to use forward genetics to study a novel class of mouse pigmentation mutants
identified by dark skin (Dsk). Among ten dominant Dsk mutants, we have identified three, Dsk1, 7,
and 10, that cause an abnormal expansion of pigment cell precursors very early in development, and
one, Dsk3, that causes an expansion of pigment cell number that becomes apparent 2 - 3 weeks after
birth. The former class of mutations leads to an accumulation of dermal melanocytes, but the latter
causes accumulation of epidermal melanocytes. Detailed characterization reveals the existence of a
mechanism for limiting the number of pigment cells allowed into the developing epidermis. We iden-
tified the molecular lesions responsible for Dsk1, 7, and 10 as missense alterations in Gnaq or Gna11
that likely represent a gain-of-function, leading to increased phosphatidylinositol-3 kinase signal-
ing and abnormal melanoblast proliferation. The Dsk1, 7, and 10 mutations are semidominant and
additive, but Dsk3/Dsk3 mutant animals die early in embryonic development. Thus, for both classes
of mutations, genetic lesions identified by virtue of their effects on pigmentation provide entry points
for studying fundamental aspects of cell signaling and cell biology. 
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Rapid quantitation of immunostained cultured cells in a formalin-fixed, paraffin-embedded
fibrin cell block
SR Florell,1 P Porter-Gill,2 H Erickson2 and SA Leachman1,2 1 Department of Dermatology,
University of Utah, Salt Lake City, UT and 2 Huntsman Cancer Institute, University of Utah, Salt
Lake City, UT
Our laboratory routinely suspends cultured human melanocytes in a fibrin cell block (FCB) followed
by formalin-fixation and paraffin-embedding. Our laboratory utilizes FCBs for confirmation of cell
lineage and estimation of population purity of cultured human melanocytes by immunostaining
with specific melanocyte markers such as Melan-A. This technique also provides a permanent archive
of cultured cells for future studies. The objective of this study was to develop an image analysis pro-
tocol designed to determine the percentage of cells labeling with various immunohistochemical mark-
ers using the alkaline phosphatase substrate, naphthol/Fast-Red, the red product of which is stable,
does not fade with storage, and is autofluorescent. The autofluorescence of Fast- Red is especially
useful when the paraffin-embedded FCB slices are counterstained with 4’, 6-diamidino-2-phenylin-
dole (DAPI) which forms fluorescent complexes with double-stranded DNA and therefore stains
nuclei. Accordingly, the total number of cell nuclei can be visualized with excitation wavelength of
350 nm. Immunofluorescence of Fast-Red labeled cells can be visualized with excitation wavelength
of 510 nm. Low power (100x) images are digitally photographed with both 350 nm and 510 nm exci-
tation wavelengths to identify the total number of cells (DAPI) and those labeling the antigenic marker
of interest (Fast-Red). The digital images are analyzed and cells are counted with NIH Image 1.63.
Up to four sequential fields are photographed in this manner, each containing several hundred to
more than one thousand cells per field. Thus, several thousand cells can be counted easily and quickly
and the percentage of immunolabeled cells can be derived. Preliminary experiments suggest that this
technique can be used for cell cycle analysis using immunohistochemical markers such as topoiso-
merase II and MIB-1. 
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Enhanced Erk phosphorylation and melanogenic enzyme expression in Nf1 +/- melanocytes
G Diwakar and TJ Hornyak Department of Dermatology, Henry Ford Health System, Detroit, MI
The role of the Ras-GTPase activating protein neurofibromin, encoded by the Nf1/NF1 genes, in
mediating both Kit-independent and Kit-dependent Erk activation in murine melanocytes was exam-
ined in this study. Prior work has shown that neurofibromin haploinsufficency causes partial rever-
sion of a coat color deficiency in KitW41/KitW41 mice and is associated with characteristic pigmen-
tary (café-au-lait) lesions in patients with type I neurofibromatosis (NF-1). KIT-mediated signaling
is known to induce Ras-dependent phosphorylation of the MAP kinase Erk-2 and the melanocyte
transcription factor MITF. We thus examined both MAP kinase activation and melanogenic enzyme
expression in neurofibromin-deficient melanocytes. Nf1 +/- and +/+ primary melanocytes were suc-
cessfully cultured from dermal suspensions of wild-type and Nf1 heterozygous knockout littermates.
Cells were stimulated with the Kit receptor ligand stem cell factor (SCF) for 0 min and 15 min. Cell
lysates were probed for expression of Erk-2, phospho-Erk (P-Erk), MITF, and melanogenic enzyme
expression by Western analysis. Primary cultures of Nf1 +/- melanocytes exhibit similar morphol-
ogy to wild-type cells when cultured up to 60 days. Nf1 +/- cells exhibit enhanced expression of P-
Erk prior to Kit stimulation. Kit stimulation increases P-Erk preferentially in Nf1 +/- cells follow-
ing Kit stimulation in comparison to wild-type cells. Both Kit-independent and Kit-dependent increases
in P-Erk in Nf1 +/- cells are inhibited by incubation with the Mek inhibitor PD98059. Expression of
the melanogenic enzymes tyrosinase, TRP-1, and Dct/TRP-2 are also increased in Nf1 +/- melanocytes.
These results show that P-Erk is increased in Nf1 +/- melanocytes independent of Kit stimulation,
and that neurofibromin haploinsufficiency potentiates the effect of Kit stimulation on MAP kinase
activity. Increased expression of melanogenic enzymes in Nf1 +/- melanocytes may be a determi-
nant of the appearance of café-au-lait macules and patches in NF-1 patients.
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Identification of antigenic markers with increased expression in immature melanocytic cells
AM Benitez-Graham, JA Burch and JM Grichnik Medicine/Dermatology, Duke University Medical
Center, Durham, NC
We believe that melanocytic precursor/stem cells are the initial target of the mutagenic events lead-
ing to melanoma/nevus development. The purpose of this study was to identify markers for early
melanocytic differentiation states. Utilizing a melanoma line that differentiates from a precursor phe-
notype to a more differentiated phenotype we performed an Affymetrix U95A microarray analysis
of both forms and identified genes highly expressed in the immature form that were down regulated
with differentiation. This list was then matched for commercially available antibodies to determine
whether the antigens were also down regulated. The antibodies matching genes that were down reg-
ulated included: glucose transporter-like protein-III (GLUT-3), N-RAS, histone H2B, c-MYC, met-
allothionein-I-A, HLA DR, E-cadherin, and secretogranin II. Studies against the immature and dif-
ferentiated forms of the tumor line confirmed that N-RAS, HLA DR, secretogranin II, H2B, GLUT-3,
and c-MYC were down regulated with differentiation. The results with E-cadherin and metalloth-
ionein-I-A were inconsistent. The antibodies for HLA DR, H2B, GLUT-3, and secretogranin II also
worked in formalin-fixed paraffin-embedded tissue and positively stained foci of nevi/melanoma
cells but failed to reveal significant staining of the epidermal melanocytes. We conclude that the
expression of these markers in melanocytic cells identifies cells that have not yet completed the dif-
ferentiation process. 
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Immature dermal melanocytic cells are present in growing melanocytic neoplasms
A Molino,1 C Lucas,1 A Benitez-Graham,1 JA Burch,1 C Herman,2 A Selim2 and JM Grichnik1 1
Medicine/Dermatology, Duke University Medical Center, Durham, NC and 2 Pathology, Duke
University Medical Center, Durham, NC
The objective of this study was to describe histopathologic characteristics of growing melanocytic
neoplasms. Clinical photos and tissue obtained from pigmented lesion clinic patients were retro-
spectively examined. Lesions were classified as changing if there was at least 2 out of 3 agreement
of greater than two-fold enlargement on photos by three dermatologists masked to the identity and
history of the patient. IRB approved protocol allowed the use of tissue sections from the surface of
the residual neoplasm in the block, thus only a portion of each of these lesions was available for
study. The tissue sections were stained with H&E and 19D7 (an antibody that identifies immature
melanocytic cells). Selected slides were also stained with S100b and Ki-67. Histopathological eval-
uation revealed that 58% (34/59) of the specimens included melanocytic cells in the papillary der-
mis. Large junctional nests (>75% of epidermal thickness) were common (25/59) and expulsion of
some of these nests through the epidermis was noted. Upwardly migrating cells were also common
(19/59). 19D7 labeled the dermal cells in the majority of lesions. S100b also stained these cells. Ki-
67 positivity was rare but could be identified in the dermal component including one case in which
only a few cells at the base of the dermal component were found to be positive. Thus, our data sug-
gests that in the majority of acquired melanocytic neoplasms (benign and malignant) a papillary
dermal component is present during the growth phase and this component is 19D7 positive. In addi-
tion, some epidermal nests and individual melanocytic cells appear to be extruded through the epi-
dermis. We propose that many acquired melanocytic neoplasms may originate in an immature pop-
ulation of cells in the papillary dermis with cells migrating into the epidermis where they accumulate
and may also be extruded. Cells not able to migrate effectively into the epidermis accumulate in the
dermis as this process continues. 
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Foxn1 and the acquisition of pigmentation
R Han, L Weiner, B Scicchitano, D Lee and JL Brissette Cutaneous Biology Research Center,
Massachusetts General Hospital and Harvard Medical School, Boston, MA
Foxn1 (Whn, Hfh11) is a transcription factor containing a winged-helix DNA-binding domain and
a negatively charged transactivation domain. In rodents, the loss of Foxn1 function causes the nude
phenotype, which is characterized by the lack of visible hair, structural abnormalities in the epider-
mis, defects in lactation, and the absence of a thymus. To assess the effects of a gain of Foxn1 func-
tion, we generated transgenic mice that express Foxn1 from the keratin 5 (Krt5) promoter. This pro-
moter targeted Foxn1 to basal epithelial cells of the epidermis and hair follicles, cell types generally
lacking endogenous Foxn1. Surprisingly, the Krt5-Foxn1 transgene caused changes in skin pig-
mentation. In contrast to wild-type epidermis, the transgenic epidermis contained melanin, and the
basal layer exhibited numerous melanocytes. While maintaining this epidermal melanocyte popula-
tion, the transgenics showed no abnormalities in coat color or density, suggesting that melanocytes
entered the hair follicles in normal numbers. Thus, the transgene reshaped the pigmentary system
and made it more human-like, as the system provided pigment to both the epidermis and hair. In
wild-type hair follicles, Foxn1 was most abundant in the differentiating precursors of the cortex,
which receive pigment from melanocytes; to a lesser extent, Foxn1 was also detected in the differ-
entiating medulla, the other melanized structure of the hair. Since Foxn1 is normally found in
melanocyte targets, we propose that Foxn1 promotes the functional association of melanocytes and
epithelial cells. In all, these results provide the first evidence of a role for Foxn1 in pigmentation. 
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Selective glucocorticoid receptor agonists express an improved effect/side effect profile in vivo
H Schaecke,1 A Schottelius,1 W Doecke,1 H Hennekes,2 S Jaroch,3 N Schmees,3 H Rehwinkel3 and
K Asadullah1 1 RBA Dermatology, Schering AG, Berlin, Berlin, Germany, 2 International Project
Management, Schering AG, Berlin, Berlin, Germany and 3 Medicinal Chemistry, Schering AG,
Berlin, Berlin, Germany
Glucocorticoids (GCs) represent a well known class of anti-inflammatory and immunosuppressive
drugs. They are used in the treatment of many chronic inflammatory and allergic diseases. However,
their therapeutic effects are often accompanied by the development of severe and sometimes irre-
versible side effects. Thus, there is a real need for “better” GCs, meaning GCs with a reduced side
effect induction while maintaining the anti-inflammatory and immunosuppressive properties of clas-
sical GCs. GCs affect gene expression by either a transactivation or a transrepression mechanism.
It has been accepted, that anti-inflammatory effects are mainly mediated via the transrepression
mechanism, while many side effects are induced by the transactivation mechanism. Therefore, our
aim was the identification of glucocorticoid receptor (GR) ligands, that preferentially induce tran-
srepression and if at all a weaker transactivation. Here we show a novel non-steroidal compound
class with a significant dissociation of transactivation from transrepression in vitro and in vivo. In
vitro a preference for the transrepression mechanism was found and cytokine expression in human
PBMCs could be inhibited. Both systemic and topical applications of a representative of the new
compound class indicated that it has anti-inflammatory activity similar to prednisolone. In rodents
we were able to demonstrate superiority of the SEGRA compound over prednisolone with regard to
blood glucose induction, spleen involution and to a lesser extent skin atrophy but not to ACTH sup-
pression. Thus, a dissociation of transactivation and transrepression mechanisms in vitro is indeed
reflected by a reduction of side effects in vivo. SEGRAs represent promising new drug candidates
with an improved effect / side effect profile since they should have a lower risk for transactivation
mediated side effects, e.g. diabetes mellitus. 
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Androgen metabolizing activity of retinol dehydrogenase-4 (RoDH-4) is inhibited by 13-cis-
retinoic acid (isotretinoin) but not by all-trans retinoic acid
T Karlsson,1 A Vahlquist,1 N Kedishvili2 and H Torma1 1 Medical Sciences, Uppsala University,
Uppsala, Sweden and 2 Molecular Biology and Biochemistry, Univ of Missouri, Kansas City, MO
Severe acne is efficiently treated by systemic 13-cis-retinoic acid (isotretinoin). The mechanism of
action of 13-cis-retinoic acid has been an enigma since it does not bind to the nuclear retinoic acid
receptors (RARs). Although, a specific conversion of 13-cis-retinoic acid into all-trans retinoic acid
was recently found in cultured sebocytes, additional effects not mediated by RARs might exist. An
enzyme expressed in human epidermis, RoDH-4, is oxidizing retinol and 13-cis-retinol into corre-
sponding aldehydes but also 3-α-androstandiol into dihydrotestosterone and androsterone into andro-
standione. Of special interest for acne is the production of dihydrotestosterone by this back-reac-
tion. Here we examined the inhibitory effect of several natural and synthetic retinoids on the androgen
metabolizing activity of microsomes prepared from Sf9 insect cells over-expressing recombinant
RoDH-4. We found a strong competitive inhibition by 13-cis-retinoic acid but less by other natural
and synthetic retinoids, i.e. all-trans retinoic acid, acitretin and adapalene. However, two other nat-
ural retinol metabolites known to be present in human epidermis and sebaceous glands; 3,4-dide-
hydroretinol and 3,4-didehydroretinoic acid, inhibited the androgen metabolizing effect of RoDH-
4, albeit 2-10 fold less efficient than by 13-cis-retinoic acid. Thus, 13-cis-retinoic acid possesses
unique properties unrelated to retinoid receptor activation which might in part explain the mecha-
nism of action of this drug in acne. 
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The mechanism promoting skin wound healing through the topical application of sugar and
povidone-iodine
H Nakao,1 R Tsuboi2 and H Ogawa3 1 Kowa Research Institute, Kowa Company, Ltd., Tsukuba,
Ibaraki, Japan, 2 Department of Dermatology, Tokyo Medical University, Shinjuku, Tokyo, Japan
and 3 Department of Dermatology, Juntendo University School of Medicine, Bunkyo, Tokyo, Japan
A combination of 70% sugar and 3% povidone-iodine with an improved vehicle (UP) has been used
to accelerate granulation tissue formation in patients with refractory cutaneous ulcers and pressure
sores. However, the healing mechanism has remained unclear. The present study examines changes
in cytokine production, extracellular matrix expression and macrophage immigration by means apply-
ing UP, sugar or povidone iodine to cultured human fibroblasts and cutaneous full-thickness wounds
in mice. A high concentration of UP depressed the proliferation of fibroblasts. On the other hand, it
accelerated collagen synthesis in cultured fibroblasts and increased TGF-beta 1 concentration in
wound tissues. These effects were induced by sugar. Furthermore, UP accelerated not only the expres-
sion of beta 1 integrins in both the cultured fibroblasts and wound tissues, but also increased the
immigration of macrophages into wound tissues, effects which were induced by povidone iodine.
The results obtained suggested that the application of UP to wounds enhances not only collagen
synthesis and ECM expression in cells, but also the migration of fibroblasts and macrophages through
the combined effect of sugar and povidone iodine, leading to the acceleration of wound healing. 
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Effects of two topical antimicrobial agents on Staphylococcus aureus biofilms in a porcine model
A Cazzaniga, SC Davis and PM Mertz Dermatology and Cutaneous Surgery, University of Miami,
Miami, FL
Biofilms are a combination of microorganisms and extrapolysaccharide matrices. Our laboratory has
previously demonstrated that biofilms are present in both acute and chronic wounds.  Once biofilms
are established, phagocytosis and diffusion of antibiotics are impaired thus contributing to antimi-
crobial resistance due to increased bacterial virulence. The purpose of this study was to determine
the efficacy of two topical antimicrobial agents on partial thickness wounds containing Staphylo-
coccus aureus biofilms. All wounds were inoculated with 106 CFU/ml and covered for 48 hrs under
a polyurthene film to promote biofilm formation. Wounds were divided into three treatment groups;
triple antibiotic ointment (Polymyxin B sulfate, bacitracin zinc, neomycin), mupirocin cream and
untreated control. Wounds were treated twice daily. Wounds were cultured for bacterial quantitation
at 24, 48, 72, 96, and 120 hrs. Significant reduction in CFU/ml was observed only after several days
of treatments. This finding supports the antimicrobial resistance that occurs when bacteria live within
biofilms. Our previous studies demonstrated that both of these agents were able to completely elim-
inate planktonic S. aureus (106) at the early time points. This study demonstrates that when bacte-
rial biofilms are established in wounds there is a longer response time for topical antimicrobial activ-
ity suggesting bacterial resistance. 
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Photodegraded nifedipine increases iron in mouse skin
J Zhou and LM Milstone Dermatology, Yale and VAConnecticut, New Haven, CT
Epidermal desquamation might be a way of treating iron overload, if more than the normal amount
of systemic iron could be delivered to the epidermis. Previous work has demonstrated that pho-
todegraded nifedipine (PDN) increases iron transport into cultured keratinocytes 80-fold, and increases
iron content in stratified keratinocyte cultures by 3-fold. We tested whether PDN would increase iron
in epidermis following topical application in vivo. The active ingredient in PDN, the nitroso-deriv-
ative of nifedipine, was recrystallized from solution following exposure of nifedipine to fluorescent
light. Solutions of this nitroso-derivative were applied repeatedly to mouse skin using several dif-
ferent protocols, and iron content was measured following heat separation of epidermis from der-
mis. Baseline iron content in epidermis was significantly different in different strains of mice. PDN
consistently increased iron in epidermis, but never more than 2-fold. Results were similar in ear and
flank skin. Twice daily application was better than daily application. Topical application of iron
ionophores, such as PDN, may load sufficient iron into desquamating epidermis to have a systemic
effect. 
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Combination of topical calcipotriol and the narrow band UVB in the treatment of vitiligo
P Kullavanijaya and HW Lim Dermatology, Henry Ford hospital, Detroit, MI
Vitiligo is a common condition affecting 1-2% of general population. PUVA and narrow band UVB
(NB-UVB) have been shown to be effective treatments. It has been postulated that there was a
defective in calcium homeostasis in affected skin; therefore calcipotriol, a vitamin D3 derivative,
may also have a beneficial role in vitiligo. Previous studies have shown that calcipotriol enhanced
the effectiveness of PUVA in treatment of vitiligo. The purpose of this study was to determine the
efficacy of topical calcipotriol / NB-UVB combination, compared to NB-UVB alone in the treat-
ment of vitiligo. Twenty patients with bilateral symmetrical vitiligo affecting •5%-50% body sur-
face areas were enrolled in the study; study period was August 2001 to October 2002. Patients were
exposed to NB-UVB three times a week, starting with 280 mJ/cm2, and dose was increased by 10-
15% per treatment. Topical calcipotriol was applied to all lesions on the left side of the body twice
daily. Seventeen patients (11 males and 6 females, age range: 14-68 years) completed the study; 3
patients failed to properly follow the instruction for application of calcipotriol. Of the 17 patients,
there were 8 African-Americans, 8 Caucasians, and 1 Hispanic. All patients tolerated the combina-
tion treatment well. Intent-to-treat analysis was used. The overall response is as follow: 8
patients(8/20=40%) had significant(66-100%) repigmentation, 6 patients(30%) had moderate(25-
65%), 1 patient(5%) had mild(10-24%), and 2 patients(10%) had minimal(less than 10%) improve-
ment. Nine patients(3 patients, 5 patients and 1 patient with significant, moderate and minimal
improvement, respectively) noticed appreciable improvement on the left side by 29-114 treatments.
As treatment was continued, the response equalized on both sides in 3 patients. Lesions on trunk
responsed better than those on hand and extremities. In conclusion, topical calcipotriol / NB-UVB




SC Davis, A Cazzaniga, CA Ricotti and PM Mertz Dermatology and Cutaneous Surgery,
University of Miami, Miami, FL
A simple method of local oxygen delivery to wounds may have important implications during wound
healing. Oxygen is a required substance for various aspects of wound repair and increased oxygen
tension in a wound has been shown to stimulate phagocytosis and speed the degradation of necrotic
wound tissue. An increase in oxygen tension has been shown to enhance collagen production, neo-
vascularization and neutrophil mediated oxidative microbial killing. We describe here the investi-
gation of a topical aqueous oxygen emulsion (AOE), which is a patented technology based on a super-
saturated oxygen suspension using perflurocarbon components. Second-degree burn wounds were
created on the backs of specific pathogen free pigs. Burn wounds were then randomly assigned to
one of the following treatment groups: AOE, AOE vehicle, or air exposed control. The topical AOE
was able to significantly enhance the rate of epithelization as compared to both vehicle and untreated
control. This data suggests that topical oxygen is beneficial for epithelization of ischemic wounds
such as burns and additional studies examining the potential use of this therapy on chronic wounds
is warranted. 
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Immunological consequence of pharmacological disruption of endogenous redox regulatory
pathways
H Matsue,1 D Edelbaum,1 D Shalhevet,1 J Oeda,2 H Masayasu2 and A Takashima1 1 UT
Southwestern, Dallas, TX and 2 Daiichi Pharmaceutical Co Ltd, Tokyo, Japan
The thioredoxin and glutaredoxin systems control many cellular activities by maintaining cytoplas-
mic proteins in their reduced state. To determine the immunological consequence of an excessively
lowered redox potential, we added a selenium-containing anti-oxidant compound PZ51 to the in vitro
Ag presentation systems composed of: a) a stable dendritic cell (DC) line XS52, KLH-specific Th1
clone HDK-1, and KLH, or b) bone marrow-derived DC, naive or Th1/Th2-primed CD4 T cells from
DO11.10 transgenic mice, and OVA peptide. PZ51 inhibited Ag-specific, DC-induced proliferation
and production of IL-2, IL-4, and/or IFNγ by each tested T cell population, with 30-100% inhibi-
tion achieved at 5-15 µM. PZ51 also suppressed T cell-dependent production of IL-6, IL-12, and
TNFα by DC in the same dose range. Unlike cyclosporin A, rapamycin, and dexamethasone, which
differentially inhibited selected aspects in Ag presentation, PZ51 inhibited all tested events accom-
panying bi-directional DC-T cell interaction in an extremely narrow dose range. LPS treatment sig-
nificantly (P<0.05) altered the expression of 223 genes in bone marrow DC, and PZ51 differed from
the conventional immunosuppressants in its relative inability to reverse DC expression of this sig-
nature gene profile. Allergic contact hypersensitivity (CH) responses of BALB/c mice to oxazolone
were suppressed significantly (>50% inhibition and P <0.001 in four experiments) by post-challenge
treatment with oral administrations of PZ51 (100 mg/kg/day), the protocol causing rapid elevation
(<2 hr) and continuous maintenance (>24 hr) of serum PZ51 levels above the in vitro identified
immunosuppressive dose (15 µM). By contrast, PZ51 failed to inhibit irritant CH responses to cro-
ton oil, indicating disease specificity of its action. These results introduce a new concept that redox
regulation plays a key role in DC-T cell communication during Ag presentation. Our data also sug-
gest that PZ51 and other anti-oxidants may be used for the treatment of immunological disorders. 
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Analysis of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis using
SCORTEN: the University of Miami experience
JT Trent,1 RS Kirsner,1,2 P Romanelli1 and FA Kerdel1 1 Dermatology, University of Miami School
of Medicine, Miami, FL and 2 Dermatology, Veterans Administration Medical Center, Miami, FL
Toxic epidermal necrolysis (TEN) is a rare, life-threatening condition caused by certain medications.
Keratinocytes affected by TEN have been found to undergo apoptosis mediated by Fas-FasL inter-
actions. Intravenous Immunoglobulin (IVIG) has been proposed to inhibit this interaction. SCORTEN
system, a validated predictor of TEN mortality, was used to retrospectively analyze the data of con-
secutive patients diagnosed with TEN treated with IVIG at the University of Miami in order to
determine the effect of IVIG on patient mortality. Sixteen consecutive patients admitted as inpatients
to the dermatology service at the University of Miami were treated with IVIG at 1g/kg/d for 4 days
(total 4g/kg). For each patient, the 7 independent risk factors [age >40 years, presence of malignancy,
%BSA involved >10%, BUN >28mg/dL (>10mmol/L), glucose >252mg/dL (>14mmol/L), HCO3
<20mEq/L (<20mmol/L), and heart rate >120 bpm within the first 24 hours of admission] of
SCORTEN prior to IVIG therapy were recorded, as was cause of TEN and other medical problems.
One patient died. Based on the SCORTEN system, 5.81 patients were expected to die. These mor-
tality rates were compared using the Standardized Mortality Ratio analysis (SMR) to determine the
efficacy of this treatment. TEN patients treated with IVIG had a 83% reduction in mortality (95%
CI: 0.0-0.96). Our data supports the use of IVIG for the treatment of TEN patients. Based on com-
parison of our mortality rate to the SCORTEN predicted mortality rate, treatment with IVIG was
shown to significantly decrease mortality in TEN patients. 
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PUVA vs. PUVA and interferon alpha for treatment of mycosis fungoides
A Kujawska, A Abrou, DP Fivenson and HW Lim Dermatology, Henry Ford Health System,
Detroit, MI
In the early stages of mycosis fungoides (MF), PUVA has been demonstrated to be an effective dis-
ease-modifying therapy. Within the past two decades, the combination of PUVA + interferon alpha
(INFa) therapy has been used with promising results. To summarize over ten years experience in the
management of MF combining our experience from both a retrospective and a prospective series to
evaluate efficacy of PUVA +/- systemic IFNa in treating early MF. A total of 48 patients were exam-
ined. In the retrospective chart review, there were 22 males and 15 females, age 22 to 81 (median 53
years). 17 subjects were African-American and twenty were Caucasian. In the randomized prospec-
tive trial, there were 9 males and 2 females, age 37 to 76 (median 64 years). Nine of these patients
were Caucasian, 1 was African-American, and 1 was Asian. Of the total 48 patients, 36 (12 females
and 24 males) were treated with PUVA alone and 12 (5 females and 7 males) received PUVA +
INFa therapy. In the retrospective chart review, a complete(CR) or partial response(PR) was achieved
in 28/30 subjects in the PUVA alone group(93.0%), while in the PUVA + INFa group a CR or PR
was attained in 5/7 patients(71.0%). In the randomized arm, 5/6 patients from the PUVA alone group
(83.0%) achieved CR or PR, and 5/5 patients (100%) from the PUVA + INFa group attained CR or
PR. Our study showed no significant difference in the outcome of the PUVA alone treatment group
vs. PUVA + INFa combined treatment group. 
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Gene expression in actinic keratoses—pharmacological modulation by imiquimod
U Tartler,1 B Lysa,2 M Walz,1 R Wolf,1 P Arenberger,2 B Benninghoff3 and T Ruzicka1 1
Department of Dermatology, Heinrich Heine University, Duesseldorf, Germany, 2 Clinic of
Dermatovenerology, Charles University, Prague, Czech Republic and 3 3 M Medica, Neuss,
Germany
Imiquimod, an imidazoquinoline amine, is an immune response modifier approved for the topical
treatment of external genital warts. Preliminary studies showed antitumorous effects. In vitro stud-
ies showed that imiquimod stimulates the synthesis of IFN-α, IFN-γ, IL-1, -6, -8, -12 and TNF-α.
However, the mechanisms of imiquimod’s activity are not clearly understood. Our aim was to study
the clinical and molecular effects of topical imiquimod in the treatment of AK. 13 patients with AK
were treated with imiquimod 5% cream over night 3 times per week for 6 weeks. Shave biopsies
were taken from healthy skin, AK lesional skin before treatment, during the treatment at the peak of
the inflammation and 2-3 weeks after the treatment. Generally we observed a positive response to
imiquimod. 12 patients showed a total or almost complete clearence of the treated lesions, 1 patient
was a non-responder. To gain insight into the molecular processes induced by imiquimod, we inves-
tigated the expression of several genes coding for inflammatory cytokines (IL-6, TNF-α, IFN-α),
IL-10R, antiapoptotic proteins (Hurpin, Hax-1), proteins involved in cell-adhesion (α- and β-catenin)
and the tumor suppressor gene p53. Additionally, we analyzed the expression of TLR-7, possibly
mediating the activity of imiquimod. Total RNA was isolated from biopsies and gene expression was
analyzed by semiquantitative RT-PCR. We found a significant upregulation of the proinflammatory
cytokines IFN-α, IL-6 and TNF-α which correlates well with the local inflammation induced by
imiquimod. Interestingly, the transcription of IL-10R and TLR-7 was also significantly increased
during imiquimod treatment. In contrast, expression of Hax-1, Hurpin, p53, α- and β-catenin was
not significantly influenced by imiquimod. Effects of imiquimod in AK correlate with specific
influences on gene expression. 
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Anti-infammatory activity of topical nanocrystalline silver cream on allergic contact dermatitis
in a guinea pig model
KC Bhol,1 J Alroy2 and PJ Schechter1 1 NUCRYST Pharmaceutials, Wakefield, MA and 2
Pathology, Tufts University, Boston, MA
The objective of the study was to assess the anti-inflammatory activity of nanocrystalline silver cream
and compare the effects with those of tacrolimus ointment (Protopic 0.1 %), using a guinea pig model
of allergic contact dermatitis. Dermatitis was induced using 5% dinitrochlorobenzene. Once der-
matitis was established, nanocrystalline silver 1% cream, tacrolimus ointment, or appropriate con-
trol formulations was applied topically once daily for 5 days to groups of 10 animals each and com-
pared to animals receiving no treatment. Erythema and edema were evaluated daily (on a score of 0
to 4, from absent to very severe/excessive) and by histopathology of skin biopsies after five days of
treatment. Prior to the onset of treatment, erythema and edema scores averaged 3.8 to 3.9 and 2.9 to
3.3, respectively. In the no treatment group these scores remained at about this level for the subse-
quent 5 days of the study. The respective control groups for each of the active treatments did not dif-
fer significantly (P>0.05) from the no treatment group. In contrast, within one day of treatment 1%
nanocrystalline silver cream reduced erythema and edema significantly (P<0.001) and this reduc-
tion progressed throughout the study period so that after five days of topical treatment, mean scores
reached 1.2 and 0.5 for erythema and edema, respectively. Tacrolimus produced similar decreases
in erythema and edema, with no significant differences compared to nanocrystalline silver. Skin biop-
sies were also evaluated on a 0-4+ scale for degree of inflammatory response. Control treatments
could not be differentiated from no treatment group. Nanocrystalline silver and tacrolimus markedly
decreased inflammatory scores (P<0.001), but were not different from each other. This study sug-
gests that nanocrystalline silver cream has therapeutic potential for topical treatment of inflamma-
tory skin diseases. 
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Development of novel NFκB decoy oligonucleotide ointment and the first successful clinical
trial for severe atopic dermatitis patients
K Tamai,1,2 R Morishita,2 H Nakamura,2 Y Chiba,1 Y Kaneda2 and K Hanada1 1 Dermatology,
Hirosaki University School of Medicine, Hirosaki, Aomori, Japan and 2 Gene Therapy Science,
Osaka University Graduate School of Medicine, Suita, Osaka, Japan
NFκB is a transcriptional factor regulating expression of various inflammatory genes. In this study,
we have developed novel anti-inflammatory ointment containing NFκB decoy oligodeoxy nucleotides
(NDON) which bind NFκB to neutralize its transcriptional activity. Topical application of 1.5%
NDON ointment to the NC/Nga atopy model mice skin resulted in a marked improvement of the der-
matitis, accompanied by a significant decrease of mast cell infiltration because of their apoptosis.
Number of ICAM1-positive cells was also significantly decreased in the NDON-treated skin. Based
on those observations, we have designed a first clinical NDON trial for treatment of severe atopic
dermatitis. Prior to the trial, adult volunteer patients were treated by vehicle ointment only for two
weeks. Finally, 7 volunteer patients, whose dermatitis conditions were not changed or the worse,
agreed to enter the trial. The first week of treatment by one-time NDON topical application per day
was followed by intermittence for the second week, and the third week of NDON treatment by two-
time administration per day was again intermitted for the fourth week before final evaluation. Sever-
ity and improvement of the skin involvement, local and systemic side effects and score of pruritis
were evaluated once a week. After the trial, six out of the 7 patients revealed significant improve-
ment, especially for severe facial involvement, although lesser effect was observed on the lesion of
the trunk and the extremities, presumably due to low permeability of NDON on these regions. No
local and systemic side effect was observed. Noteworthy points of NDON treatment were observa-
tions of no rebound and of prolonged improvement without potent steroid administration after NDON
termination, suggesting quite unique action mechanisms involving mast cell apoptosis. These suc-
cessful results promise NDON as a novel therapeutics especially for severe facial atopic dermatitis. 
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The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis in cuta-
neous T cell lymphoma cells
C Zhang, X Ni, R Talpur, N Chiao and M Duvic Dermatology, The University of Texas M. D.
Anderson Cancer Center, Houston, TX
Mycosis fungoides (MF), an indolent cutaneous T-cell lymphoma (CTCL) characterized by accu-
mulation of epidermotropic CD4+CD45RO+ helper/memory T cells in skin, may result from loss
of normal, activation-induced apoptosis. Pharmacological modulation of apoptosis may provide novel
therapeutic approaches for CTCL. Suberoylanilide hydroxamic acid (SAHA), a potent inhibitor of
histone deacetylases (HDACs), causes growth arrest, differentiation, and/or apoptosis of several types
of tumor cells both in vitro and in vivo. SAHA is in clinical trials for CTCL thus we wanted to deter-
mine its effect on cell lines and patients’s cells. Human CTCL cell lines (Hut78 and HH) and periph-
eral blood lymphocytes (PBLs) from 6 CTCL patients at baseline were treated with 0.1, 0.5, 1, 2.5,
5, and 10 uM SAHA for 24 and 48 hrs. Apoptosis was assessed by annexin V binding and cell cycle
arrest measured by flow cytometry, and proteins by Western blotting. In HH cells, apoptotic rates of
43-70% over baseline were observed at doses of 2.5-10 uM SAHA for 24-48 hours. Hut78 cells
with lower baseline bcl-2 levels and higher baseline apoptosis showed 40-56% SAHA-induced apop-
tosis at 2.5-10 uM over 48 hours. SAHA treatment in both lines induced the cyclin-dependent
kinase inhibitor, p21 (WAF1/CIP1) but did not alter the level of bcl-2 protein and there was no cor-
relation between cell sensitivity to SAHA and basal expression levels of bcl-2. In 6 CTCL patients’s
PBLs treated with SAHA, increased apoptosis started at 0.5 uM and was at a maximum of 50% at
both 5-10 uM for 48 hours. Sezary syndrome (SS) patients experiencing clinical responses to oral
SAHA at 400-550 mg/day also showed a 50% reduction in the malignant T-cell clones in vivo as
early as 4 weeks after starting treatment. SAHA is a new potential therapeutic agent for the treat-
ment of CTCL that may work through inducing of T-cell apoptosis, independent of bcl-2. 
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Phenotypic reversion of melanoma in vitro suppresses metastasis in vivo
G Lipkin, M.D.,1 M Rosenberg2 and P Brooks2 1 Dermatology, New York University, School of
Medicine, New York, NY and 2 Departments of Dermatology and Radiation Oncology, New York
University School of Medicine, New York, NY
Induced reversion of the melanoma malignant phenotype offers a theoretically novel approach to
preventing growth and spread of biologically heterogeneous, therapeutically intractable tumors. Since
lethality of most melanomas depends ultimately upon in vivo metastasis, we studied the effect on
the latter of first inducing phenotypic reversion in vitro, using an endogenous inhibitor, Contact
Inhibitory Factor (CIF), present in culture medium of a revertant line of melanoma cells. CIF was
previously shown to restore normal in vitro growth control (density-, serum-and anchorage depend-
ence) to mouse, hamster and human melanoma cells, and to also induce early G1 growth arrest, syn-
thesis of pigment differentiation antigens, upregulation of class I MHC leading to enhanced destruc-
tion by cytotoxic T cells, suppression of angiogenesis at its source, and permanent regression of
established melanomas in vivo. B16F10 cells were treated with or without CIF for 48 hours, the for-
mer inducing the characteristic morphologic changes accompanying reversion. Equal numbers of
viable control and revertant cells were then employed in the chick embryo chorioallantoic membrane
(CAM) assay, which measures the later stages of metastasis (extravasation and colony formation),
with cells injected into 10 day old embryos, followed 1 week later by scoring of lung and liver metas-
tases. In Experiment I, there was a significant difference in mean number of lung metastases (con-
trol 3.1 ± 3.0, N=11; CIF 0.5 ± 0.9, N=18; 0.003<P). In Experiment II, a similar result was seen (con-
trol 6.1 ± 2.5, N=8; CIF 2.2 ± 2.4, N=8; 0.006 <P). In both experiments there was a striking decrease
in liver metastases with revertant cells. In conclusion, decreased ability to metastasize is an addi-
tional accompaniment of phenotypic reversion. Although the molecular changes mediating sup-
pression of metastasis remain to be explored, induced reversion of the melanoma malignant pheno-
type is a valid target for future therapeutic investigation. 
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Intravenous low-dose ketamine inhibits itch-induced by histamine prick in humans
T Ebata, C Yano, R Kamide and M Niimura Dermatology, Jikei University School of Medicine,
Tokyo, Japan
The purpose of the study is to investigate the effect of intravenous low-dose ketamine on histamine-
induced itch in human volunteers. Itch was induced by skin prick of 1% histamine on a volar aspect
of the forearm in 22 healthy male volunteers (median age 34, range 26 to 51). The intensity of itch
(Numerical Rating Scale, 0-10) was monitored every minute until it disappeared. The following
parameters were assessed; the area of wheal and flare at 15 min of skin prick, the maximum itch
intensity and its duartion. Either ketamine (2mg, K) or normal saline (5ml, NS) was injected intra-
venously 2 min prior to skin prick on different days with an interval of one week in a double-blind
randomized order. A second generation antihistamine, azelastine (2mg/day for 3 days, A) was taken
orally as a positive control afterwards. The effect of K on itch and skin response to histamine prick
was compared with those of NS and A. The area of wheal (sqmm) was 39.7+/-15.8 (NS), 35.0+/-
10.1 (K) and 28.4+/-9.9 (A). The area of flare (sqmm) was 551+/-317 (NS), 420+/-263 (K) and 118+/-
96 (A). The maximum itch intensity (0-10) was 5.1+/-1.7 (NS), 4.1+/-1.6 (K) and 2.8+/-1.8 (A).
The duration of itch sensation (min) was 9.6+/-3.8 (NS), 8.0+/-4.1 (K) and 6.9+/-4.2 (A). The num-
ber of the subjects who felt slightly sedated was 5 with K and 1 with NS. There were 7 other sub-
jects who felt slight dizziness with K. These sensations disappeared within a few minutes. No seri-
ous side effects were seen throughout the experiment. Ketamine is an intravenous anesthetic with a
NMDA receptor antagonizing effect, which makes the drug used as an analgesic. It is also reported
to be effective for chronic persistent itch in patients with erythroderma. Though less potent than
azelastine, ketamine was shown to decrease itch sensation induced by histamine skin prick in healthy
volunteers. This result suggests the possible role of NMDA in the transmission of itch impulse within
the central nervous system. Further trials with varying doses and in other itchy conditions may
prove ketamine to be a possible antipruritic. 
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Pimecrolimus and tacrolimus differentially affect genes related to skin inflammation in rats
J Kehren,2 B Hartmann,1 F Hermann,1 A Stuetz1 and JG Meingassner1 1 Novartis Research Institute
Vienna, Vienna, Vienna, Austria and 2 Novartis Pharma AG, Basle, Switzerland
Contact hypersensitivity (CH) in laboratory animals has been used as model of a T cell mediated
skin disease to profile pimecrolimus (PI) for the treatment of inflammatory dermatoses. CH, assessed
by the increase in skin thickness 24 hrs after elicitation, was inhibited by 49% in rats after oral treat-
ment with 25 mg/kg, administered 2 hrs before and at time of challenge with 2,4-dinitrofluoroben-
zene (DNFB). Surprisingly, no significant effect on skin thickening was observed with tacrolimus
(TA) at the same oral dosage. In order to get a deeper insight into the different pharmacodynamic
activities of the two compounds in that model, skin of animals challenged with DNFB and treated
with PI or TA as well as skin from untreated control animals was analysed for gene expression using
a microarray technology. The genes affected by DNFB (p < 0.01) were selected and their treatment-
related changes studied. Many genes which have been induced or reduced in expression by the chal-
lenge (such as Gro alpha, MCP-1) were normalised in expression level by both, PI and TA. To
understand the mechanism underlying the lacking anti-inflammatory activity of oral TA against CH,
genes differentially affected by the two compounds were investigated. In contrast to TA, PI inhib-
ited the expression of several genes related to inflammatory or fibrotic processes such as PF4, galectin
3, heme oxygenase, alpha 2 macroglobulin or versican. Thus, that set of genes which was affected
by PI only may account for the clinically observed inhibition of the CH reaction. In conclusion, TA
and PI exhibited a strong effect on the gene expression in the elicitation phase of DNFB-induced
CH. The changes induced by TA were not related to a decreased CH reaction and the genomic data
may indicate that the effectiveness of PI results from inhibition of genes involved in inflammatory
processes that were not affected by TA. 
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An FDA perspective on dermatologic drug development: The FDA Reviewer and Dermatol-
ogy Advisory Committee Meetings
MC Luke and JK Wilkin CDER, ODE V, DDDDP, U.S. Food and Drug Administration, Rockville,
MD
FDA’s Division of Dermatologic and Dental Drug Products at the Center for Drug Evaluation and
Research reviews the majority of dermatologic drugs for safety and efficacy. Currently, the primary
reviewers in the Division consist of dermatologists, dentists, pharmacologist/toxicologists, chemists,
biostatisticians, and biopharmaceuticists. The FDA medical reviewer’s role is to evaluate informa-
tion submitted to New Drug Applications (NDAs) and conclusions from other disciplines for rele-
vance. The dermatologist reviewer is crucial to evaluation of dermatologic drug products. FDA Advi-
sory Committees make recommendations on issues related to FDA’s regulatory responsibilities. The
FDA reviewer is responsible for proposing issues, preparing and presenting the material related to
the clinical safety and efficacy of the drug under discussion. The dermatologist reviewer distills the
content of the NDA, literature, recommendations from the Advisory Committee and other informa-
tion and recommends either approval or non-approval of dermatologic drug products. The issues that
have been brought to Advisory committee are many and varied. A retrospective review of the topics
brought to the FDA Dermatology Advisory Committee meetings over the past 20 years gives insight
into the issues for which FDA dermatology medical reviewers evaluate and find solutions. 
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Consensus from 4 studies—use of twice weekly fluticasone propionate can maintain remission
in moderate to severe atopic dermatitis
J Hanifin1 and J Berth-Jones2 1 Oregon Health Sciences University, Portland, OR and 2 Walsgrave
Hospital, Coventry, United Kingdom
Four randomized placebo-controlled studies have consistently demonstrated that FP cream and
ointment significantly reduce the risk of relapse of moderate to severe AD and prolong remission
time when applied once daily, twice a week for up to 16 weeks. This regimen should be applied to
all previously affected sites of AD, or to known sites of potential relapse, and used in combination
with routine daily emollients. Crucial to this twice weekly treatment strategy is the prior stabiliza-
tion of AD (i.e. cleared/almost clear, with a target lesion score of none or mild) by regular daily FP
therapy for up to 4 weeks. In total, the 4 studies recruited 772 subjects, of whom, 429 (193 were
children 3months-15yr) were randomized to twice weekly FP ointment or cream for up to 16 weeks.
Addition of twice weekly FP to a routine daily emollient regime reduced the risk of relapse by 5 to
8-fold with FP cream and 2-fold with FP ointment. Median time to relapse of AD for FP (either for-
mulation) was in excess of 16 weeks (study monitoring period) and for emollients plus placebo was
3-6 weeks. Twice weekly FP was well tolerated in all 4 studies throughout the long-term 16 week
study period with no evidence of increased risk of skin atrophy or telangiectasia. By preventing recur-
rent relapses of AD and therefore reducing the need for acute bursts of daily topical steroid therapy,
this twice weekly FP maintenance regime may have steroid sparing potential in patients with recur-
rent disease. 
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Effects of epinastine hydrochloride on cutaneous nervous system
M Toyoda,1 M Nakamura,1 K Nakada,1 M Otani2 and M Morohashi1 1 Department of Dermatology,
Toyama Medical and Pharmaceutical University, Toyama, Toyama, Japan and 2 Marketing
Division, Product Marketing Dept. 4,, Nippon Boehringer Ingerheim Co., Ltd., Tokyo, Japan
Epinastine hydrochloride, an H1 antagonist commonly used in Japan, has clinically potent anti-pru-
ritic effect for patients with severe itch such as atopic dermatitis. We have examined new aspects of
pharmacological modes of action of this medicine except for antihistamine, especially effects of
epinastine hydrochloride on cutaneous nervous system. The dorsal root ganglia of ICR mice were
cultured in medium containing various concentrations of epinastine hydrochloride. The percentage
of ganglia showing outgrowth of neurites to all cultured ganglia, the number of neurites per one
ganglia and the total length of neurites from ganglia significantly decreased in a dose-dependent
manner after addition of epinastine hydrochloride into the culture medium. The nerve fibers out-
growing from the dorsal sensory ganglia contained substance P as one of neurotransmitters, which
were stained immunohistochemically. Epinastine hydrochloride significantly suppressed the release
of substance P from nerve fibers in culture stimulated with capsaicin in a dose-dependent fashion.
Furthermore, in vivo study revealed that the levels of both nerve growth factor and truncated form
of the nerve growth factor receptor in the urine as well as in the saliva were significantly reduced in
patients with atopic dermatitis treated with epinastine hydrochloride. These results suggest that
epinastine hydrochloride possesses direct modes of action to cutaneous nervous system, which may
in turn contribute to a marked relief of itch intensity in pruritic dermatoses such as atopic dermati-
tis. 
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Imiquimod-induced CD4+ T cell responses lead to long lasting erythema after regression of
basal cell carcinomas and actinic keratoses
C Wolber,1 B Feuerstein,1 F Offner2 and R Strohal1 1 Dermatology, Federal Academic Hospital of
Feldkirch, Feldkirch, Austria and 2 Pathology, Federal Academic Hospital of Feldkich, Feldkirch,
Austria
Therapeutic options for basal cell carcinomas (BCC) and actinic keratoses (AK) including (kryo-
)surgery and photodynamic therapy are still not fully satisfactory. Based on preliminary reports, we
have initiated topical treatment of BCC and AK by 5% imiquimod cream (Aldara, 3M, Cergy Pon-
toise Cedex, France), an immune response modifier that induces the local release of various cytokines
(IFN-α, TNF-α, IL- 1, 5, 6, 8, 10 and 12). To date, 10 patients (6 BCC, 4 AK, age range: 40-60yrs)
have been treated once daily either 5 times a week (BCC), or 3 times a week (AK) for up to 6 weeks.
All patients experienced local erythema which in 9 out of 10 (exception 1 AK) progressed to ero-
sions at the site of imiquimod application. No systemic side effects, either with regard to clinical
symptoms or laboratory value changes were observed. After 3-6 weeks, 100% of lesions presented
with histologic clearence. Clinically, the process of tumor regression was accompanied by sponta-
neous scar-free healing of erosions leaving a persistant erythema for more than 4 weeks. Immuno-
histochemical analysis of biopsies of these post-treatment erythemas (n=3) identified a quite homo-
geneous picture. Located at the upper dermis, the inflammatory infiltrate mainly consisted of CD3+
T-cells and a significant proportion of CD68+mononuclear cells. There were only small numbers of
CD20+ B-cells. CD56+ (NK-) cells were absent. With regard to T-cell subsets, activated (CD45RO+)
CD4+ helper/inducer cells clearly dominated in all specimens over the CD8+ T-cell phenotype. Taken
together, 5% imiquimod cream represents an efficient and largely safe BCC/AK therapy seemingly
working via the induction of a local, tumor-specific CD4+ T-helper response. However, post-treat-
ment erythema is cosmetically irritating and, at least at this point, we cannot decide on the natural
course of this long-lasting imiquimode effect. 
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Etretinate improves sclerotic skin of systemic sclerosis
T Ikeda,1 K Uede,1 H Hasizume2 and F Furukawa1 1 Dermatology, Wakayama Medical University,
Wakayama, Wakayama, Japan and 2 Dermatology, Hamamatu University School of Medicine,
Hamamatu, Shizuoka, Japan
There are few satisfactory effective treatments for skin sclerosis of systemic sclerosis (SSc). Recently
we reported SSc patients treated with vitamin A derivative etretinate, which is used for psoriasis with
the effect to normalize the epidermic cell turn-over time. The aim of this study is to evaluate the
advantage of etretinate for skin sclerosis of SSc by the modified Rodnan total skin thickness score.
We enrolled 32 cases whose sclerotic changes from first visits had been followed up. Twelve cases
were treated with etretinate, including 5 cases together with other treatments that have or had reported
they improved skin sclerosis of SSc, that is, systemic steroids, immunosuppressants, D-penicillamine,
and/or bucillamine. Twenty cases were not treated with etretinate, including 13 cases together with
other treatments. They were treated with 0.5mg/kg/day etretinate as the initial dose and it was tapered
after skin sclerosis improved or when side effects appeared. It was considered as significant improve-
ments that sustained score became less than 25% of the score when treatments had started. Sixty per-
cent (3/5) of cases treated with both etretinate and other treatments and 85.7% (6/7) of cases treated
with etretinate but not together with other treatments had definite significant improvements. Whereas,
improvements did not occur in the cases who did not recieve both etretinate and other treatments.
Only 7.7% (1/13) of cases treated with not etretinate but other treatments had improvements. In all
the cases treated with etretinate, and in the cases with etretinate but not together with other treat-
ments, the mean of the sustained score decreased significantly compared with that of the score when
treatments was started (P•0.01). It was suggested that etretinate was a useful treatments for sclerotic
skin of SSc. 
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A novel method to assess efficacy of enzymatic wound debriding agents
L Shi, M Anguiano, J Wright and B Shroot Research and Development, Healthpoint, Ltd., San
Antonio, TX
The in vitro determination of an enzymatic wound debriding agent’s (EWD) efficacy may be accom-
plished by determining its ability to digest collagen, fibrin and elastin, the major components of
wound eschar. Current methods allow demonstration of these activities in solution. However, solu-
tion phase tests do not provide a true measurement of an enzyme’s capacity to digest eschar proteins
in situ, where neither the enzyme nor the substrate may be present in solution. Analytical methods
have been developed to directly test the in vitro efficacy of proteolytic enzymes formulated as oint-
ments, the most common dosage form of commercial EWD. A hydroxyproline assay was performed
to determine collagenolysis and labeled fibrin and elastin were used to assay digestion of these sub-
strates. A papain/urea debriding ointment (Accuzyme®) was used as the model EWD to demonstrate
the efficacy of the test system. Samples of Accuzyme, with and without urea, were also prepared
and tested to demonstrate the method’s capacity to allow the study of the contribution of cofactors
in the formulation to specific proteolytic activities. Bovine type I collagen (native and heat-dena-
tured) was used for the collagenolysis study; fibrinolysis, and elastolysis were determined using the
labeled components, fibrin-FITC and elastin-Remazol. Closely mimicking in use conditions, the
work showed the non-solution-based, direct-digestion method is a substantially improved method
to study the in vitro efficacy of an enzymatic wound debriding agent. 
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A phase II trial to evaluate the efficacy of topical 1% bexarotene (Targretin®) gel in patients
with parapsoriasis (T0 cutaneous T cell lymphoma)
SR Lessin,1 SD Steckel2 and H Wu1 1 Fox Chase Cancer Center, Philadelphia, PA and 2 Ligand
Pharmaceuticals, Inc., San Diego, CA
Parapsoriasis is a term for a distinct precursor stage (T0N0M0) of cutaneous T-cell lymphoma (CTCL)
and is defined by the presence of skin lesions clinically and/or histologically suggestive of, but not
diagnostic of CTCL. Parapsoriasis has been reported to progress to unequivocal CTCL in up to 30%
of cases. The identification of therapies with the capacity to induce complete responses in parapso-
riasis will provide the rationale of developing a chemoprevention strategy for individuals at risk for
progression to CTCL. To develop a rational therapeutic strategy for parapsoriasis, we have initiated
an open label, phase II trial evaluating the efficacy and tolerability of topical 1% bexarotene (Tar-
gretin®) gel in patients with parapsoriasis. The secondary objective is to evaluate the antitumor host
response in pre- and post- treatment skin biopsies. Bexarotene is a retinoid analogue (rexinoid) that
binds preferentially to RXR retinoid receptors and has been approved for use in the treatment of
CTCL. To date, 42 subjects were screened (21 parapsoriasis (T0) / 20 CTCL (T1) / 1 psoriasis) and
6 have been enrolled. Five have completed 16 weeks of topical treatment (2 weeks of daily appli-
cation followed by 14 weeks of twice daily application) with a follow-up visit at week 20. 5/5 sub-
jects had responses to therapy: 1 with a complete response and 4 with partial responses as deter-
mined by a composite assessment of index lesion disease severity. 2/5 responders demonstrated
significant reduction in CD4:CD8 T-cells and increase in CD56 NK-cells from pre-(day 0) and post-
treatment (week#16) skin biopsies. Cutaneous toxicity (erythema, scaling, pruritus) was noted in all
subjects and resulted in dose reduction in 2/5 subjects. Topical 1% bexarotene (Targretin®) gel
appears to be an active therapy for parapsoriasis. 
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Non-invasive retrieval of message (mRNA) from stratum corneum of lesions of psoriasis via
adhesive films
CB Hansen,1 GG Krueger,1 R Wong2 and NB Benson2 1 Univ of Utah, Salt Lake City, UT and 2
DermTech International, San Diego, CA
Recently, via repeated application adhesive film, we learned that a significant amount of mRNA is
retained in the stratum corneum (SC) and it reflects gene expression. To determine application to
pathogenesis and treatment we studied retrieval of mRNA from the SC of patients with psoriasis.
Adhesive films were repeatedly (x4) applied to an involved and uninvolved skin site on the extrem-
ities of 5 patients. RNA was extracted from cells adherent to the tapes (presumably SC) and quan-
tified by non-competitive, quantitative RT-PCR using a fluorescence-based 5’nuclease assay on an
ABI 7000. Each sample was reverse transcribed in triplicate and each cDNA amplified and quanti-
fied in duplicate; values were converted to RNA mass via standard curve from total RNA from human
spleen. It is assumed that the relative amount of b-actin in human spleen RNA is identical to that in
SC from the adhesive films. Using specific primers the mRNAs of TNF-a and IFN-g relative to b-
actin were measured using real time PCR. RNA mass varied: for uninvolved sites, from non-detected
to 138 ng and for involved sites from 1.2 to 44 ng. In 4 samples RNA was isolated from both unin-
volved and involved sites. The levels of TNF-a and IFN-g in psoriatic lesions were normalized to
adjacent non-lesional skin and fold increase calculated. A > four-fold difference, involved vs. unin-
volved, is hypothesized as being significant. By this criterion, the 4 subjects with matched pairs of
detectable RNA mass in involved and uninvolved SC had much higher levels of TNF-a levels in
involved than in uninvolved sites, mean fold increase = 18.8, range = 8.9 to 42. Only 1 subject had
> 4 fold increase in IFN-g in lesional SC. The SC contains message adequate to measure transcrip-
tional changes in diseased skin and therewith becomes a non-invasive tool to assess pathogenesis
and response to treatment. Epidermal Genetic Information Retrieval Adhesive Films (EGIRAF)
provides a non-invasive technique to make such assessments. 
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The safety of topical cyclosporin A conjugate (CGC1072) in the treatment of mild to moderate
psoriasis
C Levin, DF Fiorentino, G Vosganian, S Chon and AB Kimball Dermatology, Stanford University,
Stanford, CA
Psoriasis can be effectively treated with the immunosuppressant Cyclosporin A (CsA), although
this treatment is associated with nephrotoxicity and hypertension. The objective of this study was to
determine the safety and preliminary efficacy of two dose formulations (0.4% and 4.0%) of a topi-
cal prodrug of CsA linked to a hepta-arginine (CGC1072)in patients with mild to moderate plaque
psoriasis. Twenty-four subjects were randomized to receive one of the two strengths of CGC1072
and vehicle control. Treatments were self-applied in a blinded fashion to contra-lateral psoriatic
plaques over 42 days. Psoriasis was evaluated by a psoriasis severity score (PSS), incorporating ery-
thema, induration, and scale. CsA levels in the skin and blood were measured periodically. Twenty-
one subjects completed the study. Blood CsA levels were not detected in any patient at any time
point. There were no serious adverse events. Adverse events possibly related to the study drug occurred
in 6 patients, transiently elevated creatinine and increase in WBC count in absence of localizing
infection (high); increased WBC thought due to gingival infection (low); lower leg edema, tender-
ness and impetigo in treated leg followed by flaring of psoriasis (high); constipation and diarrhea,
biopsied plaque on treated side slow to heal, and elevated non-fasting serum glucose and glucose in
urine (low), transient systolic BP elevation (high) and itching (low). Reductions in the overall PSS
and the erythema severity score were observed as early as day 14 when comparing the median dif-
ference from baseline of 4% CGC1072. By day 42, PSS as well as erythema and induration had
improved. (p=0.06, 0.04, and 0.07, respectively). The median concentration of 4% CGC1072 in
skin was comparable to that observed in patients using oral CsA (0.7 versus 0.8). This novel topical
cyclosporin treatment, CGC1072 appears to be well tolerated, not absorbed systemically, and offers
potential benefit in treating mild to moderate psoriatic patients without the associated systemic adverse
effects. 
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HO/01/2002, a new agent, dramatically improves wound closure and healing
I Solomonik, D Simhon, L Braiman-Wiksman, A Harel, N Haim, D Shik, S Sampson and
T Tennenbaum Heal-Or Ltd., Ramat-Gan, Israel
Heal-Or Ltd., has demonstrated the efficacy of a new therapeutic agent HO/01/2002 for accelerat-
ing the healing process of skin wounds. We completed preclinical studies using C57BL mice that
were wounded and treated with various concentrations of HO/01/2002 versus vehicle treated con-
trol . Dose response as well as the age of the mice were tested. In order to demonstrate the changes
in epidermal regeneration during stages of wound healing, we performed morphological, histolog-
ical and immunohistochemical analysis. We examined wound biopsies at days 1-7 following wound-
ing, utilizing antibodies to keratin 14 (basal layer), keratin 1 (spinous layer), Filaggrin (granular
layer) and keratin 6 (wound healing & migration). From H&E stained sections, it is clear that in com-
parison to vehicle treated controls, HO/01/2002 treated wounds are smaller and spatial differentia-
tion of the epidermis is well organized. The wound gap and the newly forming epidermis were ana-
lyzed by keratin 14 staining. Within 7 days, the epidermal gap of treated wounds is at least 2 folds
smaller than control. Moreover, in control wounds within 4 days migrating cells of the newly formed
epidermis at the wound gap preferentially expressed keratin 14 while keratin 6 expression was
restricted to the wound edges. Interestingly, HO/01/2002 induced keratin 6 expression in the migrat-
ing keratinocytes of the newly formed epidermis underlying the wound gap. In treated wounds spa-
tial differentiation was reconstructed in the newly formed epidermis as observed by keratin 1 stain-
ing. In contrast, no change in distribution or expression of filaggrin was observed in control versus
HO/01/2002 treated wounds. Overall, the results demonstrate that The agent is a wound healing
accelerator that has remarkable effect on wound closure by enhancing reconstruction of the epider-
mis and affecting migration and differentiation properties of keratinocytes at the wound gap. In order
to demonstrate the benefit of HO/01/2002 on diabetic foot ulcers, we are currently performing exper-
iments on diabetic wound healing impaired mice. 
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Phenol and trichloroacetic acid peeling is a new tool as non-invasive therapy to the aged patients
with skin cancer
Y Yamamoto, T Ohtani, K Uede, F Furukawa, N Yonei and C Kaminaka Dermatology, Wakayama
Medical University, Wakayama, Wakayama, Japan
Recetly the number of the aged patients with skin cancer has been increased in Japan. The problem
is that many aged patients refuse the operation. For such patients, non-invasive therapies might be
useful such as topical therapy, photodynamic therapy, cryosurgery and laser therapy. In this study
we focused the chemical peeling using phenol and trichloroacetic acid(TCA). First, we examined
the histological changes of normal human skin treated with 40-60%TCA, phenol and liquid nitro-
gen. On day 2 or 3, phenol had more severe degenerative changes than TCA. Interestingly, phenol
penetrated deeply into skin and induced Tunel-positive degenerations in endthelial cell of dermis.
However, TCA induced the degenerations from epidermis to dermis in the dose-dependent way with-
out endothelial changes. On day 7, reepithelization was almost completed in cases of TCA and phe-
nol, but inflammmatory cells were present in both peeling. In contrast, liquid nitrogen had less effects
compared with TCA and phenol. From January 2001 to May 2002, 268 aged patients with akin tumor
visited our Dermatology clinic. Out of them, 37 patients refused the operation or had the difficulty
in the surgery. After informed consent, chemical peeling was performed to 3 seborrheic keratosis(SK),
14 actinic keratosis(AK),10 basal cell carcinoma(BCC), one trichoepithelioma, 5 Bowen’s disease,
3 genital Paget’s disease and one squamous cell carcimoma(SCC). More than 1 year follow-up after
peeling was done in 15 cases. Thirteen cases showed complete response(CR) which was evaluated
clinically and histlogicaly. Two cases without CR were cases with genital Paget’s disease. The mean
peeling time were 3.7 in AK, 6.5 in BCC, 6 in trichoepithilioma, 8 in Bowen’s disease and 6 in SCC.
We concluded that chemical peeling was useful for the aged patients with skin cancer. 
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Infliximab therapy in scleroderma patients with complicated Raynaud syndrome: an open
label study
JL Marenco, J Escudero, P Gonzalez, S Rodriguez and E Rejon Rheumatology, Valme University
Hospital, Sevilla, Sevilla, Spain
To evaluate effectiveness of infliximab in patients with scleroderma.The following parameters were
analysed for efficacy:joint count,visual analogue scale (VAS) for Raynaud phenomenon,Rodnan
scale of skin involvement and short-form SF36 for quality of life. Case 1:A 25-years-old woman,diag-
nosed of Scleroderma 7 years old previously,scl 70+.Hospital admissions were requiered in 2 con-
secutive years for Raynaud therapy with prostaglandins.She had seronegative polyarthritis with
advanced deformities unresponsive to disease-modyfying drugs,included methotrexate.After 3 infu-
sions of infliximab at 5mg/kg she reported mild improvement.Case 2: A 43-years old woman with
CREST syndrome diagnosed 5 years previously,had been treated as inpatient for severe Raynaud in
2 consecutive years.She has received 6 infusions of Infliximab 5 mg/Kg with subjective improve-
ment.Case 3: A 51-years old woman was diagnosed of diffuse scleroderma with visceral involve-
ment,pericarditis and intersticial pneumonitis.She was treated with cyclophosphamide for 2 years.After
single Infliximab infusion developed heart failure. A echocardiograme demostrated restrictive cardy-
omiophaty. No further infusions were administered. Only patients 1 and 2 were evaluated for efi-
caccy.VAS for RAynaud reduced 40% in patient 2.None of them have required new admissions for
Raynaud complications.Quality of life by SF36 items experienced improvement:physical function
25%,physical role 12,5%,body pain 36%,vitality 10%,social function 37,5%,mental health 20%.Joint
count,Rodnan scale and patients and physician global evaluation didn’t show significative differ-
ences. No new admissions were necessary for Raynaud complications.No improvement in joint count
was obtained,but SF36 showed improvement in the majority of items.We think that better results
would be obtained in less evolutioned disease.Subclinical cardiomyophaty should be rouled out
before infliximab treatment. 
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Safety and efficacy of a bilayered skin construct in full-thickness surgical wounds
K Donohue,1 P Carson,1 M Iriondo,1 L Zhou,1 L Saap,1 K Gibson1 and V Falanga1,2 1 Dermatology
and Skin Surgery, Roger Williams Medical Center, Boston University School of Medicine,
Providence, RI and 2 Dermatology and Biochemistry, Boston University School of Medicine,
Boston, MA
This was a prospective, randomized, controlled clinical trial assessing safety and efficacy of a liv-
ing bilayered skin construct (BSC; Organogenesis, Canton, MA) in treating full-thickness surgical
excision wounds. This is a report from a single site of a multicenter trial. We enrolled 31 patients
needing excision of a non-melanoma skin cancer. They included 18 females and 13 males, with an
age range of 44 to 84 years (average 67). Each was randomized to receive a single application of
BSC or to heal by secondary intention. Primary endpoint was time to complete wound closure. Pain,
cosmetic appearance and patient satisfaction were assessed using a 10cm visual analog scale (VAS).
Wound quality was rated by the Vancouver Burn Scar Assessment Scale (VBSAS). Despite ran-
domization, average wound size was larger for the BSC-treated group (mean area in cm2: 9.45 for
BSC and 5.79 for controls; P = 0.20). No statistical significance was seen between the two treat-
ments: time to wound closure (mean number of weeks: 7.27 for BSC and 7.31 for controls; P = 0.86),
cosmetic outcome (mean VAS reading: 8.16 cm for BSC and 8.17 cm for controls, P = 0.54), VBSAS
rating (mean: 4.47 for BSC and 4.3 for controls; P = 0.69) patient satisfaction (mean VAS reading:
8.16 cm for BSC and 9.11 cm for controls, P=0.10), intensity of post-operative pain (mean: 0.46 for
BSC and 0.85 for controls, P=0.44), post-operative pain resolution (mean number of weeks: 1.73
for BSC and 3.38 for controls, P = 0.072), and infection rate (0% for BSC and 25% for controls; P
= 0.10). These findings indicate that BSC is safe in the treatment of acute excisional wounds and
may facilitate management by decreasing post-operative pain. 
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Altered gene expression in normal human epidermal keratinocytes by retinoic acid isomers
and their 4-oxo-metabolites: 4-oxo-13cis RA is the most potent derivative
R Heise,1 DR Bickers,2 G Zwadlo-Klarwasser,1 HF Merk,1 FK Jugert1 and JM Baron1 1 Hautklinik,
Aachen, NRW, Germany and 2 Dept. of Dermatology, Presbytarian Hospital, Columbia University
New York, New York, NY
Vitamin A and its natural and synthetic derivatives (retinoids) exert profound effects on fundamen-
tal processes such as cell proliferation and differentiation. In this experiment RA isomers and their
4-oxo metabolites were incubated with cultured NHEKs for 24 hours and analysis of differentially
expressed genes was performed using DNA-Chip-technology. We examined 4400 sequence-vali-
dated cDNAs and ESTs arrayed on DermArray GeneFilters microarrays. Incubation of cells with
10-5M of the respective retinoic acid isomer for 24 hours revealed the upregulation of keratin 13
and keratin 7 and metallothionein and downregulation of keratin 10 by 13cis-, all-trans- and 9cis-
RA. Expression of TIMP1 and collagen XVIII, is downregulated by 13cis and all-trans-RA but upreg-
ulated by 9-cis-RA. Expression of MMP7 is downregulated by 13cis and all-trans-RA but expres-
sion is not mediated by 9cis-RA. These data reveal that 13cis- and all-trans-RA have a similar effect
on the expression of genes related to extracellular matrix compounds and metabolism, whereas 9-
cis seems to have the opposite effect. Incubation of cells with 10-5M of the 4-oxo-metabolites for
24 hours revealed similar expression profiles compared to their parent compounds. 4-oxo-13cis-
and 4-oxo-all-trans-RA also had a similar effect on the expression of genes related to extracellular
matrix compounds and metabolism, whereas 4-oxo-9-cis RA seemed to have the opposite effect.
Concerning the number of differentially regulated genes, 4-oxo-13cis RA seems to be the most potent
compound. This substance was able to up- or down-regulate more than twice as many genes as the
other RA isomers or 4-oxo-metabolites. Interestingly, these 4-oxo metabolites showed a compara-
ble but not completely similar gene expression profile in comparison with their respective parent
compound. 
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High clinical response rate with multi-modality immunomodulatory therapy for Sezary syn-
drome
SK Richardson, CC Vittorio, KS McGinnis, M Shapiro and AH Rook Dept. of Dermatology,
University of Pennsylvania, Philadelphia, PA
Multi-modality immunomodulatory therapy for the treatment of Sezary syndrome (SS) involves the
use of biologic response modifiers in combination to enhance cell-mediated immunity and promote
tumor regression. Patients with SS exhibit profound defects in cell-mediated immunity character-
ized by deficiencies in cellular cytotoxicity and Th1 cytokine production. In an attempt to enhance
anti-tumor immunity and correct the associated immunologic defects, we have utilized this treat-
ment approach for the management of patients with erythroderma and peripheral blood involvement
(>10% Sezary cells). Since January 2000, 27 patients with SS were treated with multi-modality
immunomodulatory therapy at the Hospital of the University of Pennsylvania. Therapy consisted of
extracorporeal photophoresis (ECP) in combination with two or more systemic biologic response
modifiers: IFN-alfa, IFN-gamma, bexarotene, isotretinoin, sargramostim, and/or PUVA. All patients
received >6 cycles of ECP, with the exception of two. Among the clinical responders (93% of patients),
82% had a >50% reduction in circulating Sezary cells. Thirty percent of patients achieved a com-
plete clinical response characterized by no evidence of cutaneous disease and a Sezary count <5%.
Sixty-three percent of patients achieved a partial response defined by at least a 50% reduction in
cutaneous and blood disease. Only two patients exhibited no response to therapy. Based on our expe-
rience of a 93% response rate, multimodality immunomodulatory therapy has proven to be a dra-
matically effective treatment for the management of CTCL patients with advanced disease. The dura-
bility of response and impact on overall survival remain to be determined, however, this approach
offers an appealing alternative to treatments with higher associated morbidities. 
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NFκB is a possible target to inhibit ultraviolet irradiation induced hypermelanosis
M Komine,1 S Muto,2 A Itai2 and K Tamaki1 1 Dermatology, University of Tokyo, Tokyo, Japan and
2 Institute of Medical Molecular Design, Inc., Tokyo, Japan
Vitamin D3 is one of the commonly used dermatological therapeutics, which markedly improves
psoriatic lesions. The use of vitamin D3 with ultraviolet irradiation has been reported to be more
effective than vitamin D3 or UV monotherapy on psoriasis. The use of vitamin D3, however, some-
times causes stronger pigmentation. In order to clarify the mechanism of pigmentation of topical
use of vitamin D3 combined with UVB irradiation, we utilized 3-demensional epidermal models
containing melanocytes. UVB irradiation upregulated the number of melanocytes, which was not
significantly affected by the addition of vitamin D3. Electron microscopic observation revealed that
the number of stage 4 melanosomes per unit area of melanocyte cytosol was significantly higher in
the melanocytes incubated with vitamin D3. We have tested the effect of topical application of a
novel NF κ B activation inhibitor, IMD-0354, on the hypermelanosis model induced by UV irradi-
ation. IMD-0354 (M.W. 384) was designed starting from a lead compound discovered by virtual
screening based on a modeled protein structure of IKK β and measurement of inhibitory effect on
NF κ B. IMD-0354 inhibits NF κ B activation stimulated by TNF α at the concentration of 0.05 µM
and also releases of various inflammatory mediators. It was confirmed that the compound inhibited
neither kinases nor receptor bindings related to immune responses. As a result of the test, the addi-
tion of this compound significantly inhibited the UVB induced upregulation of melanocyte numbers.
The above results suggest that vitamin D3 promotes melanocyte differentiation rather than prolifer-
ation, and that stronger pigmentation after UV therapy combined with vitamin D3 may be the cause
of differentiation of melanocytes rather than proliferation. Inhibition of NF κ B activation is a pos-
sible target to prevent hypermelanosis after UV irradiation, and the topical application of IMD-0354
may be one of the possible means to decrease post-UV hypermelanosis. 
1209
The effect of a topical oxygen emulsion on collagen deposition and angiogenesis in second-
degree burn wound repair
L Zhu,1 Y Zhang,1 SC Davis,1 PM Mertz,1 AL Cazzaniga,1 C Ricotti,1 PJ Zalesky,2 L Hsu,2
J Creech,2 WH Eaglstein1 and J Li1 1 Dermatology and Cutaneous Surgery, University of Miami,
Miami, FL and 2 TherOx Inc., Irvine, CA
Oxygen is a required substance for wound healing. A pig model of second-degree burn wound was
used to evaluate the effect of a newly developed topical aqueous oxygen emulsion (AOE) on colla-
gen synthesis and angiogensis during wound repair. Burn wounds were treated with vehicle control,
AOE (which contains super-saturated oxygen) or air exposure (no treatment). Wound tissue samples
were collected at days 1, 4, 7, 10, 14 and 21 after wounding. Semi-quantitative RT-PCR (Reverse
Transcription and Polymerase Chain Reaction) was used to examine the pattern of changes at mRNA
levels for collagen I, collagen III and vascular endothelial growth factor (VEGF). Our preliminary
data from 2 pigs showed: 1) Higher expression of collagen I, collagen III and VEGF m-RNA in the
AOE treatment group. 2) Collagen III m-RNA expression increased earlier after wounding with a
peak of dramatic increase at day 10 and day 14. 3) Collagen I expression level increased later than
that of collagen III with the highest peak at day 14 and second higher level at day 21. 4) There was
no significant difference between AOE and control groups at day 21. The data suggests that sustained
high level of oxygen release by AOE may promote the process of wound repair through the mecha-
nism of increased expression of collagens type I and type III and VEGF, which is critical in granu-
lation tissue formation during wound healing. 
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Combination chemotherapy for the treatment of ultraviolet light B-induced skin tumors using
Efudex and Celecoxib
TA Wilgus, TS Breza, JL Hatton and TM Oberyszyn Pathology, The Ohio State University,
Columbus, OH
Despite the alarming number of non-melanoma skin cancer (NMSC) cases diagnosed every year,
standard chemotherapeutic agents used for the treatment of these lesions and precursor lesions are
not completely effective. Increasing evidence suggests that repeated inflammatory sunburn reactions,
which include the induction of cyclooxygenase-2 (COX-2) and the subsequent production of
prostaglandins, play a role in skin cancer development. Although data generated in our laboratory
as well as others has shown COX-2 inhibition to be an effective means of preventing skin cancer
development in mice, these studies suggested that COX-2 inhibitors alone are not effective as
chemotherapeutic agents, or for inducing the regression of established tumors. Limiting the proper
use of and hence the effectiveness of current therapies for skin cancer are the severe inflammatory
side-effects that result from their use. Due to these side-effects and the increasing data suggesting
greater efficacy with combination therapies in a variety of cancer types, we hypothesized that a
combination of 5-fluorouracil (5-FU; Efudex, ICN Pharmaceuticals, Inc.) in conjunction with the
COX-2 inhibitor and anti-inflammatory drug Celecoxib (Celebrex, G.D. Searle & Co.) would act
synergistically to regress tumors in a murine model of ultraviolet light B (UVB) induced carcino-
genesis. In fact, we found that depending on the dose used, a combination of topical 5-FU (1% or
2.5% Efudex) in combination with Celecoxib (1 or 2 mg) is up to 35% more effective in reducing
the number of UVB-induced skin tumors than 5-FU treatment alone. In addition, animals treated
with the combination therapy had a lower rate of recurrence compared to 5-FU treatments alone three
weeks after the cessation of treatments. This data provides hope that more effective chemotherapy
regimens can be developed to treat the millions of precancerous and cancerous skin lesions that
arise every year, which could ultimately lead to a significant reduction in costs and cosmetic defects
(scarring) associated with surgical interventions. 
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Preventing the effector phase of allergic contact dermatitis with a metabolic inhibitor of CLA
synthesis
CJ Dimitroff, L Liu, TS Kupper and R Sackstein Dermatology, Harvard Skin Disease Research
Center, Boston, MA
E- and P-selectin on post-capillary venules in inflamed skin play a critical role in the migration of
effector T-cells. Cutaneous lymphocyte-associated antigen (CLA), a specialized glycoform of P-
selectin glycoprotein ligand-1 (PSGL-1), and a fucosylated PSGL-1 equivalent are the principal
selectin ligands on human and murine skin-homing T-cells, respectively, and are required for T-cell
entry into inflamed skin. We have previously shown that a fluorinated analog of N-acetylglucosamine,
4-F-GlcNAc, inhibits CLA expression and function. To investigate the in vivo efficacy of 4-F-Glc-
NAc on a murine model of cutaneous inflammation, we performed delayed-type hypersensitivity
(DTH) experiments in mice treated with 4-F-GlcNAc (i.p.; 50-250mg/kg q.d. X 6). In addition, to
analyze the effects of 4-F-GlcNAc on antigen-recognition and/or effector phases of DTH, we exam-
ined the migration of Langerhans cells (LC) from sensitized skin to draining lymph nodes (LN), and
performed flow chamber studies on selectin ligand activities of Th1 cells and Stamper-Woodruff
assays on LN high endothelial venule (HEV) L-selectin ligand activities. We found that elicitation
of DTH was prevented with 50mg/kg 4-F-GlcNAc (p<0.01, when compared with controls), while
no differences in HEV L-selectin ligand activities were observed. Furthermore, we observed no dif-
ference in the capacity of antigen-presenting LC to migrate to draining LN. However, flow cham-
ber studies revealed that 4-F-GlcNAc (50µM) completely inhibited the capacity of Th1 cells to bind
E- and P-selectins (p<0.001; when compared with controls). These data indicate that 4-F-GlcNAc
prevents DTH by inhibiting selectin ligand activity of Th1 cells. Moreover, 4-F-GlcNAc does not
appear to affect the afferent phase of DTH, as there was no effect on LC migration to draining LN
and on the capacity of HEV to support lymphocyte entry into draining LN. The profound and spe-
cific effect of 4-F-GlcNAc on dermal lymphocytotropism suggests that 4-F-GlcNAc could be ben-
eficial in long-term treatment of chronic cutaneous inflammation. 
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Lidocaine skin penetration profile using novel foam formulations
H Tanojo,1 J Lenn,1 V Durez,2 A Abram2 and X Huang1 1 Center for Skin Biology, Connetics Corp,
Palo Alto, CA and 2 Connetics Australia, Connetics Corp, Rowville, VIC, Australia
Topical lidocaine has been widely used as a local anesthetic, usually delivered in the form of cream
or ointments. Foam formulations have emerged as a superior vehicle because they leave little sticky
or greasy residue on skin. This study investigated the effects of novel foam formulations on in vitro
skin permeation of lidocaine. Two novel foam formulations containing 1% and 5% lidocaine (base)
were tested for percutaneous penetration on human excised skin (dermatomed to 250 um).The pen-
etration was monitored by collecting receptor fluid samples every 15 minutes in the first hour and
every 30 minutes subsequently.Lidocaine content in the receptor fluid, surface wash, epidermis and
dermis was measured by scintillation counting. A commercial product containing Lidocaine base,
ELA-max 4% cream, was also studied for comparison. The penetration rate of radiolabeled lido-
caine from the 5% foam formulation was higher than that from the 1% foam formulation. Applica-
tion of 5% lidocaine in the foam formulation resulted in a similar penetration profile as the com-
mercial product (4% lidocaine cream). The presence of lidocaine in the receptor fluid was observed
starting at 30 minutes post-application of both 5% lidocaine foam and 4% lidocaine cream, whereas
it was observed later for the 1% foam. The 5% lidocaine foam formulation has a penetration profile
similar to the commercially available 4% lidocaine cream product and, therefore, is likely to show
the same onset of action. As the foam formulation provides an elegant mode of application, it may
be an attractive product for delivery of lidocaine with an efficiency similar to currently listed prod-
ucts. 
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Skin penetration profile of clobetasol propionate from foam, cream and ointment
H Tanojo, J Lenn and X Huang Center for Skin Biology, Connetics Corp, Palo Alto, CA
Clobetasol propionate (CP) has been used as a superpotent steroid (Class I) for the treatment of var-
ious skin inflammatory diseases. As formulations have been known to influence the delivery of the
drug, it is of interest to study the effect of formulations on in vitro skin permeation profile of CP.
Method: A foam formulation (OLUXTM), an ointment (TemovateTM Ointment) and a cream (Temo-
vateTM E Cream), each containing 0.05% CP, were tested for percutaneous penetration on human
excised skin. A dose of 5-10 mg/cm2 of each formulation, spiked with radiolabeled 3H-clobetasol
propionate, was applied for 48 hours using In-line cells. Penetration was monitored by collecting
receptor fluid samples every 4 hours. At the end of application time, the skin surface was washed,
wiped and stripped, then the epidermal layer was split from the dermis. Drug content in the recep-
tor fluid, surface wash, epidermis and dermis was measured by scintillation counting. Results: The
foam and cream were shown to reach the maximum delivery rate of CP at 4 to 8 hours post-appli-
cation, faster than the ointment (12-20 hours). However, the foam had a maximum rate 4 times higher
than that of the cream. The ointment maintained a higher rate much longer than the other forms,
showing a flux at 48 h still at 70% of the maximum. At the 12 h time point, foam delivered cumu-
latively the most drug into the receptor fluid, 400% more than cream (p value) and 15% more than
ointment. On the other hand, at 48 h, the ointment delivered twice as much CP as the foam and 5
times more than the cream. The cream resulted the lowest penetration rate and amount among the
three dosage forms. Conclusions: The foam formulation delivered the most CP within the first 12
hour period, and subsequently, the penetration rate went down quickly, with minimal residual steroid
remaining in the skin. The foam may be a better alternative to the ointment and cream both for short
and long-term therapy with maximum efficacy and minimum adverse reactions. 
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Arctii fructus is a prominent dietary source of linoleic acid for reversing epidermal hyper-
proliferatin of guinea pigs
Y Cho,1 K Seong,1 J Kim,1 J Woo1 and S Park2 1 Graduate School of East-West Medical Science,
Kyung Hee Univ., Seoul, Seoul, South Korea and 2 College of Oriental Medicine, Kyung Hee
University, Seoul, South Korea
Dietary deficiency of linoleic acid [LA; 18:2(n-6)], the major polyunsaturated fatty acid in human
epidermis, induces epidermal hyperproliferation. The recognition that LA is important to maintain
normal skin has been associated with metabolism of LA in the epidermis. Because of the inability
of normal epidermis to desaturate LA to γ -linolenic acid, it is metabolized by epidermal 15-lipoxy-
genase to mainly 13-hydroxyoctadecadienoic acid (13-HODE), which exerts antiproliferative biopo-
tency. Since safflower oil has been widely recognized as the major dietary source of LA and Arctii
Fructus (Arctium lappa L.) is recently reported to contain high level of LA, we compared the antipro-
liferative effects of safflower oil and Arctii fructus in this study. Essential fatty acid deficiency (EFAD)-
induced epidermal hyeprproliferation was employed in guinea pigs by hydrogenated coconut oil
(HCO) diet for 8 wk. During 2 wk, EFA deficient guinea pigs were fed safflower oil (group HS),
water extract of Arctii Fructus (group AW) or organic extract of Arctii Fructus (group AO) contain-
ing diets. Since water extract is commonly used in oriental medicine, group AW was included in this
study. Normal control group was fed safflower oil (group SO) containing diet and EFA deficient
group was fed HCO containing diet for 10 wk. By determining the thymidine incorporation, our
data revealed that epidermal hyperproliferation was reversed in groups AO (55.9% of group HCO)
and HS (74.1% of group HCO). Epidermal hyperproliferation was not reversed in group AW. The
accumulations of LA into phospholipids and ceramides, and of 13-HODE, the potent antiprolifera-
tive metabolite of LA in the epidermis of group AO were greater than of group HS. Together, our
data demonstrate that Arctii Fructus exerts higher antiproliferative biopotency than safflower oil with
higher accumulation of LA and 13-HODE in the epidermis of guinea pigs. 
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Open trial of topical tacalcitol [1α24(OH)2D3] and solar irradiation for Japanese patients with
vitiligo vulgaris: up-regulation of c-Kit mRNA by cultured melanocytes and nerve growth
factor production by cultured human keratinocyte cell line
I Katayama,1 A Maeda,1 M Ashida,1 S Bae,1 H Murota1 and M Fukuoka2 1 Department of
Dermatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan and
2 Teijin Institute for Bio-Medical Research, Tokyo, Japan
Vitiligo vulgaris is a common skin disease, however some cases show poor clinical responses to
topical steroid ointment or PUVA therapy. Such regimens are generally avoided in the treatment of
facial lesions or in pediatric cases because of the undesirable side effects. Dysregulation of c-Kit
signaling has been thought to be one candidate in the pathogenesis of vitiligo vulgaris. To confirm
the excellent response to combination therapy with topical vitamin D3 ointment and solar irradia-
tion for vitiligo achieved in the initial patients, we conducted an open trial on other patients, most
of whom had poor clinical responses to the prior therapies. Fifteen patients (9 men and 6 women)
with vitiligo vulgaris were enrolled in this study. Each patient was instructed to take sunbath for 30
minutes within 1 hour after topical application of the tacalcitol [1α24(OH)2D3] ointment or cream
to the skin lesions every day. Six of 15 patients showed fair and excellent clinical response to the
combination therapy (more than 30% clearance of the vitiligo). The clinical effect was more appar-
ent in patients with a history of less than 5 years of vitiligo ( 4 of 6 cases) in contrast to those with
a history of more than 5 years ( 2 of 9 cases). In vitro experiments revealed that tacalcitol upregu-
lated the expression of c-Kit mRNA by melanocytes irradiated with linear polarized infrared, UVA
or short period solar irradiation. In addition, the tacalcitol [1α24(OH)2D3] upregulates one of the
melanocyte growth factor, NGF mRNA and protein by cultured human keratinocytes. These results
suggest that combination therapy with topical vitamin D3 ointment and solar irradiation can be used
as an alternate therapy for vitiligo vulgaris. 
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Anti-CD20 monoclonal antibody therapy for primary cutaneous B cell lymphomas
ME Lacouture,1 LC Dy,1 JL Baron2 and K Soltani1 1 Section of Dermatology, University of
Chicago, Chicago, IL and 2 Section of Hematology/Oncology, University of Chicago, Chicago, IL
CD20 is a nonglycosylated phosphoprotein present on mature B cells and >90% of B-cell lymphomas.
It is critical in proliferation and differentiation, acting possibly via a Ca 2+ channel. Primary cuta-
neous B-cell lymphomas (PCBLs) constitute a heterogeneous group of rare B-cell derived lympho-
proliferative disorders with variable survival rates and high incidence of local recurrence with sur-
gery and/or local radiotherapy. The chimeric anti-CD20 monoclonal antibody rituximab induces
B-cell complement-mediated cytotoxicity in vitro, and transient B-cell depletion in vivo. We report
complete responses to rituximab in 2 cases of low and intermediate aggressive clinical behavior PCB-
CLs.  Staging was performed by total body CT, laboratory studies, and bone marrow biopsy. After
informed consent was obtained, both patients received 4 weekly infusions of 375mg/m 2 body sur-
face intravenous rituximab. Patient 1 presented with 0.5-2.0 cm red-brown nodules on his face. Skin
biopsy showed a dermal infiltrate of small atypical CD20+ lymphocytes, compatible with follicu-
locentric lymphoma. Despite electron beam radiation therapy (EBRT), relapse occurred 7 months
later. Rituximab was then initiated. Patient 2 presented with 3x2 cm violaceous nodules on his left
thigh. Skin biopsy showed large CD20+ cells in the dermis and hypodermis, consistent with large
B-cell lymphoma. Because treatment with PUVA and EBRT did not alter progression, rituximab was
given. There were no serious adverse drug reactions, and complete response was achieved in both
patients. There was no relapse on evaluations at 10 and 5 months, respectively. Few cases of pri-
mary CBLs treated with with rituximab have been reported, with variable responses. Rituximab is
a high-affinity monoclonal antibody with a murine variable anti-CD20 region and a human IgG1
constant region, the latter accounting for its low immunogenicity. Our observations support the treat-
ment of relapsing PCBCLs with systemic rituximab, as an effective and well-tolerated therapy. 
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Chemosensitization of melanoma cells by proapoptotic genes
CK Ho, JA Bush and G Li Medicine, University of British Columbia, Vancouver, BC, Canada
One of the obstacles in metastatic melanoma treatment is its resistance to conventional chemother-
apy. The p53 tumor suppressor has been shown to be mutated in 50% of human cancers, but only
approximately 15% in melanoma biopsies, suggesting that other factors may mediate melanoma
chemoresistance. To investigate the role of cell-death inducing proteins such as Apaf-1 (Apoptotic
Protease Activating Factor-1) and PUMA (p53-Upregulated Modulator of Apoptosis) in their involve-
ments in melanoma chemosensitivity, we overexpressed proapoptotic genes PUMA and Apaf-1, a
downstream effector in the pathway, and assessed effectiveness in sensitizing melanoma cells to drug
treatment. We demonstrated that the introduction of PUMA was able to sensitize melanoma cells by
decreasing cell survival to 64% or nearly 34% after camptothecin treatment when compared to the
baseline GFP-transfected control cells, where survival was 99% and 70%, respectively (P<0.0001;
P<0.0001). We further showed that PUMA overexpression induces apoptosis and not necrosis by
DNA-laddering. In addition, we demonstarted that overexpression of Apaf-1 in melanoma cells was
able to decrease cell survival to 73% (P<0.05) alone and nearly 39% after camptothecin treatment
(P<0.005) when compared to the baseline GFP-transfected control cells. The combination of
PUMA/Apaf-1 and camptothecin has an additive effect on cell survival. This project will continue
to explore more effective treatment regimes, at the same time to provide new insights in the mech-
anisms of chemoresistance in malignant melanoma. 
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Down-regulation of cyclin A in squamous cell carcinoma line, SCC13 by PPAR-selective ligand
E Ueda,1,2 T Nakajima,2 S Kishimoto1 and AM Jetten2 1 Dermatology, Kyoto Prefectural Univ. of
Med., Kyoto, Kyoto, Japan and 2 Cell Biology/LPP, NIEHS, NIH, Research Triangle Park, NC
Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors and
members of the nuclear hormone receptor superfamily. Recent evidence has suggested that PPARs
regulate cell growth and differentiation in many cell types including malignant neoplasm cells. In
the present study, we investigated: 1) the expression of PPARs in squamous cell carcinoma line,
SCC13; 2) the growth inhibitory effect of GW362433, a PPAR α/β selective ligand, on SCC13
cells; and 3) the molecular mechanism of GW362433 induced cell-cycle arrest. Expression of PPAR
mRNA was detected in several squamous cell carcinoma lines using Northern blot analysis. A cyto-
static effect of GW362433 was found in several squamous cell carcinoma cell lines, including SCC13,
SQ/CCY1, HaCaT, and HPV18-transformed NHEK cells. This growth inhibition was dosage-depend-
ent. Flow cytometric analysis demonstrated that GW362433 induced a G0/G1 arrest in SCC13
cells. The mRNA and protein expression levels of cyclin A, which expression correlates with the
transition of the G1 to S phase of the cell cycle, were analyzed by Northern and Western blot analy-
sis, respectively. Cell cycle arrest in SCC13 induced by GW362433 was associated with a dramatic
decrease in the level of cyclin A. Our data indicate that squamous cell carcinoma express functional
PPARs and that PPAR activation by GW362433 induces growth inhibition associated with G1 cell
cycle arrest in SCC13. Our results also indicate that the reduction in cyclin A expression is an
important indicator in the inhibition of cell growth by GW362433. The growth inhibitory effects
exhibited by GW362433 suggest that certain PPAR ligands could be useful in the treatment of human
squamous cell carcinomas and other hyperproliferative skin diseases such as psoriasis. 
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Dose-escalating study of intratumoral administration of adenovirus-interferon-γ (TG1042) in
primary cutaneous T and B cell lymphomas
M Urosevic,1 T Maier,1 J Morcinek,1 B Acres,2 P Slos,2 V Bataille,2 G Burg1 and R Dummer1 1
Dermatology, University Hospital Zurich, Zurich, Switzerland and 2 Transgene S.A., Strasbourg,
France
Primary cutaneous lymphomas (CL) have been successfully treated with interferons (IFNs) coun-
terbalancing the Th2-skewing state. We undertook a phase I, open-label, dose-escalating trial of
repeated, intratumoral administration of TG1042 in patients with advanced primary cutaneous T
cell lymphomas (CTCL) and multilesional cutaneous B cell lymphomas (CBCL). TG1042 repre-
sents non-replicating recombinant adenoviral vector containing human IFN-γ cDNA insert. Nine
patients (7 CTCL, 2 CBCL) were enrolled in 3 successive cohorts at the following TG1042 doses:
3≠109 total particles (tp), 3≠1010 tp and 3≠1011 tp. The injected lesion was biopsied at baseline and
after 3 injections, and assessed for changes in lesion’s morphology, expression of CD1a, 3, 4, 8, 20,
21, 56, 79a, TIA-1, coxsackie-adenovirus receptor (CAR) and HLA class I. In addition, the lesions
were evaluated for transgene-derived IFN-γ expression as well as for IFN-γ, IL-2, IL-13, IL-10 pro-
duction by quantitative PCR. Local clinical response has been observed in 6 out of 9 evaluable
patients. Injection site reaction was the most commonly observed adverse event. Following TG1042
injections, histology demonstrated pronounced changes in infiltrate pattern differing from initial lym-
phoma finding, with signs of vasculitis and increase in eosinophil and neutrophil numbers. Immuno-
histochemistry revealed increase in CD8 and TIA-1 immunoreactivity. All injected lesions demon-
strated clear up-regulation of CAR expression. Quantitative PCR showed decrease in CD4/CD8 ratio
in 6/8 patients. Transgene-derived IFN-γ mRNA could be detected in injected lesions, implying suc-
cessful IFN-γ gene transfer. Our results reveal for the first time the in situ immunological changes
following the administration of adenoviral vector expressing IFN-γ in primary CTCL and CBCL,
offering new insight and information of importance to the design of new gene delivery-based ther-
apeutics in cancer. 
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Treatment of atopic dermatitis with the xenon chloride excimer laser
E Baltas,1 Z Csoma,1 Z Novak,1 B Bonis,1 F Ignacz,2 A Dobozy1 and L Kemeny1 1 Dermatology
and Allergology, University of Szeged, Szeged, Szeged, Hungary and 2 Research Group on Laser
Physics of the Hungarian Academy of Sciences, University of Szeged, Szeged, Szeged, Hungary
We demonstrated earlier that the 308 nm xenon chloride (XeCl) ultraviolet B (UVB) laser is more
effective in treating psoriasis and inducing T cell apoptosis than narrow-band UVB. We also found
that the excimer laser induced repigmentation in localized vitiligo. The aim of this study was to inves-
tigate the effectiveness of the XeCl laser phototherapy in atopic dermatitis. Five patients with flex-
ural atopic eczema - less than 20 % body area involvement - were included in the study. We used the
eczema area severity index (EASI) to characterize the severity of the disease. Before the laser treat-
ment the scores were between 5.9-11 (mean 5.94). For the 308 nm laser therapy we used the XTRAC
laser (Photomedex). The energy of each light impulse was 5.5 mJ/cm2, the diameter of the light spot
was 3 cm. The initial dose was 50 mJ/cm2 less than the minimal erythema dose (MED). The dose
was increased by 50 mJ/cm2 each week. The study was conducted in a one month period. The mean
cumulative dose was 2 J/cm2. At the end of the treatment period the EASI scores were between 0-
4.6 (mean 2.0) significantly lower compared to the initial values. These results suggest that the
XeCl excimer laser is effective in treating localized atopic dermatitis. The 308 nm XeCl laser, this
super narrow band UVB light source might well be the choice of treatment in different T cell medi-
ated diseases. 
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Role of mitochondria in the therapeutic action of anthralin
A McGill, A Frank, N Emmet, MA Birch-Machin and NJ Reynolds Dermatology, University of
Newcastle-Upon-Tyne, Newcastle-Upon-Tyne, United Kingdom
Anthralin (dithranol) is an established safe and effective topical treatment for psoriasis. Anthralin
induces biochemical, structural and functional changes to mitochondria and respiratory deficient
mutant yeast cells (petite), which lack mitochondria DNA and cytochrome oxidase, are signifi-
cantly more resistant to the cell killing effects of anthralin than respiratory competent yeast cells
(grande). In this study, we examined the effect of anthralin on cell growth, mitochondrial membrane
potential (MMP) and mitochondrial morphology in a human 143B ρ0 osteosarcoma cell line lack-
ing mitochondrial DNA, cytochrome oxidase activity and respiratory competent mitochondria, the
isogenic cell parental cell line (143.TK-) and normal human keratinocytes. 143B ρ0 cells were sig-
nificantly more resistant to the killing/growth inhibitory effects of anthralin following 72h treatment,
compared to the parental cell line (median EC50 87µM and 0.087µM respectively, P,0.05, n=5), as
assessed using a Sulforhodamine B assay. Cells were loaded with a cationic dye JC1 and MMP
assessed by laser scanning confocal microscopy. Anthralin reduced MMP in the parental cells in a
time (30min-24h) and concentration (0.1-10µM) dependent manner. 143B ρ0 cells maintain a lower
MMP through glycolytic metabolism but this was unaffected by treatment with anthralin, up to 10µM
for 24h. In cultured human keratinocytes, anthralin (1-5µM) reduced MMP as early as 30mins that
persisted up to 24h. In the parental cells and human keratinocytes exposure to anthralin resulted in
morphological changes to mitochondria from filamentous to swollen and more rounded structures
which aggregated around the nucleus. This data indicates that i) respiratory competent mitochon-
dria dramatically increase the sensitivity of human cells to the growth inhibitory/cell killing effects
of anthralin and ii) the reduction of MMP induced by anthralin is dependent on the ability of cells
to perform oxidative respiration and also occures in norman human keratinocytes at therapeutically
relevant concentrations. 
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Genistein enhances the cisplatin-induced inhibition of cell growth and apoptosis in human
malignant melanoma cells
T Bito, N Sumita, M Ueda, S Tamura and M Ichihashi Dermatology, Kobe Graduata Univisersity
school of medicinety, Kobe, Hyogo, Japan
Genistein, a naturally occurring isoflavone found chiefly in soybeans, has been reported to be a potent
antitumor agent. Genistein is presumed to exert multiple effects related to the inhibition of cancer
growth. Metastatic melanoma is a chemotherapy-refractory neoplasm. The present study was designed
to explore the possible activity of genistein to inhibit the aberrant proliferation and to induce apop-
tosis of human malignant melanoma cells in cooperation with cisplatin treatment. Five human
melanoma cell lines were utilized for these experiments. Genistein at physiologic concentrations (20
microM) did not induce apoptosis by itself but did enhance cisplatin-induced apoptosis in all 5 human
melanoma cell lines tested. The enhanced susceptibility among the cell lines was diverse. The max-
imum effect of the combined treatment on the induction of apoptosis in MeWo melanoma cells was
3.8 times higher than untreated controls. The maximum effect on the enhancement of apoptosis in
A101D cells was 1.4 times more than that of cells treated with cisplatin alone. Changes in the expres-
sion of two anti-apoptotic proteins, bcl-2 and bcl-xL, and one pro-apoptotic protein, Apaf-1, were
examined. Genistein alone did not alter bcl-2 expression, but decreased bcl-xL expression and slightly
increased Apaf-1. The combined treatment with genistein and cisplatin significantly reduced bcl-2
protein and increased Apaf-1 protein expression. These data suggest that genistein therapy may
enhance the chemosensitivity of melanoma patients. 
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Effect of Imedeen Time Perfection active ingredients on collagen I and fibrillin deposition in
an in vitro skin equivalent
C Bouez,1 O Damour1 and J Vicanova2 1 Laboratoire des Substituts Cutanes, Hopital Edouard
Herriot, Lyon, France and 2 Imedeen Research, Ferrosan A/S, Soeborg, Denmark
Imedeen Time Perfection (ITP) is a skin nutritional supplement containing BioMarine complex, vita-
min C, grape seed extract and tomato extract containing 10% of lycopene. BioMarine complex with
vitamin C and zinc was shown to increase density of dermis and overall quality of skin in clinical
tria1(1). In this study, we investigated effects of ITP on the extracellular dermal matrix using in
vitro reconstructed skin equivalent (SE). The SE was cultured according to standard laboratory
method(2). A porous dermal sponge was seeded with living human fibroblasts. The fibroblasts
colonised, proliferated and synthesized extracellular matrix components. After 3 weeks, keratinocytes
were seeded on the top and gradually built a fully developed epidermis. The ITP active ingredients
were added in the culture medium at early stage of the SE development. Effect of the ingredients
was examined after 6 weeks of supplementation using morphological and immunohistochemical
methods (staining of elastin, fibrillin, colla-gen type I, III, IV and VII). The SE was shown to closely
resemble native human skin both morphologically and regarding expression of characteristic bio-
markers(3). Our new results demonstrate that treatment of SE with ITP stimulates formation of even
more in-vivo-like dermis. Histological results showed that ITP had a strong positive effect on the
dermal reconstruction by stimulating fibroblast colonisation, proliferation and deposition of extra-
cellular matrix components in the porous structure of dermal substrate. The immunohistological
results showed a marked increase of collagen type I, the major component of extracellular matrix,
and fibrillin, the major component of microfibrils of elastic tissue. 
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Effects of pimecrolimus on dendritic cell functions
M Krummen,1 A Stuetz,2 TA Luger1 and S Grabbe1 1 Department of Dermatology, University of
Munster, Munster, Germany and 2 Novartis Research Institute, Vienna, Austria
Pimecrolimus is a novel calcineurin inhibitor of the ascomycin family. It has been shown to inhibit
the production of inflammatory cytokines by T cells and mast cells in vitro, and to inhibit cutaneous
inflammation when applied systemically or topically to the skin. However, pimecrolimus does not
inhibit the sensitization phase of allergic contact dermatitis, and shows only low potential for affect-
ing other systemic immune responses. Since calcineurin inhibitors, such as cyclosporin A and
tacrolimus, have been shown to also affect dendritic cell (DC) function, we tested whether pime-
crolimus also modifies the differentiation of DC from murine bone marrow precursors. DC were
generated by culture of bone marrow (BM) cells in the presence of 150 U/mL GM-CSF and 75 U/mL
IL-4 for 6 days, followed by DC activation with 20 ng/mL LPS or 1 µg/mL CD40L. Pimecrolimus
was added either at the beginning of the BM culture (Day 0) or at the timepoint of DC activation
(Day 6). Cells were harvested and analyzed at Day 8 of culture.  Cell yield was not affected when
pimecrolimus was added at the timepoint of DC activation (Day 6 of the BM culture). The mor-
phology of DC that developed from bone marrow precursors was normal and DC surface molecules
(CD11c, CD40, CD80, CD86, I-A) were largely unaffected by the presence of pimecrolimus, when
added either at the onset of BM culture or at the time of DC activation. However, we observed a mod-
est increase in CD86 expression and a decrease in CD54 expression upon exposure with pimecrolimus.
Apart from a slight upregulation of TNFàand IL-6 release, cytokine production by DC was also not
inhibited by the presence of pimecrolimus in doses of up to 50 ng/mL. Thus, pimecrolimus sup-
pressed neither inflammatory cytokines nor the production of IL-12 and IFNã, and it also did not
induce IL-10 production by DC. In conclusion, pimecrolimus does not inhibit the differentiation
and activation of bone-marrow-derived dendritic cells in vitro. 
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Effect of pimecrolimus, tacrolimus, cyclosporin A, betamethasone 17-valerate, dexamethasone,
and hydrocortisone on cytokine production and T-cell proliferation induced in human periph-
eral blood mononuclear cells by anti-CD3 monoclonal antibody
A Winiski, S Wang, B Schwendinger and A Stuetz Novartis Research Institute, Vienna, Austria
Pimecrolimus is an ascomycin macrolactam derivative specifically designed and developed to treat
inflammatory skin diseases. It has been shown to be highly effective and safe in atopic dermatitis
after topical administration, and in chronic plaque psoriasis after oral application. T-cell activation
and the release of inflammatory cytokines play a key role in inflammatory skin diseases, such as
atopic dermatitis and psoriasis. In this study, we compared the inhibitory activity of pimecrolimus
with tacrolimus and cyclosporin A, as well as with the corticosteroids betamethasone 17-valerate,
dexamethasone and hydrocortisone, on anti-CD3 monoclonal antibody-stimulated cytokine pro-
duction (TNFα, IFNγ, GM-CSF, IL-1β and IL-8) in human peripheral blood mononuclear cells
(PBMC). The rank order of potency is (range of IC50 values for the measured cytokines): Pime-
crolimus (0.30-0.77 nM) ~ tacrolimus (0.12-0.22 nM) ~ betamethasone 17-valerate (0.32-0.63 nM)
~ dexamethasone (0.99-3.4 nM) > cyclosporin A (6.3-9.3 nM) > hydrocortisone (29-44 nM).  We
also compared the inhibitory activities of these compounds on T-cell proliferation in the same sys-
tem. The potency of T-cell inhibition (average IC50 of three independent experiments) is: Tacrolimus
(0.18 nM) > pimecrolimus (1.1 nM) ~ betamethasone 17-valerate (1.7 nM) ~ dexamethasone (2.5
nM) > cyclosporin A (11 nM) > hydrocortisone (100 nM).  In conclusion, pimecrolimus inhibits the
anti-CD3-stimulated release of inflammatory cytokines from PBMC with a similar potency to
tacrolimus, whereas tacrolimus appears to be more potent in suppressing T-cell proliferation. The
corticosteroids betamethasone 17-valerate and dexamethasone have a similar activity to pimecrolimus,
and a greater potency than cyclosporin A. 
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The combination of bexarotene capsules and photopheresis induces clinical response in patients
with mycosis fungoides
M Demierre,1 V Tan,1 M Sonabend,1 S Steckel2 and C Stefanato1 1 Dermatology, Boston University
School of Medicine, Boston, MA and 2 , Ligand Pharm., Inc., San Diego, CA
Mycosis fungoides (MF) is the most common form of cutaneous T-cell lymphoma (CTCL), a malig-
nancy of skin-homing T-cells that affects more than 1200 persons annually in the USA. Therapies
are directed to the stage of disease. Both extracorporeal photopheresis (ECP) and bexarotene (Bx),
a novel RXR selective retinoid, are effective treatments for MF. Median time to Bx response is 4
months (dose of 300 mg/m2/day) and 6 months for ECP. Bx has been shown to induce apoptosis of
CTCL cell lines in vitro. ECP works through the induction of T-cell apoptosis. The combination of
Bx-ECP may allow for the use of lower doses of Bx and provide faster time to response than for
either treatment alone. To investigate the efficacy of combination Bx-ECP therapy, 6 CTCL patients
(stages IB-IVA) were enrolled in a study of low-dose Bx (75-225mg/day) with ECP. Patients began
with low dose Bx for 7 days and subsequently also received ECP every three weeks for a total of 4
treatment cycles. Efficacy was assessed at regular intervals up to 90 days, when the study was ter-
minated. Weighted skin scores showed a substantial improvement in less than 2 months after treat-
ment initiation with significant improvement at the end of the trial (p<0.001, Friedman test). Grade
2 toxicity (incr. trigl.) was seen in 1 patient. To determine treatment effect on apoptosis, lesional
skin biopsies obtained at baseline, day 7 (Bx alone), and end of study (Bx and ECP) were processed
for TUNEL reaction. In 2 patients, TUNEL positive cells increased substantially between baseline
and end of study. One stage III patient with the most dramatic induction of apoptosis, continued to
maintain clinical improvement, with treatment, 8 months after study termination. Our data show
that combination therapy of Bx-ECP significantly improves cutaneous manifestations of CTCL and
shortens the response time as compared to each treatment modality alone. Apoptosis of T-cells in
lesional skin could be used to predict clinical response to treatment. 
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The use of N-acetyl glucosamine to replace alpha hydroxy acids in skin care
D Gan, C Fthenakis, T Mammone, K Marenus and D Maes BRD, Estee Lauder Companies, Inc,
Melville, NY
Alpha hydroxy acids have been used to treat skin for both dermatological and cosmetic problems.
Though there are many known benefits of the use of alpha hydroxy acids on skin, there have been
recent reports that topical treatments with alpha hydroxy acids increase skin damage resulting from
UVB. Additionally, high concentrations of alpha hydroxy acids have also been found to cause an
irritating effect. In order to find alternatives to alpha hydroxy acids, we investigated a variety of
amino sugar compounds that were previously reported to inhibit the reaggregation of dissociated
corneocytes by modulating cellular adhesion. In vivo, we observed that topical treatments of prod-
uct containing 10% N-acetyl glucosamine led to an increase in skin moisturization, decrease in skin
flakiness, and the normalization of stratum cornuem exfoliation. In vitro, we observed an upregula-
tion of differentiation markers, keratin 10 and involucrin, in keratinocytes treated with N-acetyl glu-
cosamine. CD44 is a lectin cell adhesion molecule that is also expressed in keratinocytes. Amino
sugars such as N-acetyl glucosamine may competitively bind to CD44, modulating keratinocyte
cellular adhesion. We hypothesize that these amino sugars modulate keratinocyte cellular adhesion
and differentation, leading to the normalization of stratum corneum exfoliation. We propose the use
of amino sugars such as N-acetyl glucosamine as alternative compounds to replace the use of alpha
hydroxy acids in skin care. 
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Influence of intravenous immunoglobulin therapy on autoantibody titers to beta4-integrin in
patients with mucous membrane pemphigoid
SW Yeh, B Ahmed, AQ Usman and AR Ahmed Department of Oral Medicine, Harvard School of
Dental Medicine, Boston, MA
Mucous membrane pemphigoid (MMP) is an autoimmune mucocutaneous blistering disease char-
acterized by the presence of circulating autoantibodies. Recently, patients with MMP have been
described to have autoantibodies to beta4 integrin. Objective: the objective of this study was to
prospectively analyze, over a 18-months period, the influence of intravenous immunoglobulin (IVIg)
therapy on autoantibody titers to b4-integrin in a group of 13 patients. Methods: levels of autoanti-
bodies to b-4 integrin were measured by specific immunoblot assay, at monthly intervals. Results:
prior to initiation of IVIg therapy, the sera of 13 patients demonstrated the presence of high autoan-
tibody titers to b-4 integrin. A statistically decline in the autoantibody titers to b-4 integrin was
observed after five months of receiving the first cycle of IVIg therapy. This gradual decline in autoan-
tibody titers continued until patients were observed to have non-detectable titers to b-4 integrin after
14 months, of receiving IVIg therapy. Once patients achieved non-detectable titers, these patients
were considered to be in a serological remission. This serological remission was sustained for an
additional four months of observation. Conclusion: autoantibody titers to b-4 integrin can be used
to monitor the serological response to treatment in patients with MMP. Patients with severe MMP,
who are treated with IVIg therapy, as described in our protocol, achieve a long-term serological
remission. 
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Pimecrolimus shows, in contrast to tacrolimus and cyclosporine, only marginal effects on immu-
nization by oral administration in a rat model
A Mahl, D Roman, M Court, P Vit and P Ulrich Novartis Pharma AG, Basel, Switzerland
The calcineurin inhibitors pimecrolimus (PI), cyclosporin A (CsA) and tacrolimus (TA) were com-
pared in a 4-week oral rat study investigating the immune system’s potential to respond to immu-
nization with keyhole limpet hemocyanin (KLH). Groups of 10 male Wistar rats were treated once
daily with 10 or 30 mg/kg PI, 3 mg/kg TA or 20 mg/kg CsA placebo. Five animals from each group
were immunized with 50 µg KLH in adjuvant on Days 16 and 24; the other five served as non-immu-
nized references. Macroscopic and microscopic aspects of the KLH-challenge site, KLH-specific
serum Ig titers, and lymphocyte phenotypes in blood, spleen and draining lymph nodes were inves-
tigated. The evaluation of the granuloma formation at the KLH challenge site revealed a suppres-
sion of the peripheral immune response in the following order: CsA > TA >PI = control. The for-
mation of KLH-specific antibodies (IgM and IgG) was fully inhibited in CsA-treated animals to the
level of non-immunized controls. KLH-specific IgM titers were similar in immunized controls, PI-
and TA-treated animals. A slight to moderate reduction of IgG titers with PI at 30 mg/kg and a slight
to severe reduction with TA at 3 mg/kg was observed. No effect on KLH-specific antibody produc-
tion was seen with PI at 10 mg/kg. Flow cytometric investigations of the lymphocytes in the lymph
node draining the KLH challenge site indicated a similar moderate decrease in total CD3+,
CD3+/CD4+ and CD3+/CD8+ T lymphocytes for PI at 30 mg/kg, TA and CsA, whereas these changes
were marginal for PI at 10 mg/kg. In peripheral blood, the KLH-induced increase in total white blood
cells and CD3+ T cells was evident with PI and to some extent with CsA, but not with TA, when
compared with the respective treated non-immunized reference groups. In conclusion, the capacity
to respond to the antigen was not affected with PI at 10 mg/kg. Only a slight effect with PI at 30
mg/kg was observed, whereas the functional inhibition of the immune system was shown to be
more pronounced with TA at 3 mg/kg and more so with CsA at 20 mg/kg. 
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Human keratinocytes treated with damaged RNA have enhanced resistance to UVB and ele-
vated DNA repair
T Mammone, E Goyarts, M Ingrassia, D Gan, K Marenus and D Maes BRD, Estee Lauder
Companies, Inc, Melville, NY
Ultraviolet irradiation of normal human keratinocytes induces a cytotoxic effect. The chromophore
for this effect is believed to be genomic DNA. However, DNA damage can be repaired in UVB irra-
diated keratinocytes. Previous work by our group and others suggest that host cell DNA repair can
be triggered by internal as well as external, damaged DNA. Therefore another possible sensor of
UVB exposure and damage to DNA may be the RNA molecule. To test this hypothesis we investi-
gated the effects of UVC damaged RNA on keratinocyte cell survival and DNA repair. Treatment of
HaCaT keratinocytes with UVC irradiated rabbit globulin mRNA pre- and post- UVB exposure
increased the survival of the HaCaT cells. The increased survival correlated with reduced DNA dam-
age as measured by the number of thymidine-thymidine dimers. Addition evidence supporting the
ability of damaged RNA to enhance host cell DNA repair is provided by the observed effects of dam-
aged RNA on host cell reactivation of DNA repair. In these experiments we observed that external
rabbit globulin mRNA enhanced repair of a plasmid inserted into the host 3T3 cells. This repair is
further enhanced if the mRNA is first pre-irradiated with UVC. The above evidence suggests that
damaged mRNA can trigger a host cell DNA repair pathway. 
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Influence of intravenous immunoglobulin therapy on autoantibody titers to BP Ag 1 and BP
Ag 2 in patients with bullous pemphigoid
AR Ahmed, N Sami and K Bhol Department of Oral Medicine, Harvard School of Dental
Medicine, Boston, MA
Bullous pemphigoid (BP) is a subepidermal autoimmune blistering disease which is characterized
by blisters on the skin. Autoantibodies to components of the basement membrane zone are usually
observed the sera of patients with BP. Autoantibodies to the bullous pemphigoid antigens, (BP Ag
1, 230 kDa desmoplakin protein) and (BP Ag 2, 180 kDa hemidesmosomal protein), are present in
the sera of BP patients. In this study, we report the influence of IVIg therapy on autoantibody titers
to both BP BP Ag 1 and BP Ag 2 in 14 patients with bullous pemphigoid.  In this prospective study,
we measured autoantibody titers to both BP Ag 1 and BP Ag 2, over a period of 18 consecutive
months on each patient, using an immunoblot assay. Prior to the initiation of IVIg therapy, the sera
of 11 patients demonstrated the presence of high autoantibody titers to both BP Ag 1 and BP Ag 2.
Three patients had autoantibodies to BP Ag 1 only.  A statistically significant decline in the autoan-
tibody titers to both BP Ag 1 and BP Ag 2, was observed after four months of receiving the first
cycle of IVIg therapy. This gradual decline in autoantibody titers continued until patients were
observed to have non-detectable titers to BP Ag 1 after 11 months, and to BP Ag 2 after 10 months
of receiving IVIg therapy. Once patients achieved non-detectable titers, these patients were consid-
ered to be in a serological remission. This serological remission was sustained for an additional seven
months of observation. Autoantibody titers to BP Ag 1 and BP Ag 2 can be used to monitor the sero-
logical response to treatment in patients with BP. Patients with severe BP, who are treated with IVIg
therapy, as described in our protocol, achieve a long-term serological remission. 
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Intravenous immunoglobulin therapy in patients with epidermolysis bullosa acquisita refrac-
tory to conventional therapy
N Sami and AR Ahmed Oral Medicine, Harvard School of Dental Medicine, Boston, MA
Epidermolysis Bullosa Acquisita (EBA) is a chronic autoimmune blistering disease. EBA can be
very frustrating to treat since patients with EBA can be refractory to conventional therapy. In this
study, intravenous immunoglobulin (IVIg) therapy was used in two patients with EBA who were
refractory to conventional therapy. Both patients received a total IVIg dose of 1-2 mg/kg per cycle.
The parameters used to assess the response to IVIg therapy included time observed for effective
control of disease, total duration of IVIg therapy, number of IVIg cycles, systemic drug therapy, and
frequency of recurrences and relapses. The differences in the following variables were statistically
analyzed using the SAS UNIVARIATE software running the two sided Wilocoxon signed rank test
pre- and post-IVIg therapy: number of side effects, frequency of recurrences and relapses, duration
and total dosage of prednisone therapy, and the quality of life.  An effective clinical response to IVIg
therapy was observed in both patients. The two patients were able to discontinue all previous sys-
temic therapies. The difference between Pre- and Post-IVIg therapy were statistically significant for
the number of side effects, frequency of recurrences and relapses, duration and total dosage of pred-
nisone, and the quality of life.  One patient achieved a sustained and prolonged clinical remission
and is off all systemic therapies.  The other patient continues to receive IVIg as monotherapy at
increased intervals while maintaining an effective clinical control of their disease.  IVIg improved
the quality of life in all patients  and demonstrated a steroid sparing effect.  IVIg therapy can induce
a long-term clinical remission in patients with EBA unresponsive to conventional agents. 
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Side effects of IVIg therapy in patients treated with long-term IVIg therapy in autoimmune
mucocutaneous blistering diseases
B Ahmed, P McPhearson, N Sami and AR Ahmed Department of Oral Medicine, Harvard School
of Dental Medicine, Boston, MA
IVIg therapy has been recently reported in the treatment of patients with pemphigus vulgaris (PV),
mucous membrane pemphigoid (MMP), and bullous pemphigoid (BP). The incidence of side effects
secondary to IVIg therapy has been reported to be low. In this study, we report the side effects of
intravenous immunoglobulin therapy in, 26 patients with PV, 20 patients with MMP, and 10 patients
with BP, who had been non-responsive to conventional therapy.  A retrospective analysis was done
to analyze the side effects of IVIg in a large case series of patients with PV, MMP, and BP and PV.
The following information was recorded in this study: demographics, dose of IVIg therapy, num-
ber of cycles of IVIg therapy, duration of IVIg therapy, the side effects of IVIg therapy, associated
symptoms of side effects, the duration and frequency of side effects, and prevention and treatment
of side effects.  There were 26 males and 30 females and the mean age of onset of disease was 60
years. All patients received an IVIg dose of 1-2 gm/kg/cycle. The mean number of cycles patients
received was 18 over a period of 22 months. The most common side effect was headache (24), flu
like symptoms (12), chills and rigors (5), nausea and vomiting (4), palpitations (2), and brochospasm
(1).  The duration of symptoms would be from about 1 to 4 days.  The headaches were prevented in
all 24 patients with premedication with intravenous salumedrol (40-60 mg) and acetaminophen
(650 mg). In conlcusion, we observed a low incidence and frequency of side effects of IVIg therapy
in patients with PV, MMP, and BP over a long-term follow-up. IVIg is a relatively safe therapy in
the treatment of autoimmune blistering diseases. 
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Topical retinol improves fine wrinkles of natural/chronological aging
R Kafi, W Schumacher, S Cho, H Kwack, V Hanft, J Neal, G Fisher, J Voorhees and S Kang
Dermatology, University of Michigan, Ann Arbor, MI
Like all organs, skin ages with the passage of time. Evident in upper inner arms of the elderly, nat-
urally aged skin is thinner, laxer and more finely wrinkled than in younger skin. These features plus
dyspigmentations are more severely manifested in photoaged skin. Since topical retinoic acid (RA)
improves photoaged phenotype, we hypothesized that similar features of natural aging would also
respond to the retinoid. Topical retinol (ROL) is metabolically converted to RA in human skin, and
causes less skin irritation than RA. Therefore, we investigated the effectiveness of ROL in amelio-
rating clinical features of skin chronoaging. Thirty-six elderly subjects in two senior homes were
enrolled in a left/right comparison study of 0.4 % ROL versus its vehicle. Mean age was 87 (80-96),
and male to female ratio was 1:2.5. Up to three times weekly treatments were administered by our
staff for 6 months. Punch biopsy was performed from both sides at baseline and at the end of treat-
ment. Unoccluded application of our 0.4% ROL lotion to normal human skin induced retinoid respon-
sive gene, CRABP-II, mRNA by 3 fold (p<0.05; n=5), indicating its ability to penetrate human skin
and cause retinoid pharmacology. Of the 36 subjects, 23 completed the study. Fine wrinkles were
assessed clinically using a semiquantitative 10 point score (0=none, 9=most severe). At baseline,
clinical severity between the left and the right upper inner arms were similar. ROL treatment sig-
nificantly reduced the fine wrinkles from 7.3±4.9 at baseline to 4.9±0.2 at week 24, where as vehi-
cle treatment had no effect (p<0.0001; n=23). The improvement was associated with a 40% increase
in glycosaminoglycan (GAG) expression (p<0.05; n=6). Topical ROL was well tolerated by the eld-
erly subjects. Mild erythema and scaling was observed with ROL treatment. In conclusion, topical
ROL improves fine wrinkles associated with natural aging. Significant induction of GAG, which is
known to retain substantial water, may be one cause of the wrinkle effacement. 
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Ultraviolet A1 is an effective antifibrotic phototherapy for scleroderma, and sclerodermoid
varient of chromic graft-versus-host disease
S Kang,1 S Cho,1 R Kafi,1 V Ratanatharathorn,2 G Fisher1 and J Voorhees1 1 Dermatology, Univ. of
Michigan, Ann Arbor, MI and 2 Bone Marrow Transplantation, Univ. of Michigan, Ann Arbor, MI
Dermal fibrosis in scleroderma (SD) and sclerodermoid graft-versus-host disease (SD-GVHD) is
indistinguishable. Despite differences in pathogenesis, the fibrosis common to both conditions is a
result of dermal collagen increase (greater synthesis and/or reduced degradation). We have previ-
ously reported that ultraviolet (UV)-B/A2 (290-340nm) irradiation induces matrix metalloproteinases
(MMPs) and simultaneously inhibits procollagen synthesis in normal human skin in vivo. Com-
pared to UVB/A2, UVA1 (340-400 nm) is minimally erythemogenic and therefore is safer to use on
patients. We investigated the response of SD (n=5) or SD-GVHD (n=6) patients to UVA1. UVA1
(65 or 130 J/cm2) irradiation was given 3 times a week for up to 16 weeks. The degree of skin hard-
ness (induration) was assessed clinically using a modified Rodnan score (mRS: 0=none, 3=severe).
The mean mRS of target area at baseline was 2.4 and 2.0 for SD and SD-GVHD, respectively.  At
the end of treatment, there was 32% (p=0.05) and 37% (p=0.04) reduction in the mean mRS for SD
and SD-GVHD, respectively. Procollagen I and III, transforming growth factor-β and connective tis-
sue growth factor mRNA levels were substantially elevated in involved skin, compared to uninvolved
normal skin.  UVA1 treatment markedly reduced the elevated levels of these gene transcripts, while
inducing those of MMPs (-1, -3, and -9). Total collagen content of the sclerotic skin, as measured
by hydroxyproline, was also significantly reduced with UVA1. In SD-GVHD, UVA1 efficiently
depleted tissue infiltrating T cells (CD3+) present in the lesional skin. All subjects tolerated UVA1
phototherapy without sunburns or other signs of phototoxicity. In conclusion, UVA1 is an effective
antifibrotic treatment for SD and SD-GVHD. We speculate that it will be beneficial in other fibrotic
conditions where collagen homeostasis has been perturbed to produce a net increase in this matrix
molecule. 
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Mechanisms of lovastatin-induced apoptosis in melanoma cell lines
YG Shellman, JP Gendall, K VanBuskirk, J Morelli, D Ribble, Y Xu, D Marr, EJ Hester, DA Norris
and RP Dellavalle Dermatology, B153, University of Colorado Health Science Center, Denver, CO
The cholesterol lowering medication lovastatin inhibits cellular proliferation and induces apoptosis
in various tumors and is associated with decreased melanoma incidence in a double-blinded, placebo-
controlled, clinical trial for coronary disease. We investigated how lovastatin affects human melanoma
cell viability in vitro. Lovastatin caused cytotoxicity in human and murine melanoma cells while at
the same doses, lovastatin induced little toxicity in an epidermoid carcinoma cell line A431. Lovas-
tatin-induced cell rounding, increased the percentage of apoptotic cells in human melanoma cells
A375, and resulted in high levels of active caspase 3 in A375 cells indicating that lovastatin induced
apoptosis in human melanoma cells. Supplementation with geranylgeranyl pyrophosphate completely
blocked the lovastatin effect in A375 cells, while farnesyl pyrophosphate supplementation only
slightly blocked the lovastatin effect. These data suggest that inhibition of geranylgeranylation is
probably the predominant mechanism of lovastatin-induced apoptosis in human melanoma cells. We
also examined the effects of lovastatin on the expression of several apoptotic regulatory proteins
including Bcl-2, Bax, IAPs etc. Preliminary data suggest that lovastatin down-regulated expression
of inhibitor of apoptosis protein 2 (IAP-2) in A375 cells. In summary, this study shows that lovas-
tain induces human melanoma cell cytotoxicity by a geranylation specific apoptotic mechanism in
A375 melanoma cells, and provides further evidence for the possible role of lovastatin as a thera-
peutic/ chemoprevention agent for melanoma. 
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Pharmacokinetic and safety analysis of a topical cyclosporine A prodrug (CGC2001)
H Fan, J Chen, S Naganathan, P McGrane, B Wylie, T Chen, M Felberg and D Steinfeld CellGate,
Inc., Sunnyvale, CA
Oral cyclosporine A (CsA) is effective in treating psoriasis, but its clinical utility is limited by its
side effects. Topical CsA could overcome these adverse effects, but it is ineffective due to poor skin
absorption. The objective of this study was to perform a pharmacokinetic (PK) and safety analysis
for a topical CsA prodrug (CGC2001), where CsA was conjugated to an oligo-D-arginine via a pH-
sensitive linker. When CGC2001 was applied to the backs of rats, full thickness skin penetration of
CsA was observed one hour after drug application using CsA specific antibody staining. Maximal
staining was observed around 6 hours and the majority of the drug was cleared from the dose site
after 24 hours. Similar kinetics were obtained using free CsA concentrations determined by
LC/MS/MS. At each time point up to 24 hours, the total CsA (free CsA plus CGC2001) was higher
than the free CsA levels in skin, suggesting some CsA was cleared as an intact conjugate. This obser-
vation was consistent with the 1:4 ratio of free CsA to CGC2001 found in fecal samples. When
CGC2001 4% Ointment was applied, the free CsA and total CsA skin concentrations were 1.0 and
5.2 ng/mg tissue respectively at 8 hours. This free CsA was comparable to the CsA skin levels (0.8
ng/mg tissue) obtained after oral dosing with 3 mg/kg CsA for 7 days, indicating that we were able
to deliver therapeutic levels of CsA via topical application of CGC2001. A study using radiolabeled
CGC2001 in rats indicated that 24% of applied drug penetrated the skin over 8 hours. There was no
detectable CsA/CGC2001 in plasma or other organs. Approximately 99% of the absorbed drug
excreted in feces and less than 1% was found in urine in 48 hours. There were no observable adverse
effects when 50 mg and 375 mg of CGC2001 4% Ointment were applied twice day for 90 days to
rats and rabbits, respectively. These data indicate that topical application of CGC2001 is safe and
provides therapeutically relevant local concentrations of CsA in skin while avoiding systemic expo-
sure and toxicity. 
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Pimecrolimus lacks the strong apoptosis-promoting activity of corticosteroids in human den-
dritic cell cultures
F Kalthoff, J Chung, P Musser and A Stuetz Novartis Research Institute, Vienna
We and others have reported previously that corticosteroids (CS) profoundly inhibit many aspects
of dendritic cell (DC) biology, such as DC differentiation, maturation and the function to stimulate
primary T cells. In contrast, pimecrolimus, a new drug for the treatment of inflammatory skin dis-
eases, does not affect DC differentiation or function. We were prompted by the finding that CS applied
topically to murine skin mediated the apoptosis of epidermal Langerhans’ cells in vivo (see Abstract
W Hoetzenecker et al., SID 2003). In this study, we focussed on human dendritic cells (DC) and their
myeloid precursors as targets of CS-mediated apoptosis. Differentiation of DC from CD14+ mono-
cytes was induced by GM-CSF + IL-4 in the absence or presence of different concentrations of pime-
crolimus or CS (dexamethasone or beta-methasone-valerate). The proportion of apoptotic cells was
measured before and during cytokine-mediated DC differentiation on days 1, 2, 3, and 6 by FACS
following annexin-V, 7-amino-actinomycin D (7-AAD) and TUNEL staining. CS induced apopto-
sis in a time- and dose-dependent fashion. At 100 nM, CS induced apoptosis of approximately 25%,
50% and 85% of all cells on days 1, 2 and 3 of culture, respectively, while 10 nM of CS induced
apoptosis of approximately 30% on any of the first 3 culture days. In sharp contrast, less than 5%
TUNEL-positive and less than 15% annexin-V-positive cells were present at any time point in mono-
cyte-DC cultures in the presence of 100 nM pimecrolimus, and this was similar to the degree of apop-
totic cells found in the controls. Taken together, in contrast to pimecrolimus, CS induce apoptosis
of myeloid-type DC and this may contribute to their unfavourable safety profile upon prolonged
use. 
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T cell-mediated internalization and clearance of a murine antibody specific for the psoriasis
drug target CD11a
G Coffey, M Gonzales, P Fielder, S Palmieri and S Pippig MS#70, Genentech, Inc., South San
Franciso, CA
Efalizumab is a humanized monoclonal antibody specific for the human antigen CD11a that is cur-
rently in phase III clinical trials for the treatment of moderate to severe psoriasis. The α-chain com-
ponent of the leukocyte function-associated antigen-1, CD11a, is involved in T-cell activation and
trafficking into the dermis and epidermis through interaction with intercellular adhesion molecules.
Efalizumab inhibits T-cell activation and trafficking, and appears to be efficacious in the treatment
of psoriasis. Fundamental to our understanding of the pharmacology of efalizumab is a detailed
knowledge of its clearance from the body. In humans, the relationship between CD11a expression
and serum levels of efalizumab has been mathematically described by a CD11a-mediated clearance
model for efalizumab. However, although hypothesized, no experimental data is available as yet to
explain how the interaction with CD11a results in the clearance of efalizumab. To explore pathways
for drug clearance, we employed the murinized monoclonal antibody muM17, specific for mouse
CD11a. muM17 was shown to have a pharmacokinetic profile and functional characteristics simi-
lar to efalizumab in humans. Using this antibody, we hypothesized that muM17 would be internal-
ized by murine T-cells both in vitro and in vivo leading eventually to the clearance of muM17 in
vivo. Initial studies to elucidate the cellular fate of the internalized antibody were also conducted.
Results from these studies indicate that muM17 is internalized by isolated murine T-cells in a time-
dependent manner. Similarly, the antibody was internalized in vivo by peripheral mononuclear blood
cells and the spleen. Nearly 75% of the internalized antibody was cleared from the cells by 24 hours
in vivo. Future studies using both efalizumab and muM17 will continue to focus on elucidating 1)
the role of CD11a in antibody internalization, 2) the molecular mechanism of antibody internaliza-
tion, and 3) the sub cellular localization and fate of the internalized antibody both in vitro and in
vivo. 
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Treatment with oral pimecrolimus significantly improves atopic dermatitis with a clear
dose-response effect
J Hanifin,1 C Fleming,2 N Korman3 and S Reitamo4 1 Oregon Health Sciences University, Portland,
OR, 2 Perth Royal Infirmary, Perth, United Kingdom, 3 University Hospitals of Cleveland,
Cleveland, OH and 4 HUS, Helsinki, Finland
Pimecrolimus is a non-steroid, selective, inflammatory-cytokine inhibitor. It has been shown to
have high skin-selective anti-inflammatory activity with a low potential for affecting systemic immune
responses. The results of a study to evaluate the efficacy and safety of pimecrolimus for the treat-
ment of moderate to severe atopic dermatitis (AD) are presented here. In a double-blind, placebo-
controlled, parallel-group, dose-finding study, 103 adult patients with moderate to severe AD were
randomized equally to receive either placebo, 10, 20 or 30 mg po pimecrolimus bid. The study con-
sisted of a pre-treatment phase, 12 weeks of double-blind treatment and a 12-week post-treatment
phase. Efficacy was assessed by EASI and the percentage of patients who were clear or almost clear
of disease as defined by the investigator’s global assessment (IGA). The median change of the EASI
score from baseline showed a dose-dependent effect and was greatest for the 30-mg bid treatment
group. At 12 weeks, the median percentage reduction of EASI was 68%, 48%, 37% and 19% in the
30 mg-bid, 20 mg-bid, 10 mg-bid and placebo groups respectively. Following treatment with the
highest dose of pimecrolimus, 27% of patients were clear or almost clear of disease at 12 weeks. In
the two highest dose cohorts, more than half of the patients had not experienced disease relapse
(defined as the time when active therapy for AD is started) 4 weeks after stopping treatment with
oral pimecrolimus. Oral pimecrolimus was well tolerated throughout the study. Pimecrolimus was
effective in the treatment of AD providing dose-dependent and prolonged disease control. Based on
its efficacy and convenience, pimecrolimus has the potential to become a systemic treatment of choice
for the management of moderate to severe atopic eczema. 
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Optimal use of extracorporeal photopheresis in cutaneous T cell Lymphoma
R Talpur, N Chiao and M Duvic Dermatology, M.D. Anderson Cancer Center, Houston, TX
Extracorporeal photopheresis (ECP) is an apheresis procedure incorporating ultraviolet-A irradia-
tion of photosensitized peripheral blood mononuclear cells approved for cutaneous T-cell lymphomas
(CTCL) mycosis fungoides and Sezary syndrome, characterized by monoclonal expansion of malig-
nant helper T cells. Our previous prospective study of ECP monotherapy [JAAD 35: 573, 1996] is
compared to a retrospective analysis of ECP/combination therapy. Eighty-six CTCL patients were
treated at our institution with ECP monotherapy or combination therapy between 1988-2002. They
included 48 males and 38 females, 70 Caucasians, 8 Blacks and 8 Hispanics with a median age of
64.5 (38-81). Fifty-four patients receiving ECP monotherapy achieved an overall response rate
(RR) based on improvement in body surface area involved of 43% (23/54). Four were stage IA-IIA
(RR=75%, 2 CR, 1 PR); 50 were stage III-IVB (RR=40%, 5 CR, 15 PR). There were 7 complete
remissions, and two were > 3 years duration. Patients received a median of 21 ECP sessions (range
5-40+) over a median of 13 months (range 1-35). The median time to response was 5 months (range
1-32 months). An additional 32 patients received ECP in combination with other active systemic
therapies (psoralen ultraviolet A, interferon, oral bexarotene or isotretinoin, denileukin diftitox, mus-
targen, or total body electron beam irradiation). Patients received a median of 14 ECP sessions (range
3-54+) over a median of 14.5 months (range 1-72). The median time to response was 5 months (range
1-36 months). They achieved an overall RR of 56% (18/32) including 4 at stage IA-IIA (RR=50%,
1 CR, 1 PR and 28 at stage III-IVB (RR=57%, 3 CR, 13 PR). Side effects were limited to interferon
seizure (1 pt) and catheter related sepsis (4 pts). Other mild symptoms included headaches, nausea,
transient increased erythema, and acral edema. ECP has a higher response rate when combined with
other conventional treatments. 
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Protection of experimental bullous pemphigoid by IVIG is mediated through the IgG protec-
tion receptor FcRn
Z Liu,1 M Zhao,1 CL Anderson,2 LA Diaz1 and DC Roopenian3 1 Dermatology, University of North
Carolina at Chapel Hill, Chapel Hill, NC, 2 Internal Medicine, The Ohio State University,
Columbus, OH and 3 The Jackson Laboratory, Bar Harbor, ME
Intravenous immune globulin (IVIG) has been used in the treatment of inflammatory and autoim-
mune diseases. Numerous mechanisms have been proposed to explain the mode of action of IVIG.
In the present study, we used a murine model of bullous pemphigoid (BP) to test the hypothesis that
the effect of IVIG in autoantibody-mediated skin bullous diseases is to accelerate the degradation
of pathogenic IgG through the FcRn. BP is a subepidermal blistering disease associated with autoan-
tibodies directed against two hemidesmosomal antigens, BP230 and BP180. The experimental mouse
model of BP is induced by passive transfer of rabbit anti-murine BP180 (mBP180) antibodies into
neonatal mice. Using this BP animal model we have demonstrated that skin disease severity is directly
correlated with the circulating anti-mBP180 antibody levels. FcRn transports IgG and is responsi-
ble for maintenance of serum IgG levels. We found that administration of IVIG to C57BL/6J mice
prevented subepidermal blistering triggered by pathogenic anti-mBP180 antibodies. This protection
is associated with a significant reduction of circulating pathogenic IgG. The protective effect of IVIG
depends on FcRn activity because total anti-mBP180 IgG levels at 24 and 48 h post-injection were
almost the same in FcRn-deficient mice with and without IVIG treatment. These data demonstrate
that IVIG treatment leads to increased FcRn-dependent clearance of pathogenic IgG; therefore, mod-
ulation of FcRn function represents a therapeutic target for autoantibody-mediated bullous diseases. 
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Pimecrolimus does not affect cytokine and chemokine secretion and adhesion molecule expres-
sion in primary human keratinocytes and dermal fibroblasts
B Wolff, G Herzig and A Stuetz Novartis Research Institute, Vienna, Austria
Pimecrolimus has been shown to inhibit the production and release of inflammatory cytokines in T
cells at nM concentrations, and to prevent the release of pro-inflammatory mediators from mast cells.
In the skin, keratinocytes and fibroblasts can modulate T-cell and mast-cell responses by the syn-
thesis of cytokines and chemokines, as well as adhesion molecules. In this study, we investigated
whether pimecrolimus affects functions in primary human epidermal keratinocytes (KC) and human
dermal fibroblasts (HDF), in comparison with the glucocorticoid dexamethasone. Pimecrolimus
had no effect on the induction of GM-CSF, IL-6, IL-8 (CXCL8), MCP-1 (CCL2), MIP-3a (CCL20),
IP-10 (CXCL10) and RANTES (CCL5) in KC and HDF, and on eotaxin (CCL11) in HDF at con-
centrations up to 10 mM. The expression of the adhesion molecules ICAM-1 (KC and HDF) and
VCAM-1 (HDF) was also unaffected. In contrast, the glucocorticoid dexamethasone inhibited IL-
6, IL-8, eotaxin and GM-SCF in HDF at IC50 concentrations ranging from 0.5 to 19 nM.  In con-
clusion, no effect was observed with pimecrolimus in keratinocytes and fibroblasts. This confirms
the high cell selectivity of pimecrolimus, acting on T cells and mast cells. 
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Bacterial quorum-sensing molecules: potential utility in the treatment of inflammatory skin
disease
J Mee,1 R Groves,1 B Bycroft2 and D Pritchard2 1 Academic Dermatology, Imperial College
London, London, United Kingdom and 2 School of Pharmaceutical Sciences, Nottingham
University, Nottingham, United Kingdom
N-acyl homoserine lactones (AHLs) are a series of signalling molecules employed by gram-nega-
tive bacteria to co-ordinate gene expression with population density, thereby acting as ‘quorum-sen-
sors’. Recent data has indicated that AHLs also interact with the mammalian immune system, result-
ing in immunosuppressive and anti-proliferative effects. Such compounds might be of utility in the
treatment of hyperproliferative and inflammatory disease such as psoriasis and we were therefore
interested to determine whether a series of AHLs had growth modulatory effects on keratinocytes.
Subconfluent normal human keratinocytes were cultured in the presence of increasing concentra-
tions of three AHLs, two (OdDHL and OtDHL) with long carbon side chains (C12 and C14 respec-
tively) and one (OHHL) with a shorter, C6, side chain. Both OdDHL and OtDHL induced a dose-
related suppression of keratinocyte growth over 24 hours at concentrations as low as 3.125 µM
when cell number was assessed by an MTT assay. Moreover, 3H incorporation was completely inhib-
ited at 25µM by both OdDHL and OtDHL. OHHL was without effect in either of the assays. To
assess potential toxicity of the AHLs, keratinocytes were cultured in increasing concentrations of
the three compounds for 24 hours and LDH release was assayed colorimetrically. No toxicity was
seen from any AHL compound at concentrations up to 50mM, though at higher concentrations a
dose-related increase in LDH release was observed with both OdDHL and OtDHL. Again, OHHL
was without effect. These data indicate that long chain bacterial AHLs have profound effects on ker-
atinocyte growth and proliferation at non-toxic doses. This observation is of relevance to the effects
that gram-negative bacteria (for example Pseudomonas aeruginosa) have on the skin, for example
non-healing cutaneous ulceration, but also suggests a potential therapeutic utility of these compounds
in inflammatory and hyperproliferative skin diseases such as psoriasis. 
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Safety profile of oral pimecrolimus in atopic eczema and psoriasis: a pooled analysis from two
dose-finding studies
K Wolff,1 I Caro,2 D Murrell3 and J Ortonne4 1 University of Vienna, Vienna, Austria, 2
Massachusetts General Hospital, Boston, MA, 3 St. George Hospital, Kogarah, NSW, Australia and
4 Hopital de lArchet, Nice, France
Pimecrolimus, a cell-selective inflammatory cytokine inhibitor, has been developed specifically for
the treatment of inflammatory skin diseases. A pooled safety analysis is presented from two dose-
finding studies performed with oral pimecrolimus. 243 adult patients were included in the pooled
safety population of the randomized, double-blind, placebo-controlled, parallel-group, dose-finding
studies of patients with moderate to severe atopic eczema or psoriasis. In both studies, patients were
randomized to receive either placebo or oral pimecrolimus 10, 20 or 30 mg bid in a 1:1:1:1 ratio for
12 weeks. Safety assessments included monitoring and recording of adverse events, regular moni-
toring of laboratory assessments (haematology, blood chemistry, urinalysis) vital signs and physi-
cal examination assessments. Oral pimecrolimus was well tolerated. Less than 3% of patients with-
drew from the study due to adverse events. The only adverse event that showed a clear dose-effect
relationship was a transient, generally mild to moderate feeling of warmth. Headache and common
gastrointestinal symptoms such as nausea and dyspepsia were the most commonly observed adverse
events. No effect of treatment on blood pressure was observed in any of the study groups. No sig-
nificant changes in mean serum creatinine and glucose tolerance were observed in any group.Eval-
uation of skin immune response to skin-recall antigens before and after treatment showed that the
skin cellular immune response to bacterial and fungal antigens was preserved during treatment with
oral pimecrolimus. Oral pimecrolimus was shown to have an excellent safety profile in the short-
term treatment of psoriasis and atopic eczema. This conforms with pharmacogenomic data from a
previous study in psoriasis. Following further evaluations in long-term studies, pimecrolimus has the
potential to become a drug of choice for the systemic treatment of inflammatory skin diseases. 
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The efficacy, safety, pharmacokinetics, and pharmacodynamics of efalizumab in patients with
plaque psoriasis: results of phase III trials
C Leonardi,1 K Gordon,2 P Walicke3 and A Menter4 1 St. Louis University School of Medicine, St.
Louis, MO, 2 Northwestern University, Chicago, IL, 3 Genentech, Inc., South San Francisco, CA
and 4 Baylor University Medical Center, Dallas, TX
Studies evaluating efalizumab, a humanized monoclonal IgG1 antibody, have consistently demon-
strated that efalizumab provides benefit for patients with plaque psoriasis. Efalizumab blocks the
interactions between leukocyte function-associated antigen-1 (LFA-1) and intercellular adhesion
molecule-1 (ICAM-1), which inhibits the activation of T cells and interferes with trafficking into
the dermis and epidermis. The effects of efalizumab therapy were evaluated in placebo-controlled
phase III trials followed by an open-label trial. During the randomized, double-blind, placebo-con-
trolled trial, subjects with moderate-to-severe plaque psoriasis received 1.0 mg/kg/wk subcutaneous
(SC) efalizumab or placebo for 12 weeks. Upon completion, subjects who had received efalizumab
were enrolled into the ongoing open-label follow-on study and received an additional 12 weeks of
SC efalizumab 1.0 mg/kg/wk, for a total of 24 weeks of continuous efalizumab therapy. The Psori-
asis Area and Severity Index (PASI) responses observed for the 556 subjects in the study are con-
sistent with response rates observed previously; pooled data from 2 prior phase III trials demon-
strated that 29.2% of 394 subjects treated with efalizumab 1.0 mg/kg/wk had 75% PASI improvement
at Day 84. The pharmacokinetics and pharmacodynamics of efalizumab were characterized, and
overall, subjects received adequate efalizumab exposure. The data from these studies are to be final-
ized and presented in detail. The results of these phase III trials are consistent and provide evidence
for the clinical benefit of efalizumab in the treatment of patients with plaque psoriasis. 
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Efficacy, safety, and pharmacokinetic outcomes observed in subjects with plaque psoriasis dur-
ing long-term efalizumab therapy: results from an open-label trial
AB Gottlieb,1 T Hamilton,2 P Walicke3 and K Gordon4 1 Clinical Research Center, UMDNJ Robert
Wood Johnson Medical School, New Brunswick, NJ, 2 Altanta Dermatology, Vein & Reseach
Center, LLC, Alpharetta, GA, 3 Genentech, Inc., South San Francisco, CA and 4 Northwestern
University Dermatology, Chicago, IL
Efalizumab, an anti-CD11a humanized monoclonal IgG1 antibody, blocks leukocyte function-asso-
ciated antigen-1/intercellular adhesion molecule-1 (LFA-1/ICAM-1) binding, inhibiting T-cell medi-
ated events in the pathogenesis of plaque psoriasis. The effects of 1 to 2 years of continuous efal-
izumab therapy for this chronic disease are being evaluated in an ongoing, open-label, multicenter
trial. Subjects with moderate-to-severe disease received 2.0 mg/kg/wk subcutaneous (SC) efalizumab
for 12 weeks. At Day 84, subjects with &#8805;50% improvement in Psoriasis Area and Severity
Index (PASI) or Overall Lesion Severity (OLS) of Mild, Minimal, or Clear were eligible for main-
tenance efalizumab therapy. Maintenance treatment (MT) consisted of SC efalizumab 1.0 mg/kg/wk
At the conclusion of the initial 12 weeks of treatment, 41% and 81.1% of the 339 subjects demon-
strated &#8805;75% and &#8805;50% PASI improvement, respectively. Preliminary analysis of 6
months of therapy showed that 77.1% of 288 subjects maintained &#8805;50% PASI improvement
and 50% of these subjects had &#8805;75% PASI improvement. Mean trough levels measured at
the end of each 12-week MT period were: MT-1 14.5 µg/mL; MT-2 15.0 µg/mL; MT-3 14.6 µg/mL;
and MT-4 15.6 µg/mL. MT is ongoing; additional data for this 12-month cohort will be presented.
Common adverse events were headache, nonspecific infection (eg, colds), chills, pain, nausea, asthe-
nia, and fever.  Consistent trough levels measured during MT show no evidence of efalizumab accu-
mulation; therefore, no pharmacokinetic changes are observed with long-term efalizumab treatment.
The efficacy outcomes suggest that long-term efalizumab therapy maintains PASI improvement and
is well tolerated. 
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Pimecrolimus induces neuropeptide release at early stages of topical application in vivo
M Steinhoff,1 S Seeliger,1 S Stander,1 A Grevelhorster,1 A Stuetz2 and TA Luger1 1 University of
Munster, Munster, Germany and 2 Novartis Research Institute, Vienna, Austria
Primary afferent neurons play an important role in mediating inflammation, pain and pruritus in the
skin. The calcineurin inhibitor pimecrolimus (PI) is highly effective in treatment of inflammatory
dermatoses, like atopic dermatitis. Due to an unknown mechanism, at the start of topical treatment,
PI may transiently induce a feeling of warmth or mild burning. Therefore, we examined whether PI
is able to stimulate neuropeptide release in normal mouse skin and in a model of experimentally
induced toxic contact dermatitis of mouse skin. Group 1: Application of pimecrolimus cream 1% on
normal mouse ears. Group 2: Application of cream (vehicle). Group 3: Benzalkonium chloride was
used to induce irritant contact dermatitis (ICD) on right mouse ears. At various timepoints (30 min-
utes, 2 hours, 6 hours) pimecrolimus cream 1% was applied, and mouse ears harvested for ELISA
(SP, CGRP) after 30 minutes. Group 4: Vehicle control to Group 3. Left ears without treatment were
used as additional controls. Expression of neuropeptide (neurokinin) receptors were quantified
from mouse ears 2—8 hours after treatment by quantitative RT—PCR. Our data show that pime-
crolimus cream 1% enhances the release of SP and CGRP in a time-dependent manner during the
early phase after PI treatment of mouse ears. Protein concentrations for SP were slightly increased
in the ICD model indicating higher release of SP in inflammatory skin compared with controls. In
contrast, no quantitative changes were observed in neuropeptide receptor expression after treatment
at all timepoints investigated. Transient early side-effects of PI may be due to stimulation of neu-
ropeptide release from afferent sensory nerve fibers at early stages of topical treatment. In addition,
neuropeptides such as SP and CGRP may contribute to the anti-inflammatory capacity of PI. Whether
this is a direct or indirect effect and whether long-term treatment with PI results in a decreased release
of cutaneous neuropeptides is currently under investigation. 
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Quantitation of cutaneous cytokine mRNA levels following anti-IL-12 psoriasis therapy: iden-
tification of a psoriasis subset
E Toichi,1,3 TS McCormick,1 CL Kaufmann,4 N Aria,4 AB Gottlieb,2 DE Everitt,5 B Frederick,5
MA Mascelli5 and KD Cooper1 1 Derm, CWRU, Cleve., OH, 2 Derm, Robert Wood Johnson
Medical School, New Brunswick, NJ, 3 Kyoto Univ. Graduate School of Medicine, Kyoto, Japan, 4
Derm, Georgetown Univ., Wash., DC and 5 Centocor, Malvern, PA
Inhibition of IL-12 may downregulate type I cytokines. Therefore, cutaneous cytokine mRNA lev-
els were evaluated in 18 psoriasis patients (pts), with at least 3% BSA, who participated in a multi-
center, nonrandomized, open-label, phase I study to assess the safety and efficacy of single, intra-
venous infusions of a human monoclonal antibody to human IL-12 (0.1-5mg/kg). Clinical efficacy
was assessed by PASI. Total RNA isolated from plaque biopsies obtained at −24h, 48h and 2wks
post infusion was evaluated for cytokine expression by real time RT-PCR, normalized by 18s ribo-
somal RNA. At baseline, TNFα, RANTES, IL-10 and IFNγ mRNA levels correlated (Pearson cor-
relation) within and among themselves. Additionally, type I cytokines in the IL-12 cascade (ie, IL-
12p40, IFNγ, TNFαand subsequent inflammatory cytokines IP-10, RANTES, IL-8), also correlated.
By contrast, MCP-1, IL-18 and IL-12p35 were not observed to correlate. Across all groups, pts who
achieved > 75% improvement in PASI at 16 wks, had significantly decreased expression of IL-12p40
and TNFαat 2 wks (n=12, p=0.04, each). The level of IFNγ mRNA decreased by 58±4.8% in all
patients at 2wks (p<0.005). This is consistent with anti-IL-12 interference of type I immunoreac-
tivity within lesions and with the notion that efficacy of anti-IL-12 therapy is associated with inhi-
bition of type I cytokines. Decreased expression of mRNA for these cytokines preceded clinical
improvement. Interestingly, across all groups, pts who achieved > 75% improvement in PASI at
16wks (n=12) had higher average baseline TNFα mRNA levels than pts who achieved ≤75% improve-
ment in PASI (n=6)(p <0.05). Thus, baseline TNFα mRNA levels may identify a novel psoriasis sub-
set and predict therapeutic responsiveness, particularly at lower doses. 
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Inhibition by levocetirizine of VCAM-1 expression on human dermal endothelial cells
L Michel, F Jean-Louis, S Boland and L Dubertret Dermatology, INSERM U532, Paris, France
Local tissue eosinophilia is a well recognized feature of allergic inflammation and adhesion mole-
cules play a potent role in such eosinophil recruitment. Cetirizine has been shown to inhibit the accu-
mulation of eosinophils in the skin of pollen sensitive subjects as well as to modulate VCAM-1
expression in atopic dermatitis skin. In the present study, we determined whether levocetirizine - a
new antihistamine - inhibited the stimulated upregulation of VCAM-1 expression on human dermal
endothelial cells (HDMEC) in response to cytokines in vitro. Since the regulation of adhesion mol-
ecule expression - including VCAM-1 - involves the nuclear factor kappa B (NF-kB) translocation,
we also evaluated the possible effects of levocetirizine on the TNFalpha-induced NF-kB activation
in HDMEC. HDMEC, obtained from normal adult skin, were grown in medium M199 supplemented
with 20% fetal calf serum, endothelial growth factor supplement, and antibiotics. Subconfluent Cells
were treated with levocetirizine (10-7 to 10-4 M) during 24h and stimulated with 10U/ml TNFalpha
for 4h. Expression of VCAM-1 was assessed by FACS analysis. NF-kB activation was measured by
electrophoretic mobility shift assay (incubation of nuclear extracts with a 32P-end-labeled oligonu-
cleotide probe containing a binding site for NF-kB; use of positive and negative probes and super-
shift assays with antibodies to the p50 and p65 subunits). Levocetirizine inhibited the VCAM-1
expression induced by TNFalpha at the surface of HDMEC in a dose-dependent fashion, from 10-
4 to 10-7M. Although there was no basal level of NF-kB activation in HDMEC alone or under lev-
ocetirizine treatment, TNFalpha induced a strong activation of NF-kB which was significantly inhib-
ited by levocetirizine according to a dose-dependent manner. These data support previous works on
anti-inflammatory effects of levocetirizine and suggest a possible mechanism whereby it may inhibit
eosinophil accumulation in vivo. 
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The proteasome inhibitor “bortezomib” overcomes melanoma chemoresistance in vitro and in
vivo
MS Soengas,1 Y Fernandez,1 S Philipp,3 S Wang,2 ME McCurrach,4 R Mosher,3 C Martin de la
Vega,1 W Sarah3 and SW Lowe4 1 Dermatology, University of Michigan, Ann Arbor, MI, 2
Chemistry, University of Michigan, Ann Arbor, MI, 3 Millennium Pharmaceuticals, Cambridge,
MA and 4 Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
Melanoma is well known for its extreme chemoresistance. Multiple studies, indicate that melanoma
cells counteract anticancer agents by inactivating programmed cell death (apoptosis) and reinforc-
ing multiple survival signals. We hypothesized that targeting survival and pro-apopototic pathways
simultaneously might be an efficient therapeutic strategy in melanoma. The proteasome inhibitor
bortezomib (Velcade, formerly known as PS-341) is exhibiting promising effects in clinical trials
for several chemoresistant tumors (e.g. multiple myeloma). The cytotoxic action of Bortezomib has
been associated, at least in part, with the inactivation of the NF-kB pathway and a still poorly-defined
induction of apoptosis. At doses that do not affect the viability of normal melanocytes (i.e. 1-50 nM),
bortezomib induced massive cell death (mean viability <10%) of a panel of 24 aggressive melanoma
cells resistant to other chemotherapeutic drugs. To test the efficacy of bortezomib in controlling
melanoma growht and metastasis vivo, GFP-tagged human melanoma cells were injected either sub-
cutaneously or intravenously, respectively. Those mice were treated with vehicle control or with 1
mg/kg of bortezomib every two days for a period of 2-3 weeks. Whole body fluorescence images
indicated that bortezomib had a significant effect in controlling growth and metastasis of melanoma
cells (p<0.01), which was confirmed by histological analyses. Biochemical studies of melanoma
cells treated in culture and in mouse xenograft models indicate that bortezomib is able to activate
multiple apoptotic executors (caspases) and bypass negative signals from antiapoptotic regulators.
Cell death was also independent of the Ras/BRAF/ERK functional status of the tested cells (p<0.01).
We consider these results as a proof of principle for the design of new strategies to overcome melanoma
chemoresistance in vivo. 
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Identification of oral pemphigoid antibody binding site(s) in human a6 integrin molecule
J Casiglia, K Bhol, SW Yeh and AR Ahmed Department of Oral Medicine, Harvard School of
Dental Medicine, Boston, MA
Oral pemphigoid (OP) is a subset of mucous membrane pemphigoid (MMP) with disease limited to
oral cavity. Recently we demonstrated that, sera from OP patients recognized a 120 kDa protein.
This binding was blocked by monoclonal antibody to human a6 integrin. This protein was further
characterized as human a6 integrin. The purpose of this study was to identify specific site(s) on human
a6 integrin molecule to which sera from OP patients bind and determine its role in the process of
blister formation. We cloned the fragments representing the extracellular and intracellular domain
of a6 molecule from normal human gingival mRNA into an expression vector and mapped the region
to which sera from OP patients bind by western blot analysis. We have attempted to determine the
role of the immunodominant region in pathogenesis by demonstrating the ability of the rabbit anti-
body to the immunodominant region to produce separation of the epithelium from the submucosa
when incubated with normal human buccal mucosa in an in vitro organ culture model. Majority of
the OP sera tested bound to the N-terminal end of the extracellular domain (EC1.0) of the human a6
integrin. Further sub-cloning of EC1.0 demonstrated that a smaller fragment extending from 23 aa
to 131 aa (EC1.1) was responsible for this binding. This region may have multiple antibody bind-
ing sites. Antibody to human EC1.1 produced in rabbit, resulted in separation of the epithelium
from the submucosa, histologically identical to that observed when normal human buccal mucosal
tissue was cultured with OP sera in an human buccal mucosa organ culture model. These observa-
tions identify EC1.1 as the antibody binding site for sera of OP patients and suggest a possible role
for it in blister formation. 
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Atorvastatin inhibits metastasis of human melanoma cells in vivo
EA Collisson,1 A De,2 S Gambhir,2 H Suzuki1 and MS Kolodney1 1 Dermatology, UCLA, Los
Angeles, CA and 2 Crump Institute for Molecular Imaging, UCLA, Los Angeles, CA
Rho GTPases are signaling molecules known to control cell motility. Several recent studies have
suggested a role for Rho proteins in mediating tumor metastasis independent of their effects on cell
proliferation. Since Rho proteins require post-translational modification with a geranlygeranyl moi-
ety for full activity, we tested the effect of blocking geranylation on localization, downstream sig-
naling and stimulation of invasion. Statin drugs, which deplete the cell of cholesterol through inhi-
bition of HMG-CoA reductase, have pleiotrophic effects on many isoprenylation events within the
cell. We hypothesized that statin treatment could prevent Rho activation and thus Rho-mediated
metastasis. We developed a luciferase based in vivo imaging model to visualize A375 cells metas-
tasizing in SCID mice in real time. Our results demonstrate that statin treatment inhibits Rho acti-
vation in vitro and furthermore, that oral administration of atorvastatin to SCID mice dramatically
inhibits the metastatic dissemination of RhoC overexpressing A375 human melanoma cells in vivo.
These results suggest that statin treatment may serve as a prophylactic regimne against metastasis
of melanoma. 
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Alefacept modulates type I inflammatory genes in psoriasis
MF Chamian, E Lee, I Cardinale and JG Krueger Investigative Dermatology, Rockefeller
University, New York, NY
In psoriasis vulgaris, a Type 1 cytokine genomic pathway is active and defined by increased expres-
sion of genes encoding pro-inflammatory cytokines (IL-12, γ-IFN), chemokines (IL-8, MIG), tran-
scription factors (STAT1, IRF-1), and the enzyme iNOS. To better understand the relationship between
expression of Type 1 genes, disease activity, and T-cell targeted biologicals, we sequentially ana-
lyzed gene expression in skin lesions of 22 patients with psoriasis vulgaris treated with a standard
regimen of alefacept. Patients were designated as responders (n=12) or non-responders (n=10) to
alefacept based on reductions in epidermal hyperplasia and reversal of keratin 16 (K16) immuno-
histochemical staining at week 13. Gene expression at weeks 0, 2, 6, and 13 was analyzed by quan-
titative, RT-PCR. In 12/12 responders, there was a marked reduction in K16 mRNA (mean 7-fold
reduction, p=0.003), whereas minimal reductions in K16 mRNA in the non-responders. Untreated
psoriasis lesions had increased of Type 1 inflammatory gene expression (IL-12p40, γ-IFN, IRF-1,
STAT1, IL-8, MIG, and iNOS) in comparison to uninvolved skin. Responders showed consistent
suppression of these mRNAs in week 13 biopsies, whereas non-responders had small changes in
expression of these key inflammation-related genes. We used a novel multivariate statistical approach
to assess the relationship of disease improvement to simultaneous changes in several Type 1 path-
way genes. There was a high correlation (r=0.759) between disease response and gene expression
in Type 1 inflammatory pathway genes. These data establish a central role for T-cells in regulating
a complex inflammatory pathway in psoriatic lesions. 
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Topical corticosteroid activity in human skin is associated with single nucleotide polymor-
phisms in three genes involved in alcohol metabolism
LK Pershing,1 A Tkachuk,2 JL Corlett1 and MR Hobbs2 1 Dermatology, University of Utah, Salt
Lake City, UT and 2 Medicine, University of Utah, Salt Lake City, UT
Betamethasone dipropionate, 0.05% in ointment without branched alcohols produces highly vari-
able baseline skin blanching response (SBR) in Caucasians that can be stratified into three major
response cateogories by reflectance colorimetry: High, Medium and Low, representing 20%, 35%
and 45% of the population (n=26), respectively. The branched alcohols propylene glycol (PG) and
isopropanol (IPA) considered inactive excipients in high potency corticosteroid products alter SBR
as a function of baseline SBR category (p < 0.05) independent of skin drug content. Betamethasone
dipropionate in ointment with PG decreases SBR 2X in High responders, but increases SBR 2X and
6X in Medium and Low responders to the drug, respectively (p< 0.05 ANOVA). In contrast, IPA in
the lotion product has no effect on High and Medium responders, but increases SBR 6X in Low
responders. When IPA and PG are combined in the lotion, IPA
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Evaluation of risk factors for fogo selvagem: case-control study
V Aoki*, EA Rivitti*, G Hans-Filhoo, V Santoso, DP Eatono, RC Millikan and LA DiazA Dept. of
Dermatology, *University of Sao Paulo and University of Mato Grosso do Sul. Brazil; and
Department of ADermatology and ‘Epidemiology, University of’North Carolina, Chapel Hill, NC
Foao Selvagem (FS) is an autoimmune blistering disease endemic in Brazil.  A population based
case-control study of FS was conducted in an Amerindian Terena community located in
Midwestern Brazil.  The focus of this case-control investigation was to evaluate the extent to which
aspects of housing and hygiene, life activities, family and social relationships, health history,
animal and other exposures.  and HLA type/status contribute to the occurrence of FS in an
environment of high endemicity such as Limao Verde.  The following studies were conducted using
a specially designed survey form.  A single interviewer (VA) obtained the information which was
entered in a database for further analysis.  All FS cases (n=30) and controls (community controls
n =108; family controls n= 90) were selected by matching on gender, age, race and occupation.  A
13-page questionnaire was administered to each patient and control, and included a final
assessment of the house and the living conditions of patients and controls made by the interviewer.
The highlights of this study are here described: 1-demographic characteristics: 228 individuals,
mean age of 40 years old; there was no predominance of gender among the population studied-
about 70% of the participants belong to the Terena ethnic group, and over 60% of the interviewees
were engaged on farming activities;2-exposure to bed bug bites were higher in FS patients (63.3%)
than controls (community=32.4%/ family=34.4%),3-exposure to kissing bugs were higher in FS
patients (53.3%) than controls (community=30.6%/family=34.4%); 4-FS patients usually live in
poorer houses, made of adobe with thatched roofs, in comparison to controls.  These results suggest
that the environmental antigen (s) triggering the autoimmune response in FS may be linked to
exposure to hematophagous insects.
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Assessment of knowledge, habits and attitudes of high-school adolescents towards skin
cancer risk factors, sun exposure, sun effects  and sun protection measures in Porto Alegre -
Brazil
C Benvenuto, D De Villa, GF Fonseca, BL Zen, C Troian and TF Cestari Federal University of Rio
Grande do Sul - Hospital de Clínicas de Porto Alegre - Brazil
Adolescence  has been identified as a high risk period for unprotected sun exposure, sunburns and
induction of skin cancer, the most prevalent malignancy in the world, as well as the most
preventable.  This study examines patterns of sun protection and sun exposure among Brazilian
adolescents and their knowledge about the effects of the sun.  Methods: During July-November,
2002, a total of 720 adolescents aged between 12 and 19 were recruited from a random sample of
25 high-schools in Porto Alegre - Brazil.  The volunteers completed a validated 40 questions survey
that provided information on sunscreen use, sunbathing habits, tanning bed use, and cutaneous
solar effects.  Results: About 99% of the adolescents have already heard about UV light hazards,
and the top source of sun protection information was the midia (89,6%), while schools and
physicians contributed with only 15% and 23,1%, respectively.  Although 85% of the students
pointed skin cancer as a risk of  sun exposure, and 25,6% answered that sun exposure brings
absolutely no benefits, only 47,6% referred frequent sunscreen use during summer time, and only
3% during the winter.  The great majority (75,6%), answered that people look better with a tan.
Among those who referred frequent use of sunscreens, 21,3% choose sunscreens factors less than
15 and 63,7% do not reapply them regularly.  Tanning bed use was referred by 3,5% of the students
and they  were more likely to be female (76,9%).  Sunburns with bullae were reported by 18,6% of
the respondents (60,4% of the female sex) Conclusions: These results suggest the need for
increased education about skin cancer prevention habits.  Students seem to be well informed about
the risks of sun exposure, but are not practicing correctly the sun protection measures. Because the
media is a major information source, and it is well known by its influence on the promotion of
tanning, it is important to ensure that messages about sun risks and sun protection are correct.
Physicians and schools should be more engaged on teaching people about the effects of the sun.
This study will be important in defining the aims of the educational campaigns on skin cancer in
Brazil.
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A randomized controlled clinical trial on the efficacy of green tea extract in reducing
UVB-Induced erythema at 2xMED
CB Angeles, ID Ampil and BB Arcilla Section of Dermatology, University of the East Ramon
Magsavsay, Memorial Medical Center, Philippines and Department of Surgery and Section of
Dermatology, UERMMMC, Philippines
Background: Chronic exposure of solar ultraviolet (UV) radiation has several adverse biologic
effects on the skin.  Protective clothing and use of sunscreens are not sufficient to protect our skin
against the harmful effects of the solar UV radiation.  Several studies have shown that green tea
extract affords significant skin photoprotection.  Objective: This study aims to determine the
efficacy of a green tea cream (10%. w/w) in reducing UVB-induced erythema. by comparing it to
placebo and sunblock.  Adverse effects from the application of the extract are also investigated.
Methodology: Thirty subjects included in the study.  On day-I. minimal erythema dose (MED)
determination was done. Dav-2. baseline ervthema of each of the six test sites on the back was
determined using a mexameter. then seventy milligrams of sunbiock. green tea and placebo. were
randomly applied, each on two test sites on the lower back; one site was exposed to UVB at
2xMED thirty minutes after application of the creams, the other site was not irradiated. Twenty four
hours after irradiation, mexameter readings were recorded, and clinical grading of erythema was
done. Results: Comparison of means of erythema indices and clinical grading showed that the
mean average of placebo exposed to UVB is significantly different from means of green tea and
sunblock exposed to UVB (p = 0.00000114. and p = 2.74 x 10 respectively), and that difference
between green tea and sunblock exposed to UVB was not significant (Duncan Test for Multiple
Comparisons). Five subjects (17%) developed irritant contact dermatitis to the green tea cream.
Conclusion: Seventy milligrams of green tea extract (10%. w/w) containing 65% catechins applied
on 2 cm x 2 cm (4 55 rng/2cm of catechins) is significantly effective in reducing UVB (2xMED)-
induced erythema compared to placebo. Its inhibition of UVB-induced erythema is comparable to
a sunscreen. Irritant contact dermatitis developed in 1 7% of subjects
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Gene p16 ink 4A in malignant melanoma- study of a family
LC Cardoso, AC Cardoso, AGS Silva, VS Salomano, HO Stolf and SR Rogatto Dept. of
Dermatology and Dept. of Genetics, University of the State of São Paulo, Botucatu, Brazil
Melanoma is a malignant tumor potentially curable if diagnosed early in it’s biological course. 
In familiar melanoma, mutations of the tumor suppressor gene TP16 /p16 ink4A, in cromossome
9p21, have been described and related to predisposition to the development of melanomas within
families.  With the objective of identifying patients with this predisposition, we studies 8
individuals of family with melanocytic lesion (melanocytic nevi, displastic nevi and /or melanoma).
We searched for point mutations in portion 3’ éxon 2 gene p16 ink4A in the DNA from skin
biopsies of the studies patients.  In two of the samples, the DNA analysis from the skin  lesion (In
this case, melanocytic nevi), Showed a different mirgration pattern  from the simple strand of
genomic DNA extracted from peripheral blood lymphocytes.  This finding suggests the existence
of genetic alterations specific of the gem cells line, which would predispose this patient  to the
development of malignant melanoma.
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Eritema nodoso in the Hospital Nacional Dos de Mayo from 1990-2001 
P Chávez de Paz Villanueva and M Rueda Alvarez Dept. of Dermatology, Hospital Nacional “Dos
de Mayo,” Lima-Perú
Erythema nodosum (EN) is an acute, nodular, eryhematous eruption that usually is limited to the
extensor aspects of the lower legs.  EN is presumed to be a hypersensitivity reaction and may occur
in association with several systemic diseases or drug therapies, or it may be idiopathic.   The
inflammatory reaction occurs in the panniculus.  The purpose of the present retrospective study was
to evaluate the principal causes of erythema nodosum in the Hospital Nacional Dos de Mayo,
Lima-Perú, in a period of 11 years, between 1990 and 2001.  104 patients have been studied.  All
patients have clinical and hispathologic–septal panniculitis-diagnosis of erythema nodosum.  The
female: male ratio was 4: 1 and the mean age was 31 years.  We found a cause in 46.15% cases,
the most frequent cause of erythema nodosum was an infectious agent, including beta-hemolytic
strptococcus (32.69%).  In 53.85% the etiology of erythema nodosum remained undetermined and
were qualified as idiophathic .  The clinical characteristic presentation of erythema nodosum was
founded in 95.19%.
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Chronic hydroarsenicism (CHA) is the prolonged exposure to arsenic (As) species in drinking
water
J Contreras-Ruiz, IE Soto-Romero, D Lechuga-Martin, P Gutierrez-Castrellon, R Ruiz-
Maldonado, RG Becerra, C Duran-McKinster, M Cruz, RM Ortiz and ME Cebrian Dept. of
Dermatology, Hospital General “Dr. Manuel Gea Gonzalez,” Mexico City, Mexico
Chronic hydroarsenicism (CHA) is the prolonged exposure to arsenic (As) species in drinking water. In 1997
we diagnosed a 10 year-old (y/o) female from Zimapán, Mexico with CHA who eventually died of related
complications. Therefore we investigated urinary arsenic (UAs) levels in Zimapán, and whether or not more
children were affected. A correlation between UAs levels and cutaneous markers of CHA in children was
sought. Method: Our study was comparative, transversal, observational, and prospective. Subjects were
randomly selected from 4 different communities where two acted as controls and two as exposed cases based
upon historic as levels in water.  The 17 y/o and younger were included and examined by two dermatologists
looking for cutaneous features of CHA. Urine samples were analyzed for as content using a method previously
described. (1)  Results: 296 controls and 263 cases were selected. Of these, 139 (47%) controls and 126 (48%)
exposed were children aged 2-17 y/o. Abnormal levels (higher than 50 mg/l) were encountered in 92 (73%) of
the cases and 8 (6%) of controls. Average UAs levels in unexposed communities were significantly lower 19+/-
18 mg/l than those encountered in exposed ones 665+/-636 mg/l (p < 0.00001). Cutaneous lesions encountered
in controls and exposed subjects were respectively: Hyperkeratoses 0% vs. 20.9%, hyperpigmentation 0% vs.
12.2%, and confetti-like pigmentation 0% vs. 2.6%, all reaching statistical significance. (p<0.001)  The two
youngest children with high UAs levels (57 and 193 mg/l) were 2 y/o. The highest level encountered was 2860
mg/l in a 13 y/o female, this patient however, had no cutaneous lesions. The youngest patient with lesions
(hyperkeratoses) was a 6 y/o female (UAs levels 33  mg/l). Conclusions: CHA has been reported worldwide.(2-
4) However, to our knowledge, CHA has only been reported in children in Chile,(5-6) Taiwan,(7) Argentina(8),
Thailand,(9) Bangladesh,(2,4), and Comarca Lagunera, Mexico.(10-11) As levels were never as high as those
here reported. A correlation was found between cutaneous signs and UAs levels. Skin manifestations are
believed to take years to appear, however we found them in children as young as 6 years of age. This could
mean either exposure to high As levels since early childhood or even in-utero. This hypothesis would be
supported by the fact that high levels of UAs have been reported in children and newborn babies, who had
normal looking skin.(2) One case of CHA-related squamous cell carcinoma has been reported in a 13 y/o
Mexican patient.(11) None of our patients had malignant lesions. CHA in Zimapán implies a severe risk for
As-related complications that may be prevented through a clean water supply.
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Chinese herbal medicines influence the follicle biology in vitro and in vivo
W Fan, Y Zhao and W Zhu Dept. of Dermatology, Nanjing Medical University, Nanjing, China
It is more than thousand year histories to treat hair diseases with Chinese herbal medicines in
China. But what component play the important role are still not very clear. With an organ culture
model of mouse vibrissa follicles we investigated the length of hair growth, morphological change
of the bulb, and 3 TdR incorporation in the follicles that were cultured with the decoctions of 55
Chinese herbal medicines, The results demonstrated that the hair growth were significantly
stimulated in the follicles cultured with ligustrum lucidum (A), angelica dahurica (B), bletilla
striata reichb (F), schizonepeta tenuifolia (B), astragalus mombranaceus (B), astragalus
complanatus (R), glycyrrhizic acid repectively (r<O.O5). These results were supported with the
data obtained from the tests of 3H-TdR incorporation. Further more, the experiment also found that
ligustrum lucidum (A), angelica dahurica (B) and bletilla striata reichb (F) deceased catagen
formation and reduced the number of apoptosic (TUNEL positive) cells in mouse hair follicles in
in vivo, when mice were fed with the decoctions of the herbs. In order to make the insights into the
specific molecular mechanisms of the Chinese herbs, suing the approach of RT-PCR, we
investigated the mRNA expressions of HGF and VEGF in follicles which were cultured with the
Chinese herbs. The results show that at day 4 of culture the steady-state levels of HGF and VEGF
were significantly higher in the herbs treated mouse vibrissae follicles than that in vehicle-treated
controls. We demonstrate that some of these 55 Chinese herbal medicines stimulates hair growth
of normal mouse vibrissae hair follicles or skin hair follicles by stimulating proliferation and
inhibiting apoptosis of hair follicle cells in vitro or in vivo, and that it effects mRNA expression
levels of HGF, \7EGF, which might contribute to the clinically observed hair growth-promoting
effects of the Chinese herbal medicines.  These results have furnished the information to develop
new medicines for hair disorder.
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Influence of age of the patient, type of the disease and site of the procedure on outcome of
epidermal grafting in vitiligo  
S Gupta and B Kumar Dept. of Dermatology, Postgraduate Institute of Medical Education and
Research, Chandigarh, India
The success of epidermal grafting may be influenced by various factors which have not been
studied to date.  The objective of the study was to determine the influence of age of the patient,
location of vitiligo patch and type of the disease on the outcome of the procedure in our patients
and in data derived from literature analysis.  Epidermal grafting was performed in patients with
stable vitiligo.  All published studies of SBEG in vitiligo involving 10 or more patients were
included in analysis.  Procedure was performed in 143 patients.  However, the sufficient length (6-
months) of follow-up was available in only 117 patients; only these patients were included.  Only
limited information was available about various factors in majority of the published studies.  The
success rates for vulgaris disease in the present study and literature were 53% (C.I. 42-64) and 91%
(C.I. 81-100) and for segmental/focal disease 61% (C.I. 46-76) 88% (C.I. 82-94) respectively.  The
success rates in patients aged <20 years in present study and literature were 82% (C.I. 67-97) and
100% respectively and in <21 years were 58% (C.I. 48-68) and 66% (C.I. 56-76) respectively.
There was no significant difference in the success rates on different body sites.  Among adverse
reactions, hyperpigmentation in 32%[24-40] and 17%[14-20], infection in 6%[2-10] and 0%[0-0],
and contact dermatitis in 1%[0-3] and 1%[0-2] patients were observed in present study and in
analyzed literature respectively.  The results were significantly better in segmental/focal vitiligo
than in vulgaris, and in individuals <20 years of age than in >20 years of age.  However, unlike in
medical therapies, the site of treated vitiligo patch did not influence the treatment outcome. 
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Nitrogen-containing biphosphonates inhibit cell cycle progression in human melanoma cells
A-M Forsea, C Miller, C Riebeling, CE Orfanos and CC Geilen 1st Clinic of Dermatology,
Colentina Hospital, “Carol Davila”; University of Medicine and Pharmacy, Bucharest, Romania;
Dept. of Dermatology, University Medical Center Benjamin Franklin, Free University of Berlin,
Germany
Cutaneous melanoma is one of the most malignant human tumours, due to hits high metastatic
potential and its resistance to classical chemotherapy regimens.  Therefore, new therapy
alternatives for melanoma are needed.  Biphosphonates are potent inhibitors of bone
demineralization, widely used for the treatment of osteoclast-mediated resorptive bone disorders,
including tumor-induced osteolysis osteolysis. Recent studies suggest that bisphosphonates may
also have a direct antiproliferative and proapoptotic effect in different types of human tumor cells.
The inhibition of the mevalonate pathway and, consequently, of the prenylation of signalling
proteins such as the small GTPases may explain this antineoplasic action in the case of the subclass
of nitrogen-containing bisphosphonates.  The present study compared the in vitro effects of
bisphosphonates with different mechanism of action and different antiresorptive potency on human
melanoma cell lines. The non-aminobisphosphonate clodronate and two amino -bisphosphonates,
pamidronate and zoledronate were analyzed. We could show that the amino -bisphosphonates
inhibited the proliferation of melanoma cells and altered the cell cycle progression, causing
accumulation of the cells in the S phase of the cell cycle. These effects were dose-dependent.
Amino -bisphosphonates also induced apoptosis in the melanoma cell lines in dose-and time-
dependent manner. In contrast, the nonamino-bisphosphonate clodronate showed no effect on
proliferation, cell cycle progression and apoptosis induction in melanoma cells.  These findings
prove a direct antitumoral effect of bisphosphonates in melanoma cells it/ vitro and further support
the hypothesis of different intracellular mechanism of action for amino- and non-amino-
bisphosphonates. Our data suggest that amino -bisphosphonates may be a promising alternative for
the adjuvant therapy of melanoma.
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Benign cephalic histiocytosis: two case reports
A Cruz, J Victoria, R Rueda and J Parra Universidad del Valle, Cali, Colombia
Benign cephalic histiocytosis is a rare, self-healing, non-Langerhans cell histiocytosis,
characterized by a popular and macular eruption mainly located on face and cheeks.  It was first
described by Gianotti et al in 1971 and until now, 40 cases have been reported.  We report two
patients, an 8 and 22 month-old boys, with a 2 and 10 month course, consisting on an
asymptomactic, slightly raised, round, brownish papules on the face and shoulders.  Oral mucosa
was spared and there was no evidence of lymphadenopathy or hepatosplenomegaly.  For both
patients haematologic blood test and X-ray of skull were normal.  The skin biopsy for both
specimens revealed a histiocytic infiltrate with few multinucleated gaint cells with peripheral
nuclei.  The lesional cells were CD1a and S-100 negative in the 8 month-old boy.  Ultraestructural
studies were performed on both patients, and comma-shaped intracytoplasmic structures were
found in histiocytes of the second patient, confirming the diagnosis.  As benign cephalic
histiocytosis is a self-healing entity, with no systemic associated disease, no treatment is needed
beside regular medical follow-up
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Use of sunscreens by Brazillian universitarian students
TCDB Irikura, MTF Carvalho and S Irikura Dept of Dermatology, University Federal of Juiz de
Fora, Brazil
Several authors have demonstrated an improvement in the cases of skin cancer in the world.  The
exposure of ultraviolet radiation is considered the main etiologic factor in these lesions.  The
correct use of sunscreens is one of the methods of protection of skin against the harmful of the
ultraviolet radiations.  Every tear the Dermatology Brazilian Society realizes a campaign of skin
cancer prevention.  Our aim was evaluate if Brazilian universitarian students had knowledge about
the risks of ultraviolet radiation exposure, through of reduce the solar exposure and improve the
daily use of sunscreens.  
We interviewed 44 Brazilian universitarian students, asking about the frequency of solar exposure
in daily frequency activities, during the practice of exercises or during tanning. We also asked about
daily frequency of the sunscreens.  The mean age of the students was 22,25.  About the frequency
of solar exposure in daily activities, 9% answered never, 75% answered sometimes and 16%
answered frequently.  About the solar exposure during practice of exercises 59% answered
sometimes and 41 % answered never.  About the intention of tanning 5% answered frequency  65%
answered sometimes and 30% answered never.  About the daily frequency use of sunscreens 66%
don’t use anytime, 18% once, 14% twice and 2% three times a day.  We conclude that in spite of
the  Education campaigns the frequency of solar exposure is still high by Brazilian universitarian
students and the most of them don’t use sunscreens.
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Outcome of mucosal lesions in pemphigus vulgaris treated with conventional or both with
conventional and pulse steroids—an analysis of 97 patients
B Kumar, R Jain, I Kaur and S Handa Postgraduate Institute of medical Education and Research
Chandigarh
AIM: Mucosal lesions in pemphigus vulgaris- Response to conventional and pulse steroids.
Material and Methods: Mucosal lesions of PV were divided in 2 groups.  Pure mucosal pemphigus
(Group1) were treated with daily oral conventional steroids whereas mucosal lesions in
mucocutaneous variety (Group II) were treated with dexamethasone-cyclophosphamide pulse
(DCP) and oral steroids added only if DCP alone failed to control activity of disease.  Severity of
mucosal disease was graded as follows: Grade I-(<2 oral mucosal areas and no eating difficulty),
Grade II- (<2 oral mucosal areas with difficulty in taking solids) & Grade III (< 2 mucosae involved
and severe eating difficulties).  Treatment continued for 3 month after total healing.  Remission
defined as free of mucosal lesions for 1 year. Results: Group I had 29 patients & mean duration of
mucosal lesions was 6.8 months.   Mean dose of oral prednisolone to cure Grade III mucosal
lesions was 31.6 mg/day for a mean of 38.8 wks and for Grade II was 25mg/day for 24.1 wks.
Group II had 68 patients with mucosal lesions of mean duration of 5.4 months.  In Group II, to cure
Grade III lesions, in addition to a mean of 12.6 DCPs, mean dose of 25mg/ day prednisolone for a
mean of 33.7 wks was required.  Grade II lesions in Group II required, in addition to a mean of
10.3 DCPs, a mean dose of 15mg/day prednisolone for a mean of 21.7 wks to heal.  Grade I lesions
responded to DCP alone.  DCP alone failed to treat 9 patients with pure mucosal lesions & shifted
to Group I.  14 patients of Group II, treated with DCP alone, had mucosal lesions when DCP was
withdrawn, & were treated with prednisolone.  Remissions were more and of longer duration in
Group I.  40% relapse rate was equal in both groups.  Conclusion: Mucosal lesions of moderate to
severe intensity (Grade II & III) Respond only to oral prednisolone with or without DCP.  DCP
alone can cure mild i.e. Grade I mucosal lesions.  Daily oral prednisolone is better mode of therapy
to treat puremucosal pemphigus.
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Experimental contact sensitivity: a model for both antigen(hapten)-specific and innate
immune mechanisms
L Kandolf-Sekulovic1´2, M Kataraanovski2 and G Milojevic2 Dept. of Dermatology, Institute for
Medical Research2, Military Medical Academy, Belgrade, Yugoslavia
Introduction: It was shown that in contact hypersensitivity reaction (CHS) not only antigen-
specific but also proinflammatory effects of haptens contribute to the elicitation of CHS,
highlighting the importance of mechanisms of innate immunity.  In the present study, experimental
model of contact sensitivity to dinitrochlorobenzene (DNCB) in inbred AO rats was employed to
determine both antigen (hapten)- specific as well as parameters of antigen-non-specific aspects  of
CHS response.  Methods: Ear swelling assay and dermal infiltrate density were employed for
quantification of CHS reactions.  Draining (axillary and suprascapular) lymph node cell activity
and phenotype were determined 72 h following sensitization.  Peripheral blood granulocytes
activity was determined 24 h following challenge.  Resulte: Following local epicutaneous
application for 2% DNCB, increased spontaneous, hapten-stimulated and interleukin (IL)-2-driven
draining lymph node cell (DLNC) proliferation was detected, reflecting the antigen (hapten)-
specific aspect of CHS.  At the dose of DNCB employed for the elicitation of CHS in sensitized
animals, increased activity of peripheral blood granulocytes (including activation, adhesion and
cell survival) was detected.  Conclusion: Collectivelly, these data demonstrate the activation of
both antigen (hapten)-specific and inmate immunity in CHS reaction, and importance of studying
both aspects of reaction in the same animal model.
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The antineoplastic skin protection in patients with psoriasis
K Kolyadenko Dept. of Dermato-Venerology, National Medical University, Kiev, Ukraine
Psoriasis is a chronic recurrent inflammatory dermatosis.  The mitotic cycle of epidermal cells in
this disease is reduced from 311 to 36 hours and ceratinocytes are formatted 36 times more than in
normal skin.  The high level of mitosis assists the appearance of mutation cells which even in a
healthy organism formed nearly 10mln.every minute.  The formation of mutation cell in psoriasis
can also rise up after applying for treatment high UVR doses.  The first information that skin cancer
might be due to light, came from Unna in 1894.  Taking into account above mention data it is
possible came to the conclusion that psoriasis patients have higher than normal occurrence of skin
cancer.  However it does not occur.  Moreover, psoriasis has fewer carcinomas of the skin than the
nonpsoriatics.  Paul H. Jacobs (1974) observed that the psoriasis patients were less likely to develop
skin cancer than the nonpsoriatics population.  Catamnesis, that we performed in 350 patients with
psoriasis, who were systematically treated hypererytematous UVR doses from 10 o 30 years in
Kiev Dermatology Department (National Medical University), did not reveal any negative effects
to the skin.  We purposed to determinate the cell and hum oral immunity indexes, that can take part
in the antineoplastic protection.  The investigations were conducted using a three color flowing
cytometry.  The immunological examinations we performed in 29 patients with psoriasis revealed
higher levels of CD4+(52,16 ± 0,44%vs. 45,09 ± 0.32% in control), CD8+(47,12 ± 0,15% vs. 35,41
± 0,72 in control), CD22+(25,15 ± 2,02% vs. 14,50 ± 1,32% in control ) and NK (CD16) (23,65 ±
0,57 vs. 17,3 ± 0,32% in control).  We also revealed higher level of TNF.  Taking into account our
research and the literature data we can came to the conclusion that in psoriasis antineoplastic
protection is formatted in  skin by the  reason  of higher levels of CD4+, CD8+, CD22+, NK and
TNF that carry out antineoplastic function in the skin.  Therefore using the immunosuppressant
drugs in psoriasis can be dangerously, because they suppress antineoplastic function
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Clinical and histopathological characteristics of striae distensae
V Kozlovskaya Dept. of Dermatovenereology, Vitebsk State Medical University, Belarus
Introduction: Striae distensae is a common skin dermatosis that does not cause any significant
medical problem.  However, they can be a symptom of serious endocrinologic diseases that should
be treated by endocrinologists.  Striae may be predictors of collagen deficiency, especially in
pregnants.  Above all, they can be significant distress to those afflicted.  The pathogenesis and
management are not fully understood.  Materials and Methods: We performed a prospective study
of 72 men called for military service in Vitbsk Dermatological Hospital aged 23 till 27 during
1999-2002.  We studied case histories, performed physical examination, laboratory analysis of
blood and urine, made 10 punch biopsies with histopathological examination of atrophic skin using
hematoxilin-aeosin and Hart’s staining.  Results: On physical examination was reveled that striae
looked as flattened, thinned skin with a pink hue.  9% has reddish – purple striae.  They were
generally several centimeters long and 1-100 millimeters wide.  Their long axis usually layed
parallel to the lines of the skin tension.  Histopathological picture was characterized with apoptosis
of the epithelium cells.  Capillares looked desolate and were absent in some regions.  Elastic fibers
were destroyed.  Sweat glands and hair were solitary and defected.  Concomitant skin pathology
was revealed in 24 patients (33,3%).  Mixed pathology was found in 10 patients (14%).  The most
frequent skin pathology included- acne (8,3%), palmar and plantar hyperhydrosis (6,9%), tinea
pedis (4,2%), pityriasis versicolor (4,2%).  It was necessary to consult an endocrinologist in 17
patients (23,7%).  The diagnosis of diencephalic syndrome was confirmed in 12 patients (16,7%),
Cushing’s syndrome in 4 patients (5,6%), using specific laboratory and instrumental examinations.
1 patient (1,4%) used anabolic steroids during 2 months.  Conclusion: So we can conclude that
striae is not occasional finding and cosmetological problem but an important diagnostic criterion
that needs special attention and treatment of accompanying pathology.  Histologically striae
represent an example of skin atrophy.  New methods of treatment and cosmetological correction
should be developed to mange patients with extended Striae.
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Gene detection of tetracycline resistance determinant (tetM) and susceptibility determination
to antimicrobial agents in Ureaplasma urealyticum
D Luo, Y Xu, WY Zhu and WY Xu Dept. of Dermatology, the First Affiliated Hospital, Nanjing
Medical University, Nanjing, China
There is an increasing tendency of Ureaplasma urealyticum (Uu) detection in the patients with
chronic and recurrent nongonococcal urethritis (NGU) in China, which may be related to the
Antimicrobial resistance.  For Uu, tetracycline resistant determinant (tetM) may play an important
part in antimicrobial resistance.  To determine and compare the MICs of Uu to those 7 kinds of
antimicrobial agents with the tetM detection rate, 551 specimens of urogenital discharges from
high risk populations of STD were screened for detecting tetM determinants by PCR.  A 392 bp
fragment corresponding to the tetM determinant was amplified and PCR products were digested by
Taq-1 restrictive endonuclease.  Also forty-two Uu isolates were subcultured for 3 passages and
then incubated with screening agents with a series of concentrations from 64ug/ml – 0.06ug/ml.
The MICs were determined after 72-hours.  The results showed that the detection rate for tetM was
higher (71.4%, 30/42) in Uu isolates than that of high risk populations (36.84%, 203/551).  Most
positive tetM determinants produced 3 cleaved fragments (190, 130 and 77 bp) after digested with
Taq-1 endonuclease.  MIC study showed the susceptibility of Uu to Tetracyclines decreased.  There
were no Uu isolates resistant simultaneously to all 3 antimicrobial agents tested, including
tetracyclines, macrolids and quinolones in the study.  Taken together, the susceptibility of Uu
isolates to the tetracyclines was low and the MIC distribution to antimicrobial agents may be
related to the detection rate of tetM determinant.  Uu isolates carrying tetM tetracycline-resistant
determinant may have a risk of developing drug resistance and should be followed for MIC
determination.  The special different endonuclease digested patterns of tetM determinants may be
existed in some Uu strains.
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Alterations of basement membrane zone in lichen sclerosus
W Mackiewicz, M Zawadzka, A Kozlowska and C Kowalewski Dept. of Dermatology, Warsaw
University School of Medicine, Warsaw, Poland
The aim of the study was to compare alterations of various regions of the BMZ in lichen sclerosus
(LS) using laser scanning confocal microscopy.  The study included two cases of bullous LS and
four cases of non-bullous LS.  Three cases of morphea as well as normal human skin were used as
controls.  Biopsies from patients’ skin and a control biopsies from normal human skin were cut into
20 um thick slides and labeled with antibodies against beta-4 integrin (lamina lucida marker),
collagen IV and N-terminal end of collagen VII (lamina densa markers) and C-terminal end of
collagen VII (lamina densa markers) and C-terminal end of collagen VII (sublamina densa marker)
using routine immunofluorescence (IF).  Three-dimensional reconstruction of various regions of
BMZ showed decreased number and size of the dermal papillae in LS as compared to normal skin.
In LS numberous invaginations and holes were present in BMZ on the level of lamina lucida and
lamina densa.  IF labeling with antibody against N-terminal end of collagen VII - presence of large
hole (up to 25 µm) in the lamina densa and revealed the presence of granular material in deep dermis
suggesting for partial degradation of lamina densa at the level of anchoring fibers.  IF mapping study
showed blister formation below the lamina densa.  In morphea, flattening of BMZ on the level of
lamina lucida, lamina densa and sublamina densa were observed but continuous character of BMZ
was preserved.  Three-dimensional reconstruction of dermal-epidermal junction in LS revealed
alterations of the BMZ, most pronounced at the level of lamina densa and sublamina densa..
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Skin organ culture in the evaluation of contact hypersensitivity reaction intensity
ZP Mijuskovic, *M Kataranovski and *G Milojevic Division of Immunodermatology, Dept. of
Dermatology, * Institute for Medical Research, Military Medical Academy, Belgrade, Yugoslavia
Introduction: Contract hypersensitivity (CHS) is a local inflammatory response of the skin following
challenge of hapten-sensitized animals.  The intensity of inflammatory could be quantitated by ear
swelling which is the classical manifestation of contact hypersensitivity. In this study-organ culture
system was employed to evaluate CHS.  Methods: Rat model of contact hypersensitivity to
dinitrochlorobenzene (DNCB) was employed.  Levels of TNF-α (determined by ELISA) and nitrite
accumulation (by Griess assay) were determined in conditioned medium (CM) of ear skin following
challenge with DNCB.  Result: Dose-dependent increase in TNF-a and in nitrite levels were noted in
CM following application of 0.65%, 1.3 % and 2.6% of DNCB to the ears of sensitized rats.  The
correlation between ear swelling and the levels (r=0.79, p<0.001 ) was found.  Conclusion: Presented
data suggest that this skin-organ system might be employed for evaluation of contact
hypersensitivity.
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Novel mutation of the ATP2CI gene in aHungarian patient with Hailey-Hailey disease
inducded by contract allergens  
E Racz, M Ciskos, E Temesvari, Gy Ponyai and S Karpati Dept. of Dermatology, Venereology,
Semmelweis University, Budapest, Hungary
Benign familial chronic pemphigus (morbus Hailey-Hailey, HHD) is a rare hereditary condition
characterized by development of blisters at sites of friction and in the intertriginous areas.  A 57-
year-old Hungarian women presenting with clinically typical HHD was studied.  The diagnosis was
confirmed by skin histopathology.  The family history was negative for skin disease.  Her skin
symptoms started at the age 31 and we speculated whether the skin disease has been induced also
by contact allergens.  A contact sensitivity to fragrance mix, PPD, iodine, tar, wood-tar was proved
by epicutan patch testing. Histology taken from the positive patch test showed a contact dermatitis
accompanied by extended suprabasal acantholysis typical for HHD.  DNA was isolated from
peripheral blood lymphocytes of the proband according to standard techniques.  PCR amplification
of the entire coding region of the ATP2CI was followed by a heterpoduplex analysis of the 28
amplified exons in a conformation –seneitive 8% acrylamid gel.  Bands of altered mobility detected
by heteroduplex analysis were directly sequenced and revealed a novel heterozygous nonsense
mutation, 1516C-T, Q506X in exon 17 of ATPC1.  The presence of the mutation was confirmed in
the proband by restriction digestion (Tse I).  These new mutations are located in the region
encoding the nucleotide-binding (N-) domain of the Golgi Ca2+ ATPase and represent a premature
termination codon (PTC). As a consequence, mRNA is probably degraded rapidly by a nonsense-
mediated mRNA decay pathway.  This study proves that vivo induced pathogenic activity of T
lymphocytes leads to pathologic desmosome and keratin network assembly in keratinocytes
carrying the Q506X mutation on one allele of the ATP2CI gene encoding a novel calcium pump
localized to the Golgi.
1277
Efficacy and safety of cyclosporine versus methotrexate in severe psoriasis
K Sandhu Chandigarh, India
Treatment of patients with severe psoriasis is difficult. From the number of systemic drugs that are
available, methotrexate has long been used, but cyclosporine has been recently recommended for
the management of severe psoriasis. The purpose of this study was to compare the efficacy and
safety of daily cyclosporine with weekly methotrexate in the management of severe psoriasis.
Thirty consecutive patients with severe psoriasis were randomly assigned to treatment with
cyclosporine or methotrexate. The initial dose of cyclosporine was 3mg/kg/day, which was
increased to a maximum of 4mg/kg after two weeks of therapy when the response was not
adequate. Methotrexate was administered weekly at a dose of 0.5mg/kg. Clinical response was
assessed by calculating PASI score in all patients at biweekly intervals. Patients were followed up
fortnightly up to a maximum of 12 weeks. The doses of both drugs were gradually tapered once
>75% reduction in disease severity was attained.  Marked improvement (>75%) reduction in PASI
was noted in all patients except for one in the cyclosporine group. The median time for marked
improvement was 5.3 weeks with methotrexate and 6.8 weeks with cyclosporine. Patients on
methotrexate were found to have more rapid and complete clearance than those on cyclosporine.
Both drugs were well tolerated. Side effects in both the treatment groups were minor, transient, and
manageable.  At doses with comparable safety profiles, methotrexate resulted in more rapid and
cost effective clearance of patients with severe psoriasis. Cyclosporine can provide an effective and
safe alternative. 
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Body site distribution of cutaneous tumours in Chile.  Analysis of 4800 tumours from five
mayor hositals in Santiago  
S Ruiz-Tagle, J Roa, V Zelmelman and JF Honeyman Dept. of Dermatology, University of Chile,
Santiago, Chile
The last 10 years have shown an increase of skin cancer incidence rates in Santiago.  The purpose
of this study was to analyse the anatomical localization of 4,800 shin tumours.  For this purpose,
600,000 histophological reports (1992-2001) from 5 hospitals belonging to the Chilean Health
Service Program were reviewed.  These hospitals covered approximately a population of 2 million
people.  A total of 568 Malignant Melanoma (MM), 1,021 Squamous Cell Carcinoma (SCC) and
3,212 Basal Cell Carinoma (BCC) were studied.  Chi square test was used for the statistical
analysis.  MM in females was mainly found on legs (23%), cheeks (19.7%) and foot (13.5%);
however, MM in male was mainly observed on foot (29.2%), truck (16.5%), arms (16.5%).  SCC
in females was mainly observed in middle face-area (19.2%), cheeks (16.7%) and genital area
(11.8%); SCC in male was also mainly observed in middle face area (12.9%), genital area (11.2%)
ears (10.2%).  BCC in females and males was mainly observed in the middle face-area (34.1%),
cheeks (27.4%), and eyelids (10.3%).  Female showed significantly higher number of MM on the
cheeks and on the legs than males, however, males showed significantly higher number of MM on
the foot.  Regarding age, patients over 50 years old showed higher number of MM in the face than
those younger than 50 years old (p<0.05).  Facial MM and facial BCC (p<0.05) show increase in
the studied decade; however, SCC in the face tend to decline (p<0.05).  The number of BCC and
SCC was significantly higher in the face than in rest of the body, the opposite is observed in MM.
Regarding the Breslow Index (BI) m the MMs located in the face, truck, and legs were mainly BI:
I; however, MMs located in arms, feet and soles were mainly BI: III and IV.  These results are
interesting, show concordance and differences with those reported in the literature.  Genetics,
environmental conditions and lifestyle factors mat explain these findings. 
1274
Analysis of the IgG response to recombinant HSP of 60 kDa from Streptococcus pyogenes,
human Gro-EL-like and  K. pneumoniae in psoriatic patients and controls and analysis of
the IgG response  to the rHSP60 of S. pyogenes in psoriatic patients before and during
treatment with cyclosporine and its correlation with PASI
G Paredes-Cabrera1, 2 , E García-Latorre1, L Jiménez-Zamudio1, ME Cancino-Díaz1, L Domínguez-
López1 and G León-Dorantes2  1Departamento de Inmunología, Escuela Nacional de Ciencias
Biológicas, Instituto Politécnico Nacional, Carpio y Plan de Ayala, México,2Servicio de
Dermatología, Hospital General de México SSA, México
Psoriasis is a cutaneous disease in which the most associated factor in the ethiopathogenesis is
streptococcal infections. The presence of IgG antibodies to S. pyogenes recombinant 60kDa heat
shock protein (rHSP60Sp) in plaque psoriatic patients has been described. There are no data of the
humoral response neither to other rHSP60kDa nor to the rHSP60Sp in psoriatic patients under
treatment, nor its association to the degree of severity during their clinical course.  Objective: The
aim was to measure the humoral response in psoriatic patients and controls to three different
recombinant heat shock proteins of 60kDa: S. pyogenes, human, and K. pneumoniae; and
determine the levels of IgG antibodies to rHSP60Sp and human GroEL-like in psoriatic patients
under cyclosporin treatment in correlation with PASI.  Design: Cases and controls and longitudinal
study.  Material and Methods: By ELISA we measured levels of IgG antibodies to rHSP60 of S.
pyogenes, human, and K. pneumoniae in 24 sera of psoriatic patients, 24 sera of healthy controls
and 24 of patients with ankylosing spondilytis; and levels of IgG antibodies to rHSP60Sp and
human in 100 sera of 28 patients with active plaque psoriasis, under cyclosporin treatment to
establish correlation with PASI. Results were analyzed estimating odds ratios with 95% confidence
intervals and RR value for the case and controls study and Spearman and Pearson’s correlation
coefficients for the longitudinal study.  Results: Plaque psoriasis patients had significantly higher
titers of IgG antibodies to the rHSP60Sp than controls (odds ratio: 17, RR:3.4, 3.7-72.9). The
correlation between antibody levels and PASI showed a positive correlation.
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Combined mutations in keratin 5 and keratin 14 genes causing epidermolysis bullosa
simplex-dowling meara
N Trisnowati13, S Klingberg, 2 L Lloyd, 2 Y Wang, 3 GAC Murrell and 3DF Murrell  1Dept. of
Dermatology, Gadjah Mada University, Yogyakarta, Indonesia;  2Dept. of Chemical Pathology,
Royal Brisbane Hospital, Brisbane, Australia;  3Orthopaedic Research Institute & Department of
Dermatology, St. George Hospital; and University of New South Wales, Sydney, Australia
Most cases of Epidermolysis Bullosa Simplex (EBS) are inherited in an autosomal dominant
fashion caused by 1 heterozygous mutation in the genes encoding keratin 5 (KRT5) and keratins
14 (KRT14).  However, here we report 2 mutation, E168D in KRT5, Which is a novel mutation,
and A413T in KRT14, both occurring in a patient with  EBS-Dowling Meara (EBS-DM) and her
EBS –affected daughter.  We studied a 3 generation non-consanguinous family in which the
proband and her daughter had different severities of EBS.  The clinical appearance in the proband
was more severe when she was a baby but improved significantly with age.  The daughter has only
blisters on the fingertips and at excoriation sites or the father of the proband’s baby who were all
clinical normal.  A long range3 PCR system was used to avoid amplifying KRT14 pseudogenes and
to increase the fidelity of the PCR products.  Screening of 50 unrelated normal controls (100
alleles) did not demonstrate either mutation.  These mutations are unlikely to be polymorphisms
and highly likely to be pathogenic.  KRT14-A412T has been reported in EBS-Koebner.  Hence,
KRT5-E168D could be increasing the effect of KRT14-A413RT resulting in EBS-DM in the
proband.  However, the daughter’s milder phenotype could be due to variable gene expression. 
ABSTRACTS THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
1279
Regulation of vascular endothelial growth factor expression in human keratinocytes by
several antipsoriatic drugs
H Zhou, Y Chen, X Li and J Zheng Institute of Dermatology, Peking Union Medical College and
Chinese Academy of Medical Sciences, Nanjing, China
Vascular endothclial growth factor is vital in the pathogenesis of psoriasis for the proinflammation
and proangiogenesis effects.  Keratinocytes is the major resource of VEGF in skin.  We investigate
if the potent anti-psoriatic properties of tretinoin, calcipotrial, cyclosporine and anthralin are
attributed in part to their interference with the regulated VEGF expression by keratinocytes.  It was
reported that retinoids could down-regulated VEGF expression in cultured human keratinocytes,
we examined tretionoin in this experiment as positive control drug.  The effect of anti-psoriatic
drugs on growth- factor- induced VEGF production by primary keratinocytes were examined at
mRNA levels.  Both tretinoin and calcipotriol were shown to suppress VEGF mRNA expression in
a dose-dependent manner.  While cyclosporine had no inhibitory effect on the VEGF production at
both mRNA and protein levels.  However, the classical anti-psoratic drug anthralin was shown to
up-regulate the expression VEGF mRNA, explaining the possibility of irritation when anthralin
was applied to skin.  Together, these studies identify VEGF down –regulation by keratinocytes as
a possible target of some anti-psoriatic drugs action in psoriasis.
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A long-term evaluation in post-burn scars in patients receiving growth hormone
GV Oliveira, KD Murphy, HMO Oliveira, JP Wilkins, DL Chinkes, RE Barrow and DN Herndon
Federal University of Minas Gerais, Brazil and Shriners Burns Hospital, Galveston, TX
The hypercatabolic state after massive burns has been effectively treated with anabolic agents, such
as human recombinant growth hormone, which stimulate protein synthesis and decrease growth
retardation in burned children.  Interest in the hypertrophic scar formation became a concern after
animal studies showed that growth hormone increased renal scarring.  A previous study showed
that the treatment of severely burned children with growth hormone during the acute-phase hospital
stay did not increase scarring of the burn wound, but the formation of hypertrophic scars, however,
are known to occur three to twelve months after injury.  The aim of this study was to evaluate
patients who received human recombinant growth hormone (0.5 mg/Kg/day) for an increase in the
incidence of hypertrophic scar formation compared to patients receiving placebo.  A retrospective
study was designed to evaluate scarring in patients randomly distributed to receive injections of
recombinant human growth factor in the dose of 0.05 mg/kg/day from the discharge date until one
year post-burn and patients who received placebo injections.  A scar on the face was scored using
two different scar scales to evaluate close-up view photographs, taken months 3, 6, 9, 12 and 18 to
24 after burn.  The scars were scored by three knowledgeable observers and a mean value
calculated for comparisons.  No significant difference for the total score of both scales.  The
evaluation of each parameter was made separately and no significant difference was observed for
each parameter.  Other ethiopathogenic factors may contribute to the hypertrophic scar formation,
and should not be considered a limit for the administration of recombinant growth hormone as a
therapeutic approach in burned children.
